data_2jx2_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 2jx2 _Structure_validation_residue.Date_analyzed 2016-10-07 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 40.8 t-20 . . . . . 0 N--CA 1.49 1.564 0 N-CA-C 109.423 -0.584 . . . . 0.0 109.423 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 41' ' ' THR . . . . . 0.415 ' O ' HD23 ' A' ' 42' ' ' LEU . 53.2 m -69.54 134.35 48.73 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.27 -0.894 . . . . 0.0 109.595 -179.861 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . 0.559 HD11 ' CD2' ' A' ' 80' ' ' TYR . 16.6 mt -115.63 146.78 41.49 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.252 -0.905 . . . . 0.0 109.372 179.97 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 43' ' ' TYR . . . . . 0.447 ' O ' ' HA ' ' A' ' 105' ' ' VAL . 74.4 t80 -97.33 124.08 41.35 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.246 -0.908 . . . . 0.0 109.551 -179.977 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 44' ' ' VAL . . . . . 0.527 ' CG1' HD23 ' A' ' 103' ' ' LEU . 53.4 t -120.84 134.49 64.09 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.558 0 O-C-N 121.274 -0.891 . . . . 0.0 109.401 179.897 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 76.3 t80 -124.25 137.21 54.54 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.241 -0.912 . . . . 0.0 109.524 -179.876 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -178.23 -177.5 46.99 Favored Glycine 0 N--CA 1.491 2.302 0 N-CA-C 109.465 -1.454 . . . . 0.0 109.465 -179.989 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . 0.422 ' O ' ' C ' ' A' ' 48' ' ' ASP . 95.2 mt-10 -118.68 155.25 31.37 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.272 -1.134 . . . . 0.0 109.482 179.957 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 48' ' ' ASP . . . . . 0.422 ' C ' ' O ' ' A' ' 47' ' ' GLU . 47.6 m-20 43.89 48.01 7.02 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.282 -0.886 . . . . 0.0 109.54 179.961 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 58.5 mtm -93.26 143.31 26.38 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.208 -0.932 . . . . 0.0 109.509 179.954 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 50' ' ' THR . . . . . 0.484 ' O ' ' CD1' ' A' ' 54' ' ' LEU . 0.1 OUTLIER -118.42 166.29 14.25 Favored Pre-proline 0 N--CA 1.491 1.577 0 O-C-N 121.236 -0.915 . . . . 0.0 109.421 179.98 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 49.6 Cg_endo -70.02 -50.47 0.43 Allowed 'Trans proline' 0 C--O 1.214 -0.678 0 C-N-CA 122.713 2.275 . . . . 0.0 111.819 -179.916 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 39.8 m -58.55 -42.16 87.23 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.243 -0.911 . . . . 0.0 109.516 179.976 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 15.2 tp -61.31 -50.86 71.26 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.253 -0.905 . . . . 0.0 109.481 179.986 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 54' ' ' LEU . . . . . 0.484 ' CD1' ' O ' ' A' ' 50' ' ' THR . 4.2 mt -59.92 -42.75 94.58 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.232 -0.917 . . . . 0.0 109.442 179.954 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 55' ' ' ARG . . . . . 0.457 ' O ' ' CB ' ' A' ' 59' ' ' SER . 48.7 ttt85 -57.19 -32.93 66.95 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.217 -0.927 . . . . 0.0 109.433 179.908 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -76.21 -33.09 50.33 Favored Glycine 0 N--CA 1.49 2.259 0 N-CA-C 109.403 -1.479 . . . . 0.0 109.403 180.0 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . 0.551 ' O ' ' CD1' ' A' ' 61' ' ' PHE . . . -73.14 -19.75 61.06 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.314 -1.11 . . . . 0.0 109.411 -179.998 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 58' ' ' PHE . . . . . 0.629 ' CZ ' ' CD1' ' A' ' 93' ' ' LEU . 96.7 m-85 -121.62 4.37 10.1 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.211 -0.931 . . . . 0.0 109.482 179.914 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 59' ' ' SER . . . . . 0.514 ' N ' ' HD2' ' A' ' 60' ' ' PRO . 0.3 OUTLIER -72.21 -57.31 3.78 Favored Pre-proline 0 N--CA 1.49 1.546 0 O-C-N 121.215 -0.928 . . . . 0.0 109.762 -179.859 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 60' ' ' PRO . . . . . 0.514 ' HD2' ' N ' ' A' ' 59' ' ' SER . 48.9 Cg_endo -69.52 -30.93 22.59 Favored 'Trans proline' 0 C--O 1.214 -0.678 0 C-N-CA 122.637 2.225 . . . . 0.0 111.94 -179.818 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 61' ' ' PHE . . . . . 0.562 ' CD2' ' HA ' ' A' ' 89' ' ' ALA . 62.6 m-85 -62.92 -33.01 74.42 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.241 -0.912 . . . . 0.0 109.455 179.974 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 173.39 -175.47 46.16 Favored Glycine 0 N--CA 1.49 2.264 0 N-CA-C 109.411 -1.476 . . . . 0.0 109.411 179.985 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 38.7 t30 -92.22 141.4 28.62 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.266 -1.138 . . . . 0.0 109.506 179.961 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 64' ' ' ILE . . . . . 0.451 HG23 ' HB2' ' A' ' 67' ' ' LEU . 71.4 mt -103.83 130.04 54.99 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.521 0 O-C-N 121.246 -0.909 . . . . 0.0 109.432 179.98 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 65' ' ' ILE . . . . . 0.524 ' CG1' HG22 ' A' ' 79' ' ' THR . 20.6 pt -94.54 -21.95 5.63 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.537 0 O-C-N 121.252 -0.905 . . . . 0.0 109.475 179.983 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 45.7 t0 -159.26 109.43 1.95 Allowed 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.277 -0.89 . . . . 0.0 109.508 -179.969 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . 0.491 HD11 ' CG1' ' A' ' 78' ' ' VAL . 0.6 OUTLIER -111.96 122.34 47.51 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.259 -0.901 . . . . 0.0 109.367 179.937 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 38.1 m -117.94 150.78 38.66 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.235 -0.915 . . . . 0.0 109.637 -179.917 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 69' ' ' MET . . . . . 0.403 ' CE ' ' CD1' ' A' ' 54' ' ' LEU . 85.6 mtp -123.74 143.59 50.2 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.229 -0.919 . . . . 0.0 109.408 179.926 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 70' ' ' ASP . . . . . 0.449 ' C ' ' HD2' ' A' ' 72' ' ' PRO . 1.7 m-20 -122.31 105.88 36.2 Favored Pre-proline 0 N--CA 1.491 1.615 0 O-C-N 121.268 -0.895 . . . . 0.0 109.493 -179.976 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 71' ' ' PRO . . . . . 0.606 ' N ' ' CD ' ' A' ' 72' ' ' PRO . 47.1 Cg_endo -74.54 -27.9 10.52 Favored 'Trans proline' 0 CA--C 1.543 0.941 0 C-N-CA 122.511 2.141 . . . . 0.0 113.686 179.99 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 72' ' ' PRO . . . . . 0.606 ' CD ' ' N ' ' A' ' 71' ' ' PRO . 55.1 Cg_endo -75.41 -29.11 7.93 Favored 'Trans proline' 0 C--N 1.353 0.793 0 C-N-CA 121.511 1.474 . . . . 0.0 111.733 -179.794 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 73' ' ' ARG . . . . . 0.441 ' O ' ' HB2' ' A' ' 74' ' ' ASN . 61.8 mtt-85 -107.89 -4.22 18.18 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.267 -0.896 . . . . 0.0 109.622 -179.919 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 74' ' ' ASN . . . . . 0.441 ' HB2' ' O ' ' A' ' 73' ' ' ARG . 84.5 m-20 61.7 36.41 16.46 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.231 -0.918 . . . . 0.0 109.493 -179.967 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 75' ' ' CYS . . . . . 0.454 ' HA ' ' O ' ' A' ' 44' ' ' VAL . 21.9 p -130.85 137.09 49.22 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.266 -0.896 . . . . 0.0 109.477 -180.0 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -110.28 148.3 32.17 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.264 -0.897 . . . . 0.0 109.421 179.998 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 77' ' ' PHE . . . . . 0.455 ' HA ' ' O ' ' A' ' 42' ' ' LEU . 96.9 m-85 -114.2 132.08 56.24 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.214 -0.929 . . . . 0.0 109.528 179.989 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . 0.491 ' CG1' HD11 ' A' ' 67' ' ' LEU . 39.5 t -123.13 128.9 75.2 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 O-C-N 121.239 -0.913 . . . . 0.0 109.474 179.966 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 79' ' ' THR . . . . . 0.524 HG22 ' CG1' ' A' ' 65' ' ' ILE . 17.5 m -101.18 132.2 46.78 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.245 -0.91 . . . . 0.0 109.437 -179.994 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 80' ' ' TYR . . . . . 0.559 ' CD2' HD11 ' A' ' 42' ' ' LEU . 1.5 m-85 -112.11 145.93 38.91 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.241 -0.912 . . . . 0.0 109.491 -179.942 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 83.4 tt0 -70.9 -28.97 64.93 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.21 -0.931 . . . . 0.0 109.423 179.817 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 44.2 mttm -124.58 145.99 49.29 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.301 -0.875 . . . . 0.0 109.391 179.956 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 83' ' ' MET . . . . . . . . . . . . . 44.1 mtt -64.62 -22.6 67.02 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.241 -0.912 . . . . 0.0 109.468 179.992 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 97.6 mt-10 -69.92 -37.68 76.01 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.204 -0.935 . . . . 0.0 109.525 -179.953 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 85' ' ' SER . . . . . 0.402 ' HB2' ' CG ' ' A' ' 80' ' ' TYR . 17.3 m -59.92 -34.11 72.77 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.271 -0.893 . . . . 0.0 109.489 179.995 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 86' ' ' ALA . . . . . 0.517 ' CB ' HD12 ' A' ' 42' ' ' LEU . . . -79.63 -28.64 40.89 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.266 -0.897 . . . . 0.0 109.518 -179.959 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 87' ' ' ASP . . . . . 0.425 ' O ' ' CB ' ' A' ' 91' ' ' ALA . 94.4 m-20 -67.11 -44.6 79.51 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.257 -0.902 . . . . 0.0 109.517 -179.923 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 88' ' ' GLN . . . . . 0.516 ' HG2' ' CE2' ' A' ' 61' ' ' PHE . 62.5 tt0 -72.16 -39.38 68.76 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.218 -0.926 . . . . 0.0 109.448 -179.942 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 89' ' ' ALA . . . . . 0.562 ' HA ' ' CD2' ' A' ' 61' ' ' PHE . . . -73.96 -45.71 48.53 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.243 -0.911 . . . . 0.0 109.552 -179.98 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 90' ' ' VAL . . . . . 0.522 ' CG2' HG13 ' A' ' 105' ' ' VAL . 65.7 t -69.75 -36.12 68.53 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.574 0 O-C-N 121.237 -0.915 . . . . 0.0 109.551 -179.935 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 91' ' ' ALA . . . . . 0.425 ' CB ' ' O ' ' A' ' 87' ' ' ASP . . . -79.02 -40.48 31.32 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.295 -0.878 . . . . 0.0 109.647 -179.866 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 92' ' ' GLU . . . . . 0.537 ' OE1' ' CE2' ' A' ' 61' ' ' PHE . 40.1 tt0 -77.29 -42.67 36.04 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.221 -0.924 . . . . 0.0 109.527 -179.866 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 93' ' ' LEU . . . . . 0.629 ' CD1' ' CZ ' ' A' ' 58' ' ' PHE . 51.2 mt -69.97 -40.87 75.11 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.226 -0.921 . . . . 0.0 109.502 -179.942 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 94' ' ' ASN . . . . . 0.464 ' HB2' ' O ' ' A' ' 90' ' ' VAL . 63.4 t-20 -64.49 130.03 42.13 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.218 -0.926 . . . . 0.0 109.506 179.975 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 88.82 26.99 25.33 Favored Glycine 0 N--CA 1.49 2.257 0 N-CA-C 109.507 -1.437 . . . . 0.0 109.507 179.978 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 96' ' ' THR . . . . . 0.451 HG21 ' O ' ' A' ' 92' ' ' GLU . 27.2 p -124.29 144.62 49.88 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.212 -1.169 . . . . 0.0 109.557 179.932 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 97' ' ' GLN . . . . . 0.441 ' HG3' ' O ' ' A' ' 101' ' ' VAL . 56.0 tt0 -119.5 142.01 48.68 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.345 -0.847 . . . . 0.0 109.412 179.972 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -85.23 -154.31 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 O-C-N 121.188 -0.945 . . . . 0.0 109.374 -179.91 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 96.4 mt-10 -58.8 -40.97 85.63 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.242 -0.911 . . . . 0.0 109.477 179.997 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 100' ' ' SER . . . . . 0.463 ' O ' ' OG ' ' A' ' 100' ' ' SER . 4.4 t -153.72 24.75 0.51 Allowed 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.295 -0.878 . . . . 0.0 109.394 -179.996 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 101' ' ' VAL . . . . . 0.441 ' O ' ' HG3' ' A' ' 97' ' ' GLN . 53.4 t -137.01 167.85 22.78 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.521 0 O-C-N 121.285 -0.885 . . . . 0.0 109.442 -179.957 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 102' ' ' GLN . . . . . 0.435 ' HG2' ' HG3' ' A' ' 97' ' ' GLN . 93.7 mt-30 -123.83 149.8 45.31 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.233 -0.917 . . . . 0.0 109.264 179.909 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 103' ' ' LEU . . . . . 0.527 HD23 ' CG1' ' A' ' 44' ' ' VAL . 0.0 OUTLIER -120.08 121.23 38.41 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.135 -0.978 . . . . 0.0 109.777 -179.859 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 29.9 mttt -106.49 131.67 53.4 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.314 -0.866 . . . . 0.0 109.24 179.81 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 105' ' ' VAL . . . . . 0.522 HG13 ' CG2' ' A' ' 90' ' ' VAL . 15.6 t . . . . . 0 N--CA 1.49 1.572 0 O-C-N 121.195 -0.941 . . . . 0.0 109.665 -179.842 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 40' ' ' ASN . . . . . 0.468 ' O ' ' HA ' ' A' ' 79' ' ' THR . 47.1 t-20 . . . . . 0 N--CA 1.49 1.572 0 N-CA-C 109.191 -0.67 . . . . 0.0 109.191 . . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 41' ' ' THR . . . . . 0.468 ' HA ' ' O ' ' A' ' 78' ' ' VAL . 86.8 m -84.81 141.56 30.39 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.219 -0.925 . . . . 0.0 109.645 -179.714 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . 0.57 HD11 ' CD2' ' A' ' 80' ' ' TYR . 5.1 mp -119.03 148.72 42.7 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.274 -0.891 . . . . 0.0 109.375 179.91 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 62.5 t80 -102.18 113.57 26.96 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.248 -0.908 . . . . 0.0 109.61 -179.927 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 44' ' ' VAL . . . . . 0.525 ' CG1' HD21 ' A' ' 103' ' ' LEU . 17.7 t -109.47 138.79 35.24 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.573 0 O-C-N 121.272 -0.892 . . . . 0.0 109.483 179.978 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 73.9 t80 -134.12 132.6 40.08 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.247 -0.908 . . . . 0.0 109.571 -179.922 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -175.74 -167.18 34.35 Favored Glycine 0 N--CA 1.49 2.269 0 N-CA-C 109.488 -1.445 . . . . 0.0 109.488 179.99 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . 0.404 ' O ' ' C ' ' A' ' 48' ' ' ASP . 89.9 mt-10 -116.92 157.85 25.02 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.2 -1.177 . . . . 0.0 109.392 -179.948 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 48' ' ' ASP . . . . . 0.404 ' C ' ' O ' ' A' ' 47' ' ' GLU . 23.0 t70 44.01 42.35 4.68 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.301 -0.874 . . . . 0.0 109.382 -179.992 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 49' ' ' MET . . . . . 0.424 ' HE3' HG11 ' A' ' 44' ' ' VAL . 54.4 mtp -73.9 139.44 44.97 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.234 -0.916 . . . . 0.0 109.549 179.943 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 50' ' ' THR . . . . . 0.502 ' O ' ' CD1' ' A' ' 54' ' ' LEU . 5.1 p -126.14 162.66 44.62 Favored Pre-proline 0 N--CA 1.49 1.566 0 O-C-N 121.336 -0.853 . . . . 0.0 109.425 179.996 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 51' ' ' PRO . . . . . 0.455 ' CA ' ' SD ' ' A' ' 69' ' ' MET . 49.4 Cg_endo -70.22 -50.73 0.39 Allowed 'Trans proline' 0 C--O 1.215 -0.65 0 C-N-CA 122.625 2.217 . . . . 0.0 111.73 -179.983 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 41.2 m -60.77 -40.74 93.65 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.225 -0.922 . . . . 0.0 109.422 179.951 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 15.7 tp -66.53 -46.88 74.7 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.298 -0.876 . . . . 0.0 109.36 179.985 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 54' ' ' LEU . . . . . 0.502 ' CD1' ' O ' ' A' ' 50' ' ' THR . 10.8 mt -58.24 -46.33 86.14 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.313 -0.867 . . . . 0.0 109.318 179.944 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 55' ' ' ARG . . . . . 0.509 ' O ' ' N ' ' A' ' 59' ' ' SER . 74.0 mtt180 -56.64 -36.7 69.79 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.282 -0.886 . . . . 0.0 109.543 179.995 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -67.64 -32.89 79.4 Favored Glycine 0 N--CA 1.49 2.294 0 N-CA-C 109.554 -1.418 . . . . 0.0 109.554 179.948 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . 0.455 ' O ' ' CD1' ' A' ' 61' ' ' PHE . . . -73.31 -23.83 60.31 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.266 -1.138 . . . . 0.0 109.411 -179.917 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 58' ' ' PHE . . . . . 0.634 ' CE1' ' CD1' ' A' ' 93' ' ' LEU . 98.6 m-85 -118.95 8.51 11.67 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.33 -0.856 . . . . 0.0 109.46 -179.98 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 59' ' ' SER . . . . . 0.511 ' N ' ' HD2' ' A' ' 60' ' ' PRO . 1.1 t -74.5 -57.51 2.06 Favored Pre-proline 0 N--CA 1.491 1.598 0 O-C-N 121.238 -0.914 . . . . 0.0 109.852 -179.715 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 60' ' ' PRO . . . . . 0.511 ' HD2' ' N ' ' A' ' 59' ' ' SER . 50.3 Cg_endo -69.84 -32.27 18.54 Favored 'Trans proline' 0 C--O 1.215 -0.627 0 C-N-CA 122.601 2.2 . . . . 0.0 111.945 -179.783 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 61' ' ' PHE . . . . . 0.566 ' CE2' ' HA ' ' A' ' 89' ' ' ALA . 67.6 m-85 -63.61 -31.82 73.11 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.163 -0.961 . . . . 0.0 109.406 -179.946 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 171.22 -176.7 44.46 Favored Glycine 0 N--CA 1.49 2.278 0 N-CA-C 109.634 -1.387 . . . . 0.0 109.634 -179.993 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 82.9 m-20 -90.04 145.15 25.29 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.302 -1.117 . . . . 0.0 109.461 179.991 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 64' ' ' ILE . . . . . 0.462 HD11 ' CG1' ' A' ' 78' ' ' VAL . 77.6 mt -106.85 131.3 57.11 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.525 0 O-C-N 121.3 -0.875 . . . . 0.0 109.619 -179.973 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 65' ' ' ILE . . . . . 0.457 HG12 HG22 ' A' ' 79' ' ' THR . 28.2 pt -91.76 -22.85 5.94 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.599 0 O-C-N 121.3 -0.875 . . . . 0.0 109.393 179.948 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 66' ' ' ASP . . . . . 0.445 ' HB3' ' OG1' ' A' ' 79' ' ' THR . 53.6 t0 -149.5 115.3 5.64 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.239 -0.913 . . . . 0.0 109.467 -179.927 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . 0.47 ' C ' ' CD1' ' A' ' 67' ' ' LEU . 0.5 OUTLIER -103.87 114.86 29.42 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.263 -0.898 . . . . 0.0 109.505 179.999 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 68' ' ' SER . . . . . 0.445 ' HB3' ' HB2' ' A' ' 77' ' ' PHE . 39.2 t -119.5 149.72 41.43 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.176 -0.952 . . . . 0.0 109.53 179.978 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 69' ' ' MET . . . . . 0.502 ' HE1' ' CA ' ' A' ' 50' ' ' THR . 77.2 mtp -128.46 148.91 50.76 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.309 -0.869 . . . . 0.0 109.472 -179.983 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 70' ' ' ASP . . . . . 0.516 ' CB ' ' O ' ' A' ' 75' ' ' CYS . 0.4 OUTLIER -127.84 94.66 36.59 Favored Pre-proline 0 N--CA 1.49 1.572 0 O-C-N 121.272 -0.892 . . . . 0.0 109.421 179.967 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 71' ' ' PRO . . . . . 0.593 ' N ' ' CD ' ' A' ' 72' ' ' PRO . 47.4 Cg_endo -74.66 -27.93 10.26 Favored 'Trans proline' 0 CA--C 1.542 0.922 0 C-N-CA 122.564 2.176 . . . . 0.0 113.584 179.98 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 72' ' ' PRO . . . . . 0.593 ' CD ' ' N ' ' A' ' 71' ' ' PRO . 55.4 Cg_endo -75.49 -21.44 14.97 Favored 'Trans proline' 0 C--N 1.352 0.761 0 C-N-CA 121.46 1.44 . . . . 0.0 111.797 -179.86 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 73' ' ' ARG . . . . . 0.411 ' O ' ' HB2' ' A' ' 74' ' ' ASN . 67.8 mtt85 -115.23 3.66 14.33 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.252 -0.905 . . . . 0.0 109.7 -179.878 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 74' ' ' ASN . . . . . 0.411 ' HB2' ' O ' ' A' ' 73' ' ' ARG . 78.6 m-20 60.12 44.64 12.72 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.234 -0.916 . . . . 0.0 109.474 179.958 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 75' ' ' CYS . . . . . 0.516 ' O ' ' CB ' ' A' ' 70' ' ' ASP . 28.0 p -149.86 153.2 36.34 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.26 -0.9 . . . . 0.0 109.566 -179.942 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -127.8 159.36 35.07 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.291 -0.88 . . . . 0.0 109.35 179.899 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 77' ' ' PHE . . . . . 0.467 ' HA ' ' O ' ' A' ' 42' ' ' LEU . 96.3 m-85 -120.94 136.79 54.87 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.179 -0.951 . . . . 0.0 109.533 179.997 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . 0.53 ' O ' ' CD1' ' A' ' 42' ' ' LEU . 39.7 t -125.45 135.14 64.93 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 O-C-N 121.247 -0.908 . . . . 0.0 109.546 -179.974 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 79' ' ' THR . . . . . 0.468 ' HA ' ' O ' ' A' ' 40' ' ' ASN . 17.3 m -104.03 127.43 51.59 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.287 -0.883 . . . . 0.0 109.451 179.964 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 80' ' ' TYR . . . . . 0.57 ' CD2' HD11 ' A' ' 42' ' ' LEU . 1.2 m-85 -108.44 139.82 42.63 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.273 -0.892 . . . . 0.0 109.507 179.958 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 76.8 tt0 -61.35 -24.43 66.46 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.232 -0.917 . . . . 0.0 109.326 179.867 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 42.8 mttm -134.18 144.61 48.59 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.28 -0.887 . . . . 0.0 109.32 179.948 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 83' ' ' MET . . . . . . . . . . . . . 53.8 mtt -65.55 -17.56 64.67 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.17 -0.956 . . . . 0.0 109.548 -179.912 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 97.4 mt-10 -69.98 -35.13 74.19 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.232 -0.918 . . . . 0.0 109.468 -179.924 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 85' ' ' SER . . . . . 0.481 ' HB2' ' CG ' ' A' ' 80' ' ' TYR . 18.0 m -66.84 -30.42 70.59 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.252 -0.905 . . . . 0.0 109.468 -179.943 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 86' ' ' ALA . . . . . 0.491 ' CB ' HD23 ' A' ' 42' ' ' LEU . . . -79.17 -37.43 38.39 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.223 -0.923 . . . . 0.0 109.504 -179.96 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 55.4 t0 -61.78 -47.19 86.27 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.166 -0.959 . . . . 0.0 109.407 179.97 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 88' ' ' GLN . . . . . 0.454 ' O ' ' HB2' ' A' ' 92' ' ' GLU . 64.2 tt0 -67.88 -39.96 83.63 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.289 -0.882 . . . . 0.0 109.316 179.957 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 89' ' ' ALA . . . . . 0.566 ' HA ' ' CE2' ' A' ' 61' ' ' PHE . . . -71.72 -38.91 70.42 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.283 -0.886 . . . . 0.0 109.531 -179.967 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 90' ' ' VAL . . . . . 0.524 ' O ' ' CB ' ' A' ' 94' ' ' ASN . 74.1 t -66.0 -45.33 91.12 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.616 0 O-C-N 121.309 -0.869 . . . . 0.0 109.627 -179.858 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -70.98 -34.51 71.46 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.196 -0.94 . . . . 0.0 109.667 -179.854 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 92' ' ' GLU . . . . . 0.522 ' HB3' ' CZ ' ' A' ' 61' ' ' PHE . 2.4 tm-20 -82.85 -49.3 9.83 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.28 -0.888 . . . . 0.0 109.617 -179.948 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 93' ' ' LEU . . . . . 0.634 ' CD1' ' CE1' ' A' ' 58' ' ' PHE . 85.3 mt -65.8 -35.0 79.46 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.222 -0.924 . . . . 0.0 109.598 -179.892 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 94' ' ' ASN . . . . . 0.524 ' CB ' ' O ' ' A' ' 90' ' ' VAL . 56.5 t-20 -71.71 130.51 41.33 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.277 -0.889 . . . . 0.0 109.463 -179.985 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 87.24 30.66 19.02 Favored Glycine 0 N--CA 1.489 2.204 0 N-CA-C 109.51 -1.436 . . . . 0.0 109.51 179.97 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 96' ' ' THR . . . . . 0.474 ' CG2' ' O ' ' A' ' 92' ' ' GLU . 28.8 p -122.56 148.08 45.63 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.228 -1.16 . . . . 0.0 109.523 -179.956 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 97' ' ' GLN . . . . . 0.419 ' HG3' ' O ' ' A' ' 101' ' ' VAL . 57.2 tt0 -118.6 143.22 46.94 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.309 -0.869 . . . . 0.0 109.444 -179.953 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 1.3 t -92.4 -148.84 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 O-C-N 121.256 -0.902 . . . . 0.0 109.368 179.975 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 96.7 mt-10 -57.61 -37.2 72.85 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.272 -0.893 . . . . 0.0 109.432 179.918 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 22.6 m -165.82 30.64 0.05 Allowed 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.27 -0.894 . . . . 0.0 109.319 179.965 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 101' ' ' VAL . . . . . 0.419 ' O ' ' HG3' ' A' ' 97' ' ' GLN . 44.4 t -137.73 168.88 19.89 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.5 0 O-C-N 121.34 -0.85 . . . . 0.0 109.465 -179.892 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 102' ' ' GLN . . . . . 0.401 ' N ' ' CG1' ' A' ' 101' ' ' VAL . 91.5 mt-30 -116.39 145.54 43.16 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.191 -0.943 . . . . 0.0 109.076 179.815 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 103' ' ' LEU . . . . . 0.525 HD21 ' CG1' ' A' ' 44' ' ' VAL . 0.0 OUTLIER -121.81 134.91 54.9 Favored 'General case' 0 N--CA 1.488 1.444 0 O-C-N 121.18 -0.95 . . . . 0.0 109.851 -179.628 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 60.5 mttt -118.07 126.65 52.68 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.343 -0.848 . . . . 0.0 109.234 179.769 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 105' ' ' VAL . . . . . 0.573 ' CG2' ' CB ' ' A' ' 93' ' ' LEU . 26.4 t . . . . . 0 N--CA 1.49 1.562 0 O-C-N 121.174 -0.953 . . . . 0.0 109.667 -179.82 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 40' ' ' ASN . . . . . 0.421 ' O ' ' HA ' ' A' ' 79' ' ' THR . 45.3 t-20 . . . . . 0 N--CA 1.49 1.561 0 N-CA-C 109.512 -0.551 . . . . 0.0 109.512 . . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 41' ' ' THR . . . . . 0.455 ' HA ' ' O ' ' A' ' 78' ' ' VAL . 60.2 m -81.0 143.67 32.35 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.274 -0.891 . . . . 0.0 109.54 179.973 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . 0.58 HD13 ' CD2' ' A' ' 80' ' ' TYR . 5.0 mp -116.08 146.7 42.0 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.176 -0.952 . . . . 0.0 109.521 -179.931 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 35.4 t80 -106.08 112.58 25.67 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.177 -0.952 . . . . 0.0 109.513 -179.976 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 44' ' ' VAL . . . . . 0.501 HG12 ' N ' ' A' ' 45' ' ' TYR . 38.2 t -110.53 150.42 13.05 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.53 0 O-C-N 121.266 -0.896 . . . . 0.0 109.535 -179.919 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 45' ' ' TYR . . . . . 0.501 ' N ' HG12 ' A' ' 44' ' ' VAL . 70.0 t80 -141.68 138.92 32.79 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.2 -0.937 . . . . 0.0 109.606 179.9 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 177.29 -167.86 39.25 Favored Glycine 0 N--CA 1.49 2.289 0 N-CA-C 109.472 -1.451 . . . . 0.0 109.472 179.909 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . 0.423 ' O ' ' C ' ' A' ' 48' ' ' ASP . 89.0 mt-10 -115.66 161.98 17.9 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.275 -1.133 . . . . 0.0 109.42 179.945 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 48' ' ' ASP . . . . . 0.423 ' C ' ' O ' ' A' ' 47' ' ' GLU . 43.9 m-20 43.73 40.74 3.21 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.281 -0.887 . . . . 0.0 109.606 179.975 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 41.3 mtp -78.6 138.79 38.52 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.282 -0.886 . . . . 0.0 109.354 179.979 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 50' ' ' THR . . . . . 0.462 ' O ' HD11 ' A' ' 54' ' ' LEU . 0.4 OUTLIER -127.04 161.28 54.8 Favored Pre-proline 0 N--CA 1.49 1.56 0 O-C-N 121.252 -0.905 . . . . 0.0 109.533 179.94 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 50.2 Cg_endo -70.07 -51.94 0.33 Allowed 'Trans proline' 0 C--O 1.214 -0.688 0 C-N-CA 122.641 2.228 . . . . 0.0 111.815 -179.985 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 31.1 m -59.16 -41.2 87.83 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.214 -0.929 . . . . 0.0 109.41 179.904 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 9.0 tt -64.89 -44.44 89.63 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.305 -0.872 . . . . 0.0 109.467 179.987 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 54' ' ' LEU . . . . . 0.496 HD12 ' CB ' ' A' ' 76' ' ' ALA . 21.9 mt -63.93 -45.86 87.35 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.211 -0.931 . . . . 0.0 109.374 179.946 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 55' ' ' ARG . . . . . 0.454 ' O ' ' N ' ' A' ' 59' ' ' SER . 76.8 mtp180 -51.3 -41.33 60.42 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.235 -0.916 . . . . 0.0 109.358 179.965 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -69.44 -32.28 71.59 Favored Glycine 0 N--CA 1.49 2.253 0 N-CA-C 109.463 -1.455 . . . . 0.0 109.463 179.871 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -71.5 -23.72 61.85 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.339 -1.095 . . . . 0.0 109.398 179.934 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 58' ' ' PHE . . . . . 0.584 ' CE2' ' CD1' ' A' ' 93' ' ' LEU . 90.1 m-85 -120.62 10.11 10.98 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.365 -0.834 . . . . 0.0 109.453 -179.997 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 59' ' ' SER . . . . . 0.525 ' N ' ' HD2' ' A' ' 60' ' ' PRO . 3.4 t -76.78 -54.34 1.7 Allowed Pre-proline 0 N--CA 1.49 1.575 0 O-C-N 121.316 -0.865 . . . . 0.0 110.413 -179.505 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 60' ' ' PRO . . . . . 0.525 ' HD2' ' N ' ' A' ' 59' ' ' SER . 48.5 Cg_endo -69.97 -35.58 11.77 Favored 'Trans proline' 0 C--O 1.215 -0.644 0 C-N-CA 122.516 2.144 . . . . 0.0 112.251 -179.276 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 61' ' ' PHE . . . . . 0.583 ' CZ ' ' HB2' ' A' ' 92' ' ' GLU . 70.0 m-85 -58.51 -39.29 79.67 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.183 -0.948 . . . . 0.0 109.631 -179.833 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 179.43 174.66 45.67 Favored Glycine 0 N--CA 1.49 2.239 0 N-CA-C 109.516 -1.434 . . . . 0.0 109.516 179.95 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 45.9 t-20 -80.18 140.9 36.13 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.263 -1.14 . . . . 0.0 109.414 179.93 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 64' ' ' ILE . . . . . 0.471 HD11 HG11 ' A' ' 78' ' ' VAL . 81.7 mt -100.78 131.04 49.16 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.52 0 O-C-N 121.223 -0.923 . . . . 0.0 109.542 -179.973 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 65' ' ' ILE . . . . . 0.443 HD12 HG22 ' A' ' 79' ' ' THR . 20.4 pt -92.82 -24.02 5.38 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 O-C-N 121.264 -0.898 . . . . 0.0 109.575 -179.841 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 18.7 t70 -149.44 113.79 5.24 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.239 -0.913 . . . . 0.0 109.621 -179.888 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . 0.459 ' C ' ' CD1' ' A' ' 67' ' ' LEU . 0.4 OUTLIER -104.74 117.06 33.14 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.282 -0.886 . . . . 0.0 109.342 179.803 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 25.9 t -128.36 148.87 50.7 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.291 -0.881 . . . . 0.0 109.566 -179.906 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 69' ' ' MET . . . . . 0.402 ' HE2' ' CD1' ' A' ' 54' ' ' LEU . 86.6 mtp -124.9 148.54 48.27 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.233 -0.917 . . . . 0.0 109.408 179.93 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 70' ' ' ASP . . . . . 0.498 ' CB ' ' O ' ' A' ' 75' ' ' CYS . 0.8 OUTLIER -120.77 100.03 46.78 Favored Pre-proline 0 N--CA 1.491 1.624 0 O-C-N 121.253 -0.904 . . . . 0.0 109.614 -179.931 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 71' ' ' PRO . . . . . 0.596 ' N ' ' CD ' ' A' ' 72' ' ' PRO . 47.9 Cg_endo -74.72 -27.85 10.22 Favored 'Trans proline' 0 CA--C 1.543 0.938 0 C-N-CA 122.543 2.162 . . . . 0.0 113.733 179.944 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 72' ' ' PRO . . . . . 0.596 ' CD ' ' N ' ' A' ' 71' ' ' PRO . 55.5 Cg_endo -75.36 -28.62 8.44 Favored 'Trans proline' 0 C--N 1.352 0.762 0 C-N-CA 121.462 1.441 . . . . 0.0 111.846 -179.91 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 73' ' ' ARG . . . . . 0.448 ' O ' ' HB2' ' A' ' 74' ' ' ASN . 55.3 mtt-85 -109.41 0.06 19.2 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.295 -0.878 . . . . 0.0 109.666 -179.826 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 74' ' ' ASN . . . . . 0.448 ' HB2' ' O ' ' A' ' 73' ' ' ARG . 83.5 m-20 61.14 41.25 13.84 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.126 -0.984 . . . . 0.0 109.544 179.984 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 75' ' ' CYS . . . . . 0.498 ' O ' ' CB ' ' A' ' 70' ' ' ASP . 30.0 p -140.93 137.01 32.8 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.183 -0.948 . . . . 0.0 109.627 179.99 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 76' ' ' ALA . . . . . 0.496 ' CB ' HD12 ' A' ' 54' ' ' LEU . . . -105.02 160.6 14.91 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.286 -0.884 . . . . 0.0 109.454 179.996 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 77' ' ' PHE . . . . . 0.466 ' HA ' ' O ' ' A' ' 42' ' ' LEU . 97.1 m-85 -124.33 130.07 51.84 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.207 -0.933 . . . . 0.0 109.487 -179.987 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . 0.527 ' O ' ' CD1' ' A' ' 42' ' ' LEU . 21.2 t -122.09 132.97 69.84 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.549 0 O-C-N 121.273 -0.892 . . . . 0.0 109.341 179.927 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 79' ' ' THR . . . . . 0.457 ' O ' ' HA ' ' A' ' 64' ' ' ILE . 6.8 m -106.01 135.86 46.71 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.238 -0.914 . . . . 0.0 109.36 -179.966 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 80' ' ' TYR . . . . . 0.58 ' CD2' HD13 ' A' ' 42' ' ' LEU . 1.6 m-85 -115.56 133.08 56.38 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.162 -0.961 . . . . 0.0 109.619 -179.932 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 76.8 tt0 -52.26 -25.81 10.32 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.339 -0.851 . . . . 0.0 109.537 179.959 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 67.6 mttm -134.23 132.97 40.33 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.176 -0.953 . . . . 0.0 109.617 -179.952 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 83' ' ' MET . . . . . . . . . . . . . 0.8 OUTLIER -57.38 -18.23 16.59 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.277 -0.889 . . . . 0.0 109.649 -179.964 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 99.5 mt-10 -65.76 -39.43 91.04 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.223 -0.923 . . . . 0.0 109.506 -179.922 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 13.9 t -63.58 -40.45 96.99 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.168 -0.957 . . . . 0.0 109.546 -179.897 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -61.11 -41.45 96.71 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.204 -0.935 . . . . 0.0 109.538 -179.917 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 54.4 t0 -62.19 -45.1 94.89 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.218 -0.926 . . . . 0.0 109.601 -179.926 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 63.6 tt0 -65.16 -37.3 86.96 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.224 -0.922 . . . . 0.0 109.583 -179.817 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 89' ' ' ALA . . . . . 0.55 ' HA ' ' CE1' ' A' ' 61' ' ' PHE . . . -75.95 -45.95 32.36 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.225 -0.922 . . . . 0.0 109.609 -179.879 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 90' ' ' VAL . . . . . 0.513 ' HA ' ' CG1' ' A' ' 105' ' ' VAL . 78.0 t -56.9 -31.92 37.57 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.52 0 O-C-N 121.207 -0.933 . . . . 0.0 109.626 -179.889 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -80.06 -53.0 7.12 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.245 -0.91 . . . . 0.0 109.733 -179.82 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 92' ' ' GLU . . . . . 0.583 ' HB2' ' CZ ' ' A' ' 61' ' ' PHE . 75.4 mm-40 -71.72 -43.88 65.11 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.214 -0.929 . . . . 0.0 109.73 -179.637 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 93' ' ' LEU . . . . . 0.584 ' CD1' ' CE2' ' A' ' 58' ' ' PHE . 36.7 mt -64.67 -40.36 95.28 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.149 -0.969 . . . . 0.0 109.474 -179.916 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 94' ' ' ASN . . . . . 0.489 ' CB ' ' O ' ' A' ' 90' ' ' VAL . 64.0 t-20 -68.4 125.74 27.42 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.244 -0.91 . . . . 0.0 109.499 179.987 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 93.85 22.81 24.79 Favored Glycine 0 N--CA 1.49 2.294 0 N-CA-C 109.536 -1.426 . . . . 0.0 109.536 179.969 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 96' ' ' THR . . . . . 0.512 ' CG2' ' O ' ' A' ' 92' ' ' GLU . 29.5 p -111.49 159.7 17.83 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.268 -1.136 . . . . 0.0 109.465 -179.948 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 60.0 tt0 -136.13 149.02 48.49 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.281 -0.887 . . . . 0.0 109.491 179.968 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 98' ' ' VAL . . . . . 0.522 ' CG2' HG12 ' A' ' 101' ' ' VAL . 1.3 t -101.59 -151.92 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.543 0 O-C-N 121.195 -0.941 . . . . 0.0 109.204 179.947 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 95.7 mt-10 -48.29 -41.34 27.77 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.115 -0.991 . . . . 0.0 109.42 179.992 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 2.4 m -165.98 25.84 0.05 OUTLIER 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.236 -0.915 . . . . 0.0 109.505 -179.97 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 101' ' ' VAL . . . . . 0.522 HG12 ' CG2' ' A' ' 98' ' ' VAL . 9.8 p -130.17 140.2 49.51 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.547 0 O-C-N 121.233 -0.917 . . . . 0.0 109.644 -179.861 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 91.7 mt-30 -86.71 141.62 28.78 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.265 -0.897 . . . . 0.0 109.328 179.887 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 103' ' ' LEU . . . . . 0.45 HD12 HG23 ' A' ' 98' ' ' VAL . 73.5 mt -106.76 137.62 44.45 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.241 -0.912 . . . . 0.0 109.763 -179.819 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 104' ' ' LYS . . . . . 0.466 ' O ' ' HA ' ' A' ' 44' ' ' VAL . 41.9 mttm -119.38 135.53 54.69 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.284 -0.885 . . . . 0.0 109.245 179.831 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 105' ' ' VAL . . . . . 0.518 HG23 ' CB ' ' A' ' 93' ' ' LEU . 46.0 t . . . . . 0 N--CA 1.49 1.55 0 O-C-N 121.186 -0.946 . . . . 0.0 109.614 -179.788 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 40' ' ' ASN . . . . . 0.458 ' O ' ' HA ' ' A' ' 79' ' ' THR . 47.3 t-20 . . . . . 0 N--CA 1.491 1.613 0 N-CA-C 109.311 -0.625 . . . . 0.0 109.311 . . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 41' ' ' THR . . . . . 0.445 ' O ' HD21 ' A' ' 42' ' ' LEU . 43.7 m -71.11 133.79 46.51 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.257 -0.902 . . . . 0.0 109.74 -179.747 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . 0.512 ' CD2' ' HB1' ' A' ' 86' ' ' ALA . 16.6 mt -114.38 145.68 41.52 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.295 -0.878 . . . . 0.0 109.32 179.824 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 74.1 t80 -100.38 122.61 43.41 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.258 -0.901 . . . . 0.0 109.488 -179.825 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 44' ' ' VAL . . . . . 0.46 ' HA ' ' O ' ' A' ' 104' ' ' LYS . 59.3 t -123.34 136.92 58.39 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.538 0 O-C-N 121.283 -0.885 . . . . 0.0 109.424 179.977 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 45' ' ' TYR . . . . . 0.452 ' HB3' ' HB2' ' A' ' 104' ' ' LYS . 70.1 t80 -120.56 142.09 49.68 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.223 -0.923 . . . . 0.0 109.46 -179.89 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . 0.445 ' HA3' ' SD ' ' A' ' 49' ' ' MET . . . 174.86 -175.87 47.02 Favored Glycine 0 N--CA 1.491 2.341 0 N-CA-C 109.54 -1.424 . . . . 0.0 109.54 -179.963 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . 0.428 ' O ' ' C ' ' A' ' 48' ' ' ASP . 94.6 mt-10 -120.85 157.03 30.68 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.265 -1.138 . . . . 0.0 109.392 179.962 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 48' ' ' ASP . . . . . 0.428 ' C ' ' O ' ' A' ' 47' ' ' GLU . 48.8 m-20 43.93 52.16 6.73 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.294 -0.879 . . . . 0.0 109.546 -179.979 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 49' ' ' MET . . . . . 0.445 ' SD ' ' HA3' ' A' ' 46' ' ' GLY . 64.8 mtm -103.4 142.41 34.28 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.314 -0.866 . . . . 0.0 109.504 179.975 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 50' ' ' THR . . . . . 0.458 ' O ' HD12 ' A' ' 54' ' ' LEU . 0.6 OUTLIER -122.15 163.62 30.73 Favored Pre-proline 0 N--CA 1.491 1.582 0 O-C-N 121.258 -0.901 . . . . 0.0 109.371 179.919 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 51' ' ' PRO . . . . . 0.469 ' HB3' HD13 ' A' ' 67' ' ' LEU . 48.8 Cg_endo -69.56 -52.99 0.31 Allowed 'Trans proline' 0 C--O 1.215 -0.64 0 C-N-CA 122.617 2.211 . . . . 0.0 111.803 179.988 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 28.6 m -50.6 -48.87 57.7 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.249 -0.907 . . . . 0.0 109.302 179.931 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 22.3 tp -60.33 -47.23 86.92 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.249 -0.907 . . . . 0.0 109.343 179.836 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 54' ' ' LEU . . . . . 0.458 HD12 ' O ' ' A' ' 50' ' ' THR . 21.9 mt -56.28 -47.09 79.29 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.284 -0.885 . . . . 0.0 109.357 179.824 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 55' ' ' ARG . . . . . 0.499 ' O ' ' N ' ' A' ' 59' ' ' SER . 36.4 mtp85 -51.43 -40.91 60.33 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.306 -0.871 . . . . 0.0 109.296 179.84 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -66.48 -34.35 87.46 Favored Glycine 0 N--CA 1.489 2.203 0 N-CA-C 109.34 -1.504 . . . . 0.0 109.34 179.864 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -71.23 -26.41 62.91 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.313 -1.11 . . . . 0.0 109.472 179.957 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 58' ' ' PHE . . . . . 0.637 ' CE2' ' CD1' ' A' ' 93' ' ' LEU . 96.9 m-85 -115.01 8.33 15.75 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.244 -0.91 . . . . 0.0 109.468 179.966 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 59' ' ' SER . . . . . 0.516 ' N ' ' HD2' ' A' ' 60' ' ' PRO . 0.8 OUTLIER -72.91 -58.14 2.76 Favored Pre-proline 0 N--CA 1.49 1.574 0 O-C-N 121.195 -0.941 . . . . 0.0 109.811 -179.784 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 60' ' ' PRO . . . . . 0.516 ' HD2' ' N ' ' A' ' 59' ' ' SER . 48.0 Cg_endo -68.9 -28.69 29.24 Favored 'Trans proline' 0 C--O 1.215 -0.65 0 C-N-CA 122.602 2.202 . . . . 0.0 111.973 -179.702 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 61' ' ' PHE . . . . . 0.569 ' CD1' ' HA ' ' A' ' 89' ' ' ALA . 61.2 m-85 -70.11 -31.74 69.44 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.181 -0.949 . . . . 0.0 109.548 -179.988 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . 0.414 ' HA3' ' HB3' ' A' ' 85' ' ' SER . . . 176.39 -171.41 44.4 Favored Glycine 0 N--CA 1.49 2.262 0 N-CA-C 109.504 -1.438 . . . . 0.0 109.504 179.881 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 85.6 m-20 -99.67 137.33 38.3 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.244 -1.15 . . . . 0.0 109.311 -179.963 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 64' ' ' ILE . . . . . 0.416 HD13 HG12 ' A' ' 78' ' ' VAL . 64.0 mt -99.53 131.72 46.35 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.517 0 O-C-N 121.238 -0.914 . . . . 0.0 109.581 -179.988 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 65' ' ' ILE . . . . . 0.479 ' CD1' HG22 ' A' ' 79' ' ' THR . 18.3 pt -96.67 -22.47 5.06 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.549 0 O-C-N 121.346 -0.846 . . . . 0.0 109.427 179.982 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 66' ' ' ASP . . . . . 0.441 ' HB3' ' OG1' ' A' ' 79' ' ' THR . 54.9 t0 -143.76 135.96 26.74 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.219 -0.925 . . . . 0.0 109.563 -179.963 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . 0.489 ' C ' ' CD1' ' A' ' 67' ' ' LEU . 3.4 tm? -122.47 114.71 21.07 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.233 -0.917 . . . . 0.0 109.314 179.918 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 68' ' ' SER . . . . . 0.446 ' HB3' ' HB2' ' A' ' 77' ' ' PHE . 37.7 t -129.25 145.43 51.35 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.247 -0.908 . . . . 0.0 109.518 -179.917 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 69' ' ' MET . . . . . 0.463 ' HA ' ' HA ' ' A' ' 76' ' ' ALA . 79.3 mtp -130.4 143.92 51.07 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.218 -0.926 . . . . 0.0 109.445 179.963 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 70' ' ' ASP . . . . . 0.453 ' C ' ' HD2' ' A' ' 72' ' ' PRO . 2.4 t70 -117.06 107.06 46.34 Favored Pre-proline 0 N--CA 1.489 1.514 0 O-C-N 121.229 -0.92 . . . . 0.0 109.575 -179.928 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 71' ' ' PRO . . . . . 0.604 ' N ' ' CD ' ' A' ' 72' ' ' PRO . 46.3 Cg_endo -74.85 -27.69 10.09 Favored 'Trans proline' 0 CA--C 1.543 0.962 0 C-N-CA 122.458 2.106 . . . . 0.0 113.571 179.923 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 72' ' ' PRO . . . . . 0.604 ' CD ' ' N ' ' A' ' 71' ' ' PRO . 55.2 Cg_endo -75.38 -29.56 7.53 Favored 'Trans proline' 0 C--N 1.353 0.787 0 C-N-CA 121.427 1.418 . . . . 0.0 111.81 -179.872 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 5.8 mtp85 -106.97 1.3 24.35 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.161 -0.962 . . . . 0.0 109.63 179.995 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 80.2 m-20 57.61 39.1 27.87 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.145 -0.972 . . . . 0.0 109.46 179.991 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 75' ' ' CYS . . . . . 0.435 ' HA ' ' O ' ' A' ' 44' ' ' VAL . 27.9 p -134.96 140.52 45.77 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.186 -0.946 . . . . 0.0 109.5 -179.963 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 76' ' ' ALA . . . . . 0.463 ' HA ' ' HA ' ' A' ' 69' ' ' MET . . . -108.22 152.23 24.86 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.34 -0.85 . . . . 0.0 109.395 179.964 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 77' ' ' PHE . . . . . 0.446 ' HB2' ' HB3' ' A' ' 68' ' ' SER . 96.8 m-85 -117.59 129.95 56.09 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.24 -0.913 . . . . 0.0 109.527 -179.955 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . 0.482 ' O ' ' N ' ' A' ' 42' ' ' LEU . 48.2 t -124.79 132.09 71.78 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.575 0 O-C-N 121.261 -0.9 . . . . 0.0 109.413 179.968 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 79' ' ' THR . . . . . 0.479 HG22 ' CD1' ' A' ' 65' ' ' ILE . 22.8 m -101.22 134.1 44.78 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.286 -0.884 . . . . 0.0 109.5 179.965 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 80' ' ' TYR . . . . . 0.469 ' OH ' ' HB3' ' A' ' 58' ' ' PHE . 0.4 OUTLIER -109.95 144.57 38.28 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.275 -0.891 . . . . 0.0 109.548 -179.977 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 84.9 tt0 -66.81 -31.16 71.6 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.177 -0.952 . . . . 0.0 109.514 179.836 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 46.1 mttm -128.11 152.32 48.14 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.327 -0.858 . . . . 0.0 109.445 -179.998 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 83' ' ' MET . . . . . . . . . . . . . 40.7 mtt -69.79 -21.98 63.37 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.226 -0.921 . . . . 0.0 109.491 179.987 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 98.7 mt-10 -71.15 -33.42 70.04 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.27 -0.894 . . . . 0.0 109.605 -179.955 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 85' ' ' SER . . . . . 0.414 ' HB3' ' HA3' ' A' ' 62' ' ' GLY . 19.4 m -66.92 -31.07 71.41 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.167 -0.958 . . . . 0.0 109.479 -179.901 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 86' ' ' ALA . . . . . 0.512 ' HB1' ' CD2' ' A' ' 42' ' ' LEU . . . -80.08 -33.74 38.61 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.253 -0.904 . . . . 0.0 109.476 -179.955 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 58.7 t0 -65.48 -40.57 93.28 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.262 -0.898 . . . . 0.0 109.589 -179.946 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 88' ' ' GLN . . . . . 0.416 ' O ' ' HB2' ' A' ' 92' ' ' GLU . 62.0 tt0 -73.92 -38.72 64.21 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.285 -0.884 . . . . 0.0 109.591 -179.917 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 89' ' ' ALA . . . . . 0.569 ' HA ' ' CD1' ' A' ' 61' ' ' PHE . . . -76.46 -41.22 48.07 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.249 -0.907 . . . . 0.0 109.507 179.975 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 90' ' ' VAL . . . . . 0.479 ' O ' ' CB ' ' A' ' 94' ' ' ASN . 55.6 t -65.91 -40.97 88.97 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.591 0 O-C-N 121.286 -0.883 . . . . 0.0 109.623 -179.812 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -74.95 -38.26 61.76 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.145 -0.972 . . . . 0.0 109.741 -179.774 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 92' ' ' GLU . . . . . 0.543 ' HB3' ' CZ ' ' A' ' 61' ' ' PHE . 5.9 tm-20 -78.85 -50.8 10.65 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.187 -0.946 . . . . 0.0 109.722 -179.744 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 93' ' ' LEU . . . . . 0.637 ' CD1' ' CE2' ' A' ' 58' ' ' PHE . 48.9 mt -62.64 -35.5 79.79 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.262 -0.899 . . . . 0.0 109.56 -179.829 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 94' ' ' ASN . . . . . 0.479 ' CB ' ' O ' ' A' ' 90' ' ' VAL . 56.8 t-20 -74.71 129.11 37.12 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.246 -0.909 . . . . 0.0 109.549 -179.909 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 91.55 24.44 26.02 Favored Glycine 0 N--CA 1.49 2.253 0 N-CA-C 109.551 -1.42 . . . . 0.0 109.551 179.926 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 96' ' ' THR . . . . . 0.48 ' CG2' ' O ' ' A' ' 92' ' ' GLU . 36.9 p -126.23 154.05 43.86 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.201 -1.176 . . . . 0.0 109.572 179.985 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 63.8 tt0 -117.83 138.9 51.78 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.225 -0.922 . . . . 0.0 109.491 -179.96 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 1.2 t -81.13 -151.99 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 121.204 -0.935 . . . . 0.0 109.315 -179.99 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 96.3 mt-10 -60.78 -37.89 83.41 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.204 -0.935 . . . . 0.0 109.477 179.983 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 100' ' ' SER . . . . . 0.405 ' O ' HG23 ' A' ' 101' ' ' VAL . 0.4 OUTLIER -158.1 22.81 0.25 Allowed 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.264 -0.897 . . . . 0.0 109.476 179.99 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 101' ' ' VAL . . . . . 0.405 HG23 ' O ' ' A' ' 100' ' ' SER . 47.9 t -139.43 154.41 24.83 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.531 0 O-C-N 121.224 -0.923 . . . . 0.0 109.496 179.993 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 92.2 mt-30 -102.45 144.18 31.23 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.242 -0.911 . . . . 0.0 109.431 179.96 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 92.0 mt -110.37 138.89 46.16 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.311 -0.868 . . . . 0.0 109.564 179.997 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 104' ' ' LYS . . . . . 0.46 ' O ' ' HA ' ' A' ' 44' ' ' VAL . 76.6 mttt -120.23 138.53 53.6 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.268 -0.895 . . . . 0.0 109.259 179.853 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 105' ' ' VAL . . . . . 0.462 HG12 ' CG1' ' A' ' 90' ' ' VAL . 18.4 t . . . . . 0 N--CA 1.49 1.549 0 O-C-N 121.142 -0.974 . . . . 0.0 109.657 -179.819 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 40' ' ' ASN . . . . . 0.454 ' O ' HD11 ' A' ' 42' ' ' LEU . 47.1 t-20 . . . . . 0 N--CA 1.49 1.531 0 N-CA-C 109.477 -0.564 . . . . 0.0 109.477 . . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 41' ' ' THR . . . . . 0.448 ' HA ' ' O ' ' A' ' 78' ' ' VAL . 66.1 m -84.32 140.42 31.63 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.225 -0.922 . . . . 0.0 109.522 -179.954 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . 0.545 HD12 ' CD2' ' A' ' 80' ' ' TYR . 5.2 mp -116.18 143.04 46.03 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.322 -0.861 . . . . 0.0 109.338 179.987 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 70.1 t80 -98.0 108.23 20.89 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.366 -0.834 . . . . 0.0 109.584 -179.951 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 44' ' ' VAL . . . . . 0.463 ' HA ' ' O ' ' A' ' 104' ' ' LYS . 95.6 t -105.37 136.43 39.37 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 O-C-N 121.268 -0.895 . . . . 0.0 109.363 -180.0 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 45' ' ' TYR . . . . . 0.42 ' HB3' ' HB2' ' A' ' 104' ' ' LYS . 70.5 t80 -123.42 131.33 53.61 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.141 -0.974 . . . . 0.0 109.524 -179.949 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -179.69 -174.55 45.74 Favored Glycine 0 N--CA 1.491 2.333 0 N-CA-C 109.401 -1.48 . . . . 0.0 109.401 179.963 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 95.6 mt-10 -121.12 156.49 32.19 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.216 -1.167 . . . . 0.0 109.476 -179.958 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 59.4 t0 46.23 52.52 10.33 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.237 -0.915 . . . . 0.0 109.487 -179.985 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 49' ' ' MET . . . . . 0.412 ' C ' ' HE2' ' A' ' 69' ' ' MET . 61.6 mtm -104.17 139.8 38.71 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.247 -0.908 . . . . 0.0 109.547 -179.928 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 50' ' ' THR . . . . . 0.459 ' O ' HD12 ' A' ' 54' ' ' LEU . 0.1 OUTLIER -121.5 166.57 15.9 Favored Pre-proline 0 N--CA 1.49 1.547 0 O-C-N 121.208 -0.932 . . . . 0.0 109.414 -179.98 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 51' ' ' PRO . . . . . 0.485 ' N ' ' SD ' ' A' ' 69' ' ' MET . 48.2 Cg_endo -70.17 -55.73 0.16 Allowed 'Trans proline' 0 C--O 1.215 -0.651 0 C-N-CA 122.599 2.199 . . . . 0.0 111.918 179.937 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 26.2 m -48.88 -49.91 37.44 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.181 -0.95 . . . . 0.0 109.287 179.877 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 24.2 tp -58.08 -50.5 73.24 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.181 -0.949 . . . . 0.0 109.161 179.782 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 54' ' ' LEU . . . . . 0.459 HD12 ' O ' ' A' ' 50' ' ' THR . 11.6 mt -56.26 -44.42 79.68 Favored 'General case' 0 N--CA 1.488 1.475 0 O-C-N 121.272 -0.893 . . . . 0.0 109.238 179.742 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 55' ' ' ARG . . . . . 0.517 ' O ' ' N ' ' A' ' 59' ' ' SER . 93.6 mtt180 -51.38 -38.63 54.36 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.242 -0.911 . . . . 0.0 109.319 179.82 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -69.56 -33.3 71.81 Favored Glycine 0 N--CA 1.49 2.295 0 N-CA-C 109.508 -1.437 . . . . 0.0 109.508 179.926 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -75.92 -23.39 55.49 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.287 -1.125 . . . . 0.0 109.461 179.969 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 58' ' ' PHE . . . . . 0.599 ' CE2' ' CD1' ' A' ' 93' ' ' LEU . 97.0 m-85 -117.56 8.37 12.88 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.305 -0.872 . . . . 0.0 109.403 179.988 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 59' ' ' SER . . . . . 0.517 ' N ' ' O ' ' A' ' 55' ' ' ARG . 0.6 OUTLIER -75.16 -57.12 1.8 Allowed Pre-proline 0 N--CA 1.491 1.606 0 O-C-N 121.231 -0.918 . . . . 0.0 110.066 -179.637 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 60' ' ' PRO . . . . . 0.516 ' HD2' ' N ' ' A' ' 59' ' ' SER . 49.8 Cg_endo -69.5 -25.12 30.1 Favored 'Trans proline' 0 C--O 1.214 -0.68 0 C-N-CA 122.62 2.213 . . . . 0.0 112.213 -179.56 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 61' ' ' PHE . . . . . 0.563 ' CZ ' ' HB2' ' A' ' 92' ' ' GLU . 64.4 m-85 -72.67 -27.17 61.93 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.149 -0.97 . . . . 0.0 109.491 179.985 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 169.31 -176.0 43.45 Favored Glycine 0 N--CA 1.49 2.275 0 N-CA-C 109.464 -1.454 . . . . 0.0 109.464 179.939 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 83.2 m-20 -93.93 139.82 30.45 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.269 -1.136 . . . . 0.0 109.416 -179.995 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 64' ' ' ILE . . . . . 0.431 ' HA ' ' O ' ' A' ' 79' ' ' THR . 61.1 mt -100.61 132.84 45.5 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.588 0 O-C-N 121.236 -0.915 . . . . 0.0 109.539 179.995 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 65' ' ' ILE . . . . . 0.462 HG12 HG22 ' A' ' 79' ' ' THR . 26.7 pt -94.27 -24.04 5.07 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.604 0 O-C-N 121.341 -0.849 . . . . 0.0 109.442 179.98 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 66' ' ' ASP . . . . . 0.457 ' HB3' ' OG1' ' A' ' 79' ' ' THR . 55.3 t0 -147.78 136.6 21.95 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.22 -0.925 . . . . 0.0 109.561 -179.974 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . 0.484 ' C ' ' CD1' ' A' ' 67' ' ' LEU . 3.5 tm? -119.92 114.18 21.68 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.348 -0.845 . . . . 0.0 109.276 179.994 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 68' ' ' SER . . . . . 0.461 ' HB2' ' HB2' ' A' ' 77' ' ' PHE . 49.1 m -123.89 141.5 51.98 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.281 -0.887 . . . . 0.0 109.625 -179.993 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 69' ' ' MET . . . . . 0.485 ' SD ' ' N ' ' A' ' 51' ' ' PRO . 84.2 mtp -129.71 148.15 51.57 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.234 -0.916 . . . . 0.0 109.434 179.888 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 70' ' ' ASP . . . . . 0.457 ' C ' ' HD2' ' A' ' 72' ' ' PRO . 0.4 OUTLIER -124.21 102.0 34.29 Favored Pre-proline 0 N--CA 1.49 1.551 0 O-C-N 121.225 -0.922 . . . . 0.0 109.525 -179.959 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 71' ' ' PRO . . . . . 0.595 ' N ' ' CD ' ' A' ' 72' ' ' PRO . 46.5 Cg_endo -74.67 -27.6 10.54 Favored 'Trans proline' 0 CA--C 1.543 0.952 0 C-N-CA 122.519 2.146 . . . . 0.0 113.57 179.957 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 72' ' ' PRO . . . . . 0.595 ' CD ' ' N ' ' A' ' 71' ' ' PRO . 55.2 Cg_endo -75.57 -31.61 5.39 Favored 'Trans proline' 0 C--N 1.354 0.832 0 C-N-CA 121.452 1.435 . . . . 0.0 111.682 -179.911 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 73' ' ' ARG . . . . . 0.462 ' HG2' ' O ' ' A' ' 73' ' ' ARG . 19.5 ttt180 -103.85 -2.63 25.99 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.188 -0.945 . . . . 0.0 109.641 179.953 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 74' ' ' ASN . . . . . 0.441 ' HB2' ' O ' ' A' ' 73' ' ' ARG . 82.3 m-20 62.11 44.41 7.95 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.228 -0.92 . . . . 0.0 109.402 -179.901 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 75' ' ' CYS . . . . . . . . . . . . . 23.9 p -143.13 134.73 26.42 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.237 -0.915 . . . . 0.0 109.439 -179.96 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 76' ' ' ALA . . . . . 0.436 ' HA ' ' HA ' ' A' ' 69' ' ' MET . . . -107.63 160.45 15.69 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.316 -0.865 . . . . 0.0 109.436 179.985 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 77' ' ' PHE . . . . . 0.467 ' HA ' ' O ' ' A' ' 42' ' ' LEU . 96.5 m-85 -128.0 130.74 48.82 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.264 -0.898 . . . . 0.0 109.546 -179.948 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . 0.505 ' O ' ' CD1' ' A' ' 42' ' ' LEU . 33.7 t -121.43 134.22 65.47 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.556 0 O-C-N 121.146 -0.971 . . . . 0.0 109.485 -179.946 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 79' ' ' THR . . . . . 0.462 HG22 HG12 ' A' ' 65' ' ' ILE . 5.2 m -102.67 130.11 49.49 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.241 -0.912 . . . . 0.0 109.452 -179.977 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 80' ' ' TYR . . . . . 0.545 ' CD2' HD12 ' A' ' 42' ' ' LEU . 0.6 OUTLIER -110.73 136.68 49.43 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.149 -0.969 . . . . 0.0 109.515 -179.945 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 81.8 tt0 -54.56 -28.6 47.06 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.218 -0.926 . . . . 0.0 109.446 179.986 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 57.4 mttm -135.9 148.78 48.72 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.204 -0.935 . . . . 0.0 109.589 -179.965 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 83' ' ' MET . . . . . . . . . . . . . 61.2 mtt -67.84 -21.06 65.21 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.175 -0.953 . . . . 0.0 109.471 -179.96 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 97.2 mt-10 -66.96 -41.48 86.81 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.239 -0.913 . . . . 0.0 109.457 -179.949 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 19.8 m -64.05 -30.94 71.97 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.336 -0.853 . . . . 0.0 109.451 179.96 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 86' ' ' ALA . . . . . 0.527 ' O ' ' CG2' ' A' ' 90' ' ' VAL . . . -73.67 -31.08 63.28 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.297 -0.877 . . . . 0.0 109.455 179.903 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 58.6 t0 -67.99 -44.69 76.04 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.2 -0.937 . . . . 0.0 109.517 179.973 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 62.1 tt0 -64.28 -39.95 94.97 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.184 -0.948 . . . . 0.0 109.483 179.906 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 89' ' ' ALA . . . . . 0.561 ' HA ' ' CE1' ' A' ' 61' ' ' PHE . . . -74.51 -43.11 57.44 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.238 -0.914 . . . . 0.0 109.496 -179.901 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 90' ' ' VAL . . . . . 0.527 ' CG2' ' O ' ' A' ' 86' ' ' ALA . 88.9 t -61.49 -32.02 52.22 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.56 0 O-C-N 121.176 -0.953 . . . . 0.0 109.685 -179.867 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -80.14 -51.92 8.4 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.23 -0.919 . . . . 0.0 109.728 -179.841 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 92' ' ' GLU . . . . . 0.563 ' HB2' ' CZ ' ' A' ' 61' ' ' PHE . 74.1 mt-10 -71.63 -47.28 55.58 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.278 -0.889 . . . . 0.0 109.927 -179.699 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 93' ' ' LEU . . . . . 0.599 ' CD1' ' CE2' ' A' ' 58' ' ' PHE . 62.4 mt -63.78 -36.76 84.96 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.188 -0.945 . . . . 0.0 109.857 -179.643 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 94' ' ' ASN . . . . . 0.524 ' CB ' ' O ' ' A' ' 90' ' ' VAL . 61.0 t-20 -74.3 125.99 29.67 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.131 -0.98 . . . . 0.0 109.475 -179.865 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 96.1 22.1 21.01 Favored Glycine 0 N--CA 1.489 2.225 0 N-CA-C 109.461 -1.456 . . . . 0.0 109.461 179.916 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 96' ' ' THR . . . . . 0.521 ' CG2' ' O ' ' A' ' 92' ' ' GLU . 21.9 p -116.03 160.26 20.53 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.217 -1.166 . . . . 0.0 109.461 -179.975 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 97' ' ' GLN . . . . . 0.441 ' HG2' ' N ' ' A' ' 98' ' ' VAL . 64.2 tt0 -132.72 158.56 42.05 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.265 -0.897 . . . . 0.0 109.484 -179.911 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 98' ' ' VAL . . . . . 0.463 HG21 ' O ' ' A' ' 101' ' ' VAL . 1.2 t -108.56 -153.31 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.572 0 O-C-N 121.234 -0.916 . . . . 0.0 109.398 179.961 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 96.9 mt-10 -57.66 -36.76 72.33 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.217 -0.927 . . . . 0.0 109.61 -179.919 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 100' ' ' SER . . . . . 0.43 ' C ' HG23 ' A' ' 101' ' ' VAL . 0.1 OUTLIER -162.86 25.48 0.09 Allowed 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.25 -0.906 . . . . 0.0 109.494 179.944 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 101' ' ' VAL . . . . . 0.463 ' O ' HG21 ' A' ' 98' ' ' VAL . 84.8 t -139.37 146.61 25.35 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 O-C-N 121.239 -0.913 . . . . 0.0 109.496 179.938 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 90.3 mt-30 -100.83 147.42 26.11 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.263 -0.898 . . . . 0.0 109.495 -179.968 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 95.9 mt -113.7 133.84 55.1 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.241 -0.912 . . . . 0.0 109.493 -179.985 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 104' ' ' LYS . . . . . 0.463 ' O ' ' HA ' ' A' ' 44' ' ' VAL . 70.5 mttt -115.75 145.31 42.9 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.264 -0.897 . . . . 0.0 109.308 179.964 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 105' ' ' VAL . . . . . 0.513 HG13 ' CG2' ' A' ' 90' ' ' VAL . 29.2 t . . . . . 0 N--CA 1.489 1.524 0 O-C-N 121.12 -0.988 . . . . 0.0 109.718 -179.789 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 40' ' ' ASN . . . . . 0.529 ' N ' ' O ' ' A' ' 80' ' ' TYR . 54.3 t30 . . . . . 0 N--CA 1.491 1.591 0 N-CA-C 109.352 -0.61 . . . . 0.0 109.352 . . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 41' ' ' THR . . . . . 0.468 ' O ' HD21 ' A' ' 42' ' ' LEU . 45.1 m -74.49 136.55 42.24 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.273 -0.892 . . . . 0.0 109.839 -179.695 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . 0.577 HD12 ' CD2' ' A' ' 80' ' ' TYR . 13.7 mt -119.47 157.21 28.74 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.363 -0.836 . . . . 0.0 109.322 179.84 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 43' ' ' TYR . . . . . 0.432 ' CZ ' ' CB ' ' A' ' 75' ' ' CYS . 69.9 t80 -114.14 121.38 43.59 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.261 -0.899 . . . . 0.0 109.448 -179.976 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 47.4 t -115.88 136.3 53.21 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.579 0 O-C-N 121.331 -0.855 . . . . 0.0 109.367 179.948 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 71.8 t80 -126.35 130.61 51.13 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.264 -0.897 . . . . 0.0 109.488 -179.923 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -175.83 -173.94 41.96 Favored Glycine 0 N--CA 1.49 2.272 0 N-CA-C 109.472 -1.451 . . . . 0.0 109.472 179.999 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . 0.422 ' O ' ' C ' ' A' ' 48' ' ' ASP . 94.8 mt-10 -115.88 156.39 26.22 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.231 -1.158 . . . . 0.0 109.487 -179.916 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 48' ' ' ASP . . . . . 0.422 ' C ' ' O ' ' A' ' 47' ' ' GLU . 38.1 m-20 44.21 51.19 7.49 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.229 -0.919 . . . . 0.0 109.551 179.936 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 55.3 mtm -100.57 137.09 39.45 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.272 -0.893 . . . . 0.0 109.433 179.981 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 50' ' ' THR . . . . . 0.406 ' O ' ' CD1' ' A' ' 54' ' ' LEU . 0.3 OUTLIER -119.76 163.21 28.86 Favored Pre-proline 0 N--CA 1.491 1.583 0 O-C-N 121.308 -0.87 . . . . 0.0 109.441 179.963 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 48.7 Cg_endo -70.13 -54.26 0.21 Allowed 'Trans proline' 0 C--O 1.214 -0.677 0 C-N-CA 122.629 2.22 . . . . 0.0 111.815 -179.992 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 37.3 m -53.27 -48.49 68.25 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.185 -0.947 . . . . 0.0 109.317 179.921 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 17.6 tp -58.63 -48.49 80.83 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.247 -0.908 . . . . 0.0 109.28 179.824 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 54' ' ' LEU . . . . . 0.49 ' CD1' ' SD ' ' A' ' 69' ' ' MET . 16.6 mt -57.87 -44.99 87.0 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.232 -0.917 . . . . 0.0 109.259 179.793 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 55' ' ' ARG . . . . . 0.514 ' O ' ' N ' ' A' ' 59' ' ' SER . 57.5 mtt-85 -50.94 -39.75 55.66 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.244 -0.91 . . . . 0.0 109.2 179.853 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -69.5 -30.87 70.92 Favored Glycine 0 N--CA 1.49 2.243 0 N-CA-C 109.313 -1.515 . . . . 0.0 109.313 179.767 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -79.51 -21.53 45.15 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.243 -1.151 . . . . 0.0 109.467 179.998 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 58' ' ' PHE . . . . . 0.634 ' CE2' ' CD1' ' A' ' 93' ' ' LEU . 94.5 m-85 -119.09 7.97 11.47 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.26 -0.9 . . . . 0.0 109.384 179.929 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 59' ' ' SER . . . . . 0.52 ' N ' ' HD2' ' A' ' 60' ' ' PRO . 0.6 OUTLIER -75.24 -55.54 2.18 Favored Pre-proline 0 N--CA 1.49 1.562 0 O-C-N 121.286 -0.884 . . . . 0.0 110.196 -179.591 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 60' ' ' PRO . . . . . 0.52 ' HD2' ' N ' ' A' ' 59' ' ' SER . 48.4 Cg_endo -69.42 -29.6 25.24 Favored 'Trans proline' 0 C--O 1.214 -0.677 0 C-N-CA 122.542 2.161 . . . . 0.0 112.208 -179.408 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 61' ' ' PHE . . . . . 0.568 ' CE1' ' HB3' ' A' ' 92' ' ' GLU . 55.2 m-85 -67.48 -28.88 68.22 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.21 -0.931 . . . . 0.0 109.534 179.984 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 172.81 -178.43 44.85 Favored Glycine 0 N--CA 1.49 2.293 0 N-CA-C 109.579 -1.408 . . . . 0.0 109.579 179.951 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 47.9 t-20 -94.26 138.25 32.49 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.292 -1.122 . . . . 0.0 109.447 179.99 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 57.7 mt -100.02 135.49 35.48 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.502 0 O-C-N 121.258 -0.901 . . . . 0.0 109.392 -179.972 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 65' ' ' ILE . . . . . 0.472 HG23 HD12 ' A' ' 65' ' ' ILE . 27.2 pt -102.6 -21.76 5.05 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.636 0 O-C-N 121.326 -0.859 . . . . 0.0 109.659 -179.833 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 66' ' ' ASP . . . . . 0.451 ' HB3' ' OG1' ' A' ' 79' ' ' THR . 56.7 t0 -145.39 111.8 5.76 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.122 -0.986 . . . . 0.0 109.675 -179.966 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 32.3 tp -108.11 123.6 48.95 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.328 -0.857 . . . . 0.0 109.358 179.919 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 68' ' ' SER . . . . . 0.463 ' HB3' ' HB2' ' A' ' 77' ' ' PHE . 23.2 t -134.25 140.71 46.64 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.271 -0.893 . . . . 0.0 109.505 -179.941 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 69' ' ' MET . . . . . 0.49 ' SD ' ' CD1' ' A' ' 54' ' ' LEU . 87.6 mmm -113.71 151.65 31.58 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.301 -0.874 . . . . 0.0 109.502 179.923 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 70' ' ' ASP . . . . . 0.448 ' C ' ' HD2' ' A' ' 72' ' ' PRO . 0.3 OUTLIER -131.84 100.29 16.14 Favored Pre-proline 0 N--CA 1.49 1.554 0 O-C-N 121.277 -0.89 . . . . 0.0 109.522 179.95 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 71' ' ' PRO . . . . . 0.595 ' CD ' ' CD ' ' A' ' 72' ' ' PRO . 46.7 Cg_endo -74.53 -27.9 10.56 Favored 'Trans proline' 0 CA--C 1.543 0.943 0 C-N-CA 122.497 2.131 . . . . 0.0 113.629 -179.897 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 72' ' ' PRO . . . . . 0.595 ' CD ' ' CD ' ' A' ' 71' ' ' PRO . 54.5 Cg_endo -75.46 -32.79 4.61 Favored 'Trans proline' 0 C--N 1.353 0.763 0 C-N-CA 121.431 1.42 . . . . 0.0 111.643 -179.89 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 73' ' ' ARG . . . . . 0.458 ' O ' ' HG3' ' A' ' 73' ' ' ARG . 13.6 tpt180 -101.45 -4.85 26.11 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.249 -0.907 . . . . 0.0 109.523 -179.978 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 74' ' ' ASN . . . . . 0.451 ' HB2' ' O ' ' A' ' 73' ' ' ARG . 77.5 m-20 61.95 43.78 8.84 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.194 -0.941 . . . . 0.0 109.507 -179.854 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 75' ' ' CYS . . . . . 0.432 ' CB ' ' CZ ' ' A' ' 43' ' ' TYR . 31.4 p -147.48 142.73 27.27 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.298 -0.876 . . . . 0.0 109.48 -179.954 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 76' ' ' ALA . . . . . 0.413 ' HB2' ' CE ' ' A' ' 69' ' ' MET . . . -107.29 163.17 13.25 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.296 -0.877 . . . . 0.0 109.469 179.984 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 77' ' ' PHE . . . . . 0.463 ' HB2' ' HB3' ' A' ' 68' ' ' SER . 96.7 m-85 -122.84 130.89 53.43 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.317 -0.864 . . . . 0.0 109.544 -179.969 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . 0.495 ' O ' ' N ' ' A' ' 42' ' ' LEU . 46.7 t -126.52 140.11 49.79 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.604 0 O-C-N 121.278 -0.889 . . . . 0.0 109.33 179.861 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 79' ' ' THR . . . . . 0.469 ' HA ' ' O ' ' A' ' 40' ' ' ASN . 2.5 m -115.55 112.73 22.63 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.224 -0.922 . . . . 0.0 109.584 -179.849 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 80' ' ' TYR . . . . . 0.577 ' CD2' HD12 ' A' ' 42' ' ' LEU . 1.4 m-85 -93.12 123.15 36.17 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.25 -0.906 . . . . 0.0 109.402 179.932 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 81' ' ' GLU . . . . . 0.451 ' C ' ' O ' ' A' ' 80' ' ' TYR . 86.1 tt0 -38.88 -34.54 0.16 Allowed 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.537 -0.727 . . . . 0.0 110.302 -179.667 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 57.2 mttp -128.52 158.38 38.57 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.068 -1.02 . . . . 0.0 109.594 -179.911 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 83' ' ' MET . . . . . . . . . . . . . 58.9 mtt -74.65 -21.71 59.29 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.274 -0.891 . . . . 0.0 109.452 179.936 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 75.6 mm-40 -68.51 -46.99 68.16 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.339 -0.851 . . . . 0.0 109.473 -179.958 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 14.0 m -55.5 -35.03 65.14 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.283 -0.885 . . . . 0.0 109.369 -179.945 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 86' ' ' ALA . . . . . 0.525 ' HB2' ' CD2' ' A' ' 42' ' ' LEU . . . -75.44 -28.75 59.46 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.318 -0.863 . . . . 0.0 109.559 -179.968 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 57.1 t0 -66.18 -40.07 90.17 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.246 -0.908 . . . . 0.0 109.551 -179.925 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 88' ' ' GLN . . . . . 0.478 ' O ' ' CB ' ' A' ' 92' ' ' GLU . 47.7 tt0 -74.99 -35.64 62.01 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.244 -0.91 . . . . 0.0 109.431 -179.895 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 89' ' ' ALA . . . . . 0.534 ' HA ' ' CD1' ' A' ' 61' ' ' PHE . . . -77.47 -41.64 38.85 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.23 -0.919 . . . . 0.0 109.614 -179.912 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 90' ' ' VAL . . . . . 0.49 ' O ' ' CB ' ' A' ' 94' ' ' ASN . 68.8 t -65.1 -47.35 88.11 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.603 0 O-C-N 121.247 -0.908 . . . . 0.0 109.638 -179.892 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -73.04 -39.65 65.77 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.218 -0.926 . . . . 0.0 109.582 -179.917 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 92' ' ' GLU . . . . . 0.568 ' HB3' ' CE1' ' A' ' 61' ' ' PHE . 44.4 tp10 -74.25 -50.22 19.93 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.266 -0.896 . . . . 0.0 109.682 -179.954 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 93' ' ' LEU . . . . . 0.634 ' CD1' ' CE2' ' A' ' 58' ' ' PHE . 42.2 mt -65.24 -38.98 92.05 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.21 -0.931 . . . . 0.0 109.534 -179.841 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 94' ' ' ASN . . . . . 0.49 ' CB ' ' O ' ' A' ' 90' ' ' VAL . 59.3 t-20 -67.74 129.37 39.69 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.241 -0.912 . . . . 0.0 109.535 179.999 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 98.94 17.31 28.13 Favored Glycine 0 N--CA 1.49 2.285 0 N-CA-C 109.543 -1.423 . . . . 0.0 109.543 -179.997 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 96' ' ' THR . . . . . 0.422 HG22 ' O ' ' A' ' 93' ' ' LEU . 16.1 p -116.16 158.79 22.71 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.251 -1.146 . . . . 0.0 109.473 179.936 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 61.3 tt0 -122.8 139.83 53.58 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.255 -0.903 . . . . 0.0 109.497 179.998 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 98' ' ' VAL . . . . . 0.453 HG23 ' O ' ' A' ' 101' ' ' VAL . 1.1 t -81.79 -157.48 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.608 0 O-C-N 121.247 -0.908 . . . . 0.0 109.302 -179.982 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 76.4 mm-40 -60.64 -38.28 84.28 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.23 -0.919 . . . . 0.0 109.584 -179.958 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 100' ' ' SER . . . . . 0.455 ' O ' ' OG ' ' A' ' 100' ' ' SER . 4.9 t -155.04 24.04 0.43 Allowed 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.248 -0.907 . . . . 0.0 109.613 179.943 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 101' ' ' VAL . . . . . 0.453 ' O ' HG23 ' A' ' 98' ' ' VAL . 57.5 t -141.0 155.91 21.93 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.553 0 O-C-N 121.226 -0.921 . . . . 0.0 109.515 179.891 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 92.8 mt-30 -98.3 143.19 29.04 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.242 -0.911 . . . . 0.0 109.447 -179.971 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 103' ' ' LEU . . . . . 0.442 ' HG ' HG21 ' A' ' 98' ' ' VAL . 92.7 mt -101.85 141.86 34.05 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.25 -0.906 . . . . 0.0 109.44 179.975 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 1.3 mtpm? -131.45 134.21 45.97 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.281 -0.887 . . . . 0.0 109.4 179.921 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 105' ' ' VAL . . . . . 0.461 HG13 ' CG2' ' A' ' 90' ' ' VAL . 17.8 t . . . . . 0 N--CA 1.49 1.534 0 O-C-N 121.17 -0.956 . . . . 0.0 109.65 -179.931 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 40' ' ' ASN . . . . . 0.49 ' N ' ' O ' ' A' ' 80' ' ' TYR . 61.7 t30 . . . . . 0 N--CA 1.493 1.686 0 CA-C-O 121.216 0.531 . . . . 0.0 109.799 . . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 41' ' ' THR . . . . . 0.466 ' HA ' ' O ' ' A' ' 78' ' ' VAL . 91.2 m -80.5 153.73 27.98 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.18 -0.95 . . . . 0.0 109.841 -179.913 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . 0.529 ' CD1' ' O ' ' A' ' 78' ' ' VAL . 4.7 mp -131.05 155.4 46.95 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.376 -0.827 . . . . 0.0 109.305 179.763 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 39.2 t80 -113.67 108.9 17.76 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.206 -0.934 . . . . 0.0 109.594 -179.923 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 44' ' ' VAL . . . . . 0.449 ' HA ' ' O ' ' A' ' 104' ' ' LYS . 39.3 t -105.28 146.04 12.8 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 O-C-N 121.289 -0.882 . . . . 0.0 109.488 179.999 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 67.0 t80 -135.59 140.47 44.66 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.21 -0.931 . . . . 0.0 109.468 179.989 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 174.82 -165.17 36.26 Favored Glycine 0 N--CA 1.491 2.321 0 N-CA-C 109.464 -1.454 . . . . 0.0 109.464 -179.995 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 90.3 mt-10 -115.07 157.48 23.46 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.238 -1.154 . . . . 0.0 109.584 -179.908 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 56.0 t0 44.76 45.16 8.13 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.273 -0.892 . . . . 0.0 109.576 179.992 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 34.2 mtp -81.79 133.43 35.34 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.195 -0.941 . . . . 0.0 109.423 179.934 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 50' ' ' THR . . . . . 0.456 ' O ' ' CD1' ' A' ' 54' ' ' LEU . 0.1 OUTLIER -125.77 162.08 47.26 Favored Pre-proline 0 N--CA 1.49 1.527 0 O-C-N 121.208 -0.932 . . . . 0.0 109.461 -179.897 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 51' ' ' PRO . . . . . 0.467 ' N ' ' SD ' ' A' ' 69' ' ' MET . 50.2 Cg_endo -70.6 -53.28 0.23 Allowed 'Trans proline' 0 C--O 1.215 -0.648 0 C-N-CA 122.696 2.264 . . . . 0.0 111.644 179.957 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 30.2 m -55.87 -47.93 76.45 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.223 -0.923 . . . . 0.0 109.317 179.867 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 15.5 tp -56.94 -54.23 48.96 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.311 -0.868 . . . . 0.0 109.231 179.871 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 54' ' ' LEU . . . . . 0.456 ' CD1' ' O ' ' A' ' 50' ' ' THR . 12.4 mt -51.63 -52.83 44.65 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.221 -0.925 . . . . 0.0 109.225 179.766 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 55' ' ' ARG . . . . . 0.508 ' O ' ' N ' ' A' ' 59' ' ' SER . 49.2 mtt180 -44.09 -40.28 4.8 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.354 -0.841 . . . . 0.0 109.212 179.872 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -70.43 -33.33 68.0 Favored Glycine 0 N--CA 1.49 2.273 0 N-CA-C 109.314 -1.514 . . . . 0.0 109.314 179.771 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . 0.456 ' N ' ' O ' ' A' ' 54' ' ' LEU . . . -79.81 -16.29 55.78 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.288 -1.125 . . . . 0.0 109.444 179.88 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 58' ' ' PHE . . . . . 0.631 ' CE2' ' CD1' ' A' ' 93' ' ' LEU . 96.3 m-85 -124.36 10.57 8.61 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.257 -0.902 . . . . 0.0 109.5 179.998 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 59' ' ' SER . . . . . 0.517 ' N ' ' HD2' ' A' ' 60' ' ' PRO . 0.6 OUTLIER -77.08 -54.47 1.54 Allowed Pre-proline 0 N--CA 1.491 1.622 0 O-C-N 121.258 -0.901 . . . . 0.0 110.268 -179.624 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 60' ' ' PRO . . . . . 0.517 ' HD2' ' N ' ' A' ' 59' ' ' SER . 50.4 Cg_endo -70.63 -35.07 10.66 Favored 'Trans proline' 0 C--O 1.214 -0.681 0 C-N-CA 122.5 2.133 . . . . 0.0 112.284 -179.213 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 61' ' ' PHE . . . . . 0.564 ' CE1' ' HA ' ' A' ' 89' ' ' ALA . 74.2 m-85 -59.53 -33.99 72.08 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.168 -0.958 . . . . 0.0 109.495 -179.907 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 175.46 178.11 45.04 Favored Glycine 0 N--CA 1.49 2.236 0 N-CA-C 109.489 -1.445 . . . . 0.0 109.489 179.921 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 54.5 t30 -86.99 144.18 27.02 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.246 -1.149 . . . . 0.0 109.433 179.938 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 64' ' ' ILE . . . . . 0.464 ' HA ' ' O ' ' A' ' 79' ' ' THR . 67.1 mt -106.28 134.32 48.21 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.534 0 O-C-N 121.23 -0.919 . . . . 0.0 109.388 -179.965 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 37.8 pt -101.67 -25.78 3.7 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.524 0 O-C-N 121.233 -0.917 . . . . 0.0 109.661 -179.774 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 66' ' ' ASP . . . . . 0.443 ' O ' ' OG1' ' A' ' 79' ' ' THR . 55.4 t0 -142.34 115.83 9.06 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.227 -0.92 . . . . 0.0 109.606 -179.853 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 15.8 tp -105.41 115.95 31.12 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.288 -0.883 . . . . 0.0 109.467 179.908 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 68' ' ' SER . . . . . 0.437 ' HB2' ' HB2' ' A' ' 77' ' ' PHE . 67.7 m -123.94 146.66 48.32 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.271 -0.893 . . . . 0.0 109.414 179.972 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 69' ' ' MET . . . . . 0.467 ' SD ' ' N ' ' A' ' 51' ' ' PRO . 72.0 mtp -131.51 150.89 51.98 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.219 -0.926 . . . . 0.0 109.609 -179.903 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 70' ' ' ASP . . . . . 0.448 ' C ' ' HD2' ' A' ' 72' ' ' PRO . 0.5 OUTLIER -126.24 103.84 25.9 Favored Pre-proline 0 N--CA 1.49 1.571 0 O-C-N 121.228 -0.92 . . . . 0.0 109.392 179.903 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 71' ' ' PRO . . . . . 0.605 ' N ' ' CD ' ' A' ' 72' ' ' PRO . 48.2 Cg_endo -74.91 -27.66 10.0 Favored 'Trans proline' 0 CA--C 1.542 0.903 0 C-N-CA 122.553 2.169 . . . . 0.0 113.793 -179.936 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 72' ' ' PRO . . . . . 0.605 ' CD ' ' N ' ' A' ' 71' ' ' PRO . 55.2 Cg_endo -74.89 -24.85 12.66 Favored 'Trans proline' 0 C--N 1.352 0.752 0 C-N-CA 121.525 1.483 . . . . 0.0 111.934 -179.783 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 61.1 mtt-85 -113.83 2.66 15.19 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.237 -0.914 . . . . 0.0 109.671 -179.812 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 82.8 m-20 58.09 38.9 26.59 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.128 -0.983 . . . . 0.0 109.533 179.924 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 75' ' ' CYS . . . . . . . . . . . . . 29.7 p -135.49 134.04 39.12 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.189 -0.944 . . . . 0.0 109.573 -179.941 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 76' ' ' ALA . . . . . 0.459 ' HA ' ' HA ' ' A' ' 69' ' ' MET . . . -106.48 161.73 14.34 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.257 -0.902 . . . . 0.0 109.339 179.882 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 77' ' ' PHE . . . . . 0.462 ' HA ' ' O ' ' A' ' 42' ' ' LEU . 97.4 m-85 -125.43 128.33 47.91 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.241 -0.912 . . . . 0.0 109.599 -179.853 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . 0.529 ' O ' ' CD1' ' A' ' 42' ' ' LEU . 13.7 t -117.88 141.01 38.82 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.526 0 O-C-N 121.24 -0.913 . . . . 0.0 109.182 179.793 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 79' ' ' THR . . . . . 0.471 ' HA ' ' O ' ' A' ' 40' ' ' ASN . 0.4 OUTLIER -112.18 127.73 56.03 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.279 -0.888 . . . . 0.0 109.612 -179.653 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 80' ' ' TYR . . . . . 0.524 ' OH ' ' CA ' ' A' ' 58' ' ' PHE . 1.8 m-85 -111.37 126.96 55.48 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.352 -0.842 . . . . 0.0 109.382 -179.948 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 81' ' ' GLU . . . . . 0.423 ' C ' ' O ' ' A' ' 80' ' ' TYR . 88.1 tt0 -40.74 -39.07 1.02 Allowed 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.456 -0.778 . . . . 0.0 110.192 -179.789 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 46.8 mttp -126.78 156.35 41.37 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.042 -1.036 . . . . 0.0 109.589 -179.766 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 83' ' ' MET . . . . . 0.419 ' HG2' ' CG ' ' A' ' 40' ' ' ASN . 40.9 mtt -73.72 -20.74 60.44 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.272 -0.892 . . . . 0.0 109.404 179.895 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 97.5 mt-10 -65.57 -50.64 64.4 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.257 -0.902 . . . . 0.0 109.392 179.875 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 27.5 m -59.25 -35.16 73.18 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.152 -0.968 . . . . 0.0 109.252 179.847 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 86' ' ' ALA . . . . . 0.495 ' HA ' ' CD2' ' A' ' 80' ' ' TYR . . . -74.94 -31.04 61.41 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.344 -0.847 . . . . 0.0 109.157 179.76 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 90.5 m-20 -67.65 -37.46 82.44 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.26 -0.9 . . . . 0.0 109.276 179.855 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 64.4 tt0 -70.96 -42.14 70.15 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.255 -0.903 . . . . 0.0 109.374 179.841 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 89' ' ' ALA . . . . . 0.564 ' HA ' ' CE1' ' A' ' 61' ' ' PHE . . . -68.83 -42.73 76.81 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.249 -0.907 . . . . 0.0 109.296 -179.971 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 90' ' ' VAL . . . . . 0.517 ' O ' ' CB ' ' A' ' 94' ' ' ASN . 79.3 t -58.1 -37.27 60.94 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.52 0 O-C-N 121.201 -0.937 . . . . 0.0 109.498 -179.944 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -76.1 -53.26 8.59 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.26 -0.9 . . . . 0.0 109.587 -179.832 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 92' ' ' GLU . . . . . 0.521 ' O ' ' CG2' ' A' ' 96' ' ' THR . 74.9 mm-40 -67.2 -42.99 83.22 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.361 -0.837 . . . . 0.0 109.648 -179.762 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 93' ' ' LEU . . . . . 0.631 ' CD1' ' CE2' ' A' ' 58' ' ' PHE . 87.4 mt -68.87 -39.0 80.08 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.206 -0.934 . . . . 0.0 109.617 -179.835 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 94' ' ' ASN . . . . . 0.517 ' CB ' ' O ' ' A' ' 90' ' ' VAL . 21.2 t-20 -67.84 129.99 41.6 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.243 -0.911 . . . . 0.0 109.51 -179.96 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 85.85 32.11 19.03 Favored Glycine 0 N--CA 1.489 2.221 0 N-CA-C 109.514 -1.435 . . . . 0.0 109.514 -179.986 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 96' ' ' THR . . . . . 0.521 ' CG2' ' O ' ' A' ' 92' ' ' GLU . 27.6 p -119.45 160.28 22.66 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.15 -1.206 . . . . 0.0 109.45 -179.994 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 97' ' ' GLN . . . . . 0.502 ' HG2' ' N ' ' A' ' 98' ' ' VAL . 62.1 tt0 -135.89 159.88 40.3 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.259 -0.9 . . . . 0.0 109.483 -179.951 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 98' ' ' VAL . . . . . 0.502 ' N ' ' HG2' ' A' ' 97' ' ' GLN . 1.1 t -113.26 -160.25 0.17 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.591 0 O-C-N 121.252 -0.905 . . . . 0.0 109.351 -179.993 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 95.9 mt-10 -51.73 -35.42 43.21 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.167 -0.958 . . . . 0.0 109.549 -179.943 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 100' ' ' SER . . . . . 0.46 ' O ' ' OG ' ' A' ' 100' ' ' SER . 6.1 t -164.9 28.59 0.06 Allowed 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.197 -0.939 . . . . 0.0 109.498 -179.943 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 59.7 t -140.42 147.99 22.7 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.564 0 O-C-N 121.244 -0.91 . . . . 0.0 109.464 179.968 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 91.5 mt-30 -97.34 146.65 24.96 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.239 -0.913 . . . . 0.0 109.508 -179.975 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 77.8 mt -111.54 135.21 52.43 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.26 -0.9 . . . . 0.0 109.489 -179.969 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 104' ' ' LYS . . . . . 0.449 ' O ' ' HA ' ' A' ' 44' ' ' VAL . 54.8 mttt -121.8 140.57 52.2 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.226 -0.921 . . . . 0.0 109.482 179.997 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 105' ' ' VAL . . . . . 0.502 ' CG1' ' HA ' ' A' ' 90' ' ' VAL . 34.3 t . . . . . 0 N--CA 1.49 1.557 0 O-C-N 121.274 -0.891 . . . . 0.0 109.421 -179.986 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 40' ' ' ASN . . . . . 0.48 ' O ' HD13 ' A' ' 42' ' ' LEU . 49.6 t30 . . . . . 0 N--CA 1.49 1.566 0 N-CA-C 108.947 -0.761 . . . . 0.0 108.947 . . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 41' ' ' THR . . . . . 0.498 HG22 ' N ' ' A' ' 42' ' ' LEU . 34.2 m -78.01 149.17 34.09 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.259 -0.9 . . . . 0.0 110.105 -179.464 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . 0.498 ' N ' HG22 ' A' ' 41' ' ' THR . 5.2 mp -126.31 154.4 43.51 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.278 -0.889 . . . . 0.0 109.28 179.723 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 43' ' ' TYR . . . . . 0.4 ' O ' ' HA ' ' A' ' 105' ' ' VAL . 76.1 t80 -107.87 114.82 29.02 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.292 -0.88 . . . . 0.0 109.52 179.875 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 44' ' ' VAL . . . . . 0.485 ' CG1' HD21 ' A' ' 103' ' ' LEU . 40.6 t -108.52 137.4 40.45 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 121.299 -0.876 . . . . 0.0 109.451 -179.959 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 45' ' ' TYR . . . . . 0.402 ' HB3' ' HB2' ' A' ' 104' ' ' LYS . 65.7 t80 -127.66 135.38 50.14 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.217 -0.927 . . . . 0.0 109.581 -179.844 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 171.24 -177.79 43.97 Favored Glycine 0 N--CA 1.49 2.259 0 N-CA-C 109.553 -1.419 . . . . 0.0 109.553 179.93 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 95.4 mt-10 -116.29 161.83 18.42 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.282 -1.128 . . . . 0.0 109.441 179.997 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 49.9 m-20 44.0 49.51 7.32 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.256 -0.902 . . . . 0.0 109.518 179.947 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 51.1 mtm -101.88 138.82 38.35 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.307 -0.871 . . . . 0.0 109.537 -179.947 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -122.55 162.94 35.56 Favored Pre-proline 0 N--CA 1.489 1.505 0 O-C-N 121.343 -0.848 . . . . 0.0 109.363 179.914 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 51' ' ' PRO . . . . . 0.457 ' HB3' HD11 ' A' ' 67' ' ' LEU . 47.8 Cg_endo -69.6 -53.61 0.27 Allowed 'Trans proline' 0 C--O 1.215 -0.674 0 C-N-CA 122.592 2.194 . . . . 0.0 111.768 -179.991 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 31.1 m -49.3 -49.23 44.73 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.232 -0.918 . . . . 0.0 109.194 179.867 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 26.8 tp -59.7 -46.54 88.77 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.309 -0.869 . . . . 0.0 109.203 179.714 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 54' ' ' LEU . . . . . 0.498 ' CD1' ' SD ' ' A' ' 69' ' ' MET . 12.4 mt -57.39 -46.25 83.63 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.322 -0.861 . . . . 0.0 109.193 179.726 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 55' ' ' ARG . . . . . 0.513 ' O ' ' N ' ' A' ' 59' ' ' SER . 83.9 mtt-85 -51.34 -39.84 57.86 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.295 -0.878 . . . . 0.0 109.175 179.79 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -68.77 -35.2 79.46 Favored Glycine 0 N--CA 1.489 2.226 0 N-CA-C 109.35 -1.5 . . . . 0.0 109.35 179.909 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . 0.456 ' O ' ' CD1' ' A' ' 61' ' ' PHE . . . -73.4 -27.64 61.57 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.216 -1.167 . . . . 0.0 109.379 179.92 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 58' ' ' PHE . . . . . 0.636 ' CE2' ' CD1' ' A' ' 93' ' ' LEU . 96.3 m-85 -112.18 8.44 19.89 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.304 -0.873 . . . . 0.0 109.34 179.969 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 59' ' ' SER . . . . . 0.517 ' N ' ' HD2' ' A' ' 60' ' ' PRO . 1.0 OUTLIER -74.09 -57.25 2.37 Favored Pre-proline 0 N--CA 1.491 1.6 0 O-C-N 121.372 -0.83 . . . . 0.0 110.106 -179.693 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 60' ' ' PRO . . . . . 0.517 ' HD2' ' N ' ' A' ' 59' ' ' SER . 47.3 Cg_endo -68.7 -27.66 31.72 Favored 'Trans proline' 0 C--O 1.215 -0.666 0 C-N-CA 122.676 2.25 . . . . 0.0 112.037 -179.511 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 61' ' ' PHE . . . . . 0.567 ' CE2' ' HA ' ' A' ' 89' ' ' ALA . 72.0 m-85 -69.56 -33.41 72.71 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.201 -0.937 . . . . 0.0 109.514 179.981 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 175.18 -169.71 42.64 Favored Glycine 0 N--CA 1.49 2.278 0 N-CA-C 109.487 -1.445 . . . . 0.0 109.487 179.996 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 83.9 m-20 -99.93 138.86 36.42 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.201 -1.176 . . . . 0.0 109.439 179.916 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 64' ' ' ILE . . . . . 0.424 ' HA ' ' O ' ' A' ' 79' ' ' THR . 49.1 mt -101.31 128.51 53.54 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.521 0 O-C-N 121.266 -0.896 . . . . 0.0 109.585 -179.938 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 65' ' ' ILE . . . . . 0.445 HD11 HG22 ' A' ' 79' ' ' THR . 23.0 pt -94.79 -25.19 4.66 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 O-C-N 121.238 -0.914 . . . . 0.0 109.409 -179.896 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 66' ' ' ASP . . . . . 0.457 ' HB3' ' OG1' ' A' ' 79' ' ' THR . 58.4 t0 -141.02 129.84 23.0 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.198 -0.939 . . . . 0.0 109.601 -179.955 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . 0.495 ' C ' ' CD1' ' A' ' 67' ' ' LEU . 3.4 tm? -119.29 116.35 26.05 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.303 -0.873 . . . . 0.0 109.364 179.934 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 68' ' ' SER . . . . . 0.468 ' HB2' ' HB2' ' A' ' 77' ' ' PHE . 58.0 m -121.13 145.35 47.9 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.14 -0.975 . . . . 0.0 109.532 -179.94 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 69' ' ' MET . . . . . 0.498 ' SD ' ' CD1' ' A' ' 54' ' ' LEU . 89.8 mmm -122.61 144.18 49.28 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.24 -0.912 . . . . 0.0 109.531 -179.952 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 70' ' ' ASP . . . . . 0.464 ' HB2' ' O ' ' A' ' 75' ' ' CYS . 0.2 OUTLIER -124.57 94.31 44.86 Favored Pre-proline 0 N--CA 1.49 1.566 0 O-C-N 121.2 -0.937 . . . . 0.0 109.461 179.917 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 71' ' ' PRO . . . . . 0.598 ' N ' ' CD ' ' A' ' 72' ' ' PRO . 46.5 Cg_endo -74.6 -28.0 10.31 Favored 'Trans proline' 0 CA--C 1.542 0.922 0 C-N-CA 122.506 2.137 . . . . 0.0 113.696 -179.989 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 72' ' ' PRO . . . . . 0.598 ' CD ' ' N ' ' A' ' 71' ' ' PRO . 55.2 Cg_endo -75.45 -22.38 14.11 Favored 'Trans proline' 0 C--N 1.352 0.722 0 C-N-CA 121.523 1.482 . . . . 0.0 111.75 -179.788 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 27.4 mtt85 -113.26 3.8 16.15 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.22 -0.925 . . . . 0.0 109.654 -179.9 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 73.4 m-20 58.23 47.86 13.59 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.244 -0.91 . . . . 0.0 109.45 179.972 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 75' ' ' CYS . . . . . 0.464 ' O ' ' HB2' ' A' ' 70' ' ' ASP . 31.1 p -152.63 148.26 27.11 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.284 -0.885 . . . . 0.0 109.456 -179.968 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 76' ' ' ALA . . . . . 0.487 ' HB1' ' CE ' ' A' ' 69' ' ' MET . . . -120.34 157.54 29.02 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.273 -0.892 . . . . 0.0 109.401 179.919 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 77' ' ' PHE . . . . . 0.468 ' HB2' ' HB2' ' A' ' 68' ' ' SER . 97.7 m-85 -119.59 139.75 51.66 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.202 -0.936 . . . . 0.0 109.569 -179.849 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . 0.471 ' O ' ' CD1' ' A' ' 42' ' ' LEU . 20.5 t -129.23 137.97 55.65 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.546 0 O-C-N 121.191 -0.943 . . . . 0.0 109.55 179.988 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 79' ' ' THR . . . . . 0.471 ' HA ' ' O ' ' A' ' 40' ' ' ASN . 23.3 m -106.19 134.83 48.7 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.194 -0.941 . . . . 0.0 109.264 179.89 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 80' ' ' TYR . . . . . 0.469 ' OH ' ' HB2' ' A' ' 61' ' ' PHE . 0.7 OUTLIER -113.21 141.63 46.74 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.214 -0.929 . . . . 0.0 109.62 -179.917 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 80.8 tt0 -64.03 -22.6 67.0 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.209 -0.932 . . . . 0.0 109.359 179.795 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 38.2 mttp -136.05 135.93 39.8 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.243 -0.91 . . . . 0.0 109.461 179.982 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 83' ' ' MET . . . . . . . . . . . . . 47.0 mtt -57.33 -24.64 56.37 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.244 -0.91 . . . . 0.0 109.401 179.928 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 98.4 mt-10 -66.2 -37.49 85.71 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.305 -0.872 . . . . 0.0 109.557 179.981 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 19.3 m -62.37 -31.48 72.15 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.236 -0.915 . . . . 0.0 109.571 -179.97 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 86' ' ' ALA . . . . . 0.484 ' O ' ' CG2' ' A' ' 90' ' ' VAL . . . -75.61 -34.54 60.6 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.255 -0.903 . . . . 0.0 109.449 -179.945 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 64.5 t0 -62.14 -45.42 93.53 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.286 -0.884 . . . . 0.0 109.647 -179.953 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 44.6 tt0 -69.08 -43.58 74.25 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.172 -0.955 . . . . 0.0 109.595 -179.882 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 89' ' ' ALA . . . . . 0.567 ' HA ' ' CE2' ' A' ' 61' ' ' PHE . . . -72.37 -37.13 68.84 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.195 -0.941 . . . . 0.0 109.552 -179.869 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 90' ' ' VAL . . . . . 0.523 ' O ' ' CB ' ' A' ' 94' ' ' ASN . 61.2 t -69.38 -47.31 73.69 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.604 0 O-C-N 121.254 -0.904 . . . . 0.0 109.652 -179.89 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -73.56 -28.51 61.9 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.236 -0.915 . . . . 0.0 109.757 -179.721 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 92' ' ' GLU . . . . . 0.565 ' HB3' ' CE2' ' A' ' 61' ' ' PHE . 39.2 tp10 -87.21 -49.77 7.05 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.245 -0.909 . . . . 0.0 109.786 -179.731 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 93' ' ' LEU . . . . . 0.636 ' CD1' ' CE2' ' A' ' 58' ' ' PHE . 39.9 mt -68.02 -39.81 83.09 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.244 -0.91 . . . . 0.0 109.612 -179.907 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 94' ' ' ASN . . . . . 0.523 ' CB ' ' O ' ' A' ' 90' ' ' VAL . 57.2 t30 -68.35 128.05 35.19 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.24 -0.912 . . . . 0.0 109.481 -179.969 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 94.87 19.38 31.59 Favored Glycine 0 N--CA 1.491 2.308 0 N-CA-C 109.591 -1.404 . . . . 0.0 109.591 -179.947 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 96' ' ' THR . . . . . 0.428 ' CG2' ' O ' ' A' ' 92' ' ' GLU . 21.8 p -120.46 148.6 43.6 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.209 -1.171 . . . . 0.0 109.493 179.978 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 97' ' ' GLN . . . . . 0.448 ' HG3' ' O ' ' A' ' 101' ' ' VAL . 59.8 tt0 -119.73 140.76 50.2 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.232 -0.917 . . . . 0.0 109.478 179.996 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 1.3 t -81.74 -162.99 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.532 0 O-C-N 121.285 -0.885 . . . . 0.0 109.347 179.997 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 96.0 mt-10 -54.18 -37.36 64.41 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.232 -0.917 . . . . 0.0 109.558 -179.975 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -155.59 25.18 0.4 Allowed 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.322 -0.861 . . . . 0.0 109.521 179.957 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 101' ' ' VAL . . . . . 0.448 ' O ' ' HG3' ' A' ' 97' ' ' GLN . 60.0 t -137.77 164.62 28.02 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.552 0 O-C-N 121.236 -0.915 . . . . 0.0 109.5 -179.953 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 91.7 mt-30 -119.06 145.36 45.96 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.309 -0.869 . . . . 0.0 109.371 179.854 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 103' ' ' LEU . . . . . 0.485 HD21 ' CG1' ' A' ' 44' ' ' VAL . 0.0 OUTLIER -124.45 130.95 53.41 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.25 -0.907 . . . . 0.0 109.591 -179.785 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 104' ' ' LYS . . . . . 0.402 ' HB2' ' HB3' ' A' ' 45' ' ' TYR . 24.1 mttm -117.89 127.24 53.66 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.346 -0.846 . . . . 0.0 109.24 179.761 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 105' ' ' VAL . . . . . 0.513 HG11 ' CG2' ' A' ' 90' ' ' VAL . 12.1 t . . . . . 0 N--CA 1.49 1.551 0 O-C-N 121.231 -0.918 . . . . 0.0 109.736 -179.764 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 40' ' ' ASN . . . . . 0.485 ' N ' ' O ' ' A' ' 80' ' ' TYR . 42.1 t30 . . . . . 0 N--CA 1.491 1.608 0 N-CA-C 109.1 -0.704 . . . . 0.0 109.1 . . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 41' ' ' THR . . . . . 0.476 ' HA ' ' O ' ' A' ' 78' ' ' VAL . 27.0 m -78.54 150.94 32.74 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.24 -0.913 . . . . 0.0 110.063 -179.479 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . 0.535 ' CD1' ' O ' ' A' ' 78' ' ' VAL . 5.1 mp -126.57 152.86 46.02 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.413 -0.805 . . . . 0.0 109.132 179.616 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 39.8 t80 -107.92 111.37 23.44 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.224 -0.923 . . . . 0.0 109.42 179.865 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 44' ' ' VAL . . . . . 0.463 ' HA ' ' O ' ' A' ' 104' ' ' LYS . 96.5 t -109.16 142.26 22.18 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.551 0 O-C-N 121.202 -0.936 . . . . 0.0 109.384 179.969 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 68.1 t80 -128.35 130.97 48.54 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.251 -0.906 . . . . 0.0 109.561 -179.882 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -176.54 -166.44 33.7 Favored Glycine 0 N--CA 1.488 2.123 0 N-CA-C 109.483 -1.447 . . . . 0.0 109.483 179.928 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . 0.415 ' O ' ' C ' ' A' ' 48' ' ' ASP . 94.8 mt-10 -132.52 161.08 34.68 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.328 -1.101 . . . . 0.0 109.485 179.987 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 48' ' ' ASP . . . . . 0.415 ' C ' ' O ' ' A' ' 47' ' ' GLU . 42.8 m-20 43.66 51.55 6.45 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.271 -0.893 . . . . 0.0 109.601 179.934 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 72.6 mtm -103.78 145.0 30.73 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.249 -0.907 . . . . 0.0 109.475 -179.944 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 50' ' ' THR . . . . . 0.407 ' O ' HD13 ' A' ' 54' ' ' LEU . 0.0 OUTLIER -117.6 161.75 32.2 Favored Pre-proline 0 N--CA 1.49 1.561 0 O-C-N 121.296 -0.878 . . . . 0.0 109.53 -179.978 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 51' ' ' PRO . . . . . 0.48 ' CA ' ' SD ' ' A' ' 69' ' ' MET . 49.2 Cg_endo -69.93 -53.93 0.24 Allowed 'Trans proline' 0 C--O 1.214 -0.694 0 C-N-CA 122.731 2.288 . . . . 0.0 111.739 179.89 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 27.1 m -56.91 -44.71 82.64 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.286 -0.884 . . . . 0.0 109.33 179.887 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . 0.479 ' CD1' ' C ' ' A' ' 53' ' ' LEU . 2.3 tm? -59.94 -47.77 84.44 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.311 -0.868 . . . . 0.0 109.384 179.97 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 54' ' ' LEU . . . . . 0.491 HD11 ' CE ' ' A' ' 69' ' ' MET . 17.3 mt -59.36 -52.31 66.16 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.255 -0.903 . . . . 0.0 109.332 179.979 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 55' ' ' ARG . . . . . 0.513 ' O ' ' N ' ' A' ' 59' ' ' SER . 52.3 mtp180 -45.0 -41.04 7.01 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.242 -0.911 . . . . 0.0 109.292 179.83 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . 0.466 ' O ' ' HD2' ' A' ' 60' ' ' PRO . . . -64.07 -40.65 98.34 Favored Glycine 0 N--CA 1.49 2.252 0 N-CA-C 109.416 -1.474 . . . . 0.0 109.416 179.904 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . 0.429 ' O ' ' CD2' ' A' ' 61' ' ' PHE . . . -65.9 -23.3 66.61 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.286 -1.126 . . . . 0.0 109.323 179.956 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 58' ' ' PHE . . . . . 0.636 ' CE2' ' CD1' ' A' ' 93' ' ' LEU . 93.6 m-85 -116.81 9.36 13.89 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.287 -0.883 . . . . 0.0 109.395 179.975 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 59' ' ' SER . . . . . 0.525 ' N ' ' HD2' ' A' ' 60' ' ' PRO . 0.9 OUTLIER -76.89 -55.45 1.47 Allowed Pre-proline 0 N--CA 1.491 1.592 0 O-C-N 121.225 -0.922 . . . . 0.0 110.37 -179.569 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 60' ' ' PRO . . . . . 0.525 ' HD2' ' N ' ' A' ' 59' ' ' SER . 47.4 Cg_endo -69.26 -30.76 24.05 Favored 'Trans proline' 0 C--O 1.215 -0.65 0 C-N-CA 122.502 2.135 . . . . 0.0 112.158 -179.25 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 61' ' ' PHE . . . . . 0.549 ' CE1' ' HA ' ' A' ' 89' ' ' ALA . 82.3 m-85 -66.06 -38.32 88.03 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.165 -0.959 . . . . 0.0 109.442 179.933 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . 0.467 ' HA3' ' OG ' ' A' ' 85' ' ' SER . . . -179.51 -177.09 47.6 Favored Glycine 0 N--CA 1.49 2.277 0 N-CA-C 109.47 -1.452 . . . . 0.0 109.47 179.973 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 85.8 m-20 -91.46 140.35 29.83 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.171 -1.194 . . . . 0.0 109.489 179.965 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 64' ' ' ILE . . . . . 0.45 HG23 HG11 ' A' ' 78' ' ' VAL . 64.3 mt -101.63 133.32 45.41 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.531 0 O-C-N 121.235 -0.916 . . . . 0.0 109.506 -179.929 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 25.9 pt -96.68 -19.57 6.06 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 O-C-N 121.284 -0.885 . . . . 0.0 109.609 -179.955 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 66' ' ' ASP . . . . . 0.457 ' HB3' ' OG1' ' A' ' 79' ' ' THR . 58.5 t0 -153.4 110.8 3.5 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.185 -0.947 . . . . 0.0 109.571 -179.917 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . 0.449 ' C ' ' CD1' ' A' ' 67' ' ' LEU . 0.2 OUTLIER -102.18 118.1 36.17 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.24 -0.913 . . . . 0.0 109.388 179.824 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 25.6 t -126.49 145.34 50.54 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.245 -0.91 . . . . 0.0 109.556 -179.836 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 69' ' ' MET . . . . . 0.491 ' CE ' HD11 ' A' ' 54' ' ' LEU . 90.5 mtp -126.89 150.96 49.03 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.371 -0.831 . . . . 0.0 109.407 179.923 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 70' ' ' ASP . . . . . 0.456 ' C ' ' HD2' ' A' ' 72' ' ' PRO . 0.2 OUTLIER -125.41 98.31 35.31 Favored Pre-proline 0 N--CA 1.49 1.57 0 O-C-N 121.29 -0.882 . . . . 0.0 109.526 179.961 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 71' ' ' PRO . . . . . 0.603 ' N ' ' CD ' ' A' ' 72' ' ' PRO . 46.2 Cg_endo -74.61 -27.85 10.44 Favored 'Trans proline' 0 CA--C 1.542 0.925 0 C-N-CA 122.529 2.153 . . . . 0.0 113.647 179.945 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 72' ' ' PRO . . . . . 0.603 ' CD ' ' N ' ' A' ' 71' ' ' PRO . 55.3 Cg_endo -75.69 -26.19 10.1 Favored 'Trans proline' 0 C--N 1.353 0.782 0 C-N-CA 121.536 1.49 . . . . 0.0 111.771 -179.958 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 73' ' ' ARG . . . . . 0.418 ' O ' ' HB2' ' A' ' 74' ' ' ASN . 96.5 mtt180 -110.85 -0.01 17.06 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.294 -0.878 . . . . 0.0 109.652 -179.822 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 74' ' ' ASN . . . . . 0.418 ' HB2' ' O ' ' A' ' 73' ' ' ARG . 8.3 m120 61.2 44.73 9.64 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.166 -0.959 . . . . 0.0 109.343 -179.91 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 75' ' ' CYS . . . . . 0.442 ' O ' ' HB2' ' A' ' 70' ' ' ASP . 22.0 p -143.5 137.37 28.46 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.286 -0.884 . . . . 0.0 109.475 179.959 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -111.45 154.16 25.08 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.205 -0.935 . . . . 0.0 109.492 -179.96 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 77' ' ' PHE . . . . . 0.467 ' HA ' ' O ' ' A' ' 42' ' ' LEU . 97.0 m-85 -121.93 129.04 52.2 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.237 -0.915 . . . . 0.0 109.577 -179.925 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . 0.535 ' O ' ' CD1' ' A' ' 42' ' ' LEU . 26.5 t -120.21 138.53 50.47 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.569 0 O-C-N 121.206 -0.934 . . . . 0.0 109.289 179.858 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 79' ' ' THR . . . . . 0.47 ' HA ' ' O ' ' A' ' 40' ' ' ASN . 1.2 m -107.2 136.36 47.16 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.286 -0.884 . . . . 0.0 109.634 -179.826 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 80' ' ' TYR . . . . . 0.566 ' CE1' ' OG ' ' A' ' 85' ' ' SER . 0.9 OUTLIER -119.81 121.27 38.74 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.295 -0.878 . . . . 0.0 109.419 179.81 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 81' ' ' GLU . . . . . 0.441 ' C ' ' O ' ' A' ' 80' ' ' TYR . 83.5 tt0 -40.37 -39.74 1.04 Allowed 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.516 -0.74 . . . . 0.0 109.85 179.964 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 9.5 mtmm -122.87 162.97 21.17 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.193 -0.942 . . . . 0.0 109.514 179.931 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 83' ' ' MET . . . . . 0.474 ' CE ' ' HB2' ' A' ' 40' ' ' ASN . 4.4 mmt -80.17 -13.94 58.85 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.188 -0.945 . . . . 0.0 109.345 -179.999 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 96.1 mt-10 -69.82 -35.77 75.08 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.241 -0.912 . . . . 0.0 109.49 179.891 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 85' ' ' SER . . . . . 0.566 ' OG ' ' CE1' ' A' ' 80' ' ' TYR . 43.4 t -71.57 -32.08 67.67 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.2 -0.937 . . . . 0.0 109.476 -179.967 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 86' ' ' ALA . . . . . 0.519 ' O ' ' CG2' ' A' ' 90' ' ' VAL . . . -78.78 -31.38 46.04 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.244 -0.91 . . . . 0.0 109.532 -179.938 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 58.3 t0 -70.62 -46.73 62.81 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.243 -0.911 . . . . 0.0 109.646 -179.938 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 65.0 tt0 -68.64 -41.31 79.6 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.269 -0.895 . . . . 0.0 109.644 -179.873 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 89' ' ' ALA . . . . . 0.549 ' HA ' ' CE1' ' A' ' 61' ' ' PHE . . . -67.92 -41.1 83.14 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.208 -0.933 . . . . 0.0 109.653 -179.935 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 90' ' ' VAL . . . . . 0.532 ' O ' ' CB ' ' A' ' 94' ' ' ASN . 55.6 t -60.4 -35.94 66.02 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.587 0 O-C-N 121.22 -0.925 . . . . 0.0 109.669 -179.902 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -75.42 -53.91 7.91 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.173 -0.954 . . . . 0.0 109.844 -179.723 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 92' ' ' GLU . . . . . 0.519 ' O ' ' CG2' ' A' ' 96' ' ' THR . 76.1 mm-40 -67.92 -44.37 77.04 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.223 -0.923 . . . . 0.0 109.768 -179.537 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 93' ' ' LEU . . . . . 0.636 ' CD1' ' CE2' ' A' ' 58' ' ' PHE . 92.1 mt -66.57 -38.95 88.14 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.079 -1.013 . . . . 0.0 109.541 -179.804 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 94' ' ' ASN . . . . . 0.532 ' CB ' ' O ' ' A' ' 90' ' ' VAL . 62.1 t-20 -72.74 120.23 18.07 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.237 -0.914 . . . . 0.0 109.553 -179.964 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 105.27 10.71 31.12 Favored Glycine 0 N--CA 1.491 2.315 0 N-CA-C 109.426 -1.47 . . . . 0.0 109.426 179.905 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 96' ' ' THR . . . . . 0.519 ' CG2' ' O ' ' A' ' 92' ' ' GLU . 27.7 p -107.77 157.62 17.98 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.201 -1.176 . . . . 0.0 109.494 -179.97 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 58.7 tt0 -129.25 145.95 51.25 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.182 -0.949 . . . . 0.0 109.479 -179.935 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 98' ' ' VAL . . . . . 0.461 HG23 ' O ' ' A' ' 101' ' ' VAL . 1.4 t -87.39 -147.8 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 O-C-N 121.275 -0.891 . . . . 0.0 109.385 179.996 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 96.7 mt-10 -63.44 -41.87 98.67 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.21 -0.931 . . . . 0.0 109.536 179.979 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 100' ' ' SER . . . . . 0.402 ' C ' HG22 ' A' ' 101' ' ' VAL . 0.5 OUTLIER -153.77 23.83 0.51 Allowed 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.257 -0.902 . . . . 0.0 109.478 -179.915 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 101' ' ' VAL . . . . . 0.461 ' O ' HG23 ' A' ' 98' ' ' VAL . 52.9 t -139.46 148.63 23.24 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 O-C-N 121.252 -0.905 . . . . 0.0 109.433 -179.979 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 47.2 tt0 -97.47 140.67 31.56 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.172 -0.955 . . . . 0.0 109.523 -179.867 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 90.7 mt -104.42 137.7 41.9 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.253 -0.904 . . . . 0.0 109.465 179.977 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 104' ' ' LYS . . . . . 0.463 ' O ' ' HA ' ' A' ' 44' ' ' VAL . 89.0 mttt -117.95 138.39 52.2 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.293 -0.88 . . . . 0.0 109.298 179.887 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 105' ' ' VAL . . . . . 0.493 ' CG1' ' HA ' ' A' ' 90' ' ' VAL . 59.9 t . . . . . 0 N--CA 1.49 1.54 0 O-C-N 121.225 -0.922 . . . . 0.0 109.458 -179.885 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 40' ' ' ASN . . . . . 0.503 ' N ' HG21 ' A' ' 79' ' ' THR . 47.4 t30 . . . . . 0 N--CA 1.491 1.596 0 N-CA-C 109.493 -0.558 . . . . 0.0 109.493 . . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 41' ' ' THR . . . . . 0.456 ' O ' HD22 ' A' ' 42' ' ' LEU . 45.1 m -61.11 140.44 57.88 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.236 -0.915 . . . . 0.0 109.815 -179.771 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . 0.552 HD12 ' CD2' ' A' ' 80' ' ' TYR . 17.9 mt -125.33 143.44 50.97 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.253 -0.904 . . . . 0.0 109.483 179.722 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 71.1 t80 -96.27 120.46 36.6 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.277 -0.889 . . . . 0.0 109.52 -179.998 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 44' ' ' VAL . . . . . 0.582 ' CG1' ' CD2' ' A' ' 103' ' ' LEU . 58.7 t -118.49 139.06 47.16 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 O-C-N 121.171 -0.956 . . . . 0.0 109.421 179.96 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 65.6 t80 -129.39 141.6 51.01 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.261 -0.9 . . . . 0.0 109.562 -179.939 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 175.2 -174.82 47.0 Favored Glycine 0 N--CA 1.49 2.292 0 N-CA-C 109.424 -1.47 . . . . 0.0 109.424 179.935 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . 0.418 ' O ' ' C ' ' A' ' 48' ' ' ASP . 94.6 mt-10 -112.86 159.32 19.15 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.195 -1.18 . . . . 0.0 109.343 179.974 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 48' ' ' ASP . . . . . 0.418 ' C ' ' O ' ' A' ' 47' ' ' GLU . 51.4 m-20 44.34 40.2 3.59 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.211 -0.93 . . . . 0.0 109.262 -179.951 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 46.9 mtp -75.46 141.09 43.18 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.282 -0.886 . . . . 0.0 109.527 -179.951 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 50' ' ' THR . . . . . 0.453 ' O ' ' HG ' ' A' ' 54' ' ' LEU . 0.7 OUTLIER -130.98 161.94 58.54 Favored Pre-proline 0 N--CA 1.49 1.553 0 O-C-N 121.19 -0.944 . . . . 0.0 109.344 -179.974 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 51' ' ' PRO . . . . . 0.505 ' N ' ' SD ' ' A' ' 69' ' ' MET . 49.7 Cg_endo -70.6 -53.47 0.22 Allowed 'Trans proline' 0 C--O 1.214 -0.683 0 C-N-CA 122.657 2.238 . . . . 0.0 111.669 179.964 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 32.9 m -58.34 -41.69 85.19 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.268 -0.895 . . . . 0.0 109.348 179.886 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 9.2 tt -62.44 -46.08 90.18 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.277 -0.889 . . . . 0.0 109.385 179.92 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 54' ' ' LEU . . . . . 0.453 ' HG ' ' O ' ' A' ' 50' ' ' THR . 40.8 mt -64.76 -46.16 83.36 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.238 -0.914 . . . . 0.0 109.207 179.79 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 55' ' ' ARG . . . . . 0.478 ' O ' ' CB ' ' A' ' 59' ' ' SER . 74.4 ttt180 -48.0 -40.79 23.64 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.244 -0.91 . . . . 0.0 109.394 179.97 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -73.71 -31.55 60.32 Favored Glycine 0 N--CA 1.49 2.243 0 N-CA-C 109.476 -1.45 . . . . 0.0 109.476 179.892 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -73.55 -24.46 60.11 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.225 -1.162 . . . . 0.0 109.435 179.982 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 58' ' ' PHE . . . . . 0.604 ' CE2' ' CD1' ' A' ' 93' ' ' LEU . 94.8 m-85 -119.09 8.86 11.65 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.371 -0.83 . . . . 0.0 109.421 179.977 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 59' ' ' SER . . . . . 0.506 ' N ' ' HD2' ' A' ' 60' ' ' PRO . 0.4 OUTLIER -74.9 -57.59 1.81 Allowed Pre-proline 0 N--CA 1.491 1.609 0 O-C-N 121.279 -0.888 . . . . 0.0 110.162 -179.582 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 60' ' ' PRO . . . . . 0.506 ' HD2' ' N ' ' A' ' 59' ' ' SER . 48.1 Cg_endo -68.74 -35.96 15.13 Favored 'Trans proline' 0 C--O 1.215 -0.63 0 C-N-CA 122.584 2.189 . . . . 0.0 112.259 -179.437 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 61' ' ' PHE . . . . . 0.572 ' CD1' ' HA ' ' A' ' 89' ' ' ALA . 64.7 m-85 -58.72 -33.89 70.73 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.16 -0.963 . . . . 0.0 109.703 -179.828 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 176.74 -174.32 46.95 Favored Glycine 0 N--CA 1.49 2.282 0 N-CA-C 109.617 -1.393 . . . . 0.0 109.617 179.974 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 82.0 m-20 -95.03 146.23 24.41 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.235 -1.156 . . . . 0.0 109.46 179.991 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 64' ' ' ILE . . . . . 0.531 ' CD1' HD13 ' A' ' 67' ' ' LEU . 51.5 mt -110.77 126.54 68.12 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 O-C-N 121.3 -0.875 . . . . 0.0 109.416 179.974 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 22.2 pt -91.15 -22.56 6.16 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 O-C-N 121.273 -0.892 . . . . 0.0 109.543 -179.896 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 45.2 t0 -155.49 95.0 1.64 Allowed 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.196 -0.94 . . . . 0.0 109.586 179.994 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . 0.531 HD13 ' CD1' ' A' ' 64' ' ' ILE . 0.5 OUTLIER -93.29 126.67 38.53 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.206 -0.934 . . . . 0.0 109.196 179.769 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 68' ' ' SER . . . . . 0.415 ' HB2' ' HB2' ' A' ' 77' ' ' PHE . 67.5 m -126.08 153.86 43.89 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.226 -0.921 . . . . 0.0 109.718 -179.802 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 69' ' ' MET . . . . . 0.505 ' SD ' ' N ' ' A' ' 51' ' ' PRO . 84.1 mtp -126.46 150.54 48.63 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.414 -0.804 . . . . 0.0 109.296 179.851 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 70' ' ' ASP . . . . . 0.458 ' C ' ' HD2' ' A' ' 72' ' ' PRO . 1.2 t0 -129.09 99.24 22.09 Favored Pre-proline 0 N--CA 1.49 1.565 0 O-C-N 121.195 -0.941 . . . . 0.0 109.55 -179.948 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 71' ' ' PRO . . . . . 0.6 ' N ' ' CD ' ' A' ' 72' ' ' PRO . 46.4 Cg_endo -74.54 -27.96 10.48 Favored 'Trans proline' 0 CA--C 1.542 0.897 0 C-N-CA 122.503 2.136 . . . . 0.0 113.523 179.845 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 72' ' ' PRO . . . . . 0.6 ' CD ' ' N ' ' A' ' 71' ' ' PRO . 55.6 Cg_endo -75.38 -26.62 10.15 Favored 'Trans proline' 0 C--N 1.353 0.772 0 C-N-CA 121.483 1.456 . . . . 0.0 111.82 -179.932 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 73' ' ' ARG . . . . . 0.444 ' O ' ' HB2' ' A' ' 74' ' ' ASN . 89.0 mtt-85 -109.23 -1.02 18.94 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.293 -0.88 . . . . 0.0 109.645 -179.959 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 74' ' ' ASN . . . . . 0.444 ' HB2' ' O ' ' A' ' 73' ' ' ARG . 79.8 m-20 61.6 43.99 9.49 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.21 -0.931 . . . . 0.0 109.568 179.955 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 75' ' ' CYS . . . . . 0.459 ' HA ' ' O ' ' A' ' 44' ' ' VAL . 27.5 p -146.94 150.5 35.3 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.271 -0.893 . . . . 0.0 109.395 179.978 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -116.35 154.25 30.55 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.171 -0.956 . . . . 0.0 109.522 -179.946 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 77' ' ' PHE . . . . . 0.461 ' HA ' ' O ' ' A' ' 42' ' ' LEU . 98.0 m-85 -124.16 106.31 10.23 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.299 -0.876 . . . . 0.0 109.476 -179.941 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . 0.525 ' CG1' ' HB2' ' A' ' 42' ' ' LEU . 5.9 p -109.8 136.19 46.48 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.503 0 O-C-N 121.131 -0.981 . . . . 0.0 109.638 179.907 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 79' ' ' THR . . . . . 0.503 HG21 ' N ' ' A' ' 40' ' ' ASN . 3.7 m -102.5 127.05 49.72 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.308 -0.87 . . . . 0.0 109.699 -179.736 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 80' ' ' TYR . . . . . 0.552 ' CD2' HD12 ' A' ' 42' ' ' LEU . 0.5 OUTLIER -102.16 126.12 49.04 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.308 -0.87 . . . . 0.0 109.465 179.948 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 81' ' ' GLU . . . . . 0.431 ' C ' ' O ' ' A' ' 80' ' ' TYR . 88.5 tt0 -42.06 -47.4 4.49 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.476 -0.765 . . . . 0.0 109.766 179.949 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 36.4 mttm -113.7 155.86 24.8 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.26 -0.9 . . . . 0.0 109.635 -179.904 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 83' ' ' MET . . . . . . . . . . . . . 57.7 mtt -77.46 -19.87 55.29 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.26 -0.9 . . . . 0.0 109.34 179.943 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 98.3 mt-10 -69.66 -44.6 70.19 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.181 -0.949 . . . . 0.0 109.303 179.918 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 16.0 m -61.56 -27.39 68.59 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.355 -0.841 . . . . 0.0 109.225 179.739 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 86' ' ' ALA . . . . . 0.517 ' CB ' HD13 ' A' ' 42' ' ' LEU . . . -78.11 -34.42 50.06 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.383 -0.823 . . . . 0.0 109.416 -179.993 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 59.2 t0 -66.9 -33.63 76.02 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.294 -0.879 . . . . 0.0 109.388 179.897 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 88' ' ' GLN . . . . . 0.46 ' O ' ' HB2' ' A' ' 92' ' ' GLU . 63.5 tt0 -77.01 -37.6 54.69 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.287 -0.883 . . . . 0.0 109.384 179.933 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 89' ' ' ALA . . . . . 0.572 ' HA ' ' CD1' ' A' ' 61' ' ' PHE . . . -76.49 -35.09 58.57 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.285 -0.884 . . . . 0.0 109.385 179.939 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 90' ' ' VAL . . . . . 0.519 ' O ' ' CB ' ' A' ' 94' ' ' ASN . 75.8 t -71.2 -39.77 73.7 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.513 0 O-C-N 121.325 -0.859 . . . . 0.0 109.464 -179.948 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -77.11 -34.31 56.76 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.209 -0.932 . . . . 0.0 109.496 -179.985 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 92' ' ' GLU . . . . . 0.564 ' HB3' ' CZ ' ' A' ' 61' ' ' PHE . 6.0 tm-20 -80.07 -46.28 16.8 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.215 -0.928 . . . . 0.0 109.644 -179.867 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 93' ' ' LEU . . . . . 0.604 ' CD1' ' CE2' ' A' ' 58' ' ' PHE . 72.6 mt -70.42 -37.69 74.45 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.22 -0.925 . . . . 0.0 109.534 -179.918 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 94' ' ' ASN . . . . . 0.519 ' CB ' ' O ' ' A' ' 90' ' ' VAL . 49.6 t30 -70.12 136.68 50.42 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.231 -0.918 . . . . 0.0 109.462 -179.933 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 83.16 26.32 44.77 Favored Glycine 0 N--CA 1.49 2.279 0 N-CA-C 109.528 -1.429 . . . . 0.0 109.528 179.988 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 96' ' ' THR . . . . . 0.506 ' CG2' ' O ' ' A' ' 92' ' ' GLU . 27.9 p -125.89 146.63 49.75 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.29 -1.123 . . . . 0.0 109.575 -179.982 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 97' ' ' GLN . . . . . 0.502 ' CG ' ' O ' ' A' ' 101' ' ' VAL . 52.7 tt0 -117.92 137.81 52.57 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.293 -0.879 . . . . 0.0 109.424 -179.938 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 1.1 t -80.12 -153.55 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 O-C-N 121.283 -0.886 . . . . 0.0 109.337 -179.983 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 96.5 mt-10 -58.4 -38.31 77.12 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.165 -0.959 . . . . 0.0 109.5 -179.965 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -156.96 25.78 0.32 Allowed 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.183 -0.948 . . . . 0.0 109.483 -179.983 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 101' ' ' VAL . . . . . 0.502 ' O ' ' CG ' ' A' ' 97' ' ' GLN . 49.0 t -137.27 167.41 23.26 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.55 0 O-C-N 121.221 -0.925 . . . . 0.0 109.541 -179.878 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 102' ' ' GLN . . . . . 0.494 ' N ' HG12 ' A' ' 101' ' ' VAL . 92.1 mt-30 -122.61 147.37 46.49 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.248 -0.907 . . . . 0.0 109.126 179.885 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 103' ' ' LEU . . . . . 0.582 ' CD2' ' CG1' ' A' ' 44' ' ' VAL . 0.0 OUTLIER -121.69 135.68 54.96 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.11 -0.994 . . . . 0.0 109.93 -179.802 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 23.9 mttt -118.19 130.88 56.35 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.334 -0.854 . . . . 0.0 109.051 179.694 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 105' ' ' VAL . . . . . 0.453 HG13 ' CG1' ' A' ' 90' ' ' VAL . 21.5 t . . . . . 0 N--CA 1.491 1.611 0 O-C-N 121.167 -0.958 . . . . 0.0 109.776 -179.788 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 40' ' ' ASN . . . . . 0.472 ' O ' HD11 ' A' ' 42' ' ' LEU . 62.0 t30 . . . . . 0 N--CA 1.489 1.506 0 N-CA-C 109.417 -0.586 . . . . 0.0 109.417 . . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 41' ' ' THR . . . . . 0.468 HG22 ' N ' ' A' ' 42' ' ' LEU . 54.4 m -77.52 148.22 35.4 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.282 -0.886 . . . . 0.0 109.826 -179.712 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . 0.526 ' CD1' ' O ' ' A' ' 78' ' ' VAL . 4.9 mp -123.79 152.29 42.39 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.352 -0.842 . . . . 0.0 109.386 179.832 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 46.8 t80 -110.22 112.07 23.8 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.246 -0.909 . . . . 0.0 109.358 179.782 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 44' ' ' VAL . . . . . 0.452 ' HA ' ' O ' ' A' ' 104' ' ' LYS . 48.8 t -108.29 143.88 17.88 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.535 0 O-C-N 121.301 -0.874 . . . . 0.0 109.351 -179.941 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 45' ' ' TYR . . . . . 0.446 ' HB3' ' HB2' ' A' ' 104' ' ' LYS . 71.1 t80 -131.53 135.87 47.39 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.282 -0.886 . . . . 0.0 109.506 -179.931 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . 0.465 ' O ' ' HB3' ' A' ' 74' ' ' ASN . . . 177.57 -170.53 43.0 Favored Glycine 0 N--CA 1.49 2.282 0 N-CA-C 109.476 -1.45 . . . . 0.0 109.476 179.989 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . 0.42 ' O ' ' C ' ' A' ' 48' ' ' ASP . 94.9 mt-10 -124.31 157.36 35.14 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.246 -1.15 . . . . 0.0 109.426 -179.922 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 48' ' ' ASP . . . . . 0.42 ' C ' ' O ' ' A' ' 47' ' ' GLU . 38.0 m-20 44.48 51.26 7.94 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.274 -0.891 . . . . 0.0 109.552 -179.977 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 60.9 mtm -102.84 137.93 40.4 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.158 -0.964 . . . . 0.0 109.432 179.992 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 50' ' ' THR . . . . . 0.488 ' O ' ' CD1' ' A' ' 54' ' ' LEU . 0.7 OUTLIER -116.29 164.15 19.15 Favored Pre-proline 0 N--CA 1.49 1.551 0 O-C-N 121.197 -0.939 . . . . 0.0 109.599 179.894 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 51' ' ' PRO . . . . . 0.431 ' HA ' HD11 ' A' ' 54' ' ' LEU . 50.4 Cg_endo -70.25 -52.03 0.31 Allowed 'Trans proline' 0 C--O 1.216 -0.594 0 C-N-CA 122.69 2.26 . . . . 0.0 111.715 179.979 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 36.5 m -53.63 -43.17 68.52 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.316 -0.865 . . . . 0.0 109.369 179.993 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . 0.494 ' CD1' ' C ' ' A' ' 53' ' ' LEU . 3.3 tm? -62.02 -46.18 90.31 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.239 -0.913 . . . . 0.0 109.319 179.967 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 54' ' ' LEU . . . . . 0.488 ' CD1' ' O ' ' A' ' 50' ' ' THR . 3.9 mt -62.49 -44.81 95.48 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.285 -0.884 . . . . 0.0 109.441 179.923 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 55' ' ' ARG . . . . . 0.505 ' O ' ' N ' ' A' ' 59' ' ' SER . 83.5 mtt180 -52.29 -39.06 60.02 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.318 -0.864 . . . . 0.0 109.379 179.919 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -70.69 -34.89 66.76 Favored Glycine 0 N--CA 1.49 2.238 0 N-CA-C 109.378 -1.489 . . . . 0.0 109.378 179.968 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -76.05 -23.7 55.11 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.282 -1.128 . . . . 0.0 109.439 179.979 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 58' ' ' PHE . . . . . 0.633 ' CE1' ' CD1' ' A' ' 93' ' ' LEU . 96.8 m-85 -116.17 7.75 14.21 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.146 -0.971 . . . . 0.0 109.46 179.995 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 59' ' ' SER . . . . . 0.515 ' N ' ' HD2' ' A' ' 60' ' ' PRO . 0.5 OUTLIER -73.51 -57.46 2.65 Favored Pre-proline 0 N--CA 1.491 1.608 0 O-C-N 121.291 -0.881 . . . . 0.0 109.96 -179.643 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 60' ' ' PRO . . . . . 0.515 ' HD2' ' N ' ' A' ' 59' ' ' SER . 49.0 Cg_endo -69.25 -33.04 19.43 Favored 'Trans proline' 0 C--O 1.214 -0.711 0 C-N-CA 122.643 2.229 . . . . 0.0 112.28 -179.597 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 61' ' ' PHE . . . . . 0.58 ' CD2' ' HA ' ' A' ' 89' ' ' ALA . 51.0 m-85 -61.64 -33.18 73.49 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.202 -0.936 . . . . 0.0 109.612 -179.874 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 176.65 -173.49 46.33 Favored Glycine 0 N--CA 1.489 2.213 0 N-CA-C 109.533 -1.427 . . . . 0.0 109.533 179.967 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 85.6 m-20 -95.7 147.42 23.62 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.248 -1.149 . . . . 0.0 109.383 -179.957 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 64' ' ' ILE . . . . . 0.427 ' HA ' ' O ' ' A' ' 79' ' ' THR . 53.6 mt -111.14 124.95 68.4 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.522 0 O-C-N 121.205 -0.934 . . . . 0.0 109.525 -179.963 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 31.1 pt -93.8 -26.79 4.53 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.573 0 O-C-N 121.342 -0.849 . . . . 0.0 109.382 179.926 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 66' ' ' ASP . . . . . 0.418 ' HB3' ' OG1' ' A' ' 79' ' ' THR . 58.2 t0 -140.43 130.36 24.65 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.214 -0.929 . . . . 0.0 109.511 179.937 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 7.1 tp -121.46 120.4 34.82 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.239 -0.913 . . . . 0.0 109.438 179.923 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 68' ' ' SER . . . . . 0.442 ' HB3' ' HB2' ' A' ' 77' ' ' PHE . 43.3 t -128.87 140.66 51.59 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.242 -0.911 . . . . 0.0 109.479 -179.985 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 69' ' ' MET . . . . . 0.418 ' SD ' ' HB3' ' A' ' 51' ' ' PRO . 86.7 mtp -123.93 149.61 45.71 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.313 -0.867 . . . . 0.0 109.44 -179.993 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 70' ' ' ASP . . . . . 0.462 ' HB2' ' O ' ' A' ' 75' ' ' CYS . 0.7 OUTLIER -127.81 101.56 23.29 Favored Pre-proline 0 N--CA 1.49 1.555 0 O-C-N 121.251 -0.905 . . . . 0.0 109.433 179.964 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 71' ' ' PRO . . . . . 0.599 ' N ' ' CD ' ' A' ' 72' ' ' PRO . 47.3 Cg_endo -74.75 -27.81 10.2 Favored 'Trans proline' 0 CA--C 1.543 0.932 0 C-N-CA 122.527 2.151 . . . . 0.0 113.69 179.998 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 72' ' ' PRO . . . . . 0.599 ' CD ' ' N ' ' A' ' 71' ' ' PRO . 55.2 Cg_endo -75.41 -23.81 12.8 Favored 'Trans proline' 0 C--N 1.353 0.793 0 C-N-CA 121.496 1.464 . . . . 0.0 111.869 -179.83 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 73' ' ' ARG . . . . . 0.417 ' O ' ' HB2' ' A' ' 74' ' ' ASN . 75.0 mtt85 -111.91 -1.11 15.59 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.197 -0.939 . . . . 0.0 109.666 -179.879 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 74' ' ' ASN . . . . . 0.465 ' HB3' ' O ' ' A' ' 46' ' ' GLY . 8.0 m120 60.78 44.21 11.29 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.133 -0.98 . . . . 0.0 109.519 179.985 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 75' ' ' CYS . . . . . 0.462 ' O ' ' HB2' ' A' ' 70' ' ' ASP . 24.4 p -144.79 140.74 28.67 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.211 -0.931 . . . . 0.0 109.541 -179.921 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -113.67 161.38 17.54 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.222 -0.924 . . . . 0.0 109.36 -180.0 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 77' ' ' PHE . . . . . 0.442 ' HB2' ' HB3' ' A' ' 68' ' ' SER . 96.9 m-85 -125.37 137.35 54.03 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.215 -0.928 . . . . 0.0 109.497 -179.9 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . 0.526 ' O ' ' CD1' ' A' ' 42' ' ' LEU . 25.3 t -130.55 139.78 50.44 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.611 0 O-C-N 121.391 -0.818 . . . . 0.0 109.362 179.849 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 79' ' ' THR . . . . . 0.468 ' HA ' ' O ' ' A' ' 40' ' ' ASN . 2.0 m -110.61 121.28 44.93 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.213 -0.929 . . . . 0.0 109.431 179.936 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 80' ' ' TYR . . . . . 0.525 ' CD2' HD12 ' A' ' 42' ' ' LEU . 1.5 m-85 -99.41 138.41 36.54 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.251 -0.906 . . . . 0.0 109.613 -179.925 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 81.6 tt0 -48.69 -25.79 1.97 Allowed 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.327 -0.858 . . . . 0.0 109.787 179.997 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 48.1 mttp -143.48 159.46 42.36 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.142 -0.974 . . . . 0.0 109.591 -179.938 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 83' ' ' MET . . . . . 0.414 ' HG2' ' CG ' ' A' ' 40' ' ' ASN . 61.8 mtt -72.83 -19.37 61.33 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.292 -0.88 . . . . 0.0 109.357 179.971 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 96.5 mt-10 -68.06 -51.4 47.11 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.277 -0.889 . . . . 0.0 109.513 179.904 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 7.4 m -56.35 -32.46 64.73 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.277 -0.89 . . . . 0.0 109.37 179.863 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 86' ' ' ALA . . . . . 0.478 ' HA ' ' CD2' ' A' ' 80' ' ' TYR . . . -74.12 -27.54 60.91 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.236 -0.915 . . . . 0.0 109.364 -179.999 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 22.1 t70 -69.31 -43.29 74.07 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.224 -0.922 . . . . 0.0 109.457 -179.933 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 88' ' ' GLN . . . . . 0.431 ' O ' ' HB2' ' A' ' 92' ' ' GLU . 61.4 tt0 -69.48 -36.75 76.84 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.289 -0.882 . . . . 0.0 109.416 -179.95 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 89' ' ' ALA . . . . . 0.58 ' HA ' ' CD2' ' A' ' 61' ' ' PHE . . . -74.02 -44.38 54.67 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.221 -0.924 . . . . 0.0 109.446 179.958 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 90' ' ' VAL . . . . . 0.515 ' O ' ' CB ' ' A' ' 94' ' ' ASN . 84.1 t -67.22 -38.19 80.56 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.549 0 O-C-N 121.337 -0.852 . . . . 0.0 109.603 179.984 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -80.06 -29.12 39.15 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.269 -0.894 . . . . 0.0 109.906 -179.681 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 92' ' ' GLU . . . . . 0.542 ' HB3' ' CE2' ' A' ' 61' ' ' PHE . 23.0 tt0 -91.9 -45.59 8.28 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.158 -0.963 . . . . 0.0 109.677 -179.749 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 93' ' ' LEU . . . . . 0.633 ' CD1' ' CE1' ' A' ' 58' ' ' PHE . 21.3 mt -69.35 -43.14 74.21 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.207 -0.933 . . . . 0.0 109.587 -179.925 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 94' ' ' ASN . . . . . 0.515 ' CB ' ' O ' ' A' ' 90' ' ' VAL . 43.8 t30 -63.74 127.11 29.9 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.205 -0.934 . . . . 0.0 109.54 179.988 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 98.79 16.3 31.47 Favored Glycine 0 N--CA 1.49 2.268 0 N-CA-C 109.455 -1.458 . . . . 0.0 109.455 179.985 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 18.1 p -116.54 157.42 25.28 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.183 -1.187 . . . . 0.0 109.383 -179.966 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 59.6 tt0 -117.99 139.55 51.01 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.194 -0.941 . . . . 0.0 109.478 -179.944 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 98' ' ' VAL . . . . . 0.517 HG22 ' CD1' ' A' ' 103' ' ' LEU . 1.2 t -83.83 -149.49 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 121.202 -0.936 . . . . 0.0 109.374 -179.966 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 76.5 mm-40 -60.38 -41.62 94.16 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.226 -0.921 . . . . 0.0 109.501 179.97 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 21.1 t -158.51 31.55 0.23 Allowed 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.293 -0.88 . . . . 0.0 109.426 179.952 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 101' ' ' VAL . . . . . 0.44 ' O ' HG21 ' A' ' 98' ' ' VAL . 58.9 t -147.03 147.86 17.23 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 O-C-N 121.227 -0.921 . . . . 0.0 109.464 179.995 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 91.7 mt-30 -86.43 145.73 26.72 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.253 -0.904 . . . . 0.0 109.574 -179.941 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 103' ' ' LEU . . . . . 0.517 ' CD1' HG22 ' A' ' 98' ' ' VAL . 96.0 mt -109.56 136.13 49.44 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.313 -0.867 . . . . 0.0 109.467 179.948 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 104' ' ' LYS . . . . . 0.452 ' O ' ' HA ' ' A' ' 44' ' ' VAL . 57.3 mttm -122.09 133.55 54.77 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.242 -0.912 . . . . 0.0 109.48 -179.938 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 105' ' ' VAL . . . . . 0.482 HG11 ' CG2' ' A' ' 90' ' ' VAL . 7.0 t . . . . . 0 N--CA 1.49 1.527 0 O-C-N 121.241 -0.912 . . . . 0.0 109.602 -179.994 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 40' ' ' ASN . . . . . 0.474 ' O ' HD13 ' A' ' 42' ' ' LEU . 60.1 t-20 . . . . . 0 N--CA 1.49 1.533 0 N-CA-C 109.134 -0.691 . . . . 0.0 109.134 . . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 41' ' ' THR . . . . . 0.455 ' HA ' ' O ' ' A' ' 78' ' ' VAL . 92.6 m -81.96 140.57 33.93 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.241 -0.912 . . . . 0.0 109.956 -179.568 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . 0.512 HD23 ' CG2' ' A' ' 90' ' ' VAL . 5.4 mp -118.05 142.62 47.2 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.375 -0.828 . . . . 0.0 109.077 179.391 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 59.7 t80 -99.76 109.91 22.32 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.322 -0.861 . . . . 0.0 109.611 -179.851 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 44' ' ' VAL . . . . . 0.465 ' HA ' ' O ' ' A' ' 104' ' ' LYS . 96.4 t -107.4 143.27 18.27 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.555 0 O-C-N 121.249 -0.907 . . . . 0.0 109.345 179.913 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 74.2 t80 -132.51 135.47 46.01 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.174 -0.954 . . . . 0.0 109.497 -179.891 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 177.9 -175.13 47.35 Favored Glycine 0 N--CA 1.489 2.222 0 N-CA-C 109.554 -1.418 . . . . 0.0 109.554 179.931 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . 0.429 ' O ' ' C ' ' A' ' 48' ' ' ASP . 94.0 mt-10 -114.9 158.51 21.88 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.254 -1.144 . . . . 0.0 109.432 -179.967 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 48' ' ' ASP . . . . . 0.429 ' C ' ' O ' ' A' ' 47' ' ' GLU . 48.8 m-20 44.07 50.44 7.35 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.302 -0.874 . . . . 0.0 109.444 -179.954 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 54.0 mtm -100.38 135.58 41.59 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.192 -0.943 . . . . 0.0 109.523 179.981 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -122.65 166.04 19.14 Favored Pre-proline 0 N--CA 1.49 1.558 0 O-C-N 121.266 -0.896 . . . . 0.0 109.41 179.946 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 51' ' ' PRO . . . . . 0.447 ' CB ' HD21 ' A' ' 67' ' ' LEU . 49.7 Cg_endo -70.24 -51.67 0.33 Allowed 'Trans proline' 0 C--O 1.214 -0.685 0 C-N-CA 122.671 2.247 . . . . 0.0 111.755 179.969 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 62.8 m -49.36 -48.65 46.54 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.217 -0.927 . . . . 0.0 109.288 179.96 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 18.0 tp -59.6 -47.82 84.06 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.175 -0.953 . . . . 0.0 109.228 179.901 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 12.8 mt -56.08 -45.61 79.29 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.26 -0.9 . . . . 0.0 109.337 179.835 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 55' ' ' ARG . . . . . 0.509 ' O ' ' N ' ' A' ' 59' ' ' SER . 15.3 mtp-105 -51.73 -42.21 62.12 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.355 -0.841 . . . . 0.0 109.286 179.863 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -70.78 -29.11 69.77 Favored Glycine 0 N--CA 1.489 2.232 0 N-CA-C 109.308 -1.517 . . . . 0.0 109.308 179.891 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . 0.461 ' O ' ' CD1' ' A' ' 61' ' ' PHE . . . -79.57 -22.8 43.32 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.267 -1.137 . . . . 0.0 109.432 179.966 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 58' ' ' PHE . . . . . 0.571 ' CZ ' HD12 ' A' ' 93' ' ' LEU . 96.3 m-85 -119.51 7.59 11.17 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.245 -0.909 . . . . 0.0 109.473 179.926 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 59' ' ' SER . . . . . 0.523 ' N ' ' HD2' ' A' ' 60' ' ' PRO . 0.6 OUTLIER -72.7 -57.07 3.41 Favored Pre-proline 0 N--CA 1.49 1.537 0 O-C-N 121.261 -0.899 . . . . 0.0 109.837 -179.888 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 60' ' ' PRO . . . . . 0.523 ' HD2' ' N ' ' A' ' 59' ' ' SER . 49.7 Cg_endo -69.57 -30.46 23.12 Favored 'Trans proline' 0 C--O 1.215 -0.664 0 C-N-CA 122.648 2.232 . . . . 0.0 111.954 -179.822 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 61' ' ' PHE . . . . . 0.538 ' CE2' ' HA ' ' A' ' 89' ' ' ALA . 58.6 m-85 -64.22 -34.38 77.97 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.231 -0.918 . . . . 0.0 109.27 179.965 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 173.62 -173.41 45.79 Favored Glycine 0 N--CA 1.49 2.235 0 N-CA-C 109.4 -1.48 . . . . 0.0 109.4 179.98 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 56.1 t30 -95.57 139.34 31.97 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.235 -1.156 . . . . 0.0 109.566 179.947 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 64' ' ' ILE . . . . . 0.413 HG22 HG11 ' A' ' 78' ' ' VAL . 58.2 mt -101.87 135.03 40.58 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 O-C-N 121.228 -0.92 . . . . 0.0 109.351 179.966 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 24.6 pt -97.72 -23.1 4.72 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.527 0 O-C-N 121.313 -0.867 . . . . 0.0 109.645 -179.963 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 53.2 t0 -149.05 126.87 11.81 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.227 -0.92 . . . . 0.0 109.552 179.981 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . 0.447 HD21 ' CB ' ' A' ' 51' ' ' PRO . 16.2 tp -112.26 117.05 31.45 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.241 -0.912 . . . . 0.0 109.466 179.949 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 68' ' ' SER . . . . . 0.452 ' HB2' ' HB2' ' A' ' 77' ' ' PHE . 68.0 m -123.35 145.61 48.6 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.191 -0.943 . . . . 0.0 109.476 -179.916 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 69' ' ' MET . . . . . 0.46 ' HA ' ' HA ' ' A' ' 76' ' ' ALA . 75.1 mtp -131.53 149.61 52.45 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.209 -0.932 . . . . 0.0 109.556 -179.966 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 70' ' ' ASP . . . . . 0.458 ' C ' ' HD2' ' A' ' 72' ' ' PRO . 2.6 t0 -123.36 104.76 34.28 Favored Pre-proline 0 N--CA 1.49 1.547 0 O-C-N 121.181 -0.949 . . . . 0.0 109.484 179.924 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 71' ' ' PRO . . . . . 0.6 ' N ' ' CD ' ' A' ' 72' ' ' PRO . 46.6 Cg_endo -74.87 -27.73 10.03 Favored 'Trans proline' 0 CA--C 1.543 0.952 0 C-N-CA 122.585 2.19 . . . . 0.0 113.608 -179.944 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 72' ' ' PRO . . . . . 0.6 ' CD ' ' N ' ' A' ' 71' ' ' PRO . 54.6 Cg_endo -75.14 -33.27 4.57 Favored 'Trans proline' 0 C--N 1.354 0.839 0 C-N-CA 121.437 1.425 . . . . 0.0 111.862 -179.82 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 73' ' ' ARG . . . . . 0.441 ' O ' ' HB2' ' A' ' 74' ' ' ASN . 67.5 ttt180 -103.62 -2.17 27.05 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.222 -0.924 . . . . 0.0 109.663 -179.927 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 74' ' ' ASN . . . . . 0.441 ' HB2' ' O ' ' A' ' 73' ' ' ARG . 79.9 m-20 61.88 40.38 12.66 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.177 -0.952 . . . . 0.0 109.505 -179.996 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 75' ' ' CYS . . . . . . . . . . . . . 24.7 p -136.03 137.43 41.16 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.286 -0.884 . . . . 0.0 109.434 -179.943 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 76' ' ' ALA . . . . . 0.46 ' HA ' ' HA ' ' A' ' 69' ' ' MET . . . -107.61 157.21 18.25 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.317 -0.864 . . . . 0.0 109.49 179.965 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 77' ' ' PHE . . . . . 0.478 ' HA ' ' O ' ' A' ' 42' ' ' LEU . 97.5 m-85 -123.45 131.19 53.57 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.282 -0.886 . . . . 0.0 109.583 -179.959 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . 0.502 ' O ' ' CD1' ' A' ' 42' ' ' LEU . 45.5 t -120.4 134.5 63.67 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 O-C-N 121.261 -0.899 . . . . 0.0 109.7 -179.954 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 79' ' ' THR . . . . . 0.467 ' HA ' ' O ' ' A' ' 40' ' ' ASN . 9.1 m -103.48 129.3 50.61 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.256 -0.902 . . . . 0.0 109.471 179.927 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 80' ' ' TYR . . . . . 0.565 ' CG ' ' HB2' ' A' ' 85' ' ' SER . 0.7 OUTLIER -112.07 137.12 50.55 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.192 -0.942 . . . . 0.0 109.542 -179.898 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 84.4 tt0 -57.67 -27.56 62.99 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.26 -0.9 . . . . 0.0 109.48 179.98 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 24.8 mttp -132.59 146.62 52.04 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.174 -0.954 . . . . 0.0 109.426 -179.955 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 83' ' ' MET . . . . . . . . . . . . . 35.6 mtt -64.73 -20.32 66.28 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.254 -0.904 . . . . 0.0 109.378 179.986 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 98.6 mt-10 -68.26 -37.06 80.35 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.317 -0.865 . . . . 0.0 109.439 179.993 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 85' ' ' SER . . . . . 0.565 ' HB2' ' CG ' ' A' ' 80' ' ' TYR . 18.7 m -61.45 -34.34 75.26 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.276 -0.89 . . . . 0.0 109.455 179.952 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 86' ' ' ALA . . . . . 0.44 ' CB ' HD23 ' A' ' 42' ' ' LEU . . . -76.26 -30.5 57.87 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.326 -0.859 . . . . 0.0 109.437 -179.995 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 54.2 t0 -63.71 -49.52 72.77 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.218 -0.926 . . . . 0.0 109.496 179.93 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 88' ' ' GLN . . . . . 0.447 ' O ' ' HB2' ' A' ' 92' ' ' GLU . 59.0 tt0 -66.72 -38.74 87.31 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.267 -0.896 . . . . 0.0 109.462 -179.988 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 89' ' ' ALA . . . . . 0.538 ' HA ' ' CE2' ' A' ' 61' ' ' PHE . . . -74.1 -49.67 22.89 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.319 -0.863 . . . . 0.0 109.624 -179.979 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 90' ' ' VAL . . . . . 0.52 ' O ' ' CB ' ' A' ' 94' ' ' ASN . 69.8 t -63.22 -37.0 78.28 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.551 0 O-C-N 121.203 -0.935 . . . . 0.0 109.61 -179.846 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -80.16 -37.83 32.6 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.212 -0.93 . . . . 0.0 109.722 -179.775 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 92' ' ' GLU . . . . . 0.522 ' HB3' ' CE2' ' A' ' 61' ' ' PHE . 24.6 tt0 -83.53 -48.78 9.91 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.171 -0.956 . . . . 0.0 109.803 -179.654 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 93' ' ' LEU . . . . . 0.571 HD12 ' CZ ' ' A' ' 58' ' ' PHE . 35.0 mt -64.15 -40.47 96.21 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.187 -0.946 . . . . 0.0 109.683 -179.753 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 94' ' ' ASN . . . . . 0.52 ' CB ' ' O ' ' A' ' 90' ' ' VAL . 56.4 t-20 -63.54 124.31 21.03 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.179 -0.951 . . . . 0.0 109.621 -179.998 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 92.05 29.84 11.02 Favored Glycine 0 N--CA 1.49 2.26 0 N-CA-C 109.502 -1.439 . . . . 0.0 109.502 179.973 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 96' ' ' THR . . . . . 0.449 HG21 ' O ' ' A' ' 93' ' ' LEU . 26.1 p -121.41 158.39 28.43 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.287 -1.125 . . . . 0.0 109.5 179.945 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 63.7 tt0 -122.67 148.93 44.71 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.236 -0.915 . . . . 0.0 109.509 -179.99 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 98' ' ' VAL . . . . . 0.456 HG22 ' O ' ' A' ' 101' ' ' VAL . 1.3 t -100.29 -148.72 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.574 0 O-C-N 121.229 -0.919 . . . . 0.0 109.373 179.971 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 96.4 mt-10 -61.24 -40.6 94.65 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.25 -0.906 . . . . 0.0 109.459 179.99 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 100' ' ' SER . . . . . 0.461 ' O ' HG22 ' A' ' 101' ' ' VAL . 32.0 t -159.36 31.56 0.2 Allowed 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.354 -0.841 . . . . 0.0 109.487 -179.942 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 101' ' ' VAL . . . . . 0.464 HG12 ' N ' ' A' ' 102' ' ' GLN . 48.6 t -148.75 154.73 9.57 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.603 0 O-C-N 121.301 -0.874 . . . . 0.0 109.365 -179.987 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 102' ' ' GLN . . . . . 0.464 ' N ' HG12 ' A' ' 101' ' ' VAL . 88.8 mt-30 -100.99 138.7 37.69 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.294 -0.879 . . . . 0.0 109.455 179.855 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 94.6 mt -106.56 136.95 45.44 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.159 -0.963 . . . . 0.0 109.57 -179.956 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 104' ' ' LYS . . . . . 0.465 ' O ' ' HA ' ' A' ' 44' ' ' VAL . 30.1 mttp -118.87 144.5 46.35 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.346 -0.846 . . . . 0.0 109.296 179.747 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 105' ' ' VAL . . . . . 0.477 HG11 ' CG2' ' A' ' 90' ' ' VAL . 17.4 t . . . . . 0 N--CA 1.491 1.585 0 O-C-N 121.231 -0.918 . . . . 0.0 109.661 -179.837 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 40' ' ' ASN . . . . . 0.474 ' O ' ' HA ' ' A' ' 79' ' ' THR . 45.8 t30 . . . . . 0 N--CA 1.493 1.698 0 CA-C-O 121.281 0.562 . . . . 0.0 109.718 . . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 41' ' ' THR . . . . . 0.514 ' CG2' ' HB3' ' A' ' 77' ' ' PHE . 24.8 m -77.95 135.33 37.81 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.28 -0.887 . . . . 0.0 109.557 179.899 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . 0.558 HD12 ' CD2' ' A' ' 80' ' ' TYR . 12.7 mt -112.2 144.9 40.84 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.147 -0.971 . . . . 0.0 109.67 179.993 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 43' ' ' TYR . . . . . 0.487 ' CD2' ' CE1' ' A' ' 77' ' ' PHE . 60.2 t80 -94.9 116.9 29.29 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.428 -0.795 . . . . 0.0 109.359 179.676 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 44' ' ' VAL . . . . . 0.479 ' O ' ' HA ' ' A' ' 75' ' ' CYS . 44.5 t -116.52 135.33 57.14 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.494 0 O-C-N 121.216 -0.927 . . . . 0.0 109.239 179.847 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 45' ' ' TYR . . . . . 0.462 ' HB3' ' HB2' ' A' ' 104' ' ' LYS . 69.1 t80 -123.53 143.53 50.13 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.257 -0.902 . . . . 0.0 109.639 -179.804 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 164.64 174.12 34.03 Favored Glycine 0 N--CA 1.491 2.327 0 N-CA-C 109.444 -1.462 . . . . 0.0 109.444 -179.994 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 95.6 mt-10 -107.98 161.89 14.53 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.293 -1.122 . . . . 0.0 109.419 -179.997 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 21.5 m-20 44.41 58.17 3.96 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.249 -0.907 . . . . 0.0 109.4 179.96 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 49' ' ' MET . . . . . 0.47 ' O ' ' HE1' ' A' ' 69' ' ' MET . 43.2 mtm -111.29 136.76 49.92 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.317 -0.865 . . . . 0.0 109.432 179.954 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 50' ' ' THR . . . . . 0.481 ' O ' ' CD1' ' A' ' 54' ' ' LEU . 0.2 OUTLIER -123.72 166.5 18.54 Favored Pre-proline 0 N--CA 1.492 1.631 0 O-C-N 121.359 -0.838 . . . . 0.0 109.26 179.901 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 51' ' ' PRO . . . . . 0.451 ' HD3' ' SD ' ' A' ' 69' ' ' MET . 50.0 Cg_endo -71.4 -55.39 0.13 Allowed 'Trans proline' 0 C--O 1.214 -0.69 0 C-N-CA 122.495 2.13 . . . . 0.0 111.845 -179.962 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 21.3 m -48.84 -50.38 34.86 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.252 -0.905 . . . . 0.0 109.263 179.783 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 17.6 tp -58.89 -51.04 71.71 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.221 -0.924 . . . . 0.0 109.141 179.777 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 54' ' ' LEU . . . . . 0.481 ' CD1' ' O ' ' A' ' 50' ' ' THR . 14.1 mt -55.59 -49.92 71.48 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.343 -0.848 . . . . 0.0 109.16 179.744 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 55' ' ' ARG . . . . . 0.518 ' O ' ' N ' ' A' ' 59' ' ' SER . 73.0 mtp180 -47.16 -38.13 11.26 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.321 -0.862 . . . . 0.0 109.282 179.741 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -71.29 -31.65 65.94 Favored Glycine 0 N--CA 1.489 2.206 0 N-CA-C 109.369 -1.492 . . . . 0.0 109.369 179.844 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . 0.406 ' O ' HD22 ' A' ' 93' ' ' LEU . . . -76.56 -24.52 53.57 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.188 -1.184 . . . . 0.0 109.372 179.808 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 58' ' ' PHE . . . . . 0.635 ' CE2' ' CD1' ' A' ' 93' ' ' LEU . 91.7 m-85 -116.82 7.57 13.39 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.356 -0.84 . . . . 0.0 109.408 179.92 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 59' ' ' SER . . . . . 0.532 ' N ' ' HD2' ' A' ' 60' ' ' PRO . 0.6 OUTLIER -74.04 -55.68 3.0 Favored Pre-proline 0 N--CA 1.491 1.584 0 O-C-N 121.291 -0.881 . . . . 0.0 110.317 -179.622 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 60' ' ' PRO . . . . . 0.532 ' HD2' ' N ' ' A' ' 59' ' ' SER . 46.6 Cg_endo -68.19 -31.02 30.29 Favored 'Trans proline' 0 C--O 1.215 -0.656 0 C-N-CA 122.521 2.148 . . . . 0.0 112.215 -179.367 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 61' ' ' PHE . . . . . 0.566 ' CD1' ' HA ' ' A' ' 89' ' ' ALA . 70.1 m-85 -65.69 -30.4 71.08 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.116 -0.99 . . . . 0.0 109.491 -179.969 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . 0.469 ' HA3' ' OG ' ' A' ' 85' ' ' SER . . . 175.61 -165.76 36.74 Favored Glycine 0 N--CA 1.49 2.297 0 N-CA-C 109.421 -1.472 . . . . 0.0 109.421 179.956 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 85.4 m-20 -103.87 134.47 47.11 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.29 -1.124 . . . . 0.0 109.499 179.961 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 64' ' ' ILE . . . . . 0.442 HG22 HG21 ' A' ' 78' ' ' VAL . 76.1 mt -95.78 140.35 17.24 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.575 0 O-C-N 121.297 -0.877 . . . . 0.0 109.565 -179.951 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 65' ' ' ILE . . . . . 0.474 HG12 HG22 ' A' ' 79' ' ' THR . 26.2 pt -100.84 -24.49 4.07 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 O-C-N 121.302 -0.873 . . . . 0.0 109.452 179.922 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 40.2 t0 -149.35 140.79 23.31 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.251 -0.906 . . . . 0.0 109.573 -179.863 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . 0.491 ' C ' ' CD1' ' A' ' 67' ' ' LEU . 2.2 tm? -118.76 104.93 11.05 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.283 -0.886 . . . . 0.0 109.136 179.785 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 68' ' ' SER . . . . . 0.47 ' HB3' ' HB2' ' A' ' 77' ' ' PHE . 46.5 t -108.65 141.07 41.15 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.226 -0.921 . . . . 0.0 109.55 -179.891 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 69' ' ' MET . . . . . 0.478 ' HA ' ' HA ' ' A' ' 76' ' ' ALA . 63.2 mtp -133.63 141.62 47.72 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.3 -0.875 . . . . 0.0 109.504 -179.986 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 70' ' ' ASP . . . . . 0.449 ' C ' ' HD2' ' A' ' 72' ' ' PRO . 0.9 OUTLIER -124.51 107.16 29.61 Favored Pre-proline 0 N--CA 1.49 1.562 0 O-C-N 121.332 -0.855 . . . . 0.0 109.378 -179.971 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 71' ' ' PRO . . . . . 0.601 ' N ' ' CD ' ' A' ' 72' ' ' PRO . 47.1 Cg_endo -74.91 -27.85 9.85 Favored 'Trans proline' 0 CA--C 1.542 0.883 0 C-N-CA 122.495 2.13 . . . . 0.0 113.747 -179.908 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 72' ' ' PRO . . . . . 0.601 ' CD ' ' N ' ' A' ' 71' ' ' PRO . 54.4 Cg_endo -74.84 -25.66 12.0 Favored 'Trans proline' 0 C--N 1.353 0.772 0 C-N-CA 121.446 1.431 . . . . 0.0 111.745 -179.771 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 75.3 mtp180 -110.46 0.9 17.98 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.273 -0.892 . . . . 0.0 109.62 -179.833 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 66.2 m-20 56.39 48.56 16.72 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.153 -0.967 . . . . 0.0 109.512 179.943 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 75' ' ' CYS . . . . . 0.479 ' HA ' ' O ' ' A' ' 44' ' ' VAL . 26.6 p -148.18 135.73 20.67 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.186 -0.946 . . . . 0.0 109.46 -179.973 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 76' ' ' ALA . . . . . 0.478 ' HA ' ' HA ' ' A' ' 69' ' ' MET . . . -110.37 133.67 53.04 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.159 -0.963 . . . . 0.0 109.74 -179.994 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 77' ' ' PHE . . . . . 0.514 ' HB3' ' CG2' ' A' ' 41' ' ' THR . 12.0 m-30 -103.79 108.39 19.68 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.335 -0.853 . . . . 0.0 109.33 179.935 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . 0.466 ' O ' ' N ' ' A' ' 42' ' ' LEU . 1.8 p -105.76 141.28 21.44 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.405 0 O-C-N 121.144 -0.973 . . . . 0.0 109.401 179.979 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 79' ' ' THR . . . . . 0.474 ' HA ' ' O ' ' A' ' 40' ' ' ASN . 11.5 m -97.47 155.42 16.94 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.138 -0.976 . . . . 0.0 109.874 -179.692 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 80' ' ' TYR . . . . . 0.558 ' CD2' HD12 ' A' ' 42' ' ' LEU . 0.1 OUTLIER -130.51 129.26 42.65 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.329 -0.857 . . . . 0.0 109.546 179.955 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 81' ' ' GLU . . . . . 0.4 ' C ' ' O ' ' A' ' 80' ' ' TYR . 69.3 tt0 -44.25 -34.5 1.92 Allowed 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.205 -0.934 . . . . 0.0 109.489 179.88 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 33.5 mttm -141.43 152.18 44.05 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.119 -0.988 . . . . 0.0 109.596 -179.774 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 83' ' ' MET . . . . . . . . . . . . . 45.8 mtt -63.89 -26.72 68.73 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.352 -0.843 . . . . 0.0 109.415 179.973 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 96.4 mt-10 -56.27 -49.09 75.21 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.292 -0.88 . . . . 0.0 109.475 -179.976 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 85' ' ' SER . . . . . 0.555 ' OG ' ' CE1' ' A' ' 80' ' ' TYR . 41.5 t -61.04 -32.05 71.68 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.213 -0.929 . . . . 0.0 109.381 179.864 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 86' ' ' ALA . . . . . 0.521 ' HB3' ' CD2' ' A' ' 42' ' ' LEU . . . -76.04 -33.42 59.62 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.308 -0.87 . . . . 0.0 109.774 -179.757 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 22.3 t70 -70.13 -43.77 70.28 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.145 -0.972 . . . . 0.0 109.725 -179.732 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 62.6 tt0 -71.14 -39.08 72.19 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.265 -0.897 . . . . 0.0 109.877 -179.717 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 89' ' ' ALA . . . . . 0.566 ' HA ' ' CD1' ' A' ' 61' ' ' PHE . . . -73.72 -43.38 59.35 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.154 -0.966 . . . . 0.0 109.741 -179.745 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 90' ' ' VAL . . . . . 0.527 ' O ' ' CB ' ' A' ' 94' ' ' ASN . 74.3 t -61.26 -31.88 51.49 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.598 0 O-C-N 121.195 -0.941 . . . . 0.0 109.667 -179.778 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -78.96 -53.32 7.17 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.272 -0.892 . . . . 0.0 109.732 -179.857 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 92' ' ' GLU . . . . . 0.514 ' HB2' ' CE1' ' A' ' 61' ' ' PHE . 75.2 mm-40 -69.53 -41.45 75.97 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.224 -0.922 . . . . 0.0 109.928 -179.632 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 93' ' ' LEU . . . . . 0.635 ' CD1' ' CE2' ' A' ' 58' ' ' PHE . 81.2 mt -69.55 -40.55 76.76 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.074 -1.016 . . . . 0.0 109.642 -179.806 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 94' ' ' ASN . . . . . 0.527 ' CB ' ' O ' ' A' ' 90' ' ' VAL . 59.1 t30 -71.47 126.41 29.59 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.201 -0.937 . . . . 0.0 109.497 -179.945 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 99.09 20.0 19.7 Favored Glycine 0 N--CA 1.489 2.182 0 N-CA-C 109.515 -1.434 . . . . 0.0 109.515 179.94 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 96' ' ' THR . . . . . 0.409 ' CG2' ' O ' ' A' ' 92' ' ' GLU . 20.5 p -121.92 159.94 25.84 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.301 -1.117 . . . . 0.0 109.504 179.964 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 63.9 tt0 -125.35 149.08 48.45 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.334 -0.854 . . . . 0.0 109.453 -179.969 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 98' ' ' VAL . . . . . 0.529 ' CG2' HG13 ' A' ' 101' ' ' VAL . 1.4 t -93.78 -148.68 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 O-C-N 121.206 -0.934 . . . . 0.0 109.35 -179.982 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 95.9 mt-10 -56.69 -44.64 81.7 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.164 -0.96 . . . . 0.0 109.449 -179.977 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 3.5 p -157.2 21.21 0.3 Allowed 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.282 -0.886 . . . . 0.0 109.449 179.974 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 101' ' ' VAL . . . . . 0.529 HG13 ' CG2' ' A' ' 98' ' ' VAL . 8.7 p -129.03 139.5 51.73 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.524 0 O-C-N 121.231 -0.918 . . . . 0.0 109.519 -179.943 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 95.3 mt-30 -87.1 136.51 32.9 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.2 -0.937 . . . . 0.0 109.387 179.959 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 97.8 mt -100.87 144.26 30.04 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.23 -0.919 . . . . 0.0 109.667 -179.934 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 104' ' ' LYS . . . . . 0.462 ' HB2' ' HB3' ' A' ' 45' ' ' TYR . 45.1 mttt -134.66 142.09 46.76 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.263 -0.898 . . . . 0.0 109.252 179.869 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 105' ' ' VAL . . . . . 0.51 HG13 ' CG2' ' A' ' 90' ' ' VAL . 25.5 t . . . . . 0 N--CA 1.491 1.59 0 O-C-N 121.225 -0.922 . . . . 0.0 109.686 -179.932 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 40' ' ' ASN . . . . . 0.464 ' O ' ' HA ' ' A' ' 79' ' ' THR . 49.6 t-20 . . . . . 0 N--CA 1.491 1.597 0 N-CA-C 109.535 -0.543 . . . . 0.0 109.535 . . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 41' ' ' THR . . . . . 0.471 ' HA ' ' HA ' ' A' ' 79' ' ' THR . 35.8 m -80.75 138.86 36.32 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.25 -0.906 . . . . 0.0 109.499 -179.997 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . 0.544 HD13 ' CD2' ' A' ' 80' ' ' TYR . 9.9 mt -120.13 151.05 39.64 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.211 -0.931 . . . . 0.0 109.626 179.941 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 43' ' ' TYR . . . . . 0.453 ' CZ ' ' HB2' ' A' ' 75' ' ' CYS . 69.0 t80 -106.29 124.92 50.33 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.236 -0.915 . . . . 0.0 109.341 179.867 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 44' ' ' VAL . . . . . 0.453 ' O ' ' HA ' ' A' ' 75' ' ' CYS . 80.2 t -122.14 137.73 54.73 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.534 0 O-C-N 121.22 -0.925 . . . . 0.0 109.467 -179.941 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 45' ' ' TYR . . . . . 0.447 ' HB3' ' HB2' ' A' ' 104' ' ' LYS . 71.0 t80 -121.07 133.58 55.24 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.276 -0.89 . . . . 0.0 109.423 179.909 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -175.73 -175.37 43.08 Favored Glycine 0 N--CA 1.49 2.277 0 N-CA-C 109.482 -1.447 . . . . 0.0 109.482 -179.974 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 94.0 mt-10 -121.41 146.53 46.79 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.212 -1.17 . . . . 0.0 109.45 179.983 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 58.4 t0 47.79 52.97 12.03 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.277 -0.889 . . . . 0.0 109.481 -179.952 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 67.5 mtm -95.7 138.09 33.85 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.27 -0.894 . . . . 0.0 109.454 -179.929 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 50' ' ' THR . . . . . 0.477 ' CG2' ' HD2' ' A' ' 51' ' ' PRO . 0.0 OUTLIER -110.8 161.5 24.57 Favored Pre-proline 0 N--CA 1.49 1.543 0 O-C-N 121.23 -0.919 . . . . 0.0 109.48 179.979 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 51' ' ' PRO . . . . . 0.477 ' HD2' ' CG2' ' A' ' 50' ' ' THR . 49.4 Cg_endo -70.12 -52.5 0.3 Allowed 'Trans proline' 0 C--O 1.215 -0.648 0 C-N-CA 122.743 2.295 . . . . 0.0 111.674 -179.959 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 37.1 m -56.27 -44.49 79.81 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.322 -0.861 . . . . 0.0 109.383 179.995 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . 0.491 ' CD1' ' C ' ' A' ' 53' ' ' LEU . 3.1 tm? -60.45 -46.56 89.61 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.241 -0.912 . . . . 0.0 109.405 179.931 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 54' ' ' LEU . . . . . 0.506 ' CD1' ' SD ' ' A' ' 69' ' ' MET . 42.7 mt -62.81 -48.03 80.85 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.242 -0.911 . . . . 0.0 109.356 -179.916 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 55' ' ' ARG . . . . . 0.467 ' O ' ' N ' ' A' ' 59' ' ' SER . 48.0 mtt180 -48.53 -39.82 24.79 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.248 -0.907 . . . . 0.0 109.392 179.936 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -69.09 -34.78 76.73 Favored Glycine 0 N--CA 1.49 2.289 0 N-CA-C 109.312 -1.515 . . . . 0.0 109.312 179.881 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . 0.459 ' O ' HD22 ' A' ' 93' ' ' LEU . . . -71.26 -25.03 62.29 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.288 -1.125 . . . . 0.0 109.414 179.921 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 58' ' ' PHE . . . . . 0.616 ' CE2' ' CD1' ' A' ' 93' ' ' LEU . 76.2 m-85 -116.81 10.3 14.16 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.323 -0.86 . . . . 0.0 109.463 -179.979 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 59' ' ' SER . . . . . 0.538 ' N ' ' HD2' ' A' ' 60' ' ' PRO . 1.4 t -76.46 -53.74 1.99 Allowed Pre-proline 0 N--CA 1.492 1.63 0 O-C-N 121.3 -0.875 . . . . 0.0 110.473 -179.558 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 60' ' ' PRO . . . . . 0.538 ' HD2' ' N ' ' A' ' 59' ' ' SER . 47.8 Cg_endo -68.88 -34.03 18.8 Favored 'Trans proline' 0 C--O 1.215 -0.659 0 C-N-CA 122.405 2.07 . . . . 0.0 112.388 -179.152 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 61' ' ' PHE . . . . . 0.569 ' CE1' ' HB2' ' A' ' 92' ' ' GLU . 87.8 m-85 -63.52 -37.04 85.8 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.057 -1.027 . . . . 0.0 109.502 -179.971 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . 0.467 ' HA3' ' OG ' ' A' ' 85' ' ' SER . . . -178.74 -172.63 43.29 Favored Glycine 0 N--CA 1.49 2.27 0 N-CA-C 109.599 -1.4 . . . . 0.0 109.599 179.94 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 51.5 t-20 -96.99 136.81 37.03 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.266 -1.138 . . . . 0.0 109.577 -179.914 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 64' ' ' ILE . . . . . 0.459 HG22 HD22 ' A' ' 67' ' ' LEU . 54.6 mt -98.51 131.29 45.93 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 O-C-N 121.209 -0.932 . . . . 0.0 109.532 -179.946 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 65' ' ' ILE . . . . . 0.529 ' CG1' HG22 ' A' ' 79' ' ' THR . 18.6 pt -95.58 -19.31 6.35 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 O-C-N 121.32 -0.862 . . . . 0.0 109.579 -179.902 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 59.6 t0 -152.38 106.25 3.11 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.205 -0.934 . . . . 0.0 109.591 -179.99 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . 0.484 ' C ' ' CD1' ' A' ' 67' ' ' LEU . 0.5 OUTLIER -99.22 120.22 39.16 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.27 -0.894 . . . . 0.0 109.375 179.755 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 68' ' ' SER . . . . . 0.429 ' N ' HD12 ' A' ' 67' ' ' LEU . 67.9 m -131.62 151.15 51.83 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.174 -0.954 . . . . 0.0 109.691 -179.793 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 69' ' ' MET . . . . . 0.506 ' SD ' ' CD1' ' A' ' 54' ' ' LEU . 18.2 mtm -130.94 144.62 51.6 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.309 -0.869 . . . . 0.0 109.346 179.886 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 70' ' ' ASP . . . . . 0.519 ' CB ' ' O ' ' A' ' 75' ' ' CYS . 0.9 OUTLIER -118.89 102.78 48.99 Favored Pre-proline 0 N--CA 1.491 1.604 0 O-C-N 121.22 -0.925 . . . . 0.0 109.533 -179.885 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 71' ' ' PRO . . . . . 0.601 ' N ' ' CD ' ' A' ' 72' ' ' PRO . 47.7 Cg_endo -74.9 -27.75 9.96 Favored 'Trans proline' 0 CA--C 1.542 0.888 0 C-N-CA 122.608 2.205 . . . . 0.0 113.697 179.886 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 72' ' ' PRO . . . . . 0.601 ' CD ' ' N ' ' A' ' 71' ' ' PRO . 55.4 Cg_endo -75.09 -25.16 11.98 Favored 'Trans proline' 0 C--N 1.353 0.814 0 C-N-CA 121.446 1.431 . . . . 0.0 111.809 -179.795 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 48.3 mtt85 -111.9 10.03 20.64 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.282 -0.886 . . . . 0.0 109.587 -179.946 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 83.1 m-20 53.3 36.61 23.24 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.249 -0.907 . . . . 0.0 109.506 -179.987 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 75' ' ' CYS . . . . . 0.519 ' O ' ' CB ' ' A' ' 70' ' ' ASP . 28.1 p -142.81 146.67 34.42 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.214 -0.929 . . . . 0.0 109.527 -179.868 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 76' ' ' ALA . . . . . 0.457 ' HA ' ' HA ' ' A' ' 69' ' ' MET . . . -114.17 162.48 16.47 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.188 -0.945 . . . . 0.0 109.553 -179.977 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 77' ' ' PHE . . . . . 0.406 ' CE1' ' HD1' ' A' ' 43' ' ' TYR . 96.7 m-85 -127.62 108.99 11.25 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.362 -0.836 . . . . 0.0 109.359 179.933 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . 0.523 ' CG1' ' HB2' ' A' ' 42' ' ' LEU . 6.1 p -109.67 135.58 48.22 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.449 0 O-C-N 121.247 -0.908 . . . . 0.0 109.624 -179.854 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 79' ' ' THR . . . . . 0.529 HG22 ' CG1' ' A' ' 65' ' ' ILE . 91.7 m -106.63 128.8 54.45 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.249 -0.907 . . . . 0.0 109.273 179.797 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 80' ' ' TYR . . . . . 0.544 ' CD2' HD13 ' A' ' 42' ' ' LEU . 0.9 OUTLIER -94.93 174.22 7.2 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.336 -0.852 . . . . 0.0 109.527 179.978 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 81' ' ' GLU . . . . . 0.479 ' O ' ' CG ' ' A' ' 82' ' ' LYS . 81.7 tt0 -86.37 -11.77 51.12 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.44 -0.787 . . . . 0.0 109.177 179.66 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 82' ' ' LYS . . . . . 0.479 ' CG ' ' O ' ' A' ' 81' ' ' GLU . 43.0 mttp -157.91 158.83 35.78 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.324 -0.86 . . . . 0.0 109.267 179.934 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 83' ' ' MET . . . . . . . . . . . . . 31.4 mtt -71.83 -12.13 61.14 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.238 -0.914 . . . . 0.0 109.384 -179.947 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . 0.43 ' HA ' ' OE1' ' A' ' 84' ' ' GLU . 70.7 mm-40 -76.4 -40.11 51.77 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.317 -0.865 . . . . 0.0 109.609 179.93 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 85' ' ' SER . . . . . 0.467 ' OG ' ' HA3' ' A' ' 62' ' ' GLY . 29.1 t -65.45 -35.44 80.93 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.255 -0.903 . . . . 0.0 109.481 179.96 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 86' ' ' ALA . . . . . 0.532 ' HB1' ' CD2' ' A' ' 42' ' ' LEU . . . -71.83 -35.78 70.0 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.425 -0.797 . . . . 0.0 109.764 -179.918 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 64.5 t0 -65.32 -43.64 90.38 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.158 -0.964 . . . . 0.0 109.786 -179.814 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 64.8 tt0 -72.57 -38.85 67.8 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.197 -0.939 . . . . 0.0 109.82 -179.745 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 89' ' ' ALA . . . . . 0.551 ' HA ' ' CD1' ' A' ' 61' ' ' PHE . . . -73.89 -42.12 61.16 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.206 -0.934 . . . . 0.0 109.745 -179.708 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 90' ' ' VAL . . . . . 0.476 ' O ' ' CB ' ' A' ' 94' ' ' ASN . 51.1 t -62.07 -34.37 63.02 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.564 0 O-C-N 121.243 -0.91 . . . . 0.0 109.74 -179.79 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -76.03 -53.74 7.91 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.185 -0.947 . . . . 0.0 109.867 -179.678 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 92' ' ' GLU . . . . . 0.569 ' HB2' ' CE1' ' A' ' 61' ' ' PHE . 75.1 mm-40 -69.24 -44.37 72.13 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.196 -0.94 . . . . 0.0 109.9 -179.634 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 93' ' ' LEU . . . . . 0.616 ' CD1' ' CE2' ' A' ' 58' ' ' PHE . 69.8 mt -65.45 -36.84 85.12 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.109 -0.994 . . . . 0.0 109.709 -179.753 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 94' ' ' ASN . . . . . 0.476 ' CB ' ' O ' ' A' ' 90' ' ' VAL . 63.1 t-20 -72.99 125.38 27.47 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.169 -0.957 . . . . 0.0 109.452 -179.888 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 95.29 26.52 12.11 Favored Glycine 0 N--CA 1.49 2.263 0 N-CA-C 109.515 -1.434 . . . . 0.0 109.515 179.908 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 96' ' ' THR . . . . . 0.489 ' CG2' ' O ' ' A' ' 92' ' ' GLU . 17.7 p -121.47 155.3 35.2 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.23 -1.159 . . . . 0.0 109.469 -179.969 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 64.2 tt0 -128.74 153.08 47.71 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.257 -0.902 . . . . 0.0 109.481 -179.97 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 1.2 t -98.33 -152.58 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.627 0 O-C-N 121.235 -0.916 . . . . 0.0 109.254 -179.897 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 75.7 mm-40 -59.79 -39.13 83.89 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.168 -0.957 . . . . 0.0 109.475 179.943 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -157.6 24.85 0.28 Allowed 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.327 -0.858 . . . . 0.0 109.485 -179.958 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 47.4 t -137.57 152.5 27.19 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.552 0 O-C-N 121.165 -0.96 . . . . 0.0 109.498 179.998 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 91.8 mt-30 -108.42 145.08 35.14 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.268 -0.895 . . . . 0.0 109.483 179.937 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 93.3 mt -111.95 145.35 39.75 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.225 -0.922 . . . . 0.0 109.525 -179.961 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 104' ' ' LYS . . . . . 0.447 ' HB2' ' HB3' ' A' ' 45' ' ' TYR . 43.8 mttt -127.33 133.1 50.13 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.264 -0.897 . . . . 0.0 109.406 179.912 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 105' ' ' VAL . . . . . 0.474 HG12 ' CG2' ' A' ' 90' ' ' VAL . 21.9 t . . . . . 0 N--CA 1.489 1.514 0 O-C-N 121.217 -0.927 . . . . 0.0 109.576 -179.866 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 45.9 t30 . . . . . 0 N--CA 1.49 1.545 0 CA-C-O 121.256 0.551 . . . . 0.0 109.605 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 41' ' ' THR . . . . . 0.437 ' HA ' ' HA ' ' A' ' 79' ' ' THR . 36.2 m -72.46 127.76 33.55 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.18 -0.95 . . . . 0.0 109.48 -179.977 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . 0.464 HD23 ' CB ' ' A' ' 86' ' ' ALA . 13.3 mt -106.44 145.92 31.17 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.195 -0.941 . . . . 0.0 109.478 -179.989 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 85.3 t80 -96.76 117.6 31.41 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.216 -0.927 . . . . 0.0 109.42 179.98 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 44' ' ' VAL . . . . . 0.456 ' HA ' ' O ' ' A' ' 104' ' ' LYS . 63.8 t -113.79 138.99 41.68 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.547 0 O-C-N 121.214 -0.929 . . . . 0.0 109.504 179.981 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 45' ' ' TYR . . . . . 0.414 ' HB3' ' HB2' ' A' ' 104' ' ' LYS . 70.4 t80 -124.5 135.32 53.11 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.273 -0.892 . . . . 0.0 109.49 179.99 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -177.6 -174.87 44.34 Favored Glycine 0 N--CA 1.491 2.353 0 N-CA-C 109.484 -1.447 . . . . 0.0 109.484 -179.951 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 95.5 mt-10 -123.57 157.51 33.5 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.237 -1.155 . . . . 0.0 109.483 -179.98 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 58.3 t0 45.96 46.59 12.44 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.287 -0.883 . . . . 0.0 109.516 179.933 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 70.7 mtm -94.48 143.85 26.07 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.291 -0.881 . . . . 0.0 109.495 179.966 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 50' ' ' THR . . . . . 0.465 ' O ' ' CD1' ' A' ' 54' ' ' LEU . 2.5 p -120.9 163.99 26.2 Favored Pre-proline 0 N--CA 1.489 1.51 0 O-C-N 121.223 -0.923 . . . . 0.0 109.43 -179.958 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 51' ' ' PRO . . . . . 0.471 ' CA ' ' SD ' ' A' ' 69' ' ' MET . 49.1 Cg_endo -69.41 -52.76 0.33 Allowed 'Trans proline' 0 C--O 1.216 -0.607 0 C-N-CA 122.672 2.248 . . . . 0.0 111.761 179.992 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 56.3 m -57.54 -46.67 83.6 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.22 -0.925 . . . . 0.0 109.319 179.965 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 17.0 tp -58.57 -55.55 33.61 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.285 -0.884 . . . . 0.0 109.299 179.872 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 54' ' ' LEU . . . . . 0.479 ' CD1' ' HE2' ' A' ' 69' ' ' MET . 9.0 mt -54.07 -42.99 69.9 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.267 -0.896 . . . . 0.0 109.285 179.806 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 55' ' ' ARG . . . . . 0.476 ' O ' ' N ' ' A' ' 59' ' ' SER . 32.4 ttt85 -51.66 -39.34 57.98 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.22 -0.925 . . . . 0.0 109.29 179.85 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . 0.437 ' HA2' ' HB2' ' A' ' 59' ' ' SER . . . -70.34 -31.43 68.68 Favored Glycine 0 N--CA 1.488 2.16 0 N-CA-C 109.436 -1.466 . . . . 0.0 109.436 179.898 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . 0.505 ' O ' ' CD2' ' A' ' 61' ' ' PHE . . . -72.85 -17.03 61.58 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.239 -1.153 . . . . 0.0 109.453 -179.958 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 58' ' ' PHE . . . . . 0.629 ' CE1' ' CD1' ' A' ' 93' ' ' LEU . 97.9 m-85 -126.54 5.34 6.84 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.238 -0.914 . . . . 0.0 109.349 179.855 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 59' ' ' SER . . . . . 0.524 ' N ' ' HD2' ' A' ' 60' ' ' PRO . 0.4 OUTLIER -74.04 -55.89 2.91 Favored Pre-proline 0 N--CA 1.49 1.565 0 O-C-N 121.249 -0.907 . . . . 0.0 109.989 -179.761 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 60' ' ' PRO . . . . . 0.524 ' HD2' ' N ' ' A' ' 59' ' ' SER . 49.5 Cg_endo -70.08 -34.15 14.05 Favored 'Trans proline' 0 C--O 1.215 -0.644 0 C-N-CA 122.51 2.14 . . . . 0.0 112.04 -179.553 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 61' ' ' PHE . . . . . 0.562 ' CE1' ' HA ' ' A' ' 89' ' ' ALA . 73.4 m-85 -58.91 -42.71 90.26 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.175 -0.953 . . . . 0.0 109.52 -179.947 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . 0.464 ' HA3' ' OG ' ' A' ' 85' ' ' SER . . . -178.79 179.88 48.71 Favored Glycine 0 N--CA 1.49 2.289 0 N-CA-C 109.469 -1.452 . . . . 0.0 109.469 179.996 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 39.8 t30 -85.29 140.9 30.47 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.276 -1.132 . . . . 0.0 109.462 179.987 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 64' ' ' ILE . . . . . 0.444 HG21 HG13 ' A' ' 78' ' ' VAL . 68.2 mt -103.92 134.22 45.77 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 O-C-N 121.223 -0.923 . . . . 0.0 109.427 -179.982 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 23.7 pt -97.56 -20.67 5.55 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.538 0 O-C-N 121.277 -0.89 . . . . 0.0 109.548 -179.928 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 54.4 t0 -160.64 106.13 1.45 Allowed 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.215 -0.928 . . . . 0.0 109.514 -179.947 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . 0.523 HD12 ' CG2' ' A' ' 78' ' ' VAL . 0.6 OUTLIER -111.7 120.23 41.34 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.293 -0.879 . . . . 0.0 109.355 179.881 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 19.9 m -118.57 152.39 36.09 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.306 -0.871 . . . . 0.0 109.641 -179.945 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 69' ' ' MET . . . . . 0.479 ' HE2' ' CD1' ' A' ' 54' ' ' LEU . 91.9 mtp -121.02 140.95 51.22 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.297 -0.877 . . . . 0.0 109.46 -179.987 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 70' ' ' ASP . . . . . 0.45 ' C ' ' HD2' ' A' ' 72' ' ' PRO . 0.4 OUTLIER -119.38 105.7 43.73 Favored Pre-proline 0 N--CA 1.491 1.6 0 O-C-N 121.2 -0.937 . . . . 0.0 109.458 179.971 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 71' ' ' PRO . . . . . 0.601 ' N ' ' CD ' ' A' ' 72' ' ' PRO . 48.0 Cg_endo -74.6 -27.78 10.51 Favored 'Trans proline' 0 CA--C 1.542 0.893 0 C-N-CA 122.569 2.18 . . . . 0.0 113.653 179.939 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 72' ' ' PRO . . . . . 0.601 ' CD ' ' N ' ' A' ' 71' ' ' PRO . 55.2 Cg_endo -75.58 -39.59 0.99 Allowed 'Trans proline' 0 C--N 1.352 0.718 0 C-N-CA 121.479 1.453 . . . . 0.0 111.718 -179.879 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 73' ' ' ARG . . . . . 0.446 ' HG2' ' O ' ' A' ' 73' ' ' ARG . 57.4 ttt85 -93.84 -3.89 51.11 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.29 -0.881 . . . . 0.0 109.559 -179.885 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 74' ' ' ASN . . . . . 0.411 ' HB2' ' O ' ' A' ' 73' ' ' ARG . 71.7 m-20 60.15 46.41 10.57 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.183 -0.948 . . . . 0.0 109.388 179.96 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 75' ' ' CYS . . . . . 0.452 ' HA ' ' O ' ' A' ' 44' ' ' VAL . 24.1 p -146.12 143.45 29.34 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.231 -0.918 . . . . 0.0 109.468 179.938 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -111.22 156.32 21.62 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.257 -0.902 . . . . 0.0 109.585 -179.939 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 77' ' ' PHE . . . . . 0.434 ' HA ' ' O ' ' A' ' 42' ' ' LEU . 97.3 m-85 -119.32 131.9 55.8 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.266 -0.896 . . . . 0.0 109.436 179.99 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . 0.523 ' CG2' HD12 ' A' ' 67' ' ' LEU . 47.2 t -125.42 120.78 58.78 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.619 0 O-C-N 121.193 -0.942 . . . . 0.0 109.533 -179.958 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 79' ' ' THR . . . . . 0.437 ' HA ' ' HA ' ' A' ' 41' ' ' THR . 17.3 m -95.12 132.59 39.86 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.244 -0.91 . . . . 0.0 109.436 179.94 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 80' ' ' TYR . . . . . 0.52 ' CE1' ' OG ' ' A' ' 85' ' ' SER . 2.0 m-85 -114.06 140.55 48.37 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.253 -0.904 . . . . 0.0 109.648 -179.862 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 81.2 tt0 -60.21 -30.07 69.13 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.326 -0.859 . . . . 0.0 109.665 -179.973 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 40.7 mttm -131.88 150.53 52.12 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.1 -1.0 . . . . 0.0 109.611 -179.922 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 83' ' ' MET . . . . . . . . . . . . . 54.0 mtt -66.67 -18.92 65.62 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.364 -0.835 . . . . 0.0 109.582 -179.997 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 98.7 mt-10 -64.39 -44.54 90.98 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.296 -0.877 . . . . 0.0 109.557 -179.86 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 85' ' ' SER . . . . . 0.52 ' OG ' ' CE1' ' A' ' 80' ' ' TYR . 43.6 t -61.51 -31.15 71.14 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.19 -0.944 . . . . 0.0 109.549 -179.89 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 86' ' ' ALA . . . . . 0.464 ' CB ' HD23 ' A' ' 42' ' ' LEU . . . -74.53 -31.03 62.0 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.237 -0.914 . . . . 0.0 109.647 -179.85 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 87' ' ' ASP . . . . . 0.423 ' O ' ' CB ' ' A' ' 91' ' ' ALA . 59.4 t0 -67.96 -49.39 62.02 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.21 -0.931 . . . . 0.0 109.559 -179.982 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 88' ' ' GLN . . . . . 0.434 ' HG2' ' CE1' ' A' ' 61' ' ' PHE . 62.9 tt0 -67.77 -36.78 81.11 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.251 -0.906 . . . . 0.0 109.524 -179.939 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 89' ' ' ALA . . . . . 0.562 ' HA ' ' CE1' ' A' ' 61' ' ' PHE . . . -75.7 -51.18 13.31 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.229 -0.919 . . . . 0.0 109.556 -179.928 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 90' ' ' VAL . . . . . 0.516 ' CG2' HG12 ' A' ' 105' ' ' VAL . 92.9 t -65.08 -33.67 65.32 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.545 0 O-C-N 121.321 -0.862 . . . . 0.0 109.552 -179.932 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 91' ' ' ALA . . . . . 0.423 ' CB ' ' O ' ' A' ' 87' ' ' ASP . . . -79.98 -45.25 18.77 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.31 -0.869 . . . . 0.0 109.663 -179.937 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 92' ' ' GLU . . . . . 0.554 ' HB3' ' CE1' ' A' ' 61' ' ' PHE . 34.0 tt0 -75.26 -46.87 30.89 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.255 -0.903 . . . . 0.0 109.658 -179.831 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 93' ' ' LEU . . . . . 0.629 ' CD1' ' CE1' ' A' ' 58' ' ' PHE . 42.5 mt -64.42 -41.84 96.38 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.206 -0.934 . . . . 0.0 109.606 -179.779 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 94' ' ' ASN . . . . . 0.492 ' CB ' ' O ' ' A' ' 90' ' ' VAL . 46.8 t30 -64.26 126.69 28.57 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.197 -0.939 . . . . 0.0 109.542 -179.93 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 91.78 25.87 21.43 Favored Glycine 0 N--CA 1.49 2.3 0 N-CA-C 109.556 -1.417 . . . . 0.0 109.556 179.966 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 96' ' ' THR . . . . . 0.478 ' CG2' ' O ' ' A' ' 92' ' ' GLU . 17.1 p -121.04 160.63 23.2 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.149 -1.206 . . . . 0.0 109.471 179.94 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 64.0 tt0 -130.38 149.92 51.84 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.257 -0.902 . . . . 0.0 109.477 -179.938 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 98' ' ' VAL . . . . . 0.457 HG21 ' O ' ' A' ' 101' ' ' VAL . 1.1 t -97.73 -151.3 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.609 0 O-C-N 121.315 -0.866 . . . . 0.0 109.357 -179.932 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 96.0 mt-10 -53.84 -38.43 64.65 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.202 -0.936 . . . . 0.0 109.529 -179.947 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 100' ' ' SER . . . . . 0.409 ' C ' HG22 ' A' ' 101' ' ' VAL . 19.2 m -164.0 30.35 0.08 Allowed 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.268 -0.895 . . . . 0.0 109.521 179.965 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 101' ' ' VAL . . . . . 0.457 ' O ' HG21 ' A' ' 98' ' ' VAL . 59.7 t -144.78 144.17 22.15 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.516 0 O-C-N 121.21 -0.931 . . . . 0.0 109.487 -179.987 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 87.1 mt-30 -94.09 150.53 20.25 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.241 -0.912 . . . . 0.0 109.373 179.97 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 88.3 mt -117.29 134.99 54.16 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.205 -0.935 . . . . 0.0 109.499 -179.954 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 104' ' ' LYS . . . . . 0.456 ' O ' ' HA ' ' A' ' 44' ' ' VAL . 23.1 mttm -113.66 135.13 54.26 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.279 -0.888 . . . . 0.0 109.351 179.936 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 105' ' ' VAL . . . . . 0.516 HG12 ' CG2' ' A' ' 90' ' ' VAL . 21.2 t . . . . . 0 N--CA 1.49 1.551 0 O-C-N 121.172 -0.955 . . . . 0.0 109.541 -179.982 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 40' ' ' ASN . . . . . 0.535 ' O ' ' CG2' ' A' ' 79' ' ' THR . 38.6 t30 . . . . . 0 N--CA 1.49 1.548 0 N-CA-C 109.311 -0.626 . . . . 0.0 109.311 . . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 41' ' ' THR . . . . . 0.434 ' C ' HD13 ' A' ' 42' ' ' LEU . 8.1 m -139.81 159.18 42.77 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.251 -0.905 . . . . 0.0 109.687 -179.732 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . 0.52 ' CD2' ' HB2' ' A' ' 86' ' ' ALA . 4.3 mp -144.78 143.91 30.9 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.279 -0.888 . . . . 0.0 109.469 -179.951 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 51.7 t80 -105.04 109.79 21.93 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.174 -0.954 . . . . 0.0 109.519 179.925 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 44' ' ' VAL . . . . . 0.418 ' HA ' ' O ' ' A' ' 104' ' ' LYS . 99.8 t -101.16 144.23 13.22 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.518 0 O-C-N 121.346 -0.846 . . . . 0.0 109.481 179.862 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 64.6 t80 -135.86 134.81 39.21 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.303 -0.873 . . . . 0.0 109.425 -179.852 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 176.09 -166.0 36.88 Favored Glycine 0 N--CA 1.49 2.257 0 N-CA-C 109.453 -1.459 . . . . 0.0 109.453 179.918 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . 0.422 ' O ' ' C ' ' A' ' 48' ' ' ASP . 94.0 mt-10 -126.04 158.04 36.37 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.288 -1.125 . . . . 0.0 109.396 180.0 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 48' ' ' ASP . . . . . 0.422 ' C ' ' O ' ' A' ' 47' ' ' GLU . 51.7 m-20 44.38 48.85 8.15 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.174 -0.954 . . . . 0.0 109.486 -179.993 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 63.5 mtm -101.41 141.12 34.75 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.228 -0.92 . . . . 0.0 109.462 -179.976 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 50' ' ' THR . . . . . 0.496 ' O ' ' CD1' ' A' ' 54' ' ' LEU . 0.6 OUTLIER -122.12 167.28 14.29 Favored Pre-proline 0 N--CA 1.49 1.531 0 O-C-N 121.211 -0.931 . . . . 0.0 109.422 179.965 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 51' ' ' PRO . . . . . 0.427 ' HD2' ' HB ' ' A' ' 50' ' ' THR . 49.5 Cg_endo -70.43 -55.0 0.17 Allowed 'Trans proline' 0 C--O 1.215 -0.664 0 C-N-CA 122.643 2.228 . . . . 0.0 111.864 180.0 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 35.3 m -51.88 -47.0 64.73 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.175 -0.953 . . . . 0.0 109.147 179.906 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 23.5 tp -59.46 -50.27 74.56 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.258 -0.901 . . . . 0.0 109.143 179.788 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 54' ' ' LEU . . . . . 0.496 ' CD1' ' O ' ' A' ' 50' ' ' THR . 8.1 mt -55.57 -48.7 74.36 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.309 -0.87 . . . . 0.0 109.175 179.705 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 55' ' ' ARG . . . . . 0.518 ' O ' ' N ' ' A' ' 59' ' ' SER . 93.5 mtt-85 -49.18 -37.04 21.24 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.275 -0.89 . . . . 0.0 109.229 179.824 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -69.38 -35.01 75.28 Favored Glycine 0 N--CA 1.489 2.223 0 N-CA-C 109.454 -1.458 . . . . 0.0 109.454 179.945 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . 0.449 ' O ' HD13 ' A' ' 93' ' ' LEU . . . -75.87 -22.83 55.77 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.217 -1.166 . . . . 0.0 109.362 179.925 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 58' ' ' PHE . . . . . 0.634 ' CE1' ' CD1' ' A' ' 93' ' ' LEU . 95.7 m-85 -116.63 9.54 14.15 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.287 -0.883 . . . . 0.0 109.328 179.825 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 59' ' ' SER . . . . . 0.539 ' N ' ' HD2' ' A' ' 60' ' ' PRO . 0.8 OUTLIER -76.92 -52.72 1.91 Allowed Pre-proline 0 N--CA 1.49 1.556 0 O-C-N 121.293 -0.879 . . . . 0.0 110.619 -179.506 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 60' ' ' PRO . . . . . 0.539 ' HD2' ' N ' ' A' ' 59' ' ' SER . 48.8 Cg_endo -70.45 -33.35 14.13 Favored 'Trans proline' 0 C--O 1.215 -0.658 0 C-N-CA 122.336 2.024 . . . . 0.0 112.526 -179.023 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 61' ' ' PHE . . . . . 0.567 ' CE1' ' HB2' ' A' ' 92' ' ' GLU . 78.1 m-85 -63.41 -36.64 84.39 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 120.983 -1.073 . . . . 0.0 109.648 -179.838 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . 0.454 ' HA3' ' OG ' ' A' ' 85' ' ' SER . . . 179.22 -176.98 48.21 Favored Glycine 0 N--CA 1.49 2.247 0 N-CA-C 109.447 -1.461 . . . . 0.0 109.447 179.952 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 78.9 m-20 -93.22 138.53 31.53 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.266 -1.138 . . . . 0.0 109.577 179.99 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 64' ' ' ILE . . . . . 0.5 ' CG2' ' O ' ' A' ' 79' ' ' THR . 41.1 mt -99.19 140.01 19.64 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.555 0 O-C-N 121.273 -0.892 . . . . 0.0 109.397 -179.989 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 22.3 pt -103.63 -19.3 6.29 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 O-C-N 121.204 -0.935 . . . . 0.0 109.705 -179.763 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 66' ' ' ASP . . . . . 0.466 ' O ' ' OG1' ' A' ' 79' ' ' THR . 21.7 t70 -152.18 126.42 9.25 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.228 -0.92 . . . . 0.0 109.405 179.946 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 8.3 tp -111.46 122.51 48.03 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.298 -0.876 . . . . 0.0 109.345 -179.965 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 68' ' ' SER . . . . . 0.445 ' HB3' ' HB2' ' A' ' 77' ' ' PHE . 26.5 t -126.21 139.19 53.54 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.328 -0.857 . . . . 0.0 109.412 -179.926 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 69' ' ' MET . . . . . . . . . . . . . 86.7 mtp -127.7 150.99 49.53 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.306 -0.872 . . . . 0.0 109.467 179.946 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 70' ' ' ASP . . . . . 0.454 ' OD1' ' N ' ' A' ' 73' ' ' ARG . 10.6 t70 -129.15 101.67 19.33 Favored Pre-proline 0 N--CA 1.491 1.577 0 O-C-N 121.276 -0.89 . . . . 0.0 109.447 179.986 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 71' ' ' PRO . . . . . 0.592 ' N ' ' CD ' ' A' ' 72' ' ' PRO . 47.5 Cg_endo -74.93 -27.89 9.77 Favored 'Trans proline' 0 CA--C 1.544 0.985 0 C-N-CA 122.561 2.174 . . . . 0.0 113.733 -179.863 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 72' ' ' PRO . . . . . 0.592 ' CD ' ' N ' ' A' ' 71' ' ' PRO . 55.4 Cg_endo -75.15 -20.63 16.38 Favored 'Trans proline' 0 C--N 1.352 0.728 0 C-N-CA 121.471 1.447 . . . . 0.0 111.803 -179.699 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 73' ' ' ARG . . . . . 0.454 ' N ' ' OD1' ' A' ' 70' ' ' ASP . 93.6 mtt180 -113.59 0.44 14.64 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.258 -0.901 . . . . 0.0 109.698 -179.899 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 74' ' ' ASN . . . . . 0.448 ' HB2' ' O ' ' A' ' 73' ' ' ARG . 81.7 m-20 61.19 41.83 12.96 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.247 -0.908 . . . . 0.0 109.493 179.938 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 75' ' ' CYS . . . . . 0.447 ' SG ' ' HB3' ' A' ' 70' ' ' ASP . 21.7 p -144.19 147.97 34.36 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.186 -0.946 . . . . 0.0 109.452 179.941 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -121.89 149.15 43.81 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.247 -0.908 . . . . 0.0 109.408 -179.954 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 77' ' ' PHE . . . . . 0.445 ' HB2' ' HB3' ' A' ' 68' ' ' SER . 90.9 m-85 -114.02 137.99 50.97 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.234 -0.916 . . . . 0.0 109.379 -179.973 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . 0.464 ' O ' HD12 ' A' ' 42' ' ' LEU . 61.7 t -123.76 145.3 31.02 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.491 0 O-C-N 121.145 -0.972 . . . . 0.0 109.615 -179.884 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 79' ' ' THR . . . . . 0.535 ' CG2' ' O ' ' A' ' 40' ' ' ASN . 1.3 m -113.99 130.77 56.51 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.316 -0.865 . . . . 0.0 108.995 179.886 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 80' ' ' TYR . . . . . 0.506 ' OH ' ' CA ' ' A' ' 58' ' ' PHE . 0.9 OUTLIER -112.22 132.37 54.96 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.168 -0.958 . . . . 0.0 109.805 -179.665 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 81' ' ' GLU . . . . . 0.409 ' C ' ' O ' ' A' ' 80' ' ' TYR . 86.7 tt0 -43.04 -25.81 0.12 Allowed 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.448 -0.782 . . . . 0.0 109.766 179.81 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 82' ' ' LYS . . . . . 0.425 ' N ' ' O ' ' A' ' 80' ' ' TYR . 34.6 mtmm -142.95 164.2 30.72 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.1 -1.0 . . . . 0.0 109.403 179.95 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 83' ' ' MET . . . . . 0.523 ' HA ' ' ND2' ' A' ' 40' ' ' ASN . 15.8 mtt -80.41 -12.95 59.51 Favored 'General case' 0 N--CA 1.487 1.42 0 O-C-N 121.267 -0.895 . . . . 0.0 109.49 179.874 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 95.1 mt-10 -73.99 -40.75 62.74 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.243 -0.91 . . . . 0.0 109.183 179.722 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 85' ' ' SER . . . . . 0.454 ' OG ' ' HA3' ' A' ' 62' ' ' GLY . 10.9 t -66.78 -39.33 87.77 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.34 -0.85 . . . . 0.0 109.258 179.744 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 86' ' ' ALA . . . . . 0.52 ' HB2' ' CD2' ' A' ' 42' ' ' LEU . . . -72.08 -23.97 61.43 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.433 -0.792 . . . . 0.0 109.24 -179.943 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 65.1 m-20 -72.97 -48.3 37.8 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.352 -0.843 . . . . 0.0 109.504 179.911 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 57.6 tt0 -68.41 -37.9 80.75 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.297 -0.877 . . . . 0.0 109.633 -179.96 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 89' ' ' ALA . . . . . 0.504 ' HB2' ' CG ' ' A' ' 61' ' ' PHE . . . -69.07 -41.35 77.66 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.213 -0.93 . . . . 0.0 109.513 -179.883 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 90' ' ' VAL . . . . . 0.521 ' O ' ' CB ' ' A' ' 94' ' ' ASN . 53.1 t -62.09 -33.21 57.33 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.535 0 O-C-N 121.205 -0.935 . . . . 0.0 109.627 -179.933 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -79.41 -48.16 14.46 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.231 -0.918 . . . . 0.0 109.856 -179.684 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 92' ' ' GLU . . . . . 0.567 ' HB2' ' CE1' ' A' ' 61' ' ' PHE . 75.6 mm-40 -73.72 -43.11 60.09 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.175 -0.953 . . . . 0.0 109.994 -179.405 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 93' ' ' LEU . . . . . 0.634 ' CD1' ' CE1' ' A' ' 58' ' ' PHE . 21.9 mt -69.6 -39.32 77.34 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.16 -0.962 . . . . 0.0 109.753 -179.655 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 94' ' ' ASN . . . . . 0.521 ' CB ' ' O ' ' A' ' 90' ' ' VAL . 51.4 t-20 -72.54 120.05 17.61 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.15 -0.968 . . . . 0.0 109.569 -179.995 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 102.03 26.61 7.37 Favored Glycine 0 N--CA 1.49 2.249 0 N-CA-C 109.493 -1.443 . . . . 0.0 109.493 179.971 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 96' ' ' THR . . . . . 0.493 ' CG2' ' O ' ' A' ' 92' ' ' GLU . 11.1 p -125.65 154.52 42.21 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.28 -1.13 . . . . 0.0 109.429 -179.957 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 63.2 tt0 -128.47 138.38 52.26 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.277 -0.89 . . . . 0.0 109.516 179.977 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 98' ' ' VAL . . . . . 0.43 HG23 ' O ' ' A' ' 101' ' ' VAL . 1.3 t -80.13 -148.48 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 O-C-N 121.286 -0.884 . . . . 0.0 109.396 -179.97 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 96.5 mt-10 -63.2 -39.2 93.96 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.271 -0.893 . . . . 0.0 109.435 179.986 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 1.2 m -155.99 25.52 0.37 Allowed 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.276 -0.89 . . . . 0.0 109.451 179.956 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 101' ' ' VAL . . . . . 0.43 ' O ' HG23 ' A' ' 98' ' ' VAL . 57.4 t -139.59 145.07 27.45 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.552 0 O-C-N 121.308 -0.87 . . . . 0.0 109.373 179.922 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 47.0 tt0 -103.11 138.72 39.57 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.221 -0.924 . . . . 0.0 109.666 -179.837 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 67.7 mt -110.23 142.97 41.07 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.217 -0.927 . . . . 0.0 109.375 179.883 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 104' ' ' LYS . . . . . 0.418 ' O ' ' HA ' ' A' ' 44' ' ' VAL . 44.7 mttp -125.76 124.23 40.56 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.267 -0.896 . . . . 0.0 109.437 179.917 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 105' ' ' VAL . . . . . 0.472 HG11 ' CG2' ' A' ' 90' ' ' VAL . 14.3 t . . . . . 0 N--CA 1.49 1.568 0 O-C-N 121.205 -0.934 . . . . 0.0 109.561 -179.886 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 40' ' ' ASN . . . . . 0.432 ' O ' ' HA ' ' A' ' 79' ' ' THR . 33.9 t-20 . . . . . 0 N--CA 1.491 1.618 0 CA-C-O 121.268 0.556 . . . . 0.0 109.571 . . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 41' ' ' THR . . . . . 0.444 ' HA ' ' HA ' ' A' ' 79' ' ' THR . 40.1 m -80.72 136.71 36.21 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.24 -0.913 . . . . 0.0 109.34 179.859 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . 0.569 HD11 ' CD2' ' A' ' 80' ' ' TYR . 8.5 mt -120.18 157.58 28.76 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.205 -0.935 . . . . 0.0 109.614 -179.945 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 43' ' ' TYR . . . . . 0.47 ' CZ ' ' HB2' ' A' ' 75' ' ' CYS . 74.6 t80 -116.92 121.76 42.37 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.317 -0.865 . . . . 0.0 109.269 179.83 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 44' ' ' VAL . . . . . 0.588 ' CG1' ' CD2' ' A' ' 103' ' ' LEU . 61.8 t -116.21 134.17 60.41 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.479 0 O-C-N 121.167 -0.958 . . . . 0.0 109.572 -179.902 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 60.7 t80 -121.49 142.4 50.09 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.287 -0.883 . . . . 0.0 109.488 -179.976 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . 0.4 ' HA3' ' SD ' ' A' ' 49' ' ' MET . . . 173.97 -178.97 45.63 Favored Glycine 0 N--CA 1.491 2.338 0 N-CA-C 109.485 -1.446 . . . . 0.0 109.485 179.958 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . 0.411 ' O ' ' C ' ' A' ' 48' ' ' ASP . 92.7 mt-10 -111.66 154.93 24.2 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.253 -1.145 . . . . 0.0 109.434 -179.952 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 48' ' ' ASP . . . . . 0.411 ' C ' ' O ' ' A' ' 47' ' ' GLU . 43.4 m-20 43.99 51.6 6.99 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.212 -0.93 . . . . 0.0 109.488 -179.993 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 49' ' ' MET . . . . . 0.4 ' SD ' ' HA3' ' A' ' 46' ' ' GLY . 49.1 mtm -98.93 142.31 30.6 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.234 -0.916 . . . . 0.0 109.494 179.971 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 50' ' ' THR . . . . . 0.471 ' O ' ' CD1' ' A' ' 54' ' ' LEU . 0.6 OUTLIER -125.16 166.62 19.57 Favored Pre-proline 0 N--CA 1.49 1.571 0 O-C-N 121.225 -0.922 . . . . 0.0 109.503 179.949 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 49.2 Cg_endo -69.95 -48.21 0.72 Allowed 'Trans proline' 0 C--O 1.216 -0.623 0 C-N-CA 122.718 2.279 . . . . 0.0 111.769 -179.96 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 36.3 m -57.54 -45.74 84.73 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.253 -0.905 . . . . 0.0 109.457 179.985 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 15.6 tp -59.71 -50.28 74.45 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.325 -0.859 . . . . 0.0 109.445 179.84 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 54' ' ' LEU . . . . . 0.48 ' CD1' ' SD ' ' A' ' 69' ' ' MET . 3.5 mt -56.81 -50.16 73.2 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.285 -0.885 . . . . 0.0 109.284 179.897 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 55' ' ' ARG . . . . . 0.506 ' O ' ' N ' ' A' ' 59' ' ' SER . 33.2 mtp180 -46.03 -41.03 11.48 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.172 -0.955 . . . . 0.0 109.262 179.895 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -69.18 -37.78 81.9 Favored Glycine 0 N--CA 1.489 2.229 0 N-CA-C 109.36 -1.496 . . . . 0.0 109.36 179.852 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -72.59 -21.05 61.2 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.245 -1.15 . . . . 0.0 109.394 179.953 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 58' ' ' PHE . . . . . 0.624 ' CE2' ' CD1' ' A' ' 93' ' ' LEU . 92.5 m-85 -117.74 8.0 12.63 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.308 -0.87 . . . . 0.0 109.431 179.881 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 59' ' ' SER . . . . . 0.535 ' N ' ' HD2' ' A' ' 60' ' ' PRO . 1.2 t -75.16 -54.45 2.52 Favored Pre-proline 0 N--CA 1.492 1.632 0 O-C-N 121.313 -0.867 . . . . 0.0 110.391 -179.699 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 60' ' ' PRO . . . . . 0.535 ' HD2' ' N ' ' A' ' 59' ' ' SER . 47.4 Cg_endo -68.95 -30.5 26.03 Favored 'Trans proline' 0 C--O 1.215 -0.653 0 C-N-CA 122.456 2.104 . . . . 0.0 112.3 -179.252 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 61' ' ' PHE . . . . . 0.574 ' CE1' ' HB3' ' A' ' 92' ' ' GLU . 60.3 m-85 -66.68 -31.13 71.59 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.119 -0.988 . . . . 0.0 109.471 -179.979 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 168.56 179.15 40.66 Favored Glycine 0 N--CA 1.491 2.308 0 N-CA-C 109.579 -1.408 . . . . 0.0 109.579 179.928 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 37.0 t30 -87.89 134.86 33.62 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.365 -1.079 . . . . 0.0 109.492 -179.979 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 33.4 mt -94.05 133.95 33.32 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.508 0 O-C-N 121.23 -0.919 . . . . 0.0 109.476 179.963 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 65' ' ' ILE . . . . . 0.462 ' CG1' HG23 ' A' ' 79' ' ' THR . 26.1 pt -97.19 -20.71 5.57 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.486 0 O-C-N 121.17 -0.956 . . . . 0.0 109.376 179.911 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 66' ' ' ASP . . . . . 0.456 ' HB3' ' HB ' ' A' ' 79' ' ' THR . 60.9 t0 -138.82 125.96 21.37 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.225 -0.922 . . . . 0.0 109.433 179.854 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . 0.495 ' C ' ' CD1' ' A' ' 67' ' ' LEU . 3.5 tm? -121.26 108.24 13.5 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.209 -0.932 . . . . 0.0 109.355 179.897 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 68' ' ' SER . . . . . 0.443 ' HB2' ' HB2' ' A' ' 77' ' ' PHE . 58.3 m -122.66 149.27 44.25 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.238 -0.914 . . . . 0.0 109.463 -179.964 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 69' ' ' MET . . . . . 0.48 ' SD ' ' CD1' ' A' ' 54' ' ' LEU . 83.8 mmm -123.39 147.68 46.85 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.234 -0.916 . . . . 0.0 109.381 -179.979 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 70' ' ' ASP . . . . . 0.46 ' CB ' ' O ' ' A' ' 75' ' ' CYS . 0.6 OUTLIER -131.64 94.2 26.34 Favored Pre-proline 0 N--CA 1.49 1.541 0 O-C-N 121.252 -0.905 . . . . 0.0 109.483 179.959 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 71' ' ' PRO . . . . . 0.598 ' CD ' ' CD ' ' A' ' 72' ' ' PRO . 47.0 Cg_endo -74.84 -27.77 10.06 Favored 'Trans proline' 0 CA--C 1.543 0.967 0 C-N-CA 122.506 2.137 . . . . 0.0 113.664 -179.974 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 72' ' ' PRO . . . . . 0.598 ' CD ' ' CD ' ' A' ' 71' ' ' PRO . 55.2 Cg_endo -75.3 -22.19 14.55 Favored 'Trans proline' 0 C--N 1.353 0.803 0 C-N-CA 121.49 1.46 . . . . 0.0 111.868 -179.844 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 73' ' ' ARG . . . . . 0.411 ' O ' ' HB2' ' A' ' 74' ' ' ASN . 62.7 mtt180 -112.24 -0.39 15.51 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.167 -0.958 . . . . 0.0 109.65 -179.992 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 74' ' ' ASN . . . . . 0.411 ' HB2' ' O ' ' A' ' 73' ' ' ARG . 8.0 m120 60.82 45.47 9.8 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.082 -1.011 . . . . 0.0 109.402 -179.981 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 75' ' ' CYS . . . . . 0.47 ' HB2' ' CZ ' ' A' ' 43' ' ' TYR . 23.2 p -152.69 143.07 22.58 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.299 -0.875 . . . . 0.0 109.458 -179.979 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 76' ' ' ALA . . . . . 0.466 ' CB ' HD12 ' A' ' 54' ' ' LEU . . . -112.08 156.99 21.33 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.307 -0.871 . . . . 0.0 109.485 179.952 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 77' ' ' PHE . . . . . 0.443 ' HB2' ' HB2' ' A' ' 68' ' ' SER . 97.0 m-85 -118.37 125.58 50.31 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.245 -0.909 . . . . 0.0 109.427 179.858 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . 0.439 ' O ' ' HG ' ' A' ' 42' ' ' LEU . 59.6 t -127.11 126.78 68.7 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.546 0 O-C-N 121.234 -0.916 . . . . 0.0 109.489 -179.858 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 79' ' ' THR . . . . . 0.462 HG23 ' CG1' ' A' ' 65' ' ' ILE . 92.3 m -105.59 126.64 52.37 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.334 -0.854 . . . . 0.0 109.446 179.812 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 80' ' ' TYR . . . . . 0.569 ' CD2' HD11 ' A' ' 42' ' ' LEU . 2.3 m-85 -92.41 174.05 7.49 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.227 -0.921 . . . . 0.0 109.169 179.898 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 81' ' ' GLU . . . . . 0.468 ' HG2' ' O ' ' A' ' 81' ' ' GLU . 71.0 tt0 -90.23 -13.56 35.19 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.352 -0.842 . . . . 0.0 109.665 -179.678 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 23.2 mttt -150.08 127.93 11.77 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.051 -1.031 . . . . 0.0 110.018 179.921 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 83' ' ' MET . . . . . 0.515 ' N ' ' SD ' ' A' ' 83' ' ' MET . 0.4 OUTLIER -45.83 -24.89 0.44 Allowed 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.458 -0.777 . . . . 0.0 109.88 179.938 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . 0.409 ' HG3' ' SD ' ' A' ' 83' ' ' MET . 97.1 mt-10 -67.56 -62.35 1.46 Allowed 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.196 -0.94 . . . . 0.0 109.571 -179.868 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 13.7 m -46.82 -38.26 9.96 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.267 -0.896 . . . . 0.0 109.818 -179.804 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 86' ' ' ALA . . . . . 0.474 ' HA ' ' CD2' ' A' ' 80' ' ' TYR . . . -69.27 -39.45 78.38 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.161 -0.962 . . . . 0.0 109.751 -179.691 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 52.4 t0 -56.76 -38.31 72.27 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.212 -0.93 . . . . 0.0 109.591 -179.739 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 88' ' ' GLN . . . . . 0.483 ' O ' ' CB ' ' A' ' 92' ' ' GLU . 59.7 tt0 -74.39 -38.49 63.12 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.15 -0.969 . . . . 0.0 109.603 -179.839 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 89' ' ' ALA . . . . . 0.539 ' HA ' ' CD1' ' A' ' 61' ' ' PHE . . . -75.36 -41.95 55.28 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.168 -0.958 . . . . 0.0 109.651 -179.871 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 90' ' ' VAL . . . . . 0.521 ' CG1' HG13 ' A' ' 105' ' ' VAL . 53.9 t -64.68 -48.72 83.51 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 O-C-N 121.257 -0.902 . . . . 0.0 109.634 -179.834 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -72.22 -38.77 68.91 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.272 -0.892 . . . . 0.0 109.702 -179.882 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 92' ' ' GLU . . . . . 0.574 ' HB3' ' CE1' ' A' ' 61' ' ' PHE . 44.5 tp10 -74.4 -45.81 44.29 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.247 -0.908 . . . . 0.0 109.583 -179.876 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 93' ' ' LEU . . . . . 0.624 ' CD1' ' CE2' ' A' ' 58' ' ' PHE . 68.0 mt -69.95 -37.76 75.93 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.165 -0.959 . . . . 0.0 109.545 -179.921 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 94' ' ' ASN . . . . . 0.484 ' N ' HG21 ' A' ' 105' ' ' VAL . 61.4 t-20 -64.64 129.85 41.39 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.226 -0.921 . . . . 0.0 109.547 -179.967 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 84.77 30.14 27.33 Favored Glycine 0 N--CA 1.489 2.219 0 N-CA-C 109.497 -1.441 . . . . 0.0 109.497 179.973 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 96' ' ' THR . . . . . 0.492 ' CG2' ' O ' ' A' ' 92' ' ' GLU . 19.7 p -121.27 151.54 39.92 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.261 -1.141 . . . . 0.0 109.468 -179.995 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 61.7 tt0 -116.94 143.73 45.37 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.314 -0.866 . . . . 0.0 109.498 -179.946 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 1.2 t -90.79 -159.41 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 O-C-N 121.233 -0.917 . . . . 0.0 109.282 179.935 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 95.9 mt-10 -54.68 -37.71 66.1 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.183 -0.948 . . . . 0.0 109.481 179.968 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 100' ' ' SER . . . . . 0.428 ' C ' HG21 ' A' ' 101' ' ' VAL . 6.9 t -159.86 25.96 0.18 Allowed 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.198 -0.938 . . . . 0.0 109.554 -179.953 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 101' ' ' VAL . . . . . 0.428 HG21 ' C ' ' A' ' 100' ' ' SER . 48.7 t -138.03 168.42 20.32 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.546 0 O-C-N 121.219 -0.926 . . . . 0.0 109.434 -179.955 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 102' ' ' GLN . . . . . 0.408 ' N ' ' CG1' ' A' ' 101' ' ' VAL . 92.5 mt-30 -116.12 147.12 41.67 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.22 -0.925 . . . . 0.0 109.169 179.874 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 103' ' ' LEU . . . . . 0.588 ' CD2' ' CG1' ' A' ' 44' ' ' VAL . 0.0 OUTLIER -122.15 130.94 53.68 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.198 -0.939 . . . . 0.0 109.715 -179.918 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 16.7 mttp -115.82 128.22 55.66 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.294 -0.879 . . . . 0.0 109.333 179.864 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 105' ' ' VAL . . . . . 0.521 HG13 ' CG1' ' A' ' 90' ' ' VAL . 22.7 t . . . . . 0 N--CA 1.489 1.519 0 O-C-N 121.179 -0.951 . . . . 0.0 109.583 -179.834 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 43.7 t30 . . . . . 0 N--CA 1.49 1.563 0 N-CA-C 109.322 -0.622 . . . . 0.0 109.322 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 41' ' ' THR . . . . . 0.407 ' O ' HD23 ' A' ' 42' ' ' LEU . 78.9 m -65.53 130.88 44.88 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.229 -0.92 . . . . 0.0 109.588 -179.935 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . 0.516 HD11 ' CB ' ' A' ' 86' ' ' ALA . 16.8 mt -111.51 146.05 37.97 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.262 -0.899 . . . . 0.0 109.464 179.957 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 70.6 t80 -104.78 122.72 46.32 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.164 -0.96 . . . . 0.0 109.46 179.999 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 44' ' ' VAL . . . . . 0.454 ' HA ' ' O ' ' A' ' 104' ' ' LYS . 47.9 t -121.57 138.15 52.84 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.523 0 O-C-N 121.214 -0.929 . . . . 0.0 109.489 179.978 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 45' ' ' TYR . . . . . 0.452 ' HB3' ' HB2' ' A' ' 104' ' ' LYS . 72.3 t80 -118.68 138.9 52.3 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.226 -0.921 . . . . 0.0 109.441 -179.951 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . 0.411 ' N ' ' HE3' ' A' ' 49' ' ' MET . . . 176.17 -178.54 47.57 Favored Glycine 0 N--CA 1.489 2.216 0 N-CA-C 109.448 -1.461 . . . . 0.0 109.448 179.929 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 94.2 mt-10 -124.91 156.04 38.58 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.344 -1.092 . . . . 0.0 109.488 179.995 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 22.2 t70 47.46 50.22 15.03 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.227 -0.92 . . . . 0.0 109.476 -179.99 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 49' ' ' MET . . . . . 0.411 ' HE3' ' N ' ' A' ' 46' ' ' GLY . 66.7 mtm -105.54 145.21 31.24 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.247 -0.908 . . . . 0.0 109.513 -179.969 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 50' ' ' THR . . . . . 0.503 ' O ' ' CD1' ' A' ' 54' ' ' LEU . 3.5 p -119.42 161.73 35.83 Favored Pre-proline 0 N--CA 1.49 1.57 0 O-C-N 121.27 -0.894 . . . . 0.0 109.395 179.978 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 51' ' ' PRO . . . . . 0.464 ' N ' ' SD ' ' A' ' 69' ' ' MET . 48.2 Cg_endo -70.1 -55.35 0.17 Allowed 'Trans proline' 0 C--O 1.216 -0.593 0 C-N-CA 122.727 2.285 . . . . 0.0 111.87 -179.949 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 27.9 m -50.83 -47.17 60.16 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.152 -0.967 . . . . 0.0 109.216 179.894 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 18.7 tp -58.06 -56.12 26.08 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.256 -0.903 . . . . 0.0 109.241 179.766 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 54' ' ' LEU . . . . . 0.503 ' CD1' ' O ' ' A' ' 50' ' ' THR . 5.1 mt -53.9 -43.17 69.46 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.285 -0.884 . . . . 0.0 109.092 179.615 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 55' ' ' ARG . . . . . 0.499 ' O ' ' N ' ' A' ' 59' ' ' SER . 73.5 ttt180 -48.83 -41.82 34.15 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.266 -0.896 . . . . 0.0 109.208 179.712 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . 0.457 ' O ' ' HD2' ' A' ' 60' ' ' PRO . . . -67.66 -35.39 85.81 Favored Glycine 0 N--CA 1.489 2.213 0 N-CA-C 109.263 -1.535 . . . . 0.0 109.263 179.857 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . 0.469 ' O ' ' CD1' ' A' ' 61' ' ' PHE . . . -70.87 -22.15 62.33 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.324 -1.103 . . . . 0.0 109.425 179.961 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 58' ' ' PHE . . . . . 0.578 ' CE2' HD13 ' A' ' 93' ' ' LEU . 96.6 m-85 -118.07 4.72 12.03 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.272 -0.892 . . . . 0.0 109.544 -179.953 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 59' ' ' SER . . . . . 0.52 ' N ' ' HD2' ' A' ' 60' ' ' PRO . 2.6 t -73.63 -56.89 2.78 Favored Pre-proline 0 N--CA 1.49 1.569 0 O-C-N 121.208 -0.932 . . . . 0.0 110.075 -179.67 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 60' ' ' PRO . . . . . 0.52 ' HD2' ' N ' ' A' ' 59' ' ' SER . 48.0 Cg_endo -68.81 -24.84 33.86 Favored 'Trans proline' 0 C--O 1.215 -0.652 0 C-N-CA 122.59 2.193 . . . . 0.0 111.989 -179.496 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 61' ' ' PHE . . . . . 0.577 ' CD2' ' HA ' ' A' ' 89' ' ' ALA . 68.0 m-85 -72.73 -25.08 61.08 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.179 -0.95 . . . . 0.0 109.508 179.968 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 166.18 -178.04 40.94 Favored Glycine 0 N--CA 1.49 2.256 0 N-CA-C 109.548 -1.421 . . . . 0.0 109.548 179.951 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 85.8 m-20 -92.43 139.51 30.52 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.305 -1.115 . . . . 0.0 109.504 179.986 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 51.4 mt -99.87 134.12 40.41 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.522 0 O-C-N 121.243 -0.911 . . . . 0.0 109.461 -179.969 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 65' ' ' ILE . . . . . 0.418 HG12 HG22 ' A' ' 79' ' ' THR . 20.0 pt -96.36 -24.29 4.6 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.537 0 O-C-N 121.314 -0.866 . . . . 0.0 109.521 -179.92 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 50.8 t0 -146.28 121.14 9.94 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.229 -0.919 . . . . 0.0 109.597 -179.946 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 8.1 tp -110.14 121.39 45.14 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.236 -0.915 . . . . 0.0 109.389 179.902 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 68' ' ' SER . . . . . 0.453 ' HB3' ' HB2' ' A' ' 77' ' ' PHE . 34.6 t -134.69 144.51 47.83 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.224 -0.922 . . . . 0.0 109.419 179.941 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 69' ' ' MET . . . . . 0.464 ' SD ' ' N ' ' A' ' 51' ' ' PRO . 83.3 mtp -129.59 151.4 50.24 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.271 -0.893 . . . . 0.0 109.563 -179.96 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 70' ' ' ASP . . . . . 0.456 ' C ' ' HD2' ' A' ' 72' ' ' PRO . 0.2 OUTLIER -127.06 99.36 28.69 Favored Pre-proline 0 N--CA 1.491 1.6 0 O-C-N 121.3 -0.875 . . . . 0.0 109.419 179.982 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 71' ' ' PRO . . . . . 0.594 ' N ' ' CD ' ' A' ' 72' ' ' PRO . 47.4 Cg_endo -74.63 -27.85 10.39 Favored 'Trans proline' 0 CA--C 1.542 0.924 0 C-N-CA 122.476 2.118 . . . . 0.0 113.759 -179.972 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 72' ' ' PRO . . . . . 0.594 ' CD ' ' N ' ' A' ' 71' ' ' PRO . 53.9 Cg_endo -75.09 -25.8 11.38 Favored 'Trans proline' 0 C--N 1.352 0.759 0 C-N-CA 121.404 1.403 . . . . 0.0 111.823 -179.851 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 73' ' ' ARG . . . . . 0.439 ' O ' ' HB2' ' A' ' 74' ' ' ASN . 97.8 mtt180 -110.1 0.12 18.21 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.222 -0.924 . . . . 0.0 109.63 -179.918 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 74' ' ' ASN . . . . . 0.439 ' HB2' ' O ' ' A' ' 73' ' ' ARG . 79.1 m-20 61.03 46.28 8.45 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.19 -0.944 . . . . 0.0 109.589 179.9 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 75' ' ' CYS . . . . . 0.436 ' HA ' ' O ' ' A' ' 44' ' ' VAL . 23.9 p -146.68 133.72 20.34 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.212 -0.93 . . . . 0.0 109.51 179.987 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 76' ' ' ALA . . . . . 0.423 ' HA ' ' HA ' ' A' ' 69' ' ' MET . . . -106.35 161.28 14.7 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.282 -0.886 . . . . 0.0 109.488 179.932 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 77' ' ' PHE . . . . . 0.453 ' HB2' ' HB3' ' A' ' 68' ' ' SER . 98.5 m-85 -126.89 132.66 50.86 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.305 -0.872 . . . . 0.0 109.461 -179.979 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . 0.484 ' O ' ' N ' ' A' ' 42' ' ' LEU . 40.8 t -128.65 131.89 68.24 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 O-C-N 121.215 -0.928 . . . . 0.0 109.477 179.935 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 79' ' ' THR . . . . . 0.418 HG22 HG12 ' A' ' 65' ' ' ILE . 7.0 m -104.38 139.39 39.4 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.228 -0.92 . . . . 0.0 109.429 -179.919 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 80' ' ' TYR . . . . . 0.463 ' OH ' ' CA ' ' A' ' 58' ' ' PHE . 0.8 OUTLIER -118.25 134.57 54.9 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.302 -0.874 . . . . 0.0 109.48 179.942 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 80.2 tt0 -52.35 -34.46 47.6 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.257 -0.902 . . . . 0.0 109.408 179.896 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 42.5 mtmt -128.55 142.17 51.14 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.277 -0.889 . . . . 0.0 109.524 179.9 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 83' ' ' MET . . . . . . . . . . . . . 31.3 mtm -62.56 -25.45 68.07 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.258 -0.901 . . . . 0.0 109.555 -179.946 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 96.9 mt-10 -62.59 -39.89 95.17 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.27 -0.894 . . . . 0.0 109.55 -179.949 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 16.0 m -63.89 -34.21 77.43 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.225 -0.922 . . . . 0.0 109.636 179.978 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 86' ' ' ALA . . . . . 0.516 ' CB ' HD11 ' A' ' 42' ' ' LEU . . . -72.39 -33.09 66.93 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.285 -0.884 . . . . 0.0 109.546 -179.966 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 22.2 t70 -65.11 -42.69 93.75 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.212 -0.93 . . . . 0.0 109.557 -179.947 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 64.6 tt0 -67.88 -36.77 80.84 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.223 -0.923 . . . . 0.0 109.579 -179.959 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 89' ' ' ALA . . . . . 0.577 ' HA ' ' CD2' ' A' ' 61' ' ' PHE . . . -76.69 -48.81 17.73 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.211 -0.931 . . . . 0.0 109.547 -179.944 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 90' ' ' VAL . . . . . 0.521 HG22 ' CG1' ' A' ' 105' ' ' VAL . 71.3 t -58.76 -29.21 39.52 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.524 0 O-C-N 121.22 -0.925 . . . . 0.0 109.455 -179.933 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -80.03 -54.18 6.03 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.248 -0.907 . . . . 0.0 109.758 -179.92 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 92' ' ' GLU . . . . . 0.498 ' HB2' ' CE2' ' A' ' 61' ' ' PHE . 91.0 mt-10 -71.21 -40.75 70.96 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.288 -0.882 . . . . 0.0 109.879 -179.597 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 93' ' ' LEU . . . . . 0.578 HD13 ' CE2' ' A' ' 58' ' ' PHE . 28.2 mt -68.56 -42.18 78.71 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.141 -0.974 . . . . 0.0 109.558 -179.828 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 94' ' ' ASN . . . . . 0.515 ' CB ' ' O ' ' A' ' 90' ' ' VAL . 60.6 t-20 -63.79 131.24 47.21 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.255 -0.903 . . . . 0.0 109.565 -179.965 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 86.66 35.21 10.49 Favored Glycine 0 N--CA 1.49 2.291 0 N-CA-C 109.513 -1.435 . . . . 0.0 109.513 -179.968 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 96' ' ' THR . . . . . 0.522 ' CG2' ' O ' ' A' ' 93' ' ' LEU . 22.0 p -124.21 160.36 28.08 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.221 -1.164 . . . . 0.0 109.367 179.952 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 97' ' ' GLN . . . . . 0.409 ' HG2' ' N ' ' A' ' 98' ' ' VAL . 62.3 tt0 -128.25 154.81 45.46 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.238 -0.914 . . . . 0.0 109.471 -179.942 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 98' ' ' VAL . . . . . 0.453 HG22 ' O ' ' A' ' 101' ' ' VAL . 1.2 t -106.19 -155.13 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.566 0 O-C-N 121.212 -0.93 . . . . 0.0 109.336 -179.978 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 96.2 mt-10 -56.76 -36.98 70.44 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.119 -0.988 . . . . 0.0 109.481 -179.943 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 20.9 t -160.95 23.28 0.14 Allowed 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.224 -0.923 . . . . 0.0 109.596 -179.953 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 101' ' ' VAL . . . . . 0.453 ' O ' HG22 ' A' ' 98' ' ' VAL . 48.7 t -138.57 154.29 26.86 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.547 0 O-C-N 121.214 -0.929 . . . . 0.0 109.558 -180.0 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 92.2 mt-30 -99.63 148.35 24.42 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.278 -0.889 . . . . 0.0 109.306 179.935 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 91.9 mt -109.04 137.05 47.55 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.184 -0.947 . . . . 0.0 109.625 -179.905 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 104' ' ' LYS . . . . . 0.454 ' O ' ' HA ' ' A' ' 44' ' ' VAL . 3.1 mtpm? -122.98 139.24 54.28 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.312 -0.868 . . . . 0.0 109.327 179.927 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 105' ' ' VAL . . . . . 0.521 ' CG1' HG22 ' A' ' 90' ' ' VAL . 25.8 t . . . . . 0 N--CA 1.489 1.519 0 O-C-N 121.207 -0.933 . . . . 0.0 109.559 -179.968 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 40' ' ' ASN . . . . . 0.52 ' N ' ' O ' ' A' ' 80' ' ' TYR . 42.3 t30 . . . . . 0 N--CA 1.489 1.525 0 N-CA-C 109.139 -0.689 . . . . 0.0 109.139 . . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 41' ' ' THR . . . . . 0.459 ' O ' HD22 ' A' ' 42' ' ' LEU . 8.2 m -63.88 134.01 54.36 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.315 -0.866 . . . . 0.0 109.986 -179.518 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . 0.565 HD12 ' CD2' ' A' ' 80' ' ' TYR . 20.4 mt -120.21 155.6 32.83 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.424 -0.797 . . . . 0.0 109.314 179.702 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 43' ' ' TYR . . . . . 0.439 ' O ' ' HA ' ' A' ' 105' ' ' VAL . 69.9 t80 -109.59 127.24 54.37 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.179 -0.951 . . . . 0.0 109.468 179.965 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 46.7 t -126.66 136.22 61.43 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.544 0 O-C-N 121.153 -0.967 . . . . 0.0 109.4 179.935 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 45' ' ' TYR . . . . . 0.461 ' HB3' ' HB2' ' A' ' 104' ' ' LYS . 65.6 t80 -127.53 136.43 51.71 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.292 -0.88 . . . . 0.0 109.596 -179.84 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -173.54 -163.88 27.85 Favored Glycine 0 N--CA 1.49 2.27 0 N-CA-C 109.374 -1.49 . . . . 0.0 109.374 179.988 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . 0.426 ' O ' ' C ' ' A' ' 48' ' ' ASP . 89.5 mt-10 -120.96 147.25 45.72 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.163 -1.199 . . . . 0.0 109.512 179.947 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 48' ' ' ASP . . . . . 0.426 ' C ' ' O ' ' A' ' 47' ' ' GLU . 47.0 m-20 43.49 54.18 5.42 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.227 -0.921 . . . . 0.0 109.477 179.966 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 54.4 mtm -97.34 136.1 38.3 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.318 -0.864 . . . . 0.0 109.607 -179.889 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 50' ' ' THR . . . . . 0.499 ' O ' ' CD1' ' A' ' 54' ' ' LEU . 0.0 OUTLIER -118.61 161.95 33.1 Favored Pre-proline 0 N--CA 1.49 1.548 0 O-C-N 121.258 -0.902 . . . . 0.0 109.49 179.927 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 51' ' ' PRO . . . . . 0.454 ' HD2' HG21 ' A' ' 50' ' ' THR . 48.1 Cg_endo -69.85 -50.19 0.48 Allowed 'Trans proline' 0 C--O 1.214 -0.683 0 C-N-CA 122.724 2.282 . . . . 0.0 111.731 -179.914 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 50.7 m -52.91 -47.43 67.99 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.228 -0.92 . . . . 0.0 109.311 179.904 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 10.8 tp -61.85 -57.2 12.74 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.402 -0.811 . . . . 0.0 109.25 179.788 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 54' ' ' LEU . . . . . 0.501 ' CD1' ' HE1' ' A' ' 69' ' ' MET . 4.4 mt -53.63 -49.66 67.4 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.284 -0.885 . . . . 0.0 109.219 179.758 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 55' ' ' ARG . . . . . 0.435 ' C ' ' O ' ' A' ' 54' ' ' LEU . 77.7 ttt180 -43.66 -44.72 6.58 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.294 -0.879 . . . . 0.0 109.201 179.87 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -68.79 -33.3 75.28 Favored Glycine 0 N--CA 1.489 2.219 0 N-CA-C 109.159 -1.577 . . . . 0.0 109.159 179.737 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . 0.443 ' N ' ' O ' ' A' ' 54' ' ' LEU . . . -72.55 -20.11 61.39 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.353 -1.087 . . . . 0.0 109.297 179.935 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 58' ' ' PHE . . . . . 0.635 ' CE2' ' CD1' ' A' ' 93' ' ' LEU . 95.2 m-85 -117.98 7.94 12.41 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.301 -0.875 . . . . 0.0 109.324 179.856 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 59' ' ' SER . . . . . 0.561 ' N ' ' HD2' ' A' ' 60' ' ' PRO . 0.5 OUTLIER -76.68 -50.1 2.6 Favored Pre-proline 0 N--CA 1.49 1.562 0 O-C-N 121.243 -0.91 . . . . 0.0 110.577 -179.644 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 60' ' ' PRO . . . . . 0.561 ' HD2' ' N ' ' A' ' 59' ' ' SER . 49.9 Cg_endo -70.72 -33.79 12.4 Favored 'Trans proline' 0 C--O 1.215 -0.654 0 C-N-CA 122.215 1.943 . . . . 0.0 112.454 -179.15 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 61' ' ' PHE . . . . . 0.575 ' CE1' ' HA ' ' A' ' 89' ' ' ALA . 77.4 m-85 -61.74 -43.96 97.83 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.042 -1.036 . . . . 0.0 109.516 -179.983 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . 0.426 ' HA3' ' OG ' ' A' ' 85' ' ' SER . . . -174.44 -168.29 35.03 Favored Glycine 0 N--CA 1.491 2.315 0 N-CA-C 109.464 -1.455 . . . . 0.0 109.464 -179.965 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 86.6 m-20 -98.1 143.5 28.58 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.235 -1.156 . . . . 0.0 109.409 -179.981 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 64' ' ' ILE . . . . . 0.463 ' HA ' ' O ' ' A' ' 79' ' ' THR . 37.8 mt -105.02 129.65 57.35 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.511 0 O-C-N 121.239 -0.913 . . . . 0.0 109.544 -179.904 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 21.3 pt -96.68 -21.58 5.35 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.602 0 O-C-N 121.324 -0.86 . . . . 0.0 109.614 -179.903 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 66' ' ' ASP . . . . . 0.442 ' HB3' ' OG1' ' A' ' 79' ' ' THR . 57.7 t0 -144.87 109.79 5.07 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.187 -0.946 . . . . 0.0 109.56 179.99 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 15.1 tp -108.07 121.48 44.91 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.301 -0.874 . . . . 0.0 109.437 179.979 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 68' ' ' SER . . . . . 0.453 ' HB3' ' HB2' ' A' ' 77' ' ' PHE . 22.7 t -131.09 139.04 49.81 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.281 -0.887 . . . . 0.0 109.421 -179.942 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 69' ' ' MET . . . . . 0.501 ' HE1' ' CD1' ' A' ' 54' ' ' LEU . 94.9 mmm -114.82 150.87 34.8 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.187 -0.946 . . . . 0.0 109.522 179.998 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 70' ' ' ASP . . . . . 0.459 ' CB ' ' O ' ' A' ' 75' ' ' CYS . 6.1 t0 -132.24 95.97 20.39 Favored Pre-proline 0 N--CA 1.49 1.542 0 O-C-N 121.222 -0.924 . . . . 0.0 109.516 -179.967 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 71' ' ' PRO . . . . . 0.592 ' N ' ' CD ' ' A' ' 72' ' ' PRO . 47.9 Cg_endo -74.81 -27.83 10.05 Favored 'Trans proline' 0 CA--C 1.543 0.956 0 C-N-CA 122.451 2.101 . . . . 0.0 113.623 -179.881 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 72' ' ' PRO . . . . . 0.592 ' CD ' ' N ' ' A' ' 71' ' ' PRO . 55.2 Cg_endo -75.13 -26.5 10.65 Favored 'Trans proline' 0 C--N 1.353 0.769 0 C-N-CA 121.51 1.473 . . . . 0.0 111.825 -179.848 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 73' ' ' ARG . . . . . 0.458 ' O ' ' HB2' ' A' ' 74' ' ' ASN . 77.7 mtt85 -109.24 -1.9 18.31 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.208 -0.932 . . . . 0.0 109.67 -179.841 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 74' ' ' ASN . . . . . 0.458 ' HB2' ' O ' ' A' ' 73' ' ' ARG . 78.4 m-20 61.89 43.12 9.59 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.159 -0.963 . . . . 0.0 109.599 179.97 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 75' ' ' CYS . . . . . 0.459 ' O ' ' CB ' ' A' ' 70' ' ' ASP . 28.4 p -146.52 141.9 27.5 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.277 -0.89 . . . . 0.0 109.47 179.941 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 76' ' ' ALA . . . . . 0.401 ' CB ' ' SD ' ' A' ' 69' ' ' MET . . . -114.11 161.88 17.2 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.214 -0.929 . . . . 0.0 109.56 -179.906 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 77' ' ' PHE . . . . . 0.453 ' HB2' ' HB3' ' A' ' 68' ' ' SER . 97.4 m-85 -123.77 130.94 53.41 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.24 -0.912 . . . . 0.0 109.385 -179.931 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . 0.505 ' O ' ' N ' ' A' ' 42' ' ' LEU . 39.2 t -128.62 132.12 68.08 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.597 0 O-C-N 121.185 -0.947 . . . . 0.0 109.592 -179.938 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 79' ' ' THR . . . . . 0.463 ' O ' ' HA ' ' A' ' 64' ' ' ILE . 7.1 m -106.74 123.15 47.72 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.203 -0.935 . . . . 0.0 109.612 179.928 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 80' ' ' TYR . . . . . 0.565 ' CD2' HD12 ' A' ' 42' ' ' LEU . 1.7 m-85 -101.94 126.45 48.85 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.261 -0.9 . . . . 0.0 109.299 179.879 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 81' ' ' GLU . . . . . 0.434 ' C ' ' O ' ' A' ' 80' ' ' TYR . 86.9 tt0 -42.89 -48.27 5.78 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.244 -0.91 . . . . 0.0 109.658 -179.758 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 29.8 mttt -110.96 153.84 24.97 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.184 -0.947 . . . . 0.0 109.526 179.972 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 83' ' ' MET . . . . . . . . . . . . . 58.8 mtt -73.05 -16.66 61.48 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.315 -0.865 . . . . 0.0 109.424 -179.939 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 75.6 mm-40 -71.92 -41.04 68.36 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.269 -0.894 . . . . 0.0 109.443 179.965 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 85' ' ' SER . . . . . 0.458 ' OG ' ' CD1' ' A' ' 80' ' ' TYR . 14.3 t -58.9 -39.67 82.18 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.219 -0.925 . . . . 0.0 109.34 179.907 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 86' ' ' ALA . . . . . 0.528 ' HB1' ' CD2' ' A' ' 42' ' ' LEU . . . -67.9 -37.76 82.13 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.374 -0.829 . . . . 0.0 109.446 179.956 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 56.6 t0 -60.13 -41.25 92.26 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.267 -0.896 . . . . 0.0 109.594 -179.971 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 88' ' ' GLN . . . . . 0.442 ' O ' ' CB ' ' A' ' 92' ' ' GLU . 60.5 tt0 -74.63 -41.98 59.38 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.189 -0.945 . . . . 0.0 109.441 179.975 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 89' ' ' ALA . . . . . 0.575 ' HA ' ' CE1' ' A' ' 61' ' ' PHE . . . -69.76 -46.98 64.63 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.222 -0.924 . . . . 0.0 109.446 -179.983 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 90' ' ' VAL . . . . . 0.526 HG12 ' CG1' ' A' ' 105' ' ' VAL . 48.4 t -64.93 -54.47 29.27 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.535 0 O-C-N 121.205 -0.935 . . . . 0.0 109.615 -179.926 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -61.53 -40.3 94.15 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.176 -0.952 . . . . 0.0 109.855 -179.671 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 92' ' ' GLU . . . . . 0.528 ' HB3' ' CE1' ' A' ' 61' ' ' PHE . 47.5 tp10 -77.73 -46.2 22.48 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.223 -0.923 . . . . 0.0 109.887 -179.672 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 93' ' ' LEU . . . . . 0.635 ' CD1' ' CE2' ' A' ' 58' ' ' PHE . 49.8 mt -67.69 -37.84 82.85 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.157 -0.964 . . . . 0.0 109.643 -179.809 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 94' ' ' ASN . . . . . 0.582 ' HB2' ' CG1' ' A' ' 105' ' ' VAL . 50.5 t-20 -61.64 139.35 58.3 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.298 -0.876 . . . . 0.0 109.562 -179.856 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 73.95 30.4 61.41 Favored Glycine 0 N--CA 1.49 2.269 0 N-CA-C 109.482 -1.447 . . . . 0.0 109.482 179.972 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 96' ' ' THR . . . . . 0.524 ' CG2' ' O ' ' A' ' 93' ' ' LEU . 24.5 p -121.18 146.41 46.8 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.275 -1.132 . . . . 0.0 109.42 -179.97 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 97' ' ' GLN . . . . . 0.425 ' HG3' ' O ' ' A' ' 101' ' ' VAL . 63.5 tt0 -116.58 137.08 52.45 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.261 -0.9 . . . . 0.0 109.522 179.982 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 1.3 t -83.01 -148.53 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.569 0 O-C-N 121.252 -0.905 . . . . 0.0 109.319 -179.976 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 95.8 mt-10 -59.33 -36.16 75.16 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.172 -0.955 . . . . 0.0 109.444 -179.995 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -161.13 23.53 0.13 Allowed 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.275 -0.891 . . . . 0.0 109.564 179.89 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 101' ' ' VAL . . . . . 0.425 ' O ' ' HG3' ' A' ' 97' ' ' GLN . 95.1 t -134.75 158.05 41.37 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.569 0 O-C-N 121.197 -0.939 . . . . 0.0 109.454 179.895 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 88.2 mt-30 -102.13 161.24 13.84 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.227 -0.921 . . . . 0.0 109.48 -179.988 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 49.3 mt -114.73 134.27 55.23 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.263 -0.898 . . . . 0.0 109.634 -179.865 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 104' ' ' LYS . . . . . 0.461 ' HB2' ' HB3' ' A' ' 45' ' ' TYR . 63.4 mttm -126.75 94.4 4.03 Favored 'General case' 0 N--CA 1.489 1.504 0 N-CA-C 108.737 -0.838 . . . . 0.0 108.737 179.746 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 105' ' ' VAL . . . . . 0.582 ' CG1' ' HB2' ' A' ' 94' ' ' ASN . 9.7 p . . . . . 0 C--N 1.301 -1.51 0 O-C-N 121.444 -0.785 . . . . 0.0 109.963 -179.421 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 40' ' ' ASN . . . . . 0.469 ' O ' ' HA ' ' A' ' 79' ' ' THR . 42.7 t30 . . . . . 0 N--CA 1.489 1.513 0 N-CA-C 109.063 -0.717 . . . . 0.0 109.063 . . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 41' ' ' THR . . . . . 0.517 HG21 ' N ' ' A' ' 42' ' ' LEU . 54.0 m -75.58 150.51 38.05 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.176 -0.953 . . . . 0.0 109.879 -179.656 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . 0.579 HD13 ' CD2' ' A' ' 80' ' ' TYR . 4.7 mp -126.56 147.25 49.89 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.331 -0.855 . . . . 0.0 109.386 179.806 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 76.4 t80 -102.5 115.43 30.57 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.246 -0.909 . . . . 0.0 109.42 179.961 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 44' ' ' VAL . . . . . 0.446 ' HA ' ' O ' ' A' ' 104' ' ' LYS . 41.1 t -113.5 143.92 22.21 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.558 0 O-C-N 121.296 -0.878 . . . . 0.0 109.396 179.832 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 45' ' ' TYR . . . . . 0.401 ' HB3' ' HB2' ' A' ' 104' ' ' LYS . 71.5 t80 -136.2 143.33 44.32 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.224 -0.923 . . . . 0.0 109.544 -179.959 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . 0.449 ' N ' ' SD ' ' A' ' 49' ' ' MET . . . 167.24 -175.06 42.45 Favored Glycine 0 N--CA 1.491 2.3 0 N-CA-C 109.506 -1.438 . . . . 0.0 109.506 179.98 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . 0.407 ' O ' ' C ' ' A' ' 48' ' ' ASP . 91.7 mt-10 -107.89 158.54 17.25 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.286 -1.126 . . . . 0.0 109.522 179.998 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 48' ' ' ASP . . . . . 0.407 ' C ' ' O ' ' A' ' 47' ' ' GLU . 44.9 m-20 43.93 45.97 6.63 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.266 -0.897 . . . . 0.0 109.457 -179.991 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 49' ' ' MET . . . . . 0.449 ' SD ' ' N ' ' A' ' 46' ' ' GLY . 23.4 mtp -85.42 132.32 34.24 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.237 -0.914 . . . . 0.0 109.449 179.942 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 50' ' ' THR . . . . . 0.513 ' O ' ' CD1' ' A' ' 54' ' ' LEU . 0.6 OUTLIER -121.4 159.77 48.74 Favored Pre-proline 0 N--CA 1.49 1.528 0 O-C-N 121.278 -0.889 . . . . 0.0 109.362 179.83 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 51' ' ' PRO . . . . . 0.465 ' HB3' HD11 ' A' ' 67' ' ' LEU . 50.2 Cg_endo -70.3 -42.73 2.63 Favored 'Trans proline' 0 C--O 1.214 -0.692 0 C-N-CA 122.574 2.183 . . . . 0.0 111.6 -179.972 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 58.4 m -64.83 -47.4 78.12 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.308 -0.87 . . . . 0.0 109.255 179.721 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 14.3 tp -57.15 -52.06 66.83 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.322 -0.861 . . . . 0.0 109.276 179.818 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 54' ' ' LEU . . . . . 0.513 ' CD1' ' O ' ' A' ' 50' ' ' THR . 5.8 mt -57.85 -45.88 85.61 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.344 -0.847 . . . . 0.0 109.225 179.713 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 55' ' ' ARG . . . . . 0.495 ' O ' ' CB ' ' A' ' 59' ' ' SER . 24.1 ttt-85 -48.86 -36.18 16.37 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.275 -0.89 . . . . 0.0 109.299 179.757 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -72.95 -36.16 57.51 Favored Glycine 0 N--CA 1.489 2.211 0 N-CA-C 109.422 -1.471 . . . . 0.0 109.422 179.847 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . 0.433 ' O ' HD11 ' A' ' 93' ' ' LEU . . . -71.65 -27.16 62.88 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.238 -1.154 . . . . 0.0 109.302 179.923 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 58' ' ' PHE . . . . . 0.575 ' CE2' HD13 ' A' ' 93' ' ' LEU . 58.2 m-85 -113.58 8.9 17.83 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.356 -0.84 . . . . 0.0 109.399 179.96 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 59' ' ' SER . . . . . 0.496 ' N ' ' HD2' ' A' ' 60' ' ' PRO . 0.6 OUTLIER -74.59 -58.84 1.67 Allowed Pre-proline 0 N--CA 1.491 1.588 0 O-C-N 121.288 -0.883 . . . . 0.0 109.958 -179.627 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 60' ' ' PRO . . . . . 0.496 ' HD2' ' N ' ' A' ' 59' ' ' SER . 48.6 Cg_endo -68.94 -27.59 30.26 Favored 'Trans proline' 0 C--O 1.215 -0.639 0 C-N-CA 122.681 2.254 . . . . 0.0 112.068 -179.6 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 61' ' ' PHE . . . . . 0.57 ' CE2' ' HB2' ' A' ' 92' ' ' GLU . 46.2 m-85 -67.17 -33.63 75.82 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.113 -0.992 . . . . 0.0 109.516 -179.966 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . 0.44 ' HA3' ' OG ' ' A' ' 85' ' ' SER . . . 178.92 -175.08 47.09 Favored Glycine 0 N--CA 1.491 2.317 0 N-CA-C 109.491 -1.444 . . . . 0.0 109.491 -179.974 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 81.7 m-20 -94.44 139.39 31.19 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.313 -1.11 . . . . 0.0 109.468 179.941 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 64' ' ' ILE . . . . . 0.449 ' HA ' ' O ' ' A' ' 79' ' ' THR . 63.7 mt -102.3 130.43 52.18 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.522 0 O-C-N 121.244 -0.91 . . . . 0.0 109.551 -179.92 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 65' ' ' ILE . . . . . 0.498 ' CG1' HG21 ' A' ' 79' ' ' THR . 19.0 pt -95.94 -18.86 6.44 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.617 0 O-C-N 121.247 -0.908 . . . . 0.0 109.521 -179.989 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 66' ' ' ASP . . . . . 0.46 ' HB3' ' OG1' ' A' ' 79' ' ' THR . 52.1 t0 -145.57 144.46 30.51 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.227 -0.921 . . . . 0.0 109.585 179.904 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . 0.489 ' C ' ' CD1' ' A' ' 67' ' ' LEU . 2.5 tm? -126.09 110.45 13.54 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.303 -0.873 . . . . 0.0 109.218 179.94 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 68' ' ' SER . . . . . 0.429 ' HB2' ' HB2' ' A' ' 77' ' ' PHE . 3.1 m -118.25 134.92 54.6 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.288 -0.883 . . . . 0.0 109.604 -179.73 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 69' ' ' MET . . . . . 0.484 ' SD ' ' CD1' ' A' ' 54' ' ' LEU . 77.7 mmm -120.57 146.47 46.3 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.33 -0.856 . . . . 0.0 109.327 179.86 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 70' ' ' ASP . . . . . 0.461 ' HB2' ' O ' ' A' ' 75' ' ' CYS . 0.1 OUTLIER -129.38 93.93 34.36 Favored Pre-proline 0 N--CA 1.491 1.582 0 O-C-N 121.147 -0.971 . . . . 0.0 109.491 -179.988 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 71' ' ' PRO . . . . . 0.593 ' N ' ' CD ' ' A' ' 72' ' ' PRO . 47.6 Cg_endo -74.93 -27.78 9.87 Favored 'Trans proline' 0 CA--C 1.543 0.936 0 C-N-CA 122.596 2.198 . . . . 0.0 113.738 179.968 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 72' ' ' PRO . . . . . 0.593 ' CD ' ' N ' ' A' ' 71' ' ' PRO . 55.2 Cg_endo -74.9 -21.5 16.03 Favored 'Trans proline' 0 C--N 1.353 0.804 0 C-N-CA 121.511 1.474 . . . . 0.0 111.86 -179.774 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 93.7 mtt-85 -115.31 4.29 14.4 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.243 -0.911 . . . . 0.0 109.591 -179.954 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 78.4 m-20 59.28 48.18 10.54 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.184 -0.948 . . . . 0.0 109.521 179.961 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 75' ' ' CYS . . . . . 0.461 ' O ' ' HB2' ' A' ' 70' ' ' ASP . 27.7 p -151.81 153.97 35.28 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.212 -0.93 . . . . 0.0 109.565 179.976 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 76' ' ' ALA . . . . . 0.513 ' CB ' HD11 ' A' ' 54' ' ' LEU . . . -127.21 159.62 33.75 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.27 -0.894 . . . . 0.0 109.32 179.86 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 77' ' ' PHE . . . . . 0.469 ' HA ' ' O ' ' A' ' 42' ' ' LEU . 96.4 m-85 -125.19 126.21 44.86 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.255 -0.903 . . . . 0.0 109.571 -179.976 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . 0.499 ' O ' ' N ' ' A' ' 42' ' ' LEU . 60.7 t -118.28 141.68 36.48 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.51 0 O-C-N 121.221 -0.924 . . . . 0.0 109.48 -179.984 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 79' ' ' THR . . . . . 0.498 HG21 ' CG1' ' A' ' 65' ' ' ILE . 26.1 m -109.1 127.85 54.5 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.275 -0.891 . . . . 0.0 109.495 179.836 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 80' ' ' TYR . . . . . 0.579 ' CD2' HD13 ' A' ' 42' ' ' LEU . 0.6 OUTLIER -103.76 148.93 25.5 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.337 -0.852 . . . . 0.0 109.511 -179.879 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 81.7 tt0 -75.11 -22.66 58.07 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.271 -0.893 . . . . 0.0 109.27 179.842 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 31.1 mttp -131.6 136.26 47.64 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.308 -0.87 . . . . 0.0 109.378 179.9 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 83' ' ' MET . . . . . . . . . . . . . 49.5 mtt -60.89 -17.29 49.78 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.211 -0.931 . . . . 0.0 109.464 -179.926 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 97.7 mt-10 -71.13 -42.18 69.53 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.244 -0.91 . . . . 0.0 109.512 179.992 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 85' ' ' SER . . . . . 0.443 ' OG ' ' CE1' ' A' ' 80' ' ' TYR . 44.0 t -60.27 -39.49 87.02 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.212 -0.93 . . . . 0.0 109.465 179.975 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -64.19 -42.12 96.79 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.266 -0.896 . . . . 0.0 109.505 -179.99 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 57.0 t0 -65.7 -39.81 91.63 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.28 -0.888 . . . . 0.0 109.577 -179.942 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 88' ' ' GLN . . . . . 0.448 ' HG2' ' CD2' ' A' ' 61' ' ' PHE . 52.2 tt0 -69.28 -41.48 76.78 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.187 -0.946 . . . . 0.0 109.613 -179.928 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 89' ' ' ALA . . . . . 0.478 ' HA ' ' CD2' ' A' ' 61' ' ' PHE . . . -74.35 -43.14 57.85 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.247 -0.908 . . . . 0.0 109.618 -179.9 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 90' ' ' VAL . . . . . 0.53 ' O ' ' CB ' ' A' ' 94' ' ' ASN . 54.2 t -60.21 -33.04 52.13 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 O-C-N 121.229 -0.919 . . . . 0.0 109.756 -179.785 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -80.37 -51.05 9.32 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.144 -0.973 . . . . 0.0 110.122 -179.61 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 92' ' ' GLU . . . . . 0.57 ' HB2' ' CE2' ' A' ' 61' ' ' PHE . 76.1 mm-40 -72.69 -43.72 62.7 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.184 -0.948 . . . . 0.0 110.116 -179.368 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 93' ' ' LEU . . . . . 0.575 HD13 ' CE2' ' A' ' 58' ' ' PHE . 24.3 mt -68.69 -36.07 78.02 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.168 -0.957 . . . . 0.0 109.898 -179.508 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 94' ' ' ASN . . . . . 0.53 ' CB ' ' O ' ' A' ' 90' ' ' VAL . 53.1 t-20 -76.73 130.8 38.22 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.142 -0.974 . . . . 0.0 109.417 -179.891 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 94.66 20.55 28.79 Favored Glycine 0 N--CA 1.491 2.314 0 N-CA-C 109.64 -1.384 . . . . 0.0 109.64 179.89 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 96' ' ' THR . . . . . 0.438 ' CG2' ' O ' ' A' ' 92' ' ' GLU . 19.4 p -118.52 156.4 29.18 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.148 -1.207 . . . . 0.0 109.483 179.928 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 64.4 tt0 -126.18 152.27 46.23 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.241 -0.912 . . . . 0.0 109.434 -179.965 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -100.22 -158.18 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 O-C-N 121.292 -0.88 . . . . 0.0 109.359 -179.943 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 76.1 mm-40 -55.51 -39.5 70.57 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.245 -0.91 . . . . 0.0 109.535 179.984 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 31.0 t -159.66 28.29 0.19 Allowed 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.267 -0.896 . . . . 0.0 109.44 -179.947 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 60.7 t -140.17 148.19 22.8 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.543 0 O-C-N 121.258 -0.901 . . . . 0.0 109.471 179.971 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 90.9 mt-30 -95.51 143.36 26.89 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.239 -0.913 . . . . 0.0 109.529 -179.911 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 82.3 mt -109.7 136.48 48.97 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.284 -0.885 . . . . 0.0 109.404 179.926 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 104' ' ' LYS . . . . . 0.446 ' O ' ' HA ' ' A' ' 44' ' ' VAL . 42.9 mttt -126.05 128.82 48.0 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.182 -0.949 . . . . 0.0 109.509 -179.952 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 105' ' ' VAL . . . . . 0.524 ' CG1' ' HA ' ' A' ' 90' ' ' VAL . 21.4 t . . . . . 0 N--CA 1.489 1.52 0 O-C-N 121.233 -0.917 . . . . 0.0 109.34 179.9 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.56 0 N-CA-C 109.459 -0.571 . . . . 0.0 109.459 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 49.4 Cg_endo -69.92 -16.34 36.85 Favored 'Trans proline' 0 C--O 1.214 -0.696 0 C-N-CA 122.672 2.248 . . . . 0.0 111.928 -179.956 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 37' ' ' ARG . . . . . 0.457 ' O ' ' HG ' ' A' ' 114' ' ' LEU . 52.3 mtt180 -127.55 147.94 50.34 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.192 -0.943 . . . . 0.0 109.587 -179.935 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 38' ' ' LYS . . . . . 0.519 ' O ' ' CD1' ' A' ' 65' ' ' ILE . 94.9 mttt -150.22 -169.18 3.31 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.315 -0.865 . . . . 0.0 109.302 179.945 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . 0.522 ' CA ' HG21 ' A' ' 79' ' ' THR . . . 150.99 86.62 0.06 OUTLIER Glycine 0 N--CA 1.49 2.245 0 N-CA-C 109.683 -1.367 . . . . 0.0 109.683 179.9 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 40' ' ' ASN . . . . . 0.443 ' HA ' ' HB3' ' A' ' 116' ' ' ALA . 40.8 t-20 -89.19 102.0 14.66 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.238 -1.154 . . . . 0.0 109.423 179.807 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 41' ' ' THR . . . . . 0.456 ' OG1' ' HB2' ' A' ' 111' ' ' GLN . 53.2 m -69.54 134.35 48.73 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.27 -0.894 . . . . 0.0 109.595 -179.861 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . 0.559 HD11 ' CD2' ' A' ' 80' ' ' TYR . 16.6 mt -115.63 146.78 41.49 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.252 -0.905 . . . . 0.0 109.372 179.97 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 43' ' ' TYR . . . . . 0.447 ' O ' ' HA ' ' A' ' 105' ' ' VAL . 74.4 t80 -97.33 124.08 41.35 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.246 -0.908 . . . . 0.0 109.551 -179.977 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . 0.527 ' CG1' HD23 ' A' ' 103' ' ' LEU . 53.4 t -120.84 134.49 64.09 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.558 0 O-C-N 121.274 -0.891 . . . . 0.0 109.401 179.897 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 76.3 t80 -124.25 137.21 54.54 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.241 -0.912 . . . . 0.0 109.524 -179.876 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -178.23 -177.5 46.99 Favored Glycine 0 N--CA 1.491 2.302 0 N-CA-C 109.465 -1.454 . . . . 0.0 109.465 -179.989 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . 0.422 ' O ' ' C ' ' A' ' 48' ' ' ASP . 95.2 mt-10 -118.68 155.25 31.37 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.272 -1.134 . . . . 0.0 109.482 179.957 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . 0.422 ' C ' ' O ' ' A' ' 47' ' ' GLU . 47.6 m-20 43.89 48.01 7.02 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.282 -0.886 . . . . 0.0 109.54 179.961 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 58.5 mtm -93.26 143.31 26.38 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.208 -0.932 . . . . 0.0 109.509 179.954 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 50' ' ' THR . . . . . 0.484 ' O ' ' CD1' ' A' ' 54' ' ' LEU . 0.1 OUTLIER -118.42 166.29 14.25 Favored Pre-proline 0 N--CA 1.491 1.577 0 O-C-N 121.236 -0.915 . . . . 0.0 109.421 179.98 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 49.6 Cg_endo -70.02 -50.47 0.43 Allowed 'Trans proline' 0 C--O 1.214 -0.678 0 C-N-CA 122.713 2.275 . . . . 0.0 111.819 -179.916 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 39.8 m -58.55 -42.16 87.23 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.243 -0.911 . . . . 0.0 109.516 179.976 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 15.2 tp -61.31 -50.86 71.26 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.253 -0.905 . . . . 0.0 109.481 179.986 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 54' ' ' LEU . . . . . 0.484 ' CD1' ' O ' ' A' ' 50' ' ' THR . 4.2 mt -59.92 -42.75 94.58 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.232 -0.917 . . . . 0.0 109.442 179.954 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 55' ' ' ARG . . . . . 0.457 ' O ' ' CB ' ' A' ' 59' ' ' SER . 48.7 ttt85 -57.19 -32.93 66.95 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.217 -0.927 . . . . 0.0 109.433 179.908 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -76.21 -33.09 50.33 Favored Glycine 0 N--CA 1.49 2.259 0 N-CA-C 109.403 -1.479 . . . . 0.0 109.403 180.0 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . 0.551 ' O ' ' CD1' ' A' ' 61' ' ' PHE . . . -73.14 -19.75 61.06 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.314 -1.11 . . . . 0.0 109.411 -179.998 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 58' ' ' PHE . . . . . 0.629 ' CZ ' ' CD1' ' A' ' 93' ' ' LEU . 96.7 m-85 -121.62 4.37 10.1 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.211 -0.931 . . . . 0.0 109.482 179.914 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 59' ' ' SER . . . . . 0.514 ' N ' ' HD2' ' A' ' 60' ' ' PRO . 0.3 OUTLIER -72.21 -57.31 3.78 Favored Pre-proline 0 N--CA 1.49 1.546 0 O-C-N 121.215 -0.928 . . . . 0.0 109.762 -179.859 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 60' ' ' PRO . . . . . 0.514 ' HD2' ' N ' ' A' ' 59' ' ' SER . 48.9 Cg_endo -69.52 -30.93 22.59 Favored 'Trans proline' 0 C--O 1.214 -0.678 0 C-N-CA 122.637 2.225 . . . . 0.0 111.94 -179.818 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 61' ' ' PHE . . . . . 0.562 ' CD2' ' HA ' ' A' ' 89' ' ' ALA . 62.6 m-85 -62.92 -33.01 74.42 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.241 -0.912 . . . . 0.0 109.455 179.974 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 173.39 -175.47 46.16 Favored Glycine 0 N--CA 1.49 2.264 0 N-CA-C 109.411 -1.476 . . . . 0.0 109.411 179.985 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 38.7 t30 -92.22 141.4 28.62 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.266 -1.138 . . . . 0.0 109.506 179.961 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 64' ' ' ILE . . . . . 0.451 HG23 ' HB2' ' A' ' 67' ' ' LEU . 71.4 mt -103.83 130.04 54.99 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.521 0 O-C-N 121.246 -0.909 . . . . 0.0 109.432 179.98 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 65' ' ' ILE . . . . . 0.524 ' CG1' HG22 ' A' ' 79' ' ' THR . 20.6 pt -94.54 -21.95 5.63 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.537 0 O-C-N 121.252 -0.905 . . . . 0.0 109.475 179.983 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 45.7 t0 -159.26 109.43 1.95 Allowed 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.277 -0.89 . . . . 0.0 109.508 -179.969 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . 0.491 HD11 ' CG1' ' A' ' 78' ' ' VAL . 0.6 OUTLIER -111.96 122.34 47.51 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.259 -0.901 . . . . 0.0 109.367 179.937 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 38.1 m -117.94 150.78 38.66 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.235 -0.915 . . . . 0.0 109.637 -179.917 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 69' ' ' MET . . . . . 0.403 ' CE ' ' CD1' ' A' ' 54' ' ' LEU . 85.6 mtp -123.74 143.59 50.2 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.229 -0.919 . . . . 0.0 109.408 179.926 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 70' ' ' ASP . . . . . 0.449 ' C ' ' HD2' ' A' ' 72' ' ' PRO . 1.7 m-20 -122.31 105.88 36.2 Favored Pre-proline 0 N--CA 1.491 1.615 0 O-C-N 121.268 -0.895 . . . . 0.0 109.493 -179.976 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 71' ' ' PRO . . . . . 0.606 ' N ' ' CD ' ' A' ' 72' ' ' PRO . 47.1 Cg_endo -74.54 -27.9 10.52 Favored 'Trans proline' 0 CA--C 1.543 0.941 0 C-N-CA 122.511 2.141 . . . . 0.0 113.686 179.99 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 72' ' ' PRO . . . . . 0.606 ' CD ' ' N ' ' A' ' 71' ' ' PRO . 55.1 Cg_endo -75.41 -29.11 7.93 Favored 'Trans proline' 0 C--N 1.353 0.793 0 C-N-CA 121.511 1.474 . . . . 0.0 111.733 -179.794 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 73' ' ' ARG . . . . . 0.441 ' O ' ' HB2' ' A' ' 74' ' ' ASN . 61.8 mtt-85 -107.89 -4.22 18.18 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.267 -0.896 . . . . 0.0 109.622 -179.919 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 74' ' ' ASN . . . . . 0.441 ' HB2' ' O ' ' A' ' 73' ' ' ARG . 84.5 m-20 61.7 36.41 16.46 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.231 -0.918 . . . . 0.0 109.493 -179.967 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 75' ' ' CYS . . . . . 0.454 ' HA ' ' O ' ' A' ' 44' ' ' VAL . 21.9 p -130.85 137.09 49.22 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.266 -0.896 . . . . 0.0 109.477 -180.0 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -110.28 148.3 32.17 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.264 -0.897 . . . . 0.0 109.421 179.998 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 77' ' ' PHE . . . . . 0.455 ' HA ' ' O ' ' A' ' 42' ' ' LEU . 96.9 m-85 -114.2 132.08 56.24 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.214 -0.929 . . . . 0.0 109.528 179.989 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . 0.491 ' CG1' HD11 ' A' ' 67' ' ' LEU . 39.5 t -123.13 128.9 75.2 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 O-C-N 121.239 -0.913 . . . . 0.0 109.474 179.966 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 79' ' ' THR . . . . . 0.524 HG22 ' CG1' ' A' ' 65' ' ' ILE . 17.5 m -101.18 132.2 46.78 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.245 -0.91 . . . . 0.0 109.437 -179.994 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 80' ' ' TYR . . . . . 0.559 ' CD2' HD11 ' A' ' 42' ' ' LEU . 1.5 m-85 -112.11 145.93 38.91 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.241 -0.912 . . . . 0.0 109.491 -179.942 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 81' ' ' GLU . . . . . 0.488 ' O ' ' CD ' ' A' ' 38' ' ' LYS . 83.4 tt0 -70.9 -28.97 64.93 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.21 -0.931 . . . . 0.0 109.423 179.817 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 44.2 mttm -124.58 145.99 49.29 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.301 -0.875 . . . . 0.0 109.391 179.956 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 83' ' ' MET . . . . . 0.52 ' HE1' ' CA ' ' A' ' 117' ' ' ALA . 44.1 mtt -64.62 -22.6 67.02 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.241 -0.912 . . . . 0.0 109.468 179.992 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 97.6 mt-10 -69.92 -37.68 76.01 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.204 -0.935 . . . . 0.0 109.525 -179.953 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 85' ' ' SER . . . . . 0.402 ' HB2' ' CG ' ' A' ' 80' ' ' TYR . 17.3 m -59.92 -34.11 72.77 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.271 -0.893 . . . . 0.0 109.489 179.995 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 86' ' ' ALA . . . . . 0.517 ' CB ' HD12 ' A' ' 42' ' ' LEU . . . -79.63 -28.64 40.89 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.266 -0.897 . . . . 0.0 109.518 -179.959 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 87' ' ' ASP . . . . . 0.425 ' O ' ' CB ' ' A' ' 91' ' ' ALA . 94.4 m-20 -67.11 -44.6 79.51 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.257 -0.902 . . . . 0.0 109.517 -179.923 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 88' ' ' GLN . . . . . 0.516 ' HG2' ' CE2' ' A' ' 61' ' ' PHE . 62.5 tt0 -72.16 -39.38 68.76 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.218 -0.926 . . . . 0.0 109.448 -179.942 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 89' ' ' ALA . . . . . 0.562 ' HA ' ' CD2' ' A' ' 61' ' ' PHE . . . -73.96 -45.71 48.53 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.243 -0.911 . . . . 0.0 109.552 -179.98 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 90' ' ' VAL . . . . . 0.522 ' CG2' HG13 ' A' ' 105' ' ' VAL . 65.7 t -69.75 -36.12 68.53 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.574 0 O-C-N 121.237 -0.915 . . . . 0.0 109.551 -179.935 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 91' ' ' ALA . . . . . 0.425 ' CB ' ' O ' ' A' ' 87' ' ' ASP . . . -79.02 -40.48 31.32 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.295 -0.878 . . . . 0.0 109.647 -179.866 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 92' ' ' GLU . . . . . 0.537 ' OE1' ' CE2' ' A' ' 61' ' ' PHE . 40.1 tt0 -77.29 -42.67 36.04 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.221 -0.924 . . . . 0.0 109.527 -179.866 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 93' ' ' LEU . . . . . 0.629 ' CD1' ' CZ ' ' A' ' 58' ' ' PHE . 51.2 mt -69.97 -40.87 75.11 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.226 -0.921 . . . . 0.0 109.502 -179.942 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 94' ' ' ASN . . . . . 0.464 ' HB2' ' O ' ' A' ' 90' ' ' VAL . 63.4 t-20 -64.49 130.03 42.13 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.218 -0.926 . . . . 0.0 109.506 179.975 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 88.82 26.99 25.33 Favored Glycine 0 N--CA 1.49 2.257 0 N-CA-C 109.507 -1.437 . . . . 0.0 109.507 179.978 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 96' ' ' THR . . . . . 0.451 HG21 ' O ' ' A' ' 92' ' ' GLU . 27.2 p -124.29 144.62 49.88 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.212 -1.169 . . . . 0.0 109.557 179.932 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 97' ' ' GLN . . . . . 0.441 ' HG3' ' O ' ' A' ' 101' ' ' VAL . 56.0 tt0 -119.5 142.01 48.68 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.345 -0.847 . . . . 0.0 109.412 179.972 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -85.23 -154.31 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 O-C-N 121.188 -0.945 . . . . 0.0 109.374 -179.91 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 96.4 mt-10 -58.8 -40.97 85.63 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.242 -0.911 . . . . 0.0 109.477 179.997 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 100' ' ' SER . . . . . 0.463 ' O ' ' OG ' ' A' ' 100' ' ' SER . 4.4 t -153.72 24.75 0.51 Allowed 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.295 -0.878 . . . . 0.0 109.394 -179.996 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 101' ' ' VAL . . . . . 0.441 ' O ' ' HG3' ' A' ' 97' ' ' GLN . 53.4 t -137.01 167.85 22.78 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.521 0 O-C-N 121.285 -0.885 . . . . 0.0 109.442 -179.957 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 102' ' ' GLN . . . . . 0.435 ' HG2' ' HG3' ' A' ' 97' ' ' GLN . 93.7 mt-30 -123.83 149.8 45.31 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.233 -0.917 . . . . 0.0 109.264 179.909 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 103' ' ' LEU . . . . . 0.527 HD23 ' CG1' ' A' ' 44' ' ' VAL . 0.0 OUTLIER -120.08 121.23 38.41 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.135 -0.978 . . . . 0.0 109.777 -179.859 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 29.9 mttt -106.49 131.67 53.4 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.314 -0.866 . . . . 0.0 109.24 179.81 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 105' ' ' VAL . . . . . 0.522 HG13 ' CG2' ' A' ' 90' ' ' VAL . 15.6 t -111.43 139.19 36.71 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.572 0 O-C-N 121.195 -0.941 . . . . 0.0 109.665 -179.842 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 106' ' ' ASN . . . . . 0.409 ' HB2' ' HB3' ' A' ' 43' ' ' TYR . 87.4 m-20 -136.18 -172.03 3.03 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.311 -0.868 . . . . 0.0 109.297 179.86 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 23.5 mm -107.1 130.84 58.52 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.528 0 O-C-N 121.175 -0.953 . . . . 0.0 109.497 179.981 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -99.79 151.82 20.82 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.285 -0.884 . . . . 0.0 109.391 -179.943 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 90.1 mtt180 -99.15 9.27 43.79 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.211 -0.931 . . . . 0.0 109.519 179.965 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 110' ' ' LYS . . . . . 0.511 ' O ' ' CB ' ' A' ' 111' ' ' GLN . 90.8 mttt -84.68 172.12 11.8 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.201 -0.937 . . . . 0.0 109.343 179.932 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 111' ' ' GLN . . . . . 0.571 ' N ' ' CD ' ' A' ' 112' ' ' PRO . 4.5 tp-100 75.69 46.51 0.16 Allowed Pre-proline 0 N--CA 1.49 1.55 0 O-C-N 121.318 -0.864 . . . . 0.0 109.549 179.927 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 112' ' ' PRO . . . . . 0.571 ' CD ' ' N ' ' A' ' 111' ' ' GLN . 52.8 Cg_endo -72.93 -18.74 24.11 Favored 'Trans proline' 0 C--O 1.215 -0.638 0 C-N-CA 122.72 2.28 . . . . 0.0 111.646 179.981 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 113' ' ' MET . . . . . 0.523 ' CE ' ' HG3' ' A' ' 111' ' ' GLN . 0.0 OUTLIER -43.55 -26.79 0.24 Allowed 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.285 -0.885 . . . . 0.0 109.6 -179.827 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 114' ' ' LEU . . . . . 0.518 ' CD1' ' O ' ' A' ' 114' ' ' LEU . 0.2 OUTLIER -155.53 20.02 0.4 Allowed 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.159 -0.963 . . . . 0.0 109.685 179.973 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 115' ' ' ASP . . . . . 0.515 ' O ' ' CB ' ' A' ' 116' ' ' ALA . 77.5 m-20 40.04 47.21 1.93 Allowed 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.612 -0.68 . . . . 0.0 109.492 179.967 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 116' ' ' ALA . . . . . 0.515 ' CB ' ' O ' ' A' ' 115' ' ' ASP . . . 78.02 -76.31 0.05 OUTLIER 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.374 -0.829 . . . . 0.0 109.347 -179.52 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 117' ' ' ALA . . . . . 0.52 ' CA ' ' HE1' ' A' ' 83' ' ' MET . . . -165.62 -148.35 0.1 Allowed 'General case' 0 C--N 1.303 -1.432 0 O-C-N 121.329 -0.857 . . . . 0.0 109.575 -179.858 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 14.2 t -127.76 155.5 43.93 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.199 -0.938 . . . . 0.0 109.424 179.992 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 170.64 -175.57 44.42 Favored Glycine 0 N--CA 1.49 2.25 0 N-CA-C 109.484 -1.446 . . . . 0.0 109.484 179.977 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 12.4 mtmt -57.34 -35.49 69.97 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.295 -1.121 . . . . 0.0 109.535 179.967 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 121' ' ' SER . . . . . 0.434 ' OXT' ' OG ' ' A' ' 121' ' ' SER . 0.7 OUTLIER . . . . . 0 N--CA 1.49 1.555 0 CA-C-O 117.987 -1.006 . . . . 0.0 109.474 -179.958 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . 0.503 ' N ' ' HD2' ' A' ' 36' ' ' PRO . . . . . . . . 0 N--CA 1.49 1.545 0 N-CA-C 109.461 -0.57 . . . . 0.0 109.461 . . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 36' ' ' PRO . . . . . 0.503 ' HD2' ' N ' ' A' ' 35' ' ' ALA . 50.2 Cg_endo -70.03 146.05 57.35 Favored 'Trans proline' 0 C--O 1.216 -0.619 0 C-N-CA 122.766 2.31 . . . . 0.0 111.79 -179.988 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 90.6 mtt-85 -129.78 134.67 47.72 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.233 -0.917 . . . . 0.0 109.536 -179.992 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 38' ' ' LYS . . . . . 0.522 ' HA ' ' CD2' ' A' ' 114' ' ' LEU . 93.9 mttt -72.87 -170.16 0.68 Allowed 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.244 -0.91 . . . . 0.0 109.446 179.971 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . 0.518 ' HA3' ' CD1' ' A' ' 65' ' ' ILE . . . 151.84 78.56 0.02 OUTLIER Glycine 0 N--CA 1.489 2.191 0 N-CA-C 109.837 -1.305 . . . . 0.0 109.837 179.873 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 40' ' ' ASN . . . . . 0.475 ' HA ' ' HB2' ' A' ' 116' ' ' ALA . 47.1 t-20 -73.16 121.2 19.88 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.177 -1.19 . . . . 0.0 109.191 179.664 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 41' ' ' THR . . . . . 0.514 ' OG1' ' CB ' ' A' ' 111' ' ' GLN . 86.8 m -84.81 141.56 30.39 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.219 -0.925 . . . . 0.0 109.645 -179.714 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . 0.57 HD11 ' CD2' ' A' ' 80' ' ' TYR . 5.1 mp -119.03 148.72 42.7 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.274 -0.891 . . . . 0.0 109.375 179.91 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 43' ' ' TYR . . . . . 0.46 ' HB3' ' HB2' ' A' ' 106' ' ' ASN . 62.5 t80 -102.18 113.57 26.96 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.248 -0.908 . . . . 0.0 109.61 -179.927 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . 0.525 ' CG1' HD21 ' A' ' 103' ' ' LEU . 17.7 t -109.47 138.79 35.24 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.573 0 O-C-N 121.272 -0.892 . . . . 0.0 109.483 179.978 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 73.9 t80 -134.12 132.6 40.08 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.247 -0.908 . . . . 0.0 109.571 -179.922 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -175.74 -167.18 34.35 Favored Glycine 0 N--CA 1.49 2.269 0 N-CA-C 109.488 -1.445 . . . . 0.0 109.488 179.99 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . 0.404 ' O ' ' C ' ' A' ' 48' ' ' ASP . 89.9 mt-10 -116.92 157.85 25.02 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.2 -1.177 . . . . 0.0 109.392 -179.948 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . 0.404 ' C ' ' O ' ' A' ' 47' ' ' GLU . 23.0 t70 44.01 42.35 4.68 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.301 -0.874 . . . . 0.0 109.382 -179.992 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 49' ' ' MET . . . . . 0.424 ' HE3' HG11 ' A' ' 44' ' ' VAL . 54.4 mtp -73.9 139.44 44.97 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.234 -0.916 . . . . 0.0 109.549 179.943 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 50' ' ' THR . . . . . 0.502 ' O ' ' CD1' ' A' ' 54' ' ' LEU . 5.1 p -126.14 162.66 44.62 Favored Pre-proline 0 N--CA 1.49 1.566 0 O-C-N 121.336 -0.853 . . . . 0.0 109.425 179.996 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 51' ' ' PRO . . . . . 0.455 ' CA ' ' SD ' ' A' ' 69' ' ' MET . 49.4 Cg_endo -70.22 -50.73 0.39 Allowed 'Trans proline' 0 C--O 1.215 -0.65 0 C-N-CA 122.625 2.217 . . . . 0.0 111.73 -179.983 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 41.2 m -60.77 -40.74 93.65 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.225 -0.922 . . . . 0.0 109.422 179.951 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 15.7 tp -66.53 -46.88 74.7 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.298 -0.876 . . . . 0.0 109.36 179.985 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 54' ' ' LEU . . . . . 0.502 ' CD1' ' O ' ' A' ' 50' ' ' THR . 10.8 mt -58.24 -46.33 86.14 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.313 -0.867 . . . . 0.0 109.318 179.944 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 55' ' ' ARG . . . . . 0.509 ' O ' ' N ' ' A' ' 59' ' ' SER . 74.0 mtt180 -56.64 -36.7 69.79 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.282 -0.886 . . . . 0.0 109.543 179.995 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -67.64 -32.89 79.4 Favored Glycine 0 N--CA 1.49 2.294 0 N-CA-C 109.554 -1.418 . . . . 0.0 109.554 179.948 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . 0.455 ' O ' ' CD1' ' A' ' 61' ' ' PHE . . . -73.31 -23.83 60.31 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.266 -1.138 . . . . 0.0 109.411 -179.917 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 58' ' ' PHE . . . . . 0.634 ' CE1' ' CD1' ' A' ' 93' ' ' LEU . 98.6 m-85 -118.95 8.51 11.67 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.33 -0.856 . . . . 0.0 109.46 -179.98 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 59' ' ' SER . . . . . 0.511 ' N ' ' HD2' ' A' ' 60' ' ' PRO . 1.1 t -74.5 -57.51 2.06 Favored Pre-proline 0 N--CA 1.491 1.598 0 O-C-N 121.238 -0.914 . . . . 0.0 109.852 -179.715 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 60' ' ' PRO . . . . . 0.511 ' HD2' ' N ' ' A' ' 59' ' ' SER . 50.3 Cg_endo -69.84 -32.27 18.54 Favored 'Trans proline' 0 C--O 1.215 -0.627 0 C-N-CA 122.601 2.2 . . . . 0.0 111.945 -179.783 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 61' ' ' PHE . . . . . 0.566 ' CE2' ' HA ' ' A' ' 89' ' ' ALA . 67.6 m-85 -63.61 -31.82 73.11 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.163 -0.961 . . . . 0.0 109.406 -179.946 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 171.22 -176.7 44.46 Favored Glycine 0 N--CA 1.49 2.278 0 N-CA-C 109.634 -1.387 . . . . 0.0 109.634 -179.993 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 82.9 m-20 -90.04 145.15 25.29 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.302 -1.117 . . . . 0.0 109.461 179.991 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 64' ' ' ILE . . . . . 0.462 HD11 ' CG1' ' A' ' 78' ' ' VAL . 77.6 mt -106.85 131.3 57.11 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.525 0 O-C-N 121.3 -0.875 . . . . 0.0 109.619 -179.973 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 65' ' ' ILE . . . . . 0.518 ' CD1' ' HA3' ' A' ' 39' ' ' GLY . 28.2 pt -91.76 -22.85 5.94 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.599 0 O-C-N 121.3 -0.875 . . . . 0.0 109.393 179.948 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 66' ' ' ASP . . . . . 0.445 ' HB3' ' OG1' ' A' ' 79' ' ' THR . 53.6 t0 -149.5 115.3 5.64 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.239 -0.913 . . . . 0.0 109.467 -179.927 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . 0.47 ' C ' ' CD1' ' A' ' 67' ' ' LEU . 0.5 OUTLIER -103.87 114.86 29.42 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.263 -0.898 . . . . 0.0 109.505 179.999 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 68' ' ' SER . . . . . 0.445 ' HB3' ' HB2' ' A' ' 77' ' ' PHE . 39.2 t -119.5 149.72 41.43 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.176 -0.952 . . . . 0.0 109.53 179.978 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 69' ' ' MET . . . . . 0.502 ' HE1' ' CA ' ' A' ' 50' ' ' THR . 77.2 mtp -128.46 148.91 50.76 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.309 -0.869 . . . . 0.0 109.472 -179.983 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 70' ' ' ASP . . . . . 0.516 ' CB ' ' O ' ' A' ' 75' ' ' CYS . 0.4 OUTLIER -127.84 94.66 36.59 Favored Pre-proline 0 N--CA 1.49 1.572 0 O-C-N 121.272 -0.892 . . . . 0.0 109.421 179.967 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 71' ' ' PRO . . . . . 0.593 ' N ' ' CD ' ' A' ' 72' ' ' PRO . 47.4 Cg_endo -74.66 -27.93 10.26 Favored 'Trans proline' 0 CA--C 1.542 0.922 0 C-N-CA 122.564 2.176 . . . . 0.0 113.584 179.98 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 72' ' ' PRO . . . . . 0.593 ' CD ' ' N ' ' A' ' 71' ' ' PRO . 55.4 Cg_endo -75.49 -21.44 14.97 Favored 'Trans proline' 0 C--N 1.352 0.761 0 C-N-CA 121.46 1.44 . . . . 0.0 111.797 -179.86 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 73' ' ' ARG . . . . . 0.411 ' O ' ' HB2' ' A' ' 74' ' ' ASN . 67.8 mtt85 -115.23 3.66 14.33 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.252 -0.905 . . . . 0.0 109.7 -179.878 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 74' ' ' ASN . . . . . 0.411 ' HB2' ' O ' ' A' ' 73' ' ' ARG . 78.6 m-20 60.12 44.64 12.72 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.234 -0.916 . . . . 0.0 109.474 179.958 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 75' ' ' CYS . . . . . 0.516 ' O ' ' CB ' ' A' ' 70' ' ' ASP . 28.0 p -149.86 153.2 36.34 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.26 -0.9 . . . . 0.0 109.566 -179.942 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -127.8 159.36 35.07 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.291 -0.88 . . . . 0.0 109.35 179.899 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 77' ' ' PHE . . . . . 0.467 ' HA ' ' O ' ' A' ' 42' ' ' LEU . 96.3 m-85 -120.94 136.79 54.87 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.179 -0.951 . . . . 0.0 109.533 179.997 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . 0.53 ' O ' ' CD1' ' A' ' 42' ' ' LEU . 39.7 t -125.45 135.14 64.93 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 O-C-N 121.247 -0.908 . . . . 0.0 109.546 -179.974 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 79' ' ' THR . . . . . 0.516 HG22 ' CA ' ' A' ' 39' ' ' GLY . 17.3 m -104.03 127.43 51.59 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.287 -0.883 . . . . 0.0 109.451 179.964 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 80' ' ' TYR . . . . . 0.57 ' CD2' HD11 ' A' ' 42' ' ' LEU . 1.2 m-85 -108.44 139.82 42.63 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.273 -0.892 . . . . 0.0 109.507 179.958 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 81' ' ' GLU . . . . . 0.444 ' O ' ' HB2' ' A' ' 38' ' ' LYS . 76.8 tt0 -61.35 -24.43 66.46 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.232 -0.917 . . . . 0.0 109.326 179.867 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 42.8 mttm -134.18 144.61 48.59 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.28 -0.887 . . . . 0.0 109.32 179.948 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 83' ' ' MET . . . . . 0.523 ' HE2' ' CA ' ' A' ' 117' ' ' ALA . 53.8 mtt -65.55 -17.56 64.67 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.17 -0.956 . . . . 0.0 109.548 -179.912 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 97.4 mt-10 -69.98 -35.13 74.19 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.232 -0.918 . . . . 0.0 109.468 -179.924 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 85' ' ' SER . . . . . 0.481 ' HB2' ' CG ' ' A' ' 80' ' ' TYR . 18.0 m -66.84 -30.42 70.59 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.252 -0.905 . . . . 0.0 109.468 -179.943 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 86' ' ' ALA . . . . . 0.491 ' CB ' HD23 ' A' ' 42' ' ' LEU . . . -79.17 -37.43 38.39 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.223 -0.923 . . . . 0.0 109.504 -179.96 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 55.4 t0 -61.78 -47.19 86.27 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.166 -0.959 . . . . 0.0 109.407 179.97 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 88' ' ' GLN . . . . . 0.454 ' O ' ' HB2' ' A' ' 92' ' ' GLU . 64.2 tt0 -67.88 -39.96 83.63 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.289 -0.882 . . . . 0.0 109.316 179.957 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 89' ' ' ALA . . . . . 0.566 ' HA ' ' CE2' ' A' ' 61' ' ' PHE . . . -71.72 -38.91 70.42 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.283 -0.886 . . . . 0.0 109.531 -179.967 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 90' ' ' VAL . . . . . 0.524 ' O ' ' CB ' ' A' ' 94' ' ' ASN . 74.1 t -66.0 -45.33 91.12 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.616 0 O-C-N 121.309 -0.869 . . . . 0.0 109.627 -179.858 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -70.98 -34.51 71.46 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.196 -0.94 . . . . 0.0 109.667 -179.854 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 92' ' ' GLU . . . . . 0.522 ' HB3' ' CZ ' ' A' ' 61' ' ' PHE . 2.4 tm-20 -82.85 -49.3 9.83 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.28 -0.888 . . . . 0.0 109.617 -179.948 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 93' ' ' LEU . . . . . 0.634 ' CD1' ' CE1' ' A' ' 58' ' ' PHE . 85.3 mt -65.8 -35.0 79.46 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.222 -0.924 . . . . 0.0 109.598 -179.892 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 94' ' ' ASN . . . . . 0.524 ' CB ' ' O ' ' A' ' 90' ' ' VAL . 56.5 t-20 -71.71 130.51 41.33 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.277 -0.889 . . . . 0.0 109.463 -179.985 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 87.24 30.66 19.02 Favored Glycine 0 N--CA 1.489 2.204 0 N-CA-C 109.51 -1.436 . . . . 0.0 109.51 179.97 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 96' ' ' THR . . . . . 0.474 ' CG2' ' O ' ' A' ' 92' ' ' GLU . 28.8 p -122.56 148.08 45.63 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.228 -1.16 . . . . 0.0 109.523 -179.956 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 97' ' ' GLN . . . . . 0.419 ' HG3' ' O ' ' A' ' 101' ' ' VAL . 57.2 tt0 -118.6 143.22 46.94 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.309 -0.869 . . . . 0.0 109.444 -179.953 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 1.3 t -92.4 -148.84 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 O-C-N 121.256 -0.902 . . . . 0.0 109.368 179.975 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 96.7 mt-10 -57.61 -37.2 72.85 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.272 -0.893 . . . . 0.0 109.432 179.918 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 22.6 m -165.82 30.64 0.05 Allowed 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.27 -0.894 . . . . 0.0 109.319 179.965 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 101' ' ' VAL . . . . . 0.419 ' O ' ' HG3' ' A' ' 97' ' ' GLN . 44.4 t -137.73 168.88 19.89 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.5 0 O-C-N 121.34 -0.85 . . . . 0.0 109.465 -179.892 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 102' ' ' GLN . . . . . 0.401 ' N ' ' CG1' ' A' ' 101' ' ' VAL . 91.5 mt-30 -116.39 145.54 43.16 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.191 -0.943 . . . . 0.0 109.076 179.815 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 103' ' ' LEU . . . . . 0.525 HD21 ' CG1' ' A' ' 44' ' ' VAL . 0.0 OUTLIER -121.81 134.91 54.9 Favored 'General case' 0 N--CA 1.488 1.444 0 O-C-N 121.18 -0.95 . . . . 0.0 109.851 -179.628 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 60.5 mttt -118.07 126.65 52.68 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.343 -0.848 . . . . 0.0 109.234 179.769 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 105' ' ' VAL . . . . . 0.573 ' CG2' ' CB ' ' A' ' 93' ' ' LEU . 26.4 t -110.48 142.3 23.32 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 O-C-N 121.174 -0.953 . . . . 0.0 109.667 -179.82 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 106' ' ' ASN . . . . . 0.499 ' ND2' ' O ' ' A' ' 105' ' ' VAL . 24.4 m120 -153.53 -168.18 2.92 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.417 -0.802 . . . . 0.0 109.266 179.85 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 22.9 mm -105.64 133.58 49.58 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 O-C-N 121.086 -1.009 . . . . 0.0 109.406 179.967 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 108' ' ' ALA . . . . . 0.461 ' O ' ' HB ' ' A' ' 41' ' ' THR . . . -124.2 153.21 41.93 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.353 -0.842 . . . . 0.0 109.505 179.912 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 89.4 mtt180 -99.77 33.64 2.49 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.265 -0.897 . . . . 0.0 109.54 -179.901 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 110' ' ' LYS . . . . . 0.456 ' HG2' ' O ' ' A' ' 110' ' ' LYS . 16.2 tttp -72.29 -8.36 54.47 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.2 -0.937 . . . . 0.0 109.436 179.889 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 111' ' ' GLN . . . . . 0.532 ' CG ' ' HE3' ' A' ' 113' ' ' MET . 5.0 tp60 -122.79 71.79 41.25 Favored Pre-proline 0 N--CA 1.49 1.561 0 O-C-N 121.205 -0.935 . . . . 0.0 109.53 -179.904 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 112' ' ' PRO . . . . . 0.438 ' O ' ' C ' ' A' ' 113' ' ' MET . 55.7 Cg_endo -82.77 -18.32 6.66 Favored 'Trans proline' 0 C--O 1.215 -0.66 0 C-N-CA 122.774 2.316 . . . . 0.0 111.929 179.992 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 113' ' ' MET . . . . . 0.532 ' HE3' ' CG ' ' A' ' 111' ' ' GLN . 0.0 OUTLIER -42.49 -37.48 1.64 Allowed 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.305 -0.872 . . . . 0.0 109.595 -179.793 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 114' ' ' LEU . . . . . 0.528 ' CD2' ' O ' ' A' ' 114' ' ' LEU . 4.2 tt -134.42 26.49 3.78 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.15 -0.969 . . . . 0.0 109.39 179.84 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 115' ' ' ASP . . . . . 0.471 ' O ' ' HB1' ' A' ' 116' ' ' ALA . 89.1 m-20 47.07 45.69 15.89 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.213 -0.929 . . . . 0.0 109.28 -179.824 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 116' ' ' ALA . . . . . 0.475 ' HB2' ' HA ' ' A' ' 40' ' ' ASN . . . 70.29 -84.03 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.2 -0.938 . . . . 0.0 109.5 -179.897 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 117' ' ' ALA . . . . . 0.523 ' CA ' ' HE2' ' A' ' 83' ' ' MET . . . -162.69 24.18 0.1 Allowed 'General case' 0 C--N 1.303 -1.454 0 O-C-N 121.382 -0.824 . . . . 0.0 109.59 -179.767 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 118' ' ' THR . . . . . 0.474 ' N ' ' HE1' ' A' ' 83' ' ' MET . 59.1 m -71.68 -34.14 69.43 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.183 -0.948 . . . . 0.0 109.419 -179.76 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 119' ' ' GLY . . . . . 0.43 ' O ' ' HB2' ' A' ' 120' ' ' LYS . . . 78.83 -169.8 54.4 Favored Glycine 0 N--CA 1.49 2.278 0 N-CA-C 109.415 -1.474 . . . . 0.0 109.415 179.984 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 120' ' ' LYS . . . . . 0.43 ' HB2' ' O ' ' A' ' 119' ' ' GLY . 26.5 mttm 60.74 46.01 9.45 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.243 -1.151 . . . . 0.0 109.468 179.965 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 38.2 t . . . . . 0 N--CA 1.49 1.533 0 CA-C-O 117.988 -1.006 . . . . 0.0 109.46 -179.951 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . 0.485 ' CB ' ' CD ' ' A' ' 36' ' ' PRO . . . . . . . . 0 N--CA 1.49 1.555 0 N-CA-C 109.461 -0.57 . . . . 0.0 109.461 . . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 36' ' ' PRO . . . . . 0.485 ' CD ' ' CB ' ' A' ' 35' ' ' ALA . 49.1 Cg_endo -69.93 149.04 65.26 Favored 'Trans proline' 0 C--O 1.215 -0.649 0 C-N-CA 122.749 2.299 . . . . 0.0 111.829 -179.979 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 34.3 ptt85 -143.05 157.33 44.63 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.314 -0.866 . . . . 0.0 109.331 179.938 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 38' ' ' LYS . . . . . 0.453 ' HE2' ' O ' ' A' ' 118' ' ' THR . 30.1 mttt -122.94 -157.26 0.74 Allowed 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.222 -0.924 . . . . 0.0 109.519 179.985 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . 0.528 ' CA ' HG21 ' A' ' 79' ' ' THR . . . 175.04 75.23 0.05 OUTLIER Glycine 0 N--CA 1.489 2.231 0 N-CA-C 109.537 -1.425 . . . . 0.0 109.537 -179.959 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 40' ' ' ASN . . . . . 0.518 ' HA ' ' CB ' ' A' ' 116' ' ' ALA . 45.3 t-20 -68.45 117.13 9.81 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.195 -1.179 . . . . 0.0 109.512 -179.976 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 41' ' ' THR . . . . . 0.455 ' HA ' ' O ' ' A' ' 78' ' ' VAL . 60.2 m -81.0 143.67 32.35 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.274 -0.891 . . . . 0.0 109.54 179.973 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . 0.58 HD13 ' CD2' ' A' ' 80' ' ' TYR . 5.0 mp -116.08 146.7 42.0 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.176 -0.952 . . . . 0.0 109.521 -179.931 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 43' ' ' TYR . . . . . 0.454 ' HB3' ' HB2' ' A' ' 106' ' ' ASN . 35.4 t80 -106.08 112.58 25.67 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.177 -0.952 . . . . 0.0 109.513 -179.976 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . 0.501 HG12 ' N ' ' A' ' 45' ' ' TYR . 38.2 t -110.53 150.42 13.05 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.53 0 O-C-N 121.266 -0.896 . . . . 0.0 109.535 -179.919 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 45' ' ' TYR . . . . . 0.501 ' N ' HG12 ' A' ' 44' ' ' VAL . 70.0 t80 -141.68 138.92 32.79 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.2 -0.937 . . . . 0.0 109.606 179.9 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 177.29 -167.86 39.25 Favored Glycine 0 N--CA 1.49 2.289 0 N-CA-C 109.472 -1.451 . . . . 0.0 109.472 179.909 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . 0.423 ' O ' ' C ' ' A' ' 48' ' ' ASP . 89.0 mt-10 -115.66 161.98 17.9 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.275 -1.133 . . . . 0.0 109.42 179.945 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . 0.423 ' C ' ' O ' ' A' ' 47' ' ' GLU . 43.9 m-20 43.73 40.74 3.21 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.281 -0.887 . . . . 0.0 109.606 179.975 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 41.3 mtp -78.6 138.79 38.52 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.282 -0.886 . . . . 0.0 109.354 179.979 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 50' ' ' THR . . . . . 0.462 ' O ' HD11 ' A' ' 54' ' ' LEU . 0.4 OUTLIER -127.04 161.28 54.8 Favored Pre-proline 0 N--CA 1.49 1.56 0 O-C-N 121.252 -0.905 . . . . 0.0 109.533 179.94 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 50.2 Cg_endo -70.07 -51.94 0.33 Allowed 'Trans proline' 0 C--O 1.214 -0.688 0 C-N-CA 122.641 2.228 . . . . 0.0 111.815 -179.985 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 31.1 m -59.16 -41.2 87.83 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.214 -0.929 . . . . 0.0 109.41 179.904 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 9.0 tt -64.89 -44.44 89.63 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.305 -0.872 . . . . 0.0 109.467 179.987 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 54' ' ' LEU . . . . . 0.496 HD12 ' CB ' ' A' ' 76' ' ' ALA . 21.9 mt -63.93 -45.86 87.35 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.211 -0.931 . . . . 0.0 109.374 179.946 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 55' ' ' ARG . . . . . 0.454 ' O ' ' N ' ' A' ' 59' ' ' SER . 76.8 mtp180 -51.3 -41.33 60.42 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.235 -0.916 . . . . 0.0 109.358 179.965 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -69.44 -32.28 71.59 Favored Glycine 0 N--CA 1.49 2.253 0 N-CA-C 109.463 -1.455 . . . . 0.0 109.463 179.871 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -71.5 -23.72 61.85 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.339 -1.095 . . . . 0.0 109.398 179.934 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 58' ' ' PHE . . . . . 0.584 ' CE2' ' CD1' ' A' ' 93' ' ' LEU . 90.1 m-85 -120.62 10.11 10.98 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.365 -0.834 . . . . 0.0 109.453 -179.997 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 59' ' ' SER . . . . . 0.525 ' N ' ' HD2' ' A' ' 60' ' ' PRO . 3.4 t -76.78 -54.34 1.7 Allowed Pre-proline 0 N--CA 1.49 1.575 0 O-C-N 121.316 -0.865 . . . . 0.0 110.413 -179.505 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 60' ' ' PRO . . . . . 0.525 ' HD2' ' N ' ' A' ' 59' ' ' SER . 48.5 Cg_endo -69.97 -35.58 11.77 Favored 'Trans proline' 0 C--O 1.215 -0.644 0 C-N-CA 122.516 2.144 . . . . 0.0 112.251 -179.276 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 61' ' ' PHE . . . . . 0.583 ' CZ ' ' HB2' ' A' ' 92' ' ' GLU . 70.0 m-85 -58.51 -39.29 79.67 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.183 -0.948 . . . . 0.0 109.631 -179.833 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 179.43 174.66 45.67 Favored Glycine 0 N--CA 1.49 2.239 0 N-CA-C 109.516 -1.434 . . . . 0.0 109.516 179.95 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 45.9 t-20 -80.18 140.9 36.13 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.263 -1.14 . . . . 0.0 109.414 179.93 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 64' ' ' ILE . . . . . 0.471 HD11 HG11 ' A' ' 78' ' ' VAL . 81.7 mt -100.78 131.04 49.16 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.52 0 O-C-N 121.223 -0.923 . . . . 0.0 109.542 -179.973 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 65' ' ' ILE . . . . . 0.516 ' CD1' ' HA3' ' A' ' 39' ' ' GLY . 20.4 pt -92.82 -24.02 5.38 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 O-C-N 121.264 -0.898 . . . . 0.0 109.575 -179.841 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 18.7 t70 -149.44 113.79 5.24 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.239 -0.913 . . . . 0.0 109.621 -179.888 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . 0.459 ' C ' ' CD1' ' A' ' 67' ' ' LEU . 0.4 OUTLIER -104.74 117.06 33.14 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.282 -0.886 . . . . 0.0 109.342 179.803 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 25.9 t -128.36 148.87 50.7 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.291 -0.881 . . . . 0.0 109.566 -179.906 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 69' ' ' MET . . . . . 0.402 ' HE2' ' CD1' ' A' ' 54' ' ' LEU . 86.6 mtp -124.9 148.54 48.27 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.233 -0.917 . . . . 0.0 109.408 179.93 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 70' ' ' ASP . . . . . 0.498 ' CB ' ' O ' ' A' ' 75' ' ' CYS . 0.8 OUTLIER -120.77 100.03 46.78 Favored Pre-proline 0 N--CA 1.491 1.624 0 O-C-N 121.253 -0.904 . . . . 0.0 109.614 -179.931 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 71' ' ' PRO . . . . . 0.596 ' N ' ' CD ' ' A' ' 72' ' ' PRO . 47.9 Cg_endo -74.72 -27.85 10.22 Favored 'Trans proline' 0 CA--C 1.543 0.938 0 C-N-CA 122.543 2.162 . . . . 0.0 113.733 179.944 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 72' ' ' PRO . . . . . 0.596 ' CD ' ' N ' ' A' ' 71' ' ' PRO . 55.5 Cg_endo -75.36 -28.62 8.44 Favored 'Trans proline' 0 C--N 1.352 0.762 0 C-N-CA 121.462 1.441 . . . . 0.0 111.846 -179.91 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 73' ' ' ARG . . . . . 0.448 ' O ' ' HB2' ' A' ' 74' ' ' ASN . 55.3 mtt-85 -109.41 0.06 19.2 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.295 -0.878 . . . . 0.0 109.666 -179.826 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 74' ' ' ASN . . . . . 0.448 ' HB2' ' O ' ' A' ' 73' ' ' ARG . 83.5 m-20 61.14 41.25 13.84 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.126 -0.984 . . . . 0.0 109.544 179.984 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 75' ' ' CYS . . . . . 0.498 ' O ' ' CB ' ' A' ' 70' ' ' ASP . 30.0 p -140.93 137.01 32.8 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.183 -0.948 . . . . 0.0 109.627 179.99 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . 0.496 ' CB ' HD12 ' A' ' 54' ' ' LEU . . . -105.02 160.6 14.91 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.286 -0.884 . . . . 0.0 109.454 179.996 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 77' ' ' PHE . . . . . 0.466 ' HA ' ' O ' ' A' ' 42' ' ' LEU . 97.1 m-85 -124.33 130.07 51.84 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.207 -0.933 . . . . 0.0 109.487 -179.987 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . 0.527 ' O ' ' CD1' ' A' ' 42' ' ' LEU . 21.2 t -122.09 132.97 69.84 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.549 0 O-C-N 121.273 -0.892 . . . . 0.0 109.341 179.927 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 79' ' ' THR . . . . . 0.528 HG21 ' CA ' ' A' ' 39' ' ' GLY . 6.8 m -106.01 135.86 46.71 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.238 -0.914 . . . . 0.0 109.36 -179.966 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 80' ' ' TYR . . . . . 0.58 ' CD2' HD13 ' A' ' 42' ' ' LEU . 1.6 m-85 -115.56 133.08 56.38 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.162 -0.961 . . . . 0.0 109.619 -179.932 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 76.8 tt0 -52.26 -25.81 10.32 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.339 -0.851 . . . . 0.0 109.537 179.959 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 67.6 mttm -134.23 132.97 40.33 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.176 -0.953 . . . . 0.0 109.617 -179.952 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 83' ' ' MET . . . . . 0.519 ' CE ' ' HB2' ' A' ' 117' ' ' ALA . 0.8 OUTLIER -57.38 -18.23 16.59 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.277 -0.889 . . . . 0.0 109.649 -179.964 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 99.5 mt-10 -65.76 -39.43 91.04 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.223 -0.923 . . . . 0.0 109.506 -179.922 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 13.9 t -63.58 -40.45 96.99 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.168 -0.957 . . . . 0.0 109.546 -179.897 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -61.11 -41.45 96.71 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.204 -0.935 . . . . 0.0 109.538 -179.917 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 54.4 t0 -62.19 -45.1 94.89 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.218 -0.926 . . . . 0.0 109.601 -179.926 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 63.6 tt0 -65.16 -37.3 86.96 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.224 -0.922 . . . . 0.0 109.583 -179.817 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 89' ' ' ALA . . . . . 0.55 ' HA ' ' CE1' ' A' ' 61' ' ' PHE . . . -75.95 -45.95 32.36 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.225 -0.922 . . . . 0.0 109.609 -179.879 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 90' ' ' VAL . . . . . 0.513 ' HA ' ' CG1' ' A' ' 105' ' ' VAL . 78.0 t -56.9 -31.92 37.57 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.52 0 O-C-N 121.207 -0.933 . . . . 0.0 109.626 -179.889 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -80.06 -53.0 7.12 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.245 -0.91 . . . . 0.0 109.733 -179.82 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 92' ' ' GLU . . . . . 0.583 ' HB2' ' CZ ' ' A' ' 61' ' ' PHE . 75.4 mm-40 -71.72 -43.88 65.11 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.214 -0.929 . . . . 0.0 109.73 -179.637 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 93' ' ' LEU . . . . . 0.584 ' CD1' ' CE2' ' A' ' 58' ' ' PHE . 36.7 mt -64.67 -40.36 95.28 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.149 -0.969 . . . . 0.0 109.474 -179.916 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 94' ' ' ASN . . . . . 0.489 ' CB ' ' O ' ' A' ' 90' ' ' VAL . 64.0 t-20 -68.4 125.74 27.42 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.244 -0.91 . . . . 0.0 109.499 179.987 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 93.85 22.81 24.79 Favored Glycine 0 N--CA 1.49 2.294 0 N-CA-C 109.536 -1.426 . . . . 0.0 109.536 179.969 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 96' ' ' THR . . . . . 0.512 ' CG2' ' O ' ' A' ' 92' ' ' GLU . 29.5 p -111.49 159.7 17.83 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.268 -1.136 . . . . 0.0 109.465 -179.948 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 60.0 tt0 -136.13 149.02 48.49 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.281 -0.887 . . . . 0.0 109.491 179.968 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 98' ' ' VAL . . . . . 0.522 ' CG2' HG12 ' A' ' 101' ' ' VAL . 1.3 t -101.59 -151.92 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.543 0 O-C-N 121.195 -0.941 . . . . 0.0 109.204 179.947 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 95.7 mt-10 -48.29 -41.34 27.77 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.115 -0.991 . . . . 0.0 109.42 179.992 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 2.4 m -165.98 25.84 0.05 OUTLIER 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.236 -0.915 . . . . 0.0 109.505 -179.97 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 101' ' ' VAL . . . . . 0.522 HG12 ' CG2' ' A' ' 98' ' ' VAL . 9.8 p -130.17 140.2 49.51 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.547 0 O-C-N 121.233 -0.917 . . . . 0.0 109.644 -179.861 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 91.7 mt-30 -86.71 141.62 28.78 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.265 -0.897 . . . . 0.0 109.328 179.887 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 103' ' ' LEU . . . . . 0.45 HD12 HG23 ' A' ' 98' ' ' VAL . 73.5 mt -106.76 137.62 44.45 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.241 -0.912 . . . . 0.0 109.763 -179.819 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 104' ' ' LYS . . . . . 0.466 ' O ' ' HA ' ' A' ' 44' ' ' VAL . 41.9 mttm -119.38 135.53 54.69 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.284 -0.885 . . . . 0.0 109.245 179.831 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 105' ' ' VAL . . . . . 0.518 HG23 ' CB ' ' A' ' 93' ' ' LEU . 46.0 t -123.43 145.49 30.32 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.55 0 O-C-N 121.186 -0.946 . . . . 0.0 109.614 -179.788 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 106' ' ' ASN . . . . . 0.454 ' HB2' ' HB3' ' A' ' 43' ' ' TYR . 83.2 m-20 -148.54 -170.92 3.73 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.362 -0.836 . . . . 0.0 109.337 179.904 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 107' ' ' ILE . . . . . 0.503 ' CD1' HG21 ' A' ' 90' ' ' VAL . 28.5 mm -111.38 126.3 68.76 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.531 0 O-C-N 121.156 -0.965 . . . . 0.0 109.509 -179.991 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 108' ' ' ALA . . . . . 0.444 ' HB2' HG23 ' A' ' 41' ' ' THR . . . -107.68 138.93 43.03 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.232 -0.917 . . . . 0.0 109.469 179.993 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 79.8 mtt85 -108.75 18.12 21.14 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.213 -0.929 . . . . 0.0 109.474 -179.936 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 110' ' ' LYS . . . . . 0.468 ' O ' ' HD3' ' A' ' 112' ' ' PRO . 84.9 tttt -59.97 -50.88 72.0 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.223 -0.923 . . . . 0.0 109.488 -179.897 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 111' ' ' GLN . . . . . 0.508 ' HG3' ' CE ' ' A' ' 113' ' ' MET . 5.2 tp-100 -42.4 98.56 0.18 Allowed Pre-proline 0 N--CA 1.492 1.668 0 O-C-N 121.282 -0.886 . . . . 0.0 109.574 -179.896 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 112' ' ' PRO . . . . . 0.468 ' HD3' ' O ' ' A' ' 110' ' ' LYS . 53.4 Cg_endo -90.65 -22.52 0.67 Allowed 'Trans proline' 0 N--CA 1.456 -0.726 0 C-N-CA 123.103 2.535 . . . . 0.0 111.895 179.98 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 113' ' ' MET . . . . . 0.508 ' CE ' ' HG3' ' A' ' 111' ' ' GLN . 0.0 OUTLIER -49.01 -34.92 14.16 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.206 -0.934 . . . . 0.0 109.548 -179.914 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 114' ' ' LEU . . . . . 0.448 ' CD2' ' HG2' ' A' ' 38' ' ' LYS . 0.4 OUTLIER -150.68 26.93 0.74 Allowed 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.27 -0.894 . . . . 0.0 109.516 -179.956 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 115' ' ' ASP . . . . . 0.463 ' O ' ' CB ' ' A' ' 116' ' ' ALA . 83.3 m-20 54.27 44.14 29.49 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.243 -0.911 . . . . 0.0 109.15 -179.844 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 116' ' ' ALA . . . . . 0.518 ' CB ' ' HA ' ' A' ' 40' ' ' ASN . . . 72.3 -83.12 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.368 -0.832 . . . . 0.0 109.52 -179.921 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 117' ' ' ALA . . . . . 0.519 ' HB2' ' CE ' ' A' ' 83' ' ' MET . . . -169.8 132.61 1.16 Allowed 'General case' 0 N--CA 1.487 1.415 0 O-C-N 121.23 -0.919 . . . . 0.0 109.604 -179.985 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 118' ' ' THR . . . . . 0.453 ' O ' ' HE2' ' A' ' 38' ' ' LYS . 21.6 p -130.04 168.31 16.93 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.286 -0.884 . . . . 0.0 109.517 179.956 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -61.39 -35.93 91.75 Favored Glycine 0 N--CA 1.49 2.279 0 N-CA-C 109.488 -1.445 . . . . 0.0 109.488 179.988 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 120' ' ' LYS . . . . . 0.423 ' O ' ' OG1' ' A' ' 118' ' ' THR . 48.0 tttp -109.05 134.19 52.0 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.236 -1.155 . . . . 0.0 109.437 179.962 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 2.9 m . . . . . 0 N--CA 1.491 1.584 0 CA-C-O 118.052 -0.975 . . . . 0.0 109.47 -179.982 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.566 0 N-CA-C 109.464 -0.569 . . . . 0.0 109.464 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 48.9 Cg_endo -69.36 145.54 59.77 Favored 'Trans proline' 0 C--O 1.215 -0.631 0 C-N-CA 122.642 2.228 . . . . 0.0 111.798 -179.998 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 72.9 mtm180 -131.56 145.14 51.57 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.214 -0.929 . . . . 0.0 109.582 -179.928 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 38' ' ' LYS . . . . . 0.525 ' O ' ' CD1' ' A' ' 65' ' ' ILE . 67.6 mttm -69.19 -167.73 0.12 Allowed 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.179 -0.95 . . . . 0.0 109.377 179.937 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . 0.526 ' CA ' HD12 ' A' ' 65' ' ' ILE . . . 150.65 99.9 0.2 Allowed Glycine 0 N--CA 1.491 2.332 0 N-CA-C 109.761 -1.336 . . . . 0.0 109.761 179.965 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 40' ' ' ASN . . . . . 0.458 ' O ' ' HA ' ' A' ' 79' ' ' THR . 47.3 t-20 -98.86 108.13 20.74 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.196 -1.179 . . . . 0.0 109.311 179.759 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 41' ' ' THR . . . . . 0.451 ' OG1' ' HB2' ' A' ' 111' ' ' GLN . 43.7 m -71.11 133.79 46.51 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.257 -0.902 . . . . 0.0 109.74 -179.747 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . 0.512 ' CD2' ' HB1' ' A' ' 86' ' ' ALA . 16.6 mt -114.38 145.68 41.52 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.295 -0.878 . . . . 0.0 109.32 179.824 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 43' ' ' TYR . . . . . 0.461 ' HB3' ' HB2' ' A' ' 106' ' ' ASN . 74.1 t80 -100.38 122.61 43.41 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.258 -0.901 . . . . 0.0 109.488 -179.825 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . 0.46 ' HA ' ' O ' ' A' ' 104' ' ' LYS . 59.3 t -123.34 136.92 58.39 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.538 0 O-C-N 121.283 -0.885 . . . . 0.0 109.424 179.977 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 45' ' ' TYR . . . . . 0.452 ' HB3' ' HB2' ' A' ' 104' ' ' LYS . 70.1 t80 -120.56 142.09 49.68 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.223 -0.923 . . . . 0.0 109.46 -179.89 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . 0.445 ' HA3' ' SD ' ' A' ' 49' ' ' MET . . . 174.86 -175.87 47.02 Favored Glycine 0 N--CA 1.491 2.341 0 N-CA-C 109.54 -1.424 . . . . 0.0 109.54 -179.963 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . 0.428 ' O ' ' C ' ' A' ' 48' ' ' ASP . 94.6 mt-10 -120.85 157.03 30.68 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.265 -1.138 . . . . 0.0 109.392 179.962 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . 0.428 ' C ' ' O ' ' A' ' 47' ' ' GLU . 48.8 m-20 43.93 52.16 6.73 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.294 -0.879 . . . . 0.0 109.546 -179.979 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 49' ' ' MET . . . . . 0.445 ' SD ' ' HA3' ' A' ' 46' ' ' GLY . 64.8 mtm -103.4 142.41 34.28 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.314 -0.866 . . . . 0.0 109.504 179.975 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 50' ' ' THR . . . . . 0.458 ' O ' HD12 ' A' ' 54' ' ' LEU . 0.6 OUTLIER -122.15 163.62 30.73 Favored Pre-proline 0 N--CA 1.491 1.582 0 O-C-N 121.258 -0.901 . . . . 0.0 109.371 179.919 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 51' ' ' PRO . . . . . 0.469 ' HB3' HD13 ' A' ' 67' ' ' LEU . 48.8 Cg_endo -69.56 -52.99 0.31 Allowed 'Trans proline' 0 C--O 1.215 -0.64 0 C-N-CA 122.617 2.211 . . . . 0.0 111.803 179.988 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 28.6 m -50.6 -48.87 57.7 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.249 -0.907 . . . . 0.0 109.302 179.931 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 22.3 tp -60.33 -47.23 86.92 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.249 -0.907 . . . . 0.0 109.343 179.836 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 54' ' ' LEU . . . . . 0.458 HD12 ' O ' ' A' ' 50' ' ' THR . 21.9 mt -56.28 -47.09 79.29 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.284 -0.885 . . . . 0.0 109.357 179.824 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 55' ' ' ARG . . . . . 0.499 ' O ' ' N ' ' A' ' 59' ' ' SER . 36.4 mtp85 -51.43 -40.91 60.33 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.306 -0.871 . . . . 0.0 109.296 179.84 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -66.48 -34.35 87.46 Favored Glycine 0 N--CA 1.489 2.203 0 N-CA-C 109.34 -1.504 . . . . 0.0 109.34 179.864 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -71.23 -26.41 62.91 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.313 -1.11 . . . . 0.0 109.472 179.957 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 58' ' ' PHE . . . . . 0.637 ' CE2' ' CD1' ' A' ' 93' ' ' LEU . 96.9 m-85 -115.01 8.33 15.75 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.244 -0.91 . . . . 0.0 109.468 179.966 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 59' ' ' SER . . . . . 0.516 ' N ' ' HD2' ' A' ' 60' ' ' PRO . 0.8 OUTLIER -72.91 -58.14 2.76 Favored Pre-proline 0 N--CA 1.49 1.574 0 O-C-N 121.195 -0.941 . . . . 0.0 109.811 -179.784 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 60' ' ' PRO . . . . . 0.516 ' HD2' ' N ' ' A' ' 59' ' ' SER . 48.0 Cg_endo -68.9 -28.69 29.24 Favored 'Trans proline' 0 C--O 1.215 -0.65 0 C-N-CA 122.602 2.202 . . . . 0.0 111.973 -179.702 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 61' ' ' PHE . . . . . 0.569 ' CD1' ' HA ' ' A' ' 89' ' ' ALA . 61.2 m-85 -70.11 -31.74 69.44 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.181 -0.949 . . . . 0.0 109.548 -179.988 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . 0.414 ' HA3' ' HB3' ' A' ' 85' ' ' SER . . . 176.39 -171.41 44.4 Favored Glycine 0 N--CA 1.49 2.262 0 N-CA-C 109.504 -1.438 . . . . 0.0 109.504 179.881 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 85.6 m-20 -99.67 137.33 38.3 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.244 -1.15 . . . . 0.0 109.311 -179.963 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 64' ' ' ILE . . . . . 0.416 HD13 HG12 ' A' ' 78' ' ' VAL . 64.0 mt -99.53 131.72 46.35 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.517 0 O-C-N 121.238 -0.914 . . . . 0.0 109.581 -179.988 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 65' ' ' ILE . . . . . 0.526 HD12 ' CA ' ' A' ' 39' ' ' GLY . 18.3 pt -96.67 -22.47 5.06 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.549 0 O-C-N 121.346 -0.846 . . . . 0.0 109.427 179.982 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 66' ' ' ASP . . . . . 0.441 ' HB3' ' OG1' ' A' ' 79' ' ' THR . 54.9 t0 -143.76 135.96 26.74 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.219 -0.925 . . . . 0.0 109.563 -179.963 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . 0.489 ' C ' ' CD1' ' A' ' 67' ' ' LEU . 3.4 tm? -122.47 114.71 21.07 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.233 -0.917 . . . . 0.0 109.314 179.918 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 68' ' ' SER . . . . . 0.446 ' HB3' ' HB2' ' A' ' 77' ' ' PHE . 37.7 t -129.25 145.43 51.35 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.247 -0.908 . . . . 0.0 109.518 -179.917 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 69' ' ' MET . . . . . 0.463 ' HA ' ' HA ' ' A' ' 76' ' ' ALA . 79.3 mtp -130.4 143.92 51.07 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.218 -0.926 . . . . 0.0 109.445 179.963 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 70' ' ' ASP . . . . . 0.453 ' C ' ' HD2' ' A' ' 72' ' ' PRO . 2.4 t70 -117.06 107.06 46.34 Favored Pre-proline 0 N--CA 1.489 1.514 0 O-C-N 121.229 -0.92 . . . . 0.0 109.575 -179.928 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 71' ' ' PRO . . . . . 0.604 ' N ' ' CD ' ' A' ' 72' ' ' PRO . 46.3 Cg_endo -74.85 -27.69 10.09 Favored 'Trans proline' 0 CA--C 1.543 0.962 0 C-N-CA 122.458 2.106 . . . . 0.0 113.571 179.923 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 72' ' ' PRO . . . . . 0.604 ' CD ' ' N ' ' A' ' 71' ' ' PRO . 55.2 Cg_endo -75.38 -29.56 7.53 Favored 'Trans proline' 0 C--N 1.353 0.787 0 C-N-CA 121.427 1.418 . . . . 0.0 111.81 -179.872 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 5.8 mtp85 -106.97 1.3 24.35 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.161 -0.962 . . . . 0.0 109.63 179.995 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 80.2 m-20 57.61 39.1 27.87 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.145 -0.972 . . . . 0.0 109.46 179.991 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 75' ' ' CYS . . . . . 0.435 ' HA ' ' O ' ' A' ' 44' ' ' VAL . 27.9 p -134.96 140.52 45.77 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.186 -0.946 . . . . 0.0 109.5 -179.963 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . 0.463 ' HA ' ' HA ' ' A' ' 69' ' ' MET . . . -108.22 152.23 24.86 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.34 -0.85 . . . . 0.0 109.395 179.964 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 77' ' ' PHE . . . . . 0.446 ' HB2' ' HB3' ' A' ' 68' ' ' SER . 96.8 m-85 -117.59 129.95 56.09 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.24 -0.913 . . . . 0.0 109.527 -179.955 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . 0.482 ' O ' ' N ' ' A' ' 42' ' ' LEU . 48.2 t -124.79 132.09 71.78 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.575 0 O-C-N 121.261 -0.9 . . . . 0.0 109.413 179.968 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 79' ' ' THR . . . . . 0.517 HG21 ' CA ' ' A' ' 39' ' ' GLY . 22.8 m -101.22 134.1 44.78 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.286 -0.884 . . . . 0.0 109.5 179.965 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 80' ' ' TYR . . . . . 0.469 ' OH ' ' HB3' ' A' ' 58' ' ' PHE . 0.4 OUTLIER -109.95 144.57 38.28 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.275 -0.891 . . . . 0.0 109.548 -179.977 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 81' ' ' GLU . . . . . 0.425 ' O ' ' CB ' ' A' ' 38' ' ' LYS . 84.9 tt0 -66.81 -31.16 71.6 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.177 -0.952 . . . . 0.0 109.514 179.836 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 46.1 mttm -128.11 152.32 48.14 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.327 -0.858 . . . . 0.0 109.445 -179.998 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 83' ' ' MET . . . . . 0.514 ' CE ' ' O ' ' A' ' 117' ' ' ALA . 40.7 mtt -69.79 -21.98 63.37 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.226 -0.921 . . . . 0.0 109.491 179.987 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 98.7 mt-10 -71.15 -33.42 70.04 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.27 -0.894 . . . . 0.0 109.605 -179.955 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 85' ' ' SER . . . . . 0.414 ' HB3' ' HA3' ' A' ' 62' ' ' GLY . 19.4 m -66.92 -31.07 71.41 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.167 -0.958 . . . . 0.0 109.479 -179.901 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 86' ' ' ALA . . . . . 0.512 ' HB1' ' CD2' ' A' ' 42' ' ' LEU . . . -80.08 -33.74 38.61 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.253 -0.904 . . . . 0.0 109.476 -179.955 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 58.7 t0 -65.48 -40.57 93.28 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.262 -0.898 . . . . 0.0 109.589 -179.946 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 88' ' ' GLN . . . . . 0.416 ' O ' ' HB2' ' A' ' 92' ' ' GLU . 62.0 tt0 -73.92 -38.72 64.21 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.285 -0.884 . . . . 0.0 109.591 -179.917 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 89' ' ' ALA . . . . . 0.569 ' HA ' ' CD1' ' A' ' 61' ' ' PHE . . . -76.46 -41.22 48.07 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.249 -0.907 . . . . 0.0 109.507 179.975 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 90' ' ' VAL . . . . . 0.479 ' O ' ' CB ' ' A' ' 94' ' ' ASN . 55.6 t -65.91 -40.97 88.97 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.591 0 O-C-N 121.286 -0.883 . . . . 0.0 109.623 -179.812 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -74.95 -38.26 61.76 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.145 -0.972 . . . . 0.0 109.741 -179.774 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 92' ' ' GLU . . . . . 0.543 ' HB3' ' CZ ' ' A' ' 61' ' ' PHE . 5.9 tm-20 -78.85 -50.8 10.65 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.187 -0.946 . . . . 0.0 109.722 -179.744 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 93' ' ' LEU . . . . . 0.637 ' CD1' ' CE2' ' A' ' 58' ' ' PHE . 48.9 mt -62.64 -35.5 79.79 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.262 -0.899 . . . . 0.0 109.56 -179.829 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 94' ' ' ASN . . . . . 0.479 ' CB ' ' O ' ' A' ' 90' ' ' VAL . 56.8 t-20 -74.71 129.11 37.12 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.246 -0.909 . . . . 0.0 109.549 -179.909 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 91.55 24.44 26.02 Favored Glycine 0 N--CA 1.49 2.253 0 N-CA-C 109.551 -1.42 . . . . 0.0 109.551 179.926 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 96' ' ' THR . . . . . 0.48 ' CG2' ' O ' ' A' ' 92' ' ' GLU . 36.9 p -126.23 154.05 43.86 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.201 -1.176 . . . . 0.0 109.572 179.985 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 63.8 tt0 -117.83 138.9 51.78 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.225 -0.922 . . . . 0.0 109.491 -179.96 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 1.2 t -81.13 -151.99 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 121.204 -0.935 . . . . 0.0 109.315 -179.99 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 96.3 mt-10 -60.78 -37.89 83.41 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.204 -0.935 . . . . 0.0 109.477 179.983 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 100' ' ' SER . . . . . 0.405 ' O ' HG23 ' A' ' 101' ' ' VAL . 0.4 OUTLIER -158.1 22.81 0.25 Allowed 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.264 -0.897 . . . . 0.0 109.476 179.99 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 101' ' ' VAL . . . . . 0.405 HG23 ' O ' ' A' ' 100' ' ' SER . 47.9 t -139.43 154.41 24.83 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.531 0 O-C-N 121.224 -0.923 . . . . 0.0 109.496 179.993 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 92.2 mt-30 -102.45 144.18 31.23 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.242 -0.911 . . . . 0.0 109.431 179.96 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 92.0 mt -110.37 138.89 46.16 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.311 -0.868 . . . . 0.0 109.564 179.997 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 104' ' ' LYS . . . . . 0.46 ' O ' ' HA ' ' A' ' 44' ' ' VAL . 76.6 mttt -120.23 138.53 53.6 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.268 -0.895 . . . . 0.0 109.259 179.853 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 105' ' ' VAL . . . . . 0.462 HG12 ' CG1' ' A' ' 90' ' ' VAL . 18.4 t -122.48 137.17 56.92 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.549 0 O-C-N 121.142 -0.974 . . . . 0.0 109.657 -179.819 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 106' ' ' ASN . . . . . 0.461 ' HB2' ' HB3' ' A' ' 43' ' ' TYR . 92.2 m-20 -136.54 -174.33 3.67 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.255 -0.903 . . . . 0.0 109.168 179.818 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 22.7 mm -107.19 134.68 48.18 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.619 0 O-C-N 121.227 -0.921 . . . . 0.0 109.563 -179.949 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -110.17 151.94 26.66 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.312 -0.867 . . . . 0.0 109.437 179.969 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 25.8 mtm180 -101.15 10.78 40.5 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.289 -0.882 . . . . 0.0 109.626 -179.951 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 110' ' ' LYS . . . . . 0.524 ' O ' ' CB ' ' A' ' 111' ' ' GLN . 74.0 mttt -81.93 176.04 9.89 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.157 -0.964 . . . . 0.0 109.434 -179.963 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 111' ' ' GLN . . . . . 0.561 ' N ' ' CD ' ' A' ' 112' ' ' PRO . 6.6 tp-100 75.61 47.9 0.17 Allowed Pre-proline 0 N--CA 1.49 1.555 0 O-C-N 121.249 -0.907 . . . . 0.0 109.343 179.919 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 112' ' ' PRO . . . . . 0.561 ' CD ' ' N ' ' A' ' 111' ' ' GLN . 53.4 Cg_endo -72.34 -20.62 24.04 Favored 'Trans proline' 0 C--O 1.216 -0.613 0 C-N-CA 122.777 2.318 . . . . 0.0 111.99 -179.93 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 113' ' ' MET . . . . . 0.523 ' CE ' ' HG3' ' A' ' 111' ' ' GLN . 0.0 OUTLIER -43.62 -33.02 1.08 Allowed 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.277 -0.889 . . . . 0.0 109.512 -179.797 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 114' ' ' LEU . . . . . 0.531 ' CD1' ' O ' ' A' ' 114' ' ' LEU . 0.3 OUTLIER -148.49 17.47 1.04 Allowed 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.258 -0.901 . . . . 0.0 109.247 179.867 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 115' ' ' ASP . . . . . 0.524 ' O ' ' CB ' ' A' ' 116' ' ' ALA . 78.0 m-20 39.92 45.24 1.53 Allowed 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.6 -0.688 . . . . 0.0 109.519 179.975 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 116' ' ' ALA . . . . . 0.524 ' CB ' ' O ' ' A' ' 115' ' ' ASP . . . 76.66 -66.6 0.25 Allowed 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.39 -0.819 . . . . 0.0 109.395 -179.58 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 117' ' ' ALA . . . . . 0.514 ' O ' ' CE ' ' A' ' 83' ' ' MET . . . -166.19 157.08 13.01 Favored 'General case' 0 C--N 1.301 -1.505 0 C-N-CA 119.585 -0.846 . . . . 0.0 109.763 -179.66 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 15.7 p -124.95 168.37 13.39 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.265 -0.897 . . . . 0.0 109.555 -179.931 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 89.52 9.75 66.33 Favored Glycine 0 N--CA 1.491 2.312 0 N-CA-C 109.448 -1.461 . . . . 0.0 109.448 179.986 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 25.4 pttm -80.32 143.78 33.33 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.207 -1.172 . . . . 0.0 109.446 179.962 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 7.8 t . . . . . 0 N--CA 1.491 1.591 0 CA-C-O 118.023 -0.989 . . . . 0.0 109.457 179.98 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.539 0 N-CA-C 109.474 -0.565 . . . . 0.0 109.474 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 48.9 Cg_endo -69.93 141.92 45.8 Favored 'Trans proline' 0 C--O 1.215 -0.65 0 C-N-CA 122.65 2.233 . . . . 0.0 111.869 -179.987 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 37' ' ' ARG . . . . . 0.415 ' O ' ' C ' ' A' ' 38' ' ' LYS . 14.6 ptm180 -145.76 158.45 43.85 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.331 -0.856 . . . . 0.0 109.305 -179.978 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 38' ' ' LYS . . . . . 0.528 ' HA ' ' CD2' ' A' ' 114' ' ' LEU . 20.1 mttm 44.49 -162.5 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.22 -0.925 . . . . 0.0 109.279 -179.97 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . 0.52 ' CA ' HG22 ' A' ' 79' ' ' THR . . . 129.57 71.36 0.13 Allowed Glycine 0 N--CA 1.49 2.291 0 N-CA-C 109.672 -1.371 . . . . 0.0 109.672 179.93 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 40' ' ' ASN . . . . . 0.463 ' HA ' ' HB3' ' A' ' 116' ' ' ALA . 47.1 t-20 -69.9 121.67 17.78 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.193 -1.181 . . . . 0.0 109.477 179.813 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 41' ' ' THR . . . . . 0.508 ' OG1' ' CB ' ' A' ' 111' ' ' GLN . 66.1 m -84.32 140.42 31.63 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.225 -0.922 . . . . 0.0 109.522 -179.954 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . 0.545 HD12 ' CD2' ' A' ' 80' ' ' TYR . 5.2 mp -116.18 143.04 46.03 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.322 -0.861 . . . . 0.0 109.338 179.987 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 43' ' ' TYR . . . . . 0.464 ' HB2' ' HB3' ' A' ' 108' ' ' ALA . 70.1 t80 -98.0 108.23 20.89 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.366 -0.834 . . . . 0.0 109.584 -179.951 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . 0.463 ' HA ' ' O ' ' A' ' 104' ' ' LYS . 95.6 t -105.37 136.43 39.37 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 O-C-N 121.268 -0.895 . . . . 0.0 109.363 -180.0 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 45' ' ' TYR . . . . . 0.42 ' HB3' ' HB2' ' A' ' 104' ' ' LYS . 70.5 t80 -123.42 131.33 53.61 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.141 -0.974 . . . . 0.0 109.524 -179.949 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -179.69 -174.55 45.74 Favored Glycine 0 N--CA 1.491 2.333 0 N-CA-C 109.401 -1.48 . . . . 0.0 109.401 179.963 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 95.6 mt-10 -121.12 156.49 32.19 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.216 -1.167 . . . . 0.0 109.476 -179.958 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 59.4 t0 46.23 52.52 10.33 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.237 -0.915 . . . . 0.0 109.487 -179.985 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 49' ' ' MET . . . . . 0.412 ' C ' ' HE2' ' A' ' 69' ' ' MET . 61.6 mtm -104.17 139.8 38.71 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.247 -0.908 . . . . 0.0 109.547 -179.928 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 50' ' ' THR . . . . . 0.459 ' O ' HD12 ' A' ' 54' ' ' LEU . 0.1 OUTLIER -121.5 166.57 15.9 Favored Pre-proline 0 N--CA 1.49 1.547 0 O-C-N 121.208 -0.932 . . . . 0.0 109.414 -179.98 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 51' ' ' PRO . . . . . 0.485 ' N ' ' SD ' ' A' ' 69' ' ' MET . 48.2 Cg_endo -70.17 -55.73 0.16 Allowed 'Trans proline' 0 C--O 1.215 -0.651 0 C-N-CA 122.599 2.199 . . . . 0.0 111.918 179.937 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 26.2 m -48.88 -49.91 37.44 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.181 -0.95 . . . . 0.0 109.287 179.877 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 24.2 tp -58.08 -50.5 73.24 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.181 -0.949 . . . . 0.0 109.161 179.782 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 54' ' ' LEU . . . . . 0.459 HD12 ' O ' ' A' ' 50' ' ' THR . 11.6 mt -56.26 -44.42 79.68 Favored 'General case' 0 N--CA 1.488 1.475 0 O-C-N 121.272 -0.893 . . . . 0.0 109.238 179.742 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 55' ' ' ARG . . . . . 0.517 ' O ' ' N ' ' A' ' 59' ' ' SER . 93.6 mtt180 -51.38 -38.63 54.36 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.242 -0.911 . . . . 0.0 109.319 179.82 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -69.56 -33.3 71.81 Favored Glycine 0 N--CA 1.49 2.295 0 N-CA-C 109.508 -1.437 . . . . 0.0 109.508 179.926 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -75.92 -23.39 55.49 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.287 -1.125 . . . . 0.0 109.461 179.969 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 58' ' ' PHE . . . . . 0.599 ' CE2' ' CD1' ' A' ' 93' ' ' LEU . 97.0 m-85 -117.56 8.37 12.88 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.305 -0.872 . . . . 0.0 109.403 179.988 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 59' ' ' SER . . . . . 0.517 ' N ' ' O ' ' A' ' 55' ' ' ARG . 0.6 OUTLIER -75.16 -57.12 1.8 Allowed Pre-proline 0 N--CA 1.491 1.606 0 O-C-N 121.231 -0.918 . . . . 0.0 110.066 -179.637 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 60' ' ' PRO . . . . . 0.516 ' HD2' ' N ' ' A' ' 59' ' ' SER . 49.8 Cg_endo -69.5 -25.12 30.1 Favored 'Trans proline' 0 C--O 1.214 -0.68 0 C-N-CA 122.62 2.213 . . . . 0.0 112.213 -179.56 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 61' ' ' PHE . . . . . 0.563 ' CZ ' ' HB2' ' A' ' 92' ' ' GLU . 64.4 m-85 -72.67 -27.17 61.93 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.149 -0.97 . . . . 0.0 109.491 179.985 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 169.31 -176.0 43.45 Favored Glycine 0 N--CA 1.49 2.275 0 N-CA-C 109.464 -1.454 . . . . 0.0 109.464 179.939 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 83.2 m-20 -93.93 139.82 30.45 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.269 -1.136 . . . . 0.0 109.416 -179.995 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 64' ' ' ILE . . . . . 0.431 ' HA ' ' O ' ' A' ' 79' ' ' THR . 61.1 mt -100.61 132.84 45.5 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.588 0 O-C-N 121.236 -0.915 . . . . 0.0 109.539 179.995 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 65' ' ' ILE . . . . . 0.49 ' CD1' ' HA3' ' A' ' 39' ' ' GLY . 26.7 pt -94.27 -24.04 5.07 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.604 0 O-C-N 121.341 -0.849 . . . . 0.0 109.442 179.98 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 66' ' ' ASP . . . . . 0.457 ' HB3' ' OG1' ' A' ' 79' ' ' THR . 55.3 t0 -147.78 136.6 21.95 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.22 -0.925 . . . . 0.0 109.561 -179.974 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . 0.484 ' C ' ' CD1' ' A' ' 67' ' ' LEU . 3.5 tm? -119.92 114.18 21.68 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.348 -0.845 . . . . 0.0 109.276 179.994 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 68' ' ' SER . . . . . 0.461 ' HB2' ' HB2' ' A' ' 77' ' ' PHE . 49.1 m -123.89 141.5 51.98 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.281 -0.887 . . . . 0.0 109.625 -179.993 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 69' ' ' MET . . . . . 0.485 ' SD ' ' N ' ' A' ' 51' ' ' PRO . 84.2 mtp -129.71 148.15 51.57 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.234 -0.916 . . . . 0.0 109.434 179.888 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 70' ' ' ASP . . . . . 0.457 ' C ' ' HD2' ' A' ' 72' ' ' PRO . 0.4 OUTLIER -124.21 102.0 34.29 Favored Pre-proline 0 N--CA 1.49 1.551 0 O-C-N 121.225 -0.922 . . . . 0.0 109.525 -179.959 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 71' ' ' PRO . . . . . 0.595 ' N ' ' CD ' ' A' ' 72' ' ' PRO . 46.5 Cg_endo -74.67 -27.6 10.54 Favored 'Trans proline' 0 CA--C 1.543 0.952 0 C-N-CA 122.519 2.146 . . . . 0.0 113.57 179.957 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 72' ' ' PRO . . . . . 0.595 ' CD ' ' N ' ' A' ' 71' ' ' PRO . 55.2 Cg_endo -75.57 -31.61 5.39 Favored 'Trans proline' 0 C--N 1.354 0.832 0 C-N-CA 121.452 1.435 . . . . 0.0 111.682 -179.911 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 73' ' ' ARG . . . . . 0.462 ' HG2' ' O ' ' A' ' 73' ' ' ARG . 19.5 ttt180 -103.85 -2.63 25.99 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.188 -0.945 . . . . 0.0 109.641 179.953 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 74' ' ' ASN . . . . . 0.441 ' HB2' ' O ' ' A' ' 73' ' ' ARG . 82.3 m-20 62.11 44.41 7.95 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.228 -0.92 . . . . 0.0 109.402 -179.901 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 75' ' ' CYS . . . . . . . . . . . . . 23.9 p -143.13 134.73 26.42 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.237 -0.915 . . . . 0.0 109.439 -179.96 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . 0.436 ' HA ' ' HA ' ' A' ' 69' ' ' MET . . . -107.63 160.45 15.69 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.316 -0.865 . . . . 0.0 109.436 179.985 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 77' ' ' PHE . . . . . 0.467 ' HA ' ' O ' ' A' ' 42' ' ' LEU . 96.5 m-85 -128.0 130.74 48.82 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.264 -0.898 . . . . 0.0 109.546 -179.948 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . 0.505 ' O ' ' CD1' ' A' ' 42' ' ' LEU . 33.7 t -121.43 134.22 65.47 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.556 0 O-C-N 121.146 -0.971 . . . . 0.0 109.485 -179.946 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 79' ' ' THR . . . . . 0.52 HG22 ' CA ' ' A' ' 39' ' ' GLY . 5.2 m -102.67 130.11 49.49 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.241 -0.912 . . . . 0.0 109.452 -179.977 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 80' ' ' TYR . . . . . 0.545 ' CD2' HD12 ' A' ' 42' ' ' LEU . 0.6 OUTLIER -110.73 136.68 49.43 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.149 -0.969 . . . . 0.0 109.515 -179.945 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 81' ' ' GLU . . . . . 0.507 ' O ' ' CB ' ' A' ' 38' ' ' LYS . 81.8 tt0 -54.56 -28.6 47.06 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.218 -0.926 . . . . 0.0 109.446 179.986 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 57.4 mttm -135.9 148.78 48.72 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.204 -0.935 . . . . 0.0 109.589 -179.965 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 83' ' ' MET . . . . . 0.528 ' HE1' ' CA ' ' A' ' 117' ' ' ALA . 61.2 mtt -67.84 -21.06 65.21 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.175 -0.953 . . . . 0.0 109.471 -179.96 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 97.2 mt-10 -66.96 -41.48 86.81 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.239 -0.913 . . . . 0.0 109.457 -179.949 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 19.8 m -64.05 -30.94 71.97 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.336 -0.853 . . . . 0.0 109.451 179.96 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 86' ' ' ALA . . . . . 0.527 ' O ' ' CG2' ' A' ' 90' ' ' VAL . . . -73.67 -31.08 63.28 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.297 -0.877 . . . . 0.0 109.455 179.903 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 58.6 t0 -67.99 -44.69 76.04 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.2 -0.937 . . . . 0.0 109.517 179.973 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 62.1 tt0 -64.28 -39.95 94.97 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.184 -0.948 . . . . 0.0 109.483 179.906 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 89' ' ' ALA . . . . . 0.561 ' HA ' ' CE1' ' A' ' 61' ' ' PHE . . . -74.51 -43.11 57.44 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.238 -0.914 . . . . 0.0 109.496 -179.901 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 90' ' ' VAL . . . . . 0.527 ' CG2' ' O ' ' A' ' 86' ' ' ALA . 88.9 t -61.49 -32.02 52.22 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.56 0 O-C-N 121.176 -0.953 . . . . 0.0 109.685 -179.867 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -80.14 -51.92 8.4 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.23 -0.919 . . . . 0.0 109.728 -179.841 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 92' ' ' GLU . . . . . 0.563 ' HB2' ' CZ ' ' A' ' 61' ' ' PHE . 74.1 mt-10 -71.63 -47.28 55.58 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.278 -0.889 . . . . 0.0 109.927 -179.699 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 93' ' ' LEU . . . . . 0.599 ' CD1' ' CE2' ' A' ' 58' ' ' PHE . 62.4 mt -63.78 -36.76 84.96 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.188 -0.945 . . . . 0.0 109.857 -179.643 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 94' ' ' ASN . . . . . 0.524 ' CB ' ' O ' ' A' ' 90' ' ' VAL . 61.0 t-20 -74.3 125.99 29.67 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.131 -0.98 . . . . 0.0 109.475 -179.865 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 96.1 22.1 21.01 Favored Glycine 0 N--CA 1.489 2.225 0 N-CA-C 109.461 -1.456 . . . . 0.0 109.461 179.916 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 96' ' ' THR . . . . . 0.521 ' CG2' ' O ' ' A' ' 92' ' ' GLU . 21.9 p -116.03 160.26 20.53 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.217 -1.166 . . . . 0.0 109.461 -179.975 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 97' ' ' GLN . . . . . 0.441 ' HG2' ' N ' ' A' ' 98' ' ' VAL . 64.2 tt0 -132.72 158.56 42.05 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.265 -0.897 . . . . 0.0 109.484 -179.911 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 98' ' ' VAL . . . . . 0.463 HG21 ' O ' ' A' ' 101' ' ' VAL . 1.2 t -108.56 -153.31 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.572 0 O-C-N 121.234 -0.916 . . . . 0.0 109.398 179.961 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 96.9 mt-10 -57.66 -36.76 72.33 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.217 -0.927 . . . . 0.0 109.61 -179.919 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 100' ' ' SER . . . . . 0.43 ' C ' HG23 ' A' ' 101' ' ' VAL . 0.1 OUTLIER -162.86 25.48 0.09 Allowed 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.25 -0.906 . . . . 0.0 109.494 179.944 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 101' ' ' VAL . . . . . 0.463 ' O ' HG21 ' A' ' 98' ' ' VAL . 84.8 t -139.37 146.61 25.35 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 O-C-N 121.239 -0.913 . . . . 0.0 109.496 179.938 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 90.3 mt-30 -100.83 147.42 26.11 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.263 -0.898 . . . . 0.0 109.495 -179.968 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 95.9 mt -113.7 133.84 55.1 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.241 -0.912 . . . . 0.0 109.493 -179.985 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 104' ' ' LYS . . . . . 0.463 ' O ' ' HA ' ' A' ' 44' ' ' VAL . 70.5 mttt -115.75 145.31 42.9 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.264 -0.897 . . . . 0.0 109.308 179.964 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 105' ' ' VAL . . . . . 0.513 HG13 ' CG2' ' A' ' 90' ' ' VAL . 29.2 t -127.52 146.73 32.78 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.524 0 O-C-N 121.12 -0.988 . . . . 0.0 109.718 -179.789 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 106' ' ' ASN . . . . . 0.448 ' HB2' ' HB3' ' A' ' 43' ' ' TYR . 74.9 m-20 -158.08 -167.9 2.35 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.315 -0.866 . . . . 0.0 109.272 179.975 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 107' ' ' ILE . . . . . 0.403 HD12 HG22 ' A' ' 107' ' ' ILE . 25.4 mm -109.55 137.28 42.44 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.553 0 O-C-N 121.189 -0.944 . . . . 0.0 109.419 -179.978 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 108' ' ' ALA . . . . . 0.464 ' HB3' ' HB2' ' A' ' 43' ' ' TYR . . . -132.16 148.8 52.49 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.192 -0.943 . . . . 0.0 109.519 179.992 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 75.3 mtp85 -102.02 32.56 3.41 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.207 -0.933 . . . . 0.0 109.555 179.973 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 110' ' ' LYS . . . . . 0.431 ' NZ ' ' HB3' ' A' ' 68' ' ' SER . 39.2 tttt -71.86 -4.49 28.37 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.272 -0.892 . . . . 0.0 109.573 -179.953 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 111' ' ' GLN . . . . . 0.515 ' NE2' ' HG2' ' A' ' 113' ' ' MET . 0.5 OUTLIER -119.08 73.33 12.89 Favored Pre-proline 0 N--CA 1.489 1.507 0 O-C-N 121.185 -0.947 . . . . 0.0 109.53 -179.983 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 112' ' ' PRO . . . . . 0.439 ' O ' ' C ' ' A' ' 113' ' ' MET . 55.7 Cg_endo -80.28 -20.93 8.09 Favored 'Trans proline' 0 C--O 1.216 -0.621 0 C-N-CA 122.759 2.306 . . . . 0.0 112.089 -179.757 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 113' ' ' MET . . . . . 0.515 ' HG2' ' NE2' ' A' ' 111' ' ' GLN . 0.0 OUTLIER -42.09 -34.43 0.73 Allowed 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.194 -0.941 . . . . 0.0 109.617 -179.707 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 114' ' ' LEU . . . . . 0.528 ' CD2' ' HA ' ' A' ' 38' ' ' LYS . 4.6 tt -142.66 25.96 1.78 Allowed 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.355 -0.841 . . . . 0.0 109.124 179.727 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 115' ' ' ASP . . . . . 0.494 ' O ' ' N ' ' A' ' 117' ' ' ALA . 75.9 m-20 44.58 55.78 5.57 Favored 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.227 -0.92 . . . . 0.0 109.076 -179.74 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 116' ' ' ALA . . . . . 0.519 ' O ' ' N ' ' A' ' 39' ' ' GLY . . . 62.8 -77.98 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.323 -0.86 . . . . 0.0 109.383 -179.667 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 117' ' ' ALA . . . . . 0.528 ' CA ' ' HE1' ' A' ' 83' ' ' MET . . . -161.81 154.51 20.17 Favored 'General case' 0 C--N 1.302 -1.496 0 O-C-N 121.368 -0.832 . . . . 0.0 109.524 -179.811 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 18.3 p -130.39 167.13 19.06 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.208 -0.933 . . . . 0.0 109.629 -179.789 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 119' ' ' GLY . . . . . 0.425 ' O ' ' HB2' ' A' ' 120' ' ' LYS . . . -145.51 176.21 24.63 Favored Glycine 0 N--CA 1.49 2.269 0 N-CA-C 109.344 -1.502 . . . . 0.0 109.344 179.915 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 120' ' ' LYS . . . . . 0.425 ' HB2' ' O ' ' A' ' 119' ' ' GLY . 35.8 mttm 60.84 43.4 12.0 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.289 -1.124 . . . . 0.0 109.429 -179.995 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 2.2 p . . . . . 0 N--CA 1.49 1.544 0 CA-C-O 118.074 -0.965 . . . . 0.0 109.439 -179.998 . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . 0.481 ' CB ' HD12 ' A' ' 114' ' ' LEU . . . . . . . . 0 N--CA 1.489 1.52 0 N-CA-C 109.498 -0.556 . . . . 0.0 109.498 . . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 49.4 Cg_endo -69.57 -9.13 25.38 Favored 'Trans proline' 0 C--O 1.215 -0.638 0 C-N-CA 122.739 2.293 . . . . 0.0 111.728 -179.985 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 72.7 mtt180 -122.25 139.9 53.23 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.274 -0.892 . . . . 0.0 109.526 -179.903 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 38' ' ' LYS . . . . . 0.478 ' CD ' ' HB1' ' A' ' 117' ' ' ALA . 12.2 mttp -111.57 -163.21 0.83 Allowed 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.259 -0.9 . . . . 0.0 109.422 179.944 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . 0.523 ' O ' ' CA ' ' A' ' 116' ' ' ALA . . . -177.09 177.07 48.29 Favored Glycine 0 N--CA 1.492 2.372 0 N-CA-C 109.548 -1.421 . . . . 0.0 109.548 179.882 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 40' ' ' ASN . . . . . 0.529 ' N ' ' O ' ' A' ' 80' ' ' TYR . 54.3 t30 -155.36 110.33 2.99 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.055 -1.262 . . . . 0.0 109.352 179.8 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 41' ' ' THR . . . . . 0.468 ' O ' HD21 ' A' ' 42' ' ' LEU . 45.1 m -74.49 136.55 42.24 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.273 -0.892 . . . . 0.0 109.839 -179.695 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . 0.577 HD12 ' CD2' ' A' ' 80' ' ' TYR . 13.7 mt -119.47 157.21 28.74 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.363 -0.836 . . . . 0.0 109.322 179.84 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 43' ' ' TYR . . . . . 0.462 ' HB3' ' HB2' ' A' ' 106' ' ' ASN . 69.9 t80 -114.14 121.38 43.59 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.261 -0.899 . . . . 0.0 109.448 -179.976 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 47.4 t -115.88 136.3 53.21 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.579 0 O-C-N 121.331 -0.855 . . . . 0.0 109.367 179.948 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 71.8 t80 -126.35 130.61 51.13 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.264 -0.897 . . . . 0.0 109.488 -179.923 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -175.83 -173.94 41.96 Favored Glycine 0 N--CA 1.49 2.272 0 N-CA-C 109.472 -1.451 . . . . 0.0 109.472 179.999 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . 0.422 ' O ' ' C ' ' A' ' 48' ' ' ASP . 94.8 mt-10 -115.88 156.39 26.22 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.231 -1.158 . . . . 0.0 109.487 -179.916 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . 0.422 ' C ' ' O ' ' A' ' 47' ' ' GLU . 38.1 m-20 44.21 51.19 7.49 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.229 -0.919 . . . . 0.0 109.551 179.936 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 55.3 mtm -100.57 137.09 39.45 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.272 -0.893 . . . . 0.0 109.433 179.981 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 50' ' ' THR . . . . . 0.406 ' O ' ' CD1' ' A' ' 54' ' ' LEU . 0.3 OUTLIER -119.76 163.21 28.86 Favored Pre-proline 0 N--CA 1.491 1.583 0 O-C-N 121.308 -0.87 . . . . 0.0 109.441 179.963 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 48.7 Cg_endo -70.13 -54.26 0.21 Allowed 'Trans proline' 0 C--O 1.214 -0.677 0 C-N-CA 122.629 2.22 . . . . 0.0 111.815 -179.992 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 37.3 m -53.27 -48.49 68.25 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.185 -0.947 . . . . 0.0 109.317 179.921 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 17.6 tp -58.63 -48.49 80.83 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.247 -0.908 . . . . 0.0 109.28 179.824 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 54' ' ' LEU . . . . . 0.49 ' CD1' ' SD ' ' A' ' 69' ' ' MET . 16.6 mt -57.87 -44.99 87.0 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.232 -0.917 . . . . 0.0 109.259 179.793 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 55' ' ' ARG . . . . . 0.514 ' O ' ' N ' ' A' ' 59' ' ' SER . 57.5 mtt-85 -50.94 -39.75 55.66 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.244 -0.91 . . . . 0.0 109.2 179.853 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -69.5 -30.87 70.92 Favored Glycine 0 N--CA 1.49 2.243 0 N-CA-C 109.313 -1.515 . . . . 0.0 109.313 179.767 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -79.51 -21.53 45.15 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.243 -1.151 . . . . 0.0 109.467 179.998 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 58' ' ' PHE . . . . . 0.634 ' CE2' ' CD1' ' A' ' 93' ' ' LEU . 94.5 m-85 -119.09 7.97 11.47 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.26 -0.9 . . . . 0.0 109.384 179.929 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 59' ' ' SER . . . . . 0.52 ' N ' ' HD2' ' A' ' 60' ' ' PRO . 0.6 OUTLIER -75.24 -55.54 2.18 Favored Pre-proline 0 N--CA 1.49 1.562 0 O-C-N 121.286 -0.884 . . . . 0.0 110.196 -179.591 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 60' ' ' PRO . . . . . 0.52 ' HD2' ' N ' ' A' ' 59' ' ' SER . 48.4 Cg_endo -69.42 -29.6 25.24 Favored 'Trans proline' 0 C--O 1.214 -0.677 0 C-N-CA 122.542 2.161 . . . . 0.0 112.208 -179.408 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 61' ' ' PHE . . . . . 0.568 ' CE1' ' HB3' ' A' ' 92' ' ' GLU . 55.2 m-85 -67.48 -28.88 68.22 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.21 -0.931 . . . . 0.0 109.534 179.984 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 172.81 -178.43 44.85 Favored Glycine 0 N--CA 1.49 2.293 0 N-CA-C 109.579 -1.408 . . . . 0.0 109.579 179.951 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 47.9 t-20 -94.26 138.25 32.49 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.292 -1.122 . . . . 0.0 109.447 179.99 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 57.7 mt -100.02 135.49 35.48 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.502 0 O-C-N 121.258 -0.901 . . . . 0.0 109.392 -179.972 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 65' ' ' ILE . . . . . 0.472 HG23 HD12 ' A' ' 65' ' ' ILE . 27.2 pt -102.6 -21.76 5.05 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.636 0 O-C-N 121.326 -0.859 . . . . 0.0 109.659 -179.833 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 66' ' ' ASP . . . . . 0.451 ' HB3' ' OG1' ' A' ' 79' ' ' THR . 56.7 t0 -145.39 111.8 5.76 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.122 -0.986 . . . . 0.0 109.675 -179.966 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 32.3 tp -108.11 123.6 48.95 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.328 -0.857 . . . . 0.0 109.358 179.919 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 68' ' ' SER . . . . . 0.463 ' HB3' ' HB2' ' A' ' 77' ' ' PHE . 23.2 t -134.25 140.71 46.64 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.271 -0.893 . . . . 0.0 109.505 -179.941 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 69' ' ' MET . . . . . 0.49 ' SD ' ' CD1' ' A' ' 54' ' ' LEU . 87.6 mmm -113.71 151.65 31.58 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.301 -0.874 . . . . 0.0 109.502 179.923 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 70' ' ' ASP . . . . . 0.448 ' C ' ' HD2' ' A' ' 72' ' ' PRO . 0.3 OUTLIER -131.84 100.29 16.14 Favored Pre-proline 0 N--CA 1.49 1.554 0 O-C-N 121.277 -0.89 . . . . 0.0 109.522 179.95 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 71' ' ' PRO . . . . . 0.595 ' CD ' ' CD ' ' A' ' 72' ' ' PRO . 46.7 Cg_endo -74.53 -27.9 10.56 Favored 'Trans proline' 0 CA--C 1.543 0.943 0 C-N-CA 122.497 2.131 . . . . 0.0 113.629 -179.897 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 72' ' ' PRO . . . . . 0.595 ' CD ' ' CD ' ' A' ' 71' ' ' PRO . 54.5 Cg_endo -75.46 -32.79 4.61 Favored 'Trans proline' 0 C--N 1.353 0.763 0 C-N-CA 121.431 1.42 . . . . 0.0 111.643 -179.89 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 73' ' ' ARG . . . . . 0.458 ' O ' ' HG3' ' A' ' 73' ' ' ARG . 13.6 tpt180 -101.45 -4.85 26.11 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.249 -0.907 . . . . 0.0 109.523 -179.978 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 74' ' ' ASN . . . . . 0.451 ' HB2' ' O ' ' A' ' 73' ' ' ARG . 77.5 m-20 61.95 43.78 8.84 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.194 -0.941 . . . . 0.0 109.507 -179.854 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 75' ' ' CYS . . . . . 0.432 ' CB ' ' CZ ' ' A' ' 43' ' ' TYR . 31.4 p -147.48 142.73 27.27 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.298 -0.876 . . . . 0.0 109.48 -179.954 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . 0.413 ' HB2' ' CE ' ' A' ' 69' ' ' MET . . . -107.29 163.17 13.25 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.296 -0.877 . . . . 0.0 109.469 179.984 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 77' ' ' PHE . . . . . 0.463 ' HB2' ' HB3' ' A' ' 68' ' ' SER . 96.7 m-85 -122.84 130.89 53.43 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.317 -0.864 . . . . 0.0 109.544 -179.969 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . 0.495 ' O ' ' N ' ' A' ' 42' ' ' LEU . 46.7 t -126.52 140.11 49.79 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.604 0 O-C-N 121.278 -0.889 . . . . 0.0 109.33 179.861 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 79' ' ' THR . . . . . 0.521 ' CG2' ' OE1' ' A' ' 111' ' ' GLN . 2.5 m -115.55 112.73 22.63 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.224 -0.922 . . . . 0.0 109.584 -179.849 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 80' ' ' TYR . . . . . 0.577 ' CD2' HD12 ' A' ' 42' ' ' LEU . 1.4 m-85 -93.12 123.15 36.17 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.25 -0.906 . . . . 0.0 109.402 179.932 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 81' ' ' GLU . . . . . 0.513 ' CA ' ' HA2' ' A' ' 39' ' ' GLY . 86.1 tt0 -38.88 -34.54 0.16 Allowed 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.537 -0.727 . . . . 0.0 110.302 -179.667 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 57.2 mttp -128.52 158.38 38.57 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.068 -1.02 . . . . 0.0 109.594 -179.911 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 83' ' ' MET . . . . . 0.523 ' HE3' ' CB ' ' A' ' 117' ' ' ALA . 58.9 mtt -74.65 -21.71 59.29 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.274 -0.891 . . . . 0.0 109.452 179.936 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 75.6 mm-40 -68.51 -46.99 68.16 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.339 -0.851 . . . . 0.0 109.473 -179.958 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 14.0 m -55.5 -35.03 65.14 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.283 -0.885 . . . . 0.0 109.369 -179.945 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 86' ' ' ALA . . . . . 0.525 ' HB2' ' CD2' ' A' ' 42' ' ' LEU . . . -75.44 -28.75 59.46 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.318 -0.863 . . . . 0.0 109.559 -179.968 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 57.1 t0 -66.18 -40.07 90.17 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.246 -0.908 . . . . 0.0 109.551 -179.925 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 88' ' ' GLN . . . . . 0.478 ' O ' ' CB ' ' A' ' 92' ' ' GLU . 47.7 tt0 -74.99 -35.64 62.01 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.244 -0.91 . . . . 0.0 109.431 -179.895 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 89' ' ' ALA . . . . . 0.534 ' HA ' ' CD1' ' A' ' 61' ' ' PHE . . . -77.47 -41.64 38.85 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.23 -0.919 . . . . 0.0 109.614 -179.912 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 90' ' ' VAL . . . . . 0.49 ' O ' ' CB ' ' A' ' 94' ' ' ASN . 68.8 t -65.1 -47.35 88.11 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.603 0 O-C-N 121.247 -0.908 . . . . 0.0 109.638 -179.892 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -73.04 -39.65 65.77 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.218 -0.926 . . . . 0.0 109.582 -179.917 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 92' ' ' GLU . . . . . 0.568 ' HB3' ' CE1' ' A' ' 61' ' ' PHE . 44.4 tp10 -74.25 -50.22 19.93 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.266 -0.896 . . . . 0.0 109.682 -179.954 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 93' ' ' LEU . . . . . 0.634 ' CD1' ' CE2' ' A' ' 58' ' ' PHE . 42.2 mt -65.24 -38.98 92.05 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.21 -0.931 . . . . 0.0 109.534 -179.841 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 94' ' ' ASN . . . . . 0.49 ' CB ' ' O ' ' A' ' 90' ' ' VAL . 59.3 t-20 -67.74 129.37 39.69 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.241 -0.912 . . . . 0.0 109.535 179.999 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 98.94 17.31 28.13 Favored Glycine 0 N--CA 1.49 2.285 0 N-CA-C 109.543 -1.423 . . . . 0.0 109.543 -179.997 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 96' ' ' THR . . . . . 0.422 HG22 ' O ' ' A' ' 93' ' ' LEU . 16.1 p -116.16 158.79 22.71 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.251 -1.146 . . . . 0.0 109.473 179.936 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 61.3 tt0 -122.8 139.83 53.58 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.255 -0.903 . . . . 0.0 109.497 179.998 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 98' ' ' VAL . . . . . 0.453 HG23 ' O ' ' A' ' 101' ' ' VAL . 1.1 t -81.79 -157.48 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.608 0 O-C-N 121.247 -0.908 . . . . 0.0 109.302 -179.982 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 76.4 mm-40 -60.64 -38.28 84.28 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.23 -0.919 . . . . 0.0 109.584 -179.958 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 100' ' ' SER . . . . . 0.455 ' O ' ' OG ' ' A' ' 100' ' ' SER . 4.9 t -155.04 24.04 0.43 Allowed 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.248 -0.907 . . . . 0.0 109.613 179.943 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 101' ' ' VAL . . . . . 0.453 ' O ' HG23 ' A' ' 98' ' ' VAL . 57.5 t -141.0 155.91 21.93 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.553 0 O-C-N 121.226 -0.921 . . . . 0.0 109.515 179.891 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 92.8 mt-30 -98.3 143.19 29.04 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.242 -0.911 . . . . 0.0 109.447 -179.971 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 103' ' ' LEU . . . . . 0.442 ' HG ' HG21 ' A' ' 98' ' ' VAL . 92.7 mt -101.85 141.86 34.05 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.25 -0.906 . . . . 0.0 109.44 179.975 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 1.3 mtpm? -131.45 134.21 45.97 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.281 -0.887 . . . . 0.0 109.4 179.921 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 105' ' ' VAL . . . . . 0.461 HG13 ' CG2' ' A' ' 90' ' ' VAL . 17.8 t -118.31 135.78 57.61 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.534 0 O-C-N 121.17 -0.956 . . . . 0.0 109.65 -179.931 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 106' ' ' ASN . . . . . 0.462 ' HB2' ' HB3' ' A' ' 43' ' ' TYR . 14.4 m120 -134.56 -178.43 5.06 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.358 -0.839 . . . . 0.0 109.401 179.812 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 107' ' ' ILE . . . . . 0.53 HG22 HD11 ' A' ' 107' ' ' ILE . 44.1 mt -108.8 133.99 52.15 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.568 0 O-C-N 121.232 -0.918 . . . . 0.0 109.509 -179.948 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -112.96 161.51 16.93 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.284 -0.885 . . . . 0.0 109.451 -179.994 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 31.9 ttt85 -45.75 144.8 1.57 Allowed 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.177 -0.952 . . . . 0.0 109.432 -179.977 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 110' ' ' LYS . . . . . 0.458 ' HB3' ' HB3' ' A' ' 116' ' ' ALA . 79.9 mttt -65.13 150.39 48.23 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.183 -0.948 . . . . 0.0 109.521 -179.923 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 111' ' ' GLN . . . . . 0.547 ' HB2' ' CE ' ' A' ' 113' ' ' MET . 0.7 OUTLIER -70.71 150.04 95.32 Favored Pre-proline 0 N--CA 1.491 1.618 0 O-C-N 121.411 -0.805 . . . . 0.0 109.648 -179.779 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 55.4 Cg_endo -74.18 -23.95 15.18 Favored 'Trans proline' 0 C--O 1.216 -0.62 0 C-N-CA 122.737 2.291 . . . . 0.0 112.756 -179.497 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 113' ' ' MET . . . . . 0.547 ' CE ' ' HB2' ' A' ' 111' ' ' GLN . 8.1 mtm -54.62 -24.14 20.15 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 120.908 -1.12 . . . . 0.0 109.516 -179.573 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 114' ' ' LEU . . . . . 0.521 ' CD2' ' O ' ' A' ' 114' ' ' LEU . 2.7 tt -176.01 29.78 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.264 -0.898 . . . . 0.0 109.599 -179.814 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 115' ' ' ASP . . . . . 0.49 ' O ' ' CB ' ' A' ' 116' ' ' ALA . 79.6 m-20 48.23 36.56 6.95 Favored 'General case' 0 C--N 1.302 -1.462 0 O-C-N 121.213 -0.929 . . . . 0.0 108.868 -179.63 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 116' ' ' ALA . . . . . 0.523 ' CA ' ' O ' ' A' ' 39' ' ' GLY . . . 75.62 -82.32 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.477 -0.764 . . . . 0.0 109.648 -179.804 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 117' ' ' ALA . . . . . 0.523 ' CB ' ' HE3' ' A' ' 83' ' ' MET . . . -167.03 -166.05 0.77 Allowed 'General case' 0 N--CA 1.487 1.416 0 O-C-N 121.11 -0.994 . . . . 0.0 109.611 -179.88 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 21.0 p -123.71 156.85 35.18 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.299 -0.875 . . . . 0.0 109.462 -179.987 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -178.34 -172.84 43.17 Favored Glycine 0 N--CA 1.491 2.303 0 N-CA-C 109.504 -1.439 . . . . 0.0 109.504 -179.985 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 9.2 tptt -58.22 -36.34 73.0 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.265 -1.138 . . . . 0.0 109.462 179.972 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 91.5 p . . . . . 0 N--CA 1.49 1.536 0 CA-C-O 118.013 -0.994 . . . . 0.0 109.477 179.971 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 1.505 0 N-CA-C 109.423 -0.584 . . . . 0.0 109.423 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 49.1 Cg_endo -70.02 -27.24 25.48 Favored 'Trans proline' 0 C--O 1.214 -0.702 0 C-N-CA 122.669 2.246 . . . . 0.0 111.767 -179.986 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 94.1 mtt180 -61.62 148.98 40.64 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.31 -0.869 . . . . 0.0 109.442 -179.986 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 38' ' ' LYS . . . . . 0.458 ' HA ' HD21 ' A' ' 114' ' ' LEU . 55.7 mttp -78.87 -166.01 0.83 Allowed 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.245 -0.909 . . . . 0.0 109.528 -179.81 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . 0.532 ' HA3' ' NE2' ' A' ' 111' ' ' GLN . . . 172.62 -178.7 44.57 Favored Glycine 0 N--CA 1.49 2.254 0 N-CA-C 109.41 -1.476 . . . . 0.0 109.41 -179.94 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 40' ' ' ASN . . . . . 0.511 ' N ' ' OE1' ' A' ' 111' ' ' GLN . 61.7 t30 -171.23 113.22 0.38 Allowed 'General case' 0 N--CA 1.493 1.686 0 O-C-N 120.992 -1.299 . . . . 0.0 109.799 179.64 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 41' ' ' THR . . . . . 0.48 HG23 ' CB ' ' A' ' 108' ' ' ALA . 91.2 m -80.5 153.73 27.98 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.18 -0.95 . . . . 0.0 109.841 -179.913 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . 0.529 ' CD1' ' O ' ' A' ' 78' ' ' VAL . 4.7 mp -131.05 155.4 46.95 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.376 -0.827 . . . . 0.0 109.305 179.763 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 43' ' ' TYR . . . . . 0.44 ' HB3' ' HB2' ' A' ' 106' ' ' ASN . 39.2 t80 -113.67 108.9 17.76 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.206 -0.934 . . . . 0.0 109.594 -179.923 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . 0.449 ' HA ' ' O ' ' A' ' 104' ' ' LYS . 39.3 t -105.28 146.04 12.8 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 O-C-N 121.289 -0.882 . . . . 0.0 109.488 179.999 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 67.0 t80 -135.59 140.47 44.66 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.21 -0.931 . . . . 0.0 109.468 179.989 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 174.82 -165.17 36.26 Favored Glycine 0 N--CA 1.491 2.321 0 N-CA-C 109.464 -1.454 . . . . 0.0 109.464 -179.995 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 90.3 mt-10 -115.07 157.48 23.46 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.238 -1.154 . . . . 0.0 109.584 -179.908 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 56.0 t0 44.76 45.16 8.13 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.273 -0.892 . . . . 0.0 109.576 179.992 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 34.2 mtp -81.79 133.43 35.34 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.195 -0.941 . . . . 0.0 109.423 179.934 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 50' ' ' THR . . . . . 0.456 ' O ' ' CD1' ' A' ' 54' ' ' LEU . 0.1 OUTLIER -125.77 162.08 47.26 Favored Pre-proline 0 N--CA 1.49 1.527 0 O-C-N 121.208 -0.932 . . . . 0.0 109.461 -179.897 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 51' ' ' PRO . . . . . 0.467 ' N ' ' SD ' ' A' ' 69' ' ' MET . 50.2 Cg_endo -70.6 -53.28 0.23 Allowed 'Trans proline' 0 C--O 1.215 -0.648 0 C-N-CA 122.696 2.264 . . . . 0.0 111.644 179.957 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 30.2 m -55.87 -47.93 76.45 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.223 -0.923 . . . . 0.0 109.317 179.867 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 15.5 tp -56.94 -54.23 48.96 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.311 -0.868 . . . . 0.0 109.231 179.871 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 54' ' ' LEU . . . . . 0.456 ' CD1' ' O ' ' A' ' 50' ' ' THR . 12.4 mt -51.63 -52.83 44.65 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.221 -0.925 . . . . 0.0 109.225 179.766 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 55' ' ' ARG . . . . . 0.508 ' O ' ' N ' ' A' ' 59' ' ' SER . 49.2 mtt180 -44.09 -40.28 4.8 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.354 -0.841 . . . . 0.0 109.212 179.872 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -70.43 -33.33 68.0 Favored Glycine 0 N--CA 1.49 2.273 0 N-CA-C 109.314 -1.514 . . . . 0.0 109.314 179.771 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . 0.456 ' N ' ' O ' ' A' ' 54' ' ' LEU . . . -79.81 -16.29 55.78 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.288 -1.125 . . . . 0.0 109.444 179.88 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 58' ' ' PHE . . . . . 0.631 ' CE2' ' CD1' ' A' ' 93' ' ' LEU . 96.3 m-85 -124.36 10.57 8.61 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.257 -0.902 . . . . 0.0 109.5 179.998 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 59' ' ' SER . . . . . 0.517 ' N ' ' HD2' ' A' ' 60' ' ' PRO . 0.6 OUTLIER -77.08 -54.47 1.54 Allowed Pre-proline 0 N--CA 1.491 1.622 0 O-C-N 121.258 -0.901 . . . . 0.0 110.268 -179.624 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 60' ' ' PRO . . . . . 0.517 ' HD2' ' N ' ' A' ' 59' ' ' SER . 50.4 Cg_endo -70.63 -35.07 10.66 Favored 'Trans proline' 0 C--O 1.214 -0.681 0 C-N-CA 122.5 2.133 . . . . 0.0 112.284 -179.213 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 61' ' ' PHE . . . . . 0.564 ' CE1' ' HA ' ' A' ' 89' ' ' ALA . 74.2 m-85 -59.53 -33.99 72.08 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.168 -0.958 . . . . 0.0 109.495 -179.907 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 175.46 178.11 45.04 Favored Glycine 0 N--CA 1.49 2.236 0 N-CA-C 109.489 -1.445 . . . . 0.0 109.489 179.921 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 54.5 t30 -86.99 144.18 27.02 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.246 -1.149 . . . . 0.0 109.433 179.938 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 64' ' ' ILE . . . . . 0.464 ' HA ' ' O ' ' A' ' 79' ' ' THR . 67.1 mt -106.28 134.32 48.21 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.534 0 O-C-N 121.23 -0.919 . . . . 0.0 109.388 -179.965 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 37.8 pt -101.67 -25.78 3.7 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.524 0 O-C-N 121.233 -0.917 . . . . 0.0 109.661 -179.774 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 66' ' ' ASP . . . . . 0.443 ' O ' ' OG1' ' A' ' 79' ' ' THR . 55.4 t0 -142.34 115.83 9.06 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.227 -0.92 . . . . 0.0 109.606 -179.853 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 15.8 tp -105.41 115.95 31.12 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.288 -0.883 . . . . 0.0 109.467 179.908 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 68' ' ' SER . . . . . 0.437 ' HB2' ' HB2' ' A' ' 77' ' ' PHE . 67.7 m -123.94 146.66 48.32 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.271 -0.893 . . . . 0.0 109.414 179.972 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 69' ' ' MET . . . . . 0.467 ' SD ' ' N ' ' A' ' 51' ' ' PRO . 72.0 mtp -131.51 150.89 51.98 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.219 -0.926 . . . . 0.0 109.609 -179.903 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 70' ' ' ASP . . . . . 0.448 ' C ' ' HD2' ' A' ' 72' ' ' PRO . 0.5 OUTLIER -126.24 103.84 25.9 Favored Pre-proline 0 N--CA 1.49 1.571 0 O-C-N 121.228 -0.92 . . . . 0.0 109.392 179.903 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 71' ' ' PRO . . . . . 0.605 ' N ' ' CD ' ' A' ' 72' ' ' PRO . 48.2 Cg_endo -74.91 -27.66 10.0 Favored 'Trans proline' 0 CA--C 1.542 0.903 0 C-N-CA 122.553 2.169 . . . . 0.0 113.793 -179.936 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 72' ' ' PRO . . . . . 0.605 ' CD ' ' N ' ' A' ' 71' ' ' PRO . 55.2 Cg_endo -74.89 -24.85 12.66 Favored 'Trans proline' 0 C--N 1.352 0.752 0 C-N-CA 121.525 1.483 . . . . 0.0 111.934 -179.783 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 61.1 mtt-85 -113.83 2.66 15.19 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.237 -0.914 . . . . 0.0 109.671 -179.812 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 82.8 m-20 58.09 38.9 26.59 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.128 -0.983 . . . . 0.0 109.533 179.924 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 75' ' ' CYS . . . . . . . . . . . . . 29.7 p -135.49 134.04 39.12 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.189 -0.944 . . . . 0.0 109.573 -179.941 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . 0.459 ' HA ' ' HA ' ' A' ' 69' ' ' MET . . . -106.48 161.73 14.34 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.257 -0.902 . . . . 0.0 109.339 179.882 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 77' ' ' PHE . . . . . 0.543 ' CD2' ' HE3' ' A' ' 110' ' ' LYS . 97.4 m-85 -125.43 128.33 47.91 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.241 -0.912 . . . . 0.0 109.599 -179.853 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . 0.529 ' O ' ' CD1' ' A' ' 42' ' ' LEU . 13.7 t -117.88 141.01 38.82 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.526 0 O-C-N 121.24 -0.913 . . . . 0.0 109.182 179.793 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 79' ' ' THR . . . . . 0.57 ' CG2' ' NE2' ' A' ' 111' ' ' GLN . 0.4 OUTLIER -112.18 127.73 56.03 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.279 -0.888 . . . . 0.0 109.612 -179.653 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 80' ' ' TYR . . . . . 0.524 ' OH ' ' CA ' ' A' ' 58' ' ' PHE . 1.8 m-85 -111.37 126.96 55.48 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.352 -0.842 . . . . 0.0 109.382 -179.948 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 81' ' ' GLU . . . . . 0.507 ' O ' ' N ' ' A' ' 39' ' ' GLY . 88.1 tt0 -40.74 -39.07 1.02 Allowed 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.456 -0.778 . . . . 0.0 110.192 -179.789 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 46.8 mttp -126.78 156.35 41.37 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.042 -1.036 . . . . 0.0 109.589 -179.766 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 83' ' ' MET . . . . . 0.524 ' CE ' ' O ' ' A' ' 117' ' ' ALA . 40.9 mtt -73.72 -20.74 60.44 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.272 -0.892 . . . . 0.0 109.404 179.895 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 97.5 mt-10 -65.57 -50.64 64.4 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.257 -0.902 . . . . 0.0 109.392 179.875 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 27.5 m -59.25 -35.16 73.18 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.152 -0.968 . . . . 0.0 109.252 179.847 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 86' ' ' ALA . . . . . 0.495 ' HA ' ' CD2' ' A' ' 80' ' ' TYR . . . -74.94 -31.04 61.41 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.344 -0.847 . . . . 0.0 109.157 179.76 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 90.5 m-20 -67.65 -37.46 82.44 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.26 -0.9 . . . . 0.0 109.276 179.855 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 64.4 tt0 -70.96 -42.14 70.15 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.255 -0.903 . . . . 0.0 109.374 179.841 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 89' ' ' ALA . . . . . 0.564 ' HA ' ' CE1' ' A' ' 61' ' ' PHE . . . -68.83 -42.73 76.81 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.249 -0.907 . . . . 0.0 109.296 -179.971 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 90' ' ' VAL . . . . . 0.517 ' O ' ' CB ' ' A' ' 94' ' ' ASN . 79.3 t -58.1 -37.27 60.94 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.52 0 O-C-N 121.201 -0.937 . . . . 0.0 109.498 -179.944 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -76.1 -53.26 8.59 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.26 -0.9 . . . . 0.0 109.587 -179.832 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 92' ' ' GLU . . . . . 0.521 ' O ' ' CG2' ' A' ' 96' ' ' THR . 74.9 mm-40 -67.2 -42.99 83.22 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.361 -0.837 . . . . 0.0 109.648 -179.762 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 93' ' ' LEU . . . . . 0.631 ' CD1' ' CE2' ' A' ' 58' ' ' PHE . 87.4 mt -68.87 -39.0 80.08 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.206 -0.934 . . . . 0.0 109.617 -179.835 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 94' ' ' ASN . . . . . 0.517 ' CB ' ' O ' ' A' ' 90' ' ' VAL . 21.2 t-20 -67.84 129.99 41.6 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.243 -0.911 . . . . 0.0 109.51 -179.96 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 85.85 32.11 19.03 Favored Glycine 0 N--CA 1.489 2.221 0 N-CA-C 109.514 -1.435 . . . . 0.0 109.514 -179.986 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 96' ' ' THR . . . . . 0.521 ' CG2' ' O ' ' A' ' 92' ' ' GLU . 27.6 p -119.45 160.28 22.66 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.15 -1.206 . . . . 0.0 109.45 -179.994 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 97' ' ' GLN . . . . . 0.502 ' HG2' ' N ' ' A' ' 98' ' ' VAL . 62.1 tt0 -135.89 159.88 40.3 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.259 -0.9 . . . . 0.0 109.483 -179.951 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 98' ' ' VAL . . . . . 0.502 ' N ' ' HG2' ' A' ' 97' ' ' GLN . 1.1 t -113.26 -160.25 0.17 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.591 0 O-C-N 121.252 -0.905 . . . . 0.0 109.351 -179.993 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 95.9 mt-10 -51.73 -35.42 43.21 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.167 -0.958 . . . . 0.0 109.549 -179.943 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 100' ' ' SER . . . . . 0.46 ' O ' ' OG ' ' A' ' 100' ' ' SER . 6.1 t -164.9 28.59 0.06 Allowed 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.197 -0.939 . . . . 0.0 109.498 -179.943 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 59.7 t -140.42 147.99 22.7 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.564 0 O-C-N 121.244 -0.91 . . . . 0.0 109.464 179.968 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 91.5 mt-30 -97.34 146.65 24.96 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.239 -0.913 . . . . 0.0 109.508 -179.975 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 77.8 mt -111.54 135.21 52.43 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.26 -0.9 . . . . 0.0 109.489 -179.969 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 104' ' ' LYS . . . . . 0.449 ' O ' ' HA ' ' A' ' 44' ' ' VAL . 54.8 mttt -121.8 140.57 52.2 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.226 -0.921 . . . . 0.0 109.482 179.997 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 105' ' ' VAL . . . . . 0.502 ' CG1' ' HA ' ' A' ' 90' ' ' VAL . 34.3 t -126.2 146.17 32.46 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 121.274 -0.891 . . . . 0.0 109.421 -179.986 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 106' ' ' ASN . . . . . 0.445 ' OD1' ' O ' ' A' ' 105' ' ' VAL . 84.2 m-20 -155.72 -167.06 2.38 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.342 -0.849 . . . . 0.0 109.505 179.995 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 65.9 mt -112.4 137.18 46.2 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.537 0 O-C-N 121.199 -0.938 . . . . 0.0 109.531 -179.905 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 108' ' ' ALA . . . . . 0.48 ' CB ' HG23 ' A' ' 41' ' ' THR . . . -110.62 155.9 21.73 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.289 -0.882 . . . . 0.0 109.422 179.928 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 20.4 mtm180 -91.15 15.12 12.4 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.331 -0.855 . . . . 0.0 109.54 -179.975 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 110' ' ' LYS . . . . . 0.543 ' HE3' ' CD2' ' A' ' 77' ' ' PHE . 23.6 mttm -72.8 -171.35 0.83 Allowed 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.329 -0.857 . . . . 0.0 109.379 179.919 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 111' ' ' GLN . . . . . 0.574 ' HG3' ' CE ' ' A' ' 113' ' ' MET . 5.0 tt0 69.26 52.13 0.45 Allowed Pre-proline 0 N--CA 1.491 1.581 0 O-C-N 121.265 -0.897 . . . . 0.0 109.521 179.922 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 112' ' ' PRO . . . . . 0.475 ' CD ' ' N ' ' A' ' 111' ' ' GLN . 51.3 Cg_endo -71.79 -26.01 19.63 Favored 'Trans proline' 0 C--O 1.214 -0.681 0 C-N-CA 122.652 2.235 . . . . 0.0 111.961 -179.905 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 113' ' ' MET . . . . . 0.574 ' CE ' ' HG3' ' A' ' 111' ' ' GLN . 1.7 ptp -53.94 -29.3 41.91 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.307 -0.871 . . . . 0.0 109.688 -179.809 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 114' ' ' LEU . . . . . 0.524 ' CG ' ' O ' ' A' ' 114' ' ' LEU . 0.9 OUTLIER -147.69 26.87 1.01 Allowed 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.165 -0.96 . . . . 0.0 109.374 -179.849 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 115' ' ' ASP . . . . . 0.466 ' O ' ' HB2' ' A' ' 116' ' ' ALA . 77.1 m-20 46.39 36.55 3.5 Favored 'General case' 0 C--N 1.302 -1.468 0 O-C-N 121.137 -0.977 . . . . 0.0 108.643 -179.536 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 116' ' ' ALA . . . . . 0.51 ' HA ' ' CG ' ' A' ' 111' ' ' GLN . . . 72.08 -80.57 0.04 OUTLIER 'General case' 0 N--CA 1.488 1.442 0 O-C-N 121.57 -0.706 . . . . 0.0 109.75 -179.762 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 117' ' ' ALA . . . . . 0.524 ' O ' ' CE ' ' A' ' 83' ' ' MET . . . -162.42 154.97 19.4 Favored 'General case' 0 C--N 1.302 -1.485 0 O-C-N 121.149 -0.969 . . . . 0.0 109.716 -179.617 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 12.1 p -123.68 164.08 19.81 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.261 -0.899 . . . . 0.0 109.538 -179.903 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -142.1 172.08 24.3 Favored Glycine 0 N--CA 1.491 2.312 0 N-CA-C 109.434 -1.467 . . . . 0.0 109.434 -179.931 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 30.0 tttt -74.27 132.1 41.8 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.23 -1.159 . . . . 0.0 109.485 179.942 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 N--CA 1.49 1.531 0 CA-C-O 118.024 -0.989 . . . . 0.0 109.542 179.973 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 1.522 0 N-CA-C 109.493 -0.558 . . . . 0.0 109.493 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 49.1 Cg_endo -69.91 143.4 50.0 Favored 'Trans proline' 0 C--O 1.215 -0.631 0 C-N-CA 122.71 2.273 . . . . 0.0 111.751 -179.971 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 37' ' ' ARG . . . . . 0.467 ' O ' ' HE3' ' A' ' 113' ' ' MET . 67.3 mtt180 -124.85 158.67 32.88 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.215 -0.928 . . . . 0.0 109.441 179.946 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 38' ' ' LYS . . . . . 0.529 ' HA ' ' CD2' ' A' ' 114' ' ' LEU . 83.0 mttt -55.36 -170.02 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.233 -0.917 . . . . 0.0 109.246 179.87 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . 0.522 ' CA ' HG21 ' A' ' 79' ' ' THR . . . 151.99 83.45 0.04 OUTLIER Glycine 0 N--CA 1.49 2.245 0 N-CA-C 109.995 -1.242 . . . . 0.0 109.995 179.921 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 40' ' ' ASN . . . . . 0.48 ' O ' HD13 ' A' ' 42' ' ' LEU . 49.6 t30 -81.49 117.34 21.82 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.169 -1.194 . . . . 0.0 108.947 179.4 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 41' ' ' THR . . . . . 0.498 HG22 ' N ' ' A' ' 42' ' ' LEU . 34.2 m -78.01 149.17 34.09 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.259 -0.9 . . . . 0.0 110.105 -179.464 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . 0.498 ' N ' HG22 ' A' ' 41' ' ' THR . 5.2 mp -126.31 154.4 43.51 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.278 -0.889 . . . . 0.0 109.28 179.723 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 43' ' ' TYR . . . . . 0.456 ' HB3' ' HB2' ' A' ' 106' ' ' ASN . 76.1 t80 -107.87 114.82 29.02 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.292 -0.88 . . . . 0.0 109.52 179.875 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . 0.485 ' CG1' HD21 ' A' ' 103' ' ' LEU . 40.6 t -108.52 137.4 40.45 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 121.299 -0.876 . . . . 0.0 109.451 -179.959 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 45' ' ' TYR . . . . . 0.402 ' HB3' ' HB2' ' A' ' 104' ' ' LYS . 65.7 t80 -127.66 135.38 50.14 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.217 -0.927 . . . . 0.0 109.581 -179.844 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 171.24 -177.79 43.97 Favored Glycine 0 N--CA 1.49 2.259 0 N-CA-C 109.553 -1.419 . . . . 0.0 109.553 179.93 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 95.4 mt-10 -116.29 161.83 18.42 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.282 -1.128 . . . . 0.0 109.441 179.997 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 49.9 m-20 44.0 49.51 7.32 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.256 -0.902 . . . . 0.0 109.518 179.947 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 51.1 mtm -101.88 138.82 38.35 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.307 -0.871 . . . . 0.0 109.537 -179.947 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -122.55 162.94 35.56 Favored Pre-proline 0 N--CA 1.489 1.505 0 O-C-N 121.343 -0.848 . . . . 0.0 109.363 179.914 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 51' ' ' PRO . . . . . 0.457 ' HB3' HD11 ' A' ' 67' ' ' LEU . 47.8 Cg_endo -69.6 -53.61 0.27 Allowed 'Trans proline' 0 C--O 1.215 -0.674 0 C-N-CA 122.592 2.194 . . . . 0.0 111.768 -179.991 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 31.1 m -49.3 -49.23 44.73 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.232 -0.918 . . . . 0.0 109.194 179.867 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 26.8 tp -59.7 -46.54 88.77 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.309 -0.869 . . . . 0.0 109.203 179.714 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 54' ' ' LEU . . . . . 0.498 ' CD1' ' SD ' ' A' ' 69' ' ' MET . 12.4 mt -57.39 -46.25 83.63 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.322 -0.861 . . . . 0.0 109.193 179.726 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 55' ' ' ARG . . . . . 0.513 ' O ' ' N ' ' A' ' 59' ' ' SER . 83.9 mtt-85 -51.34 -39.84 57.86 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.295 -0.878 . . . . 0.0 109.175 179.79 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -68.77 -35.2 79.46 Favored Glycine 0 N--CA 1.489 2.226 0 N-CA-C 109.35 -1.5 . . . . 0.0 109.35 179.909 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . 0.456 ' O ' ' CD1' ' A' ' 61' ' ' PHE . . . -73.4 -27.64 61.57 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.216 -1.167 . . . . 0.0 109.379 179.92 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 58' ' ' PHE . . . . . 0.636 ' CE2' ' CD1' ' A' ' 93' ' ' LEU . 96.3 m-85 -112.18 8.44 19.89 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.304 -0.873 . . . . 0.0 109.34 179.969 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 59' ' ' SER . . . . . 0.517 ' N ' ' HD2' ' A' ' 60' ' ' PRO . 1.0 OUTLIER -74.09 -57.25 2.37 Favored Pre-proline 0 N--CA 1.491 1.6 0 O-C-N 121.372 -0.83 . . . . 0.0 110.106 -179.693 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 60' ' ' PRO . . . . . 0.517 ' HD2' ' N ' ' A' ' 59' ' ' SER . 47.3 Cg_endo -68.7 -27.66 31.72 Favored 'Trans proline' 0 C--O 1.215 -0.666 0 C-N-CA 122.676 2.25 . . . . 0.0 112.037 -179.511 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 61' ' ' PHE . . . . . 0.567 ' CE2' ' HA ' ' A' ' 89' ' ' ALA . 72.0 m-85 -69.56 -33.41 72.71 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.201 -0.937 . . . . 0.0 109.514 179.981 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 175.18 -169.71 42.64 Favored Glycine 0 N--CA 1.49 2.278 0 N-CA-C 109.487 -1.445 . . . . 0.0 109.487 179.996 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 83.9 m-20 -99.93 138.86 36.42 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.201 -1.176 . . . . 0.0 109.439 179.916 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 64' ' ' ILE . . . . . 0.424 ' HA ' ' O ' ' A' ' 79' ' ' THR . 49.1 mt -101.31 128.51 53.54 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.521 0 O-C-N 121.266 -0.896 . . . . 0.0 109.585 -179.938 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 65' ' ' ILE . . . . . 0.459 HD11 ' HA3' ' A' ' 39' ' ' GLY . 23.0 pt -94.79 -25.19 4.66 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 O-C-N 121.238 -0.914 . . . . 0.0 109.409 -179.896 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 66' ' ' ASP . . . . . 0.457 ' HB3' ' OG1' ' A' ' 79' ' ' THR . 58.4 t0 -141.02 129.84 23.0 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.198 -0.939 . . . . 0.0 109.601 -179.955 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . 0.495 ' C ' ' CD1' ' A' ' 67' ' ' LEU . 3.4 tm? -119.29 116.35 26.05 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.303 -0.873 . . . . 0.0 109.364 179.934 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 68' ' ' SER . . . . . 0.468 ' HB2' ' HB2' ' A' ' 77' ' ' PHE . 58.0 m -121.13 145.35 47.9 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.14 -0.975 . . . . 0.0 109.532 -179.94 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 69' ' ' MET . . . . . 0.498 ' SD ' ' CD1' ' A' ' 54' ' ' LEU . 89.8 mmm -122.61 144.18 49.28 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.24 -0.912 . . . . 0.0 109.531 -179.952 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 70' ' ' ASP . . . . . 0.464 ' HB2' ' O ' ' A' ' 75' ' ' CYS . 0.2 OUTLIER -124.57 94.31 44.86 Favored Pre-proline 0 N--CA 1.49 1.566 0 O-C-N 121.2 -0.937 . . . . 0.0 109.461 179.917 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 71' ' ' PRO . . . . . 0.598 ' N ' ' CD ' ' A' ' 72' ' ' PRO . 46.5 Cg_endo -74.6 -28.0 10.31 Favored 'Trans proline' 0 CA--C 1.542 0.922 0 C-N-CA 122.506 2.137 . . . . 0.0 113.696 -179.989 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 72' ' ' PRO . . . . . 0.598 ' CD ' ' N ' ' A' ' 71' ' ' PRO . 55.2 Cg_endo -75.45 -22.38 14.11 Favored 'Trans proline' 0 C--N 1.352 0.722 0 C-N-CA 121.523 1.482 . . . . 0.0 111.75 -179.788 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 27.4 mtt85 -113.26 3.8 16.15 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.22 -0.925 . . . . 0.0 109.654 -179.9 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 73.4 m-20 58.23 47.86 13.59 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.244 -0.91 . . . . 0.0 109.45 179.972 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 75' ' ' CYS . . . . . 0.464 ' O ' ' HB2' ' A' ' 70' ' ' ASP . 31.1 p -152.63 148.26 27.11 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.284 -0.885 . . . . 0.0 109.456 -179.968 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . 0.487 ' HB1' ' CE ' ' A' ' 69' ' ' MET . . . -120.34 157.54 29.02 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.273 -0.892 . . . . 0.0 109.401 179.919 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 77' ' ' PHE . . . . . 0.468 ' HB2' ' HB2' ' A' ' 68' ' ' SER . 97.7 m-85 -119.59 139.75 51.66 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.202 -0.936 . . . . 0.0 109.569 -179.849 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . 0.471 ' O ' ' CD1' ' A' ' 42' ' ' LEU . 20.5 t -129.23 137.97 55.65 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.546 0 O-C-N 121.191 -0.943 . . . . 0.0 109.55 179.988 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 79' ' ' THR . . . . . 0.522 HG21 ' CA ' ' A' ' 39' ' ' GLY . 23.3 m -106.19 134.83 48.7 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.194 -0.941 . . . . 0.0 109.264 179.89 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 80' ' ' TYR . . . . . 0.469 ' OH ' ' HB2' ' A' ' 61' ' ' PHE . 0.7 OUTLIER -113.21 141.63 46.74 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.214 -0.929 . . . . 0.0 109.62 -179.917 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 81' ' ' GLU . . . . . 0.461 ' O ' ' HB2' ' A' ' 38' ' ' LYS . 80.8 tt0 -64.03 -22.6 67.0 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.209 -0.932 . . . . 0.0 109.359 179.795 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 38.2 mttp -136.05 135.93 39.8 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.243 -0.91 . . . . 0.0 109.461 179.982 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 83' ' ' MET . . . . . 0.526 ' HE3' ' CB ' ' A' ' 117' ' ' ALA . 47.0 mtt -57.33 -24.64 56.37 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.244 -0.91 . . . . 0.0 109.401 179.928 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 98.4 mt-10 -66.2 -37.49 85.71 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.305 -0.872 . . . . 0.0 109.557 179.981 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 19.3 m -62.37 -31.48 72.15 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.236 -0.915 . . . . 0.0 109.571 -179.97 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 86' ' ' ALA . . . . . 0.484 ' O ' ' CG2' ' A' ' 90' ' ' VAL . . . -75.61 -34.54 60.6 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.255 -0.903 . . . . 0.0 109.449 -179.945 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 64.5 t0 -62.14 -45.42 93.53 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.286 -0.884 . . . . 0.0 109.647 -179.953 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 44.6 tt0 -69.08 -43.58 74.25 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.172 -0.955 . . . . 0.0 109.595 -179.882 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 89' ' ' ALA . . . . . 0.567 ' HA ' ' CE2' ' A' ' 61' ' ' PHE . . . -72.37 -37.13 68.84 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.195 -0.941 . . . . 0.0 109.552 -179.869 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 90' ' ' VAL . . . . . 0.523 ' O ' ' CB ' ' A' ' 94' ' ' ASN . 61.2 t -69.38 -47.31 73.69 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.604 0 O-C-N 121.254 -0.904 . . . . 0.0 109.652 -179.89 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -73.56 -28.51 61.9 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.236 -0.915 . . . . 0.0 109.757 -179.721 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 92' ' ' GLU . . . . . 0.565 ' HB3' ' CE2' ' A' ' 61' ' ' PHE . 39.2 tp10 -87.21 -49.77 7.05 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.245 -0.909 . . . . 0.0 109.786 -179.731 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 93' ' ' LEU . . . . . 0.636 ' CD1' ' CE2' ' A' ' 58' ' ' PHE . 39.9 mt -68.02 -39.81 83.09 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.244 -0.91 . . . . 0.0 109.612 -179.907 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 94' ' ' ASN . . . . . 0.523 ' CB ' ' O ' ' A' ' 90' ' ' VAL . 57.2 t30 -68.35 128.05 35.19 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.24 -0.912 . . . . 0.0 109.481 -179.969 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 94.87 19.38 31.59 Favored Glycine 0 N--CA 1.491 2.308 0 N-CA-C 109.591 -1.404 . . . . 0.0 109.591 -179.947 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 96' ' ' THR . . . . . 0.428 ' CG2' ' O ' ' A' ' 92' ' ' GLU . 21.8 p -120.46 148.6 43.6 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.209 -1.171 . . . . 0.0 109.493 179.978 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 97' ' ' GLN . . . . . 0.448 ' HG3' ' O ' ' A' ' 101' ' ' VAL . 59.8 tt0 -119.73 140.76 50.2 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.232 -0.917 . . . . 0.0 109.478 179.996 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 1.3 t -81.74 -162.99 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.532 0 O-C-N 121.285 -0.885 . . . . 0.0 109.347 179.997 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 96.0 mt-10 -54.18 -37.36 64.41 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.232 -0.917 . . . . 0.0 109.558 -179.975 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -155.59 25.18 0.4 Allowed 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.322 -0.861 . . . . 0.0 109.521 179.957 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 101' ' ' VAL . . . . . 0.448 ' O ' ' HG3' ' A' ' 97' ' ' GLN . 60.0 t -137.77 164.62 28.02 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.552 0 O-C-N 121.236 -0.915 . . . . 0.0 109.5 -179.953 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 91.7 mt-30 -119.06 145.36 45.96 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.309 -0.869 . . . . 0.0 109.371 179.854 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 103' ' ' LEU . . . . . 0.485 HD21 ' CG1' ' A' ' 44' ' ' VAL . 0.0 OUTLIER -124.45 130.95 53.41 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.25 -0.907 . . . . 0.0 109.591 -179.785 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 104' ' ' LYS . . . . . 0.402 ' HB2' ' HB3' ' A' ' 45' ' ' TYR . 24.1 mttm -117.89 127.24 53.66 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.346 -0.846 . . . . 0.0 109.24 179.761 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 105' ' ' VAL . . . . . 0.513 HG11 ' CG2' ' A' ' 90' ' ' VAL . 12.1 t -106.24 146.18 13.19 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.551 0 O-C-N 121.231 -0.918 . . . . 0.0 109.736 -179.764 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 106' ' ' ASN . . . . . 0.461 ' OD1' ' O ' ' A' ' 105' ' ' VAL . 82.0 m-20 -157.87 -165.89 1.85 Allowed 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.331 -0.856 . . . . 0.0 109.296 179.871 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 23.7 mm -102.15 135.18 40.32 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.567 0 O-C-N 121.295 -0.878 . . . . 0.0 109.471 179.937 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 108' ' ' ALA . . . . . 0.412 ' O ' ' C ' ' A' ' 109' ' ' ARG . . . -114.62 -150.99 0.47 Allowed 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.2 -0.937 . . . . 0.0 109.371 179.958 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 109' ' ' ARG . . . . . 0.412 ' C ' ' O ' ' A' ' 108' ' ' ALA . 17.3 mmt-85 -45.36 149.56 0.53 Allowed 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.156 -0.965 . . . . 0.0 109.301 179.881 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 110' ' ' LYS . . . . . 0.412 ' O ' ' HB3' ' A' ' 111' ' ' GLN . 91.0 mttt -73.94 -1.78 21.2 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.182 -0.949 . . . . 0.0 109.659 -179.952 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 111' ' ' GLN . . . . . 0.423 ' CG ' ' HE2' ' A' ' 113' ' ' MET . 9.2 tp-100 61.42 98.03 0.04 OUTLIER Pre-proline 0 N--CA 1.49 1.546 0 O-C-N 121.173 -0.955 . . . . 0.0 109.549 179.953 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 112' ' ' PRO . . . . . 0.426 ' O ' ' C ' ' A' ' 113' ' ' MET . 50.4 Cg_endo -69.96 -26.18 26.88 Favored 'Trans proline' 0 C--O 1.216 -0.622 0 C-N-CA 122.639 2.226 . . . . 0.0 111.811 179.947 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 113' ' ' MET . . . . . 0.537 ' HE1' ' N ' ' A' ' 114' ' ' LEU . 0.0 OUTLIER -43.82 -27.29 0.32 Allowed 'General case' 0 N--CA 1.488 1.462 0 N-CA-C 108.829 -0.804 . . . . 0.0 108.829 179.593 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 114' ' ' LEU . . . . . 0.537 ' N ' ' HE1' ' A' ' 113' ' ' MET . 4.1 tt -173.07 29.21 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.233 -0.917 . . . . 0.0 109.263 179.616 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 115' ' ' ASP . . . . . 0.511 ' O ' ' CB ' ' A' ' 116' ' ' ALA . 75.3 m-20 46.04 35.49 2.52 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.279 -0.888 . . . . 0.0 108.885 -179.635 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 116' ' ' ALA . . . . . 0.511 ' CB ' ' O ' ' A' ' 115' ' ' ASP . . . 76.72 -78.18 0.04 OUTLIER 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.401 -0.812 . . . . 0.0 109.532 -179.775 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 117' ' ' ALA . . . . . 0.526 ' CB ' ' HE3' ' A' ' 83' ' ' MET . . . -176.51 30.29 0.0 OUTLIER 'General case' 0 C--N 1.303 -1.417 0 O-C-N 121.37 -0.831 . . . . 0.0 109.664 -179.854 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 118' ' ' THR . . . . . 0.402 ' N ' ' HE2' ' A' ' 83' ' ' MET . 3.4 t -64.49 -34.38 78.09 Favored 'General case' 0 C--N 1.302 -1.492 0 O-C-N 121.189 -0.944 . . . . 0.0 109.564 -179.669 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -82.25 175.5 53.72 Favored Glycine 0 N--CA 1.49 2.26 0 N-CA-C 109.453 -1.459 . . . . 0.0 109.453 179.904 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 19.8 tttt -55.5 -36.03 66.23 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.23 -1.159 . . . . 0.0 109.48 179.975 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 15.9 t . . . . . 0 N--CA 1.49 1.525 0 CA-C-O 117.974 -1.012 . . . . 0.0 109.518 179.941 . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 1.511 0 N-CA-C 109.481 -0.563 . . . . 0.0 109.481 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 51.0 Cg_endo -70.25 -16.17 35.42 Favored 'Trans proline' 0 C--O 1.215 -0.668 0 C-N-CA 122.74 2.293 . . . . 0.0 111.738 179.964 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 86.0 mtt-85 -58.45 141.76 50.65 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.322 -0.862 . . . . 0.0 109.488 -179.989 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 38' ' ' LYS . . . . . 0.51 ' HB3' ' CB ' ' A' ' 117' ' ' ALA . 44.5 mttp -100.32 -169.06 1.67 Allowed 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.237 -0.915 . . . . 0.0 109.343 179.954 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . 0.521 ' O ' ' CE ' ' A' ' 83' ' ' MET . . . -176.53 169.79 42.38 Favored Glycine 0 N--CA 1.491 2.315 0 N-CA-C 109.698 -1.361 . . . . 0.0 109.698 -179.879 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 40' ' ' ASN . . . . . 0.485 ' N ' ' O ' ' A' ' 80' ' ' TYR . 42.1 t30 -162.37 111.65 1.44 Allowed 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.166 -1.196 . . . . 0.0 109.1 179.801 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 41' ' ' THR . . . . . 0.476 ' HA ' ' O ' ' A' ' 78' ' ' VAL . 27.0 m -78.54 150.94 32.74 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.24 -0.913 . . . . 0.0 110.063 -179.479 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . 0.535 ' CD1' ' O ' ' A' ' 78' ' ' VAL . 5.1 mp -126.57 152.86 46.02 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.413 -0.805 . . . . 0.0 109.132 179.616 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 43' ' ' TYR . . . . . 0.425 ' HB3' ' HB2' ' A' ' 106' ' ' ASN . 39.8 t80 -107.92 111.37 23.44 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.224 -0.923 . . . . 0.0 109.42 179.865 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . 0.463 ' HA ' ' O ' ' A' ' 104' ' ' LYS . 96.5 t -109.16 142.26 22.18 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.551 0 O-C-N 121.202 -0.936 . . . . 0.0 109.384 179.969 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 68.1 t80 -128.35 130.97 48.54 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.251 -0.906 . . . . 0.0 109.561 -179.882 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -176.54 -166.44 33.7 Favored Glycine 0 N--CA 1.488 2.123 0 N-CA-C 109.483 -1.447 . . . . 0.0 109.483 179.928 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . 0.415 ' O ' ' C ' ' A' ' 48' ' ' ASP . 94.8 mt-10 -132.52 161.08 34.68 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.328 -1.101 . . . . 0.0 109.485 179.987 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . 0.415 ' C ' ' O ' ' A' ' 47' ' ' GLU . 42.8 m-20 43.66 51.55 6.45 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.271 -0.893 . . . . 0.0 109.601 179.934 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 72.6 mtm -103.78 145.0 30.73 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.249 -0.907 . . . . 0.0 109.475 -179.944 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 50' ' ' THR . . . . . 0.407 ' O ' HD13 ' A' ' 54' ' ' LEU . 0.0 OUTLIER -117.6 161.75 32.2 Favored Pre-proline 0 N--CA 1.49 1.561 0 O-C-N 121.296 -0.878 . . . . 0.0 109.53 -179.978 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 51' ' ' PRO . . . . . 0.48 ' CA ' ' SD ' ' A' ' 69' ' ' MET . 49.2 Cg_endo -69.93 -53.93 0.24 Allowed 'Trans proline' 0 C--O 1.214 -0.694 0 C-N-CA 122.731 2.288 . . . . 0.0 111.739 179.89 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 27.1 m -56.91 -44.71 82.64 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.286 -0.884 . . . . 0.0 109.33 179.887 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . 0.479 ' CD1' ' C ' ' A' ' 53' ' ' LEU . 2.3 tm? -59.94 -47.77 84.44 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.311 -0.868 . . . . 0.0 109.384 179.97 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 54' ' ' LEU . . . . . 0.491 HD11 ' CE ' ' A' ' 69' ' ' MET . 17.3 mt -59.36 -52.31 66.16 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.255 -0.903 . . . . 0.0 109.332 179.979 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 55' ' ' ARG . . . . . 0.513 ' O ' ' N ' ' A' ' 59' ' ' SER . 52.3 mtp180 -45.0 -41.04 7.01 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.242 -0.911 . . . . 0.0 109.292 179.83 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . 0.466 ' O ' ' HD2' ' A' ' 60' ' ' PRO . . . -64.07 -40.65 98.34 Favored Glycine 0 N--CA 1.49 2.252 0 N-CA-C 109.416 -1.474 . . . . 0.0 109.416 179.904 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . 0.429 ' O ' ' CD2' ' A' ' 61' ' ' PHE . . . -65.9 -23.3 66.61 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.286 -1.126 . . . . 0.0 109.323 179.956 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 58' ' ' PHE . . . . . 0.636 ' CE2' ' CD1' ' A' ' 93' ' ' LEU . 93.6 m-85 -116.81 9.36 13.89 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.287 -0.883 . . . . 0.0 109.395 179.975 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 59' ' ' SER . . . . . 0.525 ' N ' ' HD2' ' A' ' 60' ' ' PRO . 0.9 OUTLIER -76.89 -55.45 1.47 Allowed Pre-proline 0 N--CA 1.491 1.592 0 O-C-N 121.225 -0.922 . . . . 0.0 110.37 -179.569 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 60' ' ' PRO . . . . . 0.525 ' HD2' ' N ' ' A' ' 59' ' ' SER . 47.4 Cg_endo -69.26 -30.76 24.05 Favored 'Trans proline' 0 C--O 1.215 -0.65 0 C-N-CA 122.502 2.135 . . . . 0.0 112.158 -179.25 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 61' ' ' PHE . . . . . 0.549 ' CE1' ' HA ' ' A' ' 89' ' ' ALA . 82.3 m-85 -66.06 -38.32 88.03 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.165 -0.959 . . . . 0.0 109.442 179.933 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . 0.467 ' HA3' ' OG ' ' A' ' 85' ' ' SER . . . -179.51 -177.09 47.6 Favored Glycine 0 N--CA 1.49 2.277 0 N-CA-C 109.47 -1.452 . . . . 0.0 109.47 179.973 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 85.8 m-20 -91.46 140.35 29.83 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.171 -1.194 . . . . 0.0 109.489 179.965 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 64' ' ' ILE . . . . . 0.45 HG23 HG11 ' A' ' 78' ' ' VAL . 64.3 mt -101.63 133.32 45.41 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.531 0 O-C-N 121.235 -0.916 . . . . 0.0 109.506 -179.929 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 25.9 pt -96.68 -19.57 6.06 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 O-C-N 121.284 -0.885 . . . . 0.0 109.609 -179.955 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 66' ' ' ASP . . . . . 0.457 ' HB3' ' OG1' ' A' ' 79' ' ' THR . 58.5 t0 -153.4 110.8 3.5 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.185 -0.947 . . . . 0.0 109.571 -179.917 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . 0.449 ' C ' ' CD1' ' A' ' 67' ' ' LEU . 0.2 OUTLIER -102.18 118.1 36.17 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.24 -0.913 . . . . 0.0 109.388 179.824 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 25.6 t -126.49 145.34 50.54 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.245 -0.91 . . . . 0.0 109.556 -179.836 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 69' ' ' MET . . . . . 0.491 ' CE ' HD11 ' A' ' 54' ' ' LEU . 90.5 mtp -126.89 150.96 49.03 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.371 -0.831 . . . . 0.0 109.407 179.923 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 70' ' ' ASP . . . . . 0.456 ' C ' ' HD2' ' A' ' 72' ' ' PRO . 0.2 OUTLIER -125.41 98.31 35.31 Favored Pre-proline 0 N--CA 1.49 1.57 0 O-C-N 121.29 -0.882 . . . . 0.0 109.526 179.961 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 71' ' ' PRO . . . . . 0.603 ' N ' ' CD ' ' A' ' 72' ' ' PRO . 46.2 Cg_endo -74.61 -27.85 10.44 Favored 'Trans proline' 0 CA--C 1.542 0.925 0 C-N-CA 122.529 2.153 . . . . 0.0 113.647 179.945 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 72' ' ' PRO . . . . . 0.603 ' CD ' ' N ' ' A' ' 71' ' ' PRO . 55.3 Cg_endo -75.69 -26.19 10.1 Favored 'Trans proline' 0 C--N 1.353 0.782 0 C-N-CA 121.536 1.49 . . . . 0.0 111.771 -179.958 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 73' ' ' ARG . . . . . 0.418 ' O ' ' HB2' ' A' ' 74' ' ' ASN . 96.5 mtt180 -110.85 -0.01 17.06 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.294 -0.878 . . . . 0.0 109.652 -179.822 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 74' ' ' ASN . . . . . 0.418 ' HB2' ' O ' ' A' ' 73' ' ' ARG . 8.3 m120 61.2 44.73 9.64 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.166 -0.959 . . . . 0.0 109.343 -179.91 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 75' ' ' CYS . . . . . 0.442 ' O ' ' HB2' ' A' ' 70' ' ' ASP . 22.0 p -143.5 137.37 28.46 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.286 -0.884 . . . . 0.0 109.475 179.959 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -111.45 154.16 25.08 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.205 -0.935 . . . . 0.0 109.492 -179.96 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 77' ' ' PHE . . . . . 0.467 ' HA ' ' O ' ' A' ' 42' ' ' LEU . 97.0 m-85 -121.93 129.04 52.2 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.237 -0.915 . . . . 0.0 109.577 -179.925 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . 0.535 ' O ' ' CD1' ' A' ' 42' ' ' LEU . 26.5 t -120.21 138.53 50.47 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.569 0 O-C-N 121.206 -0.934 . . . . 0.0 109.289 179.858 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 79' ' ' THR . . . . . 0.47 ' HA ' ' O ' ' A' ' 40' ' ' ASN . 1.2 m -107.2 136.36 47.16 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.286 -0.884 . . . . 0.0 109.634 -179.826 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 80' ' ' TYR . . . . . 0.566 ' CE1' ' OG ' ' A' ' 85' ' ' SER . 0.9 OUTLIER -119.81 121.27 38.74 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.295 -0.878 . . . . 0.0 109.419 179.81 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 81' ' ' GLU . . . . . 0.466 ' HA ' ' HA2' ' A' ' 39' ' ' GLY . 83.5 tt0 -40.37 -39.74 1.04 Allowed 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.516 -0.74 . . . . 0.0 109.85 179.964 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 9.5 mtmm -122.87 162.97 21.17 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.193 -0.942 . . . . 0.0 109.514 179.931 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 83' ' ' MET . . . . . 0.521 ' CE ' ' O ' ' A' ' 39' ' ' GLY . 4.4 mmt -80.17 -13.94 58.85 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.188 -0.945 . . . . 0.0 109.345 -179.999 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 96.1 mt-10 -69.82 -35.77 75.08 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.241 -0.912 . . . . 0.0 109.49 179.891 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 85' ' ' SER . . . . . 0.566 ' OG ' ' CE1' ' A' ' 80' ' ' TYR . 43.4 t -71.57 -32.08 67.67 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.2 -0.937 . . . . 0.0 109.476 -179.967 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 86' ' ' ALA . . . . . 0.519 ' O ' ' CG2' ' A' ' 90' ' ' VAL . . . -78.78 -31.38 46.04 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.244 -0.91 . . . . 0.0 109.532 -179.938 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 58.3 t0 -70.62 -46.73 62.81 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.243 -0.911 . . . . 0.0 109.646 -179.938 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 65.0 tt0 -68.64 -41.31 79.6 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.269 -0.895 . . . . 0.0 109.644 -179.873 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 89' ' ' ALA . . . . . 0.549 ' HA ' ' CE1' ' A' ' 61' ' ' PHE . . . -67.92 -41.1 83.14 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.208 -0.933 . . . . 0.0 109.653 -179.935 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 90' ' ' VAL . . . . . 0.532 ' O ' ' CB ' ' A' ' 94' ' ' ASN . 55.6 t -60.4 -35.94 66.02 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.587 0 O-C-N 121.22 -0.925 . . . . 0.0 109.669 -179.902 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -75.42 -53.91 7.91 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.173 -0.954 . . . . 0.0 109.844 -179.723 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 92' ' ' GLU . . . . . 0.519 ' O ' ' CG2' ' A' ' 96' ' ' THR . 76.1 mm-40 -67.92 -44.37 77.04 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.223 -0.923 . . . . 0.0 109.768 -179.537 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 93' ' ' LEU . . . . . 0.636 ' CD1' ' CE2' ' A' ' 58' ' ' PHE . 92.1 mt -66.57 -38.95 88.14 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.079 -1.013 . . . . 0.0 109.541 -179.804 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 94' ' ' ASN . . . . . 0.532 ' CB ' ' O ' ' A' ' 90' ' ' VAL . 62.1 t-20 -72.74 120.23 18.07 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.237 -0.914 . . . . 0.0 109.553 -179.964 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 105.27 10.71 31.12 Favored Glycine 0 N--CA 1.491 2.315 0 N-CA-C 109.426 -1.47 . . . . 0.0 109.426 179.905 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 96' ' ' THR . . . . . 0.519 ' CG2' ' O ' ' A' ' 92' ' ' GLU . 27.7 p -107.77 157.62 17.98 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.201 -1.176 . . . . 0.0 109.494 -179.97 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 58.7 tt0 -129.25 145.95 51.25 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.182 -0.949 . . . . 0.0 109.479 -179.935 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 98' ' ' VAL . . . . . 0.461 HG23 ' O ' ' A' ' 101' ' ' VAL . 1.4 t -87.39 -147.8 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 O-C-N 121.275 -0.891 . . . . 0.0 109.385 179.996 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 96.7 mt-10 -63.44 -41.87 98.67 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.21 -0.931 . . . . 0.0 109.536 179.979 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 100' ' ' SER . . . . . 0.402 ' C ' HG22 ' A' ' 101' ' ' VAL . 0.5 OUTLIER -153.77 23.83 0.51 Allowed 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.257 -0.902 . . . . 0.0 109.478 -179.915 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 101' ' ' VAL . . . . . 0.461 ' O ' HG23 ' A' ' 98' ' ' VAL . 52.9 t -139.46 148.63 23.24 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 O-C-N 121.252 -0.905 . . . . 0.0 109.433 -179.979 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 47.2 tt0 -97.47 140.67 31.56 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.172 -0.955 . . . . 0.0 109.523 -179.867 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 90.7 mt -104.42 137.7 41.9 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.253 -0.904 . . . . 0.0 109.465 179.977 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 104' ' ' LYS . . . . . 0.463 ' O ' ' HA ' ' A' ' 44' ' ' VAL . 89.0 mttt -117.95 138.39 52.2 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.293 -0.88 . . . . 0.0 109.298 179.887 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 105' ' ' VAL . . . . . 0.508 ' O ' ' ND2' ' A' ' 106' ' ' ASN . 59.9 t -122.91 143.31 36.3 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.54 0 O-C-N 121.225 -0.922 . . . . 0.0 109.458 -179.885 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 106' ' ' ASN . . . . . 0.508 ' ND2' ' O ' ' A' ' 105' ' ' VAL . 21.3 m120 -149.27 178.48 8.72 Favored 'General case' 0 N--CA 1.489 1.475 0 O-C-N 121.236 -0.915 . . . . 0.0 109.495 -179.989 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 107' ' ' ILE . . . . . 0.414 HD13 HG21 ' A' ' 90' ' ' VAL . 22.3 mm -112.48 120.17 62.02 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.514 0 O-C-N 121.246 -0.908 . . . . 0.0 109.463 179.997 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -61.31 153.12 27.42 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.214 -0.929 . . . . 0.0 109.505 -179.967 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 41.2 ttt180 -47.56 -47.7 28.12 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.218 -0.926 . . . . 0.0 109.491 179.93 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 110' ' ' LYS . . . . . 0.427 ' HG2' ' N ' ' A' ' 111' ' ' GLN . 19.8 tttt -178.87 150.2 0.48 Allowed 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.24 -0.913 . . . . 0.0 109.543 179.979 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 111' ' ' GLN . . . . . 0.467 ' OE1' ' OG1' ' A' ' 41' ' ' THR . 29.0 tp60 -114.9 97.71 48.27 Favored Pre-proline 0 N--CA 1.489 1.524 0 O-C-N 121.21 -0.932 . . . . 0.0 109.413 179.921 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 112' ' ' PRO . . . . . 0.408 ' O ' ' C ' ' A' ' 113' ' ' MET . 50.2 Cg_endo -70.14 -29.39 22.11 Favored 'Trans proline' 0 C--O 1.215 -0.654 0 C-N-CA 122.668 2.246 . . . . 0.0 111.823 -179.847 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 113' ' ' MET . . . . . 0.561 ' HE3' ' N ' ' A' ' 114' ' ' LEU . 0.0 OUTLIER -44.75 -26.18 0.36 Allowed 'General case' 0 C--N 1.304 -1.406 0 O-C-N 121.292 -0.88 . . . . 0.0 108.754 179.513 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 114' ' ' LEU . . . . . 0.561 ' N ' ' HE3' ' A' ' 113' ' ' MET . 2.2 tt -148.25 25.89 0.98 Allowed 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.176 -0.952 . . . . 0.0 109.279 179.719 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 115' ' ' ASP . . . . . 0.488 ' O ' ' N ' ' A' ' 117' ' ' ALA . 88.7 m-20 48.74 31.83 3.29 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.254 -0.904 . . . . 0.0 109.403 -179.914 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 116' ' ' ALA . . . . . 0.521 ' HB2' ' CE ' ' A' ' 83' ' ' MET . . . 44.84 -95.52 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.323 -0.86 . . . . 0.0 109.642 -179.949 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 117' ' ' ALA . . . . . 0.51 ' CB ' ' HB3' ' A' ' 38' ' ' LYS . . . -173.11 -75.7 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.11 -0.994 . . . . 0.0 109.577 -179.767 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 43.8 p -72.08 -27.34 62.6 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.303 -0.873 . . . . 0.0 109.449 -179.943 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 78.92 -152.38 36.69 Favored Glycine 0 N--CA 1.489 2.2 0 N-CA-C 109.493 -1.443 . . . . 0.0 109.493 179.98 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 34.6 mttp -86.58 143.71 27.54 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.21 -1.171 . . . . 0.0 109.465 179.981 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 N--CA 1.491 1.589 0 CA-C-O 118.021 -0.99 . . . . 0.0 109.393 179.985 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.525 0 N-CA-C 109.496 -0.557 . . . . 0.0 109.496 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 50.0 Cg_endo -69.46 138.98 40.09 Favored 'Trans proline' 0 C--O 1.215 -0.641 0 C-N-CA 122.692 2.262 . . . . 0.0 111.837 179.997 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 58.2 mtt180 -126.06 154.92 42.35 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.302 -0.873 . . . . 0.0 109.447 -179.984 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 38' ' ' LYS . . . . . 0.439 ' O ' HD13 ' A' ' 65' ' ' ILE . 26.0 mttp -86.79 -162.96 0.83 Allowed 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.329 -0.857 . . . . 0.0 109.525 -179.97 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . 0.5 ' O ' ' CA ' ' A' ' 116' ' ' ALA . . . 142.21 168.98 11.93 Favored Glycine 0 N--CA 1.49 2.298 0 N-CA-C 109.299 -1.52 . . . . 0.0 109.299 -179.889 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 40' ' ' ASN . . . . . 0.503 ' N ' HG21 ' A' ' 79' ' ' THR . 47.4 t30 -155.25 100.02 2.12 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.127 -1.22 . . . . 0.0 109.493 179.988 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 41' ' ' THR . . . . . 0.456 ' O ' HD22 ' A' ' 42' ' ' LEU . 45.1 m -61.11 140.44 57.88 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.236 -0.915 . . . . 0.0 109.815 -179.771 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . 0.552 HD12 ' CD2' ' A' ' 80' ' ' TYR . 17.9 mt -125.33 143.44 50.97 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.253 -0.904 . . . . 0.0 109.483 179.722 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 71.1 t80 -96.27 120.46 36.6 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.277 -0.889 . . . . 0.0 109.52 -179.998 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . 0.582 ' CG1' ' CD2' ' A' ' 103' ' ' LEU . 58.7 t -118.49 139.06 47.16 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 O-C-N 121.171 -0.956 . . . . 0.0 109.421 179.96 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 65.6 t80 -129.39 141.6 51.01 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.261 -0.9 . . . . 0.0 109.562 -179.939 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 175.2 -174.82 47.0 Favored Glycine 0 N--CA 1.49 2.292 0 N-CA-C 109.424 -1.47 . . . . 0.0 109.424 179.935 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . 0.418 ' O ' ' C ' ' A' ' 48' ' ' ASP . 94.6 mt-10 -112.86 159.32 19.15 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.195 -1.18 . . . . 0.0 109.343 179.974 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . 0.418 ' C ' ' O ' ' A' ' 47' ' ' GLU . 51.4 m-20 44.34 40.2 3.59 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.211 -0.93 . . . . 0.0 109.262 -179.951 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 46.9 mtp -75.46 141.09 43.18 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.282 -0.886 . . . . 0.0 109.527 -179.951 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 50' ' ' THR . . . . . 0.453 ' O ' ' HG ' ' A' ' 54' ' ' LEU . 0.7 OUTLIER -130.98 161.94 58.54 Favored Pre-proline 0 N--CA 1.49 1.553 0 O-C-N 121.19 -0.944 . . . . 0.0 109.344 -179.974 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 51' ' ' PRO . . . . . 0.505 ' N ' ' SD ' ' A' ' 69' ' ' MET . 49.7 Cg_endo -70.6 -53.47 0.22 Allowed 'Trans proline' 0 C--O 1.214 -0.683 0 C-N-CA 122.657 2.238 . . . . 0.0 111.669 179.964 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 32.9 m -58.34 -41.69 85.19 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.268 -0.895 . . . . 0.0 109.348 179.886 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 9.2 tt -62.44 -46.08 90.18 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.277 -0.889 . . . . 0.0 109.385 179.92 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 54' ' ' LEU . . . . . 0.453 ' HG ' ' O ' ' A' ' 50' ' ' THR . 40.8 mt -64.76 -46.16 83.36 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.238 -0.914 . . . . 0.0 109.207 179.79 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 55' ' ' ARG . . . . . 0.478 ' O ' ' CB ' ' A' ' 59' ' ' SER . 74.4 ttt180 -48.0 -40.79 23.64 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.244 -0.91 . . . . 0.0 109.394 179.97 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -73.71 -31.55 60.32 Favored Glycine 0 N--CA 1.49 2.243 0 N-CA-C 109.476 -1.45 . . . . 0.0 109.476 179.892 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -73.55 -24.46 60.11 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.225 -1.162 . . . . 0.0 109.435 179.982 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 58' ' ' PHE . . . . . 0.604 ' CE2' ' CD1' ' A' ' 93' ' ' LEU . 94.8 m-85 -119.09 8.86 11.65 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.371 -0.83 . . . . 0.0 109.421 179.977 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 59' ' ' SER . . . . . 0.506 ' N ' ' HD2' ' A' ' 60' ' ' PRO . 0.4 OUTLIER -74.9 -57.59 1.81 Allowed Pre-proline 0 N--CA 1.491 1.609 0 O-C-N 121.279 -0.888 . . . . 0.0 110.162 -179.582 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 60' ' ' PRO . . . . . 0.506 ' HD2' ' N ' ' A' ' 59' ' ' SER . 48.1 Cg_endo -68.74 -35.96 15.13 Favored 'Trans proline' 0 C--O 1.215 -0.63 0 C-N-CA 122.584 2.189 . . . . 0.0 112.259 -179.437 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 61' ' ' PHE . . . . . 0.572 ' CD1' ' HA ' ' A' ' 89' ' ' ALA . 64.7 m-85 -58.72 -33.89 70.73 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.16 -0.963 . . . . 0.0 109.703 -179.828 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 176.74 -174.32 46.95 Favored Glycine 0 N--CA 1.49 2.282 0 N-CA-C 109.617 -1.393 . . . . 0.0 109.617 179.974 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 82.0 m-20 -95.03 146.23 24.41 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.235 -1.156 . . . . 0.0 109.46 179.991 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 64' ' ' ILE . . . . . 0.531 ' CD1' HD13 ' A' ' 67' ' ' LEU . 51.5 mt -110.77 126.54 68.12 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 O-C-N 121.3 -0.875 . . . . 0.0 109.416 179.974 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 65' ' ' ILE . . . . . 0.452 HD13 ' HA3' ' A' ' 39' ' ' GLY . 22.2 pt -91.15 -22.56 6.16 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 O-C-N 121.273 -0.892 . . . . 0.0 109.543 -179.896 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 45.2 t0 -155.49 95.0 1.64 Allowed 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.196 -0.94 . . . . 0.0 109.586 179.994 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . 0.531 HD13 ' CD1' ' A' ' 64' ' ' ILE . 0.5 OUTLIER -93.29 126.67 38.53 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.206 -0.934 . . . . 0.0 109.196 179.769 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 68' ' ' SER . . . . . 0.415 ' HB2' ' HB2' ' A' ' 77' ' ' PHE . 67.5 m -126.08 153.86 43.89 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.226 -0.921 . . . . 0.0 109.718 -179.802 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 69' ' ' MET . . . . . 0.505 ' SD ' ' N ' ' A' ' 51' ' ' PRO . 84.1 mtp -126.46 150.54 48.63 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.414 -0.804 . . . . 0.0 109.296 179.851 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 70' ' ' ASP . . . . . 0.458 ' C ' ' HD2' ' A' ' 72' ' ' PRO . 1.2 t0 -129.09 99.24 22.09 Favored Pre-proline 0 N--CA 1.49 1.565 0 O-C-N 121.195 -0.941 . . . . 0.0 109.55 -179.948 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 71' ' ' PRO . . . . . 0.6 ' N ' ' CD ' ' A' ' 72' ' ' PRO . 46.4 Cg_endo -74.54 -27.96 10.48 Favored 'Trans proline' 0 CA--C 1.542 0.897 0 C-N-CA 122.503 2.136 . . . . 0.0 113.523 179.845 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 72' ' ' PRO . . . . . 0.6 ' CD ' ' N ' ' A' ' 71' ' ' PRO . 55.6 Cg_endo -75.38 -26.62 10.15 Favored 'Trans proline' 0 C--N 1.353 0.772 0 C-N-CA 121.483 1.456 . . . . 0.0 111.82 -179.932 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 73' ' ' ARG . . . . . 0.444 ' O ' ' HB2' ' A' ' 74' ' ' ASN . 89.0 mtt-85 -109.23 -1.02 18.94 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.293 -0.88 . . . . 0.0 109.645 -179.959 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 74' ' ' ASN . . . . . 0.444 ' HB2' ' O ' ' A' ' 73' ' ' ARG . 79.8 m-20 61.6 43.99 9.49 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.21 -0.931 . . . . 0.0 109.568 179.955 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 75' ' ' CYS . . . . . 0.459 ' HA ' ' O ' ' A' ' 44' ' ' VAL . 27.5 p -146.94 150.5 35.3 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.271 -0.893 . . . . 0.0 109.395 179.978 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -116.35 154.25 30.55 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.171 -0.956 . . . . 0.0 109.522 -179.946 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 77' ' ' PHE . . . . . 0.461 ' HA ' ' O ' ' A' ' 42' ' ' LEU . 98.0 m-85 -124.16 106.31 10.23 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.299 -0.876 . . . . 0.0 109.476 -179.941 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . 0.525 ' CG1' ' HB2' ' A' ' 42' ' ' LEU . 5.9 p -109.8 136.19 46.48 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.503 0 O-C-N 121.131 -0.981 . . . . 0.0 109.638 179.907 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 79' ' ' THR . . . . . 0.53 ' CG2' ' OE1' ' A' ' 111' ' ' GLN . 3.7 m -102.5 127.05 49.72 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.308 -0.87 . . . . 0.0 109.699 -179.736 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 80' ' ' TYR . . . . . 0.552 ' CD2' HD12 ' A' ' 42' ' ' LEU . 0.5 OUTLIER -102.16 126.12 49.04 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.308 -0.87 . . . . 0.0 109.465 179.948 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 81' ' ' GLU . . . . . 0.463 ' HA ' ' HA2' ' A' ' 39' ' ' GLY . 88.5 tt0 -42.06 -47.4 4.49 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.476 -0.765 . . . . 0.0 109.766 179.949 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 36.4 mttm -113.7 155.86 24.8 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.26 -0.9 . . . . 0.0 109.635 -179.904 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 83' ' ' MET . . . . . 0.525 ' HE3' ' CB ' ' A' ' 117' ' ' ALA . 57.7 mtt -77.46 -19.87 55.29 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.26 -0.9 . . . . 0.0 109.34 179.943 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 98.3 mt-10 -69.66 -44.6 70.19 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.181 -0.949 . . . . 0.0 109.303 179.918 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 16.0 m -61.56 -27.39 68.59 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.355 -0.841 . . . . 0.0 109.225 179.739 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 86' ' ' ALA . . . . . 0.517 ' CB ' HD13 ' A' ' 42' ' ' LEU . . . -78.11 -34.42 50.06 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.383 -0.823 . . . . 0.0 109.416 -179.993 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 59.2 t0 -66.9 -33.63 76.02 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.294 -0.879 . . . . 0.0 109.388 179.897 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 88' ' ' GLN . . . . . 0.46 ' O ' ' HB2' ' A' ' 92' ' ' GLU . 63.5 tt0 -77.01 -37.6 54.69 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.287 -0.883 . . . . 0.0 109.384 179.933 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 89' ' ' ALA . . . . . 0.572 ' HA ' ' CD1' ' A' ' 61' ' ' PHE . . . -76.49 -35.09 58.57 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.285 -0.884 . . . . 0.0 109.385 179.939 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 90' ' ' VAL . . . . . 0.519 ' O ' ' CB ' ' A' ' 94' ' ' ASN . 75.8 t -71.2 -39.77 73.7 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.513 0 O-C-N 121.325 -0.859 . . . . 0.0 109.464 -179.948 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -77.11 -34.31 56.76 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.209 -0.932 . . . . 0.0 109.496 -179.985 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 92' ' ' GLU . . . . . 0.564 ' HB3' ' CZ ' ' A' ' 61' ' ' PHE . 6.0 tm-20 -80.07 -46.28 16.8 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.215 -0.928 . . . . 0.0 109.644 -179.867 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 93' ' ' LEU . . . . . 0.604 ' CD1' ' CE2' ' A' ' 58' ' ' PHE . 72.6 mt -70.42 -37.69 74.45 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.22 -0.925 . . . . 0.0 109.534 -179.918 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 94' ' ' ASN . . . . . 0.519 ' CB ' ' O ' ' A' ' 90' ' ' VAL . 49.6 t30 -70.12 136.68 50.42 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.231 -0.918 . . . . 0.0 109.462 -179.933 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 83.16 26.32 44.77 Favored Glycine 0 N--CA 1.49 2.279 0 N-CA-C 109.528 -1.429 . . . . 0.0 109.528 179.988 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 96' ' ' THR . . . . . 0.506 ' CG2' ' O ' ' A' ' 92' ' ' GLU . 27.9 p -125.89 146.63 49.75 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.29 -1.123 . . . . 0.0 109.575 -179.982 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 97' ' ' GLN . . . . . 0.502 ' CG ' ' O ' ' A' ' 101' ' ' VAL . 52.7 tt0 -117.92 137.81 52.57 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.293 -0.879 . . . . 0.0 109.424 -179.938 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 1.1 t -80.12 -153.55 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 O-C-N 121.283 -0.886 . . . . 0.0 109.337 -179.983 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 96.5 mt-10 -58.4 -38.31 77.12 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.165 -0.959 . . . . 0.0 109.5 -179.965 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -156.96 25.78 0.32 Allowed 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.183 -0.948 . . . . 0.0 109.483 -179.983 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 101' ' ' VAL . . . . . 0.502 ' O ' ' CG ' ' A' ' 97' ' ' GLN . 49.0 t -137.27 167.41 23.26 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.55 0 O-C-N 121.221 -0.925 . . . . 0.0 109.541 -179.878 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 102' ' ' GLN . . . . . 0.494 ' N ' HG12 ' A' ' 101' ' ' VAL . 92.1 mt-30 -122.61 147.37 46.49 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.248 -0.907 . . . . 0.0 109.126 179.885 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 103' ' ' LEU . . . . . 0.582 ' CD2' ' CG1' ' A' ' 44' ' ' VAL . 0.0 OUTLIER -121.69 135.68 54.96 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.11 -0.994 . . . . 0.0 109.93 -179.802 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 23.9 mttt -118.19 130.88 56.35 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.334 -0.854 . . . . 0.0 109.051 179.694 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 105' ' ' VAL . . . . . 0.453 HG13 ' CG1' ' A' ' 90' ' ' VAL . 21.5 t -109.6 132.56 57.45 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.611 0 O-C-N 121.167 -0.958 . . . . 0.0 109.776 -179.788 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 86.2 m-20 -133.12 -178.49 4.99 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.314 -0.866 . . . . 0.0 109.215 179.778 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 107' ' ' ILE . . . . . 0.402 HG22 HD11 ' A' ' 107' ' ' ILE . 56.2 mt -107.71 135.48 46.18 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.573 0 O-C-N 121.174 -0.954 . . . . 0.0 109.442 179.898 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -108.38 164.29 12.46 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.253 -0.905 . . . . 0.0 109.512 -179.985 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 56.9 ttt180 -47.09 142.68 3.51 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.239 -0.913 . . . . 0.0 109.358 179.957 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 68.1 mttm -59.0 141.13 54.74 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.288 -0.882 . . . . 0.0 109.386 -179.93 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 111' ' ' GLN . . . . . 0.549 ' HB2' ' CE ' ' A' ' 113' ' ' MET . 8.2 pt20 -69.58 144.86 94.58 Favored Pre-proline 0 N--CA 1.49 1.574 0 O-C-N 121.236 -0.915 . . . . 0.0 109.537 -179.851 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 112' ' ' PRO . . . . . 0.432 ' O ' ' N ' ' A' ' 114' ' ' LEU . 52.6 Cg_endo -72.43 -35.54 6.26 Favored 'Trans proline' 0 C--O 1.214 -0.719 0 C-N-CA 122.823 2.348 . . . . 0.0 112.736 -179.491 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 113' ' ' MET . . . . . 0.549 ' CE ' ' HB2' ' A' ' 111' ' ' GLN . 13.2 mtm -42.91 -27.04 0.16 Allowed 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.242 -0.911 . . . . 0.0 109.626 -179.484 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 114' ' ' LEU . . . . . 0.512 ' CD2' ' O ' ' A' ' 114' ' ' LEU . 2.2 tt -174.41 29.25 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.3 -0.875 . . . . 0.0 109.49 -179.895 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 115' ' ' ASP . . . . . 0.516 ' N ' ' O ' ' A' ' 111' ' ' GLN . 75.1 m-20 50.81 33.53 8.69 Favored 'General case' 0 C--N 1.302 -1.478 0 O-C-N 121.248 -0.908 . . . . 0.0 108.685 -179.476 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 116' ' ' ALA . . . . . 0.505 ' CB ' ' O ' ' A' ' 115' ' ' ASP . . . 76.03 -79.8 0.04 OUTLIER 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.411 -0.805 . . . . 0.0 109.54 -179.784 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 117' ' ' ALA . . . . . 0.525 ' CB ' ' HE3' ' A' ' 83' ' ' MET . . . -165.37 24.98 0.05 Allowed 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.273 -0.892 . . . . 0.0 109.775 -179.666 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 118' ' ' THR . . . . . 0.403 ' N ' ' HE2' ' A' ' 83' ' ' MET . 67.3 p -64.65 -11.7 38.16 Favored 'General case' 0 C--N 1.303 -1.449 0 O-C-N 121.174 -0.954 . . . . 0.0 109.572 -179.688 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -56.79 -31.04 60.49 Favored Glycine 0 N--CA 1.491 2.304 0 N-CA-C 109.556 -1.417 . . . . 0.0 109.556 -179.973 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 15.1 tptp -52.48 -34.2 48.23 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.181 -1.188 . . . . 0.0 109.582 -179.933 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 58.0 m . . . . . 0 N--CA 1.489 1.51 0 CA-C-O 118.007 -0.997 . . . . 0.0 109.541 -179.95 . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.577 0 N-CA-C 109.467 -0.568 . . . . 0.0 109.467 . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 49.3 Cg_endo -69.65 -23.2 31.58 Favored 'Trans proline' 0 C--O 1.214 -0.692 0 C-N-CA 122.72 2.28 . . . . 0.0 111.833 179.971 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 65.3 mtt85 -55.88 -41.2 74.08 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.266 -0.896 . . . . 0.0 109.362 179.865 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 38' ' ' LYS . . . . . 0.514 ' HG2' ' CD1' ' A' ' 114' ' ' LEU . 14.2 mttt -63.51 -168.86 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.25 -0.906 . . . . 0.0 109.374 179.924 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . 0.486 ' N ' ' O ' ' A' ' 116' ' ' ALA . . . 160.58 -155.1 26.21 Favored Glycine 0 N--CA 1.488 2.12 0 N-CA-C 109.484 -1.446 . . . . 0.0 109.484 179.791 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 40' ' ' ASN . . . . . 0.519 ' N ' ' OE1' ' A' ' 111' ' ' GLN . 62.0 t30 -165.8 115.31 1.0 Allowed 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.135 -1.214 . . . . 0.0 109.417 179.858 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 41' ' ' THR . . . . . 0.468 HG22 ' N ' ' A' ' 42' ' ' LEU . 54.4 m -77.52 148.22 35.4 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.282 -0.886 . . . . 0.0 109.826 -179.712 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . 0.526 ' CD1' ' O ' ' A' ' 78' ' ' VAL . 4.9 mp -123.79 152.29 42.39 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.352 -0.842 . . . . 0.0 109.386 179.832 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 46.8 t80 -110.22 112.07 23.8 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.246 -0.909 . . . . 0.0 109.358 179.782 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . 0.452 ' HA ' ' O ' ' A' ' 104' ' ' LYS . 48.8 t -108.29 143.88 17.88 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.535 0 O-C-N 121.301 -0.874 . . . . 0.0 109.351 -179.941 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 45' ' ' TYR . . . . . 0.446 ' HB3' ' HB2' ' A' ' 104' ' ' LYS . 71.1 t80 -131.53 135.87 47.39 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.282 -0.886 . . . . 0.0 109.506 -179.931 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . 0.465 ' O ' ' HB3' ' A' ' 74' ' ' ASN . . . 177.57 -170.53 43.0 Favored Glycine 0 N--CA 1.49 2.282 0 N-CA-C 109.476 -1.45 . . . . 0.0 109.476 179.989 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . 0.42 ' O ' ' C ' ' A' ' 48' ' ' ASP . 94.9 mt-10 -124.31 157.36 35.14 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.246 -1.15 . . . . 0.0 109.426 -179.922 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . 0.42 ' C ' ' O ' ' A' ' 47' ' ' GLU . 38.0 m-20 44.48 51.26 7.94 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.274 -0.891 . . . . 0.0 109.552 -179.977 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 60.9 mtm -102.84 137.93 40.4 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.158 -0.964 . . . . 0.0 109.432 179.992 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 50' ' ' THR . . . . . 0.488 ' O ' ' CD1' ' A' ' 54' ' ' LEU . 0.7 OUTLIER -116.29 164.15 19.15 Favored Pre-proline 0 N--CA 1.49 1.551 0 O-C-N 121.197 -0.939 . . . . 0.0 109.599 179.894 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 51' ' ' PRO . . . . . 0.431 ' HA ' HD11 ' A' ' 54' ' ' LEU . 50.4 Cg_endo -70.25 -52.03 0.31 Allowed 'Trans proline' 0 C--O 1.216 -0.594 0 C-N-CA 122.69 2.26 . . . . 0.0 111.715 179.979 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 36.5 m -53.63 -43.17 68.52 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.316 -0.865 . . . . 0.0 109.369 179.993 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . 0.494 ' CD1' ' C ' ' A' ' 53' ' ' LEU . 3.3 tm? -62.02 -46.18 90.31 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.239 -0.913 . . . . 0.0 109.319 179.967 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 54' ' ' LEU . . . . . 0.488 ' CD1' ' O ' ' A' ' 50' ' ' THR . 3.9 mt -62.49 -44.81 95.48 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.285 -0.884 . . . . 0.0 109.441 179.923 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 55' ' ' ARG . . . . . 0.505 ' O ' ' N ' ' A' ' 59' ' ' SER . 83.5 mtt180 -52.29 -39.06 60.02 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.318 -0.864 . . . . 0.0 109.379 179.919 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -70.69 -34.89 66.76 Favored Glycine 0 N--CA 1.49 2.238 0 N-CA-C 109.378 -1.489 . . . . 0.0 109.378 179.968 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -76.05 -23.7 55.11 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.282 -1.128 . . . . 0.0 109.439 179.979 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 58' ' ' PHE . . . . . 0.633 ' CE1' ' CD1' ' A' ' 93' ' ' LEU . 96.8 m-85 -116.17 7.75 14.21 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.146 -0.971 . . . . 0.0 109.46 179.995 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 59' ' ' SER . . . . . 0.515 ' N ' ' HD2' ' A' ' 60' ' ' PRO . 0.5 OUTLIER -73.51 -57.46 2.65 Favored Pre-proline 0 N--CA 1.491 1.608 0 O-C-N 121.291 -0.881 . . . . 0.0 109.96 -179.643 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 60' ' ' PRO . . . . . 0.515 ' HD2' ' N ' ' A' ' 59' ' ' SER . 49.0 Cg_endo -69.25 -33.04 19.43 Favored 'Trans proline' 0 C--O 1.214 -0.711 0 C-N-CA 122.643 2.229 . . . . 0.0 112.28 -179.597 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 61' ' ' PHE . . . . . 0.58 ' CD2' ' HA ' ' A' ' 89' ' ' ALA . 51.0 m-85 -61.64 -33.18 73.49 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.202 -0.936 . . . . 0.0 109.612 -179.874 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 176.65 -173.49 46.33 Favored Glycine 0 N--CA 1.489 2.213 0 N-CA-C 109.533 -1.427 . . . . 0.0 109.533 179.967 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 85.6 m-20 -95.7 147.42 23.62 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.248 -1.149 . . . . 0.0 109.383 -179.957 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 64' ' ' ILE . . . . . 0.427 ' HA ' ' O ' ' A' ' 79' ' ' THR . 53.6 mt -111.14 124.95 68.4 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.522 0 O-C-N 121.205 -0.934 . . . . 0.0 109.525 -179.963 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 31.1 pt -93.8 -26.79 4.53 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.573 0 O-C-N 121.342 -0.849 . . . . 0.0 109.382 179.926 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 66' ' ' ASP . . . . . 0.418 ' HB3' ' OG1' ' A' ' 79' ' ' THR . 58.2 t0 -140.43 130.36 24.65 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.214 -0.929 . . . . 0.0 109.511 179.937 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 7.1 tp -121.46 120.4 34.82 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.239 -0.913 . . . . 0.0 109.438 179.923 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 68' ' ' SER . . . . . 0.442 ' HB3' ' HB2' ' A' ' 77' ' ' PHE . 43.3 t -128.87 140.66 51.59 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.242 -0.911 . . . . 0.0 109.479 -179.985 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 69' ' ' MET . . . . . 0.418 ' SD ' ' HB3' ' A' ' 51' ' ' PRO . 86.7 mtp -123.93 149.61 45.71 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.313 -0.867 . . . . 0.0 109.44 -179.993 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 70' ' ' ASP . . . . . 0.462 ' HB2' ' O ' ' A' ' 75' ' ' CYS . 0.7 OUTLIER -127.81 101.56 23.29 Favored Pre-proline 0 N--CA 1.49 1.555 0 O-C-N 121.251 -0.905 . . . . 0.0 109.433 179.964 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 71' ' ' PRO . . . . . 0.599 ' N ' ' CD ' ' A' ' 72' ' ' PRO . 47.3 Cg_endo -74.75 -27.81 10.2 Favored 'Trans proline' 0 CA--C 1.543 0.932 0 C-N-CA 122.527 2.151 . . . . 0.0 113.69 179.998 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 72' ' ' PRO . . . . . 0.599 ' CD ' ' N ' ' A' ' 71' ' ' PRO . 55.2 Cg_endo -75.41 -23.81 12.8 Favored 'Trans proline' 0 C--N 1.353 0.793 0 C-N-CA 121.496 1.464 . . . . 0.0 111.869 -179.83 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 73' ' ' ARG . . . . . 0.417 ' O ' ' HB2' ' A' ' 74' ' ' ASN . 75.0 mtt85 -111.91 -1.11 15.59 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.197 -0.939 . . . . 0.0 109.666 -179.879 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 74' ' ' ASN . . . . . 0.465 ' HB3' ' O ' ' A' ' 46' ' ' GLY . 8.0 m120 60.78 44.21 11.29 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.133 -0.98 . . . . 0.0 109.519 179.985 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 75' ' ' CYS . . . . . 0.462 ' O ' ' HB2' ' A' ' 70' ' ' ASP . 24.4 p -144.79 140.74 28.67 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.211 -0.931 . . . . 0.0 109.541 -179.921 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -113.67 161.38 17.54 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.222 -0.924 . . . . 0.0 109.36 -180.0 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 77' ' ' PHE . . . . . 0.567 ' CE2' ' NZ ' ' A' ' 110' ' ' LYS . 96.9 m-85 -125.37 137.35 54.03 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.215 -0.928 . . . . 0.0 109.497 -179.9 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . 0.526 ' O ' ' CD1' ' A' ' 42' ' ' LEU . 25.3 t -130.55 139.78 50.44 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.611 0 O-C-N 121.391 -0.818 . . . . 0.0 109.362 179.849 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 79' ' ' THR . . . . . 0.51 ' CG2' ' NE2' ' A' ' 111' ' ' GLN . 2.0 m -110.61 121.28 44.93 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.213 -0.929 . . . . 0.0 109.431 179.936 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 80' ' ' TYR . . . . . 0.525 ' CD2' HD12 ' A' ' 42' ' ' LEU . 1.5 m-85 -99.41 138.41 36.54 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.251 -0.906 . . . . 0.0 109.613 -179.925 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 81' ' ' GLU . . . . . 0.441 ' C ' ' HA2' ' A' ' 39' ' ' GLY . 81.6 tt0 -48.69 -25.79 1.97 Allowed 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.327 -0.858 . . . . 0.0 109.787 179.997 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 48.1 mttp -143.48 159.46 42.36 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.142 -0.974 . . . . 0.0 109.591 -179.938 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 83' ' ' MET . . . . . 0.538 ' HE1' ' CA ' ' A' ' 117' ' ' ALA . 61.8 mtt -72.83 -19.37 61.33 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.292 -0.88 . . . . 0.0 109.357 179.971 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 96.5 mt-10 -68.06 -51.4 47.11 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.277 -0.889 . . . . 0.0 109.513 179.904 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 7.4 m -56.35 -32.46 64.73 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.277 -0.89 . . . . 0.0 109.37 179.863 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 86' ' ' ALA . . . . . 0.478 ' HA ' ' CD2' ' A' ' 80' ' ' TYR . . . -74.12 -27.54 60.91 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.236 -0.915 . . . . 0.0 109.364 -179.999 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 22.1 t70 -69.31 -43.29 74.07 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.224 -0.922 . . . . 0.0 109.457 -179.933 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 88' ' ' GLN . . . . . 0.431 ' O ' ' HB2' ' A' ' 92' ' ' GLU . 61.4 tt0 -69.48 -36.75 76.84 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.289 -0.882 . . . . 0.0 109.416 -179.95 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 89' ' ' ALA . . . . . 0.58 ' HA ' ' CD2' ' A' ' 61' ' ' PHE . . . -74.02 -44.38 54.67 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.221 -0.924 . . . . 0.0 109.446 179.958 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 90' ' ' VAL . . . . . 0.515 ' O ' ' CB ' ' A' ' 94' ' ' ASN . 84.1 t -67.22 -38.19 80.56 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.549 0 O-C-N 121.337 -0.852 . . . . 0.0 109.603 179.984 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -80.06 -29.12 39.15 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.269 -0.894 . . . . 0.0 109.906 -179.681 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 92' ' ' GLU . . . . . 0.542 ' HB3' ' CE2' ' A' ' 61' ' ' PHE . 23.0 tt0 -91.9 -45.59 8.28 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.158 -0.963 . . . . 0.0 109.677 -179.749 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 93' ' ' LEU . . . . . 0.633 ' CD1' ' CE1' ' A' ' 58' ' ' PHE . 21.3 mt -69.35 -43.14 74.21 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.207 -0.933 . . . . 0.0 109.587 -179.925 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 94' ' ' ASN . . . . . 0.515 ' CB ' ' O ' ' A' ' 90' ' ' VAL . 43.8 t30 -63.74 127.11 29.9 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.205 -0.934 . . . . 0.0 109.54 179.988 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 98.79 16.3 31.47 Favored Glycine 0 N--CA 1.49 2.268 0 N-CA-C 109.455 -1.458 . . . . 0.0 109.455 179.985 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 18.1 p -116.54 157.42 25.28 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.183 -1.187 . . . . 0.0 109.383 -179.966 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 59.6 tt0 -117.99 139.55 51.01 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.194 -0.941 . . . . 0.0 109.478 -179.944 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 98' ' ' VAL . . . . . 0.517 HG22 ' CD1' ' A' ' 103' ' ' LEU . 1.2 t -83.83 -149.49 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 121.202 -0.936 . . . . 0.0 109.374 -179.966 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 76.5 mm-40 -60.38 -41.62 94.16 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.226 -0.921 . . . . 0.0 109.501 179.97 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 21.1 t -158.51 31.55 0.23 Allowed 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.293 -0.88 . . . . 0.0 109.426 179.952 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 101' ' ' VAL . . . . . 0.44 ' O ' HG21 ' A' ' 98' ' ' VAL . 58.9 t -147.03 147.86 17.23 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 O-C-N 121.227 -0.921 . . . . 0.0 109.464 179.995 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 91.7 mt-30 -86.43 145.73 26.72 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.253 -0.904 . . . . 0.0 109.574 -179.941 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 103' ' ' LEU . . . . . 0.517 ' CD1' HG22 ' A' ' 98' ' ' VAL . 96.0 mt -109.56 136.13 49.44 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.313 -0.867 . . . . 0.0 109.467 179.948 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 104' ' ' LYS . . . . . 0.452 ' O ' ' HA ' ' A' ' 44' ' ' VAL . 57.3 mttm -122.09 133.55 54.77 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.242 -0.912 . . . . 0.0 109.48 -179.938 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 105' ' ' VAL . . . . . 0.482 HG11 ' CG2' ' A' ' 90' ' ' VAL . 7.0 t -122.01 154.5 26.52 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.527 0 O-C-N 121.241 -0.912 . . . . 0.0 109.602 -179.994 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 106' ' ' ASN . . . . . 0.409 ' OD1' ' O ' ' A' ' 105' ' ' VAL . 73.5 m-20 -158.57 -172.51 3.87 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.287 -0.883 . . . . 0.0 109.425 179.94 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 107' ' ' ILE . . . . . 0.429 HG23 HD12 ' A' ' 107' ' ' ILE . 26.2 mm -110.44 125.61 67.7 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.499 0 O-C-N 121.163 -0.961 . . . . 0.0 109.429 179.946 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -102.92 145.69 29.44 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.209 -0.932 . . . . 0.0 109.534 -179.928 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 38.0 ptt180 -88.26 17.17 5.38 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.269 -0.894 . . . . 0.0 109.447 179.968 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 110' ' ' LYS . . . . . 0.567 ' NZ ' ' CE2' ' A' ' 77' ' ' PHE . 38.3 mttp -68.68 -162.98 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.229 -0.919 . . . . 0.0 109.458 -179.891 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 111' ' ' GLN . . . . . 0.578 ' HG3' ' CE ' ' A' ' 113' ' ' MET . 3.9 tt0 70.52 61.1 0.48 Allowed Pre-proline 0 N--CA 1.49 1.566 0 O-C-N 121.332 -0.855 . . . . 0.0 109.608 -179.942 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 52.4 Cg_endo -70.99 -10.12 26.97 Favored 'Trans proline' 0 C--O 1.214 -0.681 0 C-N-CA 122.764 2.309 . . . . 0.0 111.771 179.87 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 113' ' ' MET . . . . . 0.578 ' CE ' ' HG3' ' A' ' 111' ' ' GLN . 12.5 mtm -67.82 -8.71 38.31 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.314 -0.866 . . . . 0.0 109.488 -179.926 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 114' ' ' LEU . . . . . 0.534 ' CD2' ' O ' ' A' ' 114' ' ' LEU . 2.6 tt 178.07 31.78 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.332 -0.855 . . . . 0.0 109.36 -179.71 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 115' ' ' ASP . . . . . 0.49 ' O ' ' HB3' ' A' ' 116' ' ' ALA . 77.5 m-20 47.78 42.89 16.43 Favored 'General case' 0 C--N 1.3 -1.546 0 N-CA-C 107.994 -1.113 . . . . 0.0 107.994 -179.091 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 116' ' ' ALA . . . . . 0.54 ' HA ' ' CG ' ' A' ' 111' ' ' GLN . . . 68.46 -84.49 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.646 -0.659 . . . . 0.0 109.588 -179.435 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 117' ' ' ALA . . . . . 0.538 ' CA ' ' HE1' ' A' ' 83' ' ' MET . . . -154.74 168.92 25.24 Favored 'General case' 0 C--N 1.3 -1.544 0 O-C-N 121.14 -0.975 . . . . 0.0 109.74 -179.596 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 12.3 p -122.04 163.57 19.17 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.232 -0.918 . . . . 0.0 109.472 -179.837 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -179.81 -163.38 30.38 Favored Glycine 0 N--CA 1.49 2.298 0 N-CA-C 109.388 -1.485 . . . . 0.0 109.388 -179.978 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 32.4 mttt -58.4 -31.59 67.83 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.286 -1.126 . . . . 0.0 109.449 180.0 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 1.5 p . . . . . 0 N--CA 1.49 1.561 0 CA-C-O 118.004 -0.998 . . . . 0.0 109.48 179.972 . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . 0.486 ' N ' ' HD2' ' A' ' 36' ' ' PRO . . . . . . . . 0 N--CA 1.49 1.565 0 N-CA-C 109.473 -0.565 . . . . 0.0 109.473 . . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 36' ' ' PRO . . . . . 0.486 ' HD2' ' N ' ' A' ' 35' ' ' ALA . 49.4 Cg_endo -69.93 -14.13 35.16 Favored 'Trans proline' 0 C--O 1.215 -0.665 0 C-N-CA 122.741 2.294 . . . . 0.0 111.715 -179.991 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 37' ' ' ARG . . . . . 0.46 ' O ' ' HG ' ' A' ' 114' ' ' LEU . 69.0 mtt85 -129.91 129.76 44.29 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.269 -0.894 . . . . 0.0 109.466 -179.964 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 38' ' ' LYS . . . . . 0.506 ' O ' ' CD1' ' A' ' 65' ' ' ILE . 18.0 mttt -104.14 -167.04 1.31 Allowed 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.306 -0.871 . . . . 0.0 109.404 179.953 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . 0.516 ' CA ' HG21 ' A' ' 79' ' ' THR . . . 148.68 89.92 0.08 OUTLIER Glycine 0 N--CA 1.489 2.193 0 N-CA-C 109.778 -1.329 . . . . 0.0 109.778 179.951 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 40' ' ' ASN . . . . . 0.474 ' O ' HD13 ' A' ' 42' ' ' LEU . 60.1 t-20 -84.08 121.51 27.52 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.197 -1.178 . . . . 0.0 109.134 179.634 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 41' ' ' THR . . . . . 0.509 ' CG2' ' HB3' ' A' ' 110' ' ' LYS . 92.6 m -81.96 140.57 33.93 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.241 -0.912 . . . . 0.0 109.956 -179.568 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . 0.512 HD23 ' CG2' ' A' ' 90' ' ' VAL . 5.4 mp -118.05 142.62 47.2 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.375 -0.828 . . . . 0.0 109.077 179.391 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 43' ' ' TYR . . . . . 0.462 ' HB3' ' HB2' ' A' ' 106' ' ' ASN . 59.7 t80 -99.76 109.91 22.32 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.322 -0.861 . . . . 0.0 109.611 -179.851 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . 0.465 ' HA ' ' O ' ' A' ' 104' ' ' LYS . 96.4 t -107.4 143.27 18.27 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.555 0 O-C-N 121.249 -0.907 . . . . 0.0 109.345 179.913 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 74.2 t80 -132.51 135.47 46.01 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.174 -0.954 . . . . 0.0 109.497 -179.891 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 177.9 -175.13 47.35 Favored Glycine 0 N--CA 1.489 2.222 0 N-CA-C 109.554 -1.418 . . . . 0.0 109.554 179.931 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . 0.429 ' O ' ' C ' ' A' ' 48' ' ' ASP . 94.0 mt-10 -114.9 158.51 21.88 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.254 -1.144 . . . . 0.0 109.432 -179.967 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . 0.429 ' C ' ' O ' ' A' ' 47' ' ' GLU . 48.8 m-20 44.07 50.44 7.35 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.302 -0.874 . . . . 0.0 109.444 -179.954 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 54.0 mtm -100.38 135.58 41.59 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.192 -0.943 . . . . 0.0 109.523 179.981 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -122.65 166.04 19.14 Favored Pre-proline 0 N--CA 1.49 1.558 0 O-C-N 121.266 -0.896 . . . . 0.0 109.41 179.946 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 51' ' ' PRO . . . . . 0.447 ' CB ' HD21 ' A' ' 67' ' ' LEU . 49.7 Cg_endo -70.24 -51.67 0.33 Allowed 'Trans proline' 0 C--O 1.214 -0.685 0 C-N-CA 122.671 2.247 . . . . 0.0 111.755 179.969 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 62.8 m -49.36 -48.65 46.54 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.217 -0.927 . . . . 0.0 109.288 179.96 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 18.0 tp -59.6 -47.82 84.06 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.175 -0.953 . . . . 0.0 109.228 179.901 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 12.8 mt -56.08 -45.61 79.29 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.26 -0.9 . . . . 0.0 109.337 179.835 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 55' ' ' ARG . . . . . 0.509 ' O ' ' N ' ' A' ' 59' ' ' SER . 15.3 mtp-105 -51.73 -42.21 62.12 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.355 -0.841 . . . . 0.0 109.286 179.863 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -70.78 -29.11 69.77 Favored Glycine 0 N--CA 1.489 2.232 0 N-CA-C 109.308 -1.517 . . . . 0.0 109.308 179.891 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . 0.461 ' O ' ' CD1' ' A' ' 61' ' ' PHE . . . -79.57 -22.8 43.32 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.267 -1.137 . . . . 0.0 109.432 179.966 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 58' ' ' PHE . . . . . 0.571 ' CZ ' HD12 ' A' ' 93' ' ' LEU . 96.3 m-85 -119.51 7.59 11.17 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.245 -0.909 . . . . 0.0 109.473 179.926 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 59' ' ' SER . . . . . 0.523 ' N ' ' HD2' ' A' ' 60' ' ' PRO . 0.6 OUTLIER -72.7 -57.07 3.41 Favored Pre-proline 0 N--CA 1.49 1.537 0 O-C-N 121.261 -0.899 . . . . 0.0 109.837 -179.888 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 60' ' ' PRO . . . . . 0.523 ' HD2' ' N ' ' A' ' 59' ' ' SER . 49.7 Cg_endo -69.57 -30.46 23.12 Favored 'Trans proline' 0 C--O 1.215 -0.664 0 C-N-CA 122.648 2.232 . . . . 0.0 111.954 -179.822 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 61' ' ' PHE . . . . . 0.538 ' CE2' ' HA ' ' A' ' 89' ' ' ALA . 58.6 m-85 -64.22 -34.38 77.97 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.231 -0.918 . . . . 0.0 109.27 179.965 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 173.62 -173.41 45.79 Favored Glycine 0 N--CA 1.49 2.235 0 N-CA-C 109.4 -1.48 . . . . 0.0 109.4 179.98 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 56.1 t30 -95.57 139.34 31.97 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.235 -1.156 . . . . 0.0 109.566 179.947 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 64' ' ' ILE . . . . . 0.413 HG22 HG11 ' A' ' 78' ' ' VAL . 58.2 mt -101.87 135.03 40.58 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 O-C-N 121.228 -0.92 . . . . 0.0 109.351 179.966 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 65' ' ' ILE . . . . . 0.506 ' CD1' ' O ' ' A' ' 38' ' ' LYS . 24.6 pt -97.72 -23.1 4.72 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.527 0 O-C-N 121.313 -0.867 . . . . 0.0 109.645 -179.963 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 53.2 t0 -149.05 126.87 11.81 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.227 -0.92 . . . . 0.0 109.552 179.981 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . 0.447 HD21 ' CB ' ' A' ' 51' ' ' PRO . 16.2 tp -112.26 117.05 31.45 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.241 -0.912 . . . . 0.0 109.466 179.949 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 68' ' ' SER . . . . . 0.452 ' HB2' ' HB2' ' A' ' 77' ' ' PHE . 68.0 m -123.35 145.61 48.6 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.191 -0.943 . . . . 0.0 109.476 -179.916 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 69' ' ' MET . . . . . 0.46 ' HA ' ' HA ' ' A' ' 76' ' ' ALA . 75.1 mtp -131.53 149.61 52.45 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.209 -0.932 . . . . 0.0 109.556 -179.966 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 70' ' ' ASP . . . . . 0.458 ' C ' ' HD2' ' A' ' 72' ' ' PRO . 2.6 t0 -123.36 104.76 34.28 Favored Pre-proline 0 N--CA 1.49 1.547 0 O-C-N 121.181 -0.949 . . . . 0.0 109.484 179.924 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 71' ' ' PRO . . . . . 0.6 ' N ' ' CD ' ' A' ' 72' ' ' PRO . 46.6 Cg_endo -74.87 -27.73 10.03 Favored 'Trans proline' 0 CA--C 1.543 0.952 0 C-N-CA 122.585 2.19 . . . . 0.0 113.608 -179.944 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 72' ' ' PRO . . . . . 0.6 ' CD ' ' N ' ' A' ' 71' ' ' PRO . 54.6 Cg_endo -75.14 -33.27 4.57 Favored 'Trans proline' 0 C--N 1.354 0.839 0 C-N-CA 121.437 1.425 . . . . 0.0 111.862 -179.82 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 73' ' ' ARG . . . . . 0.441 ' O ' ' HB2' ' A' ' 74' ' ' ASN . 67.5 ttt180 -103.62 -2.17 27.05 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.222 -0.924 . . . . 0.0 109.663 -179.927 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 74' ' ' ASN . . . . . 0.441 ' HB2' ' O ' ' A' ' 73' ' ' ARG . 79.9 m-20 61.88 40.38 12.66 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.177 -0.952 . . . . 0.0 109.505 -179.996 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 75' ' ' CYS . . . . . . . . . . . . . 24.7 p -136.03 137.43 41.16 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.286 -0.884 . . . . 0.0 109.434 -179.943 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . 0.46 ' HA ' ' HA ' ' A' ' 69' ' ' MET . . . -107.61 157.21 18.25 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.317 -0.864 . . . . 0.0 109.49 179.965 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 77' ' ' PHE . . . . . 0.478 ' HA ' ' O ' ' A' ' 42' ' ' LEU . 97.5 m-85 -123.45 131.19 53.57 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.282 -0.886 . . . . 0.0 109.583 -179.959 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . 0.502 ' O ' ' CD1' ' A' ' 42' ' ' LEU . 45.5 t -120.4 134.5 63.67 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 O-C-N 121.261 -0.899 . . . . 0.0 109.7 -179.954 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 79' ' ' THR . . . . . 0.516 HG21 ' CA ' ' A' ' 39' ' ' GLY . 9.1 m -103.48 129.3 50.61 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.256 -0.902 . . . . 0.0 109.471 179.927 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 80' ' ' TYR . . . . . 0.565 ' CG ' ' HB2' ' A' ' 85' ' ' SER . 0.7 OUTLIER -112.07 137.12 50.55 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.192 -0.942 . . . . 0.0 109.542 -179.898 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 81' ' ' GLU . . . . . 0.464 ' O ' ' HB2' ' A' ' 38' ' ' LYS . 84.4 tt0 -57.67 -27.56 62.99 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.26 -0.9 . . . . 0.0 109.48 179.98 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 24.8 mttp -132.59 146.62 52.04 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.174 -0.954 . . . . 0.0 109.426 -179.955 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 83' ' ' MET . . . . . 0.429 ' HE3' ' N ' ' A' ' 117' ' ' ALA . 35.6 mtt -64.73 -20.32 66.28 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.254 -0.904 . . . . 0.0 109.378 179.986 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 98.6 mt-10 -68.26 -37.06 80.35 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.317 -0.865 . . . . 0.0 109.439 179.993 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 85' ' ' SER . . . . . 0.565 ' HB2' ' CG ' ' A' ' 80' ' ' TYR . 18.7 m -61.45 -34.34 75.26 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.276 -0.89 . . . . 0.0 109.455 179.952 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 86' ' ' ALA . . . . . 0.44 ' CB ' HD23 ' A' ' 42' ' ' LEU . . . -76.26 -30.5 57.87 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.326 -0.859 . . . . 0.0 109.437 -179.995 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 54.2 t0 -63.71 -49.52 72.77 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.218 -0.926 . . . . 0.0 109.496 179.93 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 88' ' ' GLN . . . . . 0.447 ' O ' ' HB2' ' A' ' 92' ' ' GLU . 59.0 tt0 -66.72 -38.74 87.31 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.267 -0.896 . . . . 0.0 109.462 -179.988 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 89' ' ' ALA . . . . . 0.538 ' HA ' ' CE2' ' A' ' 61' ' ' PHE . . . -74.1 -49.67 22.89 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.319 -0.863 . . . . 0.0 109.624 -179.979 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 90' ' ' VAL . . . . . 0.52 ' O ' ' CB ' ' A' ' 94' ' ' ASN . 69.8 t -63.22 -37.0 78.28 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.551 0 O-C-N 121.203 -0.935 . . . . 0.0 109.61 -179.846 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -80.16 -37.83 32.6 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.212 -0.93 . . . . 0.0 109.722 -179.775 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 92' ' ' GLU . . . . . 0.522 ' HB3' ' CE2' ' A' ' 61' ' ' PHE . 24.6 tt0 -83.53 -48.78 9.91 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.171 -0.956 . . . . 0.0 109.803 -179.654 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 93' ' ' LEU . . . . . 0.571 HD12 ' CZ ' ' A' ' 58' ' ' PHE . 35.0 mt -64.15 -40.47 96.21 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.187 -0.946 . . . . 0.0 109.683 -179.753 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 94' ' ' ASN . . . . . 0.52 ' CB ' ' O ' ' A' ' 90' ' ' VAL . 56.4 t-20 -63.54 124.31 21.03 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.179 -0.951 . . . . 0.0 109.621 -179.998 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 92.05 29.84 11.02 Favored Glycine 0 N--CA 1.49 2.26 0 N-CA-C 109.502 -1.439 . . . . 0.0 109.502 179.973 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 96' ' ' THR . . . . . 0.449 HG21 ' O ' ' A' ' 93' ' ' LEU . 26.1 p -121.41 158.39 28.43 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.287 -1.125 . . . . 0.0 109.5 179.945 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 63.7 tt0 -122.67 148.93 44.71 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.236 -0.915 . . . . 0.0 109.509 -179.99 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 98' ' ' VAL . . . . . 0.456 HG22 ' O ' ' A' ' 101' ' ' VAL . 1.3 t -100.29 -148.72 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.574 0 O-C-N 121.229 -0.919 . . . . 0.0 109.373 179.971 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 96.4 mt-10 -61.24 -40.6 94.65 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.25 -0.906 . . . . 0.0 109.459 179.99 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 100' ' ' SER . . . . . 0.461 ' O ' HG22 ' A' ' 101' ' ' VAL . 32.0 t -159.36 31.56 0.2 Allowed 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.354 -0.841 . . . . 0.0 109.487 -179.942 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 101' ' ' VAL . . . . . 0.464 HG12 ' N ' ' A' ' 102' ' ' GLN . 48.6 t -148.75 154.73 9.57 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.603 0 O-C-N 121.301 -0.874 . . . . 0.0 109.365 -179.987 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 102' ' ' GLN . . . . . 0.464 ' N ' HG12 ' A' ' 101' ' ' VAL . 88.8 mt-30 -100.99 138.7 37.69 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.294 -0.879 . . . . 0.0 109.455 179.855 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 94.6 mt -106.56 136.95 45.44 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.159 -0.963 . . . . 0.0 109.57 -179.956 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 104' ' ' LYS . . . . . 0.465 ' O ' ' HA ' ' A' ' 44' ' ' VAL . 30.1 mttp -118.87 144.5 46.35 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.346 -0.846 . . . . 0.0 109.296 179.747 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 105' ' ' VAL . . . . . 0.477 HG11 ' CG2' ' A' ' 90' ' ' VAL . 17.4 t -129.23 150.39 34.58 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.585 0 O-C-N 121.231 -0.918 . . . . 0.0 109.661 -179.837 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 106' ' ' ASN . . . . . 0.462 ' HB2' ' HB3' ' A' ' 43' ' ' TYR . 80.5 m-20 -156.88 -167.48 2.38 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.308 -0.87 . . . . 0.0 109.182 179.915 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 107' ' ' ILE . . . . . 0.409 HG22 HD11 ' A' ' 107' ' ' ILE . 68.0 mt -111.76 137.66 43.55 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.552 0 O-C-N 121.103 -0.998 . . . . 0.0 109.475 -179.992 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -133.43 153.27 51.75 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.277 -0.889 . . . . 0.0 109.461 -179.973 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 20.1 mtp180 -99.81 33.01 2.67 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.207 -0.933 . . . . 0.0 109.516 -179.995 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 110' ' ' LYS . . . . . 0.509 ' HB3' ' CG2' ' A' ' 41' ' ' THR . 30.5 tttp -69.26 -9.27 52.36 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.26 -0.9 . . . . 0.0 109.523 -179.94 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 111' ' ' GLN . . . . . 0.529 ' CG ' ' HE3' ' A' ' 113' ' ' MET . 5.1 tp60 -123.43 72.4 48.97 Favored Pre-proline 0 N--CA 1.491 1.593 0 O-C-N 121.262 -0.899 . . . . 0.0 109.475 -179.972 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 112' ' ' PRO . . . . . 0.424 ' O ' ' C ' ' A' ' 113' ' ' MET . 55.6 Cg_endo -82.67 -17.93 7.0 Favored 'Trans proline' 0 C--O 1.215 -0.659 0 C-N-CA 122.826 2.351 . . . . 0.0 112.026 -179.919 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 113' ' ' MET . . . . . 0.529 ' HE3' ' CG ' ' A' ' 111' ' ' GLN . 0.0 OUTLIER -43.26 -29.4 0.4 Allowed 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.234 -0.916 . . . . 0.0 109.758 -179.75 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 114' ' ' LEU . . . . . 0.545 ' CD1' ' O ' ' A' ' 114' ' ' LEU . 1.2 tm? -148.27 22.99 1.05 Allowed 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.207 -0.933 . . . . 0.0 109.091 179.957 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 115' ' ' ASP . . . . . 0.533 ' O ' ' CB ' ' A' ' 116' ' ' ALA . 74.4 m-20 42.75 37.33 1.02 Allowed 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.311 -0.868 . . . . 0.0 109.481 179.943 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 116' ' ' ALA . . . . . 0.533 ' CB ' ' O ' ' A' ' 115' ' ' ASP . . . 76.55 -72.05 0.11 Allowed 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.279 -0.888 . . . . 0.0 109.517 179.995 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 117' ' ' ALA . . . . . 0.439 ' HB3' ' HD3' ' A' ' 38' ' ' LYS . . . -169.88 68.23 0.05 Allowed 'General case' 0 C--N 1.303 -1.437 0 O-C-N 121.341 -0.849 . . . . 0.0 109.658 -179.74 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 56.5 m -124.81 136.45 53.84 Favored 'General case' 0 C--N 1.302 -1.464 0 O-C-N 121.165 -0.96 . . . . 0.0 109.497 -179.985 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -81.91 179.43 53.33 Favored Glycine 0 N--CA 1.49 2.286 0 N-CA-C 109.472 -1.451 . . . . 0.0 109.472 179.964 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 44.6 tttt -56.44 -36.58 69.18 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.217 -1.167 . . . . 0.0 109.469 179.957 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.489 1.511 0 CA-C-O 117.955 -1.021 . . . . 0.0 109.491 -179.985 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . 0.561 ' N ' ' CD ' ' A' ' 36' ' ' PRO . . . . . . . . 0 N--CA 1.49 1.53 0 N-CA-C 109.468 -0.567 . . . . 0.0 109.468 . . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 36' ' ' PRO . . . . . 0.561 ' CD ' ' N ' ' A' ' 35' ' ' ALA . 50.0 Cg_endo -69.66 -22.57 32.34 Favored 'Trans proline' 0 C--O 1.215 -0.641 0 C-N-CA 122.742 2.294 . . . . 0.0 111.771 179.999 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 37' ' ' ARG . . . . . 0.464 ' O ' ' HB2' ' A' ' 114' ' ' LEU . 27.5 ptt180 -152.05 159.65 43.64 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.288 -0.882 . . . . 0.0 109.466 -179.951 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 38' ' ' LYS . . . . . 0.445 ' O ' HD11 ' A' ' 65' ' ' ILE . 27.7 mttm -91.31 -164.71 1.22 Allowed 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.126 -0.984 . . . . 0.0 109.459 179.988 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . 0.535 ' CA ' HG22 ' A' ' 79' ' ' THR . . . 144.14 95.68 0.21 Allowed Glycine 0 N--CA 1.49 2.284 0 N-CA-C 109.559 -1.416 . . . . 0.0 109.559 -179.976 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 40' ' ' ASN . . . . . 0.474 ' O ' ' HA ' ' A' ' 79' ' ' THR . 45.8 t30 -91.69 120.3 32.33 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.159 -1.201 . . . . 0.0 109.718 -179.873 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 41' ' ' THR . . . . . 0.514 ' CG2' ' HB3' ' A' ' 77' ' ' PHE . 24.8 m -77.95 135.33 37.81 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.28 -0.887 . . . . 0.0 109.557 179.899 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . 0.558 HD12 ' CD2' ' A' ' 80' ' ' TYR . 12.7 mt -112.2 144.9 40.84 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.147 -0.971 . . . . 0.0 109.67 179.993 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 43' ' ' TYR . . . . . 0.56 ' CD1' ' HB2' ' A' ' 106' ' ' ASN . 60.2 t80 -94.9 116.9 29.29 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.428 -0.795 . . . . 0.0 109.359 179.676 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . 0.479 ' O ' ' HA ' ' A' ' 75' ' ' CYS . 44.5 t -116.52 135.33 57.14 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.494 0 O-C-N 121.216 -0.927 . . . . 0.0 109.239 179.847 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 45' ' ' TYR . . . . . 0.462 ' HB3' ' HB2' ' A' ' 104' ' ' LYS . 69.1 t80 -123.53 143.53 50.13 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.257 -0.902 . . . . 0.0 109.639 -179.804 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 164.64 174.12 34.03 Favored Glycine 0 N--CA 1.491 2.327 0 N-CA-C 109.444 -1.462 . . . . 0.0 109.444 -179.994 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 95.6 mt-10 -107.98 161.89 14.53 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.293 -1.122 . . . . 0.0 109.419 -179.997 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 21.5 m-20 44.41 58.17 3.96 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.249 -0.907 . . . . 0.0 109.4 179.96 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 49' ' ' MET . . . . . 0.47 ' O ' ' HE1' ' A' ' 69' ' ' MET . 43.2 mtm -111.29 136.76 49.92 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.317 -0.865 . . . . 0.0 109.432 179.954 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 50' ' ' THR . . . . . 0.481 ' O ' ' CD1' ' A' ' 54' ' ' LEU . 0.2 OUTLIER -123.72 166.5 18.54 Favored Pre-proline 0 N--CA 1.492 1.631 0 O-C-N 121.359 -0.838 . . . . 0.0 109.26 179.901 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 51' ' ' PRO . . . . . 0.451 ' HD3' ' SD ' ' A' ' 69' ' ' MET . 50.0 Cg_endo -71.4 -55.39 0.13 Allowed 'Trans proline' 0 C--O 1.214 -0.69 0 C-N-CA 122.495 2.13 . . . . 0.0 111.845 -179.962 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 21.3 m -48.84 -50.38 34.86 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.252 -0.905 . . . . 0.0 109.263 179.783 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 17.6 tp -58.89 -51.04 71.71 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.221 -0.924 . . . . 0.0 109.141 179.777 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 54' ' ' LEU . . . . . 0.481 ' CD1' ' O ' ' A' ' 50' ' ' THR . 14.1 mt -55.59 -49.92 71.48 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.343 -0.848 . . . . 0.0 109.16 179.744 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 55' ' ' ARG . . . . . 0.518 ' O ' ' N ' ' A' ' 59' ' ' SER . 73.0 mtp180 -47.16 -38.13 11.26 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.321 -0.862 . . . . 0.0 109.282 179.741 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -71.29 -31.65 65.94 Favored Glycine 0 N--CA 1.489 2.206 0 N-CA-C 109.369 -1.492 . . . . 0.0 109.369 179.844 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . 0.406 ' O ' HD22 ' A' ' 93' ' ' LEU . . . -76.56 -24.52 53.57 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.188 -1.184 . . . . 0.0 109.372 179.808 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 58' ' ' PHE . . . . . 0.635 ' CE2' ' CD1' ' A' ' 93' ' ' LEU . 91.7 m-85 -116.82 7.57 13.39 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.356 -0.84 . . . . 0.0 109.408 179.92 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 59' ' ' SER . . . . . 0.532 ' N ' ' HD2' ' A' ' 60' ' ' PRO . 0.6 OUTLIER -74.04 -55.68 3.0 Favored Pre-proline 0 N--CA 1.491 1.584 0 O-C-N 121.291 -0.881 . . . . 0.0 110.317 -179.622 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 60' ' ' PRO . . . . . 0.532 ' HD2' ' N ' ' A' ' 59' ' ' SER . 46.6 Cg_endo -68.19 -31.02 30.29 Favored 'Trans proline' 0 C--O 1.215 -0.656 0 C-N-CA 122.521 2.148 . . . . 0.0 112.215 -179.367 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 61' ' ' PHE . . . . . 0.566 ' CD1' ' HA ' ' A' ' 89' ' ' ALA . 70.1 m-85 -65.69 -30.4 71.08 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.116 -0.99 . . . . 0.0 109.491 -179.969 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . 0.469 ' HA3' ' OG ' ' A' ' 85' ' ' SER . . . 175.61 -165.76 36.74 Favored Glycine 0 N--CA 1.49 2.297 0 N-CA-C 109.421 -1.472 . . . . 0.0 109.421 179.956 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 85.4 m-20 -103.87 134.47 47.11 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.29 -1.124 . . . . 0.0 109.499 179.961 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 64' ' ' ILE . . . . . 0.442 HG22 HG21 ' A' ' 78' ' ' VAL . 76.1 mt -95.78 140.35 17.24 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.575 0 O-C-N 121.297 -0.877 . . . . 0.0 109.565 -179.951 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 65' ' ' ILE . . . . . 0.532 ' CD1' ' HA3' ' A' ' 39' ' ' GLY . 26.2 pt -100.84 -24.49 4.07 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 O-C-N 121.302 -0.873 . . . . 0.0 109.452 179.922 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 40.2 t0 -149.35 140.79 23.31 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.251 -0.906 . . . . 0.0 109.573 -179.863 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . 0.491 ' C ' ' CD1' ' A' ' 67' ' ' LEU . 2.2 tm? -118.76 104.93 11.05 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.283 -0.886 . . . . 0.0 109.136 179.785 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 68' ' ' SER . . . . . 0.47 ' HB3' ' HB2' ' A' ' 77' ' ' PHE . 46.5 t -108.65 141.07 41.15 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.226 -0.921 . . . . 0.0 109.55 -179.891 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 69' ' ' MET . . . . . 0.478 ' HA ' ' HA ' ' A' ' 76' ' ' ALA . 63.2 mtp -133.63 141.62 47.72 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.3 -0.875 . . . . 0.0 109.504 -179.986 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 70' ' ' ASP . . . . . 0.449 ' C ' ' HD2' ' A' ' 72' ' ' PRO . 0.9 OUTLIER -124.51 107.16 29.61 Favored Pre-proline 0 N--CA 1.49 1.562 0 O-C-N 121.332 -0.855 . . . . 0.0 109.378 -179.971 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 71' ' ' PRO . . . . . 0.601 ' N ' ' CD ' ' A' ' 72' ' ' PRO . 47.1 Cg_endo -74.91 -27.85 9.85 Favored 'Trans proline' 0 CA--C 1.542 0.883 0 C-N-CA 122.495 2.13 . . . . 0.0 113.747 -179.908 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 72' ' ' PRO . . . . . 0.601 ' CD ' ' N ' ' A' ' 71' ' ' PRO . 54.4 Cg_endo -74.84 -25.66 12.0 Favored 'Trans proline' 0 C--N 1.353 0.772 0 C-N-CA 121.446 1.431 . . . . 0.0 111.745 -179.771 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 75.3 mtp180 -110.46 0.9 17.98 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.273 -0.892 . . . . 0.0 109.62 -179.833 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 66.2 m-20 56.39 48.56 16.72 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.153 -0.967 . . . . 0.0 109.512 179.943 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 75' ' ' CYS . . . . . 0.479 ' HA ' ' O ' ' A' ' 44' ' ' VAL . 26.6 p -148.18 135.73 20.67 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.186 -0.946 . . . . 0.0 109.46 -179.973 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . 0.478 ' HA ' ' HA ' ' A' ' 69' ' ' MET . . . -110.37 133.67 53.04 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.159 -0.963 . . . . 0.0 109.74 -179.994 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 77' ' ' PHE . . . . . 0.514 ' HB3' ' CG2' ' A' ' 41' ' ' THR . 12.0 m-30 -103.79 108.39 19.68 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.335 -0.853 . . . . 0.0 109.33 179.935 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . 0.466 ' O ' ' N ' ' A' ' 42' ' ' LEU . 1.8 p -105.76 141.28 21.44 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.405 0 O-C-N 121.144 -0.973 . . . . 0.0 109.401 179.979 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 79' ' ' THR . . . . . 0.535 HG22 ' CA ' ' A' ' 39' ' ' GLY . 11.5 m -97.47 155.42 16.94 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.138 -0.976 . . . . 0.0 109.874 -179.692 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 80' ' ' TYR . . . . . 0.558 ' CD2' HD12 ' A' ' 42' ' ' LEU . 0.1 OUTLIER -130.51 129.26 42.65 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.329 -0.857 . . . . 0.0 109.546 179.955 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 81' ' ' GLU . . . . . 0.43 ' O ' ' HB2' ' A' ' 38' ' ' LYS . 69.3 tt0 -44.25 -34.5 1.92 Allowed 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.205 -0.934 . . . . 0.0 109.489 179.88 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 33.5 mttm -141.43 152.18 44.05 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.119 -0.988 . . . . 0.0 109.596 -179.774 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 83' ' ' MET . . . . . 0.519 ' HE1' ' CB ' ' A' ' 117' ' ' ALA . 45.8 mtt -63.89 -26.72 68.73 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.352 -0.843 . . . . 0.0 109.415 179.973 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 96.4 mt-10 -56.27 -49.09 75.21 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.292 -0.88 . . . . 0.0 109.475 -179.976 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 85' ' ' SER . . . . . 0.555 ' OG ' ' CE1' ' A' ' 80' ' ' TYR . 41.5 t -61.04 -32.05 71.68 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.213 -0.929 . . . . 0.0 109.381 179.864 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 86' ' ' ALA . . . . . 0.521 ' HB3' ' CD2' ' A' ' 42' ' ' LEU . . . -76.04 -33.42 59.62 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.308 -0.87 . . . . 0.0 109.774 -179.757 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 22.3 t70 -70.13 -43.77 70.28 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.145 -0.972 . . . . 0.0 109.725 -179.732 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 62.6 tt0 -71.14 -39.08 72.19 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.265 -0.897 . . . . 0.0 109.877 -179.717 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 89' ' ' ALA . . . . . 0.566 ' HA ' ' CD1' ' A' ' 61' ' ' PHE . . . -73.72 -43.38 59.35 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.154 -0.966 . . . . 0.0 109.741 -179.745 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 90' ' ' VAL . . . . . 0.527 ' O ' ' CB ' ' A' ' 94' ' ' ASN . 74.3 t -61.26 -31.88 51.49 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.598 0 O-C-N 121.195 -0.941 . . . . 0.0 109.667 -179.778 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -78.96 -53.32 7.17 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.272 -0.892 . . . . 0.0 109.732 -179.857 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 92' ' ' GLU . . . . . 0.514 ' HB2' ' CE1' ' A' ' 61' ' ' PHE . 75.2 mm-40 -69.53 -41.45 75.97 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.224 -0.922 . . . . 0.0 109.928 -179.632 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 93' ' ' LEU . . . . . 0.635 ' CD1' ' CE2' ' A' ' 58' ' ' PHE . 81.2 mt -69.55 -40.55 76.76 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.074 -1.016 . . . . 0.0 109.642 -179.806 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 94' ' ' ASN . . . . . 0.527 ' CB ' ' O ' ' A' ' 90' ' ' VAL . 59.1 t30 -71.47 126.41 29.59 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.201 -0.937 . . . . 0.0 109.497 -179.945 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 99.09 20.0 19.7 Favored Glycine 0 N--CA 1.489 2.182 0 N-CA-C 109.515 -1.434 . . . . 0.0 109.515 179.94 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 96' ' ' THR . . . . . 0.409 ' CG2' ' O ' ' A' ' 92' ' ' GLU . 20.5 p -121.92 159.94 25.84 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.301 -1.117 . . . . 0.0 109.504 179.964 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 63.9 tt0 -125.35 149.08 48.45 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.334 -0.854 . . . . 0.0 109.453 -179.969 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 98' ' ' VAL . . . . . 0.529 ' CG2' HG13 ' A' ' 101' ' ' VAL . 1.4 t -93.78 -148.68 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 O-C-N 121.206 -0.934 . . . . 0.0 109.35 -179.982 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 95.9 mt-10 -56.69 -44.64 81.7 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.164 -0.96 . . . . 0.0 109.449 -179.977 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 3.5 p -157.2 21.21 0.3 Allowed 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.282 -0.886 . . . . 0.0 109.449 179.974 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 101' ' ' VAL . . . . . 0.529 HG13 ' CG2' ' A' ' 98' ' ' VAL . 8.7 p -129.03 139.5 51.73 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.524 0 O-C-N 121.231 -0.918 . . . . 0.0 109.519 -179.943 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 95.3 mt-30 -87.1 136.51 32.9 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.2 -0.937 . . . . 0.0 109.387 179.959 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 97.8 mt -100.87 144.26 30.04 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.23 -0.919 . . . . 0.0 109.667 -179.934 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 104' ' ' LYS . . . . . 0.462 ' HB2' ' HB3' ' A' ' 45' ' ' TYR . 45.1 mttt -134.66 142.09 46.76 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.263 -0.898 . . . . 0.0 109.252 179.869 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 105' ' ' VAL . . . . . 0.51 HG13 ' CG2' ' A' ' 90' ' ' VAL . 25.5 t -126.28 138.21 55.34 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 O-C-N 121.225 -0.922 . . . . 0.0 109.686 -179.932 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 106' ' ' ASN . . . . . 0.56 ' HB2' ' CD1' ' A' ' 43' ' ' TYR . 80.1 m-20 -138.83 -161.19 1.15 Allowed 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.303 -0.873 . . . . 0.0 109.259 179.871 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 24.2 mm -107.65 134.14 50.32 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.526 0 O-C-N 121.144 -0.973 . . . . 0.0 109.462 -179.971 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 108' ' ' ALA . . . . . 0.407 ' HB3' ' HB2' ' A' ' 43' ' ' TYR . . . -131.82 157.19 44.56 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.313 -0.867 . . . . 0.0 109.521 179.948 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 37.9 mtm180 -131.47 121.44 24.53 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.245 -0.909 . . . . 0.0 109.561 179.951 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 110' ' ' LYS . . . . . 0.452 ' HG2' ' O ' ' A' ' 110' ' ' LYS . 55.9 tttm -173.09 34.03 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.276 -0.89 . . . . 0.0 109.372 179.96 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 111' ' ' GLN . . . . . 0.542 ' HG3' ' CE ' ' A' ' 113' ' ' MET . 7.4 tp-100 -130.5 83.47 62.19 Favored Pre-proline 0 N--CA 1.489 1.506 0 O-C-N 121.406 -0.808 . . . . 0.0 109.334 -179.948 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 112' ' ' PRO . . . . . 0.438 ' O ' ' C ' ' A' ' 113' ' ' MET . 51.2 Cg_endo -71.71 -29.49 15.75 Favored 'Trans proline' 0 C--O 1.214 -0.69 0 C-N-CA 122.696 2.264 . . . . 0.0 112.369 -179.6 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 113' ' ' MET . . . . . 0.542 ' CE ' ' HG3' ' A' ' 111' ' ' GLN . 0.0 OUTLIER -43.11 -27.19 0.19 Allowed 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.256 -0.903 . . . . 0.0 109.398 179.949 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 114' ' ' LEU . . . . . 0.464 ' HB2' ' O ' ' A' ' 37' ' ' ARG . 2.7 tt -161.59 27.77 0.13 Allowed 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.409 -0.807 . . . . 0.0 109.298 179.88 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 115' ' ' ASP . . . . . 0.513 ' O ' ' CB ' ' A' ' 116' ' ' ALA . 80.4 m-20 52.73 47.53 24.48 Favored 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.139 -0.976 . . . . 0.0 108.812 -179.561 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 116' ' ' ALA . . . . . 0.513 ' CB ' ' O ' ' A' ' 115' ' ' ASP . . . 76.16 -74.85 0.07 Allowed 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.367 -0.833 . . . . 0.0 109.239 -179.55 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 117' ' ' ALA . . . . . 0.519 ' CB ' ' HE1' ' A' ' 83' ' ' MET . . . -169.78 168.29 8.98 Favored 'General case' 0 C--N 1.304 -1.399 0 O-C-N 121.351 -0.843 . . . . 0.0 109.465 -179.897 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 13.5 t -115.87 162.73 16.9 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.275 -0.891 . . . . 0.0 109.414 179.979 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -177.34 179.51 48.07 Favored Glycine 0 N--CA 1.489 2.217 0 N-CA-C 109.379 -1.488 . . . . 0.0 109.379 -179.923 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 93.7 mttt -116.28 143.12 45.94 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.23 -1.159 . . . . 0.0 109.57 -179.982 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.49 1.53 0 CA-C-O 118.04 -0.981 . . . . 0.0 109.457 179.995 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.578 0 N-CA-C 109.435 -0.58 . . . . 0.0 109.435 . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 48.5 Cg_endo -69.91 138.67 37.88 Favored 'Trans proline' 0 C--O 1.214 -0.701 0 C-N-CA 122.696 2.264 . . . . 0.0 111.789 179.946 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 37' ' ' ARG . . . . . 0.508 ' HG3' ' N ' ' A' ' 38' ' ' LYS . 24.1 tpt180 -117.28 149.69 40.03 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.251 -0.906 . . . . 0.0 109.355 -179.915 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 38' ' ' LYS . . . . . 0.508 ' N ' ' HG3' ' A' ' 37' ' ' ARG . 25.3 mttt -77.36 -165.04 0.53 Allowed 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.236 -0.915 . . . . 0.0 109.716 -179.828 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . 0.525 ' CA ' ' O ' ' A' ' 80' ' ' TYR . . . 155.85 -167.38 33.19 Favored Glycine 0 N--CA 1.49 2.277 0 N-CA-C 109.505 -1.438 . . . . 0.0 109.505 -179.932 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 40' ' ' ASN . . . . . 0.464 ' O ' ' HA ' ' A' ' 79' ' ' THR . 49.6 t-20 -159.71 122.71 3.54 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.131 -1.217 . . . . 0.0 109.535 179.974 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 41' ' ' THR . . . . . 0.471 ' HA ' ' HA ' ' A' ' 79' ' ' THR . 35.8 m -80.75 138.86 36.32 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.25 -0.906 . . . . 0.0 109.499 -179.997 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . 0.544 HD13 ' CD2' ' A' ' 80' ' ' TYR . 9.9 mt -120.13 151.05 39.64 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.211 -0.931 . . . . 0.0 109.626 179.941 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 43' ' ' TYR . . . . . 0.464 ' HB2' ' HB2' ' A' ' 108' ' ' ALA . 69.0 t80 -106.29 124.92 50.33 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.236 -0.915 . . . . 0.0 109.341 179.867 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . 0.453 ' O ' ' HA ' ' A' ' 75' ' ' CYS . 80.2 t -122.14 137.73 54.73 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.534 0 O-C-N 121.22 -0.925 . . . . 0.0 109.467 -179.941 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 45' ' ' TYR . . . . . 0.447 ' HB3' ' HB2' ' A' ' 104' ' ' LYS . 71.0 t80 -121.07 133.58 55.24 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.276 -0.89 . . . . 0.0 109.423 179.909 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -175.73 -175.37 43.08 Favored Glycine 0 N--CA 1.49 2.277 0 N-CA-C 109.482 -1.447 . . . . 0.0 109.482 -179.974 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 94.0 mt-10 -121.41 146.53 46.79 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.212 -1.17 . . . . 0.0 109.45 179.983 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 58.4 t0 47.79 52.97 12.03 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.277 -0.889 . . . . 0.0 109.481 -179.952 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 67.5 mtm -95.7 138.09 33.85 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.27 -0.894 . . . . 0.0 109.454 -179.929 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 50' ' ' THR . . . . . 0.477 ' CG2' ' HD2' ' A' ' 51' ' ' PRO . 0.0 OUTLIER -110.8 161.5 24.57 Favored Pre-proline 0 N--CA 1.49 1.543 0 O-C-N 121.23 -0.919 . . . . 0.0 109.48 179.979 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 51' ' ' PRO . . . . . 0.477 ' HD2' ' CG2' ' A' ' 50' ' ' THR . 49.4 Cg_endo -70.12 -52.5 0.3 Allowed 'Trans proline' 0 C--O 1.215 -0.648 0 C-N-CA 122.743 2.295 . . . . 0.0 111.674 -179.959 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 37.1 m -56.27 -44.49 79.81 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.322 -0.861 . . . . 0.0 109.383 179.995 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . 0.491 ' CD1' ' C ' ' A' ' 53' ' ' LEU . 3.1 tm? -60.45 -46.56 89.61 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.241 -0.912 . . . . 0.0 109.405 179.931 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 54' ' ' LEU . . . . . 0.506 ' CD1' ' SD ' ' A' ' 69' ' ' MET . 42.7 mt -62.81 -48.03 80.85 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.242 -0.911 . . . . 0.0 109.356 -179.916 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 55' ' ' ARG . . . . . 0.467 ' O ' ' N ' ' A' ' 59' ' ' SER . 48.0 mtt180 -48.53 -39.82 24.79 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.248 -0.907 . . . . 0.0 109.392 179.936 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -69.09 -34.78 76.73 Favored Glycine 0 N--CA 1.49 2.289 0 N-CA-C 109.312 -1.515 . . . . 0.0 109.312 179.881 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . 0.459 ' O ' HD22 ' A' ' 93' ' ' LEU . . . -71.26 -25.03 62.29 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.288 -1.125 . . . . 0.0 109.414 179.921 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 58' ' ' PHE . . . . . 0.616 ' CE2' ' CD1' ' A' ' 93' ' ' LEU . 76.2 m-85 -116.81 10.3 14.16 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.323 -0.86 . . . . 0.0 109.463 -179.979 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 59' ' ' SER . . . . . 0.538 ' N ' ' HD2' ' A' ' 60' ' ' PRO . 1.4 t -76.46 -53.74 1.99 Allowed Pre-proline 0 N--CA 1.492 1.63 0 O-C-N 121.3 -0.875 . . . . 0.0 110.473 -179.558 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 60' ' ' PRO . . . . . 0.538 ' HD2' ' N ' ' A' ' 59' ' ' SER . 47.8 Cg_endo -68.88 -34.03 18.8 Favored 'Trans proline' 0 C--O 1.215 -0.659 0 C-N-CA 122.405 2.07 . . . . 0.0 112.388 -179.152 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 61' ' ' PHE . . . . . 0.569 ' CE1' ' HB2' ' A' ' 92' ' ' GLU . 87.8 m-85 -63.52 -37.04 85.8 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.057 -1.027 . . . . 0.0 109.502 -179.971 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . 0.467 ' HA3' ' OG ' ' A' ' 85' ' ' SER . . . -178.74 -172.63 43.29 Favored Glycine 0 N--CA 1.49 2.27 0 N-CA-C 109.599 -1.4 . . . . 0.0 109.599 179.94 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 51.5 t-20 -96.99 136.81 37.03 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.266 -1.138 . . . . 0.0 109.577 -179.914 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 64' ' ' ILE . . . . . 0.459 HG22 HD22 ' A' ' 67' ' ' LEU . 54.6 mt -98.51 131.29 45.93 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 O-C-N 121.209 -0.932 . . . . 0.0 109.532 -179.946 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 65' ' ' ILE . . . . . 0.529 ' CG1' HG22 ' A' ' 79' ' ' THR . 18.6 pt -95.58 -19.31 6.35 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 O-C-N 121.32 -0.862 . . . . 0.0 109.579 -179.902 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 59.6 t0 -152.38 106.25 3.11 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.205 -0.934 . . . . 0.0 109.591 -179.99 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . 0.484 ' C ' ' CD1' ' A' ' 67' ' ' LEU . 0.5 OUTLIER -99.22 120.22 39.16 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.27 -0.894 . . . . 0.0 109.375 179.755 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 68' ' ' SER . . . . . 0.429 ' N ' HD12 ' A' ' 67' ' ' LEU . 67.9 m -131.62 151.15 51.83 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.174 -0.954 . . . . 0.0 109.691 -179.793 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 69' ' ' MET . . . . . 0.506 ' SD ' ' CD1' ' A' ' 54' ' ' LEU . 18.2 mtm -130.94 144.62 51.6 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.309 -0.869 . . . . 0.0 109.346 179.886 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 70' ' ' ASP . . . . . 0.519 ' CB ' ' O ' ' A' ' 75' ' ' CYS . 0.9 OUTLIER -118.89 102.78 48.99 Favored Pre-proline 0 N--CA 1.491 1.604 0 O-C-N 121.22 -0.925 . . . . 0.0 109.533 -179.885 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 71' ' ' PRO . . . . . 0.601 ' N ' ' CD ' ' A' ' 72' ' ' PRO . 47.7 Cg_endo -74.9 -27.75 9.96 Favored 'Trans proline' 0 CA--C 1.542 0.888 0 C-N-CA 122.608 2.205 . . . . 0.0 113.697 179.886 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 72' ' ' PRO . . . . . 0.601 ' CD ' ' N ' ' A' ' 71' ' ' PRO . 55.4 Cg_endo -75.09 -25.16 11.98 Favored 'Trans proline' 0 C--N 1.353 0.814 0 C-N-CA 121.446 1.431 . . . . 0.0 111.809 -179.795 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 48.3 mtt85 -111.9 10.03 20.64 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.282 -0.886 . . . . 0.0 109.587 -179.946 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 83.1 m-20 53.3 36.61 23.24 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.249 -0.907 . . . . 0.0 109.506 -179.987 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 75' ' ' CYS . . . . . 0.519 ' O ' ' CB ' ' A' ' 70' ' ' ASP . 28.1 p -142.81 146.67 34.42 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.214 -0.929 . . . . 0.0 109.527 -179.868 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . 0.457 ' HA ' ' HA ' ' A' ' 69' ' ' MET . . . -114.17 162.48 16.47 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.188 -0.945 . . . . 0.0 109.553 -179.977 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 77' ' ' PHE . . . . . 0.406 ' CE1' ' HD1' ' A' ' 43' ' ' TYR . 96.7 m-85 -127.62 108.99 11.25 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.362 -0.836 . . . . 0.0 109.359 179.933 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . 0.523 ' CG1' ' HB2' ' A' ' 42' ' ' LEU . 6.1 p -109.67 135.58 48.22 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.449 0 O-C-N 121.247 -0.908 . . . . 0.0 109.624 -179.854 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 79' ' ' THR . . . . . 0.529 HG22 ' CG1' ' A' ' 65' ' ' ILE . 91.7 m -106.63 128.8 54.45 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.249 -0.907 . . . . 0.0 109.273 179.797 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 80' ' ' TYR . . . . . 0.544 ' CD2' HD13 ' A' ' 42' ' ' LEU . 0.9 OUTLIER -94.93 174.22 7.2 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.336 -0.852 . . . . 0.0 109.527 179.978 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 81' ' ' GLU . . . . . 0.479 ' O ' ' CG ' ' A' ' 82' ' ' LYS . 81.7 tt0 -86.37 -11.77 51.12 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.44 -0.787 . . . . 0.0 109.177 179.66 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 82' ' ' LYS . . . . . 0.479 ' CG ' ' O ' ' A' ' 81' ' ' GLU . 43.0 mttp -157.91 158.83 35.78 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.324 -0.86 . . . . 0.0 109.267 179.934 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 83' ' ' MET . . . . . 0.523 ' CE ' ' O ' ' A' ' 117' ' ' ALA . 31.4 mtt -71.83 -12.13 61.14 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.238 -0.914 . . . . 0.0 109.384 -179.947 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . 0.43 ' HA ' ' OE1' ' A' ' 84' ' ' GLU . 70.7 mm-40 -76.4 -40.11 51.77 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.317 -0.865 . . . . 0.0 109.609 179.93 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 85' ' ' SER . . . . . 0.467 ' OG ' ' HA3' ' A' ' 62' ' ' GLY . 29.1 t -65.45 -35.44 80.93 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.255 -0.903 . . . . 0.0 109.481 179.96 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 86' ' ' ALA . . . . . 0.532 ' HB1' ' CD2' ' A' ' 42' ' ' LEU . . . -71.83 -35.78 70.0 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.425 -0.797 . . . . 0.0 109.764 -179.918 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 64.5 t0 -65.32 -43.64 90.38 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.158 -0.964 . . . . 0.0 109.786 -179.814 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 64.8 tt0 -72.57 -38.85 67.8 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.197 -0.939 . . . . 0.0 109.82 -179.745 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 89' ' ' ALA . . . . . 0.551 ' HA ' ' CD1' ' A' ' 61' ' ' PHE . . . -73.89 -42.12 61.16 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.206 -0.934 . . . . 0.0 109.745 -179.708 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 90' ' ' VAL . . . . . 0.476 ' O ' ' CB ' ' A' ' 94' ' ' ASN . 51.1 t -62.07 -34.37 63.02 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.564 0 O-C-N 121.243 -0.91 . . . . 0.0 109.74 -179.79 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -76.03 -53.74 7.91 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.185 -0.947 . . . . 0.0 109.867 -179.678 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 92' ' ' GLU . . . . . 0.569 ' HB2' ' CE1' ' A' ' 61' ' ' PHE . 75.1 mm-40 -69.24 -44.37 72.13 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.196 -0.94 . . . . 0.0 109.9 -179.634 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 93' ' ' LEU . . . . . 0.616 ' CD1' ' CE2' ' A' ' 58' ' ' PHE . 69.8 mt -65.45 -36.84 85.12 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.109 -0.994 . . . . 0.0 109.709 -179.753 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 94' ' ' ASN . . . . . 0.476 ' CB ' ' O ' ' A' ' 90' ' ' VAL . 63.1 t-20 -72.99 125.38 27.47 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.169 -0.957 . . . . 0.0 109.452 -179.888 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 95.29 26.52 12.11 Favored Glycine 0 N--CA 1.49 2.263 0 N-CA-C 109.515 -1.434 . . . . 0.0 109.515 179.908 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 96' ' ' THR . . . . . 0.489 ' CG2' ' O ' ' A' ' 92' ' ' GLU . 17.7 p -121.47 155.3 35.2 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.23 -1.159 . . . . 0.0 109.469 -179.969 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 64.2 tt0 -128.74 153.08 47.71 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.257 -0.902 . . . . 0.0 109.481 -179.97 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 1.2 t -98.33 -152.58 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.627 0 O-C-N 121.235 -0.916 . . . . 0.0 109.254 -179.897 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 75.7 mm-40 -59.79 -39.13 83.89 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.168 -0.957 . . . . 0.0 109.475 179.943 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -157.6 24.85 0.28 Allowed 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.327 -0.858 . . . . 0.0 109.485 -179.958 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 47.4 t -137.57 152.5 27.19 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.552 0 O-C-N 121.165 -0.96 . . . . 0.0 109.498 179.998 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 91.8 mt-30 -108.42 145.08 35.14 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.268 -0.895 . . . . 0.0 109.483 179.937 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 93.3 mt -111.95 145.35 39.75 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.225 -0.922 . . . . 0.0 109.525 -179.961 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 104' ' ' LYS . . . . . 0.447 ' HB2' ' HB3' ' A' ' 45' ' ' TYR . 43.8 mttt -127.33 133.1 50.13 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.264 -0.897 . . . . 0.0 109.406 179.912 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 105' ' ' VAL . . . . . 0.513 ' O ' ' ND2' ' A' ' 106' ' ' ASN . 21.9 t -116.9 133.41 63.7 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.514 0 O-C-N 121.217 -0.927 . . . . 0.0 109.576 -179.866 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 106' ' ' ASN . . . . . 0.513 ' ND2' ' O ' ' A' ' 105' ' ' VAL . 14.8 m120 -137.76 -172.77 3.32 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.31 -0.869 . . . . 0.0 109.368 179.908 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 24.4 mm -104.88 126.55 59.77 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.518 0 O-C-N 121.18 -0.95 . . . . 0.0 109.426 179.965 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 108' ' ' ALA . . . . . 0.464 ' HB2' ' HB2' ' A' ' 43' ' ' TYR . . . -106.39 166.75 10.31 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.218 -0.926 . . . . 0.0 109.474 -179.917 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 85.3 mtm-85 -51.2 148.35 4.71 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.262 -0.898 . . . . 0.0 109.409 179.883 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 110' ' ' LYS . . . . . 0.467 ' HD3' ' O ' ' A' ' 115' ' ' ASP . 73.5 mttt -71.59 142.99 49.99 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.273 -0.892 . . . . 0.0 109.392 179.981 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 111' ' ' GLN . . . . . 0.556 ' HB2' ' CE ' ' A' ' 113' ' ' MET . 0.9 OUTLIER -63.04 145.61 96.52 Favored Pre-proline 0 N--CA 1.49 1.538 0 O-C-N 121.259 -0.9 . . . . 0.0 109.715 -179.78 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 55.3 Cg_endo -74.65 -15.34 21.72 Favored 'Trans proline' 0 C--O 1.214 -0.703 0 C-N-CA 122.835 2.357 . . . . 0.0 112.987 -179.313 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 113' ' ' MET . . . . . 0.556 ' CE ' ' HB2' ' A' ' 111' ' ' GLN . 6.5 mtm -62.38 -16.28 53.7 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 120.8 -1.187 . . . . 0.0 109.26 -179.764 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 114' ' ' LEU . . . . . 0.508 ' CD2' ' HA ' ' A' ' 117' ' ' ALA . 1.1 tt 178.27 31.69 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.394 -0.817 . . . . 0.0 109.42 -179.679 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 115' ' ' ASP . . . . . 0.523 ' O ' ' CB ' ' A' ' 116' ' ' ALA . 76.6 m-20 50.42 40.23 22.51 Favored 'General case' 0 C--N 1.302 -1.498 0 O-C-N 121.218 -0.927 . . . . 0.0 108.63 -179.417 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 116' ' ' ALA . . . . . 0.523 ' CB ' ' O ' ' A' ' 115' ' ' ASP . . . 77.55 -78.54 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.498 -0.751 . . . . 0.0 109.428 -179.618 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 117' ' ' ALA . . . . . 0.523 ' O ' ' CE ' ' A' ' 83' ' ' MET . . . -164.84 152.91 11.89 Favored 'General case' 0 N--CA 1.487 1.405 0 O-C-N 121.284 -0.885 . . . . 0.0 109.758 -179.785 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 118' ' ' THR . . . . . 0.4 HG22 ' C ' ' A' ' 117' ' ' ALA . 16.6 p -134.25 169.46 17.17 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.288 -0.882 . . . . 0.0 109.426 179.842 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 92.32 8.81 62.45 Favored Glycine 0 N--CA 1.491 2.341 0 N-CA-C 109.48 -1.448 . . . . 0.0 109.48 179.976 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 29.2 tttm -73.13 133.26 44.05 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.252 -1.146 . . . . 0.0 109.47 -179.994 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 N--CA 1.49 1.562 0 CA-C-O 118.017 -0.992 . . . . 0.0 109.447 179.999 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.571 0 N-CA-C 109.485 -0.561 . . . . 0.0 109.485 . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 48.9 Cg_endo -69.69 149.99 68.04 Favored 'Trans proline' 0 C--O 1.214 -0.718 0 C-N-CA 122.796 2.331 . . . . 0.0 111.72 -179.936 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 37' ' ' ARG . . . . . 0.493 ' CB ' HD13 ' A' ' 114' ' ' LEU . 79.1 mtm180 -102.1 -7.94 21.84 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.266 -0.896 . . . . 0.0 109.525 179.985 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 38' ' ' LYS . . . . . 0.508 ' O ' ' CD1' ' A' ' 65' ' ' ILE . 43.7 mttp -69.89 -173.81 0.68 Allowed 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.191 -0.943 . . . . 0.0 109.443 179.939 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . 0.52 ' CA ' HD11 ' A' ' 65' ' ' ILE . . . 148.16 99.78 0.23 Allowed Glycine 0 N--CA 1.49 2.29 0 N-CA-C 109.569 -1.412 . . . . 0.0 109.569 179.93 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 40' ' ' ASN . . . . . 0.505 ' CB ' ' HB1' ' A' ' 116' ' ' ALA . 45.9 t30 -95.66 102.29 14.07 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.109 -1.23 . . . . 0.0 109.605 179.873 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 41' ' ' THR . . . . . 0.448 ' OG1' ' HB2' ' A' ' 111' ' ' GLN . 36.2 m -72.46 127.76 33.55 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.18 -0.95 . . . . 0.0 109.48 -179.977 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . 0.464 HD23 ' CB ' ' A' ' 86' ' ' ALA . 13.3 mt -106.44 145.92 31.17 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.195 -0.941 . . . . 0.0 109.478 -179.989 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 85.3 t80 -96.76 117.6 31.41 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.216 -0.927 . . . . 0.0 109.42 179.98 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . 0.456 ' HA ' ' O ' ' A' ' 104' ' ' LYS . 63.8 t -113.79 138.99 41.68 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.547 0 O-C-N 121.214 -0.929 . . . . 0.0 109.504 179.981 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 45' ' ' TYR . . . . . 0.414 ' HB3' ' HB2' ' A' ' 104' ' ' LYS . 70.4 t80 -124.5 135.32 53.11 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.273 -0.892 . . . . 0.0 109.49 179.99 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -177.6 -174.87 44.34 Favored Glycine 0 N--CA 1.491 2.353 0 N-CA-C 109.484 -1.447 . . . . 0.0 109.484 -179.951 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 95.5 mt-10 -123.57 157.51 33.5 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.237 -1.155 . . . . 0.0 109.483 -179.98 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 58.3 t0 45.96 46.59 12.44 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.287 -0.883 . . . . 0.0 109.516 179.933 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 70.7 mtm -94.48 143.85 26.07 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.291 -0.881 . . . . 0.0 109.495 179.966 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 50' ' ' THR . . . . . 0.465 ' O ' ' CD1' ' A' ' 54' ' ' LEU . 2.5 p -120.9 163.99 26.2 Favored Pre-proline 0 N--CA 1.489 1.51 0 O-C-N 121.223 -0.923 . . . . 0.0 109.43 -179.958 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 51' ' ' PRO . . . . . 0.471 ' CA ' ' SD ' ' A' ' 69' ' ' MET . 49.1 Cg_endo -69.41 -52.76 0.33 Allowed 'Trans proline' 0 C--O 1.216 -0.607 0 C-N-CA 122.672 2.248 . . . . 0.0 111.761 179.992 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 56.3 m -57.54 -46.67 83.6 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.22 -0.925 . . . . 0.0 109.319 179.965 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 17.0 tp -58.57 -55.55 33.61 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.285 -0.884 . . . . 0.0 109.299 179.872 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 54' ' ' LEU . . . . . 0.479 ' CD1' ' HE2' ' A' ' 69' ' ' MET . 9.0 mt -54.07 -42.99 69.9 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.267 -0.896 . . . . 0.0 109.285 179.806 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 55' ' ' ARG . . . . . 0.476 ' O ' ' N ' ' A' ' 59' ' ' SER . 32.4 ttt85 -51.66 -39.34 57.98 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.22 -0.925 . . . . 0.0 109.29 179.85 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . 0.437 ' HA2' ' HB2' ' A' ' 59' ' ' SER . . . -70.34 -31.43 68.68 Favored Glycine 0 N--CA 1.488 2.16 0 N-CA-C 109.436 -1.466 . . . . 0.0 109.436 179.898 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . 0.505 ' O ' ' CD2' ' A' ' 61' ' ' PHE . . . -72.85 -17.03 61.58 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.239 -1.153 . . . . 0.0 109.453 -179.958 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 58' ' ' PHE . . . . . 0.629 ' CE1' ' CD1' ' A' ' 93' ' ' LEU . 97.9 m-85 -126.54 5.34 6.84 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.238 -0.914 . . . . 0.0 109.349 179.855 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 59' ' ' SER . . . . . 0.524 ' N ' ' HD2' ' A' ' 60' ' ' PRO . 0.4 OUTLIER -74.04 -55.89 2.91 Favored Pre-proline 0 N--CA 1.49 1.565 0 O-C-N 121.249 -0.907 . . . . 0.0 109.989 -179.761 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 60' ' ' PRO . . . . . 0.524 ' HD2' ' N ' ' A' ' 59' ' ' SER . 49.5 Cg_endo -70.08 -34.15 14.05 Favored 'Trans proline' 0 C--O 1.215 -0.644 0 C-N-CA 122.51 2.14 . . . . 0.0 112.04 -179.553 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 61' ' ' PHE . . . . . 0.562 ' CE1' ' HA ' ' A' ' 89' ' ' ALA . 73.4 m-85 -58.91 -42.71 90.26 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.175 -0.953 . . . . 0.0 109.52 -179.947 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . 0.464 ' HA3' ' OG ' ' A' ' 85' ' ' SER . . . -178.79 179.88 48.71 Favored Glycine 0 N--CA 1.49 2.289 0 N-CA-C 109.469 -1.452 . . . . 0.0 109.469 179.996 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 39.8 t30 -85.29 140.9 30.47 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.276 -1.132 . . . . 0.0 109.462 179.987 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 64' ' ' ILE . . . . . 0.444 HG21 HG13 ' A' ' 78' ' ' VAL . 68.2 mt -103.92 134.22 45.77 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 O-C-N 121.223 -0.923 . . . . 0.0 109.427 -179.982 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 65' ' ' ILE . . . . . 0.52 HD11 ' CA ' ' A' ' 39' ' ' GLY . 23.7 pt -97.56 -20.67 5.55 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.538 0 O-C-N 121.277 -0.89 . . . . 0.0 109.548 -179.928 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 54.4 t0 -160.64 106.13 1.45 Allowed 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.215 -0.928 . . . . 0.0 109.514 -179.947 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . 0.523 HD12 ' CG2' ' A' ' 78' ' ' VAL . 0.6 OUTLIER -111.7 120.23 41.34 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.293 -0.879 . . . . 0.0 109.355 179.881 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 19.9 m -118.57 152.39 36.09 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.306 -0.871 . . . . 0.0 109.641 -179.945 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 69' ' ' MET . . . . . 0.479 ' HE2' ' CD1' ' A' ' 54' ' ' LEU . 91.9 mtp -121.02 140.95 51.22 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.297 -0.877 . . . . 0.0 109.46 -179.987 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 70' ' ' ASP . . . . . 0.45 ' C ' ' HD2' ' A' ' 72' ' ' PRO . 0.4 OUTLIER -119.38 105.7 43.73 Favored Pre-proline 0 N--CA 1.491 1.6 0 O-C-N 121.2 -0.937 . . . . 0.0 109.458 179.971 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 71' ' ' PRO . . . . . 0.601 ' N ' ' CD ' ' A' ' 72' ' ' PRO . 48.0 Cg_endo -74.6 -27.78 10.51 Favored 'Trans proline' 0 CA--C 1.542 0.893 0 C-N-CA 122.569 2.18 . . . . 0.0 113.653 179.939 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 72' ' ' PRO . . . . . 0.601 ' CD ' ' N ' ' A' ' 71' ' ' PRO . 55.2 Cg_endo -75.58 -39.59 0.99 Allowed 'Trans proline' 0 C--N 1.352 0.718 0 C-N-CA 121.479 1.453 . . . . 0.0 111.718 -179.879 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 73' ' ' ARG . . . . . 0.446 ' HG2' ' O ' ' A' ' 73' ' ' ARG . 57.4 ttt85 -93.84 -3.89 51.11 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.29 -0.881 . . . . 0.0 109.559 -179.885 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 74' ' ' ASN . . . . . 0.411 ' HB2' ' O ' ' A' ' 73' ' ' ARG . 71.7 m-20 60.15 46.41 10.57 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.183 -0.948 . . . . 0.0 109.388 179.96 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 75' ' ' CYS . . . . . 0.452 ' HA ' ' O ' ' A' ' 44' ' ' VAL . 24.1 p -146.12 143.45 29.34 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.231 -0.918 . . . . 0.0 109.468 179.938 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -111.22 156.32 21.62 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.257 -0.902 . . . . 0.0 109.585 -179.939 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 77' ' ' PHE . . . . . 0.434 ' HA ' ' O ' ' A' ' 42' ' ' LEU . 97.3 m-85 -119.32 131.9 55.8 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.266 -0.896 . . . . 0.0 109.436 179.99 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . 0.523 ' CG2' HD12 ' A' ' 67' ' ' LEU . 47.2 t -125.42 120.78 58.78 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.619 0 O-C-N 121.193 -0.942 . . . . 0.0 109.533 -179.958 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 79' ' ' THR . . . . . 0.513 HG22 ' CA ' ' A' ' 39' ' ' GLY . 17.3 m -95.12 132.59 39.86 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.244 -0.91 . . . . 0.0 109.436 179.94 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 80' ' ' TYR . . . . . 0.52 ' CE1' ' OG ' ' A' ' 85' ' ' SER . 2.0 m-85 -114.06 140.55 48.37 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.253 -0.904 . . . . 0.0 109.648 -179.862 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 81.2 tt0 -60.21 -30.07 69.13 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.326 -0.859 . . . . 0.0 109.665 -179.973 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 40.7 mttm -131.88 150.53 52.12 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.1 -1.0 . . . . 0.0 109.611 -179.922 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 83' ' ' MET . . . . . 0.522 ' CE ' ' HB2' ' A' ' 116' ' ' ALA . 54.0 mtt -66.67 -18.92 65.62 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.364 -0.835 . . . . 0.0 109.582 -179.997 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 98.7 mt-10 -64.39 -44.54 90.98 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.296 -0.877 . . . . 0.0 109.557 -179.86 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 85' ' ' SER . . . . . 0.52 ' OG ' ' CE1' ' A' ' 80' ' ' TYR . 43.6 t -61.51 -31.15 71.14 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.19 -0.944 . . . . 0.0 109.549 -179.89 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 86' ' ' ALA . . . . . 0.464 ' CB ' HD23 ' A' ' 42' ' ' LEU . . . -74.53 -31.03 62.0 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.237 -0.914 . . . . 0.0 109.647 -179.85 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 87' ' ' ASP . . . . . 0.423 ' O ' ' CB ' ' A' ' 91' ' ' ALA . 59.4 t0 -67.96 -49.39 62.02 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.21 -0.931 . . . . 0.0 109.559 -179.982 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 88' ' ' GLN . . . . . 0.434 ' HG2' ' CE1' ' A' ' 61' ' ' PHE . 62.9 tt0 -67.77 -36.78 81.11 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.251 -0.906 . . . . 0.0 109.524 -179.939 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 89' ' ' ALA . . . . . 0.562 ' HA ' ' CE1' ' A' ' 61' ' ' PHE . . . -75.7 -51.18 13.31 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.229 -0.919 . . . . 0.0 109.556 -179.928 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 90' ' ' VAL . . . . . 0.516 ' CG2' HG12 ' A' ' 105' ' ' VAL . 92.9 t -65.08 -33.67 65.32 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.545 0 O-C-N 121.321 -0.862 . . . . 0.0 109.552 -179.932 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 91' ' ' ALA . . . . . 0.423 ' CB ' ' O ' ' A' ' 87' ' ' ASP . . . -79.98 -45.25 18.77 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.31 -0.869 . . . . 0.0 109.663 -179.937 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 92' ' ' GLU . . . . . 0.554 ' HB3' ' CE1' ' A' ' 61' ' ' PHE . 34.0 tt0 -75.26 -46.87 30.89 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.255 -0.903 . . . . 0.0 109.658 -179.831 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 93' ' ' LEU . . . . . 0.629 ' CD1' ' CE1' ' A' ' 58' ' ' PHE . 42.5 mt -64.42 -41.84 96.38 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.206 -0.934 . . . . 0.0 109.606 -179.779 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 94' ' ' ASN . . . . . 0.492 ' CB ' ' O ' ' A' ' 90' ' ' VAL . 46.8 t30 -64.26 126.69 28.57 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.197 -0.939 . . . . 0.0 109.542 -179.93 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 91.78 25.87 21.43 Favored Glycine 0 N--CA 1.49 2.3 0 N-CA-C 109.556 -1.417 . . . . 0.0 109.556 179.966 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 96' ' ' THR . . . . . 0.478 ' CG2' ' O ' ' A' ' 92' ' ' GLU . 17.1 p -121.04 160.63 23.2 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.149 -1.206 . . . . 0.0 109.471 179.94 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 64.0 tt0 -130.38 149.92 51.84 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.257 -0.902 . . . . 0.0 109.477 -179.938 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 98' ' ' VAL . . . . . 0.457 HG21 ' O ' ' A' ' 101' ' ' VAL . 1.1 t -97.73 -151.3 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.609 0 O-C-N 121.315 -0.866 . . . . 0.0 109.357 -179.932 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 96.0 mt-10 -53.84 -38.43 64.65 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.202 -0.936 . . . . 0.0 109.529 -179.947 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 100' ' ' SER . . . . . 0.409 ' C ' HG22 ' A' ' 101' ' ' VAL . 19.2 m -164.0 30.35 0.08 Allowed 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.268 -0.895 . . . . 0.0 109.521 179.965 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 101' ' ' VAL . . . . . 0.457 ' O ' HG21 ' A' ' 98' ' ' VAL . 59.7 t -144.78 144.17 22.15 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.516 0 O-C-N 121.21 -0.931 . . . . 0.0 109.487 -179.987 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 87.1 mt-30 -94.09 150.53 20.25 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.241 -0.912 . . . . 0.0 109.373 179.97 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 88.3 mt -117.29 134.99 54.16 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.205 -0.935 . . . . 0.0 109.499 -179.954 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 104' ' ' LYS . . . . . 0.456 ' O ' ' HA ' ' A' ' 44' ' ' VAL . 23.1 mttm -113.66 135.13 54.26 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.279 -0.888 . . . . 0.0 109.351 179.936 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 105' ' ' VAL . . . . . 0.516 HG12 ' CG2' ' A' ' 90' ' ' VAL . 21.2 t -118.83 139.28 46.72 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.551 0 O-C-N 121.172 -0.955 . . . . 0.0 109.541 -179.982 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 106' ' ' ASN . . . . . 0.444 ' OD1' ' O ' ' A' ' 105' ' ' VAL . 97.2 m-20 -143.57 -175.86 4.73 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.194 -0.941 . . . . 0.0 109.376 179.956 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 107' ' ' ILE . . . . . 0.475 HG21 HD13 ' A' ' 107' ' ' ILE . 51.0 mt -100.01 135.61 34.96 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.511 0 O-C-N 121.234 -0.916 . . . . 0.0 109.596 -179.965 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 108' ' ' ALA . . . . . 0.447 ' HB3' HG22 ' A' ' 41' ' ' THR . . . -116.17 144.87 43.6 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.331 -0.856 . . . . 0.0 109.474 179.982 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 94.4 mtt180 -110.16 26.29 10.83 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.2 -0.937 . . . . 0.0 109.507 179.993 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 24.7 mttt -87.25 13.94 8.73 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.227 -0.921 . . . . 0.0 109.426 179.924 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 111' ' ' GLN . . . . . 0.469 ' CG ' ' HE3' ' A' ' 113' ' ' MET . 4.5 tp-100 -120.46 71.02 17.55 Favored Pre-proline 0 N--CA 1.49 1.541 0 O-C-N 121.219 -0.926 . . . . 0.0 109.701 -179.901 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 112' ' ' PRO . . . . . 0.427 ' O ' ' C ' ' A' ' 113' ' ' MET . 51.9 Cg_endo -72.63 -17.73 26.03 Favored 'Trans proline' 0 C--O 1.215 -0.634 0 C-N-CA 122.625 2.217 . . . . 0.0 110.826 179.485 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 113' ' ' MET . . . . . 0.469 ' HE3' ' CG ' ' A' ' 111' ' ' GLN . 0.0 OUTLIER -42.58 -27.98 0.2 Allowed 'General case' 0 C--N 1.303 -1.424 0 N-CA-C 109.122 -0.695 . . . . 0.0 109.122 179.715 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 114' ' ' LEU . . . . . 0.535 ' CD2' ' HA ' ' A' ' 117' ' ' ALA . 2.5 tt -170.18 25.38 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.024 -1.047 . . . . 0.0 110.305 179.885 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 115' ' ' ASP . . . . . 0.521 ' CB ' ' HA3' ' A' ' 119' ' ' GLY . 88.0 m-20 41.94 42.06 2.15 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.291 -0.881 . . . . 0.0 109.348 179.927 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 116' ' ' ALA . . . . . 0.522 ' HB2' ' CE ' ' A' ' 83' ' ' MET . . . 78.72 -71.57 0.09 Allowed 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.459 -0.776 . . . . 0.0 110.021 -179.862 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 117' ' ' ALA . . . . . 0.535 ' HA ' ' CD2' ' A' ' 114' ' ' LEU . . . -167.45 -80.03 0.02 OUTLIER 'General case' 0 C--N 1.303 -1.447 0 O-C-N 121.142 -0.974 . . . . 0.0 110.465 -179.29 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 118' ' ' THR . . . . . 0.473 ' OG1' ' HE1' ' A' ' 83' ' ' MET . 55.2 p -54.37 -17.98 3.61 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.124 -0.985 . . . . 0.0 109.802 -179.509 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 119' ' ' GLY . . . . . 0.521 ' HA3' ' CB ' ' A' ' 115' ' ' ASP . . . -51.77 140.55 25.71 Favored Glycine 0 N--CA 1.489 2.232 0 N-CA-C 109.36 -1.496 . . . . 0.0 109.36 179.797 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 120' ' ' LYS . . . . . 0.463 ' HB2' ' O ' ' A' ' 119' ' ' GLY . 60.6 mttp 61.54 45.29 8.37 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.228 -1.16 . . . . 0.0 109.408 -179.964 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 121' ' ' SER . . . . . 0.434 ' OG ' ' O ' ' A' ' 118' ' ' THR . 92.5 p . . . . . 0 N--CA 1.489 1.508 0 CA-C-O 118.032 -0.985 . . . . 0.0 109.487 -179.979 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . 0.513 ' N ' ' CD ' ' A' ' 36' ' ' PRO . . . . . . . . 0 N--CA 1.489 1.508 0 N-CA-C 109.473 -0.565 . . . . 0.0 109.473 . . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 36' ' ' PRO . . . . . 0.513 ' CD ' ' N ' ' A' ' 35' ' ' ALA . 49.5 Cg_endo -69.61 -15.4 37.64 Favored 'Trans proline' 0 C--O 1.216 -0.603 0 C-N-CA 122.72 2.28 . . . . 0.0 111.843 -179.956 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 75.7 mtm-85 -124.25 138.65 54.37 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.2 -0.937 . . . . 0.0 109.523 179.987 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 38' ' ' LYS . . . . . 0.469 ' HB3' ' HB3' ' A' ' 117' ' ' ALA . 39.0 mttt -108.17 -166.72 1.16 Allowed 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.188 -0.945 . . . . 0.0 109.423 179.951 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . 0.515 ' N ' ' CD2' ' A' ' 114' ' ' LEU . . . -174.17 -178.7 44.29 Favored Glycine 0 N--CA 1.491 2.309 0 N-CA-C 109.789 -1.324 . . . . 0.0 109.789 179.942 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 40' ' ' ASN . . . . . 0.535 ' O ' ' CG2' ' A' ' 79' ' ' THR . 38.6 t30 -162.55 -178.35 6.18 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.163 -1.198 . . . . 0.0 109.311 179.576 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 41' ' ' THR . . . . . 0.439 HG21 ' HB3' ' A' ' 108' ' ' ALA . 8.1 m -139.81 159.18 42.77 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.251 -0.905 . . . . 0.0 109.687 -179.732 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . 0.52 ' CD2' ' HB2' ' A' ' 86' ' ' ALA . 4.3 mp -144.78 143.91 30.9 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.279 -0.888 . . . . 0.0 109.469 -179.951 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 43' ' ' TYR . . . . . 0.443 ' HB3' ' HB2' ' A' ' 106' ' ' ASN . 51.7 t80 -105.04 109.79 21.93 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.174 -0.954 . . . . 0.0 109.519 179.925 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . 0.418 ' HA ' ' O ' ' A' ' 104' ' ' LYS . 99.8 t -101.16 144.23 13.22 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.518 0 O-C-N 121.346 -0.846 . . . . 0.0 109.481 179.862 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 64.6 t80 -135.86 134.81 39.21 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.303 -0.873 . . . . 0.0 109.425 -179.852 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 176.09 -166.0 36.88 Favored Glycine 0 N--CA 1.49 2.257 0 N-CA-C 109.453 -1.459 . . . . 0.0 109.453 179.918 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . 0.422 ' O ' ' C ' ' A' ' 48' ' ' ASP . 94.0 mt-10 -126.04 158.04 36.37 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.288 -1.125 . . . . 0.0 109.396 180.0 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . 0.422 ' C ' ' O ' ' A' ' 47' ' ' GLU . 51.7 m-20 44.38 48.85 8.15 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.174 -0.954 . . . . 0.0 109.486 -179.993 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 63.5 mtm -101.41 141.12 34.75 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.228 -0.92 . . . . 0.0 109.462 -179.976 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 50' ' ' THR . . . . . 0.496 ' O ' ' CD1' ' A' ' 54' ' ' LEU . 0.6 OUTLIER -122.12 167.28 14.29 Favored Pre-proline 0 N--CA 1.49 1.531 0 O-C-N 121.211 -0.931 . . . . 0.0 109.422 179.965 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 51' ' ' PRO . . . . . 0.427 ' HD2' ' HB ' ' A' ' 50' ' ' THR . 49.5 Cg_endo -70.43 -55.0 0.17 Allowed 'Trans proline' 0 C--O 1.215 -0.664 0 C-N-CA 122.643 2.228 . . . . 0.0 111.864 180.0 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 35.3 m -51.88 -47.0 64.73 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.175 -0.953 . . . . 0.0 109.147 179.906 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 23.5 tp -59.46 -50.27 74.56 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.258 -0.901 . . . . 0.0 109.143 179.788 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 54' ' ' LEU . . . . . 0.496 ' CD1' ' O ' ' A' ' 50' ' ' THR . 8.1 mt -55.57 -48.7 74.36 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.309 -0.87 . . . . 0.0 109.175 179.705 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 55' ' ' ARG . . . . . 0.518 ' O ' ' N ' ' A' ' 59' ' ' SER . 93.5 mtt-85 -49.18 -37.04 21.24 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.275 -0.89 . . . . 0.0 109.229 179.824 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -69.38 -35.01 75.28 Favored Glycine 0 N--CA 1.489 2.223 0 N-CA-C 109.454 -1.458 . . . . 0.0 109.454 179.945 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . 0.449 ' O ' HD13 ' A' ' 93' ' ' LEU . . . -75.87 -22.83 55.77 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.217 -1.166 . . . . 0.0 109.362 179.925 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 58' ' ' PHE . . . . . 0.634 ' CE1' ' CD1' ' A' ' 93' ' ' LEU . 95.7 m-85 -116.63 9.54 14.15 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.287 -0.883 . . . . 0.0 109.328 179.825 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 59' ' ' SER . . . . . 0.539 ' N ' ' HD2' ' A' ' 60' ' ' PRO . 0.8 OUTLIER -76.92 -52.72 1.91 Allowed Pre-proline 0 N--CA 1.49 1.556 0 O-C-N 121.293 -0.879 . . . . 0.0 110.619 -179.506 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 60' ' ' PRO . . . . . 0.539 ' HD2' ' N ' ' A' ' 59' ' ' SER . 48.8 Cg_endo -70.45 -33.35 14.13 Favored 'Trans proline' 0 C--O 1.215 -0.658 0 C-N-CA 122.336 2.024 . . . . 0.0 112.526 -179.023 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 61' ' ' PHE . . . . . 0.567 ' CE1' ' HB2' ' A' ' 92' ' ' GLU . 78.1 m-85 -63.41 -36.64 84.39 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 120.983 -1.073 . . . . 0.0 109.648 -179.838 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . 0.454 ' HA3' ' OG ' ' A' ' 85' ' ' SER . . . 179.22 -176.98 48.21 Favored Glycine 0 N--CA 1.49 2.247 0 N-CA-C 109.447 -1.461 . . . . 0.0 109.447 179.952 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 78.9 m-20 -93.22 138.53 31.53 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.266 -1.138 . . . . 0.0 109.577 179.99 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 64' ' ' ILE . . . . . 0.5 ' CG2' ' O ' ' A' ' 79' ' ' THR . 41.1 mt -99.19 140.01 19.64 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.555 0 O-C-N 121.273 -0.892 . . . . 0.0 109.397 -179.989 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 22.3 pt -103.63 -19.3 6.29 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 O-C-N 121.204 -0.935 . . . . 0.0 109.705 -179.763 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 66' ' ' ASP . . . . . 0.466 ' O ' ' OG1' ' A' ' 79' ' ' THR . 21.7 t70 -152.18 126.42 9.25 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.228 -0.92 . . . . 0.0 109.405 179.946 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 8.3 tp -111.46 122.51 48.03 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.298 -0.876 . . . . 0.0 109.345 -179.965 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 68' ' ' SER . . . . . 0.445 ' HB3' ' HB2' ' A' ' 77' ' ' PHE . 26.5 t -126.21 139.19 53.54 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.328 -0.857 . . . . 0.0 109.412 -179.926 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 69' ' ' MET . . . . . . . . . . . . . 86.7 mtp -127.7 150.99 49.53 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.306 -0.872 . . . . 0.0 109.467 179.946 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 70' ' ' ASP . . . . . 0.454 ' OD1' ' N ' ' A' ' 73' ' ' ARG . 10.6 t70 -129.15 101.67 19.33 Favored Pre-proline 0 N--CA 1.491 1.577 0 O-C-N 121.276 -0.89 . . . . 0.0 109.447 179.986 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 71' ' ' PRO . . . . . 0.592 ' N ' ' CD ' ' A' ' 72' ' ' PRO . 47.5 Cg_endo -74.93 -27.89 9.77 Favored 'Trans proline' 0 CA--C 1.544 0.985 0 C-N-CA 122.561 2.174 . . . . 0.0 113.733 -179.863 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 72' ' ' PRO . . . . . 0.592 ' CD ' ' N ' ' A' ' 71' ' ' PRO . 55.4 Cg_endo -75.15 -20.63 16.38 Favored 'Trans proline' 0 C--N 1.352 0.728 0 C-N-CA 121.471 1.447 . . . . 0.0 111.803 -179.699 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 73' ' ' ARG . . . . . 0.454 ' N ' ' OD1' ' A' ' 70' ' ' ASP . 93.6 mtt180 -113.59 0.44 14.64 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.258 -0.901 . . . . 0.0 109.698 -179.899 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 74' ' ' ASN . . . . . 0.448 ' HB2' ' O ' ' A' ' 73' ' ' ARG . 81.7 m-20 61.19 41.83 12.96 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.247 -0.908 . . . . 0.0 109.493 179.938 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 75' ' ' CYS . . . . . 0.447 ' SG ' ' HB3' ' A' ' 70' ' ' ASP . 21.7 p -144.19 147.97 34.36 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.186 -0.946 . . . . 0.0 109.452 179.941 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -121.89 149.15 43.81 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.247 -0.908 . . . . 0.0 109.408 -179.954 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 77' ' ' PHE . . . . . 0.445 ' HB2' ' HB3' ' A' ' 68' ' ' SER . 90.9 m-85 -114.02 137.99 50.97 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.234 -0.916 . . . . 0.0 109.379 -179.973 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . 0.464 ' O ' HD12 ' A' ' 42' ' ' LEU . 61.7 t -123.76 145.3 31.02 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.491 0 O-C-N 121.145 -0.972 . . . . 0.0 109.615 -179.884 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 79' ' ' THR . . . . . 0.535 ' CG2' ' O ' ' A' ' 40' ' ' ASN . 1.3 m -113.99 130.77 56.51 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.316 -0.865 . . . . 0.0 108.995 179.886 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 80' ' ' TYR . . . . . 0.507 ' O ' ' HA2' ' A' ' 39' ' ' GLY . 0.9 OUTLIER -112.22 132.37 54.96 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.168 -0.958 . . . . 0.0 109.805 -179.665 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 81' ' ' GLU . . . . . 0.435 ' C ' ' HA2' ' A' ' 39' ' ' GLY . 86.7 tt0 -43.04 -25.81 0.12 Allowed 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.448 -0.782 . . . . 0.0 109.766 179.81 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 82' ' ' LYS . . . . . 0.425 ' N ' ' O ' ' A' ' 80' ' ' TYR . 34.6 mtmm -142.95 164.2 30.72 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.1 -1.0 . . . . 0.0 109.403 179.95 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 83' ' ' MET . . . . . 0.593 ' CE ' ' N ' ' A' ' 117' ' ' ALA . 15.8 mtt -80.41 -12.95 59.51 Favored 'General case' 0 N--CA 1.487 1.42 0 O-C-N 121.267 -0.895 . . . . 0.0 109.49 179.874 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 95.1 mt-10 -73.99 -40.75 62.74 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.243 -0.91 . . . . 0.0 109.183 179.722 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 85' ' ' SER . . . . . 0.454 ' OG ' ' HA3' ' A' ' 62' ' ' GLY . 10.9 t -66.78 -39.33 87.77 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.34 -0.85 . . . . 0.0 109.258 179.744 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 86' ' ' ALA . . . . . 0.52 ' HB2' ' CD2' ' A' ' 42' ' ' LEU . . . -72.08 -23.97 61.43 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.433 -0.792 . . . . 0.0 109.24 -179.943 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 65.1 m-20 -72.97 -48.3 37.8 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.352 -0.843 . . . . 0.0 109.504 179.911 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 57.6 tt0 -68.41 -37.9 80.75 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.297 -0.877 . . . . 0.0 109.633 -179.96 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 89' ' ' ALA . . . . . 0.504 ' HB2' ' CG ' ' A' ' 61' ' ' PHE . . . -69.07 -41.35 77.66 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.213 -0.93 . . . . 0.0 109.513 -179.883 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 90' ' ' VAL . . . . . 0.521 ' O ' ' CB ' ' A' ' 94' ' ' ASN . 53.1 t -62.09 -33.21 57.33 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.535 0 O-C-N 121.205 -0.935 . . . . 0.0 109.627 -179.933 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -79.41 -48.16 14.46 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.231 -0.918 . . . . 0.0 109.856 -179.684 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 92' ' ' GLU . . . . . 0.567 ' HB2' ' CE1' ' A' ' 61' ' ' PHE . 75.6 mm-40 -73.72 -43.11 60.09 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.175 -0.953 . . . . 0.0 109.994 -179.405 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 93' ' ' LEU . . . . . 0.634 ' CD1' ' CE1' ' A' ' 58' ' ' PHE . 21.9 mt -69.6 -39.32 77.34 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.16 -0.962 . . . . 0.0 109.753 -179.655 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 94' ' ' ASN . . . . . 0.521 ' CB ' ' O ' ' A' ' 90' ' ' VAL . 51.4 t-20 -72.54 120.05 17.61 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.15 -0.968 . . . . 0.0 109.569 -179.995 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 102.03 26.61 7.37 Favored Glycine 0 N--CA 1.49 2.249 0 N-CA-C 109.493 -1.443 . . . . 0.0 109.493 179.971 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 96' ' ' THR . . . . . 0.493 ' CG2' ' O ' ' A' ' 92' ' ' GLU . 11.1 p -125.65 154.52 42.21 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.28 -1.13 . . . . 0.0 109.429 -179.957 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 63.2 tt0 -128.47 138.38 52.26 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.277 -0.89 . . . . 0.0 109.516 179.977 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 98' ' ' VAL . . . . . 0.43 HG23 ' O ' ' A' ' 101' ' ' VAL . 1.3 t -80.13 -148.48 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 O-C-N 121.286 -0.884 . . . . 0.0 109.396 -179.97 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 96.5 mt-10 -63.2 -39.2 93.96 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.271 -0.893 . . . . 0.0 109.435 179.986 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 1.2 m -155.99 25.52 0.37 Allowed 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.276 -0.89 . . . . 0.0 109.451 179.956 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 101' ' ' VAL . . . . . 0.43 ' O ' HG23 ' A' ' 98' ' ' VAL . 57.4 t -139.59 145.07 27.45 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.552 0 O-C-N 121.308 -0.87 . . . . 0.0 109.373 179.922 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 47.0 tt0 -103.11 138.72 39.57 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.221 -0.924 . . . . 0.0 109.666 -179.837 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 67.7 mt -110.23 142.97 41.07 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.217 -0.927 . . . . 0.0 109.375 179.883 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 104' ' ' LYS . . . . . 0.418 ' O ' ' HA ' ' A' ' 44' ' ' VAL . 44.7 mttp -125.76 124.23 40.56 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.267 -0.896 . . . . 0.0 109.437 179.917 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 105' ' ' VAL . . . . . 0.472 HG11 ' CG2' ' A' ' 90' ' ' VAL . 14.3 t -107.95 149.75 11.07 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.568 0 O-C-N 121.205 -0.934 . . . . 0.0 109.561 -179.886 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 106' ' ' ASN . . . . . 0.443 ' HB2' ' HB3' ' A' ' 43' ' ' TYR . 82.1 m-20 -157.03 -166.05 1.99 Allowed 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.294 -0.879 . . . . 0.0 109.389 179.88 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 27.4 mm -108.0 126.03 64.55 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.523 0 O-C-N 121.185 -0.947 . . . . 0.0 109.519 -179.975 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 108' ' ' ALA . . . . . 0.439 ' HB3' HG21 ' A' ' 41' ' ' THR . . . -101.07 169.3 9.03 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.309 -0.869 . . . . 0.0 109.409 179.926 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 109' ' ' ARG . . . . . 0.418 ' NH1' ' HG2' ' A' ' 109' ' ' ARG . 34.8 mtp85 -46.32 151.29 0.54 Allowed 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.216 -0.927 . . . . 0.0 109.432 179.942 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 31.3 mttp -76.21 113.15 13.45 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.215 -0.928 . . . . 0.0 109.505 -179.957 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 111' ' ' GLN . . . . . 0.513 ' N ' ' OE1' ' A' ' 111' ' ' GLN . 0.0 OUTLIER -55.04 125.89 58.33 Favored Pre-proline 0 N--CA 1.489 1.478 0 O-C-N 121.262 -0.899 . . . . 0.0 109.478 -179.904 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 52.2 Cg_endo -72.26 -30.41 12.99 Favored 'Trans proline' 0 C--O 1.216 -0.622 0 C-N-CA 122.603 2.202 . . . . 0.0 111.679 -179.906 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 113' ' ' MET . . . . . 0.531 ' CE ' ' HB3' ' A' ' 114' ' ' LEU . 0.0 OUTLIER -45.79 -24.53 0.39 Allowed 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.307 -0.871 . . . . 0.0 109.57 179.901 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 114' ' ' LEU . . . . . 0.565 ' CD2' ' O ' ' A' ' 116' ' ' ALA . 2.1 tt -146.29 24.02 1.29 Allowed 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.082 -1.011 . . . . 0.0 109.824 -179.937 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 115' ' ' ASP . . . . . 0.433 ' C ' ' O ' ' A' ' 114' ' ' LEU . 71.5 m-20 42.7 31.45 0.3 Allowed 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.239 -0.913 . . . . 0.0 109.886 179.814 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 116' ' ' ALA . . . . . 0.565 ' O ' ' CD2' ' A' ' 114' ' ' LEU . . . 57.83 -89.1 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.168 -0.958 . . . . 0.0 109.988 179.786 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 117' ' ' ALA . . . . . 0.593 ' N ' ' CE ' ' A' ' 83' ' ' MET . . . -177.69 30.61 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.49 0 O-C-N 120.94 -1.1 . . . . 0.0 109.789 -179.701 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 118' ' ' THR . . . . . 0.42 ' CG2' ' HE1' ' A' ' 83' ' ' MET . 22.3 p -112.57 161.52 16.69 Favored 'General case' 0 C--N 1.302 -1.468 0 O-C-N 121.088 -1.007 . . . . 0.0 109.732 -179.752 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 97.45 167.58 32.58 Favored Glycine 0 N--CA 1.49 2.248 0 N-CA-C 109.55 -1.42 . . . . 0.0 109.55 179.916 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 120' ' ' LYS . . . . . 0.428 ' O ' ' HB3' ' A' ' 121' ' ' SER . 62.0 tttm -58.62 -38.43 78.02 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.219 -1.165 . . . . 0.0 109.461 179.923 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 121' ' ' SER . . . . . 0.428 ' HB3' ' O ' ' A' ' 120' ' ' LYS . 1.3 p . . . . . 0 N--CA 1.49 1.536 0 CA-C-O 117.948 -1.025 . . . . 0.0 109.494 179.954 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . 0.491 ' CB ' ' HG2' ' A' ' 113' ' ' MET . . . . . . . . 0 N--CA 1.491 1.577 0 N-CA-C 109.511 -0.552 . . . . 0.0 109.511 . . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 48.7 Cg_endo -69.65 -4.2 13.47 Favored 'Trans proline' 0 C--O 1.215 -0.669 0 C-N-CA 122.68 2.254 . . . . 0.0 111.939 -179.957 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 37' ' ' ARG . . . . . 0.439 ' O ' HD11 ' A' ' 114' ' ' LEU . 82.0 mtm180 -125.89 145.78 50.11 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.19 -0.944 . . . . 0.0 109.558 -179.977 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 38' ' ' LYS . . . . . 0.521 ' HA ' ' CD2' ' A' ' 114' ' ' LEU . 18.9 mttm -79.45 -163.09 0.47 Allowed 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.351 -0.843 . . . . 0.0 109.612 -179.876 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . 0.492 ' N ' ' O ' ' A' ' 116' ' ' ALA . . . 178.72 -160.54 26.39 Favored Glycine 0 N--CA 1.49 2.292 0 N-CA-C 109.598 -1.401 . . . . 0.0 109.598 -179.925 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 40' ' ' ASN . . . . . 0.459 ' HB2' ' O ' ' A' ' 39' ' ' GLY . 33.9 t-20 178.25 113.83 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.291 -1.123 . . . . 0.0 109.571 179.74 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 41' ' ' THR . . . . . 0.444 ' HA ' ' HA ' ' A' ' 79' ' ' THR . 40.1 m -80.72 136.71 36.21 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.24 -0.913 . . . . 0.0 109.34 179.859 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . 0.569 HD11 ' CD2' ' A' ' 80' ' ' TYR . 8.5 mt -120.18 157.58 28.76 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.205 -0.935 . . . . 0.0 109.614 -179.945 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 43' ' ' TYR . . . . . 0.47 ' CZ ' ' HB2' ' A' ' 75' ' ' CYS . 74.6 t80 -116.92 121.76 42.37 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.317 -0.865 . . . . 0.0 109.269 179.83 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . 0.588 ' CG1' ' CD2' ' A' ' 103' ' ' LEU . 61.8 t -116.21 134.17 60.41 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.479 0 O-C-N 121.167 -0.958 . . . . 0.0 109.572 -179.902 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 60.7 t80 -121.49 142.4 50.09 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.287 -0.883 . . . . 0.0 109.488 -179.976 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . 0.4 ' HA3' ' SD ' ' A' ' 49' ' ' MET . . . 173.97 -178.97 45.63 Favored Glycine 0 N--CA 1.491 2.338 0 N-CA-C 109.485 -1.446 . . . . 0.0 109.485 179.958 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . 0.411 ' O ' ' C ' ' A' ' 48' ' ' ASP . 92.7 mt-10 -111.66 154.93 24.2 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.253 -1.145 . . . . 0.0 109.434 -179.952 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . 0.411 ' C ' ' O ' ' A' ' 47' ' ' GLU . 43.4 m-20 43.99 51.6 6.99 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.212 -0.93 . . . . 0.0 109.488 -179.993 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 49' ' ' MET . . . . . 0.4 ' SD ' ' HA3' ' A' ' 46' ' ' GLY . 49.1 mtm -98.93 142.31 30.6 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.234 -0.916 . . . . 0.0 109.494 179.971 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 50' ' ' THR . . . . . 0.471 ' O ' ' CD1' ' A' ' 54' ' ' LEU . 0.6 OUTLIER -125.16 166.62 19.57 Favored Pre-proline 0 N--CA 1.49 1.571 0 O-C-N 121.225 -0.922 . . . . 0.0 109.503 179.949 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 49.2 Cg_endo -69.95 -48.21 0.72 Allowed 'Trans proline' 0 C--O 1.216 -0.623 0 C-N-CA 122.718 2.279 . . . . 0.0 111.769 -179.96 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 36.3 m -57.54 -45.74 84.73 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.253 -0.905 . . . . 0.0 109.457 179.985 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 15.6 tp -59.71 -50.28 74.45 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.325 -0.859 . . . . 0.0 109.445 179.84 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 54' ' ' LEU . . . . . 0.48 ' CD1' ' SD ' ' A' ' 69' ' ' MET . 3.5 mt -56.81 -50.16 73.2 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.285 -0.885 . . . . 0.0 109.284 179.897 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 55' ' ' ARG . . . . . 0.506 ' O ' ' N ' ' A' ' 59' ' ' SER . 33.2 mtp180 -46.03 -41.03 11.48 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.172 -0.955 . . . . 0.0 109.262 179.895 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -69.18 -37.78 81.9 Favored Glycine 0 N--CA 1.489 2.229 0 N-CA-C 109.36 -1.496 . . . . 0.0 109.36 179.852 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -72.59 -21.05 61.2 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.245 -1.15 . . . . 0.0 109.394 179.953 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 58' ' ' PHE . . . . . 0.624 ' CE2' ' CD1' ' A' ' 93' ' ' LEU . 92.5 m-85 -117.74 8.0 12.63 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.308 -0.87 . . . . 0.0 109.431 179.881 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 59' ' ' SER . . . . . 0.535 ' N ' ' HD2' ' A' ' 60' ' ' PRO . 1.2 t -75.16 -54.45 2.52 Favored Pre-proline 0 N--CA 1.492 1.632 0 O-C-N 121.313 -0.867 . . . . 0.0 110.391 -179.699 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 60' ' ' PRO . . . . . 0.535 ' HD2' ' N ' ' A' ' 59' ' ' SER . 47.4 Cg_endo -68.95 -30.5 26.03 Favored 'Trans proline' 0 C--O 1.215 -0.653 0 C-N-CA 122.456 2.104 . . . . 0.0 112.3 -179.252 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 61' ' ' PHE . . . . . 0.574 ' CE1' ' HB3' ' A' ' 92' ' ' GLU . 60.3 m-85 -66.68 -31.13 71.59 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.119 -0.988 . . . . 0.0 109.471 -179.979 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 168.56 179.15 40.66 Favored Glycine 0 N--CA 1.491 2.308 0 N-CA-C 109.579 -1.408 . . . . 0.0 109.579 179.928 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 37.0 t30 -87.89 134.86 33.62 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.365 -1.079 . . . . 0.0 109.492 -179.979 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 33.4 mt -94.05 133.95 33.32 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.508 0 O-C-N 121.23 -0.919 . . . . 0.0 109.476 179.963 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 65' ' ' ILE . . . . . 0.515 ' CD1' ' OE1' ' A' ' 111' ' ' GLN . 26.1 pt -97.19 -20.71 5.57 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.486 0 O-C-N 121.17 -0.956 . . . . 0.0 109.376 179.911 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 66' ' ' ASP . . . . . 0.456 ' HB3' ' HB ' ' A' ' 79' ' ' THR . 60.9 t0 -138.82 125.96 21.37 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.225 -0.922 . . . . 0.0 109.433 179.854 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . 0.495 ' C ' ' CD1' ' A' ' 67' ' ' LEU . 3.5 tm? -121.26 108.24 13.5 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.209 -0.932 . . . . 0.0 109.355 179.897 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 68' ' ' SER . . . . . 0.443 ' HB2' ' HB2' ' A' ' 77' ' ' PHE . 58.3 m -122.66 149.27 44.25 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.238 -0.914 . . . . 0.0 109.463 -179.964 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 69' ' ' MET . . . . . 0.48 ' SD ' ' CD1' ' A' ' 54' ' ' LEU . 83.8 mmm -123.39 147.68 46.85 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.234 -0.916 . . . . 0.0 109.381 -179.979 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 70' ' ' ASP . . . . . 0.46 ' CB ' ' O ' ' A' ' 75' ' ' CYS . 0.6 OUTLIER -131.64 94.2 26.34 Favored Pre-proline 0 N--CA 1.49 1.541 0 O-C-N 121.252 -0.905 . . . . 0.0 109.483 179.959 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 71' ' ' PRO . . . . . 0.598 ' CD ' ' CD ' ' A' ' 72' ' ' PRO . 47.0 Cg_endo -74.84 -27.77 10.06 Favored 'Trans proline' 0 CA--C 1.543 0.967 0 C-N-CA 122.506 2.137 . . . . 0.0 113.664 -179.974 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 72' ' ' PRO . . . . . 0.598 ' CD ' ' CD ' ' A' ' 71' ' ' PRO . 55.2 Cg_endo -75.3 -22.19 14.55 Favored 'Trans proline' 0 C--N 1.353 0.803 0 C-N-CA 121.49 1.46 . . . . 0.0 111.868 -179.844 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 73' ' ' ARG . . . . . 0.411 ' O ' ' HB2' ' A' ' 74' ' ' ASN . 62.7 mtt180 -112.24 -0.39 15.51 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.167 -0.958 . . . . 0.0 109.65 -179.992 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 74' ' ' ASN . . . . . 0.411 ' HB2' ' O ' ' A' ' 73' ' ' ARG . 8.0 m120 60.82 45.47 9.8 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.082 -1.011 . . . . 0.0 109.402 -179.981 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 75' ' ' CYS . . . . . 0.47 ' HB2' ' CZ ' ' A' ' 43' ' ' TYR . 23.2 p -152.69 143.07 22.58 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.299 -0.875 . . . . 0.0 109.458 -179.979 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . 0.466 ' CB ' HD12 ' A' ' 54' ' ' LEU . . . -112.08 156.99 21.33 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.307 -0.871 . . . . 0.0 109.485 179.952 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 77' ' ' PHE . . . . . 0.443 ' HB2' ' HB2' ' A' ' 68' ' ' SER . 97.0 m-85 -118.37 125.58 50.31 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.245 -0.909 . . . . 0.0 109.427 179.858 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . 0.439 ' O ' ' HG ' ' A' ' 42' ' ' LEU . 59.6 t -127.11 126.78 68.7 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.546 0 O-C-N 121.234 -0.916 . . . . 0.0 109.489 -179.858 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 79' ' ' THR . . . . . 0.541 ' CG2' ' OE1' ' A' ' 111' ' ' GLN . 92.3 m -105.59 126.64 52.37 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.334 -0.854 . . . . 0.0 109.446 179.812 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 80' ' ' TYR . . . . . 0.569 ' CD2' HD11 ' A' ' 42' ' ' LEU . 2.3 m-85 -92.41 174.05 7.49 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.227 -0.921 . . . . 0.0 109.169 179.898 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 81' ' ' GLU . . . . . 0.468 ' HG2' ' O ' ' A' ' 81' ' ' GLU . 71.0 tt0 -90.23 -13.56 35.19 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.352 -0.842 . . . . 0.0 109.665 -179.678 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 23.2 mttt -150.08 127.93 11.77 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.051 -1.031 . . . . 0.0 110.018 179.921 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 83' ' ' MET . . . . . 0.538 ' CE ' ' HB2' ' A' ' 117' ' ' ALA . 0.4 OUTLIER -45.83 -24.89 0.44 Allowed 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.458 -0.777 . . . . 0.0 109.88 179.938 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . 0.409 ' HG3' ' SD ' ' A' ' 83' ' ' MET . 97.1 mt-10 -67.56 -62.35 1.46 Allowed 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.196 -0.94 . . . . 0.0 109.571 -179.868 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 13.7 m -46.82 -38.26 9.96 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.267 -0.896 . . . . 0.0 109.818 -179.804 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 86' ' ' ALA . . . . . 0.474 ' HA ' ' CD2' ' A' ' 80' ' ' TYR . . . -69.27 -39.45 78.38 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.161 -0.962 . . . . 0.0 109.751 -179.691 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 52.4 t0 -56.76 -38.31 72.27 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.212 -0.93 . . . . 0.0 109.591 -179.739 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 88' ' ' GLN . . . . . 0.483 ' O ' ' CB ' ' A' ' 92' ' ' GLU . 59.7 tt0 -74.39 -38.49 63.12 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.15 -0.969 . . . . 0.0 109.603 -179.839 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 89' ' ' ALA . . . . . 0.539 ' HA ' ' CD1' ' A' ' 61' ' ' PHE . . . -75.36 -41.95 55.28 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.168 -0.958 . . . . 0.0 109.651 -179.871 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 90' ' ' VAL . . . . . 0.521 ' CG1' HG13 ' A' ' 105' ' ' VAL . 53.9 t -64.68 -48.72 83.51 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 O-C-N 121.257 -0.902 . . . . 0.0 109.634 -179.834 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -72.22 -38.77 68.91 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.272 -0.892 . . . . 0.0 109.702 -179.882 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 92' ' ' GLU . . . . . 0.574 ' HB3' ' CE1' ' A' ' 61' ' ' PHE . 44.5 tp10 -74.4 -45.81 44.29 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.247 -0.908 . . . . 0.0 109.583 -179.876 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 93' ' ' LEU . . . . . 0.624 ' CD1' ' CE2' ' A' ' 58' ' ' PHE . 68.0 mt -69.95 -37.76 75.93 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.165 -0.959 . . . . 0.0 109.545 -179.921 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 94' ' ' ASN . . . . . 0.484 ' N ' HG21 ' A' ' 105' ' ' VAL . 61.4 t-20 -64.64 129.85 41.39 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.226 -0.921 . . . . 0.0 109.547 -179.967 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 84.77 30.14 27.33 Favored Glycine 0 N--CA 1.489 2.219 0 N-CA-C 109.497 -1.441 . . . . 0.0 109.497 179.973 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 96' ' ' THR . . . . . 0.492 ' CG2' ' O ' ' A' ' 92' ' ' GLU . 19.7 p -121.27 151.54 39.92 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.261 -1.141 . . . . 0.0 109.468 -179.995 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 61.7 tt0 -116.94 143.73 45.37 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.314 -0.866 . . . . 0.0 109.498 -179.946 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 1.2 t -90.79 -159.41 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 O-C-N 121.233 -0.917 . . . . 0.0 109.282 179.935 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 95.9 mt-10 -54.68 -37.71 66.1 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.183 -0.948 . . . . 0.0 109.481 179.968 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 100' ' ' SER . . . . . 0.428 ' C ' HG21 ' A' ' 101' ' ' VAL . 6.9 t -159.86 25.96 0.18 Allowed 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.198 -0.938 . . . . 0.0 109.554 -179.953 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 101' ' ' VAL . . . . . 0.428 HG21 ' C ' ' A' ' 100' ' ' SER . 48.7 t -138.03 168.42 20.32 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.546 0 O-C-N 121.219 -0.926 . . . . 0.0 109.434 -179.955 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 102' ' ' GLN . . . . . 0.408 ' N ' ' CG1' ' A' ' 101' ' ' VAL . 92.5 mt-30 -116.12 147.12 41.67 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.22 -0.925 . . . . 0.0 109.169 179.874 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 103' ' ' LEU . . . . . 0.588 ' CD2' ' CG1' ' A' ' 44' ' ' VAL . 0.0 OUTLIER -122.15 130.94 53.68 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.198 -0.939 . . . . 0.0 109.715 -179.918 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 16.7 mttp -115.82 128.22 55.66 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.294 -0.879 . . . . 0.0 109.333 179.864 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 105' ' ' VAL . . . . . 0.521 HG13 ' CG1' ' A' ' 90' ' ' VAL . 22.7 t -104.18 136.15 38.73 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.519 0 O-C-N 121.179 -0.951 . . . . 0.0 109.583 -179.834 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 106' ' ' ASN . . . . . 0.442 ' HB2' ' HB3' ' A' ' 43' ' ' TYR . 90.2 m-20 -136.03 -168.04 2.15 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.195 -0.941 . . . . 0.0 109.296 179.897 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 22.9 mm -108.2 123.68 63.94 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.543 0 O-C-N 121.257 -0.902 . . . . 0.0 109.528 179.918 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -102.22 167.77 9.78 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.239 -0.913 . . . . 0.0 109.434 -179.998 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 28.0 mtp-105 -51.82 139.57 21.44 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.279 -0.888 . . . . 0.0 109.52 179.958 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 110' ' ' LYS . . . . . 0.455 ' HB3' ' HB3' ' A' ' 116' ' ' ALA . 50.7 mttp -71.97 146.87 47.45 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.221 -0.924 . . . . 0.0 109.388 179.967 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 111' ' ' GLN . . . . . 0.541 ' OE1' ' CG2' ' A' ' 79' ' ' THR . 5.5 pt20 -83.68 156.09 65.06 Favored Pre-proline 0 N--CA 1.489 1.516 0 O-C-N 121.243 -0.911 . . . . 0.0 109.562 179.991 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 112' ' ' PRO . . . . . 0.414 ' O ' ' C ' ' A' ' 113' ' ' MET . 49.7 Cg_endo -69.88 -26.26 27.19 Favored 'Trans proline' 0 C--O 1.214 -0.683 0 C-N-CA 122.79 2.327 . . . . 0.0 112.043 -179.474 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 113' ' ' MET . . . . . 0.545 ' HE3' ' N ' ' A' ' 114' ' ' LEU . 0.0 OUTLIER -43.79 -27.2 0.31 Allowed 'General case' 0 N--CA 1.489 1.504 0 N-CA-C 108.777 -0.823 . . . . 0.0 108.777 179.55 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 114' ' ' LEU . . . . . 0.545 ' N ' ' HE3' ' A' ' 113' ' ' MET . 0.7 OUTLIER -179.03 31.4 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.218 -0.926 . . . . 0.0 109.367 179.878 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 115' ' ' ASP . . . . . 0.452 ' O ' ' HB3' ' A' ' 116' ' ' ALA . 86.1 m-20 46.91 49.46 14.56 Favored 'General case' 0 C--N 1.303 -1.454 0 N-CA-C 108.251 -1.018 . . . . 0.0 108.251 -179.327 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 116' ' ' ALA . . . . . 0.492 ' O ' ' N ' ' A' ' 39' ' ' GLY . . . 68.93 -86.71 0.03 OUTLIER 'General case' 0 N--CA 1.488 1.441 0 N-CA-C 108.842 -0.799 . . . . 0.0 108.842 -179.162 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 117' ' ' ALA . . . . . 0.538 ' HB2' ' CE ' ' A' ' 83' ' ' MET . . . -172.9 -34.78 0.01 OUTLIER 'General case' 0 C--N 1.304 -1.411 0 O-C-N 121.301 -0.875 . . . . 0.0 109.658 179.749 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 34.0 m -112.81 139.49 48.4 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.238 -0.914 . . . . 0.0 109.528 179.988 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 149.81 77.12 0.02 OUTLIER Glycine 0 N--CA 1.49 2.276 0 N-CA-C 109.454 -1.458 . . . . 0.0 109.454 179.928 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 120' ' ' LYS . . . . . 0.427 ' O ' ' CB ' ' A' ' 121' ' ' SER . 7.4 ttmm -57.04 -39.0 74.01 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.232 -1.157 . . . . 0.0 109.524 179.995 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 121' ' ' SER . . . . . 0.427 ' CB ' ' O ' ' A' ' 120' ' ' LYS . 1.3 t . . . . . 0 N--CA 1.49 1.544 0 CA-C-O 118.017 -0.992 . . . . 0.0 109.455 179.979 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . 0.525 ' CB ' ' CD ' ' A' ' 36' ' ' PRO . . . . . . . . 0 N--CA 1.491 1.593 0 N-CA-C 109.459 -0.571 . . . . 0.0 109.459 . . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 36' ' ' PRO . . . . . 0.525 ' CD ' ' CB ' ' A' ' 35' ' ' ALA . 49.3 Cg_endo -69.79 150.49 68.11 Favored 'Trans proline' 0 C--O 1.216 -0.607 0 C-N-CA 122.81 2.34 . . . . 0.0 111.829 -179.94 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 37' ' ' ARG . . . . . 0.516 ' HB3' ' CD1' ' A' ' 114' ' ' LEU . 82.5 mtt85 -61.37 -36.64 80.81 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.229 -0.919 . . . . 0.0 109.614 179.98 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 38' ' ' LYS . . . . . 0.519 ' O ' ' CD1' ' A' ' 65' ' ' ILE . 56.9 mttm -64.25 -173.33 0.09 Allowed 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.168 -0.958 . . . . 0.0 109.275 179.966 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . 0.527 ' CA ' HD12 ' A' ' 65' ' ' ILE . . . 144.03 98.22 0.26 Allowed Glycine 0 N--CA 1.491 2.317 0 N-CA-C 109.63 -1.388 . . . . 0.0 109.63 179.948 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 40' ' ' ASN . . . . . 0.47 ' CB ' ' HB1' ' A' ' 116' ' ' ALA . 43.7 t30 -87.21 101.55 13.62 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.273 -1.134 . . . . 0.0 109.322 179.878 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 41' ' ' THR . . . . . 0.452 ' OG1' ' HB3' ' A' ' 111' ' ' GLN . 78.9 m -65.53 130.88 44.88 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.229 -0.92 . . . . 0.0 109.588 -179.935 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . 0.516 HD11 ' CB ' ' A' ' 86' ' ' ALA . 16.8 mt -111.51 146.05 37.97 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.262 -0.899 . . . . 0.0 109.464 179.957 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 43' ' ' TYR . . . . . 0.448 ' HB2' ' HB1' ' A' ' 108' ' ' ALA . 70.6 t80 -104.78 122.72 46.32 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.164 -0.96 . . . . 0.0 109.46 179.999 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . 0.454 ' HA ' ' O ' ' A' ' 104' ' ' LYS . 47.9 t -121.57 138.15 52.84 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.523 0 O-C-N 121.214 -0.929 . . . . 0.0 109.489 179.978 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 45' ' ' TYR . . . . . 0.452 ' HB3' ' HB2' ' A' ' 104' ' ' LYS . 72.3 t80 -118.68 138.9 52.3 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.226 -0.921 . . . . 0.0 109.441 -179.951 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . 0.411 ' N ' ' HE3' ' A' ' 49' ' ' MET . . . 176.17 -178.54 47.57 Favored Glycine 0 N--CA 1.489 2.216 0 N-CA-C 109.448 -1.461 . . . . 0.0 109.448 179.929 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 94.2 mt-10 -124.91 156.04 38.58 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.344 -1.092 . . . . 0.0 109.488 179.995 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 22.2 t70 47.46 50.22 15.03 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.227 -0.92 . . . . 0.0 109.476 -179.99 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 49' ' ' MET . . . . . 0.411 ' HE3' ' N ' ' A' ' 46' ' ' GLY . 66.7 mtm -105.54 145.21 31.24 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.247 -0.908 . . . . 0.0 109.513 -179.969 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 50' ' ' THR . . . . . 0.503 ' O ' ' CD1' ' A' ' 54' ' ' LEU . 3.5 p -119.42 161.73 35.83 Favored Pre-proline 0 N--CA 1.49 1.57 0 O-C-N 121.27 -0.894 . . . . 0.0 109.395 179.978 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 51' ' ' PRO . . . . . 0.464 ' N ' ' SD ' ' A' ' 69' ' ' MET . 48.2 Cg_endo -70.1 -55.35 0.17 Allowed 'Trans proline' 0 C--O 1.216 -0.593 0 C-N-CA 122.727 2.285 . . . . 0.0 111.87 -179.949 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 27.9 m -50.83 -47.17 60.16 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.152 -0.967 . . . . 0.0 109.216 179.894 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 18.7 tp -58.06 -56.12 26.08 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.256 -0.903 . . . . 0.0 109.241 179.766 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 54' ' ' LEU . . . . . 0.503 ' CD1' ' O ' ' A' ' 50' ' ' THR . 5.1 mt -53.9 -43.17 69.46 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.285 -0.884 . . . . 0.0 109.092 179.615 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 55' ' ' ARG . . . . . 0.499 ' O ' ' N ' ' A' ' 59' ' ' SER . 73.5 ttt180 -48.83 -41.82 34.15 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.266 -0.896 . . . . 0.0 109.208 179.712 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . 0.457 ' O ' ' HD2' ' A' ' 60' ' ' PRO . . . -67.66 -35.39 85.81 Favored Glycine 0 N--CA 1.489 2.213 0 N-CA-C 109.263 -1.535 . . . . 0.0 109.263 179.857 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . 0.469 ' O ' ' CD1' ' A' ' 61' ' ' PHE . . . -70.87 -22.15 62.33 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.324 -1.103 . . . . 0.0 109.425 179.961 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 58' ' ' PHE . . . . . 0.578 ' CE2' HD13 ' A' ' 93' ' ' LEU . 96.6 m-85 -118.07 4.72 12.03 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.272 -0.892 . . . . 0.0 109.544 -179.953 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 59' ' ' SER . . . . . 0.52 ' N ' ' HD2' ' A' ' 60' ' ' PRO . 2.6 t -73.63 -56.89 2.78 Favored Pre-proline 0 N--CA 1.49 1.569 0 O-C-N 121.208 -0.932 . . . . 0.0 110.075 -179.67 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 60' ' ' PRO . . . . . 0.52 ' HD2' ' N ' ' A' ' 59' ' ' SER . 48.0 Cg_endo -68.81 -24.84 33.86 Favored 'Trans proline' 0 C--O 1.215 -0.652 0 C-N-CA 122.59 2.193 . . . . 0.0 111.989 -179.496 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 61' ' ' PHE . . . . . 0.577 ' CD2' ' HA ' ' A' ' 89' ' ' ALA . 68.0 m-85 -72.73 -25.08 61.08 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.179 -0.95 . . . . 0.0 109.508 179.968 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 166.18 -178.04 40.94 Favored Glycine 0 N--CA 1.49 2.256 0 N-CA-C 109.548 -1.421 . . . . 0.0 109.548 179.951 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 85.8 m-20 -92.43 139.51 30.52 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.305 -1.115 . . . . 0.0 109.504 179.986 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 51.4 mt -99.87 134.12 40.41 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.522 0 O-C-N 121.243 -0.911 . . . . 0.0 109.461 -179.969 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 65' ' ' ILE . . . . . 0.527 HD12 ' CA ' ' A' ' 39' ' ' GLY . 20.0 pt -96.36 -24.29 4.6 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.537 0 O-C-N 121.314 -0.866 . . . . 0.0 109.521 -179.92 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 50.8 t0 -146.28 121.14 9.94 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.229 -0.919 . . . . 0.0 109.597 -179.946 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 8.1 tp -110.14 121.39 45.14 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.236 -0.915 . . . . 0.0 109.389 179.902 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 68' ' ' SER . . . . . 0.453 ' HB3' ' HB2' ' A' ' 77' ' ' PHE . 34.6 t -134.69 144.51 47.83 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.224 -0.922 . . . . 0.0 109.419 179.941 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 69' ' ' MET . . . . . 0.464 ' SD ' ' N ' ' A' ' 51' ' ' PRO . 83.3 mtp -129.59 151.4 50.24 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.271 -0.893 . . . . 0.0 109.563 -179.96 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 70' ' ' ASP . . . . . 0.456 ' C ' ' HD2' ' A' ' 72' ' ' PRO . 0.2 OUTLIER -127.06 99.36 28.69 Favored Pre-proline 0 N--CA 1.491 1.6 0 O-C-N 121.3 -0.875 . . . . 0.0 109.419 179.982 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 71' ' ' PRO . . . . . 0.594 ' N ' ' CD ' ' A' ' 72' ' ' PRO . 47.4 Cg_endo -74.63 -27.85 10.39 Favored 'Trans proline' 0 CA--C 1.542 0.924 0 C-N-CA 122.476 2.118 . . . . 0.0 113.759 -179.972 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 72' ' ' PRO . . . . . 0.594 ' CD ' ' N ' ' A' ' 71' ' ' PRO . 53.9 Cg_endo -75.09 -25.8 11.38 Favored 'Trans proline' 0 C--N 1.352 0.759 0 C-N-CA 121.404 1.403 . . . . 0.0 111.823 -179.851 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 73' ' ' ARG . . . . . 0.439 ' O ' ' HB2' ' A' ' 74' ' ' ASN . 97.8 mtt180 -110.1 0.12 18.21 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.222 -0.924 . . . . 0.0 109.63 -179.918 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 74' ' ' ASN . . . . . 0.439 ' HB2' ' O ' ' A' ' 73' ' ' ARG . 79.1 m-20 61.03 46.28 8.45 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.19 -0.944 . . . . 0.0 109.589 179.9 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 75' ' ' CYS . . . . . 0.436 ' HA ' ' O ' ' A' ' 44' ' ' VAL . 23.9 p -146.68 133.72 20.34 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.212 -0.93 . . . . 0.0 109.51 179.987 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . 0.423 ' HA ' ' HA ' ' A' ' 69' ' ' MET . . . -106.35 161.28 14.7 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.282 -0.886 . . . . 0.0 109.488 179.932 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 77' ' ' PHE . . . . . 0.464 ' CZ ' ' HE3' ' A' ' 110' ' ' LYS . 98.5 m-85 -126.89 132.66 50.86 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.305 -0.872 . . . . 0.0 109.461 -179.979 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . 0.484 ' O ' ' N ' ' A' ' 42' ' ' LEU . 40.8 t -128.65 131.89 68.24 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 O-C-N 121.215 -0.928 . . . . 0.0 109.477 179.935 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 79' ' ' THR . . . . . 0.487 HG22 ' CA ' ' A' ' 39' ' ' GLY . 7.0 m -104.38 139.39 39.4 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.228 -0.92 . . . . 0.0 109.429 -179.919 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 80' ' ' TYR . . . . . 0.463 ' OH ' ' CA ' ' A' ' 58' ' ' PHE . 0.8 OUTLIER -118.25 134.57 54.9 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.302 -0.874 . . . . 0.0 109.48 179.942 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 80.2 tt0 -52.35 -34.46 47.6 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.257 -0.902 . . . . 0.0 109.408 179.896 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 42.5 mtmt -128.55 142.17 51.14 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.277 -0.889 . . . . 0.0 109.524 179.9 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 83' ' ' MET . . . . . 0.517 ' HE1' ' CB ' ' A' ' 117' ' ' ALA . 31.3 mtm -62.56 -25.45 68.07 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.258 -0.901 . . . . 0.0 109.555 -179.946 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 96.9 mt-10 -62.59 -39.89 95.17 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.27 -0.894 . . . . 0.0 109.55 -179.949 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 16.0 m -63.89 -34.21 77.43 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.225 -0.922 . . . . 0.0 109.636 179.978 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 86' ' ' ALA . . . . . 0.516 ' CB ' HD11 ' A' ' 42' ' ' LEU . . . -72.39 -33.09 66.93 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.285 -0.884 . . . . 0.0 109.546 -179.966 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 22.2 t70 -65.11 -42.69 93.75 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.212 -0.93 . . . . 0.0 109.557 -179.947 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 64.6 tt0 -67.88 -36.77 80.84 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.223 -0.923 . . . . 0.0 109.579 -179.959 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 89' ' ' ALA . . . . . 0.577 ' HA ' ' CD2' ' A' ' 61' ' ' PHE . . . -76.69 -48.81 17.73 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.211 -0.931 . . . . 0.0 109.547 -179.944 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 90' ' ' VAL . . . . . 0.521 HG22 ' CG1' ' A' ' 105' ' ' VAL . 71.3 t -58.76 -29.21 39.52 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.524 0 O-C-N 121.22 -0.925 . . . . 0.0 109.455 -179.933 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -80.03 -54.18 6.03 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.248 -0.907 . . . . 0.0 109.758 -179.92 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 92' ' ' GLU . . . . . 0.498 ' HB2' ' CE2' ' A' ' 61' ' ' PHE . 91.0 mt-10 -71.21 -40.75 70.96 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.288 -0.882 . . . . 0.0 109.879 -179.597 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 93' ' ' LEU . . . . . 0.578 HD13 ' CE2' ' A' ' 58' ' ' PHE . 28.2 mt -68.56 -42.18 78.71 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.141 -0.974 . . . . 0.0 109.558 -179.828 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 94' ' ' ASN . . . . . 0.515 ' CB ' ' O ' ' A' ' 90' ' ' VAL . 60.6 t-20 -63.79 131.24 47.21 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.255 -0.903 . . . . 0.0 109.565 -179.965 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 86.66 35.21 10.49 Favored Glycine 0 N--CA 1.49 2.291 0 N-CA-C 109.513 -1.435 . . . . 0.0 109.513 -179.968 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 96' ' ' THR . . . . . 0.522 ' CG2' ' O ' ' A' ' 93' ' ' LEU . 22.0 p -124.21 160.36 28.08 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.221 -1.164 . . . . 0.0 109.367 179.952 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 97' ' ' GLN . . . . . 0.409 ' HG2' ' N ' ' A' ' 98' ' ' VAL . 62.3 tt0 -128.25 154.81 45.46 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.238 -0.914 . . . . 0.0 109.471 -179.942 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 98' ' ' VAL . . . . . 0.453 HG22 ' O ' ' A' ' 101' ' ' VAL . 1.2 t -106.19 -155.13 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.566 0 O-C-N 121.212 -0.93 . . . . 0.0 109.336 -179.978 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 96.2 mt-10 -56.76 -36.98 70.44 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.119 -0.988 . . . . 0.0 109.481 -179.943 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 20.9 t -160.95 23.28 0.14 Allowed 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.224 -0.923 . . . . 0.0 109.596 -179.953 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 101' ' ' VAL . . . . . 0.453 ' O ' HG22 ' A' ' 98' ' ' VAL . 48.7 t -138.57 154.29 26.86 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.547 0 O-C-N 121.214 -0.929 . . . . 0.0 109.558 -180.0 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 92.2 mt-30 -99.63 148.35 24.42 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.278 -0.889 . . . . 0.0 109.306 179.935 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 91.9 mt -109.04 137.05 47.55 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.184 -0.947 . . . . 0.0 109.625 -179.905 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 104' ' ' LYS . . . . . 0.454 ' O ' ' HA ' ' A' ' 44' ' ' VAL . 3.1 mtpm? -122.98 139.24 54.28 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.312 -0.868 . . . . 0.0 109.327 179.927 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 105' ' ' VAL . . . . . 0.521 ' CG1' HG22 ' A' ' 90' ' ' VAL . 25.8 t -121.96 136.65 58.16 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.519 0 O-C-N 121.207 -0.933 . . . . 0.0 109.559 -179.968 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 106' ' ' ASN . . . . . 0.458 ' OD1' ' O ' ' A' ' 105' ' ' VAL . 99.1 m-20 -142.17 -178.41 5.71 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.298 -0.876 . . . . 0.0 109.392 179.957 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 41.0 mt -102.15 137.54 29.68 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.567 0 O-C-N 121.212 -0.93 . . . . 0.0 109.574 -179.891 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 108' ' ' ALA . . . . . 0.448 ' HB1' ' HB2' ' A' ' 43' ' ' TYR . . . -124.98 141.75 51.93 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.26 -0.9 . . . . 0.0 109.446 179.945 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 49.6 mtt180 -111.48 40.1 2.18 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.244 -0.91 . . . . 0.0 109.408 179.885 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 110' ' ' LYS . . . . . 0.467 ' O ' ' HD2' ' A' ' 112' ' ' PRO . 67.3 mttm -81.59 -11.87 58.97 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.193 -0.942 . . . . 0.0 109.526 -179.881 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 111' ' ' GLN . . . . . 0.586 ' CG ' ' O ' ' A' ' 111' ' ' GLN . 0.0 OUTLIER -113.94 57.16 0.77 Allowed Pre-proline 0 N--CA 1.491 1.589 0 O-C-N 121.205 -0.935 . . . . 0.0 109.356 179.746 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 112' ' ' PRO . . . . . 0.467 ' HD2' ' O ' ' A' ' 110' ' ' LYS . 44.0 Cg_endo -66.69 -2.6 7.81 Favored 'Trans proline' 0 C--O 1.214 -0.708 0 C-N-CA 122.785 2.324 . . . . 0.0 112.032 -179.848 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 113' ' ' MET . . . . . 0.542 ' CE ' ' HB2' ' A' ' 111' ' ' GLN . 0.0 OUTLIER -56.86 -23.23 42.84 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.178 -0.951 . . . . 0.0 109.089 179.586 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 114' ' ' LEU . . . . . 0.541 ' N ' ' HG2' ' A' ' 113' ' ' MET . 0.3 OUTLIER -153.59 17.7 0.53 Allowed 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.322 -0.861 . . . . 0.0 109.894 -179.721 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 115' ' ' ASP . . . . . 0.547 ' O ' ' CB ' ' A' ' 116' ' ' ALA . 77.1 m-20 40.62 43.03 1.51 Allowed 'General case' 0 N--CA 1.492 1.639 0 N-CA-C 109.151 -0.685 . . . . 0.0 109.151 -179.768 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 116' ' ' ALA . . . . . 0.547 ' CB ' ' O ' ' A' ' 115' ' ' ASP . . . 79.62 -74.82 0.05 OUTLIER 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.567 -0.708 . . . . 0.0 109.312 -179.294 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 117' ' ' ALA . . . . . 0.517 ' CB ' ' HE1' ' A' ' 83' ' ' MET . . . -168.48 59.11 0.06 Allowed 'General case' 0 C--N 1.304 -1.399 0 O-C-N 121.385 -0.822 . . . . 0.0 109.726 -179.929 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 44.3 m -118.17 148.61 42.18 Favored 'General case' 0 C--N 1.303 -1.434 0 O-C-N 121.158 -0.964 . . . . 0.0 109.553 -179.965 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -147.24 179.39 24.2 Favored Glycine 0 N--CA 1.489 2.232 0 N-CA-C 109.541 -1.424 . . . . 0.0 109.541 179.937 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 33.5 mmtp -82.29 144.93 30.27 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.238 -1.154 . . . . 0.0 109.5 179.969 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 7.3 m . . . . . 0 N--CA 1.49 1.543 0 CA-C-O 117.99 -1.005 . . . . 0.0 109.448 -179.988 . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.552 0 N-CA-C 109.465 -0.569 . . . . 0.0 109.465 . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 49.5 Cg_endo -69.41 -4.73 14.38 Favored 'Trans proline' 0 C--O 1.215 -0.657 0 C-N-CA 122.727 2.285 . . . . 0.0 111.889 179.935 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 37' ' ' ARG . . . . . 0.451 ' O ' HD11 ' A' ' 114' ' ' LEU . 74.3 mtt-85 -128.52 135.27 49.17 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.161 -0.962 . . . . 0.0 109.588 -179.939 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 38' ' ' LYS . . . . . 0.473 ' HB2' ' O ' ' A' ' 81' ' ' GLU . 44.5 mttp -133.85 -160.21 1.03 Allowed 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.287 -0.883 . . . . 0.0 109.284 179.942 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . 0.473 ' O ' ' HA ' ' A' ' 116' ' ' ALA . . . -172.34 168.51 41.6 Favored Glycine 0 N--CA 1.492 2.37 0 N-CA-C 109.793 -1.323 . . . . 0.0 109.793 -179.97 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 40' ' ' ASN . . . . . 0.52 ' N ' ' O ' ' A' ' 80' ' ' TYR . 42.3 t30 -151.41 98.26 2.5 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.345 -1.091 . . . . 0.0 109.139 179.853 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 41' ' ' THR . . . . . 0.459 ' O ' HD22 ' A' ' 42' ' ' LEU . 8.2 m -63.88 134.01 54.36 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.315 -0.866 . . . . 0.0 109.986 -179.518 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . 0.565 HD12 ' CD2' ' A' ' 80' ' ' TYR . 20.4 mt -120.21 155.6 32.83 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.424 -0.797 . . . . 0.0 109.314 179.702 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 43' ' ' TYR . . . . . 0.439 ' O ' ' HA ' ' A' ' 105' ' ' VAL . 69.9 t80 -109.59 127.24 54.37 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.179 -0.951 . . . . 0.0 109.468 179.965 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 46.7 t -126.66 136.22 61.43 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.544 0 O-C-N 121.153 -0.967 . . . . 0.0 109.4 179.935 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 45' ' ' TYR . . . . . 0.461 ' HB3' ' HB2' ' A' ' 104' ' ' LYS . 65.6 t80 -127.53 136.43 51.71 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.292 -0.88 . . . . 0.0 109.596 -179.84 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -173.54 -163.88 27.85 Favored Glycine 0 N--CA 1.49 2.27 0 N-CA-C 109.374 -1.49 . . . . 0.0 109.374 179.988 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . 0.426 ' O ' ' C ' ' A' ' 48' ' ' ASP . 89.5 mt-10 -120.96 147.25 45.72 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.163 -1.199 . . . . 0.0 109.512 179.947 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . 0.426 ' C ' ' O ' ' A' ' 47' ' ' GLU . 47.0 m-20 43.49 54.18 5.42 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.227 -0.921 . . . . 0.0 109.477 179.966 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 54.4 mtm -97.34 136.1 38.3 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.318 -0.864 . . . . 0.0 109.607 -179.889 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 50' ' ' THR . . . . . 0.499 ' O ' ' CD1' ' A' ' 54' ' ' LEU . 0.0 OUTLIER -118.61 161.95 33.1 Favored Pre-proline 0 N--CA 1.49 1.548 0 O-C-N 121.258 -0.902 . . . . 0.0 109.49 179.927 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 51' ' ' PRO . . . . . 0.454 ' HD2' HG21 ' A' ' 50' ' ' THR . 48.1 Cg_endo -69.85 -50.19 0.48 Allowed 'Trans proline' 0 C--O 1.214 -0.683 0 C-N-CA 122.724 2.282 . . . . 0.0 111.731 -179.914 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 50.7 m -52.91 -47.43 67.99 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.228 -0.92 . . . . 0.0 109.311 179.904 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 10.8 tp -61.85 -57.2 12.74 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.402 -0.811 . . . . 0.0 109.25 179.788 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 54' ' ' LEU . . . . . 0.501 ' CD1' ' HE1' ' A' ' 69' ' ' MET . 4.4 mt -53.63 -49.66 67.4 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.284 -0.885 . . . . 0.0 109.219 179.758 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 55' ' ' ARG . . . . . 0.435 ' C ' ' O ' ' A' ' 54' ' ' LEU . 77.7 ttt180 -43.66 -44.72 6.58 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.294 -0.879 . . . . 0.0 109.201 179.87 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -68.79 -33.3 75.28 Favored Glycine 0 N--CA 1.489 2.219 0 N-CA-C 109.159 -1.577 . . . . 0.0 109.159 179.737 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . 0.443 ' N ' ' O ' ' A' ' 54' ' ' LEU . . . -72.55 -20.11 61.39 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.353 -1.087 . . . . 0.0 109.297 179.935 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 58' ' ' PHE . . . . . 0.635 ' CE2' ' CD1' ' A' ' 93' ' ' LEU . 95.2 m-85 -117.98 7.94 12.41 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.301 -0.875 . . . . 0.0 109.324 179.856 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 59' ' ' SER . . . . . 0.561 ' N ' ' HD2' ' A' ' 60' ' ' PRO . 0.5 OUTLIER -76.68 -50.1 2.6 Favored Pre-proline 0 N--CA 1.49 1.562 0 O-C-N 121.243 -0.91 . . . . 0.0 110.577 -179.644 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 60' ' ' PRO . . . . . 0.561 ' HD2' ' N ' ' A' ' 59' ' ' SER . 49.9 Cg_endo -70.72 -33.79 12.4 Favored 'Trans proline' 0 C--O 1.215 -0.654 0 C-N-CA 122.215 1.943 . . . . 0.0 112.454 -179.15 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 61' ' ' PHE . . . . . 0.575 ' CE1' ' HA ' ' A' ' 89' ' ' ALA . 77.4 m-85 -61.74 -43.96 97.83 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.042 -1.036 . . . . 0.0 109.516 -179.983 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . 0.426 ' HA3' ' OG ' ' A' ' 85' ' ' SER . . . -174.44 -168.29 35.03 Favored Glycine 0 N--CA 1.491 2.315 0 N-CA-C 109.464 -1.455 . . . . 0.0 109.464 -179.965 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 86.6 m-20 -98.1 143.5 28.58 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.235 -1.156 . . . . 0.0 109.409 -179.981 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 64' ' ' ILE . . . . . 0.463 ' HA ' ' O ' ' A' ' 79' ' ' THR . 37.8 mt -105.02 129.65 57.35 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.511 0 O-C-N 121.239 -0.913 . . . . 0.0 109.544 -179.904 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 65' ' ' ILE . . . . . 0.422 HD13 ' HA3' ' A' ' 39' ' ' GLY . 21.3 pt -96.68 -21.58 5.35 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.602 0 O-C-N 121.324 -0.86 . . . . 0.0 109.614 -179.903 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 66' ' ' ASP . . . . . 0.442 ' HB3' ' OG1' ' A' ' 79' ' ' THR . 57.7 t0 -144.87 109.79 5.07 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.187 -0.946 . . . . 0.0 109.56 179.99 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 15.1 tp -108.07 121.48 44.91 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.301 -0.874 . . . . 0.0 109.437 179.979 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 68' ' ' SER . . . . . 0.453 ' HB3' ' HB2' ' A' ' 77' ' ' PHE . 22.7 t -131.09 139.04 49.81 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.281 -0.887 . . . . 0.0 109.421 -179.942 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 69' ' ' MET . . . . . 0.501 ' HE1' ' CD1' ' A' ' 54' ' ' LEU . 94.9 mmm -114.82 150.87 34.8 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.187 -0.946 . . . . 0.0 109.522 179.998 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 70' ' ' ASP . . . . . 0.459 ' CB ' ' O ' ' A' ' 75' ' ' CYS . 6.1 t0 -132.24 95.97 20.39 Favored Pre-proline 0 N--CA 1.49 1.542 0 O-C-N 121.222 -0.924 . . . . 0.0 109.516 -179.967 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 71' ' ' PRO . . . . . 0.592 ' N ' ' CD ' ' A' ' 72' ' ' PRO . 47.9 Cg_endo -74.81 -27.83 10.05 Favored 'Trans proline' 0 CA--C 1.543 0.956 0 C-N-CA 122.451 2.101 . . . . 0.0 113.623 -179.881 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 72' ' ' PRO . . . . . 0.592 ' CD ' ' N ' ' A' ' 71' ' ' PRO . 55.2 Cg_endo -75.13 -26.5 10.65 Favored 'Trans proline' 0 C--N 1.353 0.769 0 C-N-CA 121.51 1.473 . . . . 0.0 111.825 -179.848 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 73' ' ' ARG . . . . . 0.458 ' O ' ' HB2' ' A' ' 74' ' ' ASN . 77.7 mtt85 -109.24 -1.9 18.31 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.208 -0.932 . . . . 0.0 109.67 -179.841 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 74' ' ' ASN . . . . . 0.458 ' HB2' ' O ' ' A' ' 73' ' ' ARG . 78.4 m-20 61.89 43.12 9.59 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.159 -0.963 . . . . 0.0 109.599 179.97 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 75' ' ' CYS . . . . . 0.459 ' O ' ' CB ' ' A' ' 70' ' ' ASP . 28.4 p -146.52 141.9 27.5 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.277 -0.89 . . . . 0.0 109.47 179.941 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . 0.401 ' CB ' ' SD ' ' A' ' 69' ' ' MET . . . -114.11 161.88 17.2 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.214 -0.929 . . . . 0.0 109.56 -179.906 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 77' ' ' PHE . . . . . 0.453 ' HB2' ' HB3' ' A' ' 68' ' ' SER . 97.4 m-85 -123.77 130.94 53.41 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.24 -0.912 . . . . 0.0 109.385 -179.931 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . 0.505 ' O ' ' N ' ' A' ' 42' ' ' LEU . 39.2 t -128.62 132.12 68.08 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.597 0 O-C-N 121.185 -0.947 . . . . 0.0 109.592 -179.938 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 79' ' ' THR . . . . . 0.463 ' O ' ' HA ' ' A' ' 64' ' ' ILE . 7.1 m -106.74 123.15 47.72 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.203 -0.935 . . . . 0.0 109.612 179.928 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 80' ' ' TYR . . . . . 0.565 ' CD2' HD12 ' A' ' 42' ' ' LEU . 1.7 m-85 -101.94 126.45 48.85 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.261 -0.9 . . . . 0.0 109.299 179.879 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 81' ' ' GLU . . . . . 0.473 ' O ' ' HB2' ' A' ' 38' ' ' LYS . 86.9 tt0 -42.89 -48.27 5.78 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.244 -0.91 . . . . 0.0 109.658 -179.758 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 29.8 mttt -110.96 153.84 24.97 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.184 -0.947 . . . . 0.0 109.526 179.972 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 83' ' ' MET . . . . . 0.523 ' HE3' ' CB ' ' A' ' 117' ' ' ALA . 58.8 mtt -73.05 -16.66 61.48 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.315 -0.865 . . . . 0.0 109.424 -179.939 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 75.6 mm-40 -71.92 -41.04 68.36 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.269 -0.894 . . . . 0.0 109.443 179.965 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 85' ' ' SER . . . . . 0.458 ' OG ' ' CD1' ' A' ' 80' ' ' TYR . 14.3 t -58.9 -39.67 82.18 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.219 -0.925 . . . . 0.0 109.34 179.907 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 86' ' ' ALA . . . . . 0.528 ' HB1' ' CD2' ' A' ' 42' ' ' LEU . . . -67.9 -37.76 82.13 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.374 -0.829 . . . . 0.0 109.446 179.956 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 56.6 t0 -60.13 -41.25 92.26 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.267 -0.896 . . . . 0.0 109.594 -179.971 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 88' ' ' GLN . . . . . 0.442 ' O ' ' CB ' ' A' ' 92' ' ' GLU . 60.5 tt0 -74.63 -41.98 59.38 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.189 -0.945 . . . . 0.0 109.441 179.975 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 89' ' ' ALA . . . . . 0.575 ' HA ' ' CE1' ' A' ' 61' ' ' PHE . . . -69.76 -46.98 64.63 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.222 -0.924 . . . . 0.0 109.446 -179.983 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 90' ' ' VAL . . . . . 0.526 HG12 ' CG1' ' A' ' 105' ' ' VAL . 48.4 t -64.93 -54.47 29.27 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.535 0 O-C-N 121.205 -0.935 . . . . 0.0 109.615 -179.926 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -61.53 -40.3 94.15 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.176 -0.952 . . . . 0.0 109.855 -179.671 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 92' ' ' GLU . . . . . 0.528 ' HB3' ' CE1' ' A' ' 61' ' ' PHE . 47.5 tp10 -77.73 -46.2 22.48 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.223 -0.923 . . . . 0.0 109.887 -179.672 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 93' ' ' LEU . . . . . 0.635 ' CD1' ' CE2' ' A' ' 58' ' ' PHE . 49.8 mt -67.69 -37.84 82.85 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.157 -0.964 . . . . 0.0 109.643 -179.809 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 94' ' ' ASN . . . . . 0.582 ' HB2' ' CG1' ' A' ' 105' ' ' VAL . 50.5 t-20 -61.64 139.35 58.3 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.298 -0.876 . . . . 0.0 109.562 -179.856 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 73.95 30.4 61.41 Favored Glycine 0 N--CA 1.49 2.269 0 N-CA-C 109.482 -1.447 . . . . 0.0 109.482 179.972 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 96' ' ' THR . . . . . 0.524 ' CG2' ' O ' ' A' ' 93' ' ' LEU . 24.5 p -121.18 146.41 46.8 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.275 -1.132 . . . . 0.0 109.42 -179.97 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 97' ' ' GLN . . . . . 0.425 ' HG3' ' O ' ' A' ' 101' ' ' VAL . 63.5 tt0 -116.58 137.08 52.45 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.261 -0.9 . . . . 0.0 109.522 179.982 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 1.3 t -83.01 -148.53 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.569 0 O-C-N 121.252 -0.905 . . . . 0.0 109.319 -179.976 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 95.8 mt-10 -59.33 -36.16 75.16 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.172 -0.955 . . . . 0.0 109.444 -179.995 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -161.13 23.53 0.13 Allowed 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.275 -0.891 . . . . 0.0 109.564 179.89 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 101' ' ' VAL . . . . . 0.425 ' O ' ' HG3' ' A' ' 97' ' ' GLN . 95.1 t -134.75 158.05 41.37 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.569 0 O-C-N 121.197 -0.939 . . . . 0.0 109.454 179.895 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 88.2 mt-30 -102.13 161.24 13.84 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.227 -0.921 . . . . 0.0 109.48 -179.988 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 49.3 mt -114.73 134.27 55.23 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.263 -0.898 . . . . 0.0 109.634 -179.865 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 104' ' ' LYS . . . . . 0.461 ' HB2' ' HB3' ' A' ' 45' ' ' TYR . 63.4 mttm -126.75 94.4 4.03 Favored 'General case' 0 N--CA 1.489 1.504 0 N-CA-C 108.737 -0.838 . . . . 0.0 108.737 179.746 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 105' ' ' VAL . . . . . 0.582 ' CG1' ' HB2' ' A' ' 94' ' ' ASN . 9.7 p -96.24 140.56 16.99 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.51 0 O-C-N 121.444 -0.785 . . . . 0.0 109.963 -179.421 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 106' ' ' ASN . . . . . 0.441 ' OD1' ' O ' ' A' ' 105' ' ' VAL . 97.7 m-20 -141.41 -165.68 2.03 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.379 -0.825 . . . . 0.0 109.101 179.777 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 28.2 mm -97.23 132.06 42.66 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.564 0 O-C-N 121.062 -1.024 . . . . 0.0 109.428 179.807 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -111.18 170.74 7.91 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.289 -0.882 . . . . 0.0 109.539 -179.883 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 29.5 ttm105 -44.6 148.13 0.53 Allowed 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.248 -0.908 . . . . 0.0 109.52 179.925 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 110' ' ' LYS . . . . . 0.429 ' O ' ' C ' ' A' ' 111' ' ' GLN . 18.8 mttt -87.4 108.92 19.21 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.226 -0.921 . . . . 0.0 109.517 179.849 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 111' ' ' GLN . . . . . 0.57 ' NE2' ' N ' ' A' ' 111' ' ' GLN . 0.7 OUTLIER -42.49 133.73 2.73 Favored Pre-proline 0 N--CA 1.491 1.601 0 O-C-N 121.389 -0.819 . . . . 0.0 109.733 -179.889 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 112' ' ' PRO . . . . . 0.427 ' O ' ' C ' ' A' ' 113' ' ' MET . 55.6 Cg_endo -78.13 -24.46 8.13 Favored 'Trans proline' 0 C--O 1.215 -0.635 0 C-N-CA 122.718 2.278 . . . . 0.0 111.769 -179.814 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 113' ' ' MET . . . . . 0.515 ' CE ' ' HG3' ' A' ' 111' ' ' GLN . 0.0 OUTLIER -43.28 -26.55 0.19 Allowed 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.334 -0.854 . . . . 0.0 109.768 -179.978 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 114' ' ' LEU . . . . . 0.506 ' CD2' ' O ' ' A' ' 114' ' ' LEU . 3.4 tt -164.64 26.8 0.06 Allowed 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.195 -0.941 . . . . 0.0 109.618 -179.951 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 115' ' ' ASP . . . . . 0.466 ' O ' ' HB1' ' A' ' 116' ' ' ALA . 74.9 m-20 45.15 42.55 6.9 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.182 -0.949 . . . . 0.0 109.09 -179.897 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 116' ' ' ALA . . . . . 0.536 ' CA ' ' NE2' ' A' ' 111' ' ' GLN . . . 73.3 -83.61 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.334 -0.854 . . . . 0.0 109.606 -179.898 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 117' ' ' ALA . . . . . 0.523 ' CB ' ' HE3' ' A' ' 83' ' ' MET . . . -171.58 27.9 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.299 -0.875 . . . . 0.0 109.716 179.986 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 9.7 t -120.0 4.5 10.92 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.15 -0.969 . . . . 0.0 109.715 -179.844 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -49.56 -36.91 25.48 Favored Glycine 0 N--CA 1.49 2.269 0 N-CA-C 109.549 -1.42 . . . . 0.0 109.549 -179.861 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 67.3 mttm -55.2 -32.85 62.55 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.243 -1.151 . . . . 0.0 109.562 -179.9 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 4.1 m . . . . . 0 N--CA 1.49 1.573 0 CA-C-O 117.994 -1.003 . . . . 0.0 109.423 -179.904 . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 1.52 0 N-CA-C 109.476 -0.565 . . . . 0.0 109.476 . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 50.2 Cg_endo -69.95 142.33 46.81 Favored 'Trans proline' 0 C--O 1.215 -0.672 0 C-N-CA 122.768 2.312 . . . . 0.0 111.911 -179.956 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 37' ' ' ARG . . . . . 0.455 ' O ' ' O ' ' A' ' 38' ' ' LYS . 62.1 mtt180 -122.64 153.07 39.84 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.301 -0.874 . . . . 0.0 109.307 179.885 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 38' ' ' LYS . . . . . 0.528 ' HA ' ' CD1' ' A' ' 114' ' ' LEU . 96.5 mttt 44.6 -168.21 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.254 -0.904 . . . . 0.0 109.42 -179.893 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . 0.532 ' CA ' HD12 ' A' ' 65' ' ' ILE . . . 144.47 76.05 0.03 OUTLIER Glycine 0 N--CA 1.489 2.216 0 N-CA-C 109.829 -1.308 . . . . 0.0 109.829 179.921 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 40' ' ' ASN . . . . . 0.469 ' O ' ' HA ' ' A' ' 79' ' ' THR . 42.7 t30 -80.51 117.08 20.92 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.161 -1.199 . . . . 0.0 109.063 179.63 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 41' ' ' THR . . . . . 0.517 HG21 ' N ' ' A' ' 42' ' ' LEU . 54.0 m -75.58 150.51 38.05 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.176 -0.953 . . . . 0.0 109.879 -179.656 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . 0.579 HD13 ' CD2' ' A' ' 80' ' ' TYR . 4.7 mp -126.56 147.25 49.89 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.331 -0.855 . . . . 0.0 109.386 179.806 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 76.4 t80 -102.5 115.43 30.57 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.246 -0.909 . . . . 0.0 109.42 179.961 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . 0.446 ' HA ' ' O ' ' A' ' 104' ' ' LYS . 41.1 t -113.5 143.92 22.21 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.558 0 O-C-N 121.296 -0.878 . . . . 0.0 109.396 179.832 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 45' ' ' TYR . . . . . 0.401 ' HB3' ' HB2' ' A' ' 104' ' ' LYS . 71.5 t80 -136.2 143.33 44.32 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.224 -0.923 . . . . 0.0 109.544 -179.959 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . 0.449 ' N ' ' SD ' ' A' ' 49' ' ' MET . . . 167.24 -175.06 42.45 Favored Glycine 0 N--CA 1.491 2.3 0 N-CA-C 109.506 -1.438 . . . . 0.0 109.506 179.98 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . 0.407 ' O ' ' C ' ' A' ' 48' ' ' ASP . 91.7 mt-10 -107.89 158.54 17.25 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.286 -1.126 . . . . 0.0 109.522 179.998 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . 0.407 ' C ' ' O ' ' A' ' 47' ' ' GLU . 44.9 m-20 43.93 45.97 6.63 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.266 -0.897 . . . . 0.0 109.457 -179.991 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 49' ' ' MET . . . . . 0.449 ' SD ' ' N ' ' A' ' 46' ' ' GLY . 23.4 mtp -85.42 132.32 34.24 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.237 -0.914 . . . . 0.0 109.449 179.942 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 50' ' ' THR . . . . . 0.513 ' O ' ' CD1' ' A' ' 54' ' ' LEU . 0.6 OUTLIER -121.4 159.77 48.74 Favored Pre-proline 0 N--CA 1.49 1.528 0 O-C-N 121.278 -0.889 . . . . 0.0 109.362 179.83 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 51' ' ' PRO . . . . . 0.465 ' HB3' HD11 ' A' ' 67' ' ' LEU . 50.2 Cg_endo -70.3 -42.73 2.63 Favored 'Trans proline' 0 C--O 1.214 -0.692 0 C-N-CA 122.574 2.183 . . . . 0.0 111.6 -179.972 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 58.4 m -64.83 -47.4 78.12 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.308 -0.87 . . . . 0.0 109.255 179.721 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 14.3 tp -57.15 -52.06 66.83 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.322 -0.861 . . . . 0.0 109.276 179.818 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 54' ' ' LEU . . . . . 0.513 ' CD1' ' O ' ' A' ' 50' ' ' THR . 5.8 mt -57.85 -45.88 85.61 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.344 -0.847 . . . . 0.0 109.225 179.713 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 55' ' ' ARG . . . . . 0.495 ' O ' ' CB ' ' A' ' 59' ' ' SER . 24.1 ttt-85 -48.86 -36.18 16.37 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.275 -0.89 . . . . 0.0 109.299 179.757 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -72.95 -36.16 57.51 Favored Glycine 0 N--CA 1.489 2.211 0 N-CA-C 109.422 -1.471 . . . . 0.0 109.422 179.847 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . 0.433 ' O ' HD11 ' A' ' 93' ' ' LEU . . . -71.65 -27.16 62.88 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.238 -1.154 . . . . 0.0 109.302 179.923 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 58' ' ' PHE . . . . . 0.575 ' CE2' HD13 ' A' ' 93' ' ' LEU . 58.2 m-85 -113.58 8.9 17.83 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.356 -0.84 . . . . 0.0 109.399 179.96 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 59' ' ' SER . . . . . 0.496 ' N ' ' HD2' ' A' ' 60' ' ' PRO . 0.6 OUTLIER -74.59 -58.84 1.67 Allowed Pre-proline 0 N--CA 1.491 1.588 0 O-C-N 121.288 -0.883 . . . . 0.0 109.958 -179.627 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 60' ' ' PRO . . . . . 0.496 ' HD2' ' N ' ' A' ' 59' ' ' SER . 48.6 Cg_endo -68.94 -27.59 30.26 Favored 'Trans proline' 0 C--O 1.215 -0.639 0 C-N-CA 122.681 2.254 . . . . 0.0 112.068 -179.6 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 61' ' ' PHE . . . . . 0.57 ' CE2' ' HB2' ' A' ' 92' ' ' GLU . 46.2 m-85 -67.17 -33.63 75.82 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.113 -0.992 . . . . 0.0 109.516 -179.966 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . 0.44 ' HA3' ' OG ' ' A' ' 85' ' ' SER . . . 178.92 -175.08 47.09 Favored Glycine 0 N--CA 1.491 2.317 0 N-CA-C 109.491 -1.444 . . . . 0.0 109.491 -179.974 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 81.7 m-20 -94.44 139.39 31.19 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.313 -1.11 . . . . 0.0 109.468 179.941 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 64' ' ' ILE . . . . . 0.449 ' HA ' ' O ' ' A' ' 79' ' ' THR . 63.7 mt -102.3 130.43 52.18 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.522 0 O-C-N 121.244 -0.91 . . . . 0.0 109.551 -179.92 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 65' ' ' ILE . . . . . 0.532 HD12 ' CA ' ' A' ' 39' ' ' GLY . 19.0 pt -95.94 -18.86 6.44 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.617 0 O-C-N 121.247 -0.908 . . . . 0.0 109.521 -179.989 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 66' ' ' ASP . . . . . 0.46 ' HB3' ' OG1' ' A' ' 79' ' ' THR . 52.1 t0 -145.57 144.46 30.51 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.227 -0.921 . . . . 0.0 109.585 179.904 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . 0.489 ' C ' ' CD1' ' A' ' 67' ' ' LEU . 2.5 tm? -126.09 110.45 13.54 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.303 -0.873 . . . . 0.0 109.218 179.94 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 68' ' ' SER . . . . . 0.429 ' HB2' ' HB2' ' A' ' 77' ' ' PHE . 3.1 m -118.25 134.92 54.6 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.288 -0.883 . . . . 0.0 109.604 -179.73 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 69' ' ' MET . . . . . 0.484 ' SD ' ' CD1' ' A' ' 54' ' ' LEU . 77.7 mmm -120.57 146.47 46.3 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.33 -0.856 . . . . 0.0 109.327 179.86 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 70' ' ' ASP . . . . . 0.461 ' HB2' ' O ' ' A' ' 75' ' ' CYS . 0.1 OUTLIER -129.38 93.93 34.36 Favored Pre-proline 0 N--CA 1.491 1.582 0 O-C-N 121.147 -0.971 . . . . 0.0 109.491 -179.988 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 71' ' ' PRO . . . . . 0.593 ' N ' ' CD ' ' A' ' 72' ' ' PRO . 47.6 Cg_endo -74.93 -27.78 9.87 Favored 'Trans proline' 0 CA--C 1.543 0.936 0 C-N-CA 122.596 2.198 . . . . 0.0 113.738 179.968 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 72' ' ' PRO . . . . . 0.593 ' CD ' ' N ' ' A' ' 71' ' ' PRO . 55.2 Cg_endo -74.9 -21.5 16.03 Favored 'Trans proline' 0 C--N 1.353 0.804 0 C-N-CA 121.511 1.474 . . . . 0.0 111.86 -179.774 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 93.7 mtt-85 -115.31 4.29 14.4 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.243 -0.911 . . . . 0.0 109.591 -179.954 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 78.4 m-20 59.28 48.18 10.54 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.184 -0.948 . . . . 0.0 109.521 179.961 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 75' ' ' CYS . . . . . 0.461 ' O ' ' HB2' ' A' ' 70' ' ' ASP . 27.7 p -151.81 153.97 35.28 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.212 -0.93 . . . . 0.0 109.565 179.976 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . 0.513 ' CB ' HD11 ' A' ' 54' ' ' LEU . . . -127.21 159.62 33.75 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.27 -0.894 . . . . 0.0 109.32 179.86 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 77' ' ' PHE . . . . . 0.469 ' HA ' ' O ' ' A' ' 42' ' ' LEU . 96.4 m-85 -125.19 126.21 44.86 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.255 -0.903 . . . . 0.0 109.571 -179.976 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . 0.499 ' O ' ' N ' ' A' ' 42' ' ' LEU . 60.7 t -118.28 141.68 36.48 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.51 0 O-C-N 121.221 -0.924 . . . . 0.0 109.48 -179.984 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 79' ' ' THR . . . . . 0.523 HG23 ' CA ' ' A' ' 39' ' ' GLY . 26.1 m -109.1 127.85 54.5 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.275 -0.891 . . . . 0.0 109.495 179.836 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 80' ' ' TYR . . . . . 0.579 ' CD2' HD13 ' A' ' 42' ' ' LEU . 0.6 OUTLIER -103.76 148.93 25.5 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.337 -0.852 . . . . 0.0 109.511 -179.879 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 81' ' ' GLU . . . . . 0.452 ' O ' ' CD ' ' A' ' 38' ' ' LYS . 81.7 tt0 -75.11 -22.66 58.07 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.271 -0.893 . . . . 0.0 109.27 179.842 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 31.1 mttp -131.6 136.26 47.64 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.308 -0.87 . . . . 0.0 109.378 179.9 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 83' ' ' MET . . . . . 0.528 ' HE3' ' CB ' ' A' ' 117' ' ' ALA . 49.5 mtt -60.89 -17.29 49.78 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.211 -0.931 . . . . 0.0 109.464 -179.926 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 97.7 mt-10 -71.13 -42.18 69.53 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.244 -0.91 . . . . 0.0 109.512 179.992 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 85' ' ' SER . . . . . 0.443 ' OG ' ' CE1' ' A' ' 80' ' ' TYR . 44.0 t -60.27 -39.49 87.02 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.212 -0.93 . . . . 0.0 109.465 179.975 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -64.19 -42.12 96.79 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.266 -0.896 . . . . 0.0 109.505 -179.99 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 57.0 t0 -65.7 -39.81 91.63 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.28 -0.888 . . . . 0.0 109.577 -179.942 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 88' ' ' GLN . . . . . 0.448 ' HG2' ' CD2' ' A' ' 61' ' ' PHE . 52.2 tt0 -69.28 -41.48 76.78 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.187 -0.946 . . . . 0.0 109.613 -179.928 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 89' ' ' ALA . . . . . 0.478 ' HA ' ' CD2' ' A' ' 61' ' ' PHE . . . -74.35 -43.14 57.85 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.247 -0.908 . . . . 0.0 109.618 -179.9 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 90' ' ' VAL . . . . . 0.53 ' O ' ' CB ' ' A' ' 94' ' ' ASN . 54.2 t -60.21 -33.04 52.13 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 O-C-N 121.229 -0.919 . . . . 0.0 109.756 -179.785 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -80.37 -51.05 9.32 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.144 -0.973 . . . . 0.0 110.122 -179.61 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 92' ' ' GLU . . . . . 0.57 ' HB2' ' CE2' ' A' ' 61' ' ' PHE . 76.1 mm-40 -72.69 -43.72 62.7 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.184 -0.948 . . . . 0.0 110.116 -179.368 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 93' ' ' LEU . . . . . 0.575 HD13 ' CE2' ' A' ' 58' ' ' PHE . 24.3 mt -68.69 -36.07 78.02 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.168 -0.957 . . . . 0.0 109.898 -179.508 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 94' ' ' ASN . . . . . 0.53 ' CB ' ' O ' ' A' ' 90' ' ' VAL . 53.1 t-20 -76.73 130.8 38.22 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.142 -0.974 . . . . 0.0 109.417 -179.891 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 94.66 20.55 28.79 Favored Glycine 0 N--CA 1.491 2.314 0 N-CA-C 109.64 -1.384 . . . . 0.0 109.64 179.89 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 96' ' ' THR . . . . . 0.438 ' CG2' ' O ' ' A' ' 92' ' ' GLU . 19.4 p -118.52 156.4 29.18 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.148 -1.207 . . . . 0.0 109.483 179.928 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 64.4 tt0 -126.18 152.27 46.23 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.241 -0.912 . . . . 0.0 109.434 -179.965 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -100.22 -158.18 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 O-C-N 121.292 -0.88 . . . . 0.0 109.359 -179.943 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 76.1 mm-40 -55.51 -39.5 70.57 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.245 -0.91 . . . . 0.0 109.535 179.984 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 31.0 t -159.66 28.29 0.19 Allowed 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.267 -0.896 . . . . 0.0 109.44 -179.947 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 60.7 t -140.17 148.19 22.8 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.543 0 O-C-N 121.258 -0.901 . . . . 0.0 109.471 179.971 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 90.9 mt-30 -95.51 143.36 26.89 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.239 -0.913 . . . . 0.0 109.529 -179.911 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 82.3 mt -109.7 136.48 48.97 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.284 -0.885 . . . . 0.0 109.404 179.926 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 104' ' ' LYS . . . . . 0.446 ' O ' ' HA ' ' A' ' 44' ' ' VAL . 42.9 mttt -126.05 128.82 48.0 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.182 -0.949 . . . . 0.0 109.509 -179.952 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 105' ' ' VAL . . . . . 0.524 ' CG1' ' HA ' ' A' ' 90' ' ' VAL . 21.4 t -121.18 145.16 28.14 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.52 0 O-C-N 121.233 -0.917 . . . . 0.0 109.34 179.9 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 106' ' ' ASN . . . . . 0.464 ' OD1' ' O ' ' A' ' 105' ' ' VAL . 81.8 m-20 -158.55 -165.7 1.73 Allowed 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.216 -0.928 . . . . 0.0 109.497 -179.901 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 107' ' ' ILE . . . . . 0.422 HG23 HD13 ' A' ' 107' ' ' ILE . 27.2 mm -106.04 123.62 60.78 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.564 0 O-C-N 121.297 -0.877 . . . . 0.0 109.474 179.892 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 108' ' ' ALA . . . . . 0.491 ' HB1' ' CG2' ' A' ' 41' ' ' THR . . . -92.42 -156.71 0.48 Allowed 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.26 -0.9 . . . . 0.0 109.549 -179.936 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 46.0 mtm105 -47.07 164.85 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.248 -0.907 . . . . 0.0 109.468 179.95 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 30.0 mttt -81.77 7.31 12.96 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.127 -0.983 . . . . 0.0 109.59 -179.91 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 111' ' ' GLN . . . . . 0.444 ' CG ' ' HE1' ' A' ' 113' ' ' MET . 10.1 tp-100 55.76 100.29 0.04 OUTLIER Pre-proline 0 N--CA 1.491 1.59 0 O-C-N 121.245 -0.909 . . . . 0.0 109.467 179.903 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 112' ' ' PRO . . . . . 0.44 ' O ' ' C ' ' A' ' 113' ' ' MET . 51.2 Cg_endo -71.17 -27.2 20.31 Favored 'Trans proline' 0 C--O 1.214 -0.683 0 C-N-CA 122.608 2.205 . . . . 0.0 111.755 179.875 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 113' ' ' MET . . . . . 0.535 ' HE3' ' N ' ' A' ' 114' ' ' LEU . 0.0 OUTLIER -43.81 -27.61 0.35 Allowed 'General case' 0 N--CA 1.489 1.491 0 N-CA-C 108.677 -0.86 . . . . 0.0 108.677 179.628 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 114' ' ' LEU . . . . . 0.56 ' CD1' ' O ' ' A' ' 114' ' ' LEU . 0.9 OUTLIER -169.03 27.21 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.229 -0.919 . . . . 0.0 109.158 179.667 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 115' ' ' ASP . . . . . 0.523 ' O ' ' CB ' ' A' ' 116' ' ' ALA . 88.3 m-20 52.21 37.34 21.68 Favored 'General case' 0 N--CA 1.488 1.437 0 O-C-N 121.017 -1.052 . . . . 0.0 108.966 -179.711 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 116' ' ' ALA . . . . . 0.523 ' CB ' ' O ' ' A' ' 115' ' ' ASP . . . 77.03 -77.61 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.393 -0.817 . . . . 0.0 109.416 -179.811 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 117' ' ' ALA . . . . . 0.528 ' CB ' ' HE3' ' A' ' 83' ' ' MET . . . -167.77 65.95 0.08 Allowed 'General case' 0 C--N 1.302 -1.491 0 O-C-N 121.201 -0.937 . . . . 0.0 109.719 -179.882 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 17.7 p -121.96 162.0 21.87 Favored 'General case' 0 C--N 1.303 -1.422 0 O-C-N 121.091 -1.006 . . . . 0.0 109.399 179.915 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 80.69 18.5 70.38 Favored Glycine 0 N--CA 1.49 2.251 0 N-CA-C 109.397 -1.481 . . . . 0.0 109.397 -179.874 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 22.4 mtmt -53.18 -33.31 52.09 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.288 -1.125 . . . . 0.0 109.503 -179.967 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.49 1.538 0 CA-C-O 118.019 -0.991 . . . . 0.0 109.433 -179.925 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 40' ' ' ASN . . . . . 0.429 ' N ' ' O ' ' A' ' 80' ' ' TYR . 40.8 t-20 . . . . . 0 N--CA 1.49 1.564 0 N-CA-C 109.423 -0.584 . . . . 0.0 109.423 . . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 41' ' ' THR . . . . . 0.449 ' O ' HD23 ' A' ' 42' ' ' LEU . 53.2 m -69.54 134.35 48.73 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.27 -0.894 . . . . 0.0 109.595 -179.861 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 42' ' ' LEU . . . . . 0.695 HD11 ' CD2' ' A' ' 80' ' ' TYR . 16.6 mt -115.63 146.78 41.49 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.252 -0.905 . . . . 0.0 109.372 179.97 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 43' ' ' TYR . . . . . 0.455 ' O ' ' HA ' ' A' ' 105' ' ' VAL . 74.4 t80 -97.33 124.08 41.35 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.246 -0.908 . . . . 0.0 109.551 -179.977 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 44' ' ' VAL . . . . . 0.623 HG13 HD23 ' A' ' 103' ' ' LEU . 53.4 t -120.84 134.49 64.09 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.558 0 O-C-N 121.274 -0.891 . . . . 0.0 109.401 179.897 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 76.3 t80 -124.25 137.21 54.54 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.241 -0.912 . . . . 0.0 109.524 -179.876 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -178.23 -177.5 46.99 Favored Glycine 0 N--CA 1.491 2.302 0 N-CA-C 109.465 -1.454 . . . . 0.0 109.465 -179.989 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 47' ' ' GLU . . . . . 0.422 ' O ' ' C ' ' A' ' 48' ' ' ASP . 95.2 mt-10 -118.68 155.25 31.37 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.272 -1.134 . . . . 0.0 109.482 179.957 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 48' ' ' ASP . . . . . 0.422 ' C ' ' O ' ' A' ' 47' ' ' GLU . 47.6 m-20 43.89 48.01 7.02 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.282 -0.886 . . . . 0.0 109.54 179.961 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 58.5 mtm -93.26 143.31 26.38 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.208 -0.932 . . . . 0.0 109.509 179.954 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 50' ' ' THR . . . . . 0.786 ' O ' HD12 ' A' ' 54' ' ' LEU . 0.1 OUTLIER -118.42 166.29 14.25 Favored Pre-proline 0 N--CA 1.491 1.577 0 O-C-N 121.236 -0.915 . . . . 0.0 109.421 179.98 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 49.6 Cg_endo -70.02 -50.47 0.43 Allowed 'Trans proline' 0 C--O 1.214 -0.678 0 C-N-CA 122.713 2.275 . . . . 0.0 111.819 -179.916 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 39.8 m -58.55 -42.16 87.23 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.243 -0.911 . . . . 0.0 109.516 179.976 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 15.2 tp -61.31 -50.86 71.26 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.253 -0.905 . . . . 0.0 109.481 179.986 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 54' ' ' LEU . . . . . 0.786 HD12 ' O ' ' A' ' 50' ' ' THR . 4.2 mt -59.92 -42.75 94.58 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.232 -0.917 . . . . 0.0 109.442 179.954 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 55' ' ' ARG . . . . . 0.457 ' O ' ' CB ' ' A' ' 59' ' ' SER . 48.7 ttt85 -57.19 -32.93 66.95 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.217 -0.927 . . . . 0.0 109.433 179.908 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -76.21 -33.09 50.33 Favored Glycine 0 N--CA 1.49 2.259 0 N-CA-C 109.403 -1.479 . . . . 0.0 109.403 180.0 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 57' ' ' ALA . . . . . 0.551 ' O ' ' CD1' ' A' ' 61' ' ' PHE . . . -73.14 -19.75 61.06 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.314 -1.11 . . . . 0.0 109.411 -179.998 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 58' ' ' PHE . . . . . 0.694 ' CZ ' HD13 ' A' ' 93' ' ' LEU . 96.7 m-85 -121.62 4.37 10.1 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.211 -0.931 . . . . 0.0 109.482 179.914 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 59' ' ' SER . . . . . 0.534 ' N ' ' HD2' ' A' ' 60' ' ' PRO . 0.3 OUTLIER -72.21 -57.31 3.78 Favored Pre-proline 0 N--CA 1.49 1.546 0 O-C-N 121.215 -0.928 . . . . 0.0 109.762 -179.859 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 60' ' ' PRO . . . . . 0.534 ' HD2' ' N ' ' A' ' 59' ' ' SER . 48.9 Cg_endo -69.52 -30.93 22.59 Favored 'Trans proline' 0 C--O 1.214 -0.678 0 C-N-CA 122.637 2.225 . . . . 0.0 111.94 -179.818 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 61' ' ' PHE . . . . . 0.569 ' CD2' ' HA ' ' A' ' 89' ' ' ALA . 62.6 m-85 -62.92 -33.01 74.42 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.241 -0.912 . . . . 0.0 109.455 179.974 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 173.39 -175.47 46.16 Favored Glycine 0 N--CA 1.49 2.264 0 N-CA-C 109.411 -1.476 . . . . 0.0 109.411 179.985 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 38.7 t30 -92.22 141.4 28.62 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.266 -1.138 . . . . 0.0 109.506 179.961 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 64' ' ' ILE . . . . . 0.575 HD13 HD13 ' A' ' 67' ' ' LEU . 71.4 mt -103.83 130.04 54.99 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.521 0 O-C-N 121.246 -0.909 . . . . 0.0 109.432 179.98 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 20.6 pt -94.54 -21.95 5.63 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.537 0 O-C-N 121.252 -0.905 . . . . 0.0 109.475 179.983 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 45.7 t0 -159.26 109.43 1.95 Allowed 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.277 -0.89 . . . . 0.0 109.508 -179.969 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 67' ' ' LEU . . . . . 0.964 HD11 HG22 ' A' ' 78' ' ' VAL . 0.6 OUTLIER -111.96 122.34 47.51 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.259 -0.901 . . . . 0.0 109.367 179.937 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 38.1 m -117.94 150.78 38.66 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.235 -0.915 . . . . 0.0 109.637 -179.917 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 69' ' ' MET . . . . . 0.403 ' CE ' ' CD1' ' A' ' 54' ' ' LEU . 85.6 mtp -123.74 143.59 50.2 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.229 -0.919 . . . . 0.0 109.408 179.926 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 70' ' ' ASP . . . . . 0.476 ' C ' ' HD2' ' A' ' 72' ' ' PRO . 1.7 m-20 -122.31 105.88 36.2 Favored Pre-proline 0 N--CA 1.491 1.615 0 O-C-N 121.268 -0.895 . . . . 0.0 109.493 -179.976 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 71' ' ' PRO . . . . . 0.606 ' N ' ' CD ' ' A' ' 72' ' ' PRO . 47.1 Cg_endo -74.54 -27.9 10.52 Favored 'Trans proline' 0 CA--C 1.543 0.941 0 C-N-CA 122.511 2.141 . . . . 0.0 113.686 179.99 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 72' ' ' PRO . . . . . 0.606 ' CD ' ' N ' ' A' ' 71' ' ' PRO . 55.1 Cg_endo -75.41 -29.11 7.93 Favored 'Trans proline' 0 C--N 1.353 0.793 0 C-N-CA 121.511 1.474 . . . . 0.0 111.733 -179.794 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 73' ' ' ARG . . . . . 0.432 ' O ' ' HB2' ' A' ' 74' ' ' ASN . 61.8 mtt-85 -107.89 -4.22 18.18 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.267 -0.896 . . . . 0.0 109.622 -179.919 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 74' ' ' ASN . . . . . 0.432 ' HB2' ' O ' ' A' ' 73' ' ' ARG . 84.5 m-20 61.7 36.41 16.46 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.231 -0.918 . . . . 0.0 109.493 -179.967 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 75' ' ' CYS . . . . . 0.465 ' SG ' ' HB2' ' A' ' 70' ' ' ASP . 21.9 p -130.85 137.09 49.22 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.266 -0.896 . . . . 0.0 109.477 -180.0 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -110.28 148.3 32.17 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.264 -0.897 . . . . 0.0 109.421 179.998 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 77' ' ' PHE . . . . . 0.465 ' HA ' ' O ' ' A' ' 42' ' ' LEU . 96.9 m-85 -114.2 132.08 56.24 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.214 -0.929 . . . . 0.0 109.528 179.989 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 78' ' ' VAL . . . . . 0.964 HG22 HD11 ' A' ' 67' ' ' LEU . 39.5 t -123.13 128.9 75.2 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 O-C-N 121.239 -0.913 . . . . 0.0 109.474 179.966 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 79' ' ' THR . . . . . 0.449 ' O ' ' HA ' ' A' ' 64' ' ' ILE . 17.5 m -101.18 132.2 46.78 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.245 -0.91 . . . . 0.0 109.437 -179.994 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 80' ' ' TYR . . . . . 0.695 ' CD2' HD11 ' A' ' 42' ' ' LEU . 1.5 m-85 -112.11 145.93 38.91 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.241 -0.912 . . . . 0.0 109.491 -179.942 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 83.4 tt0 -70.9 -28.97 64.93 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.21 -0.931 . . . . 0.0 109.423 179.817 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 44.2 mttm -124.58 145.99 49.29 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.301 -0.875 . . . . 0.0 109.391 179.956 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 83' ' ' MET . . . . . . . . . . . . . 44.1 mtt -64.62 -22.6 67.02 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.241 -0.912 . . . . 0.0 109.468 179.992 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 97.6 mt-10 -69.92 -37.68 76.01 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.204 -0.935 . . . . 0.0 109.525 -179.953 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 85' ' ' SER . . . . . 0.426 ' HB2' ' CG ' ' A' ' 80' ' ' TYR . 17.3 m -59.92 -34.11 72.77 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.271 -0.893 . . . . 0.0 109.489 179.995 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 86' ' ' ALA . . . . . 0.56 ' CB ' HD21 ' A' ' 42' ' ' LEU . . . -79.63 -28.64 40.89 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.266 -0.897 . . . . 0.0 109.518 -179.959 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 87' ' ' ASP . . . . . 0.425 ' O ' ' CB ' ' A' ' 91' ' ' ALA . 94.4 m-20 -67.11 -44.6 79.51 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.257 -0.902 . . . . 0.0 109.517 -179.923 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 88' ' ' GLN . . . . . 0.52 ' HG2' ' CE2' ' A' ' 61' ' ' PHE . 62.5 tt0 -72.16 -39.38 68.76 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.218 -0.926 . . . . 0.0 109.448 -179.942 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 89' ' ' ALA . . . . . 0.569 ' HA ' ' CD2' ' A' ' 61' ' ' PHE . . . -73.96 -45.71 48.53 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.243 -0.911 . . . . 0.0 109.552 -179.98 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 90' ' ' VAL . . . . . 0.698 HG22 HG11 ' A' ' 105' ' ' VAL . 65.7 t -69.75 -36.12 68.53 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.574 0 O-C-N 121.237 -0.915 . . . . 0.0 109.551 -179.935 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 91' ' ' ALA . . . . . 0.425 ' CB ' ' O ' ' A' ' 87' ' ' ASP . . . -79.02 -40.48 31.32 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.295 -0.878 . . . . 0.0 109.647 -179.866 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 92' ' ' GLU . . . . . 0.537 ' OE1' ' CE2' ' A' ' 61' ' ' PHE . 40.1 tt0 -77.29 -42.67 36.04 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.221 -0.924 . . . . 0.0 109.527 -179.866 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 93' ' ' LEU . . . . . 0.694 HD13 ' CZ ' ' A' ' 58' ' ' PHE . 51.2 mt -69.97 -40.87 75.11 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.226 -0.921 . . . . 0.0 109.502 -179.942 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 94' ' ' ASN . . . . . 0.486 ' HB2' ' O ' ' A' ' 90' ' ' VAL . 63.4 t-20 -64.49 130.03 42.13 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.218 -0.926 . . . . 0.0 109.506 179.975 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 88.82 26.99 25.33 Favored Glycine 0 N--CA 1.49 2.257 0 N-CA-C 109.507 -1.437 . . . . 0.0 109.507 179.978 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 96' ' ' THR . . . . . 0.433 HG23 ' O ' ' A' ' 93' ' ' LEU . 27.2 p -124.29 144.62 49.88 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.212 -1.169 . . . . 0.0 109.557 179.932 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 97' ' ' GLN . . . . . 0.464 ' HG3' ' O ' ' A' ' 101' ' ' VAL . 56.0 tt0 -119.5 142.01 48.68 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.345 -0.847 . . . . 0.0 109.412 179.972 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 98' ' ' VAL . . . . . 0.53 HG12 ' H ' ' A' ' 99' ' ' GLU . 1.0 OUTLIER -85.23 -154.31 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 O-C-N 121.188 -0.945 . . . . 0.0 109.374 -179.91 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 99' ' ' GLU . . . . . 0.53 ' H ' HG12 ' A' ' 98' ' ' VAL . 96.4 mt-10 -58.8 -40.97 85.63 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.242 -0.911 . . . . 0.0 109.477 179.997 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 100' ' ' SER . . . . . 0.463 ' O ' ' OG ' ' A' ' 100' ' ' SER . 4.4 t -153.72 24.75 0.51 Allowed 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.295 -0.878 . . . . 0.0 109.394 -179.996 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 101' ' ' VAL . . . . . 0.604 HG12 ' N ' ' A' ' 102' ' ' GLN . 53.4 t -137.01 167.85 22.78 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.521 0 O-C-N 121.285 -0.885 . . . . 0.0 109.442 -179.957 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 102' ' ' GLN . . . . . 0.604 ' N ' HG12 ' A' ' 101' ' ' VAL . 93.7 mt-30 -123.83 149.8 45.31 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.233 -0.917 . . . . 0.0 109.264 179.909 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 103' ' ' LEU . . . . . 0.623 HD23 HG13 ' A' ' 44' ' ' VAL . 0.0 OUTLIER -120.08 121.23 38.41 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.135 -0.978 . . . . 0.0 109.777 -179.859 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 29.9 mttt -106.49 131.67 53.4 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.314 -0.866 . . . . 0.0 109.24 179.81 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 105' ' ' VAL . . . . . 0.698 HG11 HG22 ' A' ' 90' ' ' VAL . 15.6 t . . . . . 0 N--CA 1.49 1.572 0 O-C-N 121.195 -0.941 . . . . 0.0 109.665 -179.842 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 40' ' ' ASN . . . . . 0.476 ' O ' ' HA ' ' A' ' 79' ' ' THR . 47.1 t-20 . . . . . 0 N--CA 1.49 1.572 0 N-CA-C 109.191 -0.67 . . . . 0.0 109.191 . . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 41' ' ' THR . . . . . 0.477 ' HA ' ' O ' ' A' ' 78' ' ' VAL . 86.8 m -84.81 141.56 30.39 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.219 -0.925 . . . . 0.0 109.645 -179.714 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 42' ' ' LEU . . . . . 0.844 HD12 ' O ' ' A' ' 78' ' ' VAL . 5.1 mp -119.03 148.72 42.7 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.274 -0.891 . . . . 0.0 109.375 179.91 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 62.5 t80 -102.18 113.57 26.96 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.248 -0.908 . . . . 0.0 109.61 -179.927 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 44' ' ' VAL . . . . . 0.525 HG13 HD23 ' A' ' 103' ' ' LEU . 17.7 t -109.47 138.79 35.24 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.573 0 O-C-N 121.272 -0.892 . . . . 0.0 109.483 179.978 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 73.9 t80 -134.12 132.6 40.08 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.247 -0.908 . . . . 0.0 109.571 -179.922 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -175.74 -167.18 34.35 Favored Glycine 0 N--CA 1.49 2.269 0 N-CA-C 109.488 -1.445 . . . . 0.0 109.488 179.99 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 47' ' ' GLU . . . . . 0.49 ' H ' HG11 ' A' ' 101' ' ' VAL . 89.9 mt-10 -116.92 157.85 25.02 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.2 -1.177 . . . . 0.0 109.392 -179.948 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 48' ' ' ASP . . . . . 0.404 ' C ' ' O ' ' A' ' 47' ' ' GLU . 23.0 t70 44.01 42.35 4.68 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.301 -0.874 . . . . 0.0 109.382 -179.992 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 49' ' ' MET . . . . . 0.409 ' HE1' HG12 ' A' ' 44' ' ' VAL . 54.4 mtp -73.9 139.44 44.97 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.234 -0.916 . . . . 0.0 109.549 179.943 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 50' ' ' THR . . . . . 0.668 ' O ' HD12 ' A' ' 54' ' ' LEU . 5.1 p -126.14 162.66 44.62 Favored Pre-proline 0 N--CA 1.49 1.566 0 O-C-N 121.336 -0.853 . . . . 0.0 109.425 179.996 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 51' ' ' PRO . . . . . 0.455 ' CA ' ' SD ' ' A' ' 69' ' ' MET . 49.4 Cg_endo -70.22 -50.73 0.39 Allowed 'Trans proline' 0 C--O 1.215 -0.65 0 C-N-CA 122.625 2.217 . . . . 0.0 111.73 -179.983 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 41.2 m -60.77 -40.74 93.65 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.225 -0.922 . . . . 0.0 109.422 179.951 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 15.7 tp -66.53 -46.88 74.7 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.298 -0.876 . . . . 0.0 109.36 179.985 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 54' ' ' LEU . . . . . 0.668 HD12 ' O ' ' A' ' 50' ' ' THR . 10.8 mt -58.24 -46.33 86.14 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.313 -0.867 . . . . 0.0 109.318 179.944 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 55' ' ' ARG . . . . . 0.509 ' O ' ' N ' ' A' ' 59' ' ' SER . 74.0 mtt180 -56.64 -36.7 69.79 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.282 -0.886 . . . . 0.0 109.543 179.995 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -67.64 -32.89 79.4 Favored Glycine 0 N--CA 1.49 2.294 0 N-CA-C 109.554 -1.418 . . . . 0.0 109.554 179.948 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 57' ' ' ALA . . . . . 0.455 ' O ' ' CD1' ' A' ' 61' ' ' PHE . . . -73.31 -23.83 60.31 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.266 -1.138 . . . . 0.0 109.411 -179.917 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 58' ' ' PHE . . . . . 0.807 ' HB2' HD11 ' A' ' 64' ' ' ILE . 98.6 m-85 -118.95 8.51 11.67 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.33 -0.856 . . . . 0.0 109.46 -179.98 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 59' ' ' SER . . . . . 0.53 ' N ' ' HD2' ' A' ' 60' ' ' PRO . 1.1 t -74.5 -57.51 2.06 Favored Pre-proline 0 N--CA 1.491 1.598 0 O-C-N 121.238 -0.914 . . . . 0.0 109.852 -179.715 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 60' ' ' PRO . . . . . 0.53 ' HD2' ' N ' ' A' ' 59' ' ' SER . 50.3 Cg_endo -69.84 -32.27 18.54 Favored 'Trans proline' 0 C--O 1.215 -0.627 0 C-N-CA 122.601 2.2 . . . . 0.0 111.945 -179.783 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 61' ' ' PHE . . . . . 0.577 ' CE2' ' HA ' ' A' ' 89' ' ' ALA . 67.6 m-85 -63.61 -31.82 73.11 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.163 -0.961 . . . . 0.0 109.406 -179.946 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 171.22 -176.7 44.46 Favored Glycine 0 N--CA 1.49 2.278 0 N-CA-C 109.634 -1.387 . . . . 0.0 109.634 -179.993 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 82.9 m-20 -90.04 145.15 25.29 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.302 -1.117 . . . . 0.0 109.461 179.991 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 64' ' ' ILE . . . . . 0.807 HD11 ' HB2' ' A' ' 58' ' ' PHE . 77.6 mt -106.85 131.3 57.11 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.525 0 O-C-N 121.3 -0.875 . . . . 0.0 109.619 -179.973 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 65' ' ' ILE . . . . . 0.64 HD11 HG21 ' A' ' 79' ' ' THR . 28.2 pt -91.76 -22.85 5.94 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.599 0 O-C-N 121.3 -0.875 . . . . 0.0 109.393 179.948 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 66' ' ' ASP . . . . . 0.456 ' HB3' ' OG1' ' A' ' 79' ' ' THR . 53.6 t0 -149.5 115.3 5.64 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.239 -0.913 . . . . 0.0 109.467 -179.927 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 67' ' ' LEU . . . . . 0.701 HD23 HD13 ' A' ' 64' ' ' ILE . 0.5 OUTLIER -103.87 114.86 29.42 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.263 -0.898 . . . . 0.0 109.505 179.999 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 68' ' ' SER . . . . . 0.643 ' N ' HD13 ' A' ' 67' ' ' LEU . 39.2 t -119.5 149.72 41.43 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.176 -0.952 . . . . 0.0 109.53 179.978 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 69' ' ' MET . . . . . 0.455 ' SD ' ' CA ' ' A' ' 51' ' ' PRO . 77.2 mtp -128.46 148.91 50.76 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.309 -0.869 . . . . 0.0 109.472 -179.983 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 70' ' ' ASP . . . . . 0.516 ' CB ' ' O ' ' A' ' 75' ' ' CYS . 0.4 OUTLIER -127.84 94.66 36.59 Favored Pre-proline 0 N--CA 1.49 1.572 0 O-C-N 121.272 -0.892 . . . . 0.0 109.421 179.967 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 71' ' ' PRO . . . . . 0.593 ' N ' ' CD ' ' A' ' 72' ' ' PRO . 47.4 Cg_endo -74.66 -27.93 10.26 Favored 'Trans proline' 0 CA--C 1.542 0.922 0 C-N-CA 122.564 2.176 . . . . 0.0 113.584 179.98 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 72' ' ' PRO . . . . . 0.593 ' CD ' ' N ' ' A' ' 71' ' ' PRO . 55.4 Cg_endo -75.49 -21.44 14.97 Favored 'Trans proline' 0 C--N 1.352 0.761 0 C-N-CA 121.46 1.44 . . . . 0.0 111.797 -179.86 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 67.8 mtt85 -115.23 3.66 14.33 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.252 -0.905 . . . . 0.0 109.7 -179.878 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 78.6 m-20 60.12 44.64 12.72 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.234 -0.916 . . . . 0.0 109.474 179.958 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 75' ' ' CYS . . . . . 0.516 ' O ' ' CB ' ' A' ' 70' ' ' ASP . 28.0 p -149.86 153.2 36.34 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.26 -0.9 . . . . 0.0 109.566 -179.942 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -127.8 159.36 35.07 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.291 -0.88 . . . . 0.0 109.35 179.899 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 77' ' ' PHE . . . . . 0.476 ' HA ' ' O ' ' A' ' 42' ' ' LEU . 96.3 m-85 -120.94 136.79 54.87 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.179 -0.951 . . . . 0.0 109.533 179.997 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 78' ' ' VAL . . . . . 0.844 ' O ' HD12 ' A' ' 42' ' ' LEU . 39.7 t -125.45 135.14 64.93 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 O-C-N 121.247 -0.908 . . . . 0.0 109.546 -179.974 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 79' ' ' THR . . . . . 0.64 HG21 HD11 ' A' ' 65' ' ' ILE . 17.3 m -104.03 127.43 51.59 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.287 -0.883 . . . . 0.0 109.451 179.964 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 80' ' ' TYR . . . . . 0.504 ' CG ' ' HB2' ' A' ' 85' ' ' SER . 1.2 m-85 -108.44 139.82 42.63 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.273 -0.892 . . . . 0.0 109.507 179.958 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 76.8 tt0 -61.35 -24.43 66.46 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.232 -0.917 . . . . 0.0 109.326 179.867 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 42.8 mttm -134.18 144.61 48.59 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.28 -0.887 . . . . 0.0 109.32 179.948 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 83' ' ' MET . . . . . . . . . . . . . 53.8 mtt -65.55 -17.56 64.67 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.17 -0.956 . . . . 0.0 109.548 -179.912 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 97.4 mt-10 -69.98 -35.13 74.19 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.232 -0.918 . . . . 0.0 109.468 -179.924 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 85' ' ' SER . . . . . 0.504 ' HB2' ' CG ' ' A' ' 80' ' ' TYR . 18.0 m -66.84 -30.42 70.59 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.252 -0.905 . . . . 0.0 109.468 -179.943 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 86' ' ' ALA . . . . . 0.76 ' HA ' HD21 ' A' ' 42' ' ' LEU . . . -79.17 -37.43 38.39 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.223 -0.923 . . . . 0.0 109.504 -179.96 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 55.4 t0 -61.78 -47.19 86.27 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.166 -0.959 . . . . 0.0 109.407 179.97 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 88' ' ' GLN . . . . . 0.469 ' O ' ' HB2' ' A' ' 92' ' ' GLU . 64.2 tt0 -67.88 -39.96 83.63 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.289 -0.882 . . . . 0.0 109.316 179.957 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 89' ' ' ALA . . . . . 0.577 ' HA ' ' CE2' ' A' ' 61' ' ' PHE . . . -71.72 -38.91 70.42 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.283 -0.886 . . . . 0.0 109.531 -179.967 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 90' ' ' VAL . . . . . 0.778 HG22 HG12 ' A' ' 105' ' ' VAL . 74.1 t -66.0 -45.33 91.12 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.616 0 O-C-N 121.309 -0.869 . . . . 0.0 109.627 -179.858 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -70.98 -34.51 71.46 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.196 -0.94 . . . . 0.0 109.667 -179.854 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 92' ' ' GLU . . . . . 0.536 ' HB3' ' CZ ' ' A' ' 61' ' ' PHE . 2.4 tm-20 -82.85 -49.3 9.83 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.28 -0.888 . . . . 0.0 109.617 -179.948 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 93' ' ' LEU . . . . . 1.058 ' HB2' HG21 ' A' ' 105' ' ' VAL . 85.3 mt -65.8 -35.0 79.46 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.222 -0.924 . . . . 0.0 109.598 -179.892 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 94' ' ' ASN . . . . . 0.524 ' CB ' ' O ' ' A' ' 90' ' ' VAL . 56.5 t-20 -71.71 130.51 41.33 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.277 -0.889 . . . . 0.0 109.463 -179.985 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 87.24 30.66 19.02 Favored Glycine 0 N--CA 1.489 2.204 0 N-CA-C 109.51 -1.436 . . . . 0.0 109.51 179.97 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 96' ' ' THR . . . . . 0.474 ' CG2' ' O ' ' A' ' 92' ' ' GLU . 28.8 p -122.56 148.08 45.63 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.228 -1.16 . . . . 0.0 109.523 -179.956 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 97' ' ' GLN . . . . . 0.442 ' HG3' ' O ' ' A' ' 101' ' ' VAL . 57.2 tt0 -118.6 143.22 46.94 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.309 -0.869 . . . . 0.0 109.444 -179.953 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 98' ' ' VAL . . . . . 0.49 HG12 ' H ' ' A' ' 99' ' ' GLU . 1.3 t -92.4 -148.84 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 O-C-N 121.256 -0.902 . . . . 0.0 109.368 179.975 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 99' ' ' GLU . . . . . 0.49 ' H ' HG12 ' A' ' 98' ' ' VAL . 96.7 mt-10 -57.61 -37.2 72.85 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.272 -0.893 . . . . 0.0 109.432 179.918 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 22.6 m -165.82 30.64 0.05 Allowed 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.27 -0.894 . . . . 0.0 109.319 179.965 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 101' ' ' VAL . . . . . 0.604 HG12 ' N ' ' A' ' 102' ' ' GLN . 44.4 t -137.73 168.88 19.89 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.5 0 O-C-N 121.34 -0.85 . . . . 0.0 109.465 -179.892 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 102' ' ' GLN . . . . . 0.604 ' N ' HG12 ' A' ' 101' ' ' VAL . 91.5 mt-30 -116.39 145.54 43.16 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.191 -0.943 . . . . 0.0 109.076 179.815 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 103' ' ' LEU . . . . . 0.525 HD23 HG13 ' A' ' 44' ' ' VAL . 0.0 OUTLIER -121.81 134.91 54.9 Favored 'General case' 0 N--CA 1.488 1.444 0 O-C-N 121.18 -0.95 . . . . 0.0 109.851 -179.628 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 60.5 mttt -118.07 126.65 52.68 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.343 -0.848 . . . . 0.0 109.234 179.769 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 105' ' ' VAL . . . . . 1.058 HG21 ' HB2' ' A' ' 93' ' ' LEU . 26.4 t . . . . . 0 N--CA 1.49 1.562 0 O-C-N 121.174 -0.953 . . . . 0.0 109.667 -179.82 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 40' ' ' ASN . . . . . 0.43 ' O ' ' HA ' ' A' ' 79' ' ' THR . 45.3 t-20 . . . . . 0 N--CA 1.49 1.561 0 N-CA-C 109.512 -0.551 . . . . 0.0 109.512 . . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 41' ' ' THR . . . . . 0.463 ' HA ' ' O ' ' A' ' 78' ' ' VAL . 60.2 m -81.0 143.67 32.35 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.274 -0.891 . . . . 0.0 109.54 179.973 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 42' ' ' LEU . . . . . 0.895 HD12 ' O ' ' A' ' 78' ' ' VAL . 5.0 mp -116.08 146.7 42.0 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.176 -0.952 . . . . 0.0 109.521 -179.931 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 35.4 t80 -106.08 112.58 25.67 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.177 -0.952 . . . . 0.0 109.513 -179.976 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 44' ' ' VAL . . . . . 0.473 ' HA ' ' O ' ' A' ' 104' ' ' LYS . 38.2 t -110.53 150.42 13.05 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.53 0 O-C-N 121.266 -0.896 . . . . 0.0 109.535 -179.919 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 70.0 t80 -141.68 138.92 32.79 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.2 -0.937 . . . . 0.0 109.606 179.9 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 177.29 -167.86 39.25 Favored Glycine 0 N--CA 1.49 2.289 0 N-CA-C 109.472 -1.451 . . . . 0.0 109.472 179.909 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 47' ' ' GLU . . . . . 0.423 ' O ' ' C ' ' A' ' 48' ' ' ASP . 89.0 mt-10 -115.66 161.98 17.9 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.275 -1.133 . . . . 0.0 109.42 179.945 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 48' ' ' ASP . . . . . 0.423 ' C ' ' O ' ' A' ' 47' ' ' GLU . 43.9 m-20 43.73 40.74 3.21 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.281 -0.887 . . . . 0.0 109.606 179.975 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 41.3 mtp -78.6 138.79 38.52 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.282 -0.886 . . . . 0.0 109.354 179.979 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 50' ' ' THR . . . . . 0.446 ' O ' ' HG ' ' A' ' 54' ' ' LEU . 0.4 OUTLIER -127.04 161.28 54.8 Favored Pre-proline 0 N--CA 1.49 1.56 0 O-C-N 121.252 -0.905 . . . . 0.0 109.533 179.94 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 50.2 Cg_endo -70.07 -51.94 0.33 Allowed 'Trans proline' 0 C--O 1.214 -0.688 0 C-N-CA 122.641 2.228 . . . . 0.0 111.815 -179.985 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 31.1 m -59.16 -41.2 87.83 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.214 -0.929 . . . . 0.0 109.41 179.904 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 53' ' ' LEU . . . . . 0.558 ' C ' HD23 ' A' ' 53' ' ' LEU . 9.0 tt -64.89 -44.44 89.63 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.305 -0.872 . . . . 0.0 109.467 179.987 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 54' ' ' LEU . . . . . 0.451 HD13 ' CB ' ' A' ' 76' ' ' ALA . 21.9 mt -63.93 -45.86 87.35 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.211 -0.931 . . . . 0.0 109.374 179.946 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 55' ' ' ARG . . . . . 0.454 ' O ' ' N ' ' A' ' 59' ' ' SER . 76.8 mtp180 -51.3 -41.33 60.42 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.235 -0.916 . . . . 0.0 109.358 179.965 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -69.44 -32.28 71.59 Favored Glycine 0 N--CA 1.49 2.253 0 N-CA-C 109.463 -1.455 . . . . 0.0 109.463 179.871 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -71.5 -23.72 61.85 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.339 -1.095 . . . . 0.0 109.398 179.934 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 58' ' ' PHE . . . . . 0.584 ' CE2' ' CD1' ' A' ' 93' ' ' LEU . 90.1 m-85 -120.62 10.11 10.98 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.365 -0.834 . . . . 0.0 109.453 -179.997 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 59' ' ' SER . . . . . 0.547 ' N ' ' HD2' ' A' ' 60' ' ' PRO . 3.4 t -76.78 -54.34 1.7 Allowed Pre-proline 0 N--CA 1.49 1.575 0 O-C-N 121.316 -0.865 . . . . 0.0 110.413 -179.505 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 60' ' ' PRO . . . . . 0.547 ' HD2' ' N ' ' A' ' 59' ' ' SER . 48.5 Cg_endo -69.97 -35.58 11.77 Favored 'Trans proline' 0 C--O 1.215 -0.644 0 C-N-CA 122.516 2.144 . . . . 0.0 112.251 -179.276 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 61' ' ' PHE . . . . . 0.663 ' CE2' HD21 ' A' ' 93' ' ' LEU . 70.0 m-85 -58.51 -39.29 79.67 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.183 -0.948 . . . . 0.0 109.631 -179.833 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 179.43 174.66 45.67 Favored Glycine 0 N--CA 1.49 2.239 0 N-CA-C 109.516 -1.434 . . . . 0.0 109.516 179.95 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 45.9 t-20 -80.18 140.9 36.13 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.263 -1.14 . . . . 0.0 109.414 179.93 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 64' ' ' ILE . . . . . 0.731 HD13 HD23 ' A' ' 67' ' ' LEU . 81.7 mt -100.78 131.04 49.16 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.52 0 O-C-N 121.223 -0.923 . . . . 0.0 109.542 -179.973 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 65' ' ' ILE . . . . . 0.456 HD11 HG21 ' A' ' 79' ' ' THR . 20.4 pt -92.82 -24.02 5.38 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 O-C-N 121.264 -0.898 . . . . 0.0 109.575 -179.841 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 18.7 t70 -149.44 113.79 5.24 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.239 -0.913 . . . . 0.0 109.621 -179.888 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 67' ' ' LEU . . . . . 0.731 HD23 HD13 ' A' ' 64' ' ' ILE . 0.4 OUTLIER -104.74 117.06 33.14 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.282 -0.886 . . . . 0.0 109.342 179.803 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 68' ' ' SER . . . . . 0.665 ' N ' HD13 ' A' ' 67' ' ' LEU . 25.9 t -128.36 148.87 50.7 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.291 -0.881 . . . . 0.0 109.566 -179.906 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 69' ' ' MET . . . . . . . . . . . . . 86.6 mtp -124.9 148.54 48.27 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.233 -0.917 . . . . 0.0 109.408 179.93 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 70' ' ' ASP . . . . . 0.498 ' CB ' ' O ' ' A' ' 75' ' ' CYS . 0.8 OUTLIER -120.77 100.03 46.78 Favored Pre-proline 0 N--CA 1.491 1.624 0 O-C-N 121.253 -0.904 . . . . 0.0 109.614 -179.931 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 71' ' ' PRO . . . . . 0.596 ' N ' ' CD ' ' A' ' 72' ' ' PRO . 47.9 Cg_endo -74.72 -27.85 10.22 Favored 'Trans proline' 0 CA--C 1.543 0.938 0 C-N-CA 122.543 2.162 . . . . 0.0 113.733 179.944 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 72' ' ' PRO . . . . . 0.596 ' CD ' ' N ' ' A' ' 71' ' ' PRO . 55.5 Cg_endo -75.36 -28.62 8.44 Favored 'Trans proline' 0 C--N 1.352 0.762 0 C-N-CA 121.462 1.441 . . . . 0.0 111.846 -179.91 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 73' ' ' ARG . . . . . 0.439 ' O ' ' HB2' ' A' ' 74' ' ' ASN . 55.3 mtt-85 -109.41 0.06 19.2 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.295 -0.878 . . . . 0.0 109.666 -179.826 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 74' ' ' ASN . . . . . 0.439 ' HB2' ' O ' ' A' ' 73' ' ' ARG . 83.5 m-20 61.14 41.25 13.84 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.126 -0.984 . . . . 0.0 109.544 179.984 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 75' ' ' CYS . . . . . 0.498 ' O ' ' CB ' ' A' ' 70' ' ' ASP . 30.0 p -140.93 137.01 32.8 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.183 -0.948 . . . . 0.0 109.627 179.99 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 76' ' ' ALA . . . . . 0.451 ' CB ' HD13 ' A' ' 54' ' ' LEU . . . -105.02 160.6 14.91 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.286 -0.884 . . . . 0.0 109.454 179.996 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 77' ' ' PHE . . . . . 0.475 ' HA ' ' O ' ' A' ' 42' ' ' LEU . 97.1 m-85 -124.33 130.07 51.84 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.207 -0.933 . . . . 0.0 109.487 -179.987 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 78' ' ' VAL . . . . . 0.895 ' O ' HD12 ' A' ' 42' ' ' LEU . 21.2 t -122.09 132.97 69.84 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.549 0 O-C-N 121.273 -0.892 . . . . 0.0 109.341 179.927 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 79' ' ' THR . . . . . 0.465 ' O ' ' HA ' ' A' ' 64' ' ' ILE . 6.8 m -106.01 135.86 46.71 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.238 -0.914 . . . . 0.0 109.36 -179.966 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 80' ' ' TYR . . . . . 0.52 ' OH ' ' CA ' ' A' ' 58' ' ' PHE . 1.6 m-85 -115.56 133.08 56.38 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.162 -0.961 . . . . 0.0 109.619 -179.932 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 76.8 tt0 -52.26 -25.81 10.32 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.339 -0.851 . . . . 0.0 109.537 179.959 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 67.6 mttm -134.23 132.97 40.33 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.176 -0.953 . . . . 0.0 109.617 -179.952 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 83' ' ' MET . . . . . . . . . . . . . 0.8 OUTLIER -57.38 -18.23 16.59 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.277 -0.889 . . . . 0.0 109.649 -179.964 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 99.5 mt-10 -65.76 -39.43 91.04 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.223 -0.923 . . . . 0.0 109.506 -179.922 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 13.9 t -63.58 -40.45 96.99 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.168 -0.957 . . . . 0.0 109.546 -179.897 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 86' ' ' ALA . . . . . 0.684 ' HA ' HD21 ' A' ' 42' ' ' LEU . . . -61.11 -41.45 96.71 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.204 -0.935 . . . . 0.0 109.538 -179.917 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 54.4 t0 -62.19 -45.1 94.89 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.218 -0.926 . . . . 0.0 109.601 -179.926 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 63.6 tt0 -65.16 -37.3 86.96 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.224 -0.922 . . . . 0.0 109.583 -179.817 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 89' ' ' ALA . . . . . 0.596 ' HB1' ' CD1' ' A' ' 93' ' ' LEU . . . -75.95 -45.95 32.36 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.225 -0.922 . . . . 0.0 109.609 -179.879 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 90' ' ' VAL . . . . . 0.689 HG22 HG12 ' A' ' 105' ' ' VAL . 78.0 t -56.9 -31.92 37.57 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.52 0 O-C-N 121.207 -0.933 . . . . 0.0 109.626 -179.889 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -80.06 -53.0 7.12 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.245 -0.91 . . . . 0.0 109.733 -179.82 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 92' ' ' GLU . . . . . 0.607 ' HB2' ' CZ ' ' A' ' 61' ' ' PHE . 75.4 mm-40 -71.72 -43.88 65.11 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.214 -0.929 . . . . 0.0 109.73 -179.637 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 93' ' ' LEU . . . . . 1.003 ' CB ' HG21 ' A' ' 105' ' ' VAL . 36.7 mt -64.67 -40.36 95.28 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.149 -0.969 . . . . 0.0 109.474 -179.916 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 94' ' ' ASN . . . . . 0.489 ' CB ' ' O ' ' A' ' 90' ' ' VAL . 64.0 t-20 -68.4 125.74 27.42 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.244 -0.91 . . . . 0.0 109.499 179.987 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 93.85 22.81 24.79 Favored Glycine 0 N--CA 1.49 2.294 0 N-CA-C 109.536 -1.426 . . . . 0.0 109.536 179.969 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 96' ' ' THR . . . . . 0.594 HG23 ' O ' ' A' ' 93' ' ' LEU . 29.5 p -111.49 159.7 17.83 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.268 -1.136 . . . . 0.0 109.465 -179.948 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 60.0 tt0 -136.13 149.02 48.49 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.281 -0.887 . . . . 0.0 109.491 179.968 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 98' ' ' VAL . . . . . 0.607 ' HB ' HG12 ' A' ' 101' ' ' VAL . 1.3 t -101.59 -151.92 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.543 0 O-C-N 121.195 -0.941 . . . . 0.0 109.204 179.947 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 99' ' ' GLU . . . . . 0.534 ' H ' HG12 ' A' ' 98' ' ' VAL . 95.7 mt-10 -48.29 -41.34 27.77 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.115 -0.991 . . . . 0.0 109.42 179.992 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 2.4 m -165.98 25.84 0.05 OUTLIER 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.236 -0.915 . . . . 0.0 109.505 -179.97 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 101' ' ' VAL . . . . . 0.607 HG12 ' HB ' ' A' ' 98' ' ' VAL . 9.8 p -130.17 140.2 49.51 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.547 0 O-C-N 121.233 -0.917 . . . . 0.0 109.644 -179.861 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 91.7 mt-30 -86.71 141.62 28.78 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.265 -0.897 . . . . 0.0 109.328 179.887 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 103' ' ' LEU . . . . . 0.438 HD23 ' HA ' ' A' ' 103' ' ' LEU . 73.5 mt -106.76 137.62 44.45 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.241 -0.912 . . . . 0.0 109.763 -179.819 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 104' ' ' LYS . . . . . 0.473 ' O ' ' HA ' ' A' ' 44' ' ' VAL . 41.9 mttm -119.38 135.53 54.69 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.284 -0.885 . . . . 0.0 109.245 179.831 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 105' ' ' VAL . . . . . 1.003 HG21 ' CB ' ' A' ' 93' ' ' LEU . 46.0 t . . . . . 0 N--CA 1.49 1.55 0 O-C-N 121.186 -0.946 . . . . 0.0 109.614 -179.788 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 40' ' ' ASN . . . . . 0.482 ' N ' ' O ' ' A' ' 80' ' ' TYR . 47.3 t-20 . . . . . 0 N--CA 1.491 1.613 0 N-CA-C 109.311 -0.625 . . . . 0.0 109.311 . . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 41' ' ' THR . . . . . 0.464 ' O ' HD23 ' A' ' 42' ' ' LEU . 43.7 m -71.11 133.79 46.51 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.257 -0.902 . . . . 0.0 109.74 -179.747 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 42' ' ' LEU . . . . . 0.795 HD11 ' CD2' ' A' ' 80' ' ' TYR . 16.6 mt -114.38 145.68 41.52 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.295 -0.878 . . . . 0.0 109.32 179.824 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 74.1 t80 -100.38 122.61 43.41 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.258 -0.901 . . . . 0.0 109.488 -179.825 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 44' ' ' VAL . . . . . 0.468 ' HA ' ' O ' ' A' ' 104' ' ' LYS . 59.3 t -123.34 136.92 58.39 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.538 0 O-C-N 121.283 -0.885 . . . . 0.0 109.424 179.977 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 45' ' ' TYR . . . . . 0.476 ' HB3' ' HB2' ' A' ' 104' ' ' LYS . 70.1 t80 -120.56 142.09 49.68 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.223 -0.923 . . . . 0.0 109.46 -179.89 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 46' ' ' GLY . . . . . 0.429 ' HA3' ' SD ' ' A' ' 49' ' ' MET . . . 174.86 -175.87 47.02 Favored Glycine 0 N--CA 1.491 2.341 0 N-CA-C 109.54 -1.424 . . . . 0.0 109.54 -179.963 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 47' ' ' GLU . . . . . 0.428 ' O ' ' C ' ' A' ' 48' ' ' ASP . 94.6 mt-10 -120.85 157.03 30.68 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.265 -1.138 . . . . 0.0 109.392 179.962 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 48' ' ' ASP . . . . . 0.428 ' C ' ' O ' ' A' ' 47' ' ' GLU . 48.8 m-20 43.93 52.16 6.73 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.294 -0.879 . . . . 0.0 109.546 -179.979 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 49' ' ' MET . . . . . 0.429 ' SD ' ' HA3' ' A' ' 46' ' ' GLY . 64.8 mtm -103.4 142.41 34.28 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.314 -0.866 . . . . 0.0 109.504 179.975 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -122.15 163.62 30.73 Favored Pre-proline 0 N--CA 1.491 1.582 0 O-C-N 121.258 -0.901 . . . . 0.0 109.371 179.919 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 51' ' ' PRO . . . . . 0.44 ' HD3' ' SD ' ' A' ' 69' ' ' MET . 48.8 Cg_endo -69.56 -52.99 0.31 Allowed 'Trans proline' 0 C--O 1.215 -0.64 0 C-N-CA 122.617 2.211 . . . . 0.0 111.803 179.988 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 28.6 m -50.6 -48.87 57.7 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.249 -0.907 . . . . 0.0 109.302 179.931 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 22.3 tp -60.33 -47.23 86.92 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.249 -0.907 . . . . 0.0 109.343 179.836 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 21.9 mt -56.28 -47.09 79.29 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.284 -0.885 . . . . 0.0 109.357 179.824 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 55' ' ' ARG . . . . . 0.499 ' O ' ' N ' ' A' ' 59' ' ' SER . 36.4 mtp85 -51.43 -40.91 60.33 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.306 -0.871 . . . . 0.0 109.296 179.84 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -66.48 -34.35 87.46 Favored Glycine 0 N--CA 1.489 2.203 0 N-CA-C 109.34 -1.504 . . . . 0.0 109.34 179.864 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -71.23 -26.41 62.91 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.313 -1.11 . . . . 0.0 109.472 179.957 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 58' ' ' PHE . . . . . 0.856 ' HB2' HD11 ' A' ' 64' ' ' ILE . 96.9 m-85 -115.01 8.33 15.75 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.244 -0.91 . . . . 0.0 109.468 179.966 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 59' ' ' SER . . . . . 0.533 ' N ' ' HD2' ' A' ' 60' ' ' PRO . 0.8 OUTLIER -72.91 -58.14 2.76 Favored Pre-proline 0 N--CA 1.49 1.574 0 O-C-N 121.195 -0.941 . . . . 0.0 109.811 -179.784 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 60' ' ' PRO . . . . . 0.533 ' HD2' ' N ' ' A' ' 59' ' ' SER . 48.0 Cg_endo -68.9 -28.69 29.24 Favored 'Trans proline' 0 C--O 1.215 -0.65 0 C-N-CA 122.602 2.202 . . . . 0.0 111.973 -179.702 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 61' ' ' PHE . . . . . 0.572 ' CD1' ' HA ' ' A' ' 89' ' ' ALA . 61.2 m-85 -70.11 -31.74 69.44 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.181 -0.949 . . . . 0.0 109.548 -179.988 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 62' ' ' GLY . . . . . 0.413 ' HA3' ' HB3' ' A' ' 85' ' ' SER . . . 176.39 -171.41 44.4 Favored Glycine 0 N--CA 1.49 2.262 0 N-CA-C 109.504 -1.438 . . . . 0.0 109.504 179.881 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 85.6 m-20 -99.67 137.33 38.3 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.244 -1.15 . . . . 0.0 109.311 -179.963 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 64' ' ' ILE . . . . . 0.856 HD11 ' HB2' ' A' ' 58' ' ' PHE . 64.0 mt -99.53 131.72 46.35 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.517 0 O-C-N 121.238 -0.914 . . . . 0.0 109.581 -179.988 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 65' ' ' ILE . . . . . 0.407 HD11 HG21 ' A' ' 79' ' ' THR . 18.3 pt -96.67 -22.47 5.06 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.549 0 O-C-N 121.346 -0.846 . . . . 0.0 109.427 179.982 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 66' ' ' ASP . . . . . 0.452 ' HB3' ' OG1' ' A' ' 79' ' ' THR . 54.9 t0 -143.76 135.96 26.74 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.219 -0.925 . . . . 0.0 109.563 -179.963 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 67' ' ' LEU . . . . . 0.747 ' C ' HD13 ' A' ' 67' ' ' LEU . 3.4 tm? -122.47 114.71 21.07 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.233 -0.917 . . . . 0.0 109.314 179.918 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 68' ' ' SER . . . . . 0.501 ' N ' HD13 ' A' ' 67' ' ' LEU . 37.7 t -129.25 145.43 51.35 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.247 -0.908 . . . . 0.0 109.518 -179.917 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 69' ' ' MET . . . . . 0.481 ' HA ' ' HA ' ' A' ' 76' ' ' ALA . 79.3 mtp -130.4 143.92 51.07 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.218 -0.926 . . . . 0.0 109.445 179.963 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 70' ' ' ASP . . . . . 0.478 ' C ' ' HD2' ' A' ' 72' ' ' PRO . 2.4 t70 -117.06 107.06 46.34 Favored Pre-proline 0 N--CA 1.489 1.514 0 O-C-N 121.229 -0.92 . . . . 0.0 109.575 -179.928 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 71' ' ' PRO . . . . . 0.604 ' N ' ' CD ' ' A' ' 72' ' ' PRO . 46.3 Cg_endo -74.85 -27.69 10.09 Favored 'Trans proline' 0 CA--C 1.543 0.962 0 C-N-CA 122.458 2.106 . . . . 0.0 113.571 179.923 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 72' ' ' PRO . . . . . 0.604 ' CD ' ' N ' ' A' ' 71' ' ' PRO . 55.2 Cg_endo -75.38 -29.56 7.53 Favored 'Trans proline' 0 C--N 1.353 0.787 0 C-N-CA 121.427 1.418 . . . . 0.0 111.81 -179.872 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 5.8 mtp85 -106.97 1.3 24.35 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.161 -0.962 . . . . 0.0 109.63 179.995 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 80.2 m-20 57.61 39.1 27.87 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.145 -0.972 . . . . 0.0 109.46 179.991 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 75' ' ' CYS . . . . . 0.44 ' HA ' ' O ' ' A' ' 44' ' ' VAL . 27.9 p -134.96 140.52 45.77 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.186 -0.946 . . . . 0.0 109.5 -179.963 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 76' ' ' ALA . . . . . 0.481 ' HA ' ' HA ' ' A' ' 69' ' ' MET . . . -108.22 152.23 24.86 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.34 -0.85 . . . . 0.0 109.395 179.964 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 77' ' ' PHE . . . . . 0.46 ' HB2' ' HB3' ' A' ' 68' ' ' SER . 96.8 m-85 -117.59 129.95 56.09 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.24 -0.913 . . . . 0.0 109.527 -179.955 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 78' ' ' VAL . . . . . 0.482 ' O ' ' N ' ' A' ' 42' ' ' LEU . 48.2 t -124.79 132.09 71.78 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.575 0 O-C-N 121.261 -0.9 . . . . 0.0 109.413 179.968 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 79' ' ' THR . . . . . 0.467 ' HA ' ' O ' ' A' ' 40' ' ' ASN . 22.8 m -101.22 134.1 44.78 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.286 -0.884 . . . . 0.0 109.5 179.965 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 80' ' ' TYR . . . . . 0.795 ' CD2' HD11 ' A' ' 42' ' ' LEU . 0.4 OUTLIER -109.95 144.57 38.28 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.275 -0.891 . . . . 0.0 109.548 -179.977 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 84.9 tt0 -66.81 -31.16 71.6 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.177 -0.952 . . . . 0.0 109.514 179.836 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 46.1 mttm -128.11 152.32 48.14 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.327 -0.858 . . . . 0.0 109.445 -179.998 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 83' ' ' MET . . . . . . . . . . . . . 40.7 mtt -69.79 -21.98 63.37 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.226 -0.921 . . . . 0.0 109.491 179.987 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 98.7 mt-10 -71.15 -33.42 70.04 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.27 -0.894 . . . . 0.0 109.605 -179.955 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 85' ' ' SER . . . . . 0.413 ' HB3' ' HA3' ' A' ' 62' ' ' GLY . 19.4 m -66.92 -31.07 71.41 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.167 -0.958 . . . . 0.0 109.479 -179.901 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 86' ' ' ALA . . . . . 0.496 ' O ' HG23 ' A' ' 90' ' ' VAL . . . -80.08 -33.74 38.61 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.253 -0.904 . . . . 0.0 109.476 -179.955 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 58.7 t0 -65.48 -40.57 93.28 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.262 -0.898 . . . . 0.0 109.589 -179.946 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 88' ' ' GLN . . . . . 0.437 ' O ' ' HB2' ' A' ' 92' ' ' GLU . 62.0 tt0 -73.92 -38.72 64.21 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.285 -0.884 . . . . 0.0 109.591 -179.917 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 89' ' ' ALA . . . . . 0.572 ' HA ' ' CD1' ' A' ' 61' ' ' PHE . . . -76.46 -41.22 48.07 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.249 -0.907 . . . . 0.0 109.507 179.975 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 90' ' ' VAL . . . . . 0.772 ' HA ' HG11 ' A' ' 105' ' ' VAL . 55.6 t -65.91 -40.97 88.97 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.591 0 O-C-N 121.286 -0.883 . . . . 0.0 109.623 -179.812 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -74.95 -38.26 61.76 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.145 -0.972 . . . . 0.0 109.741 -179.774 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 92' ' ' GLU . . . . . 0.557 ' HB3' ' CZ ' ' A' ' 61' ' ' PHE . 5.9 tm-20 -78.85 -50.8 10.65 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.187 -0.946 . . . . 0.0 109.722 -179.744 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 93' ' ' LEU . . . . . 0.724 HD13 ' CZ ' ' A' ' 58' ' ' PHE . 48.9 mt -62.64 -35.5 79.79 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.262 -0.899 . . . . 0.0 109.56 -179.829 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 94' ' ' ASN . . . . . 0.485 ' HB2' ' O ' ' A' ' 90' ' ' VAL . 56.8 t-20 -74.71 129.11 37.12 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.246 -0.909 . . . . 0.0 109.549 -179.909 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 91.55 24.44 26.02 Favored Glycine 0 N--CA 1.49 2.253 0 N-CA-C 109.551 -1.42 . . . . 0.0 109.551 179.926 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 96' ' ' THR . . . . . 0.48 ' CG2' ' O ' ' A' ' 92' ' ' GLU . 36.9 p -126.23 154.05 43.86 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.201 -1.176 . . . . 0.0 109.572 179.985 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 63.8 tt0 -117.83 138.9 51.78 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.225 -0.922 . . . . 0.0 109.491 -179.96 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 98' ' ' VAL . . . . . 0.552 HG23 ' O ' ' A' ' 101' ' ' VAL . 1.2 t -81.13 -151.99 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 121.204 -0.935 . . . . 0.0 109.315 -179.99 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 99' ' ' GLU . . . . . 0.533 ' H ' HG12 ' A' ' 98' ' ' VAL . 96.3 mt-10 -60.78 -37.89 83.41 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.204 -0.935 . . . . 0.0 109.477 179.983 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -158.1 22.81 0.25 Allowed 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.264 -0.897 . . . . 0.0 109.476 179.99 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 101' ' ' VAL . . . . . 0.552 ' O ' HG23 ' A' ' 98' ' ' VAL . 47.9 t -139.43 154.41 24.83 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.531 0 O-C-N 121.224 -0.923 . . . . 0.0 109.496 179.993 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 92.2 mt-30 -102.45 144.18 31.23 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.242 -0.911 . . . . 0.0 109.431 179.96 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 92.0 mt -110.37 138.89 46.16 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.311 -0.868 . . . . 0.0 109.564 179.997 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 104' ' ' LYS . . . . . 0.476 ' HB2' ' HB3' ' A' ' 45' ' ' TYR . 76.6 mttt -120.23 138.53 53.6 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.268 -0.895 . . . . 0.0 109.259 179.853 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 105' ' ' VAL . . . . . 0.772 HG11 ' HA ' ' A' ' 90' ' ' VAL . 18.4 t . . . . . 0 N--CA 1.49 1.549 0 O-C-N 121.142 -0.974 . . . . 0.0 109.657 -179.819 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 40' ' ' ASN . . . . . 0.44 ' O ' ' HA ' ' A' ' 79' ' ' THR . 47.1 t-20 . . . . . 0 N--CA 1.49 1.531 0 N-CA-C 109.477 -0.564 . . . . 0.0 109.477 . . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 41' ' ' THR . . . . . 0.458 ' HA ' ' O ' ' A' ' 78' ' ' VAL . 66.1 m -84.32 140.42 31.63 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.225 -0.922 . . . . 0.0 109.522 -179.954 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 42' ' ' LEU . . . . . 0.823 HD12 ' O ' ' A' ' 78' ' ' VAL . 5.2 mp -116.18 143.04 46.03 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.322 -0.861 . . . . 0.0 109.338 179.987 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 70.1 t80 -98.0 108.23 20.89 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.366 -0.834 . . . . 0.0 109.584 -179.951 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 44' ' ' VAL . . . . . 0.474 ' HA ' ' O ' ' A' ' 104' ' ' LYS . 95.6 t -105.37 136.43 39.37 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 O-C-N 121.268 -0.895 . . . . 0.0 109.363 -180.0 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 45' ' ' TYR . . . . . 0.442 ' HB3' ' HB2' ' A' ' 104' ' ' LYS . 70.5 t80 -123.42 131.33 53.61 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.141 -0.974 . . . . 0.0 109.524 -179.949 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -179.69 -174.55 45.74 Favored Glycine 0 N--CA 1.491 2.333 0 N-CA-C 109.401 -1.48 . . . . 0.0 109.401 179.963 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 95.6 mt-10 -121.12 156.49 32.19 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.216 -1.167 . . . . 0.0 109.476 -179.958 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 59.4 t0 46.23 52.52 10.33 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.237 -0.915 . . . . 0.0 109.487 -179.985 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 49' ' ' MET . . . . . 0.408 ' O ' ' HE1' ' A' ' 69' ' ' MET . 61.6 mtm -104.17 139.8 38.71 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.247 -0.908 . . . . 0.0 109.547 -179.928 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 50' ' ' THR . . . . . 0.506 ' O ' HD12 ' A' ' 54' ' ' LEU . 0.1 OUTLIER -121.5 166.57 15.9 Favored Pre-proline 0 N--CA 1.49 1.547 0 O-C-N 121.208 -0.932 . . . . 0.0 109.414 -179.98 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 51' ' ' PRO . . . . . 0.485 ' N ' ' SD ' ' A' ' 69' ' ' MET . 48.2 Cg_endo -70.17 -55.73 0.16 Allowed 'Trans proline' 0 C--O 1.215 -0.651 0 C-N-CA 122.599 2.199 . . . . 0.0 111.918 179.937 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 26.2 m -48.88 -49.91 37.44 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.181 -0.95 . . . . 0.0 109.287 179.877 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 24.2 tp -58.08 -50.5 73.24 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.181 -0.949 . . . . 0.0 109.161 179.782 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 54' ' ' LEU . . . . . 0.506 HD12 ' O ' ' A' ' 50' ' ' THR . 11.6 mt -56.26 -44.42 79.68 Favored 'General case' 0 N--CA 1.488 1.475 0 O-C-N 121.272 -0.893 . . . . 0.0 109.238 179.742 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 55' ' ' ARG . . . . . 0.517 ' O ' ' N ' ' A' ' 59' ' ' SER . 93.6 mtt180 -51.38 -38.63 54.36 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.242 -0.911 . . . . 0.0 109.319 179.82 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -69.56 -33.3 71.81 Favored Glycine 0 N--CA 1.49 2.295 0 N-CA-C 109.508 -1.437 . . . . 0.0 109.508 179.926 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -75.92 -23.39 55.49 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.287 -1.125 . . . . 0.0 109.461 179.969 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 58' ' ' PHE . . . . . 0.672 ' HB2' HD11 ' A' ' 64' ' ' ILE . 97.0 m-85 -117.56 8.37 12.88 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.305 -0.872 . . . . 0.0 109.403 179.988 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 59' ' ' SER . . . . . 0.534 ' N ' ' HD2' ' A' ' 60' ' ' PRO . 0.6 OUTLIER -75.16 -57.12 1.8 Allowed Pre-proline 0 N--CA 1.491 1.606 0 O-C-N 121.231 -0.918 . . . . 0.0 110.066 -179.637 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 60' ' ' PRO . . . . . 0.534 ' HD2' ' N ' ' A' ' 59' ' ' SER . 49.8 Cg_endo -69.5 -25.12 30.1 Favored 'Trans proline' 0 C--O 1.214 -0.68 0 C-N-CA 122.62 2.213 . . . . 0.0 112.213 -179.56 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 61' ' ' PHE . . . . . 0.583 ' CZ ' ' HB2' ' A' ' 92' ' ' GLU . 64.4 m-85 -72.67 -27.17 61.93 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.149 -0.97 . . . . 0.0 109.491 179.985 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 169.31 -176.0 43.45 Favored Glycine 0 N--CA 1.49 2.275 0 N-CA-C 109.464 -1.454 . . . . 0.0 109.464 179.939 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 83.2 m-20 -93.93 139.82 30.45 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.269 -1.136 . . . . 0.0 109.416 -179.995 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 64' ' ' ILE . . . . . 0.672 HD11 ' HB2' ' A' ' 58' ' ' PHE . 61.1 mt -100.61 132.84 45.5 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.588 0 O-C-N 121.236 -0.915 . . . . 0.0 109.539 179.995 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 65' ' ' ILE . . . . . 0.503 HD11 HG21 ' A' ' 79' ' ' THR . 26.7 pt -94.27 -24.04 5.07 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.604 0 O-C-N 121.341 -0.849 . . . . 0.0 109.442 179.98 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 66' ' ' ASP . . . . . 0.467 ' HB3' ' OG1' ' A' ' 79' ' ' THR . 55.3 t0 -147.78 136.6 21.95 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.22 -0.925 . . . . 0.0 109.561 -179.974 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 67' ' ' LEU . . . . . 0.748 ' C ' HD13 ' A' ' 67' ' ' LEU . 3.5 tm? -119.92 114.18 21.68 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.348 -0.845 . . . . 0.0 109.276 179.994 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 68' ' ' SER . . . . . 0.495 ' HB2' ' HB2' ' A' ' 77' ' ' PHE . 49.1 m -123.89 141.5 51.98 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.281 -0.887 . . . . 0.0 109.625 -179.993 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 69' ' ' MET . . . . . 0.485 ' SD ' ' N ' ' A' ' 51' ' ' PRO . 84.2 mtp -129.71 148.15 51.57 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.234 -0.916 . . . . 0.0 109.434 179.888 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 70' ' ' ASP . . . . . 0.485 ' C ' ' HD2' ' A' ' 72' ' ' PRO . 0.4 OUTLIER -124.21 102.0 34.29 Favored Pre-proline 0 N--CA 1.49 1.551 0 O-C-N 121.225 -0.922 . . . . 0.0 109.525 -179.959 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 71' ' ' PRO . . . . . 0.595 ' N ' ' CD ' ' A' ' 72' ' ' PRO . 46.5 Cg_endo -74.67 -27.6 10.54 Favored 'Trans proline' 0 CA--C 1.543 0.952 0 C-N-CA 122.519 2.146 . . . . 0.0 113.57 179.957 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 72' ' ' PRO . . . . . 0.595 ' CD ' ' N ' ' A' ' 71' ' ' PRO . 55.2 Cg_endo -75.57 -31.61 5.39 Favored 'Trans proline' 0 C--N 1.354 0.832 0 C-N-CA 121.452 1.435 . . . . 0.0 111.682 -179.911 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 73' ' ' ARG . . . . . 0.469 ' HG2' ' O ' ' A' ' 73' ' ' ARG . 19.5 ttt180 -103.85 -2.63 25.99 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.188 -0.945 . . . . 0.0 109.641 179.953 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 74' ' ' ASN . . . . . 0.432 ' HB2' ' O ' ' A' ' 73' ' ' ARG . 82.3 m-20 62.11 44.41 7.95 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.228 -0.92 . . . . 0.0 109.402 -179.901 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 75' ' ' CYS . . . . . 0.404 ' HA ' ' O ' ' A' ' 44' ' ' VAL . 23.9 p -143.13 134.73 26.42 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.237 -0.915 . . . . 0.0 109.439 -179.96 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 76' ' ' ALA . . . . . 0.452 ' HA ' ' HA ' ' A' ' 69' ' ' MET . . . -107.63 160.45 15.69 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.316 -0.865 . . . . 0.0 109.436 179.985 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 77' ' ' PHE . . . . . 0.495 ' HB2' ' HB2' ' A' ' 68' ' ' SER . 96.5 m-85 -128.0 130.74 48.82 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.264 -0.898 . . . . 0.0 109.546 -179.948 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 78' ' ' VAL . . . . . 0.823 ' O ' HD12 ' A' ' 42' ' ' LEU . 33.7 t -121.43 134.22 65.47 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.556 0 O-C-N 121.146 -0.971 . . . . 0.0 109.485 -179.946 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 79' ' ' THR . . . . . 0.503 HG21 HD11 ' A' ' 65' ' ' ILE . 5.2 m -102.67 130.11 49.49 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.241 -0.912 . . . . 0.0 109.452 -179.977 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 80' ' ' TYR . . . . . 0.492 ' OH ' ' HB2' ' A' ' 61' ' ' PHE . 0.6 OUTLIER -110.73 136.68 49.43 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.149 -0.969 . . . . 0.0 109.515 -179.945 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 81.8 tt0 -54.56 -28.6 47.06 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.218 -0.926 . . . . 0.0 109.446 179.986 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 57.4 mttm -135.9 148.78 48.72 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.204 -0.935 . . . . 0.0 109.589 -179.965 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 83' ' ' MET . . . . . . . . . . . . . 61.2 mtt -67.84 -21.06 65.21 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.175 -0.953 . . . . 0.0 109.471 -179.96 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 97.2 mt-10 -66.96 -41.48 86.81 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.239 -0.913 . . . . 0.0 109.457 -179.949 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 19.8 m -64.05 -30.94 71.97 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.336 -0.853 . . . . 0.0 109.451 179.96 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 86' ' ' ALA . . . . . 0.833 ' O ' HG23 ' A' ' 90' ' ' VAL . . . -73.67 -31.08 63.28 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.297 -0.877 . . . . 0.0 109.455 179.903 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 58.6 t0 -67.99 -44.69 76.04 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.2 -0.937 . . . . 0.0 109.517 179.973 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 62.1 tt0 -64.28 -39.95 94.97 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.184 -0.948 . . . . 0.0 109.483 179.906 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 89' ' ' ALA . . . . . 0.893 ' HB1' ' CD1' ' A' ' 93' ' ' LEU . . . -74.51 -43.11 57.44 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.238 -0.914 . . . . 0.0 109.496 -179.901 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 90' ' ' VAL . . . . . 0.833 HG23 ' O ' ' A' ' 86' ' ' ALA . 88.9 t -61.49 -32.02 52.22 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.56 0 O-C-N 121.176 -0.953 . . . . 0.0 109.685 -179.867 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -80.14 -51.92 8.4 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.23 -0.919 . . . . 0.0 109.728 -179.841 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 92' ' ' GLU . . . . . 0.583 ' HB2' ' CZ ' ' A' ' 61' ' ' PHE . 74.1 mt-10 -71.63 -47.28 55.58 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.278 -0.889 . . . . 0.0 109.927 -179.699 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 93' ' ' LEU . . . . . 0.893 ' CD1' ' HB1' ' A' ' 89' ' ' ALA . 62.4 mt -63.78 -36.76 84.96 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.188 -0.945 . . . . 0.0 109.857 -179.643 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 94' ' ' ASN . . . . . 0.524 ' CB ' ' O ' ' A' ' 90' ' ' VAL . 61.0 t-20 -74.3 125.99 29.67 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.131 -0.98 . . . . 0.0 109.475 -179.865 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 96.1 22.1 21.01 Favored Glycine 0 N--CA 1.489 2.225 0 N-CA-C 109.461 -1.456 . . . . 0.0 109.461 179.916 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 96' ' ' THR . . . . . 0.521 ' CG2' ' O ' ' A' ' 92' ' ' GLU . 21.9 p -116.03 160.26 20.53 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.217 -1.166 . . . . 0.0 109.461 -179.975 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 97' ' ' GLN . . . . . 0.451 ' HG2' ' N ' ' A' ' 98' ' ' VAL . 64.2 tt0 -132.72 158.56 42.05 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.265 -0.897 . . . . 0.0 109.484 -179.911 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 98' ' ' VAL . . . . . 0.605 HG23 ' O ' ' A' ' 101' ' ' VAL . 1.2 t -108.56 -153.31 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.572 0 O-C-N 121.234 -0.916 . . . . 0.0 109.398 179.961 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 99' ' ' GLU . . . . . 0.537 ' H ' HG12 ' A' ' 98' ' ' VAL . 96.9 mt-10 -57.66 -36.76 72.33 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.217 -0.927 . . . . 0.0 109.61 -179.919 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -162.86 25.48 0.09 Allowed 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.25 -0.906 . . . . 0.0 109.494 179.944 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 101' ' ' VAL . . . . . 0.605 ' O ' HG23 ' A' ' 98' ' ' VAL . 84.8 t -139.37 146.61 25.35 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 O-C-N 121.239 -0.913 . . . . 0.0 109.496 179.938 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 90.3 mt-30 -100.83 147.42 26.11 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.263 -0.898 . . . . 0.0 109.495 -179.968 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 95.9 mt -113.7 133.84 55.1 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.241 -0.912 . . . . 0.0 109.493 -179.985 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 104' ' ' LYS . . . . . 0.474 ' O ' ' HA ' ' A' ' 44' ' ' VAL . 70.5 mttt -115.75 145.31 42.9 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.264 -0.897 . . . . 0.0 109.308 179.964 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 105' ' ' VAL . . . . . 0.773 HG11 ' HA ' ' A' ' 90' ' ' VAL . 29.2 t . . . . . 0 N--CA 1.489 1.524 0 O-C-N 121.12 -0.988 . . . . 0.0 109.718 -179.789 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 40' ' ' ASN . . . . . 0.529 ' N ' ' O ' ' A' ' 80' ' ' TYR . 54.3 t30 . . . . . 0 N--CA 1.491 1.591 0 N-CA-C 109.352 -0.61 . . . . 0.0 109.352 . . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 41' ' ' THR . . . . . 0.492 ' O ' HD23 ' A' ' 42' ' ' LEU . 45.1 m -74.49 136.55 42.24 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.273 -0.892 . . . . 0.0 109.839 -179.695 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 42' ' ' LEU . . . . . 0.867 HD11 ' CD2' ' A' ' 80' ' ' TYR . 13.7 mt -119.47 157.21 28.74 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.363 -0.836 . . . . 0.0 109.322 179.84 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 43' ' ' TYR . . . . . 0.432 ' CZ ' ' CB ' ' A' ' 75' ' ' CYS . 69.9 t80 -114.14 121.38 43.59 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.261 -0.899 . . . . 0.0 109.448 -179.976 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 47.4 t -115.88 136.3 53.21 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.579 0 O-C-N 121.331 -0.855 . . . . 0.0 109.367 179.948 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 71.8 t80 -126.35 130.61 51.13 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.264 -0.897 . . . . 0.0 109.488 -179.923 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -175.83 -173.94 41.96 Favored Glycine 0 N--CA 1.49 2.272 0 N-CA-C 109.472 -1.451 . . . . 0.0 109.472 179.999 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 47' ' ' GLU . . . . . 0.422 ' O ' ' C ' ' A' ' 48' ' ' ASP . 94.8 mt-10 -115.88 156.39 26.22 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.231 -1.158 . . . . 0.0 109.487 -179.916 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 48' ' ' ASP . . . . . 0.422 ' C ' ' O ' ' A' ' 47' ' ' GLU . 38.1 m-20 44.21 51.19 7.49 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.229 -0.919 . . . . 0.0 109.551 179.936 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 55.3 mtm -100.57 137.09 39.45 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.272 -0.893 . . . . 0.0 109.433 179.981 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 50' ' ' THR . . . . . 0.476 ' O ' HD12 ' A' ' 54' ' ' LEU . 0.3 OUTLIER -119.76 163.21 28.86 Favored Pre-proline 0 N--CA 1.491 1.583 0 O-C-N 121.308 -0.87 . . . . 0.0 109.441 179.963 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 48.7 Cg_endo -70.13 -54.26 0.21 Allowed 'Trans proline' 0 C--O 1.214 -0.677 0 C-N-CA 122.629 2.22 . . . . 0.0 111.815 -179.992 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 37.3 m -53.27 -48.49 68.25 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.185 -0.947 . . . . 0.0 109.317 179.921 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 17.6 tp -58.63 -48.49 80.83 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.247 -0.908 . . . . 0.0 109.28 179.824 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 54' ' ' LEU . . . . . 0.66 HD11 ' HE1' ' A' ' 69' ' ' MET . 16.6 mt -57.87 -44.99 87.0 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.232 -0.917 . . . . 0.0 109.259 179.793 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 55' ' ' ARG . . . . . 0.514 ' O ' ' N ' ' A' ' 59' ' ' SER . 57.5 mtt-85 -50.94 -39.75 55.66 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.244 -0.91 . . . . 0.0 109.2 179.853 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -69.5 -30.87 70.92 Favored Glycine 0 N--CA 1.49 2.243 0 N-CA-C 109.313 -1.515 . . . . 0.0 109.313 179.767 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -79.51 -21.53 45.15 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.243 -1.151 . . . . 0.0 109.467 179.998 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 58' ' ' PHE . . . . . 0.66 ' CZ ' HD13 ' A' ' 93' ' ' LEU . 94.5 m-85 -119.09 7.97 11.47 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.26 -0.9 . . . . 0.0 109.384 179.929 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 59' ' ' SER . . . . . 0.539 ' N ' ' HD2' ' A' ' 60' ' ' PRO . 0.6 OUTLIER -75.24 -55.54 2.18 Favored Pre-proline 0 N--CA 1.49 1.562 0 O-C-N 121.286 -0.884 . . . . 0.0 110.196 -179.591 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 60' ' ' PRO . . . . . 0.539 ' HD2' ' N ' ' A' ' 59' ' ' SER . 48.4 Cg_endo -69.42 -29.6 25.24 Favored 'Trans proline' 0 C--O 1.214 -0.677 0 C-N-CA 122.542 2.161 . . . . 0.0 112.208 -179.408 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 61' ' ' PHE . . . . . 0.588 ' CB ' ' HB2' ' A' ' 89' ' ' ALA . 55.2 m-85 -67.48 -28.88 68.22 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.21 -0.931 . . . . 0.0 109.534 179.984 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 172.81 -178.43 44.85 Favored Glycine 0 N--CA 1.49 2.293 0 N-CA-C 109.579 -1.408 . . . . 0.0 109.579 179.951 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 47.9 t-20 -94.26 138.25 32.49 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.292 -1.122 . . . . 0.0 109.447 179.99 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 64' ' ' ILE . . . . . 0.514 HD11 ' HB2' ' A' ' 58' ' ' PHE . 57.7 mt -100.02 135.49 35.48 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.502 0 O-C-N 121.258 -0.901 . . . . 0.0 109.392 -179.972 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 65' ' ' ILE . . . . . 0.428 HG12 ' HB ' ' A' ' 79' ' ' THR . 27.2 pt -102.6 -21.76 5.05 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.636 0 O-C-N 121.326 -0.859 . . . . 0.0 109.659 -179.833 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 66' ' ' ASP . . . . . 0.458 ' HB3' ' OG1' ' A' ' 79' ' ' THR . 56.7 t0 -145.39 111.8 5.76 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.122 -0.986 . . . . 0.0 109.675 -179.966 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 67' ' ' LEU . . . . . 0.446 HD22 ' NE ' ' A' ' 55' ' ' ARG . 32.3 tp -108.11 123.6 48.95 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.328 -0.857 . . . . 0.0 109.358 179.919 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 68' ' ' SER . . . . . 0.481 ' HB3' ' HB2' ' A' ' 77' ' ' PHE . 23.2 t -134.25 140.71 46.64 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.271 -0.893 . . . . 0.0 109.505 -179.941 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 69' ' ' MET . . . . . 0.66 ' HE1' HD11 ' A' ' 54' ' ' LEU . 87.6 mmm -113.71 151.65 31.58 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.301 -0.874 . . . . 0.0 109.502 179.923 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 70' ' ' ASP . . . . . 0.472 ' C ' ' HD2' ' A' ' 72' ' ' PRO . 0.3 OUTLIER -131.84 100.29 16.14 Favored Pre-proline 0 N--CA 1.49 1.554 0 O-C-N 121.277 -0.89 . . . . 0.0 109.522 179.95 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 71' ' ' PRO . . . . . 0.595 ' CD ' ' CD ' ' A' ' 72' ' ' PRO . 46.7 Cg_endo -74.53 -27.9 10.56 Favored 'Trans proline' 0 CA--C 1.543 0.943 0 C-N-CA 122.497 2.131 . . . . 0.0 113.629 -179.897 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 72' ' ' PRO . . . . . 0.595 ' CD ' ' CD ' ' A' ' 71' ' ' PRO . 54.5 Cg_endo -75.46 -32.79 4.61 Favored 'Trans proline' 0 C--N 1.353 0.763 0 C-N-CA 121.431 1.42 . . . . 0.0 111.643 -179.89 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 73' ' ' ARG . . . . . 0.45 ' O ' ' HG3' ' A' ' 73' ' ' ARG . 13.6 tpt180 -101.45 -4.85 26.11 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.249 -0.907 . . . . 0.0 109.523 -179.978 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 74' ' ' ASN . . . . . 0.437 ' HB2' ' O ' ' A' ' 73' ' ' ARG . 77.5 m-20 61.95 43.78 8.84 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.194 -0.941 . . . . 0.0 109.507 -179.854 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 75' ' ' CYS . . . . . 0.432 ' CB ' ' CZ ' ' A' ' 43' ' ' TYR . 31.4 p -147.48 142.73 27.27 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.298 -0.876 . . . . 0.0 109.48 -179.954 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 76' ' ' ALA . . . . . 0.446 ' HB1' ' SD ' ' A' ' 69' ' ' MET . . . -107.29 163.17 13.25 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.296 -0.877 . . . . 0.0 109.469 179.984 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 77' ' ' PHE . . . . . 0.481 ' HB2' ' HB3' ' A' ' 68' ' ' SER . 96.7 m-85 -122.84 130.89 53.43 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.317 -0.864 . . . . 0.0 109.544 -179.969 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 78' ' ' VAL . . . . . 0.495 ' O ' ' N ' ' A' ' 42' ' ' LEU . 46.7 t -126.52 140.11 49.79 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.604 0 O-C-N 121.278 -0.889 . . . . 0.0 109.33 179.861 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 79' ' ' THR . . . . . 0.481 ' HA ' ' O ' ' A' ' 40' ' ' ASN . 2.5 m -115.55 112.73 22.63 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.224 -0.922 . . . . 0.0 109.584 -179.849 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 80' ' ' TYR . . . . . 0.867 ' CD2' HD11 ' A' ' 42' ' ' LEU . 1.4 m-85 -93.12 123.15 36.17 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.25 -0.906 . . . . 0.0 109.402 179.932 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 81' ' ' GLU . . . . . 0.451 ' C ' ' O ' ' A' ' 80' ' ' TYR . 86.1 tt0 -38.88 -34.54 0.16 Allowed 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.537 -0.727 . . . . 0.0 110.302 -179.667 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 57.2 mttp -128.52 158.38 38.57 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.068 -1.02 . . . . 0.0 109.594 -179.911 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 83' ' ' MET . . . . . . . . . . . . . 58.9 mtt -74.65 -21.71 59.29 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.274 -0.891 . . . . 0.0 109.452 179.936 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 75.6 mm-40 -68.51 -46.99 68.16 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.339 -0.851 . . . . 0.0 109.473 -179.958 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 14.0 m -55.5 -35.03 65.14 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.283 -0.885 . . . . 0.0 109.369 -179.945 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 86' ' ' ALA . . . . . 0.548 ' O ' HG23 ' A' ' 90' ' ' VAL . . . -75.44 -28.75 59.46 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.318 -0.863 . . . . 0.0 109.559 -179.968 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 57.1 t0 -66.18 -40.07 90.17 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.246 -0.908 . . . . 0.0 109.551 -179.925 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 88' ' ' GLN . . . . . 0.478 ' O ' ' CB ' ' A' ' 92' ' ' GLU . 47.7 tt0 -74.99 -35.64 62.01 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.244 -0.91 . . . . 0.0 109.431 -179.895 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 89' ' ' ALA . . . . . 0.624 ' HB1' ' CD1' ' A' ' 93' ' ' LEU . . . -77.47 -41.64 38.85 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.23 -0.919 . . . . 0.0 109.614 -179.912 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 90' ' ' VAL . . . . . 0.587 HG22 HG11 ' A' ' 105' ' ' VAL . 68.8 t -65.1 -47.35 88.11 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.603 0 O-C-N 121.247 -0.908 . . . . 0.0 109.638 -179.892 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -73.04 -39.65 65.77 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.218 -0.926 . . . . 0.0 109.582 -179.917 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 92' ' ' GLU . . . . . 0.583 ' HB3' ' CE1' ' A' ' 61' ' ' PHE . 44.4 tp10 -74.25 -50.22 19.93 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.266 -0.896 . . . . 0.0 109.682 -179.954 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 93' ' ' LEU . . . . . 0.66 HD13 ' CZ ' ' A' ' 58' ' ' PHE . 42.2 mt -65.24 -38.98 92.05 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.21 -0.931 . . . . 0.0 109.534 -179.841 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 94' ' ' ASN . . . . . 0.49 ' CB ' ' O ' ' A' ' 90' ' ' VAL . 59.3 t-20 -67.74 129.37 39.69 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.241 -0.912 . . . . 0.0 109.535 179.999 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 98.94 17.31 28.13 Favored Glycine 0 N--CA 1.49 2.285 0 N-CA-C 109.543 -1.423 . . . . 0.0 109.543 -179.997 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 96' ' ' THR . . . . . 0.516 HG23 ' O ' ' A' ' 93' ' ' LEU . 16.1 p -116.16 158.79 22.71 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.251 -1.146 . . . . 0.0 109.473 179.936 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 61.3 tt0 -122.8 139.83 53.58 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.255 -0.903 . . . . 0.0 109.497 179.998 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 98' ' ' VAL . . . . . 0.587 HG12 ' H ' ' A' ' 99' ' ' GLU . 1.1 t -81.79 -157.48 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.608 0 O-C-N 121.247 -0.908 . . . . 0.0 109.302 -179.982 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 99' ' ' GLU . . . . . 0.587 ' H ' HG12 ' A' ' 98' ' ' VAL . 76.4 mm-40 -60.64 -38.28 84.28 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.23 -0.919 . . . . 0.0 109.584 -179.958 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 100' ' ' SER . . . . . 0.426 ' O ' ' OG ' ' A' ' 100' ' ' SER . 4.9 t -155.04 24.04 0.43 Allowed 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.248 -0.907 . . . . 0.0 109.613 179.943 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 101' ' ' VAL . . . . . 0.548 ' O ' HG23 ' A' ' 98' ' ' VAL . 57.5 t -141.0 155.91 21.93 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.553 0 O-C-N 121.226 -0.921 . . . . 0.0 109.515 179.891 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 102' ' ' GLN . . . . . 0.415 ' N ' HG12 ' A' ' 101' ' ' VAL . 92.8 mt-30 -98.3 143.19 29.04 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.242 -0.911 . . . . 0.0 109.447 -179.971 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 103' ' ' LEU . . . . . 0.408 HD23 ' HA ' ' A' ' 103' ' ' LEU . 92.7 mt -101.85 141.86 34.05 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.25 -0.906 . . . . 0.0 109.44 179.975 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 1.3 mtpm? -131.45 134.21 45.97 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.281 -0.887 . . . . 0.0 109.4 179.921 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 105' ' ' VAL . . . . . 0.587 HG11 HG22 ' A' ' 90' ' ' VAL . 17.8 t . . . . . 0 N--CA 1.49 1.534 0 O-C-N 121.17 -0.956 . . . . 0.0 109.65 -179.931 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 40' ' ' ASN . . . . . 0.49 ' N ' ' O ' ' A' ' 80' ' ' TYR . 1.7 t-20 . . . . . 0 N--CA 1.493 1.686 0 CA-C-O 121.216 0.531 . . . . 0.0 109.799 . . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 41' ' ' THR . . . . . 0.475 ' HA ' ' O ' ' A' ' 78' ' ' VAL . 91.2 m -80.5 153.73 27.98 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.18 -0.95 . . . . 0.0 109.841 -179.913 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 42' ' ' LEU . . . . . 0.924 HD12 ' O ' ' A' ' 78' ' ' VAL . 4.7 mp -131.05 155.4 46.95 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.376 -0.827 . . . . 0.0 109.305 179.763 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 39.2 t80 -113.67 108.9 17.76 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.206 -0.934 . . . . 0.0 109.594 -179.923 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 44' ' ' VAL . . . . . 0.459 ' HA ' ' O ' ' A' ' 104' ' ' LYS . 39.3 t -105.28 146.04 12.8 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 O-C-N 121.289 -0.882 . . . . 0.0 109.488 179.999 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 67.0 t80 -135.59 140.47 44.66 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.21 -0.931 . . . . 0.0 109.468 179.989 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 174.82 -165.17 36.26 Favored Glycine 0 N--CA 1.491 2.321 0 N-CA-C 109.464 -1.454 . . . . 0.0 109.464 -179.995 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 90.3 mt-10 -115.07 157.48 23.46 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.238 -1.154 . . . . 0.0 109.584 -179.908 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 56.0 t0 44.76 45.16 8.13 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.273 -0.892 . . . . 0.0 109.576 179.992 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 34.2 mtp -81.79 133.43 35.34 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.195 -0.941 . . . . 0.0 109.423 179.934 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 50' ' ' THR . . . . . 0.512 ' O ' HD12 ' A' ' 54' ' ' LEU . 0.1 OUTLIER -125.77 162.08 47.26 Favored Pre-proline 0 N--CA 1.49 1.527 0 O-C-N 121.208 -0.932 . . . . 0.0 109.461 -179.897 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 51' ' ' PRO . . . . . 0.467 ' N ' ' SD ' ' A' ' 69' ' ' MET . 50.2 Cg_endo -70.6 -53.28 0.23 Allowed 'Trans proline' 0 C--O 1.215 -0.648 0 C-N-CA 122.696 2.264 . . . . 0.0 111.644 179.957 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 30.2 m -55.87 -47.93 76.45 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.223 -0.923 . . . . 0.0 109.317 179.867 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 15.5 tp -56.94 -54.23 48.96 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.311 -0.868 . . . . 0.0 109.231 179.871 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 54' ' ' LEU . . . . . 0.512 HD12 ' O ' ' A' ' 50' ' ' THR . 12.4 mt -51.63 -52.83 44.65 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.221 -0.925 . . . . 0.0 109.225 179.766 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 55' ' ' ARG . . . . . 0.563 ' HE ' HD22 ' A' ' 67' ' ' LEU . 49.2 mtt180 -44.09 -40.28 4.8 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.354 -0.841 . . . . 0.0 109.212 179.872 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -70.43 -33.33 68.0 Favored Glycine 0 N--CA 1.49 2.273 0 N-CA-C 109.314 -1.514 . . . . 0.0 109.314 179.771 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 57' ' ' ALA . . . . . 0.456 ' N ' ' O ' ' A' ' 54' ' ' LEU . . . -79.81 -16.29 55.78 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.288 -1.125 . . . . 0.0 109.444 179.88 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 58' ' ' PHE . . . . . 0.631 ' CE2' ' CD1' ' A' ' 93' ' ' LEU . 96.3 m-85 -124.36 10.57 8.61 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.257 -0.902 . . . . 0.0 109.5 179.998 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 59' ' ' SER . . . . . 0.538 ' N ' ' HD2' ' A' ' 60' ' ' PRO . 0.6 OUTLIER -77.08 -54.47 1.54 Allowed Pre-proline 0 N--CA 1.491 1.622 0 O-C-N 121.258 -0.901 . . . . 0.0 110.268 -179.624 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 60' ' ' PRO . . . . . 0.538 ' HD2' ' N ' ' A' ' 59' ' ' SER . 50.4 Cg_endo -70.63 -35.07 10.66 Favored 'Trans proline' 0 C--O 1.214 -0.681 0 C-N-CA 122.5 2.133 . . . . 0.0 112.284 -179.213 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 61' ' ' PHE . . . . . 0.575 ' CE1' ' HA ' ' A' ' 89' ' ' ALA . 74.2 m-85 -59.53 -33.99 72.08 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.168 -0.958 . . . . 0.0 109.495 -179.907 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 175.46 178.11 45.04 Favored Glycine 0 N--CA 1.49 2.236 0 N-CA-C 109.489 -1.445 . . . . 0.0 109.489 179.921 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 54.5 t30 -86.99 144.18 27.02 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.246 -1.149 . . . . 0.0 109.433 179.938 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 64' ' ' ILE . . . . . 0.513 HD11 ' HB2' ' A' ' 58' ' ' PHE . 67.1 mt -106.28 134.32 48.21 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.534 0 O-C-N 121.23 -0.919 . . . . 0.0 109.388 -179.965 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 37.8 pt -101.67 -25.78 3.7 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.524 0 O-C-N 121.233 -0.917 . . . . 0.0 109.661 -179.774 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 66' ' ' ASP . . . . . 0.426 ' HB3' ' OG1' ' A' ' 79' ' ' THR . 55.4 t0 -142.34 115.83 9.06 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.227 -0.92 . . . . 0.0 109.606 -179.853 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 67' ' ' LEU . . . . . 0.563 HD22 ' HE ' ' A' ' 55' ' ' ARG . 15.8 tp -105.41 115.95 31.12 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.288 -0.883 . . . . 0.0 109.467 179.908 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 68' ' ' SER . . . . . 0.469 ' HB2' ' HB2' ' A' ' 77' ' ' PHE . 67.7 m -123.94 146.66 48.32 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.271 -0.893 . . . . 0.0 109.414 179.972 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 69' ' ' MET . . . . . 0.478 ' HA ' ' HA ' ' A' ' 76' ' ' ALA . 72.0 mtp -131.51 150.89 51.98 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.219 -0.926 . . . . 0.0 109.609 -179.903 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 70' ' ' ASP . . . . . 0.474 ' C ' ' HD2' ' A' ' 72' ' ' PRO . 0.5 OUTLIER -126.24 103.84 25.9 Favored Pre-proline 0 N--CA 1.49 1.571 0 O-C-N 121.228 -0.92 . . . . 0.0 109.392 179.903 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 71' ' ' PRO . . . . . 0.605 ' N ' ' CD ' ' A' ' 72' ' ' PRO . 48.2 Cg_endo -74.91 -27.66 10.0 Favored 'Trans proline' 0 CA--C 1.542 0.903 0 C-N-CA 122.553 2.169 . . . . 0.0 113.793 -179.936 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 72' ' ' PRO . . . . . 0.605 ' CD ' ' N ' ' A' ' 71' ' ' PRO . 55.2 Cg_endo -74.89 -24.85 12.66 Favored 'Trans proline' 0 C--N 1.352 0.752 0 C-N-CA 121.525 1.483 . . . . 0.0 111.934 -179.783 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 61.1 mtt-85 -113.83 2.66 15.19 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.237 -0.914 . . . . 0.0 109.671 -179.812 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 82.8 m-20 58.09 38.9 26.59 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.128 -0.983 . . . . 0.0 109.533 179.924 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 75' ' ' CYS . . . . . . . . . . . . . 29.7 p -135.49 134.04 39.12 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.189 -0.944 . . . . 0.0 109.573 -179.941 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 76' ' ' ALA . . . . . 0.478 ' HA ' ' HA ' ' A' ' 69' ' ' MET . . . -106.48 161.73 14.34 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.257 -0.902 . . . . 0.0 109.339 179.882 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 77' ' ' PHE . . . . . 0.47 ' HA ' ' O ' ' A' ' 42' ' ' LEU . 97.4 m-85 -125.43 128.33 47.91 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.241 -0.912 . . . . 0.0 109.599 -179.853 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 78' ' ' VAL . . . . . 0.924 ' O ' HD12 ' A' ' 42' ' ' LEU . 13.7 t -117.88 141.01 38.82 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.526 0 O-C-N 121.24 -0.913 . . . . 0.0 109.182 179.793 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 79' ' ' THR . . . . . 0.483 ' HA ' ' O ' ' A' ' 40' ' ' ASN . 0.4 OUTLIER -112.18 127.73 56.03 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.279 -0.888 . . . . 0.0 109.612 -179.653 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 80' ' ' TYR . . . . . 0.524 ' OH ' ' CA ' ' A' ' 58' ' ' PHE . 1.8 m-85 -111.37 126.96 55.48 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.352 -0.842 . . . . 0.0 109.382 -179.948 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 81' ' ' GLU . . . . . 0.423 ' C ' ' O ' ' A' ' 80' ' ' TYR . 88.1 tt0 -40.74 -39.07 1.02 Allowed 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.456 -0.778 . . . . 0.0 110.192 -179.789 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 46.8 mttp -126.78 156.35 41.37 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.042 -1.036 . . . . 0.0 109.589 -179.766 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 83' ' ' MET . . . . . 0.42 ' HG2' ' CG ' ' A' ' 40' ' ' ASN . 40.9 mtt -73.72 -20.74 60.44 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.272 -0.892 . . . . 0.0 109.404 179.895 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 97.5 mt-10 -65.57 -50.64 64.4 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.257 -0.902 . . . . 0.0 109.392 179.875 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 27.5 m -59.25 -35.16 73.18 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.152 -0.968 . . . . 0.0 109.252 179.847 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 86' ' ' ALA . . . . . 0.821 ' HB1' HD21 ' A' ' 42' ' ' LEU . . . -74.94 -31.04 61.41 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.344 -0.847 . . . . 0.0 109.157 179.76 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 90.5 m-20 -67.65 -37.46 82.44 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.26 -0.9 . . . . 0.0 109.276 179.855 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 64.4 tt0 -70.96 -42.14 70.15 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.255 -0.903 . . . . 0.0 109.374 179.841 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 89' ' ' ALA . . . . . 0.628 ' HB1' ' CD1' ' A' ' 93' ' ' LEU . . . -68.83 -42.73 76.81 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.249 -0.907 . . . . 0.0 109.296 -179.971 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 90' ' ' VAL . . . . . 0.782 ' HA ' HG11 ' A' ' 105' ' ' VAL . 79.3 t -58.1 -37.27 60.94 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.52 0 O-C-N 121.201 -0.937 . . . . 0.0 109.498 -179.944 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -76.1 -53.26 8.59 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.26 -0.9 . . . . 0.0 109.587 -179.832 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 92' ' ' GLU . . . . . 0.521 ' O ' ' CG2' ' A' ' 96' ' ' THR . 74.9 mm-40 -67.2 -42.99 83.22 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.361 -0.837 . . . . 0.0 109.648 -179.762 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 93' ' ' LEU . . . . . 0.94 ' HB2' HG21 ' A' ' 105' ' ' VAL . 87.4 mt -68.87 -39.0 80.08 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.206 -0.934 . . . . 0.0 109.617 -179.835 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 94' ' ' ASN . . . . . 0.517 ' CB ' ' O ' ' A' ' 90' ' ' VAL . 21.2 t-20 -67.84 129.99 41.6 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.243 -0.911 . . . . 0.0 109.51 -179.96 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 85.85 32.11 19.03 Favored Glycine 0 N--CA 1.489 2.221 0 N-CA-C 109.514 -1.435 . . . . 0.0 109.514 -179.986 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 96' ' ' THR . . . . . 0.612 HG23 ' O ' ' A' ' 93' ' ' LEU . 27.6 p -119.45 160.28 22.66 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.15 -1.206 . . . . 0.0 109.45 -179.994 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 97' ' ' GLN . . . . . 0.516 ' HG2' ' N ' ' A' ' 98' ' ' VAL . 62.1 tt0 -135.89 159.88 40.3 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.259 -0.9 . . . . 0.0 109.483 -179.951 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 98' ' ' VAL . . . . . 0.609 HG12 ' H ' ' A' ' 99' ' ' GLU . 1.1 t -113.26 -160.25 0.17 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.591 0 O-C-N 121.252 -0.905 . . . . 0.0 109.351 -179.993 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 99' ' ' GLU . . . . . 0.609 ' H ' HG12 ' A' ' 98' ' ' VAL . 95.9 mt-10 -51.73 -35.42 43.21 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.167 -0.958 . . . . 0.0 109.549 -179.943 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 100' ' ' SER . . . . . 0.431 ' O ' ' OG ' ' A' ' 100' ' ' SER . 6.1 t -164.9 28.59 0.06 Allowed 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.197 -0.939 . . . . 0.0 109.498 -179.943 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 101' ' ' VAL . . . . . 0.554 ' O ' HG23 ' A' ' 98' ' ' VAL . 59.7 t -140.42 147.99 22.7 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.564 0 O-C-N 121.244 -0.91 . . . . 0.0 109.464 179.968 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 91.5 mt-30 -97.34 146.65 24.96 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.239 -0.913 . . . . 0.0 109.508 -179.975 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 77.8 mt -111.54 135.21 52.43 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.26 -0.9 . . . . 0.0 109.489 -179.969 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 104' ' ' LYS . . . . . 0.459 ' O ' ' HA ' ' A' ' 44' ' ' VAL . 54.8 mttt -121.8 140.57 52.2 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.226 -0.921 . . . . 0.0 109.482 179.997 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 105' ' ' VAL . . . . . 0.94 HG21 ' HB2' ' A' ' 93' ' ' LEU . 34.3 t . . . . . 0 N--CA 1.49 1.557 0 O-C-N 121.274 -0.891 . . . . 0.0 109.421 -179.986 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 40' ' ' ASN . . . . . 0.477 ' O ' ' HA ' ' A' ' 79' ' ' THR . 49.6 t30 . . . . . 0 N--CA 1.49 1.566 0 N-CA-C 108.947 -0.761 . . . . 0.0 108.947 . . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 41' ' ' THR . . . . . 0.481 ' HA ' ' O ' ' A' ' 78' ' ' VAL . 34.2 m -78.01 149.17 34.09 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.259 -0.9 . . . . 0.0 110.105 -179.464 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 42' ' ' LEU . . . . . 0.781 HD12 ' O ' ' A' ' 78' ' ' VAL . 5.2 mp -126.31 154.4 43.51 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.278 -0.889 . . . . 0.0 109.28 179.723 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 43' ' ' TYR . . . . . 0.411 ' O ' ' HA ' ' A' ' 105' ' ' VAL . 76.1 t80 -107.87 114.82 29.02 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.292 -0.88 . . . . 0.0 109.52 179.875 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 44' ' ' VAL . . . . . 0.625 HG13 HD23 ' A' ' 103' ' ' LEU . 40.6 t -108.52 137.4 40.45 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 121.299 -0.876 . . . . 0.0 109.451 -179.959 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 45' ' ' TYR . . . . . 0.422 ' HB3' ' HB2' ' A' ' 104' ' ' LYS . 65.7 t80 -127.66 135.38 50.14 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.217 -0.927 . . . . 0.0 109.581 -179.844 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 171.24 -177.79 43.97 Favored Glycine 0 N--CA 1.49 2.259 0 N-CA-C 109.553 -1.419 . . . . 0.0 109.553 179.93 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 95.4 mt-10 -116.29 161.83 18.42 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.282 -1.128 . . . . 0.0 109.441 179.997 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 49.9 m-20 44.0 49.51 7.32 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.256 -0.902 . . . . 0.0 109.518 179.947 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 51.1 mtm -101.88 138.82 38.35 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.307 -0.871 . . . . 0.0 109.537 -179.947 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 50' ' ' THR . . . . . 0.405 ' O ' ' HG ' ' A' ' 54' ' ' LEU . 0.9 OUTLIER -122.55 162.94 35.56 Favored Pre-proline 0 N--CA 1.489 1.505 0 O-C-N 121.343 -0.848 . . . . 0.0 109.363 179.914 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 51' ' ' PRO . . . . . 0.628 ' HA ' HD12 ' A' ' 54' ' ' LEU . 47.8 Cg_endo -69.6 -53.61 0.27 Allowed 'Trans proline' 0 C--O 1.215 -0.674 0 C-N-CA 122.592 2.194 . . . . 0.0 111.768 -179.991 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 31.1 m -49.3 -49.23 44.73 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.232 -0.918 . . . . 0.0 109.194 179.867 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 26.8 tp -59.7 -46.54 88.77 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.309 -0.869 . . . . 0.0 109.203 179.714 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 54' ' ' LEU . . . . . 0.657 HD11 ' HE1' ' A' ' 69' ' ' MET . 12.4 mt -57.39 -46.25 83.63 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.322 -0.861 . . . . 0.0 109.193 179.726 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 55' ' ' ARG . . . . . 0.513 ' O ' ' N ' ' A' ' 59' ' ' SER . 83.9 mtt-85 -51.34 -39.84 57.86 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.295 -0.878 . . . . 0.0 109.175 179.79 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -68.77 -35.2 79.46 Favored Glycine 0 N--CA 1.489 2.226 0 N-CA-C 109.35 -1.5 . . . . 0.0 109.35 179.909 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 57' ' ' ALA . . . . . 0.456 ' O ' ' CD1' ' A' ' 61' ' ' PHE . . . -73.4 -27.64 61.57 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.216 -1.167 . . . . 0.0 109.379 179.92 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 58' ' ' PHE . . . . . 0.794 ' HB2' HD11 ' A' ' 64' ' ' ILE . 96.3 m-85 -112.18 8.44 19.89 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.304 -0.873 . . . . 0.0 109.34 179.969 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 59' ' ' SER . . . . . 0.534 ' N ' ' HD2' ' A' ' 60' ' ' PRO . 1.0 OUTLIER -74.09 -57.25 2.37 Favored Pre-proline 0 N--CA 1.491 1.6 0 O-C-N 121.372 -0.83 . . . . 0.0 110.106 -179.693 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 60' ' ' PRO . . . . . 0.534 ' HD2' ' N ' ' A' ' 59' ' ' SER . 47.3 Cg_endo -68.7 -27.66 31.72 Favored 'Trans proline' 0 C--O 1.215 -0.666 0 C-N-CA 122.676 2.25 . . . . 0.0 112.037 -179.511 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 61' ' ' PHE . . . . . 0.583 ' CE2' ' HB3' ' A' ' 92' ' ' GLU . 72.0 m-85 -69.56 -33.41 72.71 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.201 -0.937 . . . . 0.0 109.514 179.981 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 175.18 -169.71 42.64 Favored Glycine 0 N--CA 1.49 2.278 0 N-CA-C 109.487 -1.445 . . . . 0.0 109.487 179.996 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 83.9 m-20 -99.93 138.86 36.42 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.201 -1.176 . . . . 0.0 109.439 179.916 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 64' ' ' ILE . . . . . 0.794 HD11 ' HB2' ' A' ' 58' ' ' PHE . 49.1 mt -101.31 128.51 53.54 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.521 0 O-C-N 121.266 -0.896 . . . . 0.0 109.585 -179.938 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 23.0 pt -94.79 -25.19 4.66 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 O-C-N 121.238 -0.914 . . . . 0.0 109.409 -179.896 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 66' ' ' ASP . . . . . 0.466 ' HB3' ' OG1' ' A' ' 79' ' ' THR . 58.4 t0 -141.02 129.84 23.0 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.198 -0.939 . . . . 0.0 109.601 -179.955 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 67' ' ' LEU . . . . . 0.741 ' C ' HD13 ' A' ' 67' ' ' LEU . 3.4 tm? -119.29 116.35 26.05 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.303 -0.873 . . . . 0.0 109.364 179.934 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 68' ' ' SER . . . . . 0.492 ' HB2' ' HB2' ' A' ' 77' ' ' PHE . 58.0 m -121.13 145.35 47.9 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.14 -0.975 . . . . 0.0 109.532 -179.94 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 69' ' ' MET . . . . . 0.657 ' HE1' HD11 ' A' ' 54' ' ' LEU . 89.8 mmm -122.61 144.18 49.28 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.24 -0.912 . . . . 0.0 109.531 -179.952 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 70' ' ' ASP . . . . . 0.479 ' HB2' ' O ' ' A' ' 75' ' ' CYS . 0.2 OUTLIER -124.57 94.31 44.86 Favored Pre-proline 0 N--CA 1.49 1.566 0 O-C-N 121.2 -0.937 . . . . 0.0 109.461 179.917 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 71' ' ' PRO . . . . . 0.598 ' N ' ' CD ' ' A' ' 72' ' ' PRO . 46.5 Cg_endo -74.6 -28.0 10.31 Favored 'Trans proline' 0 CA--C 1.542 0.922 0 C-N-CA 122.506 2.137 . . . . 0.0 113.696 -179.989 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 72' ' ' PRO . . . . . 0.598 ' CD ' ' N ' ' A' ' 71' ' ' PRO . 55.2 Cg_endo -75.45 -22.38 14.11 Favored 'Trans proline' 0 C--N 1.352 0.722 0 C-N-CA 121.523 1.482 . . . . 0.0 111.75 -179.788 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 27.4 mtt85 -113.26 3.8 16.15 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.22 -0.925 . . . . 0.0 109.654 -179.9 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 73.4 m-20 58.23 47.86 13.59 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.244 -0.91 . . . . 0.0 109.45 179.972 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 75' ' ' CYS . . . . . 0.479 ' O ' ' HB2' ' A' ' 70' ' ' ASP . 31.1 p -152.63 148.26 27.11 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.284 -0.885 . . . . 0.0 109.456 -179.968 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 76' ' ' ALA . . . . . 0.468 ' HB1' ' SD ' ' A' ' 69' ' ' MET . . . -120.34 157.54 29.02 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.273 -0.892 . . . . 0.0 109.401 179.919 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 77' ' ' PHE . . . . . 0.492 ' HB2' ' HB2' ' A' ' 68' ' ' SER . 97.7 m-85 -119.59 139.75 51.66 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.202 -0.936 . . . . 0.0 109.569 -179.849 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 78' ' ' VAL . . . . . 0.781 ' O ' HD12 ' A' ' 42' ' ' LEU . 20.5 t -129.23 137.97 55.65 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.546 0 O-C-N 121.191 -0.943 . . . . 0.0 109.55 179.988 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 79' ' ' THR . . . . . 0.477 ' HA ' ' O ' ' A' ' 40' ' ' ASN . 23.3 m -106.19 134.83 48.7 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.194 -0.941 . . . . 0.0 109.264 179.89 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 80' ' ' TYR . . . . . 0.612 ' HH ' ' HD2' ' A' ' 58' ' ' PHE . 0.7 OUTLIER -113.21 141.63 46.74 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.214 -0.929 . . . . 0.0 109.62 -179.917 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 80.8 tt0 -64.03 -22.6 67.0 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.209 -0.932 . . . . 0.0 109.359 179.795 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 38.2 mttp -136.05 135.93 39.8 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.243 -0.91 . . . . 0.0 109.461 179.982 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 83' ' ' MET . . . . . . . . . . . . . 47.0 mtt -57.33 -24.64 56.37 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.244 -0.91 . . . . 0.0 109.401 179.928 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 98.4 mt-10 -66.2 -37.49 85.71 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.305 -0.872 . . . . 0.0 109.557 179.981 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 19.3 m -62.37 -31.48 72.15 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.236 -0.915 . . . . 0.0 109.571 -179.97 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 86' ' ' ALA . . . . . 0.645 ' O ' HG23 ' A' ' 90' ' ' VAL . . . -75.61 -34.54 60.6 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.255 -0.903 . . . . 0.0 109.449 -179.945 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 64.5 t0 -62.14 -45.42 93.53 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.286 -0.884 . . . . 0.0 109.647 -179.953 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 44.6 tt0 -69.08 -43.58 74.25 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.172 -0.955 . . . . 0.0 109.595 -179.882 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 89' ' ' ALA . . . . . 0.624 ' HB1' ' CD1' ' A' ' 93' ' ' LEU . . . -72.37 -37.13 68.84 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.195 -0.941 . . . . 0.0 109.552 -179.869 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 90' ' ' VAL . . . . . 0.747 ' CG2' HD23 ' A' ' 42' ' ' LEU . 61.2 t -69.38 -47.31 73.69 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.604 0 O-C-N 121.254 -0.904 . . . . 0.0 109.652 -179.89 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -73.56 -28.51 61.9 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.236 -0.915 . . . . 0.0 109.757 -179.721 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 92' ' ' GLU . . . . . 0.583 ' HB3' ' CE2' ' A' ' 61' ' ' PHE . 39.2 tp10 -87.21 -49.77 7.05 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.245 -0.909 . . . . 0.0 109.786 -179.731 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 93' ' ' LEU . . . . . 0.929 ' HB2' HG21 ' A' ' 105' ' ' VAL . 39.9 mt -68.02 -39.81 83.09 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.244 -0.91 . . . . 0.0 109.612 -179.907 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 94' ' ' ASN . . . . . 0.523 ' CB ' ' O ' ' A' ' 90' ' ' VAL . 57.2 t30 -68.35 128.05 35.19 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.24 -0.912 . . . . 0.0 109.481 -179.969 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 94.87 19.38 31.59 Favored Glycine 0 N--CA 1.491 2.308 0 N-CA-C 109.591 -1.404 . . . . 0.0 109.591 -179.947 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 96' ' ' THR . . . . . 0.428 ' CG2' ' O ' ' A' ' 92' ' ' GLU . 21.8 p -120.46 148.6 43.6 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.209 -1.171 . . . . 0.0 109.493 179.978 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 97' ' ' GLN . . . . . 0.474 ' HG3' ' O ' ' A' ' 101' ' ' VAL . 59.8 tt0 -119.73 140.76 50.2 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.232 -0.917 . . . . 0.0 109.478 179.996 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 98' ' ' VAL . . . . . 0.642 HG12 ' H ' ' A' ' 99' ' ' GLU . 1.3 t -81.74 -162.99 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.532 0 O-C-N 121.285 -0.885 . . . . 0.0 109.347 179.997 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 99' ' ' GLU . . . . . 0.642 ' H ' HG12 ' A' ' 98' ' ' VAL . 96.0 mt-10 -54.18 -37.36 64.41 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.232 -0.917 . . . . 0.0 109.558 -179.975 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -155.59 25.18 0.4 Allowed 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.322 -0.861 . . . . 0.0 109.521 179.957 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 101' ' ' VAL . . . . . 0.564 HG12 ' N ' ' A' ' 102' ' ' GLN . 60.0 t -137.77 164.62 28.02 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.552 0 O-C-N 121.236 -0.915 . . . . 0.0 109.5 -179.953 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 102' ' ' GLN . . . . . 0.564 ' N ' HG12 ' A' ' 101' ' ' VAL . 91.7 mt-30 -119.06 145.36 45.96 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.309 -0.869 . . . . 0.0 109.371 179.854 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 103' ' ' LEU . . . . . 0.625 HD23 HG13 ' A' ' 44' ' ' VAL . 0.0 OUTLIER -124.45 130.95 53.41 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.25 -0.907 . . . . 0.0 109.591 -179.785 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 104' ' ' LYS . . . . . 0.422 ' HB2' ' HB3' ' A' ' 45' ' ' TYR . 24.1 mttm -117.89 127.24 53.66 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.346 -0.846 . . . . 0.0 109.24 179.761 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 105' ' ' VAL . . . . . 0.929 HG21 ' HB2' ' A' ' 93' ' ' LEU . 12.1 t . . . . . 0 N--CA 1.49 1.551 0 O-C-N 121.231 -0.918 . . . . 0.0 109.736 -179.764 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 40' ' ' ASN . . . . . 0.485 ' N ' ' O ' ' A' ' 80' ' ' TYR . 1.5 t-20 . . . . . 0 N--CA 1.491 1.608 0 N-CA-C 109.1 -0.704 . . . . 0.0 109.1 . . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 41' ' ' THR . . . . . 0.487 ' HA ' ' O ' ' A' ' 78' ' ' VAL . 27.0 m -78.54 150.94 32.74 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.24 -0.913 . . . . 0.0 110.063 -179.479 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 42' ' ' LEU . . . . . 0.906 HD12 ' O ' ' A' ' 78' ' ' VAL . 5.1 mp -126.57 152.86 46.02 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.413 -0.805 . . . . 0.0 109.132 179.616 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 39.8 t80 -107.92 111.37 23.44 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.224 -0.923 . . . . 0.0 109.42 179.865 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 44' ' ' VAL . . . . . 0.473 ' HA ' ' O ' ' A' ' 104' ' ' LYS . 96.5 t -109.16 142.26 22.18 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.551 0 O-C-N 121.202 -0.936 . . . . 0.0 109.384 179.969 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 68.1 t80 -128.35 130.97 48.54 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.251 -0.906 . . . . 0.0 109.561 -179.882 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -176.54 -166.44 33.7 Favored Glycine 0 N--CA 1.488 2.123 0 N-CA-C 109.483 -1.447 . . . . 0.0 109.483 179.928 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 47' ' ' GLU . . . . . 0.415 ' O ' ' C ' ' A' ' 48' ' ' ASP . 94.8 mt-10 -132.52 161.08 34.68 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.328 -1.101 . . . . 0.0 109.485 179.987 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 48' ' ' ASP . . . . . 0.415 ' C ' ' O ' ' A' ' 47' ' ' GLU . 42.8 m-20 43.66 51.55 6.45 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.271 -0.893 . . . . 0.0 109.601 179.934 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 72.6 mtm -103.78 145.0 30.73 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.249 -0.907 . . . . 0.0 109.475 -179.944 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 50' ' ' THR . . . . . 0.407 ' O ' HD12 ' A' ' 54' ' ' LEU . 0.0 OUTLIER -117.6 161.75 32.2 Favored Pre-proline 0 N--CA 1.49 1.561 0 O-C-N 121.296 -0.878 . . . . 0.0 109.53 -179.978 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 51' ' ' PRO . . . . . 0.48 ' CA ' ' SD ' ' A' ' 69' ' ' MET . 49.2 Cg_endo -69.93 -53.93 0.24 Allowed 'Trans proline' 0 C--O 1.214 -0.694 0 C-N-CA 122.731 2.288 . . . . 0.0 111.739 179.89 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 27.1 m -56.91 -44.71 82.64 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.286 -0.884 . . . . 0.0 109.33 179.887 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 53' ' ' LEU . . . . . 0.771 ' O ' HD13 ' A' ' 53' ' ' LEU . 2.3 tm? -59.94 -47.77 84.44 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.311 -0.868 . . . . 0.0 109.384 179.97 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 54' ' ' LEU . . . . . 0.498 HD11 ' CE ' ' A' ' 69' ' ' MET . 17.3 mt -59.36 -52.31 66.16 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.255 -0.903 . . . . 0.0 109.332 179.979 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 55' ' ' ARG . . . . . 0.513 ' O ' ' N ' ' A' ' 59' ' ' SER . 52.3 mtp180 -45.0 -41.04 7.01 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.242 -0.911 . . . . 0.0 109.292 179.83 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 56' ' ' GLY . . . . . 0.487 ' O ' ' HD2' ' A' ' 60' ' ' PRO . . . -64.07 -40.65 98.34 Favored Glycine 0 N--CA 1.49 2.252 0 N-CA-C 109.416 -1.474 . . . . 0.0 109.416 179.904 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 57' ' ' ALA . . . . . 0.429 ' O ' ' CD2' ' A' ' 61' ' ' PHE . . . -65.9 -23.3 66.61 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.286 -1.126 . . . . 0.0 109.323 179.956 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 58' ' ' PHE . . . . . 0.808 ' HB2' HD11 ' A' ' 64' ' ' ILE . 93.6 m-85 -116.81 9.36 13.89 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.287 -0.883 . . . . 0.0 109.395 179.975 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 59' ' ' SER . . . . . 0.548 ' N ' ' HD2' ' A' ' 60' ' ' PRO . 0.9 OUTLIER -76.89 -55.45 1.47 Allowed Pre-proline 0 N--CA 1.491 1.592 0 O-C-N 121.225 -0.922 . . . . 0.0 110.37 -179.569 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 60' ' ' PRO . . . . . 0.548 ' HD2' ' N ' ' A' ' 59' ' ' SER . 47.4 Cg_endo -69.26 -30.76 24.05 Favored 'Trans proline' 0 C--O 1.215 -0.65 0 C-N-CA 122.502 2.135 . . . . 0.0 112.158 -179.25 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 61' ' ' PHE . . . . . 0.557 ' CE1' ' HA ' ' A' ' 89' ' ' ALA . 82.3 m-85 -66.06 -38.32 88.03 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.165 -0.959 . . . . 0.0 109.442 179.933 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 62' ' ' GLY . . . . . 0.462 ' HA3' ' OG ' ' A' ' 85' ' ' SER . . . -179.51 -177.09 47.6 Favored Glycine 0 N--CA 1.49 2.277 0 N-CA-C 109.47 -1.452 . . . . 0.0 109.47 179.973 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 85.8 m-20 -91.46 140.35 29.83 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.171 -1.194 . . . . 0.0 109.489 179.965 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 64' ' ' ILE . . . . . 0.808 HD11 ' HB2' ' A' ' 58' ' ' PHE . 64.3 mt -101.63 133.32 45.41 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.531 0 O-C-N 121.235 -0.916 . . . . 0.0 109.506 -179.929 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 25.9 pt -96.68 -19.57 6.06 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 O-C-N 121.284 -0.885 . . . . 0.0 109.609 -179.955 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 66' ' ' ASP . . . . . 0.459 ' HB3' ' OG1' ' A' ' 79' ' ' THR . 58.5 t0 -153.4 110.8 3.5 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.185 -0.947 . . . . 0.0 109.571 -179.917 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 67' ' ' LEU . . . . . 0.747 HD23 HD13 ' A' ' 64' ' ' ILE . 0.2 OUTLIER -102.18 118.1 36.17 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.24 -0.913 . . . . 0.0 109.388 179.824 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 68' ' ' SER . . . . . 0.652 ' N ' HD13 ' A' ' 67' ' ' LEU . 25.6 t -126.49 145.34 50.54 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.245 -0.91 . . . . 0.0 109.556 -179.836 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 69' ' ' MET . . . . . 0.498 ' CE ' HD11 ' A' ' 54' ' ' LEU . 90.5 mtp -126.89 150.96 49.03 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.371 -0.831 . . . . 0.0 109.407 179.923 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 70' ' ' ASP . . . . . 0.48 ' C ' ' HD2' ' A' ' 72' ' ' PRO . 0.2 OUTLIER -125.41 98.31 35.31 Favored Pre-proline 0 N--CA 1.49 1.57 0 O-C-N 121.29 -0.882 . . . . 0.0 109.526 179.961 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 71' ' ' PRO . . . . . 0.603 ' N ' ' CD ' ' A' ' 72' ' ' PRO . 46.2 Cg_endo -74.61 -27.85 10.44 Favored 'Trans proline' 0 CA--C 1.542 0.925 0 C-N-CA 122.529 2.153 . . . . 0.0 113.647 179.945 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 72' ' ' PRO . . . . . 0.603 ' CD ' ' N ' ' A' ' 71' ' ' PRO . 55.3 Cg_endo -75.69 -26.19 10.1 Favored 'Trans proline' 0 C--N 1.353 0.782 0 C-N-CA 121.536 1.49 . . . . 0.0 111.771 -179.958 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 73' ' ' ARG . . . . . 0.406 ' O ' ' HB2' ' A' ' 74' ' ' ASN . 96.5 mtt180 -110.85 -0.01 17.06 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.294 -0.878 . . . . 0.0 109.652 -179.822 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 74' ' ' ASN . . . . . 0.406 ' HB2' ' O ' ' A' ' 73' ' ' ARG . 60.2 m-20 61.2 44.73 9.64 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.166 -0.959 . . . . 0.0 109.343 -179.91 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 75' ' ' CYS . . . . . 0.458 ' O ' ' HB2' ' A' ' 70' ' ' ASP . 22.0 p -143.5 137.37 28.46 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.286 -0.884 . . . . 0.0 109.475 179.959 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -111.45 154.16 25.08 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.205 -0.935 . . . . 0.0 109.492 -179.96 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 77' ' ' PHE . . . . . 0.476 ' HA ' ' O ' ' A' ' 42' ' ' LEU . 97.0 m-85 -121.93 129.04 52.2 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.237 -0.915 . . . . 0.0 109.577 -179.925 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 78' ' ' VAL . . . . . 0.906 ' O ' HD12 ' A' ' 42' ' ' LEU . 26.5 t -120.21 138.53 50.47 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.569 0 O-C-N 121.206 -0.934 . . . . 0.0 109.289 179.858 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 79' ' ' THR . . . . . 0.534 ' O ' HG23 ' A' ' 64' ' ' ILE . 1.2 m -107.2 136.36 47.16 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.286 -0.884 . . . . 0.0 109.634 -179.826 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 80' ' ' TYR . . . . . 0.565 ' CE1' ' OG ' ' A' ' 85' ' ' SER . 0.9 OUTLIER -119.81 121.27 38.74 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.295 -0.878 . . . . 0.0 109.419 179.81 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 81' ' ' GLU . . . . . 0.441 ' C ' ' O ' ' A' ' 80' ' ' TYR . 83.5 tt0 -40.37 -39.74 1.04 Allowed 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.516 -0.74 . . . . 0.0 109.85 179.964 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 9.5 mtmm -122.87 162.97 21.17 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.193 -0.942 . . . . 0.0 109.514 179.931 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 83' ' ' MET . . . . . 0.465 ' CE ' ' HB2' ' A' ' 40' ' ' ASN . 4.4 mmt -80.17 -13.94 58.85 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.188 -0.945 . . . . 0.0 109.345 -179.999 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 96.1 mt-10 -69.82 -35.77 75.08 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.241 -0.912 . . . . 0.0 109.49 179.891 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 85' ' ' SER . . . . . 0.565 ' OG ' ' CE1' ' A' ' 80' ' ' TYR . 43.4 t -71.57 -32.08 67.67 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.2 -0.937 . . . . 0.0 109.476 -179.967 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 86' ' ' ALA . . . . . 0.81 ' O ' HG23 ' A' ' 90' ' ' VAL . . . -78.78 -31.38 46.04 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.244 -0.91 . . . . 0.0 109.532 -179.938 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 58.3 t0 -70.62 -46.73 62.81 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.243 -0.911 . . . . 0.0 109.646 -179.938 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 65.0 tt0 -68.64 -41.31 79.6 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.269 -0.895 . . . . 0.0 109.644 -179.873 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 89' ' ' ALA . . . . . 0.613 ' HB1' ' CD1' ' A' ' 93' ' ' LEU . . . -67.92 -41.1 83.14 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.208 -0.933 . . . . 0.0 109.653 -179.935 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 90' ' ' VAL . . . . . 0.81 HG23 ' O ' ' A' ' 86' ' ' ALA . 55.6 t -60.4 -35.94 66.02 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.587 0 O-C-N 121.22 -0.925 . . . . 0.0 109.669 -179.902 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -75.42 -53.91 7.91 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.173 -0.954 . . . . 0.0 109.844 -179.723 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 92' ' ' GLU . . . . . 0.519 ' O ' ' CG2' ' A' ' 96' ' ' THR . 76.1 mm-40 -67.92 -44.37 77.04 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.223 -0.923 . . . . 0.0 109.768 -179.537 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 93' ' ' LEU . . . . . 0.756 ' HB2' HG21 ' A' ' 105' ' ' VAL . 92.1 mt -66.57 -38.95 88.14 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.079 -1.013 . . . . 0.0 109.541 -179.804 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 94' ' ' ASN . . . . . 0.532 ' CB ' ' O ' ' A' ' 90' ' ' VAL . 62.1 t-20 -72.74 120.23 18.07 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.237 -0.914 . . . . 0.0 109.553 -179.964 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 105.27 10.71 31.12 Favored Glycine 0 N--CA 1.491 2.315 0 N-CA-C 109.426 -1.47 . . . . 0.0 109.426 179.905 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 96' ' ' THR . . . . . 0.519 ' CG2' ' O ' ' A' ' 92' ' ' GLU . 27.7 p -107.77 157.62 17.98 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.201 -1.176 . . . . 0.0 109.494 -179.97 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 58.7 tt0 -129.25 145.95 51.25 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.182 -0.949 . . . . 0.0 109.479 -179.935 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 98' ' ' VAL . . . . . 0.478 HG23 ' O ' ' A' ' 101' ' ' VAL . 1.4 t -87.39 -147.8 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 O-C-N 121.275 -0.891 . . . . 0.0 109.385 179.996 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 99' ' ' GLU . . . . . 0.473 ' H ' HG12 ' A' ' 98' ' ' VAL . 96.7 mt-10 -63.44 -41.87 98.67 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.21 -0.931 . . . . 0.0 109.536 179.979 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -153.77 23.83 0.51 Allowed 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.257 -0.902 . . . . 0.0 109.478 -179.915 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 101' ' ' VAL . . . . . 0.478 ' O ' HG23 ' A' ' 98' ' ' VAL . 52.9 t -139.46 148.63 23.24 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 O-C-N 121.252 -0.905 . . . . 0.0 109.433 -179.979 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 47.2 tt0 -97.47 140.67 31.56 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.172 -0.955 . . . . 0.0 109.523 -179.867 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 90.7 mt -104.42 137.7 41.9 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.253 -0.904 . . . . 0.0 109.465 179.977 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 104' ' ' LYS . . . . . 0.473 ' O ' ' HA ' ' A' ' 44' ' ' VAL . 89.0 mttt -117.95 138.39 52.2 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.293 -0.88 . . . . 0.0 109.298 179.887 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 105' ' ' VAL . . . . . 0.756 HG21 ' HB2' ' A' ' 93' ' ' LEU . 59.9 t . . . . . 0 N--CA 1.49 1.54 0 O-C-N 121.225 -0.922 . . . . 0.0 109.458 -179.885 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 40' ' ' ASN . . . . . 0.566 ' N ' HG22 ' A' ' 79' ' ' THR . 47.4 t30 . . . . . 0 N--CA 1.491 1.596 0 N-CA-C 109.493 -0.558 . . . . 0.0 109.493 . . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 41' ' ' THR . . . . . 0.823 ' O ' HD23 ' A' ' 42' ' ' LEU . 45.1 m -61.11 140.44 57.88 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.236 -0.915 . . . . 0.0 109.815 -179.771 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 42' ' ' LEU . . . . . 0.823 HD23 ' O ' ' A' ' 41' ' ' THR . 17.9 mt -125.33 143.44 50.97 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.253 -0.904 . . . . 0.0 109.483 179.722 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 71.1 t80 -96.27 120.46 36.6 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.277 -0.889 . . . . 0.0 109.52 -179.998 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 44' ' ' VAL . . . . . 0.643 ' CG1' HD21 ' A' ' 103' ' ' LEU . 58.7 t -118.49 139.06 47.16 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 O-C-N 121.171 -0.956 . . . . 0.0 109.421 179.96 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 65.6 t80 -129.39 141.6 51.01 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.261 -0.9 . . . . 0.0 109.562 -179.939 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 175.2 -174.82 47.0 Favored Glycine 0 N--CA 1.49 2.292 0 N-CA-C 109.424 -1.47 . . . . 0.0 109.424 179.935 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 47' ' ' GLU . . . . . 0.418 ' O ' ' C ' ' A' ' 48' ' ' ASP . 94.6 mt-10 -112.86 159.32 19.15 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.195 -1.18 . . . . 0.0 109.343 179.974 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 48' ' ' ASP . . . . . 0.418 ' C ' ' O ' ' A' ' 47' ' ' GLU . 51.4 m-20 44.34 40.2 3.59 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.211 -0.93 . . . . 0.0 109.262 -179.951 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 46.9 mtp -75.46 141.09 43.18 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.282 -0.886 . . . . 0.0 109.527 -179.951 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 50' ' ' THR . . . . . 0.457 ' O ' ' HG ' ' A' ' 54' ' ' LEU . 0.7 OUTLIER -130.98 161.94 58.54 Favored Pre-proline 0 N--CA 1.49 1.553 0 O-C-N 121.19 -0.944 . . . . 0.0 109.344 -179.974 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 51' ' ' PRO . . . . . 0.505 ' N ' ' SD ' ' A' ' 69' ' ' MET . 49.7 Cg_endo -70.6 -53.47 0.22 Allowed 'Trans proline' 0 C--O 1.214 -0.683 0 C-N-CA 122.657 2.238 . . . . 0.0 111.669 179.964 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 32.9 m -58.34 -41.69 85.19 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.268 -0.895 . . . . 0.0 109.348 179.886 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 53' ' ' LEU . . . . . 0.496 ' C ' HD23 ' A' ' 53' ' ' LEU . 9.2 tt -62.44 -46.08 90.18 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.277 -0.889 . . . . 0.0 109.385 179.92 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 54' ' ' LEU . . . . . 0.457 ' HG ' ' O ' ' A' ' 50' ' ' THR . 40.8 mt -64.76 -46.16 83.36 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.238 -0.914 . . . . 0.0 109.207 179.79 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 55' ' ' ARG . . . . . 0.478 ' O ' ' CB ' ' A' ' 59' ' ' SER . 74.4 ttt180 -48.0 -40.79 23.64 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.244 -0.91 . . . . 0.0 109.394 179.97 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -73.71 -31.55 60.32 Favored Glycine 0 N--CA 1.49 2.243 0 N-CA-C 109.476 -1.45 . . . . 0.0 109.476 179.892 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -73.55 -24.46 60.11 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.225 -1.162 . . . . 0.0 109.435 179.982 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 58' ' ' PHE . . . . . 0.713 ' CZ ' HD13 ' A' ' 93' ' ' LEU . 94.8 m-85 -119.09 8.86 11.65 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.371 -0.83 . . . . 0.0 109.421 179.977 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 59' ' ' SER . . . . . 0.526 ' N ' ' HD2' ' A' ' 60' ' ' PRO . 0.4 OUTLIER -74.9 -57.59 1.81 Allowed Pre-proline 0 N--CA 1.491 1.609 0 O-C-N 121.279 -0.888 . . . . 0.0 110.162 -179.582 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 60' ' ' PRO . . . . . 0.526 ' HD2' ' N ' ' A' ' 59' ' ' SER . 48.1 Cg_endo -68.74 -35.96 15.13 Favored 'Trans proline' 0 C--O 1.215 -0.63 0 C-N-CA 122.584 2.189 . . . . 0.0 112.259 -179.437 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 61' ' ' PHE . . . . . 0.579 ' CD1' ' HA ' ' A' ' 89' ' ' ALA . 64.7 m-85 -58.72 -33.89 70.73 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.16 -0.963 . . . . 0.0 109.703 -179.828 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 176.74 -174.32 46.95 Favored Glycine 0 N--CA 1.49 2.282 0 N-CA-C 109.617 -1.393 . . . . 0.0 109.617 179.974 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 82.0 m-20 -95.03 146.23 24.41 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.235 -1.156 . . . . 0.0 109.46 179.991 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 64' ' ' ILE . . . . . 0.797 HD13 HD12 ' A' ' 67' ' ' LEU . 51.5 mt -110.77 126.54 68.12 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 O-C-N 121.3 -0.875 . . . . 0.0 109.416 179.974 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 22.2 pt -91.15 -22.56 6.16 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 O-C-N 121.273 -0.892 . . . . 0.0 109.543 -179.896 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 45.2 t0 -155.49 95.0 1.64 Allowed 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.196 -0.94 . . . . 0.0 109.586 179.994 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 67' ' ' LEU . . . . . 0.797 HD12 HD13 ' A' ' 64' ' ' ILE . 0.5 OUTLIER -93.29 126.67 38.53 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.206 -0.934 . . . . 0.0 109.196 179.769 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 68' ' ' SER . . . . . 0.44 ' HB2' ' HB2' ' A' ' 77' ' ' PHE . 67.5 m -126.08 153.86 43.89 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.226 -0.921 . . . . 0.0 109.718 -179.802 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 69' ' ' MET . . . . . 0.505 ' SD ' ' N ' ' A' ' 51' ' ' PRO . 84.1 mtp -126.46 150.54 48.63 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.414 -0.804 . . . . 0.0 109.296 179.851 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 70' ' ' ASP . . . . . 0.484 ' C ' ' HD2' ' A' ' 72' ' ' PRO . 1.2 t0 -129.09 99.24 22.09 Favored Pre-proline 0 N--CA 1.49 1.565 0 O-C-N 121.195 -0.941 . . . . 0.0 109.55 -179.948 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 71' ' ' PRO . . . . . 0.6 ' N ' ' CD ' ' A' ' 72' ' ' PRO . 46.4 Cg_endo -74.54 -27.96 10.48 Favored 'Trans proline' 0 CA--C 1.542 0.897 0 C-N-CA 122.503 2.136 . . . . 0.0 113.523 179.845 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 72' ' ' PRO . . . . . 0.6 ' CD ' ' N ' ' A' ' 71' ' ' PRO . 55.6 Cg_endo -75.38 -26.62 10.15 Favored 'Trans proline' 0 C--N 1.353 0.772 0 C-N-CA 121.483 1.456 . . . . 0.0 111.82 -179.932 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 73' ' ' ARG . . . . . 0.429 ' O ' ' HB2' ' A' ' 74' ' ' ASN . 89.0 mtt-85 -109.23 -1.02 18.94 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.293 -0.88 . . . . 0.0 109.645 -179.959 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 74' ' ' ASN . . . . . 0.429 ' HB2' ' O ' ' A' ' 73' ' ' ARG . 79.8 m-20 61.6 43.99 9.49 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.21 -0.931 . . . . 0.0 109.568 179.955 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 75' ' ' CYS . . . . . 0.466 ' HA ' ' O ' ' A' ' 44' ' ' VAL . 27.5 p -146.94 150.5 35.3 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.271 -0.893 . . . . 0.0 109.395 179.978 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -116.35 154.25 30.55 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.171 -0.956 . . . . 0.0 109.522 -179.946 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 77' ' ' PHE . . . . . 0.47 ' HA ' ' O ' ' A' ' 42' ' ' LEU . 98.0 m-85 -124.16 106.31 10.23 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.299 -0.876 . . . . 0.0 109.476 -179.941 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 78' ' ' VAL . . . . . 0.735 HG23 HD12 ' A' ' 67' ' ' LEU . 5.9 p -109.8 136.19 46.48 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.503 0 O-C-N 121.131 -0.981 . . . . 0.0 109.638 179.907 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 79' ' ' THR . . . . . 0.566 HG22 ' N ' ' A' ' 40' ' ' ASN . 3.7 m -102.5 127.05 49.72 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.308 -0.87 . . . . 0.0 109.699 -179.736 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 80' ' ' TYR . . . . . 0.823 ' HD2' HD11 ' A' ' 42' ' ' LEU . 0.5 OUTLIER -102.16 126.12 49.04 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.308 -0.87 . . . . 0.0 109.465 179.948 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 81' ' ' GLU . . . . . 0.431 ' C ' ' O ' ' A' ' 80' ' ' TYR . 88.5 tt0 -42.06 -47.4 4.49 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.476 -0.765 . . . . 0.0 109.766 179.949 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 36.4 mttm -113.7 155.86 24.8 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.26 -0.9 . . . . 0.0 109.635 -179.904 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 83' ' ' MET . . . . . . . . . . . . . 57.7 mtt -77.46 -19.87 55.29 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.26 -0.9 . . . . 0.0 109.34 179.943 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 98.3 mt-10 -69.66 -44.6 70.19 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.181 -0.949 . . . . 0.0 109.303 179.918 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 16.0 m -61.56 -27.39 68.59 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.355 -0.841 . . . . 0.0 109.225 179.739 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 86' ' ' ALA . . . . . 0.611 ' O ' HG23 ' A' ' 90' ' ' VAL . . . -78.11 -34.42 50.06 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.383 -0.823 . . . . 0.0 109.416 -179.993 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 59.2 t0 -66.9 -33.63 76.02 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.294 -0.879 . . . . 0.0 109.388 179.897 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 88' ' ' GLN . . . . . 0.479 ' O ' ' HB2' ' A' ' 92' ' ' GLU . 63.5 tt0 -77.01 -37.6 54.69 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.287 -0.883 . . . . 0.0 109.384 179.933 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 89' ' ' ALA . . . . . 0.579 ' HA ' ' CD1' ' A' ' 61' ' ' PHE . . . -76.49 -35.09 58.57 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.285 -0.884 . . . . 0.0 109.385 179.939 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 90' ' ' VAL . . . . . 0.728 HG22 ' CG1' ' A' ' 105' ' ' VAL . 75.8 t -71.2 -39.77 73.7 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.513 0 O-C-N 121.325 -0.859 . . . . 0.0 109.464 -179.948 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -77.11 -34.31 56.76 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.209 -0.932 . . . . 0.0 109.496 -179.985 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 92' ' ' GLU . . . . . 0.579 ' HB3' ' CZ ' ' A' ' 61' ' ' PHE . 6.0 tm-20 -80.07 -46.28 16.8 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.215 -0.928 . . . . 0.0 109.644 -179.867 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 93' ' ' LEU . . . . . 0.713 HD13 ' CZ ' ' A' ' 58' ' ' PHE . 72.6 mt -70.42 -37.69 74.45 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.22 -0.925 . . . . 0.0 109.534 -179.918 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 94' ' ' ASN . . . . . 0.519 ' CB ' ' O ' ' A' ' 90' ' ' VAL . 49.6 t30 -70.12 136.68 50.42 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.231 -0.918 . . . . 0.0 109.462 -179.933 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 83.16 26.32 44.77 Favored Glycine 0 N--CA 1.49 2.279 0 N-CA-C 109.528 -1.429 . . . . 0.0 109.528 179.988 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 96' ' ' THR . . . . . 0.556 HG21 ' O ' ' A' ' 92' ' ' GLU . 27.9 p -125.89 146.63 49.75 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.29 -1.123 . . . . 0.0 109.575 -179.982 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 97' ' ' GLN . . . . . 0.502 ' CG ' ' O ' ' A' ' 101' ' ' VAL . 52.7 tt0 -117.92 137.81 52.57 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.293 -0.879 . . . . 0.0 109.424 -179.938 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 98' ' ' VAL . . . . . 0.547 HG12 ' H ' ' A' ' 99' ' ' GLU . 1.1 t -80.12 -153.55 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 O-C-N 121.283 -0.886 . . . . 0.0 109.337 -179.983 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 99' ' ' GLU . . . . . 0.547 ' H ' HG12 ' A' ' 98' ' ' VAL . 96.5 mt-10 -58.4 -38.31 77.12 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.165 -0.959 . . . . 0.0 109.5 -179.965 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -156.96 25.78 0.32 Allowed 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.183 -0.948 . . . . 0.0 109.483 -179.983 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 101' ' ' VAL . . . . . 0.586 HG12 ' N ' ' A' ' 102' ' ' GLN . 49.0 t -137.27 167.41 23.26 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.55 0 O-C-N 121.221 -0.925 . . . . 0.0 109.541 -179.878 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 102' ' ' GLN . . . . . 0.586 ' N ' HG12 ' A' ' 101' ' ' VAL . 92.1 mt-30 -122.61 147.37 46.49 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.248 -0.907 . . . . 0.0 109.126 179.885 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 103' ' ' LEU . . . . . 0.643 HD21 ' CG1' ' A' ' 44' ' ' VAL . 0.0 OUTLIER -121.69 135.68 54.96 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.11 -0.994 . . . . 0.0 109.93 -179.802 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 23.9 mttt -118.19 130.88 56.35 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.334 -0.854 . . . . 0.0 109.051 179.694 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 105' ' ' VAL . . . . . 0.728 ' CG1' HG22 ' A' ' 90' ' ' VAL . 21.5 t . . . . . 0 N--CA 1.491 1.611 0 O-C-N 121.167 -0.958 . . . . 0.0 109.776 -179.788 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 40' ' ' ASN . . . . . 0.476 ' O ' ' HA ' ' A' ' 79' ' ' THR . 62.0 t30 . . . . . 0 N--CA 1.489 1.506 0 N-CA-C 109.417 -0.586 . . . . 0.0 109.417 . . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 41' ' ' THR . . . . . 0.466 ' HA ' ' O ' ' A' ' 78' ' ' VAL . 54.4 m -77.52 148.22 35.4 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.282 -0.886 . . . . 0.0 109.826 -179.712 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 42' ' ' LEU . . . . . 0.914 HD12 ' O ' ' A' ' 78' ' ' VAL . 4.9 mp -123.79 152.29 42.39 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.352 -0.842 . . . . 0.0 109.386 179.832 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 46.8 t80 -110.22 112.07 23.8 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.246 -0.909 . . . . 0.0 109.358 179.782 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 44' ' ' VAL . . . . . 0.461 ' HA ' ' O ' ' A' ' 104' ' ' LYS . 48.8 t -108.29 143.88 17.88 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.535 0 O-C-N 121.301 -0.874 . . . . 0.0 109.351 -179.941 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 45' ' ' TYR . . . . . 0.468 ' HB3' ' HB2' ' A' ' 104' ' ' LYS . 71.1 t80 -131.53 135.87 47.39 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.282 -0.886 . . . . 0.0 109.506 -179.931 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 46' ' ' GLY . . . . . 0.474 ' O ' ' HB3' ' A' ' 74' ' ' ASN . . . 177.57 -170.53 43.0 Favored Glycine 0 N--CA 1.49 2.282 0 N-CA-C 109.476 -1.45 . . . . 0.0 109.476 179.989 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 47' ' ' GLU . . . . . 0.42 ' O ' ' C ' ' A' ' 48' ' ' ASP . 94.9 mt-10 -124.31 157.36 35.14 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.246 -1.15 . . . . 0.0 109.426 -179.922 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 48' ' ' ASP . . . . . 0.42 ' C ' ' O ' ' A' ' 47' ' ' GLU . 38.0 m-20 44.48 51.26 7.94 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.274 -0.891 . . . . 0.0 109.552 -179.977 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 60.9 mtm -102.84 137.93 40.4 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.158 -0.964 . . . . 0.0 109.432 179.992 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 50' ' ' THR . . . . . 0.745 ' O ' HD12 ' A' ' 54' ' ' LEU . 0.7 OUTLIER -116.29 164.15 19.15 Favored Pre-proline 0 N--CA 1.49 1.551 0 O-C-N 121.197 -0.939 . . . . 0.0 109.599 179.894 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 50.4 Cg_endo -70.25 -52.03 0.31 Allowed 'Trans proline' 0 C--O 1.216 -0.594 0 C-N-CA 122.69 2.26 . . . . 0.0 111.715 179.979 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 36.5 m -53.63 -43.17 68.52 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.316 -0.865 . . . . 0.0 109.369 179.993 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 53' ' ' LEU . . . . . 0.737 ' O ' HD13 ' A' ' 53' ' ' LEU . 3.3 tm? -62.02 -46.18 90.31 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.239 -0.913 . . . . 0.0 109.319 179.967 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 54' ' ' LEU . . . . . 0.745 HD12 ' O ' ' A' ' 50' ' ' THR . 3.9 mt -62.49 -44.81 95.48 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.285 -0.884 . . . . 0.0 109.441 179.923 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 55' ' ' ARG . . . . . 0.761 ' HE ' HD22 ' A' ' 67' ' ' LEU . 83.5 mtt180 -52.29 -39.06 60.02 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.318 -0.864 . . . . 0.0 109.379 179.919 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -70.69 -34.89 66.76 Favored Glycine 0 N--CA 1.49 2.238 0 N-CA-C 109.378 -1.489 . . . . 0.0 109.378 179.968 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 57' ' ' ALA . . . . . 0.47 ' HB1' HD22 ' A' ' 93' ' ' LEU . . . -76.05 -23.7 55.11 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.282 -1.128 . . . . 0.0 109.439 179.979 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 58' ' ' PHE . . . . . 0.633 ' CE1' ' CD1' ' A' ' 93' ' ' LEU . 96.8 m-85 -116.17 7.75 14.21 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.146 -0.971 . . . . 0.0 109.46 179.995 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 59' ' ' SER . . . . . 0.532 ' N ' ' HD2' ' A' ' 60' ' ' PRO . 0.5 OUTLIER -73.51 -57.46 2.65 Favored Pre-proline 0 N--CA 1.491 1.608 0 O-C-N 121.291 -0.881 . . . . 0.0 109.96 -179.643 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 60' ' ' PRO . . . . . 0.532 ' HD2' ' N ' ' A' ' 59' ' ' SER . 49.0 Cg_endo -69.25 -33.04 19.43 Favored 'Trans proline' 0 C--O 1.214 -0.711 0 C-N-CA 122.643 2.229 . . . . 0.0 112.28 -179.597 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 61' ' ' PHE . . . . . 0.584 ' CD2' ' HA ' ' A' ' 89' ' ' ALA . 51.0 m-85 -61.64 -33.18 73.49 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.202 -0.936 . . . . 0.0 109.612 -179.874 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 176.65 -173.49 46.33 Favored Glycine 0 N--CA 1.489 2.213 0 N-CA-C 109.533 -1.427 . . . . 0.0 109.533 179.967 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 85.6 m-20 -95.7 147.42 23.62 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.248 -1.149 . . . . 0.0 109.383 -179.957 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 64' ' ' ILE . . . . . 0.436 ' HA ' ' O ' ' A' ' 79' ' ' THR . 53.6 mt -111.14 124.95 68.4 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.522 0 O-C-N 121.205 -0.934 . . . . 0.0 109.525 -179.963 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 31.1 pt -93.8 -26.79 4.53 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.573 0 O-C-N 121.342 -0.849 . . . . 0.0 109.382 179.926 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 66' ' ' ASP . . . . . 0.425 ' HB3' ' OG1' ' A' ' 79' ' ' THR . 58.2 t0 -140.43 130.36 24.65 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.214 -0.929 . . . . 0.0 109.511 179.937 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 67' ' ' LEU . . . . . 0.761 HD22 ' HE ' ' A' ' 55' ' ' ARG . 7.1 tp -121.46 120.4 34.82 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.239 -0.913 . . . . 0.0 109.438 179.923 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 68' ' ' SER . . . . . 0.458 ' HB3' ' HB2' ' A' ' 77' ' ' PHE . 43.3 t -128.87 140.66 51.59 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.242 -0.911 . . . . 0.0 109.479 -179.985 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 69' ' ' MET . . . . . . . . . . . . . 86.7 mtp -123.93 149.61 45.71 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.313 -0.867 . . . . 0.0 109.44 -179.993 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 70' ' ' ASP . . . . . 0.48 ' C ' ' HD2' ' A' ' 72' ' ' PRO . 0.7 OUTLIER -127.81 101.56 23.29 Favored Pre-proline 0 N--CA 1.49 1.555 0 O-C-N 121.251 -0.905 . . . . 0.0 109.433 179.964 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 71' ' ' PRO . . . . . 0.599 ' N ' ' CD ' ' A' ' 72' ' ' PRO . 47.3 Cg_endo -74.75 -27.81 10.2 Favored 'Trans proline' 0 CA--C 1.543 0.932 0 C-N-CA 122.527 2.151 . . . . 0.0 113.69 179.998 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 72' ' ' PRO . . . . . 0.599 ' CD ' ' N ' ' A' ' 71' ' ' PRO . 55.2 Cg_endo -75.41 -23.81 12.8 Favored 'Trans proline' 0 C--N 1.353 0.793 0 C-N-CA 121.496 1.464 . . . . 0.0 111.869 -179.83 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 73' ' ' ARG . . . . . 0.436 ' HB2' ' SG ' ' A' ' 75' ' ' CYS . 75.0 mtt85 -111.91 -1.11 15.59 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.197 -0.939 . . . . 0.0 109.666 -179.879 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 74' ' ' ASN . . . . . 0.474 ' HB3' ' O ' ' A' ' 46' ' ' GLY . 61.1 m-20 60.78 44.21 11.29 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.133 -0.98 . . . . 0.0 109.519 179.985 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 75' ' ' CYS . . . . . 0.475 ' O ' ' HB2' ' A' ' 70' ' ' ASP . 24.4 p -144.79 140.74 28.67 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.211 -0.931 . . . . 0.0 109.541 -179.921 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -113.67 161.38 17.54 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.222 -0.924 . . . . 0.0 109.36 -180.0 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 77' ' ' PHE . . . . . 0.458 ' HB2' ' HB3' ' A' ' 68' ' ' SER . 96.9 m-85 -125.37 137.35 54.03 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.215 -0.928 . . . . 0.0 109.497 -179.9 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 78' ' ' VAL . . . . . 0.914 ' O ' HD12 ' A' ' 42' ' ' LEU . 25.3 t -130.55 139.78 50.44 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.611 0 O-C-N 121.391 -0.818 . . . . 0.0 109.362 179.849 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 79' ' ' THR . . . . . 0.476 ' HA ' ' O ' ' A' ' 40' ' ' ASN . 2.0 m -110.61 121.28 44.93 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.213 -0.929 . . . . 0.0 109.431 179.936 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 80' ' ' TYR . . . . . 0.571 ' HH ' ' HD1' ' A' ' 58' ' ' PHE . 1.5 m-85 -99.41 138.41 36.54 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.251 -0.906 . . . . 0.0 109.613 -179.925 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 81.6 tt0 -48.69 -25.79 1.97 Allowed 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.327 -0.858 . . . . 0.0 109.787 179.997 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 48.1 mttp -143.48 159.46 42.36 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.142 -0.974 . . . . 0.0 109.591 -179.938 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 83' ' ' MET . . . . . 0.421 ' HG2' ' CG ' ' A' ' 40' ' ' ASN . 61.8 mtt -72.83 -19.37 61.33 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.292 -0.88 . . . . 0.0 109.357 179.971 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 96.5 mt-10 -68.06 -51.4 47.11 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.277 -0.889 . . . . 0.0 109.513 179.904 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 7.4 m -56.35 -32.46 64.73 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.277 -0.89 . . . . 0.0 109.37 179.863 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 86' ' ' ALA . . . . . 0.596 ' HB1' HD21 ' A' ' 42' ' ' LEU . . . -74.12 -27.54 60.91 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.236 -0.915 . . . . 0.0 109.364 -179.999 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 22.1 t70 -69.31 -43.29 74.07 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.224 -0.922 . . . . 0.0 109.457 -179.933 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 88' ' ' GLN . . . . . 0.453 ' O ' ' HB2' ' A' ' 92' ' ' GLU . 61.4 tt0 -69.48 -36.75 76.84 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.289 -0.882 . . . . 0.0 109.416 -179.95 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 89' ' ' ALA . . . . . 0.781 ' HB1' ' CD1' ' A' ' 93' ' ' LEU . . . -74.02 -44.38 54.67 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.221 -0.924 . . . . 0.0 109.446 179.958 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 90' ' ' VAL . . . . . 0.787 HG22 HG12 ' A' ' 105' ' ' VAL . 84.1 t -67.22 -38.19 80.56 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.549 0 O-C-N 121.337 -0.852 . . . . 0.0 109.603 179.984 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -80.06 -29.12 39.15 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.269 -0.894 . . . . 0.0 109.906 -179.681 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 92' ' ' GLU . . . . . 0.566 ' HB3' ' CE2' ' A' ' 61' ' ' PHE . 23.0 tt0 -91.9 -45.59 8.28 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.158 -0.963 . . . . 0.0 109.677 -179.749 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 93' ' ' LEU . . . . . 0.781 ' CD1' ' HB1' ' A' ' 89' ' ' ALA . 21.3 mt -69.35 -43.14 74.21 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.207 -0.933 . . . . 0.0 109.587 -179.925 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 94' ' ' ASN . . . . . 0.515 ' CB ' ' O ' ' A' ' 90' ' ' VAL . 43.8 t30 -63.74 127.11 29.9 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.205 -0.934 . . . . 0.0 109.54 179.988 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 98.79 16.3 31.47 Favored Glycine 0 N--CA 1.49 2.268 0 N-CA-C 109.455 -1.458 . . . . 0.0 109.455 179.985 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 96' ' ' THR . . . . . 0.552 HG23 ' O ' ' A' ' 93' ' ' LEU . 18.1 p -116.54 157.42 25.28 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.183 -1.187 . . . . 0.0 109.383 -179.966 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 59.6 tt0 -117.99 139.55 51.01 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.194 -0.941 . . . . 0.0 109.478 -179.944 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 98' ' ' VAL . . . . . 0.784 HG22 HD11 ' A' ' 103' ' ' LEU . 1.2 t -83.83 -149.49 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 121.202 -0.936 . . . . 0.0 109.374 -179.966 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 99' ' ' GLU . . . . . 0.504 ' H ' HG12 ' A' ' 98' ' ' VAL . 76.5 mm-40 -60.38 -41.62 94.16 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.226 -0.921 . . . . 0.0 109.501 179.97 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 21.1 t -158.51 31.55 0.23 Allowed 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.293 -0.88 . . . . 0.0 109.426 179.952 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 101' ' ' VAL . . . . . 0.542 ' O ' HG23 ' A' ' 98' ' ' VAL . 58.9 t -147.03 147.86 17.23 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 O-C-N 121.227 -0.921 . . . . 0.0 109.464 179.995 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 91.7 mt-30 -86.43 145.73 26.72 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.253 -0.904 . . . . 0.0 109.574 -179.941 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 103' ' ' LEU . . . . . 0.784 HD11 HG22 ' A' ' 98' ' ' VAL . 96.0 mt -109.56 136.13 49.44 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.313 -0.867 . . . . 0.0 109.467 179.948 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 104' ' ' LYS . . . . . 0.468 ' HB2' ' HB3' ' A' ' 45' ' ' TYR . 57.3 mttm -122.09 133.55 54.77 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.242 -0.912 . . . . 0.0 109.48 -179.938 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 105' ' ' VAL . . . . . 0.787 HG12 HG22 ' A' ' 90' ' ' VAL . 7.0 t . . . . . 0 N--CA 1.49 1.527 0 O-C-N 121.241 -0.912 . . . . 0.0 109.602 -179.994 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 40' ' ' ASN . . . . . 0.477 ' O ' ' HA ' ' A' ' 79' ' ' THR . 60.1 t-20 . . . . . 0 N--CA 1.49 1.533 0 N-CA-C 109.134 -0.691 . . . . 0.0 109.134 . . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 41' ' ' THR . . . . . 0.466 ' HA ' ' O ' ' A' ' 78' ' ' VAL . 92.6 m -81.96 140.57 33.93 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.241 -0.912 . . . . 0.0 109.956 -179.568 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 42' ' ' LEU . . . . . 0.889 HD23 ' CG2' ' A' ' 90' ' ' VAL . 5.4 mp -118.05 142.62 47.2 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.375 -0.828 . . . . 0.0 109.077 179.391 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 59.7 t80 -99.76 109.91 22.32 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.322 -0.861 . . . . 0.0 109.611 -179.851 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 44' ' ' VAL . . . . . 0.475 ' HA ' ' O ' ' A' ' 104' ' ' LYS . 96.4 t -107.4 143.27 18.27 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.555 0 O-C-N 121.249 -0.907 . . . . 0.0 109.345 179.913 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 74.2 t80 -132.51 135.47 46.01 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.174 -0.954 . . . . 0.0 109.497 -179.891 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 177.9 -175.13 47.35 Favored Glycine 0 N--CA 1.489 2.222 0 N-CA-C 109.554 -1.418 . . . . 0.0 109.554 179.931 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 47' ' ' GLU . . . . . 0.429 ' O ' ' C ' ' A' ' 48' ' ' ASP . 94.0 mt-10 -114.9 158.51 21.88 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.254 -1.144 . . . . 0.0 109.432 -179.967 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 48' ' ' ASP . . . . . 0.429 ' C ' ' O ' ' A' ' 47' ' ' GLU . 48.8 m-20 44.07 50.44 7.35 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.302 -0.874 . . . . 0.0 109.444 -179.954 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 54.0 mtm -100.38 135.58 41.59 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.192 -0.943 . . . . 0.0 109.523 179.981 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -122.65 166.04 19.14 Favored Pre-proline 0 N--CA 1.49 1.558 0 O-C-N 121.266 -0.896 . . . . 0.0 109.41 179.946 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 51' ' ' PRO . . . . . 0.664 ' HA ' HD12 ' A' ' 54' ' ' LEU . 49.7 Cg_endo -70.24 -51.67 0.33 Allowed 'Trans proline' 0 C--O 1.214 -0.685 0 C-N-CA 122.671 2.247 . . . . 0.0 111.755 179.969 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 62.8 m -49.36 -48.65 46.54 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.217 -0.927 . . . . 0.0 109.288 179.96 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 18.0 tp -59.6 -47.82 84.06 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.175 -0.953 . . . . 0.0 109.228 179.901 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 54' ' ' LEU . . . . . 0.664 HD12 ' HA ' ' A' ' 51' ' ' PRO . 12.8 mt -56.08 -45.61 79.29 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.26 -0.9 . . . . 0.0 109.337 179.835 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 55' ' ' ARG . . . . . 0.509 ' O ' ' N ' ' A' ' 59' ' ' SER . 15.3 mtp-105 -51.73 -42.21 62.12 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.355 -0.841 . . . . 0.0 109.286 179.863 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -70.78 -29.11 69.77 Favored Glycine 0 N--CA 1.489 2.232 0 N-CA-C 109.308 -1.517 . . . . 0.0 109.308 179.891 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 57' ' ' ALA . . . . . 0.461 ' O ' ' CD1' ' A' ' 61' ' ' PHE . . . -79.57 -22.8 43.32 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.267 -1.137 . . . . 0.0 109.432 179.966 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 58' ' ' PHE . . . . . 0.698 ' HB2' HD11 ' A' ' 64' ' ' ILE . 96.3 m-85 -119.51 7.59 11.17 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.245 -0.909 . . . . 0.0 109.473 179.926 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 59' ' ' SER . . . . . 0.541 ' N ' ' HD2' ' A' ' 60' ' ' PRO . 0.6 OUTLIER -72.7 -57.07 3.41 Favored Pre-proline 0 N--CA 1.49 1.537 0 O-C-N 121.261 -0.899 . . . . 0.0 109.837 -179.888 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 60' ' ' PRO . . . . . 0.541 ' HD2' ' N ' ' A' ' 59' ' ' SER . 49.7 Cg_endo -69.57 -30.46 23.12 Favored 'Trans proline' 0 C--O 1.215 -0.664 0 C-N-CA 122.648 2.232 . . . . 0.0 111.954 -179.822 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 61' ' ' PHE . . . . . 0.679 ' CE1' HD21 ' A' ' 93' ' ' LEU . 58.6 m-85 -64.22 -34.38 77.97 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.231 -0.918 . . . . 0.0 109.27 179.965 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 173.62 -173.41 45.79 Favored Glycine 0 N--CA 1.49 2.235 0 N-CA-C 109.4 -1.48 . . . . 0.0 109.4 179.98 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 56.1 t30 -95.57 139.34 31.97 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.235 -1.156 . . . . 0.0 109.566 179.947 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 64' ' ' ILE . . . . . 0.698 HD11 ' HB2' ' A' ' 58' ' ' PHE . 58.2 mt -101.87 135.03 40.58 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 O-C-N 121.228 -0.92 . . . . 0.0 109.351 179.966 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 24.6 pt -97.72 -23.1 4.72 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.527 0 O-C-N 121.313 -0.867 . . . . 0.0 109.645 -179.963 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 53.2 t0 -149.05 126.87 11.81 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.227 -0.92 . . . . 0.0 109.552 179.981 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 16.2 tp -112.26 117.05 31.45 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.241 -0.912 . . . . 0.0 109.466 179.949 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 68' ' ' SER . . . . . 0.488 ' HB2' ' HB2' ' A' ' 77' ' ' PHE . 68.0 m -123.35 145.61 48.6 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.191 -0.943 . . . . 0.0 109.476 -179.916 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 69' ' ' MET . . . . . 0.477 ' HA ' ' HA ' ' A' ' 76' ' ' ALA . 75.1 mtp -131.53 149.61 52.45 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.209 -0.932 . . . . 0.0 109.556 -179.966 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 70' ' ' ASP . . . . . 0.483 ' C ' ' HD2' ' A' ' 72' ' ' PRO . 2.6 t0 -123.36 104.76 34.28 Favored Pre-proline 0 N--CA 1.49 1.547 0 O-C-N 121.181 -0.949 . . . . 0.0 109.484 179.924 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 71' ' ' PRO . . . . . 0.6 ' N ' ' CD ' ' A' ' 72' ' ' PRO . 46.6 Cg_endo -74.87 -27.73 10.03 Favored 'Trans proline' 0 CA--C 1.543 0.952 0 C-N-CA 122.585 2.19 . . . . 0.0 113.608 -179.944 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 72' ' ' PRO . . . . . 0.6 ' CD ' ' N ' ' A' ' 71' ' ' PRO . 54.6 Cg_endo -75.14 -33.27 4.57 Favored 'Trans proline' 0 C--N 1.354 0.839 0 C-N-CA 121.437 1.425 . . . . 0.0 111.862 -179.82 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 73' ' ' ARG . . . . . 0.443 ' HG2' ' O ' ' A' ' 73' ' ' ARG . 67.5 ttt180 -103.62 -2.17 27.05 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.222 -0.924 . . . . 0.0 109.663 -179.927 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 74' ' ' ASN . . . . . 0.426 ' HB2' ' O ' ' A' ' 73' ' ' ARG . 79.9 m-20 61.88 40.38 12.66 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.177 -0.952 . . . . 0.0 109.505 -179.996 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 75' ' ' CYS . . . . . . . . . . . . . 24.7 p -136.03 137.43 41.16 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.286 -0.884 . . . . 0.0 109.434 -179.943 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 76' ' ' ALA . . . . . 0.477 ' HA ' ' HA ' ' A' ' 69' ' ' MET . . . -107.61 157.21 18.25 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.317 -0.864 . . . . 0.0 109.49 179.965 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 77' ' ' PHE . . . . . 0.488 ' HA ' ' O ' ' A' ' 42' ' ' LEU . 97.5 m-85 -123.45 131.19 53.57 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.282 -0.886 . . . . 0.0 109.583 -179.959 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 78' ' ' VAL . . . . . 0.794 ' O ' HD12 ' A' ' 42' ' ' LEU . 45.5 t -120.4 134.5 63.67 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 O-C-N 121.261 -0.899 . . . . 0.0 109.7 -179.954 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 79' ' ' THR . . . . . 0.477 ' HA ' ' O ' ' A' ' 40' ' ' ASN . 9.1 m -103.48 129.3 50.61 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.256 -0.902 . . . . 0.0 109.471 179.927 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 80' ' ' TYR . . . . . 0.588 ' CG ' ' HB2' ' A' ' 85' ' ' SER . 0.7 OUTLIER -112.07 137.12 50.55 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.192 -0.942 . . . . 0.0 109.542 -179.898 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 84.4 tt0 -57.67 -27.56 62.99 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.26 -0.9 . . . . 0.0 109.48 179.98 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 24.8 mttp -132.59 146.62 52.04 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.174 -0.954 . . . . 0.0 109.426 -179.955 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 83' ' ' MET . . . . . . . . . . . . . 35.6 mtt -64.73 -20.32 66.28 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.254 -0.904 . . . . 0.0 109.378 179.986 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 98.6 mt-10 -68.26 -37.06 80.35 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.317 -0.865 . . . . 0.0 109.439 179.993 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 85' ' ' SER . . . . . 0.588 ' HB2' ' CG ' ' A' ' 80' ' ' TYR . 18.7 m -61.45 -34.34 75.26 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.276 -0.89 . . . . 0.0 109.455 179.952 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 86' ' ' ALA . . . . . 0.646 ' CB ' HD21 ' A' ' 42' ' ' LEU . . . -76.26 -30.5 57.87 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.326 -0.859 . . . . 0.0 109.437 -179.995 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 54.2 t0 -63.71 -49.52 72.77 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.218 -0.926 . . . . 0.0 109.496 179.93 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 88' ' ' GLN . . . . . 0.467 ' O ' ' HB2' ' A' ' 92' ' ' GLU . 59.0 tt0 -66.72 -38.74 87.31 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.267 -0.896 . . . . 0.0 109.462 -179.988 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 89' ' ' ALA . . . . . 0.547 ' HA ' ' CE2' ' A' ' 61' ' ' PHE . . . -74.1 -49.67 22.89 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.319 -0.863 . . . . 0.0 109.624 -179.979 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 90' ' ' VAL . . . . . 0.889 ' CG2' HD23 ' A' ' 42' ' ' LEU . 69.8 t -63.22 -37.0 78.28 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.551 0 O-C-N 121.203 -0.935 . . . . 0.0 109.61 -179.846 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -80.16 -37.83 32.6 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.212 -0.93 . . . . 0.0 109.722 -179.775 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 92' ' ' GLU . . . . . 0.547 ' HB3' ' CE2' ' A' ' 61' ' ' PHE . 24.6 tt0 -83.53 -48.78 9.91 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.171 -0.956 . . . . 0.0 109.803 -179.654 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 93' ' ' LEU . . . . . 0.838 ' HB2' HG21 ' A' ' 105' ' ' VAL . 35.0 mt -64.15 -40.47 96.21 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.187 -0.946 . . . . 0.0 109.683 -179.753 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 94' ' ' ASN . . . . . 0.52 ' CB ' ' O ' ' A' ' 90' ' ' VAL . 56.4 t-20 -63.54 124.31 21.03 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.179 -0.951 . . . . 0.0 109.621 -179.998 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 92.05 29.84 11.02 Favored Glycine 0 N--CA 1.49 2.26 0 N-CA-C 109.502 -1.439 . . . . 0.0 109.502 179.973 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 96' ' ' THR . . . . . 0.637 HG23 ' O ' ' A' ' 93' ' ' LEU . 26.1 p -121.41 158.39 28.43 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.287 -1.125 . . . . 0.0 109.5 179.945 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 63.7 tt0 -122.67 148.93 44.71 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.236 -0.915 . . . . 0.0 109.509 -179.99 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 98' ' ' VAL . . . . . 0.495 HG12 ' H ' ' A' ' 99' ' ' GLU . 1.3 t -100.29 -148.72 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.574 0 O-C-N 121.229 -0.919 . . . . 0.0 109.373 179.971 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 99' ' ' GLU . . . . . 0.495 ' H ' HG12 ' A' ' 98' ' ' VAL . 96.4 mt-10 -61.24 -40.6 94.65 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.25 -0.906 . . . . 0.0 109.459 179.99 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 32.0 t -159.36 31.56 0.2 Allowed 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.354 -0.841 . . . . 0.0 109.487 -179.942 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 101' ' ' VAL . . . . . 0.481 ' O ' HG23 ' A' ' 98' ' ' VAL . 48.6 t -148.75 154.73 9.57 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.603 0 O-C-N 121.301 -0.874 . . . . 0.0 109.365 -179.987 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 88.8 mt-30 -100.99 138.7 37.69 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.294 -0.879 . . . . 0.0 109.455 179.855 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 94.6 mt -106.56 136.95 45.44 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.159 -0.963 . . . . 0.0 109.57 -179.956 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 104' ' ' LYS . . . . . 0.475 ' O ' ' HA ' ' A' ' 44' ' ' VAL . 30.1 mttp -118.87 144.5 46.35 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.346 -0.846 . . . . 0.0 109.296 179.747 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 105' ' ' VAL . . . . . 0.838 HG21 ' HB2' ' A' ' 93' ' ' LEU . 17.4 t . . . . . 0 N--CA 1.491 1.585 0 O-C-N 121.231 -0.918 . . . . 0.0 109.661 -179.837 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 40' ' ' ASN . . . . . 0.484 ' O ' ' HA ' ' A' ' 79' ' ' THR . 45.8 t30 . . . . . 0 N--CA 1.493 1.698 0 CA-C-O 121.281 0.562 . . . . 0.0 109.718 . . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 41' ' ' THR . . . . . 0.522 ' CG2' ' HB3' ' A' ' 77' ' ' PHE . 24.8 m -77.95 135.33 37.81 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.28 -0.887 . . . . 0.0 109.557 179.899 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 42' ' ' LEU . . . . . 0.902 HD11 ' CD2' ' A' ' 80' ' ' TYR . 12.7 mt -112.2 144.9 40.84 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.147 -0.971 . . . . 0.0 109.67 179.993 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 43' ' ' TYR . . . . . 0.487 ' CD2' ' CE1' ' A' ' 77' ' ' PHE . 60.2 t80 -94.9 116.9 29.29 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.428 -0.795 . . . . 0.0 109.359 179.676 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 44' ' ' VAL . . . . . 0.487 ' O ' ' HA ' ' A' ' 75' ' ' CYS . 44.5 t -116.52 135.33 57.14 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.494 0 O-C-N 121.216 -0.927 . . . . 0.0 109.239 179.847 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 45' ' ' TYR . . . . . 0.488 ' HB3' ' HB2' ' A' ' 104' ' ' LYS . 69.1 t80 -123.53 143.53 50.13 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.257 -0.902 . . . . 0.0 109.639 -179.804 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 164.64 174.12 34.03 Favored Glycine 0 N--CA 1.491 2.327 0 N-CA-C 109.444 -1.462 . . . . 0.0 109.444 -179.994 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 95.6 mt-10 -107.98 161.89 14.53 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.293 -1.122 . . . . 0.0 109.419 -179.997 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 21.5 m-20 44.41 58.17 3.96 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.249 -0.907 . . . . 0.0 109.4 179.96 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 43.2 mtm -111.29 136.76 49.92 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.317 -0.865 . . . . 0.0 109.432 179.954 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 50' ' ' THR . . . . . 0.584 ' O ' HD12 ' A' ' 54' ' ' LEU . 0.2 OUTLIER -123.72 166.5 18.54 Favored Pre-proline 0 N--CA 1.492 1.631 0 O-C-N 121.359 -0.838 . . . . 0.0 109.26 179.901 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 51' ' ' PRO . . . . . 0.443 ' HD3' ' SD ' ' A' ' 69' ' ' MET . 50.0 Cg_endo -71.4 -55.39 0.13 Allowed 'Trans proline' 0 C--O 1.214 -0.69 0 C-N-CA 122.495 2.13 . . . . 0.0 111.845 -179.962 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 21.3 m -48.84 -50.38 34.86 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.252 -0.905 . . . . 0.0 109.263 179.783 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 17.6 tp -58.89 -51.04 71.71 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.221 -0.924 . . . . 0.0 109.141 179.777 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 54' ' ' LEU . . . . . 0.584 HD12 ' O ' ' A' ' 50' ' ' THR . 14.1 mt -55.59 -49.92 71.48 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.343 -0.848 . . . . 0.0 109.16 179.744 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 55' ' ' ARG . . . . . 0.518 ' O ' ' N ' ' A' ' 59' ' ' SER . 73.0 mtp180 -47.16 -38.13 11.26 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.321 -0.862 . . . . 0.0 109.282 179.741 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -71.29 -31.65 65.94 Favored Glycine 0 N--CA 1.489 2.206 0 N-CA-C 109.369 -1.492 . . . . 0.0 109.369 179.844 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -76.56 -24.52 53.57 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.188 -1.184 . . . . 0.0 109.372 179.808 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 58' ' ' PHE . . . . . 0.762 ' HB2' HD11 ' A' ' 64' ' ' ILE . 91.7 m-85 -116.82 7.57 13.39 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.356 -0.84 . . . . 0.0 109.408 179.92 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 59' ' ' SER . . . . . 0.553 ' N ' ' HD2' ' A' ' 60' ' ' PRO . 0.6 OUTLIER -74.04 -55.68 3.0 Favored Pre-proline 0 N--CA 1.491 1.584 0 O-C-N 121.291 -0.881 . . . . 0.0 110.317 -179.622 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 60' ' ' PRO . . . . . 0.553 ' HD2' ' N ' ' A' ' 59' ' ' SER . 46.6 Cg_endo -68.19 -31.02 30.29 Favored 'Trans proline' 0 C--O 1.215 -0.656 0 C-N-CA 122.521 2.148 . . . . 0.0 112.215 -179.367 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 61' ' ' PHE . . . . . 0.571 ' CD1' ' HA ' ' A' ' 89' ' ' ALA . 70.1 m-85 -65.69 -30.4 71.08 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.116 -0.99 . . . . 0.0 109.491 -179.969 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 62' ' ' GLY . . . . . 0.464 ' HA3' ' OG ' ' A' ' 85' ' ' SER . . . 175.61 -165.76 36.74 Favored Glycine 0 N--CA 1.49 2.297 0 N-CA-C 109.421 -1.472 . . . . 0.0 109.421 179.956 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 85.4 m-20 -103.87 134.47 47.11 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.29 -1.124 . . . . 0.0 109.499 179.961 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 64' ' ' ILE . . . . . 0.762 HD11 ' HB2' ' A' ' 58' ' ' PHE . 76.1 mt -95.78 140.35 17.24 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.575 0 O-C-N 121.297 -0.877 . . . . 0.0 109.565 -179.951 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 65' ' ' ILE . . . . . 0.734 HD11 HG21 ' A' ' 79' ' ' THR . 26.2 pt -100.84 -24.49 4.07 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 O-C-N 121.302 -0.873 . . . . 0.0 109.452 179.922 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 40.2 t0 -149.35 140.79 23.31 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.251 -0.906 . . . . 0.0 109.573 -179.863 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 67' ' ' LEU . . . . . 0.7 ' C ' HD13 ' A' ' 67' ' ' LEU . 2.2 tm? -118.76 104.93 11.05 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.283 -0.886 . . . . 0.0 109.136 179.785 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 68' ' ' SER . . . . . 0.487 ' HB3' ' HB2' ' A' ' 77' ' ' PHE . 46.5 t -108.65 141.07 41.15 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.226 -0.921 . . . . 0.0 109.55 -179.891 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 69' ' ' MET . . . . . 0.495 ' HA ' ' HA ' ' A' ' 76' ' ' ALA . 63.2 mtp -133.63 141.62 47.72 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.3 -0.875 . . . . 0.0 109.504 -179.986 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 70' ' ' ASP . . . . . 0.474 ' C ' ' HD2' ' A' ' 72' ' ' PRO . 0.9 OUTLIER -124.51 107.16 29.61 Favored Pre-proline 0 N--CA 1.49 1.562 0 O-C-N 121.332 -0.855 . . . . 0.0 109.378 -179.971 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 71' ' ' PRO . . . . . 0.601 ' N ' ' CD ' ' A' ' 72' ' ' PRO . 47.1 Cg_endo -74.91 -27.85 9.85 Favored 'Trans proline' 0 CA--C 1.542 0.883 0 C-N-CA 122.495 2.13 . . . . 0.0 113.747 -179.908 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 72' ' ' PRO . . . . . 0.601 ' CD ' ' N ' ' A' ' 71' ' ' PRO . 54.4 Cg_endo -74.84 -25.66 12.0 Favored 'Trans proline' 0 C--N 1.353 0.772 0 C-N-CA 121.446 1.431 . . . . 0.0 111.745 -179.771 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 75.3 mtp180 -110.46 0.9 17.98 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.273 -0.892 . . . . 0.0 109.62 -179.833 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 66.2 m-20 56.39 48.56 16.72 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.153 -0.967 . . . . 0.0 109.512 179.943 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 75' ' ' CYS . . . . . 0.487 ' HA ' ' O ' ' A' ' 44' ' ' VAL . 26.6 p -148.18 135.73 20.67 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.186 -0.946 . . . . 0.0 109.46 -179.973 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 76' ' ' ALA . . . . . 0.495 ' HA ' ' HA ' ' A' ' 69' ' ' MET . . . -110.37 133.67 53.04 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.159 -0.963 . . . . 0.0 109.74 -179.994 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 77' ' ' PHE . . . . . 0.522 ' HB3' ' CG2' ' A' ' 41' ' ' THR . 12.0 m-30 -103.79 108.39 19.68 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.335 -0.853 . . . . 0.0 109.33 179.935 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 78' ' ' VAL . . . . . 0.494 ' O ' ' N ' ' A' ' 42' ' ' LEU . 1.8 p -105.76 141.28 21.44 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.405 0 O-C-N 121.144 -0.973 . . . . 0.0 109.401 179.979 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 79' ' ' THR . . . . . 0.734 HG21 HD11 ' A' ' 65' ' ' ILE . 11.5 m -97.47 155.42 16.94 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.138 -0.976 . . . . 0.0 109.874 -179.692 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 80' ' ' TYR . . . . . 0.902 ' CD2' HD11 ' A' ' 42' ' ' LEU . 0.1 OUTLIER -130.51 129.26 42.65 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.329 -0.857 . . . . 0.0 109.546 179.955 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 81' ' ' GLU . . . . . 0.4 ' C ' ' O ' ' A' ' 80' ' ' TYR . 69.3 tt0 -44.25 -34.5 1.92 Allowed 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.205 -0.934 . . . . 0.0 109.489 179.88 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 33.5 mttm -141.43 152.18 44.05 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.119 -0.988 . . . . 0.0 109.596 -179.774 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 83' ' ' MET . . . . . . . . . . . . . 45.8 mtt -63.89 -26.72 68.73 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.352 -0.843 . . . . 0.0 109.415 179.973 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 96.4 mt-10 -56.27 -49.09 75.21 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.292 -0.88 . . . . 0.0 109.475 -179.976 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 85' ' ' SER . . . . . 0.555 ' OG ' ' CE1' ' A' ' 80' ' ' TYR . 41.5 t -61.04 -32.05 71.68 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.213 -0.929 . . . . 0.0 109.381 179.864 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 86' ' ' ALA . . . . . 0.684 ' O ' HG23 ' A' ' 90' ' ' VAL . . . -76.04 -33.42 59.62 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.308 -0.87 . . . . 0.0 109.774 -179.757 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 22.3 t70 -70.13 -43.77 70.28 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.145 -0.972 . . . . 0.0 109.725 -179.732 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 62.6 tt0 -71.14 -39.08 72.19 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.265 -0.897 . . . . 0.0 109.877 -179.717 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 89' ' ' ALA . . . . . 0.704 ' HB1' ' CD1' ' A' ' 93' ' ' LEU . . . -73.72 -43.38 59.35 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.154 -0.966 . . . . 0.0 109.741 -179.745 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 90' ' ' VAL . . . . . 0.753 HG22 HG11 ' A' ' 105' ' ' VAL . 74.3 t -61.26 -31.88 51.49 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.598 0 O-C-N 121.195 -0.941 . . . . 0.0 109.667 -179.778 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -78.96 -53.32 7.17 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.272 -0.892 . . . . 0.0 109.732 -179.857 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 92' ' ' GLU . . . . . 0.527 ' HB2' ' CE1' ' A' ' 61' ' ' PHE . 75.2 mm-40 -69.53 -41.45 75.97 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.224 -0.922 . . . . 0.0 109.928 -179.632 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 93' ' ' LEU . . . . . 0.704 ' CD1' ' HB1' ' A' ' 89' ' ' ALA . 81.2 mt -69.55 -40.55 76.76 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.074 -1.016 . . . . 0.0 109.642 -179.806 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 94' ' ' ASN . . . . . 0.527 ' CB ' ' O ' ' A' ' 90' ' ' VAL . 59.1 t30 -71.47 126.41 29.59 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.201 -0.937 . . . . 0.0 109.497 -179.945 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 99.09 20.0 19.7 Favored Glycine 0 N--CA 1.489 2.182 0 N-CA-C 109.515 -1.434 . . . . 0.0 109.515 179.94 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 96' ' ' THR . . . . . 0.409 ' CG2' ' O ' ' A' ' 92' ' ' GLU . 20.5 p -121.92 159.94 25.84 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.301 -1.117 . . . . 0.0 109.504 179.964 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 63.9 tt0 -125.35 149.08 48.45 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.334 -0.854 . . . . 0.0 109.453 -179.969 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 98' ' ' VAL . . . . . 0.627 ' HB ' HG12 ' A' ' 101' ' ' VAL . 1.4 t -93.78 -148.68 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 O-C-N 121.206 -0.934 . . . . 0.0 109.35 -179.982 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 99' ' ' GLU . . . . . 0.497 ' H ' HG12 ' A' ' 98' ' ' VAL . 95.9 mt-10 -56.69 -44.64 81.7 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.164 -0.96 . . . . 0.0 109.449 -179.977 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 3.5 p -157.2 21.21 0.3 Allowed 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.282 -0.886 . . . . 0.0 109.449 179.974 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 101' ' ' VAL . . . . . 0.627 HG12 ' HB ' ' A' ' 98' ' ' VAL . 8.7 p -129.03 139.5 51.73 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.524 0 O-C-N 121.231 -0.918 . . . . 0.0 109.519 -179.943 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 95.3 mt-30 -87.1 136.51 32.9 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.2 -0.937 . . . . 0.0 109.387 179.959 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 103' ' ' LEU . . . . . 0.57 HD11 HG22 ' A' ' 98' ' ' VAL . 97.8 mt -100.87 144.26 30.04 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.23 -0.919 . . . . 0.0 109.667 -179.934 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 104' ' ' LYS . . . . . 0.488 ' HB2' ' HB3' ' A' ' 45' ' ' TYR . 45.1 mttt -134.66 142.09 46.76 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.263 -0.898 . . . . 0.0 109.252 179.869 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 105' ' ' VAL . . . . . 0.753 HG11 HG22 ' A' ' 90' ' ' VAL . 25.5 t . . . . . 0 N--CA 1.491 1.59 0 O-C-N 121.225 -0.922 . . . . 0.0 109.686 -179.932 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 40' ' ' ASN . . . . . 0.468 ' O ' ' HA ' ' A' ' 79' ' ' THR . 49.6 t-20 . . . . . 0 N--CA 1.491 1.597 0 N-CA-C 109.535 -0.543 . . . . 0.0 109.535 . . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 41' ' ' THR . . . . . 0.613 ' O ' HD23 ' A' ' 42' ' ' LEU . 35.8 m -80.75 138.86 36.32 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.25 -0.906 . . . . 0.0 109.499 -179.997 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 42' ' ' LEU . . . . . 0.94 HD11 ' CD2' ' A' ' 80' ' ' TYR . 9.9 mt -120.13 151.05 39.64 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.211 -0.931 . . . . 0.0 109.626 179.941 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 43' ' ' TYR . . . . . 0.475 ' CZ ' ' HB2' ' A' ' 75' ' ' CYS . 69.0 t80 -106.29 124.92 50.33 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.236 -0.915 . . . . 0.0 109.341 179.867 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 44' ' ' VAL . . . . . 0.459 ' O ' ' HA ' ' A' ' 75' ' ' CYS . 80.2 t -122.14 137.73 54.73 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.534 0 O-C-N 121.22 -0.925 . . . . 0.0 109.467 -179.941 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 45' ' ' TYR . . . . . 0.472 ' HB3' ' HB2' ' A' ' 104' ' ' LYS . 71.0 t80 -121.07 133.58 55.24 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.276 -0.89 . . . . 0.0 109.423 179.909 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -175.73 -175.37 43.08 Favored Glycine 0 N--CA 1.49 2.277 0 N-CA-C 109.482 -1.447 . . . . 0.0 109.482 -179.974 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 94.0 mt-10 -121.41 146.53 46.79 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.212 -1.17 . . . . 0.0 109.45 179.983 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 58.4 t0 47.79 52.97 12.03 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.277 -0.889 . . . . 0.0 109.481 -179.952 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 67.5 mtm -95.7 138.09 33.85 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.27 -0.894 . . . . 0.0 109.454 -179.929 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 50' ' ' THR . . . . . 0.814 HG22 ' HD2' ' A' ' 51' ' ' PRO . 0.0 OUTLIER -110.8 161.5 24.57 Favored Pre-proline 0 N--CA 1.49 1.543 0 O-C-N 121.23 -0.919 . . . . 0.0 109.48 179.979 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 51' ' ' PRO . . . . . 0.814 ' HD2' HG22 ' A' ' 50' ' ' THR . 49.4 Cg_endo -70.12 -52.5 0.3 Allowed 'Trans proline' 0 C--O 1.215 -0.648 0 C-N-CA 122.743 2.295 . . . . 0.0 111.674 -179.959 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 37.1 m -56.27 -44.49 79.81 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.322 -0.861 . . . . 0.0 109.383 179.995 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 53' ' ' LEU . . . . . 0.765 ' O ' HD13 ' A' ' 53' ' ' LEU . 3.1 tm? -60.45 -46.56 89.61 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.241 -0.912 . . . . 0.0 109.405 179.931 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 54' ' ' LEU . . . . . 0.693 HD12 ' SD ' ' A' ' 69' ' ' MET . 42.7 mt -62.81 -48.03 80.85 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.242 -0.911 . . . . 0.0 109.356 -179.916 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 55' ' ' ARG . . . . . 0.467 ' O ' ' N ' ' A' ' 59' ' ' SER . 48.0 mtt180 -48.53 -39.82 24.79 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.248 -0.907 . . . . 0.0 109.392 179.936 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -69.09 -34.78 76.73 Favored Glycine 0 N--CA 1.49 2.289 0 N-CA-C 109.312 -1.515 . . . . 0.0 109.312 179.881 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 57' ' ' ALA . . . . . 0.417 ' O ' HD21 ' A' ' 93' ' ' LEU . . . -71.26 -25.03 62.29 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.288 -1.125 . . . . 0.0 109.414 179.921 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 58' ' ' PHE . . . . . 0.736 ' HB2' HD11 ' A' ' 64' ' ' ILE . 76.2 m-85 -116.81 10.3 14.16 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.323 -0.86 . . . . 0.0 109.463 -179.979 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 59' ' ' SER . . . . . 0.559 ' N ' ' HD2' ' A' ' 60' ' ' PRO . 1.4 t -76.46 -53.74 1.99 Allowed Pre-proline 0 N--CA 1.492 1.63 0 O-C-N 121.3 -0.875 . . . . 0.0 110.473 -179.558 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 60' ' ' PRO . . . . . 0.559 ' HD2' ' N ' ' A' ' 59' ' ' SER . 47.8 Cg_endo -68.88 -34.03 18.8 Favored 'Trans proline' 0 C--O 1.215 -0.659 0 C-N-CA 122.405 2.07 . . . . 0.0 112.388 -179.152 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 61' ' ' PHE . . . . . 0.611 ' CE2' HD21 ' A' ' 93' ' ' LEU . 87.8 m-85 -63.52 -37.04 85.8 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.057 -1.027 . . . . 0.0 109.502 -179.971 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 62' ' ' GLY . . . . . 0.463 ' HA3' ' OG ' ' A' ' 85' ' ' SER . . . -178.74 -172.63 43.29 Favored Glycine 0 N--CA 1.49 2.27 0 N-CA-C 109.599 -1.4 . . . . 0.0 109.599 179.94 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 51.5 t-20 -96.99 136.81 37.03 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.266 -1.138 . . . . 0.0 109.577 -179.914 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 64' ' ' ILE . . . . . 0.776 HD13 HD23 ' A' ' 67' ' ' LEU . 54.6 mt -98.51 131.29 45.93 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 O-C-N 121.209 -0.932 . . . . 0.0 109.532 -179.946 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 18.6 pt -95.58 -19.31 6.35 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 O-C-N 121.32 -0.862 . . . . 0.0 109.579 -179.902 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 59.6 t0 -152.38 106.25 3.11 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.205 -0.934 . . . . 0.0 109.591 -179.99 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 67' ' ' LEU . . . . . 0.776 HD23 HD13 ' A' ' 64' ' ' ILE . 0.5 OUTLIER -99.22 120.22 39.16 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.27 -0.894 . . . . 0.0 109.375 179.755 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 68' ' ' SER . . . . . 0.748 ' N ' HD13 ' A' ' 67' ' ' LEU . 67.9 m -131.62 151.15 51.83 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.174 -0.954 . . . . 0.0 109.691 -179.793 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 69' ' ' MET . . . . . 0.693 ' SD ' HD12 ' A' ' 54' ' ' LEU . 18.2 mtm -130.94 144.62 51.6 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.309 -0.869 . . . . 0.0 109.346 179.886 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 70' ' ' ASP . . . . . 0.519 ' CB ' ' O ' ' A' ' 75' ' ' CYS . 0.9 OUTLIER -118.89 102.78 48.99 Favored Pre-proline 0 N--CA 1.491 1.604 0 O-C-N 121.22 -0.925 . . . . 0.0 109.533 -179.885 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 71' ' ' PRO . . . . . 0.601 ' N ' ' CD ' ' A' ' 72' ' ' PRO . 47.7 Cg_endo -74.9 -27.75 9.96 Favored 'Trans proline' 0 CA--C 1.542 0.888 0 C-N-CA 122.608 2.205 . . . . 0.0 113.697 179.886 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 72' ' ' PRO . . . . . 0.601 ' CD ' ' N ' ' A' ' 71' ' ' PRO . 55.4 Cg_endo -75.09 -25.16 11.98 Favored 'Trans proline' 0 C--N 1.353 0.814 0 C-N-CA 121.446 1.431 . . . . 0.0 111.809 -179.795 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 48.3 mtt85 -111.9 10.03 20.64 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.282 -0.886 . . . . 0.0 109.587 -179.946 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 83.1 m-20 53.3 36.61 23.24 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.249 -0.907 . . . . 0.0 109.506 -179.987 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 75' ' ' CYS . . . . . 0.519 ' O ' ' CB ' ' A' ' 70' ' ' ASP . 28.1 p -142.81 146.67 34.42 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.214 -0.929 . . . . 0.0 109.527 -179.868 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 76' ' ' ALA . . . . . 0.47 ' HA ' ' HA ' ' A' ' 69' ' ' MET . . . -114.17 162.48 16.47 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.188 -0.945 . . . . 0.0 109.553 -179.977 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 77' ' ' PHE . . . . . 0.406 ' CE1' ' HD1' ' A' ' 43' ' ' TYR . 96.7 m-85 -127.62 108.99 11.25 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.362 -0.836 . . . . 0.0 109.359 179.933 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 78' ' ' VAL . . . . . 0.533 HG23 ' CD2' ' A' ' 67' ' ' LEU . 6.1 p -109.67 135.58 48.22 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.449 0 O-C-N 121.247 -0.908 . . . . 0.0 109.624 -179.854 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 79' ' ' THR . . . . . 0.641 ' O ' HG23 ' A' ' 64' ' ' ILE . 91.7 m -106.63 128.8 54.45 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.249 -0.907 . . . . 0.0 109.273 179.797 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 80' ' ' TYR . . . . . 0.94 ' CD2' HD11 ' A' ' 42' ' ' LEU . 0.9 OUTLIER -94.93 174.22 7.2 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.336 -0.852 . . . . 0.0 109.527 179.978 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 81' ' ' GLU . . . . . 0.479 ' O ' ' CG ' ' A' ' 82' ' ' LYS . 81.7 tt0 -86.37 -11.77 51.12 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.44 -0.787 . . . . 0.0 109.177 179.66 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 82' ' ' LYS . . . . . 0.479 ' CG ' ' O ' ' A' ' 81' ' ' GLU . 43.0 mttp -157.91 158.83 35.78 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.324 -0.86 . . . . 0.0 109.267 179.934 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 83' ' ' MET . . . . . . . . . . . . . 31.4 mtt -71.83 -12.13 61.14 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.238 -0.914 . . . . 0.0 109.384 -179.947 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 84' ' ' GLU . . . . . 0.434 ' HA ' ' OE1' ' A' ' 84' ' ' GLU . 70.7 mm-40 -76.4 -40.11 51.77 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.317 -0.865 . . . . 0.0 109.609 179.93 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 85' ' ' SER . . . . . 0.463 ' OG ' ' HA3' ' A' ' 62' ' ' GLY . 29.1 t -65.45 -35.44 80.93 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.255 -0.903 . . . . 0.0 109.481 179.96 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 86' ' ' ALA . . . . . 0.547 ' O ' HG23 ' A' ' 90' ' ' VAL . . . -71.83 -35.78 70.0 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.425 -0.797 . . . . 0.0 109.764 -179.918 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 64.5 t0 -65.32 -43.64 90.38 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.158 -0.964 . . . . 0.0 109.786 -179.814 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 64.8 tt0 -72.57 -38.85 67.8 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.197 -0.939 . . . . 0.0 109.82 -179.745 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 89' ' ' ALA . . . . . 0.773 ' HB1' ' CD1' ' A' ' 93' ' ' LEU . . . -73.89 -42.12 61.16 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.206 -0.934 . . . . 0.0 109.745 -179.708 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 90' ' ' VAL . . . . . 0.836 ' HA ' HG11 ' A' ' 105' ' ' VAL . 51.1 t -62.07 -34.37 63.02 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.564 0 O-C-N 121.243 -0.91 . . . . 0.0 109.74 -179.79 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -76.03 -53.74 7.91 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.185 -0.947 . . . . 0.0 109.867 -179.678 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 92' ' ' GLU . . . . . 0.581 ' HB2' ' CE1' ' A' ' 61' ' ' PHE . 75.1 mm-40 -69.24 -44.37 72.13 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.196 -0.94 . . . . 0.0 109.9 -179.634 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 93' ' ' LEU . . . . . 0.773 ' CD1' ' HB1' ' A' ' 89' ' ' ALA . 69.8 mt -65.45 -36.84 85.12 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.109 -0.994 . . . . 0.0 109.709 -179.753 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 94' ' ' ASN . . . . . 0.485 ' HB2' ' O ' ' A' ' 90' ' ' VAL . 63.1 t-20 -72.99 125.38 27.47 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.169 -0.957 . . . . 0.0 109.452 -179.888 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 95.29 26.52 12.11 Favored Glycine 0 N--CA 1.49 2.263 0 N-CA-C 109.515 -1.434 . . . . 0.0 109.515 179.908 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 96' ' ' THR . . . . . 0.489 ' CG2' ' O ' ' A' ' 92' ' ' GLU . 17.7 p -121.47 155.3 35.2 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.23 -1.159 . . . . 0.0 109.469 -179.969 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 64.2 tt0 -128.74 153.08 47.71 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.257 -0.902 . . . . 0.0 109.481 -179.97 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 98' ' ' VAL . . . . . 0.538 HG12 ' H ' ' A' ' 99' ' ' GLU . 1.2 t -98.33 -152.58 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.627 0 O-C-N 121.235 -0.916 . . . . 0.0 109.254 -179.897 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 99' ' ' GLU . . . . . 0.538 ' H ' HG12 ' A' ' 98' ' ' VAL . 75.7 mm-40 -59.79 -39.13 83.89 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.168 -0.957 . . . . 0.0 109.475 179.943 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -157.6 24.85 0.28 Allowed 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.327 -0.858 . . . . 0.0 109.485 -179.958 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 101' ' ' VAL . . . . . 0.42 ' O ' HG23 ' A' ' 98' ' ' VAL . 47.4 t -137.57 152.5 27.19 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.552 0 O-C-N 121.165 -0.96 . . . . 0.0 109.498 179.998 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 91.8 mt-30 -108.42 145.08 35.14 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.268 -0.895 . . . . 0.0 109.483 179.937 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 93.3 mt -111.95 145.35 39.75 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.225 -0.922 . . . . 0.0 109.525 -179.961 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 104' ' ' LYS . . . . . 0.472 ' HB2' ' HB3' ' A' ' 45' ' ' TYR . 43.8 mttt -127.33 133.1 50.13 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.264 -0.897 . . . . 0.0 109.406 179.912 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 105' ' ' VAL . . . . . 0.836 HG11 ' HA ' ' A' ' 90' ' ' VAL . 21.9 t . . . . . 0 N--CA 1.489 1.514 0 O-C-N 121.217 -0.927 . . . . 0.0 109.576 -179.866 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 40' ' ' ASN . . . . . 0.467 ' N ' ' O ' ' A' ' 80' ' ' TYR . 45.9 t30 . . . . . 0 N--CA 1.49 1.545 0 CA-C-O 121.256 0.551 . . . . 0.0 109.605 . . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 41' ' ' THR . . . . . 0.449 ' HA ' ' HA ' ' A' ' 79' ' ' THR . 36.2 m -72.46 127.76 33.55 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.18 -0.95 . . . . 0.0 109.48 -179.977 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 42' ' ' LEU . . . . . 0.77 HD13 HG23 ' A' ' 90' ' ' VAL . 13.3 mt -106.44 145.92 31.17 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.195 -0.941 . . . . 0.0 109.478 -179.989 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 85.3 t80 -96.76 117.6 31.41 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.216 -0.927 . . . . 0.0 109.42 179.98 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 44' ' ' VAL . . . . . 0.464 ' HA ' ' O ' ' A' ' 104' ' ' LYS . 63.8 t -113.79 138.99 41.68 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.547 0 O-C-N 121.214 -0.929 . . . . 0.0 109.504 179.981 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 45' ' ' TYR . . . . . 0.435 ' HB3' ' HB2' ' A' ' 104' ' ' LYS . 70.4 t80 -124.5 135.32 53.11 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.273 -0.892 . . . . 0.0 109.49 179.99 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -177.6 -174.87 44.34 Favored Glycine 0 N--CA 1.491 2.353 0 N-CA-C 109.484 -1.447 . . . . 0.0 109.484 -179.951 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 95.5 mt-10 -123.57 157.51 33.5 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.237 -1.155 . . . . 0.0 109.483 -179.98 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 58.3 t0 45.96 46.59 12.44 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.287 -0.883 . . . . 0.0 109.516 179.933 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 70.7 mtm -94.48 143.85 26.07 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.291 -0.881 . . . . 0.0 109.495 179.966 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 50' ' ' THR . . . . . 0.709 ' O ' HD12 ' A' ' 54' ' ' LEU . 2.5 p -120.9 163.99 26.2 Favored Pre-proline 0 N--CA 1.489 1.51 0 O-C-N 121.223 -0.923 . . . . 0.0 109.43 -179.958 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 51' ' ' PRO . . . . . 0.471 ' HD2' ' HB ' ' A' ' 50' ' ' THR . 49.1 Cg_endo -69.41 -52.76 0.33 Allowed 'Trans proline' 0 C--O 1.216 -0.607 0 C-N-CA 122.672 2.248 . . . . 0.0 111.761 179.992 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 56.3 m -57.54 -46.67 83.6 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.22 -0.925 . . . . 0.0 109.319 179.965 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 17.0 tp -58.57 -55.55 33.61 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.285 -0.884 . . . . 0.0 109.299 179.872 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 54' ' ' LEU . . . . . 0.709 HD12 ' O ' ' A' ' 50' ' ' THR . 9.0 mt -54.07 -42.99 69.9 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.267 -0.896 . . . . 0.0 109.285 179.806 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 55' ' ' ARG . . . . . 0.476 ' O ' ' N ' ' A' ' 59' ' ' SER . 32.4 ttt85 -51.66 -39.34 57.98 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.22 -0.925 . . . . 0.0 109.29 179.85 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 56' ' ' GLY . . . . . 0.435 ' HA2' ' HB2' ' A' ' 59' ' ' SER . . . -70.34 -31.43 68.68 Favored Glycine 0 N--CA 1.488 2.16 0 N-CA-C 109.436 -1.466 . . . . 0.0 109.436 179.898 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 57' ' ' ALA . . . . . 0.505 ' O ' ' CD2' ' A' ' 61' ' ' PHE . . . -72.85 -17.03 61.58 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.239 -1.153 . . . . 0.0 109.453 -179.958 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 58' ' ' PHE . . . . . 0.688 ' HB2' HD11 ' A' ' 64' ' ' ILE . 97.9 m-85 -126.54 5.34 6.84 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.238 -0.914 . . . . 0.0 109.349 179.855 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 59' ' ' SER . . . . . 0.544 ' N ' ' HD2' ' A' ' 60' ' ' PRO . 0.4 OUTLIER -74.04 -55.89 2.91 Favored Pre-proline 0 N--CA 1.49 1.565 0 O-C-N 121.249 -0.907 . . . . 0.0 109.989 -179.761 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 60' ' ' PRO . . . . . 0.544 ' HD2' ' N ' ' A' ' 59' ' ' SER . 49.5 Cg_endo -70.08 -34.15 14.05 Favored 'Trans proline' 0 C--O 1.215 -0.644 0 C-N-CA 122.51 2.14 . . . . 0.0 112.04 -179.553 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 61' ' ' PHE . . . . . 0.579 ' CE1' ' HB3' ' A' ' 92' ' ' GLU . 73.4 m-85 -58.91 -42.71 90.26 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.175 -0.953 . . . . 0.0 109.52 -179.947 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 62' ' ' GLY . . . . . 0.459 ' HA3' ' OG ' ' A' ' 85' ' ' SER . . . -178.79 179.88 48.71 Favored Glycine 0 N--CA 1.49 2.289 0 N-CA-C 109.469 -1.452 . . . . 0.0 109.469 179.996 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 39.8 t30 -85.29 140.9 30.47 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.276 -1.132 . . . . 0.0 109.462 179.987 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 64' ' ' ILE . . . . . 0.688 HD11 ' HB2' ' A' ' 58' ' ' PHE . 68.2 mt -103.92 134.22 45.77 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 O-C-N 121.223 -0.923 . . . . 0.0 109.427 -179.982 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 23.7 pt -97.56 -20.67 5.55 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.538 0 O-C-N 121.277 -0.89 . . . . 0.0 109.548 -179.928 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 54.4 t0 -160.64 106.13 1.45 Allowed 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.215 -0.928 . . . . 0.0 109.514 -179.947 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 67' ' ' LEU . . . . . 1.028 HD11 HG22 ' A' ' 78' ' ' VAL . 0.6 OUTLIER -111.7 120.23 41.34 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.293 -0.879 . . . . 0.0 109.355 179.881 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 19.9 m -118.57 152.39 36.09 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.306 -0.871 . . . . 0.0 109.641 -179.945 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 69' ' ' MET . . . . . 0.471 ' SD ' ' CA ' ' A' ' 51' ' ' PRO . 91.9 mtp -121.02 140.95 51.22 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.297 -0.877 . . . . 0.0 109.46 -179.987 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 70' ' ' ASP . . . . . 0.473 ' C ' ' HD2' ' A' ' 72' ' ' PRO . 0.4 OUTLIER -119.38 105.7 43.73 Favored Pre-proline 0 N--CA 1.491 1.6 0 O-C-N 121.2 -0.937 . . . . 0.0 109.458 179.971 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 71' ' ' PRO . . . . . 0.601 ' N ' ' CD ' ' A' ' 72' ' ' PRO . 48.0 Cg_endo -74.6 -27.78 10.51 Favored 'Trans proline' 0 CA--C 1.542 0.893 0 C-N-CA 122.569 2.18 . . . . 0.0 113.653 179.939 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 72' ' ' PRO . . . . . 0.601 ' CD ' ' N ' ' A' ' 71' ' ' PRO . 55.2 Cg_endo -75.58 -39.59 0.99 Allowed 'Trans proline' 0 C--N 1.352 0.718 0 C-N-CA 121.479 1.453 . . . . 0.0 111.718 -179.879 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 73' ' ' ARG . . . . . 0.454 ' HG2' ' O ' ' A' ' 73' ' ' ARG . 57.4 ttt85 -93.84 -3.89 51.11 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.29 -0.881 . . . . 0.0 109.559 -179.885 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 71.7 m-20 60.15 46.41 10.57 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.183 -0.948 . . . . 0.0 109.388 179.96 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 75' ' ' CYS . . . . . 0.457 ' HA ' ' O ' ' A' ' 44' ' ' VAL . 24.1 p -146.12 143.45 29.34 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.231 -0.918 . . . . 0.0 109.468 179.938 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -111.22 156.32 21.62 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.257 -0.902 . . . . 0.0 109.585 -179.939 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 77' ' ' PHE . . . . . 0.442 ' HA ' ' O ' ' A' ' 42' ' ' LEU . 97.3 m-85 -119.32 131.9 55.8 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.266 -0.896 . . . . 0.0 109.436 179.99 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 78' ' ' VAL . . . . . 1.028 HG22 HD11 ' A' ' 67' ' ' LEU . 47.2 t -125.42 120.78 58.78 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.619 0 O-C-N 121.193 -0.942 . . . . 0.0 109.533 -179.958 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 79' ' ' THR . . . . . 0.449 ' HA ' ' HA ' ' A' ' 41' ' ' THR . 17.3 m -95.12 132.59 39.86 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.244 -0.91 . . . . 0.0 109.436 179.94 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 80' ' ' TYR . . . . . 0.513 ' CE1' ' OG ' ' A' ' 85' ' ' SER . 2.0 m-85 -114.06 140.55 48.37 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.253 -0.904 . . . . 0.0 109.648 -179.862 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 81.2 tt0 -60.21 -30.07 69.13 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.326 -0.859 . . . . 0.0 109.665 -179.973 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 40.7 mttm -131.88 150.53 52.12 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.1 -1.0 . . . . 0.0 109.611 -179.922 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 83' ' ' MET . . . . . . . . . . . . . 54.0 mtt -66.67 -18.92 65.62 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.364 -0.835 . . . . 0.0 109.582 -179.997 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 98.7 mt-10 -64.39 -44.54 90.98 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.296 -0.877 . . . . 0.0 109.557 -179.86 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 85' ' ' SER . . . . . 0.513 ' OG ' ' CE1' ' A' ' 80' ' ' TYR . 43.6 t -61.51 -31.15 71.14 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.19 -0.944 . . . . 0.0 109.549 -179.89 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 86' ' ' ALA . . . . . 0.497 ' HA ' HD11 ' A' ' 42' ' ' LEU . . . -74.53 -31.03 62.0 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.237 -0.914 . . . . 0.0 109.647 -179.85 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 87' ' ' ASP . . . . . 0.423 ' O ' ' CB ' ' A' ' 91' ' ' ALA . 59.4 t0 -67.96 -49.39 62.02 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.21 -0.931 . . . . 0.0 109.559 -179.982 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 88' ' ' GLN . . . . . 0.438 ' HG2' ' CE1' ' A' ' 61' ' ' PHE . 62.9 tt0 -67.77 -36.78 81.11 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.251 -0.906 . . . . 0.0 109.524 -179.939 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 89' ' ' ALA . . . . . 0.57 ' HA ' ' CE1' ' A' ' 61' ' ' PHE . . . -75.7 -51.18 13.31 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.229 -0.919 . . . . 0.0 109.556 -179.928 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 90' ' ' VAL . . . . . 0.789 ' HA ' HG11 ' A' ' 105' ' ' VAL . 92.9 t -65.08 -33.67 65.32 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.545 0 O-C-N 121.321 -0.862 . . . . 0.0 109.552 -179.932 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 91' ' ' ALA . . . . . 0.423 ' CB ' ' O ' ' A' ' 87' ' ' ASP . . . -79.98 -45.25 18.77 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.31 -0.869 . . . . 0.0 109.663 -179.937 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 92' ' ' GLU . . . . . 0.579 ' HB3' ' CE1' ' A' ' 61' ' ' PHE . 34.0 tt0 -75.26 -46.87 30.89 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.255 -0.903 . . . . 0.0 109.658 -179.831 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 93' ' ' LEU . . . . . 0.773 ' HB2' HG21 ' A' ' 105' ' ' VAL . 42.5 mt -64.42 -41.84 96.38 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.206 -0.934 . . . . 0.0 109.606 -179.779 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 94' ' ' ASN . . . . . 0.492 ' CB ' ' O ' ' A' ' 90' ' ' VAL . 46.8 t30 -64.26 126.69 28.57 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.197 -0.939 . . . . 0.0 109.542 -179.93 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 91.78 25.87 21.43 Favored Glycine 0 N--CA 1.49 2.3 0 N-CA-C 109.556 -1.417 . . . . 0.0 109.556 179.966 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 96' ' ' THR . . . . . 0.637 HG23 ' O ' ' A' ' 93' ' ' LEU . 17.1 p -121.04 160.63 23.2 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.149 -1.206 . . . . 0.0 109.471 179.94 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 64.0 tt0 -130.38 149.92 51.84 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.257 -0.902 . . . . 0.0 109.477 -179.938 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 98' ' ' VAL . . . . . 0.547 HG23 ' O ' ' A' ' 101' ' ' VAL . 1.1 t -97.73 -151.3 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.609 0 O-C-N 121.315 -0.866 . . . . 0.0 109.357 -179.932 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 99' ' ' GLU . . . . . 0.513 ' H ' HG12 ' A' ' 98' ' ' VAL . 96.0 mt-10 -53.84 -38.43 64.65 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.202 -0.936 . . . . 0.0 109.529 -179.947 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 19.2 m -164.0 30.35 0.08 Allowed 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.268 -0.895 . . . . 0.0 109.521 179.965 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 101' ' ' VAL . . . . . 0.547 ' O ' HG23 ' A' ' 98' ' ' VAL . 59.7 t -144.78 144.17 22.15 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.516 0 O-C-N 121.21 -0.931 . . . . 0.0 109.487 -179.987 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 87.1 mt-30 -94.09 150.53 20.25 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.241 -0.912 . . . . 0.0 109.373 179.97 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 88.3 mt -117.29 134.99 54.16 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.205 -0.935 . . . . 0.0 109.499 -179.954 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 104' ' ' LYS . . . . . 0.464 ' O ' ' HA ' ' A' ' 44' ' ' VAL . 23.1 mttm -113.66 135.13 54.26 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.279 -0.888 . . . . 0.0 109.351 179.936 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 105' ' ' VAL . . . . . 0.789 HG11 ' HA ' ' A' ' 90' ' ' VAL . 21.2 t . . . . . 0 N--CA 1.49 1.551 0 O-C-N 121.172 -0.955 . . . . 0.0 109.541 -179.982 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 40' ' ' ASN . . . . . 0.624 ' O ' HG23 ' A' ' 79' ' ' THR . 0.8 OUTLIER . . . . . 0 N--CA 1.49 1.548 0 N-CA-C 109.311 -0.626 . . . . 0.0 109.311 . . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 41' ' ' THR . . . . . 0.443 ' C ' HD12 ' A' ' 42' ' ' LEU . 8.1 m -139.81 159.18 42.77 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.251 -0.905 . . . . 0.0 109.687 -179.732 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 42' ' ' LEU . . . . . 0.783 HD12 ' O ' ' A' ' 78' ' ' VAL . 4.3 mp -144.78 143.91 30.9 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.279 -0.888 . . . . 0.0 109.469 -179.951 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 51.7 t80 -105.04 109.79 21.93 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.174 -0.954 . . . . 0.0 109.519 179.925 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 44' ' ' VAL . . . . . 0.425 ' HA ' ' O ' ' A' ' 104' ' ' LYS . 99.8 t -101.16 144.23 13.22 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.518 0 O-C-N 121.346 -0.846 . . . . 0.0 109.481 179.862 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 64.6 t80 -135.86 134.81 39.21 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.303 -0.873 . . . . 0.0 109.425 -179.852 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 176.09 -166.0 36.88 Favored Glycine 0 N--CA 1.49 2.257 0 N-CA-C 109.453 -1.459 . . . . 0.0 109.453 179.918 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 47' ' ' GLU . . . . . 0.422 ' O ' ' C ' ' A' ' 48' ' ' ASP . 94.0 mt-10 -126.04 158.04 36.37 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.288 -1.125 . . . . 0.0 109.396 180.0 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 48' ' ' ASP . . . . . 0.422 ' C ' ' O ' ' A' ' 47' ' ' GLU . 51.7 m-20 44.38 48.85 8.15 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.174 -0.954 . . . . 0.0 109.486 -179.993 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 63.5 mtm -101.41 141.12 34.75 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.228 -0.92 . . . . 0.0 109.462 -179.976 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 50' ' ' THR . . . . . 0.602 ' O ' HD12 ' A' ' 54' ' ' LEU . 0.6 OUTLIER -122.12 167.28 14.29 Favored Pre-proline 0 N--CA 1.49 1.531 0 O-C-N 121.211 -0.931 . . . . 0.0 109.422 179.965 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 51' ' ' PRO . . . . . 0.471 ' CB ' HD21 ' A' ' 67' ' ' LEU . 49.5 Cg_endo -70.43 -55.0 0.17 Allowed 'Trans proline' 0 C--O 1.215 -0.664 0 C-N-CA 122.643 2.228 . . . . 0.0 111.864 180.0 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 35.3 m -51.88 -47.0 64.73 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.175 -0.953 . . . . 0.0 109.147 179.906 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 23.5 tp -59.46 -50.27 74.56 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.258 -0.901 . . . . 0.0 109.143 179.788 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 54' ' ' LEU . . . . . 0.602 HD12 ' O ' ' A' ' 50' ' ' THR . 8.1 mt -55.57 -48.7 74.36 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.309 -0.87 . . . . 0.0 109.175 179.705 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 55' ' ' ARG . . . . . 0.518 ' O ' ' N ' ' A' ' 59' ' ' SER . 93.5 mtt-85 -49.18 -37.04 21.24 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.275 -0.89 . . . . 0.0 109.229 179.824 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -69.38 -35.01 75.28 Favored Glycine 0 N--CA 1.489 2.223 0 N-CA-C 109.454 -1.458 . . . . 0.0 109.454 179.945 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 57' ' ' ALA . . . . . 0.511 ' O ' HD11 ' A' ' 93' ' ' LEU . . . -75.87 -22.83 55.77 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.217 -1.166 . . . . 0.0 109.362 179.925 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 58' ' ' PHE . . . . . 0.882 ' CE1' HD12 ' A' ' 93' ' ' LEU . 95.7 m-85 -116.63 9.54 14.15 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.287 -0.883 . . . . 0.0 109.328 179.825 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 59' ' ' SER . . . . . 0.562 ' N ' ' HD2' ' A' ' 60' ' ' PRO . 0.8 OUTLIER -76.92 -52.72 1.91 Allowed Pre-proline 0 N--CA 1.49 1.556 0 O-C-N 121.293 -0.879 . . . . 0.0 110.619 -179.506 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 60' ' ' PRO . . . . . 0.562 ' HD2' ' N ' ' A' ' 59' ' ' SER . 48.8 Cg_endo -70.45 -33.35 14.13 Favored 'Trans proline' 0 C--O 1.215 -0.658 0 C-N-CA 122.336 2.024 . . . . 0.0 112.526 -179.023 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 61' ' ' PHE . . . . . 0.73 ' CE2' HD21 ' A' ' 93' ' ' LEU . 78.1 m-85 -63.41 -36.64 84.39 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 120.983 -1.073 . . . . 0.0 109.648 -179.838 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 62' ' ' GLY . . . . . 0.452 ' HA3' ' OG ' ' A' ' 85' ' ' SER . . . 179.22 -176.98 48.21 Favored Glycine 0 N--CA 1.49 2.247 0 N-CA-C 109.447 -1.461 . . . . 0.0 109.447 179.952 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 78.9 m-20 -93.22 138.53 31.53 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.266 -1.138 . . . . 0.0 109.577 179.99 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 64' ' ' ILE . . . . . 0.901 HG23 ' O ' ' A' ' 79' ' ' THR . 41.1 mt -99.19 140.01 19.64 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.555 0 O-C-N 121.273 -0.892 . . . . 0.0 109.397 -179.989 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 22.3 pt -103.63 -19.3 6.29 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 O-C-N 121.204 -0.935 . . . . 0.0 109.705 -179.763 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 66' ' ' ASP . . . . . 0.462 ' HB3' ' OG1' ' A' ' 79' ' ' THR . 21.7 t70 -152.18 126.42 9.25 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.228 -0.92 . . . . 0.0 109.405 179.946 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 67' ' ' LEU . . . . . 0.471 HD21 ' CB ' ' A' ' 51' ' ' PRO . 8.3 tp -111.46 122.51 48.03 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.298 -0.876 . . . . 0.0 109.345 -179.965 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 68' ' ' SER . . . . . 0.459 ' HB3' ' HB2' ' A' ' 77' ' ' PHE . 26.5 t -126.21 139.19 53.54 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.328 -0.857 . . . . 0.0 109.412 -179.926 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 69' ' ' MET . . . . . 0.415 ' HA ' ' HA ' ' A' ' 76' ' ' ALA . 86.7 mtp -127.7 150.99 49.53 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.306 -0.872 . . . . 0.0 109.467 179.946 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 70' ' ' ASP . . . . . 0.469 ' C ' ' HD2' ' A' ' 72' ' ' PRO . 10.6 t70 -129.15 101.67 19.33 Favored Pre-proline 0 N--CA 1.491 1.577 0 O-C-N 121.276 -0.89 . . . . 0.0 109.447 179.986 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 71' ' ' PRO . . . . . 0.592 ' N ' ' CD ' ' A' ' 72' ' ' PRO . 47.5 Cg_endo -74.93 -27.89 9.77 Favored 'Trans proline' 0 CA--C 1.544 0.985 0 C-N-CA 122.561 2.174 . . . . 0.0 113.733 -179.863 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 72' ' ' PRO . . . . . 0.592 ' CD ' ' N ' ' A' ' 71' ' ' PRO . 55.4 Cg_endo -75.15 -20.63 16.38 Favored 'Trans proline' 0 C--N 1.352 0.728 0 C-N-CA 121.471 1.447 . . . . 0.0 111.803 -179.699 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 73' ' ' ARG . . . . . 0.454 ' N ' ' OD1' ' A' ' 70' ' ' ASP . 93.6 mtt180 -113.59 0.44 14.64 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.258 -0.901 . . . . 0.0 109.698 -179.899 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 74' ' ' ASN . . . . . 0.437 ' HB2' ' O ' ' A' ' 73' ' ' ARG . 81.7 m-20 61.19 41.83 12.96 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.247 -0.908 . . . . 0.0 109.493 179.938 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 75' ' ' CYS . . . . . 0.465 ' SG ' ' HB3' ' A' ' 70' ' ' ASP . 21.7 p -144.19 147.97 34.36 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.186 -0.946 . . . . 0.0 109.452 179.941 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 76' ' ' ALA . . . . . 0.415 ' HA ' ' HA ' ' A' ' 69' ' ' MET . . . -121.89 149.15 43.81 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.247 -0.908 . . . . 0.0 109.408 -179.954 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 77' ' ' PHE . . . . . 0.459 ' HB2' ' HB3' ' A' ' 68' ' ' SER . 90.9 m-85 -114.02 137.99 50.97 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.234 -0.916 . . . . 0.0 109.379 -179.973 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 78' ' ' VAL . . . . . 0.783 ' O ' HD12 ' A' ' 42' ' ' LEU . 61.7 t -123.76 145.3 31.02 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.491 0 O-C-N 121.145 -0.972 . . . . 0.0 109.615 -179.884 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 79' ' ' THR . . . . . 0.901 ' O ' HG23 ' A' ' 64' ' ' ILE . 1.3 m -113.99 130.77 56.51 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.316 -0.865 . . . . 0.0 108.995 179.886 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 80' ' ' TYR . . . . . 0.506 ' OH ' ' CA ' ' A' ' 58' ' ' PHE . 0.9 OUTLIER -112.22 132.37 54.96 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.168 -0.958 . . . . 0.0 109.805 -179.665 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 81' ' ' GLU . . . . . 0.409 ' C ' ' O ' ' A' ' 80' ' ' TYR . 86.7 tt0 -43.04 -25.81 0.12 Allowed 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.448 -0.782 . . . . 0.0 109.766 179.81 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 82' ' ' LYS . . . . . 0.425 ' N ' ' O ' ' A' ' 80' ' ' TYR . 34.6 mtmm -142.95 164.2 30.72 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.1 -1.0 . . . . 0.0 109.403 179.95 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 83' ' ' MET . . . . . . . . . . . . . 15.8 mtt -80.41 -12.95 59.51 Favored 'General case' 0 N--CA 1.487 1.42 0 O-C-N 121.267 -0.895 . . . . 0.0 109.49 179.874 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 95.1 mt-10 -73.99 -40.75 62.74 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.243 -0.91 . . . . 0.0 109.183 179.722 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 85' ' ' SER . . . . . 0.452 ' OG ' ' HA3' ' A' ' 62' ' ' GLY . 10.9 t -66.78 -39.33 87.77 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.34 -0.85 . . . . 0.0 109.258 179.744 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 86' ' ' ALA . . . . . 0.795 ' O ' HG23 ' A' ' 90' ' ' VAL . . . -72.08 -23.97 61.43 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.433 -0.792 . . . . 0.0 109.24 -179.943 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 65.1 m-20 -72.97 -48.3 37.8 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.352 -0.843 . . . . 0.0 109.504 179.911 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 57.6 tt0 -68.41 -37.9 80.75 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.297 -0.877 . . . . 0.0 109.633 -179.96 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 89' ' ' ALA . . . . . 0.452 ' HA ' ' CD1' ' A' ' 61' ' ' PHE . . . -69.07 -41.35 77.66 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.213 -0.93 . . . . 0.0 109.513 -179.883 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 90' ' ' VAL . . . . . 0.795 HG23 ' O ' ' A' ' 86' ' ' ALA . 53.1 t -62.09 -33.21 57.33 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.535 0 O-C-N 121.205 -0.935 . . . . 0.0 109.627 -179.933 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -79.41 -48.16 14.46 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.231 -0.918 . . . . 0.0 109.856 -179.684 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 92' ' ' GLU . . . . . 0.58 ' HB2' ' CE1' ' A' ' 61' ' ' PHE . 75.6 mm-40 -73.72 -43.11 60.09 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.175 -0.953 . . . . 0.0 109.994 -179.405 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 93' ' ' LEU . . . . . 0.946 ' HB2' HG21 ' A' ' 105' ' ' VAL . 21.9 mt -69.6 -39.32 77.34 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.16 -0.962 . . . . 0.0 109.753 -179.655 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 94' ' ' ASN . . . . . 0.521 ' CB ' ' O ' ' A' ' 90' ' ' VAL . 51.4 t-20 -72.54 120.05 17.61 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.15 -0.968 . . . . 0.0 109.569 -179.995 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 102.03 26.61 7.37 Favored Glycine 0 N--CA 1.49 2.249 0 N-CA-C 109.493 -1.443 . . . . 0.0 109.493 179.971 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 96' ' ' THR . . . . . 0.493 ' CG2' ' O ' ' A' ' 92' ' ' GLU . 11.1 p -125.65 154.52 42.21 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.28 -1.13 . . . . 0.0 109.429 -179.957 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 63.2 tt0 -128.47 138.38 52.26 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.277 -0.89 . . . . 0.0 109.516 179.977 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 98' ' ' VAL . . . . . 0.479 HG23 ' O ' ' A' ' 101' ' ' VAL . 1.3 t -80.13 -148.48 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 O-C-N 121.286 -0.884 . . . . 0.0 109.396 -179.97 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 99' ' ' GLU . . . . . 0.473 ' H ' HG12 ' A' ' 98' ' ' VAL . 96.5 mt-10 -63.2 -39.2 93.96 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.271 -0.893 . . . . 0.0 109.435 179.986 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 1.2 m -155.99 25.52 0.37 Allowed 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.276 -0.89 . . . . 0.0 109.451 179.956 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 101' ' ' VAL . . . . . 0.479 ' O ' HG23 ' A' ' 98' ' ' VAL . 57.4 t -139.59 145.07 27.45 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.552 0 O-C-N 121.308 -0.87 . . . . 0.0 109.373 179.922 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 47.0 tt0 -103.11 138.72 39.57 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.221 -0.924 . . . . 0.0 109.666 -179.837 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 67.7 mt -110.23 142.97 41.07 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.217 -0.927 . . . . 0.0 109.375 179.883 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 104' ' ' LYS . . . . . 0.425 ' O ' ' HA ' ' A' ' 44' ' ' VAL . 44.7 mttp -125.76 124.23 40.56 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.267 -0.896 . . . . 0.0 109.437 179.917 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 105' ' ' VAL . . . . . 0.946 HG21 ' HB2' ' A' ' 93' ' ' LEU . 14.3 t . . . . . 0 N--CA 1.49 1.568 0 O-C-N 121.205 -0.934 . . . . 0.0 109.561 -179.886 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 40' ' ' ASN . . . . . 0.44 ' O ' ' HA ' ' A' ' 79' ' ' THR . 0.6 OUTLIER . . . . . 0 N--CA 1.491 1.618 0 CA-C-O 121.268 0.556 . . . . 0.0 109.571 . . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 41' ' ' THR . . . . . 0.595 ' O ' HD23 ' A' ' 42' ' ' LEU . 40.1 m -80.72 136.71 36.21 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.24 -0.913 . . . . 0.0 109.34 179.859 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 42' ' ' LEU . . . . . 0.852 HD11 ' CD2' ' A' ' 80' ' ' TYR . 8.5 mt -120.18 157.58 28.76 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.205 -0.935 . . . . 0.0 109.614 -179.945 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 43' ' ' TYR . . . . . 0.489 ' CZ ' ' HB2' ' A' ' 75' ' ' CYS . 74.6 t80 -116.92 121.76 42.37 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.317 -0.865 . . . . 0.0 109.269 179.83 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 44' ' ' VAL . . . . . 0.773 HG13 HD23 ' A' ' 103' ' ' LEU . 61.8 t -116.21 134.17 60.41 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.479 0 O-C-N 121.167 -0.958 . . . . 0.0 109.572 -179.902 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 60.7 t80 -121.49 142.4 50.09 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.287 -0.883 . . . . 0.0 109.488 -179.976 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 173.97 -178.97 45.63 Favored Glycine 0 N--CA 1.491 2.338 0 N-CA-C 109.485 -1.446 . . . . 0.0 109.485 179.958 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 47' ' ' GLU . . . . . 0.411 ' O ' ' C ' ' A' ' 48' ' ' ASP . 92.7 mt-10 -111.66 154.93 24.2 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.253 -1.145 . . . . 0.0 109.434 -179.952 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 48' ' ' ASP . . . . . 0.411 ' C ' ' O ' ' A' ' 47' ' ' GLU . 43.4 m-20 43.99 51.6 6.99 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.212 -0.93 . . . . 0.0 109.488 -179.993 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 49.1 mtm -98.93 142.31 30.6 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.234 -0.916 . . . . 0.0 109.494 179.971 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 50' ' ' THR . . . . . 0.832 ' O ' HD12 ' A' ' 54' ' ' LEU . 0.6 OUTLIER -125.16 166.62 19.57 Favored Pre-proline 0 N--CA 1.49 1.571 0 O-C-N 121.225 -0.922 . . . . 0.0 109.503 179.949 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 51' ' ' PRO . . . . . 0.405 ' HD2' ' HB ' ' A' ' 50' ' ' THR . 49.2 Cg_endo -69.95 -48.21 0.72 Allowed 'Trans proline' 0 C--O 1.216 -0.623 0 C-N-CA 122.718 2.279 . . . . 0.0 111.769 -179.96 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 36.3 m -57.54 -45.74 84.73 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.253 -0.905 . . . . 0.0 109.457 179.985 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 15.6 tp -59.71 -50.28 74.45 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.325 -0.859 . . . . 0.0 109.445 179.84 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 54' ' ' LEU . . . . . 0.832 HD12 ' O ' ' A' ' 50' ' ' THR . 3.5 mt -56.81 -50.16 73.2 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.285 -0.885 . . . . 0.0 109.284 179.897 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 55' ' ' ARG . . . . . 0.506 ' O ' ' N ' ' A' ' 59' ' ' SER . 33.2 mtp180 -46.03 -41.03 11.48 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.172 -0.955 . . . . 0.0 109.262 179.895 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -69.18 -37.78 81.9 Favored Glycine 0 N--CA 1.489 2.229 0 N-CA-C 109.36 -1.496 . . . . 0.0 109.36 179.852 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -72.59 -21.05 61.2 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.245 -1.15 . . . . 0.0 109.394 179.953 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 58' ' ' PHE . . . . . 0.675 ' CZ ' HD13 ' A' ' 93' ' ' LEU . 92.5 m-85 -117.74 8.0 12.63 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.308 -0.87 . . . . 0.0 109.431 179.881 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 59' ' ' SER . . . . . 0.559 ' N ' ' HD2' ' A' ' 60' ' ' PRO . 1.2 t -75.16 -54.45 2.52 Favored Pre-proline 0 N--CA 1.492 1.632 0 O-C-N 121.313 -0.867 . . . . 0.0 110.391 -179.699 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 60' ' ' PRO . . . . . 0.559 ' HD2' ' N ' ' A' ' 59' ' ' SER . 47.4 Cg_endo -68.95 -30.5 26.03 Favored 'Trans proline' 0 C--O 1.215 -0.653 0 C-N-CA 122.456 2.104 . . . . 0.0 112.3 -179.252 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 61' ' ' PHE . . . . . 0.619 ' CB ' ' HB2' ' A' ' 89' ' ' ALA . 60.3 m-85 -66.68 -31.13 71.59 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.119 -0.988 . . . . 0.0 109.471 -179.979 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 168.56 179.15 40.66 Favored Glycine 0 N--CA 1.491 2.308 0 N-CA-C 109.579 -1.408 . . . . 0.0 109.579 179.928 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 37.0 t30 -87.89 134.86 33.62 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.365 -1.079 . . . . 0.0 109.492 -179.979 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 64' ' ' ILE . . . . . 0.656 HD11 ' HB2' ' A' ' 58' ' ' PHE . 33.4 mt -94.05 133.95 33.32 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.508 0 O-C-N 121.23 -0.919 . . . . 0.0 109.476 179.963 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 26.1 pt -97.19 -20.71 5.57 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.486 0 O-C-N 121.17 -0.956 . . . . 0.0 109.376 179.911 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 66' ' ' ASP . . . . . 0.479 ' HB3' ' HB ' ' A' ' 79' ' ' THR . 60.9 t0 -138.82 125.96 21.37 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.225 -0.922 . . . . 0.0 109.433 179.854 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 67' ' ' LEU . . . . . 0.758 ' C ' HD13 ' A' ' 67' ' ' LEU . 3.5 tm? -121.26 108.24 13.5 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.209 -0.932 . . . . 0.0 109.355 179.897 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 68' ' ' SER . . . . . 0.476 ' HB2' ' HB2' ' A' ' 77' ' ' PHE . 58.3 m -122.66 149.27 44.25 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.238 -0.914 . . . . 0.0 109.463 -179.964 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 69' ' ' MET . . . . . 0.48 ' SD ' ' CD1' ' A' ' 54' ' ' LEU . 83.8 mmm -123.39 147.68 46.85 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.234 -0.916 . . . . 0.0 109.381 -179.979 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 70' ' ' ASP . . . . . 0.478 ' C ' ' HD2' ' A' ' 72' ' ' PRO . 0.6 OUTLIER -131.64 94.2 26.34 Favored Pre-proline 0 N--CA 1.49 1.541 0 O-C-N 121.252 -0.905 . . . . 0.0 109.483 179.959 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 71' ' ' PRO . . . . . 0.598 ' CD ' ' CD ' ' A' ' 72' ' ' PRO . 47.0 Cg_endo -74.84 -27.77 10.06 Favored 'Trans proline' 0 CA--C 1.543 0.967 0 C-N-CA 122.506 2.137 . . . . 0.0 113.664 -179.974 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 72' ' ' PRO . . . . . 0.598 ' CD ' ' CD ' ' A' ' 71' ' ' PRO . 55.2 Cg_endo -75.3 -22.19 14.55 Favored 'Trans proline' 0 C--N 1.353 0.803 0 C-N-CA 121.49 1.46 . . . . 0.0 111.868 -179.844 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 73' ' ' ARG . . . . . 0.401 ' O ' ' HB2' ' A' ' 74' ' ' ASN . 62.7 mtt180 -112.24 -0.39 15.51 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.167 -0.958 . . . . 0.0 109.65 -179.992 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 74' ' ' ASN . . . . . 0.401 ' HB2' ' O ' ' A' ' 73' ' ' ARG . 59.4 m-20 60.82 45.47 9.8 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.082 -1.011 . . . . 0.0 109.402 -179.981 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 75' ' ' CYS . . . . . 0.489 ' HB2' ' CZ ' ' A' ' 43' ' ' TYR . 23.2 p -152.69 143.07 22.58 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.299 -0.875 . . . . 0.0 109.458 -179.979 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -112.08 156.99 21.33 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.307 -0.871 . . . . 0.0 109.485 179.952 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 77' ' ' PHE . . . . . 0.476 ' HB2' ' HB2' ' A' ' 68' ' ' SER . 97.0 m-85 -118.37 125.58 50.31 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.245 -0.909 . . . . 0.0 109.427 179.858 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 78' ' ' VAL . . . . . 0.485 HG13 HG21 ' A' ' 64' ' ' ILE . 59.6 t -127.11 126.78 68.7 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.546 0 O-C-N 121.234 -0.916 . . . . 0.0 109.489 -179.858 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 79' ' ' THR . . . . . 0.479 ' HB ' ' HB3' ' A' ' 66' ' ' ASP . 92.3 m -105.59 126.64 52.37 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.334 -0.854 . . . . 0.0 109.446 179.812 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 80' ' ' TYR . . . . . 0.852 ' CD2' HD11 ' A' ' 42' ' ' LEU . 2.3 m-85 -92.41 174.05 7.49 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.227 -0.921 . . . . 0.0 109.169 179.898 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 81' ' ' GLU . . . . . 0.475 ' HG2' ' O ' ' A' ' 81' ' ' GLU . 71.0 tt0 -90.23 -13.56 35.19 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.352 -0.842 . . . . 0.0 109.665 -179.678 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 23.2 mttt -150.08 127.93 11.77 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.051 -1.031 . . . . 0.0 110.018 179.921 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 83' ' ' MET . . . . . 0.515 ' N ' ' SD ' ' A' ' 83' ' ' MET . 0.4 OUTLIER -45.83 -24.89 0.44 Allowed 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.458 -0.777 . . . . 0.0 109.88 179.938 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 84' ' ' GLU . . . . . 0.422 ' HG3' ' SD ' ' A' ' 83' ' ' MET . 97.1 mt-10 -67.56 -62.35 1.46 Allowed 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.196 -0.94 . . . . 0.0 109.571 -179.868 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 13.7 m -46.82 -38.26 9.96 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.267 -0.896 . . . . 0.0 109.818 -179.804 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 86' ' ' ALA . . . . . 0.588 ' HB1' HD21 ' A' ' 42' ' ' LEU . . . -69.27 -39.45 78.38 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.161 -0.962 . . . . 0.0 109.751 -179.691 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 52.4 t0 -56.76 -38.31 72.27 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.212 -0.93 . . . . 0.0 109.591 -179.739 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 88' ' ' GLN . . . . . 0.483 ' O ' ' CB ' ' A' ' 92' ' ' GLU . 59.7 tt0 -74.39 -38.49 63.12 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.15 -0.969 . . . . 0.0 109.603 -179.839 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 89' ' ' ALA . . . . . 0.619 ' HB2' ' CB ' ' A' ' 61' ' ' PHE . . . -75.36 -41.95 55.28 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.168 -0.958 . . . . 0.0 109.651 -179.871 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 90' ' ' VAL . . . . . 0.852 ' HA ' HG11 ' A' ' 105' ' ' VAL . 53.9 t -64.68 -48.72 83.51 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 O-C-N 121.257 -0.902 . . . . 0.0 109.634 -179.834 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -72.22 -38.77 68.91 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.272 -0.892 . . . . 0.0 109.702 -179.882 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 92' ' ' GLU . . . . . 0.59 ' HB3' ' CE1' ' A' ' 61' ' ' PHE . 44.5 tp10 -74.4 -45.81 44.29 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.247 -0.908 . . . . 0.0 109.583 -179.876 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 93' ' ' LEU . . . . . 0.675 HD13 ' CZ ' ' A' ' 58' ' ' PHE . 68.0 mt -69.95 -37.76 75.93 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.165 -0.959 . . . . 0.0 109.545 -179.921 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 94' ' ' ASN . . . . . 0.475 ' HB2' ' O ' ' A' ' 90' ' ' VAL . 61.4 t-20 -64.64 129.85 41.39 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.226 -0.921 . . . . 0.0 109.547 -179.967 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 84.77 30.14 27.33 Favored Glycine 0 N--CA 1.489 2.219 0 N-CA-C 109.497 -1.441 . . . . 0.0 109.497 179.973 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 96' ' ' THR . . . . . 0.666 HG23 ' O ' ' A' ' 93' ' ' LEU . 19.7 p -121.27 151.54 39.92 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.261 -1.141 . . . . 0.0 109.468 -179.995 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 61.7 tt0 -116.94 143.73 45.37 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.314 -0.866 . . . . 0.0 109.498 -179.946 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 98' ' ' VAL . . . . . 0.602 HG12 ' H ' ' A' ' 99' ' ' GLU . 1.2 t -90.79 -159.41 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 O-C-N 121.233 -0.917 . . . . 0.0 109.282 179.935 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 99' ' ' GLU . . . . . 0.602 ' H ' HG12 ' A' ' 98' ' ' VAL . 95.9 mt-10 -54.68 -37.71 66.1 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.183 -0.948 . . . . 0.0 109.481 179.968 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 100' ' ' SER . . . . . 0.422 ' O ' ' OG ' ' A' ' 100' ' ' SER . 6.9 t -159.86 25.96 0.18 Allowed 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.198 -0.938 . . . . 0.0 109.554 -179.953 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 101' ' ' VAL . . . . . 0.606 HG12 ' N ' ' A' ' 102' ' ' GLN . 48.7 t -138.03 168.42 20.32 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.546 0 O-C-N 121.219 -0.926 . . . . 0.0 109.434 -179.955 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 102' ' ' GLN . . . . . 0.606 ' N ' HG12 ' A' ' 101' ' ' VAL . 92.5 mt-30 -116.12 147.12 41.67 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.22 -0.925 . . . . 0.0 109.169 179.874 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 103' ' ' LEU . . . . . 0.773 HD23 HG13 ' A' ' 44' ' ' VAL . 0.0 OUTLIER -122.15 130.94 53.68 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.198 -0.939 . . . . 0.0 109.715 -179.918 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 16.7 mttp -115.82 128.22 55.66 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.294 -0.879 . . . . 0.0 109.333 179.864 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 105' ' ' VAL . . . . . 0.852 HG11 ' HA ' ' A' ' 90' ' ' VAL . 22.7 t . . . . . 0 N--CA 1.489 1.519 0 O-C-N 121.179 -0.951 . . . . 0.0 109.583 -179.834 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 43.7 t30 . . . . . 0 N--CA 1.49 1.563 0 N-CA-C 109.322 -0.622 . . . . 0.0 109.322 . . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 41' ' ' THR . . . . . 0.415 ' O ' HD23 ' A' ' 42' ' ' LEU . 78.9 m -65.53 130.88 44.88 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.229 -0.92 . . . . 0.0 109.588 -179.935 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 42' ' ' LEU . . . . . 0.56 HD11 ' HD2' ' A' ' 80' ' ' TYR . 16.8 mt -111.51 146.05 37.97 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.262 -0.899 . . . . 0.0 109.464 179.957 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 70.6 t80 -104.78 122.72 46.32 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.164 -0.96 . . . . 0.0 109.46 179.999 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 44' ' ' VAL . . . . . 0.462 ' HA ' ' O ' ' A' ' 104' ' ' LYS . 47.9 t -121.57 138.15 52.84 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.523 0 O-C-N 121.214 -0.929 . . . . 0.0 109.489 179.978 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 45' ' ' TYR . . . . . 0.476 ' HB3' ' HB2' ' A' ' 104' ' ' LYS . 72.3 t80 -118.68 138.9 52.3 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.226 -0.921 . . . . 0.0 109.441 -179.951 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 176.17 -178.54 47.57 Favored Glycine 0 N--CA 1.489 2.216 0 N-CA-C 109.448 -1.461 . . . . 0.0 109.448 179.929 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 94.2 mt-10 -124.91 156.04 38.58 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.344 -1.092 . . . . 0.0 109.488 179.995 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 22.2 t70 47.46 50.22 15.03 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.227 -0.92 . . . . 0.0 109.476 -179.99 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 66.7 mtm -105.54 145.21 31.24 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.247 -0.908 . . . . 0.0 109.513 -179.969 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 50' ' ' THR . . . . . 0.728 ' O ' HD12 ' A' ' 54' ' ' LEU . 3.5 p -119.42 161.73 35.83 Favored Pre-proline 0 N--CA 1.49 1.57 0 O-C-N 121.27 -0.894 . . . . 0.0 109.395 179.978 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 51' ' ' PRO . . . . . 0.464 ' N ' ' SD ' ' A' ' 69' ' ' MET . 48.2 Cg_endo -70.1 -55.35 0.17 Allowed 'Trans proline' 0 C--O 1.216 -0.593 0 C-N-CA 122.727 2.285 . . . . 0.0 111.87 -179.949 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 27.9 m -50.83 -47.17 60.16 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.152 -0.967 . . . . 0.0 109.216 179.894 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 18.7 tp -58.06 -56.12 26.08 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.256 -0.903 . . . . 0.0 109.241 179.766 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 54' ' ' LEU . . . . . 0.728 HD12 ' O ' ' A' ' 50' ' ' THR . 5.1 mt -53.9 -43.17 69.46 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.285 -0.884 . . . . 0.0 109.092 179.615 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 55' ' ' ARG . . . . . 0.499 ' O ' ' N ' ' A' ' 59' ' ' SER . 73.5 ttt180 -48.83 -41.82 34.15 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.266 -0.896 . . . . 0.0 109.208 179.712 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 56' ' ' GLY . . . . . 0.474 ' O ' ' HD2' ' A' ' 60' ' ' PRO . . . -67.66 -35.39 85.81 Favored Glycine 0 N--CA 1.489 2.213 0 N-CA-C 109.263 -1.535 . . . . 0.0 109.263 179.857 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 57' ' ' ALA . . . . . 0.469 ' O ' ' CD1' ' A' ' 61' ' ' PHE . . . -70.87 -22.15 62.33 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.324 -1.103 . . . . 0.0 109.425 179.961 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 58' ' ' PHE . . . . . 0.675 ' CE2' HD12 ' A' ' 93' ' ' LEU . 96.6 m-85 -118.07 4.72 12.03 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.272 -0.892 . . . . 0.0 109.544 -179.953 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 59' ' ' SER . . . . . 0.538 ' N ' ' HD2' ' A' ' 60' ' ' PRO . 2.6 t -73.63 -56.89 2.78 Favored Pre-proline 0 N--CA 1.49 1.569 0 O-C-N 121.208 -0.932 . . . . 0.0 110.075 -179.67 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 60' ' ' PRO . . . . . 0.538 ' HD2' ' N ' ' A' ' 59' ' ' SER . 48.0 Cg_endo -68.81 -24.84 33.86 Favored 'Trans proline' 0 C--O 1.215 -0.652 0 C-N-CA 122.59 2.193 . . . . 0.0 111.989 -179.496 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 61' ' ' PHE . . . . . 0.587 ' CE2' ' HA ' ' A' ' 89' ' ' ALA . 68.0 m-85 -72.73 -25.08 61.08 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.179 -0.95 . . . . 0.0 109.508 179.968 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 166.18 -178.04 40.94 Favored Glycine 0 N--CA 1.49 2.256 0 N-CA-C 109.548 -1.421 . . . . 0.0 109.548 179.951 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 85.8 m-20 -92.43 139.51 30.52 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.305 -1.115 . . . . 0.0 109.504 179.986 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 64' ' ' ILE . . . . . 0.588 HG23 ' O ' ' A' ' 79' ' ' THR . 51.4 mt -99.87 134.12 40.41 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.522 0 O-C-N 121.243 -0.911 . . . . 0.0 109.461 -179.969 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 20.0 pt -96.36 -24.29 4.6 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.537 0 O-C-N 121.314 -0.866 . . . . 0.0 109.521 -179.92 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 50.8 t0 -146.28 121.14 9.94 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.229 -0.919 . . . . 0.0 109.597 -179.946 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 8.1 tp -110.14 121.39 45.14 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.236 -0.915 . . . . 0.0 109.389 179.902 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 68' ' ' SER . . . . . 0.468 ' HB3' ' HB2' ' A' ' 77' ' ' PHE . 34.6 t -134.69 144.51 47.83 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.224 -0.922 . . . . 0.0 109.419 179.941 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 69' ' ' MET . . . . . 0.464 ' SD ' ' N ' ' A' ' 51' ' ' PRO . 83.3 mtp -129.59 151.4 50.24 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.271 -0.893 . . . . 0.0 109.563 -179.96 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 70' ' ' ASP . . . . . 0.478 ' C ' ' HD2' ' A' ' 72' ' ' PRO . 0.2 OUTLIER -127.06 99.36 28.69 Favored Pre-proline 0 N--CA 1.491 1.6 0 O-C-N 121.3 -0.875 . . . . 0.0 109.419 179.982 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 71' ' ' PRO . . . . . 0.594 ' N ' ' CD ' ' A' ' 72' ' ' PRO . 47.4 Cg_endo -74.63 -27.85 10.39 Favored 'Trans proline' 0 CA--C 1.542 0.924 0 C-N-CA 122.476 2.118 . . . . 0.0 113.759 -179.972 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 72' ' ' PRO . . . . . 0.594 ' CD ' ' N ' ' A' ' 71' ' ' PRO . 53.9 Cg_endo -75.09 -25.8 11.38 Favored 'Trans proline' 0 C--N 1.352 0.759 0 C-N-CA 121.404 1.403 . . . . 0.0 111.823 -179.851 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 73' ' ' ARG . . . . . 0.431 ' O ' ' HB2' ' A' ' 74' ' ' ASN . 97.8 mtt180 -110.1 0.12 18.21 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.222 -0.924 . . . . 0.0 109.63 -179.918 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 74' ' ' ASN . . . . . 0.431 ' HB2' ' O ' ' A' ' 73' ' ' ARG . 79.1 m-20 61.03 46.28 8.45 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.19 -0.944 . . . . 0.0 109.589 179.9 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 75' ' ' CYS . . . . . 0.442 ' HA ' ' O ' ' A' ' 44' ' ' VAL . 23.9 p -146.68 133.72 20.34 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.212 -0.93 . . . . 0.0 109.51 179.987 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 76' ' ' ALA . . . . . 0.439 ' HA ' ' HA ' ' A' ' 69' ' ' MET . . . -106.35 161.28 14.7 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.282 -0.886 . . . . 0.0 109.488 179.932 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 77' ' ' PHE . . . . . 0.468 ' HB2' ' HB3' ' A' ' 68' ' ' SER . 98.5 m-85 -126.89 132.66 50.86 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.305 -0.872 . . . . 0.0 109.461 -179.979 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 78' ' ' VAL . . . . . 0.484 ' O ' ' N ' ' A' ' 42' ' ' LEU . 40.8 t -128.65 131.89 68.24 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 O-C-N 121.215 -0.928 . . . . 0.0 109.477 179.935 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 79' ' ' THR . . . . . 0.588 ' O ' HG23 ' A' ' 64' ' ' ILE . 7.0 m -104.38 139.39 39.4 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.228 -0.92 . . . . 0.0 109.429 -179.919 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 80' ' ' TYR . . . . . 0.56 ' HD2' HD11 ' A' ' 42' ' ' LEU . 0.8 OUTLIER -118.25 134.57 54.9 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.302 -0.874 . . . . 0.0 109.48 179.942 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 80.2 tt0 -52.35 -34.46 47.6 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.257 -0.902 . . . . 0.0 109.408 179.896 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 42.5 mtmt -128.55 142.17 51.14 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.277 -0.889 . . . . 0.0 109.524 179.9 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 83' ' ' MET . . . . . . . . . . . . . 31.3 mtm -62.56 -25.45 68.07 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.258 -0.901 . . . . 0.0 109.555 -179.946 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 96.9 mt-10 -62.59 -39.89 95.17 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.27 -0.894 . . . . 0.0 109.55 -179.949 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 16.0 m -63.89 -34.21 77.43 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.225 -0.922 . . . . 0.0 109.636 179.978 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 86' ' ' ALA . . . . . 0.469 ' CB ' HD21 ' A' ' 42' ' ' LEU . . . -72.39 -33.09 66.93 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.285 -0.884 . . . . 0.0 109.546 -179.966 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 22.2 t70 -65.11 -42.69 93.75 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.212 -0.93 . . . . 0.0 109.557 -179.947 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 64.6 tt0 -67.88 -36.77 80.84 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.223 -0.923 . . . . 0.0 109.579 -179.959 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 89' ' ' ALA . . . . . 0.587 ' HA ' ' CE2' ' A' ' 61' ' ' PHE . . . -76.69 -48.81 17.73 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.211 -0.931 . . . . 0.0 109.547 -179.944 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 90' ' ' VAL . . . . . 0.854 HG22 ' CG1' ' A' ' 105' ' ' VAL . 71.3 t -58.76 -29.21 39.52 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.524 0 O-C-N 121.22 -0.925 . . . . 0.0 109.455 -179.933 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -80.03 -54.18 6.03 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.248 -0.907 . . . . 0.0 109.758 -179.92 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 92' ' ' GLU . . . . . 0.506 ' HB2' ' CE2' ' A' ' 61' ' ' PHE . 91.0 mt-10 -71.21 -40.75 70.96 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.288 -0.882 . . . . 0.0 109.879 -179.597 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 93' ' ' LEU . . . . . 0.775 ' O ' HG23 ' A' ' 96' ' ' THR . 28.2 mt -68.56 -42.18 78.71 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.141 -0.974 . . . . 0.0 109.558 -179.828 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 94' ' ' ASN . . . . . 0.515 ' CB ' ' O ' ' A' ' 90' ' ' VAL . 60.6 t-20 -63.79 131.24 47.21 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.255 -0.903 . . . . 0.0 109.565 -179.965 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 86.66 35.21 10.49 Favored Glycine 0 N--CA 1.49 2.291 0 N-CA-C 109.513 -1.435 . . . . 0.0 109.513 -179.968 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 96' ' ' THR . . . . . 0.775 HG23 ' O ' ' A' ' 93' ' ' LEU . 22.0 p -124.21 160.36 28.08 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.221 -1.164 . . . . 0.0 109.367 179.952 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 97' ' ' GLN . . . . . 0.421 ' HG2' ' N ' ' A' ' 98' ' ' VAL . 62.3 tt0 -128.25 154.81 45.46 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.238 -0.914 . . . . 0.0 109.471 -179.942 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 98' ' ' VAL . . . . . 0.57 HG12 ' H ' ' A' ' 99' ' ' GLU . 1.2 t -106.19 -155.13 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.566 0 O-C-N 121.212 -0.93 . . . . 0.0 109.336 -179.978 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 99' ' ' GLU . . . . . 0.57 ' H ' HG12 ' A' ' 98' ' ' VAL . 96.2 mt-10 -56.76 -36.98 70.44 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.119 -0.988 . . . . 0.0 109.481 -179.943 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 20.9 t -160.95 23.28 0.14 Allowed 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.224 -0.923 . . . . 0.0 109.596 -179.953 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 101' ' ' VAL . . . . . 0.534 ' O ' HG23 ' A' ' 98' ' ' VAL . 48.7 t -138.57 154.29 26.86 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.547 0 O-C-N 121.214 -0.929 . . . . 0.0 109.558 -180.0 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 92.2 mt-30 -99.63 148.35 24.42 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.278 -0.889 . . . . 0.0 109.306 179.935 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 103' ' ' LEU . . . . . 0.421 HD23 ' HA ' ' A' ' 103' ' ' LEU . 91.9 mt -109.04 137.05 47.55 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.184 -0.947 . . . . 0.0 109.625 -179.905 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 104' ' ' LYS . . . . . 0.476 ' HB2' ' HB3' ' A' ' 45' ' ' TYR . 3.1 mtpm? -122.98 139.24 54.28 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.312 -0.868 . . . . 0.0 109.327 179.927 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 105' ' ' VAL . . . . . 0.854 ' CG1' HG22 ' A' ' 90' ' ' VAL . 25.8 t . . . . . 0 N--CA 1.489 1.519 0 O-C-N 121.207 -0.933 . . . . 0.0 109.559 -179.968 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 40' ' ' ASN . . . . . 0.52 ' N ' ' O ' ' A' ' 80' ' ' TYR . 42.3 t30 . . . . . 0 N--CA 1.489 1.525 0 N-CA-C 109.139 -0.689 . . . . 0.0 109.139 . . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 41' ' ' THR . . . . . 0.51 ' O ' HD23 ' A' ' 42' ' ' LEU . 8.2 m -63.88 134.01 54.36 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.315 -0.866 . . . . 0.0 109.986 -179.518 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 42' ' ' LEU . . . . . 0.87 HD11 ' HD2' ' A' ' 80' ' ' TYR . 20.4 mt -120.21 155.6 32.83 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.424 -0.797 . . . . 0.0 109.314 179.702 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 43' ' ' TYR . . . . . 0.455 ' O ' ' HA ' ' A' ' 105' ' ' VAL . 69.9 t80 -109.59 127.24 54.37 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.179 -0.951 . . . . 0.0 109.468 179.965 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 46.7 t -126.66 136.22 61.43 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.544 0 O-C-N 121.153 -0.967 . . . . 0.0 109.4 179.935 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 45' ' ' TYR . . . . . 0.486 ' HB3' ' HB2' ' A' ' 104' ' ' LYS . 65.6 t80 -127.53 136.43 51.71 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.292 -0.88 . . . . 0.0 109.596 -179.84 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -173.54 -163.88 27.85 Favored Glycine 0 N--CA 1.49 2.27 0 N-CA-C 109.374 -1.49 . . . . 0.0 109.374 179.988 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 47' ' ' GLU . . . . . 0.426 ' O ' ' C ' ' A' ' 48' ' ' ASP . 89.5 mt-10 -120.96 147.25 45.72 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.163 -1.199 . . . . 0.0 109.512 179.947 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 48' ' ' ASP . . . . . 0.426 ' C ' ' O ' ' A' ' 47' ' ' GLU . 47.0 m-20 43.49 54.18 5.42 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.227 -0.921 . . . . 0.0 109.477 179.966 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 54.4 mtm -97.34 136.1 38.3 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.318 -0.864 . . . . 0.0 109.607 -179.889 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 50' ' ' THR . . . . . 0.863 ' O ' HD12 ' A' ' 54' ' ' LEU . 0.0 OUTLIER -118.61 161.95 33.1 Favored Pre-proline 0 N--CA 1.49 1.548 0 O-C-N 121.258 -0.902 . . . . 0.0 109.49 179.927 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 51' ' ' PRO . . . . . 0.671 ' HD2' HG22 ' A' ' 50' ' ' THR . 48.1 Cg_endo -69.85 -50.19 0.48 Allowed 'Trans proline' 0 C--O 1.214 -0.683 0 C-N-CA 122.724 2.282 . . . . 0.0 111.731 -179.914 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 50.7 m -52.91 -47.43 67.99 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.228 -0.92 . . . . 0.0 109.311 179.904 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 10.8 tp -61.85 -57.2 12.74 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.402 -0.811 . . . . 0.0 109.25 179.788 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 54' ' ' LEU . . . . . 0.863 HD12 ' O ' ' A' ' 50' ' ' THR . 4.4 mt -53.63 -49.66 67.4 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.284 -0.885 . . . . 0.0 109.219 179.758 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 55' ' ' ARG . . . . . 0.435 ' C ' ' O ' ' A' ' 54' ' ' LEU . 77.7 ttt180 -43.66 -44.72 6.58 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.294 -0.879 . . . . 0.0 109.201 179.87 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -68.79 -33.3 75.28 Favored Glycine 0 N--CA 1.489 2.219 0 N-CA-C 109.159 -1.577 . . . . 0.0 109.159 179.737 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 57' ' ' ALA . . . . . 0.443 ' N ' ' O ' ' A' ' 54' ' ' LEU . . . -72.55 -20.11 61.39 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.353 -1.087 . . . . 0.0 109.297 179.935 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 58' ' ' PHE . . . . . 0.712 ' CZ ' HD13 ' A' ' 93' ' ' LEU . 95.2 m-85 -117.98 7.94 12.41 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.301 -0.875 . . . . 0.0 109.324 179.856 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 59' ' ' SER . . . . . 0.586 ' N ' ' HD2' ' A' ' 60' ' ' PRO . 0.5 OUTLIER -76.68 -50.1 2.6 Favored Pre-proline 0 N--CA 1.49 1.562 0 O-C-N 121.243 -0.91 . . . . 0.0 110.577 -179.644 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 60' ' ' PRO . . . . . 0.586 ' HD2' ' N ' ' A' ' 59' ' ' SER . 49.9 Cg_endo -70.72 -33.79 12.4 Favored 'Trans proline' 0 C--O 1.215 -0.654 0 C-N-CA 122.215 1.943 . . . . 0.0 112.454 -179.15 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 61' ' ' PHE . . . . . 0.584 ' CE1' ' HA ' ' A' ' 89' ' ' ALA . 77.4 m-85 -61.74 -43.96 97.83 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.042 -1.036 . . . . 0.0 109.516 -179.983 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 62' ' ' GLY . . . . . 0.42 ' HA3' ' OG ' ' A' ' 85' ' ' SER . . . -174.44 -168.29 35.03 Favored Glycine 0 N--CA 1.491 2.315 0 N-CA-C 109.464 -1.455 . . . . 0.0 109.464 -179.965 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 86.6 m-20 -98.1 143.5 28.58 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.235 -1.156 . . . . 0.0 109.409 -179.981 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 64' ' ' ILE . . . . . 0.482 HD11 ' HB2' ' A' ' 58' ' ' PHE . 37.8 mt -105.02 129.65 57.35 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.511 0 O-C-N 121.239 -0.913 . . . . 0.0 109.544 -179.904 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 21.3 pt -96.68 -21.58 5.35 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.602 0 O-C-N 121.324 -0.86 . . . . 0.0 109.614 -179.903 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 66' ' ' ASP . . . . . 0.451 ' HB3' ' OG1' ' A' ' 79' ' ' THR . 57.7 t0 -144.87 109.79 5.07 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.187 -0.946 . . . . 0.0 109.56 179.99 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 15.1 tp -108.07 121.48 44.91 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.301 -0.874 . . . . 0.0 109.437 179.979 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 68' ' ' SER . . . . . 0.473 ' HB3' ' HB2' ' A' ' 77' ' ' PHE . 22.7 t -131.09 139.04 49.81 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.281 -0.887 . . . . 0.0 109.421 -179.942 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 69' ' ' MET . . . . . 0.7 ' HE1' ' CD1' ' A' ' 54' ' ' LEU . 94.9 mmm -114.82 150.87 34.8 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.187 -0.946 . . . . 0.0 109.522 179.998 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 70' ' ' ASP . . . . . 0.477 ' C ' ' HD2' ' A' ' 72' ' ' PRO . 6.1 t0 -132.24 95.97 20.39 Favored Pre-proline 0 N--CA 1.49 1.542 0 O-C-N 121.222 -0.924 . . . . 0.0 109.516 -179.967 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 71' ' ' PRO . . . . . 0.592 ' N ' ' CD ' ' A' ' 72' ' ' PRO . 47.9 Cg_endo -74.81 -27.83 10.05 Favored 'Trans proline' 0 CA--C 1.543 0.956 0 C-N-CA 122.451 2.101 . . . . 0.0 113.623 -179.881 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 72' ' ' PRO . . . . . 0.592 ' CD ' ' N ' ' A' ' 71' ' ' PRO . 55.2 Cg_endo -75.13 -26.5 10.65 Favored 'Trans proline' 0 C--N 1.353 0.769 0 C-N-CA 121.51 1.473 . . . . 0.0 111.825 -179.848 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 73' ' ' ARG . . . . . 0.448 ' O ' ' HB2' ' A' ' 74' ' ' ASN . 77.7 mtt85 -109.24 -1.9 18.31 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.208 -0.932 . . . . 0.0 109.67 -179.841 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 74' ' ' ASN . . . . . 0.448 ' HB2' ' O ' ' A' ' 73' ' ' ARG . 78.4 m-20 61.89 43.12 9.59 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.159 -0.963 . . . . 0.0 109.599 179.97 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 75' ' ' CYS . . . . . 0.459 ' O ' ' CB ' ' A' ' 70' ' ' ASP . 28.4 p -146.52 141.9 27.5 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.277 -0.89 . . . . 0.0 109.47 179.941 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 76' ' ' ALA . . . . . 0.458 ' HB1' ' SD ' ' A' ' 69' ' ' MET . . . -114.11 161.88 17.2 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.214 -0.929 . . . . 0.0 109.56 -179.906 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 77' ' ' PHE . . . . . 0.473 ' HB2' ' HB3' ' A' ' 68' ' ' SER . 97.4 m-85 -123.77 130.94 53.41 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.24 -0.912 . . . . 0.0 109.385 -179.931 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 78' ' ' VAL . . . . . 0.505 ' O ' ' N ' ' A' ' 42' ' ' LEU . 39.2 t -128.62 132.12 68.08 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.597 0 O-C-N 121.185 -0.947 . . . . 0.0 109.592 -179.938 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 79' ' ' THR . . . . . 0.473 ' O ' ' HA ' ' A' ' 64' ' ' ILE . 7.1 m -106.74 123.15 47.72 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.203 -0.935 . . . . 0.0 109.612 179.928 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 80' ' ' TYR . . . . . 0.87 ' HD2' HD11 ' A' ' 42' ' ' LEU . 1.7 m-85 -101.94 126.45 48.85 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.261 -0.9 . . . . 0.0 109.299 179.879 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 81' ' ' GLU . . . . . 0.434 ' C ' ' O ' ' A' ' 80' ' ' TYR . 86.9 tt0 -42.89 -48.27 5.78 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.244 -0.91 . . . . 0.0 109.658 -179.758 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 29.8 mttt -110.96 153.84 24.97 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.184 -0.947 . . . . 0.0 109.526 179.972 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 83' ' ' MET . . . . . . . . . . . . . 58.8 mtt -73.05 -16.66 61.48 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.315 -0.865 . . . . 0.0 109.424 -179.939 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 75.6 mm-40 -71.92 -41.04 68.36 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.269 -0.894 . . . . 0.0 109.443 179.965 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 85' ' ' SER . . . . . 0.449 ' OG ' ' CD1' ' A' ' 80' ' ' TYR . 14.3 t -58.9 -39.67 82.18 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.219 -0.925 . . . . 0.0 109.34 179.907 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 86' ' ' ALA . . . . . 0.519 ' CB ' HD21 ' A' ' 42' ' ' LEU . . . -67.9 -37.76 82.13 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.374 -0.829 . . . . 0.0 109.446 179.956 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 56.6 t0 -60.13 -41.25 92.26 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.267 -0.896 . . . . 0.0 109.594 -179.971 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 88' ' ' GLN . . . . . 0.442 ' O ' ' CB ' ' A' ' 92' ' ' GLU . 60.5 tt0 -74.63 -41.98 59.38 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.189 -0.945 . . . . 0.0 109.441 179.975 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 89' ' ' ALA . . . . . 0.584 ' HA ' ' CE1' ' A' ' 61' ' ' PHE . . . -69.76 -46.98 64.63 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.222 -0.924 . . . . 0.0 109.446 -179.983 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 90' ' ' VAL . . . . . 0.719 HG22 HG21 ' A' ' 105' ' ' VAL . 48.4 t -64.93 -54.47 29.27 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.535 0 O-C-N 121.205 -0.935 . . . . 0.0 109.615 -179.926 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -61.53 -40.3 94.15 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.176 -0.952 . . . . 0.0 109.855 -179.671 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 92' ' ' GLU . . . . . 0.546 ' HB3' ' CE1' ' A' ' 61' ' ' PHE . 47.5 tp10 -77.73 -46.2 22.48 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.223 -0.923 . . . . 0.0 109.887 -179.672 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 93' ' ' LEU . . . . . 0.712 HD13 ' CZ ' ' A' ' 58' ' ' PHE . 49.8 mt -67.69 -37.84 82.85 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.157 -0.964 . . . . 0.0 109.643 -179.809 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 94' ' ' ASN . . . . . 0.572 ' HB2' ' CG1' ' A' ' 105' ' ' VAL . 50.5 t-20 -61.64 139.35 58.3 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.298 -0.876 . . . . 0.0 109.562 -179.856 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 73.95 30.4 61.41 Favored Glycine 0 N--CA 1.49 2.269 0 N-CA-C 109.482 -1.447 . . . . 0.0 109.482 179.972 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 96' ' ' THR . . . . . 0.699 HG23 ' O ' ' A' ' 93' ' ' LEU . 24.5 p -121.18 146.41 46.8 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.275 -1.132 . . . . 0.0 109.42 -179.97 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 97' ' ' GLN . . . . . 0.446 ' HG3' ' O ' ' A' ' 101' ' ' VAL . 63.5 tt0 -116.58 137.08 52.45 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.261 -0.9 . . . . 0.0 109.522 179.982 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 98' ' ' VAL . . . . . 0.489 HG12 ' H ' ' A' ' 99' ' ' GLU . 1.3 t -83.01 -148.53 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.569 0 O-C-N 121.252 -0.905 . . . . 0.0 109.319 -179.976 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 99' ' ' GLU . . . . . 0.489 ' H ' HG12 ' A' ' 98' ' ' VAL . 95.8 mt-10 -59.33 -36.16 75.16 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.172 -0.955 . . . . 0.0 109.444 -179.995 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -161.13 23.53 0.13 Allowed 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.275 -0.891 . . . . 0.0 109.564 179.89 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 101' ' ' VAL . . . . . 0.465 HG12 ' N ' ' A' ' 102' ' ' GLN . 95.1 t -134.75 158.05 41.37 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.569 0 O-C-N 121.197 -0.939 . . . . 0.0 109.454 179.895 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 102' ' ' GLN . . . . . 0.465 ' N ' HG12 ' A' ' 101' ' ' VAL . 88.2 mt-30 -102.13 161.24 13.84 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.227 -0.921 . . . . 0.0 109.48 -179.988 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 103' ' ' LEU . . . . . 0.689 HD12 ' OG1' ' A' ' 96' ' ' THR . 49.3 mt -114.73 134.27 55.23 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.263 -0.898 . . . . 0.0 109.634 -179.865 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 104' ' ' LYS . . . . . 0.486 ' HB2' ' HB3' ' A' ' 45' ' ' TYR . 63.4 mttm -126.75 94.4 4.03 Favored 'General case' 0 N--CA 1.489 1.504 0 N-CA-C 108.737 -0.838 . . . . 0.0 108.737 179.746 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 105' ' ' VAL . . . . . 0.719 HG21 HG22 ' A' ' 90' ' ' VAL . 9.7 p . . . . . 0 C--N 1.301 -1.51 0 O-C-N 121.444 -0.785 . . . . 0.0 109.963 -179.421 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 40' ' ' ASN . . . . . 0.48 ' N ' ' O ' ' A' ' 80' ' ' TYR . 42.7 t30 . . . . . 0 N--CA 1.489 1.513 0 N-CA-C 109.063 -0.717 . . . . 0.0 109.063 . . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 41' ' ' THR . . . . . 0.475 ' HA ' ' O ' ' A' ' 78' ' ' VAL . 54.0 m -75.58 150.51 38.05 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.176 -0.953 . . . . 0.0 109.879 -179.656 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 42' ' ' LEU . . . . . 0.856 HD12 ' O ' ' A' ' 78' ' ' VAL . 4.7 mp -126.56 147.25 49.89 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.331 -0.855 . . . . 0.0 109.386 179.806 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 76.4 t80 -102.5 115.43 30.57 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.246 -0.909 . . . . 0.0 109.42 179.961 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 44' ' ' VAL . . . . . 0.454 ' HA ' ' O ' ' A' ' 104' ' ' LYS . 41.1 t -113.5 143.92 22.21 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.558 0 O-C-N 121.296 -0.878 . . . . 0.0 109.396 179.832 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 45' ' ' TYR . . . . . 0.424 ' HB3' ' HB2' ' A' ' 104' ' ' LYS . 71.5 t80 -136.2 143.33 44.32 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.224 -0.923 . . . . 0.0 109.544 -179.959 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 46' ' ' GLY . . . . . 0.449 ' N ' ' SD ' ' A' ' 49' ' ' MET . . . 167.24 -175.06 42.45 Favored Glycine 0 N--CA 1.491 2.3 0 N-CA-C 109.506 -1.438 . . . . 0.0 109.506 179.98 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 47' ' ' GLU . . . . . 0.407 ' O ' ' C ' ' A' ' 48' ' ' ASP . 91.7 mt-10 -107.89 158.54 17.25 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.286 -1.126 . . . . 0.0 109.522 179.998 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 48' ' ' ASP . . . . . 0.407 ' C ' ' O ' ' A' ' 47' ' ' GLU . 44.9 m-20 43.93 45.97 6.63 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.266 -0.897 . . . . 0.0 109.457 -179.991 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 49' ' ' MET . . . . . 0.449 ' SD ' ' N ' ' A' ' 46' ' ' GLY . 23.4 mtp -85.42 132.32 34.24 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.237 -0.914 . . . . 0.0 109.449 179.942 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 50' ' ' THR . . . . . 0.769 ' O ' HD12 ' A' ' 54' ' ' LEU . 0.6 OUTLIER -121.4 159.77 48.74 Favored Pre-proline 0 N--CA 1.49 1.528 0 O-C-N 121.278 -0.889 . . . . 0.0 109.362 179.83 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 50.2 Cg_endo -70.3 -42.73 2.63 Favored 'Trans proline' 0 C--O 1.214 -0.692 0 C-N-CA 122.574 2.183 . . . . 0.0 111.6 -179.972 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 58.4 m -64.83 -47.4 78.12 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.308 -0.87 . . . . 0.0 109.255 179.721 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 14.3 tp -57.15 -52.06 66.83 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.322 -0.861 . . . . 0.0 109.276 179.818 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 54' ' ' LEU . . . . . 0.769 HD12 ' O ' ' A' ' 50' ' ' THR . 5.8 mt -57.85 -45.88 85.61 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.344 -0.847 . . . . 0.0 109.225 179.713 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 55' ' ' ARG . . . . . 0.495 ' O ' ' CB ' ' A' ' 59' ' ' SER . 24.1 ttt-85 -48.86 -36.18 16.37 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.275 -0.89 . . . . 0.0 109.299 179.757 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -72.95 -36.16 57.51 Favored Glycine 0 N--CA 1.489 2.211 0 N-CA-C 109.422 -1.471 . . . . 0.0 109.422 179.847 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -71.65 -27.16 62.88 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.238 -1.154 . . . . 0.0 109.302 179.923 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 58' ' ' PHE . . . . . 0.679 ' CE2' HD12 ' A' ' 93' ' ' LEU . 58.2 m-85 -113.58 8.9 17.83 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.356 -0.84 . . . . 0.0 109.399 179.96 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 59' ' ' SER . . . . . 0.514 ' N ' ' HD2' ' A' ' 60' ' ' PRO . 0.6 OUTLIER -74.59 -58.84 1.67 Allowed Pre-proline 0 N--CA 1.491 1.588 0 O-C-N 121.288 -0.883 . . . . 0.0 109.958 -179.627 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 60' ' ' PRO . . . . . 0.514 ' HD2' ' N ' ' A' ' 59' ' ' SER . 48.6 Cg_endo -68.94 -27.59 30.26 Favored 'Trans proline' 0 C--O 1.215 -0.639 0 C-N-CA 122.681 2.254 . . . . 0.0 112.068 -179.6 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 61' ' ' PHE . . . . . 0.583 ' CE2' ' HB2' ' A' ' 92' ' ' GLU . 46.2 m-85 -67.17 -33.63 75.82 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.113 -0.992 . . . . 0.0 109.516 -179.966 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 62' ' ' GLY . . . . . 0.442 ' HA3' ' OG ' ' A' ' 85' ' ' SER . . . 178.92 -175.08 47.09 Favored Glycine 0 N--CA 1.491 2.317 0 N-CA-C 109.491 -1.444 . . . . 0.0 109.491 -179.974 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 81.7 m-20 -94.44 139.39 31.19 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.313 -1.11 . . . . 0.0 109.468 179.941 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 64' ' ' ILE . . . . . 0.457 ' HA ' ' O ' ' A' ' 79' ' ' THR . 63.7 mt -102.3 130.43 52.18 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.522 0 O-C-N 121.244 -0.91 . . . . 0.0 109.551 -179.92 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 19.0 pt -95.94 -18.86 6.44 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.617 0 O-C-N 121.247 -0.908 . . . . 0.0 109.521 -179.989 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 66' ' ' ASP . . . . . 0.474 ' HB3' ' OG1' ' A' ' 79' ' ' THR . 52.1 t0 -145.57 144.46 30.51 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.227 -0.921 . . . . 0.0 109.585 179.904 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 67' ' ' LEU . . . . . 0.703 ' C ' HD13 ' A' ' 67' ' ' LEU . 2.5 tm? -126.09 110.45 13.54 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.303 -0.873 . . . . 0.0 109.218 179.94 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 68' ' ' SER . . . . . 0.519 ' N ' HD13 ' A' ' 67' ' ' LEU . 3.1 m -118.25 134.92 54.6 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.288 -0.883 . . . . 0.0 109.604 -179.73 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 69' ' ' MET . . . . . 0.499 ' SD ' ' HB1' ' A' ' 76' ' ' ALA . 77.7 mmm -120.57 146.47 46.3 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.33 -0.856 . . . . 0.0 109.327 179.86 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 70' ' ' ASP . . . . . 0.479 ' C ' ' HD2' ' A' ' 72' ' ' PRO . 0.1 OUTLIER -129.38 93.93 34.36 Favored Pre-proline 0 N--CA 1.491 1.582 0 O-C-N 121.147 -0.971 . . . . 0.0 109.491 -179.988 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 71' ' ' PRO . . . . . 0.593 ' N ' ' CD ' ' A' ' 72' ' ' PRO . 47.6 Cg_endo -74.93 -27.78 9.87 Favored 'Trans proline' 0 CA--C 1.543 0.936 0 C-N-CA 122.596 2.198 . . . . 0.0 113.738 179.968 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 72' ' ' PRO . . . . . 0.593 ' CD ' ' N ' ' A' ' 71' ' ' PRO . 55.2 Cg_endo -74.9 -21.5 16.03 Favored 'Trans proline' 0 C--N 1.353 0.804 0 C-N-CA 121.511 1.474 . . . . 0.0 111.86 -179.774 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 93.7 mtt-85 -115.31 4.29 14.4 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.243 -0.911 . . . . 0.0 109.591 -179.954 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 78.4 m-20 59.28 48.18 10.54 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.184 -0.948 . . . . 0.0 109.521 179.961 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 75' ' ' CYS . . . . . 0.472 ' O ' ' HB2' ' A' ' 70' ' ' ASP . 27.7 p -151.81 153.97 35.28 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.212 -0.93 . . . . 0.0 109.565 179.976 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 76' ' ' ALA . . . . . 0.499 ' HB1' ' SD ' ' A' ' 69' ' ' MET . . . -127.21 159.62 33.75 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.27 -0.894 . . . . 0.0 109.32 179.86 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 77' ' ' PHE . . . . . 0.48 ' HA ' ' O ' ' A' ' 42' ' ' LEU . 96.4 m-85 -125.19 126.21 44.86 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.255 -0.903 . . . . 0.0 109.571 -179.976 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 78' ' ' VAL . . . . . 0.856 ' O ' HD12 ' A' ' 42' ' ' LEU . 60.7 t -118.28 141.68 36.48 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.51 0 O-C-N 121.221 -0.924 . . . . 0.0 109.48 -179.984 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 79' ' ' THR . . . . . 0.478 ' HA ' ' O ' ' A' ' 40' ' ' ASN . 26.1 m -109.1 127.85 54.5 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.275 -0.891 . . . . 0.0 109.495 179.836 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 80' ' ' TYR . . . . . 0.48 ' O ' ' N ' ' A' ' 40' ' ' ASN . 0.6 OUTLIER -103.76 148.93 25.5 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.337 -0.852 . . . . 0.0 109.511 -179.879 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 81.7 tt0 -75.11 -22.66 58.07 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.271 -0.893 . . . . 0.0 109.27 179.842 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 31.1 mttp -131.6 136.26 47.64 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.308 -0.87 . . . . 0.0 109.378 179.9 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 83' ' ' MET . . . . . . . . . . . . . 49.5 mtt -60.89 -17.29 49.78 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.211 -0.931 . . . . 0.0 109.464 -179.926 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 97.7 mt-10 -71.13 -42.18 69.53 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.244 -0.91 . . . . 0.0 109.512 179.992 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 85' ' ' SER . . . . . 0.442 ' OG ' ' HA3' ' A' ' 62' ' ' GLY . 44.0 t -60.27 -39.49 87.02 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.212 -0.93 . . . . 0.0 109.465 179.975 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 86' ' ' ALA . . . . . 0.636 ' HA ' HD21 ' A' ' 42' ' ' LEU . . . -64.19 -42.12 96.79 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.266 -0.896 . . . . 0.0 109.505 -179.99 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 57.0 t0 -65.7 -39.81 91.63 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.28 -0.888 . . . . 0.0 109.577 -179.942 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 88' ' ' GLN . . . . . 0.437 ' HG2' ' CD2' ' A' ' 61' ' ' PHE . 52.2 tt0 -69.28 -41.48 76.78 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.187 -0.946 . . . . 0.0 109.613 -179.928 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 89' ' ' ALA . . . . . 0.482 ' HA ' ' CD2' ' A' ' 61' ' ' PHE . . . -74.35 -43.14 57.85 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.247 -0.908 . . . . 0.0 109.618 -179.9 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 90' ' ' VAL . . . . . 0.783 HG22 HG12 ' A' ' 105' ' ' VAL . 54.2 t -60.21 -33.04 52.13 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 O-C-N 121.229 -0.919 . . . . 0.0 109.756 -179.785 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -80.37 -51.05 9.32 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.144 -0.973 . . . . 0.0 110.122 -179.61 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 92' ' ' GLU . . . . . 0.583 ' HB2' ' CE2' ' A' ' 61' ' ' PHE . 76.1 mm-40 -72.69 -43.72 62.7 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.184 -0.948 . . . . 0.0 110.116 -179.368 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 93' ' ' LEU . . . . . 0.91 ' HB2' HG21 ' A' ' 105' ' ' VAL . 24.3 mt -68.69 -36.07 78.02 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.168 -0.957 . . . . 0.0 109.898 -179.508 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 94' ' ' ASN . . . . . 0.53 ' CB ' ' O ' ' A' ' 90' ' ' VAL . 53.1 t-20 -76.73 130.8 38.22 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.142 -0.974 . . . . 0.0 109.417 -179.891 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 94.66 20.55 28.79 Favored Glycine 0 N--CA 1.491 2.314 0 N-CA-C 109.64 -1.384 . . . . 0.0 109.64 179.89 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 96' ' ' THR . . . . . 0.438 ' CG2' ' O ' ' A' ' 92' ' ' GLU . 19.4 p -118.52 156.4 29.18 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.148 -1.207 . . . . 0.0 109.483 179.928 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 64.4 tt0 -126.18 152.27 46.23 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.241 -0.912 . . . . 0.0 109.434 -179.965 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 98' ' ' VAL . . . . . 0.595 HG12 ' H ' ' A' ' 99' ' ' GLU . 1.0 OUTLIER -100.22 -158.18 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 O-C-N 121.292 -0.88 . . . . 0.0 109.359 -179.943 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 99' ' ' GLU . . . . . 0.595 ' H ' HG12 ' A' ' 98' ' ' VAL . 76.1 mm-40 -55.51 -39.5 70.57 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.245 -0.91 . . . . 0.0 109.535 179.984 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 31.0 t -159.66 28.29 0.19 Allowed 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.267 -0.896 . . . . 0.0 109.44 -179.947 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 101' ' ' VAL . . . . . 0.558 ' O ' HG23 ' A' ' 98' ' ' VAL . 60.7 t -140.17 148.19 22.8 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.543 0 O-C-N 121.258 -0.901 . . . . 0.0 109.471 179.971 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 90.9 mt-30 -95.51 143.36 26.89 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.239 -0.913 . . . . 0.0 109.529 -179.911 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 103' ' ' LEU . . . . . 0.426 ' HA ' HD23 ' A' ' 103' ' ' LEU . 82.3 mt -109.7 136.48 48.97 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.284 -0.885 . . . . 0.0 109.404 179.926 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 104' ' ' LYS . . . . . 0.454 ' O ' ' HA ' ' A' ' 44' ' ' VAL . 42.9 mttt -126.05 128.82 48.0 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.182 -0.949 . . . . 0.0 109.509 -179.952 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 105' ' ' VAL . . . . . 0.91 HG21 ' HB2' ' A' ' 93' ' ' LEU . 21.4 t . . . . . 0 N--CA 1.489 1.52 0 O-C-N 121.233 -0.917 . . . . 0.0 109.34 179.9 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.56 0 N-CA-C 109.459 -0.571 . . . . 0.0 109.459 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 49.4 Cg_endo -69.92 -16.34 36.85 Favored 'Trans proline' 0 C--O 1.214 -0.696 0 C-N-CA 122.672 2.248 . . . . 0.0 111.928 -179.956 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 37' ' ' ARG . . . . . 0.468 ' O ' ' HG ' ' A' ' 114' ' ' LEU . 52.3 mtt180 -127.55 147.94 50.34 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.192 -0.943 . . . . 0.0 109.587 -179.935 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 38' ' ' LYS . . . . . 0.519 ' O ' ' CD1' ' A' ' 65' ' ' ILE . 94.9 mttt -150.22 -169.18 3.31 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.315 -0.865 . . . . 0.0 109.302 179.945 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 39' ' ' GLY . . . . . 0.81 ' HA3' HD11 ' A' ' 65' ' ' ILE . . . 150.99 86.62 0.06 OUTLIER Glycine 0 N--CA 1.49 2.245 0 N-CA-C 109.683 -1.367 . . . . 0.0 109.683 179.9 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 40.8 t-20 -89.19 102.0 14.66 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.238 -1.154 . . . . 0.0 109.423 179.807 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 41' ' ' THR . . . . . 0.472 ' OG1' ' HB2' ' A' ' 111' ' ' GLN . 53.2 m -69.54 134.35 48.73 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.27 -0.894 . . . . 0.0 109.595 -179.861 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 42' ' ' LEU . . . . . 0.695 HD11 ' CD2' ' A' ' 80' ' ' TYR . 16.6 mt -115.63 146.78 41.49 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.252 -0.905 . . . . 0.0 109.372 179.97 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 43' ' ' TYR . . . . . 0.455 ' O ' ' HA ' ' A' ' 105' ' ' VAL . 74.4 t80 -97.33 124.08 41.35 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.246 -0.908 . . . . 0.0 109.551 -179.977 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 44' ' ' VAL . . . . . 0.623 HG13 HD23 ' A' ' 103' ' ' LEU . 53.4 t -120.84 134.49 64.09 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.558 0 O-C-N 121.274 -0.891 . . . . 0.0 109.401 179.897 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 76.3 t80 -124.25 137.21 54.54 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.241 -0.912 . . . . 0.0 109.524 -179.876 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -178.23 -177.5 46.99 Favored Glycine 0 N--CA 1.491 2.302 0 N-CA-C 109.465 -1.454 . . . . 0.0 109.465 -179.989 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 47' ' ' GLU . . . . . 0.422 ' O ' ' C ' ' A' ' 48' ' ' ASP . 95.2 mt-10 -118.68 155.25 31.37 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.272 -1.134 . . . . 0.0 109.482 179.957 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 48' ' ' ASP . . . . . 0.422 ' C ' ' O ' ' A' ' 47' ' ' GLU . 47.6 m-20 43.89 48.01 7.02 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.282 -0.886 . . . . 0.0 109.54 179.961 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 58.5 mtm -93.26 143.31 26.38 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.208 -0.932 . . . . 0.0 109.509 179.954 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 50' ' ' THR . . . . . 0.786 ' O ' HD12 ' A' ' 54' ' ' LEU . 0.1 OUTLIER -118.42 166.29 14.25 Favored Pre-proline 0 N--CA 1.491 1.577 0 O-C-N 121.236 -0.915 . . . . 0.0 109.421 179.98 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 49.6 Cg_endo -70.02 -50.47 0.43 Allowed 'Trans proline' 0 C--O 1.214 -0.678 0 C-N-CA 122.713 2.275 . . . . 0.0 111.819 -179.916 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 39.8 m -58.55 -42.16 87.23 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.243 -0.911 . . . . 0.0 109.516 179.976 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 15.2 tp -61.31 -50.86 71.26 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.253 -0.905 . . . . 0.0 109.481 179.986 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 54' ' ' LEU . . . . . 0.786 HD12 ' O ' ' A' ' 50' ' ' THR . 4.2 mt -59.92 -42.75 94.58 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.232 -0.917 . . . . 0.0 109.442 179.954 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 55' ' ' ARG . . . . . 0.457 ' O ' ' CB ' ' A' ' 59' ' ' SER . 48.7 ttt85 -57.19 -32.93 66.95 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.217 -0.927 . . . . 0.0 109.433 179.908 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -76.21 -33.09 50.33 Favored Glycine 0 N--CA 1.49 2.259 0 N-CA-C 109.403 -1.479 . . . . 0.0 109.403 180.0 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 57' ' ' ALA . . . . . 0.551 ' O ' ' CD1' ' A' ' 61' ' ' PHE . . . -73.14 -19.75 61.06 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.314 -1.11 . . . . 0.0 109.411 -179.998 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 58' ' ' PHE . . . . . 0.694 ' CZ ' HD13 ' A' ' 93' ' ' LEU . 96.7 m-85 -121.62 4.37 10.1 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.211 -0.931 . . . . 0.0 109.482 179.914 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 59' ' ' SER . . . . . 0.534 ' N ' ' HD2' ' A' ' 60' ' ' PRO . 0.3 OUTLIER -72.21 -57.31 3.78 Favored Pre-proline 0 N--CA 1.49 1.546 0 O-C-N 121.215 -0.928 . . . . 0.0 109.762 -179.859 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 60' ' ' PRO . . . . . 0.534 ' HD2' ' N ' ' A' ' 59' ' ' SER . 48.9 Cg_endo -69.52 -30.93 22.59 Favored 'Trans proline' 0 C--O 1.214 -0.678 0 C-N-CA 122.637 2.225 . . . . 0.0 111.94 -179.818 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 61' ' ' PHE . . . . . 0.569 ' CD2' ' HA ' ' A' ' 89' ' ' ALA . 62.6 m-85 -62.92 -33.01 74.42 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.241 -0.912 . . . . 0.0 109.455 179.974 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 173.39 -175.47 46.16 Favored Glycine 0 N--CA 1.49 2.264 0 N-CA-C 109.411 -1.476 . . . . 0.0 109.411 179.985 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 38.7 t30 -92.22 141.4 28.62 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.266 -1.138 . . . . 0.0 109.506 179.961 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 64' ' ' ILE . . . . . 0.575 HD13 HD13 ' A' ' 67' ' ' LEU . 71.4 mt -103.83 130.04 54.99 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.521 0 O-C-N 121.246 -0.909 . . . . 0.0 109.432 179.98 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 65' ' ' ILE . . . . . 0.81 HD11 ' HA3' ' A' ' 39' ' ' GLY . 20.6 pt -94.54 -21.95 5.63 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.537 0 O-C-N 121.252 -0.905 . . . . 0.0 109.475 179.983 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 45.7 t0 -159.26 109.43 1.95 Allowed 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.277 -0.89 . . . . 0.0 109.508 -179.969 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 67' ' ' LEU . . . . . 0.964 HD11 HG22 ' A' ' 78' ' ' VAL . 0.6 OUTLIER -111.96 122.34 47.51 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.259 -0.901 . . . . 0.0 109.367 179.937 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 38.1 m -117.94 150.78 38.66 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.235 -0.915 . . . . 0.0 109.637 -179.917 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 69' ' ' MET . . . . . 0.403 ' CE ' ' CD1' ' A' ' 54' ' ' LEU . 85.6 mtp -123.74 143.59 50.2 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.229 -0.919 . . . . 0.0 109.408 179.926 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 70' ' ' ASP . . . . . 0.476 ' C ' ' HD2' ' A' ' 72' ' ' PRO . 1.7 m-20 -122.31 105.88 36.2 Favored Pre-proline 0 N--CA 1.491 1.615 0 O-C-N 121.268 -0.895 . . . . 0.0 109.493 -179.976 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 71' ' ' PRO . . . . . 0.606 ' N ' ' CD ' ' A' ' 72' ' ' PRO . 47.1 Cg_endo -74.54 -27.9 10.52 Favored 'Trans proline' 0 CA--C 1.543 0.941 0 C-N-CA 122.511 2.141 . . . . 0.0 113.686 179.99 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 72' ' ' PRO . . . . . 0.606 ' CD ' ' N ' ' A' ' 71' ' ' PRO . 55.1 Cg_endo -75.41 -29.11 7.93 Favored 'Trans proline' 0 C--N 1.353 0.793 0 C-N-CA 121.511 1.474 . . . . 0.0 111.733 -179.794 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 73' ' ' ARG . . . . . 0.432 ' O ' ' HB2' ' A' ' 74' ' ' ASN . 61.8 mtt-85 -107.89 -4.22 18.18 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.267 -0.896 . . . . 0.0 109.622 -179.919 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 74' ' ' ASN . . . . . 0.432 ' HB2' ' O ' ' A' ' 73' ' ' ARG . 84.5 m-20 61.7 36.41 16.46 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.231 -0.918 . . . . 0.0 109.493 -179.967 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 75' ' ' CYS . . . . . 0.465 ' SG ' ' HB2' ' A' ' 70' ' ' ASP . 21.9 p -130.85 137.09 49.22 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.266 -0.896 . . . . 0.0 109.477 -180.0 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -110.28 148.3 32.17 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.264 -0.897 . . . . 0.0 109.421 179.998 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 77' ' ' PHE . . . . . 0.465 ' HA ' ' O ' ' A' ' 42' ' ' LEU . 96.9 m-85 -114.2 132.08 56.24 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.214 -0.929 . . . . 0.0 109.528 179.989 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 78' ' ' VAL . . . . . 0.964 HG22 HD11 ' A' ' 67' ' ' LEU . 39.5 t -123.13 128.9 75.2 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 O-C-N 121.239 -0.913 . . . . 0.0 109.474 179.966 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 79' ' ' THR . . . . . 0.634 HG22 ' HA2' ' A' ' 39' ' ' GLY . 17.5 m -101.18 132.2 46.78 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.245 -0.91 . . . . 0.0 109.437 -179.994 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 80' ' ' TYR . . . . . 0.695 ' CD2' HD11 ' A' ' 42' ' ' LEU . 1.5 m-85 -112.11 145.93 38.91 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.241 -0.912 . . . . 0.0 109.491 -179.942 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 81' ' ' GLU . . . . . 0.488 ' O ' ' CD ' ' A' ' 38' ' ' LYS . 83.4 tt0 -70.9 -28.97 64.93 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.21 -0.931 . . . . 0.0 109.423 179.817 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 44.2 mttm -124.58 145.99 49.29 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.301 -0.875 . . . . 0.0 109.391 179.956 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 83' ' ' MET . . . . . 0.674 ' HG3' ' HB3' ' A' ' 117' ' ' ALA . 44.1 mtt -64.62 -22.6 67.02 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.241 -0.912 . . . . 0.0 109.468 179.992 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 97.6 mt-10 -69.92 -37.68 76.01 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.204 -0.935 . . . . 0.0 109.525 -179.953 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 85' ' ' SER . . . . . 0.426 ' HB2' ' CG ' ' A' ' 80' ' ' TYR . 17.3 m -59.92 -34.11 72.77 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.271 -0.893 . . . . 0.0 109.489 179.995 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 86' ' ' ALA . . . . . 0.56 ' CB ' HD21 ' A' ' 42' ' ' LEU . . . -79.63 -28.64 40.89 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.266 -0.897 . . . . 0.0 109.518 -179.959 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 87' ' ' ASP . . . . . 0.425 ' O ' ' CB ' ' A' ' 91' ' ' ALA . 94.4 m-20 -67.11 -44.6 79.51 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.257 -0.902 . . . . 0.0 109.517 -179.923 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 88' ' ' GLN . . . . . 0.52 ' HG2' ' CE2' ' A' ' 61' ' ' PHE . 62.5 tt0 -72.16 -39.38 68.76 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.218 -0.926 . . . . 0.0 109.448 -179.942 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 89' ' ' ALA . . . . . 0.569 ' HA ' ' CD2' ' A' ' 61' ' ' PHE . . . -73.96 -45.71 48.53 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.243 -0.911 . . . . 0.0 109.552 -179.98 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 90' ' ' VAL . . . . . 0.698 HG22 HG11 ' A' ' 105' ' ' VAL . 65.7 t -69.75 -36.12 68.53 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.574 0 O-C-N 121.237 -0.915 . . . . 0.0 109.551 -179.935 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 91' ' ' ALA . . . . . 0.425 ' CB ' ' O ' ' A' ' 87' ' ' ASP . . . -79.02 -40.48 31.32 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.295 -0.878 . . . . 0.0 109.647 -179.866 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 92' ' ' GLU . . . . . 0.537 ' OE1' ' CE2' ' A' ' 61' ' ' PHE . 40.1 tt0 -77.29 -42.67 36.04 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.221 -0.924 . . . . 0.0 109.527 -179.866 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 93' ' ' LEU . . . . . 0.694 HD13 ' CZ ' ' A' ' 58' ' ' PHE . 51.2 mt -69.97 -40.87 75.11 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.226 -0.921 . . . . 0.0 109.502 -179.942 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 94' ' ' ASN . . . . . 0.486 ' HB2' ' O ' ' A' ' 90' ' ' VAL . 63.4 t-20 -64.49 130.03 42.13 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.218 -0.926 . . . . 0.0 109.506 179.975 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 88.82 26.99 25.33 Favored Glycine 0 N--CA 1.49 2.257 0 N-CA-C 109.507 -1.437 . . . . 0.0 109.507 179.978 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 96' ' ' THR . . . . . 0.433 HG23 ' O ' ' A' ' 93' ' ' LEU . 27.2 p -124.29 144.62 49.88 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.212 -1.169 . . . . 0.0 109.557 179.932 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 97' ' ' GLN . . . . . 0.464 ' HG3' ' O ' ' A' ' 101' ' ' VAL . 56.0 tt0 -119.5 142.01 48.68 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.345 -0.847 . . . . 0.0 109.412 179.972 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 98' ' ' VAL . . . . . 0.53 HG12 ' H ' ' A' ' 99' ' ' GLU . 1.0 OUTLIER -85.23 -154.31 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 O-C-N 121.188 -0.945 . . . . 0.0 109.374 -179.91 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 99' ' ' GLU . . . . . 0.53 ' H ' HG12 ' A' ' 98' ' ' VAL . 96.4 mt-10 -58.8 -40.97 85.63 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.242 -0.911 . . . . 0.0 109.477 179.997 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 100' ' ' SER . . . . . 0.463 ' O ' ' OG ' ' A' ' 100' ' ' SER . 4.4 t -153.72 24.75 0.51 Allowed 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.295 -0.878 . . . . 0.0 109.394 -179.996 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 101' ' ' VAL . . . . . 0.604 HG12 ' N ' ' A' ' 102' ' ' GLN . 53.4 t -137.01 167.85 22.78 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.521 0 O-C-N 121.285 -0.885 . . . . 0.0 109.442 -179.957 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 102' ' ' GLN . . . . . 0.604 ' N ' HG12 ' A' ' 101' ' ' VAL . 93.7 mt-30 -123.83 149.8 45.31 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.233 -0.917 . . . . 0.0 109.264 179.909 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 103' ' ' LEU . . . . . 0.623 HD23 HG13 ' A' ' 44' ' ' VAL . 0.0 OUTLIER -120.08 121.23 38.41 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.135 -0.978 . . . . 0.0 109.777 -179.859 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 29.9 mttt -106.49 131.67 53.4 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.314 -0.866 . . . . 0.0 109.24 179.81 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 105' ' ' VAL . . . . . 0.698 HG11 HG22 ' A' ' 90' ' ' VAL . 15.6 t -111.43 139.19 36.71 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.572 0 O-C-N 121.195 -0.941 . . . . 0.0 109.665 -179.842 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 106' ' ' ASN . . . . . 0.421 ' HB2' ' HB3' ' A' ' 43' ' ' TYR . 87.4 m-20 -136.18 -172.03 3.03 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.311 -0.868 . . . . 0.0 109.297 179.86 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 23.5 mm -107.1 130.84 58.52 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.528 0 O-C-N 121.175 -0.953 . . . . 0.0 109.497 179.981 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -99.79 151.82 20.82 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.285 -0.884 . . . . 0.0 109.391 -179.943 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 90.1 mtt180 -99.15 9.27 43.79 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.211 -0.931 . . . . 0.0 109.519 179.965 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 110' ' ' LYS . . . . . 0.511 ' O ' ' CB ' ' A' ' 111' ' ' GLN . 90.8 mttt -84.68 172.12 11.8 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.201 -0.937 . . . . 0.0 109.343 179.932 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 111' ' ' GLN . . . . . 0.733 ' HG3' ' HE2' ' A' ' 113' ' ' MET . 4.5 tp-100 75.69 46.51 0.16 Allowed Pre-proline 0 N--CA 1.49 1.55 0 O-C-N 121.318 -0.864 . . . . 0.0 109.549 179.927 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 112' ' ' PRO . . . . . 0.571 ' CD ' ' N ' ' A' ' 111' ' ' GLN . 52.8 Cg_endo -72.93 -18.74 24.11 Favored 'Trans proline' 0 C--O 1.215 -0.638 0 C-N-CA 122.72 2.28 . . . . 0.0 111.646 179.981 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 113' ' ' MET . . . . . 0.733 ' HE2' ' HG3' ' A' ' 111' ' ' GLN . 0.0 OUTLIER -43.55 -26.79 0.24 Allowed 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.285 -0.885 . . . . 0.0 109.6 -179.827 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 114' ' ' LEU . . . . . 0.546 HD13 ' O ' ' A' ' 114' ' ' LEU . 0.2 OUTLIER -155.53 20.02 0.4 Allowed 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.159 -0.963 . . . . 0.0 109.685 179.973 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 115' ' ' ASP . . . . . 0.712 ' O ' ' HB3' ' A' ' 116' ' ' ALA . 77.5 m-20 40.04 47.21 1.93 Allowed 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.612 -0.68 . . . . 0.0 109.492 179.967 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 116' ' ' ALA . . . . . 0.712 ' HB3' ' O ' ' A' ' 115' ' ' ASP . . . 78.02 -76.31 0.05 OUTLIER 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.374 -0.829 . . . . 0.0 109.347 -179.52 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 117' ' ' ALA . . . . . 0.674 ' HB3' ' HG3' ' A' ' 83' ' ' MET . . . -165.62 -148.35 0.1 Allowed 'General case' 0 C--N 1.303 -1.432 0 O-C-N 121.329 -0.857 . . . . 0.0 109.575 -179.858 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 14.2 t -127.76 155.5 43.93 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.199 -0.938 . . . . 0.0 109.424 179.992 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 170.64 -175.57 44.42 Favored Glycine 0 N--CA 1.49 2.25 0 N-CA-C 109.484 -1.446 . . . . 0.0 109.484 179.977 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 12.4 mtmt -57.34 -35.49 69.97 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.295 -1.121 . . . . 0.0 109.535 179.967 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 121' ' ' SER . . . . . 0.422 ' OXT' ' OG ' ' A' ' 121' ' ' SER . 0.7 OUTLIER . . . . . 0 N--CA 1.49 1.555 0 CA-C-O 117.987 -1.006 . . . . 0.0 109.474 -179.958 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 35' ' ' ALA . . . . . 0.816 ' HB3' ' HD3' ' A' ' 36' ' ' PRO . . . . . . . . 0 N--CA 1.49 1.545 0 N-CA-C 109.461 -0.57 . . . . 0.0 109.461 . . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 36' ' ' PRO . . . . . 0.816 ' HD3' ' HB3' ' A' ' 35' ' ' ALA . 50.2 Cg_endo -70.03 146.05 57.35 Favored 'Trans proline' 0 C--O 1.216 -0.619 0 C-N-CA 122.766 2.31 . . . . 0.0 111.79 -179.988 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 37' ' ' ARG . . . . . 0.85 ' O ' HD13 ' A' ' 114' ' ' LEU . 90.6 mtt-85 -129.78 134.67 47.72 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.233 -0.917 . . . . 0.0 109.536 -179.992 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 38' ' ' LYS . . . . . 1.034 ' HA ' HD22 ' A' ' 114' ' ' LEU . 93.9 mttt -72.87 -170.16 0.68 Allowed 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.244 -0.91 . . . . 0.0 109.446 179.971 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 39' ' ' GLY . . . . . 0.818 ' HA3' HD11 ' A' ' 65' ' ' ILE . . . 151.84 78.56 0.02 OUTLIER Glycine 0 N--CA 1.489 2.191 0 N-CA-C 109.837 -1.305 . . . . 0.0 109.837 179.873 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 40' ' ' ASN . . . . . 0.476 ' O ' ' HA ' ' A' ' 79' ' ' THR . 47.1 t-20 -73.16 121.2 19.88 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.177 -1.19 . . . . 0.0 109.191 179.664 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 41' ' ' THR . . . . . 0.809 HG21 ' HB3' ' A' ' 110' ' ' LYS . 86.8 m -84.81 141.56 30.39 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.219 -0.925 . . . . 0.0 109.645 -179.714 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 42' ' ' LEU . . . . . 0.844 HD12 ' O ' ' A' ' 78' ' ' VAL . 5.1 mp -119.03 148.72 42.7 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.274 -0.891 . . . . 0.0 109.375 179.91 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 43' ' ' TYR . . . . . 0.48 ' HB3' ' HB2' ' A' ' 106' ' ' ASN . 62.5 t80 -102.18 113.57 26.96 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.248 -0.908 . . . . 0.0 109.61 -179.927 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 44' ' ' VAL . . . . . 0.525 HG13 HD23 ' A' ' 103' ' ' LEU . 17.7 t -109.47 138.79 35.24 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.573 0 O-C-N 121.272 -0.892 . . . . 0.0 109.483 179.978 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 73.9 t80 -134.12 132.6 40.08 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.247 -0.908 . . . . 0.0 109.571 -179.922 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -175.74 -167.18 34.35 Favored Glycine 0 N--CA 1.49 2.269 0 N-CA-C 109.488 -1.445 . . . . 0.0 109.488 179.99 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 47' ' ' GLU . . . . . 0.49 ' H ' HG11 ' A' ' 101' ' ' VAL . 89.9 mt-10 -116.92 157.85 25.02 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.2 -1.177 . . . . 0.0 109.392 -179.948 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 48' ' ' ASP . . . . . 0.404 ' C ' ' O ' ' A' ' 47' ' ' GLU . 23.0 t70 44.01 42.35 4.68 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.301 -0.874 . . . . 0.0 109.382 -179.992 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 49' ' ' MET . . . . . 0.409 ' HE1' HG12 ' A' ' 44' ' ' VAL . 54.4 mtp -73.9 139.44 44.97 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.234 -0.916 . . . . 0.0 109.549 179.943 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 50' ' ' THR . . . . . 0.668 ' O ' HD12 ' A' ' 54' ' ' LEU . 5.1 p -126.14 162.66 44.62 Favored Pre-proline 0 N--CA 1.49 1.566 0 O-C-N 121.336 -0.853 . . . . 0.0 109.425 179.996 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 51' ' ' PRO . . . . . 0.455 ' CA ' ' SD ' ' A' ' 69' ' ' MET . 49.4 Cg_endo -70.22 -50.73 0.39 Allowed 'Trans proline' 0 C--O 1.215 -0.65 0 C-N-CA 122.625 2.217 . . . . 0.0 111.73 -179.983 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 41.2 m -60.77 -40.74 93.65 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.225 -0.922 . . . . 0.0 109.422 179.951 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 15.7 tp -66.53 -46.88 74.7 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.298 -0.876 . . . . 0.0 109.36 179.985 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 54' ' ' LEU . . . . . 0.668 HD12 ' O ' ' A' ' 50' ' ' THR . 10.8 mt -58.24 -46.33 86.14 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.313 -0.867 . . . . 0.0 109.318 179.944 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 55' ' ' ARG . . . . . 0.509 ' O ' ' N ' ' A' ' 59' ' ' SER . 74.0 mtt180 -56.64 -36.7 69.79 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.282 -0.886 . . . . 0.0 109.543 179.995 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -67.64 -32.89 79.4 Favored Glycine 0 N--CA 1.49 2.294 0 N-CA-C 109.554 -1.418 . . . . 0.0 109.554 179.948 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 57' ' ' ALA . . . . . 0.455 ' O ' ' CD1' ' A' ' 61' ' ' PHE . . . -73.31 -23.83 60.31 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.266 -1.138 . . . . 0.0 109.411 -179.917 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 58' ' ' PHE . . . . . 0.807 ' HB2' HD11 ' A' ' 64' ' ' ILE . 98.6 m-85 -118.95 8.51 11.67 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.33 -0.856 . . . . 0.0 109.46 -179.98 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 59' ' ' SER . . . . . 0.53 ' N ' ' HD2' ' A' ' 60' ' ' PRO . 1.1 t -74.5 -57.51 2.06 Favored Pre-proline 0 N--CA 1.491 1.598 0 O-C-N 121.238 -0.914 . . . . 0.0 109.852 -179.715 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 60' ' ' PRO . . . . . 0.53 ' HD2' ' N ' ' A' ' 59' ' ' SER . 50.3 Cg_endo -69.84 -32.27 18.54 Favored 'Trans proline' 0 C--O 1.215 -0.627 0 C-N-CA 122.601 2.2 . . . . 0.0 111.945 -179.783 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 61' ' ' PHE . . . . . 0.577 ' CE2' ' HA ' ' A' ' 89' ' ' ALA . 67.6 m-85 -63.61 -31.82 73.11 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.163 -0.961 . . . . 0.0 109.406 -179.946 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 171.22 -176.7 44.46 Favored Glycine 0 N--CA 1.49 2.278 0 N-CA-C 109.634 -1.387 . . . . 0.0 109.634 -179.993 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 82.9 m-20 -90.04 145.15 25.29 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.302 -1.117 . . . . 0.0 109.461 179.991 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 64' ' ' ILE . . . . . 0.807 HD11 ' HB2' ' A' ' 58' ' ' PHE . 77.6 mt -106.85 131.3 57.11 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.525 0 O-C-N 121.3 -0.875 . . . . 0.0 109.619 -179.973 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 65' ' ' ILE . . . . . 0.818 HD11 ' HA3' ' A' ' 39' ' ' GLY . 28.2 pt -91.76 -22.85 5.94 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.599 0 O-C-N 121.3 -0.875 . . . . 0.0 109.393 179.948 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 66' ' ' ASP . . . . . 0.456 ' HB3' ' OG1' ' A' ' 79' ' ' THR . 53.6 t0 -149.5 115.3 5.64 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.239 -0.913 . . . . 0.0 109.467 -179.927 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 67' ' ' LEU . . . . . 0.701 HD23 HD13 ' A' ' 64' ' ' ILE . 0.5 OUTLIER -103.87 114.86 29.42 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.263 -0.898 . . . . 0.0 109.505 179.999 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 68' ' ' SER . . . . . 0.643 ' N ' HD13 ' A' ' 67' ' ' LEU . 39.2 t -119.5 149.72 41.43 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.176 -0.952 . . . . 0.0 109.53 179.978 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 69' ' ' MET . . . . . 0.455 ' SD ' ' CA ' ' A' ' 51' ' ' PRO . 77.2 mtp -128.46 148.91 50.76 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.309 -0.869 . . . . 0.0 109.472 -179.983 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 70' ' ' ASP . . . . . 0.516 ' CB ' ' O ' ' A' ' 75' ' ' CYS . 0.4 OUTLIER -127.84 94.66 36.59 Favored Pre-proline 0 N--CA 1.49 1.572 0 O-C-N 121.272 -0.892 . . . . 0.0 109.421 179.967 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 71' ' ' PRO . . . . . 0.593 ' N ' ' CD ' ' A' ' 72' ' ' PRO . 47.4 Cg_endo -74.66 -27.93 10.26 Favored 'Trans proline' 0 CA--C 1.542 0.922 0 C-N-CA 122.564 2.176 . . . . 0.0 113.584 179.98 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 72' ' ' PRO . . . . . 0.593 ' CD ' ' N ' ' A' ' 71' ' ' PRO . 55.4 Cg_endo -75.49 -21.44 14.97 Favored 'Trans proline' 0 C--N 1.352 0.761 0 C-N-CA 121.46 1.44 . . . . 0.0 111.797 -179.86 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 67.8 mtt85 -115.23 3.66 14.33 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.252 -0.905 . . . . 0.0 109.7 -179.878 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 78.6 m-20 60.12 44.64 12.72 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.234 -0.916 . . . . 0.0 109.474 179.958 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 75' ' ' CYS . . . . . 0.516 ' O ' ' CB ' ' A' ' 70' ' ' ASP . 28.0 p -149.86 153.2 36.34 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.26 -0.9 . . . . 0.0 109.566 -179.942 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -127.8 159.36 35.07 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.291 -0.88 . . . . 0.0 109.35 179.899 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 77' ' ' PHE . . . . . 0.476 ' HA ' ' O ' ' A' ' 42' ' ' LEU . 96.3 m-85 -120.94 136.79 54.87 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.179 -0.951 . . . . 0.0 109.533 179.997 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 78' ' ' VAL . . . . . 0.844 ' O ' HD12 ' A' ' 42' ' ' LEU . 39.7 t -125.45 135.14 64.93 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 O-C-N 121.247 -0.908 . . . . 0.0 109.546 -179.974 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 79' ' ' THR . . . . . 0.64 HG21 HD11 ' A' ' 65' ' ' ILE . 17.3 m -104.03 127.43 51.59 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.287 -0.883 . . . . 0.0 109.451 179.964 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 80' ' ' TYR . . . . . 0.504 ' CG ' ' HB2' ' A' ' 85' ' ' SER . 1.2 m-85 -108.44 139.82 42.63 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.273 -0.892 . . . . 0.0 109.507 179.958 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 81' ' ' GLU . . . . . 0.466 ' O ' ' HB2' ' A' ' 38' ' ' LYS . 76.8 tt0 -61.35 -24.43 66.46 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.232 -0.917 . . . . 0.0 109.326 179.867 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 42.8 mttm -134.18 144.61 48.59 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.28 -0.887 . . . . 0.0 109.32 179.948 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 83' ' ' MET . . . . . 0.674 ' HG3' ' HB3' ' A' ' 117' ' ' ALA . 53.8 mtt -65.55 -17.56 64.67 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.17 -0.956 . . . . 0.0 109.548 -179.912 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 97.4 mt-10 -69.98 -35.13 74.19 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.232 -0.918 . . . . 0.0 109.468 -179.924 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 85' ' ' SER . . . . . 0.504 ' HB2' ' CG ' ' A' ' 80' ' ' TYR . 18.0 m -66.84 -30.42 70.59 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.252 -0.905 . . . . 0.0 109.468 -179.943 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 86' ' ' ALA . . . . . 0.76 ' HA ' HD21 ' A' ' 42' ' ' LEU . . . -79.17 -37.43 38.39 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.223 -0.923 . . . . 0.0 109.504 -179.96 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 55.4 t0 -61.78 -47.19 86.27 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.166 -0.959 . . . . 0.0 109.407 179.97 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 88' ' ' GLN . . . . . 0.469 ' O ' ' HB2' ' A' ' 92' ' ' GLU . 64.2 tt0 -67.88 -39.96 83.63 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.289 -0.882 . . . . 0.0 109.316 179.957 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 89' ' ' ALA . . . . . 0.577 ' HA ' ' CE2' ' A' ' 61' ' ' PHE . . . -71.72 -38.91 70.42 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.283 -0.886 . . . . 0.0 109.531 -179.967 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 90' ' ' VAL . . . . . 0.778 HG22 HG12 ' A' ' 105' ' ' VAL . 74.1 t -66.0 -45.33 91.12 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.616 0 O-C-N 121.309 -0.869 . . . . 0.0 109.627 -179.858 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -70.98 -34.51 71.46 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.196 -0.94 . . . . 0.0 109.667 -179.854 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 92' ' ' GLU . . . . . 0.536 ' HB3' ' CZ ' ' A' ' 61' ' ' PHE . 2.4 tm-20 -82.85 -49.3 9.83 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.28 -0.888 . . . . 0.0 109.617 -179.948 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 93' ' ' LEU . . . . . 1.058 ' HB2' HG21 ' A' ' 105' ' ' VAL . 85.3 mt -65.8 -35.0 79.46 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.222 -0.924 . . . . 0.0 109.598 -179.892 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 94' ' ' ASN . . . . . 0.524 ' CB ' ' O ' ' A' ' 90' ' ' VAL . 56.5 t-20 -71.71 130.51 41.33 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.277 -0.889 . . . . 0.0 109.463 -179.985 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 87.24 30.66 19.02 Favored Glycine 0 N--CA 1.489 2.204 0 N-CA-C 109.51 -1.436 . . . . 0.0 109.51 179.97 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 96' ' ' THR . . . . . 0.474 ' CG2' ' O ' ' A' ' 92' ' ' GLU . 28.8 p -122.56 148.08 45.63 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.228 -1.16 . . . . 0.0 109.523 -179.956 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 97' ' ' GLN . . . . . 0.442 ' HG3' ' O ' ' A' ' 101' ' ' VAL . 57.2 tt0 -118.6 143.22 46.94 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.309 -0.869 . . . . 0.0 109.444 -179.953 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 98' ' ' VAL . . . . . 0.49 HG12 ' H ' ' A' ' 99' ' ' GLU . 1.3 t -92.4 -148.84 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 O-C-N 121.256 -0.902 . . . . 0.0 109.368 179.975 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 99' ' ' GLU . . . . . 0.49 ' H ' HG12 ' A' ' 98' ' ' VAL . 96.7 mt-10 -57.61 -37.2 72.85 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.272 -0.893 . . . . 0.0 109.432 179.918 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 22.6 m -165.82 30.64 0.05 Allowed 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.27 -0.894 . . . . 0.0 109.319 179.965 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 101' ' ' VAL . . . . . 0.604 HG12 ' N ' ' A' ' 102' ' ' GLN . 44.4 t -137.73 168.88 19.89 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.5 0 O-C-N 121.34 -0.85 . . . . 0.0 109.465 -179.892 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 102' ' ' GLN . . . . . 0.604 ' N ' HG12 ' A' ' 101' ' ' VAL . 91.5 mt-30 -116.39 145.54 43.16 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.191 -0.943 . . . . 0.0 109.076 179.815 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 103' ' ' LEU . . . . . 0.525 HD23 HG13 ' A' ' 44' ' ' VAL . 0.0 OUTLIER -121.81 134.91 54.9 Favored 'General case' 0 N--CA 1.488 1.444 0 O-C-N 121.18 -0.95 . . . . 0.0 109.851 -179.628 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 60.5 mttt -118.07 126.65 52.68 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.343 -0.848 . . . . 0.0 109.234 179.769 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 105' ' ' VAL . . . . . 1.058 HG21 ' HB2' ' A' ' 93' ' ' LEU . 26.4 t -110.48 142.3 23.32 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 O-C-N 121.174 -0.953 . . . . 0.0 109.667 -179.82 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 106' ' ' ASN . . . . . 0.48 ' HB2' ' HB3' ' A' ' 43' ' ' TYR . 82.1 m-20 -153.53 -168.18 2.92 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.417 -0.802 . . . . 0.0 109.266 179.85 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 22.9 mm -105.64 133.58 49.58 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 O-C-N 121.086 -1.009 . . . . 0.0 109.406 179.967 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 108' ' ' ALA . . . . . 0.472 ' O ' ' HB ' ' A' ' 41' ' ' THR . . . -124.2 153.21 41.93 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.353 -0.842 . . . . 0.0 109.505 179.912 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 89.4 mtt180 -99.77 33.64 2.49 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.265 -0.897 . . . . 0.0 109.54 -179.901 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 110' ' ' LYS . . . . . 0.809 ' HB3' HG21 ' A' ' 41' ' ' THR . 16.2 tttp -72.29 -8.36 54.47 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.2 -0.937 . . . . 0.0 109.436 179.889 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 111' ' ' GLN . . . . . 0.677 ' HG3' ' HE2' ' A' ' 113' ' ' MET . 5.0 tp60 -122.79 71.79 41.25 Favored Pre-proline 0 N--CA 1.49 1.561 0 O-C-N 121.205 -0.935 . . . . 0.0 109.53 -179.904 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 112' ' ' PRO . . . . . 0.438 ' O ' ' C ' ' A' ' 113' ' ' MET . 55.7 Cg_endo -82.77 -18.32 6.66 Favored 'Trans proline' 0 C--O 1.215 -0.66 0 C-N-CA 122.774 2.316 . . . . 0.0 111.929 179.992 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 113' ' ' MET . . . . . 0.677 ' HE2' ' HG3' ' A' ' 111' ' ' GLN . 0.0 OUTLIER -42.49 -37.48 1.64 Allowed 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.305 -0.872 . . . . 0.0 109.595 -179.793 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 114' ' ' LEU . . . . . 1.034 HD22 ' HA ' ' A' ' 38' ' ' LYS . 4.2 tt -134.42 26.49 3.78 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.15 -0.969 . . . . 0.0 109.39 179.84 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 115' ' ' ASP . . . . . 0.615 ' O ' ' HB3' ' A' ' 116' ' ' ALA . 89.1 m-20 47.07 45.69 15.89 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.213 -0.929 . . . . 0.0 109.28 -179.824 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 116' ' ' ALA . . . . . 0.615 ' HB3' ' O ' ' A' ' 115' ' ' ASP . . . 70.29 -84.03 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.2 -0.938 . . . . 0.0 109.5 -179.897 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 117' ' ' ALA . . . . . 0.674 ' HB3' ' HG3' ' A' ' 83' ' ' MET . . . -162.69 24.18 0.1 Allowed 'General case' 0 C--N 1.303 -1.454 0 O-C-N 121.382 -0.824 . . . . 0.0 109.59 -179.767 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 118' ' ' THR . . . . . 0.477 ' N ' ' HE3' ' A' ' 83' ' ' MET . 59.1 m -71.68 -34.14 69.43 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.183 -0.948 . . . . 0.0 109.419 -179.76 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 119' ' ' GLY . . . . . 0.417 ' O ' ' HB2' ' A' ' 120' ' ' LYS . . . 78.83 -169.8 54.4 Favored Glycine 0 N--CA 1.49 2.278 0 N-CA-C 109.415 -1.474 . . . . 0.0 109.415 179.984 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 120' ' ' LYS . . . . . 0.417 ' HB2' ' O ' ' A' ' 119' ' ' GLY . 26.5 mttm 60.74 46.01 9.45 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.243 -1.151 . . . . 0.0 109.468 179.965 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 38.2 t . . . . . 0 N--CA 1.49 1.533 0 CA-C-O 117.988 -1.006 . . . . 0.0 109.46 -179.951 . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 35' ' ' ALA . . . . . 0.847 ' HB3' ' HD3' ' A' ' 36' ' ' PRO . . . . . . . . 0 N--CA 1.49 1.555 0 N-CA-C 109.461 -0.57 . . . . 0.0 109.461 . . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 36' ' ' PRO . . . . . 0.847 ' HD3' ' HB3' ' A' ' 35' ' ' ALA . 49.1 Cg_endo -69.93 149.04 65.26 Favored 'Trans proline' 0 C--O 1.215 -0.649 0 C-N-CA 122.749 2.299 . . . . 0.0 111.829 -179.979 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 37' ' ' ARG . . . . . 0.507 ' O ' HD13 ' A' ' 114' ' ' LEU . 34.3 ptt85 -143.05 157.33 44.63 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.314 -0.866 . . . . 0.0 109.331 179.938 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 38' ' ' LYS . . . . . 0.704 ' HG2' HD22 ' A' ' 114' ' ' LEU . 30.1 mttt -122.94 -157.26 0.74 Allowed 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.222 -0.924 . . . . 0.0 109.519 179.985 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 39' ' ' GLY . . . . . 0.664 ' HA3' HD11 ' A' ' 65' ' ' ILE . . . 175.04 75.23 0.05 OUTLIER Glycine 0 N--CA 1.489 2.231 0 N-CA-C 109.537 -1.425 . . . . 0.0 109.537 -179.959 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 40' ' ' ASN . . . . . 0.782 ' HA ' ' HB1' ' A' ' 116' ' ' ALA . 45.3 t-20 -68.45 117.13 9.81 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.195 -1.179 . . . . 0.0 109.512 -179.976 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 41' ' ' THR . . . . . 0.734 HG22 ' HB3' ' A' ' 108' ' ' ALA . 60.2 m -81.0 143.67 32.35 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.274 -0.891 . . . . 0.0 109.54 179.973 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 42' ' ' LEU . . . . . 0.895 HD12 ' O ' ' A' ' 78' ' ' VAL . 5.0 mp -116.08 146.7 42.0 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.176 -0.952 . . . . 0.0 109.521 -179.931 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 43' ' ' TYR . . . . . 0.471 ' HB3' ' HB2' ' A' ' 106' ' ' ASN . 35.4 t80 -106.08 112.58 25.67 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.177 -0.952 . . . . 0.0 109.513 -179.976 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 44' ' ' VAL . . . . . 0.473 ' HA ' ' O ' ' A' ' 104' ' ' LYS . 38.2 t -110.53 150.42 13.05 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.53 0 O-C-N 121.266 -0.896 . . . . 0.0 109.535 -179.919 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 70.0 t80 -141.68 138.92 32.79 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.2 -0.937 . . . . 0.0 109.606 179.9 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 177.29 -167.86 39.25 Favored Glycine 0 N--CA 1.49 2.289 0 N-CA-C 109.472 -1.451 . . . . 0.0 109.472 179.909 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 47' ' ' GLU . . . . . 0.423 ' O ' ' C ' ' A' ' 48' ' ' ASP . 89.0 mt-10 -115.66 161.98 17.9 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.275 -1.133 . . . . 0.0 109.42 179.945 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 48' ' ' ASP . . . . . 0.423 ' C ' ' O ' ' A' ' 47' ' ' GLU . 43.9 m-20 43.73 40.74 3.21 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.281 -0.887 . . . . 0.0 109.606 179.975 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 41.3 mtp -78.6 138.79 38.52 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.282 -0.886 . . . . 0.0 109.354 179.979 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 50' ' ' THR . . . . . 0.446 ' O ' ' HG ' ' A' ' 54' ' ' LEU . 0.4 OUTLIER -127.04 161.28 54.8 Favored Pre-proline 0 N--CA 1.49 1.56 0 O-C-N 121.252 -0.905 . . . . 0.0 109.533 179.94 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 50.2 Cg_endo -70.07 -51.94 0.33 Allowed 'Trans proline' 0 C--O 1.214 -0.688 0 C-N-CA 122.641 2.228 . . . . 0.0 111.815 -179.985 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 31.1 m -59.16 -41.2 87.83 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.214 -0.929 . . . . 0.0 109.41 179.904 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 53' ' ' LEU . . . . . 0.558 ' C ' HD23 ' A' ' 53' ' ' LEU . 9.0 tt -64.89 -44.44 89.63 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.305 -0.872 . . . . 0.0 109.467 179.987 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 54' ' ' LEU . . . . . 0.451 HD13 ' CB ' ' A' ' 76' ' ' ALA . 21.9 mt -63.93 -45.86 87.35 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.211 -0.931 . . . . 0.0 109.374 179.946 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 55' ' ' ARG . . . . . 0.454 ' O ' ' N ' ' A' ' 59' ' ' SER . 76.8 mtp180 -51.3 -41.33 60.42 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.235 -0.916 . . . . 0.0 109.358 179.965 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -69.44 -32.28 71.59 Favored Glycine 0 N--CA 1.49 2.253 0 N-CA-C 109.463 -1.455 . . . . 0.0 109.463 179.871 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -71.5 -23.72 61.85 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.339 -1.095 . . . . 0.0 109.398 179.934 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 58' ' ' PHE . . . . . 0.584 ' CE2' ' CD1' ' A' ' 93' ' ' LEU . 90.1 m-85 -120.62 10.11 10.98 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.365 -0.834 . . . . 0.0 109.453 -179.997 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 59' ' ' SER . . . . . 0.547 ' N ' ' HD2' ' A' ' 60' ' ' PRO . 3.4 t -76.78 -54.34 1.7 Allowed Pre-proline 0 N--CA 1.49 1.575 0 O-C-N 121.316 -0.865 . . . . 0.0 110.413 -179.505 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 60' ' ' PRO . . . . . 0.547 ' HD2' ' N ' ' A' ' 59' ' ' SER . 48.5 Cg_endo -69.97 -35.58 11.77 Favored 'Trans proline' 0 C--O 1.215 -0.644 0 C-N-CA 122.516 2.144 . . . . 0.0 112.251 -179.276 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 61' ' ' PHE . . . . . 0.663 ' CE2' HD21 ' A' ' 93' ' ' LEU . 70.0 m-85 -58.51 -39.29 79.67 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.183 -0.948 . . . . 0.0 109.631 -179.833 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 179.43 174.66 45.67 Favored Glycine 0 N--CA 1.49 2.239 0 N-CA-C 109.516 -1.434 . . . . 0.0 109.516 179.95 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 45.9 t-20 -80.18 140.9 36.13 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.263 -1.14 . . . . 0.0 109.414 179.93 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 64' ' ' ILE . . . . . 0.731 HD13 HD23 ' A' ' 67' ' ' LEU . 81.7 mt -100.78 131.04 49.16 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.52 0 O-C-N 121.223 -0.923 . . . . 0.0 109.542 -179.973 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 65' ' ' ILE . . . . . 0.664 HD11 ' HA3' ' A' ' 39' ' ' GLY . 20.4 pt -92.82 -24.02 5.38 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 O-C-N 121.264 -0.898 . . . . 0.0 109.575 -179.841 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 18.7 t70 -149.44 113.79 5.24 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.239 -0.913 . . . . 0.0 109.621 -179.888 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 67' ' ' LEU . . . . . 0.731 HD23 HD13 ' A' ' 64' ' ' ILE . 0.4 OUTLIER -104.74 117.06 33.14 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.282 -0.886 . . . . 0.0 109.342 179.803 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 68' ' ' SER . . . . . 0.665 ' N ' HD13 ' A' ' 67' ' ' LEU . 25.9 t -128.36 148.87 50.7 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.291 -0.881 . . . . 0.0 109.566 -179.906 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 69' ' ' MET . . . . . . . . . . . . . 86.6 mtp -124.9 148.54 48.27 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.233 -0.917 . . . . 0.0 109.408 179.93 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 70' ' ' ASP . . . . . 0.498 ' CB ' ' O ' ' A' ' 75' ' ' CYS . 0.8 OUTLIER -120.77 100.03 46.78 Favored Pre-proline 0 N--CA 1.491 1.624 0 O-C-N 121.253 -0.904 . . . . 0.0 109.614 -179.931 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 71' ' ' PRO . . . . . 0.596 ' N ' ' CD ' ' A' ' 72' ' ' PRO . 47.9 Cg_endo -74.72 -27.85 10.22 Favored 'Trans proline' 0 CA--C 1.543 0.938 0 C-N-CA 122.543 2.162 . . . . 0.0 113.733 179.944 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 72' ' ' PRO . . . . . 0.596 ' CD ' ' N ' ' A' ' 71' ' ' PRO . 55.5 Cg_endo -75.36 -28.62 8.44 Favored 'Trans proline' 0 C--N 1.352 0.762 0 C-N-CA 121.462 1.441 . . . . 0.0 111.846 -179.91 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 73' ' ' ARG . . . . . 0.439 ' O ' ' HB2' ' A' ' 74' ' ' ASN . 55.3 mtt-85 -109.41 0.06 19.2 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.295 -0.878 . . . . 0.0 109.666 -179.826 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 74' ' ' ASN . . . . . 0.439 ' HB2' ' O ' ' A' ' 73' ' ' ARG . 83.5 m-20 61.14 41.25 13.84 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.126 -0.984 . . . . 0.0 109.544 179.984 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 75' ' ' CYS . . . . . 0.498 ' O ' ' CB ' ' A' ' 70' ' ' ASP . 30.0 p -140.93 137.01 32.8 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.183 -0.948 . . . . 0.0 109.627 179.99 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 76' ' ' ALA . . . . . 0.451 ' CB ' HD13 ' A' ' 54' ' ' LEU . . . -105.02 160.6 14.91 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.286 -0.884 . . . . 0.0 109.454 179.996 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 77' ' ' PHE . . . . . 0.475 ' HA ' ' O ' ' A' ' 42' ' ' LEU . 97.1 m-85 -124.33 130.07 51.84 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.207 -0.933 . . . . 0.0 109.487 -179.987 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 78' ' ' VAL . . . . . 0.895 ' O ' HD12 ' A' ' 42' ' ' LEU . 21.2 t -122.09 132.97 69.84 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.549 0 O-C-N 121.273 -0.892 . . . . 0.0 109.341 179.927 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 79' ' ' THR . . . . . 0.543 HG22 ' CA ' ' A' ' 39' ' ' GLY . 6.8 m -106.01 135.86 46.71 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.238 -0.914 . . . . 0.0 109.36 -179.966 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 80' ' ' TYR . . . . . 0.52 ' OH ' ' CA ' ' A' ' 58' ' ' PHE . 1.6 m-85 -115.56 133.08 56.38 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.162 -0.961 . . . . 0.0 109.619 -179.932 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 76.8 tt0 -52.26 -25.81 10.32 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.339 -0.851 . . . . 0.0 109.537 179.959 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 67.6 mttm -134.23 132.97 40.33 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.176 -0.953 . . . . 0.0 109.617 -179.952 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 83' ' ' MET . . . . . 0.686 ' HB3' ' HB3' ' A' ' 117' ' ' ALA . 0.8 OUTLIER -57.38 -18.23 16.59 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.277 -0.889 . . . . 0.0 109.649 -179.964 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 99.5 mt-10 -65.76 -39.43 91.04 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.223 -0.923 . . . . 0.0 109.506 -179.922 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 13.9 t -63.58 -40.45 96.99 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.168 -0.957 . . . . 0.0 109.546 -179.897 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 86' ' ' ALA . . . . . 0.684 ' HA ' HD21 ' A' ' 42' ' ' LEU . . . -61.11 -41.45 96.71 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.204 -0.935 . . . . 0.0 109.538 -179.917 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 54.4 t0 -62.19 -45.1 94.89 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.218 -0.926 . . . . 0.0 109.601 -179.926 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 63.6 tt0 -65.16 -37.3 86.96 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.224 -0.922 . . . . 0.0 109.583 -179.817 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 89' ' ' ALA . . . . . 0.596 ' HB1' ' CD1' ' A' ' 93' ' ' LEU . . . -75.95 -45.95 32.36 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.225 -0.922 . . . . 0.0 109.609 -179.879 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 90' ' ' VAL . . . . . 0.772 HG21 HD11 ' A' ' 107' ' ' ILE . 78.0 t -56.9 -31.92 37.57 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.52 0 O-C-N 121.207 -0.933 . . . . 0.0 109.626 -179.889 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -80.06 -53.0 7.12 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.245 -0.91 . . . . 0.0 109.733 -179.82 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 92' ' ' GLU . . . . . 0.607 ' HB2' ' CZ ' ' A' ' 61' ' ' PHE . 75.4 mm-40 -71.72 -43.88 65.11 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.214 -0.929 . . . . 0.0 109.73 -179.637 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 93' ' ' LEU . . . . . 1.003 ' CB ' HG21 ' A' ' 105' ' ' VAL . 36.7 mt -64.67 -40.36 95.28 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.149 -0.969 . . . . 0.0 109.474 -179.916 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 94' ' ' ASN . . . . . 0.489 ' CB ' ' O ' ' A' ' 90' ' ' VAL . 64.0 t-20 -68.4 125.74 27.42 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.244 -0.91 . . . . 0.0 109.499 179.987 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 93.85 22.81 24.79 Favored Glycine 0 N--CA 1.49 2.294 0 N-CA-C 109.536 -1.426 . . . . 0.0 109.536 179.969 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 96' ' ' THR . . . . . 0.594 HG23 ' O ' ' A' ' 93' ' ' LEU . 29.5 p -111.49 159.7 17.83 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.268 -1.136 . . . . 0.0 109.465 -179.948 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 60.0 tt0 -136.13 149.02 48.49 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.281 -0.887 . . . . 0.0 109.491 179.968 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 98' ' ' VAL . . . . . 0.607 ' HB ' HG12 ' A' ' 101' ' ' VAL . 1.3 t -101.59 -151.92 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.543 0 O-C-N 121.195 -0.941 . . . . 0.0 109.204 179.947 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 99' ' ' GLU . . . . . 0.534 ' H ' HG12 ' A' ' 98' ' ' VAL . 95.7 mt-10 -48.29 -41.34 27.77 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.115 -0.991 . . . . 0.0 109.42 179.992 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 2.4 m -165.98 25.84 0.05 OUTLIER 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.236 -0.915 . . . . 0.0 109.505 -179.97 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 101' ' ' VAL . . . . . 0.607 HG12 ' HB ' ' A' ' 98' ' ' VAL . 9.8 p -130.17 140.2 49.51 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.547 0 O-C-N 121.233 -0.917 . . . . 0.0 109.644 -179.861 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 91.7 mt-30 -86.71 141.62 28.78 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.265 -0.897 . . . . 0.0 109.328 179.887 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 103' ' ' LEU . . . . . 0.438 HD23 ' HA ' ' A' ' 103' ' ' LEU . 73.5 mt -106.76 137.62 44.45 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.241 -0.912 . . . . 0.0 109.763 -179.819 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 104' ' ' LYS . . . . . 0.473 ' O ' ' HA ' ' A' ' 44' ' ' VAL . 41.9 mttm -119.38 135.53 54.69 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.284 -0.885 . . . . 0.0 109.245 179.831 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 105' ' ' VAL . . . . . 1.003 HG21 ' CB ' ' A' ' 93' ' ' LEU . 46.0 t -123.43 145.49 30.32 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.55 0 O-C-N 121.186 -0.946 . . . . 0.0 109.614 -179.788 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 106' ' ' ASN . . . . . 0.471 ' HB2' ' HB3' ' A' ' 43' ' ' TYR . 83.2 m-20 -148.54 -170.92 3.73 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.362 -0.836 . . . . 0.0 109.337 179.904 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 107' ' ' ILE . . . . . 0.772 HD11 HG21 ' A' ' 90' ' ' VAL . 28.5 mm -111.38 126.3 68.76 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.531 0 O-C-N 121.156 -0.965 . . . . 0.0 109.509 -179.991 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 108' ' ' ALA . . . . . 0.734 ' HB3' HG22 ' A' ' 41' ' ' THR . . . -107.68 138.93 43.03 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.232 -0.917 . . . . 0.0 109.469 179.993 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 79.8 mtt85 -108.75 18.12 21.14 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.213 -0.929 . . . . 0.0 109.474 -179.936 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 110' ' ' LYS . . . . . 0.465 ' O ' ' CD ' ' A' ' 112' ' ' PRO . 84.9 tttt -59.97 -50.88 72.0 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.223 -0.923 . . . . 0.0 109.488 -179.897 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 111' ' ' GLN . . . . . 0.53 ' HG3' ' CE ' ' A' ' 113' ' ' MET . 5.2 tp-100 -42.4 98.56 0.18 Allowed Pre-proline 0 N--CA 1.492 1.668 0 O-C-N 121.282 -0.886 . . . . 0.0 109.574 -179.896 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 112' ' ' PRO . . . . . 0.465 ' CD ' ' O ' ' A' ' 110' ' ' LYS . 53.4 Cg_endo -90.65 -22.52 0.67 Allowed 'Trans proline' 0 N--CA 1.456 -0.726 0 C-N-CA 123.103 2.535 . . . . 0.0 111.895 179.98 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 113' ' ' MET . . . . . 0.53 ' CE ' ' HG3' ' A' ' 111' ' ' GLN . 0.0 OUTLIER -49.01 -34.92 14.16 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.206 -0.934 . . . . 0.0 109.548 -179.914 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 114' ' ' LEU . . . . . 0.704 HD22 ' HG2' ' A' ' 38' ' ' LYS . 0.4 OUTLIER -150.68 26.93 0.74 Allowed 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.27 -0.894 . . . . 0.0 109.516 -179.956 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 115' ' ' ASP . . . . . 0.622 ' O ' ' HB3' ' A' ' 116' ' ' ALA . 83.3 m-20 54.27 44.14 29.49 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.243 -0.911 . . . . 0.0 109.15 -179.844 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 116' ' ' ALA . . . . . 0.782 ' HB1' ' HA ' ' A' ' 40' ' ' ASN . . . 72.3 -83.12 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.368 -0.832 . . . . 0.0 109.52 -179.921 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 117' ' ' ALA . . . . . 0.686 ' HB3' ' HB3' ' A' ' 83' ' ' MET . . . -169.8 132.61 1.16 Allowed 'General case' 0 N--CA 1.487 1.415 0 O-C-N 121.23 -0.919 . . . . 0.0 109.604 -179.985 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 118' ' ' THR . . . . . 0.572 ' N ' ' HE1' ' A' ' 83' ' ' MET . 21.6 p -130.04 168.31 16.93 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.286 -0.884 . . . . 0.0 109.517 179.956 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -61.39 -35.93 91.75 Favored Glycine 0 N--CA 1.49 2.279 0 N-CA-C 109.488 -1.445 . . . . 0.0 109.488 179.988 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 120' ' ' LYS . . . . . 0.423 ' O ' ' OG1' ' A' ' 118' ' ' THR . 48.0 tttp -109.05 134.19 52.0 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.236 -1.155 . . . . 0.0 109.437 179.962 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 2.9 m . . . . . 0 N--CA 1.491 1.584 0 CA-C-O 118.052 -0.975 . . . . 0.0 109.47 -179.982 . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.566 0 N-CA-C 109.464 -0.569 . . . . 0.0 109.464 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 48.9 Cg_endo -69.36 145.54 59.77 Favored 'Trans proline' 0 C--O 1.215 -0.631 0 C-N-CA 122.642 2.228 . . . . 0.0 111.798 -179.998 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 72.9 mtm180 -131.56 145.14 51.57 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.214 -0.929 . . . . 0.0 109.582 -179.928 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 38' ' ' LYS . . . . . 0.525 ' O ' ' CD1' ' A' ' 65' ' ' ILE . 67.6 mttm -69.19 -167.73 0.12 Allowed 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.179 -0.95 . . . . 0.0 109.377 179.937 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 39' ' ' GLY . . . . . 0.737 ' HA3' HD11 ' A' ' 65' ' ' ILE . . . 150.65 99.9 0.2 Allowed Glycine 0 N--CA 1.491 2.332 0 N-CA-C 109.761 -1.336 . . . . 0.0 109.761 179.965 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 40' ' ' ASN . . . . . 0.475 ' N ' ' O ' ' A' ' 80' ' ' TYR . 47.3 t-20 -98.86 108.13 20.74 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.196 -1.179 . . . . 0.0 109.311 179.759 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 41' ' ' THR . . . . . 0.464 ' O ' HD23 ' A' ' 42' ' ' LEU . 43.7 m -71.11 133.79 46.51 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.257 -0.902 . . . . 0.0 109.74 -179.747 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 42' ' ' LEU . . . . . 0.795 HD11 ' CD2' ' A' ' 80' ' ' TYR . 16.6 mt -114.38 145.68 41.52 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.295 -0.878 . . . . 0.0 109.32 179.824 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 43' ' ' TYR . . . . . 0.473 ' HB3' ' HB2' ' A' ' 106' ' ' ASN . 74.1 t80 -100.38 122.61 43.41 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.258 -0.901 . . . . 0.0 109.488 -179.825 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 44' ' ' VAL . . . . . 0.468 ' HA ' ' O ' ' A' ' 104' ' ' LYS . 59.3 t -123.34 136.92 58.39 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.538 0 O-C-N 121.283 -0.885 . . . . 0.0 109.424 179.977 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 45' ' ' TYR . . . . . 0.476 ' HB3' ' HB2' ' A' ' 104' ' ' LYS . 70.1 t80 -120.56 142.09 49.68 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.223 -0.923 . . . . 0.0 109.46 -179.89 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 46' ' ' GLY . . . . . 0.429 ' HA3' ' SD ' ' A' ' 49' ' ' MET . . . 174.86 -175.87 47.02 Favored Glycine 0 N--CA 1.491 2.341 0 N-CA-C 109.54 -1.424 . . . . 0.0 109.54 -179.963 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 47' ' ' GLU . . . . . 0.428 ' O ' ' C ' ' A' ' 48' ' ' ASP . 94.6 mt-10 -120.85 157.03 30.68 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.265 -1.138 . . . . 0.0 109.392 179.962 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 48' ' ' ASP . . . . . 0.428 ' C ' ' O ' ' A' ' 47' ' ' GLU . 48.8 m-20 43.93 52.16 6.73 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.294 -0.879 . . . . 0.0 109.546 -179.979 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 49' ' ' MET . . . . . 0.429 ' SD ' ' HA3' ' A' ' 46' ' ' GLY . 64.8 mtm -103.4 142.41 34.28 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.314 -0.866 . . . . 0.0 109.504 179.975 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -122.15 163.62 30.73 Favored Pre-proline 0 N--CA 1.491 1.582 0 O-C-N 121.258 -0.901 . . . . 0.0 109.371 179.919 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 51' ' ' PRO . . . . . 0.44 ' HD3' ' SD ' ' A' ' 69' ' ' MET . 48.8 Cg_endo -69.56 -52.99 0.31 Allowed 'Trans proline' 0 C--O 1.215 -0.64 0 C-N-CA 122.617 2.211 . . . . 0.0 111.803 179.988 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 28.6 m -50.6 -48.87 57.7 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.249 -0.907 . . . . 0.0 109.302 179.931 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 22.3 tp -60.33 -47.23 86.92 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.249 -0.907 . . . . 0.0 109.343 179.836 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 21.9 mt -56.28 -47.09 79.29 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.284 -0.885 . . . . 0.0 109.357 179.824 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 55' ' ' ARG . . . . . 0.499 ' O ' ' N ' ' A' ' 59' ' ' SER . 36.4 mtp85 -51.43 -40.91 60.33 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.306 -0.871 . . . . 0.0 109.296 179.84 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -66.48 -34.35 87.46 Favored Glycine 0 N--CA 1.489 2.203 0 N-CA-C 109.34 -1.504 . . . . 0.0 109.34 179.864 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -71.23 -26.41 62.91 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.313 -1.11 . . . . 0.0 109.472 179.957 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 58' ' ' PHE . . . . . 0.856 ' HB2' HD11 ' A' ' 64' ' ' ILE . 96.9 m-85 -115.01 8.33 15.75 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.244 -0.91 . . . . 0.0 109.468 179.966 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 59' ' ' SER . . . . . 0.533 ' N ' ' HD2' ' A' ' 60' ' ' PRO . 0.8 OUTLIER -72.91 -58.14 2.76 Favored Pre-proline 0 N--CA 1.49 1.574 0 O-C-N 121.195 -0.941 . . . . 0.0 109.811 -179.784 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 60' ' ' PRO . . . . . 0.533 ' HD2' ' N ' ' A' ' 59' ' ' SER . 48.0 Cg_endo -68.9 -28.69 29.24 Favored 'Trans proline' 0 C--O 1.215 -0.65 0 C-N-CA 122.602 2.202 . . . . 0.0 111.973 -179.702 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 61' ' ' PHE . . . . . 0.572 ' CD1' ' HA ' ' A' ' 89' ' ' ALA . 61.2 m-85 -70.11 -31.74 69.44 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.181 -0.949 . . . . 0.0 109.548 -179.988 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 62' ' ' GLY . . . . . 0.413 ' HA3' ' HB3' ' A' ' 85' ' ' SER . . . 176.39 -171.41 44.4 Favored Glycine 0 N--CA 1.49 2.262 0 N-CA-C 109.504 -1.438 . . . . 0.0 109.504 179.881 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 85.6 m-20 -99.67 137.33 38.3 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.244 -1.15 . . . . 0.0 109.311 -179.963 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 64' ' ' ILE . . . . . 0.856 HD11 ' HB2' ' A' ' 58' ' ' PHE . 64.0 mt -99.53 131.72 46.35 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.517 0 O-C-N 121.238 -0.914 . . . . 0.0 109.581 -179.988 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 65' ' ' ILE . . . . . 0.737 HD11 ' HA3' ' A' ' 39' ' ' GLY . 18.3 pt -96.67 -22.47 5.06 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.549 0 O-C-N 121.346 -0.846 . . . . 0.0 109.427 179.982 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 66' ' ' ASP . . . . . 0.452 ' HB3' ' OG1' ' A' ' 79' ' ' THR . 54.9 t0 -143.76 135.96 26.74 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.219 -0.925 . . . . 0.0 109.563 -179.963 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 67' ' ' LEU . . . . . 0.747 ' C ' HD13 ' A' ' 67' ' ' LEU . 3.4 tm? -122.47 114.71 21.07 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.233 -0.917 . . . . 0.0 109.314 179.918 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 68' ' ' SER . . . . . 0.501 ' N ' HD13 ' A' ' 67' ' ' LEU . 37.7 t -129.25 145.43 51.35 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.247 -0.908 . . . . 0.0 109.518 -179.917 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 69' ' ' MET . . . . . 0.481 ' HA ' ' HA ' ' A' ' 76' ' ' ALA . 79.3 mtp -130.4 143.92 51.07 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.218 -0.926 . . . . 0.0 109.445 179.963 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 70' ' ' ASP . . . . . 0.478 ' C ' ' HD2' ' A' ' 72' ' ' PRO . 2.4 t70 -117.06 107.06 46.34 Favored Pre-proline 0 N--CA 1.489 1.514 0 O-C-N 121.229 -0.92 . . . . 0.0 109.575 -179.928 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 71' ' ' PRO . . . . . 0.604 ' N ' ' CD ' ' A' ' 72' ' ' PRO . 46.3 Cg_endo -74.85 -27.69 10.09 Favored 'Trans proline' 0 CA--C 1.543 0.962 0 C-N-CA 122.458 2.106 . . . . 0.0 113.571 179.923 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 72' ' ' PRO . . . . . 0.604 ' CD ' ' N ' ' A' ' 71' ' ' PRO . 55.2 Cg_endo -75.38 -29.56 7.53 Favored 'Trans proline' 0 C--N 1.353 0.787 0 C-N-CA 121.427 1.418 . . . . 0.0 111.81 -179.872 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 5.8 mtp85 -106.97 1.3 24.35 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.161 -0.962 . . . . 0.0 109.63 179.995 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 80.2 m-20 57.61 39.1 27.87 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.145 -0.972 . . . . 0.0 109.46 179.991 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 75' ' ' CYS . . . . . 0.44 ' HA ' ' O ' ' A' ' 44' ' ' VAL . 27.9 p -134.96 140.52 45.77 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.186 -0.946 . . . . 0.0 109.5 -179.963 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 76' ' ' ALA . . . . . 0.481 ' HA ' ' HA ' ' A' ' 69' ' ' MET . . . -108.22 152.23 24.86 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.34 -0.85 . . . . 0.0 109.395 179.964 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 77' ' ' PHE . . . . . 0.46 ' HB2' ' HB3' ' A' ' 68' ' ' SER . 96.8 m-85 -117.59 129.95 56.09 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.24 -0.913 . . . . 0.0 109.527 -179.955 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 78' ' ' VAL . . . . . 0.482 ' O ' ' N ' ' A' ' 42' ' ' LEU . 48.2 t -124.79 132.09 71.78 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.575 0 O-C-N 121.261 -0.9 . . . . 0.0 109.413 179.968 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 79' ' ' THR . . . . . 0.576 HG22 ' CA ' ' A' ' 39' ' ' GLY . 22.8 m -101.22 134.1 44.78 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.286 -0.884 . . . . 0.0 109.5 179.965 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 80' ' ' TYR . . . . . 0.795 ' CD2' HD11 ' A' ' 42' ' ' LEU . 0.4 OUTLIER -109.95 144.57 38.28 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.275 -0.891 . . . . 0.0 109.548 -179.977 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 81' ' ' GLU . . . . . 0.425 ' O ' ' CB ' ' A' ' 38' ' ' LYS . 84.9 tt0 -66.81 -31.16 71.6 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.177 -0.952 . . . . 0.0 109.514 179.836 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 46.1 mttm -128.11 152.32 48.14 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.327 -0.858 . . . . 0.0 109.445 -179.998 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 83' ' ' MET . . . . . 0.715 ' HE2' ' N ' ' A' ' 117' ' ' ALA . 40.7 mtt -69.79 -21.98 63.37 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.226 -0.921 . . . . 0.0 109.491 179.987 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 98.7 mt-10 -71.15 -33.42 70.04 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.27 -0.894 . . . . 0.0 109.605 -179.955 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 85' ' ' SER . . . . . 0.413 ' HB3' ' HA3' ' A' ' 62' ' ' GLY . 19.4 m -66.92 -31.07 71.41 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.167 -0.958 . . . . 0.0 109.479 -179.901 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 86' ' ' ALA . . . . . 0.496 ' O ' HG23 ' A' ' 90' ' ' VAL . . . -80.08 -33.74 38.61 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.253 -0.904 . . . . 0.0 109.476 -179.955 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 58.7 t0 -65.48 -40.57 93.28 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.262 -0.898 . . . . 0.0 109.589 -179.946 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 88' ' ' GLN . . . . . 0.437 ' O ' ' HB2' ' A' ' 92' ' ' GLU . 62.0 tt0 -73.92 -38.72 64.21 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.285 -0.884 . . . . 0.0 109.591 -179.917 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 89' ' ' ALA . . . . . 0.572 ' HA ' ' CD1' ' A' ' 61' ' ' PHE . . . -76.46 -41.22 48.07 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.249 -0.907 . . . . 0.0 109.507 179.975 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 90' ' ' VAL . . . . . 0.772 ' HA ' HG11 ' A' ' 105' ' ' VAL . 55.6 t -65.91 -40.97 88.97 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.591 0 O-C-N 121.286 -0.883 . . . . 0.0 109.623 -179.812 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -74.95 -38.26 61.76 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.145 -0.972 . . . . 0.0 109.741 -179.774 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 92' ' ' GLU . . . . . 0.557 ' HB3' ' CZ ' ' A' ' 61' ' ' PHE . 5.9 tm-20 -78.85 -50.8 10.65 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.187 -0.946 . . . . 0.0 109.722 -179.744 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 93' ' ' LEU . . . . . 0.724 HD13 ' CZ ' ' A' ' 58' ' ' PHE . 48.9 mt -62.64 -35.5 79.79 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.262 -0.899 . . . . 0.0 109.56 -179.829 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 94' ' ' ASN . . . . . 0.485 ' HB2' ' O ' ' A' ' 90' ' ' VAL . 56.8 t-20 -74.71 129.11 37.12 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.246 -0.909 . . . . 0.0 109.549 -179.909 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 91.55 24.44 26.02 Favored Glycine 0 N--CA 1.49 2.253 0 N-CA-C 109.551 -1.42 . . . . 0.0 109.551 179.926 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 96' ' ' THR . . . . . 0.48 ' CG2' ' O ' ' A' ' 92' ' ' GLU . 36.9 p -126.23 154.05 43.86 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.201 -1.176 . . . . 0.0 109.572 179.985 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 63.8 tt0 -117.83 138.9 51.78 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.225 -0.922 . . . . 0.0 109.491 -179.96 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 98' ' ' VAL . . . . . 0.552 HG23 ' O ' ' A' ' 101' ' ' VAL . 1.2 t -81.13 -151.99 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 121.204 -0.935 . . . . 0.0 109.315 -179.99 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 99' ' ' GLU . . . . . 0.533 ' H ' HG12 ' A' ' 98' ' ' VAL . 96.3 mt-10 -60.78 -37.89 83.41 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.204 -0.935 . . . . 0.0 109.477 179.983 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -158.1 22.81 0.25 Allowed 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.264 -0.897 . . . . 0.0 109.476 179.99 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 101' ' ' VAL . . . . . 0.552 ' O ' HG23 ' A' ' 98' ' ' VAL . 47.9 t -139.43 154.41 24.83 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.531 0 O-C-N 121.224 -0.923 . . . . 0.0 109.496 179.993 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 92.2 mt-30 -102.45 144.18 31.23 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.242 -0.911 . . . . 0.0 109.431 179.96 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 92.0 mt -110.37 138.89 46.16 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.311 -0.868 . . . . 0.0 109.564 179.997 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 104' ' ' LYS . . . . . 0.476 ' HB2' ' HB3' ' A' ' 45' ' ' TYR . 76.6 mttt -120.23 138.53 53.6 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.268 -0.895 . . . . 0.0 109.259 179.853 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 105' ' ' VAL . . . . . 0.772 HG11 ' HA ' ' A' ' 90' ' ' VAL . 18.4 t -122.48 137.17 56.92 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.549 0 O-C-N 121.142 -0.974 . . . . 0.0 109.657 -179.819 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 106' ' ' ASN . . . . . 0.473 ' HB2' ' HB3' ' A' ' 43' ' ' TYR . 92.2 m-20 -136.54 -174.33 3.67 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.255 -0.903 . . . . 0.0 109.168 179.818 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 22.7 mm -107.19 134.68 48.18 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.619 0 O-C-N 121.227 -0.921 . . . . 0.0 109.563 -179.949 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -110.17 151.94 26.66 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.312 -0.867 . . . . 0.0 109.437 179.969 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 25.8 mtm180 -101.15 10.78 40.5 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.289 -0.882 . . . . 0.0 109.626 -179.951 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 110' ' ' LYS . . . . . 0.524 ' O ' ' CB ' ' A' ' 111' ' ' GLN . 74.0 mttt -81.93 176.04 9.89 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.157 -0.964 . . . . 0.0 109.434 -179.963 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 111' ' ' GLN . . . . . 0.561 ' N ' ' CD ' ' A' ' 112' ' ' PRO . 6.6 tp-100 75.61 47.9 0.17 Allowed Pre-proline 0 N--CA 1.49 1.555 0 O-C-N 121.249 -0.907 . . . . 0.0 109.343 179.919 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 112' ' ' PRO . . . . . 0.561 ' CD ' ' N ' ' A' ' 111' ' ' GLN . 53.4 Cg_endo -72.34 -20.62 24.04 Favored 'Trans proline' 0 C--O 1.216 -0.613 0 C-N-CA 122.777 2.318 . . . . 0.0 111.99 -179.93 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 113' ' ' MET . . . . . 0.537 ' HE2' ' HG3' ' A' ' 111' ' ' GLN . 0.0 OUTLIER -43.62 -33.02 1.08 Allowed 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.277 -0.889 . . . . 0.0 109.512 -179.797 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 114' ' ' LEU . . . . . 0.7 ' CD1' HG23 ' A' ' 118' ' ' THR . 0.3 OUTLIER -148.49 17.47 1.04 Allowed 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.258 -0.901 . . . . 0.0 109.247 179.867 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 115' ' ' ASP . . . . . 0.718 ' O ' ' HB3' ' A' ' 116' ' ' ALA . 78.0 m-20 39.92 45.24 1.53 Allowed 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.6 -0.688 . . . . 0.0 109.519 179.975 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 116' ' ' ALA . . . . . 0.718 ' HB3' ' O ' ' A' ' 115' ' ' ASP . . . 76.66 -66.6 0.25 Allowed 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.39 -0.819 . . . . 0.0 109.395 -179.58 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 117' ' ' ALA . . . . . 0.715 ' N ' ' HE2' ' A' ' 83' ' ' MET . . . -166.19 157.08 13.01 Favored 'General case' 0 C--N 1.301 -1.505 0 C-N-CA 119.585 -0.846 . . . . 0.0 109.763 -179.66 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 118' ' ' THR . . . . . 0.7 HG23 ' CD1' ' A' ' 114' ' ' LEU . 15.7 p -124.95 168.37 13.39 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.265 -0.897 . . . . 0.0 109.555 -179.931 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 89.52 9.75 66.33 Favored Glycine 0 N--CA 1.491 2.312 0 N-CA-C 109.448 -1.461 . . . . 0.0 109.448 179.986 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 25.4 pttm -80.32 143.78 33.33 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.207 -1.172 . . . . 0.0 109.446 179.962 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 7.8 t . . . . . 0 N--CA 1.491 1.591 0 CA-C-O 118.023 -0.989 . . . . 0.0 109.457 179.98 . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.539 0 N-CA-C 109.474 -0.565 . . . . 0.0 109.474 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 48.9 Cg_endo -69.93 141.92 45.8 Favored 'Trans proline' 0 C--O 1.215 -0.65 0 C-N-CA 122.65 2.233 . . . . 0.0 111.869 -179.987 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 37' ' ' ARG . . . . . 0.415 ' O ' ' C ' ' A' ' 38' ' ' LYS . 14.6 ptm180 -145.76 158.45 43.85 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.331 -0.856 . . . . 0.0 109.305 -179.978 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 38' ' ' LYS . . . . . 0.921 ' HA ' HD22 ' A' ' 114' ' ' LEU . 20.1 mttm 44.49 -162.5 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.22 -0.925 . . . . 0.0 109.279 -179.97 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 39' ' ' GLY . . . . . 0.777 ' HA3' HD11 ' A' ' 65' ' ' ILE . . . 129.57 71.36 0.13 Allowed Glycine 0 N--CA 1.49 2.291 0 N-CA-C 109.672 -1.371 . . . . 0.0 109.672 179.93 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 40' ' ' ASN . . . . . 0.493 ' HA ' ' HB1' ' A' ' 116' ' ' ALA . 47.1 t-20 -69.9 121.67 17.78 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.193 -1.181 . . . . 0.0 109.477 179.813 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 41' ' ' THR . . . . . 0.552 HG21 ' HB3' ' A' ' 110' ' ' LYS . 66.1 m -84.32 140.42 31.63 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.225 -0.922 . . . . 0.0 109.522 -179.954 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 42' ' ' LEU . . . . . 0.823 HD12 ' O ' ' A' ' 78' ' ' VAL . 5.2 mp -116.18 143.04 46.03 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.322 -0.861 . . . . 0.0 109.338 179.987 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 43' ' ' TYR . . . . . 0.505 ' HB2' ' HB2' ' A' ' 108' ' ' ALA . 70.1 t80 -98.0 108.23 20.89 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.366 -0.834 . . . . 0.0 109.584 -179.951 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 44' ' ' VAL . . . . . 0.474 ' HA ' ' O ' ' A' ' 104' ' ' LYS . 95.6 t -105.37 136.43 39.37 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 O-C-N 121.268 -0.895 . . . . 0.0 109.363 -180.0 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 45' ' ' TYR . . . . . 0.442 ' HB3' ' HB2' ' A' ' 104' ' ' LYS . 70.5 t80 -123.42 131.33 53.61 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.141 -0.974 . . . . 0.0 109.524 -179.949 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -179.69 -174.55 45.74 Favored Glycine 0 N--CA 1.491 2.333 0 N-CA-C 109.401 -1.48 . . . . 0.0 109.401 179.963 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 95.6 mt-10 -121.12 156.49 32.19 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.216 -1.167 . . . . 0.0 109.476 -179.958 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 59.4 t0 46.23 52.52 10.33 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.237 -0.915 . . . . 0.0 109.487 -179.985 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 49' ' ' MET . . . . . 0.408 ' O ' ' HE1' ' A' ' 69' ' ' MET . 61.6 mtm -104.17 139.8 38.71 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.247 -0.908 . . . . 0.0 109.547 -179.928 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 50' ' ' THR . . . . . 0.506 ' O ' HD12 ' A' ' 54' ' ' LEU . 0.1 OUTLIER -121.5 166.57 15.9 Favored Pre-proline 0 N--CA 1.49 1.547 0 O-C-N 121.208 -0.932 . . . . 0.0 109.414 -179.98 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 51' ' ' PRO . . . . . 0.485 ' N ' ' SD ' ' A' ' 69' ' ' MET . 48.2 Cg_endo -70.17 -55.73 0.16 Allowed 'Trans proline' 0 C--O 1.215 -0.651 0 C-N-CA 122.599 2.199 . . . . 0.0 111.918 179.937 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 26.2 m -48.88 -49.91 37.44 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.181 -0.95 . . . . 0.0 109.287 179.877 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 24.2 tp -58.08 -50.5 73.24 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.181 -0.949 . . . . 0.0 109.161 179.782 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 54' ' ' LEU . . . . . 0.506 HD12 ' O ' ' A' ' 50' ' ' THR . 11.6 mt -56.26 -44.42 79.68 Favored 'General case' 0 N--CA 1.488 1.475 0 O-C-N 121.272 -0.893 . . . . 0.0 109.238 179.742 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 55' ' ' ARG . . . . . 0.517 ' O ' ' N ' ' A' ' 59' ' ' SER . 93.6 mtt180 -51.38 -38.63 54.36 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.242 -0.911 . . . . 0.0 109.319 179.82 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -69.56 -33.3 71.81 Favored Glycine 0 N--CA 1.49 2.295 0 N-CA-C 109.508 -1.437 . . . . 0.0 109.508 179.926 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -75.92 -23.39 55.49 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.287 -1.125 . . . . 0.0 109.461 179.969 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 58' ' ' PHE . . . . . 0.672 ' HB2' HD11 ' A' ' 64' ' ' ILE . 97.0 m-85 -117.56 8.37 12.88 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.305 -0.872 . . . . 0.0 109.403 179.988 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 59' ' ' SER . . . . . 0.534 ' N ' ' HD2' ' A' ' 60' ' ' PRO . 0.6 OUTLIER -75.16 -57.12 1.8 Allowed Pre-proline 0 N--CA 1.491 1.606 0 O-C-N 121.231 -0.918 . . . . 0.0 110.066 -179.637 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 60' ' ' PRO . . . . . 0.534 ' HD2' ' N ' ' A' ' 59' ' ' SER . 49.8 Cg_endo -69.5 -25.12 30.1 Favored 'Trans proline' 0 C--O 1.214 -0.68 0 C-N-CA 122.62 2.213 . . . . 0.0 112.213 -179.56 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 61' ' ' PHE . . . . . 0.583 ' CZ ' ' HB2' ' A' ' 92' ' ' GLU . 64.4 m-85 -72.67 -27.17 61.93 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.149 -0.97 . . . . 0.0 109.491 179.985 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 169.31 -176.0 43.45 Favored Glycine 0 N--CA 1.49 2.275 0 N-CA-C 109.464 -1.454 . . . . 0.0 109.464 179.939 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 83.2 m-20 -93.93 139.82 30.45 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.269 -1.136 . . . . 0.0 109.416 -179.995 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 64' ' ' ILE . . . . . 0.672 HD11 ' HB2' ' A' ' 58' ' ' PHE . 61.1 mt -100.61 132.84 45.5 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.588 0 O-C-N 121.236 -0.915 . . . . 0.0 109.539 179.995 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 65' ' ' ILE . . . . . 0.777 HD11 ' HA3' ' A' ' 39' ' ' GLY . 26.7 pt -94.27 -24.04 5.07 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.604 0 O-C-N 121.341 -0.849 . . . . 0.0 109.442 179.98 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 66' ' ' ASP . . . . . 0.467 ' HB3' ' OG1' ' A' ' 79' ' ' THR . 55.3 t0 -147.78 136.6 21.95 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.22 -0.925 . . . . 0.0 109.561 -179.974 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 67' ' ' LEU . . . . . 0.748 ' C ' HD13 ' A' ' 67' ' ' LEU . 3.5 tm? -119.92 114.18 21.68 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.348 -0.845 . . . . 0.0 109.276 179.994 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 68' ' ' SER . . . . . 0.495 ' HB2' ' HB2' ' A' ' 77' ' ' PHE . 49.1 m -123.89 141.5 51.98 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.281 -0.887 . . . . 0.0 109.625 -179.993 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 69' ' ' MET . . . . . 0.485 ' SD ' ' N ' ' A' ' 51' ' ' PRO . 84.2 mtp -129.71 148.15 51.57 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.234 -0.916 . . . . 0.0 109.434 179.888 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 70' ' ' ASP . . . . . 0.485 ' C ' ' HD2' ' A' ' 72' ' ' PRO . 0.4 OUTLIER -124.21 102.0 34.29 Favored Pre-proline 0 N--CA 1.49 1.551 0 O-C-N 121.225 -0.922 . . . . 0.0 109.525 -179.959 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 71' ' ' PRO . . . . . 0.595 ' N ' ' CD ' ' A' ' 72' ' ' PRO . 46.5 Cg_endo -74.67 -27.6 10.54 Favored 'Trans proline' 0 CA--C 1.543 0.952 0 C-N-CA 122.519 2.146 . . . . 0.0 113.57 179.957 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 72' ' ' PRO . . . . . 0.595 ' CD ' ' N ' ' A' ' 71' ' ' PRO . 55.2 Cg_endo -75.57 -31.61 5.39 Favored 'Trans proline' 0 C--N 1.354 0.832 0 C-N-CA 121.452 1.435 . . . . 0.0 111.682 -179.911 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 73' ' ' ARG . . . . . 0.469 ' HG2' ' O ' ' A' ' 73' ' ' ARG . 19.5 ttt180 -103.85 -2.63 25.99 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.188 -0.945 . . . . 0.0 109.641 179.953 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 74' ' ' ASN . . . . . 0.432 ' HB2' ' O ' ' A' ' 73' ' ' ARG . 82.3 m-20 62.11 44.41 7.95 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.228 -0.92 . . . . 0.0 109.402 -179.901 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 75' ' ' CYS . . . . . 0.404 ' HA ' ' O ' ' A' ' 44' ' ' VAL . 23.9 p -143.13 134.73 26.42 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.237 -0.915 . . . . 0.0 109.439 -179.96 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 76' ' ' ALA . . . . . 0.452 ' HA ' ' HA ' ' A' ' 69' ' ' MET . . . -107.63 160.45 15.69 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.316 -0.865 . . . . 0.0 109.436 179.985 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 77' ' ' PHE . . . . . 0.495 ' HB2' ' HB2' ' A' ' 68' ' ' SER . 96.5 m-85 -128.0 130.74 48.82 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.264 -0.898 . . . . 0.0 109.546 -179.948 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 78' ' ' VAL . . . . . 0.823 ' O ' HD12 ' A' ' 42' ' ' LEU . 33.7 t -121.43 134.22 65.47 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.556 0 O-C-N 121.146 -0.971 . . . . 0.0 109.485 -179.946 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 79' ' ' THR . . . . . 0.621 HG22 ' CA ' ' A' ' 39' ' ' GLY . 5.2 m -102.67 130.11 49.49 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.241 -0.912 . . . . 0.0 109.452 -179.977 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 80' ' ' TYR . . . . . 0.492 ' OH ' ' HB2' ' A' ' 61' ' ' PHE . 0.6 OUTLIER -110.73 136.68 49.43 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.149 -0.969 . . . . 0.0 109.515 -179.945 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 81' ' ' GLU . . . . . 0.507 ' O ' ' CB ' ' A' ' 38' ' ' LYS . 81.8 tt0 -54.56 -28.6 47.06 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.218 -0.926 . . . . 0.0 109.446 179.986 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 57.4 mttm -135.9 148.78 48.72 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.204 -0.935 . . . . 0.0 109.589 -179.965 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 83' ' ' MET . . . . . 0.995 ' HE3' ' O ' ' A' ' 117' ' ' ALA . 61.2 mtt -67.84 -21.06 65.21 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.175 -0.953 . . . . 0.0 109.471 -179.96 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 97.2 mt-10 -66.96 -41.48 86.81 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.239 -0.913 . . . . 0.0 109.457 -179.949 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 19.8 m -64.05 -30.94 71.97 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.336 -0.853 . . . . 0.0 109.451 179.96 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 86' ' ' ALA . . . . . 0.833 ' O ' HG23 ' A' ' 90' ' ' VAL . . . -73.67 -31.08 63.28 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.297 -0.877 . . . . 0.0 109.455 179.903 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 58.6 t0 -67.99 -44.69 76.04 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.2 -0.937 . . . . 0.0 109.517 179.973 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 62.1 tt0 -64.28 -39.95 94.97 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.184 -0.948 . . . . 0.0 109.483 179.906 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 89' ' ' ALA . . . . . 0.893 ' HB1' ' CD1' ' A' ' 93' ' ' LEU . . . -74.51 -43.11 57.44 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.238 -0.914 . . . . 0.0 109.496 -179.901 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 90' ' ' VAL . . . . . 0.833 HG23 ' O ' ' A' ' 86' ' ' ALA . 88.9 t -61.49 -32.02 52.22 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.56 0 O-C-N 121.176 -0.953 . . . . 0.0 109.685 -179.867 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -80.14 -51.92 8.4 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.23 -0.919 . . . . 0.0 109.728 -179.841 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 92' ' ' GLU . . . . . 0.583 ' HB2' ' CZ ' ' A' ' 61' ' ' PHE . 74.1 mt-10 -71.63 -47.28 55.58 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.278 -0.889 . . . . 0.0 109.927 -179.699 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 93' ' ' LEU . . . . . 0.893 ' CD1' ' HB1' ' A' ' 89' ' ' ALA . 62.4 mt -63.78 -36.76 84.96 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.188 -0.945 . . . . 0.0 109.857 -179.643 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 94' ' ' ASN . . . . . 0.524 ' CB ' ' O ' ' A' ' 90' ' ' VAL . 61.0 t-20 -74.3 125.99 29.67 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.131 -0.98 . . . . 0.0 109.475 -179.865 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 96.1 22.1 21.01 Favored Glycine 0 N--CA 1.489 2.225 0 N-CA-C 109.461 -1.456 . . . . 0.0 109.461 179.916 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 96' ' ' THR . . . . . 0.521 ' CG2' ' O ' ' A' ' 92' ' ' GLU . 21.9 p -116.03 160.26 20.53 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.217 -1.166 . . . . 0.0 109.461 -179.975 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 97' ' ' GLN . . . . . 0.451 ' HG2' ' N ' ' A' ' 98' ' ' VAL . 64.2 tt0 -132.72 158.56 42.05 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.265 -0.897 . . . . 0.0 109.484 -179.911 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 98' ' ' VAL . . . . . 0.605 HG23 ' O ' ' A' ' 101' ' ' VAL . 1.2 t -108.56 -153.31 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.572 0 O-C-N 121.234 -0.916 . . . . 0.0 109.398 179.961 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 99' ' ' GLU . . . . . 0.537 ' H ' HG12 ' A' ' 98' ' ' VAL . 96.9 mt-10 -57.66 -36.76 72.33 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.217 -0.927 . . . . 0.0 109.61 -179.919 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -162.86 25.48 0.09 Allowed 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.25 -0.906 . . . . 0.0 109.494 179.944 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 101' ' ' VAL . . . . . 0.605 ' O ' HG23 ' A' ' 98' ' ' VAL . 84.8 t -139.37 146.61 25.35 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 O-C-N 121.239 -0.913 . . . . 0.0 109.496 179.938 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 90.3 mt-30 -100.83 147.42 26.11 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.263 -0.898 . . . . 0.0 109.495 -179.968 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 95.9 mt -113.7 133.84 55.1 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.241 -0.912 . . . . 0.0 109.493 -179.985 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 104' ' ' LYS . . . . . 0.474 ' O ' ' HA ' ' A' ' 44' ' ' VAL . 70.5 mttt -115.75 145.31 42.9 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.264 -0.897 . . . . 0.0 109.308 179.964 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 105' ' ' VAL . . . . . 0.773 HG11 ' HA ' ' A' ' 90' ' ' VAL . 29.2 t -127.52 146.73 32.78 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.524 0 O-C-N 121.12 -0.988 . . . . 0.0 109.718 -179.789 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 106' ' ' ASN . . . . . 0.463 ' HB2' ' HB3' ' A' ' 43' ' ' TYR . 74.9 m-20 -158.08 -167.9 2.35 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.315 -0.866 . . . . 0.0 109.272 179.975 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 25.4 mm -109.55 137.28 42.44 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.553 0 O-C-N 121.189 -0.944 . . . . 0.0 109.419 -179.978 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 108' ' ' ALA . . . . . 0.505 ' HB2' ' HB2' ' A' ' 43' ' ' TYR . . . -132.16 148.8 52.49 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.192 -0.943 . . . . 0.0 109.519 179.992 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 75.3 mtp85 -102.02 32.56 3.41 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.207 -0.933 . . . . 0.0 109.555 179.973 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 110' ' ' LYS . . . . . 0.552 ' HB3' HG21 ' A' ' 41' ' ' THR . 39.2 tttt -71.86 -4.49 28.37 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.272 -0.892 . . . . 0.0 109.573 -179.953 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 111' ' ' GLN . . . . . 0.528 ' HG3' ' HE2' ' A' ' 113' ' ' MET . 0.5 OUTLIER -119.08 73.33 12.89 Favored Pre-proline 0 N--CA 1.489 1.507 0 O-C-N 121.185 -0.947 . . . . 0.0 109.53 -179.983 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 112' ' ' PRO . . . . . 0.439 ' O ' ' C ' ' A' ' 113' ' ' MET . 55.7 Cg_endo -80.28 -20.93 8.09 Favored 'Trans proline' 0 C--O 1.216 -0.621 0 C-N-CA 122.759 2.306 . . . . 0.0 112.089 -179.757 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 113' ' ' MET . . . . . 0.528 ' HE2' ' HG3' ' A' ' 111' ' ' GLN . 0.0 OUTLIER -42.09 -34.43 0.73 Allowed 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.194 -0.941 . . . . 0.0 109.617 -179.707 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 114' ' ' LEU . . . . . 0.921 HD22 ' HA ' ' A' ' 38' ' ' LYS . 4.6 tt -142.66 25.96 1.78 Allowed 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.355 -0.841 . . . . 0.0 109.124 179.727 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 115' ' ' ASP . . . . . 0.494 ' O ' ' N ' ' A' ' 117' ' ' ALA . 75.9 m-20 44.58 55.78 5.57 Favored 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.227 -0.92 . . . . 0.0 109.076 -179.74 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 116' ' ' ALA . . . . . 0.519 ' O ' ' N ' ' A' ' 39' ' ' GLY . . . 62.8 -77.98 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.323 -0.86 . . . . 0.0 109.383 -179.667 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 117' ' ' ALA . . . . . 0.995 ' O ' ' HE3' ' A' ' 83' ' ' MET . . . -161.81 154.51 20.17 Favored 'General case' 0 C--N 1.302 -1.496 0 O-C-N 121.368 -0.832 . . . . 0.0 109.524 -179.811 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 18.3 p -130.39 167.13 19.06 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.208 -0.933 . . . . 0.0 109.629 -179.789 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 119' ' ' GLY . . . . . 0.416 ' O ' ' HB2' ' A' ' 120' ' ' LYS . . . -145.51 176.21 24.63 Favored Glycine 0 N--CA 1.49 2.269 0 N-CA-C 109.344 -1.502 . . . . 0.0 109.344 179.915 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 120' ' ' LYS . . . . . 0.416 ' HB2' ' O ' ' A' ' 119' ' ' GLY . 35.8 mttm 60.84 43.4 12.0 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.289 -1.124 . . . . 0.0 109.429 -179.995 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 2.2 p . . . . . 0 N--CA 1.49 1.544 0 CA-C-O 118.074 -0.965 . . . . 0.0 109.439 -179.998 . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 35' ' ' ALA . . . . . 0.784 ' HB1' HD12 ' A' ' 114' ' ' LEU . . . . . . . . 0 N--CA 1.489 1.52 0 N-CA-C 109.498 -0.556 . . . . 0.0 109.498 . . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 49.4 Cg_endo -69.57 -9.13 25.38 Favored 'Trans proline' 0 C--O 1.215 -0.638 0 C-N-CA 122.739 2.293 . . . . 0.0 111.728 -179.985 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 72.7 mtt180 -122.25 139.9 53.23 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.274 -0.892 . . . . 0.0 109.526 -179.903 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 38' ' ' LYS . . . . . 0.467 ' HB3' ' O ' ' A' ' 116' ' ' ALA . 12.2 mttp -111.57 -163.21 0.83 Allowed 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.259 -0.9 . . . . 0.0 109.422 179.944 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 39' ' ' GLY . . . . . 0.526 ' HA2' ' CA ' ' A' ' 81' ' ' GLU . . . -177.09 177.07 48.29 Favored Glycine 0 N--CA 1.492 2.372 0 N-CA-C 109.548 -1.421 . . . . 0.0 109.548 179.882 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 40' ' ' ASN . . . . . 0.529 ' N ' ' O ' ' A' ' 80' ' ' TYR . 54.3 t30 -155.36 110.33 2.99 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.055 -1.262 . . . . 0.0 109.352 179.8 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 41' ' ' THR . . . . . 0.492 ' O ' HD23 ' A' ' 42' ' ' LEU . 45.1 m -74.49 136.55 42.24 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.273 -0.892 . . . . 0.0 109.839 -179.695 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 42' ' ' LEU . . . . . 0.867 HD11 ' CD2' ' A' ' 80' ' ' TYR . 13.7 mt -119.47 157.21 28.74 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.363 -0.836 . . . . 0.0 109.322 179.84 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 43' ' ' TYR . . . . . 0.471 ' HB3' ' HB2' ' A' ' 106' ' ' ASN . 69.9 t80 -114.14 121.38 43.59 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.261 -0.899 . . . . 0.0 109.448 -179.976 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 47.4 t -115.88 136.3 53.21 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.579 0 O-C-N 121.331 -0.855 . . . . 0.0 109.367 179.948 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 71.8 t80 -126.35 130.61 51.13 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.264 -0.897 . . . . 0.0 109.488 -179.923 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -175.83 -173.94 41.96 Favored Glycine 0 N--CA 1.49 2.272 0 N-CA-C 109.472 -1.451 . . . . 0.0 109.472 179.999 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 47' ' ' GLU . . . . . 0.422 ' O ' ' C ' ' A' ' 48' ' ' ASP . 94.8 mt-10 -115.88 156.39 26.22 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.231 -1.158 . . . . 0.0 109.487 -179.916 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 48' ' ' ASP . . . . . 0.422 ' C ' ' O ' ' A' ' 47' ' ' GLU . 38.1 m-20 44.21 51.19 7.49 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.229 -0.919 . . . . 0.0 109.551 179.936 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 55.3 mtm -100.57 137.09 39.45 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.272 -0.893 . . . . 0.0 109.433 179.981 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 50' ' ' THR . . . . . 0.476 ' O ' HD12 ' A' ' 54' ' ' LEU . 0.3 OUTLIER -119.76 163.21 28.86 Favored Pre-proline 0 N--CA 1.491 1.583 0 O-C-N 121.308 -0.87 . . . . 0.0 109.441 179.963 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 48.7 Cg_endo -70.13 -54.26 0.21 Allowed 'Trans proline' 0 C--O 1.214 -0.677 0 C-N-CA 122.629 2.22 . . . . 0.0 111.815 -179.992 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 37.3 m -53.27 -48.49 68.25 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.185 -0.947 . . . . 0.0 109.317 179.921 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 17.6 tp -58.63 -48.49 80.83 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.247 -0.908 . . . . 0.0 109.28 179.824 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 54' ' ' LEU . . . . . 0.66 HD11 ' HE1' ' A' ' 69' ' ' MET . 16.6 mt -57.87 -44.99 87.0 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.232 -0.917 . . . . 0.0 109.259 179.793 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 55' ' ' ARG . . . . . 0.514 ' O ' ' N ' ' A' ' 59' ' ' SER . 57.5 mtt-85 -50.94 -39.75 55.66 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.244 -0.91 . . . . 0.0 109.2 179.853 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -69.5 -30.87 70.92 Favored Glycine 0 N--CA 1.49 2.243 0 N-CA-C 109.313 -1.515 . . . . 0.0 109.313 179.767 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -79.51 -21.53 45.15 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.243 -1.151 . . . . 0.0 109.467 179.998 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 58' ' ' PHE . . . . . 0.66 ' CZ ' HD13 ' A' ' 93' ' ' LEU . 94.5 m-85 -119.09 7.97 11.47 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.26 -0.9 . . . . 0.0 109.384 179.929 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 59' ' ' SER . . . . . 0.539 ' N ' ' HD2' ' A' ' 60' ' ' PRO . 0.6 OUTLIER -75.24 -55.54 2.18 Favored Pre-proline 0 N--CA 1.49 1.562 0 O-C-N 121.286 -0.884 . . . . 0.0 110.196 -179.591 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 60' ' ' PRO . . . . . 0.539 ' HD2' ' N ' ' A' ' 59' ' ' SER . 48.4 Cg_endo -69.42 -29.6 25.24 Favored 'Trans proline' 0 C--O 1.214 -0.677 0 C-N-CA 122.542 2.161 . . . . 0.0 112.208 -179.408 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 61' ' ' PHE . . . . . 0.588 ' CB ' ' HB2' ' A' ' 89' ' ' ALA . 55.2 m-85 -67.48 -28.88 68.22 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.21 -0.931 . . . . 0.0 109.534 179.984 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 172.81 -178.43 44.85 Favored Glycine 0 N--CA 1.49 2.293 0 N-CA-C 109.579 -1.408 . . . . 0.0 109.579 179.951 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 47.9 t-20 -94.26 138.25 32.49 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.292 -1.122 . . . . 0.0 109.447 179.99 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 64' ' ' ILE . . . . . 0.514 HD11 ' HB2' ' A' ' 58' ' ' PHE . 57.7 mt -100.02 135.49 35.48 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.502 0 O-C-N 121.258 -0.901 . . . . 0.0 109.392 -179.972 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 65' ' ' ILE . . . . . 0.428 HG12 ' HB ' ' A' ' 79' ' ' THR . 27.2 pt -102.6 -21.76 5.05 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.636 0 O-C-N 121.326 -0.859 . . . . 0.0 109.659 -179.833 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 66' ' ' ASP . . . . . 0.458 ' HB3' ' OG1' ' A' ' 79' ' ' THR . 56.7 t0 -145.39 111.8 5.76 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.122 -0.986 . . . . 0.0 109.675 -179.966 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 67' ' ' LEU . . . . . 0.446 HD22 ' NE ' ' A' ' 55' ' ' ARG . 32.3 tp -108.11 123.6 48.95 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.328 -0.857 . . . . 0.0 109.358 179.919 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 68' ' ' SER . . . . . 0.481 ' HB3' ' HB2' ' A' ' 77' ' ' PHE . 23.2 t -134.25 140.71 46.64 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.271 -0.893 . . . . 0.0 109.505 -179.941 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 69' ' ' MET . . . . . 0.66 ' HE1' HD11 ' A' ' 54' ' ' LEU . 87.6 mmm -113.71 151.65 31.58 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.301 -0.874 . . . . 0.0 109.502 179.923 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 70' ' ' ASP . . . . . 0.472 ' C ' ' HD2' ' A' ' 72' ' ' PRO . 0.3 OUTLIER -131.84 100.29 16.14 Favored Pre-proline 0 N--CA 1.49 1.554 0 O-C-N 121.277 -0.89 . . . . 0.0 109.522 179.95 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 71' ' ' PRO . . . . . 0.595 ' CD ' ' CD ' ' A' ' 72' ' ' PRO . 46.7 Cg_endo -74.53 -27.9 10.56 Favored 'Trans proline' 0 CA--C 1.543 0.943 0 C-N-CA 122.497 2.131 . . . . 0.0 113.629 -179.897 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 72' ' ' PRO . . . . . 0.595 ' CD ' ' CD ' ' A' ' 71' ' ' PRO . 54.5 Cg_endo -75.46 -32.79 4.61 Favored 'Trans proline' 0 C--N 1.353 0.763 0 C-N-CA 121.431 1.42 . . . . 0.0 111.643 -179.89 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 73' ' ' ARG . . . . . 0.45 ' O ' ' HG3' ' A' ' 73' ' ' ARG . 13.6 tpt180 -101.45 -4.85 26.11 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.249 -0.907 . . . . 0.0 109.523 -179.978 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 74' ' ' ASN . . . . . 0.437 ' HB2' ' O ' ' A' ' 73' ' ' ARG . 77.5 m-20 61.95 43.78 8.84 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.194 -0.941 . . . . 0.0 109.507 -179.854 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 75' ' ' CYS . . . . . 0.432 ' CB ' ' CZ ' ' A' ' 43' ' ' TYR . 31.4 p -147.48 142.73 27.27 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.298 -0.876 . . . . 0.0 109.48 -179.954 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 76' ' ' ALA . . . . . 0.446 ' HB1' ' SD ' ' A' ' 69' ' ' MET . . . -107.29 163.17 13.25 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.296 -0.877 . . . . 0.0 109.469 179.984 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 77' ' ' PHE . . . . . 0.481 ' HB2' ' HB3' ' A' ' 68' ' ' SER . 96.7 m-85 -122.84 130.89 53.43 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.317 -0.864 . . . . 0.0 109.544 -179.969 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 78' ' ' VAL . . . . . 0.495 ' O ' ' N ' ' A' ' 42' ' ' LEU . 46.7 t -126.52 140.11 49.79 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.604 0 O-C-N 121.278 -0.889 . . . . 0.0 109.33 179.861 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 79' ' ' THR . . . . . 0.521 ' CG2' ' OE1' ' A' ' 111' ' ' GLN . 2.5 m -115.55 112.73 22.63 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.224 -0.922 . . . . 0.0 109.584 -179.849 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 80' ' ' TYR . . . . . 0.867 ' CD2' HD11 ' A' ' 42' ' ' LEU . 1.4 m-85 -93.12 123.15 36.17 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.25 -0.906 . . . . 0.0 109.402 179.932 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 81' ' ' GLU . . . . . 0.526 ' CA ' ' HA2' ' A' ' 39' ' ' GLY . 86.1 tt0 -38.88 -34.54 0.16 Allowed 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.537 -0.727 . . . . 0.0 110.302 -179.667 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 57.2 mttp -128.52 158.38 38.57 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.068 -1.02 . . . . 0.0 109.594 -179.911 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 83' ' ' MET . . . . . 0.631 ' HE3' ' C ' ' A' ' 117' ' ' ALA . 58.9 mtt -74.65 -21.71 59.29 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.274 -0.891 . . . . 0.0 109.452 179.936 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 75.6 mm-40 -68.51 -46.99 68.16 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.339 -0.851 . . . . 0.0 109.473 -179.958 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 14.0 m -55.5 -35.03 65.14 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.283 -0.885 . . . . 0.0 109.369 -179.945 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 86' ' ' ALA . . . . . 0.548 ' O ' HG23 ' A' ' 90' ' ' VAL . . . -75.44 -28.75 59.46 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.318 -0.863 . . . . 0.0 109.559 -179.968 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 57.1 t0 -66.18 -40.07 90.17 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.246 -0.908 . . . . 0.0 109.551 -179.925 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 88' ' ' GLN . . . . . 0.478 ' O ' ' CB ' ' A' ' 92' ' ' GLU . 47.7 tt0 -74.99 -35.64 62.01 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.244 -0.91 . . . . 0.0 109.431 -179.895 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 89' ' ' ALA . . . . . 0.624 ' HB1' ' CD1' ' A' ' 93' ' ' LEU . . . -77.47 -41.64 38.85 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.23 -0.919 . . . . 0.0 109.614 -179.912 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 90' ' ' VAL . . . . . 0.587 HG22 HG11 ' A' ' 105' ' ' VAL . 68.8 t -65.1 -47.35 88.11 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.603 0 O-C-N 121.247 -0.908 . . . . 0.0 109.638 -179.892 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -73.04 -39.65 65.77 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.218 -0.926 . . . . 0.0 109.582 -179.917 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 92' ' ' GLU . . . . . 0.583 ' HB3' ' CE1' ' A' ' 61' ' ' PHE . 44.4 tp10 -74.25 -50.22 19.93 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.266 -0.896 . . . . 0.0 109.682 -179.954 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 93' ' ' LEU . . . . . 0.66 HD13 ' CZ ' ' A' ' 58' ' ' PHE . 42.2 mt -65.24 -38.98 92.05 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.21 -0.931 . . . . 0.0 109.534 -179.841 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 94' ' ' ASN . . . . . 0.49 ' CB ' ' O ' ' A' ' 90' ' ' VAL . 59.3 t-20 -67.74 129.37 39.69 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.241 -0.912 . . . . 0.0 109.535 179.999 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 98.94 17.31 28.13 Favored Glycine 0 N--CA 1.49 2.285 0 N-CA-C 109.543 -1.423 . . . . 0.0 109.543 -179.997 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 96' ' ' THR . . . . . 0.516 HG23 ' O ' ' A' ' 93' ' ' LEU . 16.1 p -116.16 158.79 22.71 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.251 -1.146 . . . . 0.0 109.473 179.936 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 61.3 tt0 -122.8 139.83 53.58 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.255 -0.903 . . . . 0.0 109.497 179.998 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 98' ' ' VAL . . . . . 0.587 HG12 ' H ' ' A' ' 99' ' ' GLU . 1.1 t -81.79 -157.48 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.608 0 O-C-N 121.247 -0.908 . . . . 0.0 109.302 -179.982 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 99' ' ' GLU . . . . . 0.587 ' H ' HG12 ' A' ' 98' ' ' VAL . 76.4 mm-40 -60.64 -38.28 84.28 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.23 -0.919 . . . . 0.0 109.584 -179.958 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 100' ' ' SER . . . . . 0.426 ' O ' ' OG ' ' A' ' 100' ' ' SER . 4.9 t -155.04 24.04 0.43 Allowed 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.248 -0.907 . . . . 0.0 109.613 179.943 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 101' ' ' VAL . . . . . 0.548 ' O ' HG23 ' A' ' 98' ' ' VAL . 57.5 t -141.0 155.91 21.93 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.553 0 O-C-N 121.226 -0.921 . . . . 0.0 109.515 179.891 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 102' ' ' GLN . . . . . 0.415 ' N ' HG12 ' A' ' 101' ' ' VAL . 92.8 mt-30 -98.3 143.19 29.04 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.242 -0.911 . . . . 0.0 109.447 -179.971 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 103' ' ' LEU . . . . . 0.408 HD23 ' HA ' ' A' ' 103' ' ' LEU . 92.7 mt -101.85 141.86 34.05 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.25 -0.906 . . . . 0.0 109.44 179.975 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 1.3 mtpm? -131.45 134.21 45.97 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.281 -0.887 . . . . 0.0 109.4 179.921 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 105' ' ' VAL . . . . . 0.587 HG11 HG22 ' A' ' 90' ' ' VAL . 17.8 t -118.31 135.78 57.61 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.534 0 O-C-N 121.17 -0.956 . . . . 0.0 109.65 -179.931 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 106' ' ' ASN . . . . . 0.471 ' HB2' ' HB3' ' A' ' 43' ' ' TYR . 78.8 m-20 -134.56 -178.43 5.06 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.358 -0.839 . . . . 0.0 109.401 179.812 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 44.1 mt -108.8 133.99 52.15 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.568 0 O-C-N 121.232 -0.918 . . . . 0.0 109.509 -179.948 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -112.96 161.51 16.93 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.284 -0.885 . . . . 0.0 109.451 -179.994 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 31.9 ttt85 -45.75 144.8 1.57 Allowed 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.177 -0.952 . . . . 0.0 109.432 -179.977 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 110' ' ' LYS . . . . . 0.471 ' HD3' ' O ' ' A' ' 115' ' ' ASP . 79.9 mttt -65.13 150.39 48.23 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.183 -0.948 . . . . 0.0 109.521 -179.923 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 111' ' ' GLN . . . . . 0.709 ' HB2' ' HE2' ' A' ' 113' ' ' MET . 0.7 OUTLIER -70.71 150.04 95.32 Favored Pre-proline 0 N--CA 1.491 1.618 0 O-C-N 121.411 -0.805 . . . . 0.0 109.648 -179.779 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 55.4 Cg_endo -74.18 -23.95 15.18 Favored 'Trans proline' 0 C--O 1.216 -0.62 0 C-N-CA 122.737 2.291 . . . . 0.0 112.756 -179.497 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 113' ' ' MET . . . . . 0.709 ' HE2' ' HB2' ' A' ' 111' ' ' GLN . 8.1 mtm -54.62 -24.14 20.15 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 120.908 -1.12 . . . . 0.0 109.516 -179.573 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 114' ' ' LEU . . . . . 0.784 HD12 ' HB1' ' A' ' 35' ' ' ALA . 2.7 tt -176.01 29.78 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.264 -0.898 . . . . 0.0 109.599 -179.814 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 115' ' ' ASP . . . . . 0.661 ' O ' ' HB3' ' A' ' 116' ' ' ALA . 79.6 m-20 48.23 36.56 6.95 Favored 'General case' 0 C--N 1.302 -1.462 0 O-C-N 121.213 -0.929 . . . . 0.0 108.868 -179.63 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 116' ' ' ALA . . . . . 0.661 ' HB3' ' O ' ' A' ' 115' ' ' ASP . . . 75.62 -82.32 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.477 -0.764 . . . . 0.0 109.648 -179.804 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 117' ' ' ALA . . . . . 0.631 ' C ' ' HE3' ' A' ' 83' ' ' MET . . . -167.03 -166.05 0.77 Allowed 'General case' 0 N--CA 1.487 1.416 0 O-C-N 121.11 -0.994 . . . . 0.0 109.611 -179.88 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 21.0 p -123.71 156.85 35.18 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.299 -0.875 . . . . 0.0 109.462 -179.987 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -178.34 -172.84 43.17 Favored Glycine 0 N--CA 1.491 2.303 0 N-CA-C 109.504 -1.439 . . . . 0.0 109.504 -179.985 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 9.2 tptt -58.22 -36.34 73.0 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.265 -1.138 . . . . 0.0 109.462 179.972 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 91.5 p . . . . . 0 N--CA 1.49 1.536 0 CA-C-O 118.013 -0.994 . . . . 0.0 109.477 179.971 . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 1.505 0 N-CA-C 109.423 -0.584 . . . . 0.0 109.423 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 49.1 Cg_endo -70.02 -27.24 25.48 Favored 'Trans proline' 0 C--O 1.214 -0.702 0 C-N-CA 122.669 2.246 . . . . 0.0 111.767 -179.986 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 94.1 mtt180 -61.62 148.98 40.64 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.31 -0.869 . . . . 0.0 109.442 -179.986 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 38' ' ' LYS . . . . . 0.637 ' HA ' HD22 ' A' ' 114' ' ' LEU . 55.7 mttp -78.87 -166.01 0.83 Allowed 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.245 -0.909 . . . . 0.0 109.528 -179.81 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 39' ' ' GLY . . . . . 0.538 ' HA3' ' NE2' ' A' ' 111' ' ' GLN . . . 172.62 -178.7 44.57 Favored Glycine 0 N--CA 1.49 2.254 0 N-CA-C 109.41 -1.476 . . . . 0.0 109.41 -179.94 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 40' ' ' ASN . . . . . 0.698 ' HA ' ' HB1' ' A' ' 116' ' ' ALA . 1.7 t-20 -171.23 113.22 0.38 Allowed 'General case' 0 N--CA 1.493 1.686 0 O-C-N 120.992 -1.299 . . . . 0.0 109.799 179.64 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 41' ' ' THR . . . . . 0.767 HG21 ' HB2' ' A' ' 110' ' ' LYS . 91.2 m -80.5 153.73 27.98 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.18 -0.95 . . . . 0.0 109.841 -179.913 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 42' ' ' LEU . . . . . 0.924 HD12 ' O ' ' A' ' 78' ' ' VAL . 4.7 mp -131.05 155.4 46.95 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.376 -0.827 . . . . 0.0 109.305 179.763 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 43' ' ' TYR . . . . . 0.455 ' HB3' ' HB2' ' A' ' 106' ' ' ASN . 39.2 t80 -113.67 108.9 17.76 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.206 -0.934 . . . . 0.0 109.594 -179.923 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 44' ' ' VAL . . . . . 0.459 ' HA ' ' O ' ' A' ' 104' ' ' LYS . 39.3 t -105.28 146.04 12.8 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 O-C-N 121.289 -0.882 . . . . 0.0 109.488 179.999 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 67.0 t80 -135.59 140.47 44.66 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.21 -0.931 . . . . 0.0 109.468 179.989 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 174.82 -165.17 36.26 Favored Glycine 0 N--CA 1.491 2.321 0 N-CA-C 109.464 -1.454 . . . . 0.0 109.464 -179.995 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 90.3 mt-10 -115.07 157.48 23.46 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.238 -1.154 . . . . 0.0 109.584 -179.908 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 56.0 t0 44.76 45.16 8.13 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.273 -0.892 . . . . 0.0 109.576 179.992 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 34.2 mtp -81.79 133.43 35.34 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.195 -0.941 . . . . 0.0 109.423 179.934 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 50' ' ' THR . . . . . 0.512 ' O ' HD12 ' A' ' 54' ' ' LEU . 0.1 OUTLIER -125.77 162.08 47.26 Favored Pre-proline 0 N--CA 1.49 1.527 0 O-C-N 121.208 -0.932 . . . . 0.0 109.461 -179.897 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 51' ' ' PRO . . . . . 0.467 ' N ' ' SD ' ' A' ' 69' ' ' MET . 50.2 Cg_endo -70.6 -53.28 0.23 Allowed 'Trans proline' 0 C--O 1.215 -0.648 0 C-N-CA 122.696 2.264 . . . . 0.0 111.644 179.957 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 30.2 m -55.87 -47.93 76.45 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.223 -0.923 . . . . 0.0 109.317 179.867 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 15.5 tp -56.94 -54.23 48.96 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.311 -0.868 . . . . 0.0 109.231 179.871 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 54' ' ' LEU . . . . . 0.512 HD12 ' O ' ' A' ' 50' ' ' THR . 12.4 mt -51.63 -52.83 44.65 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.221 -0.925 . . . . 0.0 109.225 179.766 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 55' ' ' ARG . . . . . 0.563 ' HE ' HD22 ' A' ' 67' ' ' LEU . 49.2 mtt180 -44.09 -40.28 4.8 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.354 -0.841 . . . . 0.0 109.212 179.872 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -70.43 -33.33 68.0 Favored Glycine 0 N--CA 1.49 2.273 0 N-CA-C 109.314 -1.514 . . . . 0.0 109.314 179.771 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 57' ' ' ALA . . . . . 0.456 ' N ' ' O ' ' A' ' 54' ' ' LEU . . . -79.81 -16.29 55.78 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.288 -1.125 . . . . 0.0 109.444 179.88 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 58' ' ' PHE . . . . . 0.631 ' CE2' ' CD1' ' A' ' 93' ' ' LEU . 96.3 m-85 -124.36 10.57 8.61 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.257 -0.902 . . . . 0.0 109.5 179.998 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 59' ' ' SER . . . . . 0.538 ' N ' ' HD2' ' A' ' 60' ' ' PRO . 0.6 OUTLIER -77.08 -54.47 1.54 Allowed Pre-proline 0 N--CA 1.491 1.622 0 O-C-N 121.258 -0.901 . . . . 0.0 110.268 -179.624 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 60' ' ' PRO . . . . . 0.538 ' HD2' ' N ' ' A' ' 59' ' ' SER . 50.4 Cg_endo -70.63 -35.07 10.66 Favored 'Trans proline' 0 C--O 1.214 -0.681 0 C-N-CA 122.5 2.133 . . . . 0.0 112.284 -179.213 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 61' ' ' PHE . . . . . 0.575 ' CE1' ' HA ' ' A' ' 89' ' ' ALA . 74.2 m-85 -59.53 -33.99 72.08 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.168 -0.958 . . . . 0.0 109.495 -179.907 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 175.46 178.11 45.04 Favored Glycine 0 N--CA 1.49 2.236 0 N-CA-C 109.489 -1.445 . . . . 0.0 109.489 179.921 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 54.5 t30 -86.99 144.18 27.02 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.246 -1.149 . . . . 0.0 109.433 179.938 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 64' ' ' ILE . . . . . 0.513 HD11 ' HB2' ' A' ' 58' ' ' PHE . 67.1 mt -106.28 134.32 48.21 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.534 0 O-C-N 121.23 -0.919 . . . . 0.0 109.388 -179.965 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 65' ' ' ILE . . . . . 0.605 HD11 ' NE2' ' A' ' 111' ' ' GLN . 37.8 pt -101.67 -25.78 3.7 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.524 0 O-C-N 121.233 -0.917 . . . . 0.0 109.661 -179.774 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 66' ' ' ASP . . . . . 0.426 ' HB3' ' OG1' ' A' ' 79' ' ' THR . 55.4 t0 -142.34 115.83 9.06 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.227 -0.92 . . . . 0.0 109.606 -179.853 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 67' ' ' LEU . . . . . 0.563 HD22 ' HE ' ' A' ' 55' ' ' ARG . 15.8 tp -105.41 115.95 31.12 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.288 -0.883 . . . . 0.0 109.467 179.908 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 68' ' ' SER . . . . . 0.469 ' HB2' ' HB2' ' A' ' 77' ' ' PHE . 67.7 m -123.94 146.66 48.32 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.271 -0.893 . . . . 0.0 109.414 179.972 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 69' ' ' MET . . . . . 0.478 ' HA ' ' HA ' ' A' ' 76' ' ' ALA . 72.0 mtp -131.51 150.89 51.98 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.219 -0.926 . . . . 0.0 109.609 -179.903 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 70' ' ' ASP . . . . . 0.474 ' C ' ' HD2' ' A' ' 72' ' ' PRO . 0.5 OUTLIER -126.24 103.84 25.9 Favored Pre-proline 0 N--CA 1.49 1.571 0 O-C-N 121.228 -0.92 . . . . 0.0 109.392 179.903 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 71' ' ' PRO . . . . . 0.605 ' N ' ' CD ' ' A' ' 72' ' ' PRO . 48.2 Cg_endo -74.91 -27.66 10.0 Favored 'Trans proline' 0 CA--C 1.542 0.903 0 C-N-CA 122.553 2.169 . . . . 0.0 113.793 -179.936 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 72' ' ' PRO . . . . . 0.605 ' CD ' ' N ' ' A' ' 71' ' ' PRO . 55.2 Cg_endo -74.89 -24.85 12.66 Favored 'Trans proline' 0 C--N 1.352 0.752 0 C-N-CA 121.525 1.483 . . . . 0.0 111.934 -179.783 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 61.1 mtt-85 -113.83 2.66 15.19 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.237 -0.914 . . . . 0.0 109.671 -179.812 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 82.8 m-20 58.09 38.9 26.59 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.128 -0.983 . . . . 0.0 109.533 179.924 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 75' ' ' CYS . . . . . . . . . . . . . 29.7 p -135.49 134.04 39.12 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.189 -0.944 . . . . 0.0 109.573 -179.941 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 76' ' ' ALA . . . . . 0.478 ' HA ' ' HA ' ' A' ' 69' ' ' MET . . . -106.48 161.73 14.34 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.257 -0.902 . . . . 0.0 109.339 179.882 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 77' ' ' PHE . . . . . 0.558 ' CD2' ' HE3' ' A' ' 110' ' ' LYS . 97.4 m-85 -125.43 128.33 47.91 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.241 -0.912 . . . . 0.0 109.599 -179.853 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 78' ' ' VAL . . . . . 0.924 ' O ' HD12 ' A' ' 42' ' ' LEU . 13.7 t -117.88 141.01 38.82 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.526 0 O-C-N 121.24 -0.913 . . . . 0.0 109.182 179.793 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 79' ' ' THR . . . . . 0.57 ' CG2' ' NE2' ' A' ' 111' ' ' GLN . 0.4 OUTLIER -112.18 127.73 56.03 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.279 -0.888 . . . . 0.0 109.612 -179.653 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 80' ' ' TYR . . . . . 0.524 ' OH ' ' CA ' ' A' ' 58' ' ' PHE . 1.8 m-85 -111.37 126.96 55.48 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.352 -0.842 . . . . 0.0 109.382 -179.948 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 81' ' ' GLU . . . . . 0.507 ' O ' ' N ' ' A' ' 39' ' ' GLY . 88.1 tt0 -40.74 -39.07 1.02 Allowed 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.456 -0.778 . . . . 0.0 110.192 -179.789 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 46.8 mttp -126.78 156.35 41.37 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.042 -1.036 . . . . 0.0 109.589 -179.766 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 83' ' ' MET . . . . . 1.04 ' HE3' ' O ' ' A' ' 117' ' ' ALA . 40.9 mtt -73.72 -20.74 60.44 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.272 -0.892 . . . . 0.0 109.404 179.895 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 97.5 mt-10 -65.57 -50.64 64.4 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.257 -0.902 . . . . 0.0 109.392 179.875 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 27.5 m -59.25 -35.16 73.18 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.152 -0.968 . . . . 0.0 109.252 179.847 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 86' ' ' ALA . . . . . 0.821 ' HB1' HD21 ' A' ' 42' ' ' LEU . . . -74.94 -31.04 61.41 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.344 -0.847 . . . . 0.0 109.157 179.76 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 90.5 m-20 -67.65 -37.46 82.44 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.26 -0.9 . . . . 0.0 109.276 179.855 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 64.4 tt0 -70.96 -42.14 70.15 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.255 -0.903 . . . . 0.0 109.374 179.841 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 89' ' ' ALA . . . . . 0.628 ' HB1' ' CD1' ' A' ' 93' ' ' LEU . . . -68.83 -42.73 76.81 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.249 -0.907 . . . . 0.0 109.296 -179.971 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 90' ' ' VAL . . . . . 0.782 ' HA ' HG11 ' A' ' 105' ' ' VAL . 79.3 t -58.1 -37.27 60.94 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.52 0 O-C-N 121.201 -0.937 . . . . 0.0 109.498 -179.944 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -76.1 -53.26 8.59 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.26 -0.9 . . . . 0.0 109.587 -179.832 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 92' ' ' GLU . . . . . 0.521 ' O ' ' CG2' ' A' ' 96' ' ' THR . 74.9 mm-40 -67.2 -42.99 83.22 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.361 -0.837 . . . . 0.0 109.648 -179.762 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 93' ' ' LEU . . . . . 0.94 ' HB2' HG21 ' A' ' 105' ' ' VAL . 87.4 mt -68.87 -39.0 80.08 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.206 -0.934 . . . . 0.0 109.617 -179.835 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 94' ' ' ASN . . . . . 0.517 ' CB ' ' O ' ' A' ' 90' ' ' VAL . 21.2 t-20 -67.84 129.99 41.6 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.243 -0.911 . . . . 0.0 109.51 -179.96 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 85.85 32.11 19.03 Favored Glycine 0 N--CA 1.489 2.221 0 N-CA-C 109.514 -1.435 . . . . 0.0 109.514 -179.986 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 96' ' ' THR . . . . . 0.612 HG23 ' O ' ' A' ' 93' ' ' LEU . 27.6 p -119.45 160.28 22.66 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.15 -1.206 . . . . 0.0 109.45 -179.994 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 97' ' ' GLN . . . . . 0.516 ' HG2' ' N ' ' A' ' 98' ' ' VAL . 62.1 tt0 -135.89 159.88 40.3 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.259 -0.9 . . . . 0.0 109.483 -179.951 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 98' ' ' VAL . . . . . 0.609 HG12 ' H ' ' A' ' 99' ' ' GLU . 1.1 t -113.26 -160.25 0.17 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.591 0 O-C-N 121.252 -0.905 . . . . 0.0 109.351 -179.993 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 99' ' ' GLU . . . . . 0.609 ' H ' HG12 ' A' ' 98' ' ' VAL . 95.9 mt-10 -51.73 -35.42 43.21 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.167 -0.958 . . . . 0.0 109.549 -179.943 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 100' ' ' SER . . . . . 0.431 ' O ' ' OG ' ' A' ' 100' ' ' SER . 6.1 t -164.9 28.59 0.06 Allowed 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.197 -0.939 . . . . 0.0 109.498 -179.943 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 101' ' ' VAL . . . . . 0.554 ' O ' HG23 ' A' ' 98' ' ' VAL . 59.7 t -140.42 147.99 22.7 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.564 0 O-C-N 121.244 -0.91 . . . . 0.0 109.464 179.968 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 91.5 mt-30 -97.34 146.65 24.96 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.239 -0.913 . . . . 0.0 109.508 -179.975 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 77.8 mt -111.54 135.21 52.43 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.26 -0.9 . . . . 0.0 109.489 -179.969 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 104' ' ' LYS . . . . . 0.459 ' O ' ' HA ' ' A' ' 44' ' ' VAL . 54.8 mttt -121.8 140.57 52.2 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.226 -0.921 . . . . 0.0 109.482 179.997 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 105' ' ' VAL . . . . . 0.94 HG21 ' HB2' ' A' ' 93' ' ' LEU . 34.3 t -126.2 146.17 32.46 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 121.274 -0.891 . . . . 0.0 109.421 -179.986 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 106' ' ' ASN . . . . . 0.455 ' HB2' ' HB3' ' A' ' 43' ' ' TYR . 84.2 m-20 -155.72 -167.06 2.38 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.342 -0.849 . . . . 0.0 109.505 179.995 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 65.9 mt -112.4 137.18 46.2 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.537 0 O-C-N 121.199 -0.938 . . . . 0.0 109.531 -179.905 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 108' ' ' ALA . . . . . 0.439 ' HB3' HG22 ' A' ' 41' ' ' THR . . . -110.62 155.9 21.73 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.289 -0.882 . . . . 0.0 109.422 179.928 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 20.4 mtm180 -91.15 15.12 12.4 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.331 -0.855 . . . . 0.0 109.54 -179.975 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 110' ' ' LYS . . . . . 0.767 ' HB2' HG21 ' A' ' 41' ' ' THR . 23.6 mttm -72.8 -171.35 0.83 Allowed 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.329 -0.857 . . . . 0.0 109.379 179.919 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 111' ' ' GLN . . . . . 0.605 ' NE2' HD11 ' A' ' 65' ' ' ILE . 5.0 tt0 69.26 52.13 0.45 Allowed Pre-proline 0 N--CA 1.491 1.581 0 O-C-N 121.265 -0.897 . . . . 0.0 109.521 179.922 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 112' ' ' PRO . . . . . 0.475 ' CD ' ' N ' ' A' ' 111' ' ' GLN . 51.3 Cg_endo -71.79 -26.01 19.63 Favored 'Trans proline' 0 C--O 1.214 -0.681 0 C-N-CA 122.652 2.235 . . . . 0.0 111.961 -179.905 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 113' ' ' MET . . . . . 0.589 ' CE ' ' HG3' ' A' ' 111' ' ' GLN . 1.7 ptp -53.94 -29.3 41.91 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.307 -0.871 . . . . 0.0 109.688 -179.809 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 114' ' ' LEU . . . . . 0.637 HD22 ' HA ' ' A' ' 38' ' ' LYS . 0.9 OUTLIER -147.69 26.87 1.01 Allowed 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.165 -0.96 . . . . 0.0 109.374 -179.849 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 115' ' ' ASP . . . . . 0.628 ' O ' ' HB3' ' A' ' 116' ' ' ALA . 77.1 m-20 46.39 36.55 3.5 Favored 'General case' 0 C--N 1.302 -1.468 0 O-C-N 121.137 -0.977 . . . . 0.0 108.643 -179.536 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 116' ' ' ALA . . . . . 0.698 ' HB1' ' HA ' ' A' ' 40' ' ' ASN . . . 72.08 -80.57 0.04 OUTLIER 'General case' 0 N--CA 1.488 1.442 0 O-C-N 121.57 -0.706 . . . . 0.0 109.75 -179.762 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 117' ' ' ALA . . . . . 1.04 ' O ' ' HE3' ' A' ' 83' ' ' MET . . . -162.42 154.97 19.4 Favored 'General case' 0 C--N 1.302 -1.485 0 O-C-N 121.149 -0.969 . . . . 0.0 109.716 -179.617 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 12.1 p -123.68 164.08 19.81 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.261 -0.899 . . . . 0.0 109.538 -179.903 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -142.1 172.08 24.3 Favored Glycine 0 N--CA 1.491 2.312 0 N-CA-C 109.434 -1.467 . . . . 0.0 109.434 -179.931 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 30.0 tttt -74.27 132.1 41.8 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.23 -1.159 . . . . 0.0 109.485 179.942 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 N--CA 1.49 1.531 0 CA-C-O 118.024 -0.989 . . . . 0.0 109.542 179.973 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 1.522 0 N-CA-C 109.493 -0.558 . . . . 0.0 109.493 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 36' ' ' PRO . . . . . 0.424 ' HB2' HD12 ' A' ' 114' ' ' LEU . 49.1 Cg_endo -69.91 143.4 50.0 Favored 'Trans proline' 0 C--O 1.215 -0.631 0 C-N-CA 122.71 2.273 . . . . 0.0 111.751 -179.971 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 37' ' ' ARG . . . . . 0.797 ' C ' HD13 ' A' ' 114' ' ' LEU . 67.3 mtt180 -124.85 158.67 32.88 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.215 -0.928 . . . . 0.0 109.441 179.946 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 38' ' ' LYS . . . . . 1.013 ' HA ' HD22 ' A' ' 114' ' ' LEU . 83.0 mttt -55.36 -170.02 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.233 -0.917 . . . . 0.0 109.246 179.87 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 39' ' ' GLY . . . . . 0.576 ' HA3' HD11 ' A' ' 65' ' ' ILE . . . 151.99 83.45 0.04 OUTLIER Glycine 0 N--CA 1.49 2.245 0 N-CA-C 109.995 -1.242 . . . . 0.0 109.995 179.921 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 40' ' ' ASN . . . . . 0.477 ' O ' ' HA ' ' A' ' 79' ' ' THR . 49.6 t30 -81.49 117.34 21.82 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.169 -1.194 . . . . 0.0 108.947 179.4 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 41' ' ' THR . . . . . 0.481 ' HA ' ' O ' ' A' ' 78' ' ' VAL . 34.2 m -78.01 149.17 34.09 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.259 -0.9 . . . . 0.0 110.105 -179.464 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 42' ' ' LEU . . . . . 0.781 HD12 ' O ' ' A' ' 78' ' ' VAL . 5.2 mp -126.31 154.4 43.51 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.278 -0.889 . . . . 0.0 109.28 179.723 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 43' ' ' TYR . . . . . 0.468 ' HB3' ' HB2' ' A' ' 106' ' ' ASN . 76.1 t80 -107.87 114.82 29.02 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.292 -0.88 . . . . 0.0 109.52 179.875 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 44' ' ' VAL . . . . . 0.625 HG13 HD23 ' A' ' 103' ' ' LEU . 40.6 t -108.52 137.4 40.45 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 121.299 -0.876 . . . . 0.0 109.451 -179.959 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 45' ' ' TYR . . . . . 0.422 ' HB3' ' HB2' ' A' ' 104' ' ' LYS . 65.7 t80 -127.66 135.38 50.14 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.217 -0.927 . . . . 0.0 109.581 -179.844 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 171.24 -177.79 43.97 Favored Glycine 0 N--CA 1.49 2.259 0 N-CA-C 109.553 -1.419 . . . . 0.0 109.553 179.93 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 95.4 mt-10 -116.29 161.83 18.42 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.282 -1.128 . . . . 0.0 109.441 179.997 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 49.9 m-20 44.0 49.51 7.32 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.256 -0.902 . . . . 0.0 109.518 179.947 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 51.1 mtm -101.88 138.82 38.35 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.307 -0.871 . . . . 0.0 109.537 -179.947 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 50' ' ' THR . . . . . 0.405 ' O ' ' HG ' ' A' ' 54' ' ' LEU . 0.9 OUTLIER -122.55 162.94 35.56 Favored Pre-proline 0 N--CA 1.489 1.505 0 O-C-N 121.343 -0.848 . . . . 0.0 109.363 179.914 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 51' ' ' PRO . . . . . 0.628 ' HA ' HD12 ' A' ' 54' ' ' LEU . 47.8 Cg_endo -69.6 -53.61 0.27 Allowed 'Trans proline' 0 C--O 1.215 -0.674 0 C-N-CA 122.592 2.194 . . . . 0.0 111.768 -179.991 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 31.1 m -49.3 -49.23 44.73 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.232 -0.918 . . . . 0.0 109.194 179.867 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 26.8 tp -59.7 -46.54 88.77 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.309 -0.869 . . . . 0.0 109.203 179.714 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 54' ' ' LEU . . . . . 0.657 HD11 ' HE1' ' A' ' 69' ' ' MET . 12.4 mt -57.39 -46.25 83.63 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.322 -0.861 . . . . 0.0 109.193 179.726 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 55' ' ' ARG . . . . . 0.513 ' O ' ' N ' ' A' ' 59' ' ' SER . 83.9 mtt-85 -51.34 -39.84 57.86 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.295 -0.878 . . . . 0.0 109.175 179.79 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -68.77 -35.2 79.46 Favored Glycine 0 N--CA 1.489 2.226 0 N-CA-C 109.35 -1.5 . . . . 0.0 109.35 179.909 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 57' ' ' ALA . . . . . 0.456 ' O ' ' CD1' ' A' ' 61' ' ' PHE . . . -73.4 -27.64 61.57 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.216 -1.167 . . . . 0.0 109.379 179.92 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 58' ' ' PHE . . . . . 0.794 ' HB2' HD11 ' A' ' 64' ' ' ILE . 96.3 m-85 -112.18 8.44 19.89 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.304 -0.873 . . . . 0.0 109.34 179.969 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 59' ' ' SER . . . . . 0.534 ' N ' ' HD2' ' A' ' 60' ' ' PRO . 1.0 OUTLIER -74.09 -57.25 2.37 Favored Pre-proline 0 N--CA 1.491 1.6 0 O-C-N 121.372 -0.83 . . . . 0.0 110.106 -179.693 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 60' ' ' PRO . . . . . 0.534 ' HD2' ' N ' ' A' ' 59' ' ' SER . 47.3 Cg_endo -68.7 -27.66 31.72 Favored 'Trans proline' 0 C--O 1.215 -0.666 0 C-N-CA 122.676 2.25 . . . . 0.0 112.037 -179.511 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 61' ' ' PHE . . . . . 0.583 ' CE2' ' HB3' ' A' ' 92' ' ' GLU . 72.0 m-85 -69.56 -33.41 72.71 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.201 -0.937 . . . . 0.0 109.514 179.981 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 175.18 -169.71 42.64 Favored Glycine 0 N--CA 1.49 2.278 0 N-CA-C 109.487 -1.445 . . . . 0.0 109.487 179.996 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 83.9 m-20 -99.93 138.86 36.42 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.201 -1.176 . . . . 0.0 109.439 179.916 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 64' ' ' ILE . . . . . 0.794 HD11 ' HB2' ' A' ' 58' ' ' PHE . 49.1 mt -101.31 128.51 53.54 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.521 0 O-C-N 121.266 -0.896 . . . . 0.0 109.585 -179.938 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 65' ' ' ILE . . . . . 0.576 HD11 ' HA3' ' A' ' 39' ' ' GLY . 23.0 pt -94.79 -25.19 4.66 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 O-C-N 121.238 -0.914 . . . . 0.0 109.409 -179.896 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 66' ' ' ASP . . . . . 0.466 ' HB3' ' OG1' ' A' ' 79' ' ' THR . 58.4 t0 -141.02 129.84 23.0 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.198 -0.939 . . . . 0.0 109.601 -179.955 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 67' ' ' LEU . . . . . 0.741 ' C ' HD13 ' A' ' 67' ' ' LEU . 3.4 tm? -119.29 116.35 26.05 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.303 -0.873 . . . . 0.0 109.364 179.934 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 68' ' ' SER . . . . . 0.492 ' HB2' ' HB2' ' A' ' 77' ' ' PHE . 58.0 m -121.13 145.35 47.9 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.14 -0.975 . . . . 0.0 109.532 -179.94 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 69' ' ' MET . . . . . 0.657 ' HE1' HD11 ' A' ' 54' ' ' LEU . 89.8 mmm -122.61 144.18 49.28 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.24 -0.912 . . . . 0.0 109.531 -179.952 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 70' ' ' ASP . . . . . 0.479 ' HB2' ' O ' ' A' ' 75' ' ' CYS . 0.2 OUTLIER -124.57 94.31 44.86 Favored Pre-proline 0 N--CA 1.49 1.566 0 O-C-N 121.2 -0.937 . . . . 0.0 109.461 179.917 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 71' ' ' PRO . . . . . 0.598 ' N ' ' CD ' ' A' ' 72' ' ' PRO . 46.5 Cg_endo -74.6 -28.0 10.31 Favored 'Trans proline' 0 CA--C 1.542 0.922 0 C-N-CA 122.506 2.137 . . . . 0.0 113.696 -179.989 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 72' ' ' PRO . . . . . 0.598 ' CD ' ' N ' ' A' ' 71' ' ' PRO . 55.2 Cg_endo -75.45 -22.38 14.11 Favored 'Trans proline' 0 C--N 1.352 0.722 0 C-N-CA 121.523 1.482 . . . . 0.0 111.75 -179.788 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 27.4 mtt85 -113.26 3.8 16.15 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.22 -0.925 . . . . 0.0 109.654 -179.9 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 73.4 m-20 58.23 47.86 13.59 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.244 -0.91 . . . . 0.0 109.45 179.972 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 75' ' ' CYS . . . . . 0.479 ' O ' ' HB2' ' A' ' 70' ' ' ASP . 31.1 p -152.63 148.26 27.11 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.284 -0.885 . . . . 0.0 109.456 -179.968 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 76' ' ' ALA . . . . . 0.468 ' HB1' ' SD ' ' A' ' 69' ' ' MET . . . -120.34 157.54 29.02 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.273 -0.892 . . . . 0.0 109.401 179.919 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 77' ' ' PHE . . . . . 0.492 ' HB2' ' HB2' ' A' ' 68' ' ' SER . 97.7 m-85 -119.59 139.75 51.66 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.202 -0.936 . . . . 0.0 109.569 -179.849 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 78' ' ' VAL . . . . . 0.781 ' O ' HD12 ' A' ' 42' ' ' LEU . 20.5 t -129.23 137.97 55.65 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.546 0 O-C-N 121.191 -0.943 . . . . 0.0 109.55 179.988 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 79' ' ' THR . . . . . 0.57 HG22 ' CA ' ' A' ' 39' ' ' GLY . 23.3 m -106.19 134.83 48.7 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.194 -0.941 . . . . 0.0 109.264 179.89 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 80' ' ' TYR . . . . . 0.612 ' HH ' ' HD2' ' A' ' 58' ' ' PHE . 0.7 OUTLIER -113.21 141.63 46.74 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.214 -0.929 . . . . 0.0 109.62 -179.917 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 81' ' ' GLU . . . . . 0.483 ' O ' ' HB2' ' A' ' 38' ' ' LYS . 80.8 tt0 -64.03 -22.6 67.0 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.209 -0.932 . . . . 0.0 109.359 179.795 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 38.2 mttp -136.05 135.93 39.8 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.243 -0.91 . . . . 0.0 109.461 179.982 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 83' ' ' MET . . . . . 0.687 ' HE2' ' N ' ' A' ' 117' ' ' ALA . 47.0 mtt -57.33 -24.64 56.37 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.244 -0.91 . . . . 0.0 109.401 179.928 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 98.4 mt-10 -66.2 -37.49 85.71 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.305 -0.872 . . . . 0.0 109.557 179.981 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 19.3 m -62.37 -31.48 72.15 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.236 -0.915 . . . . 0.0 109.571 -179.97 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 86' ' ' ALA . . . . . 0.645 ' O ' HG23 ' A' ' 90' ' ' VAL . . . -75.61 -34.54 60.6 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.255 -0.903 . . . . 0.0 109.449 -179.945 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 64.5 t0 -62.14 -45.42 93.53 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.286 -0.884 . . . . 0.0 109.647 -179.953 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 44.6 tt0 -69.08 -43.58 74.25 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.172 -0.955 . . . . 0.0 109.595 -179.882 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 89' ' ' ALA . . . . . 0.624 ' HB1' ' CD1' ' A' ' 93' ' ' LEU . . . -72.37 -37.13 68.84 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.195 -0.941 . . . . 0.0 109.552 -179.869 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 90' ' ' VAL . . . . . 0.747 ' CG2' HD23 ' A' ' 42' ' ' LEU . 61.2 t -69.38 -47.31 73.69 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.604 0 O-C-N 121.254 -0.904 . . . . 0.0 109.652 -179.89 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -73.56 -28.51 61.9 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.236 -0.915 . . . . 0.0 109.757 -179.721 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 92' ' ' GLU . . . . . 0.583 ' HB3' ' CE2' ' A' ' 61' ' ' PHE . 39.2 tp10 -87.21 -49.77 7.05 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.245 -0.909 . . . . 0.0 109.786 -179.731 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 93' ' ' LEU . . . . . 0.929 ' HB2' HG21 ' A' ' 105' ' ' VAL . 39.9 mt -68.02 -39.81 83.09 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.244 -0.91 . . . . 0.0 109.612 -179.907 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 94' ' ' ASN . . . . . 0.523 ' CB ' ' O ' ' A' ' 90' ' ' VAL . 57.2 t30 -68.35 128.05 35.19 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.24 -0.912 . . . . 0.0 109.481 -179.969 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 94.87 19.38 31.59 Favored Glycine 0 N--CA 1.491 2.308 0 N-CA-C 109.591 -1.404 . . . . 0.0 109.591 -179.947 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 96' ' ' THR . . . . . 0.428 ' CG2' ' O ' ' A' ' 92' ' ' GLU . 21.8 p -120.46 148.6 43.6 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.209 -1.171 . . . . 0.0 109.493 179.978 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 97' ' ' GLN . . . . . 0.474 ' HG3' ' O ' ' A' ' 101' ' ' VAL . 59.8 tt0 -119.73 140.76 50.2 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.232 -0.917 . . . . 0.0 109.478 179.996 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 98' ' ' VAL . . . . . 0.642 HG12 ' H ' ' A' ' 99' ' ' GLU . 1.3 t -81.74 -162.99 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.532 0 O-C-N 121.285 -0.885 . . . . 0.0 109.347 179.997 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 99' ' ' GLU . . . . . 0.642 ' H ' HG12 ' A' ' 98' ' ' VAL . 96.0 mt-10 -54.18 -37.36 64.41 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.232 -0.917 . . . . 0.0 109.558 -179.975 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -155.59 25.18 0.4 Allowed 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.322 -0.861 . . . . 0.0 109.521 179.957 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 101' ' ' VAL . . . . . 0.564 HG12 ' N ' ' A' ' 102' ' ' GLN . 60.0 t -137.77 164.62 28.02 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.552 0 O-C-N 121.236 -0.915 . . . . 0.0 109.5 -179.953 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 102' ' ' GLN . . . . . 0.564 ' N ' HG12 ' A' ' 101' ' ' VAL . 91.7 mt-30 -119.06 145.36 45.96 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.309 -0.869 . . . . 0.0 109.371 179.854 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 103' ' ' LEU . . . . . 0.625 HD23 HG13 ' A' ' 44' ' ' VAL . 0.0 OUTLIER -124.45 130.95 53.41 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.25 -0.907 . . . . 0.0 109.591 -179.785 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 104' ' ' LYS . . . . . 0.422 ' HB2' ' HB3' ' A' ' 45' ' ' TYR . 24.1 mttm -117.89 127.24 53.66 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.346 -0.846 . . . . 0.0 109.24 179.761 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 105' ' ' VAL . . . . . 0.929 HG21 ' HB2' ' A' ' 93' ' ' LEU . 12.1 t -106.24 146.18 13.19 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.551 0 O-C-N 121.231 -0.918 . . . . 0.0 109.736 -179.764 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 106' ' ' ASN . . . . . 0.468 ' HB2' ' HB3' ' A' ' 43' ' ' TYR . 82.0 m-20 -157.87 -165.89 1.85 Allowed 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.331 -0.856 . . . . 0.0 109.296 179.871 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 23.7 mm -102.15 135.18 40.32 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.567 0 O-C-N 121.295 -0.878 . . . . 0.0 109.471 179.937 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 108' ' ' ALA . . . . . 0.412 ' O ' ' C ' ' A' ' 109' ' ' ARG . . . -114.62 -150.99 0.47 Allowed 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.2 -0.937 . . . . 0.0 109.371 179.958 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 109' ' ' ARG . . . . . 0.412 ' C ' ' O ' ' A' ' 108' ' ' ALA . 17.3 mmt-85 -45.36 149.56 0.53 Allowed 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.156 -0.965 . . . . 0.0 109.301 179.881 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 110' ' ' LYS . . . . . 0.412 ' O ' ' HB3' ' A' ' 111' ' ' GLN . 91.0 mttt -73.94 -1.78 21.2 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.182 -0.949 . . . . 0.0 109.659 -179.952 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 111' ' ' GLN . . . . . 0.412 ' HB3' ' O ' ' A' ' 110' ' ' LYS . 9.2 tp-100 61.42 98.03 0.04 OUTLIER Pre-proline 0 N--CA 1.49 1.546 0 O-C-N 121.173 -0.955 . . . . 0.0 109.549 179.953 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 112' ' ' PRO . . . . . 0.426 ' O ' ' C ' ' A' ' 113' ' ' MET . 50.4 Cg_endo -69.96 -26.18 26.88 Favored 'Trans proline' 0 C--O 1.216 -0.622 0 C-N-CA 122.639 2.226 . . . . 0.0 111.811 179.947 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 113' ' ' MET . . . . . 0.537 ' HE3' ' HB3' ' A' ' 114' ' ' LEU . 0.0 OUTLIER -43.82 -27.29 0.32 Allowed 'General case' 0 N--CA 1.488 1.462 0 N-CA-C 108.829 -0.804 . . . . 0.0 108.829 179.593 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 114' ' ' LEU . . . . . 1.013 HD22 ' HA ' ' A' ' 38' ' ' LYS . 4.1 tt -173.07 29.21 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.233 -0.917 . . . . 0.0 109.263 179.616 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 115' ' ' ASP . . . . . 0.711 ' O ' ' HB3' ' A' ' 116' ' ' ALA . 75.3 m-20 46.04 35.49 2.52 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.279 -0.888 . . . . 0.0 108.885 -179.635 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 116' ' ' ALA . . . . . 0.711 ' HB3' ' O ' ' A' ' 115' ' ' ASP . . . 76.72 -78.18 0.04 OUTLIER 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.401 -0.812 . . . . 0.0 109.532 -179.775 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 117' ' ' ALA . . . . . 0.687 ' N ' ' HE2' ' A' ' 83' ' ' MET . . . -176.51 30.29 0.0 OUTLIER 'General case' 0 C--N 1.303 -1.417 0 O-C-N 121.37 -0.831 . . . . 0.0 109.664 -179.854 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 3.4 t -64.49 -34.38 78.09 Favored 'General case' 0 C--N 1.302 -1.492 0 O-C-N 121.189 -0.944 . . . . 0.0 109.564 -179.669 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -82.25 175.5 53.72 Favored Glycine 0 N--CA 1.49 2.26 0 N-CA-C 109.453 -1.459 . . . . 0.0 109.453 179.904 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 19.8 tttt -55.5 -36.03 66.23 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.23 -1.159 . . . . 0.0 109.48 179.975 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 121' ' ' SER . . . . . 0.583 ' O ' HD11 ' A' ' 114' ' ' LEU . 15.9 t . . . . . 0 N--CA 1.49 1.525 0 CA-C-O 117.974 -1.012 . . . . 0.0 109.518 179.941 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 1.511 0 N-CA-C 109.481 -0.563 . . . . 0.0 109.481 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 51.0 Cg_endo -70.25 -16.17 35.42 Favored 'Trans proline' 0 C--O 1.215 -0.668 0 C-N-CA 122.74 2.293 . . . . 0.0 111.738 179.964 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 86.0 mtt-85 -58.45 141.76 50.65 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.322 -0.862 . . . . 0.0 109.488 -179.989 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 38' ' ' LYS . . . . . 0.635 ' C ' HD21 ' A' ' 114' ' ' LEU . 44.5 mttp -100.32 -169.06 1.67 Allowed 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.237 -0.915 . . . . 0.0 109.343 179.954 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 39' ' ' GLY . . . . . 0.548 ' HA3' HD22 ' A' ' 114' ' ' LEU . . . -176.53 169.79 42.38 Favored Glycine 0 N--CA 1.491 2.315 0 N-CA-C 109.698 -1.361 . . . . 0.0 109.698 -179.879 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 40' ' ' ASN . . . . . 0.485 ' N ' ' O ' ' A' ' 80' ' ' TYR . 1.5 t-20 -162.37 111.65 1.44 Allowed 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.166 -1.196 . . . . 0.0 109.1 179.801 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 41' ' ' THR . . . . . 0.487 ' HA ' ' O ' ' A' ' 78' ' ' VAL . 27.0 m -78.54 150.94 32.74 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.24 -0.913 . . . . 0.0 110.063 -179.479 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 42' ' ' LEU . . . . . 0.906 HD12 ' O ' ' A' ' 78' ' ' VAL . 5.1 mp -126.57 152.86 46.02 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.413 -0.805 . . . . 0.0 109.132 179.616 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 43' ' ' TYR . . . . . 0.446 ' HB3' ' HB2' ' A' ' 106' ' ' ASN . 39.8 t80 -107.92 111.37 23.44 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.224 -0.923 . . . . 0.0 109.42 179.865 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 44' ' ' VAL . . . . . 0.473 ' HA ' ' O ' ' A' ' 104' ' ' LYS . 96.5 t -109.16 142.26 22.18 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.551 0 O-C-N 121.202 -0.936 . . . . 0.0 109.384 179.969 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 68.1 t80 -128.35 130.97 48.54 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.251 -0.906 . . . . 0.0 109.561 -179.882 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -176.54 -166.44 33.7 Favored Glycine 0 N--CA 1.488 2.123 0 N-CA-C 109.483 -1.447 . . . . 0.0 109.483 179.928 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 47' ' ' GLU . . . . . 0.415 ' O ' ' C ' ' A' ' 48' ' ' ASP . 94.8 mt-10 -132.52 161.08 34.68 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.328 -1.101 . . . . 0.0 109.485 179.987 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 48' ' ' ASP . . . . . 0.415 ' C ' ' O ' ' A' ' 47' ' ' GLU . 42.8 m-20 43.66 51.55 6.45 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.271 -0.893 . . . . 0.0 109.601 179.934 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 72.6 mtm -103.78 145.0 30.73 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.249 -0.907 . . . . 0.0 109.475 -179.944 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 50' ' ' THR . . . . . 0.407 ' O ' HD12 ' A' ' 54' ' ' LEU . 0.0 OUTLIER -117.6 161.75 32.2 Favored Pre-proline 0 N--CA 1.49 1.561 0 O-C-N 121.296 -0.878 . . . . 0.0 109.53 -179.978 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 51' ' ' PRO . . . . . 0.48 ' CA ' ' SD ' ' A' ' 69' ' ' MET . 49.2 Cg_endo -69.93 -53.93 0.24 Allowed 'Trans proline' 0 C--O 1.214 -0.694 0 C-N-CA 122.731 2.288 . . . . 0.0 111.739 179.89 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 27.1 m -56.91 -44.71 82.64 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.286 -0.884 . . . . 0.0 109.33 179.887 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 53' ' ' LEU . . . . . 0.771 ' O ' HD13 ' A' ' 53' ' ' LEU . 2.3 tm? -59.94 -47.77 84.44 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.311 -0.868 . . . . 0.0 109.384 179.97 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 54' ' ' LEU . . . . . 0.498 HD11 ' CE ' ' A' ' 69' ' ' MET . 17.3 mt -59.36 -52.31 66.16 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.255 -0.903 . . . . 0.0 109.332 179.979 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 55' ' ' ARG . . . . . 0.513 ' O ' ' N ' ' A' ' 59' ' ' SER . 52.3 mtp180 -45.0 -41.04 7.01 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.242 -0.911 . . . . 0.0 109.292 179.83 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 56' ' ' GLY . . . . . 0.487 ' O ' ' HD2' ' A' ' 60' ' ' PRO . . . -64.07 -40.65 98.34 Favored Glycine 0 N--CA 1.49 2.252 0 N-CA-C 109.416 -1.474 . . . . 0.0 109.416 179.904 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 57' ' ' ALA . . . . . 0.429 ' O ' ' CD2' ' A' ' 61' ' ' PHE . . . -65.9 -23.3 66.61 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.286 -1.126 . . . . 0.0 109.323 179.956 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 58' ' ' PHE . . . . . 0.808 ' HB2' HD11 ' A' ' 64' ' ' ILE . 93.6 m-85 -116.81 9.36 13.89 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.287 -0.883 . . . . 0.0 109.395 179.975 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 59' ' ' SER . . . . . 0.548 ' N ' ' HD2' ' A' ' 60' ' ' PRO . 0.9 OUTLIER -76.89 -55.45 1.47 Allowed Pre-proline 0 N--CA 1.491 1.592 0 O-C-N 121.225 -0.922 . . . . 0.0 110.37 -179.569 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 60' ' ' PRO . . . . . 0.548 ' HD2' ' N ' ' A' ' 59' ' ' SER . 47.4 Cg_endo -69.26 -30.76 24.05 Favored 'Trans proline' 0 C--O 1.215 -0.65 0 C-N-CA 122.502 2.135 . . . . 0.0 112.158 -179.25 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 61' ' ' PHE . . . . . 0.557 ' CE1' ' HA ' ' A' ' 89' ' ' ALA . 82.3 m-85 -66.06 -38.32 88.03 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.165 -0.959 . . . . 0.0 109.442 179.933 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 62' ' ' GLY . . . . . 0.462 ' HA3' ' OG ' ' A' ' 85' ' ' SER . . . -179.51 -177.09 47.6 Favored Glycine 0 N--CA 1.49 2.277 0 N-CA-C 109.47 -1.452 . . . . 0.0 109.47 179.973 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 85.8 m-20 -91.46 140.35 29.83 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.171 -1.194 . . . . 0.0 109.489 179.965 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 64' ' ' ILE . . . . . 0.808 HD11 ' HB2' ' A' ' 58' ' ' PHE . 64.3 mt -101.63 133.32 45.41 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.531 0 O-C-N 121.235 -0.916 . . . . 0.0 109.506 -179.929 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 25.9 pt -96.68 -19.57 6.06 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 O-C-N 121.284 -0.885 . . . . 0.0 109.609 -179.955 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 66' ' ' ASP . . . . . 0.459 ' HB3' ' OG1' ' A' ' 79' ' ' THR . 58.5 t0 -153.4 110.8 3.5 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.185 -0.947 . . . . 0.0 109.571 -179.917 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 67' ' ' LEU . . . . . 0.747 HD23 HD13 ' A' ' 64' ' ' ILE . 0.2 OUTLIER -102.18 118.1 36.17 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.24 -0.913 . . . . 0.0 109.388 179.824 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 68' ' ' SER . . . . . 0.652 ' N ' HD13 ' A' ' 67' ' ' LEU . 25.6 t -126.49 145.34 50.54 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.245 -0.91 . . . . 0.0 109.556 -179.836 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 69' ' ' MET . . . . . 0.498 ' CE ' HD11 ' A' ' 54' ' ' LEU . 90.5 mtp -126.89 150.96 49.03 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.371 -0.831 . . . . 0.0 109.407 179.923 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 70' ' ' ASP . . . . . 0.48 ' C ' ' HD2' ' A' ' 72' ' ' PRO . 0.2 OUTLIER -125.41 98.31 35.31 Favored Pre-proline 0 N--CA 1.49 1.57 0 O-C-N 121.29 -0.882 . . . . 0.0 109.526 179.961 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 71' ' ' PRO . . . . . 0.603 ' N ' ' CD ' ' A' ' 72' ' ' PRO . 46.2 Cg_endo -74.61 -27.85 10.44 Favored 'Trans proline' 0 CA--C 1.542 0.925 0 C-N-CA 122.529 2.153 . . . . 0.0 113.647 179.945 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 72' ' ' PRO . . . . . 0.603 ' CD ' ' N ' ' A' ' 71' ' ' PRO . 55.3 Cg_endo -75.69 -26.19 10.1 Favored 'Trans proline' 0 C--N 1.353 0.782 0 C-N-CA 121.536 1.49 . . . . 0.0 111.771 -179.958 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 73' ' ' ARG . . . . . 0.406 ' O ' ' HB2' ' A' ' 74' ' ' ASN . 96.5 mtt180 -110.85 -0.01 17.06 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.294 -0.878 . . . . 0.0 109.652 -179.822 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 74' ' ' ASN . . . . . 0.406 ' HB2' ' O ' ' A' ' 73' ' ' ARG . 60.2 m-20 61.2 44.73 9.64 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.166 -0.959 . . . . 0.0 109.343 -179.91 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 75' ' ' CYS . . . . . 0.458 ' O ' ' HB2' ' A' ' 70' ' ' ASP . 22.0 p -143.5 137.37 28.46 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.286 -0.884 . . . . 0.0 109.475 179.959 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -111.45 154.16 25.08 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.205 -0.935 . . . . 0.0 109.492 -179.96 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 77' ' ' PHE . . . . . 0.476 ' HA ' ' O ' ' A' ' 42' ' ' LEU . 97.0 m-85 -121.93 129.04 52.2 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.237 -0.915 . . . . 0.0 109.577 -179.925 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 78' ' ' VAL . . . . . 0.906 ' O ' HD12 ' A' ' 42' ' ' LEU . 26.5 t -120.21 138.53 50.47 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.569 0 O-C-N 121.206 -0.934 . . . . 0.0 109.289 179.858 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 79' ' ' THR . . . . . 0.534 ' O ' HG23 ' A' ' 64' ' ' ILE . 1.2 m -107.2 136.36 47.16 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.286 -0.884 . . . . 0.0 109.634 -179.826 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 80' ' ' TYR . . . . . 0.565 ' CE1' ' OG ' ' A' ' 85' ' ' SER . 0.9 OUTLIER -119.81 121.27 38.74 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.295 -0.878 . . . . 0.0 109.419 179.81 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 81' ' ' GLU . . . . . 0.487 ' HA ' ' HA2' ' A' ' 39' ' ' GLY . 83.5 tt0 -40.37 -39.74 1.04 Allowed 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.516 -0.74 . . . . 0.0 109.85 179.964 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 9.5 mtmm -122.87 162.97 21.17 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.193 -0.942 . . . . 0.0 109.514 179.931 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 83' ' ' MET . . . . . 0.68 ' HE1' ' HB1' ' A' ' 116' ' ' ALA . 4.4 mmt -80.17 -13.94 58.85 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.188 -0.945 . . . . 0.0 109.345 -179.999 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 96.1 mt-10 -69.82 -35.77 75.08 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.241 -0.912 . . . . 0.0 109.49 179.891 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 85' ' ' SER . . . . . 0.565 ' OG ' ' CE1' ' A' ' 80' ' ' TYR . 43.4 t -71.57 -32.08 67.67 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.2 -0.937 . . . . 0.0 109.476 -179.967 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 86' ' ' ALA . . . . . 0.81 ' O ' HG23 ' A' ' 90' ' ' VAL . . . -78.78 -31.38 46.04 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.244 -0.91 . . . . 0.0 109.532 -179.938 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 58.3 t0 -70.62 -46.73 62.81 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.243 -0.911 . . . . 0.0 109.646 -179.938 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 65.0 tt0 -68.64 -41.31 79.6 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.269 -0.895 . . . . 0.0 109.644 -179.873 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 89' ' ' ALA . . . . . 0.613 ' HB1' ' CD1' ' A' ' 93' ' ' LEU . . . -67.92 -41.1 83.14 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.208 -0.933 . . . . 0.0 109.653 -179.935 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 90' ' ' VAL . . . . . 0.953 HG21 HD11 ' A' ' 107' ' ' ILE . 55.6 t -60.4 -35.94 66.02 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.587 0 O-C-N 121.22 -0.925 . . . . 0.0 109.669 -179.902 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -75.42 -53.91 7.91 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.173 -0.954 . . . . 0.0 109.844 -179.723 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 92' ' ' GLU . . . . . 0.519 ' O ' ' CG2' ' A' ' 96' ' ' THR . 76.1 mm-40 -67.92 -44.37 77.04 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.223 -0.923 . . . . 0.0 109.768 -179.537 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 93' ' ' LEU . . . . . 0.756 ' HB2' HG21 ' A' ' 105' ' ' VAL . 92.1 mt -66.57 -38.95 88.14 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.079 -1.013 . . . . 0.0 109.541 -179.804 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 94' ' ' ASN . . . . . 0.532 ' CB ' ' O ' ' A' ' 90' ' ' VAL . 62.1 t-20 -72.74 120.23 18.07 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.237 -0.914 . . . . 0.0 109.553 -179.964 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 105.27 10.71 31.12 Favored Glycine 0 N--CA 1.491 2.315 0 N-CA-C 109.426 -1.47 . . . . 0.0 109.426 179.905 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 96' ' ' THR . . . . . 0.519 ' CG2' ' O ' ' A' ' 92' ' ' GLU . 27.7 p -107.77 157.62 17.98 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.201 -1.176 . . . . 0.0 109.494 -179.97 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 58.7 tt0 -129.25 145.95 51.25 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.182 -0.949 . . . . 0.0 109.479 -179.935 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 98' ' ' VAL . . . . . 0.478 HG23 ' O ' ' A' ' 101' ' ' VAL . 1.4 t -87.39 -147.8 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 O-C-N 121.275 -0.891 . . . . 0.0 109.385 179.996 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 99' ' ' GLU . . . . . 0.473 ' H ' HG12 ' A' ' 98' ' ' VAL . 96.7 mt-10 -63.44 -41.87 98.67 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.21 -0.931 . . . . 0.0 109.536 179.979 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -153.77 23.83 0.51 Allowed 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.257 -0.902 . . . . 0.0 109.478 -179.915 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 101' ' ' VAL . . . . . 0.478 ' O ' HG23 ' A' ' 98' ' ' VAL . 52.9 t -139.46 148.63 23.24 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 O-C-N 121.252 -0.905 . . . . 0.0 109.433 -179.979 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 47.2 tt0 -97.47 140.67 31.56 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.172 -0.955 . . . . 0.0 109.523 -179.867 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 90.7 mt -104.42 137.7 41.9 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.253 -0.904 . . . . 0.0 109.465 179.977 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 104' ' ' LYS . . . . . 0.473 ' O ' ' HA ' ' A' ' 44' ' ' VAL . 89.0 mttt -117.95 138.39 52.2 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.293 -0.88 . . . . 0.0 109.298 179.887 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 105' ' ' VAL . . . . . 0.756 HG21 ' HB2' ' A' ' 93' ' ' LEU . 59.9 t -122.91 143.31 36.3 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.54 0 O-C-N 121.225 -0.922 . . . . 0.0 109.458 -179.885 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 106' ' ' ASN . . . . . 0.446 ' HB2' ' HB3' ' A' ' 43' ' ' TYR . 86.3 m-20 -149.27 178.48 8.72 Favored 'General case' 0 N--CA 1.489 1.475 0 O-C-N 121.236 -0.915 . . . . 0.0 109.495 -179.989 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 107' ' ' ILE . . . . . 0.953 HD11 HG21 ' A' ' 90' ' ' VAL . 22.3 mm -112.48 120.17 62.02 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.514 0 O-C-N 121.246 -0.908 . . . . 0.0 109.463 179.997 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -61.31 153.12 27.42 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.214 -0.929 . . . . 0.0 109.505 -179.967 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 41.2 ttt180 -47.56 -47.7 28.12 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.218 -0.926 . . . . 0.0 109.491 179.93 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 110' ' ' LYS . . . . . 0.438 ' HG2' ' N ' ' A' ' 111' ' ' GLN . 19.8 tttt -178.87 150.2 0.48 Allowed 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.24 -0.913 . . . . 0.0 109.543 179.979 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 111' ' ' GLN . . . . . 0.46 ' CG ' ' OG1' ' A' ' 41' ' ' THR . 29.0 tp60 -114.9 97.71 48.27 Favored Pre-proline 0 N--CA 1.489 1.524 0 O-C-N 121.21 -0.932 . . . . 0.0 109.413 179.921 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 112' ' ' PRO . . . . . 0.408 ' O ' ' C ' ' A' ' 113' ' ' MET . 50.2 Cg_endo -70.14 -29.39 22.11 Favored 'Trans proline' 0 C--O 1.215 -0.654 0 C-N-CA 122.668 2.246 . . . . 0.0 111.823 -179.847 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 113' ' ' MET . . . . . 0.564 ' HE3' ' CB ' ' A' ' 114' ' ' LEU . 0.0 OUTLIER -44.75 -26.18 0.36 Allowed 'General case' 0 C--N 1.304 -1.406 0 O-C-N 121.292 -0.88 . . . . 0.0 108.754 179.513 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 114' ' ' LEU . . . . . 0.676 HD23 ' O ' ' A' ' 114' ' ' LEU . 2.2 tt -148.25 25.89 0.98 Allowed 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.176 -0.952 . . . . 0.0 109.279 179.719 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 115' ' ' ASP . . . . . 0.488 ' O ' ' N ' ' A' ' 117' ' ' ALA . 88.7 m-20 48.74 31.83 3.29 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.254 -0.904 . . . . 0.0 109.403 -179.914 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 116' ' ' ALA . . . . . 0.68 ' HB1' ' HE1' ' A' ' 83' ' ' MET . . . 44.84 -95.52 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.323 -0.86 . . . . 0.0 109.642 -179.949 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 117' ' ' ALA . . . . . 0.572 ' HB3' ' CE ' ' A' ' 83' ' ' MET . . . -173.11 -75.7 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.11 -0.994 . . . . 0.0 109.577 -179.767 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 118' ' ' THR . . . . . 0.581 HG23 ' HG3' ' A' ' 83' ' ' MET . 43.8 p -72.08 -27.34 62.6 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.303 -0.873 . . . . 0.0 109.449 -179.943 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 78.92 -152.38 36.69 Favored Glycine 0 N--CA 1.489 2.2 0 N-CA-C 109.493 -1.443 . . . . 0.0 109.493 179.98 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 34.6 mttp -86.58 143.71 27.54 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.21 -1.171 . . . . 0.0 109.465 179.981 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 N--CA 1.491 1.589 0 CA-C-O 118.021 -0.99 . . . . 0.0 109.393 179.985 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.525 0 N-CA-C 109.496 -0.557 . . . . 0.0 109.496 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 50.0 Cg_endo -69.46 138.98 40.09 Favored 'Trans proline' 0 C--O 1.215 -0.641 0 C-N-CA 122.692 2.262 . . . . 0.0 111.837 179.997 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 58.2 mtt180 -126.06 154.92 42.35 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.302 -0.873 . . . . 0.0 109.447 -179.984 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 38' ' ' LYS . . . . . 0.941 ' HA ' HD22 ' A' ' 114' ' ' LEU . 26.0 mttp -86.79 -162.96 0.83 Allowed 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.329 -0.857 . . . . 0.0 109.525 -179.97 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 39' ' ' GLY . . . . . 0.5 ' O ' ' CA ' ' A' ' 116' ' ' ALA . . . 142.21 168.98 11.93 Favored Glycine 0 N--CA 1.49 2.298 0 N-CA-C 109.299 -1.52 . . . . 0.0 109.299 -179.889 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 40' ' ' ASN . . . . . 0.596 ' H ' HG22 ' A' ' 79' ' ' THR . 47.4 t30 -155.25 100.02 2.12 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.127 -1.22 . . . . 0.0 109.493 179.988 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 41' ' ' THR . . . . . 0.823 ' O ' HD23 ' A' ' 42' ' ' LEU . 45.1 m -61.11 140.44 57.88 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.236 -0.915 . . . . 0.0 109.815 -179.771 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 42' ' ' LEU . . . . . 0.823 HD23 ' O ' ' A' ' 41' ' ' THR . 17.9 mt -125.33 143.44 50.97 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.253 -0.904 . . . . 0.0 109.483 179.722 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 71.1 t80 -96.27 120.46 36.6 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.277 -0.889 . . . . 0.0 109.52 -179.998 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 44' ' ' VAL . . . . . 0.643 ' CG1' HD21 ' A' ' 103' ' ' LEU . 58.7 t -118.49 139.06 47.16 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 O-C-N 121.171 -0.956 . . . . 0.0 109.421 179.96 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 65.6 t80 -129.39 141.6 51.01 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.261 -0.9 . . . . 0.0 109.562 -179.939 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 175.2 -174.82 47.0 Favored Glycine 0 N--CA 1.49 2.292 0 N-CA-C 109.424 -1.47 . . . . 0.0 109.424 179.935 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 47' ' ' GLU . . . . . 0.418 ' O ' ' C ' ' A' ' 48' ' ' ASP . 94.6 mt-10 -112.86 159.32 19.15 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.195 -1.18 . . . . 0.0 109.343 179.974 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 48' ' ' ASP . . . . . 0.418 ' C ' ' O ' ' A' ' 47' ' ' GLU . 51.4 m-20 44.34 40.2 3.59 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.211 -0.93 . . . . 0.0 109.262 -179.951 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 46.9 mtp -75.46 141.09 43.18 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.282 -0.886 . . . . 0.0 109.527 -179.951 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 50' ' ' THR . . . . . 0.457 ' O ' ' HG ' ' A' ' 54' ' ' LEU . 0.7 OUTLIER -130.98 161.94 58.54 Favored Pre-proline 0 N--CA 1.49 1.553 0 O-C-N 121.19 -0.944 . . . . 0.0 109.344 -179.974 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 51' ' ' PRO . . . . . 0.505 ' N ' ' SD ' ' A' ' 69' ' ' MET . 49.7 Cg_endo -70.6 -53.47 0.22 Allowed 'Trans proline' 0 C--O 1.214 -0.683 0 C-N-CA 122.657 2.238 . . . . 0.0 111.669 179.964 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 32.9 m -58.34 -41.69 85.19 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.268 -0.895 . . . . 0.0 109.348 179.886 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 53' ' ' LEU . . . . . 0.496 ' C ' HD23 ' A' ' 53' ' ' LEU . 9.2 tt -62.44 -46.08 90.18 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.277 -0.889 . . . . 0.0 109.385 179.92 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 54' ' ' LEU . . . . . 0.457 ' HG ' ' O ' ' A' ' 50' ' ' THR . 40.8 mt -64.76 -46.16 83.36 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.238 -0.914 . . . . 0.0 109.207 179.79 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 55' ' ' ARG . . . . . 0.478 ' O ' ' CB ' ' A' ' 59' ' ' SER . 74.4 ttt180 -48.0 -40.79 23.64 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.244 -0.91 . . . . 0.0 109.394 179.97 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -73.71 -31.55 60.32 Favored Glycine 0 N--CA 1.49 2.243 0 N-CA-C 109.476 -1.45 . . . . 0.0 109.476 179.892 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -73.55 -24.46 60.11 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.225 -1.162 . . . . 0.0 109.435 179.982 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 58' ' ' PHE . . . . . 0.713 ' CZ ' HD13 ' A' ' 93' ' ' LEU . 94.8 m-85 -119.09 8.86 11.65 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.371 -0.83 . . . . 0.0 109.421 179.977 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 59' ' ' SER . . . . . 0.526 ' N ' ' HD2' ' A' ' 60' ' ' PRO . 0.4 OUTLIER -74.9 -57.59 1.81 Allowed Pre-proline 0 N--CA 1.491 1.609 0 O-C-N 121.279 -0.888 . . . . 0.0 110.162 -179.582 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 60' ' ' PRO . . . . . 0.526 ' HD2' ' N ' ' A' ' 59' ' ' SER . 48.1 Cg_endo -68.74 -35.96 15.13 Favored 'Trans proline' 0 C--O 1.215 -0.63 0 C-N-CA 122.584 2.189 . . . . 0.0 112.259 -179.437 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 61' ' ' PHE . . . . . 0.579 ' CD1' ' HA ' ' A' ' 89' ' ' ALA . 64.7 m-85 -58.72 -33.89 70.73 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.16 -0.963 . . . . 0.0 109.703 -179.828 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 176.74 -174.32 46.95 Favored Glycine 0 N--CA 1.49 2.282 0 N-CA-C 109.617 -1.393 . . . . 0.0 109.617 179.974 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 82.0 m-20 -95.03 146.23 24.41 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.235 -1.156 . . . . 0.0 109.46 179.991 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 64' ' ' ILE . . . . . 0.797 HD13 HD12 ' A' ' 67' ' ' LEU . 51.5 mt -110.77 126.54 68.12 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 O-C-N 121.3 -0.875 . . . . 0.0 109.416 179.974 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 65' ' ' ILE . . . . . 0.459 HD13 ' O ' ' A' ' 38' ' ' LYS . 22.2 pt -91.15 -22.56 6.16 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 O-C-N 121.273 -0.892 . . . . 0.0 109.543 -179.896 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 45.2 t0 -155.49 95.0 1.64 Allowed 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.196 -0.94 . . . . 0.0 109.586 179.994 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 67' ' ' LEU . . . . . 0.797 HD12 HD13 ' A' ' 64' ' ' ILE . 0.5 OUTLIER -93.29 126.67 38.53 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.206 -0.934 . . . . 0.0 109.196 179.769 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 68' ' ' SER . . . . . 0.44 ' HB2' ' HB2' ' A' ' 77' ' ' PHE . 67.5 m -126.08 153.86 43.89 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.226 -0.921 . . . . 0.0 109.718 -179.802 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 69' ' ' MET . . . . . 0.505 ' SD ' ' N ' ' A' ' 51' ' ' PRO . 84.1 mtp -126.46 150.54 48.63 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.414 -0.804 . . . . 0.0 109.296 179.851 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 70' ' ' ASP . . . . . 0.484 ' C ' ' HD2' ' A' ' 72' ' ' PRO . 1.2 t0 -129.09 99.24 22.09 Favored Pre-proline 0 N--CA 1.49 1.565 0 O-C-N 121.195 -0.941 . . . . 0.0 109.55 -179.948 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 71' ' ' PRO . . . . . 0.6 ' N ' ' CD ' ' A' ' 72' ' ' PRO . 46.4 Cg_endo -74.54 -27.96 10.48 Favored 'Trans proline' 0 CA--C 1.542 0.897 0 C-N-CA 122.503 2.136 . . . . 0.0 113.523 179.845 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 72' ' ' PRO . . . . . 0.6 ' CD ' ' N ' ' A' ' 71' ' ' PRO . 55.6 Cg_endo -75.38 -26.62 10.15 Favored 'Trans proline' 0 C--N 1.353 0.772 0 C-N-CA 121.483 1.456 . . . . 0.0 111.82 -179.932 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 73' ' ' ARG . . . . . 0.429 ' O ' ' HB2' ' A' ' 74' ' ' ASN . 89.0 mtt-85 -109.23 -1.02 18.94 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.293 -0.88 . . . . 0.0 109.645 -179.959 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 74' ' ' ASN . . . . . 0.429 ' HB2' ' O ' ' A' ' 73' ' ' ARG . 79.8 m-20 61.6 43.99 9.49 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.21 -0.931 . . . . 0.0 109.568 179.955 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 75' ' ' CYS . . . . . 0.466 ' HA ' ' O ' ' A' ' 44' ' ' VAL . 27.5 p -146.94 150.5 35.3 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.271 -0.893 . . . . 0.0 109.395 179.978 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -116.35 154.25 30.55 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.171 -0.956 . . . . 0.0 109.522 -179.946 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 77' ' ' PHE . . . . . 0.47 ' HA ' ' O ' ' A' ' 42' ' ' LEU . 98.0 m-85 -124.16 106.31 10.23 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.299 -0.876 . . . . 0.0 109.476 -179.941 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 78' ' ' VAL . . . . . 0.735 HG23 HD12 ' A' ' 67' ' ' LEU . 5.9 p -109.8 136.19 46.48 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.503 0 O-C-N 121.131 -0.981 . . . . 0.0 109.638 179.907 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 79' ' ' THR . . . . . 0.7 HG23 ' OE1' ' A' ' 111' ' ' GLN . 3.7 m -102.5 127.05 49.72 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.308 -0.87 . . . . 0.0 109.699 -179.736 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 80' ' ' TYR . . . . . 0.823 ' HD2' HD11 ' A' ' 42' ' ' LEU . 0.5 OUTLIER -102.16 126.12 49.04 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.308 -0.87 . . . . 0.0 109.465 179.948 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 81' ' ' GLU . . . . . 0.477 ' HA ' ' HA2' ' A' ' 39' ' ' GLY . 88.5 tt0 -42.06 -47.4 4.49 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.476 -0.765 . . . . 0.0 109.766 179.949 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 36.4 mttm -113.7 155.86 24.8 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.26 -0.9 . . . . 0.0 109.635 -179.904 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 83' ' ' MET . . . . . 0.658 ' HE3' ' C ' ' A' ' 117' ' ' ALA . 57.7 mtt -77.46 -19.87 55.29 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.26 -0.9 . . . . 0.0 109.34 179.943 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 98.3 mt-10 -69.66 -44.6 70.19 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.181 -0.949 . . . . 0.0 109.303 179.918 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 16.0 m -61.56 -27.39 68.59 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.355 -0.841 . . . . 0.0 109.225 179.739 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 86' ' ' ALA . . . . . 0.611 ' O ' HG23 ' A' ' 90' ' ' VAL . . . -78.11 -34.42 50.06 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.383 -0.823 . . . . 0.0 109.416 -179.993 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 59.2 t0 -66.9 -33.63 76.02 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.294 -0.879 . . . . 0.0 109.388 179.897 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 88' ' ' GLN . . . . . 0.479 ' O ' ' HB2' ' A' ' 92' ' ' GLU . 63.5 tt0 -77.01 -37.6 54.69 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.287 -0.883 . . . . 0.0 109.384 179.933 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 89' ' ' ALA . . . . . 0.579 ' HA ' ' CD1' ' A' ' 61' ' ' PHE . . . -76.49 -35.09 58.57 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.285 -0.884 . . . . 0.0 109.385 179.939 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 90' ' ' VAL . . . . . 0.728 HG22 ' CG1' ' A' ' 105' ' ' VAL . 75.8 t -71.2 -39.77 73.7 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.513 0 O-C-N 121.325 -0.859 . . . . 0.0 109.464 -179.948 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -77.11 -34.31 56.76 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.209 -0.932 . . . . 0.0 109.496 -179.985 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 92' ' ' GLU . . . . . 0.579 ' HB3' ' CZ ' ' A' ' 61' ' ' PHE . 6.0 tm-20 -80.07 -46.28 16.8 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.215 -0.928 . . . . 0.0 109.644 -179.867 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 93' ' ' LEU . . . . . 0.713 HD13 ' CZ ' ' A' ' 58' ' ' PHE . 72.6 mt -70.42 -37.69 74.45 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.22 -0.925 . . . . 0.0 109.534 -179.918 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 94' ' ' ASN . . . . . 0.519 ' CB ' ' O ' ' A' ' 90' ' ' VAL . 49.6 t30 -70.12 136.68 50.42 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.231 -0.918 . . . . 0.0 109.462 -179.933 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 83.16 26.32 44.77 Favored Glycine 0 N--CA 1.49 2.279 0 N-CA-C 109.528 -1.429 . . . . 0.0 109.528 179.988 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 96' ' ' THR . . . . . 0.556 HG21 ' O ' ' A' ' 92' ' ' GLU . 27.9 p -125.89 146.63 49.75 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.29 -1.123 . . . . 0.0 109.575 -179.982 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 97' ' ' GLN . . . . . 0.502 ' CG ' ' O ' ' A' ' 101' ' ' VAL . 52.7 tt0 -117.92 137.81 52.57 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.293 -0.879 . . . . 0.0 109.424 -179.938 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 98' ' ' VAL . . . . . 0.547 HG12 ' H ' ' A' ' 99' ' ' GLU . 1.1 t -80.12 -153.55 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 O-C-N 121.283 -0.886 . . . . 0.0 109.337 -179.983 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 99' ' ' GLU . . . . . 0.547 ' H ' HG12 ' A' ' 98' ' ' VAL . 96.5 mt-10 -58.4 -38.31 77.12 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.165 -0.959 . . . . 0.0 109.5 -179.965 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -156.96 25.78 0.32 Allowed 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.183 -0.948 . . . . 0.0 109.483 -179.983 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 101' ' ' VAL . . . . . 0.586 HG12 ' N ' ' A' ' 102' ' ' GLN . 49.0 t -137.27 167.41 23.26 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.55 0 O-C-N 121.221 -0.925 . . . . 0.0 109.541 -179.878 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 102' ' ' GLN . . . . . 0.586 ' N ' HG12 ' A' ' 101' ' ' VAL . 92.1 mt-30 -122.61 147.37 46.49 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.248 -0.907 . . . . 0.0 109.126 179.885 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 103' ' ' LEU . . . . . 0.643 HD21 ' CG1' ' A' ' 44' ' ' VAL . 0.0 OUTLIER -121.69 135.68 54.96 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.11 -0.994 . . . . 0.0 109.93 -179.802 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 23.9 mttt -118.19 130.88 56.35 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.334 -0.854 . . . . 0.0 109.051 179.694 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 105' ' ' VAL . . . . . 0.728 ' CG1' HG22 ' A' ' 90' ' ' VAL . 21.5 t -109.6 132.56 57.45 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.611 0 O-C-N 121.167 -0.958 . . . . 0.0 109.776 -179.788 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 86.2 m-20 -133.12 -178.49 4.99 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.314 -0.866 . . . . 0.0 109.215 179.778 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 56.2 mt -107.71 135.48 46.18 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.573 0 O-C-N 121.174 -0.954 . . . . 0.0 109.442 179.898 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -108.38 164.29 12.46 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.253 -0.905 . . . . 0.0 109.512 -179.985 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 56.9 ttt180 -47.09 142.68 3.51 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.239 -0.913 . . . . 0.0 109.358 179.957 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 68.1 mttm -59.0 141.13 54.74 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.288 -0.882 . . . . 0.0 109.386 -179.93 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 111' ' ' GLN . . . . . 0.789 ' HB2' ' HE2' ' A' ' 113' ' ' MET . 8.2 pt20 -69.58 144.86 94.58 Favored Pre-proline 0 N--CA 1.49 1.574 0 O-C-N 121.236 -0.915 . . . . 0.0 109.537 -179.851 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 112' ' ' PRO . . . . . 0.432 ' O ' ' N ' ' A' ' 114' ' ' LEU . 52.6 Cg_endo -72.43 -35.54 6.26 Favored 'Trans proline' 0 C--O 1.214 -0.719 0 C-N-CA 122.823 2.348 . . . . 0.0 112.736 -179.491 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 113' ' ' MET . . . . . 0.789 ' HE2' ' HB2' ' A' ' 111' ' ' GLN . 13.2 mtm -42.91 -27.04 0.16 Allowed 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.242 -0.911 . . . . 0.0 109.626 -179.484 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 114' ' ' LEU . . . . . 0.941 HD22 ' HA ' ' A' ' 38' ' ' LYS . 2.2 tt -174.41 29.25 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.3 -0.875 . . . . 0.0 109.49 -179.895 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 115' ' ' ASP . . . . . 0.693 ' O ' ' HB3' ' A' ' 116' ' ' ALA . 75.1 m-20 50.81 33.53 8.69 Favored 'General case' 0 C--N 1.302 -1.478 0 O-C-N 121.248 -0.908 . . . . 0.0 108.685 -179.476 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 116' ' ' ALA . . . . . 0.693 ' HB3' ' O ' ' A' ' 115' ' ' ASP . . . 76.03 -79.8 0.04 OUTLIER 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.411 -0.805 . . . . 0.0 109.54 -179.784 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 117' ' ' ALA . . . . . 0.658 ' C ' ' HE3' ' A' ' 83' ' ' MET . . . -165.37 24.98 0.05 Allowed 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.273 -0.892 . . . . 0.0 109.775 -179.666 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 67.3 p -64.65 -11.7 38.16 Favored 'General case' 0 C--N 1.303 -1.449 0 O-C-N 121.174 -0.954 . . . . 0.0 109.572 -179.688 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -56.79 -31.04 60.49 Favored Glycine 0 N--CA 1.491 2.304 0 N-CA-C 109.556 -1.417 . . . . 0.0 109.556 -179.973 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 15.1 tptp -52.48 -34.2 48.23 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.181 -1.188 . . . . 0.0 109.582 -179.933 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 58.0 m . . . . . 0 N--CA 1.489 1.51 0 CA-C-O 118.007 -0.997 . . . . 0.0 109.541 -179.95 . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.577 0 N-CA-C 109.467 -0.568 . . . . 0.0 109.467 . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 49.3 Cg_endo -69.65 -23.2 31.58 Favored 'Trans proline' 0 C--O 1.214 -0.692 0 C-N-CA 122.72 2.28 . . . . 0.0 111.833 179.971 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 65.3 mtt85 -55.88 -41.2 74.08 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.266 -0.896 . . . . 0.0 109.362 179.865 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 38' ' ' LYS . . . . . 0.742 ' HG2' HD13 ' A' ' 114' ' ' LEU . 14.2 mttt -63.51 -168.86 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.25 -0.906 . . . . 0.0 109.374 179.924 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 39' ' ' GLY . . . . . 0.496 ' HA2' ' O ' ' A' ' 80' ' ' TYR . . . 160.58 -155.1 26.21 Favored Glycine 0 N--CA 1.488 2.12 0 N-CA-C 109.484 -1.446 . . . . 0.0 109.484 179.791 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 40' ' ' ASN . . . . . 0.749 ' HA ' ' HB1' ' A' ' 116' ' ' ALA . 62.0 t30 -165.8 115.31 1.0 Allowed 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.135 -1.214 . . . . 0.0 109.417 179.858 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 41' ' ' THR . . . . . 0.64 HG21 ' HB2' ' A' ' 110' ' ' LYS . 54.4 m -77.52 148.22 35.4 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.282 -0.886 . . . . 0.0 109.826 -179.712 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 42' ' ' LEU . . . . . 0.914 HD12 ' O ' ' A' ' 78' ' ' VAL . 4.9 mp -123.79 152.29 42.39 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.352 -0.842 . . . . 0.0 109.386 179.832 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 43' ' ' TYR . . . . . 0.415 ' HB3' ' HB2' ' A' ' 106' ' ' ASN . 46.8 t80 -110.22 112.07 23.8 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.246 -0.909 . . . . 0.0 109.358 179.782 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 44' ' ' VAL . . . . . 0.461 ' HA ' ' O ' ' A' ' 104' ' ' LYS . 48.8 t -108.29 143.88 17.88 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.535 0 O-C-N 121.301 -0.874 . . . . 0.0 109.351 -179.941 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 45' ' ' TYR . . . . . 0.468 ' HB3' ' HB2' ' A' ' 104' ' ' LYS . 71.1 t80 -131.53 135.87 47.39 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.282 -0.886 . . . . 0.0 109.506 -179.931 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 46' ' ' GLY . . . . . 0.474 ' O ' ' HB3' ' A' ' 74' ' ' ASN . . . 177.57 -170.53 43.0 Favored Glycine 0 N--CA 1.49 2.282 0 N-CA-C 109.476 -1.45 . . . . 0.0 109.476 179.989 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 47' ' ' GLU . . . . . 0.42 ' O ' ' C ' ' A' ' 48' ' ' ASP . 94.9 mt-10 -124.31 157.36 35.14 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.246 -1.15 . . . . 0.0 109.426 -179.922 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 48' ' ' ASP . . . . . 0.42 ' C ' ' O ' ' A' ' 47' ' ' GLU . 38.0 m-20 44.48 51.26 7.94 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.274 -0.891 . . . . 0.0 109.552 -179.977 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 60.9 mtm -102.84 137.93 40.4 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.158 -0.964 . . . . 0.0 109.432 179.992 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 50' ' ' THR . . . . . 0.745 ' O ' HD12 ' A' ' 54' ' ' LEU . 0.7 OUTLIER -116.29 164.15 19.15 Favored Pre-proline 0 N--CA 1.49 1.551 0 O-C-N 121.197 -0.939 . . . . 0.0 109.599 179.894 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 50.4 Cg_endo -70.25 -52.03 0.31 Allowed 'Trans proline' 0 C--O 1.216 -0.594 0 C-N-CA 122.69 2.26 . . . . 0.0 111.715 179.979 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 36.5 m -53.63 -43.17 68.52 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.316 -0.865 . . . . 0.0 109.369 179.993 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 53' ' ' LEU . . . . . 0.737 ' O ' HD13 ' A' ' 53' ' ' LEU . 3.3 tm? -62.02 -46.18 90.31 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.239 -0.913 . . . . 0.0 109.319 179.967 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 54' ' ' LEU . . . . . 0.745 HD12 ' O ' ' A' ' 50' ' ' THR . 3.9 mt -62.49 -44.81 95.48 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.285 -0.884 . . . . 0.0 109.441 179.923 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 55' ' ' ARG . . . . . 0.761 ' HE ' HD22 ' A' ' 67' ' ' LEU . 83.5 mtt180 -52.29 -39.06 60.02 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.318 -0.864 . . . . 0.0 109.379 179.919 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -70.69 -34.89 66.76 Favored Glycine 0 N--CA 1.49 2.238 0 N-CA-C 109.378 -1.489 . . . . 0.0 109.378 179.968 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 57' ' ' ALA . . . . . 0.47 ' HB1' HD22 ' A' ' 93' ' ' LEU . . . -76.05 -23.7 55.11 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.282 -1.128 . . . . 0.0 109.439 179.979 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 58' ' ' PHE . . . . . 0.633 ' CE1' ' CD1' ' A' ' 93' ' ' LEU . 96.8 m-85 -116.17 7.75 14.21 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.146 -0.971 . . . . 0.0 109.46 179.995 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 59' ' ' SER . . . . . 0.532 ' N ' ' HD2' ' A' ' 60' ' ' PRO . 0.5 OUTLIER -73.51 -57.46 2.65 Favored Pre-proline 0 N--CA 1.491 1.608 0 O-C-N 121.291 -0.881 . . . . 0.0 109.96 -179.643 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 60' ' ' PRO . . . . . 0.532 ' HD2' ' N ' ' A' ' 59' ' ' SER . 49.0 Cg_endo -69.25 -33.04 19.43 Favored 'Trans proline' 0 C--O 1.214 -0.711 0 C-N-CA 122.643 2.229 . . . . 0.0 112.28 -179.597 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 61' ' ' PHE . . . . . 0.584 ' CD2' ' HA ' ' A' ' 89' ' ' ALA . 51.0 m-85 -61.64 -33.18 73.49 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.202 -0.936 . . . . 0.0 109.612 -179.874 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 176.65 -173.49 46.33 Favored Glycine 0 N--CA 1.489 2.213 0 N-CA-C 109.533 -1.427 . . . . 0.0 109.533 179.967 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 85.6 m-20 -95.7 147.42 23.62 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.248 -1.149 . . . . 0.0 109.383 -179.957 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 64' ' ' ILE . . . . . 0.436 ' HA ' ' O ' ' A' ' 79' ' ' THR . 53.6 mt -111.14 124.95 68.4 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.522 0 O-C-N 121.205 -0.934 . . . . 0.0 109.525 -179.963 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 65' ' ' ILE . . . . . 0.719 HD11 ' NE2' ' A' ' 111' ' ' GLN . 31.1 pt -93.8 -26.79 4.53 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.573 0 O-C-N 121.342 -0.849 . . . . 0.0 109.382 179.926 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 66' ' ' ASP . . . . . 0.425 ' HB3' ' OG1' ' A' ' 79' ' ' THR . 58.2 t0 -140.43 130.36 24.65 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.214 -0.929 . . . . 0.0 109.511 179.937 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 67' ' ' LEU . . . . . 0.761 HD22 ' HE ' ' A' ' 55' ' ' ARG . 7.1 tp -121.46 120.4 34.82 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.239 -0.913 . . . . 0.0 109.438 179.923 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 68' ' ' SER . . . . . 0.458 ' HB3' ' HB2' ' A' ' 77' ' ' PHE . 43.3 t -128.87 140.66 51.59 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.242 -0.911 . . . . 0.0 109.479 -179.985 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 69' ' ' MET . . . . . . . . . . . . . 86.7 mtp -123.93 149.61 45.71 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.313 -0.867 . . . . 0.0 109.44 -179.993 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 70' ' ' ASP . . . . . 0.48 ' C ' ' HD2' ' A' ' 72' ' ' PRO . 0.7 OUTLIER -127.81 101.56 23.29 Favored Pre-proline 0 N--CA 1.49 1.555 0 O-C-N 121.251 -0.905 . . . . 0.0 109.433 179.964 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 71' ' ' PRO . . . . . 0.599 ' N ' ' CD ' ' A' ' 72' ' ' PRO . 47.3 Cg_endo -74.75 -27.81 10.2 Favored 'Trans proline' 0 CA--C 1.543 0.932 0 C-N-CA 122.527 2.151 . . . . 0.0 113.69 179.998 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 72' ' ' PRO . . . . . 0.599 ' CD ' ' N ' ' A' ' 71' ' ' PRO . 55.2 Cg_endo -75.41 -23.81 12.8 Favored 'Trans proline' 0 C--N 1.353 0.793 0 C-N-CA 121.496 1.464 . . . . 0.0 111.869 -179.83 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 73' ' ' ARG . . . . . 0.436 ' HB2' ' SG ' ' A' ' 75' ' ' CYS . 75.0 mtt85 -111.91 -1.11 15.59 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.197 -0.939 . . . . 0.0 109.666 -179.879 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 74' ' ' ASN . . . . . 0.474 ' HB3' ' O ' ' A' ' 46' ' ' GLY . 61.1 m-20 60.78 44.21 11.29 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.133 -0.98 . . . . 0.0 109.519 179.985 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 75' ' ' CYS . . . . . 0.475 ' O ' ' HB2' ' A' ' 70' ' ' ASP . 24.4 p -144.79 140.74 28.67 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.211 -0.931 . . . . 0.0 109.541 -179.921 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -113.67 161.38 17.54 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.222 -0.924 . . . . 0.0 109.36 -180.0 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 77' ' ' PHE . . . . . 0.567 ' CE2' ' NZ ' ' A' ' 110' ' ' LYS . 96.9 m-85 -125.37 137.35 54.03 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.215 -0.928 . . . . 0.0 109.497 -179.9 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 78' ' ' VAL . . . . . 0.914 ' O ' HD12 ' A' ' 42' ' ' LEU . 25.3 t -130.55 139.78 50.44 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.611 0 O-C-N 121.391 -0.818 . . . . 0.0 109.362 179.849 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 79' ' ' THR . . . . . 0.51 ' CG2' ' NE2' ' A' ' 111' ' ' GLN . 2.0 m -110.61 121.28 44.93 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.213 -0.929 . . . . 0.0 109.431 179.936 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 80' ' ' TYR . . . . . 0.571 ' HH ' ' HD1' ' A' ' 58' ' ' PHE . 1.5 m-85 -99.41 138.41 36.54 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.251 -0.906 . . . . 0.0 109.613 -179.925 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 81' ' ' GLU . . . . . 0.454 ' C ' ' HA2' ' A' ' 39' ' ' GLY . 81.6 tt0 -48.69 -25.79 1.97 Allowed 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.327 -0.858 . . . . 0.0 109.787 179.997 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 48.1 mttp -143.48 159.46 42.36 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.142 -0.974 . . . . 0.0 109.591 -179.938 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 83' ' ' MET . . . . . 0.891 ' HE3' ' O ' ' A' ' 117' ' ' ALA . 61.8 mtt -72.83 -19.37 61.33 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.292 -0.88 . . . . 0.0 109.357 179.971 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 96.5 mt-10 -68.06 -51.4 47.11 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.277 -0.889 . . . . 0.0 109.513 179.904 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 7.4 m -56.35 -32.46 64.73 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.277 -0.89 . . . . 0.0 109.37 179.863 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 86' ' ' ALA . . . . . 0.596 ' HB1' HD21 ' A' ' 42' ' ' LEU . . . -74.12 -27.54 60.91 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.236 -0.915 . . . . 0.0 109.364 -179.999 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 22.1 t70 -69.31 -43.29 74.07 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.224 -0.922 . . . . 0.0 109.457 -179.933 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 88' ' ' GLN . . . . . 0.453 ' O ' ' HB2' ' A' ' 92' ' ' GLU . 61.4 tt0 -69.48 -36.75 76.84 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.289 -0.882 . . . . 0.0 109.416 -179.95 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 89' ' ' ALA . . . . . 0.781 ' HB1' ' CD1' ' A' ' 93' ' ' LEU . . . -74.02 -44.38 54.67 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.221 -0.924 . . . . 0.0 109.446 179.958 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 90' ' ' VAL . . . . . 0.787 HG22 HG12 ' A' ' 105' ' ' VAL . 84.1 t -67.22 -38.19 80.56 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.549 0 O-C-N 121.337 -0.852 . . . . 0.0 109.603 179.984 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -80.06 -29.12 39.15 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.269 -0.894 . . . . 0.0 109.906 -179.681 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 92' ' ' GLU . . . . . 0.566 ' HB3' ' CE2' ' A' ' 61' ' ' PHE . 23.0 tt0 -91.9 -45.59 8.28 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.158 -0.963 . . . . 0.0 109.677 -179.749 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 93' ' ' LEU . . . . . 0.781 ' CD1' ' HB1' ' A' ' 89' ' ' ALA . 21.3 mt -69.35 -43.14 74.21 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.207 -0.933 . . . . 0.0 109.587 -179.925 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 94' ' ' ASN . . . . . 0.515 ' CB ' ' O ' ' A' ' 90' ' ' VAL . 43.8 t30 -63.74 127.11 29.9 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.205 -0.934 . . . . 0.0 109.54 179.988 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 98.79 16.3 31.47 Favored Glycine 0 N--CA 1.49 2.268 0 N-CA-C 109.455 -1.458 . . . . 0.0 109.455 179.985 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 96' ' ' THR . . . . . 0.552 HG23 ' O ' ' A' ' 93' ' ' LEU . 18.1 p -116.54 157.42 25.28 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.183 -1.187 . . . . 0.0 109.383 -179.966 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 59.6 tt0 -117.99 139.55 51.01 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.194 -0.941 . . . . 0.0 109.478 -179.944 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 98' ' ' VAL . . . . . 0.784 HG22 HD11 ' A' ' 103' ' ' LEU . 1.2 t -83.83 -149.49 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 121.202 -0.936 . . . . 0.0 109.374 -179.966 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 99' ' ' GLU . . . . . 0.504 ' H ' HG12 ' A' ' 98' ' ' VAL . 76.5 mm-40 -60.38 -41.62 94.16 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.226 -0.921 . . . . 0.0 109.501 179.97 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 21.1 t -158.51 31.55 0.23 Allowed 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.293 -0.88 . . . . 0.0 109.426 179.952 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 101' ' ' VAL . . . . . 0.542 ' O ' HG23 ' A' ' 98' ' ' VAL . 58.9 t -147.03 147.86 17.23 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 O-C-N 121.227 -0.921 . . . . 0.0 109.464 179.995 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 91.7 mt-30 -86.43 145.73 26.72 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.253 -0.904 . . . . 0.0 109.574 -179.941 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 103' ' ' LEU . . . . . 0.784 HD11 HG22 ' A' ' 98' ' ' VAL . 96.0 mt -109.56 136.13 49.44 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.313 -0.867 . . . . 0.0 109.467 179.948 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 104' ' ' LYS . . . . . 0.468 ' HB2' ' HB3' ' A' ' 45' ' ' TYR . 57.3 mttm -122.09 133.55 54.77 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.242 -0.912 . . . . 0.0 109.48 -179.938 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 105' ' ' VAL . . . . . 0.787 HG12 HG22 ' A' ' 90' ' ' VAL . 7.0 t -122.01 154.5 26.52 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.527 0 O-C-N 121.241 -0.912 . . . . 0.0 109.602 -179.994 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 106' ' ' ASN . . . . . 0.415 ' HB2' ' HB3' ' A' ' 43' ' ' TYR . 73.5 m-20 -158.57 -172.51 3.87 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.287 -0.883 . . . . 0.0 109.425 179.94 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 26.2 mm -110.44 125.61 67.7 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.499 0 O-C-N 121.163 -0.961 . . . . 0.0 109.429 179.946 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -102.92 145.69 29.44 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.209 -0.932 . . . . 0.0 109.534 -179.928 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 38.0 ptt180 -88.26 17.17 5.38 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.269 -0.894 . . . . 0.0 109.447 179.968 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 110' ' ' LYS . . . . . 0.64 ' HB2' HG21 ' A' ' 41' ' ' THR . 38.3 mttp -68.68 -162.98 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.229 -0.919 . . . . 0.0 109.458 -179.891 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 111' ' ' GLN . . . . . 0.719 ' NE2' HD11 ' A' ' 65' ' ' ILE . 3.9 tt0 70.52 61.1 0.48 Allowed Pre-proline 0 N--CA 1.49 1.566 0 O-C-N 121.332 -0.855 . . . . 0.0 109.608 -179.942 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 52.4 Cg_endo -70.99 -10.12 26.97 Favored 'Trans proline' 0 C--O 1.214 -0.681 0 C-N-CA 122.764 2.309 . . . . 0.0 111.771 179.87 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 113' ' ' MET . . . . . 0.591 ' CE ' ' HG3' ' A' ' 111' ' ' GLN . 12.5 mtm -67.82 -8.71 38.31 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.314 -0.866 . . . . 0.0 109.488 -179.926 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 114' ' ' LEU . . . . . 0.8 HD23 ' O ' ' A' ' 114' ' ' LEU . 2.6 tt 178.07 31.78 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.332 -0.855 . . . . 0.0 109.36 -179.71 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 115' ' ' ASP . . . . . 0.538 ' O ' ' HB3' ' A' ' 116' ' ' ALA . 77.5 m-20 47.78 42.89 16.43 Favored 'General case' 0 C--N 1.3 -1.546 0 N-CA-C 107.994 -1.113 . . . . 0.0 107.994 -179.091 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 116' ' ' ALA . . . . . 0.749 ' HB1' ' HA ' ' A' ' 40' ' ' ASN . . . 68.46 -84.49 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.646 -0.659 . . . . 0.0 109.588 -179.435 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 117' ' ' ALA . . . . . 0.891 ' O ' ' HE3' ' A' ' 83' ' ' MET . . . -154.74 168.92 25.24 Favored 'General case' 0 C--N 1.3 -1.544 0 O-C-N 121.14 -0.975 . . . . 0.0 109.74 -179.596 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 12.3 p -122.04 163.57 19.17 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.232 -0.918 . . . . 0.0 109.472 -179.837 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -179.81 -163.38 30.38 Favored Glycine 0 N--CA 1.49 2.298 0 N-CA-C 109.388 -1.485 . . . . 0.0 109.388 -179.978 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 32.4 mttt -58.4 -31.59 67.83 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.286 -1.126 . . . . 0.0 109.449 180.0 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 1.5 p . . . . . 0 N--CA 1.49 1.561 0 CA-C-O 118.004 -0.998 . . . . 0.0 109.48 179.972 . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 35' ' ' ALA . . . . . 0.802 ' HB3' ' HD3' ' A' ' 36' ' ' PRO . . . . . . . . 0 N--CA 1.49 1.565 0 N-CA-C 109.473 -0.565 . . . . 0.0 109.473 . . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 36' ' ' PRO . . . . . 0.802 ' HD3' ' HB3' ' A' ' 35' ' ' ALA . 49.4 Cg_endo -69.93 -14.13 35.16 Favored 'Trans proline' 0 C--O 1.215 -0.665 0 C-N-CA 122.741 2.294 . . . . 0.0 111.715 -179.991 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 37' ' ' ARG . . . . . 0.457 ' O ' ' HG ' ' A' ' 114' ' ' LEU . 69.0 mtt85 -129.91 129.76 44.29 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.269 -0.894 . . . . 0.0 109.466 -179.964 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 38' ' ' LYS . . . . . 0.701 ' HA ' HD12 ' A' ' 114' ' ' LEU . 18.0 mttt -104.14 -167.04 1.31 Allowed 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.306 -0.871 . . . . 0.0 109.404 179.953 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 39' ' ' GLY . . . . . 0.604 ' CA ' HG22 ' A' ' 79' ' ' THR . . . 148.68 89.92 0.08 OUTLIER Glycine 0 N--CA 1.489 2.193 0 N-CA-C 109.778 -1.329 . . . . 0.0 109.778 179.951 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 40' ' ' ASN . . . . . 0.477 ' O ' ' HA ' ' A' ' 79' ' ' THR . 60.1 t-20 -84.08 121.51 27.52 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.197 -1.178 . . . . 0.0 109.134 179.634 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 41' ' ' THR . . . . . 0.916 HG21 ' HB3' ' A' ' 110' ' ' LYS . 92.6 m -81.96 140.57 33.93 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.241 -0.912 . . . . 0.0 109.956 -179.568 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 42' ' ' LEU . . . . . 0.889 HD23 ' CG2' ' A' ' 90' ' ' VAL . 5.4 mp -118.05 142.62 47.2 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.375 -0.828 . . . . 0.0 109.077 179.391 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 43' ' ' TYR . . . . . 0.575 ' HB2' ' HB2' ' A' ' 108' ' ' ALA . 59.7 t80 -99.76 109.91 22.32 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.322 -0.861 . . . . 0.0 109.611 -179.851 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 44' ' ' VAL . . . . . 0.475 ' HA ' ' O ' ' A' ' 104' ' ' LYS . 96.4 t -107.4 143.27 18.27 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.555 0 O-C-N 121.249 -0.907 . . . . 0.0 109.345 179.913 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 74.2 t80 -132.51 135.47 46.01 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.174 -0.954 . . . . 0.0 109.497 -179.891 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 177.9 -175.13 47.35 Favored Glycine 0 N--CA 1.489 2.222 0 N-CA-C 109.554 -1.418 . . . . 0.0 109.554 179.931 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 47' ' ' GLU . . . . . 0.429 ' O ' ' C ' ' A' ' 48' ' ' ASP . 94.0 mt-10 -114.9 158.51 21.88 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.254 -1.144 . . . . 0.0 109.432 -179.967 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 48' ' ' ASP . . . . . 0.429 ' C ' ' O ' ' A' ' 47' ' ' GLU . 48.8 m-20 44.07 50.44 7.35 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.302 -0.874 . . . . 0.0 109.444 -179.954 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 54.0 mtm -100.38 135.58 41.59 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.192 -0.943 . . . . 0.0 109.523 179.981 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -122.65 166.04 19.14 Favored Pre-proline 0 N--CA 1.49 1.558 0 O-C-N 121.266 -0.896 . . . . 0.0 109.41 179.946 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 51' ' ' PRO . . . . . 0.664 ' HA ' HD12 ' A' ' 54' ' ' LEU . 49.7 Cg_endo -70.24 -51.67 0.33 Allowed 'Trans proline' 0 C--O 1.214 -0.685 0 C-N-CA 122.671 2.247 . . . . 0.0 111.755 179.969 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 62.8 m -49.36 -48.65 46.54 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.217 -0.927 . . . . 0.0 109.288 179.96 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 18.0 tp -59.6 -47.82 84.06 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.175 -0.953 . . . . 0.0 109.228 179.901 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 54' ' ' LEU . . . . . 0.664 HD12 ' HA ' ' A' ' 51' ' ' PRO . 12.8 mt -56.08 -45.61 79.29 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.26 -0.9 . . . . 0.0 109.337 179.835 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 55' ' ' ARG . . . . . 0.509 ' O ' ' N ' ' A' ' 59' ' ' SER . 15.3 mtp-105 -51.73 -42.21 62.12 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.355 -0.841 . . . . 0.0 109.286 179.863 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -70.78 -29.11 69.77 Favored Glycine 0 N--CA 1.489 2.232 0 N-CA-C 109.308 -1.517 . . . . 0.0 109.308 179.891 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 57' ' ' ALA . . . . . 0.461 ' O ' ' CD1' ' A' ' 61' ' ' PHE . . . -79.57 -22.8 43.32 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.267 -1.137 . . . . 0.0 109.432 179.966 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 58' ' ' PHE . . . . . 0.698 ' HB2' HD11 ' A' ' 64' ' ' ILE . 96.3 m-85 -119.51 7.59 11.17 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.245 -0.909 . . . . 0.0 109.473 179.926 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 59' ' ' SER . . . . . 0.541 ' N ' ' HD2' ' A' ' 60' ' ' PRO . 0.6 OUTLIER -72.7 -57.07 3.41 Favored Pre-proline 0 N--CA 1.49 1.537 0 O-C-N 121.261 -0.899 . . . . 0.0 109.837 -179.888 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 60' ' ' PRO . . . . . 0.541 ' HD2' ' N ' ' A' ' 59' ' ' SER . 49.7 Cg_endo -69.57 -30.46 23.12 Favored 'Trans proline' 0 C--O 1.215 -0.664 0 C-N-CA 122.648 2.232 . . . . 0.0 111.954 -179.822 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 61' ' ' PHE . . . . . 0.679 ' CE1' HD21 ' A' ' 93' ' ' LEU . 58.6 m-85 -64.22 -34.38 77.97 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.231 -0.918 . . . . 0.0 109.27 179.965 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 173.62 -173.41 45.79 Favored Glycine 0 N--CA 1.49 2.235 0 N-CA-C 109.4 -1.48 . . . . 0.0 109.4 179.98 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 56.1 t30 -95.57 139.34 31.97 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.235 -1.156 . . . . 0.0 109.566 179.947 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 64' ' ' ILE . . . . . 0.698 HD11 ' HB2' ' A' ' 58' ' ' PHE . 58.2 mt -101.87 135.03 40.58 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 O-C-N 121.228 -0.92 . . . . 0.0 109.351 179.966 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 65' ' ' ILE . . . . . 0.594 HD11 ' HA3' ' A' ' 39' ' ' GLY . 24.6 pt -97.72 -23.1 4.72 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.527 0 O-C-N 121.313 -0.867 . . . . 0.0 109.645 -179.963 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 53.2 t0 -149.05 126.87 11.81 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.227 -0.92 . . . . 0.0 109.552 179.981 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 16.2 tp -112.26 117.05 31.45 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.241 -0.912 . . . . 0.0 109.466 179.949 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 68' ' ' SER . . . . . 0.488 ' HB2' ' HB2' ' A' ' 77' ' ' PHE . 68.0 m -123.35 145.61 48.6 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.191 -0.943 . . . . 0.0 109.476 -179.916 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 69' ' ' MET . . . . . 0.477 ' HA ' ' HA ' ' A' ' 76' ' ' ALA . 75.1 mtp -131.53 149.61 52.45 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.209 -0.932 . . . . 0.0 109.556 -179.966 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 70' ' ' ASP . . . . . 0.483 ' C ' ' HD2' ' A' ' 72' ' ' PRO . 2.6 t0 -123.36 104.76 34.28 Favored Pre-proline 0 N--CA 1.49 1.547 0 O-C-N 121.181 -0.949 . . . . 0.0 109.484 179.924 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 71' ' ' PRO . . . . . 0.6 ' N ' ' CD ' ' A' ' 72' ' ' PRO . 46.6 Cg_endo -74.87 -27.73 10.03 Favored 'Trans proline' 0 CA--C 1.543 0.952 0 C-N-CA 122.585 2.19 . . . . 0.0 113.608 -179.944 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 72' ' ' PRO . . . . . 0.6 ' CD ' ' N ' ' A' ' 71' ' ' PRO . 54.6 Cg_endo -75.14 -33.27 4.57 Favored 'Trans proline' 0 C--N 1.354 0.839 0 C-N-CA 121.437 1.425 . . . . 0.0 111.862 -179.82 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 73' ' ' ARG . . . . . 0.443 ' HG2' ' O ' ' A' ' 73' ' ' ARG . 67.5 ttt180 -103.62 -2.17 27.05 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.222 -0.924 . . . . 0.0 109.663 -179.927 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 74' ' ' ASN . . . . . 0.426 ' HB2' ' O ' ' A' ' 73' ' ' ARG . 79.9 m-20 61.88 40.38 12.66 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.177 -0.952 . . . . 0.0 109.505 -179.996 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 75' ' ' CYS . . . . . . . . . . . . . 24.7 p -136.03 137.43 41.16 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.286 -0.884 . . . . 0.0 109.434 -179.943 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 76' ' ' ALA . . . . . 0.477 ' HA ' ' HA ' ' A' ' 69' ' ' MET . . . -107.61 157.21 18.25 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.317 -0.864 . . . . 0.0 109.49 179.965 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 77' ' ' PHE . . . . . 0.488 ' HA ' ' O ' ' A' ' 42' ' ' LEU . 97.5 m-85 -123.45 131.19 53.57 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.282 -0.886 . . . . 0.0 109.583 -179.959 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 78' ' ' VAL . . . . . 0.794 ' O ' HD12 ' A' ' 42' ' ' LEU . 45.5 t -120.4 134.5 63.67 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 O-C-N 121.261 -0.899 . . . . 0.0 109.7 -179.954 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 79' ' ' THR . . . . . 0.604 HG22 ' CA ' ' A' ' 39' ' ' GLY . 9.1 m -103.48 129.3 50.61 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.256 -0.902 . . . . 0.0 109.471 179.927 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 80' ' ' TYR . . . . . 0.588 ' CG ' ' HB2' ' A' ' 85' ' ' SER . 0.7 OUTLIER -112.07 137.12 50.55 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.192 -0.942 . . . . 0.0 109.542 -179.898 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 81' ' ' GLU . . . . . 0.487 ' O ' ' HB2' ' A' ' 38' ' ' LYS . 84.4 tt0 -57.67 -27.56 62.99 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.26 -0.9 . . . . 0.0 109.48 179.98 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 24.8 mttp -132.59 146.62 52.04 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.174 -0.954 . . . . 0.0 109.426 -179.955 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 83' ' ' MET . . . . . 0.584 ' HE2' ' N ' ' A' ' 117' ' ' ALA . 35.6 mtt -64.73 -20.32 66.28 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.254 -0.904 . . . . 0.0 109.378 179.986 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 98.6 mt-10 -68.26 -37.06 80.35 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.317 -0.865 . . . . 0.0 109.439 179.993 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 85' ' ' SER . . . . . 0.588 ' HB2' ' CG ' ' A' ' 80' ' ' TYR . 18.7 m -61.45 -34.34 75.26 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.276 -0.89 . . . . 0.0 109.455 179.952 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 86' ' ' ALA . . . . . 0.646 ' CB ' HD21 ' A' ' 42' ' ' LEU . . . -76.26 -30.5 57.87 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.326 -0.859 . . . . 0.0 109.437 -179.995 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 54.2 t0 -63.71 -49.52 72.77 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.218 -0.926 . . . . 0.0 109.496 179.93 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 88' ' ' GLN . . . . . 0.467 ' O ' ' HB2' ' A' ' 92' ' ' GLU . 59.0 tt0 -66.72 -38.74 87.31 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.267 -0.896 . . . . 0.0 109.462 -179.988 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 89' ' ' ALA . . . . . 0.547 ' HA ' ' CE2' ' A' ' 61' ' ' PHE . . . -74.1 -49.67 22.89 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.319 -0.863 . . . . 0.0 109.624 -179.979 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 90' ' ' VAL . . . . . 0.889 ' CG2' HD23 ' A' ' 42' ' ' LEU . 69.8 t -63.22 -37.0 78.28 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.551 0 O-C-N 121.203 -0.935 . . . . 0.0 109.61 -179.846 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -80.16 -37.83 32.6 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.212 -0.93 . . . . 0.0 109.722 -179.775 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 92' ' ' GLU . . . . . 0.547 ' HB3' ' CE2' ' A' ' 61' ' ' PHE . 24.6 tt0 -83.53 -48.78 9.91 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.171 -0.956 . . . . 0.0 109.803 -179.654 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 93' ' ' LEU . . . . . 0.838 ' HB2' HG21 ' A' ' 105' ' ' VAL . 35.0 mt -64.15 -40.47 96.21 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.187 -0.946 . . . . 0.0 109.683 -179.753 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 94' ' ' ASN . . . . . 0.52 ' CB ' ' O ' ' A' ' 90' ' ' VAL . 56.4 t-20 -63.54 124.31 21.03 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.179 -0.951 . . . . 0.0 109.621 -179.998 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 92.05 29.84 11.02 Favored Glycine 0 N--CA 1.49 2.26 0 N-CA-C 109.502 -1.439 . . . . 0.0 109.502 179.973 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 96' ' ' THR . . . . . 0.637 HG23 ' O ' ' A' ' 93' ' ' LEU . 26.1 p -121.41 158.39 28.43 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.287 -1.125 . . . . 0.0 109.5 179.945 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 63.7 tt0 -122.67 148.93 44.71 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.236 -0.915 . . . . 0.0 109.509 -179.99 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 98' ' ' VAL . . . . . 0.495 HG12 ' H ' ' A' ' 99' ' ' GLU . 1.3 t -100.29 -148.72 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.574 0 O-C-N 121.229 -0.919 . . . . 0.0 109.373 179.971 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 99' ' ' GLU . . . . . 0.495 ' H ' HG12 ' A' ' 98' ' ' VAL . 96.4 mt-10 -61.24 -40.6 94.65 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.25 -0.906 . . . . 0.0 109.459 179.99 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 32.0 t -159.36 31.56 0.2 Allowed 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.354 -0.841 . . . . 0.0 109.487 -179.942 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 101' ' ' VAL . . . . . 0.481 ' O ' HG23 ' A' ' 98' ' ' VAL . 48.6 t -148.75 154.73 9.57 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.603 0 O-C-N 121.301 -0.874 . . . . 0.0 109.365 -179.987 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 88.8 mt-30 -100.99 138.7 37.69 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.294 -0.879 . . . . 0.0 109.455 179.855 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 94.6 mt -106.56 136.95 45.44 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.159 -0.963 . . . . 0.0 109.57 -179.956 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 104' ' ' LYS . . . . . 0.475 ' O ' ' HA ' ' A' ' 44' ' ' VAL . 30.1 mttp -118.87 144.5 46.35 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.346 -0.846 . . . . 0.0 109.296 179.747 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 105' ' ' VAL . . . . . 0.838 HG21 ' HB2' ' A' ' 93' ' ' LEU . 17.4 t -129.23 150.39 34.58 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.585 0 O-C-N 121.231 -0.918 . . . . 0.0 109.661 -179.837 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 106' ' ' ASN . . . . . 0.48 ' HB2' ' HB3' ' A' ' 43' ' ' TYR . 80.5 m-20 -156.88 -167.48 2.38 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.308 -0.87 . . . . 0.0 109.182 179.915 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 68.0 mt -111.76 137.66 43.55 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.552 0 O-C-N 121.103 -0.998 . . . . 0.0 109.475 -179.992 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 108' ' ' ALA . . . . . 0.575 ' HB2' ' HB2' ' A' ' 43' ' ' TYR . . . -133.43 153.27 51.75 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.277 -0.889 . . . . 0.0 109.461 -179.973 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 20.1 mtp180 -99.81 33.01 2.67 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.207 -0.933 . . . . 0.0 109.516 -179.995 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 110' ' ' LYS . . . . . 0.916 ' HB3' HG21 ' A' ' 41' ' ' THR . 30.5 tttp -69.26 -9.27 52.36 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.26 -0.9 . . . . 0.0 109.523 -179.94 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 111' ' ' GLN . . . . . 0.769 ' HG3' ' HE2' ' A' ' 113' ' ' MET . 5.1 tp60 -123.43 72.4 48.97 Favored Pre-proline 0 N--CA 1.491 1.593 0 O-C-N 121.262 -0.899 . . . . 0.0 109.475 -179.972 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 112' ' ' PRO . . . . . 0.424 ' O ' ' C ' ' A' ' 113' ' ' MET . 55.6 Cg_endo -82.67 -17.93 7.0 Favored 'Trans proline' 0 C--O 1.215 -0.659 0 C-N-CA 122.826 2.351 . . . . 0.0 112.026 -179.919 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 113' ' ' MET . . . . . 0.769 ' HE2' ' HG3' ' A' ' 111' ' ' GLN . 0.0 OUTLIER -43.26 -29.4 0.4 Allowed 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.234 -0.916 . . . . 0.0 109.758 -179.75 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 114' ' ' LEU . . . . . 0.955 HD13 ' O ' ' A' ' 114' ' ' LEU . 1.2 tm? -148.27 22.99 1.05 Allowed 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.207 -0.933 . . . . 0.0 109.091 179.957 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 115' ' ' ASP . . . . . 0.696 ' O ' ' HB3' ' A' ' 116' ' ' ALA . 74.4 m-20 42.75 37.33 1.02 Allowed 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.311 -0.868 . . . . 0.0 109.481 179.943 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 116' ' ' ALA . . . . . 0.696 ' HB3' ' O ' ' A' ' 115' ' ' ASP . . . 76.55 -72.05 0.11 Allowed 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.279 -0.888 . . . . 0.0 109.517 179.995 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 117' ' ' ALA . . . . . 0.584 ' N ' ' HE2' ' A' ' 83' ' ' MET . . . -169.88 68.23 0.05 Allowed 'General case' 0 C--N 1.303 -1.437 0 O-C-N 121.341 -0.849 . . . . 0.0 109.658 -179.74 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 56.5 m -124.81 136.45 53.84 Favored 'General case' 0 C--N 1.302 -1.464 0 O-C-N 121.165 -0.96 . . . . 0.0 109.497 -179.985 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -81.91 179.43 53.33 Favored Glycine 0 N--CA 1.49 2.286 0 N-CA-C 109.472 -1.451 . . . . 0.0 109.472 179.964 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 44.6 tttt -56.44 -36.58 69.18 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.217 -1.167 . . . . 0.0 109.469 179.957 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.489 1.511 0 CA-C-O 117.955 -1.021 . . . . 0.0 109.491 -179.985 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 35' ' ' ALA . . . . . 0.561 ' N ' ' CD ' ' A' ' 36' ' ' PRO . . . . . . . . 0 N--CA 1.49 1.53 0 N-CA-C 109.468 -0.567 . . . . 0.0 109.468 . . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 36' ' ' PRO . . . . . 0.561 ' CD ' ' N ' ' A' ' 35' ' ' ALA . 50.0 Cg_endo -69.66 -22.57 32.34 Favored 'Trans proline' 0 C--O 1.215 -0.641 0 C-N-CA 122.742 2.294 . . . . 0.0 111.771 179.999 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 37' ' ' ARG . . . . . 0.542 ' O ' HD13 ' A' ' 114' ' ' LEU . 27.5 ptt180 -152.05 159.65 43.64 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.288 -0.882 . . . . 0.0 109.466 -179.951 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 38' ' ' LYS . . . . . 0.454 ' HB2' ' O ' ' A' ' 81' ' ' GLU . 27.7 mttm -91.31 -164.71 1.22 Allowed 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.126 -0.984 . . . . 0.0 109.459 179.988 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 39' ' ' GLY . . . . . 0.553 ' HA3' ' CD1' ' A' ' 65' ' ' ILE . . . 144.14 95.68 0.21 Allowed Glycine 0 N--CA 1.49 2.284 0 N-CA-C 109.559 -1.416 . . . . 0.0 109.559 -179.976 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 40' ' ' ASN . . . . . 0.484 ' O ' ' HA ' ' A' ' 79' ' ' THR . 45.8 t30 -91.69 120.3 32.33 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.159 -1.201 . . . . 0.0 109.718 -179.873 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 41' ' ' THR . . . . . 0.522 ' CG2' ' HB3' ' A' ' 77' ' ' PHE . 24.8 m -77.95 135.33 37.81 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.28 -0.887 . . . . 0.0 109.557 179.899 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 42' ' ' LEU . . . . . 0.902 HD11 ' CD2' ' A' ' 80' ' ' TYR . 12.7 mt -112.2 144.9 40.84 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.147 -0.971 . . . . 0.0 109.67 179.993 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 43' ' ' TYR . . . . . 0.652 ' HB2' ' HB2' ' A' ' 108' ' ' ALA . 60.2 t80 -94.9 116.9 29.29 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.428 -0.795 . . . . 0.0 109.359 179.676 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 44' ' ' VAL . . . . . 0.487 ' O ' ' HA ' ' A' ' 75' ' ' CYS . 44.5 t -116.52 135.33 57.14 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.494 0 O-C-N 121.216 -0.927 . . . . 0.0 109.239 179.847 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 45' ' ' TYR . . . . . 0.488 ' HB3' ' HB2' ' A' ' 104' ' ' LYS . 69.1 t80 -123.53 143.53 50.13 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.257 -0.902 . . . . 0.0 109.639 -179.804 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 164.64 174.12 34.03 Favored Glycine 0 N--CA 1.491 2.327 0 N-CA-C 109.444 -1.462 . . . . 0.0 109.444 -179.994 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 95.6 mt-10 -107.98 161.89 14.53 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.293 -1.122 . . . . 0.0 109.419 -179.997 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 21.5 m-20 44.41 58.17 3.96 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.249 -0.907 . . . . 0.0 109.4 179.96 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 43.2 mtm -111.29 136.76 49.92 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.317 -0.865 . . . . 0.0 109.432 179.954 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 50' ' ' THR . . . . . 0.584 ' O ' HD12 ' A' ' 54' ' ' LEU . 0.2 OUTLIER -123.72 166.5 18.54 Favored Pre-proline 0 N--CA 1.492 1.631 0 O-C-N 121.359 -0.838 . . . . 0.0 109.26 179.901 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 51' ' ' PRO . . . . . 0.443 ' HD3' ' SD ' ' A' ' 69' ' ' MET . 50.0 Cg_endo -71.4 -55.39 0.13 Allowed 'Trans proline' 0 C--O 1.214 -0.69 0 C-N-CA 122.495 2.13 . . . . 0.0 111.845 -179.962 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 21.3 m -48.84 -50.38 34.86 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.252 -0.905 . . . . 0.0 109.263 179.783 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 17.6 tp -58.89 -51.04 71.71 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.221 -0.924 . . . . 0.0 109.141 179.777 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 54' ' ' LEU . . . . . 0.584 HD12 ' O ' ' A' ' 50' ' ' THR . 14.1 mt -55.59 -49.92 71.48 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.343 -0.848 . . . . 0.0 109.16 179.744 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 55' ' ' ARG . . . . . 0.518 ' O ' ' N ' ' A' ' 59' ' ' SER . 73.0 mtp180 -47.16 -38.13 11.26 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.321 -0.862 . . . . 0.0 109.282 179.741 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -71.29 -31.65 65.94 Favored Glycine 0 N--CA 1.489 2.206 0 N-CA-C 109.369 -1.492 . . . . 0.0 109.369 179.844 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -76.56 -24.52 53.57 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.188 -1.184 . . . . 0.0 109.372 179.808 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 58' ' ' PHE . . . . . 0.762 ' HB2' HD11 ' A' ' 64' ' ' ILE . 91.7 m-85 -116.82 7.57 13.39 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.356 -0.84 . . . . 0.0 109.408 179.92 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 59' ' ' SER . . . . . 0.553 ' N ' ' HD2' ' A' ' 60' ' ' PRO . 0.6 OUTLIER -74.04 -55.68 3.0 Favored Pre-proline 0 N--CA 1.491 1.584 0 O-C-N 121.291 -0.881 . . . . 0.0 110.317 -179.622 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 60' ' ' PRO . . . . . 0.553 ' HD2' ' N ' ' A' ' 59' ' ' SER . 46.6 Cg_endo -68.19 -31.02 30.29 Favored 'Trans proline' 0 C--O 1.215 -0.656 0 C-N-CA 122.521 2.148 . . . . 0.0 112.215 -179.367 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 61' ' ' PHE . . . . . 0.571 ' CD1' ' HA ' ' A' ' 89' ' ' ALA . 70.1 m-85 -65.69 -30.4 71.08 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.116 -0.99 . . . . 0.0 109.491 -179.969 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 62' ' ' GLY . . . . . 0.464 ' HA3' ' OG ' ' A' ' 85' ' ' SER . . . 175.61 -165.76 36.74 Favored Glycine 0 N--CA 1.49 2.297 0 N-CA-C 109.421 -1.472 . . . . 0.0 109.421 179.956 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 85.4 m-20 -103.87 134.47 47.11 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.29 -1.124 . . . . 0.0 109.499 179.961 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 64' ' ' ILE . . . . . 0.762 HD11 ' HB2' ' A' ' 58' ' ' PHE . 76.1 mt -95.78 140.35 17.24 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.575 0 O-C-N 121.297 -0.877 . . . . 0.0 109.565 -179.951 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 65' ' ' ILE . . . . . 0.734 HD11 HG21 ' A' ' 79' ' ' THR . 26.2 pt -100.84 -24.49 4.07 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 O-C-N 121.302 -0.873 . . . . 0.0 109.452 179.922 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 40.2 t0 -149.35 140.79 23.31 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.251 -0.906 . . . . 0.0 109.573 -179.863 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 67' ' ' LEU . . . . . 0.7 ' C ' HD13 ' A' ' 67' ' ' LEU . 2.2 tm? -118.76 104.93 11.05 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.283 -0.886 . . . . 0.0 109.136 179.785 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 68' ' ' SER . . . . . 0.487 ' HB3' ' HB2' ' A' ' 77' ' ' PHE . 46.5 t -108.65 141.07 41.15 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.226 -0.921 . . . . 0.0 109.55 -179.891 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 69' ' ' MET . . . . . 0.495 ' HA ' ' HA ' ' A' ' 76' ' ' ALA . 63.2 mtp -133.63 141.62 47.72 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.3 -0.875 . . . . 0.0 109.504 -179.986 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 70' ' ' ASP . . . . . 0.474 ' C ' ' HD2' ' A' ' 72' ' ' PRO . 0.9 OUTLIER -124.51 107.16 29.61 Favored Pre-proline 0 N--CA 1.49 1.562 0 O-C-N 121.332 -0.855 . . . . 0.0 109.378 -179.971 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 71' ' ' PRO . . . . . 0.601 ' N ' ' CD ' ' A' ' 72' ' ' PRO . 47.1 Cg_endo -74.91 -27.85 9.85 Favored 'Trans proline' 0 CA--C 1.542 0.883 0 C-N-CA 122.495 2.13 . . . . 0.0 113.747 -179.908 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 72' ' ' PRO . . . . . 0.601 ' CD ' ' N ' ' A' ' 71' ' ' PRO . 54.4 Cg_endo -74.84 -25.66 12.0 Favored 'Trans proline' 0 C--N 1.353 0.772 0 C-N-CA 121.446 1.431 . . . . 0.0 111.745 -179.771 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 75.3 mtp180 -110.46 0.9 17.98 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.273 -0.892 . . . . 0.0 109.62 -179.833 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 66.2 m-20 56.39 48.56 16.72 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.153 -0.967 . . . . 0.0 109.512 179.943 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 75' ' ' CYS . . . . . 0.487 ' HA ' ' O ' ' A' ' 44' ' ' VAL . 26.6 p -148.18 135.73 20.67 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.186 -0.946 . . . . 0.0 109.46 -179.973 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 76' ' ' ALA . . . . . 0.495 ' HA ' ' HA ' ' A' ' 69' ' ' MET . . . -110.37 133.67 53.04 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.159 -0.963 . . . . 0.0 109.74 -179.994 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 77' ' ' PHE . . . . . 0.522 ' HB3' ' CG2' ' A' ' 41' ' ' THR . 12.0 m-30 -103.79 108.39 19.68 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.335 -0.853 . . . . 0.0 109.33 179.935 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 78' ' ' VAL . . . . . 0.494 ' O ' ' N ' ' A' ' 42' ' ' LEU . 1.8 p -105.76 141.28 21.44 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.405 0 O-C-N 121.144 -0.973 . . . . 0.0 109.401 179.979 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 79' ' ' THR . . . . . 0.734 HG21 HD11 ' A' ' 65' ' ' ILE . 11.5 m -97.47 155.42 16.94 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.138 -0.976 . . . . 0.0 109.874 -179.692 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 80' ' ' TYR . . . . . 0.902 ' CD2' HD11 ' A' ' 42' ' ' LEU . 0.1 OUTLIER -130.51 129.26 42.65 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.329 -0.857 . . . . 0.0 109.546 179.955 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 81' ' ' GLU . . . . . 0.454 ' O ' ' HB2' ' A' ' 38' ' ' LYS . 69.3 tt0 -44.25 -34.5 1.92 Allowed 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.205 -0.934 . . . . 0.0 109.489 179.88 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 33.5 mttm -141.43 152.18 44.05 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.119 -0.988 . . . . 0.0 109.596 -179.774 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 83' ' ' MET . . . . . 0.613 ' CE ' ' HB3' ' A' ' 117' ' ' ALA . 45.8 mtt -63.89 -26.72 68.73 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.352 -0.843 . . . . 0.0 109.415 179.973 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 96.4 mt-10 -56.27 -49.09 75.21 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.292 -0.88 . . . . 0.0 109.475 -179.976 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 85' ' ' SER . . . . . 0.555 ' OG ' ' CE1' ' A' ' 80' ' ' TYR . 41.5 t -61.04 -32.05 71.68 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.213 -0.929 . . . . 0.0 109.381 179.864 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 86' ' ' ALA . . . . . 0.684 ' O ' HG23 ' A' ' 90' ' ' VAL . . . -76.04 -33.42 59.62 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.308 -0.87 . . . . 0.0 109.774 -179.757 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 22.3 t70 -70.13 -43.77 70.28 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.145 -0.972 . . . . 0.0 109.725 -179.732 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 62.6 tt0 -71.14 -39.08 72.19 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.265 -0.897 . . . . 0.0 109.877 -179.717 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 89' ' ' ALA . . . . . 0.704 ' HB1' ' CD1' ' A' ' 93' ' ' LEU . . . -73.72 -43.38 59.35 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.154 -0.966 . . . . 0.0 109.741 -179.745 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 90' ' ' VAL . . . . . 0.753 HG22 HG11 ' A' ' 105' ' ' VAL . 74.3 t -61.26 -31.88 51.49 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.598 0 O-C-N 121.195 -0.941 . . . . 0.0 109.667 -179.778 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -78.96 -53.32 7.17 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.272 -0.892 . . . . 0.0 109.732 -179.857 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 92' ' ' GLU . . . . . 0.527 ' HB2' ' CE1' ' A' ' 61' ' ' PHE . 75.2 mm-40 -69.53 -41.45 75.97 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.224 -0.922 . . . . 0.0 109.928 -179.632 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 93' ' ' LEU . . . . . 0.704 ' CD1' ' HB1' ' A' ' 89' ' ' ALA . 81.2 mt -69.55 -40.55 76.76 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.074 -1.016 . . . . 0.0 109.642 -179.806 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 94' ' ' ASN . . . . . 0.527 ' CB ' ' O ' ' A' ' 90' ' ' VAL . 59.1 t30 -71.47 126.41 29.59 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.201 -0.937 . . . . 0.0 109.497 -179.945 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 99.09 20.0 19.7 Favored Glycine 0 N--CA 1.489 2.182 0 N-CA-C 109.515 -1.434 . . . . 0.0 109.515 179.94 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 96' ' ' THR . . . . . 0.409 ' CG2' ' O ' ' A' ' 92' ' ' GLU . 20.5 p -121.92 159.94 25.84 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.301 -1.117 . . . . 0.0 109.504 179.964 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 63.9 tt0 -125.35 149.08 48.45 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.334 -0.854 . . . . 0.0 109.453 -179.969 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 98' ' ' VAL . . . . . 0.627 ' HB ' HG12 ' A' ' 101' ' ' VAL . 1.4 t -93.78 -148.68 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 O-C-N 121.206 -0.934 . . . . 0.0 109.35 -179.982 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 99' ' ' GLU . . . . . 0.497 ' H ' HG12 ' A' ' 98' ' ' VAL . 95.9 mt-10 -56.69 -44.64 81.7 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.164 -0.96 . . . . 0.0 109.449 -179.977 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 3.5 p -157.2 21.21 0.3 Allowed 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.282 -0.886 . . . . 0.0 109.449 179.974 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 101' ' ' VAL . . . . . 0.627 HG12 ' HB ' ' A' ' 98' ' ' VAL . 8.7 p -129.03 139.5 51.73 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.524 0 O-C-N 121.231 -0.918 . . . . 0.0 109.519 -179.943 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 95.3 mt-30 -87.1 136.51 32.9 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.2 -0.937 . . . . 0.0 109.387 179.959 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 103' ' ' LEU . . . . . 0.57 HD11 HG22 ' A' ' 98' ' ' VAL . 97.8 mt -100.87 144.26 30.04 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.23 -0.919 . . . . 0.0 109.667 -179.934 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 104' ' ' LYS . . . . . 0.488 ' HB2' ' HB3' ' A' ' 45' ' ' TYR . 45.1 mttt -134.66 142.09 46.76 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.263 -0.898 . . . . 0.0 109.252 179.869 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 105' ' ' VAL . . . . . 0.753 HG11 HG22 ' A' ' 90' ' ' VAL . 25.5 t -126.28 138.21 55.34 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 O-C-N 121.225 -0.922 . . . . 0.0 109.686 -179.932 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 106' ' ' ASN . . . . . 0.559 ' HB2' ' CD1' ' A' ' 43' ' ' TYR . 80.1 m-20 -138.83 -161.19 1.15 Allowed 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.303 -0.873 . . . . 0.0 109.259 179.871 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 24.2 mm -107.65 134.14 50.32 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.526 0 O-C-N 121.144 -0.973 . . . . 0.0 109.462 -179.971 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 108' ' ' ALA . . . . . 0.652 ' HB2' ' HB2' ' A' ' 43' ' ' TYR . . . -131.82 157.19 44.56 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.313 -0.867 . . . . 0.0 109.521 179.948 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 37.9 mtm180 -131.47 121.44 24.53 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.245 -0.909 . . . . 0.0 109.561 179.951 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 110' ' ' LYS . . . . . 0.447 ' HG2' ' O ' ' A' ' 110' ' ' LYS . 55.9 tttm -173.09 34.03 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.276 -0.89 . . . . 0.0 109.372 179.96 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 111' ' ' GLN . . . . . 0.62 ' HG3' ' HE3' ' A' ' 113' ' ' MET . 7.4 tp-100 -130.5 83.47 62.19 Favored Pre-proline 0 N--CA 1.489 1.506 0 O-C-N 121.406 -0.808 . . . . 0.0 109.334 -179.948 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 112' ' ' PRO . . . . . 0.438 ' O ' ' C ' ' A' ' 113' ' ' MET . 51.2 Cg_endo -71.71 -29.49 15.75 Favored 'Trans proline' 0 C--O 1.214 -0.69 0 C-N-CA 122.696 2.264 . . . . 0.0 112.369 -179.6 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 113' ' ' MET . . . . . 0.62 ' HE3' ' HG3' ' A' ' 111' ' ' GLN . 0.0 OUTLIER -43.11 -27.19 0.19 Allowed 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.256 -0.903 . . . . 0.0 109.398 179.949 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 114' ' ' LEU . . . . . 0.85 HD23 ' O ' ' A' ' 114' ' ' LEU . 2.7 tt -161.59 27.77 0.13 Allowed 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.409 -0.807 . . . . 0.0 109.298 179.88 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 115' ' ' ASP . . . . . 0.708 ' O ' ' HB3' ' A' ' 116' ' ' ALA . 80.4 m-20 52.73 47.53 24.48 Favored 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.139 -0.976 . . . . 0.0 108.812 -179.561 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 116' ' ' ALA . . . . . 0.708 ' HB3' ' O ' ' A' ' 115' ' ' ASP . . . 76.16 -74.85 0.07 Allowed 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.367 -0.833 . . . . 0.0 109.239 -179.55 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 117' ' ' ALA . . . . . 0.613 ' HB3' ' CE ' ' A' ' 83' ' ' MET . . . -169.78 168.29 8.98 Favored 'General case' 0 C--N 1.304 -1.399 0 O-C-N 121.351 -0.843 . . . . 0.0 109.465 -179.897 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 13.5 t -115.87 162.73 16.9 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.275 -0.891 . . . . 0.0 109.414 179.979 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -177.34 179.51 48.07 Favored Glycine 0 N--CA 1.489 2.217 0 N-CA-C 109.379 -1.488 . . . . 0.0 109.379 -179.923 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 93.7 mttt -116.28 143.12 45.94 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.23 -1.159 . . . . 0.0 109.57 -179.982 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.49 1.53 0 CA-C-O 118.04 -0.981 . . . . 0.0 109.457 179.995 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.578 0 N-CA-C 109.435 -0.58 . . . . 0.0 109.435 . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 48.5 Cg_endo -69.91 138.67 37.88 Favored 'Trans proline' 0 C--O 1.214 -0.701 0 C-N-CA 122.696 2.264 . . . . 0.0 111.789 179.946 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 37' ' ' ARG . . . . . 0.498 ' HG3' ' N ' ' A' ' 38' ' ' LYS . 24.1 tpt180 -117.28 149.69 40.03 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.251 -0.906 . . . . 0.0 109.355 -179.915 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 38' ' ' LYS . . . . . 0.498 ' N ' ' HG3' ' A' ' 37' ' ' ARG . 25.3 mttt -77.36 -165.04 0.53 Allowed 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.236 -0.915 . . . . 0.0 109.716 -179.828 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 39' ' ' GLY . . . . . 0.525 ' CA ' ' O ' ' A' ' 80' ' ' TYR . . . 155.85 -167.38 33.19 Favored Glycine 0 N--CA 1.49 2.277 0 N-CA-C 109.505 -1.438 . . . . 0.0 109.505 -179.932 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 40' ' ' ASN . . . . . 0.468 ' O ' ' HA ' ' A' ' 79' ' ' THR . 49.6 t-20 -159.71 122.71 3.54 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.131 -1.217 . . . . 0.0 109.535 179.974 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 41' ' ' THR . . . . . 0.613 ' O ' HD23 ' A' ' 42' ' ' LEU . 35.8 m -80.75 138.86 36.32 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.25 -0.906 . . . . 0.0 109.499 -179.997 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 42' ' ' LEU . . . . . 0.94 HD11 ' CD2' ' A' ' 80' ' ' TYR . 9.9 mt -120.13 151.05 39.64 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.211 -0.931 . . . . 0.0 109.626 179.941 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 43' ' ' TYR . . . . . 0.598 ' HB2' ' HB2' ' A' ' 108' ' ' ALA . 69.0 t80 -106.29 124.92 50.33 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.236 -0.915 . . . . 0.0 109.341 179.867 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 44' ' ' VAL . . . . . 0.459 ' O ' ' HA ' ' A' ' 75' ' ' CYS . 80.2 t -122.14 137.73 54.73 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.534 0 O-C-N 121.22 -0.925 . . . . 0.0 109.467 -179.941 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 45' ' ' TYR . . . . . 0.472 ' HB3' ' HB2' ' A' ' 104' ' ' LYS . 71.0 t80 -121.07 133.58 55.24 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.276 -0.89 . . . . 0.0 109.423 179.909 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -175.73 -175.37 43.08 Favored Glycine 0 N--CA 1.49 2.277 0 N-CA-C 109.482 -1.447 . . . . 0.0 109.482 -179.974 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 94.0 mt-10 -121.41 146.53 46.79 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.212 -1.17 . . . . 0.0 109.45 179.983 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 58.4 t0 47.79 52.97 12.03 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.277 -0.889 . . . . 0.0 109.481 -179.952 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 67.5 mtm -95.7 138.09 33.85 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.27 -0.894 . . . . 0.0 109.454 -179.929 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 50' ' ' THR . . . . . 0.814 HG22 ' HD2' ' A' ' 51' ' ' PRO . 0.0 OUTLIER -110.8 161.5 24.57 Favored Pre-proline 0 N--CA 1.49 1.543 0 O-C-N 121.23 -0.919 . . . . 0.0 109.48 179.979 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 51' ' ' PRO . . . . . 0.814 ' HD2' HG22 ' A' ' 50' ' ' THR . 49.4 Cg_endo -70.12 -52.5 0.3 Allowed 'Trans proline' 0 C--O 1.215 -0.648 0 C-N-CA 122.743 2.295 . . . . 0.0 111.674 -179.959 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 37.1 m -56.27 -44.49 79.81 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.322 -0.861 . . . . 0.0 109.383 179.995 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 53' ' ' LEU . . . . . 0.765 ' O ' HD13 ' A' ' 53' ' ' LEU . 3.1 tm? -60.45 -46.56 89.61 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.241 -0.912 . . . . 0.0 109.405 179.931 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 54' ' ' LEU . . . . . 0.693 HD12 ' SD ' ' A' ' 69' ' ' MET . 42.7 mt -62.81 -48.03 80.85 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.242 -0.911 . . . . 0.0 109.356 -179.916 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 55' ' ' ARG . . . . . 0.467 ' O ' ' N ' ' A' ' 59' ' ' SER . 48.0 mtt180 -48.53 -39.82 24.79 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.248 -0.907 . . . . 0.0 109.392 179.936 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -69.09 -34.78 76.73 Favored Glycine 0 N--CA 1.49 2.289 0 N-CA-C 109.312 -1.515 . . . . 0.0 109.312 179.881 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 57' ' ' ALA . . . . . 0.417 ' O ' HD21 ' A' ' 93' ' ' LEU . . . -71.26 -25.03 62.29 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.288 -1.125 . . . . 0.0 109.414 179.921 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 58' ' ' PHE . . . . . 0.736 ' HB2' HD11 ' A' ' 64' ' ' ILE . 76.2 m-85 -116.81 10.3 14.16 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.323 -0.86 . . . . 0.0 109.463 -179.979 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 59' ' ' SER . . . . . 0.559 ' N ' ' HD2' ' A' ' 60' ' ' PRO . 1.4 t -76.46 -53.74 1.99 Allowed Pre-proline 0 N--CA 1.492 1.63 0 O-C-N 121.3 -0.875 . . . . 0.0 110.473 -179.558 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 60' ' ' PRO . . . . . 0.559 ' HD2' ' N ' ' A' ' 59' ' ' SER . 47.8 Cg_endo -68.88 -34.03 18.8 Favored 'Trans proline' 0 C--O 1.215 -0.659 0 C-N-CA 122.405 2.07 . . . . 0.0 112.388 -179.152 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 61' ' ' PHE . . . . . 0.611 ' CE2' HD21 ' A' ' 93' ' ' LEU . 87.8 m-85 -63.52 -37.04 85.8 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.057 -1.027 . . . . 0.0 109.502 -179.971 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 62' ' ' GLY . . . . . 0.463 ' HA3' ' OG ' ' A' ' 85' ' ' SER . . . -178.74 -172.63 43.29 Favored Glycine 0 N--CA 1.49 2.27 0 N-CA-C 109.599 -1.4 . . . . 0.0 109.599 179.94 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 51.5 t-20 -96.99 136.81 37.03 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.266 -1.138 . . . . 0.0 109.577 -179.914 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 64' ' ' ILE . . . . . 0.776 HD13 HD23 ' A' ' 67' ' ' LEU . 54.6 mt -98.51 131.29 45.93 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 O-C-N 121.209 -0.932 . . . . 0.0 109.532 -179.946 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 18.6 pt -95.58 -19.31 6.35 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 O-C-N 121.32 -0.862 . . . . 0.0 109.579 -179.902 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 59.6 t0 -152.38 106.25 3.11 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.205 -0.934 . . . . 0.0 109.591 -179.99 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 67' ' ' LEU . . . . . 0.776 HD23 HD13 ' A' ' 64' ' ' ILE . 0.5 OUTLIER -99.22 120.22 39.16 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.27 -0.894 . . . . 0.0 109.375 179.755 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 68' ' ' SER . . . . . 0.748 ' N ' HD13 ' A' ' 67' ' ' LEU . 67.9 m -131.62 151.15 51.83 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.174 -0.954 . . . . 0.0 109.691 -179.793 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 69' ' ' MET . . . . . 0.693 ' SD ' HD12 ' A' ' 54' ' ' LEU . 18.2 mtm -130.94 144.62 51.6 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.309 -0.869 . . . . 0.0 109.346 179.886 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 70' ' ' ASP . . . . . 0.519 ' CB ' ' O ' ' A' ' 75' ' ' CYS . 0.9 OUTLIER -118.89 102.78 48.99 Favored Pre-proline 0 N--CA 1.491 1.604 0 O-C-N 121.22 -0.925 . . . . 0.0 109.533 -179.885 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 71' ' ' PRO . . . . . 0.601 ' N ' ' CD ' ' A' ' 72' ' ' PRO . 47.7 Cg_endo -74.9 -27.75 9.96 Favored 'Trans proline' 0 CA--C 1.542 0.888 0 C-N-CA 122.608 2.205 . . . . 0.0 113.697 179.886 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 72' ' ' PRO . . . . . 0.601 ' CD ' ' N ' ' A' ' 71' ' ' PRO . 55.4 Cg_endo -75.09 -25.16 11.98 Favored 'Trans proline' 0 C--N 1.353 0.814 0 C-N-CA 121.446 1.431 . . . . 0.0 111.809 -179.795 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 48.3 mtt85 -111.9 10.03 20.64 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.282 -0.886 . . . . 0.0 109.587 -179.946 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 83.1 m-20 53.3 36.61 23.24 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.249 -0.907 . . . . 0.0 109.506 -179.987 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 75' ' ' CYS . . . . . 0.519 ' O ' ' CB ' ' A' ' 70' ' ' ASP . 28.1 p -142.81 146.67 34.42 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.214 -0.929 . . . . 0.0 109.527 -179.868 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 76' ' ' ALA . . . . . 0.47 ' HA ' ' HA ' ' A' ' 69' ' ' MET . . . -114.17 162.48 16.47 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.188 -0.945 . . . . 0.0 109.553 -179.977 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 77' ' ' PHE . . . . . 0.406 ' CE1' ' HD1' ' A' ' 43' ' ' TYR . 96.7 m-85 -127.62 108.99 11.25 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.362 -0.836 . . . . 0.0 109.359 179.933 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 78' ' ' VAL . . . . . 0.533 HG23 ' CD2' ' A' ' 67' ' ' LEU . 6.1 p -109.67 135.58 48.22 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.449 0 O-C-N 121.247 -0.908 . . . . 0.0 109.624 -179.854 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 79' ' ' THR . . . . . 0.769 HG23 HE22 ' A' ' 111' ' ' GLN . 91.7 m -106.63 128.8 54.45 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.249 -0.907 . . . . 0.0 109.273 179.797 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 80' ' ' TYR . . . . . 0.94 ' CD2' HD11 ' A' ' 42' ' ' LEU . 0.9 OUTLIER -94.93 174.22 7.2 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.336 -0.852 . . . . 0.0 109.527 179.978 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 81' ' ' GLU . . . . . 0.479 ' O ' ' CG ' ' A' ' 82' ' ' LYS . 81.7 tt0 -86.37 -11.77 51.12 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.44 -0.787 . . . . 0.0 109.177 179.66 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 82' ' ' LYS . . . . . 0.479 ' CG ' ' O ' ' A' ' 81' ' ' GLU . 43.0 mttp -157.91 158.83 35.78 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.324 -0.86 . . . . 0.0 109.267 179.934 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 83' ' ' MET . . . . . 0.912 ' HE1' ' O ' ' A' ' 117' ' ' ALA . 31.4 mtt -71.83 -12.13 61.14 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.238 -0.914 . . . . 0.0 109.384 -179.947 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 84' ' ' GLU . . . . . 0.434 ' HA ' ' OE1' ' A' ' 84' ' ' GLU . 70.7 mm-40 -76.4 -40.11 51.77 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.317 -0.865 . . . . 0.0 109.609 179.93 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 85' ' ' SER . . . . . 0.463 ' OG ' ' HA3' ' A' ' 62' ' ' GLY . 29.1 t -65.45 -35.44 80.93 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.255 -0.903 . . . . 0.0 109.481 179.96 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 86' ' ' ALA . . . . . 0.547 ' O ' HG23 ' A' ' 90' ' ' VAL . . . -71.83 -35.78 70.0 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.425 -0.797 . . . . 0.0 109.764 -179.918 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 64.5 t0 -65.32 -43.64 90.38 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.158 -0.964 . . . . 0.0 109.786 -179.814 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 64.8 tt0 -72.57 -38.85 67.8 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.197 -0.939 . . . . 0.0 109.82 -179.745 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 89' ' ' ALA . . . . . 0.773 ' HB1' ' CD1' ' A' ' 93' ' ' LEU . . . -73.89 -42.12 61.16 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.206 -0.934 . . . . 0.0 109.745 -179.708 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 90' ' ' VAL . . . . . 0.836 ' HA ' HG11 ' A' ' 105' ' ' VAL . 51.1 t -62.07 -34.37 63.02 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.564 0 O-C-N 121.243 -0.91 . . . . 0.0 109.74 -179.79 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -76.03 -53.74 7.91 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.185 -0.947 . . . . 0.0 109.867 -179.678 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 92' ' ' GLU . . . . . 0.581 ' HB2' ' CE1' ' A' ' 61' ' ' PHE . 75.1 mm-40 -69.24 -44.37 72.13 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.196 -0.94 . . . . 0.0 109.9 -179.634 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 93' ' ' LEU . . . . . 0.773 ' CD1' ' HB1' ' A' ' 89' ' ' ALA . 69.8 mt -65.45 -36.84 85.12 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.109 -0.994 . . . . 0.0 109.709 -179.753 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 94' ' ' ASN . . . . . 0.485 ' HB2' ' O ' ' A' ' 90' ' ' VAL . 63.1 t-20 -72.99 125.38 27.47 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.169 -0.957 . . . . 0.0 109.452 -179.888 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 95.29 26.52 12.11 Favored Glycine 0 N--CA 1.49 2.263 0 N-CA-C 109.515 -1.434 . . . . 0.0 109.515 179.908 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 96' ' ' THR . . . . . 0.489 ' CG2' ' O ' ' A' ' 92' ' ' GLU . 17.7 p -121.47 155.3 35.2 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.23 -1.159 . . . . 0.0 109.469 -179.969 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 64.2 tt0 -128.74 153.08 47.71 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.257 -0.902 . . . . 0.0 109.481 -179.97 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 98' ' ' VAL . . . . . 0.538 HG12 ' H ' ' A' ' 99' ' ' GLU . 1.2 t -98.33 -152.58 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.627 0 O-C-N 121.235 -0.916 . . . . 0.0 109.254 -179.897 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 99' ' ' GLU . . . . . 0.538 ' H ' HG12 ' A' ' 98' ' ' VAL . 75.7 mm-40 -59.79 -39.13 83.89 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.168 -0.957 . . . . 0.0 109.475 179.943 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -157.6 24.85 0.28 Allowed 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.327 -0.858 . . . . 0.0 109.485 -179.958 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 101' ' ' VAL . . . . . 0.42 ' O ' HG23 ' A' ' 98' ' ' VAL . 47.4 t -137.57 152.5 27.19 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.552 0 O-C-N 121.165 -0.96 . . . . 0.0 109.498 179.998 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 91.8 mt-30 -108.42 145.08 35.14 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.268 -0.895 . . . . 0.0 109.483 179.937 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 93.3 mt -111.95 145.35 39.75 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.225 -0.922 . . . . 0.0 109.525 -179.961 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 104' ' ' LYS . . . . . 0.472 ' HB2' ' HB3' ' A' ' 45' ' ' TYR . 43.8 mttt -127.33 133.1 50.13 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.264 -0.897 . . . . 0.0 109.406 179.912 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 105' ' ' VAL . . . . . 0.836 HG11 ' HA ' ' A' ' 90' ' ' VAL . 21.9 t -116.9 133.41 63.7 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.514 0 O-C-N 121.217 -0.927 . . . . 0.0 109.576 -179.866 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 79.5 m-20 -137.76 -172.77 3.32 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.31 -0.869 . . . . 0.0 109.368 179.908 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 24.4 mm -104.88 126.55 59.77 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.518 0 O-C-N 121.18 -0.95 . . . . 0.0 109.426 179.965 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 108' ' ' ALA . . . . . 0.598 ' HB2' ' HB2' ' A' ' 43' ' ' TYR . . . -106.39 166.75 10.31 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.218 -0.926 . . . . 0.0 109.474 -179.917 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 85.3 mtm-85 -51.2 148.35 4.71 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.262 -0.898 . . . . 0.0 109.409 179.883 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 110' ' ' LYS . . . . . 0.485 ' HD3' ' O ' ' A' ' 115' ' ' ASP . 73.5 mttt -71.59 142.99 49.99 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.273 -0.892 . . . . 0.0 109.392 179.981 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 111' ' ' GLN . . . . . 0.769 HE22 HG23 ' A' ' 79' ' ' THR . 0.9 OUTLIER -63.04 145.61 96.52 Favored Pre-proline 0 N--CA 1.49 1.538 0 O-C-N 121.259 -0.9 . . . . 0.0 109.715 -179.78 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 55.3 Cg_endo -74.65 -15.34 21.72 Favored 'Trans proline' 0 C--O 1.214 -0.703 0 C-N-CA 122.835 2.357 . . . . 0.0 112.987 -179.313 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 113' ' ' MET . . . . . 0.674 ' HE2' ' HB2' ' A' ' 111' ' ' GLN . 6.5 mtm -62.38 -16.28 53.7 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 120.8 -1.187 . . . . 0.0 109.26 -179.764 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 114' ' ' LEU . . . . . 0.608 HD23 ' O ' ' A' ' 114' ' ' LEU . 1.1 tt 178.27 31.69 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.394 -0.817 . . . . 0.0 109.42 -179.679 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 115' ' ' ASP . . . . . 0.691 ' O ' ' HB3' ' A' ' 116' ' ' ALA . 76.6 m-20 50.42 40.23 22.51 Favored 'General case' 0 C--N 1.302 -1.498 0 O-C-N 121.218 -0.927 . . . . 0.0 108.63 -179.417 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 116' ' ' ALA . . . . . 0.691 ' HB3' ' O ' ' A' ' 115' ' ' ASP . . . 77.55 -78.54 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.498 -0.751 . . . . 0.0 109.428 -179.618 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 117' ' ' ALA . . . . . 0.912 ' O ' ' HE1' ' A' ' 83' ' ' MET . . . -164.84 152.91 11.89 Favored 'General case' 0 N--CA 1.487 1.405 0 O-C-N 121.284 -0.885 . . . . 0.0 109.758 -179.785 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 16.6 p -134.25 169.46 17.17 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.288 -0.882 . . . . 0.0 109.426 179.842 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 92.32 8.81 62.45 Favored Glycine 0 N--CA 1.491 2.341 0 N-CA-C 109.48 -1.448 . . . . 0.0 109.48 179.976 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 29.2 tttm -73.13 133.26 44.05 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.252 -1.146 . . . . 0.0 109.47 -179.994 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 N--CA 1.49 1.562 0 CA-C-O 118.017 -0.992 . . . . 0.0 109.447 179.999 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 35' ' ' ALA . . . . . 0.411 ' HA ' ' HD2' ' A' ' 36' ' ' PRO . . . . . . . . 0 N--CA 1.49 1.571 0 N-CA-C 109.485 -0.561 . . . . 0.0 109.485 . . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 36' ' ' PRO . . . . . 0.411 ' HD2' ' HA ' ' A' ' 35' ' ' ALA . 48.9 Cg_endo -69.69 149.99 68.04 Favored 'Trans proline' 0 C--O 1.214 -0.718 0 C-N-CA 122.796 2.331 . . . . 0.0 111.72 -179.936 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 37' ' ' ARG . . . . . 0.553 ' C ' HD13 ' A' ' 114' ' ' LEU . 79.1 mtm180 -102.1 -7.94 21.84 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.266 -0.896 . . . . 0.0 109.525 179.985 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 38' ' ' LYS . . . . . 0.508 ' O ' ' CD1' ' A' ' 65' ' ' ILE . 43.7 mttp -69.89 -173.81 0.68 Allowed 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.191 -0.943 . . . . 0.0 109.443 179.939 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 39' ' ' GLY . . . . . 0.864 ' HA3' HD11 ' A' ' 65' ' ' ILE . . . 148.16 99.78 0.23 Allowed Glycine 0 N--CA 1.49 2.29 0 N-CA-C 109.569 -1.412 . . . . 0.0 109.569 179.93 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 40' ' ' ASN . . . . . 0.456 ' N ' ' O ' ' A' ' 80' ' ' TYR . 45.9 t30 -95.66 102.29 14.07 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.109 -1.23 . . . . 0.0 109.605 179.873 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 41' ' ' THR . . . . . 0.456 ' OG1' ' HB2' ' A' ' 111' ' ' GLN . 36.2 m -72.46 127.76 33.55 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.18 -0.95 . . . . 0.0 109.48 -179.977 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 42' ' ' LEU . . . . . 0.77 HD13 HG23 ' A' ' 90' ' ' VAL . 13.3 mt -106.44 145.92 31.17 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.195 -0.941 . . . . 0.0 109.478 -179.989 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 85.3 t80 -96.76 117.6 31.41 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.216 -0.927 . . . . 0.0 109.42 179.98 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 44' ' ' VAL . . . . . 0.464 ' HA ' ' O ' ' A' ' 104' ' ' LYS . 63.8 t -113.79 138.99 41.68 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.547 0 O-C-N 121.214 -0.929 . . . . 0.0 109.504 179.981 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 45' ' ' TYR . . . . . 0.435 ' HB3' ' HB2' ' A' ' 104' ' ' LYS . 70.4 t80 -124.5 135.32 53.11 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.273 -0.892 . . . . 0.0 109.49 179.99 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -177.6 -174.87 44.34 Favored Glycine 0 N--CA 1.491 2.353 0 N-CA-C 109.484 -1.447 . . . . 0.0 109.484 -179.951 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 95.5 mt-10 -123.57 157.51 33.5 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.237 -1.155 . . . . 0.0 109.483 -179.98 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 58.3 t0 45.96 46.59 12.44 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.287 -0.883 . . . . 0.0 109.516 179.933 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 70.7 mtm -94.48 143.85 26.07 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.291 -0.881 . . . . 0.0 109.495 179.966 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 50' ' ' THR . . . . . 0.709 ' O ' HD12 ' A' ' 54' ' ' LEU . 2.5 p -120.9 163.99 26.2 Favored Pre-proline 0 N--CA 1.489 1.51 0 O-C-N 121.223 -0.923 . . . . 0.0 109.43 -179.958 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 51' ' ' PRO . . . . . 0.471 ' HD2' ' HB ' ' A' ' 50' ' ' THR . 49.1 Cg_endo -69.41 -52.76 0.33 Allowed 'Trans proline' 0 C--O 1.216 -0.607 0 C-N-CA 122.672 2.248 . . . . 0.0 111.761 179.992 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 56.3 m -57.54 -46.67 83.6 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.22 -0.925 . . . . 0.0 109.319 179.965 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 17.0 tp -58.57 -55.55 33.61 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.285 -0.884 . . . . 0.0 109.299 179.872 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 54' ' ' LEU . . . . . 0.709 HD12 ' O ' ' A' ' 50' ' ' THR . 9.0 mt -54.07 -42.99 69.9 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.267 -0.896 . . . . 0.0 109.285 179.806 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 55' ' ' ARG . . . . . 0.476 ' O ' ' N ' ' A' ' 59' ' ' SER . 32.4 ttt85 -51.66 -39.34 57.98 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.22 -0.925 . . . . 0.0 109.29 179.85 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 56' ' ' GLY . . . . . 0.435 ' HA2' ' HB2' ' A' ' 59' ' ' SER . . . -70.34 -31.43 68.68 Favored Glycine 0 N--CA 1.488 2.16 0 N-CA-C 109.436 -1.466 . . . . 0.0 109.436 179.898 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 57' ' ' ALA . . . . . 0.505 ' O ' ' CD2' ' A' ' 61' ' ' PHE . . . -72.85 -17.03 61.58 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.239 -1.153 . . . . 0.0 109.453 -179.958 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 58' ' ' PHE . . . . . 0.688 ' HB2' HD11 ' A' ' 64' ' ' ILE . 97.9 m-85 -126.54 5.34 6.84 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.238 -0.914 . . . . 0.0 109.349 179.855 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 59' ' ' SER . . . . . 0.544 ' N ' ' HD2' ' A' ' 60' ' ' PRO . 0.4 OUTLIER -74.04 -55.89 2.91 Favored Pre-proline 0 N--CA 1.49 1.565 0 O-C-N 121.249 -0.907 . . . . 0.0 109.989 -179.761 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 60' ' ' PRO . . . . . 0.544 ' HD2' ' N ' ' A' ' 59' ' ' SER . 49.5 Cg_endo -70.08 -34.15 14.05 Favored 'Trans proline' 0 C--O 1.215 -0.644 0 C-N-CA 122.51 2.14 . . . . 0.0 112.04 -179.553 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 61' ' ' PHE . . . . . 0.579 ' CE1' ' HB3' ' A' ' 92' ' ' GLU . 73.4 m-85 -58.91 -42.71 90.26 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.175 -0.953 . . . . 0.0 109.52 -179.947 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 62' ' ' GLY . . . . . 0.459 ' HA3' ' OG ' ' A' ' 85' ' ' SER . . . -178.79 179.88 48.71 Favored Glycine 0 N--CA 1.49 2.289 0 N-CA-C 109.469 -1.452 . . . . 0.0 109.469 179.996 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 39.8 t30 -85.29 140.9 30.47 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.276 -1.132 . . . . 0.0 109.462 179.987 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 64' ' ' ILE . . . . . 0.688 HD11 ' HB2' ' A' ' 58' ' ' PHE . 68.2 mt -103.92 134.22 45.77 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 O-C-N 121.223 -0.923 . . . . 0.0 109.427 -179.982 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 65' ' ' ILE . . . . . 0.864 HD11 ' HA3' ' A' ' 39' ' ' GLY . 23.7 pt -97.56 -20.67 5.55 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.538 0 O-C-N 121.277 -0.89 . . . . 0.0 109.548 -179.928 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 54.4 t0 -160.64 106.13 1.45 Allowed 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.215 -0.928 . . . . 0.0 109.514 -179.947 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 67' ' ' LEU . . . . . 1.028 HD11 HG22 ' A' ' 78' ' ' VAL . 0.6 OUTLIER -111.7 120.23 41.34 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.293 -0.879 . . . . 0.0 109.355 179.881 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 19.9 m -118.57 152.39 36.09 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.306 -0.871 . . . . 0.0 109.641 -179.945 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 69' ' ' MET . . . . . 0.471 ' SD ' ' CA ' ' A' ' 51' ' ' PRO . 91.9 mtp -121.02 140.95 51.22 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.297 -0.877 . . . . 0.0 109.46 -179.987 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 70' ' ' ASP . . . . . 0.473 ' C ' ' HD2' ' A' ' 72' ' ' PRO . 0.4 OUTLIER -119.38 105.7 43.73 Favored Pre-proline 0 N--CA 1.491 1.6 0 O-C-N 121.2 -0.937 . . . . 0.0 109.458 179.971 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 71' ' ' PRO . . . . . 0.601 ' N ' ' CD ' ' A' ' 72' ' ' PRO . 48.0 Cg_endo -74.6 -27.78 10.51 Favored 'Trans proline' 0 CA--C 1.542 0.893 0 C-N-CA 122.569 2.18 . . . . 0.0 113.653 179.939 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 72' ' ' PRO . . . . . 0.601 ' CD ' ' N ' ' A' ' 71' ' ' PRO . 55.2 Cg_endo -75.58 -39.59 0.99 Allowed 'Trans proline' 0 C--N 1.352 0.718 0 C-N-CA 121.479 1.453 . . . . 0.0 111.718 -179.879 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 73' ' ' ARG . . . . . 0.454 ' HG2' ' O ' ' A' ' 73' ' ' ARG . 57.4 ttt85 -93.84 -3.89 51.11 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.29 -0.881 . . . . 0.0 109.559 -179.885 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 71.7 m-20 60.15 46.41 10.57 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.183 -0.948 . . . . 0.0 109.388 179.96 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 75' ' ' CYS . . . . . 0.457 ' HA ' ' O ' ' A' ' 44' ' ' VAL . 24.1 p -146.12 143.45 29.34 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.231 -0.918 . . . . 0.0 109.468 179.938 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -111.22 156.32 21.62 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.257 -0.902 . . . . 0.0 109.585 -179.939 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 77' ' ' PHE . . . . . 0.442 ' HA ' ' O ' ' A' ' 42' ' ' LEU . 97.3 m-85 -119.32 131.9 55.8 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.266 -0.896 . . . . 0.0 109.436 179.99 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 78' ' ' VAL . . . . . 1.028 HG22 HD11 ' A' ' 67' ' ' LEU . 47.2 t -125.42 120.78 58.78 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.619 0 O-C-N 121.193 -0.942 . . . . 0.0 109.533 -179.958 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 79' ' ' THR . . . . . 0.562 HG22 ' CA ' ' A' ' 39' ' ' GLY . 17.3 m -95.12 132.59 39.86 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.244 -0.91 . . . . 0.0 109.436 179.94 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 80' ' ' TYR . . . . . 0.513 ' CE1' ' OG ' ' A' ' 85' ' ' SER . 2.0 m-85 -114.06 140.55 48.37 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.253 -0.904 . . . . 0.0 109.648 -179.862 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 81.2 tt0 -60.21 -30.07 69.13 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.326 -0.859 . . . . 0.0 109.665 -179.973 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 40.7 mttm -131.88 150.53 52.12 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.1 -1.0 . . . . 0.0 109.611 -179.922 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 83' ' ' MET . . . . . 0.859 ' HE2' ' HB3' ' A' ' 116' ' ' ALA . 54.0 mtt -66.67 -18.92 65.62 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.364 -0.835 . . . . 0.0 109.582 -179.997 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 98.7 mt-10 -64.39 -44.54 90.98 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.296 -0.877 . . . . 0.0 109.557 -179.86 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 85' ' ' SER . . . . . 0.513 ' OG ' ' CE1' ' A' ' 80' ' ' TYR . 43.6 t -61.51 -31.15 71.14 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.19 -0.944 . . . . 0.0 109.549 -179.89 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 86' ' ' ALA . . . . . 0.497 ' HA ' HD11 ' A' ' 42' ' ' LEU . . . -74.53 -31.03 62.0 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.237 -0.914 . . . . 0.0 109.647 -179.85 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 87' ' ' ASP . . . . . 0.423 ' O ' ' CB ' ' A' ' 91' ' ' ALA . 59.4 t0 -67.96 -49.39 62.02 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.21 -0.931 . . . . 0.0 109.559 -179.982 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 88' ' ' GLN . . . . . 0.438 ' HG2' ' CE1' ' A' ' 61' ' ' PHE . 62.9 tt0 -67.77 -36.78 81.11 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.251 -0.906 . . . . 0.0 109.524 -179.939 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 89' ' ' ALA . . . . . 0.57 ' HA ' ' CE1' ' A' ' 61' ' ' PHE . . . -75.7 -51.18 13.31 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.229 -0.919 . . . . 0.0 109.556 -179.928 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 90' ' ' VAL . . . . . 0.789 ' HA ' HG11 ' A' ' 105' ' ' VAL . 92.9 t -65.08 -33.67 65.32 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.545 0 O-C-N 121.321 -0.862 . . . . 0.0 109.552 -179.932 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 91' ' ' ALA . . . . . 0.423 ' CB ' ' O ' ' A' ' 87' ' ' ASP . . . -79.98 -45.25 18.77 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.31 -0.869 . . . . 0.0 109.663 -179.937 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 92' ' ' GLU . . . . . 0.579 ' HB3' ' CE1' ' A' ' 61' ' ' PHE . 34.0 tt0 -75.26 -46.87 30.89 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.255 -0.903 . . . . 0.0 109.658 -179.831 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 93' ' ' LEU . . . . . 0.773 ' HB2' HG21 ' A' ' 105' ' ' VAL . 42.5 mt -64.42 -41.84 96.38 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.206 -0.934 . . . . 0.0 109.606 -179.779 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 94' ' ' ASN . . . . . 0.492 ' CB ' ' O ' ' A' ' 90' ' ' VAL . 46.8 t30 -64.26 126.69 28.57 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.197 -0.939 . . . . 0.0 109.542 -179.93 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 91.78 25.87 21.43 Favored Glycine 0 N--CA 1.49 2.3 0 N-CA-C 109.556 -1.417 . . . . 0.0 109.556 179.966 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 96' ' ' THR . . . . . 0.637 HG23 ' O ' ' A' ' 93' ' ' LEU . 17.1 p -121.04 160.63 23.2 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.149 -1.206 . . . . 0.0 109.471 179.94 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 64.0 tt0 -130.38 149.92 51.84 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.257 -0.902 . . . . 0.0 109.477 -179.938 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 98' ' ' VAL . . . . . 0.547 HG23 ' O ' ' A' ' 101' ' ' VAL . 1.1 t -97.73 -151.3 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.609 0 O-C-N 121.315 -0.866 . . . . 0.0 109.357 -179.932 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 99' ' ' GLU . . . . . 0.513 ' H ' HG12 ' A' ' 98' ' ' VAL . 96.0 mt-10 -53.84 -38.43 64.65 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.202 -0.936 . . . . 0.0 109.529 -179.947 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 19.2 m -164.0 30.35 0.08 Allowed 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.268 -0.895 . . . . 0.0 109.521 179.965 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 101' ' ' VAL . . . . . 0.547 ' O ' HG23 ' A' ' 98' ' ' VAL . 59.7 t -144.78 144.17 22.15 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.516 0 O-C-N 121.21 -0.931 . . . . 0.0 109.487 -179.987 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 87.1 mt-30 -94.09 150.53 20.25 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.241 -0.912 . . . . 0.0 109.373 179.97 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 88.3 mt -117.29 134.99 54.16 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.205 -0.935 . . . . 0.0 109.499 -179.954 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 104' ' ' LYS . . . . . 0.464 ' O ' ' HA ' ' A' ' 44' ' ' VAL . 23.1 mttm -113.66 135.13 54.26 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.279 -0.888 . . . . 0.0 109.351 179.936 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 105' ' ' VAL . . . . . 0.789 HG11 ' HA ' ' A' ' 90' ' ' VAL . 21.2 t -118.83 139.28 46.72 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.551 0 O-C-N 121.172 -0.955 . . . . 0.0 109.541 -179.982 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 106' ' ' ASN . . . . . 0.444 ' OD1' ' O ' ' A' ' 105' ' ' VAL . 97.2 m-20 -143.57 -175.86 4.73 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.194 -0.941 . . . . 0.0 109.376 179.956 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 51.0 mt -100.01 135.61 34.96 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.511 0 O-C-N 121.234 -0.916 . . . . 0.0 109.596 -179.965 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -116.17 144.87 43.6 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.331 -0.856 . . . . 0.0 109.474 179.982 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 94.4 mtt180 -110.16 26.29 10.83 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.2 -0.937 . . . . 0.0 109.507 179.993 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 24.7 mttt -87.25 13.94 8.73 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.227 -0.921 . . . . 0.0 109.426 179.924 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 111' ' ' GLN . . . . . 0.491 ' HG2' ' O ' ' A' ' 39' ' ' GLY . 4.5 tp-100 -120.46 71.02 17.55 Favored Pre-proline 0 N--CA 1.49 1.541 0 O-C-N 121.219 -0.926 . . . . 0.0 109.701 -179.901 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 112' ' ' PRO . . . . . 0.427 ' O ' ' C ' ' A' ' 113' ' ' MET . 51.9 Cg_endo -72.63 -17.73 26.03 Favored 'Trans proline' 0 C--O 1.215 -0.634 0 C-N-CA 122.625 2.217 . . . . 0.0 110.826 179.485 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 113' ' ' MET . . . . . 0.523 ' HB3' ' HE2' ' A' ' 113' ' ' MET . 0.0 OUTLIER -42.58 -27.98 0.2 Allowed 'General case' 0 C--N 1.303 -1.424 0 N-CA-C 109.122 -0.695 . . . . 0.0 109.122 179.715 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 114' ' ' LEU . . . . . 0.941 HD23 ' O ' ' A' ' 114' ' ' LEU . 2.5 tt -170.18 25.38 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.024 -1.047 . . . . 0.0 110.305 179.885 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 115' ' ' ASP . . . . . 0.701 ' O ' ' HB3' ' A' ' 116' ' ' ALA . 88.0 m-20 41.94 42.06 2.15 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.291 -0.881 . . . . 0.0 109.348 179.927 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 116' ' ' ALA . . . . . 0.859 ' HB3' ' HE2' ' A' ' 83' ' ' MET . . . 78.72 -71.57 0.09 Allowed 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.459 -0.776 . . . . 0.0 110.021 -179.862 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 117' ' ' ALA . . . . . 0.556 ' HA ' ' CD2' ' A' ' 114' ' ' LEU . . . -167.45 -80.03 0.02 OUTLIER 'General case' 0 C--N 1.303 -1.447 0 O-C-N 121.142 -0.974 . . . . 0.0 110.465 -179.29 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 118' ' ' THR . . . . . 0.447 ' OG1' ' HE1' ' A' ' 83' ' ' MET . 55.2 p -54.37 -17.98 3.61 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.124 -0.985 . . . . 0.0 109.802 -179.509 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 119' ' ' GLY . . . . . 0.529 ' HA3' ' CB ' ' A' ' 115' ' ' ASP . . . -51.77 140.55 25.71 Favored Glycine 0 N--CA 1.489 2.232 0 N-CA-C 109.36 -1.496 . . . . 0.0 109.36 179.797 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 120' ' ' LYS . . . . . 0.455 ' HB2' ' O ' ' A' ' 119' ' ' GLY . 60.6 mttp 61.54 45.29 8.37 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.228 -1.16 . . . . 0.0 109.408 -179.964 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 121' ' ' SER . . . . . 0.434 ' OG ' ' O ' ' A' ' 118' ' ' THR . 92.5 p . . . . . 0 N--CA 1.489 1.508 0 CA-C-O 118.032 -0.985 . . . . 0.0 109.487 -179.979 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 35' ' ' ALA . . . . . 0.513 ' N ' ' CD ' ' A' ' 36' ' ' PRO . . . . . . . . 0 N--CA 1.489 1.508 0 N-CA-C 109.473 -0.565 . . . . 0.0 109.473 . . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 36' ' ' PRO . . . . . 0.513 ' CD ' ' N ' ' A' ' 35' ' ' ALA . 49.5 Cg_endo -69.61 -15.4 37.64 Favored 'Trans proline' 0 C--O 1.216 -0.603 0 C-N-CA 122.72 2.28 . . . . 0.0 111.843 -179.956 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 37' ' ' ARG . . . . . 0.478 ' O ' HD11 ' A' ' 114' ' ' LEU . 75.7 mtm-85 -124.25 138.65 54.37 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.2 -0.937 . . . . 0.0 109.523 179.987 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 38' ' ' LYS . . . . . 0.596 ' C ' HD21 ' A' ' 114' ' ' LEU . 39.0 mttt -108.17 -166.72 1.16 Allowed 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.188 -0.945 . . . . 0.0 109.423 179.951 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 39' ' ' GLY . . . . . 0.523 ' HA3' HD22 ' A' ' 114' ' ' LEU . . . -174.17 -178.7 44.29 Favored Glycine 0 N--CA 1.491 2.309 0 N-CA-C 109.789 -1.324 . . . . 0.0 109.789 179.942 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 40' ' ' ASN . . . . . 0.624 ' O ' HG23 ' A' ' 79' ' ' THR . 0.8 OUTLIER -162.55 -178.35 6.18 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.163 -1.198 . . . . 0.0 109.311 179.576 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 41' ' ' THR . . . . . 0.604 HG22 ' HB3' ' A' ' 108' ' ' ALA . 8.1 m -139.81 159.18 42.77 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.251 -0.905 . . . . 0.0 109.687 -179.732 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 42' ' ' LEU . . . . . 0.783 HD12 ' O ' ' A' ' 78' ' ' VAL . 4.3 mp -144.78 143.91 30.9 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.279 -0.888 . . . . 0.0 109.469 -179.951 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 43' ' ' TYR . . . . . 0.458 ' HB3' ' HB2' ' A' ' 106' ' ' ASN . 51.7 t80 -105.04 109.79 21.93 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.174 -0.954 . . . . 0.0 109.519 179.925 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 44' ' ' VAL . . . . . 0.425 ' HA ' ' O ' ' A' ' 104' ' ' LYS . 99.8 t -101.16 144.23 13.22 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.518 0 O-C-N 121.346 -0.846 . . . . 0.0 109.481 179.862 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 64.6 t80 -135.86 134.81 39.21 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.303 -0.873 . . . . 0.0 109.425 -179.852 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 176.09 -166.0 36.88 Favored Glycine 0 N--CA 1.49 2.257 0 N-CA-C 109.453 -1.459 . . . . 0.0 109.453 179.918 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 47' ' ' GLU . . . . . 0.422 ' O ' ' C ' ' A' ' 48' ' ' ASP . 94.0 mt-10 -126.04 158.04 36.37 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.288 -1.125 . . . . 0.0 109.396 180.0 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 48' ' ' ASP . . . . . 0.422 ' C ' ' O ' ' A' ' 47' ' ' GLU . 51.7 m-20 44.38 48.85 8.15 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.174 -0.954 . . . . 0.0 109.486 -179.993 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 63.5 mtm -101.41 141.12 34.75 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.228 -0.92 . . . . 0.0 109.462 -179.976 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 50' ' ' THR . . . . . 0.602 ' O ' HD12 ' A' ' 54' ' ' LEU . 0.6 OUTLIER -122.12 167.28 14.29 Favored Pre-proline 0 N--CA 1.49 1.531 0 O-C-N 121.211 -0.931 . . . . 0.0 109.422 179.965 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 51' ' ' PRO . . . . . 0.471 ' CB ' HD21 ' A' ' 67' ' ' LEU . 49.5 Cg_endo -70.43 -55.0 0.17 Allowed 'Trans proline' 0 C--O 1.215 -0.664 0 C-N-CA 122.643 2.228 . . . . 0.0 111.864 180.0 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 35.3 m -51.88 -47.0 64.73 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.175 -0.953 . . . . 0.0 109.147 179.906 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 23.5 tp -59.46 -50.27 74.56 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.258 -0.901 . . . . 0.0 109.143 179.788 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 54' ' ' LEU . . . . . 0.602 HD12 ' O ' ' A' ' 50' ' ' THR . 8.1 mt -55.57 -48.7 74.36 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.309 -0.87 . . . . 0.0 109.175 179.705 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 55' ' ' ARG . . . . . 0.518 ' O ' ' N ' ' A' ' 59' ' ' SER . 93.5 mtt-85 -49.18 -37.04 21.24 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.275 -0.89 . . . . 0.0 109.229 179.824 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -69.38 -35.01 75.28 Favored Glycine 0 N--CA 1.489 2.223 0 N-CA-C 109.454 -1.458 . . . . 0.0 109.454 179.945 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 57' ' ' ALA . . . . . 0.511 ' O ' HD11 ' A' ' 93' ' ' LEU . . . -75.87 -22.83 55.77 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.217 -1.166 . . . . 0.0 109.362 179.925 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 58' ' ' PHE . . . . . 0.882 ' CE1' HD12 ' A' ' 93' ' ' LEU . 95.7 m-85 -116.63 9.54 14.15 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.287 -0.883 . . . . 0.0 109.328 179.825 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 59' ' ' SER . . . . . 0.562 ' N ' ' HD2' ' A' ' 60' ' ' PRO . 0.8 OUTLIER -76.92 -52.72 1.91 Allowed Pre-proline 0 N--CA 1.49 1.556 0 O-C-N 121.293 -0.879 . . . . 0.0 110.619 -179.506 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 60' ' ' PRO . . . . . 0.562 ' HD2' ' N ' ' A' ' 59' ' ' SER . 48.8 Cg_endo -70.45 -33.35 14.13 Favored 'Trans proline' 0 C--O 1.215 -0.658 0 C-N-CA 122.336 2.024 . . . . 0.0 112.526 -179.023 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 61' ' ' PHE . . . . . 0.73 ' CE2' HD21 ' A' ' 93' ' ' LEU . 78.1 m-85 -63.41 -36.64 84.39 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 120.983 -1.073 . . . . 0.0 109.648 -179.838 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 62' ' ' GLY . . . . . 0.452 ' HA3' ' OG ' ' A' ' 85' ' ' SER . . . 179.22 -176.98 48.21 Favored Glycine 0 N--CA 1.49 2.247 0 N-CA-C 109.447 -1.461 . . . . 0.0 109.447 179.952 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 78.9 m-20 -93.22 138.53 31.53 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.266 -1.138 . . . . 0.0 109.577 179.99 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 64' ' ' ILE . . . . . 0.901 HG23 ' O ' ' A' ' 79' ' ' THR . 41.1 mt -99.19 140.01 19.64 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.555 0 O-C-N 121.273 -0.892 . . . . 0.0 109.397 -179.989 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 22.3 pt -103.63 -19.3 6.29 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 O-C-N 121.204 -0.935 . . . . 0.0 109.705 -179.763 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 66' ' ' ASP . . . . . 0.462 ' HB3' ' OG1' ' A' ' 79' ' ' THR . 21.7 t70 -152.18 126.42 9.25 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.228 -0.92 . . . . 0.0 109.405 179.946 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 67' ' ' LEU . . . . . 0.471 HD21 ' CB ' ' A' ' 51' ' ' PRO . 8.3 tp -111.46 122.51 48.03 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.298 -0.876 . . . . 0.0 109.345 -179.965 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 68' ' ' SER . . . . . 0.459 ' HB3' ' HB2' ' A' ' 77' ' ' PHE . 26.5 t -126.21 139.19 53.54 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.328 -0.857 . . . . 0.0 109.412 -179.926 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 69' ' ' MET . . . . . 0.415 ' HA ' ' HA ' ' A' ' 76' ' ' ALA . 86.7 mtp -127.7 150.99 49.53 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.306 -0.872 . . . . 0.0 109.467 179.946 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 70' ' ' ASP . . . . . 0.469 ' C ' ' HD2' ' A' ' 72' ' ' PRO . 10.6 t70 -129.15 101.67 19.33 Favored Pre-proline 0 N--CA 1.491 1.577 0 O-C-N 121.276 -0.89 . . . . 0.0 109.447 179.986 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 71' ' ' PRO . . . . . 0.592 ' N ' ' CD ' ' A' ' 72' ' ' PRO . 47.5 Cg_endo -74.93 -27.89 9.77 Favored 'Trans proline' 0 CA--C 1.544 0.985 0 C-N-CA 122.561 2.174 . . . . 0.0 113.733 -179.863 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 72' ' ' PRO . . . . . 0.592 ' CD ' ' N ' ' A' ' 71' ' ' PRO . 55.4 Cg_endo -75.15 -20.63 16.38 Favored 'Trans proline' 0 C--N 1.352 0.728 0 C-N-CA 121.471 1.447 . . . . 0.0 111.803 -179.699 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 73' ' ' ARG . . . . . 0.454 ' N ' ' OD1' ' A' ' 70' ' ' ASP . 93.6 mtt180 -113.59 0.44 14.64 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.258 -0.901 . . . . 0.0 109.698 -179.899 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 74' ' ' ASN . . . . . 0.437 ' HB2' ' O ' ' A' ' 73' ' ' ARG . 81.7 m-20 61.19 41.83 12.96 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.247 -0.908 . . . . 0.0 109.493 179.938 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 75' ' ' CYS . . . . . 0.465 ' SG ' ' HB3' ' A' ' 70' ' ' ASP . 21.7 p -144.19 147.97 34.36 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.186 -0.946 . . . . 0.0 109.452 179.941 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 76' ' ' ALA . . . . . 0.415 ' HA ' ' HA ' ' A' ' 69' ' ' MET . . . -121.89 149.15 43.81 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.247 -0.908 . . . . 0.0 109.408 -179.954 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 77' ' ' PHE . . . . . 0.459 ' HB2' ' HB3' ' A' ' 68' ' ' SER . 90.9 m-85 -114.02 137.99 50.97 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.234 -0.916 . . . . 0.0 109.379 -179.973 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 78' ' ' VAL . . . . . 0.783 ' O ' HD12 ' A' ' 42' ' ' LEU . 61.7 t -123.76 145.3 31.02 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.491 0 O-C-N 121.145 -0.972 . . . . 0.0 109.615 -179.884 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 79' ' ' THR . . . . . 0.901 ' O ' HG23 ' A' ' 64' ' ' ILE . 1.3 m -113.99 130.77 56.51 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.316 -0.865 . . . . 0.0 108.995 179.886 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 80' ' ' TYR . . . . . 0.514 ' O ' ' HA2' ' A' ' 39' ' ' GLY . 0.9 OUTLIER -112.22 132.37 54.96 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.168 -0.958 . . . . 0.0 109.805 -179.665 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 81' ' ' GLU . . . . . 0.433 ' C ' ' HA2' ' A' ' 39' ' ' GLY . 86.7 tt0 -43.04 -25.81 0.12 Allowed 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.448 -0.782 . . . . 0.0 109.766 179.81 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 82' ' ' LYS . . . . . 0.425 ' N ' ' O ' ' A' ' 80' ' ' TYR . 34.6 mtmm -142.95 164.2 30.72 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.1 -1.0 . . . . 0.0 109.403 179.95 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 83' ' ' MET . . . . . 0.593 ' CE ' ' N ' ' A' ' 117' ' ' ALA . 15.8 mtt -80.41 -12.95 59.51 Favored 'General case' 0 N--CA 1.487 1.42 0 O-C-N 121.267 -0.895 . . . . 0.0 109.49 179.874 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 95.1 mt-10 -73.99 -40.75 62.74 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.243 -0.91 . . . . 0.0 109.183 179.722 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 85' ' ' SER . . . . . 0.452 ' OG ' ' HA3' ' A' ' 62' ' ' GLY . 10.9 t -66.78 -39.33 87.77 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.34 -0.85 . . . . 0.0 109.258 179.744 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 86' ' ' ALA . . . . . 0.795 ' O ' HG23 ' A' ' 90' ' ' VAL . . . -72.08 -23.97 61.43 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.433 -0.792 . . . . 0.0 109.24 -179.943 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 65.1 m-20 -72.97 -48.3 37.8 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.352 -0.843 . . . . 0.0 109.504 179.911 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 57.6 tt0 -68.41 -37.9 80.75 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.297 -0.877 . . . . 0.0 109.633 -179.96 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 89' ' ' ALA . . . . . 0.452 ' HA ' ' CD1' ' A' ' 61' ' ' PHE . . . -69.07 -41.35 77.66 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.213 -0.93 . . . . 0.0 109.513 -179.883 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 90' ' ' VAL . . . . . 0.795 HG23 ' O ' ' A' ' 86' ' ' ALA . 53.1 t -62.09 -33.21 57.33 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.535 0 O-C-N 121.205 -0.935 . . . . 0.0 109.627 -179.933 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -79.41 -48.16 14.46 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.231 -0.918 . . . . 0.0 109.856 -179.684 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 92' ' ' GLU . . . . . 0.58 ' HB2' ' CE1' ' A' ' 61' ' ' PHE . 75.6 mm-40 -73.72 -43.11 60.09 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.175 -0.953 . . . . 0.0 109.994 -179.405 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 93' ' ' LEU . . . . . 0.946 ' HB2' HG21 ' A' ' 105' ' ' VAL . 21.9 mt -69.6 -39.32 77.34 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.16 -0.962 . . . . 0.0 109.753 -179.655 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 94' ' ' ASN . . . . . 0.521 ' CB ' ' O ' ' A' ' 90' ' ' VAL . 51.4 t-20 -72.54 120.05 17.61 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.15 -0.968 . . . . 0.0 109.569 -179.995 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 102.03 26.61 7.37 Favored Glycine 0 N--CA 1.49 2.249 0 N-CA-C 109.493 -1.443 . . . . 0.0 109.493 179.971 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 96' ' ' THR . . . . . 0.493 ' CG2' ' O ' ' A' ' 92' ' ' GLU . 11.1 p -125.65 154.52 42.21 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.28 -1.13 . . . . 0.0 109.429 -179.957 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 63.2 tt0 -128.47 138.38 52.26 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.277 -0.89 . . . . 0.0 109.516 179.977 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 98' ' ' VAL . . . . . 0.479 HG23 ' O ' ' A' ' 101' ' ' VAL . 1.3 t -80.13 -148.48 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 O-C-N 121.286 -0.884 . . . . 0.0 109.396 -179.97 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 99' ' ' GLU . . . . . 0.473 ' H ' HG12 ' A' ' 98' ' ' VAL . 96.5 mt-10 -63.2 -39.2 93.96 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.271 -0.893 . . . . 0.0 109.435 179.986 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 1.2 m -155.99 25.52 0.37 Allowed 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.276 -0.89 . . . . 0.0 109.451 179.956 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 101' ' ' VAL . . . . . 0.479 ' O ' HG23 ' A' ' 98' ' ' VAL . 57.4 t -139.59 145.07 27.45 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.552 0 O-C-N 121.308 -0.87 . . . . 0.0 109.373 179.922 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 47.0 tt0 -103.11 138.72 39.57 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.221 -0.924 . . . . 0.0 109.666 -179.837 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 67.7 mt -110.23 142.97 41.07 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.217 -0.927 . . . . 0.0 109.375 179.883 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 104' ' ' LYS . . . . . 0.425 ' O ' ' HA ' ' A' ' 44' ' ' VAL . 44.7 mttp -125.76 124.23 40.56 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.267 -0.896 . . . . 0.0 109.437 179.917 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 105' ' ' VAL . . . . . 0.946 HG21 ' HB2' ' A' ' 93' ' ' LEU . 14.3 t -107.95 149.75 11.07 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.568 0 O-C-N 121.205 -0.934 . . . . 0.0 109.561 -179.886 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 106' ' ' ASN . . . . . 0.458 ' HB2' ' HB3' ' A' ' 43' ' ' TYR . 82.1 m-20 -157.03 -166.05 1.99 Allowed 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.294 -0.879 . . . . 0.0 109.389 179.88 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 27.4 mm -108.0 126.03 64.55 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.523 0 O-C-N 121.185 -0.947 . . . . 0.0 109.519 -179.975 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 108' ' ' ALA . . . . . 0.604 ' HB3' HG22 ' A' ' 41' ' ' THR . . . -101.07 169.3 9.03 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.309 -0.869 . . . . 0.0 109.409 179.926 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 109' ' ' ARG . . . . . 0.404 ' NH1' ' HG2' ' A' ' 109' ' ' ARG . 34.8 mtp85 -46.32 151.29 0.54 Allowed 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.216 -0.927 . . . . 0.0 109.432 179.942 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 110' ' ' LYS . . . . . 0.405 ' HB3' ' HB2' ' A' ' 116' ' ' ALA . 31.3 mttp -76.21 113.15 13.45 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.215 -0.928 . . . . 0.0 109.505 -179.957 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 111' ' ' GLN . . . . . 0.551 ' HG3' ' HE1' ' A' ' 113' ' ' MET . 0.0 OUTLIER -55.04 125.89 58.33 Favored Pre-proline 0 N--CA 1.489 1.478 0 O-C-N 121.262 -0.899 . . . . 0.0 109.478 -179.904 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 52.2 Cg_endo -72.26 -30.41 12.99 Favored 'Trans proline' 0 C--O 1.216 -0.622 0 C-N-CA 122.603 2.202 . . . . 0.0 111.679 -179.906 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 113' ' ' MET . . . . . 0.559 ' CE ' ' HB3' ' A' ' 114' ' ' LEU . 0.0 OUTLIER -45.79 -24.53 0.39 Allowed 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.307 -0.871 . . . . 0.0 109.57 179.901 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 114' ' ' LEU . . . . . 0.648 HD23 ' O ' ' A' ' 114' ' ' LEU . 2.1 tt -146.29 24.02 1.29 Allowed 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.082 -1.011 . . . . 0.0 109.824 -179.937 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 115' ' ' ASP . . . . . 0.433 ' C ' ' O ' ' A' ' 114' ' ' LEU . 71.5 m-20 42.7 31.45 0.3 Allowed 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.239 -0.913 . . . . 0.0 109.886 179.814 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 116' ' ' ALA . . . . . 0.58 ' O ' HD23 ' A' ' 114' ' ' LEU . . . 57.83 -89.1 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.168 -0.958 . . . . 0.0 109.988 179.786 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 117' ' ' ALA . . . . . 0.593 ' N ' ' CE ' ' A' ' 83' ' ' MET . . . -177.69 30.61 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.49 0 O-C-N 120.94 -1.1 . . . . 0.0 109.789 -179.701 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 118' ' ' THR . . . . . 0.574 HG23 ' HE3' ' A' ' 83' ' ' MET . 22.3 p -112.57 161.52 16.69 Favored 'General case' 0 C--N 1.302 -1.468 0 O-C-N 121.088 -1.007 . . . . 0.0 109.732 -179.752 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 97.45 167.58 32.58 Favored Glycine 0 N--CA 1.49 2.248 0 N-CA-C 109.55 -1.42 . . . . 0.0 109.55 179.916 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 120' ' ' LYS . . . . . 0.433 ' O ' ' HB3' ' A' ' 121' ' ' SER . 62.0 tttm -58.62 -38.43 78.02 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.219 -1.165 . . . . 0.0 109.461 179.923 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 121' ' ' SER . . . . . 0.433 ' HB3' ' O ' ' A' ' 120' ' ' LYS . 1.3 p . . . . . 0 N--CA 1.49 1.536 0 CA-C-O 117.948 -1.025 . . . . 0.0 109.494 179.954 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 35' ' ' ALA . . . . . 0.62 ' HB3' ' HG2' ' A' ' 113' ' ' MET . . . . . . . . 0 N--CA 1.491 1.577 0 N-CA-C 109.511 -0.552 . . . . 0.0 109.511 . . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 48.7 Cg_endo -69.65 -4.2 13.47 Favored 'Trans proline' 0 C--O 1.215 -0.669 0 C-N-CA 122.68 2.254 . . . . 0.0 111.939 -179.957 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 37' ' ' ARG . . . . . 0.546 ' O ' HD13 ' A' ' 114' ' ' LEU . 82.0 mtm180 -125.89 145.78 50.11 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.19 -0.944 . . . . 0.0 109.558 -179.977 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 38' ' ' LYS . . . . . 0.887 ' HA ' HD22 ' A' ' 114' ' ' LEU . 18.9 mttm -79.45 -163.09 0.47 Allowed 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.351 -0.843 . . . . 0.0 109.612 -179.876 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 39' ' ' GLY . . . . . 0.639 ' O ' ' HB2' ' A' ' 117' ' ' ALA . . . 178.72 -160.54 26.39 Favored Glycine 0 N--CA 1.49 2.292 0 N-CA-C 109.598 -1.401 . . . . 0.0 109.598 -179.925 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 40' ' ' ASN . . . . . 0.45 ' HB2' ' O ' ' A' ' 39' ' ' GLY . 0.6 OUTLIER 178.25 113.83 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.291 -1.123 . . . . 0.0 109.571 179.74 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 41' ' ' THR . . . . . 0.595 ' O ' HD23 ' A' ' 42' ' ' LEU . 40.1 m -80.72 136.71 36.21 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.24 -0.913 . . . . 0.0 109.34 179.859 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 42' ' ' LEU . . . . . 0.852 HD11 ' CD2' ' A' ' 80' ' ' TYR . 8.5 mt -120.18 157.58 28.76 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.205 -0.935 . . . . 0.0 109.614 -179.945 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 43' ' ' TYR . . . . . 0.489 ' CZ ' ' HB2' ' A' ' 75' ' ' CYS . 74.6 t80 -116.92 121.76 42.37 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.317 -0.865 . . . . 0.0 109.269 179.83 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 44' ' ' VAL . . . . . 0.773 HG13 HD23 ' A' ' 103' ' ' LEU . 61.8 t -116.21 134.17 60.41 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.479 0 O-C-N 121.167 -0.958 . . . . 0.0 109.572 -179.902 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 60.7 t80 -121.49 142.4 50.09 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.287 -0.883 . . . . 0.0 109.488 -179.976 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 173.97 -178.97 45.63 Favored Glycine 0 N--CA 1.491 2.338 0 N-CA-C 109.485 -1.446 . . . . 0.0 109.485 179.958 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 47' ' ' GLU . . . . . 0.411 ' O ' ' C ' ' A' ' 48' ' ' ASP . 92.7 mt-10 -111.66 154.93 24.2 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.253 -1.145 . . . . 0.0 109.434 -179.952 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 48' ' ' ASP . . . . . 0.411 ' C ' ' O ' ' A' ' 47' ' ' GLU . 43.4 m-20 43.99 51.6 6.99 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.212 -0.93 . . . . 0.0 109.488 -179.993 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 49.1 mtm -98.93 142.31 30.6 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.234 -0.916 . . . . 0.0 109.494 179.971 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 50' ' ' THR . . . . . 0.832 ' O ' HD12 ' A' ' 54' ' ' LEU . 0.6 OUTLIER -125.16 166.62 19.57 Favored Pre-proline 0 N--CA 1.49 1.571 0 O-C-N 121.225 -0.922 . . . . 0.0 109.503 179.949 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 51' ' ' PRO . . . . . 0.405 ' HD2' ' HB ' ' A' ' 50' ' ' THR . 49.2 Cg_endo -69.95 -48.21 0.72 Allowed 'Trans proline' 0 C--O 1.216 -0.623 0 C-N-CA 122.718 2.279 . . . . 0.0 111.769 -179.96 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 36.3 m -57.54 -45.74 84.73 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.253 -0.905 . . . . 0.0 109.457 179.985 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 15.6 tp -59.71 -50.28 74.45 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.325 -0.859 . . . . 0.0 109.445 179.84 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 54' ' ' LEU . . . . . 0.832 HD12 ' O ' ' A' ' 50' ' ' THR . 3.5 mt -56.81 -50.16 73.2 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.285 -0.885 . . . . 0.0 109.284 179.897 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 55' ' ' ARG . . . . . 0.506 ' O ' ' N ' ' A' ' 59' ' ' SER . 33.2 mtp180 -46.03 -41.03 11.48 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.172 -0.955 . . . . 0.0 109.262 179.895 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -69.18 -37.78 81.9 Favored Glycine 0 N--CA 1.489 2.229 0 N-CA-C 109.36 -1.496 . . . . 0.0 109.36 179.852 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -72.59 -21.05 61.2 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.245 -1.15 . . . . 0.0 109.394 179.953 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 58' ' ' PHE . . . . . 0.675 ' CZ ' HD13 ' A' ' 93' ' ' LEU . 92.5 m-85 -117.74 8.0 12.63 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.308 -0.87 . . . . 0.0 109.431 179.881 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 59' ' ' SER . . . . . 0.559 ' N ' ' HD2' ' A' ' 60' ' ' PRO . 1.2 t -75.16 -54.45 2.52 Favored Pre-proline 0 N--CA 1.492 1.632 0 O-C-N 121.313 -0.867 . . . . 0.0 110.391 -179.699 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 60' ' ' PRO . . . . . 0.559 ' HD2' ' N ' ' A' ' 59' ' ' SER . 47.4 Cg_endo -68.95 -30.5 26.03 Favored 'Trans proline' 0 C--O 1.215 -0.653 0 C-N-CA 122.456 2.104 . . . . 0.0 112.3 -179.252 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 61' ' ' PHE . . . . . 0.619 ' CB ' ' HB2' ' A' ' 89' ' ' ALA . 60.3 m-85 -66.68 -31.13 71.59 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.119 -0.988 . . . . 0.0 109.471 -179.979 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 168.56 179.15 40.66 Favored Glycine 0 N--CA 1.491 2.308 0 N-CA-C 109.579 -1.408 . . . . 0.0 109.579 179.928 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 37.0 t30 -87.89 134.86 33.62 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.365 -1.079 . . . . 0.0 109.492 -179.979 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 64' ' ' ILE . . . . . 0.656 HD11 ' HB2' ' A' ' 58' ' ' PHE . 33.4 mt -94.05 133.95 33.32 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.508 0 O-C-N 121.23 -0.919 . . . . 0.0 109.476 179.963 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 65' ' ' ILE . . . . . 1.028 HD11 ' OE1' ' A' ' 111' ' ' GLN . 26.1 pt -97.19 -20.71 5.57 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.486 0 O-C-N 121.17 -0.956 . . . . 0.0 109.376 179.911 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 66' ' ' ASP . . . . . 0.479 ' HB3' ' HB ' ' A' ' 79' ' ' THR . 60.9 t0 -138.82 125.96 21.37 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.225 -0.922 . . . . 0.0 109.433 179.854 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 67' ' ' LEU . . . . . 0.758 ' C ' HD13 ' A' ' 67' ' ' LEU . 3.5 tm? -121.26 108.24 13.5 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.209 -0.932 . . . . 0.0 109.355 179.897 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 68' ' ' SER . . . . . 0.476 ' HB2' ' HB2' ' A' ' 77' ' ' PHE . 58.3 m -122.66 149.27 44.25 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.238 -0.914 . . . . 0.0 109.463 -179.964 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 69' ' ' MET . . . . . 0.48 ' SD ' ' CD1' ' A' ' 54' ' ' LEU . 83.8 mmm -123.39 147.68 46.85 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.234 -0.916 . . . . 0.0 109.381 -179.979 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 70' ' ' ASP . . . . . 0.478 ' C ' ' HD2' ' A' ' 72' ' ' PRO . 0.6 OUTLIER -131.64 94.2 26.34 Favored Pre-proline 0 N--CA 1.49 1.541 0 O-C-N 121.252 -0.905 . . . . 0.0 109.483 179.959 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 71' ' ' PRO . . . . . 0.598 ' CD ' ' CD ' ' A' ' 72' ' ' PRO . 47.0 Cg_endo -74.84 -27.77 10.06 Favored 'Trans proline' 0 CA--C 1.543 0.967 0 C-N-CA 122.506 2.137 . . . . 0.0 113.664 -179.974 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 72' ' ' PRO . . . . . 0.598 ' CD ' ' CD ' ' A' ' 71' ' ' PRO . 55.2 Cg_endo -75.3 -22.19 14.55 Favored 'Trans proline' 0 C--N 1.353 0.803 0 C-N-CA 121.49 1.46 . . . . 0.0 111.868 -179.844 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 73' ' ' ARG . . . . . 0.401 ' O ' ' HB2' ' A' ' 74' ' ' ASN . 62.7 mtt180 -112.24 -0.39 15.51 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.167 -0.958 . . . . 0.0 109.65 -179.992 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 74' ' ' ASN . . . . . 0.401 ' HB2' ' O ' ' A' ' 73' ' ' ARG . 59.4 m-20 60.82 45.47 9.8 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.082 -1.011 . . . . 0.0 109.402 -179.981 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 75' ' ' CYS . . . . . 0.489 ' HB2' ' CZ ' ' A' ' 43' ' ' TYR . 23.2 p -152.69 143.07 22.58 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.299 -0.875 . . . . 0.0 109.458 -179.979 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -112.08 156.99 21.33 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.307 -0.871 . . . . 0.0 109.485 179.952 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 77' ' ' PHE . . . . . 0.476 ' HB2' ' HB2' ' A' ' 68' ' ' SER . 97.0 m-85 -118.37 125.58 50.31 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.245 -0.909 . . . . 0.0 109.427 179.858 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 78' ' ' VAL . . . . . 0.485 HG13 HG21 ' A' ' 64' ' ' ILE . 59.6 t -127.11 126.78 68.7 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.546 0 O-C-N 121.234 -0.916 . . . . 0.0 109.489 -179.858 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 79' ' ' THR . . . . . 0.932 HG21 ' OE1' ' A' ' 111' ' ' GLN . 92.3 m -105.59 126.64 52.37 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.334 -0.854 . . . . 0.0 109.446 179.812 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 80' ' ' TYR . . . . . 0.852 ' CD2' HD11 ' A' ' 42' ' ' LEU . 2.3 m-85 -92.41 174.05 7.49 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.227 -0.921 . . . . 0.0 109.169 179.898 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 81' ' ' GLU . . . . . 0.475 ' HG2' ' O ' ' A' ' 81' ' ' GLU . 71.0 tt0 -90.23 -13.56 35.19 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.352 -0.842 . . . . 0.0 109.665 -179.678 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 23.2 mttt -150.08 127.93 11.77 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.051 -1.031 . . . . 0.0 110.018 179.921 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 83' ' ' MET . . . . . 0.885 ' HB3' ' HB3' ' A' ' 117' ' ' ALA . 0.4 OUTLIER -45.83 -24.89 0.44 Allowed 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.458 -0.777 . . . . 0.0 109.88 179.938 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 84' ' ' GLU . . . . . 0.422 ' HG3' ' SD ' ' A' ' 83' ' ' MET . 97.1 mt-10 -67.56 -62.35 1.46 Allowed 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.196 -0.94 . . . . 0.0 109.571 -179.868 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 13.7 m -46.82 -38.26 9.96 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.267 -0.896 . . . . 0.0 109.818 -179.804 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 86' ' ' ALA . . . . . 0.588 ' HB1' HD21 ' A' ' 42' ' ' LEU . . . -69.27 -39.45 78.38 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.161 -0.962 . . . . 0.0 109.751 -179.691 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 52.4 t0 -56.76 -38.31 72.27 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.212 -0.93 . . . . 0.0 109.591 -179.739 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 88' ' ' GLN . . . . . 0.483 ' O ' ' CB ' ' A' ' 92' ' ' GLU . 59.7 tt0 -74.39 -38.49 63.12 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.15 -0.969 . . . . 0.0 109.603 -179.839 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 89' ' ' ALA . . . . . 0.619 ' HB2' ' CB ' ' A' ' 61' ' ' PHE . . . -75.36 -41.95 55.28 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.168 -0.958 . . . . 0.0 109.651 -179.871 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 90' ' ' VAL . . . . . 0.852 ' HA ' HG11 ' A' ' 105' ' ' VAL . 53.9 t -64.68 -48.72 83.51 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 O-C-N 121.257 -0.902 . . . . 0.0 109.634 -179.834 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -72.22 -38.77 68.91 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.272 -0.892 . . . . 0.0 109.702 -179.882 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 92' ' ' GLU . . . . . 0.59 ' HB3' ' CE1' ' A' ' 61' ' ' PHE . 44.5 tp10 -74.4 -45.81 44.29 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.247 -0.908 . . . . 0.0 109.583 -179.876 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 93' ' ' LEU . . . . . 0.675 HD13 ' CZ ' ' A' ' 58' ' ' PHE . 68.0 mt -69.95 -37.76 75.93 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.165 -0.959 . . . . 0.0 109.545 -179.921 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 94' ' ' ASN . . . . . 0.475 ' HB2' ' O ' ' A' ' 90' ' ' VAL . 61.4 t-20 -64.64 129.85 41.39 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.226 -0.921 . . . . 0.0 109.547 -179.967 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 84.77 30.14 27.33 Favored Glycine 0 N--CA 1.489 2.219 0 N-CA-C 109.497 -1.441 . . . . 0.0 109.497 179.973 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 96' ' ' THR . . . . . 0.666 HG23 ' O ' ' A' ' 93' ' ' LEU . 19.7 p -121.27 151.54 39.92 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.261 -1.141 . . . . 0.0 109.468 -179.995 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 61.7 tt0 -116.94 143.73 45.37 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.314 -0.866 . . . . 0.0 109.498 -179.946 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 98' ' ' VAL . . . . . 0.602 HG12 ' H ' ' A' ' 99' ' ' GLU . 1.2 t -90.79 -159.41 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 O-C-N 121.233 -0.917 . . . . 0.0 109.282 179.935 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 99' ' ' GLU . . . . . 0.602 ' H ' HG12 ' A' ' 98' ' ' VAL . 95.9 mt-10 -54.68 -37.71 66.1 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.183 -0.948 . . . . 0.0 109.481 179.968 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 100' ' ' SER . . . . . 0.422 ' O ' ' OG ' ' A' ' 100' ' ' SER . 6.9 t -159.86 25.96 0.18 Allowed 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.198 -0.938 . . . . 0.0 109.554 -179.953 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 101' ' ' VAL . . . . . 0.606 HG12 ' N ' ' A' ' 102' ' ' GLN . 48.7 t -138.03 168.42 20.32 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.546 0 O-C-N 121.219 -0.926 . . . . 0.0 109.434 -179.955 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 102' ' ' GLN . . . . . 0.606 ' N ' HG12 ' A' ' 101' ' ' VAL . 92.5 mt-30 -116.12 147.12 41.67 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.22 -0.925 . . . . 0.0 109.169 179.874 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 103' ' ' LEU . . . . . 0.773 HD23 HG13 ' A' ' 44' ' ' VAL . 0.0 OUTLIER -122.15 130.94 53.68 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.198 -0.939 . . . . 0.0 109.715 -179.918 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 16.7 mttp -115.82 128.22 55.66 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.294 -0.879 . . . . 0.0 109.333 179.864 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 105' ' ' VAL . . . . . 0.852 HG11 ' HA ' ' A' ' 90' ' ' VAL . 22.7 t -104.18 136.15 38.73 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.519 0 O-C-N 121.179 -0.951 . . . . 0.0 109.583 -179.834 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 106' ' ' ASN . . . . . 0.451 ' HB2' ' HB3' ' A' ' 43' ' ' TYR . 90.2 m-20 -136.03 -168.04 2.15 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.195 -0.941 . . . . 0.0 109.296 179.897 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 22.9 mm -108.2 123.68 63.94 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.543 0 O-C-N 121.257 -0.902 . . . . 0.0 109.528 179.918 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 108' ' ' ALA . . . . . 0.594 ' HB3' HG22 ' A' ' 41' ' ' THR . . . -102.22 167.77 9.78 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.239 -0.913 . . . . 0.0 109.434 -179.998 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 28.0 mtp-105 -51.82 139.57 21.44 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.279 -0.888 . . . . 0.0 109.52 179.958 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 110' ' ' LYS . . . . . 0.424 ' HB3' ' C ' ' A' ' 115' ' ' ASP . 50.7 mttp -71.97 146.87 47.45 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.221 -0.924 . . . . 0.0 109.388 179.967 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 111' ' ' GLN . . . . . 1.028 ' OE1' HD11 ' A' ' 65' ' ' ILE . 5.5 pt20 -83.68 156.09 65.06 Favored Pre-proline 0 N--CA 1.489 1.516 0 O-C-N 121.243 -0.911 . . . . 0.0 109.562 179.991 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 112' ' ' PRO . . . . . 0.414 ' O ' ' C ' ' A' ' 113' ' ' MET . 49.7 Cg_endo -69.88 -26.26 27.19 Favored 'Trans proline' 0 C--O 1.214 -0.683 0 C-N-CA 122.79 2.327 . . . . 0.0 112.043 -179.474 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 113' ' ' MET . . . . . 0.657 ' HE3' ' HB3' ' A' ' 114' ' ' LEU . 0.0 OUTLIER -43.79 -27.2 0.31 Allowed 'General case' 0 N--CA 1.489 1.504 0 N-CA-C 108.777 -0.823 . . . . 0.0 108.777 179.55 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 114' ' ' LEU . . . . . 0.887 HD22 ' HA ' ' A' ' 38' ' ' LYS . 0.7 OUTLIER -179.03 31.4 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.218 -0.926 . . . . 0.0 109.367 179.878 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 115' ' ' ASP . . . . . 0.579 ' O ' ' HB3' ' A' ' 116' ' ' ALA . 86.1 m-20 46.91 49.46 14.56 Favored 'General case' 0 C--N 1.303 -1.454 0 N-CA-C 108.251 -1.018 . . . . 0.0 108.251 -179.327 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 116' ' ' ALA . . . . . 0.579 ' HB3' ' O ' ' A' ' 115' ' ' ASP . . . 68.93 -86.71 0.03 OUTLIER 'General case' 0 N--CA 1.488 1.441 0 N-CA-C 108.842 -0.799 . . . . 0.0 108.842 -179.162 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 117' ' ' ALA . . . . . 0.885 ' HB3' ' HB3' ' A' ' 83' ' ' MET . . . -172.9 -34.78 0.01 OUTLIER 'General case' 0 C--N 1.304 -1.411 0 O-C-N 121.301 -0.875 . . . . 0.0 109.658 179.749 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 34.0 m -112.81 139.49 48.4 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.238 -0.914 . . . . 0.0 109.528 179.988 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 149.81 77.12 0.02 OUTLIER Glycine 0 N--CA 1.49 2.276 0 N-CA-C 109.454 -1.458 . . . . 0.0 109.454 179.928 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 120' ' ' LYS . . . . . 0.427 ' O ' ' CB ' ' A' ' 121' ' ' SER . 7.4 ttmm -57.04 -39.0 74.01 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.232 -1.157 . . . . 0.0 109.524 179.995 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 121' ' ' SER . . . . . 0.427 ' CB ' ' O ' ' A' ' 120' ' ' LYS . 1.3 t . . . . . 0 N--CA 1.49 1.544 0 CA-C-O 118.017 -0.992 . . . . 0.0 109.455 179.979 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 35' ' ' ALA . . . . . 0.883 ' HB3' ' HD3' ' A' ' 36' ' ' PRO . . . . . . . . 0 N--CA 1.491 1.593 0 N-CA-C 109.459 -0.571 . . . . 0.0 109.459 . . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 36' ' ' PRO . . . . . 0.883 ' HD3' ' HB3' ' A' ' 35' ' ' ALA . 49.3 Cg_endo -69.79 150.49 68.11 Favored 'Trans proline' 0 C--O 1.216 -0.607 0 C-N-CA 122.81 2.34 . . . . 0.0 111.829 -179.94 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 37' ' ' ARG . . . . . 0.546 ' C ' HD13 ' A' ' 114' ' ' LEU . 82.5 mtt85 -61.37 -36.64 80.81 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.229 -0.919 . . . . 0.0 109.614 179.98 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 38' ' ' LYS . . . . . 0.519 ' O ' ' CD1' ' A' ' 65' ' ' ILE . 56.9 mttm -64.25 -173.33 0.09 Allowed 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.168 -0.958 . . . . 0.0 109.275 179.966 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 39' ' ' GLY . . . . . 0.813 ' HA3' HD11 ' A' ' 65' ' ' ILE . . . 144.03 98.22 0.26 Allowed Glycine 0 N--CA 1.491 2.317 0 N-CA-C 109.63 -1.388 . . . . 0.0 109.63 179.948 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 43.7 t30 -87.21 101.55 13.62 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.273 -1.134 . . . . 0.0 109.322 179.878 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 41' ' ' THR . . . . . 0.447 ' OG1' ' HB3' ' A' ' 111' ' ' GLN . 78.9 m -65.53 130.88 44.88 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.229 -0.92 . . . . 0.0 109.588 -179.935 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 42' ' ' LEU . . . . . 0.56 HD11 ' HD2' ' A' ' 80' ' ' TYR . 16.8 mt -111.51 146.05 37.97 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.262 -0.899 . . . . 0.0 109.464 179.957 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 43' ' ' TYR . . . . . 0.469 ' HB2' ' HB2' ' A' ' 108' ' ' ALA . 70.6 t80 -104.78 122.72 46.32 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.164 -0.96 . . . . 0.0 109.46 179.999 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 44' ' ' VAL . . . . . 0.462 ' HA ' ' O ' ' A' ' 104' ' ' LYS . 47.9 t -121.57 138.15 52.84 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.523 0 O-C-N 121.214 -0.929 . . . . 0.0 109.489 179.978 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 45' ' ' TYR . . . . . 0.476 ' HB3' ' HB2' ' A' ' 104' ' ' LYS . 72.3 t80 -118.68 138.9 52.3 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.226 -0.921 . . . . 0.0 109.441 -179.951 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 176.17 -178.54 47.57 Favored Glycine 0 N--CA 1.489 2.216 0 N-CA-C 109.448 -1.461 . . . . 0.0 109.448 179.929 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 94.2 mt-10 -124.91 156.04 38.58 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.344 -1.092 . . . . 0.0 109.488 179.995 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 22.2 t70 47.46 50.22 15.03 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.227 -0.92 . . . . 0.0 109.476 -179.99 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 66.7 mtm -105.54 145.21 31.24 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.247 -0.908 . . . . 0.0 109.513 -179.969 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 50' ' ' THR . . . . . 0.728 ' O ' HD12 ' A' ' 54' ' ' LEU . 3.5 p -119.42 161.73 35.83 Favored Pre-proline 0 N--CA 1.49 1.57 0 O-C-N 121.27 -0.894 . . . . 0.0 109.395 179.978 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 51' ' ' PRO . . . . . 0.464 ' N ' ' SD ' ' A' ' 69' ' ' MET . 48.2 Cg_endo -70.1 -55.35 0.17 Allowed 'Trans proline' 0 C--O 1.216 -0.593 0 C-N-CA 122.727 2.285 . . . . 0.0 111.87 -179.949 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 27.9 m -50.83 -47.17 60.16 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.152 -0.967 . . . . 0.0 109.216 179.894 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 18.7 tp -58.06 -56.12 26.08 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.256 -0.903 . . . . 0.0 109.241 179.766 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 54' ' ' LEU . . . . . 0.728 HD12 ' O ' ' A' ' 50' ' ' THR . 5.1 mt -53.9 -43.17 69.46 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.285 -0.884 . . . . 0.0 109.092 179.615 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 55' ' ' ARG . . . . . 0.499 ' O ' ' N ' ' A' ' 59' ' ' SER . 73.5 ttt180 -48.83 -41.82 34.15 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.266 -0.896 . . . . 0.0 109.208 179.712 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 56' ' ' GLY . . . . . 0.474 ' O ' ' HD2' ' A' ' 60' ' ' PRO . . . -67.66 -35.39 85.81 Favored Glycine 0 N--CA 1.489 2.213 0 N-CA-C 109.263 -1.535 . . . . 0.0 109.263 179.857 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 57' ' ' ALA . . . . . 0.469 ' O ' ' CD1' ' A' ' 61' ' ' PHE . . . -70.87 -22.15 62.33 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.324 -1.103 . . . . 0.0 109.425 179.961 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 58' ' ' PHE . . . . . 0.675 ' CE2' HD12 ' A' ' 93' ' ' LEU . 96.6 m-85 -118.07 4.72 12.03 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.272 -0.892 . . . . 0.0 109.544 -179.953 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 59' ' ' SER . . . . . 0.538 ' N ' ' HD2' ' A' ' 60' ' ' PRO . 2.6 t -73.63 -56.89 2.78 Favored Pre-proline 0 N--CA 1.49 1.569 0 O-C-N 121.208 -0.932 . . . . 0.0 110.075 -179.67 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 60' ' ' PRO . . . . . 0.538 ' HD2' ' N ' ' A' ' 59' ' ' SER . 48.0 Cg_endo -68.81 -24.84 33.86 Favored 'Trans proline' 0 C--O 1.215 -0.652 0 C-N-CA 122.59 2.193 . . . . 0.0 111.989 -179.496 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 61' ' ' PHE . . . . . 0.587 ' CE2' ' HA ' ' A' ' 89' ' ' ALA . 68.0 m-85 -72.73 -25.08 61.08 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.179 -0.95 . . . . 0.0 109.508 179.968 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 166.18 -178.04 40.94 Favored Glycine 0 N--CA 1.49 2.256 0 N-CA-C 109.548 -1.421 . . . . 0.0 109.548 179.951 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 85.8 m-20 -92.43 139.51 30.52 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.305 -1.115 . . . . 0.0 109.504 179.986 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 64' ' ' ILE . . . . . 0.588 HG23 ' O ' ' A' ' 79' ' ' THR . 51.4 mt -99.87 134.12 40.41 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.522 0 O-C-N 121.243 -0.911 . . . . 0.0 109.461 -179.969 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 65' ' ' ILE . . . . . 0.813 HD11 ' HA3' ' A' ' 39' ' ' GLY . 20.0 pt -96.36 -24.29 4.6 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.537 0 O-C-N 121.314 -0.866 . . . . 0.0 109.521 -179.92 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 50.8 t0 -146.28 121.14 9.94 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.229 -0.919 . . . . 0.0 109.597 -179.946 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 8.1 tp -110.14 121.39 45.14 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.236 -0.915 . . . . 0.0 109.389 179.902 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 68' ' ' SER . . . . . 0.468 ' HB3' ' HB2' ' A' ' 77' ' ' PHE . 34.6 t -134.69 144.51 47.83 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.224 -0.922 . . . . 0.0 109.419 179.941 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 69' ' ' MET . . . . . 0.464 ' SD ' ' N ' ' A' ' 51' ' ' PRO . 83.3 mtp -129.59 151.4 50.24 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.271 -0.893 . . . . 0.0 109.563 -179.96 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 70' ' ' ASP . . . . . 0.478 ' C ' ' HD2' ' A' ' 72' ' ' PRO . 0.2 OUTLIER -127.06 99.36 28.69 Favored Pre-proline 0 N--CA 1.491 1.6 0 O-C-N 121.3 -0.875 . . . . 0.0 109.419 179.982 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 71' ' ' PRO . . . . . 0.594 ' N ' ' CD ' ' A' ' 72' ' ' PRO . 47.4 Cg_endo -74.63 -27.85 10.39 Favored 'Trans proline' 0 CA--C 1.542 0.924 0 C-N-CA 122.476 2.118 . . . . 0.0 113.759 -179.972 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 72' ' ' PRO . . . . . 0.594 ' CD ' ' N ' ' A' ' 71' ' ' PRO . 53.9 Cg_endo -75.09 -25.8 11.38 Favored 'Trans proline' 0 C--N 1.352 0.759 0 C-N-CA 121.404 1.403 . . . . 0.0 111.823 -179.851 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 73' ' ' ARG . . . . . 0.431 ' O ' ' HB2' ' A' ' 74' ' ' ASN . 97.8 mtt180 -110.1 0.12 18.21 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.222 -0.924 . . . . 0.0 109.63 -179.918 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 74' ' ' ASN . . . . . 0.431 ' HB2' ' O ' ' A' ' 73' ' ' ARG . 79.1 m-20 61.03 46.28 8.45 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.19 -0.944 . . . . 0.0 109.589 179.9 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 75' ' ' CYS . . . . . 0.442 ' HA ' ' O ' ' A' ' 44' ' ' VAL . 23.9 p -146.68 133.72 20.34 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.212 -0.93 . . . . 0.0 109.51 179.987 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 76' ' ' ALA . . . . . 0.439 ' HA ' ' HA ' ' A' ' 69' ' ' MET . . . -106.35 161.28 14.7 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.282 -0.886 . . . . 0.0 109.488 179.932 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 77' ' ' PHE . . . . . 0.484 ' CZ ' ' HE3' ' A' ' 110' ' ' LYS . 98.5 m-85 -126.89 132.66 50.86 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.305 -0.872 . . . . 0.0 109.461 -179.979 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 78' ' ' VAL . . . . . 0.484 ' O ' ' N ' ' A' ' 42' ' ' LEU . 40.8 t -128.65 131.89 68.24 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 O-C-N 121.215 -0.928 . . . . 0.0 109.477 179.935 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 79' ' ' THR . . . . . 0.588 ' O ' HG23 ' A' ' 64' ' ' ILE . 7.0 m -104.38 139.39 39.4 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.228 -0.92 . . . . 0.0 109.429 -179.919 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 80' ' ' TYR . . . . . 0.56 ' HD2' HD11 ' A' ' 42' ' ' LEU . 0.8 OUTLIER -118.25 134.57 54.9 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.302 -0.874 . . . . 0.0 109.48 179.942 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 80.2 tt0 -52.35 -34.46 47.6 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.257 -0.902 . . . . 0.0 109.408 179.896 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 42.5 mtmt -128.55 142.17 51.14 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.277 -0.889 . . . . 0.0 109.524 179.9 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 83' ' ' MET . . . . . 0.821 ' HE2' ' HB3' ' A' ' 117' ' ' ALA . 31.3 mtm -62.56 -25.45 68.07 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.258 -0.901 . . . . 0.0 109.555 -179.946 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 96.9 mt-10 -62.59 -39.89 95.17 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.27 -0.894 . . . . 0.0 109.55 -179.949 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 16.0 m -63.89 -34.21 77.43 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.225 -0.922 . . . . 0.0 109.636 179.978 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 86' ' ' ALA . . . . . 0.469 ' CB ' HD21 ' A' ' 42' ' ' LEU . . . -72.39 -33.09 66.93 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.285 -0.884 . . . . 0.0 109.546 -179.966 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 22.2 t70 -65.11 -42.69 93.75 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.212 -0.93 . . . . 0.0 109.557 -179.947 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 64.6 tt0 -67.88 -36.77 80.84 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.223 -0.923 . . . . 0.0 109.579 -179.959 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 89' ' ' ALA . . . . . 0.587 ' HA ' ' CE2' ' A' ' 61' ' ' PHE . . . -76.69 -48.81 17.73 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.211 -0.931 . . . . 0.0 109.547 -179.944 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 90' ' ' VAL . . . . . 0.854 HG22 ' CG1' ' A' ' 105' ' ' VAL . 71.3 t -58.76 -29.21 39.52 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.524 0 O-C-N 121.22 -0.925 . . . . 0.0 109.455 -179.933 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -80.03 -54.18 6.03 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.248 -0.907 . . . . 0.0 109.758 -179.92 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 92' ' ' GLU . . . . . 0.506 ' HB2' ' CE2' ' A' ' 61' ' ' PHE . 91.0 mt-10 -71.21 -40.75 70.96 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.288 -0.882 . . . . 0.0 109.879 -179.597 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 93' ' ' LEU . . . . . 0.775 ' O ' HG23 ' A' ' 96' ' ' THR . 28.2 mt -68.56 -42.18 78.71 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.141 -0.974 . . . . 0.0 109.558 -179.828 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 94' ' ' ASN . . . . . 0.515 ' CB ' ' O ' ' A' ' 90' ' ' VAL . 60.6 t-20 -63.79 131.24 47.21 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.255 -0.903 . . . . 0.0 109.565 -179.965 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 86.66 35.21 10.49 Favored Glycine 0 N--CA 1.49 2.291 0 N-CA-C 109.513 -1.435 . . . . 0.0 109.513 -179.968 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 96' ' ' THR . . . . . 0.775 HG23 ' O ' ' A' ' 93' ' ' LEU . 22.0 p -124.21 160.36 28.08 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.221 -1.164 . . . . 0.0 109.367 179.952 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 97' ' ' GLN . . . . . 0.421 ' HG2' ' N ' ' A' ' 98' ' ' VAL . 62.3 tt0 -128.25 154.81 45.46 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.238 -0.914 . . . . 0.0 109.471 -179.942 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 98' ' ' VAL . . . . . 0.57 HG12 ' H ' ' A' ' 99' ' ' GLU . 1.2 t -106.19 -155.13 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.566 0 O-C-N 121.212 -0.93 . . . . 0.0 109.336 -179.978 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 99' ' ' GLU . . . . . 0.57 ' H ' HG12 ' A' ' 98' ' ' VAL . 96.2 mt-10 -56.76 -36.98 70.44 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.119 -0.988 . . . . 0.0 109.481 -179.943 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 20.9 t -160.95 23.28 0.14 Allowed 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.224 -0.923 . . . . 0.0 109.596 -179.953 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 101' ' ' VAL . . . . . 0.534 ' O ' HG23 ' A' ' 98' ' ' VAL . 48.7 t -138.57 154.29 26.86 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.547 0 O-C-N 121.214 -0.929 . . . . 0.0 109.558 -180.0 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 92.2 mt-30 -99.63 148.35 24.42 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.278 -0.889 . . . . 0.0 109.306 179.935 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 103' ' ' LEU . . . . . 0.421 HD23 ' HA ' ' A' ' 103' ' ' LEU . 91.9 mt -109.04 137.05 47.55 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.184 -0.947 . . . . 0.0 109.625 -179.905 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 104' ' ' LYS . . . . . 0.476 ' HB2' ' HB3' ' A' ' 45' ' ' TYR . 3.1 mtpm? -122.98 139.24 54.28 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.312 -0.868 . . . . 0.0 109.327 179.927 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 105' ' ' VAL . . . . . 0.854 ' CG1' HG22 ' A' ' 90' ' ' VAL . 25.8 t -121.96 136.65 58.16 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.519 0 O-C-N 121.207 -0.933 . . . . 0.0 109.559 -179.968 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 106' ' ' ASN . . . . . 0.458 ' OD1' ' O ' ' A' ' 105' ' ' VAL . 99.1 m-20 -142.17 -178.41 5.71 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.298 -0.876 . . . . 0.0 109.392 179.957 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 107' ' ' ILE . . . . . 0.417 HD13 HG21 ' A' ' 107' ' ' ILE . 41.0 mt -102.15 137.54 29.68 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.567 0 O-C-N 121.212 -0.93 . . . . 0.0 109.574 -179.891 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 108' ' ' ALA . . . . . 0.469 ' HB2' ' HB2' ' A' ' 43' ' ' TYR . . . -124.98 141.75 51.93 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.26 -0.9 . . . . 0.0 109.446 179.945 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 49.6 mtt180 -111.48 40.1 2.18 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.244 -0.91 . . . . 0.0 109.408 179.885 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 110' ' ' LYS . . . . . 0.496 ' O ' ' HD2' ' A' ' 112' ' ' PRO . 67.3 mttm -81.59 -11.87 58.97 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.193 -0.942 . . . . 0.0 109.526 -179.881 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 111' ' ' GLN . . . . . 0.586 ' CG ' ' O ' ' A' ' 111' ' ' GLN . 0.0 OUTLIER -113.94 57.16 0.77 Allowed Pre-proline 0 N--CA 1.491 1.589 0 O-C-N 121.205 -0.935 . . . . 0.0 109.356 179.746 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 112' ' ' PRO . . . . . 0.496 ' HD2' ' O ' ' A' ' 110' ' ' LYS . 44.0 Cg_endo -66.69 -2.6 7.81 Favored 'Trans proline' 0 C--O 1.214 -0.708 0 C-N-CA 122.785 2.324 . . . . 0.0 112.032 -179.848 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 113' ' ' MET . . . . . 0.554 ' HG2' ' N ' ' A' ' 114' ' ' LEU . 0.0 OUTLIER -56.86 -23.23 42.84 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.178 -0.951 . . . . 0.0 109.089 179.586 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 114' ' ' LEU . . . . . 0.554 ' N ' ' HG2' ' A' ' 113' ' ' MET . 0.3 OUTLIER -153.59 17.7 0.53 Allowed 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.322 -0.861 . . . . 0.0 109.894 -179.721 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 115' ' ' ASP . . . . . 0.728 ' O ' ' HB3' ' A' ' 116' ' ' ALA . 77.1 m-20 40.62 43.03 1.51 Allowed 'General case' 0 N--CA 1.492 1.639 0 N-CA-C 109.151 -0.685 . . . . 0.0 109.151 -179.768 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 116' ' ' ALA . . . . . 0.728 ' HB3' ' O ' ' A' ' 115' ' ' ASP . . . 79.62 -74.82 0.05 OUTLIER 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.567 -0.708 . . . . 0.0 109.312 -179.294 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 117' ' ' ALA . . . . . 0.821 ' HB3' ' HE2' ' A' ' 83' ' ' MET . . . -168.48 59.11 0.06 Allowed 'General case' 0 C--N 1.304 -1.399 0 O-C-N 121.385 -0.822 . . . . 0.0 109.726 -179.929 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 44.3 m -118.17 148.61 42.18 Favored 'General case' 0 C--N 1.303 -1.434 0 O-C-N 121.158 -0.964 . . . . 0.0 109.553 -179.965 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -147.24 179.39 24.2 Favored Glycine 0 N--CA 1.489 2.232 0 N-CA-C 109.541 -1.424 . . . . 0.0 109.541 179.937 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 33.5 mmtp -82.29 144.93 30.27 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.238 -1.154 . . . . 0.0 109.5 179.969 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 7.3 m . . . . . 0 N--CA 1.49 1.543 0 CA-C-O 117.99 -1.005 . . . . 0.0 109.448 -179.988 . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 35' ' ' ALA . . . . . 0.416 ' HA ' ' HD2' ' A' ' 36' ' ' PRO . . . . . . . . 0 N--CA 1.49 1.552 0 N-CA-C 109.465 -0.569 . . . . 0.0 109.465 . . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 36' ' ' PRO . . . . . 0.416 ' HD2' ' HA ' ' A' ' 35' ' ' ALA . 49.5 Cg_endo -69.41 -4.73 14.38 Favored 'Trans proline' 0 C--O 1.215 -0.657 0 C-N-CA 122.727 2.285 . . . . 0.0 111.889 179.935 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 37' ' ' ARG . . . . . 0.653 ' O ' HD13 ' A' ' 114' ' ' LEU . 74.3 mtt-85 -128.52 135.27 49.17 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.161 -0.962 . . . . 0.0 109.588 -179.939 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 38' ' ' LYS . . . . . 0.489 ' HB2' ' O ' ' A' ' 81' ' ' GLU . 44.5 mttp -133.85 -160.21 1.03 Allowed 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.287 -0.883 . . . . 0.0 109.284 179.942 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 39' ' ' GLY . . . . . 0.474 ' O ' ' HA ' ' A' ' 116' ' ' ALA . . . -172.34 168.51 41.6 Favored Glycine 0 N--CA 1.492 2.37 0 N-CA-C 109.793 -1.323 . . . . 0.0 109.793 -179.97 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 40' ' ' ASN . . . . . 0.52 ' N ' ' O ' ' A' ' 80' ' ' TYR . 42.3 t30 -151.41 98.26 2.5 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.345 -1.091 . . . . 0.0 109.139 179.853 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 41' ' ' THR . . . . . 0.51 ' O ' HD23 ' A' ' 42' ' ' LEU . 8.2 m -63.88 134.01 54.36 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.315 -0.866 . . . . 0.0 109.986 -179.518 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 42' ' ' LEU . . . . . 0.87 HD11 ' HD2' ' A' ' 80' ' ' TYR . 20.4 mt -120.21 155.6 32.83 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.424 -0.797 . . . . 0.0 109.314 179.702 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 43' ' ' TYR . . . . . 0.577 ' HB2' ' HB2' ' A' ' 108' ' ' ALA . 69.9 t80 -109.59 127.24 54.37 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.179 -0.951 . . . . 0.0 109.468 179.965 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 46.7 t -126.66 136.22 61.43 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.544 0 O-C-N 121.153 -0.967 . . . . 0.0 109.4 179.935 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 45' ' ' TYR . . . . . 0.486 ' HB3' ' HB2' ' A' ' 104' ' ' LYS . 65.6 t80 -127.53 136.43 51.71 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.292 -0.88 . . . . 0.0 109.596 -179.84 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -173.54 -163.88 27.85 Favored Glycine 0 N--CA 1.49 2.27 0 N-CA-C 109.374 -1.49 . . . . 0.0 109.374 179.988 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 47' ' ' GLU . . . . . 0.426 ' O ' ' C ' ' A' ' 48' ' ' ASP . 89.5 mt-10 -120.96 147.25 45.72 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.163 -1.199 . . . . 0.0 109.512 179.947 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 48' ' ' ASP . . . . . 0.426 ' C ' ' O ' ' A' ' 47' ' ' GLU . 47.0 m-20 43.49 54.18 5.42 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.227 -0.921 . . . . 0.0 109.477 179.966 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 54.4 mtm -97.34 136.1 38.3 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.318 -0.864 . . . . 0.0 109.607 -179.889 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 50' ' ' THR . . . . . 0.863 ' O ' HD12 ' A' ' 54' ' ' LEU . 0.0 OUTLIER -118.61 161.95 33.1 Favored Pre-proline 0 N--CA 1.49 1.548 0 O-C-N 121.258 -0.902 . . . . 0.0 109.49 179.927 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 51' ' ' PRO . . . . . 0.671 ' HD2' HG22 ' A' ' 50' ' ' THR . 48.1 Cg_endo -69.85 -50.19 0.48 Allowed 'Trans proline' 0 C--O 1.214 -0.683 0 C-N-CA 122.724 2.282 . . . . 0.0 111.731 -179.914 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 50.7 m -52.91 -47.43 67.99 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.228 -0.92 . . . . 0.0 109.311 179.904 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 10.8 tp -61.85 -57.2 12.74 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.402 -0.811 . . . . 0.0 109.25 179.788 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 54' ' ' LEU . . . . . 0.863 HD12 ' O ' ' A' ' 50' ' ' THR . 4.4 mt -53.63 -49.66 67.4 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.284 -0.885 . . . . 0.0 109.219 179.758 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 55' ' ' ARG . . . . . 0.435 ' C ' ' O ' ' A' ' 54' ' ' LEU . 77.7 ttt180 -43.66 -44.72 6.58 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.294 -0.879 . . . . 0.0 109.201 179.87 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -68.79 -33.3 75.28 Favored Glycine 0 N--CA 1.489 2.219 0 N-CA-C 109.159 -1.577 . . . . 0.0 109.159 179.737 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 57' ' ' ALA . . . . . 0.443 ' N ' ' O ' ' A' ' 54' ' ' LEU . . . -72.55 -20.11 61.39 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.353 -1.087 . . . . 0.0 109.297 179.935 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 58' ' ' PHE . . . . . 0.712 ' CZ ' HD13 ' A' ' 93' ' ' LEU . 95.2 m-85 -117.98 7.94 12.41 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.301 -0.875 . . . . 0.0 109.324 179.856 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 59' ' ' SER . . . . . 0.586 ' N ' ' HD2' ' A' ' 60' ' ' PRO . 0.5 OUTLIER -76.68 -50.1 2.6 Favored Pre-proline 0 N--CA 1.49 1.562 0 O-C-N 121.243 -0.91 . . . . 0.0 110.577 -179.644 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 60' ' ' PRO . . . . . 0.586 ' HD2' ' N ' ' A' ' 59' ' ' SER . 49.9 Cg_endo -70.72 -33.79 12.4 Favored 'Trans proline' 0 C--O 1.215 -0.654 0 C-N-CA 122.215 1.943 . . . . 0.0 112.454 -179.15 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 61' ' ' PHE . . . . . 0.584 ' CE1' ' HA ' ' A' ' 89' ' ' ALA . 77.4 m-85 -61.74 -43.96 97.83 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.042 -1.036 . . . . 0.0 109.516 -179.983 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 62' ' ' GLY . . . . . 0.42 ' HA3' ' OG ' ' A' ' 85' ' ' SER . . . -174.44 -168.29 35.03 Favored Glycine 0 N--CA 1.491 2.315 0 N-CA-C 109.464 -1.455 . . . . 0.0 109.464 -179.965 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 86.6 m-20 -98.1 143.5 28.58 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.235 -1.156 . . . . 0.0 109.409 -179.981 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 64' ' ' ILE . . . . . 0.482 HD11 ' HB2' ' A' ' 58' ' ' PHE . 37.8 mt -105.02 129.65 57.35 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.511 0 O-C-N 121.239 -0.913 . . . . 0.0 109.544 -179.904 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 65' ' ' ILE . . . . . 0.405 HD13 ' O ' ' A' ' 38' ' ' LYS . 21.3 pt -96.68 -21.58 5.35 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.602 0 O-C-N 121.324 -0.86 . . . . 0.0 109.614 -179.903 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 66' ' ' ASP . . . . . 0.451 ' HB3' ' OG1' ' A' ' 79' ' ' THR . 57.7 t0 -144.87 109.79 5.07 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.187 -0.946 . . . . 0.0 109.56 179.99 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 15.1 tp -108.07 121.48 44.91 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.301 -0.874 . . . . 0.0 109.437 179.979 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 68' ' ' SER . . . . . 0.473 ' HB3' ' HB2' ' A' ' 77' ' ' PHE . 22.7 t -131.09 139.04 49.81 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.281 -0.887 . . . . 0.0 109.421 -179.942 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 69' ' ' MET . . . . . 0.7 ' HE1' ' CD1' ' A' ' 54' ' ' LEU . 94.9 mmm -114.82 150.87 34.8 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.187 -0.946 . . . . 0.0 109.522 179.998 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 70' ' ' ASP . . . . . 0.477 ' C ' ' HD2' ' A' ' 72' ' ' PRO . 6.1 t0 -132.24 95.97 20.39 Favored Pre-proline 0 N--CA 1.49 1.542 0 O-C-N 121.222 -0.924 . . . . 0.0 109.516 -179.967 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 71' ' ' PRO . . . . . 0.592 ' N ' ' CD ' ' A' ' 72' ' ' PRO . 47.9 Cg_endo -74.81 -27.83 10.05 Favored 'Trans proline' 0 CA--C 1.543 0.956 0 C-N-CA 122.451 2.101 . . . . 0.0 113.623 -179.881 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 72' ' ' PRO . . . . . 0.592 ' CD ' ' N ' ' A' ' 71' ' ' PRO . 55.2 Cg_endo -75.13 -26.5 10.65 Favored 'Trans proline' 0 C--N 1.353 0.769 0 C-N-CA 121.51 1.473 . . . . 0.0 111.825 -179.848 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 73' ' ' ARG . . . . . 0.448 ' O ' ' HB2' ' A' ' 74' ' ' ASN . 77.7 mtt85 -109.24 -1.9 18.31 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.208 -0.932 . . . . 0.0 109.67 -179.841 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 74' ' ' ASN . . . . . 0.448 ' HB2' ' O ' ' A' ' 73' ' ' ARG . 78.4 m-20 61.89 43.12 9.59 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.159 -0.963 . . . . 0.0 109.599 179.97 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 75' ' ' CYS . . . . . 0.459 ' O ' ' CB ' ' A' ' 70' ' ' ASP . 28.4 p -146.52 141.9 27.5 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.277 -0.89 . . . . 0.0 109.47 179.941 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 76' ' ' ALA . . . . . 0.458 ' HB1' ' SD ' ' A' ' 69' ' ' MET . . . -114.11 161.88 17.2 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.214 -0.929 . . . . 0.0 109.56 -179.906 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 77' ' ' PHE . . . . . 0.473 ' HB2' ' HB3' ' A' ' 68' ' ' SER . 97.4 m-85 -123.77 130.94 53.41 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.24 -0.912 . . . . 0.0 109.385 -179.931 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 78' ' ' VAL . . . . . 0.505 ' O ' ' N ' ' A' ' 42' ' ' LEU . 39.2 t -128.62 132.12 68.08 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.597 0 O-C-N 121.185 -0.947 . . . . 0.0 109.592 -179.938 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 79' ' ' THR . . . . . 0.473 ' O ' ' HA ' ' A' ' 64' ' ' ILE . 7.1 m -106.74 123.15 47.72 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.203 -0.935 . . . . 0.0 109.612 179.928 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 80' ' ' TYR . . . . . 0.87 ' HD2' HD11 ' A' ' 42' ' ' LEU . 1.7 m-85 -101.94 126.45 48.85 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.261 -0.9 . . . . 0.0 109.299 179.879 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 81' ' ' GLU . . . . . 0.489 ' O ' ' HB2' ' A' ' 38' ' ' LYS . 86.9 tt0 -42.89 -48.27 5.78 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.244 -0.91 . . . . 0.0 109.658 -179.758 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 29.8 mttt -110.96 153.84 24.97 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.184 -0.947 . . . . 0.0 109.526 179.972 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 83' ' ' MET . . . . . 0.587 ' HE3' ' C ' ' A' ' 117' ' ' ALA . 58.8 mtt -73.05 -16.66 61.48 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.315 -0.865 . . . . 0.0 109.424 -179.939 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 75.6 mm-40 -71.92 -41.04 68.36 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.269 -0.894 . . . . 0.0 109.443 179.965 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 85' ' ' SER . . . . . 0.449 ' OG ' ' CD1' ' A' ' 80' ' ' TYR . 14.3 t -58.9 -39.67 82.18 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.219 -0.925 . . . . 0.0 109.34 179.907 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 86' ' ' ALA . . . . . 0.519 ' CB ' HD21 ' A' ' 42' ' ' LEU . . . -67.9 -37.76 82.13 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.374 -0.829 . . . . 0.0 109.446 179.956 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 56.6 t0 -60.13 -41.25 92.26 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.267 -0.896 . . . . 0.0 109.594 -179.971 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 88' ' ' GLN . . . . . 0.442 ' O ' ' CB ' ' A' ' 92' ' ' GLU . 60.5 tt0 -74.63 -41.98 59.38 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.189 -0.945 . . . . 0.0 109.441 179.975 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 89' ' ' ALA . . . . . 0.584 ' HA ' ' CE1' ' A' ' 61' ' ' PHE . . . -69.76 -46.98 64.63 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.222 -0.924 . . . . 0.0 109.446 -179.983 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 90' ' ' VAL . . . . . 0.719 HG22 HG21 ' A' ' 105' ' ' VAL . 48.4 t -64.93 -54.47 29.27 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.535 0 O-C-N 121.205 -0.935 . . . . 0.0 109.615 -179.926 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -61.53 -40.3 94.15 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.176 -0.952 . . . . 0.0 109.855 -179.671 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 92' ' ' GLU . . . . . 0.546 ' HB3' ' CE1' ' A' ' 61' ' ' PHE . 47.5 tp10 -77.73 -46.2 22.48 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.223 -0.923 . . . . 0.0 109.887 -179.672 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 93' ' ' LEU . . . . . 0.712 HD13 ' CZ ' ' A' ' 58' ' ' PHE . 49.8 mt -67.69 -37.84 82.85 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.157 -0.964 . . . . 0.0 109.643 -179.809 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 94' ' ' ASN . . . . . 0.572 ' HB2' ' CG1' ' A' ' 105' ' ' VAL . 50.5 t-20 -61.64 139.35 58.3 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.298 -0.876 . . . . 0.0 109.562 -179.856 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 73.95 30.4 61.41 Favored Glycine 0 N--CA 1.49 2.269 0 N-CA-C 109.482 -1.447 . . . . 0.0 109.482 179.972 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 96' ' ' THR . . . . . 0.699 HG23 ' O ' ' A' ' 93' ' ' LEU . 24.5 p -121.18 146.41 46.8 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.275 -1.132 . . . . 0.0 109.42 -179.97 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 97' ' ' GLN . . . . . 0.446 ' HG3' ' O ' ' A' ' 101' ' ' VAL . 63.5 tt0 -116.58 137.08 52.45 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.261 -0.9 . . . . 0.0 109.522 179.982 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 98' ' ' VAL . . . . . 0.489 HG12 ' H ' ' A' ' 99' ' ' GLU . 1.3 t -83.01 -148.53 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.569 0 O-C-N 121.252 -0.905 . . . . 0.0 109.319 -179.976 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 99' ' ' GLU . . . . . 0.489 ' H ' HG12 ' A' ' 98' ' ' VAL . 95.8 mt-10 -59.33 -36.16 75.16 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.172 -0.955 . . . . 0.0 109.444 -179.995 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -161.13 23.53 0.13 Allowed 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.275 -0.891 . . . . 0.0 109.564 179.89 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 101' ' ' VAL . . . . . 0.465 HG12 ' N ' ' A' ' 102' ' ' GLN . 95.1 t -134.75 158.05 41.37 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.569 0 O-C-N 121.197 -0.939 . . . . 0.0 109.454 179.895 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 102' ' ' GLN . . . . . 0.465 ' N ' HG12 ' A' ' 101' ' ' VAL . 88.2 mt-30 -102.13 161.24 13.84 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.227 -0.921 . . . . 0.0 109.48 -179.988 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 103' ' ' LEU . . . . . 0.689 HD12 ' OG1' ' A' ' 96' ' ' THR . 49.3 mt -114.73 134.27 55.23 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.263 -0.898 . . . . 0.0 109.634 -179.865 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 104' ' ' LYS . . . . . 0.486 ' HB2' ' HB3' ' A' ' 45' ' ' TYR . 63.4 mttm -126.75 94.4 4.03 Favored 'General case' 0 N--CA 1.489 1.504 0 N-CA-C 108.737 -0.838 . . . . 0.0 108.737 179.746 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 105' ' ' VAL . . . . . 0.719 HG21 HG22 ' A' ' 90' ' ' VAL . 9.7 p -96.24 140.56 16.99 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.51 0 O-C-N 121.444 -0.785 . . . . 0.0 109.963 -179.421 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 106' ' ' ASN . . . . . 0.441 ' OD1' ' O ' ' A' ' 105' ' ' VAL . 97.7 m-20 -141.41 -165.68 2.03 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.379 -0.825 . . . . 0.0 109.101 179.777 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 28.2 mm -97.23 132.06 42.66 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.564 0 O-C-N 121.062 -1.024 . . . . 0.0 109.428 179.807 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 108' ' ' ALA . . . . . 0.577 ' HB2' ' HB2' ' A' ' 43' ' ' TYR . . . -111.18 170.74 7.91 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.289 -0.882 . . . . 0.0 109.539 -179.883 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 29.5 ttm105 -44.6 148.13 0.53 Allowed 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.248 -0.908 . . . . 0.0 109.52 179.925 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 110' ' ' LYS . . . . . 0.429 ' O ' ' C ' ' A' ' 111' ' ' GLN . 18.8 mttt -87.4 108.92 19.21 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.226 -0.921 . . . . 0.0 109.517 179.849 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 111' ' ' GLN . . . . . 0.57 ' NE2' ' N ' ' A' ' 111' ' ' GLN . 0.7 OUTLIER -42.49 133.73 2.73 Favored Pre-proline 0 N--CA 1.491 1.601 0 O-C-N 121.389 -0.819 . . . . 0.0 109.733 -179.889 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 112' ' ' PRO . . . . . 0.427 ' O ' ' C ' ' A' ' 113' ' ' MET . 55.6 Cg_endo -78.13 -24.46 8.13 Favored 'Trans proline' 0 C--O 1.215 -0.635 0 C-N-CA 122.718 2.278 . . . . 0.0 111.769 -179.814 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 113' ' ' MET . . . . . 0.543 ' CE ' ' HG3' ' A' ' 111' ' ' GLN . 0.0 OUTLIER -43.28 -26.55 0.19 Allowed 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.334 -0.854 . . . . 0.0 109.768 -179.978 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 114' ' ' LEU . . . . . 0.846 HD23 ' O ' ' A' ' 114' ' ' LEU . 3.4 tt -164.64 26.8 0.06 Allowed 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.195 -0.941 . . . . 0.0 109.618 -179.951 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 115' ' ' ASP . . . . . 0.632 ' O ' ' HB3' ' A' ' 116' ' ' ALA . 74.9 m-20 45.15 42.55 6.9 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.182 -0.949 . . . . 0.0 109.09 -179.897 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 116' ' ' ALA . . . . . 0.632 ' HB3' ' O ' ' A' ' 115' ' ' ASP . . . 73.3 -83.61 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.334 -0.854 . . . . 0.0 109.606 -179.898 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 117' ' ' ALA . . . . . 0.587 ' C ' ' HE3' ' A' ' 83' ' ' MET . . . -171.58 27.9 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.299 -0.875 . . . . 0.0 109.716 179.986 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 9.7 t -120.0 4.5 10.92 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.15 -0.969 . . . . 0.0 109.715 -179.844 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -49.56 -36.91 25.48 Favored Glycine 0 N--CA 1.49 2.269 0 N-CA-C 109.549 -1.42 . . . . 0.0 109.549 -179.861 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 67.3 mttm -55.2 -32.85 62.55 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.243 -1.151 . . . . 0.0 109.562 -179.9 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 4.1 m . . . . . 0 N--CA 1.49 1.573 0 CA-C-O 117.994 -1.003 . . . . 0.0 109.423 -179.904 . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 1.52 0 N-CA-C 109.476 -0.565 . . . . 0.0 109.476 . . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 50.2 Cg_endo -69.95 142.33 46.81 Favored 'Trans proline' 0 C--O 1.215 -0.672 0 C-N-CA 122.768 2.312 . . . . 0.0 111.911 -179.956 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 37' ' ' ARG . . . . . 0.455 ' O ' ' O ' ' A' ' 38' ' ' LYS . 62.1 mtt180 -122.64 153.07 39.84 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.301 -0.874 . . . . 0.0 109.307 179.885 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 38' ' ' LYS . . . . . 1.055 ' HA ' HD12 ' A' ' 114' ' ' LEU . 96.5 mttt 44.6 -168.21 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.254 -0.904 . . . . 0.0 109.42 -179.893 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 39' ' ' GLY . . . . . 0.756 ' HA3' HD11 ' A' ' 65' ' ' ILE . . . 144.47 76.05 0.03 OUTLIER Glycine 0 N--CA 1.489 2.216 0 N-CA-C 109.829 -1.308 . . . . 0.0 109.829 179.921 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 40' ' ' ASN . . . . . 0.478 ' O ' ' HA ' ' A' ' 79' ' ' THR . 42.7 t30 -80.51 117.08 20.92 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.161 -1.199 . . . . 0.0 109.063 179.63 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 41' ' ' THR . . . . . 0.65 HG22 ' HB3' ' A' ' 108' ' ' ALA . 54.0 m -75.58 150.51 38.05 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.176 -0.953 . . . . 0.0 109.879 -179.656 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 42' ' ' LEU . . . . . 0.856 HD12 ' O ' ' A' ' 78' ' ' VAL . 4.7 mp -126.56 147.25 49.89 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.331 -0.855 . . . . 0.0 109.386 179.806 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 76.4 t80 -102.5 115.43 30.57 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.246 -0.909 . . . . 0.0 109.42 179.961 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 44' ' ' VAL . . . . . 0.454 ' HA ' ' O ' ' A' ' 104' ' ' LYS . 41.1 t -113.5 143.92 22.21 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.558 0 O-C-N 121.296 -0.878 . . . . 0.0 109.396 179.832 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 45' ' ' TYR . . . . . 0.424 ' HB3' ' HB2' ' A' ' 104' ' ' LYS . 71.5 t80 -136.2 143.33 44.32 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.224 -0.923 . . . . 0.0 109.544 -179.959 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 46' ' ' GLY . . . . . 0.449 ' N ' ' SD ' ' A' ' 49' ' ' MET . . . 167.24 -175.06 42.45 Favored Glycine 0 N--CA 1.491 2.3 0 N-CA-C 109.506 -1.438 . . . . 0.0 109.506 179.98 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 47' ' ' GLU . . . . . 0.407 ' O ' ' C ' ' A' ' 48' ' ' ASP . 91.7 mt-10 -107.89 158.54 17.25 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.286 -1.126 . . . . 0.0 109.522 179.998 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 48' ' ' ASP . . . . . 0.407 ' C ' ' O ' ' A' ' 47' ' ' GLU . 44.9 m-20 43.93 45.97 6.63 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.266 -0.897 . . . . 0.0 109.457 -179.991 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 49' ' ' MET . . . . . 0.449 ' SD ' ' N ' ' A' ' 46' ' ' GLY . 23.4 mtp -85.42 132.32 34.24 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.237 -0.914 . . . . 0.0 109.449 179.942 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 50' ' ' THR . . . . . 0.769 ' O ' HD12 ' A' ' 54' ' ' LEU . 0.6 OUTLIER -121.4 159.77 48.74 Favored Pre-proline 0 N--CA 1.49 1.528 0 O-C-N 121.278 -0.889 . . . . 0.0 109.362 179.83 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 50.2 Cg_endo -70.3 -42.73 2.63 Favored 'Trans proline' 0 C--O 1.214 -0.692 0 C-N-CA 122.574 2.183 . . . . 0.0 111.6 -179.972 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 58.4 m -64.83 -47.4 78.12 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.308 -0.87 . . . . 0.0 109.255 179.721 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 14.3 tp -57.15 -52.06 66.83 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.322 -0.861 . . . . 0.0 109.276 179.818 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 54' ' ' LEU . . . . . 0.769 HD12 ' O ' ' A' ' 50' ' ' THR . 5.8 mt -57.85 -45.88 85.61 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.344 -0.847 . . . . 0.0 109.225 179.713 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 55' ' ' ARG . . . . . 0.495 ' O ' ' CB ' ' A' ' 59' ' ' SER . 24.1 ttt-85 -48.86 -36.18 16.37 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.275 -0.89 . . . . 0.0 109.299 179.757 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -72.95 -36.16 57.51 Favored Glycine 0 N--CA 1.489 2.211 0 N-CA-C 109.422 -1.471 . . . . 0.0 109.422 179.847 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -71.65 -27.16 62.88 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.238 -1.154 . . . . 0.0 109.302 179.923 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 58' ' ' PHE . . . . . 0.679 ' CE2' HD12 ' A' ' 93' ' ' LEU . 58.2 m-85 -113.58 8.9 17.83 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.356 -0.84 . . . . 0.0 109.399 179.96 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 59' ' ' SER . . . . . 0.514 ' N ' ' HD2' ' A' ' 60' ' ' PRO . 0.6 OUTLIER -74.59 -58.84 1.67 Allowed Pre-proline 0 N--CA 1.491 1.588 0 O-C-N 121.288 -0.883 . . . . 0.0 109.958 -179.627 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 60' ' ' PRO . . . . . 0.514 ' HD2' ' N ' ' A' ' 59' ' ' SER . 48.6 Cg_endo -68.94 -27.59 30.26 Favored 'Trans proline' 0 C--O 1.215 -0.639 0 C-N-CA 122.681 2.254 . . . . 0.0 112.068 -179.6 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 61' ' ' PHE . . . . . 0.583 ' CE2' ' HB2' ' A' ' 92' ' ' GLU . 46.2 m-85 -67.17 -33.63 75.82 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.113 -0.992 . . . . 0.0 109.516 -179.966 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 62' ' ' GLY . . . . . 0.442 ' HA3' ' OG ' ' A' ' 85' ' ' SER . . . 178.92 -175.08 47.09 Favored Glycine 0 N--CA 1.491 2.317 0 N-CA-C 109.491 -1.444 . . . . 0.0 109.491 -179.974 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 81.7 m-20 -94.44 139.39 31.19 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.313 -1.11 . . . . 0.0 109.468 179.941 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 64' ' ' ILE . . . . . 0.457 ' HA ' ' O ' ' A' ' 79' ' ' THR . 63.7 mt -102.3 130.43 52.18 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.522 0 O-C-N 121.244 -0.91 . . . . 0.0 109.551 -179.92 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 65' ' ' ILE . . . . . 0.756 HD11 ' HA3' ' A' ' 39' ' ' GLY . 19.0 pt -95.94 -18.86 6.44 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.617 0 O-C-N 121.247 -0.908 . . . . 0.0 109.521 -179.989 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 66' ' ' ASP . . . . . 0.474 ' HB3' ' OG1' ' A' ' 79' ' ' THR . 52.1 t0 -145.57 144.46 30.51 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.227 -0.921 . . . . 0.0 109.585 179.904 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 67' ' ' LEU . . . . . 0.703 ' C ' HD13 ' A' ' 67' ' ' LEU . 2.5 tm? -126.09 110.45 13.54 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.303 -0.873 . . . . 0.0 109.218 179.94 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 68' ' ' SER . . . . . 0.519 ' N ' HD13 ' A' ' 67' ' ' LEU . 3.1 m -118.25 134.92 54.6 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.288 -0.883 . . . . 0.0 109.604 -179.73 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 69' ' ' MET . . . . . 0.499 ' SD ' ' HB1' ' A' ' 76' ' ' ALA . 77.7 mmm -120.57 146.47 46.3 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.33 -0.856 . . . . 0.0 109.327 179.86 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 70' ' ' ASP . . . . . 0.479 ' C ' ' HD2' ' A' ' 72' ' ' PRO . 0.1 OUTLIER -129.38 93.93 34.36 Favored Pre-proline 0 N--CA 1.491 1.582 0 O-C-N 121.147 -0.971 . . . . 0.0 109.491 -179.988 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 71' ' ' PRO . . . . . 0.593 ' N ' ' CD ' ' A' ' 72' ' ' PRO . 47.6 Cg_endo -74.93 -27.78 9.87 Favored 'Trans proline' 0 CA--C 1.543 0.936 0 C-N-CA 122.596 2.198 . . . . 0.0 113.738 179.968 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 72' ' ' PRO . . . . . 0.593 ' CD ' ' N ' ' A' ' 71' ' ' PRO . 55.2 Cg_endo -74.9 -21.5 16.03 Favored 'Trans proline' 0 C--N 1.353 0.804 0 C-N-CA 121.511 1.474 . . . . 0.0 111.86 -179.774 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 93.7 mtt-85 -115.31 4.29 14.4 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.243 -0.911 . . . . 0.0 109.591 -179.954 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 78.4 m-20 59.28 48.18 10.54 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.184 -0.948 . . . . 0.0 109.521 179.961 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 75' ' ' CYS . . . . . 0.472 ' O ' ' HB2' ' A' ' 70' ' ' ASP . 27.7 p -151.81 153.97 35.28 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.212 -0.93 . . . . 0.0 109.565 179.976 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 76' ' ' ALA . . . . . 0.499 ' HB1' ' SD ' ' A' ' 69' ' ' MET . . . -127.21 159.62 33.75 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.27 -0.894 . . . . 0.0 109.32 179.86 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 77' ' ' PHE . . . . . 0.48 ' HA ' ' O ' ' A' ' 42' ' ' LEU . 96.4 m-85 -125.19 126.21 44.86 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.255 -0.903 . . . . 0.0 109.571 -179.976 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 78' ' ' VAL . . . . . 0.856 ' O ' HD12 ' A' ' 42' ' ' LEU . 60.7 t -118.28 141.68 36.48 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.51 0 O-C-N 121.221 -0.924 . . . . 0.0 109.48 -179.984 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 79' ' ' THR . . . . . 0.575 HG22 ' CA ' ' A' ' 39' ' ' GLY . 26.1 m -109.1 127.85 54.5 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.275 -0.891 . . . . 0.0 109.495 179.836 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 80' ' ' TYR . . . . . 0.474 ' OH ' ' HB2' ' A' ' 61' ' ' PHE . 0.6 OUTLIER -103.76 148.93 25.5 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.337 -0.852 . . . . 0.0 109.511 -179.879 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 81' ' ' GLU . . . . . 0.452 ' O ' ' CD ' ' A' ' 38' ' ' LYS . 81.7 tt0 -75.11 -22.66 58.07 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.271 -0.893 . . . . 0.0 109.27 179.842 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 31.1 mttp -131.6 136.26 47.64 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.308 -0.87 . . . . 0.0 109.378 179.9 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 83' ' ' MET . . . . . 0.625 ' HE2' ' N ' ' A' ' 117' ' ' ALA . 49.5 mtt -60.89 -17.29 49.78 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.211 -0.931 . . . . 0.0 109.464 -179.926 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 97.7 mt-10 -71.13 -42.18 69.53 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.244 -0.91 . . . . 0.0 109.512 179.992 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 85' ' ' SER . . . . . 0.442 ' OG ' ' HA3' ' A' ' 62' ' ' GLY . 44.0 t -60.27 -39.49 87.02 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.212 -0.93 . . . . 0.0 109.465 179.975 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 86' ' ' ALA . . . . . 0.636 ' HA ' HD21 ' A' ' 42' ' ' LEU . . . -64.19 -42.12 96.79 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.266 -0.896 . . . . 0.0 109.505 -179.99 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 57.0 t0 -65.7 -39.81 91.63 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.28 -0.888 . . . . 0.0 109.577 -179.942 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 88' ' ' GLN . . . . . 0.437 ' HG2' ' CD2' ' A' ' 61' ' ' PHE . 52.2 tt0 -69.28 -41.48 76.78 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.187 -0.946 . . . . 0.0 109.613 -179.928 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 89' ' ' ALA . . . . . 0.482 ' HA ' ' CD2' ' A' ' 61' ' ' PHE . . . -74.35 -43.14 57.85 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.247 -0.908 . . . . 0.0 109.618 -179.9 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 90' ' ' VAL . . . . . 0.783 HG22 HG12 ' A' ' 105' ' ' VAL . 54.2 t -60.21 -33.04 52.13 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 O-C-N 121.229 -0.919 . . . . 0.0 109.756 -179.785 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -80.37 -51.05 9.32 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.144 -0.973 . . . . 0.0 110.122 -179.61 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 92' ' ' GLU . . . . . 0.583 ' HB2' ' CE2' ' A' ' 61' ' ' PHE . 76.1 mm-40 -72.69 -43.72 62.7 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.184 -0.948 . . . . 0.0 110.116 -179.368 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 93' ' ' LEU . . . . . 0.91 ' HB2' HG21 ' A' ' 105' ' ' VAL . 24.3 mt -68.69 -36.07 78.02 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.168 -0.957 . . . . 0.0 109.898 -179.508 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 94' ' ' ASN . . . . . 0.53 ' CB ' ' O ' ' A' ' 90' ' ' VAL . 53.1 t-20 -76.73 130.8 38.22 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.142 -0.974 . . . . 0.0 109.417 -179.891 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 94.66 20.55 28.79 Favored Glycine 0 N--CA 1.491 2.314 0 N-CA-C 109.64 -1.384 . . . . 0.0 109.64 179.89 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 96' ' ' THR . . . . . 0.438 ' CG2' ' O ' ' A' ' 92' ' ' GLU . 19.4 p -118.52 156.4 29.18 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.148 -1.207 . . . . 0.0 109.483 179.928 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 64.4 tt0 -126.18 152.27 46.23 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.241 -0.912 . . . . 0.0 109.434 -179.965 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 98' ' ' VAL . . . . . 0.595 HG12 ' H ' ' A' ' 99' ' ' GLU . 1.0 OUTLIER -100.22 -158.18 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 O-C-N 121.292 -0.88 . . . . 0.0 109.359 -179.943 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 99' ' ' GLU . . . . . 0.595 ' H ' HG12 ' A' ' 98' ' ' VAL . 76.1 mm-40 -55.51 -39.5 70.57 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.245 -0.91 . . . . 0.0 109.535 179.984 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 31.0 t -159.66 28.29 0.19 Allowed 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.267 -0.896 . . . . 0.0 109.44 -179.947 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 101' ' ' VAL . . . . . 0.558 ' O ' HG23 ' A' ' 98' ' ' VAL . 60.7 t -140.17 148.19 22.8 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.543 0 O-C-N 121.258 -0.901 . . . . 0.0 109.471 179.971 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 90.9 mt-30 -95.51 143.36 26.89 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.239 -0.913 . . . . 0.0 109.529 -179.911 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 103' ' ' LEU . . . . . 0.426 ' HA ' HD23 ' A' ' 103' ' ' LEU . 82.3 mt -109.7 136.48 48.97 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.284 -0.885 . . . . 0.0 109.404 179.926 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 104' ' ' LYS . . . . . 0.454 ' O ' ' HA ' ' A' ' 44' ' ' VAL . 42.9 mttt -126.05 128.82 48.0 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.182 -0.949 . . . . 0.0 109.509 -179.952 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 105' ' ' VAL . . . . . 0.91 HG21 ' HB2' ' A' ' 93' ' ' LEU . 21.4 t -121.18 145.16 28.14 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.52 0 O-C-N 121.233 -0.917 . . . . 0.0 109.34 179.9 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 106' ' ' ASN . . . . . 0.464 ' OD1' ' O ' ' A' ' 105' ' ' VAL . 81.8 m-20 -158.55 -165.7 1.73 Allowed 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.216 -0.928 . . . . 0.0 109.497 -179.901 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 27.2 mm -106.04 123.62 60.78 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.564 0 O-C-N 121.297 -0.877 . . . . 0.0 109.474 179.892 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 108' ' ' ALA . . . . . 0.65 ' HB3' HG22 ' A' ' 41' ' ' THR . . . -92.42 -156.71 0.48 Allowed 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.26 -0.9 . . . . 0.0 109.549 -179.936 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 46.0 mtm105 -47.07 164.85 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.248 -0.907 . . . . 0.0 109.468 179.95 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 30.0 mttt -81.77 7.31 12.96 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.127 -0.983 . . . . 0.0 109.59 -179.91 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 111' ' ' GLN . . . . . 0.417 ' HG2' ' O ' ' A' ' 39' ' ' GLY . 10.1 tp-100 55.76 100.29 0.04 OUTLIER Pre-proline 0 N--CA 1.491 1.59 0 O-C-N 121.245 -0.909 . . . . 0.0 109.467 179.903 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 112' ' ' PRO . . . . . 0.44 ' O ' ' C ' ' A' ' 113' ' ' MET . 51.2 Cg_endo -71.17 -27.2 20.31 Favored 'Trans proline' 0 C--O 1.214 -0.683 0 C-N-CA 122.608 2.205 . . . . 0.0 111.755 179.875 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 113' ' ' MET . . . . . 0.559 ' HE3' ' HB3' ' A' ' 114' ' ' LEU . 0.0 OUTLIER -43.81 -27.61 0.35 Allowed 'General case' 0 N--CA 1.489 1.491 0 N-CA-C 108.677 -0.86 . . . . 0.0 108.677 179.628 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 114' ' ' LEU . . . . . 1.055 HD12 ' HA ' ' A' ' 38' ' ' LYS . 0.9 OUTLIER -169.03 27.21 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.229 -0.919 . . . . 0.0 109.158 179.667 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 115' ' ' ASP . . . . . 0.708 ' O ' ' HB3' ' A' ' 116' ' ' ALA . 88.3 m-20 52.21 37.34 21.68 Favored 'General case' 0 N--CA 1.488 1.437 0 O-C-N 121.017 -1.052 . . . . 0.0 108.966 -179.711 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 116' ' ' ALA . . . . . 0.708 ' HB3' ' O ' ' A' ' 115' ' ' ASP . . . 77.03 -77.61 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.393 -0.817 . . . . 0.0 109.416 -179.811 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 117' ' ' ALA . . . . . 0.625 ' N ' ' HE2' ' A' ' 83' ' ' MET . . . -167.77 65.95 0.08 Allowed 'General case' 0 C--N 1.302 -1.491 0 O-C-N 121.201 -0.937 . . . . 0.0 109.719 -179.882 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 17.7 p -121.96 162.0 21.87 Favored 'General case' 0 C--N 1.303 -1.422 0 O-C-N 121.091 -1.006 . . . . 0.0 109.399 179.915 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 80.69 18.5 70.38 Favored Glycine 0 N--CA 1.49 2.251 0 N-CA-C 109.397 -1.481 . . . . 0.0 109.397 -179.874 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 22.4 mtmt -53.18 -33.31 52.09 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.288 -1.125 . . . . 0.0 109.503 -179.967 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.49 1.538 0 CA-C-O 118.019 -0.991 . . . . 0.0 109.433 -179.925 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 40' ' ' ASN . . . . . 0.429 ' N ' ' O ' ' A' ' 80' ' ' TYR . 40.8 t-20 . . . . . 0 N--CA 1.49 1.564 0 N-CA-C 109.423 -0.584 . . . . 0.0 109.423 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 41' ' ' THR . . . . . 0.449 ' O ' HD23 ' A' ' 42' ' ' LEU . 53.2 m -69.54 134.35 48.73 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.27 -0.894 . . . . 0.0 109.595 -179.861 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . 0.695 HD11 ' CD2' ' A' ' 80' ' ' TYR . 16.6 mt -115.63 146.78 41.49 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.252 -0.905 . . . . 0.0 109.372 179.97 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 43' ' ' TYR . . . . . 0.455 ' O ' ' HA ' ' A' ' 105' ' ' VAL . 74.4 t80 -97.33 124.08 41.35 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.246 -0.908 . . . . 0.0 109.551 -179.977 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 44' ' ' VAL . . . . . 0.623 HG13 HD23 ' A' ' 103' ' ' LEU . 53.4 t -120.84 134.49 64.09 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.558 0 O-C-N 121.274 -0.891 . . . . 0.0 109.401 179.897 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 76.3 t80 -124.25 137.21 54.54 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.241 -0.912 . . . . 0.0 109.524 -179.876 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -178.23 -177.5 46.99 Favored Glycine 0 N--CA 1.491 2.302 0 N-CA-C 109.465 -1.454 . . . . 0.0 109.465 -179.989 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . 0.422 ' O ' ' C ' ' A' ' 48' ' ' ASP . 95.2 mt-10 -118.68 155.25 31.37 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.272 -1.134 . . . . 0.0 109.482 179.957 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 48' ' ' ASP . . . . . 0.422 ' C ' ' O ' ' A' ' 47' ' ' GLU . 47.6 m-20 43.89 48.01 7.02 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.282 -0.886 . . . . 0.0 109.54 179.961 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 58.5 mtm -93.26 143.31 26.38 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.208 -0.932 . . . . 0.0 109.509 179.954 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 50' ' ' THR . . . . . 0.786 ' O ' HD12 ' A' ' 54' ' ' LEU . 0.1 OUTLIER -118.42 166.29 14.25 Favored Pre-proline 0 N--CA 1.491 1.577 0 O-C-N 121.236 -0.915 . . . . 0.0 109.421 179.98 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 49.6 Cg_endo -70.02 -50.47 0.43 Allowed 'Trans proline' 0 C--O 1.214 -0.678 0 C-N-CA 122.713 2.275 . . . . 0.0 111.819 -179.916 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 39.8 m -58.55 -42.16 87.23 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.243 -0.911 . . . . 0.0 109.516 179.976 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 15.2 tp -61.31 -50.86 71.26 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.253 -0.905 . . . . 0.0 109.481 179.986 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 54' ' ' LEU . . . . . 0.786 HD12 ' O ' ' A' ' 50' ' ' THR . 4.2 mt -59.92 -42.75 94.58 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.232 -0.917 . . . . 0.0 109.442 179.954 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 55' ' ' ARG . . . . . 0.457 ' O ' ' CB ' ' A' ' 59' ' ' SER . 48.7 ttt85 -57.19 -32.93 66.95 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.217 -0.927 . . . . 0.0 109.433 179.908 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -76.21 -33.09 50.33 Favored Glycine 0 N--CA 1.49 2.259 0 N-CA-C 109.403 -1.479 . . . . 0.0 109.403 180.0 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . 0.551 ' O ' ' CD1' ' A' ' 61' ' ' PHE . . . -73.14 -19.75 61.06 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.314 -1.11 . . . . 0.0 109.411 -179.998 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 58' ' ' PHE . . . . . 0.694 ' CZ ' HD13 ' A' ' 93' ' ' LEU . 96.7 m-85 -121.62 4.37 10.1 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.211 -0.931 . . . . 0.0 109.482 179.914 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 59' ' ' SER . . . . . 0.534 ' N ' ' HD2' ' A' ' 60' ' ' PRO . 0.3 OUTLIER -72.21 -57.31 3.78 Favored Pre-proline 0 N--CA 1.49 1.546 0 O-C-N 121.215 -0.928 . . . . 0.0 109.762 -179.859 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 60' ' ' PRO . . . . . 0.534 ' HD2' ' N ' ' A' ' 59' ' ' SER . 48.9 Cg_endo -69.52 -30.93 22.59 Favored 'Trans proline' 0 C--O 1.214 -0.678 0 C-N-CA 122.637 2.225 . . . . 0.0 111.94 -179.818 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 61' ' ' PHE . . . . . 0.569 ' CD2' ' HA ' ' A' ' 89' ' ' ALA . 62.6 m-85 -62.92 -33.01 74.42 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.241 -0.912 . . . . 0.0 109.455 179.974 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 173.39 -175.47 46.16 Favored Glycine 0 N--CA 1.49 2.264 0 N-CA-C 109.411 -1.476 . . . . 0.0 109.411 179.985 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 38.7 t30 -92.22 141.4 28.62 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.266 -1.138 . . . . 0.0 109.506 179.961 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 64' ' ' ILE . . . . . 0.575 HD13 HD13 ' A' ' 67' ' ' LEU . 71.4 mt -103.83 130.04 54.99 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.521 0 O-C-N 121.246 -0.909 . . . . 0.0 109.432 179.98 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 20.6 pt -94.54 -21.95 5.63 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.537 0 O-C-N 121.252 -0.905 . . . . 0.0 109.475 179.983 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 45.7 t0 -159.26 109.43 1.95 Allowed 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.277 -0.89 . . . . 0.0 109.508 -179.969 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . 0.964 HD11 HG22 ' A' ' 78' ' ' VAL . 0.6 OUTLIER -111.96 122.34 47.51 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.259 -0.901 . . . . 0.0 109.367 179.937 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 38.1 m -117.94 150.78 38.66 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.235 -0.915 . . . . 0.0 109.637 -179.917 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 69' ' ' MET . . . . . 0.403 ' CE ' ' CD1' ' A' ' 54' ' ' LEU . 85.6 mtp -123.74 143.59 50.2 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.229 -0.919 . . . . 0.0 109.408 179.926 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 70' ' ' ASP . . . . . 0.476 ' C ' ' HD2' ' A' ' 72' ' ' PRO . 1.7 m-20 -122.31 105.88 36.2 Favored Pre-proline 0 N--CA 1.491 1.615 0 O-C-N 121.268 -0.895 . . . . 0.0 109.493 -179.976 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 71' ' ' PRO . . . . . 0.606 ' N ' ' CD ' ' A' ' 72' ' ' PRO . 47.1 Cg_endo -74.54 -27.9 10.52 Favored 'Trans proline' 0 CA--C 1.543 0.941 0 C-N-CA 122.511 2.141 . . . . 0.0 113.686 179.99 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 72' ' ' PRO . . . . . 0.606 ' CD ' ' N ' ' A' ' 71' ' ' PRO . 55.1 Cg_endo -75.41 -29.11 7.93 Favored 'Trans proline' 0 C--N 1.353 0.793 0 C-N-CA 121.511 1.474 . . . . 0.0 111.733 -179.794 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 73' ' ' ARG . . . . . 0.432 ' O ' ' HB2' ' A' ' 74' ' ' ASN . 61.8 mtt-85 -107.89 -4.22 18.18 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.267 -0.896 . . . . 0.0 109.622 -179.919 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 74' ' ' ASN . . . . . 0.432 ' HB2' ' O ' ' A' ' 73' ' ' ARG . 84.5 m-20 61.7 36.41 16.46 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.231 -0.918 . . . . 0.0 109.493 -179.967 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 75' ' ' CYS . . . . . 0.465 ' SG ' ' HB2' ' A' ' 70' ' ' ASP . 21.9 p -130.85 137.09 49.22 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.266 -0.896 . . . . 0.0 109.477 -180.0 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -110.28 148.3 32.17 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.264 -0.897 . . . . 0.0 109.421 179.998 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 77' ' ' PHE . . . . . 0.465 ' HA ' ' O ' ' A' ' 42' ' ' LEU . 96.9 m-85 -114.2 132.08 56.24 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.214 -0.929 . . . . 0.0 109.528 179.989 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . 0.964 HG22 HD11 ' A' ' 67' ' ' LEU . 39.5 t -123.13 128.9 75.2 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 O-C-N 121.239 -0.913 . . . . 0.0 109.474 179.966 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 79' ' ' THR . . . . . 0.449 ' O ' ' HA ' ' A' ' 64' ' ' ILE . 17.5 m -101.18 132.2 46.78 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.245 -0.91 . . . . 0.0 109.437 -179.994 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 80' ' ' TYR . . . . . 0.695 ' CD2' HD11 ' A' ' 42' ' ' LEU . 1.5 m-85 -112.11 145.93 38.91 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.241 -0.912 . . . . 0.0 109.491 -179.942 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 83.4 tt0 -70.9 -28.97 64.93 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.21 -0.931 . . . . 0.0 109.423 179.817 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 44.2 mttm -124.58 145.99 49.29 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.301 -0.875 . . . . 0.0 109.391 179.956 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 83' ' ' MET . . . . . . . . . . . . . 44.1 mtt -64.62 -22.6 67.02 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.241 -0.912 . . . . 0.0 109.468 179.992 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 97.6 mt-10 -69.92 -37.68 76.01 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.204 -0.935 . . . . 0.0 109.525 -179.953 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 85' ' ' SER . . . . . 0.426 ' HB2' ' CG ' ' A' ' 80' ' ' TYR . 17.3 m -59.92 -34.11 72.77 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.271 -0.893 . . . . 0.0 109.489 179.995 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 86' ' ' ALA . . . . . 0.56 ' CB ' HD21 ' A' ' 42' ' ' LEU . . . -79.63 -28.64 40.89 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.266 -0.897 . . . . 0.0 109.518 -179.959 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 87' ' ' ASP . . . . . 0.425 ' O ' ' CB ' ' A' ' 91' ' ' ALA . 94.4 m-20 -67.11 -44.6 79.51 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.257 -0.902 . . . . 0.0 109.517 -179.923 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 88' ' ' GLN . . . . . 0.52 ' HG2' ' CE2' ' A' ' 61' ' ' PHE . 62.5 tt0 -72.16 -39.38 68.76 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.218 -0.926 . . . . 0.0 109.448 -179.942 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 89' ' ' ALA . . . . . 0.569 ' HA ' ' CD2' ' A' ' 61' ' ' PHE . . . -73.96 -45.71 48.53 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.243 -0.911 . . . . 0.0 109.552 -179.98 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 90' ' ' VAL . . . . . 0.698 HG22 HG11 ' A' ' 105' ' ' VAL . 65.7 t -69.75 -36.12 68.53 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.574 0 O-C-N 121.237 -0.915 . . . . 0.0 109.551 -179.935 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 91' ' ' ALA . . . . . 0.425 ' CB ' ' O ' ' A' ' 87' ' ' ASP . . . -79.02 -40.48 31.32 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.295 -0.878 . . . . 0.0 109.647 -179.866 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 92' ' ' GLU . . . . . 0.537 ' OE1' ' CE2' ' A' ' 61' ' ' PHE . 40.1 tt0 -77.29 -42.67 36.04 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.221 -0.924 . . . . 0.0 109.527 -179.866 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 93' ' ' LEU . . . . . 0.694 HD13 ' CZ ' ' A' ' 58' ' ' PHE . 51.2 mt -69.97 -40.87 75.11 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.226 -0.921 . . . . 0.0 109.502 -179.942 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 94' ' ' ASN . . . . . 0.486 ' HB2' ' O ' ' A' ' 90' ' ' VAL . 63.4 t-20 -64.49 130.03 42.13 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.218 -0.926 . . . . 0.0 109.506 179.975 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 88.82 26.99 25.33 Favored Glycine 0 N--CA 1.49 2.257 0 N-CA-C 109.507 -1.437 . . . . 0.0 109.507 179.978 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 96' ' ' THR . . . . . 0.433 HG23 ' O ' ' A' ' 93' ' ' LEU . 27.2 p -124.29 144.62 49.88 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.212 -1.169 . . . . 0.0 109.557 179.932 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 97' ' ' GLN . . . . . 0.464 ' HG3' ' O ' ' A' ' 101' ' ' VAL . 56.0 tt0 -119.5 142.01 48.68 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.345 -0.847 . . . . 0.0 109.412 179.972 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 98' ' ' VAL . . . . . 0.53 HG12 ' H ' ' A' ' 99' ' ' GLU . 1.0 OUTLIER -85.23 -154.31 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 O-C-N 121.188 -0.945 . . . . 0.0 109.374 -179.91 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 99' ' ' GLU . . . . . 0.53 ' H ' HG12 ' A' ' 98' ' ' VAL . 96.4 mt-10 -58.8 -40.97 85.63 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.242 -0.911 . . . . 0.0 109.477 179.997 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 100' ' ' SER . . . . . 0.463 ' O ' ' OG ' ' A' ' 100' ' ' SER . 4.4 t -153.72 24.75 0.51 Allowed 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.295 -0.878 . . . . 0.0 109.394 -179.996 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 101' ' ' VAL . . . . . 0.604 HG12 ' N ' ' A' ' 102' ' ' GLN . 53.4 t -137.01 167.85 22.78 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.521 0 O-C-N 121.285 -0.885 . . . . 0.0 109.442 -179.957 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 102' ' ' GLN . . . . . 0.604 ' N ' HG12 ' A' ' 101' ' ' VAL . 93.7 mt-30 -123.83 149.8 45.31 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.233 -0.917 . . . . 0.0 109.264 179.909 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 103' ' ' LEU . . . . . 0.623 HD23 HG13 ' A' ' 44' ' ' VAL . 0.0 OUTLIER -120.08 121.23 38.41 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.135 -0.978 . . . . 0.0 109.777 -179.859 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 29.9 mttt -106.49 131.67 53.4 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.314 -0.866 . . . . 0.0 109.24 179.81 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 105' ' ' VAL . . . . . 0.698 HG11 HG22 ' A' ' 90' ' ' VAL . 15.6 t . . . . . 0 N--CA 1.49 1.572 0 O-C-N 121.195 -0.941 . . . . 0.0 109.665 -179.842 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 40' ' ' ASN . . . . . 0.476 ' O ' ' HA ' ' A' ' 79' ' ' THR . 47.1 t-20 . . . . . 0 N--CA 1.49 1.572 0 N-CA-C 109.191 -0.67 . . . . 0.0 109.191 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 41' ' ' THR . . . . . 0.477 ' HA ' ' O ' ' A' ' 78' ' ' VAL . 86.8 m -84.81 141.56 30.39 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.219 -0.925 . . . . 0.0 109.645 -179.714 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . 0.844 HD12 ' O ' ' A' ' 78' ' ' VAL . 5.1 mp -119.03 148.72 42.7 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.274 -0.891 . . . . 0.0 109.375 179.91 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 62.5 t80 -102.18 113.57 26.96 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.248 -0.908 . . . . 0.0 109.61 -179.927 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 44' ' ' VAL . . . . . 0.525 HG13 HD23 ' A' ' 103' ' ' LEU . 17.7 t -109.47 138.79 35.24 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.573 0 O-C-N 121.272 -0.892 . . . . 0.0 109.483 179.978 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 73.9 t80 -134.12 132.6 40.08 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.247 -0.908 . . . . 0.0 109.571 -179.922 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -175.74 -167.18 34.35 Favored Glycine 0 N--CA 1.49 2.269 0 N-CA-C 109.488 -1.445 . . . . 0.0 109.488 179.99 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . 0.49 ' H ' HG11 ' A' ' 101' ' ' VAL . 89.9 mt-10 -116.92 157.85 25.02 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.2 -1.177 . . . . 0.0 109.392 -179.948 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 48' ' ' ASP . . . . . 0.404 ' C ' ' O ' ' A' ' 47' ' ' GLU . 23.0 t70 44.01 42.35 4.68 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.301 -0.874 . . . . 0.0 109.382 -179.992 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 49' ' ' MET . . . . . 0.409 ' HE1' HG12 ' A' ' 44' ' ' VAL . 54.4 mtp -73.9 139.44 44.97 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.234 -0.916 . . . . 0.0 109.549 179.943 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 50' ' ' THR . . . . . 0.668 ' O ' HD12 ' A' ' 54' ' ' LEU . 5.1 p -126.14 162.66 44.62 Favored Pre-proline 0 N--CA 1.49 1.566 0 O-C-N 121.336 -0.853 . . . . 0.0 109.425 179.996 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 51' ' ' PRO . . . . . 0.455 ' CA ' ' SD ' ' A' ' 69' ' ' MET . 49.4 Cg_endo -70.22 -50.73 0.39 Allowed 'Trans proline' 0 C--O 1.215 -0.65 0 C-N-CA 122.625 2.217 . . . . 0.0 111.73 -179.983 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 41.2 m -60.77 -40.74 93.65 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.225 -0.922 . . . . 0.0 109.422 179.951 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 15.7 tp -66.53 -46.88 74.7 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.298 -0.876 . . . . 0.0 109.36 179.985 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 54' ' ' LEU . . . . . 0.668 HD12 ' O ' ' A' ' 50' ' ' THR . 10.8 mt -58.24 -46.33 86.14 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.313 -0.867 . . . . 0.0 109.318 179.944 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 55' ' ' ARG . . . . . 0.509 ' O ' ' N ' ' A' ' 59' ' ' SER . 74.0 mtt180 -56.64 -36.7 69.79 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.282 -0.886 . . . . 0.0 109.543 179.995 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -67.64 -32.89 79.4 Favored Glycine 0 N--CA 1.49 2.294 0 N-CA-C 109.554 -1.418 . . . . 0.0 109.554 179.948 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . 0.455 ' O ' ' CD1' ' A' ' 61' ' ' PHE . . . -73.31 -23.83 60.31 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.266 -1.138 . . . . 0.0 109.411 -179.917 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 58' ' ' PHE . . . . . 0.807 ' HB2' HD11 ' A' ' 64' ' ' ILE . 98.6 m-85 -118.95 8.51 11.67 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.33 -0.856 . . . . 0.0 109.46 -179.98 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 59' ' ' SER . . . . . 0.53 ' N ' ' HD2' ' A' ' 60' ' ' PRO . 1.1 t -74.5 -57.51 2.06 Favored Pre-proline 0 N--CA 1.491 1.598 0 O-C-N 121.238 -0.914 . . . . 0.0 109.852 -179.715 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 60' ' ' PRO . . . . . 0.53 ' HD2' ' N ' ' A' ' 59' ' ' SER . 50.3 Cg_endo -69.84 -32.27 18.54 Favored 'Trans proline' 0 C--O 1.215 -0.627 0 C-N-CA 122.601 2.2 . . . . 0.0 111.945 -179.783 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 61' ' ' PHE . . . . . 0.577 ' CE2' ' HA ' ' A' ' 89' ' ' ALA . 67.6 m-85 -63.61 -31.82 73.11 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.163 -0.961 . . . . 0.0 109.406 -179.946 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 171.22 -176.7 44.46 Favored Glycine 0 N--CA 1.49 2.278 0 N-CA-C 109.634 -1.387 . . . . 0.0 109.634 -179.993 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 82.9 m-20 -90.04 145.15 25.29 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.302 -1.117 . . . . 0.0 109.461 179.991 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 64' ' ' ILE . . . . . 0.807 HD11 ' HB2' ' A' ' 58' ' ' PHE . 77.6 mt -106.85 131.3 57.11 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.525 0 O-C-N 121.3 -0.875 . . . . 0.0 109.619 -179.973 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 65' ' ' ILE . . . . . 0.64 HD11 HG21 ' A' ' 79' ' ' THR . 28.2 pt -91.76 -22.85 5.94 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.599 0 O-C-N 121.3 -0.875 . . . . 0.0 109.393 179.948 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 66' ' ' ASP . . . . . 0.456 ' HB3' ' OG1' ' A' ' 79' ' ' THR . 53.6 t0 -149.5 115.3 5.64 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.239 -0.913 . . . . 0.0 109.467 -179.927 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . 0.701 HD23 HD13 ' A' ' 64' ' ' ILE . 0.5 OUTLIER -103.87 114.86 29.42 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.263 -0.898 . . . . 0.0 109.505 179.999 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 68' ' ' SER . . . . . 0.643 ' N ' HD13 ' A' ' 67' ' ' LEU . 39.2 t -119.5 149.72 41.43 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.176 -0.952 . . . . 0.0 109.53 179.978 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 69' ' ' MET . . . . . 0.455 ' SD ' ' CA ' ' A' ' 51' ' ' PRO . 77.2 mtp -128.46 148.91 50.76 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.309 -0.869 . . . . 0.0 109.472 -179.983 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 70' ' ' ASP . . . . . 0.516 ' CB ' ' O ' ' A' ' 75' ' ' CYS . 0.4 OUTLIER -127.84 94.66 36.59 Favored Pre-proline 0 N--CA 1.49 1.572 0 O-C-N 121.272 -0.892 . . . . 0.0 109.421 179.967 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 71' ' ' PRO . . . . . 0.593 ' N ' ' CD ' ' A' ' 72' ' ' PRO . 47.4 Cg_endo -74.66 -27.93 10.26 Favored 'Trans proline' 0 CA--C 1.542 0.922 0 C-N-CA 122.564 2.176 . . . . 0.0 113.584 179.98 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 72' ' ' PRO . . . . . 0.593 ' CD ' ' N ' ' A' ' 71' ' ' PRO . 55.4 Cg_endo -75.49 -21.44 14.97 Favored 'Trans proline' 0 C--N 1.352 0.761 0 C-N-CA 121.46 1.44 . . . . 0.0 111.797 -179.86 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 67.8 mtt85 -115.23 3.66 14.33 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.252 -0.905 . . . . 0.0 109.7 -179.878 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 78.6 m-20 60.12 44.64 12.72 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.234 -0.916 . . . . 0.0 109.474 179.958 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 75' ' ' CYS . . . . . 0.516 ' O ' ' CB ' ' A' ' 70' ' ' ASP . 28.0 p -149.86 153.2 36.34 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.26 -0.9 . . . . 0.0 109.566 -179.942 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -127.8 159.36 35.07 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.291 -0.88 . . . . 0.0 109.35 179.899 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 77' ' ' PHE . . . . . 0.476 ' HA ' ' O ' ' A' ' 42' ' ' LEU . 96.3 m-85 -120.94 136.79 54.87 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.179 -0.951 . . . . 0.0 109.533 179.997 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . 0.844 ' O ' HD12 ' A' ' 42' ' ' LEU . 39.7 t -125.45 135.14 64.93 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 O-C-N 121.247 -0.908 . . . . 0.0 109.546 -179.974 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 79' ' ' THR . . . . . 0.64 HG21 HD11 ' A' ' 65' ' ' ILE . 17.3 m -104.03 127.43 51.59 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.287 -0.883 . . . . 0.0 109.451 179.964 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 80' ' ' TYR . . . . . 0.504 ' CG ' ' HB2' ' A' ' 85' ' ' SER . 1.2 m-85 -108.44 139.82 42.63 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.273 -0.892 . . . . 0.0 109.507 179.958 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 76.8 tt0 -61.35 -24.43 66.46 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.232 -0.917 . . . . 0.0 109.326 179.867 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 42.8 mttm -134.18 144.61 48.59 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.28 -0.887 . . . . 0.0 109.32 179.948 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 83' ' ' MET . . . . . . . . . . . . . 53.8 mtt -65.55 -17.56 64.67 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.17 -0.956 . . . . 0.0 109.548 -179.912 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 97.4 mt-10 -69.98 -35.13 74.19 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.232 -0.918 . . . . 0.0 109.468 -179.924 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 85' ' ' SER . . . . . 0.504 ' HB2' ' CG ' ' A' ' 80' ' ' TYR . 18.0 m -66.84 -30.42 70.59 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.252 -0.905 . . . . 0.0 109.468 -179.943 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 86' ' ' ALA . . . . . 0.76 ' HA ' HD21 ' A' ' 42' ' ' LEU . . . -79.17 -37.43 38.39 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.223 -0.923 . . . . 0.0 109.504 -179.96 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 55.4 t0 -61.78 -47.19 86.27 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.166 -0.959 . . . . 0.0 109.407 179.97 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 88' ' ' GLN . . . . . 0.469 ' O ' ' HB2' ' A' ' 92' ' ' GLU . 64.2 tt0 -67.88 -39.96 83.63 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.289 -0.882 . . . . 0.0 109.316 179.957 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 89' ' ' ALA . . . . . 0.577 ' HA ' ' CE2' ' A' ' 61' ' ' PHE . . . -71.72 -38.91 70.42 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.283 -0.886 . . . . 0.0 109.531 -179.967 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 90' ' ' VAL . . . . . 0.778 HG22 HG12 ' A' ' 105' ' ' VAL . 74.1 t -66.0 -45.33 91.12 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.616 0 O-C-N 121.309 -0.869 . . . . 0.0 109.627 -179.858 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -70.98 -34.51 71.46 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.196 -0.94 . . . . 0.0 109.667 -179.854 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 92' ' ' GLU . . . . . 0.536 ' HB3' ' CZ ' ' A' ' 61' ' ' PHE . 2.4 tm-20 -82.85 -49.3 9.83 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.28 -0.888 . . . . 0.0 109.617 -179.948 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 93' ' ' LEU . . . . . 1.058 ' HB2' HG21 ' A' ' 105' ' ' VAL . 85.3 mt -65.8 -35.0 79.46 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.222 -0.924 . . . . 0.0 109.598 -179.892 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 94' ' ' ASN . . . . . 0.524 ' CB ' ' O ' ' A' ' 90' ' ' VAL . 56.5 t-20 -71.71 130.51 41.33 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.277 -0.889 . . . . 0.0 109.463 -179.985 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 87.24 30.66 19.02 Favored Glycine 0 N--CA 1.489 2.204 0 N-CA-C 109.51 -1.436 . . . . 0.0 109.51 179.97 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 96' ' ' THR . . . . . 0.474 ' CG2' ' O ' ' A' ' 92' ' ' GLU . 28.8 p -122.56 148.08 45.63 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.228 -1.16 . . . . 0.0 109.523 -179.956 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 97' ' ' GLN . . . . . 0.442 ' HG3' ' O ' ' A' ' 101' ' ' VAL . 57.2 tt0 -118.6 143.22 46.94 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.309 -0.869 . . . . 0.0 109.444 -179.953 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 98' ' ' VAL . . . . . 0.49 HG12 ' H ' ' A' ' 99' ' ' GLU . 1.3 t -92.4 -148.84 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 O-C-N 121.256 -0.902 . . . . 0.0 109.368 179.975 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 99' ' ' GLU . . . . . 0.49 ' H ' HG12 ' A' ' 98' ' ' VAL . 96.7 mt-10 -57.61 -37.2 72.85 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.272 -0.893 . . . . 0.0 109.432 179.918 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 22.6 m -165.82 30.64 0.05 Allowed 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.27 -0.894 . . . . 0.0 109.319 179.965 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 101' ' ' VAL . . . . . 0.604 HG12 ' N ' ' A' ' 102' ' ' GLN . 44.4 t -137.73 168.88 19.89 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.5 0 O-C-N 121.34 -0.85 . . . . 0.0 109.465 -179.892 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 102' ' ' GLN . . . . . 0.604 ' N ' HG12 ' A' ' 101' ' ' VAL . 91.5 mt-30 -116.39 145.54 43.16 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.191 -0.943 . . . . 0.0 109.076 179.815 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 103' ' ' LEU . . . . . 0.525 HD23 HG13 ' A' ' 44' ' ' VAL . 0.0 OUTLIER -121.81 134.91 54.9 Favored 'General case' 0 N--CA 1.488 1.444 0 O-C-N 121.18 -0.95 . . . . 0.0 109.851 -179.628 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 60.5 mttt -118.07 126.65 52.68 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.343 -0.848 . . . . 0.0 109.234 179.769 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 105' ' ' VAL . . . . . 1.058 HG21 ' HB2' ' A' ' 93' ' ' LEU . 26.4 t . . . . . 0 N--CA 1.49 1.562 0 O-C-N 121.174 -0.953 . . . . 0.0 109.667 -179.82 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 40' ' ' ASN . . . . . 0.43 ' O ' ' HA ' ' A' ' 79' ' ' THR . 45.3 t-20 . . . . . 0 N--CA 1.49 1.561 0 N-CA-C 109.512 -0.551 . . . . 0.0 109.512 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 41' ' ' THR . . . . . 0.463 ' HA ' ' O ' ' A' ' 78' ' ' VAL . 60.2 m -81.0 143.67 32.35 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.274 -0.891 . . . . 0.0 109.54 179.973 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . 0.895 HD12 ' O ' ' A' ' 78' ' ' VAL . 5.0 mp -116.08 146.7 42.0 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.176 -0.952 . . . . 0.0 109.521 -179.931 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 35.4 t80 -106.08 112.58 25.67 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.177 -0.952 . . . . 0.0 109.513 -179.976 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 44' ' ' VAL . . . . . 0.473 ' HA ' ' O ' ' A' ' 104' ' ' LYS . 38.2 t -110.53 150.42 13.05 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.53 0 O-C-N 121.266 -0.896 . . . . 0.0 109.535 -179.919 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 70.0 t80 -141.68 138.92 32.79 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.2 -0.937 . . . . 0.0 109.606 179.9 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 177.29 -167.86 39.25 Favored Glycine 0 N--CA 1.49 2.289 0 N-CA-C 109.472 -1.451 . . . . 0.0 109.472 179.909 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . 0.423 ' O ' ' C ' ' A' ' 48' ' ' ASP . 89.0 mt-10 -115.66 161.98 17.9 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.275 -1.133 . . . . 0.0 109.42 179.945 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 48' ' ' ASP . . . . . 0.423 ' C ' ' O ' ' A' ' 47' ' ' GLU . 43.9 m-20 43.73 40.74 3.21 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.281 -0.887 . . . . 0.0 109.606 179.975 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 41.3 mtp -78.6 138.79 38.52 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.282 -0.886 . . . . 0.0 109.354 179.979 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 50' ' ' THR . . . . . 0.446 ' O ' ' HG ' ' A' ' 54' ' ' LEU . 0.4 OUTLIER -127.04 161.28 54.8 Favored Pre-proline 0 N--CA 1.49 1.56 0 O-C-N 121.252 -0.905 . . . . 0.0 109.533 179.94 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 50.2 Cg_endo -70.07 -51.94 0.33 Allowed 'Trans proline' 0 C--O 1.214 -0.688 0 C-N-CA 122.641 2.228 . . . . 0.0 111.815 -179.985 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 31.1 m -59.16 -41.2 87.83 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.214 -0.929 . . . . 0.0 109.41 179.904 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . 0.558 ' C ' HD23 ' A' ' 53' ' ' LEU . 9.0 tt -64.89 -44.44 89.63 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.305 -0.872 . . . . 0.0 109.467 179.987 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 54' ' ' LEU . . . . . 0.451 HD13 ' CB ' ' A' ' 76' ' ' ALA . 21.9 mt -63.93 -45.86 87.35 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.211 -0.931 . . . . 0.0 109.374 179.946 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 55' ' ' ARG . . . . . 0.454 ' O ' ' N ' ' A' ' 59' ' ' SER . 76.8 mtp180 -51.3 -41.33 60.42 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.235 -0.916 . . . . 0.0 109.358 179.965 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -69.44 -32.28 71.59 Favored Glycine 0 N--CA 1.49 2.253 0 N-CA-C 109.463 -1.455 . . . . 0.0 109.463 179.871 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -71.5 -23.72 61.85 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.339 -1.095 . . . . 0.0 109.398 179.934 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 58' ' ' PHE . . . . . 0.584 ' CE2' ' CD1' ' A' ' 93' ' ' LEU . 90.1 m-85 -120.62 10.11 10.98 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.365 -0.834 . . . . 0.0 109.453 -179.997 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 59' ' ' SER . . . . . 0.547 ' N ' ' HD2' ' A' ' 60' ' ' PRO . 3.4 t -76.78 -54.34 1.7 Allowed Pre-proline 0 N--CA 1.49 1.575 0 O-C-N 121.316 -0.865 . . . . 0.0 110.413 -179.505 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 60' ' ' PRO . . . . . 0.547 ' HD2' ' N ' ' A' ' 59' ' ' SER . 48.5 Cg_endo -69.97 -35.58 11.77 Favored 'Trans proline' 0 C--O 1.215 -0.644 0 C-N-CA 122.516 2.144 . . . . 0.0 112.251 -179.276 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 61' ' ' PHE . . . . . 0.663 ' CE2' HD21 ' A' ' 93' ' ' LEU . 70.0 m-85 -58.51 -39.29 79.67 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.183 -0.948 . . . . 0.0 109.631 -179.833 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 179.43 174.66 45.67 Favored Glycine 0 N--CA 1.49 2.239 0 N-CA-C 109.516 -1.434 . . . . 0.0 109.516 179.95 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 45.9 t-20 -80.18 140.9 36.13 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.263 -1.14 . . . . 0.0 109.414 179.93 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 64' ' ' ILE . . . . . 0.731 HD13 HD23 ' A' ' 67' ' ' LEU . 81.7 mt -100.78 131.04 49.16 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.52 0 O-C-N 121.223 -0.923 . . . . 0.0 109.542 -179.973 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 65' ' ' ILE . . . . . 0.456 HD11 HG21 ' A' ' 79' ' ' THR . 20.4 pt -92.82 -24.02 5.38 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 O-C-N 121.264 -0.898 . . . . 0.0 109.575 -179.841 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 18.7 t70 -149.44 113.79 5.24 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.239 -0.913 . . . . 0.0 109.621 -179.888 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . 0.731 HD23 HD13 ' A' ' 64' ' ' ILE . 0.4 OUTLIER -104.74 117.06 33.14 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.282 -0.886 . . . . 0.0 109.342 179.803 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 68' ' ' SER . . . . . 0.665 ' N ' HD13 ' A' ' 67' ' ' LEU . 25.9 t -128.36 148.87 50.7 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.291 -0.881 . . . . 0.0 109.566 -179.906 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 69' ' ' MET . . . . . . . . . . . . . 86.6 mtp -124.9 148.54 48.27 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.233 -0.917 . . . . 0.0 109.408 179.93 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 70' ' ' ASP . . . . . 0.498 ' CB ' ' O ' ' A' ' 75' ' ' CYS . 0.8 OUTLIER -120.77 100.03 46.78 Favored Pre-proline 0 N--CA 1.491 1.624 0 O-C-N 121.253 -0.904 . . . . 0.0 109.614 -179.931 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 71' ' ' PRO . . . . . 0.596 ' N ' ' CD ' ' A' ' 72' ' ' PRO . 47.9 Cg_endo -74.72 -27.85 10.22 Favored 'Trans proline' 0 CA--C 1.543 0.938 0 C-N-CA 122.543 2.162 . . . . 0.0 113.733 179.944 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 72' ' ' PRO . . . . . 0.596 ' CD ' ' N ' ' A' ' 71' ' ' PRO . 55.5 Cg_endo -75.36 -28.62 8.44 Favored 'Trans proline' 0 C--N 1.352 0.762 0 C-N-CA 121.462 1.441 . . . . 0.0 111.846 -179.91 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 73' ' ' ARG . . . . . 0.439 ' O ' ' HB2' ' A' ' 74' ' ' ASN . 55.3 mtt-85 -109.41 0.06 19.2 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.295 -0.878 . . . . 0.0 109.666 -179.826 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 74' ' ' ASN . . . . . 0.439 ' HB2' ' O ' ' A' ' 73' ' ' ARG . 83.5 m-20 61.14 41.25 13.84 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.126 -0.984 . . . . 0.0 109.544 179.984 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 75' ' ' CYS . . . . . 0.498 ' O ' ' CB ' ' A' ' 70' ' ' ASP . 30.0 p -140.93 137.01 32.8 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.183 -0.948 . . . . 0.0 109.627 179.99 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 76' ' ' ALA . . . . . 0.451 ' CB ' HD13 ' A' ' 54' ' ' LEU . . . -105.02 160.6 14.91 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.286 -0.884 . . . . 0.0 109.454 179.996 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 77' ' ' PHE . . . . . 0.475 ' HA ' ' O ' ' A' ' 42' ' ' LEU . 97.1 m-85 -124.33 130.07 51.84 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.207 -0.933 . . . . 0.0 109.487 -179.987 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . 0.895 ' O ' HD12 ' A' ' 42' ' ' LEU . 21.2 t -122.09 132.97 69.84 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.549 0 O-C-N 121.273 -0.892 . . . . 0.0 109.341 179.927 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 79' ' ' THR . . . . . 0.465 ' O ' ' HA ' ' A' ' 64' ' ' ILE . 6.8 m -106.01 135.86 46.71 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.238 -0.914 . . . . 0.0 109.36 -179.966 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 80' ' ' TYR . . . . . 0.52 ' OH ' ' CA ' ' A' ' 58' ' ' PHE . 1.6 m-85 -115.56 133.08 56.38 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.162 -0.961 . . . . 0.0 109.619 -179.932 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 76.8 tt0 -52.26 -25.81 10.32 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.339 -0.851 . . . . 0.0 109.537 179.959 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 67.6 mttm -134.23 132.97 40.33 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.176 -0.953 . . . . 0.0 109.617 -179.952 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 83' ' ' MET . . . . . . . . . . . . . 0.8 OUTLIER -57.38 -18.23 16.59 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.277 -0.889 . . . . 0.0 109.649 -179.964 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 99.5 mt-10 -65.76 -39.43 91.04 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.223 -0.923 . . . . 0.0 109.506 -179.922 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 13.9 t -63.58 -40.45 96.99 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.168 -0.957 . . . . 0.0 109.546 -179.897 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 86' ' ' ALA . . . . . 0.684 ' HA ' HD21 ' A' ' 42' ' ' LEU . . . -61.11 -41.45 96.71 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.204 -0.935 . . . . 0.0 109.538 -179.917 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 54.4 t0 -62.19 -45.1 94.89 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.218 -0.926 . . . . 0.0 109.601 -179.926 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 63.6 tt0 -65.16 -37.3 86.96 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.224 -0.922 . . . . 0.0 109.583 -179.817 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 89' ' ' ALA . . . . . 0.596 ' HB1' ' CD1' ' A' ' 93' ' ' LEU . . . -75.95 -45.95 32.36 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.225 -0.922 . . . . 0.0 109.609 -179.879 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 90' ' ' VAL . . . . . 0.689 HG22 HG12 ' A' ' 105' ' ' VAL . 78.0 t -56.9 -31.92 37.57 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.52 0 O-C-N 121.207 -0.933 . . . . 0.0 109.626 -179.889 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -80.06 -53.0 7.12 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.245 -0.91 . . . . 0.0 109.733 -179.82 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 92' ' ' GLU . . . . . 0.607 ' HB2' ' CZ ' ' A' ' 61' ' ' PHE . 75.4 mm-40 -71.72 -43.88 65.11 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.214 -0.929 . . . . 0.0 109.73 -179.637 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 93' ' ' LEU . . . . . 1.003 ' CB ' HG21 ' A' ' 105' ' ' VAL . 36.7 mt -64.67 -40.36 95.28 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.149 -0.969 . . . . 0.0 109.474 -179.916 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 94' ' ' ASN . . . . . 0.489 ' CB ' ' O ' ' A' ' 90' ' ' VAL . 64.0 t-20 -68.4 125.74 27.42 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.244 -0.91 . . . . 0.0 109.499 179.987 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 93.85 22.81 24.79 Favored Glycine 0 N--CA 1.49 2.294 0 N-CA-C 109.536 -1.426 . . . . 0.0 109.536 179.969 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 96' ' ' THR . . . . . 0.594 HG23 ' O ' ' A' ' 93' ' ' LEU . 29.5 p -111.49 159.7 17.83 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.268 -1.136 . . . . 0.0 109.465 -179.948 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 60.0 tt0 -136.13 149.02 48.49 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.281 -0.887 . . . . 0.0 109.491 179.968 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 98' ' ' VAL . . . . . 0.607 ' HB ' HG12 ' A' ' 101' ' ' VAL . 1.3 t -101.59 -151.92 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.543 0 O-C-N 121.195 -0.941 . . . . 0.0 109.204 179.947 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 99' ' ' GLU . . . . . 0.534 ' H ' HG12 ' A' ' 98' ' ' VAL . 95.7 mt-10 -48.29 -41.34 27.77 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.115 -0.991 . . . . 0.0 109.42 179.992 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 2.4 m -165.98 25.84 0.05 OUTLIER 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.236 -0.915 . . . . 0.0 109.505 -179.97 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 101' ' ' VAL . . . . . 0.607 HG12 ' HB ' ' A' ' 98' ' ' VAL . 9.8 p -130.17 140.2 49.51 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.547 0 O-C-N 121.233 -0.917 . . . . 0.0 109.644 -179.861 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 91.7 mt-30 -86.71 141.62 28.78 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.265 -0.897 . . . . 0.0 109.328 179.887 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 103' ' ' LEU . . . . . 0.438 HD23 ' HA ' ' A' ' 103' ' ' LEU . 73.5 mt -106.76 137.62 44.45 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.241 -0.912 . . . . 0.0 109.763 -179.819 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 104' ' ' LYS . . . . . 0.473 ' O ' ' HA ' ' A' ' 44' ' ' VAL . 41.9 mttm -119.38 135.53 54.69 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.284 -0.885 . . . . 0.0 109.245 179.831 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 105' ' ' VAL . . . . . 1.003 HG21 ' CB ' ' A' ' 93' ' ' LEU . 46.0 t . . . . . 0 N--CA 1.49 1.55 0 O-C-N 121.186 -0.946 . . . . 0.0 109.614 -179.788 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 40' ' ' ASN . . . . . 0.482 ' N ' ' O ' ' A' ' 80' ' ' TYR . 47.3 t-20 . . . . . 0 N--CA 1.491 1.613 0 N-CA-C 109.311 -0.625 . . . . 0.0 109.311 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 41' ' ' THR . . . . . 0.464 ' O ' HD23 ' A' ' 42' ' ' LEU . 43.7 m -71.11 133.79 46.51 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.257 -0.902 . . . . 0.0 109.74 -179.747 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . 0.795 HD11 ' CD2' ' A' ' 80' ' ' TYR . 16.6 mt -114.38 145.68 41.52 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.295 -0.878 . . . . 0.0 109.32 179.824 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 74.1 t80 -100.38 122.61 43.41 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.258 -0.901 . . . . 0.0 109.488 -179.825 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 44' ' ' VAL . . . . . 0.468 ' HA ' ' O ' ' A' ' 104' ' ' LYS . 59.3 t -123.34 136.92 58.39 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.538 0 O-C-N 121.283 -0.885 . . . . 0.0 109.424 179.977 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 45' ' ' TYR . . . . . 0.476 ' HB3' ' HB2' ' A' ' 104' ' ' LYS . 70.1 t80 -120.56 142.09 49.68 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.223 -0.923 . . . . 0.0 109.46 -179.89 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . 0.429 ' HA3' ' SD ' ' A' ' 49' ' ' MET . . . 174.86 -175.87 47.02 Favored Glycine 0 N--CA 1.491 2.341 0 N-CA-C 109.54 -1.424 . . . . 0.0 109.54 -179.963 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . 0.428 ' O ' ' C ' ' A' ' 48' ' ' ASP . 94.6 mt-10 -120.85 157.03 30.68 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.265 -1.138 . . . . 0.0 109.392 179.962 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 48' ' ' ASP . . . . . 0.428 ' C ' ' O ' ' A' ' 47' ' ' GLU . 48.8 m-20 43.93 52.16 6.73 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.294 -0.879 . . . . 0.0 109.546 -179.979 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 49' ' ' MET . . . . . 0.429 ' SD ' ' HA3' ' A' ' 46' ' ' GLY . 64.8 mtm -103.4 142.41 34.28 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.314 -0.866 . . . . 0.0 109.504 179.975 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -122.15 163.62 30.73 Favored Pre-proline 0 N--CA 1.491 1.582 0 O-C-N 121.258 -0.901 . . . . 0.0 109.371 179.919 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 51' ' ' PRO . . . . . 0.44 ' HD3' ' SD ' ' A' ' 69' ' ' MET . 48.8 Cg_endo -69.56 -52.99 0.31 Allowed 'Trans proline' 0 C--O 1.215 -0.64 0 C-N-CA 122.617 2.211 . . . . 0.0 111.803 179.988 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 28.6 m -50.6 -48.87 57.7 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.249 -0.907 . . . . 0.0 109.302 179.931 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 22.3 tp -60.33 -47.23 86.92 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.249 -0.907 . . . . 0.0 109.343 179.836 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 21.9 mt -56.28 -47.09 79.29 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.284 -0.885 . . . . 0.0 109.357 179.824 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 55' ' ' ARG . . . . . 0.499 ' O ' ' N ' ' A' ' 59' ' ' SER . 36.4 mtp85 -51.43 -40.91 60.33 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.306 -0.871 . . . . 0.0 109.296 179.84 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -66.48 -34.35 87.46 Favored Glycine 0 N--CA 1.489 2.203 0 N-CA-C 109.34 -1.504 . . . . 0.0 109.34 179.864 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -71.23 -26.41 62.91 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.313 -1.11 . . . . 0.0 109.472 179.957 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 58' ' ' PHE . . . . . 0.856 ' HB2' HD11 ' A' ' 64' ' ' ILE . 96.9 m-85 -115.01 8.33 15.75 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.244 -0.91 . . . . 0.0 109.468 179.966 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 59' ' ' SER . . . . . 0.533 ' N ' ' HD2' ' A' ' 60' ' ' PRO . 0.8 OUTLIER -72.91 -58.14 2.76 Favored Pre-proline 0 N--CA 1.49 1.574 0 O-C-N 121.195 -0.941 . . . . 0.0 109.811 -179.784 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 60' ' ' PRO . . . . . 0.533 ' HD2' ' N ' ' A' ' 59' ' ' SER . 48.0 Cg_endo -68.9 -28.69 29.24 Favored 'Trans proline' 0 C--O 1.215 -0.65 0 C-N-CA 122.602 2.202 . . . . 0.0 111.973 -179.702 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 61' ' ' PHE . . . . . 0.572 ' CD1' ' HA ' ' A' ' 89' ' ' ALA . 61.2 m-85 -70.11 -31.74 69.44 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.181 -0.949 . . . . 0.0 109.548 -179.988 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . 0.413 ' HA3' ' HB3' ' A' ' 85' ' ' SER . . . 176.39 -171.41 44.4 Favored Glycine 0 N--CA 1.49 2.262 0 N-CA-C 109.504 -1.438 . . . . 0.0 109.504 179.881 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 85.6 m-20 -99.67 137.33 38.3 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.244 -1.15 . . . . 0.0 109.311 -179.963 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 64' ' ' ILE . . . . . 0.856 HD11 ' HB2' ' A' ' 58' ' ' PHE . 64.0 mt -99.53 131.72 46.35 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.517 0 O-C-N 121.238 -0.914 . . . . 0.0 109.581 -179.988 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 65' ' ' ILE . . . . . 0.407 HD11 HG21 ' A' ' 79' ' ' THR . 18.3 pt -96.67 -22.47 5.06 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.549 0 O-C-N 121.346 -0.846 . . . . 0.0 109.427 179.982 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 66' ' ' ASP . . . . . 0.452 ' HB3' ' OG1' ' A' ' 79' ' ' THR . 54.9 t0 -143.76 135.96 26.74 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.219 -0.925 . . . . 0.0 109.563 -179.963 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . 0.747 ' C ' HD13 ' A' ' 67' ' ' LEU . 3.4 tm? -122.47 114.71 21.07 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.233 -0.917 . . . . 0.0 109.314 179.918 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 68' ' ' SER . . . . . 0.501 ' N ' HD13 ' A' ' 67' ' ' LEU . 37.7 t -129.25 145.43 51.35 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.247 -0.908 . . . . 0.0 109.518 -179.917 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 69' ' ' MET . . . . . 0.481 ' HA ' ' HA ' ' A' ' 76' ' ' ALA . 79.3 mtp -130.4 143.92 51.07 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.218 -0.926 . . . . 0.0 109.445 179.963 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 70' ' ' ASP . . . . . 0.478 ' C ' ' HD2' ' A' ' 72' ' ' PRO . 2.4 t70 -117.06 107.06 46.34 Favored Pre-proline 0 N--CA 1.489 1.514 0 O-C-N 121.229 -0.92 . . . . 0.0 109.575 -179.928 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 71' ' ' PRO . . . . . 0.604 ' N ' ' CD ' ' A' ' 72' ' ' PRO . 46.3 Cg_endo -74.85 -27.69 10.09 Favored 'Trans proline' 0 CA--C 1.543 0.962 0 C-N-CA 122.458 2.106 . . . . 0.0 113.571 179.923 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 72' ' ' PRO . . . . . 0.604 ' CD ' ' N ' ' A' ' 71' ' ' PRO . 55.2 Cg_endo -75.38 -29.56 7.53 Favored 'Trans proline' 0 C--N 1.353 0.787 0 C-N-CA 121.427 1.418 . . . . 0.0 111.81 -179.872 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 5.8 mtp85 -106.97 1.3 24.35 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.161 -0.962 . . . . 0.0 109.63 179.995 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 80.2 m-20 57.61 39.1 27.87 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.145 -0.972 . . . . 0.0 109.46 179.991 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 75' ' ' CYS . . . . . 0.44 ' HA ' ' O ' ' A' ' 44' ' ' VAL . 27.9 p -134.96 140.52 45.77 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.186 -0.946 . . . . 0.0 109.5 -179.963 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 76' ' ' ALA . . . . . 0.481 ' HA ' ' HA ' ' A' ' 69' ' ' MET . . . -108.22 152.23 24.86 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.34 -0.85 . . . . 0.0 109.395 179.964 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 77' ' ' PHE . . . . . 0.46 ' HB2' ' HB3' ' A' ' 68' ' ' SER . 96.8 m-85 -117.59 129.95 56.09 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.24 -0.913 . . . . 0.0 109.527 -179.955 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . 0.482 ' O ' ' N ' ' A' ' 42' ' ' LEU . 48.2 t -124.79 132.09 71.78 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.575 0 O-C-N 121.261 -0.9 . . . . 0.0 109.413 179.968 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 79' ' ' THR . . . . . 0.467 ' HA ' ' O ' ' A' ' 40' ' ' ASN . 22.8 m -101.22 134.1 44.78 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.286 -0.884 . . . . 0.0 109.5 179.965 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 80' ' ' TYR . . . . . 0.795 ' CD2' HD11 ' A' ' 42' ' ' LEU . 0.4 OUTLIER -109.95 144.57 38.28 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.275 -0.891 . . . . 0.0 109.548 -179.977 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 84.9 tt0 -66.81 -31.16 71.6 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.177 -0.952 . . . . 0.0 109.514 179.836 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 46.1 mttm -128.11 152.32 48.14 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.327 -0.858 . . . . 0.0 109.445 -179.998 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 83' ' ' MET . . . . . . . . . . . . . 40.7 mtt -69.79 -21.98 63.37 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.226 -0.921 . . . . 0.0 109.491 179.987 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 98.7 mt-10 -71.15 -33.42 70.04 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.27 -0.894 . . . . 0.0 109.605 -179.955 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 85' ' ' SER . . . . . 0.413 ' HB3' ' HA3' ' A' ' 62' ' ' GLY . 19.4 m -66.92 -31.07 71.41 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.167 -0.958 . . . . 0.0 109.479 -179.901 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 86' ' ' ALA . . . . . 0.496 ' O ' HG23 ' A' ' 90' ' ' VAL . . . -80.08 -33.74 38.61 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.253 -0.904 . . . . 0.0 109.476 -179.955 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 58.7 t0 -65.48 -40.57 93.28 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.262 -0.898 . . . . 0.0 109.589 -179.946 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 88' ' ' GLN . . . . . 0.437 ' O ' ' HB2' ' A' ' 92' ' ' GLU . 62.0 tt0 -73.92 -38.72 64.21 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.285 -0.884 . . . . 0.0 109.591 -179.917 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 89' ' ' ALA . . . . . 0.572 ' HA ' ' CD1' ' A' ' 61' ' ' PHE . . . -76.46 -41.22 48.07 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.249 -0.907 . . . . 0.0 109.507 179.975 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 90' ' ' VAL . . . . . 0.772 ' HA ' HG11 ' A' ' 105' ' ' VAL . 55.6 t -65.91 -40.97 88.97 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.591 0 O-C-N 121.286 -0.883 . . . . 0.0 109.623 -179.812 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -74.95 -38.26 61.76 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.145 -0.972 . . . . 0.0 109.741 -179.774 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 92' ' ' GLU . . . . . 0.557 ' HB3' ' CZ ' ' A' ' 61' ' ' PHE . 5.9 tm-20 -78.85 -50.8 10.65 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.187 -0.946 . . . . 0.0 109.722 -179.744 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 93' ' ' LEU . . . . . 0.724 HD13 ' CZ ' ' A' ' 58' ' ' PHE . 48.9 mt -62.64 -35.5 79.79 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.262 -0.899 . . . . 0.0 109.56 -179.829 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 94' ' ' ASN . . . . . 0.485 ' HB2' ' O ' ' A' ' 90' ' ' VAL . 56.8 t-20 -74.71 129.11 37.12 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.246 -0.909 . . . . 0.0 109.549 -179.909 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 91.55 24.44 26.02 Favored Glycine 0 N--CA 1.49 2.253 0 N-CA-C 109.551 -1.42 . . . . 0.0 109.551 179.926 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 96' ' ' THR . . . . . 0.48 ' CG2' ' O ' ' A' ' 92' ' ' GLU . 36.9 p -126.23 154.05 43.86 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.201 -1.176 . . . . 0.0 109.572 179.985 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 63.8 tt0 -117.83 138.9 51.78 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.225 -0.922 . . . . 0.0 109.491 -179.96 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 98' ' ' VAL . . . . . 0.552 HG23 ' O ' ' A' ' 101' ' ' VAL . 1.2 t -81.13 -151.99 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 121.204 -0.935 . . . . 0.0 109.315 -179.99 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 99' ' ' GLU . . . . . 0.533 ' H ' HG12 ' A' ' 98' ' ' VAL . 96.3 mt-10 -60.78 -37.89 83.41 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.204 -0.935 . . . . 0.0 109.477 179.983 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -158.1 22.81 0.25 Allowed 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.264 -0.897 . . . . 0.0 109.476 179.99 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 101' ' ' VAL . . . . . 0.552 ' O ' HG23 ' A' ' 98' ' ' VAL . 47.9 t -139.43 154.41 24.83 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.531 0 O-C-N 121.224 -0.923 . . . . 0.0 109.496 179.993 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 92.2 mt-30 -102.45 144.18 31.23 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.242 -0.911 . . . . 0.0 109.431 179.96 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 92.0 mt -110.37 138.89 46.16 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.311 -0.868 . . . . 0.0 109.564 179.997 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 104' ' ' LYS . . . . . 0.476 ' HB2' ' HB3' ' A' ' 45' ' ' TYR . 76.6 mttt -120.23 138.53 53.6 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.268 -0.895 . . . . 0.0 109.259 179.853 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 105' ' ' VAL . . . . . 0.772 HG11 ' HA ' ' A' ' 90' ' ' VAL . 18.4 t . . . . . 0 N--CA 1.49 1.549 0 O-C-N 121.142 -0.974 . . . . 0.0 109.657 -179.819 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 40' ' ' ASN . . . . . 0.44 ' O ' ' HA ' ' A' ' 79' ' ' THR . 47.1 t-20 . . . . . 0 N--CA 1.49 1.531 0 N-CA-C 109.477 -0.564 . . . . 0.0 109.477 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 41' ' ' THR . . . . . 0.458 ' HA ' ' O ' ' A' ' 78' ' ' VAL . 66.1 m -84.32 140.42 31.63 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.225 -0.922 . . . . 0.0 109.522 -179.954 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . 0.823 HD12 ' O ' ' A' ' 78' ' ' VAL . 5.2 mp -116.18 143.04 46.03 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.322 -0.861 . . . . 0.0 109.338 179.987 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 70.1 t80 -98.0 108.23 20.89 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.366 -0.834 . . . . 0.0 109.584 -179.951 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 44' ' ' VAL . . . . . 0.474 ' HA ' ' O ' ' A' ' 104' ' ' LYS . 95.6 t -105.37 136.43 39.37 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 O-C-N 121.268 -0.895 . . . . 0.0 109.363 -180.0 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 45' ' ' TYR . . . . . 0.442 ' HB3' ' HB2' ' A' ' 104' ' ' LYS . 70.5 t80 -123.42 131.33 53.61 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.141 -0.974 . . . . 0.0 109.524 -179.949 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -179.69 -174.55 45.74 Favored Glycine 0 N--CA 1.491 2.333 0 N-CA-C 109.401 -1.48 . . . . 0.0 109.401 179.963 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 95.6 mt-10 -121.12 156.49 32.19 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.216 -1.167 . . . . 0.0 109.476 -179.958 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 59.4 t0 46.23 52.52 10.33 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.237 -0.915 . . . . 0.0 109.487 -179.985 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 49' ' ' MET . . . . . 0.408 ' O ' ' HE1' ' A' ' 69' ' ' MET . 61.6 mtm -104.17 139.8 38.71 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.247 -0.908 . . . . 0.0 109.547 -179.928 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 50' ' ' THR . . . . . 0.506 ' O ' HD12 ' A' ' 54' ' ' LEU . 0.1 OUTLIER -121.5 166.57 15.9 Favored Pre-proline 0 N--CA 1.49 1.547 0 O-C-N 121.208 -0.932 . . . . 0.0 109.414 -179.98 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 51' ' ' PRO . . . . . 0.485 ' N ' ' SD ' ' A' ' 69' ' ' MET . 48.2 Cg_endo -70.17 -55.73 0.16 Allowed 'Trans proline' 0 C--O 1.215 -0.651 0 C-N-CA 122.599 2.199 . . . . 0.0 111.918 179.937 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 26.2 m -48.88 -49.91 37.44 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.181 -0.95 . . . . 0.0 109.287 179.877 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 24.2 tp -58.08 -50.5 73.24 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.181 -0.949 . . . . 0.0 109.161 179.782 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 54' ' ' LEU . . . . . 0.506 HD12 ' O ' ' A' ' 50' ' ' THR . 11.6 mt -56.26 -44.42 79.68 Favored 'General case' 0 N--CA 1.488 1.475 0 O-C-N 121.272 -0.893 . . . . 0.0 109.238 179.742 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 55' ' ' ARG . . . . . 0.517 ' O ' ' N ' ' A' ' 59' ' ' SER . 93.6 mtt180 -51.38 -38.63 54.36 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.242 -0.911 . . . . 0.0 109.319 179.82 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -69.56 -33.3 71.81 Favored Glycine 0 N--CA 1.49 2.295 0 N-CA-C 109.508 -1.437 . . . . 0.0 109.508 179.926 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -75.92 -23.39 55.49 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.287 -1.125 . . . . 0.0 109.461 179.969 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 58' ' ' PHE . . . . . 0.672 ' HB2' HD11 ' A' ' 64' ' ' ILE . 97.0 m-85 -117.56 8.37 12.88 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.305 -0.872 . . . . 0.0 109.403 179.988 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 59' ' ' SER . . . . . 0.534 ' N ' ' HD2' ' A' ' 60' ' ' PRO . 0.6 OUTLIER -75.16 -57.12 1.8 Allowed Pre-proline 0 N--CA 1.491 1.606 0 O-C-N 121.231 -0.918 . . . . 0.0 110.066 -179.637 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 60' ' ' PRO . . . . . 0.534 ' HD2' ' N ' ' A' ' 59' ' ' SER . 49.8 Cg_endo -69.5 -25.12 30.1 Favored 'Trans proline' 0 C--O 1.214 -0.68 0 C-N-CA 122.62 2.213 . . . . 0.0 112.213 -179.56 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 61' ' ' PHE . . . . . 0.583 ' CZ ' ' HB2' ' A' ' 92' ' ' GLU . 64.4 m-85 -72.67 -27.17 61.93 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.149 -0.97 . . . . 0.0 109.491 179.985 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 169.31 -176.0 43.45 Favored Glycine 0 N--CA 1.49 2.275 0 N-CA-C 109.464 -1.454 . . . . 0.0 109.464 179.939 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 83.2 m-20 -93.93 139.82 30.45 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.269 -1.136 . . . . 0.0 109.416 -179.995 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 64' ' ' ILE . . . . . 0.672 HD11 ' HB2' ' A' ' 58' ' ' PHE . 61.1 mt -100.61 132.84 45.5 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.588 0 O-C-N 121.236 -0.915 . . . . 0.0 109.539 179.995 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 65' ' ' ILE . . . . . 0.503 HD11 HG21 ' A' ' 79' ' ' THR . 26.7 pt -94.27 -24.04 5.07 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.604 0 O-C-N 121.341 -0.849 . . . . 0.0 109.442 179.98 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 66' ' ' ASP . . . . . 0.467 ' HB3' ' OG1' ' A' ' 79' ' ' THR . 55.3 t0 -147.78 136.6 21.95 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.22 -0.925 . . . . 0.0 109.561 -179.974 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . 0.748 ' C ' HD13 ' A' ' 67' ' ' LEU . 3.5 tm? -119.92 114.18 21.68 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.348 -0.845 . . . . 0.0 109.276 179.994 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 68' ' ' SER . . . . . 0.495 ' HB2' ' HB2' ' A' ' 77' ' ' PHE . 49.1 m -123.89 141.5 51.98 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.281 -0.887 . . . . 0.0 109.625 -179.993 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 69' ' ' MET . . . . . 0.485 ' SD ' ' N ' ' A' ' 51' ' ' PRO . 84.2 mtp -129.71 148.15 51.57 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.234 -0.916 . . . . 0.0 109.434 179.888 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 70' ' ' ASP . . . . . 0.485 ' C ' ' HD2' ' A' ' 72' ' ' PRO . 0.4 OUTLIER -124.21 102.0 34.29 Favored Pre-proline 0 N--CA 1.49 1.551 0 O-C-N 121.225 -0.922 . . . . 0.0 109.525 -179.959 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 71' ' ' PRO . . . . . 0.595 ' N ' ' CD ' ' A' ' 72' ' ' PRO . 46.5 Cg_endo -74.67 -27.6 10.54 Favored 'Trans proline' 0 CA--C 1.543 0.952 0 C-N-CA 122.519 2.146 . . . . 0.0 113.57 179.957 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 72' ' ' PRO . . . . . 0.595 ' CD ' ' N ' ' A' ' 71' ' ' PRO . 55.2 Cg_endo -75.57 -31.61 5.39 Favored 'Trans proline' 0 C--N 1.354 0.832 0 C-N-CA 121.452 1.435 . . . . 0.0 111.682 -179.911 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 73' ' ' ARG . . . . . 0.469 ' HG2' ' O ' ' A' ' 73' ' ' ARG . 19.5 ttt180 -103.85 -2.63 25.99 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.188 -0.945 . . . . 0.0 109.641 179.953 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 74' ' ' ASN . . . . . 0.432 ' HB2' ' O ' ' A' ' 73' ' ' ARG . 82.3 m-20 62.11 44.41 7.95 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.228 -0.92 . . . . 0.0 109.402 -179.901 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 75' ' ' CYS . . . . . 0.404 ' HA ' ' O ' ' A' ' 44' ' ' VAL . 23.9 p -143.13 134.73 26.42 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.237 -0.915 . . . . 0.0 109.439 -179.96 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 76' ' ' ALA . . . . . 0.452 ' HA ' ' HA ' ' A' ' 69' ' ' MET . . . -107.63 160.45 15.69 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.316 -0.865 . . . . 0.0 109.436 179.985 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 77' ' ' PHE . . . . . 0.495 ' HB2' ' HB2' ' A' ' 68' ' ' SER . 96.5 m-85 -128.0 130.74 48.82 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.264 -0.898 . . . . 0.0 109.546 -179.948 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . 0.823 ' O ' HD12 ' A' ' 42' ' ' LEU . 33.7 t -121.43 134.22 65.47 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.556 0 O-C-N 121.146 -0.971 . . . . 0.0 109.485 -179.946 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 79' ' ' THR . . . . . 0.503 HG21 HD11 ' A' ' 65' ' ' ILE . 5.2 m -102.67 130.11 49.49 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.241 -0.912 . . . . 0.0 109.452 -179.977 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 80' ' ' TYR . . . . . 0.492 ' OH ' ' HB2' ' A' ' 61' ' ' PHE . 0.6 OUTLIER -110.73 136.68 49.43 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.149 -0.969 . . . . 0.0 109.515 -179.945 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 81.8 tt0 -54.56 -28.6 47.06 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.218 -0.926 . . . . 0.0 109.446 179.986 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 57.4 mttm -135.9 148.78 48.72 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.204 -0.935 . . . . 0.0 109.589 -179.965 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 83' ' ' MET . . . . . . . . . . . . . 61.2 mtt -67.84 -21.06 65.21 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.175 -0.953 . . . . 0.0 109.471 -179.96 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 97.2 mt-10 -66.96 -41.48 86.81 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.239 -0.913 . . . . 0.0 109.457 -179.949 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 19.8 m -64.05 -30.94 71.97 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.336 -0.853 . . . . 0.0 109.451 179.96 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 86' ' ' ALA . . . . . 0.833 ' O ' HG23 ' A' ' 90' ' ' VAL . . . -73.67 -31.08 63.28 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.297 -0.877 . . . . 0.0 109.455 179.903 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 58.6 t0 -67.99 -44.69 76.04 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.2 -0.937 . . . . 0.0 109.517 179.973 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 62.1 tt0 -64.28 -39.95 94.97 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.184 -0.948 . . . . 0.0 109.483 179.906 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 89' ' ' ALA . . . . . 0.893 ' HB1' ' CD1' ' A' ' 93' ' ' LEU . . . -74.51 -43.11 57.44 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.238 -0.914 . . . . 0.0 109.496 -179.901 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 90' ' ' VAL . . . . . 0.833 HG23 ' O ' ' A' ' 86' ' ' ALA . 88.9 t -61.49 -32.02 52.22 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.56 0 O-C-N 121.176 -0.953 . . . . 0.0 109.685 -179.867 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -80.14 -51.92 8.4 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.23 -0.919 . . . . 0.0 109.728 -179.841 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 92' ' ' GLU . . . . . 0.583 ' HB2' ' CZ ' ' A' ' 61' ' ' PHE . 74.1 mt-10 -71.63 -47.28 55.58 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.278 -0.889 . . . . 0.0 109.927 -179.699 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 93' ' ' LEU . . . . . 0.893 ' CD1' ' HB1' ' A' ' 89' ' ' ALA . 62.4 mt -63.78 -36.76 84.96 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.188 -0.945 . . . . 0.0 109.857 -179.643 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 94' ' ' ASN . . . . . 0.524 ' CB ' ' O ' ' A' ' 90' ' ' VAL . 61.0 t-20 -74.3 125.99 29.67 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.131 -0.98 . . . . 0.0 109.475 -179.865 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 96.1 22.1 21.01 Favored Glycine 0 N--CA 1.489 2.225 0 N-CA-C 109.461 -1.456 . . . . 0.0 109.461 179.916 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 96' ' ' THR . . . . . 0.521 ' CG2' ' O ' ' A' ' 92' ' ' GLU . 21.9 p -116.03 160.26 20.53 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.217 -1.166 . . . . 0.0 109.461 -179.975 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 97' ' ' GLN . . . . . 0.451 ' HG2' ' N ' ' A' ' 98' ' ' VAL . 64.2 tt0 -132.72 158.56 42.05 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.265 -0.897 . . . . 0.0 109.484 -179.911 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 98' ' ' VAL . . . . . 0.605 HG23 ' O ' ' A' ' 101' ' ' VAL . 1.2 t -108.56 -153.31 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.572 0 O-C-N 121.234 -0.916 . . . . 0.0 109.398 179.961 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 99' ' ' GLU . . . . . 0.537 ' H ' HG12 ' A' ' 98' ' ' VAL . 96.9 mt-10 -57.66 -36.76 72.33 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.217 -0.927 . . . . 0.0 109.61 -179.919 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -162.86 25.48 0.09 Allowed 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.25 -0.906 . . . . 0.0 109.494 179.944 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 101' ' ' VAL . . . . . 0.605 ' O ' HG23 ' A' ' 98' ' ' VAL . 84.8 t -139.37 146.61 25.35 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 O-C-N 121.239 -0.913 . . . . 0.0 109.496 179.938 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 90.3 mt-30 -100.83 147.42 26.11 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.263 -0.898 . . . . 0.0 109.495 -179.968 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 95.9 mt -113.7 133.84 55.1 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.241 -0.912 . . . . 0.0 109.493 -179.985 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 104' ' ' LYS . . . . . 0.474 ' O ' ' HA ' ' A' ' 44' ' ' VAL . 70.5 mttt -115.75 145.31 42.9 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.264 -0.897 . . . . 0.0 109.308 179.964 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 105' ' ' VAL . . . . . 0.773 HG11 ' HA ' ' A' ' 90' ' ' VAL . 29.2 t . . . . . 0 N--CA 1.489 1.524 0 O-C-N 121.12 -0.988 . . . . 0.0 109.718 -179.789 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 40' ' ' ASN . . . . . 0.529 ' N ' ' O ' ' A' ' 80' ' ' TYR . 54.3 t30 . . . . . 0 N--CA 1.491 1.591 0 N-CA-C 109.352 -0.61 . . . . 0.0 109.352 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 41' ' ' THR . . . . . 0.492 ' O ' HD23 ' A' ' 42' ' ' LEU . 45.1 m -74.49 136.55 42.24 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.273 -0.892 . . . . 0.0 109.839 -179.695 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . 0.867 HD11 ' CD2' ' A' ' 80' ' ' TYR . 13.7 mt -119.47 157.21 28.74 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.363 -0.836 . . . . 0.0 109.322 179.84 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 43' ' ' TYR . . . . . 0.432 ' CZ ' ' CB ' ' A' ' 75' ' ' CYS . 69.9 t80 -114.14 121.38 43.59 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.261 -0.899 . . . . 0.0 109.448 -179.976 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 47.4 t -115.88 136.3 53.21 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.579 0 O-C-N 121.331 -0.855 . . . . 0.0 109.367 179.948 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 71.8 t80 -126.35 130.61 51.13 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.264 -0.897 . . . . 0.0 109.488 -179.923 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -175.83 -173.94 41.96 Favored Glycine 0 N--CA 1.49 2.272 0 N-CA-C 109.472 -1.451 . . . . 0.0 109.472 179.999 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . 0.422 ' O ' ' C ' ' A' ' 48' ' ' ASP . 94.8 mt-10 -115.88 156.39 26.22 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.231 -1.158 . . . . 0.0 109.487 -179.916 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 48' ' ' ASP . . . . . 0.422 ' C ' ' O ' ' A' ' 47' ' ' GLU . 38.1 m-20 44.21 51.19 7.49 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.229 -0.919 . . . . 0.0 109.551 179.936 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 55.3 mtm -100.57 137.09 39.45 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.272 -0.893 . . . . 0.0 109.433 179.981 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 50' ' ' THR . . . . . 0.476 ' O ' HD12 ' A' ' 54' ' ' LEU . 0.3 OUTLIER -119.76 163.21 28.86 Favored Pre-proline 0 N--CA 1.491 1.583 0 O-C-N 121.308 -0.87 . . . . 0.0 109.441 179.963 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 48.7 Cg_endo -70.13 -54.26 0.21 Allowed 'Trans proline' 0 C--O 1.214 -0.677 0 C-N-CA 122.629 2.22 . . . . 0.0 111.815 -179.992 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 37.3 m -53.27 -48.49 68.25 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.185 -0.947 . . . . 0.0 109.317 179.921 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 17.6 tp -58.63 -48.49 80.83 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.247 -0.908 . . . . 0.0 109.28 179.824 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 54' ' ' LEU . . . . . 0.66 HD11 ' HE1' ' A' ' 69' ' ' MET . 16.6 mt -57.87 -44.99 87.0 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.232 -0.917 . . . . 0.0 109.259 179.793 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 55' ' ' ARG . . . . . 0.514 ' O ' ' N ' ' A' ' 59' ' ' SER . 57.5 mtt-85 -50.94 -39.75 55.66 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.244 -0.91 . . . . 0.0 109.2 179.853 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -69.5 -30.87 70.92 Favored Glycine 0 N--CA 1.49 2.243 0 N-CA-C 109.313 -1.515 . . . . 0.0 109.313 179.767 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -79.51 -21.53 45.15 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.243 -1.151 . . . . 0.0 109.467 179.998 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 58' ' ' PHE . . . . . 0.66 ' CZ ' HD13 ' A' ' 93' ' ' LEU . 94.5 m-85 -119.09 7.97 11.47 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.26 -0.9 . . . . 0.0 109.384 179.929 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 59' ' ' SER . . . . . 0.539 ' N ' ' HD2' ' A' ' 60' ' ' PRO . 0.6 OUTLIER -75.24 -55.54 2.18 Favored Pre-proline 0 N--CA 1.49 1.562 0 O-C-N 121.286 -0.884 . . . . 0.0 110.196 -179.591 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 60' ' ' PRO . . . . . 0.539 ' HD2' ' N ' ' A' ' 59' ' ' SER . 48.4 Cg_endo -69.42 -29.6 25.24 Favored 'Trans proline' 0 C--O 1.214 -0.677 0 C-N-CA 122.542 2.161 . . . . 0.0 112.208 -179.408 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 61' ' ' PHE . . . . . 0.588 ' CB ' ' HB2' ' A' ' 89' ' ' ALA . 55.2 m-85 -67.48 -28.88 68.22 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.21 -0.931 . . . . 0.0 109.534 179.984 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 172.81 -178.43 44.85 Favored Glycine 0 N--CA 1.49 2.293 0 N-CA-C 109.579 -1.408 . . . . 0.0 109.579 179.951 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 47.9 t-20 -94.26 138.25 32.49 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.292 -1.122 . . . . 0.0 109.447 179.99 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 64' ' ' ILE . . . . . 0.514 HD11 ' HB2' ' A' ' 58' ' ' PHE . 57.7 mt -100.02 135.49 35.48 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.502 0 O-C-N 121.258 -0.901 . . . . 0.0 109.392 -179.972 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 65' ' ' ILE . . . . . 0.428 HG12 ' HB ' ' A' ' 79' ' ' THR . 27.2 pt -102.6 -21.76 5.05 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.636 0 O-C-N 121.326 -0.859 . . . . 0.0 109.659 -179.833 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 66' ' ' ASP . . . . . 0.458 ' HB3' ' OG1' ' A' ' 79' ' ' THR . 56.7 t0 -145.39 111.8 5.76 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.122 -0.986 . . . . 0.0 109.675 -179.966 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . 0.446 HD22 ' NE ' ' A' ' 55' ' ' ARG . 32.3 tp -108.11 123.6 48.95 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.328 -0.857 . . . . 0.0 109.358 179.919 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 68' ' ' SER . . . . . 0.481 ' HB3' ' HB2' ' A' ' 77' ' ' PHE . 23.2 t -134.25 140.71 46.64 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.271 -0.893 . . . . 0.0 109.505 -179.941 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 69' ' ' MET . . . . . 0.66 ' HE1' HD11 ' A' ' 54' ' ' LEU . 87.6 mmm -113.71 151.65 31.58 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.301 -0.874 . . . . 0.0 109.502 179.923 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 70' ' ' ASP . . . . . 0.472 ' C ' ' HD2' ' A' ' 72' ' ' PRO . 0.3 OUTLIER -131.84 100.29 16.14 Favored Pre-proline 0 N--CA 1.49 1.554 0 O-C-N 121.277 -0.89 . . . . 0.0 109.522 179.95 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 71' ' ' PRO . . . . . 0.595 ' CD ' ' CD ' ' A' ' 72' ' ' PRO . 46.7 Cg_endo -74.53 -27.9 10.56 Favored 'Trans proline' 0 CA--C 1.543 0.943 0 C-N-CA 122.497 2.131 . . . . 0.0 113.629 -179.897 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 72' ' ' PRO . . . . . 0.595 ' CD ' ' CD ' ' A' ' 71' ' ' PRO . 54.5 Cg_endo -75.46 -32.79 4.61 Favored 'Trans proline' 0 C--N 1.353 0.763 0 C-N-CA 121.431 1.42 . . . . 0.0 111.643 -179.89 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 73' ' ' ARG . . . . . 0.45 ' O ' ' HG3' ' A' ' 73' ' ' ARG . 13.6 tpt180 -101.45 -4.85 26.11 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.249 -0.907 . . . . 0.0 109.523 -179.978 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 74' ' ' ASN . . . . . 0.437 ' HB2' ' O ' ' A' ' 73' ' ' ARG . 77.5 m-20 61.95 43.78 8.84 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.194 -0.941 . . . . 0.0 109.507 -179.854 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 75' ' ' CYS . . . . . 0.432 ' CB ' ' CZ ' ' A' ' 43' ' ' TYR . 31.4 p -147.48 142.73 27.27 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.298 -0.876 . . . . 0.0 109.48 -179.954 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 76' ' ' ALA . . . . . 0.446 ' HB1' ' SD ' ' A' ' 69' ' ' MET . . . -107.29 163.17 13.25 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.296 -0.877 . . . . 0.0 109.469 179.984 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 77' ' ' PHE . . . . . 0.481 ' HB2' ' HB3' ' A' ' 68' ' ' SER . 96.7 m-85 -122.84 130.89 53.43 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.317 -0.864 . . . . 0.0 109.544 -179.969 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . 0.495 ' O ' ' N ' ' A' ' 42' ' ' LEU . 46.7 t -126.52 140.11 49.79 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.604 0 O-C-N 121.278 -0.889 . . . . 0.0 109.33 179.861 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 79' ' ' THR . . . . . 0.481 ' HA ' ' O ' ' A' ' 40' ' ' ASN . 2.5 m -115.55 112.73 22.63 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.224 -0.922 . . . . 0.0 109.584 -179.849 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 80' ' ' TYR . . . . . 0.867 ' CD2' HD11 ' A' ' 42' ' ' LEU . 1.4 m-85 -93.12 123.15 36.17 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.25 -0.906 . . . . 0.0 109.402 179.932 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 81' ' ' GLU . . . . . 0.451 ' C ' ' O ' ' A' ' 80' ' ' TYR . 86.1 tt0 -38.88 -34.54 0.16 Allowed 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.537 -0.727 . . . . 0.0 110.302 -179.667 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 57.2 mttp -128.52 158.38 38.57 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.068 -1.02 . . . . 0.0 109.594 -179.911 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 83' ' ' MET . . . . . . . . . . . . . 58.9 mtt -74.65 -21.71 59.29 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.274 -0.891 . . . . 0.0 109.452 179.936 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 75.6 mm-40 -68.51 -46.99 68.16 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.339 -0.851 . . . . 0.0 109.473 -179.958 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 14.0 m -55.5 -35.03 65.14 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.283 -0.885 . . . . 0.0 109.369 -179.945 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 86' ' ' ALA . . . . . 0.548 ' O ' HG23 ' A' ' 90' ' ' VAL . . . -75.44 -28.75 59.46 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.318 -0.863 . . . . 0.0 109.559 -179.968 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 57.1 t0 -66.18 -40.07 90.17 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.246 -0.908 . . . . 0.0 109.551 -179.925 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 88' ' ' GLN . . . . . 0.478 ' O ' ' CB ' ' A' ' 92' ' ' GLU . 47.7 tt0 -74.99 -35.64 62.01 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.244 -0.91 . . . . 0.0 109.431 -179.895 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 89' ' ' ALA . . . . . 0.624 ' HB1' ' CD1' ' A' ' 93' ' ' LEU . . . -77.47 -41.64 38.85 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.23 -0.919 . . . . 0.0 109.614 -179.912 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 90' ' ' VAL . . . . . 0.587 HG22 HG11 ' A' ' 105' ' ' VAL . 68.8 t -65.1 -47.35 88.11 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.603 0 O-C-N 121.247 -0.908 . . . . 0.0 109.638 -179.892 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -73.04 -39.65 65.77 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.218 -0.926 . . . . 0.0 109.582 -179.917 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 92' ' ' GLU . . . . . 0.583 ' HB3' ' CE1' ' A' ' 61' ' ' PHE . 44.4 tp10 -74.25 -50.22 19.93 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.266 -0.896 . . . . 0.0 109.682 -179.954 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 93' ' ' LEU . . . . . 0.66 HD13 ' CZ ' ' A' ' 58' ' ' PHE . 42.2 mt -65.24 -38.98 92.05 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.21 -0.931 . . . . 0.0 109.534 -179.841 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 94' ' ' ASN . . . . . 0.49 ' CB ' ' O ' ' A' ' 90' ' ' VAL . 59.3 t-20 -67.74 129.37 39.69 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.241 -0.912 . . . . 0.0 109.535 179.999 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 98.94 17.31 28.13 Favored Glycine 0 N--CA 1.49 2.285 0 N-CA-C 109.543 -1.423 . . . . 0.0 109.543 -179.997 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 96' ' ' THR . . . . . 0.516 HG23 ' O ' ' A' ' 93' ' ' LEU . 16.1 p -116.16 158.79 22.71 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.251 -1.146 . . . . 0.0 109.473 179.936 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 61.3 tt0 -122.8 139.83 53.58 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.255 -0.903 . . . . 0.0 109.497 179.998 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 98' ' ' VAL . . . . . 0.587 HG12 ' H ' ' A' ' 99' ' ' GLU . 1.1 t -81.79 -157.48 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.608 0 O-C-N 121.247 -0.908 . . . . 0.0 109.302 -179.982 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 99' ' ' GLU . . . . . 0.587 ' H ' HG12 ' A' ' 98' ' ' VAL . 76.4 mm-40 -60.64 -38.28 84.28 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.23 -0.919 . . . . 0.0 109.584 -179.958 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 100' ' ' SER . . . . . 0.426 ' O ' ' OG ' ' A' ' 100' ' ' SER . 4.9 t -155.04 24.04 0.43 Allowed 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.248 -0.907 . . . . 0.0 109.613 179.943 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 101' ' ' VAL . . . . . 0.548 ' O ' HG23 ' A' ' 98' ' ' VAL . 57.5 t -141.0 155.91 21.93 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.553 0 O-C-N 121.226 -0.921 . . . . 0.0 109.515 179.891 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 102' ' ' GLN . . . . . 0.415 ' N ' HG12 ' A' ' 101' ' ' VAL . 92.8 mt-30 -98.3 143.19 29.04 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.242 -0.911 . . . . 0.0 109.447 -179.971 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 103' ' ' LEU . . . . . 0.408 HD23 ' HA ' ' A' ' 103' ' ' LEU . 92.7 mt -101.85 141.86 34.05 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.25 -0.906 . . . . 0.0 109.44 179.975 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 1.3 mtpm? -131.45 134.21 45.97 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.281 -0.887 . . . . 0.0 109.4 179.921 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 105' ' ' VAL . . . . . 0.587 HG11 HG22 ' A' ' 90' ' ' VAL . 17.8 t . . . . . 0 N--CA 1.49 1.534 0 O-C-N 121.17 -0.956 . . . . 0.0 109.65 -179.931 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 40' ' ' ASN . . . . . 0.639 HD22 ' HB3' ' A' ' 86' ' ' ALA . 61.7 t30 . . . . . 0 N--CA 1.493 1.686 0 CA-C-O 121.216 0.531 . . . . 0.0 109.799 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 41' ' ' THR . . . . . 0.475 ' HA ' ' O ' ' A' ' 78' ' ' VAL . 91.2 m -80.5 153.73 27.98 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.18 -0.95 . . . . 0.0 109.841 -179.913 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . 0.924 HD12 ' O ' ' A' ' 78' ' ' VAL . 4.7 mp -131.05 155.4 46.95 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.376 -0.827 . . . . 0.0 109.305 179.763 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 39.2 t80 -113.67 108.9 17.76 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.206 -0.934 . . . . 0.0 109.594 -179.923 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 44' ' ' VAL . . . . . 0.459 ' HA ' ' O ' ' A' ' 104' ' ' LYS . 39.3 t -105.28 146.04 12.8 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 O-C-N 121.289 -0.882 . . . . 0.0 109.488 179.999 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 67.0 t80 -135.59 140.47 44.66 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.21 -0.931 . . . . 0.0 109.468 179.989 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 174.82 -165.17 36.26 Favored Glycine 0 N--CA 1.491 2.321 0 N-CA-C 109.464 -1.454 . . . . 0.0 109.464 -179.995 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 90.3 mt-10 -115.07 157.48 23.46 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.238 -1.154 . . . . 0.0 109.584 -179.908 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 56.0 t0 44.76 45.16 8.13 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.273 -0.892 . . . . 0.0 109.576 179.992 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 34.2 mtp -81.79 133.43 35.34 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.195 -0.941 . . . . 0.0 109.423 179.934 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 50' ' ' THR . . . . . 0.512 ' O ' HD12 ' A' ' 54' ' ' LEU . 0.1 OUTLIER -125.77 162.08 47.26 Favored Pre-proline 0 N--CA 1.49 1.527 0 O-C-N 121.208 -0.932 . . . . 0.0 109.461 -179.897 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 51' ' ' PRO . . . . . 0.467 ' N ' ' SD ' ' A' ' 69' ' ' MET . 50.2 Cg_endo -70.6 -53.28 0.23 Allowed 'Trans proline' 0 C--O 1.215 -0.648 0 C-N-CA 122.696 2.264 . . . . 0.0 111.644 179.957 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 30.2 m -55.87 -47.93 76.45 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.223 -0.923 . . . . 0.0 109.317 179.867 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 15.5 tp -56.94 -54.23 48.96 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.311 -0.868 . . . . 0.0 109.231 179.871 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 54' ' ' LEU . . . . . 0.512 HD12 ' O ' ' A' ' 50' ' ' THR . 12.4 mt -51.63 -52.83 44.65 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.221 -0.925 . . . . 0.0 109.225 179.766 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 55' ' ' ARG . . . . . 0.563 ' HE ' HD22 ' A' ' 67' ' ' LEU . 49.2 mtt180 -44.09 -40.28 4.8 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.354 -0.841 . . . . 0.0 109.212 179.872 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -70.43 -33.33 68.0 Favored Glycine 0 N--CA 1.49 2.273 0 N-CA-C 109.314 -1.514 . . . . 0.0 109.314 179.771 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . 0.456 ' N ' ' O ' ' A' ' 54' ' ' LEU . . . -79.81 -16.29 55.78 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.288 -1.125 . . . . 0.0 109.444 179.88 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 58' ' ' PHE . . . . . 0.631 ' CE2' ' CD1' ' A' ' 93' ' ' LEU . 96.3 m-85 -124.36 10.57 8.61 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.257 -0.902 . . . . 0.0 109.5 179.998 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 59' ' ' SER . . . . . 0.538 ' N ' ' HD2' ' A' ' 60' ' ' PRO . 0.6 OUTLIER -77.08 -54.47 1.54 Allowed Pre-proline 0 N--CA 1.491 1.622 0 O-C-N 121.258 -0.901 . . . . 0.0 110.268 -179.624 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 60' ' ' PRO . . . . . 0.538 ' HD2' ' N ' ' A' ' 59' ' ' SER . 50.4 Cg_endo -70.63 -35.07 10.66 Favored 'Trans proline' 0 C--O 1.214 -0.681 0 C-N-CA 122.5 2.133 . . . . 0.0 112.284 -179.213 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 61' ' ' PHE . . . . . 0.575 ' CE1' ' HA ' ' A' ' 89' ' ' ALA . 74.2 m-85 -59.53 -33.99 72.08 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.168 -0.958 . . . . 0.0 109.495 -179.907 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 175.46 178.11 45.04 Favored Glycine 0 N--CA 1.49 2.236 0 N-CA-C 109.489 -1.445 . . . . 0.0 109.489 179.921 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 54.5 t30 -86.99 144.18 27.02 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.246 -1.149 . . . . 0.0 109.433 179.938 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 64' ' ' ILE . . . . . 0.513 HD11 ' HB2' ' A' ' 58' ' ' PHE . 67.1 mt -106.28 134.32 48.21 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.534 0 O-C-N 121.23 -0.919 . . . . 0.0 109.388 -179.965 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 37.8 pt -101.67 -25.78 3.7 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.524 0 O-C-N 121.233 -0.917 . . . . 0.0 109.661 -179.774 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 66' ' ' ASP . . . . . 0.426 ' HB3' ' OG1' ' A' ' 79' ' ' THR . 55.4 t0 -142.34 115.83 9.06 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.227 -0.92 . . . . 0.0 109.606 -179.853 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . 0.563 HD22 ' HE ' ' A' ' 55' ' ' ARG . 15.8 tp -105.41 115.95 31.12 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.288 -0.883 . . . . 0.0 109.467 179.908 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 68' ' ' SER . . . . . 0.469 ' HB2' ' HB2' ' A' ' 77' ' ' PHE . 67.7 m -123.94 146.66 48.32 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.271 -0.893 . . . . 0.0 109.414 179.972 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 69' ' ' MET . . . . . 0.478 ' HA ' ' HA ' ' A' ' 76' ' ' ALA . 72.0 mtp -131.51 150.89 51.98 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.219 -0.926 . . . . 0.0 109.609 -179.903 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 70' ' ' ASP . . . . . 0.474 ' C ' ' HD2' ' A' ' 72' ' ' PRO . 0.5 OUTLIER -126.24 103.84 25.9 Favored Pre-proline 0 N--CA 1.49 1.571 0 O-C-N 121.228 -0.92 . . . . 0.0 109.392 179.903 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 71' ' ' PRO . . . . . 0.605 ' N ' ' CD ' ' A' ' 72' ' ' PRO . 48.2 Cg_endo -74.91 -27.66 10.0 Favored 'Trans proline' 0 CA--C 1.542 0.903 0 C-N-CA 122.553 2.169 . . . . 0.0 113.793 -179.936 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 72' ' ' PRO . . . . . 0.605 ' CD ' ' N ' ' A' ' 71' ' ' PRO . 55.2 Cg_endo -74.89 -24.85 12.66 Favored 'Trans proline' 0 C--N 1.352 0.752 0 C-N-CA 121.525 1.483 . . . . 0.0 111.934 -179.783 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 61.1 mtt-85 -113.83 2.66 15.19 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.237 -0.914 . . . . 0.0 109.671 -179.812 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 82.8 m-20 58.09 38.9 26.59 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.128 -0.983 . . . . 0.0 109.533 179.924 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 75' ' ' CYS . . . . . . . . . . . . . 29.7 p -135.49 134.04 39.12 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.189 -0.944 . . . . 0.0 109.573 -179.941 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 76' ' ' ALA . . . . . 0.478 ' HA ' ' HA ' ' A' ' 69' ' ' MET . . . -106.48 161.73 14.34 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.257 -0.902 . . . . 0.0 109.339 179.882 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 77' ' ' PHE . . . . . 0.47 ' HA ' ' O ' ' A' ' 42' ' ' LEU . 97.4 m-85 -125.43 128.33 47.91 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.241 -0.912 . . . . 0.0 109.599 -179.853 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . 0.924 ' O ' HD12 ' A' ' 42' ' ' LEU . 13.7 t -117.88 141.01 38.82 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.526 0 O-C-N 121.24 -0.913 . . . . 0.0 109.182 179.793 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 79' ' ' THR . . . . . 0.483 ' HA ' ' O ' ' A' ' 40' ' ' ASN . 0.4 OUTLIER -112.18 127.73 56.03 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.279 -0.888 . . . . 0.0 109.612 -179.653 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 80' ' ' TYR . . . . . 0.524 ' OH ' ' CA ' ' A' ' 58' ' ' PHE . 1.8 m-85 -111.37 126.96 55.48 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.352 -0.842 . . . . 0.0 109.382 -179.948 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 81' ' ' GLU . . . . . 0.423 ' C ' ' O ' ' A' ' 80' ' ' TYR . 88.1 tt0 -40.74 -39.07 1.02 Allowed 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.456 -0.778 . . . . 0.0 110.192 -179.789 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 46.8 mttp -126.78 156.35 41.37 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.042 -1.036 . . . . 0.0 109.589 -179.766 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 83' ' ' MET . . . . . 0.42 ' HG2' ' CG ' ' A' ' 40' ' ' ASN . 40.9 mtt -73.72 -20.74 60.44 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.272 -0.892 . . . . 0.0 109.404 179.895 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 97.5 mt-10 -65.57 -50.64 64.4 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.257 -0.902 . . . . 0.0 109.392 179.875 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 27.5 m -59.25 -35.16 73.18 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.152 -0.968 . . . . 0.0 109.252 179.847 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 86' ' ' ALA . . . . . 0.821 ' HB1' HD21 ' A' ' 42' ' ' LEU . . . -74.94 -31.04 61.41 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.344 -0.847 . . . . 0.0 109.157 179.76 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 90.5 m-20 -67.65 -37.46 82.44 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.26 -0.9 . . . . 0.0 109.276 179.855 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 64.4 tt0 -70.96 -42.14 70.15 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.255 -0.903 . . . . 0.0 109.374 179.841 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 89' ' ' ALA . . . . . 0.628 ' HB1' ' CD1' ' A' ' 93' ' ' LEU . . . -68.83 -42.73 76.81 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.249 -0.907 . . . . 0.0 109.296 -179.971 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 90' ' ' VAL . . . . . 0.782 ' HA ' HG11 ' A' ' 105' ' ' VAL . 79.3 t -58.1 -37.27 60.94 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.52 0 O-C-N 121.201 -0.937 . . . . 0.0 109.498 -179.944 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -76.1 -53.26 8.59 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.26 -0.9 . . . . 0.0 109.587 -179.832 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 92' ' ' GLU . . . . . 0.521 ' O ' ' CG2' ' A' ' 96' ' ' THR . 74.9 mm-40 -67.2 -42.99 83.22 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.361 -0.837 . . . . 0.0 109.648 -179.762 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 93' ' ' LEU . . . . . 0.94 ' HB2' HG21 ' A' ' 105' ' ' VAL . 87.4 mt -68.87 -39.0 80.08 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.206 -0.934 . . . . 0.0 109.617 -179.835 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 94' ' ' ASN . . . . . 0.517 ' CB ' ' O ' ' A' ' 90' ' ' VAL . 21.2 t-20 -67.84 129.99 41.6 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.243 -0.911 . . . . 0.0 109.51 -179.96 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 85.85 32.11 19.03 Favored Glycine 0 N--CA 1.489 2.221 0 N-CA-C 109.514 -1.435 . . . . 0.0 109.514 -179.986 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 96' ' ' THR . . . . . 0.612 HG23 ' O ' ' A' ' 93' ' ' LEU . 27.6 p -119.45 160.28 22.66 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.15 -1.206 . . . . 0.0 109.45 -179.994 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 97' ' ' GLN . . . . . 0.516 ' HG2' ' N ' ' A' ' 98' ' ' VAL . 62.1 tt0 -135.89 159.88 40.3 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.259 -0.9 . . . . 0.0 109.483 -179.951 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 98' ' ' VAL . . . . . 0.609 HG12 ' H ' ' A' ' 99' ' ' GLU . 1.1 t -113.26 -160.25 0.17 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.591 0 O-C-N 121.252 -0.905 . . . . 0.0 109.351 -179.993 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 99' ' ' GLU . . . . . 0.609 ' H ' HG12 ' A' ' 98' ' ' VAL . 95.9 mt-10 -51.73 -35.42 43.21 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.167 -0.958 . . . . 0.0 109.549 -179.943 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 100' ' ' SER . . . . . 0.431 ' O ' ' OG ' ' A' ' 100' ' ' SER . 6.1 t -164.9 28.59 0.06 Allowed 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.197 -0.939 . . . . 0.0 109.498 -179.943 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 101' ' ' VAL . . . . . 0.554 ' O ' HG23 ' A' ' 98' ' ' VAL . 59.7 t -140.42 147.99 22.7 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.564 0 O-C-N 121.244 -0.91 . . . . 0.0 109.464 179.968 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 91.5 mt-30 -97.34 146.65 24.96 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.239 -0.913 . . . . 0.0 109.508 -179.975 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 77.8 mt -111.54 135.21 52.43 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.26 -0.9 . . . . 0.0 109.489 -179.969 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 104' ' ' LYS . . . . . 0.459 ' O ' ' HA ' ' A' ' 44' ' ' VAL . 54.8 mttt -121.8 140.57 52.2 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.226 -0.921 . . . . 0.0 109.482 179.997 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 105' ' ' VAL . . . . . 0.94 HG21 ' HB2' ' A' ' 93' ' ' LEU . 34.3 t . . . . . 0 N--CA 1.49 1.557 0 O-C-N 121.274 -0.891 . . . . 0.0 109.421 -179.986 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 40' ' ' ASN . . . . . 0.477 ' O ' ' HA ' ' A' ' 79' ' ' THR . 49.6 t30 . . . . . 0 N--CA 1.49 1.566 0 N-CA-C 108.947 -0.761 . . . . 0.0 108.947 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 41' ' ' THR . . . . . 0.481 ' HA ' ' O ' ' A' ' 78' ' ' VAL . 34.2 m -78.01 149.17 34.09 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.259 -0.9 . . . . 0.0 110.105 -179.464 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . 0.781 HD12 ' O ' ' A' ' 78' ' ' VAL . 5.2 mp -126.31 154.4 43.51 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.278 -0.889 . . . . 0.0 109.28 179.723 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 43' ' ' TYR . . . . . 0.411 ' O ' ' HA ' ' A' ' 105' ' ' VAL . 76.1 t80 -107.87 114.82 29.02 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.292 -0.88 . . . . 0.0 109.52 179.875 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 44' ' ' VAL . . . . . 0.625 HG13 HD23 ' A' ' 103' ' ' LEU . 40.6 t -108.52 137.4 40.45 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 121.299 -0.876 . . . . 0.0 109.451 -179.959 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 45' ' ' TYR . . . . . 0.422 ' HB3' ' HB2' ' A' ' 104' ' ' LYS . 65.7 t80 -127.66 135.38 50.14 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.217 -0.927 . . . . 0.0 109.581 -179.844 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 171.24 -177.79 43.97 Favored Glycine 0 N--CA 1.49 2.259 0 N-CA-C 109.553 -1.419 . . . . 0.0 109.553 179.93 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 95.4 mt-10 -116.29 161.83 18.42 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.282 -1.128 . . . . 0.0 109.441 179.997 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 49.9 m-20 44.0 49.51 7.32 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.256 -0.902 . . . . 0.0 109.518 179.947 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 51.1 mtm -101.88 138.82 38.35 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.307 -0.871 . . . . 0.0 109.537 -179.947 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 50' ' ' THR . . . . . 0.405 ' O ' ' HG ' ' A' ' 54' ' ' LEU . 0.9 OUTLIER -122.55 162.94 35.56 Favored Pre-proline 0 N--CA 1.489 1.505 0 O-C-N 121.343 -0.848 . . . . 0.0 109.363 179.914 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 51' ' ' PRO . . . . . 0.628 ' HA ' HD12 ' A' ' 54' ' ' LEU . 47.8 Cg_endo -69.6 -53.61 0.27 Allowed 'Trans proline' 0 C--O 1.215 -0.674 0 C-N-CA 122.592 2.194 . . . . 0.0 111.768 -179.991 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 31.1 m -49.3 -49.23 44.73 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.232 -0.918 . . . . 0.0 109.194 179.867 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 26.8 tp -59.7 -46.54 88.77 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.309 -0.869 . . . . 0.0 109.203 179.714 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 54' ' ' LEU . . . . . 0.657 HD11 ' HE1' ' A' ' 69' ' ' MET . 12.4 mt -57.39 -46.25 83.63 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.322 -0.861 . . . . 0.0 109.193 179.726 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 55' ' ' ARG . . . . . 0.513 ' O ' ' N ' ' A' ' 59' ' ' SER . 83.9 mtt-85 -51.34 -39.84 57.86 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.295 -0.878 . . . . 0.0 109.175 179.79 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -68.77 -35.2 79.46 Favored Glycine 0 N--CA 1.489 2.226 0 N-CA-C 109.35 -1.5 . . . . 0.0 109.35 179.909 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . 0.456 ' O ' ' CD1' ' A' ' 61' ' ' PHE . . . -73.4 -27.64 61.57 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.216 -1.167 . . . . 0.0 109.379 179.92 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 58' ' ' PHE . . . . . 0.794 ' HB2' HD11 ' A' ' 64' ' ' ILE . 96.3 m-85 -112.18 8.44 19.89 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.304 -0.873 . . . . 0.0 109.34 179.969 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 59' ' ' SER . . . . . 0.534 ' N ' ' HD2' ' A' ' 60' ' ' PRO . 1.0 OUTLIER -74.09 -57.25 2.37 Favored Pre-proline 0 N--CA 1.491 1.6 0 O-C-N 121.372 -0.83 . . . . 0.0 110.106 -179.693 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 60' ' ' PRO . . . . . 0.534 ' HD2' ' N ' ' A' ' 59' ' ' SER . 47.3 Cg_endo -68.7 -27.66 31.72 Favored 'Trans proline' 0 C--O 1.215 -0.666 0 C-N-CA 122.676 2.25 . . . . 0.0 112.037 -179.511 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 61' ' ' PHE . . . . . 0.583 ' CE2' ' HB3' ' A' ' 92' ' ' GLU . 72.0 m-85 -69.56 -33.41 72.71 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.201 -0.937 . . . . 0.0 109.514 179.981 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 175.18 -169.71 42.64 Favored Glycine 0 N--CA 1.49 2.278 0 N-CA-C 109.487 -1.445 . . . . 0.0 109.487 179.996 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 83.9 m-20 -99.93 138.86 36.42 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.201 -1.176 . . . . 0.0 109.439 179.916 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 64' ' ' ILE . . . . . 0.794 HD11 ' HB2' ' A' ' 58' ' ' PHE . 49.1 mt -101.31 128.51 53.54 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.521 0 O-C-N 121.266 -0.896 . . . . 0.0 109.585 -179.938 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 23.0 pt -94.79 -25.19 4.66 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 O-C-N 121.238 -0.914 . . . . 0.0 109.409 -179.896 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 66' ' ' ASP . . . . . 0.466 ' HB3' ' OG1' ' A' ' 79' ' ' THR . 58.4 t0 -141.02 129.84 23.0 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.198 -0.939 . . . . 0.0 109.601 -179.955 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . 0.741 ' C ' HD13 ' A' ' 67' ' ' LEU . 3.4 tm? -119.29 116.35 26.05 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.303 -0.873 . . . . 0.0 109.364 179.934 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 68' ' ' SER . . . . . 0.492 ' HB2' ' HB2' ' A' ' 77' ' ' PHE . 58.0 m -121.13 145.35 47.9 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.14 -0.975 . . . . 0.0 109.532 -179.94 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 69' ' ' MET . . . . . 0.657 ' HE1' HD11 ' A' ' 54' ' ' LEU . 89.8 mmm -122.61 144.18 49.28 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.24 -0.912 . . . . 0.0 109.531 -179.952 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 70' ' ' ASP . . . . . 0.479 ' HB2' ' O ' ' A' ' 75' ' ' CYS . 0.2 OUTLIER -124.57 94.31 44.86 Favored Pre-proline 0 N--CA 1.49 1.566 0 O-C-N 121.2 -0.937 . . . . 0.0 109.461 179.917 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 71' ' ' PRO . . . . . 0.598 ' N ' ' CD ' ' A' ' 72' ' ' PRO . 46.5 Cg_endo -74.6 -28.0 10.31 Favored 'Trans proline' 0 CA--C 1.542 0.922 0 C-N-CA 122.506 2.137 . . . . 0.0 113.696 -179.989 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 72' ' ' PRO . . . . . 0.598 ' CD ' ' N ' ' A' ' 71' ' ' PRO . 55.2 Cg_endo -75.45 -22.38 14.11 Favored 'Trans proline' 0 C--N 1.352 0.722 0 C-N-CA 121.523 1.482 . . . . 0.0 111.75 -179.788 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 27.4 mtt85 -113.26 3.8 16.15 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.22 -0.925 . . . . 0.0 109.654 -179.9 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 73.4 m-20 58.23 47.86 13.59 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.244 -0.91 . . . . 0.0 109.45 179.972 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 75' ' ' CYS . . . . . 0.479 ' O ' ' HB2' ' A' ' 70' ' ' ASP . 31.1 p -152.63 148.26 27.11 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.284 -0.885 . . . . 0.0 109.456 -179.968 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 76' ' ' ALA . . . . . 0.468 ' HB1' ' SD ' ' A' ' 69' ' ' MET . . . -120.34 157.54 29.02 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.273 -0.892 . . . . 0.0 109.401 179.919 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 77' ' ' PHE . . . . . 0.492 ' HB2' ' HB2' ' A' ' 68' ' ' SER . 97.7 m-85 -119.59 139.75 51.66 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.202 -0.936 . . . . 0.0 109.569 -179.849 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . 0.781 ' O ' HD12 ' A' ' 42' ' ' LEU . 20.5 t -129.23 137.97 55.65 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.546 0 O-C-N 121.191 -0.943 . . . . 0.0 109.55 179.988 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 79' ' ' THR . . . . . 0.477 ' HA ' ' O ' ' A' ' 40' ' ' ASN . 23.3 m -106.19 134.83 48.7 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.194 -0.941 . . . . 0.0 109.264 179.89 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 80' ' ' TYR . . . . . 0.612 ' HH ' ' HD2' ' A' ' 58' ' ' PHE . 0.7 OUTLIER -113.21 141.63 46.74 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.214 -0.929 . . . . 0.0 109.62 -179.917 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 80.8 tt0 -64.03 -22.6 67.0 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.209 -0.932 . . . . 0.0 109.359 179.795 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 38.2 mttp -136.05 135.93 39.8 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.243 -0.91 . . . . 0.0 109.461 179.982 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 83' ' ' MET . . . . . . . . . . . . . 47.0 mtt -57.33 -24.64 56.37 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.244 -0.91 . . . . 0.0 109.401 179.928 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 98.4 mt-10 -66.2 -37.49 85.71 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.305 -0.872 . . . . 0.0 109.557 179.981 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 19.3 m -62.37 -31.48 72.15 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.236 -0.915 . . . . 0.0 109.571 -179.97 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 86' ' ' ALA . . . . . 0.645 ' O ' HG23 ' A' ' 90' ' ' VAL . . . -75.61 -34.54 60.6 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.255 -0.903 . . . . 0.0 109.449 -179.945 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 64.5 t0 -62.14 -45.42 93.53 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.286 -0.884 . . . . 0.0 109.647 -179.953 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 44.6 tt0 -69.08 -43.58 74.25 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.172 -0.955 . . . . 0.0 109.595 -179.882 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 89' ' ' ALA . . . . . 0.624 ' HB1' ' CD1' ' A' ' 93' ' ' LEU . . . -72.37 -37.13 68.84 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.195 -0.941 . . . . 0.0 109.552 -179.869 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 90' ' ' VAL . . . . . 0.747 ' CG2' HD23 ' A' ' 42' ' ' LEU . 61.2 t -69.38 -47.31 73.69 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.604 0 O-C-N 121.254 -0.904 . . . . 0.0 109.652 -179.89 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -73.56 -28.51 61.9 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.236 -0.915 . . . . 0.0 109.757 -179.721 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 92' ' ' GLU . . . . . 0.583 ' HB3' ' CE2' ' A' ' 61' ' ' PHE . 39.2 tp10 -87.21 -49.77 7.05 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.245 -0.909 . . . . 0.0 109.786 -179.731 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 93' ' ' LEU . . . . . 0.929 ' HB2' HG21 ' A' ' 105' ' ' VAL . 39.9 mt -68.02 -39.81 83.09 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.244 -0.91 . . . . 0.0 109.612 -179.907 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 94' ' ' ASN . . . . . 0.523 ' CB ' ' O ' ' A' ' 90' ' ' VAL . 57.2 t30 -68.35 128.05 35.19 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.24 -0.912 . . . . 0.0 109.481 -179.969 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 94.87 19.38 31.59 Favored Glycine 0 N--CA 1.491 2.308 0 N-CA-C 109.591 -1.404 . . . . 0.0 109.591 -179.947 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 96' ' ' THR . . . . . 0.428 ' CG2' ' O ' ' A' ' 92' ' ' GLU . 21.8 p -120.46 148.6 43.6 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.209 -1.171 . . . . 0.0 109.493 179.978 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 97' ' ' GLN . . . . . 0.474 ' HG3' ' O ' ' A' ' 101' ' ' VAL . 59.8 tt0 -119.73 140.76 50.2 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.232 -0.917 . . . . 0.0 109.478 179.996 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 98' ' ' VAL . . . . . 0.642 HG12 ' H ' ' A' ' 99' ' ' GLU . 1.3 t -81.74 -162.99 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.532 0 O-C-N 121.285 -0.885 . . . . 0.0 109.347 179.997 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 99' ' ' GLU . . . . . 0.642 ' H ' HG12 ' A' ' 98' ' ' VAL . 96.0 mt-10 -54.18 -37.36 64.41 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.232 -0.917 . . . . 0.0 109.558 -179.975 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -155.59 25.18 0.4 Allowed 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.322 -0.861 . . . . 0.0 109.521 179.957 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 101' ' ' VAL . . . . . 0.564 HG12 ' N ' ' A' ' 102' ' ' GLN . 60.0 t -137.77 164.62 28.02 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.552 0 O-C-N 121.236 -0.915 . . . . 0.0 109.5 -179.953 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 102' ' ' GLN . . . . . 0.564 ' N ' HG12 ' A' ' 101' ' ' VAL . 91.7 mt-30 -119.06 145.36 45.96 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.309 -0.869 . . . . 0.0 109.371 179.854 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 103' ' ' LEU . . . . . 0.625 HD23 HG13 ' A' ' 44' ' ' VAL . 0.0 OUTLIER -124.45 130.95 53.41 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.25 -0.907 . . . . 0.0 109.591 -179.785 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 104' ' ' LYS . . . . . 0.422 ' HB2' ' HB3' ' A' ' 45' ' ' TYR . 24.1 mttm -117.89 127.24 53.66 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.346 -0.846 . . . . 0.0 109.24 179.761 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 105' ' ' VAL . . . . . 0.929 HG21 ' HB2' ' A' ' 93' ' ' LEU . 12.1 t . . . . . 0 N--CA 1.49 1.551 0 O-C-N 121.231 -0.918 . . . . 0.0 109.736 -179.764 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 40' ' ' ASN . . . . . 0.546 HD22 ' HB3' ' A' ' 86' ' ' ALA . 42.1 t30 . . . . . 0 N--CA 1.491 1.608 0 N-CA-C 109.1 -0.704 . . . . 0.0 109.1 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 41' ' ' THR . . . . . 0.487 ' HA ' ' O ' ' A' ' 78' ' ' VAL . 27.0 m -78.54 150.94 32.74 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.24 -0.913 . . . . 0.0 110.063 -179.479 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . 0.906 HD12 ' O ' ' A' ' 78' ' ' VAL . 5.1 mp -126.57 152.86 46.02 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.413 -0.805 . . . . 0.0 109.132 179.616 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 39.8 t80 -107.92 111.37 23.44 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.224 -0.923 . . . . 0.0 109.42 179.865 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 44' ' ' VAL . . . . . 0.473 ' HA ' ' O ' ' A' ' 104' ' ' LYS . 96.5 t -109.16 142.26 22.18 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.551 0 O-C-N 121.202 -0.936 . . . . 0.0 109.384 179.969 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 68.1 t80 -128.35 130.97 48.54 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.251 -0.906 . . . . 0.0 109.561 -179.882 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -176.54 -166.44 33.7 Favored Glycine 0 N--CA 1.488 2.123 0 N-CA-C 109.483 -1.447 . . . . 0.0 109.483 179.928 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . 0.415 ' O ' ' C ' ' A' ' 48' ' ' ASP . 94.8 mt-10 -132.52 161.08 34.68 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.328 -1.101 . . . . 0.0 109.485 179.987 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 48' ' ' ASP . . . . . 0.415 ' C ' ' O ' ' A' ' 47' ' ' GLU . 42.8 m-20 43.66 51.55 6.45 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.271 -0.893 . . . . 0.0 109.601 179.934 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 72.6 mtm -103.78 145.0 30.73 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.249 -0.907 . . . . 0.0 109.475 -179.944 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 50' ' ' THR . . . . . 0.407 ' O ' HD12 ' A' ' 54' ' ' LEU . 0.0 OUTLIER -117.6 161.75 32.2 Favored Pre-proline 0 N--CA 1.49 1.561 0 O-C-N 121.296 -0.878 . . . . 0.0 109.53 -179.978 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 51' ' ' PRO . . . . . 0.48 ' CA ' ' SD ' ' A' ' 69' ' ' MET . 49.2 Cg_endo -69.93 -53.93 0.24 Allowed 'Trans proline' 0 C--O 1.214 -0.694 0 C-N-CA 122.731 2.288 . . . . 0.0 111.739 179.89 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 27.1 m -56.91 -44.71 82.64 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.286 -0.884 . . . . 0.0 109.33 179.887 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . 0.771 ' O ' HD13 ' A' ' 53' ' ' LEU . 2.3 tm? -59.94 -47.77 84.44 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.311 -0.868 . . . . 0.0 109.384 179.97 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 54' ' ' LEU . . . . . 0.498 HD11 ' CE ' ' A' ' 69' ' ' MET . 17.3 mt -59.36 -52.31 66.16 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.255 -0.903 . . . . 0.0 109.332 179.979 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 55' ' ' ARG . . . . . 0.513 ' O ' ' N ' ' A' ' 59' ' ' SER . 52.3 mtp180 -45.0 -41.04 7.01 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.242 -0.911 . . . . 0.0 109.292 179.83 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . 0.487 ' O ' ' HD2' ' A' ' 60' ' ' PRO . . . -64.07 -40.65 98.34 Favored Glycine 0 N--CA 1.49 2.252 0 N-CA-C 109.416 -1.474 . . . . 0.0 109.416 179.904 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . 0.429 ' O ' ' CD2' ' A' ' 61' ' ' PHE . . . -65.9 -23.3 66.61 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.286 -1.126 . . . . 0.0 109.323 179.956 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 58' ' ' PHE . . . . . 0.808 ' HB2' HD11 ' A' ' 64' ' ' ILE . 93.6 m-85 -116.81 9.36 13.89 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.287 -0.883 . . . . 0.0 109.395 179.975 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 59' ' ' SER . . . . . 0.548 ' N ' ' HD2' ' A' ' 60' ' ' PRO . 0.9 OUTLIER -76.89 -55.45 1.47 Allowed Pre-proline 0 N--CA 1.491 1.592 0 O-C-N 121.225 -0.922 . . . . 0.0 110.37 -179.569 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 60' ' ' PRO . . . . . 0.548 ' HD2' ' N ' ' A' ' 59' ' ' SER . 47.4 Cg_endo -69.26 -30.76 24.05 Favored 'Trans proline' 0 C--O 1.215 -0.65 0 C-N-CA 122.502 2.135 . . . . 0.0 112.158 -179.25 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 61' ' ' PHE . . . . . 0.557 ' CE1' ' HA ' ' A' ' 89' ' ' ALA . 82.3 m-85 -66.06 -38.32 88.03 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.165 -0.959 . . . . 0.0 109.442 179.933 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . 0.462 ' HA3' ' OG ' ' A' ' 85' ' ' SER . . . -179.51 -177.09 47.6 Favored Glycine 0 N--CA 1.49 2.277 0 N-CA-C 109.47 -1.452 . . . . 0.0 109.47 179.973 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 85.8 m-20 -91.46 140.35 29.83 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.171 -1.194 . . . . 0.0 109.489 179.965 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 64' ' ' ILE . . . . . 0.808 HD11 ' HB2' ' A' ' 58' ' ' PHE . 64.3 mt -101.63 133.32 45.41 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.531 0 O-C-N 121.235 -0.916 . . . . 0.0 109.506 -179.929 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 25.9 pt -96.68 -19.57 6.06 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 O-C-N 121.284 -0.885 . . . . 0.0 109.609 -179.955 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 66' ' ' ASP . . . . . 0.459 ' HB3' ' OG1' ' A' ' 79' ' ' THR . 58.5 t0 -153.4 110.8 3.5 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.185 -0.947 . . . . 0.0 109.571 -179.917 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . 0.747 HD23 HD13 ' A' ' 64' ' ' ILE . 0.2 OUTLIER -102.18 118.1 36.17 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.24 -0.913 . . . . 0.0 109.388 179.824 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 68' ' ' SER . . . . . 0.652 ' N ' HD13 ' A' ' 67' ' ' LEU . 25.6 t -126.49 145.34 50.54 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.245 -0.91 . . . . 0.0 109.556 -179.836 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 69' ' ' MET . . . . . 0.498 ' CE ' HD11 ' A' ' 54' ' ' LEU . 90.5 mtp -126.89 150.96 49.03 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.371 -0.831 . . . . 0.0 109.407 179.923 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 70' ' ' ASP . . . . . 0.48 ' C ' ' HD2' ' A' ' 72' ' ' PRO . 0.2 OUTLIER -125.41 98.31 35.31 Favored Pre-proline 0 N--CA 1.49 1.57 0 O-C-N 121.29 -0.882 . . . . 0.0 109.526 179.961 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 71' ' ' PRO . . . . . 0.603 ' N ' ' CD ' ' A' ' 72' ' ' PRO . 46.2 Cg_endo -74.61 -27.85 10.44 Favored 'Trans proline' 0 CA--C 1.542 0.925 0 C-N-CA 122.529 2.153 . . . . 0.0 113.647 179.945 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 72' ' ' PRO . . . . . 0.603 ' CD ' ' N ' ' A' ' 71' ' ' PRO . 55.3 Cg_endo -75.69 -26.19 10.1 Favored 'Trans proline' 0 C--N 1.353 0.782 0 C-N-CA 121.536 1.49 . . . . 0.0 111.771 -179.958 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 73' ' ' ARG . . . . . 0.406 ' O ' ' HB2' ' A' ' 74' ' ' ASN . 96.5 mtt180 -110.85 -0.01 17.06 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.294 -0.878 . . . . 0.0 109.652 -179.822 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 74' ' ' ASN . . . . . 0.406 ' HB2' ' O ' ' A' ' 73' ' ' ARG . 8.3 m120 61.2 44.73 9.64 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.166 -0.959 . . . . 0.0 109.343 -179.91 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 75' ' ' CYS . . . . . 0.458 ' O ' ' HB2' ' A' ' 70' ' ' ASP . 22.0 p -143.5 137.37 28.46 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.286 -0.884 . . . . 0.0 109.475 179.959 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -111.45 154.16 25.08 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.205 -0.935 . . . . 0.0 109.492 -179.96 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 77' ' ' PHE . . . . . 0.476 ' HA ' ' O ' ' A' ' 42' ' ' LEU . 97.0 m-85 -121.93 129.04 52.2 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.237 -0.915 . . . . 0.0 109.577 -179.925 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . 0.906 ' O ' HD12 ' A' ' 42' ' ' LEU . 26.5 t -120.21 138.53 50.47 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.569 0 O-C-N 121.206 -0.934 . . . . 0.0 109.289 179.858 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 79' ' ' THR . . . . . 0.534 ' O ' HG23 ' A' ' 64' ' ' ILE . 1.2 m -107.2 136.36 47.16 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.286 -0.884 . . . . 0.0 109.634 -179.826 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 80' ' ' TYR . . . . . 0.565 ' CE1' ' OG ' ' A' ' 85' ' ' SER . 0.9 OUTLIER -119.81 121.27 38.74 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.295 -0.878 . . . . 0.0 109.419 179.81 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 81' ' ' GLU . . . . . 0.441 ' C ' ' O ' ' A' ' 80' ' ' TYR . 83.5 tt0 -40.37 -39.74 1.04 Allowed 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.516 -0.74 . . . . 0.0 109.85 179.964 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 9.5 mtmm -122.87 162.97 21.17 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.193 -0.942 . . . . 0.0 109.514 179.931 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 83' ' ' MET . . . . . 0.465 ' CE ' ' HB2' ' A' ' 40' ' ' ASN . 4.4 mmt -80.17 -13.94 58.85 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.188 -0.945 . . . . 0.0 109.345 -179.999 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 96.1 mt-10 -69.82 -35.77 75.08 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.241 -0.912 . . . . 0.0 109.49 179.891 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 85' ' ' SER . . . . . 0.565 ' OG ' ' CE1' ' A' ' 80' ' ' TYR . 43.4 t -71.57 -32.08 67.67 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.2 -0.937 . . . . 0.0 109.476 -179.967 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 86' ' ' ALA . . . . . 0.81 ' O ' HG23 ' A' ' 90' ' ' VAL . . . -78.78 -31.38 46.04 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.244 -0.91 . . . . 0.0 109.532 -179.938 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 58.3 t0 -70.62 -46.73 62.81 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.243 -0.911 . . . . 0.0 109.646 -179.938 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 65.0 tt0 -68.64 -41.31 79.6 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.269 -0.895 . . . . 0.0 109.644 -179.873 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 89' ' ' ALA . . . . . 0.613 ' HB1' ' CD1' ' A' ' 93' ' ' LEU . . . -67.92 -41.1 83.14 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.208 -0.933 . . . . 0.0 109.653 -179.935 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 90' ' ' VAL . . . . . 0.81 HG23 ' O ' ' A' ' 86' ' ' ALA . 55.6 t -60.4 -35.94 66.02 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.587 0 O-C-N 121.22 -0.925 . . . . 0.0 109.669 -179.902 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -75.42 -53.91 7.91 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.173 -0.954 . . . . 0.0 109.844 -179.723 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 92' ' ' GLU . . . . . 0.519 ' O ' ' CG2' ' A' ' 96' ' ' THR . 76.1 mm-40 -67.92 -44.37 77.04 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.223 -0.923 . . . . 0.0 109.768 -179.537 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 93' ' ' LEU . . . . . 0.756 ' HB2' HG21 ' A' ' 105' ' ' VAL . 92.1 mt -66.57 -38.95 88.14 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.079 -1.013 . . . . 0.0 109.541 -179.804 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 94' ' ' ASN . . . . . 0.532 ' CB ' ' O ' ' A' ' 90' ' ' VAL . 62.1 t-20 -72.74 120.23 18.07 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.237 -0.914 . . . . 0.0 109.553 -179.964 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 105.27 10.71 31.12 Favored Glycine 0 N--CA 1.491 2.315 0 N-CA-C 109.426 -1.47 . . . . 0.0 109.426 179.905 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 96' ' ' THR . . . . . 0.519 ' CG2' ' O ' ' A' ' 92' ' ' GLU . 27.7 p -107.77 157.62 17.98 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.201 -1.176 . . . . 0.0 109.494 -179.97 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 58.7 tt0 -129.25 145.95 51.25 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.182 -0.949 . . . . 0.0 109.479 -179.935 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 98' ' ' VAL . . . . . 0.478 HG23 ' O ' ' A' ' 101' ' ' VAL . 1.4 t -87.39 -147.8 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 O-C-N 121.275 -0.891 . . . . 0.0 109.385 179.996 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 99' ' ' GLU . . . . . 0.473 ' H ' HG12 ' A' ' 98' ' ' VAL . 96.7 mt-10 -63.44 -41.87 98.67 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.21 -0.931 . . . . 0.0 109.536 179.979 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -153.77 23.83 0.51 Allowed 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.257 -0.902 . . . . 0.0 109.478 -179.915 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 101' ' ' VAL . . . . . 0.478 ' O ' HG23 ' A' ' 98' ' ' VAL . 52.9 t -139.46 148.63 23.24 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 O-C-N 121.252 -0.905 . . . . 0.0 109.433 -179.979 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 47.2 tt0 -97.47 140.67 31.56 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.172 -0.955 . . . . 0.0 109.523 -179.867 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 90.7 mt -104.42 137.7 41.9 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.253 -0.904 . . . . 0.0 109.465 179.977 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 104' ' ' LYS . . . . . 0.473 ' O ' ' HA ' ' A' ' 44' ' ' VAL . 89.0 mttt -117.95 138.39 52.2 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.293 -0.88 . . . . 0.0 109.298 179.887 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 105' ' ' VAL . . . . . 0.756 HG21 ' HB2' ' A' ' 93' ' ' LEU . 59.9 t . . . . . 0 N--CA 1.49 1.54 0 O-C-N 121.225 -0.922 . . . . 0.0 109.458 -179.885 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 40' ' ' ASN . . . . . 0.566 ' N ' HG22 ' A' ' 79' ' ' THR . 47.4 t30 . . . . . 0 N--CA 1.491 1.596 0 N-CA-C 109.493 -0.558 . . . . 0.0 109.493 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 41' ' ' THR . . . . . 0.823 ' O ' HD23 ' A' ' 42' ' ' LEU . 45.1 m -61.11 140.44 57.88 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.236 -0.915 . . . . 0.0 109.815 -179.771 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . 0.823 HD23 ' O ' ' A' ' 41' ' ' THR . 17.9 mt -125.33 143.44 50.97 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.253 -0.904 . . . . 0.0 109.483 179.722 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 71.1 t80 -96.27 120.46 36.6 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.277 -0.889 . . . . 0.0 109.52 -179.998 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 44' ' ' VAL . . . . . 0.643 ' CG1' HD21 ' A' ' 103' ' ' LEU . 58.7 t -118.49 139.06 47.16 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 O-C-N 121.171 -0.956 . . . . 0.0 109.421 179.96 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 65.6 t80 -129.39 141.6 51.01 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.261 -0.9 . . . . 0.0 109.562 -179.939 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 175.2 -174.82 47.0 Favored Glycine 0 N--CA 1.49 2.292 0 N-CA-C 109.424 -1.47 . . . . 0.0 109.424 179.935 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . 0.418 ' O ' ' C ' ' A' ' 48' ' ' ASP . 94.6 mt-10 -112.86 159.32 19.15 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.195 -1.18 . . . . 0.0 109.343 179.974 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 48' ' ' ASP . . . . . 0.418 ' C ' ' O ' ' A' ' 47' ' ' GLU . 51.4 m-20 44.34 40.2 3.59 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.211 -0.93 . . . . 0.0 109.262 -179.951 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 46.9 mtp -75.46 141.09 43.18 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.282 -0.886 . . . . 0.0 109.527 -179.951 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 50' ' ' THR . . . . . 0.457 ' O ' ' HG ' ' A' ' 54' ' ' LEU . 0.7 OUTLIER -130.98 161.94 58.54 Favored Pre-proline 0 N--CA 1.49 1.553 0 O-C-N 121.19 -0.944 . . . . 0.0 109.344 -179.974 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 51' ' ' PRO . . . . . 0.505 ' N ' ' SD ' ' A' ' 69' ' ' MET . 49.7 Cg_endo -70.6 -53.47 0.22 Allowed 'Trans proline' 0 C--O 1.214 -0.683 0 C-N-CA 122.657 2.238 . . . . 0.0 111.669 179.964 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 32.9 m -58.34 -41.69 85.19 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.268 -0.895 . . . . 0.0 109.348 179.886 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . 0.496 ' C ' HD23 ' A' ' 53' ' ' LEU . 9.2 tt -62.44 -46.08 90.18 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.277 -0.889 . . . . 0.0 109.385 179.92 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 54' ' ' LEU . . . . . 0.457 ' HG ' ' O ' ' A' ' 50' ' ' THR . 40.8 mt -64.76 -46.16 83.36 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.238 -0.914 . . . . 0.0 109.207 179.79 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 55' ' ' ARG . . . . . 0.478 ' O ' ' CB ' ' A' ' 59' ' ' SER . 74.4 ttt180 -48.0 -40.79 23.64 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.244 -0.91 . . . . 0.0 109.394 179.97 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -73.71 -31.55 60.32 Favored Glycine 0 N--CA 1.49 2.243 0 N-CA-C 109.476 -1.45 . . . . 0.0 109.476 179.892 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -73.55 -24.46 60.11 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.225 -1.162 . . . . 0.0 109.435 179.982 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 58' ' ' PHE . . . . . 0.713 ' CZ ' HD13 ' A' ' 93' ' ' LEU . 94.8 m-85 -119.09 8.86 11.65 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.371 -0.83 . . . . 0.0 109.421 179.977 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 59' ' ' SER . . . . . 0.526 ' N ' ' HD2' ' A' ' 60' ' ' PRO . 0.4 OUTLIER -74.9 -57.59 1.81 Allowed Pre-proline 0 N--CA 1.491 1.609 0 O-C-N 121.279 -0.888 . . . . 0.0 110.162 -179.582 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 60' ' ' PRO . . . . . 0.526 ' HD2' ' N ' ' A' ' 59' ' ' SER . 48.1 Cg_endo -68.74 -35.96 15.13 Favored 'Trans proline' 0 C--O 1.215 -0.63 0 C-N-CA 122.584 2.189 . . . . 0.0 112.259 -179.437 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 61' ' ' PHE . . . . . 0.579 ' CD1' ' HA ' ' A' ' 89' ' ' ALA . 64.7 m-85 -58.72 -33.89 70.73 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.16 -0.963 . . . . 0.0 109.703 -179.828 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 176.74 -174.32 46.95 Favored Glycine 0 N--CA 1.49 2.282 0 N-CA-C 109.617 -1.393 . . . . 0.0 109.617 179.974 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 82.0 m-20 -95.03 146.23 24.41 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.235 -1.156 . . . . 0.0 109.46 179.991 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 64' ' ' ILE . . . . . 0.797 HD13 HD12 ' A' ' 67' ' ' LEU . 51.5 mt -110.77 126.54 68.12 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 O-C-N 121.3 -0.875 . . . . 0.0 109.416 179.974 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 22.2 pt -91.15 -22.56 6.16 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 O-C-N 121.273 -0.892 . . . . 0.0 109.543 -179.896 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 45.2 t0 -155.49 95.0 1.64 Allowed 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.196 -0.94 . . . . 0.0 109.586 179.994 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . 0.797 HD12 HD13 ' A' ' 64' ' ' ILE . 0.5 OUTLIER -93.29 126.67 38.53 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.206 -0.934 . . . . 0.0 109.196 179.769 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 68' ' ' SER . . . . . 0.44 ' HB2' ' HB2' ' A' ' 77' ' ' PHE . 67.5 m -126.08 153.86 43.89 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.226 -0.921 . . . . 0.0 109.718 -179.802 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 69' ' ' MET . . . . . 0.505 ' SD ' ' N ' ' A' ' 51' ' ' PRO . 84.1 mtp -126.46 150.54 48.63 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.414 -0.804 . . . . 0.0 109.296 179.851 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 70' ' ' ASP . . . . . 0.484 ' C ' ' HD2' ' A' ' 72' ' ' PRO . 1.2 t0 -129.09 99.24 22.09 Favored Pre-proline 0 N--CA 1.49 1.565 0 O-C-N 121.195 -0.941 . . . . 0.0 109.55 -179.948 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 71' ' ' PRO . . . . . 0.6 ' N ' ' CD ' ' A' ' 72' ' ' PRO . 46.4 Cg_endo -74.54 -27.96 10.48 Favored 'Trans proline' 0 CA--C 1.542 0.897 0 C-N-CA 122.503 2.136 . . . . 0.0 113.523 179.845 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 72' ' ' PRO . . . . . 0.6 ' CD ' ' N ' ' A' ' 71' ' ' PRO . 55.6 Cg_endo -75.38 -26.62 10.15 Favored 'Trans proline' 0 C--N 1.353 0.772 0 C-N-CA 121.483 1.456 . . . . 0.0 111.82 -179.932 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 73' ' ' ARG . . . . . 0.429 ' O ' ' HB2' ' A' ' 74' ' ' ASN . 89.0 mtt-85 -109.23 -1.02 18.94 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.293 -0.88 . . . . 0.0 109.645 -179.959 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 74' ' ' ASN . . . . . 0.429 ' HB2' ' O ' ' A' ' 73' ' ' ARG . 79.8 m-20 61.6 43.99 9.49 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.21 -0.931 . . . . 0.0 109.568 179.955 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 75' ' ' CYS . . . . . 0.466 ' HA ' ' O ' ' A' ' 44' ' ' VAL . 27.5 p -146.94 150.5 35.3 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.271 -0.893 . . . . 0.0 109.395 179.978 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -116.35 154.25 30.55 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.171 -0.956 . . . . 0.0 109.522 -179.946 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 77' ' ' PHE . . . . . 0.47 ' HA ' ' O ' ' A' ' 42' ' ' LEU . 98.0 m-85 -124.16 106.31 10.23 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.299 -0.876 . . . . 0.0 109.476 -179.941 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . 0.735 HG23 HD12 ' A' ' 67' ' ' LEU . 5.9 p -109.8 136.19 46.48 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.503 0 O-C-N 121.131 -0.981 . . . . 0.0 109.638 179.907 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 79' ' ' THR . . . . . 0.566 HG22 ' N ' ' A' ' 40' ' ' ASN . 3.7 m -102.5 127.05 49.72 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.308 -0.87 . . . . 0.0 109.699 -179.736 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 80' ' ' TYR . . . . . 0.823 ' HD2' HD11 ' A' ' 42' ' ' LEU . 0.5 OUTLIER -102.16 126.12 49.04 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.308 -0.87 . . . . 0.0 109.465 179.948 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 81' ' ' GLU . . . . . 0.431 ' C ' ' O ' ' A' ' 80' ' ' TYR . 88.5 tt0 -42.06 -47.4 4.49 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.476 -0.765 . . . . 0.0 109.766 179.949 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 36.4 mttm -113.7 155.86 24.8 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.26 -0.9 . . . . 0.0 109.635 -179.904 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 83' ' ' MET . . . . . . . . . . . . . 57.7 mtt -77.46 -19.87 55.29 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.26 -0.9 . . . . 0.0 109.34 179.943 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 98.3 mt-10 -69.66 -44.6 70.19 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.181 -0.949 . . . . 0.0 109.303 179.918 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 16.0 m -61.56 -27.39 68.59 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.355 -0.841 . . . . 0.0 109.225 179.739 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 86' ' ' ALA . . . . . 0.611 ' O ' HG23 ' A' ' 90' ' ' VAL . . . -78.11 -34.42 50.06 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.383 -0.823 . . . . 0.0 109.416 -179.993 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 59.2 t0 -66.9 -33.63 76.02 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.294 -0.879 . . . . 0.0 109.388 179.897 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 88' ' ' GLN . . . . . 0.479 ' O ' ' HB2' ' A' ' 92' ' ' GLU . 63.5 tt0 -77.01 -37.6 54.69 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.287 -0.883 . . . . 0.0 109.384 179.933 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 89' ' ' ALA . . . . . 0.579 ' HA ' ' CD1' ' A' ' 61' ' ' PHE . . . -76.49 -35.09 58.57 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.285 -0.884 . . . . 0.0 109.385 179.939 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 90' ' ' VAL . . . . . 0.728 HG22 ' CG1' ' A' ' 105' ' ' VAL . 75.8 t -71.2 -39.77 73.7 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.513 0 O-C-N 121.325 -0.859 . . . . 0.0 109.464 -179.948 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -77.11 -34.31 56.76 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.209 -0.932 . . . . 0.0 109.496 -179.985 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 92' ' ' GLU . . . . . 0.579 ' HB3' ' CZ ' ' A' ' 61' ' ' PHE . 6.0 tm-20 -80.07 -46.28 16.8 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.215 -0.928 . . . . 0.0 109.644 -179.867 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 93' ' ' LEU . . . . . 0.713 HD13 ' CZ ' ' A' ' 58' ' ' PHE . 72.6 mt -70.42 -37.69 74.45 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.22 -0.925 . . . . 0.0 109.534 -179.918 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 94' ' ' ASN . . . . . 0.519 ' CB ' ' O ' ' A' ' 90' ' ' VAL . 49.6 t30 -70.12 136.68 50.42 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.231 -0.918 . . . . 0.0 109.462 -179.933 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 83.16 26.32 44.77 Favored Glycine 0 N--CA 1.49 2.279 0 N-CA-C 109.528 -1.429 . . . . 0.0 109.528 179.988 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 96' ' ' THR . . . . . 0.556 HG21 ' O ' ' A' ' 92' ' ' GLU . 27.9 p -125.89 146.63 49.75 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.29 -1.123 . . . . 0.0 109.575 -179.982 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 97' ' ' GLN . . . . . 0.502 ' CG ' ' O ' ' A' ' 101' ' ' VAL . 52.7 tt0 -117.92 137.81 52.57 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.293 -0.879 . . . . 0.0 109.424 -179.938 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 98' ' ' VAL . . . . . 0.547 HG12 ' H ' ' A' ' 99' ' ' GLU . 1.1 t -80.12 -153.55 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 O-C-N 121.283 -0.886 . . . . 0.0 109.337 -179.983 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 99' ' ' GLU . . . . . 0.547 ' H ' HG12 ' A' ' 98' ' ' VAL . 96.5 mt-10 -58.4 -38.31 77.12 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.165 -0.959 . . . . 0.0 109.5 -179.965 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -156.96 25.78 0.32 Allowed 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.183 -0.948 . . . . 0.0 109.483 -179.983 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 101' ' ' VAL . . . . . 0.586 HG12 ' N ' ' A' ' 102' ' ' GLN . 49.0 t -137.27 167.41 23.26 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.55 0 O-C-N 121.221 -0.925 . . . . 0.0 109.541 -179.878 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 102' ' ' GLN . . . . . 0.586 ' N ' HG12 ' A' ' 101' ' ' VAL . 92.1 mt-30 -122.61 147.37 46.49 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.248 -0.907 . . . . 0.0 109.126 179.885 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 103' ' ' LEU . . . . . 0.643 HD21 ' CG1' ' A' ' 44' ' ' VAL . 0.0 OUTLIER -121.69 135.68 54.96 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.11 -0.994 . . . . 0.0 109.93 -179.802 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 23.9 mttt -118.19 130.88 56.35 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.334 -0.854 . . . . 0.0 109.051 179.694 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 105' ' ' VAL . . . . . 0.728 ' CG1' HG22 ' A' ' 90' ' ' VAL . 21.5 t . . . . . 0 N--CA 1.491 1.611 0 O-C-N 121.167 -0.958 . . . . 0.0 109.776 -179.788 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 40' ' ' ASN . . . . . 0.476 ' O ' ' HA ' ' A' ' 79' ' ' THR . 62.0 t30 . . . . . 0 N--CA 1.489 1.506 0 N-CA-C 109.417 -0.586 . . . . 0.0 109.417 . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 41' ' ' THR . . . . . 0.466 ' HA ' ' O ' ' A' ' 78' ' ' VAL . 54.4 m -77.52 148.22 35.4 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.282 -0.886 . . . . 0.0 109.826 -179.712 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . 0.914 HD12 ' O ' ' A' ' 78' ' ' VAL . 4.9 mp -123.79 152.29 42.39 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.352 -0.842 . . . . 0.0 109.386 179.832 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 46.8 t80 -110.22 112.07 23.8 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.246 -0.909 . . . . 0.0 109.358 179.782 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 44' ' ' VAL . . . . . 0.461 ' HA ' ' O ' ' A' ' 104' ' ' LYS . 48.8 t -108.29 143.88 17.88 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.535 0 O-C-N 121.301 -0.874 . . . . 0.0 109.351 -179.941 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 45' ' ' TYR . . . . . 0.468 ' HB3' ' HB2' ' A' ' 104' ' ' LYS . 71.1 t80 -131.53 135.87 47.39 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.282 -0.886 . . . . 0.0 109.506 -179.931 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . 0.474 ' O ' ' HB3' ' A' ' 74' ' ' ASN . . . 177.57 -170.53 43.0 Favored Glycine 0 N--CA 1.49 2.282 0 N-CA-C 109.476 -1.45 . . . . 0.0 109.476 179.989 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . 0.42 ' O ' ' C ' ' A' ' 48' ' ' ASP . 94.9 mt-10 -124.31 157.36 35.14 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.246 -1.15 . . . . 0.0 109.426 -179.922 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 48' ' ' ASP . . . . . 0.42 ' C ' ' O ' ' A' ' 47' ' ' GLU . 38.0 m-20 44.48 51.26 7.94 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.274 -0.891 . . . . 0.0 109.552 -179.977 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 60.9 mtm -102.84 137.93 40.4 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.158 -0.964 . . . . 0.0 109.432 179.992 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 50' ' ' THR . . . . . 0.745 ' O ' HD12 ' A' ' 54' ' ' LEU . 0.7 OUTLIER -116.29 164.15 19.15 Favored Pre-proline 0 N--CA 1.49 1.551 0 O-C-N 121.197 -0.939 . . . . 0.0 109.599 179.894 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 50.4 Cg_endo -70.25 -52.03 0.31 Allowed 'Trans proline' 0 C--O 1.216 -0.594 0 C-N-CA 122.69 2.26 . . . . 0.0 111.715 179.979 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 36.5 m -53.63 -43.17 68.52 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.316 -0.865 . . . . 0.0 109.369 179.993 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . 0.737 ' O ' HD13 ' A' ' 53' ' ' LEU . 3.3 tm? -62.02 -46.18 90.31 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.239 -0.913 . . . . 0.0 109.319 179.967 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 54' ' ' LEU . . . . . 0.745 HD12 ' O ' ' A' ' 50' ' ' THR . 3.9 mt -62.49 -44.81 95.48 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.285 -0.884 . . . . 0.0 109.441 179.923 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 55' ' ' ARG . . . . . 0.761 ' HE ' HD22 ' A' ' 67' ' ' LEU . 83.5 mtt180 -52.29 -39.06 60.02 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.318 -0.864 . . . . 0.0 109.379 179.919 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -70.69 -34.89 66.76 Favored Glycine 0 N--CA 1.49 2.238 0 N-CA-C 109.378 -1.489 . . . . 0.0 109.378 179.968 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . 0.47 ' HB1' HD22 ' A' ' 93' ' ' LEU . . . -76.05 -23.7 55.11 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.282 -1.128 . . . . 0.0 109.439 179.979 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 58' ' ' PHE . . . . . 0.633 ' CE1' ' CD1' ' A' ' 93' ' ' LEU . 96.8 m-85 -116.17 7.75 14.21 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.146 -0.971 . . . . 0.0 109.46 179.995 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 59' ' ' SER . . . . . 0.532 ' N ' ' HD2' ' A' ' 60' ' ' PRO . 0.5 OUTLIER -73.51 -57.46 2.65 Favored Pre-proline 0 N--CA 1.491 1.608 0 O-C-N 121.291 -0.881 . . . . 0.0 109.96 -179.643 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 60' ' ' PRO . . . . . 0.532 ' HD2' ' N ' ' A' ' 59' ' ' SER . 49.0 Cg_endo -69.25 -33.04 19.43 Favored 'Trans proline' 0 C--O 1.214 -0.711 0 C-N-CA 122.643 2.229 . . . . 0.0 112.28 -179.597 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 61' ' ' PHE . . . . . 0.584 ' CD2' ' HA ' ' A' ' 89' ' ' ALA . 51.0 m-85 -61.64 -33.18 73.49 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.202 -0.936 . . . . 0.0 109.612 -179.874 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 176.65 -173.49 46.33 Favored Glycine 0 N--CA 1.489 2.213 0 N-CA-C 109.533 -1.427 . . . . 0.0 109.533 179.967 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 85.6 m-20 -95.7 147.42 23.62 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.248 -1.149 . . . . 0.0 109.383 -179.957 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 64' ' ' ILE . . . . . 0.436 ' HA ' ' O ' ' A' ' 79' ' ' THR . 53.6 mt -111.14 124.95 68.4 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.522 0 O-C-N 121.205 -0.934 . . . . 0.0 109.525 -179.963 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 31.1 pt -93.8 -26.79 4.53 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.573 0 O-C-N 121.342 -0.849 . . . . 0.0 109.382 179.926 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 66' ' ' ASP . . . . . 0.425 ' HB3' ' OG1' ' A' ' 79' ' ' THR . 58.2 t0 -140.43 130.36 24.65 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.214 -0.929 . . . . 0.0 109.511 179.937 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . 0.761 HD22 ' HE ' ' A' ' 55' ' ' ARG . 7.1 tp -121.46 120.4 34.82 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.239 -0.913 . . . . 0.0 109.438 179.923 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 68' ' ' SER . . . . . 0.458 ' HB3' ' HB2' ' A' ' 77' ' ' PHE . 43.3 t -128.87 140.66 51.59 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.242 -0.911 . . . . 0.0 109.479 -179.985 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 69' ' ' MET . . . . . . . . . . . . . 86.7 mtp -123.93 149.61 45.71 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.313 -0.867 . . . . 0.0 109.44 -179.993 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 70' ' ' ASP . . . . . 0.48 ' C ' ' HD2' ' A' ' 72' ' ' PRO . 0.7 OUTLIER -127.81 101.56 23.29 Favored Pre-proline 0 N--CA 1.49 1.555 0 O-C-N 121.251 -0.905 . . . . 0.0 109.433 179.964 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 71' ' ' PRO . . . . . 0.599 ' N ' ' CD ' ' A' ' 72' ' ' PRO . 47.3 Cg_endo -74.75 -27.81 10.2 Favored 'Trans proline' 0 CA--C 1.543 0.932 0 C-N-CA 122.527 2.151 . . . . 0.0 113.69 179.998 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 72' ' ' PRO . . . . . 0.599 ' CD ' ' N ' ' A' ' 71' ' ' PRO . 55.2 Cg_endo -75.41 -23.81 12.8 Favored 'Trans proline' 0 C--N 1.353 0.793 0 C-N-CA 121.496 1.464 . . . . 0.0 111.869 -179.83 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 73' ' ' ARG . . . . . 0.436 ' HB2' ' SG ' ' A' ' 75' ' ' CYS . 75.0 mtt85 -111.91 -1.11 15.59 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.197 -0.939 . . . . 0.0 109.666 -179.879 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 74' ' ' ASN . . . . . 0.474 ' HB3' ' O ' ' A' ' 46' ' ' GLY . 8.0 m120 60.78 44.21 11.29 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.133 -0.98 . . . . 0.0 109.519 179.985 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 75' ' ' CYS . . . . . 0.475 ' O ' ' HB2' ' A' ' 70' ' ' ASP . 24.4 p -144.79 140.74 28.67 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.211 -0.931 . . . . 0.0 109.541 -179.921 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -113.67 161.38 17.54 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.222 -0.924 . . . . 0.0 109.36 -180.0 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 77' ' ' PHE . . . . . 0.458 ' HB2' ' HB3' ' A' ' 68' ' ' SER . 96.9 m-85 -125.37 137.35 54.03 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.215 -0.928 . . . . 0.0 109.497 -179.9 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . 0.914 ' O ' HD12 ' A' ' 42' ' ' LEU . 25.3 t -130.55 139.78 50.44 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.611 0 O-C-N 121.391 -0.818 . . . . 0.0 109.362 179.849 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 79' ' ' THR . . . . . 0.476 ' HA ' ' O ' ' A' ' 40' ' ' ASN . 2.0 m -110.61 121.28 44.93 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.213 -0.929 . . . . 0.0 109.431 179.936 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 80' ' ' TYR . . . . . 0.571 ' HH ' ' HD1' ' A' ' 58' ' ' PHE . 1.5 m-85 -99.41 138.41 36.54 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.251 -0.906 . . . . 0.0 109.613 -179.925 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 81.6 tt0 -48.69 -25.79 1.97 Allowed 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.327 -0.858 . . . . 0.0 109.787 179.997 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 48.1 mttp -143.48 159.46 42.36 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.142 -0.974 . . . . 0.0 109.591 -179.938 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 83' ' ' MET . . . . . 0.421 ' HG2' ' CG ' ' A' ' 40' ' ' ASN . 61.8 mtt -72.83 -19.37 61.33 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.292 -0.88 . . . . 0.0 109.357 179.971 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 96.5 mt-10 -68.06 -51.4 47.11 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.277 -0.889 . . . . 0.0 109.513 179.904 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 7.4 m -56.35 -32.46 64.73 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.277 -0.89 . . . . 0.0 109.37 179.863 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 86' ' ' ALA . . . . . 0.596 ' HB1' HD21 ' A' ' 42' ' ' LEU . . . -74.12 -27.54 60.91 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.236 -0.915 . . . . 0.0 109.364 -179.999 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 22.1 t70 -69.31 -43.29 74.07 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.224 -0.922 . . . . 0.0 109.457 -179.933 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 88' ' ' GLN . . . . . 0.453 ' O ' ' HB2' ' A' ' 92' ' ' GLU . 61.4 tt0 -69.48 -36.75 76.84 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.289 -0.882 . . . . 0.0 109.416 -179.95 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 89' ' ' ALA . . . . . 0.781 ' HB1' ' CD1' ' A' ' 93' ' ' LEU . . . -74.02 -44.38 54.67 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.221 -0.924 . . . . 0.0 109.446 179.958 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 90' ' ' VAL . . . . . 0.787 HG22 HG12 ' A' ' 105' ' ' VAL . 84.1 t -67.22 -38.19 80.56 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.549 0 O-C-N 121.337 -0.852 . . . . 0.0 109.603 179.984 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -80.06 -29.12 39.15 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.269 -0.894 . . . . 0.0 109.906 -179.681 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 92' ' ' GLU . . . . . 0.566 ' HB3' ' CE2' ' A' ' 61' ' ' PHE . 23.0 tt0 -91.9 -45.59 8.28 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.158 -0.963 . . . . 0.0 109.677 -179.749 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 93' ' ' LEU . . . . . 0.781 ' CD1' ' HB1' ' A' ' 89' ' ' ALA . 21.3 mt -69.35 -43.14 74.21 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.207 -0.933 . . . . 0.0 109.587 -179.925 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 94' ' ' ASN . . . . . 0.515 ' CB ' ' O ' ' A' ' 90' ' ' VAL . 43.8 t30 -63.74 127.11 29.9 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.205 -0.934 . . . . 0.0 109.54 179.988 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 98.79 16.3 31.47 Favored Glycine 0 N--CA 1.49 2.268 0 N-CA-C 109.455 -1.458 . . . . 0.0 109.455 179.985 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 96' ' ' THR . . . . . 0.552 HG23 ' O ' ' A' ' 93' ' ' LEU . 18.1 p -116.54 157.42 25.28 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.183 -1.187 . . . . 0.0 109.383 -179.966 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 59.6 tt0 -117.99 139.55 51.01 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.194 -0.941 . . . . 0.0 109.478 -179.944 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 98' ' ' VAL . . . . . 0.784 HG22 HD11 ' A' ' 103' ' ' LEU . 1.2 t -83.83 -149.49 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 121.202 -0.936 . . . . 0.0 109.374 -179.966 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 99' ' ' GLU . . . . . 0.504 ' H ' HG12 ' A' ' 98' ' ' VAL . 76.5 mm-40 -60.38 -41.62 94.16 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.226 -0.921 . . . . 0.0 109.501 179.97 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 21.1 t -158.51 31.55 0.23 Allowed 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.293 -0.88 . . . . 0.0 109.426 179.952 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 101' ' ' VAL . . . . . 0.542 ' O ' HG23 ' A' ' 98' ' ' VAL . 58.9 t -147.03 147.86 17.23 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 O-C-N 121.227 -0.921 . . . . 0.0 109.464 179.995 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 91.7 mt-30 -86.43 145.73 26.72 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.253 -0.904 . . . . 0.0 109.574 -179.941 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 103' ' ' LEU . . . . . 0.784 HD11 HG22 ' A' ' 98' ' ' VAL . 96.0 mt -109.56 136.13 49.44 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.313 -0.867 . . . . 0.0 109.467 179.948 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 104' ' ' LYS . . . . . 0.468 ' HB2' ' HB3' ' A' ' 45' ' ' TYR . 57.3 mttm -122.09 133.55 54.77 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.242 -0.912 . . . . 0.0 109.48 -179.938 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 105' ' ' VAL . . . . . 0.787 HG12 HG22 ' A' ' 90' ' ' VAL . 7.0 t . . . . . 0 N--CA 1.49 1.527 0 O-C-N 121.241 -0.912 . . . . 0.0 109.602 -179.994 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 40' ' ' ASN . . . . . 0.477 ' O ' ' HA ' ' A' ' 79' ' ' THR . 60.1 t-20 . . . . . 0 N--CA 1.49 1.533 0 N-CA-C 109.134 -0.691 . . . . 0.0 109.134 . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 41' ' ' THR . . . . . 0.466 ' HA ' ' O ' ' A' ' 78' ' ' VAL . 92.6 m -81.96 140.57 33.93 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.241 -0.912 . . . . 0.0 109.956 -179.568 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . 0.889 HD23 ' CG2' ' A' ' 90' ' ' VAL . 5.4 mp -118.05 142.62 47.2 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.375 -0.828 . . . . 0.0 109.077 179.391 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 59.7 t80 -99.76 109.91 22.32 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.322 -0.861 . . . . 0.0 109.611 -179.851 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 44' ' ' VAL . . . . . 0.475 ' HA ' ' O ' ' A' ' 104' ' ' LYS . 96.4 t -107.4 143.27 18.27 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.555 0 O-C-N 121.249 -0.907 . . . . 0.0 109.345 179.913 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 74.2 t80 -132.51 135.47 46.01 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.174 -0.954 . . . . 0.0 109.497 -179.891 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 177.9 -175.13 47.35 Favored Glycine 0 N--CA 1.489 2.222 0 N-CA-C 109.554 -1.418 . . . . 0.0 109.554 179.931 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . 0.429 ' O ' ' C ' ' A' ' 48' ' ' ASP . 94.0 mt-10 -114.9 158.51 21.88 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.254 -1.144 . . . . 0.0 109.432 -179.967 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 48' ' ' ASP . . . . . 0.429 ' C ' ' O ' ' A' ' 47' ' ' GLU . 48.8 m-20 44.07 50.44 7.35 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.302 -0.874 . . . . 0.0 109.444 -179.954 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 54.0 mtm -100.38 135.58 41.59 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.192 -0.943 . . . . 0.0 109.523 179.981 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -122.65 166.04 19.14 Favored Pre-proline 0 N--CA 1.49 1.558 0 O-C-N 121.266 -0.896 . . . . 0.0 109.41 179.946 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 51' ' ' PRO . . . . . 0.664 ' HA ' HD12 ' A' ' 54' ' ' LEU . 49.7 Cg_endo -70.24 -51.67 0.33 Allowed 'Trans proline' 0 C--O 1.214 -0.685 0 C-N-CA 122.671 2.247 . . . . 0.0 111.755 179.969 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 62.8 m -49.36 -48.65 46.54 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.217 -0.927 . . . . 0.0 109.288 179.96 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 18.0 tp -59.6 -47.82 84.06 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.175 -0.953 . . . . 0.0 109.228 179.901 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 54' ' ' LEU . . . . . 0.664 HD12 ' HA ' ' A' ' 51' ' ' PRO . 12.8 mt -56.08 -45.61 79.29 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.26 -0.9 . . . . 0.0 109.337 179.835 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 55' ' ' ARG . . . . . 0.509 ' O ' ' N ' ' A' ' 59' ' ' SER . 15.3 mtp-105 -51.73 -42.21 62.12 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.355 -0.841 . . . . 0.0 109.286 179.863 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -70.78 -29.11 69.77 Favored Glycine 0 N--CA 1.489 2.232 0 N-CA-C 109.308 -1.517 . . . . 0.0 109.308 179.891 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . 0.461 ' O ' ' CD1' ' A' ' 61' ' ' PHE . . . -79.57 -22.8 43.32 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.267 -1.137 . . . . 0.0 109.432 179.966 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 58' ' ' PHE . . . . . 0.698 ' HB2' HD11 ' A' ' 64' ' ' ILE . 96.3 m-85 -119.51 7.59 11.17 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.245 -0.909 . . . . 0.0 109.473 179.926 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 59' ' ' SER . . . . . 0.541 ' N ' ' HD2' ' A' ' 60' ' ' PRO . 0.6 OUTLIER -72.7 -57.07 3.41 Favored Pre-proline 0 N--CA 1.49 1.537 0 O-C-N 121.261 -0.899 . . . . 0.0 109.837 -179.888 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 60' ' ' PRO . . . . . 0.541 ' HD2' ' N ' ' A' ' 59' ' ' SER . 49.7 Cg_endo -69.57 -30.46 23.12 Favored 'Trans proline' 0 C--O 1.215 -0.664 0 C-N-CA 122.648 2.232 . . . . 0.0 111.954 -179.822 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 61' ' ' PHE . . . . . 0.679 ' CE1' HD21 ' A' ' 93' ' ' LEU . 58.6 m-85 -64.22 -34.38 77.97 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.231 -0.918 . . . . 0.0 109.27 179.965 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 173.62 -173.41 45.79 Favored Glycine 0 N--CA 1.49 2.235 0 N-CA-C 109.4 -1.48 . . . . 0.0 109.4 179.98 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 56.1 t30 -95.57 139.34 31.97 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.235 -1.156 . . . . 0.0 109.566 179.947 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 64' ' ' ILE . . . . . 0.698 HD11 ' HB2' ' A' ' 58' ' ' PHE . 58.2 mt -101.87 135.03 40.58 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 O-C-N 121.228 -0.92 . . . . 0.0 109.351 179.966 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 24.6 pt -97.72 -23.1 4.72 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.527 0 O-C-N 121.313 -0.867 . . . . 0.0 109.645 -179.963 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 53.2 t0 -149.05 126.87 11.81 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.227 -0.92 . . . . 0.0 109.552 179.981 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 16.2 tp -112.26 117.05 31.45 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.241 -0.912 . . . . 0.0 109.466 179.949 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 68' ' ' SER . . . . . 0.488 ' HB2' ' HB2' ' A' ' 77' ' ' PHE . 68.0 m -123.35 145.61 48.6 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.191 -0.943 . . . . 0.0 109.476 -179.916 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 69' ' ' MET . . . . . 0.477 ' HA ' ' HA ' ' A' ' 76' ' ' ALA . 75.1 mtp -131.53 149.61 52.45 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.209 -0.932 . . . . 0.0 109.556 -179.966 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 70' ' ' ASP . . . . . 0.483 ' C ' ' HD2' ' A' ' 72' ' ' PRO . 2.6 t0 -123.36 104.76 34.28 Favored Pre-proline 0 N--CA 1.49 1.547 0 O-C-N 121.181 -0.949 . . . . 0.0 109.484 179.924 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 71' ' ' PRO . . . . . 0.6 ' N ' ' CD ' ' A' ' 72' ' ' PRO . 46.6 Cg_endo -74.87 -27.73 10.03 Favored 'Trans proline' 0 CA--C 1.543 0.952 0 C-N-CA 122.585 2.19 . . . . 0.0 113.608 -179.944 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 72' ' ' PRO . . . . . 0.6 ' CD ' ' N ' ' A' ' 71' ' ' PRO . 54.6 Cg_endo -75.14 -33.27 4.57 Favored 'Trans proline' 0 C--N 1.354 0.839 0 C-N-CA 121.437 1.425 . . . . 0.0 111.862 -179.82 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 73' ' ' ARG . . . . . 0.443 ' HG2' ' O ' ' A' ' 73' ' ' ARG . 67.5 ttt180 -103.62 -2.17 27.05 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.222 -0.924 . . . . 0.0 109.663 -179.927 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 74' ' ' ASN . . . . . 0.426 ' HB2' ' O ' ' A' ' 73' ' ' ARG . 79.9 m-20 61.88 40.38 12.66 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.177 -0.952 . . . . 0.0 109.505 -179.996 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 75' ' ' CYS . . . . . . . . . . . . . 24.7 p -136.03 137.43 41.16 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.286 -0.884 . . . . 0.0 109.434 -179.943 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 76' ' ' ALA . . . . . 0.477 ' HA ' ' HA ' ' A' ' 69' ' ' MET . . . -107.61 157.21 18.25 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.317 -0.864 . . . . 0.0 109.49 179.965 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 77' ' ' PHE . . . . . 0.488 ' HA ' ' O ' ' A' ' 42' ' ' LEU . 97.5 m-85 -123.45 131.19 53.57 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.282 -0.886 . . . . 0.0 109.583 -179.959 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . 0.794 ' O ' HD12 ' A' ' 42' ' ' LEU . 45.5 t -120.4 134.5 63.67 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 O-C-N 121.261 -0.899 . . . . 0.0 109.7 -179.954 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 79' ' ' THR . . . . . 0.477 ' HA ' ' O ' ' A' ' 40' ' ' ASN . 9.1 m -103.48 129.3 50.61 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.256 -0.902 . . . . 0.0 109.471 179.927 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 80' ' ' TYR . . . . . 0.588 ' CG ' ' HB2' ' A' ' 85' ' ' SER . 0.7 OUTLIER -112.07 137.12 50.55 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.192 -0.942 . . . . 0.0 109.542 -179.898 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 84.4 tt0 -57.67 -27.56 62.99 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.26 -0.9 . . . . 0.0 109.48 179.98 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 24.8 mttp -132.59 146.62 52.04 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.174 -0.954 . . . . 0.0 109.426 -179.955 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 83' ' ' MET . . . . . . . . . . . . . 35.6 mtt -64.73 -20.32 66.28 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.254 -0.904 . . . . 0.0 109.378 179.986 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 98.6 mt-10 -68.26 -37.06 80.35 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.317 -0.865 . . . . 0.0 109.439 179.993 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 85' ' ' SER . . . . . 0.588 ' HB2' ' CG ' ' A' ' 80' ' ' TYR . 18.7 m -61.45 -34.34 75.26 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.276 -0.89 . . . . 0.0 109.455 179.952 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 86' ' ' ALA . . . . . 0.646 ' CB ' HD21 ' A' ' 42' ' ' LEU . . . -76.26 -30.5 57.87 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.326 -0.859 . . . . 0.0 109.437 -179.995 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 54.2 t0 -63.71 -49.52 72.77 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.218 -0.926 . . . . 0.0 109.496 179.93 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 88' ' ' GLN . . . . . 0.467 ' O ' ' HB2' ' A' ' 92' ' ' GLU . 59.0 tt0 -66.72 -38.74 87.31 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.267 -0.896 . . . . 0.0 109.462 -179.988 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 89' ' ' ALA . . . . . 0.547 ' HA ' ' CE2' ' A' ' 61' ' ' PHE . . . -74.1 -49.67 22.89 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.319 -0.863 . . . . 0.0 109.624 -179.979 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 90' ' ' VAL . . . . . 0.889 ' CG2' HD23 ' A' ' 42' ' ' LEU . 69.8 t -63.22 -37.0 78.28 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.551 0 O-C-N 121.203 -0.935 . . . . 0.0 109.61 -179.846 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -80.16 -37.83 32.6 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.212 -0.93 . . . . 0.0 109.722 -179.775 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 92' ' ' GLU . . . . . 0.547 ' HB3' ' CE2' ' A' ' 61' ' ' PHE . 24.6 tt0 -83.53 -48.78 9.91 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.171 -0.956 . . . . 0.0 109.803 -179.654 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 93' ' ' LEU . . . . . 0.838 ' HB2' HG21 ' A' ' 105' ' ' VAL . 35.0 mt -64.15 -40.47 96.21 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.187 -0.946 . . . . 0.0 109.683 -179.753 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 94' ' ' ASN . . . . . 0.52 ' CB ' ' O ' ' A' ' 90' ' ' VAL . 56.4 t-20 -63.54 124.31 21.03 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.179 -0.951 . . . . 0.0 109.621 -179.998 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 92.05 29.84 11.02 Favored Glycine 0 N--CA 1.49 2.26 0 N-CA-C 109.502 -1.439 . . . . 0.0 109.502 179.973 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 96' ' ' THR . . . . . 0.637 HG23 ' O ' ' A' ' 93' ' ' LEU . 26.1 p -121.41 158.39 28.43 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.287 -1.125 . . . . 0.0 109.5 179.945 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 63.7 tt0 -122.67 148.93 44.71 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.236 -0.915 . . . . 0.0 109.509 -179.99 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 98' ' ' VAL . . . . . 0.495 HG12 ' H ' ' A' ' 99' ' ' GLU . 1.3 t -100.29 -148.72 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.574 0 O-C-N 121.229 -0.919 . . . . 0.0 109.373 179.971 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 99' ' ' GLU . . . . . 0.495 ' H ' HG12 ' A' ' 98' ' ' VAL . 96.4 mt-10 -61.24 -40.6 94.65 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.25 -0.906 . . . . 0.0 109.459 179.99 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 32.0 t -159.36 31.56 0.2 Allowed 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.354 -0.841 . . . . 0.0 109.487 -179.942 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 101' ' ' VAL . . . . . 0.481 ' O ' HG23 ' A' ' 98' ' ' VAL . 48.6 t -148.75 154.73 9.57 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.603 0 O-C-N 121.301 -0.874 . . . . 0.0 109.365 -179.987 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 88.8 mt-30 -100.99 138.7 37.69 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.294 -0.879 . . . . 0.0 109.455 179.855 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 94.6 mt -106.56 136.95 45.44 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.159 -0.963 . . . . 0.0 109.57 -179.956 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 104' ' ' LYS . . . . . 0.475 ' O ' ' HA ' ' A' ' 44' ' ' VAL . 30.1 mttp -118.87 144.5 46.35 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.346 -0.846 . . . . 0.0 109.296 179.747 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 105' ' ' VAL . . . . . 0.838 HG21 ' HB2' ' A' ' 93' ' ' LEU . 17.4 t . . . . . 0 N--CA 1.491 1.585 0 O-C-N 121.231 -0.918 . . . . 0.0 109.661 -179.837 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 40' ' ' ASN . . . . . 0.484 ' O ' ' HA ' ' A' ' 79' ' ' THR . 45.8 t30 . . . . . 0 N--CA 1.493 1.698 0 CA-C-O 121.281 0.562 . . . . 0.0 109.718 . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 41' ' ' THR . . . . . 0.522 ' CG2' ' HB3' ' A' ' 77' ' ' PHE . 24.8 m -77.95 135.33 37.81 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.28 -0.887 . . . . 0.0 109.557 179.899 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . 0.902 HD11 ' CD2' ' A' ' 80' ' ' TYR . 12.7 mt -112.2 144.9 40.84 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.147 -0.971 . . . . 0.0 109.67 179.993 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 43' ' ' TYR . . . . . 0.487 ' CD2' ' CE1' ' A' ' 77' ' ' PHE . 60.2 t80 -94.9 116.9 29.29 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.428 -0.795 . . . . 0.0 109.359 179.676 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 44' ' ' VAL . . . . . 0.487 ' O ' ' HA ' ' A' ' 75' ' ' CYS . 44.5 t -116.52 135.33 57.14 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.494 0 O-C-N 121.216 -0.927 . . . . 0.0 109.239 179.847 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 45' ' ' TYR . . . . . 0.488 ' HB3' ' HB2' ' A' ' 104' ' ' LYS . 69.1 t80 -123.53 143.53 50.13 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.257 -0.902 . . . . 0.0 109.639 -179.804 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 164.64 174.12 34.03 Favored Glycine 0 N--CA 1.491 2.327 0 N-CA-C 109.444 -1.462 . . . . 0.0 109.444 -179.994 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 95.6 mt-10 -107.98 161.89 14.53 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.293 -1.122 . . . . 0.0 109.419 -179.997 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 21.5 m-20 44.41 58.17 3.96 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.249 -0.907 . . . . 0.0 109.4 179.96 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 43.2 mtm -111.29 136.76 49.92 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.317 -0.865 . . . . 0.0 109.432 179.954 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 50' ' ' THR . . . . . 0.584 ' O ' HD12 ' A' ' 54' ' ' LEU . 0.2 OUTLIER -123.72 166.5 18.54 Favored Pre-proline 0 N--CA 1.492 1.631 0 O-C-N 121.359 -0.838 . . . . 0.0 109.26 179.901 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 51' ' ' PRO . . . . . 0.443 ' HD3' ' SD ' ' A' ' 69' ' ' MET . 50.0 Cg_endo -71.4 -55.39 0.13 Allowed 'Trans proline' 0 C--O 1.214 -0.69 0 C-N-CA 122.495 2.13 . . . . 0.0 111.845 -179.962 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 21.3 m -48.84 -50.38 34.86 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.252 -0.905 . . . . 0.0 109.263 179.783 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 17.6 tp -58.89 -51.04 71.71 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.221 -0.924 . . . . 0.0 109.141 179.777 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 54' ' ' LEU . . . . . 0.584 HD12 ' O ' ' A' ' 50' ' ' THR . 14.1 mt -55.59 -49.92 71.48 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.343 -0.848 . . . . 0.0 109.16 179.744 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 55' ' ' ARG . . . . . 0.518 ' O ' ' N ' ' A' ' 59' ' ' SER . 73.0 mtp180 -47.16 -38.13 11.26 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.321 -0.862 . . . . 0.0 109.282 179.741 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -71.29 -31.65 65.94 Favored Glycine 0 N--CA 1.489 2.206 0 N-CA-C 109.369 -1.492 . . . . 0.0 109.369 179.844 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -76.56 -24.52 53.57 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.188 -1.184 . . . . 0.0 109.372 179.808 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 58' ' ' PHE . . . . . 0.762 ' HB2' HD11 ' A' ' 64' ' ' ILE . 91.7 m-85 -116.82 7.57 13.39 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.356 -0.84 . . . . 0.0 109.408 179.92 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 59' ' ' SER . . . . . 0.553 ' N ' ' HD2' ' A' ' 60' ' ' PRO . 0.6 OUTLIER -74.04 -55.68 3.0 Favored Pre-proline 0 N--CA 1.491 1.584 0 O-C-N 121.291 -0.881 . . . . 0.0 110.317 -179.622 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 60' ' ' PRO . . . . . 0.553 ' HD2' ' N ' ' A' ' 59' ' ' SER . 46.6 Cg_endo -68.19 -31.02 30.29 Favored 'Trans proline' 0 C--O 1.215 -0.656 0 C-N-CA 122.521 2.148 . . . . 0.0 112.215 -179.367 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 61' ' ' PHE . . . . . 0.571 ' CD1' ' HA ' ' A' ' 89' ' ' ALA . 70.1 m-85 -65.69 -30.4 71.08 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.116 -0.99 . . . . 0.0 109.491 -179.969 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . 0.464 ' HA3' ' OG ' ' A' ' 85' ' ' SER . . . 175.61 -165.76 36.74 Favored Glycine 0 N--CA 1.49 2.297 0 N-CA-C 109.421 -1.472 . . . . 0.0 109.421 179.956 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 85.4 m-20 -103.87 134.47 47.11 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.29 -1.124 . . . . 0.0 109.499 179.961 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 64' ' ' ILE . . . . . 0.762 HD11 ' HB2' ' A' ' 58' ' ' PHE . 76.1 mt -95.78 140.35 17.24 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.575 0 O-C-N 121.297 -0.877 . . . . 0.0 109.565 -179.951 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 65' ' ' ILE . . . . . 0.734 HD11 HG21 ' A' ' 79' ' ' THR . 26.2 pt -100.84 -24.49 4.07 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 O-C-N 121.302 -0.873 . . . . 0.0 109.452 179.922 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 40.2 t0 -149.35 140.79 23.31 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.251 -0.906 . . . . 0.0 109.573 -179.863 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . 0.7 ' C ' HD13 ' A' ' 67' ' ' LEU . 2.2 tm? -118.76 104.93 11.05 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.283 -0.886 . . . . 0.0 109.136 179.785 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 68' ' ' SER . . . . . 0.487 ' HB3' ' HB2' ' A' ' 77' ' ' PHE . 46.5 t -108.65 141.07 41.15 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.226 -0.921 . . . . 0.0 109.55 -179.891 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 69' ' ' MET . . . . . 0.495 ' HA ' ' HA ' ' A' ' 76' ' ' ALA . 63.2 mtp -133.63 141.62 47.72 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.3 -0.875 . . . . 0.0 109.504 -179.986 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 70' ' ' ASP . . . . . 0.474 ' C ' ' HD2' ' A' ' 72' ' ' PRO . 0.9 OUTLIER -124.51 107.16 29.61 Favored Pre-proline 0 N--CA 1.49 1.562 0 O-C-N 121.332 -0.855 . . . . 0.0 109.378 -179.971 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 71' ' ' PRO . . . . . 0.601 ' N ' ' CD ' ' A' ' 72' ' ' PRO . 47.1 Cg_endo -74.91 -27.85 9.85 Favored 'Trans proline' 0 CA--C 1.542 0.883 0 C-N-CA 122.495 2.13 . . . . 0.0 113.747 -179.908 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 72' ' ' PRO . . . . . 0.601 ' CD ' ' N ' ' A' ' 71' ' ' PRO . 54.4 Cg_endo -74.84 -25.66 12.0 Favored 'Trans proline' 0 C--N 1.353 0.772 0 C-N-CA 121.446 1.431 . . . . 0.0 111.745 -179.771 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 75.3 mtp180 -110.46 0.9 17.98 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.273 -0.892 . . . . 0.0 109.62 -179.833 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 66.2 m-20 56.39 48.56 16.72 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.153 -0.967 . . . . 0.0 109.512 179.943 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 75' ' ' CYS . . . . . 0.487 ' HA ' ' O ' ' A' ' 44' ' ' VAL . 26.6 p -148.18 135.73 20.67 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.186 -0.946 . . . . 0.0 109.46 -179.973 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 76' ' ' ALA . . . . . 0.495 ' HA ' ' HA ' ' A' ' 69' ' ' MET . . . -110.37 133.67 53.04 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.159 -0.963 . . . . 0.0 109.74 -179.994 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 77' ' ' PHE . . . . . 0.522 ' HB3' ' CG2' ' A' ' 41' ' ' THR . 12.0 m-30 -103.79 108.39 19.68 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.335 -0.853 . . . . 0.0 109.33 179.935 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . 0.494 ' O ' ' N ' ' A' ' 42' ' ' LEU . 1.8 p -105.76 141.28 21.44 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.405 0 O-C-N 121.144 -0.973 . . . . 0.0 109.401 179.979 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 79' ' ' THR . . . . . 0.734 HG21 HD11 ' A' ' 65' ' ' ILE . 11.5 m -97.47 155.42 16.94 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.138 -0.976 . . . . 0.0 109.874 -179.692 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 80' ' ' TYR . . . . . 0.902 ' CD2' HD11 ' A' ' 42' ' ' LEU . 0.1 OUTLIER -130.51 129.26 42.65 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.329 -0.857 . . . . 0.0 109.546 179.955 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 81' ' ' GLU . . . . . 0.4 ' C ' ' O ' ' A' ' 80' ' ' TYR . 69.3 tt0 -44.25 -34.5 1.92 Allowed 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.205 -0.934 . . . . 0.0 109.489 179.88 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 33.5 mttm -141.43 152.18 44.05 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.119 -0.988 . . . . 0.0 109.596 -179.774 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 83' ' ' MET . . . . . . . . . . . . . 45.8 mtt -63.89 -26.72 68.73 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.352 -0.843 . . . . 0.0 109.415 179.973 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 96.4 mt-10 -56.27 -49.09 75.21 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.292 -0.88 . . . . 0.0 109.475 -179.976 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 85' ' ' SER . . . . . 0.555 ' OG ' ' CE1' ' A' ' 80' ' ' TYR . 41.5 t -61.04 -32.05 71.68 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.213 -0.929 . . . . 0.0 109.381 179.864 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 86' ' ' ALA . . . . . 0.684 ' O ' HG23 ' A' ' 90' ' ' VAL . . . -76.04 -33.42 59.62 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.308 -0.87 . . . . 0.0 109.774 -179.757 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 22.3 t70 -70.13 -43.77 70.28 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.145 -0.972 . . . . 0.0 109.725 -179.732 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 62.6 tt0 -71.14 -39.08 72.19 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.265 -0.897 . . . . 0.0 109.877 -179.717 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 89' ' ' ALA . . . . . 0.704 ' HB1' ' CD1' ' A' ' 93' ' ' LEU . . . -73.72 -43.38 59.35 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.154 -0.966 . . . . 0.0 109.741 -179.745 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 90' ' ' VAL . . . . . 0.753 HG22 HG11 ' A' ' 105' ' ' VAL . 74.3 t -61.26 -31.88 51.49 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.598 0 O-C-N 121.195 -0.941 . . . . 0.0 109.667 -179.778 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -78.96 -53.32 7.17 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.272 -0.892 . . . . 0.0 109.732 -179.857 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 92' ' ' GLU . . . . . 0.527 ' HB2' ' CE1' ' A' ' 61' ' ' PHE . 75.2 mm-40 -69.53 -41.45 75.97 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.224 -0.922 . . . . 0.0 109.928 -179.632 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 93' ' ' LEU . . . . . 0.704 ' CD1' ' HB1' ' A' ' 89' ' ' ALA . 81.2 mt -69.55 -40.55 76.76 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.074 -1.016 . . . . 0.0 109.642 -179.806 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 94' ' ' ASN . . . . . 0.527 ' CB ' ' O ' ' A' ' 90' ' ' VAL . 59.1 t30 -71.47 126.41 29.59 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.201 -0.937 . . . . 0.0 109.497 -179.945 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 99.09 20.0 19.7 Favored Glycine 0 N--CA 1.489 2.182 0 N-CA-C 109.515 -1.434 . . . . 0.0 109.515 179.94 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 96' ' ' THR . . . . . 0.409 ' CG2' ' O ' ' A' ' 92' ' ' GLU . 20.5 p -121.92 159.94 25.84 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.301 -1.117 . . . . 0.0 109.504 179.964 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 63.9 tt0 -125.35 149.08 48.45 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.334 -0.854 . . . . 0.0 109.453 -179.969 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 98' ' ' VAL . . . . . 0.627 ' HB ' HG12 ' A' ' 101' ' ' VAL . 1.4 t -93.78 -148.68 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 O-C-N 121.206 -0.934 . . . . 0.0 109.35 -179.982 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 99' ' ' GLU . . . . . 0.497 ' H ' HG12 ' A' ' 98' ' ' VAL . 95.9 mt-10 -56.69 -44.64 81.7 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.164 -0.96 . . . . 0.0 109.449 -179.977 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 3.5 p -157.2 21.21 0.3 Allowed 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.282 -0.886 . . . . 0.0 109.449 179.974 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 101' ' ' VAL . . . . . 0.627 HG12 ' HB ' ' A' ' 98' ' ' VAL . 8.7 p -129.03 139.5 51.73 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.524 0 O-C-N 121.231 -0.918 . . . . 0.0 109.519 -179.943 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 95.3 mt-30 -87.1 136.51 32.9 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.2 -0.937 . . . . 0.0 109.387 179.959 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 103' ' ' LEU . . . . . 0.57 HD11 HG22 ' A' ' 98' ' ' VAL . 97.8 mt -100.87 144.26 30.04 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.23 -0.919 . . . . 0.0 109.667 -179.934 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 104' ' ' LYS . . . . . 0.488 ' HB2' ' HB3' ' A' ' 45' ' ' TYR . 45.1 mttt -134.66 142.09 46.76 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.263 -0.898 . . . . 0.0 109.252 179.869 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 105' ' ' VAL . . . . . 0.753 HG11 HG22 ' A' ' 90' ' ' VAL . 25.5 t . . . . . 0 N--CA 1.491 1.59 0 O-C-N 121.225 -0.922 . . . . 0.0 109.686 -179.932 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 40' ' ' ASN . . . . . 0.468 ' O ' ' HA ' ' A' ' 79' ' ' THR . 49.6 t-20 . . . . . 0 N--CA 1.491 1.597 0 N-CA-C 109.535 -0.543 . . . . 0.0 109.535 . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 41' ' ' THR . . . . . 0.613 ' O ' HD23 ' A' ' 42' ' ' LEU . 35.8 m -80.75 138.86 36.32 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.25 -0.906 . . . . 0.0 109.499 -179.997 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . 0.94 HD11 ' CD2' ' A' ' 80' ' ' TYR . 9.9 mt -120.13 151.05 39.64 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.211 -0.931 . . . . 0.0 109.626 179.941 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 43' ' ' TYR . . . . . 0.475 ' CZ ' ' HB2' ' A' ' 75' ' ' CYS . 69.0 t80 -106.29 124.92 50.33 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.236 -0.915 . . . . 0.0 109.341 179.867 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 44' ' ' VAL . . . . . 0.459 ' O ' ' HA ' ' A' ' 75' ' ' CYS . 80.2 t -122.14 137.73 54.73 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.534 0 O-C-N 121.22 -0.925 . . . . 0.0 109.467 -179.941 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 45' ' ' TYR . . . . . 0.472 ' HB3' ' HB2' ' A' ' 104' ' ' LYS . 71.0 t80 -121.07 133.58 55.24 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.276 -0.89 . . . . 0.0 109.423 179.909 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -175.73 -175.37 43.08 Favored Glycine 0 N--CA 1.49 2.277 0 N-CA-C 109.482 -1.447 . . . . 0.0 109.482 -179.974 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 94.0 mt-10 -121.41 146.53 46.79 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.212 -1.17 . . . . 0.0 109.45 179.983 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 58.4 t0 47.79 52.97 12.03 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.277 -0.889 . . . . 0.0 109.481 -179.952 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 67.5 mtm -95.7 138.09 33.85 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.27 -0.894 . . . . 0.0 109.454 -179.929 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 50' ' ' THR . . . . . 0.814 HG22 ' HD2' ' A' ' 51' ' ' PRO . 0.0 OUTLIER -110.8 161.5 24.57 Favored Pre-proline 0 N--CA 1.49 1.543 0 O-C-N 121.23 -0.919 . . . . 0.0 109.48 179.979 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 51' ' ' PRO . . . . . 0.814 ' HD2' HG22 ' A' ' 50' ' ' THR . 49.4 Cg_endo -70.12 -52.5 0.3 Allowed 'Trans proline' 0 C--O 1.215 -0.648 0 C-N-CA 122.743 2.295 . . . . 0.0 111.674 -179.959 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 37.1 m -56.27 -44.49 79.81 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.322 -0.861 . . . . 0.0 109.383 179.995 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . 0.765 ' O ' HD13 ' A' ' 53' ' ' LEU . 3.1 tm? -60.45 -46.56 89.61 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.241 -0.912 . . . . 0.0 109.405 179.931 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 54' ' ' LEU . . . . . 0.693 HD12 ' SD ' ' A' ' 69' ' ' MET . 42.7 mt -62.81 -48.03 80.85 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.242 -0.911 . . . . 0.0 109.356 -179.916 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 55' ' ' ARG . . . . . 0.467 ' O ' ' N ' ' A' ' 59' ' ' SER . 48.0 mtt180 -48.53 -39.82 24.79 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.248 -0.907 . . . . 0.0 109.392 179.936 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -69.09 -34.78 76.73 Favored Glycine 0 N--CA 1.49 2.289 0 N-CA-C 109.312 -1.515 . . . . 0.0 109.312 179.881 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . 0.417 ' O ' HD21 ' A' ' 93' ' ' LEU . . . -71.26 -25.03 62.29 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.288 -1.125 . . . . 0.0 109.414 179.921 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 58' ' ' PHE . . . . . 0.736 ' HB2' HD11 ' A' ' 64' ' ' ILE . 76.2 m-85 -116.81 10.3 14.16 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.323 -0.86 . . . . 0.0 109.463 -179.979 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 59' ' ' SER . . . . . 0.559 ' N ' ' HD2' ' A' ' 60' ' ' PRO . 1.4 t -76.46 -53.74 1.99 Allowed Pre-proline 0 N--CA 1.492 1.63 0 O-C-N 121.3 -0.875 . . . . 0.0 110.473 -179.558 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 60' ' ' PRO . . . . . 0.559 ' HD2' ' N ' ' A' ' 59' ' ' SER . 47.8 Cg_endo -68.88 -34.03 18.8 Favored 'Trans proline' 0 C--O 1.215 -0.659 0 C-N-CA 122.405 2.07 . . . . 0.0 112.388 -179.152 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 61' ' ' PHE . . . . . 0.611 ' CE2' HD21 ' A' ' 93' ' ' LEU . 87.8 m-85 -63.52 -37.04 85.8 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.057 -1.027 . . . . 0.0 109.502 -179.971 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . 0.463 ' HA3' ' OG ' ' A' ' 85' ' ' SER . . . -178.74 -172.63 43.29 Favored Glycine 0 N--CA 1.49 2.27 0 N-CA-C 109.599 -1.4 . . . . 0.0 109.599 179.94 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 51.5 t-20 -96.99 136.81 37.03 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.266 -1.138 . . . . 0.0 109.577 -179.914 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 64' ' ' ILE . . . . . 0.776 HD13 HD23 ' A' ' 67' ' ' LEU . 54.6 mt -98.51 131.29 45.93 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 O-C-N 121.209 -0.932 . . . . 0.0 109.532 -179.946 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 18.6 pt -95.58 -19.31 6.35 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 O-C-N 121.32 -0.862 . . . . 0.0 109.579 -179.902 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 59.6 t0 -152.38 106.25 3.11 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.205 -0.934 . . . . 0.0 109.591 -179.99 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . 0.776 HD23 HD13 ' A' ' 64' ' ' ILE . 0.5 OUTLIER -99.22 120.22 39.16 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.27 -0.894 . . . . 0.0 109.375 179.755 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 68' ' ' SER . . . . . 0.748 ' N ' HD13 ' A' ' 67' ' ' LEU . 67.9 m -131.62 151.15 51.83 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.174 -0.954 . . . . 0.0 109.691 -179.793 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 69' ' ' MET . . . . . 0.693 ' SD ' HD12 ' A' ' 54' ' ' LEU . 18.2 mtm -130.94 144.62 51.6 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.309 -0.869 . . . . 0.0 109.346 179.886 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 70' ' ' ASP . . . . . 0.519 ' CB ' ' O ' ' A' ' 75' ' ' CYS . 0.9 OUTLIER -118.89 102.78 48.99 Favored Pre-proline 0 N--CA 1.491 1.604 0 O-C-N 121.22 -0.925 . . . . 0.0 109.533 -179.885 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 71' ' ' PRO . . . . . 0.601 ' N ' ' CD ' ' A' ' 72' ' ' PRO . 47.7 Cg_endo -74.9 -27.75 9.96 Favored 'Trans proline' 0 CA--C 1.542 0.888 0 C-N-CA 122.608 2.205 . . . . 0.0 113.697 179.886 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 72' ' ' PRO . . . . . 0.601 ' CD ' ' N ' ' A' ' 71' ' ' PRO . 55.4 Cg_endo -75.09 -25.16 11.98 Favored 'Trans proline' 0 C--N 1.353 0.814 0 C-N-CA 121.446 1.431 . . . . 0.0 111.809 -179.795 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 48.3 mtt85 -111.9 10.03 20.64 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.282 -0.886 . . . . 0.0 109.587 -179.946 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 83.1 m-20 53.3 36.61 23.24 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.249 -0.907 . . . . 0.0 109.506 -179.987 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 75' ' ' CYS . . . . . 0.519 ' O ' ' CB ' ' A' ' 70' ' ' ASP . 28.1 p -142.81 146.67 34.42 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.214 -0.929 . . . . 0.0 109.527 -179.868 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 76' ' ' ALA . . . . . 0.47 ' HA ' ' HA ' ' A' ' 69' ' ' MET . . . -114.17 162.48 16.47 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.188 -0.945 . . . . 0.0 109.553 -179.977 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 77' ' ' PHE . . . . . 0.406 ' CE1' ' HD1' ' A' ' 43' ' ' TYR . 96.7 m-85 -127.62 108.99 11.25 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.362 -0.836 . . . . 0.0 109.359 179.933 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . 0.533 HG23 ' CD2' ' A' ' 67' ' ' LEU . 6.1 p -109.67 135.58 48.22 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.449 0 O-C-N 121.247 -0.908 . . . . 0.0 109.624 -179.854 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 79' ' ' THR . . . . . 0.641 ' O ' HG23 ' A' ' 64' ' ' ILE . 91.7 m -106.63 128.8 54.45 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.249 -0.907 . . . . 0.0 109.273 179.797 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 80' ' ' TYR . . . . . 0.94 ' CD2' HD11 ' A' ' 42' ' ' LEU . 0.9 OUTLIER -94.93 174.22 7.2 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.336 -0.852 . . . . 0.0 109.527 179.978 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 81' ' ' GLU . . . . . 0.479 ' O ' ' CG ' ' A' ' 82' ' ' LYS . 81.7 tt0 -86.37 -11.77 51.12 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.44 -0.787 . . . . 0.0 109.177 179.66 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 82' ' ' LYS . . . . . 0.479 ' CG ' ' O ' ' A' ' 81' ' ' GLU . 43.0 mttp -157.91 158.83 35.78 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.324 -0.86 . . . . 0.0 109.267 179.934 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 83' ' ' MET . . . . . . . . . . . . . 31.4 mtt -71.83 -12.13 61.14 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.238 -0.914 . . . . 0.0 109.384 -179.947 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . 0.434 ' HA ' ' OE1' ' A' ' 84' ' ' GLU . 70.7 mm-40 -76.4 -40.11 51.77 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.317 -0.865 . . . . 0.0 109.609 179.93 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 85' ' ' SER . . . . . 0.463 ' OG ' ' HA3' ' A' ' 62' ' ' GLY . 29.1 t -65.45 -35.44 80.93 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.255 -0.903 . . . . 0.0 109.481 179.96 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 86' ' ' ALA . . . . . 0.547 ' O ' HG23 ' A' ' 90' ' ' VAL . . . -71.83 -35.78 70.0 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.425 -0.797 . . . . 0.0 109.764 -179.918 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 64.5 t0 -65.32 -43.64 90.38 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.158 -0.964 . . . . 0.0 109.786 -179.814 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 64.8 tt0 -72.57 -38.85 67.8 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.197 -0.939 . . . . 0.0 109.82 -179.745 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 89' ' ' ALA . . . . . 0.773 ' HB1' ' CD1' ' A' ' 93' ' ' LEU . . . -73.89 -42.12 61.16 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.206 -0.934 . . . . 0.0 109.745 -179.708 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 90' ' ' VAL . . . . . 0.836 ' HA ' HG11 ' A' ' 105' ' ' VAL . 51.1 t -62.07 -34.37 63.02 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.564 0 O-C-N 121.243 -0.91 . . . . 0.0 109.74 -179.79 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -76.03 -53.74 7.91 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.185 -0.947 . . . . 0.0 109.867 -179.678 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 92' ' ' GLU . . . . . 0.581 ' HB2' ' CE1' ' A' ' 61' ' ' PHE . 75.1 mm-40 -69.24 -44.37 72.13 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.196 -0.94 . . . . 0.0 109.9 -179.634 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 93' ' ' LEU . . . . . 0.773 ' CD1' ' HB1' ' A' ' 89' ' ' ALA . 69.8 mt -65.45 -36.84 85.12 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.109 -0.994 . . . . 0.0 109.709 -179.753 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 94' ' ' ASN . . . . . 0.485 ' HB2' ' O ' ' A' ' 90' ' ' VAL . 63.1 t-20 -72.99 125.38 27.47 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.169 -0.957 . . . . 0.0 109.452 -179.888 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 95.29 26.52 12.11 Favored Glycine 0 N--CA 1.49 2.263 0 N-CA-C 109.515 -1.434 . . . . 0.0 109.515 179.908 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 96' ' ' THR . . . . . 0.489 ' CG2' ' O ' ' A' ' 92' ' ' GLU . 17.7 p -121.47 155.3 35.2 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.23 -1.159 . . . . 0.0 109.469 -179.969 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 64.2 tt0 -128.74 153.08 47.71 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.257 -0.902 . . . . 0.0 109.481 -179.97 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 98' ' ' VAL . . . . . 0.538 HG12 ' H ' ' A' ' 99' ' ' GLU . 1.2 t -98.33 -152.58 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.627 0 O-C-N 121.235 -0.916 . . . . 0.0 109.254 -179.897 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 99' ' ' GLU . . . . . 0.538 ' H ' HG12 ' A' ' 98' ' ' VAL . 75.7 mm-40 -59.79 -39.13 83.89 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.168 -0.957 . . . . 0.0 109.475 179.943 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -157.6 24.85 0.28 Allowed 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.327 -0.858 . . . . 0.0 109.485 -179.958 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 101' ' ' VAL . . . . . 0.42 ' O ' HG23 ' A' ' 98' ' ' VAL . 47.4 t -137.57 152.5 27.19 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.552 0 O-C-N 121.165 -0.96 . . . . 0.0 109.498 179.998 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 91.8 mt-30 -108.42 145.08 35.14 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.268 -0.895 . . . . 0.0 109.483 179.937 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 93.3 mt -111.95 145.35 39.75 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.225 -0.922 . . . . 0.0 109.525 -179.961 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 104' ' ' LYS . . . . . 0.472 ' HB2' ' HB3' ' A' ' 45' ' ' TYR . 43.8 mttt -127.33 133.1 50.13 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.264 -0.897 . . . . 0.0 109.406 179.912 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 105' ' ' VAL . . . . . 0.836 HG11 ' HA ' ' A' ' 90' ' ' VAL . 21.9 t . . . . . 0 N--CA 1.489 1.514 0 O-C-N 121.217 -0.927 . . . . 0.0 109.576 -179.866 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 40' ' ' ASN . . . . . 0.467 ' N ' ' O ' ' A' ' 80' ' ' TYR . 45.9 t30 . . . . . 0 N--CA 1.49 1.545 0 CA-C-O 121.256 0.551 . . . . 0.0 109.605 . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 41' ' ' THR . . . . . 0.449 ' HA ' ' HA ' ' A' ' 79' ' ' THR . 36.2 m -72.46 127.76 33.55 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.18 -0.95 . . . . 0.0 109.48 -179.977 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . 0.77 HD13 HG23 ' A' ' 90' ' ' VAL . 13.3 mt -106.44 145.92 31.17 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.195 -0.941 . . . . 0.0 109.478 -179.989 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 85.3 t80 -96.76 117.6 31.41 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.216 -0.927 . . . . 0.0 109.42 179.98 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 44' ' ' VAL . . . . . 0.464 ' HA ' ' O ' ' A' ' 104' ' ' LYS . 63.8 t -113.79 138.99 41.68 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.547 0 O-C-N 121.214 -0.929 . . . . 0.0 109.504 179.981 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 45' ' ' TYR . . . . . 0.435 ' HB3' ' HB2' ' A' ' 104' ' ' LYS . 70.4 t80 -124.5 135.32 53.11 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.273 -0.892 . . . . 0.0 109.49 179.99 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -177.6 -174.87 44.34 Favored Glycine 0 N--CA 1.491 2.353 0 N-CA-C 109.484 -1.447 . . . . 0.0 109.484 -179.951 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 95.5 mt-10 -123.57 157.51 33.5 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.237 -1.155 . . . . 0.0 109.483 -179.98 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 58.3 t0 45.96 46.59 12.44 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.287 -0.883 . . . . 0.0 109.516 179.933 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 70.7 mtm -94.48 143.85 26.07 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.291 -0.881 . . . . 0.0 109.495 179.966 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 50' ' ' THR . . . . . 0.709 ' O ' HD12 ' A' ' 54' ' ' LEU . 2.5 p -120.9 163.99 26.2 Favored Pre-proline 0 N--CA 1.489 1.51 0 O-C-N 121.223 -0.923 . . . . 0.0 109.43 -179.958 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 51' ' ' PRO . . . . . 0.471 ' HD2' ' HB ' ' A' ' 50' ' ' THR . 49.1 Cg_endo -69.41 -52.76 0.33 Allowed 'Trans proline' 0 C--O 1.216 -0.607 0 C-N-CA 122.672 2.248 . . . . 0.0 111.761 179.992 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 56.3 m -57.54 -46.67 83.6 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.22 -0.925 . . . . 0.0 109.319 179.965 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 17.0 tp -58.57 -55.55 33.61 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.285 -0.884 . . . . 0.0 109.299 179.872 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 54' ' ' LEU . . . . . 0.709 HD12 ' O ' ' A' ' 50' ' ' THR . 9.0 mt -54.07 -42.99 69.9 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.267 -0.896 . . . . 0.0 109.285 179.806 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 55' ' ' ARG . . . . . 0.476 ' O ' ' N ' ' A' ' 59' ' ' SER . 32.4 ttt85 -51.66 -39.34 57.98 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.22 -0.925 . . . . 0.0 109.29 179.85 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . 0.435 ' HA2' ' HB2' ' A' ' 59' ' ' SER . . . -70.34 -31.43 68.68 Favored Glycine 0 N--CA 1.488 2.16 0 N-CA-C 109.436 -1.466 . . . . 0.0 109.436 179.898 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . 0.505 ' O ' ' CD2' ' A' ' 61' ' ' PHE . . . -72.85 -17.03 61.58 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.239 -1.153 . . . . 0.0 109.453 -179.958 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 58' ' ' PHE . . . . . 0.688 ' HB2' HD11 ' A' ' 64' ' ' ILE . 97.9 m-85 -126.54 5.34 6.84 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.238 -0.914 . . . . 0.0 109.349 179.855 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 59' ' ' SER . . . . . 0.544 ' N ' ' HD2' ' A' ' 60' ' ' PRO . 0.4 OUTLIER -74.04 -55.89 2.91 Favored Pre-proline 0 N--CA 1.49 1.565 0 O-C-N 121.249 -0.907 . . . . 0.0 109.989 -179.761 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 60' ' ' PRO . . . . . 0.544 ' HD2' ' N ' ' A' ' 59' ' ' SER . 49.5 Cg_endo -70.08 -34.15 14.05 Favored 'Trans proline' 0 C--O 1.215 -0.644 0 C-N-CA 122.51 2.14 . . . . 0.0 112.04 -179.553 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 61' ' ' PHE . . . . . 0.579 ' CE1' ' HB3' ' A' ' 92' ' ' GLU . 73.4 m-85 -58.91 -42.71 90.26 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.175 -0.953 . . . . 0.0 109.52 -179.947 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . 0.459 ' HA3' ' OG ' ' A' ' 85' ' ' SER . . . -178.79 179.88 48.71 Favored Glycine 0 N--CA 1.49 2.289 0 N-CA-C 109.469 -1.452 . . . . 0.0 109.469 179.996 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 39.8 t30 -85.29 140.9 30.47 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.276 -1.132 . . . . 0.0 109.462 179.987 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 64' ' ' ILE . . . . . 0.688 HD11 ' HB2' ' A' ' 58' ' ' PHE . 68.2 mt -103.92 134.22 45.77 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 O-C-N 121.223 -0.923 . . . . 0.0 109.427 -179.982 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 23.7 pt -97.56 -20.67 5.55 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.538 0 O-C-N 121.277 -0.89 . . . . 0.0 109.548 -179.928 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 54.4 t0 -160.64 106.13 1.45 Allowed 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.215 -0.928 . . . . 0.0 109.514 -179.947 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . 1.028 HD11 HG22 ' A' ' 78' ' ' VAL . 0.6 OUTLIER -111.7 120.23 41.34 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.293 -0.879 . . . . 0.0 109.355 179.881 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 19.9 m -118.57 152.39 36.09 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.306 -0.871 . . . . 0.0 109.641 -179.945 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 69' ' ' MET . . . . . 0.471 ' SD ' ' CA ' ' A' ' 51' ' ' PRO . 91.9 mtp -121.02 140.95 51.22 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.297 -0.877 . . . . 0.0 109.46 -179.987 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 70' ' ' ASP . . . . . 0.473 ' C ' ' HD2' ' A' ' 72' ' ' PRO . 0.4 OUTLIER -119.38 105.7 43.73 Favored Pre-proline 0 N--CA 1.491 1.6 0 O-C-N 121.2 -0.937 . . . . 0.0 109.458 179.971 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 71' ' ' PRO . . . . . 0.601 ' N ' ' CD ' ' A' ' 72' ' ' PRO . 48.0 Cg_endo -74.6 -27.78 10.51 Favored 'Trans proline' 0 CA--C 1.542 0.893 0 C-N-CA 122.569 2.18 . . . . 0.0 113.653 179.939 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 72' ' ' PRO . . . . . 0.601 ' CD ' ' N ' ' A' ' 71' ' ' PRO . 55.2 Cg_endo -75.58 -39.59 0.99 Allowed 'Trans proline' 0 C--N 1.352 0.718 0 C-N-CA 121.479 1.453 . . . . 0.0 111.718 -179.879 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 73' ' ' ARG . . . . . 0.454 ' HG2' ' O ' ' A' ' 73' ' ' ARG . 57.4 ttt85 -93.84 -3.89 51.11 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.29 -0.881 . . . . 0.0 109.559 -179.885 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 71.7 m-20 60.15 46.41 10.57 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.183 -0.948 . . . . 0.0 109.388 179.96 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 75' ' ' CYS . . . . . 0.457 ' HA ' ' O ' ' A' ' 44' ' ' VAL . 24.1 p -146.12 143.45 29.34 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.231 -0.918 . . . . 0.0 109.468 179.938 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -111.22 156.32 21.62 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.257 -0.902 . . . . 0.0 109.585 -179.939 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 77' ' ' PHE . . . . . 0.442 ' HA ' ' O ' ' A' ' 42' ' ' LEU . 97.3 m-85 -119.32 131.9 55.8 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.266 -0.896 . . . . 0.0 109.436 179.99 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . 1.028 HG22 HD11 ' A' ' 67' ' ' LEU . 47.2 t -125.42 120.78 58.78 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.619 0 O-C-N 121.193 -0.942 . . . . 0.0 109.533 -179.958 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 79' ' ' THR . . . . . 0.449 ' HA ' ' HA ' ' A' ' 41' ' ' THR . 17.3 m -95.12 132.59 39.86 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.244 -0.91 . . . . 0.0 109.436 179.94 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 80' ' ' TYR . . . . . 0.513 ' CE1' ' OG ' ' A' ' 85' ' ' SER . 2.0 m-85 -114.06 140.55 48.37 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.253 -0.904 . . . . 0.0 109.648 -179.862 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 81.2 tt0 -60.21 -30.07 69.13 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.326 -0.859 . . . . 0.0 109.665 -179.973 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 40.7 mttm -131.88 150.53 52.12 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.1 -1.0 . . . . 0.0 109.611 -179.922 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 83' ' ' MET . . . . . . . . . . . . . 54.0 mtt -66.67 -18.92 65.62 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.364 -0.835 . . . . 0.0 109.582 -179.997 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 98.7 mt-10 -64.39 -44.54 90.98 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.296 -0.877 . . . . 0.0 109.557 -179.86 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 85' ' ' SER . . . . . 0.513 ' OG ' ' CE1' ' A' ' 80' ' ' TYR . 43.6 t -61.51 -31.15 71.14 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.19 -0.944 . . . . 0.0 109.549 -179.89 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 86' ' ' ALA . . . . . 0.497 ' HA ' HD11 ' A' ' 42' ' ' LEU . . . -74.53 -31.03 62.0 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.237 -0.914 . . . . 0.0 109.647 -179.85 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 87' ' ' ASP . . . . . 0.423 ' O ' ' CB ' ' A' ' 91' ' ' ALA . 59.4 t0 -67.96 -49.39 62.02 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.21 -0.931 . . . . 0.0 109.559 -179.982 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 88' ' ' GLN . . . . . 0.438 ' HG2' ' CE1' ' A' ' 61' ' ' PHE . 62.9 tt0 -67.77 -36.78 81.11 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.251 -0.906 . . . . 0.0 109.524 -179.939 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 89' ' ' ALA . . . . . 0.57 ' HA ' ' CE1' ' A' ' 61' ' ' PHE . . . -75.7 -51.18 13.31 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.229 -0.919 . . . . 0.0 109.556 -179.928 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 90' ' ' VAL . . . . . 0.789 ' HA ' HG11 ' A' ' 105' ' ' VAL . 92.9 t -65.08 -33.67 65.32 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.545 0 O-C-N 121.321 -0.862 . . . . 0.0 109.552 -179.932 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 91' ' ' ALA . . . . . 0.423 ' CB ' ' O ' ' A' ' 87' ' ' ASP . . . -79.98 -45.25 18.77 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.31 -0.869 . . . . 0.0 109.663 -179.937 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 92' ' ' GLU . . . . . 0.579 ' HB3' ' CE1' ' A' ' 61' ' ' PHE . 34.0 tt0 -75.26 -46.87 30.89 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.255 -0.903 . . . . 0.0 109.658 -179.831 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 93' ' ' LEU . . . . . 0.773 ' HB2' HG21 ' A' ' 105' ' ' VAL . 42.5 mt -64.42 -41.84 96.38 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.206 -0.934 . . . . 0.0 109.606 -179.779 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 94' ' ' ASN . . . . . 0.492 ' CB ' ' O ' ' A' ' 90' ' ' VAL . 46.8 t30 -64.26 126.69 28.57 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.197 -0.939 . . . . 0.0 109.542 -179.93 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 91.78 25.87 21.43 Favored Glycine 0 N--CA 1.49 2.3 0 N-CA-C 109.556 -1.417 . . . . 0.0 109.556 179.966 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 96' ' ' THR . . . . . 0.637 HG23 ' O ' ' A' ' 93' ' ' LEU . 17.1 p -121.04 160.63 23.2 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.149 -1.206 . . . . 0.0 109.471 179.94 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 64.0 tt0 -130.38 149.92 51.84 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.257 -0.902 . . . . 0.0 109.477 -179.938 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 98' ' ' VAL . . . . . 0.547 HG23 ' O ' ' A' ' 101' ' ' VAL . 1.1 t -97.73 -151.3 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.609 0 O-C-N 121.315 -0.866 . . . . 0.0 109.357 -179.932 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 99' ' ' GLU . . . . . 0.513 ' H ' HG12 ' A' ' 98' ' ' VAL . 96.0 mt-10 -53.84 -38.43 64.65 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.202 -0.936 . . . . 0.0 109.529 -179.947 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 19.2 m -164.0 30.35 0.08 Allowed 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.268 -0.895 . . . . 0.0 109.521 179.965 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 101' ' ' VAL . . . . . 0.547 ' O ' HG23 ' A' ' 98' ' ' VAL . 59.7 t -144.78 144.17 22.15 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.516 0 O-C-N 121.21 -0.931 . . . . 0.0 109.487 -179.987 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 87.1 mt-30 -94.09 150.53 20.25 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.241 -0.912 . . . . 0.0 109.373 179.97 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 88.3 mt -117.29 134.99 54.16 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.205 -0.935 . . . . 0.0 109.499 -179.954 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 104' ' ' LYS . . . . . 0.464 ' O ' ' HA ' ' A' ' 44' ' ' VAL . 23.1 mttm -113.66 135.13 54.26 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.279 -0.888 . . . . 0.0 109.351 179.936 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 105' ' ' VAL . . . . . 0.789 HG11 ' HA ' ' A' ' 90' ' ' VAL . 21.2 t . . . . . 0 N--CA 1.49 1.551 0 O-C-N 121.172 -0.955 . . . . 0.0 109.541 -179.982 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 40' ' ' ASN . . . . . 0.76 HD22 ' HB3' ' A' ' 86' ' ' ALA . 38.6 t30 . . . . . 0 N--CA 1.49 1.548 0 N-CA-C 109.311 -0.626 . . . . 0.0 109.311 . . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 41' ' ' THR . . . . . 0.443 ' C ' HD12 ' A' ' 42' ' ' LEU . 8.1 m -139.81 159.18 42.77 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.251 -0.905 . . . . 0.0 109.687 -179.732 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . 0.783 HD12 ' O ' ' A' ' 78' ' ' VAL . 4.3 mp -144.78 143.91 30.9 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.279 -0.888 . . . . 0.0 109.469 -179.951 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 51.7 t80 -105.04 109.79 21.93 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.174 -0.954 . . . . 0.0 109.519 179.925 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 44' ' ' VAL . . . . . 0.425 ' HA ' ' O ' ' A' ' 104' ' ' LYS . 99.8 t -101.16 144.23 13.22 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.518 0 O-C-N 121.346 -0.846 . . . . 0.0 109.481 179.862 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 64.6 t80 -135.86 134.81 39.21 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.303 -0.873 . . . . 0.0 109.425 -179.852 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 176.09 -166.0 36.88 Favored Glycine 0 N--CA 1.49 2.257 0 N-CA-C 109.453 -1.459 . . . . 0.0 109.453 179.918 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . 0.422 ' O ' ' C ' ' A' ' 48' ' ' ASP . 94.0 mt-10 -126.04 158.04 36.37 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.288 -1.125 . . . . 0.0 109.396 180.0 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 48' ' ' ASP . . . . . 0.422 ' C ' ' O ' ' A' ' 47' ' ' GLU . 51.7 m-20 44.38 48.85 8.15 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.174 -0.954 . . . . 0.0 109.486 -179.993 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 63.5 mtm -101.41 141.12 34.75 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.228 -0.92 . . . . 0.0 109.462 -179.976 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 50' ' ' THR . . . . . 0.602 ' O ' HD12 ' A' ' 54' ' ' LEU . 0.6 OUTLIER -122.12 167.28 14.29 Favored Pre-proline 0 N--CA 1.49 1.531 0 O-C-N 121.211 -0.931 . . . . 0.0 109.422 179.965 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 51' ' ' PRO . . . . . 0.471 ' CB ' HD21 ' A' ' 67' ' ' LEU . 49.5 Cg_endo -70.43 -55.0 0.17 Allowed 'Trans proline' 0 C--O 1.215 -0.664 0 C-N-CA 122.643 2.228 . . . . 0.0 111.864 180.0 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 35.3 m -51.88 -47.0 64.73 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.175 -0.953 . . . . 0.0 109.147 179.906 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 23.5 tp -59.46 -50.27 74.56 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.258 -0.901 . . . . 0.0 109.143 179.788 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 54' ' ' LEU . . . . . 0.602 HD12 ' O ' ' A' ' 50' ' ' THR . 8.1 mt -55.57 -48.7 74.36 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.309 -0.87 . . . . 0.0 109.175 179.705 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 55' ' ' ARG . . . . . 0.518 ' O ' ' N ' ' A' ' 59' ' ' SER . 93.5 mtt-85 -49.18 -37.04 21.24 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.275 -0.89 . . . . 0.0 109.229 179.824 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -69.38 -35.01 75.28 Favored Glycine 0 N--CA 1.489 2.223 0 N-CA-C 109.454 -1.458 . . . . 0.0 109.454 179.945 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . 0.511 ' O ' HD11 ' A' ' 93' ' ' LEU . . . -75.87 -22.83 55.77 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.217 -1.166 . . . . 0.0 109.362 179.925 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 58' ' ' PHE . . . . . 0.882 ' CE1' HD12 ' A' ' 93' ' ' LEU . 95.7 m-85 -116.63 9.54 14.15 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.287 -0.883 . . . . 0.0 109.328 179.825 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 59' ' ' SER . . . . . 0.562 ' N ' ' HD2' ' A' ' 60' ' ' PRO . 0.8 OUTLIER -76.92 -52.72 1.91 Allowed Pre-proline 0 N--CA 1.49 1.556 0 O-C-N 121.293 -0.879 . . . . 0.0 110.619 -179.506 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 60' ' ' PRO . . . . . 0.562 ' HD2' ' N ' ' A' ' 59' ' ' SER . 48.8 Cg_endo -70.45 -33.35 14.13 Favored 'Trans proline' 0 C--O 1.215 -0.658 0 C-N-CA 122.336 2.024 . . . . 0.0 112.526 -179.023 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 61' ' ' PHE . . . . . 0.73 ' CE2' HD21 ' A' ' 93' ' ' LEU . 78.1 m-85 -63.41 -36.64 84.39 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 120.983 -1.073 . . . . 0.0 109.648 -179.838 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . 0.452 ' HA3' ' OG ' ' A' ' 85' ' ' SER . . . 179.22 -176.98 48.21 Favored Glycine 0 N--CA 1.49 2.247 0 N-CA-C 109.447 -1.461 . . . . 0.0 109.447 179.952 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 78.9 m-20 -93.22 138.53 31.53 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.266 -1.138 . . . . 0.0 109.577 179.99 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 64' ' ' ILE . . . . . 0.901 HG23 ' O ' ' A' ' 79' ' ' THR . 41.1 mt -99.19 140.01 19.64 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.555 0 O-C-N 121.273 -0.892 . . . . 0.0 109.397 -179.989 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 22.3 pt -103.63 -19.3 6.29 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 O-C-N 121.204 -0.935 . . . . 0.0 109.705 -179.763 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 66' ' ' ASP . . . . . 0.462 ' HB3' ' OG1' ' A' ' 79' ' ' THR . 21.7 t70 -152.18 126.42 9.25 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.228 -0.92 . . . . 0.0 109.405 179.946 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . 0.471 HD21 ' CB ' ' A' ' 51' ' ' PRO . 8.3 tp -111.46 122.51 48.03 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.298 -0.876 . . . . 0.0 109.345 -179.965 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 68' ' ' SER . . . . . 0.459 ' HB3' ' HB2' ' A' ' 77' ' ' PHE . 26.5 t -126.21 139.19 53.54 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.328 -0.857 . . . . 0.0 109.412 -179.926 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 69' ' ' MET . . . . . 0.415 ' HA ' ' HA ' ' A' ' 76' ' ' ALA . 86.7 mtp -127.7 150.99 49.53 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.306 -0.872 . . . . 0.0 109.467 179.946 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 70' ' ' ASP . . . . . 0.469 ' C ' ' HD2' ' A' ' 72' ' ' PRO . 10.6 t70 -129.15 101.67 19.33 Favored Pre-proline 0 N--CA 1.491 1.577 0 O-C-N 121.276 -0.89 . . . . 0.0 109.447 179.986 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 71' ' ' PRO . . . . . 0.592 ' N ' ' CD ' ' A' ' 72' ' ' PRO . 47.5 Cg_endo -74.93 -27.89 9.77 Favored 'Trans proline' 0 CA--C 1.544 0.985 0 C-N-CA 122.561 2.174 . . . . 0.0 113.733 -179.863 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 72' ' ' PRO . . . . . 0.592 ' CD ' ' N ' ' A' ' 71' ' ' PRO . 55.4 Cg_endo -75.15 -20.63 16.38 Favored 'Trans proline' 0 C--N 1.352 0.728 0 C-N-CA 121.471 1.447 . . . . 0.0 111.803 -179.699 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 73' ' ' ARG . . . . . 0.454 ' N ' ' OD1' ' A' ' 70' ' ' ASP . 93.6 mtt180 -113.59 0.44 14.64 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.258 -0.901 . . . . 0.0 109.698 -179.899 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 74' ' ' ASN . . . . . 0.437 ' HB2' ' O ' ' A' ' 73' ' ' ARG . 81.7 m-20 61.19 41.83 12.96 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.247 -0.908 . . . . 0.0 109.493 179.938 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 75' ' ' CYS . . . . . 0.465 ' SG ' ' HB3' ' A' ' 70' ' ' ASP . 21.7 p -144.19 147.97 34.36 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.186 -0.946 . . . . 0.0 109.452 179.941 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 76' ' ' ALA . . . . . 0.415 ' HA ' ' HA ' ' A' ' 69' ' ' MET . . . -121.89 149.15 43.81 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.247 -0.908 . . . . 0.0 109.408 -179.954 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 77' ' ' PHE . . . . . 0.459 ' HB2' ' HB3' ' A' ' 68' ' ' SER . 90.9 m-85 -114.02 137.99 50.97 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.234 -0.916 . . . . 0.0 109.379 -179.973 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . 0.783 ' O ' HD12 ' A' ' 42' ' ' LEU . 61.7 t -123.76 145.3 31.02 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.491 0 O-C-N 121.145 -0.972 . . . . 0.0 109.615 -179.884 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 79' ' ' THR . . . . . 0.901 ' O ' HG23 ' A' ' 64' ' ' ILE . 1.3 m -113.99 130.77 56.51 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.316 -0.865 . . . . 0.0 108.995 179.886 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 80' ' ' TYR . . . . . 0.506 ' OH ' ' CA ' ' A' ' 58' ' ' PHE . 0.9 OUTLIER -112.22 132.37 54.96 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.168 -0.958 . . . . 0.0 109.805 -179.665 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 81' ' ' GLU . . . . . 0.409 ' C ' ' O ' ' A' ' 80' ' ' TYR . 86.7 tt0 -43.04 -25.81 0.12 Allowed 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.448 -0.782 . . . . 0.0 109.766 179.81 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 82' ' ' LYS . . . . . 0.425 ' N ' ' O ' ' A' ' 80' ' ' TYR . 34.6 mtmm -142.95 164.2 30.72 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.1 -1.0 . . . . 0.0 109.403 179.95 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 83' ' ' MET . . . . . 0.535 ' HA ' ' ND2' ' A' ' 40' ' ' ASN . 15.8 mtt -80.41 -12.95 59.51 Favored 'General case' 0 N--CA 1.487 1.42 0 O-C-N 121.267 -0.895 . . . . 0.0 109.49 179.874 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 95.1 mt-10 -73.99 -40.75 62.74 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.243 -0.91 . . . . 0.0 109.183 179.722 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 85' ' ' SER . . . . . 0.452 ' OG ' ' HA3' ' A' ' 62' ' ' GLY . 10.9 t -66.78 -39.33 87.77 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.34 -0.85 . . . . 0.0 109.258 179.744 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 86' ' ' ALA . . . . . 0.795 ' O ' HG23 ' A' ' 90' ' ' VAL . . . -72.08 -23.97 61.43 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.433 -0.792 . . . . 0.0 109.24 -179.943 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 65.1 m-20 -72.97 -48.3 37.8 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.352 -0.843 . . . . 0.0 109.504 179.911 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 57.6 tt0 -68.41 -37.9 80.75 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.297 -0.877 . . . . 0.0 109.633 -179.96 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 89' ' ' ALA . . . . . 0.452 ' HA ' ' CD1' ' A' ' 61' ' ' PHE . . . -69.07 -41.35 77.66 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.213 -0.93 . . . . 0.0 109.513 -179.883 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 90' ' ' VAL . . . . . 0.795 HG23 ' O ' ' A' ' 86' ' ' ALA . 53.1 t -62.09 -33.21 57.33 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.535 0 O-C-N 121.205 -0.935 . . . . 0.0 109.627 -179.933 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -79.41 -48.16 14.46 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.231 -0.918 . . . . 0.0 109.856 -179.684 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 92' ' ' GLU . . . . . 0.58 ' HB2' ' CE1' ' A' ' 61' ' ' PHE . 75.6 mm-40 -73.72 -43.11 60.09 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.175 -0.953 . . . . 0.0 109.994 -179.405 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 93' ' ' LEU . . . . . 0.946 ' HB2' HG21 ' A' ' 105' ' ' VAL . 21.9 mt -69.6 -39.32 77.34 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.16 -0.962 . . . . 0.0 109.753 -179.655 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 94' ' ' ASN . . . . . 0.521 ' CB ' ' O ' ' A' ' 90' ' ' VAL . 51.4 t-20 -72.54 120.05 17.61 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.15 -0.968 . . . . 0.0 109.569 -179.995 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 102.03 26.61 7.37 Favored Glycine 0 N--CA 1.49 2.249 0 N-CA-C 109.493 -1.443 . . . . 0.0 109.493 179.971 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 96' ' ' THR . . . . . 0.493 ' CG2' ' O ' ' A' ' 92' ' ' GLU . 11.1 p -125.65 154.52 42.21 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.28 -1.13 . . . . 0.0 109.429 -179.957 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 63.2 tt0 -128.47 138.38 52.26 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.277 -0.89 . . . . 0.0 109.516 179.977 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 98' ' ' VAL . . . . . 0.479 HG23 ' O ' ' A' ' 101' ' ' VAL . 1.3 t -80.13 -148.48 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 O-C-N 121.286 -0.884 . . . . 0.0 109.396 -179.97 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 99' ' ' GLU . . . . . 0.473 ' H ' HG12 ' A' ' 98' ' ' VAL . 96.5 mt-10 -63.2 -39.2 93.96 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.271 -0.893 . . . . 0.0 109.435 179.986 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 1.2 m -155.99 25.52 0.37 Allowed 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.276 -0.89 . . . . 0.0 109.451 179.956 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 101' ' ' VAL . . . . . 0.479 ' O ' HG23 ' A' ' 98' ' ' VAL . 57.4 t -139.59 145.07 27.45 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.552 0 O-C-N 121.308 -0.87 . . . . 0.0 109.373 179.922 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 47.0 tt0 -103.11 138.72 39.57 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.221 -0.924 . . . . 0.0 109.666 -179.837 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 67.7 mt -110.23 142.97 41.07 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.217 -0.927 . . . . 0.0 109.375 179.883 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 104' ' ' LYS . . . . . 0.425 ' O ' ' HA ' ' A' ' 44' ' ' VAL . 44.7 mttp -125.76 124.23 40.56 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.267 -0.896 . . . . 0.0 109.437 179.917 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 105' ' ' VAL . . . . . 0.946 HG21 ' HB2' ' A' ' 93' ' ' LEU . 14.3 t . . . . . 0 N--CA 1.49 1.568 0 O-C-N 121.205 -0.934 . . . . 0.0 109.561 -179.886 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 40' ' ' ASN . . . . . 0.776 HD22 ' HB3' ' A' ' 86' ' ' ALA . 33.9 t-20 . . . . . 0 N--CA 1.491 1.618 0 CA-C-O 121.268 0.556 . . . . 0.0 109.571 . . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 41' ' ' THR . . . . . 0.595 ' O ' HD23 ' A' ' 42' ' ' LEU . 40.1 m -80.72 136.71 36.21 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.24 -0.913 . . . . 0.0 109.34 179.859 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . 0.852 HD11 ' CD2' ' A' ' 80' ' ' TYR . 8.5 mt -120.18 157.58 28.76 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.205 -0.935 . . . . 0.0 109.614 -179.945 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 43' ' ' TYR . . . . . 0.489 ' CZ ' ' HB2' ' A' ' 75' ' ' CYS . 74.6 t80 -116.92 121.76 42.37 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.317 -0.865 . . . . 0.0 109.269 179.83 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 44' ' ' VAL . . . . . 0.773 HG13 HD23 ' A' ' 103' ' ' LEU . 61.8 t -116.21 134.17 60.41 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.479 0 O-C-N 121.167 -0.958 . . . . 0.0 109.572 -179.902 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 60.7 t80 -121.49 142.4 50.09 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.287 -0.883 . . . . 0.0 109.488 -179.976 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 173.97 -178.97 45.63 Favored Glycine 0 N--CA 1.491 2.338 0 N-CA-C 109.485 -1.446 . . . . 0.0 109.485 179.958 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . 0.411 ' O ' ' C ' ' A' ' 48' ' ' ASP . 92.7 mt-10 -111.66 154.93 24.2 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.253 -1.145 . . . . 0.0 109.434 -179.952 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 48' ' ' ASP . . . . . 0.411 ' C ' ' O ' ' A' ' 47' ' ' GLU . 43.4 m-20 43.99 51.6 6.99 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.212 -0.93 . . . . 0.0 109.488 -179.993 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 49.1 mtm -98.93 142.31 30.6 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.234 -0.916 . . . . 0.0 109.494 179.971 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 50' ' ' THR . . . . . 0.832 ' O ' HD12 ' A' ' 54' ' ' LEU . 0.6 OUTLIER -125.16 166.62 19.57 Favored Pre-proline 0 N--CA 1.49 1.571 0 O-C-N 121.225 -0.922 . . . . 0.0 109.503 179.949 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 51' ' ' PRO . . . . . 0.405 ' HD2' ' HB ' ' A' ' 50' ' ' THR . 49.2 Cg_endo -69.95 -48.21 0.72 Allowed 'Trans proline' 0 C--O 1.216 -0.623 0 C-N-CA 122.718 2.279 . . . . 0.0 111.769 -179.96 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 36.3 m -57.54 -45.74 84.73 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.253 -0.905 . . . . 0.0 109.457 179.985 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 15.6 tp -59.71 -50.28 74.45 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.325 -0.859 . . . . 0.0 109.445 179.84 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 54' ' ' LEU . . . . . 0.832 HD12 ' O ' ' A' ' 50' ' ' THR . 3.5 mt -56.81 -50.16 73.2 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.285 -0.885 . . . . 0.0 109.284 179.897 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 55' ' ' ARG . . . . . 0.506 ' O ' ' N ' ' A' ' 59' ' ' SER . 33.2 mtp180 -46.03 -41.03 11.48 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.172 -0.955 . . . . 0.0 109.262 179.895 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -69.18 -37.78 81.9 Favored Glycine 0 N--CA 1.489 2.229 0 N-CA-C 109.36 -1.496 . . . . 0.0 109.36 179.852 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -72.59 -21.05 61.2 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.245 -1.15 . . . . 0.0 109.394 179.953 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 58' ' ' PHE . . . . . 0.675 ' CZ ' HD13 ' A' ' 93' ' ' LEU . 92.5 m-85 -117.74 8.0 12.63 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.308 -0.87 . . . . 0.0 109.431 179.881 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 59' ' ' SER . . . . . 0.559 ' N ' ' HD2' ' A' ' 60' ' ' PRO . 1.2 t -75.16 -54.45 2.52 Favored Pre-proline 0 N--CA 1.492 1.632 0 O-C-N 121.313 -0.867 . . . . 0.0 110.391 -179.699 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 60' ' ' PRO . . . . . 0.559 ' HD2' ' N ' ' A' ' 59' ' ' SER . 47.4 Cg_endo -68.95 -30.5 26.03 Favored 'Trans proline' 0 C--O 1.215 -0.653 0 C-N-CA 122.456 2.104 . . . . 0.0 112.3 -179.252 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 61' ' ' PHE . . . . . 0.619 ' CB ' ' HB2' ' A' ' 89' ' ' ALA . 60.3 m-85 -66.68 -31.13 71.59 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.119 -0.988 . . . . 0.0 109.471 -179.979 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 168.56 179.15 40.66 Favored Glycine 0 N--CA 1.491 2.308 0 N-CA-C 109.579 -1.408 . . . . 0.0 109.579 179.928 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 37.0 t30 -87.89 134.86 33.62 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.365 -1.079 . . . . 0.0 109.492 -179.979 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 64' ' ' ILE . . . . . 0.656 HD11 ' HB2' ' A' ' 58' ' ' PHE . 33.4 mt -94.05 133.95 33.32 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.508 0 O-C-N 121.23 -0.919 . . . . 0.0 109.476 179.963 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 26.1 pt -97.19 -20.71 5.57 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.486 0 O-C-N 121.17 -0.956 . . . . 0.0 109.376 179.911 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 66' ' ' ASP . . . . . 0.479 ' HB3' ' HB ' ' A' ' 79' ' ' THR . 60.9 t0 -138.82 125.96 21.37 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.225 -0.922 . . . . 0.0 109.433 179.854 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . 0.758 ' C ' HD13 ' A' ' 67' ' ' LEU . 3.5 tm? -121.26 108.24 13.5 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.209 -0.932 . . . . 0.0 109.355 179.897 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 68' ' ' SER . . . . . 0.476 ' HB2' ' HB2' ' A' ' 77' ' ' PHE . 58.3 m -122.66 149.27 44.25 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.238 -0.914 . . . . 0.0 109.463 -179.964 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 69' ' ' MET . . . . . 0.48 ' SD ' ' CD1' ' A' ' 54' ' ' LEU . 83.8 mmm -123.39 147.68 46.85 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.234 -0.916 . . . . 0.0 109.381 -179.979 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 70' ' ' ASP . . . . . 0.478 ' C ' ' HD2' ' A' ' 72' ' ' PRO . 0.6 OUTLIER -131.64 94.2 26.34 Favored Pre-proline 0 N--CA 1.49 1.541 0 O-C-N 121.252 -0.905 . . . . 0.0 109.483 179.959 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 71' ' ' PRO . . . . . 0.598 ' CD ' ' CD ' ' A' ' 72' ' ' PRO . 47.0 Cg_endo -74.84 -27.77 10.06 Favored 'Trans proline' 0 CA--C 1.543 0.967 0 C-N-CA 122.506 2.137 . . . . 0.0 113.664 -179.974 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 72' ' ' PRO . . . . . 0.598 ' CD ' ' CD ' ' A' ' 71' ' ' PRO . 55.2 Cg_endo -75.3 -22.19 14.55 Favored 'Trans proline' 0 C--N 1.353 0.803 0 C-N-CA 121.49 1.46 . . . . 0.0 111.868 -179.844 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 73' ' ' ARG . . . . . 0.401 ' O ' ' HB2' ' A' ' 74' ' ' ASN . 62.7 mtt180 -112.24 -0.39 15.51 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.167 -0.958 . . . . 0.0 109.65 -179.992 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 74' ' ' ASN . . . . . 0.401 ' HB2' ' O ' ' A' ' 73' ' ' ARG . 8.0 m120 60.82 45.47 9.8 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.082 -1.011 . . . . 0.0 109.402 -179.981 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 75' ' ' CYS . . . . . 0.489 ' HB2' ' CZ ' ' A' ' 43' ' ' TYR . 23.2 p -152.69 143.07 22.58 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.299 -0.875 . . . . 0.0 109.458 -179.979 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -112.08 156.99 21.33 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.307 -0.871 . . . . 0.0 109.485 179.952 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 77' ' ' PHE . . . . . 0.476 ' HB2' ' HB2' ' A' ' 68' ' ' SER . 97.0 m-85 -118.37 125.58 50.31 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.245 -0.909 . . . . 0.0 109.427 179.858 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . 0.485 HG13 HG21 ' A' ' 64' ' ' ILE . 59.6 t -127.11 126.78 68.7 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.546 0 O-C-N 121.234 -0.916 . . . . 0.0 109.489 -179.858 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 79' ' ' THR . . . . . 0.479 ' HB ' ' HB3' ' A' ' 66' ' ' ASP . 92.3 m -105.59 126.64 52.37 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.334 -0.854 . . . . 0.0 109.446 179.812 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 80' ' ' TYR . . . . . 0.852 ' CD2' HD11 ' A' ' 42' ' ' LEU . 2.3 m-85 -92.41 174.05 7.49 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.227 -0.921 . . . . 0.0 109.169 179.898 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 81' ' ' GLU . . . . . 0.475 ' HG2' ' O ' ' A' ' 81' ' ' GLU . 71.0 tt0 -90.23 -13.56 35.19 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.352 -0.842 . . . . 0.0 109.665 -179.678 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 23.2 mttt -150.08 127.93 11.77 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.051 -1.031 . . . . 0.0 110.018 179.921 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 83' ' ' MET . . . . . 0.515 ' N ' ' SD ' ' A' ' 83' ' ' MET . 0.4 OUTLIER -45.83 -24.89 0.44 Allowed 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.458 -0.777 . . . . 0.0 109.88 179.938 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . 0.422 ' HG3' ' SD ' ' A' ' 83' ' ' MET . 97.1 mt-10 -67.56 -62.35 1.46 Allowed 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.196 -0.94 . . . . 0.0 109.571 -179.868 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 13.7 m -46.82 -38.26 9.96 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.267 -0.896 . . . . 0.0 109.818 -179.804 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 86' ' ' ALA . . . . . 0.776 ' HB3' HD22 ' A' ' 40' ' ' ASN . . . -69.27 -39.45 78.38 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.161 -0.962 . . . . 0.0 109.751 -179.691 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 52.4 t0 -56.76 -38.31 72.27 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.212 -0.93 . . . . 0.0 109.591 -179.739 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 88' ' ' GLN . . . . . 0.483 ' O ' ' CB ' ' A' ' 92' ' ' GLU . 59.7 tt0 -74.39 -38.49 63.12 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.15 -0.969 . . . . 0.0 109.603 -179.839 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 89' ' ' ALA . . . . . 0.619 ' HB2' ' CB ' ' A' ' 61' ' ' PHE . . . -75.36 -41.95 55.28 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.168 -0.958 . . . . 0.0 109.651 -179.871 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 90' ' ' VAL . . . . . 0.852 ' HA ' HG11 ' A' ' 105' ' ' VAL . 53.9 t -64.68 -48.72 83.51 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 O-C-N 121.257 -0.902 . . . . 0.0 109.634 -179.834 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -72.22 -38.77 68.91 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.272 -0.892 . . . . 0.0 109.702 -179.882 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 92' ' ' GLU . . . . . 0.59 ' HB3' ' CE1' ' A' ' 61' ' ' PHE . 44.5 tp10 -74.4 -45.81 44.29 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.247 -0.908 . . . . 0.0 109.583 -179.876 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 93' ' ' LEU . . . . . 0.675 HD13 ' CZ ' ' A' ' 58' ' ' PHE . 68.0 mt -69.95 -37.76 75.93 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.165 -0.959 . . . . 0.0 109.545 -179.921 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 94' ' ' ASN . . . . . 0.475 ' HB2' ' O ' ' A' ' 90' ' ' VAL . 61.4 t-20 -64.64 129.85 41.39 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.226 -0.921 . . . . 0.0 109.547 -179.967 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 84.77 30.14 27.33 Favored Glycine 0 N--CA 1.489 2.219 0 N-CA-C 109.497 -1.441 . . . . 0.0 109.497 179.973 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 96' ' ' THR . . . . . 0.666 HG23 ' O ' ' A' ' 93' ' ' LEU . 19.7 p -121.27 151.54 39.92 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.261 -1.141 . . . . 0.0 109.468 -179.995 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 61.7 tt0 -116.94 143.73 45.37 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.314 -0.866 . . . . 0.0 109.498 -179.946 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 98' ' ' VAL . . . . . 0.602 HG12 ' H ' ' A' ' 99' ' ' GLU . 1.2 t -90.79 -159.41 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 O-C-N 121.233 -0.917 . . . . 0.0 109.282 179.935 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 99' ' ' GLU . . . . . 0.602 ' H ' HG12 ' A' ' 98' ' ' VAL . 95.9 mt-10 -54.68 -37.71 66.1 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.183 -0.948 . . . . 0.0 109.481 179.968 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 100' ' ' SER . . . . . 0.422 ' O ' ' OG ' ' A' ' 100' ' ' SER . 6.9 t -159.86 25.96 0.18 Allowed 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.198 -0.938 . . . . 0.0 109.554 -179.953 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 101' ' ' VAL . . . . . 0.606 HG12 ' N ' ' A' ' 102' ' ' GLN . 48.7 t -138.03 168.42 20.32 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.546 0 O-C-N 121.219 -0.926 . . . . 0.0 109.434 -179.955 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 102' ' ' GLN . . . . . 0.606 ' N ' HG12 ' A' ' 101' ' ' VAL . 92.5 mt-30 -116.12 147.12 41.67 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.22 -0.925 . . . . 0.0 109.169 179.874 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 103' ' ' LEU . . . . . 0.773 HD23 HG13 ' A' ' 44' ' ' VAL . 0.0 OUTLIER -122.15 130.94 53.68 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.198 -0.939 . . . . 0.0 109.715 -179.918 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 16.7 mttp -115.82 128.22 55.66 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.294 -0.879 . . . . 0.0 109.333 179.864 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 105' ' ' VAL . . . . . 0.852 HG11 ' HA ' ' A' ' 90' ' ' VAL . 22.7 t . . . . . 0 N--CA 1.489 1.519 0 O-C-N 121.179 -0.951 . . . . 0.0 109.583 -179.834 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 43.7 t30 . . . . . 0 N--CA 1.49 1.563 0 N-CA-C 109.322 -0.622 . . . . 0.0 109.322 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 41' ' ' THR . . . . . 0.415 ' O ' HD23 ' A' ' 42' ' ' LEU . 78.9 m -65.53 130.88 44.88 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.229 -0.92 . . . . 0.0 109.588 -179.935 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . 0.56 HD11 ' HD2' ' A' ' 80' ' ' TYR . 16.8 mt -111.51 146.05 37.97 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.262 -0.899 . . . . 0.0 109.464 179.957 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 70.6 t80 -104.78 122.72 46.32 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.164 -0.96 . . . . 0.0 109.46 179.999 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 44' ' ' VAL . . . . . 0.462 ' HA ' ' O ' ' A' ' 104' ' ' LYS . 47.9 t -121.57 138.15 52.84 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.523 0 O-C-N 121.214 -0.929 . . . . 0.0 109.489 179.978 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 45' ' ' TYR . . . . . 0.476 ' HB3' ' HB2' ' A' ' 104' ' ' LYS . 72.3 t80 -118.68 138.9 52.3 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.226 -0.921 . . . . 0.0 109.441 -179.951 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 176.17 -178.54 47.57 Favored Glycine 0 N--CA 1.489 2.216 0 N-CA-C 109.448 -1.461 . . . . 0.0 109.448 179.929 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 94.2 mt-10 -124.91 156.04 38.58 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.344 -1.092 . . . . 0.0 109.488 179.995 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 22.2 t70 47.46 50.22 15.03 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.227 -0.92 . . . . 0.0 109.476 -179.99 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 66.7 mtm -105.54 145.21 31.24 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.247 -0.908 . . . . 0.0 109.513 -179.969 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 50' ' ' THR . . . . . 0.728 ' O ' HD12 ' A' ' 54' ' ' LEU . 3.5 p -119.42 161.73 35.83 Favored Pre-proline 0 N--CA 1.49 1.57 0 O-C-N 121.27 -0.894 . . . . 0.0 109.395 179.978 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 51' ' ' PRO . . . . . 0.464 ' N ' ' SD ' ' A' ' 69' ' ' MET . 48.2 Cg_endo -70.1 -55.35 0.17 Allowed 'Trans proline' 0 C--O 1.216 -0.593 0 C-N-CA 122.727 2.285 . . . . 0.0 111.87 -179.949 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 27.9 m -50.83 -47.17 60.16 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.152 -0.967 . . . . 0.0 109.216 179.894 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 18.7 tp -58.06 -56.12 26.08 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.256 -0.903 . . . . 0.0 109.241 179.766 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 54' ' ' LEU . . . . . 0.728 HD12 ' O ' ' A' ' 50' ' ' THR . 5.1 mt -53.9 -43.17 69.46 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.285 -0.884 . . . . 0.0 109.092 179.615 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 55' ' ' ARG . . . . . 0.499 ' O ' ' N ' ' A' ' 59' ' ' SER . 73.5 ttt180 -48.83 -41.82 34.15 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.266 -0.896 . . . . 0.0 109.208 179.712 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . 0.474 ' O ' ' HD2' ' A' ' 60' ' ' PRO . . . -67.66 -35.39 85.81 Favored Glycine 0 N--CA 1.489 2.213 0 N-CA-C 109.263 -1.535 . . . . 0.0 109.263 179.857 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . 0.469 ' O ' ' CD1' ' A' ' 61' ' ' PHE . . . -70.87 -22.15 62.33 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.324 -1.103 . . . . 0.0 109.425 179.961 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 58' ' ' PHE . . . . . 0.675 ' CE2' HD12 ' A' ' 93' ' ' LEU . 96.6 m-85 -118.07 4.72 12.03 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.272 -0.892 . . . . 0.0 109.544 -179.953 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 59' ' ' SER . . . . . 0.538 ' N ' ' HD2' ' A' ' 60' ' ' PRO . 2.6 t -73.63 -56.89 2.78 Favored Pre-proline 0 N--CA 1.49 1.569 0 O-C-N 121.208 -0.932 . . . . 0.0 110.075 -179.67 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 60' ' ' PRO . . . . . 0.538 ' HD2' ' N ' ' A' ' 59' ' ' SER . 48.0 Cg_endo -68.81 -24.84 33.86 Favored 'Trans proline' 0 C--O 1.215 -0.652 0 C-N-CA 122.59 2.193 . . . . 0.0 111.989 -179.496 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 61' ' ' PHE . . . . . 0.587 ' CE2' ' HA ' ' A' ' 89' ' ' ALA . 68.0 m-85 -72.73 -25.08 61.08 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.179 -0.95 . . . . 0.0 109.508 179.968 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 166.18 -178.04 40.94 Favored Glycine 0 N--CA 1.49 2.256 0 N-CA-C 109.548 -1.421 . . . . 0.0 109.548 179.951 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 85.8 m-20 -92.43 139.51 30.52 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.305 -1.115 . . . . 0.0 109.504 179.986 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 64' ' ' ILE . . . . . 0.588 HG23 ' O ' ' A' ' 79' ' ' THR . 51.4 mt -99.87 134.12 40.41 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.522 0 O-C-N 121.243 -0.911 . . . . 0.0 109.461 -179.969 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 20.0 pt -96.36 -24.29 4.6 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.537 0 O-C-N 121.314 -0.866 . . . . 0.0 109.521 -179.92 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 50.8 t0 -146.28 121.14 9.94 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.229 -0.919 . . . . 0.0 109.597 -179.946 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 8.1 tp -110.14 121.39 45.14 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.236 -0.915 . . . . 0.0 109.389 179.902 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 68' ' ' SER . . . . . 0.468 ' HB3' ' HB2' ' A' ' 77' ' ' PHE . 34.6 t -134.69 144.51 47.83 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.224 -0.922 . . . . 0.0 109.419 179.941 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 69' ' ' MET . . . . . 0.464 ' SD ' ' N ' ' A' ' 51' ' ' PRO . 83.3 mtp -129.59 151.4 50.24 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.271 -0.893 . . . . 0.0 109.563 -179.96 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 70' ' ' ASP . . . . . 0.478 ' C ' ' HD2' ' A' ' 72' ' ' PRO . 0.2 OUTLIER -127.06 99.36 28.69 Favored Pre-proline 0 N--CA 1.491 1.6 0 O-C-N 121.3 -0.875 . . . . 0.0 109.419 179.982 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 71' ' ' PRO . . . . . 0.594 ' N ' ' CD ' ' A' ' 72' ' ' PRO . 47.4 Cg_endo -74.63 -27.85 10.39 Favored 'Trans proline' 0 CA--C 1.542 0.924 0 C-N-CA 122.476 2.118 . . . . 0.0 113.759 -179.972 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 72' ' ' PRO . . . . . 0.594 ' CD ' ' N ' ' A' ' 71' ' ' PRO . 53.9 Cg_endo -75.09 -25.8 11.38 Favored 'Trans proline' 0 C--N 1.352 0.759 0 C-N-CA 121.404 1.403 . . . . 0.0 111.823 -179.851 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 73' ' ' ARG . . . . . 0.431 ' O ' ' HB2' ' A' ' 74' ' ' ASN . 97.8 mtt180 -110.1 0.12 18.21 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.222 -0.924 . . . . 0.0 109.63 -179.918 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 74' ' ' ASN . . . . . 0.431 ' HB2' ' O ' ' A' ' 73' ' ' ARG . 79.1 m-20 61.03 46.28 8.45 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.19 -0.944 . . . . 0.0 109.589 179.9 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 75' ' ' CYS . . . . . 0.442 ' HA ' ' O ' ' A' ' 44' ' ' VAL . 23.9 p -146.68 133.72 20.34 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.212 -0.93 . . . . 0.0 109.51 179.987 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 76' ' ' ALA . . . . . 0.439 ' HA ' ' HA ' ' A' ' 69' ' ' MET . . . -106.35 161.28 14.7 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.282 -0.886 . . . . 0.0 109.488 179.932 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 77' ' ' PHE . . . . . 0.468 ' HB2' ' HB3' ' A' ' 68' ' ' SER . 98.5 m-85 -126.89 132.66 50.86 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.305 -0.872 . . . . 0.0 109.461 -179.979 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . 0.484 ' O ' ' N ' ' A' ' 42' ' ' LEU . 40.8 t -128.65 131.89 68.24 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 O-C-N 121.215 -0.928 . . . . 0.0 109.477 179.935 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 79' ' ' THR . . . . . 0.588 ' O ' HG23 ' A' ' 64' ' ' ILE . 7.0 m -104.38 139.39 39.4 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.228 -0.92 . . . . 0.0 109.429 -179.919 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 80' ' ' TYR . . . . . 0.56 ' HD2' HD11 ' A' ' 42' ' ' LEU . 0.8 OUTLIER -118.25 134.57 54.9 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.302 -0.874 . . . . 0.0 109.48 179.942 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 80.2 tt0 -52.35 -34.46 47.6 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.257 -0.902 . . . . 0.0 109.408 179.896 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 42.5 mtmt -128.55 142.17 51.14 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.277 -0.889 . . . . 0.0 109.524 179.9 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 83' ' ' MET . . . . . . . . . . . . . 31.3 mtm -62.56 -25.45 68.07 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.258 -0.901 . . . . 0.0 109.555 -179.946 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 96.9 mt-10 -62.59 -39.89 95.17 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.27 -0.894 . . . . 0.0 109.55 -179.949 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 16.0 m -63.89 -34.21 77.43 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.225 -0.922 . . . . 0.0 109.636 179.978 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 86' ' ' ALA . . . . . 0.469 ' CB ' HD21 ' A' ' 42' ' ' LEU . . . -72.39 -33.09 66.93 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.285 -0.884 . . . . 0.0 109.546 -179.966 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 22.2 t70 -65.11 -42.69 93.75 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.212 -0.93 . . . . 0.0 109.557 -179.947 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 64.6 tt0 -67.88 -36.77 80.84 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.223 -0.923 . . . . 0.0 109.579 -179.959 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 89' ' ' ALA . . . . . 0.587 ' HA ' ' CE2' ' A' ' 61' ' ' PHE . . . -76.69 -48.81 17.73 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.211 -0.931 . . . . 0.0 109.547 -179.944 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 90' ' ' VAL . . . . . 0.854 HG22 ' CG1' ' A' ' 105' ' ' VAL . 71.3 t -58.76 -29.21 39.52 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.524 0 O-C-N 121.22 -0.925 . . . . 0.0 109.455 -179.933 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -80.03 -54.18 6.03 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.248 -0.907 . . . . 0.0 109.758 -179.92 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 92' ' ' GLU . . . . . 0.506 ' HB2' ' CE2' ' A' ' 61' ' ' PHE . 91.0 mt-10 -71.21 -40.75 70.96 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.288 -0.882 . . . . 0.0 109.879 -179.597 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 93' ' ' LEU . . . . . 0.775 ' O ' HG23 ' A' ' 96' ' ' THR . 28.2 mt -68.56 -42.18 78.71 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.141 -0.974 . . . . 0.0 109.558 -179.828 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 94' ' ' ASN . . . . . 0.515 ' CB ' ' O ' ' A' ' 90' ' ' VAL . 60.6 t-20 -63.79 131.24 47.21 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.255 -0.903 . . . . 0.0 109.565 -179.965 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 86.66 35.21 10.49 Favored Glycine 0 N--CA 1.49 2.291 0 N-CA-C 109.513 -1.435 . . . . 0.0 109.513 -179.968 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 96' ' ' THR . . . . . 0.775 HG23 ' O ' ' A' ' 93' ' ' LEU . 22.0 p -124.21 160.36 28.08 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.221 -1.164 . . . . 0.0 109.367 179.952 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 97' ' ' GLN . . . . . 0.421 ' HG2' ' N ' ' A' ' 98' ' ' VAL . 62.3 tt0 -128.25 154.81 45.46 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.238 -0.914 . . . . 0.0 109.471 -179.942 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 98' ' ' VAL . . . . . 0.57 HG12 ' H ' ' A' ' 99' ' ' GLU . 1.2 t -106.19 -155.13 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.566 0 O-C-N 121.212 -0.93 . . . . 0.0 109.336 -179.978 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 99' ' ' GLU . . . . . 0.57 ' H ' HG12 ' A' ' 98' ' ' VAL . 96.2 mt-10 -56.76 -36.98 70.44 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.119 -0.988 . . . . 0.0 109.481 -179.943 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 20.9 t -160.95 23.28 0.14 Allowed 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.224 -0.923 . . . . 0.0 109.596 -179.953 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 101' ' ' VAL . . . . . 0.534 ' O ' HG23 ' A' ' 98' ' ' VAL . 48.7 t -138.57 154.29 26.86 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.547 0 O-C-N 121.214 -0.929 . . . . 0.0 109.558 -180.0 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 92.2 mt-30 -99.63 148.35 24.42 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.278 -0.889 . . . . 0.0 109.306 179.935 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 103' ' ' LEU . . . . . 0.421 HD23 ' HA ' ' A' ' 103' ' ' LEU . 91.9 mt -109.04 137.05 47.55 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.184 -0.947 . . . . 0.0 109.625 -179.905 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 104' ' ' LYS . . . . . 0.476 ' HB2' ' HB3' ' A' ' 45' ' ' TYR . 3.1 mtpm? -122.98 139.24 54.28 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.312 -0.868 . . . . 0.0 109.327 179.927 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 105' ' ' VAL . . . . . 0.854 ' CG1' HG22 ' A' ' 90' ' ' VAL . 25.8 t . . . . . 0 N--CA 1.489 1.519 0 O-C-N 121.207 -0.933 . . . . 0.0 109.559 -179.968 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 40' ' ' ASN . . . . . 0.52 ' N ' ' O ' ' A' ' 80' ' ' TYR . 42.3 t30 . . . . . 0 N--CA 1.489 1.525 0 N-CA-C 109.139 -0.689 . . . . 0.0 109.139 . . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 41' ' ' THR . . . . . 0.51 ' O ' HD23 ' A' ' 42' ' ' LEU . 8.2 m -63.88 134.01 54.36 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.315 -0.866 . . . . 0.0 109.986 -179.518 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . 0.87 HD11 ' HD2' ' A' ' 80' ' ' TYR . 20.4 mt -120.21 155.6 32.83 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.424 -0.797 . . . . 0.0 109.314 179.702 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 43' ' ' TYR . . . . . 0.455 ' O ' ' HA ' ' A' ' 105' ' ' VAL . 69.9 t80 -109.59 127.24 54.37 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.179 -0.951 . . . . 0.0 109.468 179.965 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 46.7 t -126.66 136.22 61.43 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.544 0 O-C-N 121.153 -0.967 . . . . 0.0 109.4 179.935 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 45' ' ' TYR . . . . . 0.486 ' HB3' ' HB2' ' A' ' 104' ' ' LYS . 65.6 t80 -127.53 136.43 51.71 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.292 -0.88 . . . . 0.0 109.596 -179.84 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -173.54 -163.88 27.85 Favored Glycine 0 N--CA 1.49 2.27 0 N-CA-C 109.374 -1.49 . . . . 0.0 109.374 179.988 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . 0.426 ' O ' ' C ' ' A' ' 48' ' ' ASP . 89.5 mt-10 -120.96 147.25 45.72 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.163 -1.199 . . . . 0.0 109.512 179.947 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 48' ' ' ASP . . . . . 0.426 ' C ' ' O ' ' A' ' 47' ' ' GLU . 47.0 m-20 43.49 54.18 5.42 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.227 -0.921 . . . . 0.0 109.477 179.966 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 54.4 mtm -97.34 136.1 38.3 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.318 -0.864 . . . . 0.0 109.607 -179.889 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 50' ' ' THR . . . . . 0.863 ' O ' HD12 ' A' ' 54' ' ' LEU . 0.0 OUTLIER -118.61 161.95 33.1 Favored Pre-proline 0 N--CA 1.49 1.548 0 O-C-N 121.258 -0.902 . . . . 0.0 109.49 179.927 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 51' ' ' PRO . . . . . 0.671 ' HD2' HG22 ' A' ' 50' ' ' THR . 48.1 Cg_endo -69.85 -50.19 0.48 Allowed 'Trans proline' 0 C--O 1.214 -0.683 0 C-N-CA 122.724 2.282 . . . . 0.0 111.731 -179.914 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 50.7 m -52.91 -47.43 67.99 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.228 -0.92 . . . . 0.0 109.311 179.904 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 10.8 tp -61.85 -57.2 12.74 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.402 -0.811 . . . . 0.0 109.25 179.788 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 54' ' ' LEU . . . . . 0.863 HD12 ' O ' ' A' ' 50' ' ' THR . 4.4 mt -53.63 -49.66 67.4 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.284 -0.885 . . . . 0.0 109.219 179.758 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 55' ' ' ARG . . . . . 0.435 ' C ' ' O ' ' A' ' 54' ' ' LEU . 77.7 ttt180 -43.66 -44.72 6.58 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.294 -0.879 . . . . 0.0 109.201 179.87 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -68.79 -33.3 75.28 Favored Glycine 0 N--CA 1.489 2.219 0 N-CA-C 109.159 -1.577 . . . . 0.0 109.159 179.737 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . 0.443 ' N ' ' O ' ' A' ' 54' ' ' LEU . . . -72.55 -20.11 61.39 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.353 -1.087 . . . . 0.0 109.297 179.935 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 58' ' ' PHE . . . . . 0.712 ' CZ ' HD13 ' A' ' 93' ' ' LEU . 95.2 m-85 -117.98 7.94 12.41 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.301 -0.875 . . . . 0.0 109.324 179.856 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 59' ' ' SER . . . . . 0.586 ' N ' ' HD2' ' A' ' 60' ' ' PRO . 0.5 OUTLIER -76.68 -50.1 2.6 Favored Pre-proline 0 N--CA 1.49 1.562 0 O-C-N 121.243 -0.91 . . . . 0.0 110.577 -179.644 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 60' ' ' PRO . . . . . 0.586 ' HD2' ' N ' ' A' ' 59' ' ' SER . 49.9 Cg_endo -70.72 -33.79 12.4 Favored 'Trans proline' 0 C--O 1.215 -0.654 0 C-N-CA 122.215 1.943 . . . . 0.0 112.454 -179.15 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 61' ' ' PHE . . . . . 0.584 ' CE1' ' HA ' ' A' ' 89' ' ' ALA . 77.4 m-85 -61.74 -43.96 97.83 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.042 -1.036 . . . . 0.0 109.516 -179.983 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . 0.42 ' HA3' ' OG ' ' A' ' 85' ' ' SER . . . -174.44 -168.29 35.03 Favored Glycine 0 N--CA 1.491 2.315 0 N-CA-C 109.464 -1.455 . . . . 0.0 109.464 -179.965 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 86.6 m-20 -98.1 143.5 28.58 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.235 -1.156 . . . . 0.0 109.409 -179.981 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 64' ' ' ILE . . . . . 0.482 HD11 ' HB2' ' A' ' 58' ' ' PHE . 37.8 mt -105.02 129.65 57.35 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.511 0 O-C-N 121.239 -0.913 . . . . 0.0 109.544 -179.904 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 21.3 pt -96.68 -21.58 5.35 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.602 0 O-C-N 121.324 -0.86 . . . . 0.0 109.614 -179.903 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 66' ' ' ASP . . . . . 0.451 ' HB3' ' OG1' ' A' ' 79' ' ' THR . 57.7 t0 -144.87 109.79 5.07 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.187 -0.946 . . . . 0.0 109.56 179.99 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 15.1 tp -108.07 121.48 44.91 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.301 -0.874 . . . . 0.0 109.437 179.979 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 68' ' ' SER . . . . . 0.473 ' HB3' ' HB2' ' A' ' 77' ' ' PHE . 22.7 t -131.09 139.04 49.81 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.281 -0.887 . . . . 0.0 109.421 -179.942 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 69' ' ' MET . . . . . 0.7 ' HE1' ' CD1' ' A' ' 54' ' ' LEU . 94.9 mmm -114.82 150.87 34.8 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.187 -0.946 . . . . 0.0 109.522 179.998 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 70' ' ' ASP . . . . . 0.477 ' C ' ' HD2' ' A' ' 72' ' ' PRO . 6.1 t0 -132.24 95.97 20.39 Favored Pre-proline 0 N--CA 1.49 1.542 0 O-C-N 121.222 -0.924 . . . . 0.0 109.516 -179.967 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 71' ' ' PRO . . . . . 0.592 ' N ' ' CD ' ' A' ' 72' ' ' PRO . 47.9 Cg_endo -74.81 -27.83 10.05 Favored 'Trans proline' 0 CA--C 1.543 0.956 0 C-N-CA 122.451 2.101 . . . . 0.0 113.623 -179.881 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 72' ' ' PRO . . . . . 0.592 ' CD ' ' N ' ' A' ' 71' ' ' PRO . 55.2 Cg_endo -75.13 -26.5 10.65 Favored 'Trans proline' 0 C--N 1.353 0.769 0 C-N-CA 121.51 1.473 . . . . 0.0 111.825 -179.848 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 73' ' ' ARG . . . . . 0.448 ' O ' ' HB2' ' A' ' 74' ' ' ASN . 77.7 mtt85 -109.24 -1.9 18.31 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.208 -0.932 . . . . 0.0 109.67 -179.841 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 74' ' ' ASN . . . . . 0.448 ' HB2' ' O ' ' A' ' 73' ' ' ARG . 78.4 m-20 61.89 43.12 9.59 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.159 -0.963 . . . . 0.0 109.599 179.97 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 75' ' ' CYS . . . . . 0.459 ' O ' ' CB ' ' A' ' 70' ' ' ASP . 28.4 p -146.52 141.9 27.5 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.277 -0.89 . . . . 0.0 109.47 179.941 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 76' ' ' ALA . . . . . 0.458 ' HB1' ' SD ' ' A' ' 69' ' ' MET . . . -114.11 161.88 17.2 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.214 -0.929 . . . . 0.0 109.56 -179.906 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 77' ' ' PHE . . . . . 0.473 ' HB2' ' HB3' ' A' ' 68' ' ' SER . 97.4 m-85 -123.77 130.94 53.41 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.24 -0.912 . . . . 0.0 109.385 -179.931 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . 0.505 ' O ' ' N ' ' A' ' 42' ' ' LEU . 39.2 t -128.62 132.12 68.08 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.597 0 O-C-N 121.185 -0.947 . . . . 0.0 109.592 -179.938 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 79' ' ' THR . . . . . 0.473 ' O ' ' HA ' ' A' ' 64' ' ' ILE . 7.1 m -106.74 123.15 47.72 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.203 -0.935 . . . . 0.0 109.612 179.928 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 80' ' ' TYR . . . . . 0.87 ' HD2' HD11 ' A' ' 42' ' ' LEU . 1.7 m-85 -101.94 126.45 48.85 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.261 -0.9 . . . . 0.0 109.299 179.879 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 81' ' ' GLU . . . . . 0.434 ' C ' ' O ' ' A' ' 80' ' ' TYR . 86.9 tt0 -42.89 -48.27 5.78 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.244 -0.91 . . . . 0.0 109.658 -179.758 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 29.8 mttt -110.96 153.84 24.97 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.184 -0.947 . . . . 0.0 109.526 179.972 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 83' ' ' MET . . . . . . . . . . . . . 58.8 mtt -73.05 -16.66 61.48 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.315 -0.865 . . . . 0.0 109.424 -179.939 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 75.6 mm-40 -71.92 -41.04 68.36 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.269 -0.894 . . . . 0.0 109.443 179.965 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 85' ' ' SER . . . . . 0.449 ' OG ' ' CD1' ' A' ' 80' ' ' TYR . 14.3 t -58.9 -39.67 82.18 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.219 -0.925 . . . . 0.0 109.34 179.907 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 86' ' ' ALA . . . . . 0.519 ' CB ' HD21 ' A' ' 42' ' ' LEU . . . -67.9 -37.76 82.13 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.374 -0.829 . . . . 0.0 109.446 179.956 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 56.6 t0 -60.13 -41.25 92.26 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.267 -0.896 . . . . 0.0 109.594 -179.971 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 88' ' ' GLN . . . . . 0.442 ' O ' ' CB ' ' A' ' 92' ' ' GLU . 60.5 tt0 -74.63 -41.98 59.38 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.189 -0.945 . . . . 0.0 109.441 179.975 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 89' ' ' ALA . . . . . 0.584 ' HA ' ' CE1' ' A' ' 61' ' ' PHE . . . -69.76 -46.98 64.63 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.222 -0.924 . . . . 0.0 109.446 -179.983 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 90' ' ' VAL . . . . . 0.719 HG22 HG21 ' A' ' 105' ' ' VAL . 48.4 t -64.93 -54.47 29.27 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.535 0 O-C-N 121.205 -0.935 . . . . 0.0 109.615 -179.926 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -61.53 -40.3 94.15 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.176 -0.952 . . . . 0.0 109.855 -179.671 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 92' ' ' GLU . . . . . 0.546 ' HB3' ' CE1' ' A' ' 61' ' ' PHE . 47.5 tp10 -77.73 -46.2 22.48 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.223 -0.923 . . . . 0.0 109.887 -179.672 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 93' ' ' LEU . . . . . 0.712 HD13 ' CZ ' ' A' ' 58' ' ' PHE . 49.8 mt -67.69 -37.84 82.85 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.157 -0.964 . . . . 0.0 109.643 -179.809 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 94' ' ' ASN . . . . . 0.572 ' HB2' ' CG1' ' A' ' 105' ' ' VAL . 50.5 t-20 -61.64 139.35 58.3 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.298 -0.876 . . . . 0.0 109.562 -179.856 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 73.95 30.4 61.41 Favored Glycine 0 N--CA 1.49 2.269 0 N-CA-C 109.482 -1.447 . . . . 0.0 109.482 179.972 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 96' ' ' THR . . . . . 0.699 HG23 ' O ' ' A' ' 93' ' ' LEU . 24.5 p -121.18 146.41 46.8 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.275 -1.132 . . . . 0.0 109.42 -179.97 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 97' ' ' GLN . . . . . 0.446 ' HG3' ' O ' ' A' ' 101' ' ' VAL . 63.5 tt0 -116.58 137.08 52.45 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.261 -0.9 . . . . 0.0 109.522 179.982 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 98' ' ' VAL . . . . . 0.489 HG12 ' H ' ' A' ' 99' ' ' GLU . 1.3 t -83.01 -148.53 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.569 0 O-C-N 121.252 -0.905 . . . . 0.0 109.319 -179.976 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 99' ' ' GLU . . . . . 0.489 ' H ' HG12 ' A' ' 98' ' ' VAL . 95.8 mt-10 -59.33 -36.16 75.16 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.172 -0.955 . . . . 0.0 109.444 -179.995 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -161.13 23.53 0.13 Allowed 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.275 -0.891 . . . . 0.0 109.564 179.89 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 101' ' ' VAL . . . . . 0.465 HG12 ' N ' ' A' ' 102' ' ' GLN . 95.1 t -134.75 158.05 41.37 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.569 0 O-C-N 121.197 -0.939 . . . . 0.0 109.454 179.895 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 102' ' ' GLN . . . . . 0.465 ' N ' HG12 ' A' ' 101' ' ' VAL . 88.2 mt-30 -102.13 161.24 13.84 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.227 -0.921 . . . . 0.0 109.48 -179.988 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 103' ' ' LEU . . . . . 0.689 HD12 ' OG1' ' A' ' 96' ' ' THR . 49.3 mt -114.73 134.27 55.23 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.263 -0.898 . . . . 0.0 109.634 -179.865 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 104' ' ' LYS . . . . . 0.486 ' HB2' ' HB3' ' A' ' 45' ' ' TYR . 63.4 mttm -126.75 94.4 4.03 Favored 'General case' 0 N--CA 1.489 1.504 0 N-CA-C 108.737 -0.838 . . . . 0.0 108.737 179.746 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 105' ' ' VAL . . . . . 0.719 HG21 HG22 ' A' ' 90' ' ' VAL . 9.7 p . . . . . 0 C--N 1.301 -1.51 0 O-C-N 121.444 -0.785 . . . . 0.0 109.963 -179.421 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 40' ' ' ASN . . . . . 0.48 ' N ' ' O ' ' A' ' 80' ' ' TYR . 42.7 t30 . . . . . 0 N--CA 1.489 1.513 0 N-CA-C 109.063 -0.717 . . . . 0.0 109.063 . . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 41' ' ' THR . . . . . 0.475 ' HA ' ' O ' ' A' ' 78' ' ' VAL . 54.0 m -75.58 150.51 38.05 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.176 -0.953 . . . . 0.0 109.879 -179.656 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . 0.856 HD12 ' O ' ' A' ' 78' ' ' VAL . 4.7 mp -126.56 147.25 49.89 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.331 -0.855 . . . . 0.0 109.386 179.806 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 76.4 t80 -102.5 115.43 30.57 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.246 -0.909 . . . . 0.0 109.42 179.961 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 44' ' ' VAL . . . . . 0.454 ' HA ' ' O ' ' A' ' 104' ' ' LYS . 41.1 t -113.5 143.92 22.21 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.558 0 O-C-N 121.296 -0.878 . . . . 0.0 109.396 179.832 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 45' ' ' TYR . . . . . 0.424 ' HB3' ' HB2' ' A' ' 104' ' ' LYS . 71.5 t80 -136.2 143.33 44.32 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.224 -0.923 . . . . 0.0 109.544 -179.959 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . 0.449 ' N ' ' SD ' ' A' ' 49' ' ' MET . . . 167.24 -175.06 42.45 Favored Glycine 0 N--CA 1.491 2.3 0 N-CA-C 109.506 -1.438 . . . . 0.0 109.506 179.98 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . 0.407 ' O ' ' C ' ' A' ' 48' ' ' ASP . 91.7 mt-10 -107.89 158.54 17.25 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.286 -1.126 . . . . 0.0 109.522 179.998 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 48' ' ' ASP . . . . . 0.407 ' C ' ' O ' ' A' ' 47' ' ' GLU . 44.9 m-20 43.93 45.97 6.63 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.266 -0.897 . . . . 0.0 109.457 -179.991 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 49' ' ' MET . . . . . 0.449 ' SD ' ' N ' ' A' ' 46' ' ' GLY . 23.4 mtp -85.42 132.32 34.24 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.237 -0.914 . . . . 0.0 109.449 179.942 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 50' ' ' THR . . . . . 0.769 ' O ' HD12 ' A' ' 54' ' ' LEU . 0.6 OUTLIER -121.4 159.77 48.74 Favored Pre-proline 0 N--CA 1.49 1.528 0 O-C-N 121.278 -0.889 . . . . 0.0 109.362 179.83 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 50.2 Cg_endo -70.3 -42.73 2.63 Favored 'Trans proline' 0 C--O 1.214 -0.692 0 C-N-CA 122.574 2.183 . . . . 0.0 111.6 -179.972 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 58.4 m -64.83 -47.4 78.12 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.308 -0.87 . . . . 0.0 109.255 179.721 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 14.3 tp -57.15 -52.06 66.83 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.322 -0.861 . . . . 0.0 109.276 179.818 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 54' ' ' LEU . . . . . 0.769 HD12 ' O ' ' A' ' 50' ' ' THR . 5.8 mt -57.85 -45.88 85.61 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.344 -0.847 . . . . 0.0 109.225 179.713 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 55' ' ' ARG . . . . . 0.495 ' O ' ' CB ' ' A' ' 59' ' ' SER . 24.1 ttt-85 -48.86 -36.18 16.37 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.275 -0.89 . . . . 0.0 109.299 179.757 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -72.95 -36.16 57.51 Favored Glycine 0 N--CA 1.489 2.211 0 N-CA-C 109.422 -1.471 . . . . 0.0 109.422 179.847 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -71.65 -27.16 62.88 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.238 -1.154 . . . . 0.0 109.302 179.923 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 58' ' ' PHE . . . . . 0.679 ' CE2' HD12 ' A' ' 93' ' ' LEU . 58.2 m-85 -113.58 8.9 17.83 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.356 -0.84 . . . . 0.0 109.399 179.96 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 59' ' ' SER . . . . . 0.514 ' N ' ' HD2' ' A' ' 60' ' ' PRO . 0.6 OUTLIER -74.59 -58.84 1.67 Allowed Pre-proline 0 N--CA 1.491 1.588 0 O-C-N 121.288 -0.883 . . . . 0.0 109.958 -179.627 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 60' ' ' PRO . . . . . 0.514 ' HD2' ' N ' ' A' ' 59' ' ' SER . 48.6 Cg_endo -68.94 -27.59 30.26 Favored 'Trans proline' 0 C--O 1.215 -0.639 0 C-N-CA 122.681 2.254 . . . . 0.0 112.068 -179.6 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 61' ' ' PHE . . . . . 0.583 ' CE2' ' HB2' ' A' ' 92' ' ' GLU . 46.2 m-85 -67.17 -33.63 75.82 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.113 -0.992 . . . . 0.0 109.516 -179.966 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . 0.442 ' HA3' ' OG ' ' A' ' 85' ' ' SER . . . 178.92 -175.08 47.09 Favored Glycine 0 N--CA 1.491 2.317 0 N-CA-C 109.491 -1.444 . . . . 0.0 109.491 -179.974 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 81.7 m-20 -94.44 139.39 31.19 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.313 -1.11 . . . . 0.0 109.468 179.941 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 64' ' ' ILE . . . . . 0.457 ' HA ' ' O ' ' A' ' 79' ' ' THR . 63.7 mt -102.3 130.43 52.18 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.522 0 O-C-N 121.244 -0.91 . . . . 0.0 109.551 -179.92 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 19.0 pt -95.94 -18.86 6.44 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.617 0 O-C-N 121.247 -0.908 . . . . 0.0 109.521 -179.989 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 66' ' ' ASP . . . . . 0.474 ' HB3' ' OG1' ' A' ' 79' ' ' THR . 52.1 t0 -145.57 144.46 30.51 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.227 -0.921 . . . . 0.0 109.585 179.904 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . 0.703 ' C ' HD13 ' A' ' 67' ' ' LEU . 2.5 tm? -126.09 110.45 13.54 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.303 -0.873 . . . . 0.0 109.218 179.94 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 68' ' ' SER . . . . . 0.519 ' N ' HD13 ' A' ' 67' ' ' LEU . 3.1 m -118.25 134.92 54.6 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.288 -0.883 . . . . 0.0 109.604 -179.73 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 69' ' ' MET . . . . . 0.499 ' SD ' ' HB1' ' A' ' 76' ' ' ALA . 77.7 mmm -120.57 146.47 46.3 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.33 -0.856 . . . . 0.0 109.327 179.86 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 70' ' ' ASP . . . . . 0.479 ' C ' ' HD2' ' A' ' 72' ' ' PRO . 0.1 OUTLIER -129.38 93.93 34.36 Favored Pre-proline 0 N--CA 1.491 1.582 0 O-C-N 121.147 -0.971 . . . . 0.0 109.491 -179.988 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 71' ' ' PRO . . . . . 0.593 ' N ' ' CD ' ' A' ' 72' ' ' PRO . 47.6 Cg_endo -74.93 -27.78 9.87 Favored 'Trans proline' 0 CA--C 1.543 0.936 0 C-N-CA 122.596 2.198 . . . . 0.0 113.738 179.968 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 72' ' ' PRO . . . . . 0.593 ' CD ' ' N ' ' A' ' 71' ' ' PRO . 55.2 Cg_endo -74.9 -21.5 16.03 Favored 'Trans proline' 0 C--N 1.353 0.804 0 C-N-CA 121.511 1.474 . . . . 0.0 111.86 -179.774 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 93.7 mtt-85 -115.31 4.29 14.4 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.243 -0.911 . . . . 0.0 109.591 -179.954 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 78.4 m-20 59.28 48.18 10.54 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.184 -0.948 . . . . 0.0 109.521 179.961 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 75' ' ' CYS . . . . . 0.472 ' O ' ' HB2' ' A' ' 70' ' ' ASP . 27.7 p -151.81 153.97 35.28 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.212 -0.93 . . . . 0.0 109.565 179.976 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 76' ' ' ALA . . . . . 0.499 ' HB1' ' SD ' ' A' ' 69' ' ' MET . . . -127.21 159.62 33.75 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.27 -0.894 . . . . 0.0 109.32 179.86 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 77' ' ' PHE . . . . . 0.48 ' HA ' ' O ' ' A' ' 42' ' ' LEU . 96.4 m-85 -125.19 126.21 44.86 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.255 -0.903 . . . . 0.0 109.571 -179.976 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . 0.856 ' O ' HD12 ' A' ' 42' ' ' LEU . 60.7 t -118.28 141.68 36.48 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.51 0 O-C-N 121.221 -0.924 . . . . 0.0 109.48 -179.984 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 79' ' ' THR . . . . . 0.478 ' HA ' ' O ' ' A' ' 40' ' ' ASN . 26.1 m -109.1 127.85 54.5 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.275 -0.891 . . . . 0.0 109.495 179.836 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 80' ' ' TYR . . . . . 0.48 ' O ' ' N ' ' A' ' 40' ' ' ASN . 0.6 OUTLIER -103.76 148.93 25.5 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.337 -0.852 . . . . 0.0 109.511 -179.879 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 81.7 tt0 -75.11 -22.66 58.07 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.271 -0.893 . . . . 0.0 109.27 179.842 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 31.1 mttp -131.6 136.26 47.64 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.308 -0.87 . . . . 0.0 109.378 179.9 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 83' ' ' MET . . . . . . . . . . . . . 49.5 mtt -60.89 -17.29 49.78 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.211 -0.931 . . . . 0.0 109.464 -179.926 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 97.7 mt-10 -71.13 -42.18 69.53 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.244 -0.91 . . . . 0.0 109.512 179.992 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 85' ' ' SER . . . . . 0.442 ' OG ' ' HA3' ' A' ' 62' ' ' GLY . 44.0 t -60.27 -39.49 87.02 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.212 -0.93 . . . . 0.0 109.465 179.975 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 86' ' ' ALA . . . . . 0.636 ' HA ' HD21 ' A' ' 42' ' ' LEU . . . -64.19 -42.12 96.79 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.266 -0.896 . . . . 0.0 109.505 -179.99 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 57.0 t0 -65.7 -39.81 91.63 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.28 -0.888 . . . . 0.0 109.577 -179.942 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 88' ' ' GLN . . . . . 0.437 ' HG2' ' CD2' ' A' ' 61' ' ' PHE . 52.2 tt0 -69.28 -41.48 76.78 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.187 -0.946 . . . . 0.0 109.613 -179.928 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 89' ' ' ALA . . . . . 0.482 ' HA ' ' CD2' ' A' ' 61' ' ' PHE . . . -74.35 -43.14 57.85 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.247 -0.908 . . . . 0.0 109.618 -179.9 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 90' ' ' VAL . . . . . 0.783 HG22 HG12 ' A' ' 105' ' ' VAL . 54.2 t -60.21 -33.04 52.13 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 O-C-N 121.229 -0.919 . . . . 0.0 109.756 -179.785 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -80.37 -51.05 9.32 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.144 -0.973 . . . . 0.0 110.122 -179.61 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 92' ' ' GLU . . . . . 0.583 ' HB2' ' CE2' ' A' ' 61' ' ' PHE . 76.1 mm-40 -72.69 -43.72 62.7 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.184 -0.948 . . . . 0.0 110.116 -179.368 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 93' ' ' LEU . . . . . 0.91 ' HB2' HG21 ' A' ' 105' ' ' VAL . 24.3 mt -68.69 -36.07 78.02 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.168 -0.957 . . . . 0.0 109.898 -179.508 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 94' ' ' ASN . . . . . 0.53 ' CB ' ' O ' ' A' ' 90' ' ' VAL . 53.1 t-20 -76.73 130.8 38.22 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.142 -0.974 . . . . 0.0 109.417 -179.891 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 94.66 20.55 28.79 Favored Glycine 0 N--CA 1.491 2.314 0 N-CA-C 109.64 -1.384 . . . . 0.0 109.64 179.89 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 96' ' ' THR . . . . . 0.438 ' CG2' ' O ' ' A' ' 92' ' ' GLU . 19.4 p -118.52 156.4 29.18 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.148 -1.207 . . . . 0.0 109.483 179.928 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 64.4 tt0 -126.18 152.27 46.23 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.241 -0.912 . . . . 0.0 109.434 -179.965 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 98' ' ' VAL . . . . . 0.595 HG12 ' H ' ' A' ' 99' ' ' GLU . 1.0 OUTLIER -100.22 -158.18 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 O-C-N 121.292 -0.88 . . . . 0.0 109.359 -179.943 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 99' ' ' GLU . . . . . 0.595 ' H ' HG12 ' A' ' 98' ' ' VAL . 76.1 mm-40 -55.51 -39.5 70.57 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.245 -0.91 . . . . 0.0 109.535 179.984 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 31.0 t -159.66 28.29 0.19 Allowed 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.267 -0.896 . . . . 0.0 109.44 -179.947 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 101' ' ' VAL . . . . . 0.558 ' O ' HG23 ' A' ' 98' ' ' VAL . 60.7 t -140.17 148.19 22.8 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.543 0 O-C-N 121.258 -0.901 . . . . 0.0 109.471 179.971 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 90.9 mt-30 -95.51 143.36 26.89 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.239 -0.913 . . . . 0.0 109.529 -179.911 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 103' ' ' LEU . . . . . 0.426 ' HA ' HD23 ' A' ' 103' ' ' LEU . 82.3 mt -109.7 136.48 48.97 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.284 -0.885 . . . . 0.0 109.404 179.926 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 104' ' ' LYS . . . . . 0.454 ' O ' ' HA ' ' A' ' 44' ' ' VAL . 42.9 mttt -126.05 128.82 48.0 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.182 -0.949 . . . . 0.0 109.509 -179.952 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 105' ' ' VAL . . . . . 0.91 HG21 ' HB2' ' A' ' 93' ' ' LEU . 21.4 t . . . . . 0 N--CA 1.489 1.52 0 O-C-N 121.233 -0.917 . . . . 0.0 109.34 179.9 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.56 0 N-CA-C 109.459 -0.571 . . . . 0.0 109.459 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 49.4 Cg_endo -69.92 -16.34 36.85 Favored 'Trans proline' 0 C--O 1.214 -0.696 0 C-N-CA 122.672 2.248 . . . . 0.0 111.928 -179.956 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 37' ' ' ARG . . . . . 0.468 ' O ' ' HG ' ' A' ' 114' ' ' LEU . 52.3 mtt180 -127.55 147.94 50.34 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.192 -0.943 . . . . 0.0 109.587 -179.935 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 38' ' ' LYS . . . . . 0.519 ' O ' ' CD1' ' A' ' 65' ' ' ILE . 94.9 mttt -150.22 -169.18 3.31 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.315 -0.865 . . . . 0.0 109.302 179.945 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . 0.81 ' HA3' HD11 ' A' ' 65' ' ' ILE . . . 150.99 86.62 0.06 OUTLIER Glycine 0 N--CA 1.49 2.245 0 N-CA-C 109.683 -1.367 . . . . 0.0 109.683 179.9 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 40.8 t-20 -89.19 102.0 14.66 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.238 -1.154 . . . . 0.0 109.423 179.807 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 41' ' ' THR . . . . . 0.472 ' OG1' ' HB2' ' A' ' 111' ' ' GLN . 53.2 m -69.54 134.35 48.73 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.27 -0.894 . . . . 0.0 109.595 -179.861 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . 0.695 HD11 ' CD2' ' A' ' 80' ' ' TYR . 16.6 mt -115.63 146.78 41.49 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.252 -0.905 . . . . 0.0 109.372 179.97 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 43' ' ' TYR . . . . . 0.455 ' O ' ' HA ' ' A' ' 105' ' ' VAL . 74.4 t80 -97.33 124.08 41.35 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.246 -0.908 . . . . 0.0 109.551 -179.977 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . 0.623 HG13 HD23 ' A' ' 103' ' ' LEU . 53.4 t -120.84 134.49 64.09 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.558 0 O-C-N 121.274 -0.891 . . . . 0.0 109.401 179.897 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 76.3 t80 -124.25 137.21 54.54 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.241 -0.912 . . . . 0.0 109.524 -179.876 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -178.23 -177.5 46.99 Favored Glycine 0 N--CA 1.491 2.302 0 N-CA-C 109.465 -1.454 . . . . 0.0 109.465 -179.989 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . 0.422 ' O ' ' C ' ' A' ' 48' ' ' ASP . 95.2 mt-10 -118.68 155.25 31.37 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.272 -1.134 . . . . 0.0 109.482 179.957 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . 0.422 ' C ' ' O ' ' A' ' 47' ' ' GLU . 47.6 m-20 43.89 48.01 7.02 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.282 -0.886 . . . . 0.0 109.54 179.961 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 58.5 mtm -93.26 143.31 26.38 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.208 -0.932 . . . . 0.0 109.509 179.954 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 50' ' ' THR . . . . . 0.786 ' O ' HD12 ' A' ' 54' ' ' LEU . 0.1 OUTLIER -118.42 166.29 14.25 Favored Pre-proline 0 N--CA 1.491 1.577 0 O-C-N 121.236 -0.915 . . . . 0.0 109.421 179.98 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 49.6 Cg_endo -70.02 -50.47 0.43 Allowed 'Trans proline' 0 C--O 1.214 -0.678 0 C-N-CA 122.713 2.275 . . . . 0.0 111.819 -179.916 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 39.8 m -58.55 -42.16 87.23 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.243 -0.911 . . . . 0.0 109.516 179.976 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 15.2 tp -61.31 -50.86 71.26 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.253 -0.905 . . . . 0.0 109.481 179.986 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 54' ' ' LEU . . . . . 0.786 HD12 ' O ' ' A' ' 50' ' ' THR . 4.2 mt -59.92 -42.75 94.58 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.232 -0.917 . . . . 0.0 109.442 179.954 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 55' ' ' ARG . . . . . 0.457 ' O ' ' CB ' ' A' ' 59' ' ' SER . 48.7 ttt85 -57.19 -32.93 66.95 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.217 -0.927 . . . . 0.0 109.433 179.908 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -76.21 -33.09 50.33 Favored Glycine 0 N--CA 1.49 2.259 0 N-CA-C 109.403 -1.479 . . . . 0.0 109.403 180.0 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . 0.551 ' O ' ' CD1' ' A' ' 61' ' ' PHE . . . -73.14 -19.75 61.06 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.314 -1.11 . . . . 0.0 109.411 -179.998 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 58' ' ' PHE . . . . . 0.694 ' CZ ' HD13 ' A' ' 93' ' ' LEU . 96.7 m-85 -121.62 4.37 10.1 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.211 -0.931 . . . . 0.0 109.482 179.914 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 59' ' ' SER . . . . . 0.534 ' N ' ' HD2' ' A' ' 60' ' ' PRO . 0.3 OUTLIER -72.21 -57.31 3.78 Favored Pre-proline 0 N--CA 1.49 1.546 0 O-C-N 121.215 -0.928 . . . . 0.0 109.762 -179.859 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 60' ' ' PRO . . . . . 0.534 ' HD2' ' N ' ' A' ' 59' ' ' SER . 48.9 Cg_endo -69.52 -30.93 22.59 Favored 'Trans proline' 0 C--O 1.214 -0.678 0 C-N-CA 122.637 2.225 . . . . 0.0 111.94 -179.818 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 61' ' ' PHE . . . . . 0.569 ' CD2' ' HA ' ' A' ' 89' ' ' ALA . 62.6 m-85 -62.92 -33.01 74.42 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.241 -0.912 . . . . 0.0 109.455 179.974 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 173.39 -175.47 46.16 Favored Glycine 0 N--CA 1.49 2.264 0 N-CA-C 109.411 -1.476 . . . . 0.0 109.411 179.985 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 38.7 t30 -92.22 141.4 28.62 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.266 -1.138 . . . . 0.0 109.506 179.961 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 64' ' ' ILE . . . . . 0.575 HD13 HD13 ' A' ' 67' ' ' LEU . 71.4 mt -103.83 130.04 54.99 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.521 0 O-C-N 121.246 -0.909 . . . . 0.0 109.432 179.98 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 65' ' ' ILE . . . . . 0.81 HD11 ' HA3' ' A' ' 39' ' ' GLY . 20.6 pt -94.54 -21.95 5.63 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.537 0 O-C-N 121.252 -0.905 . . . . 0.0 109.475 179.983 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 45.7 t0 -159.26 109.43 1.95 Allowed 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.277 -0.89 . . . . 0.0 109.508 -179.969 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . 0.964 HD11 HG22 ' A' ' 78' ' ' VAL . 0.6 OUTLIER -111.96 122.34 47.51 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.259 -0.901 . . . . 0.0 109.367 179.937 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 38.1 m -117.94 150.78 38.66 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.235 -0.915 . . . . 0.0 109.637 -179.917 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 69' ' ' MET . . . . . 0.403 ' CE ' ' CD1' ' A' ' 54' ' ' LEU . 85.6 mtp -123.74 143.59 50.2 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.229 -0.919 . . . . 0.0 109.408 179.926 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 70' ' ' ASP . . . . . 0.476 ' C ' ' HD2' ' A' ' 72' ' ' PRO . 1.7 m-20 -122.31 105.88 36.2 Favored Pre-proline 0 N--CA 1.491 1.615 0 O-C-N 121.268 -0.895 . . . . 0.0 109.493 -179.976 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 71' ' ' PRO . . . . . 0.606 ' N ' ' CD ' ' A' ' 72' ' ' PRO . 47.1 Cg_endo -74.54 -27.9 10.52 Favored 'Trans proline' 0 CA--C 1.543 0.941 0 C-N-CA 122.511 2.141 . . . . 0.0 113.686 179.99 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 72' ' ' PRO . . . . . 0.606 ' CD ' ' N ' ' A' ' 71' ' ' PRO . 55.1 Cg_endo -75.41 -29.11 7.93 Favored 'Trans proline' 0 C--N 1.353 0.793 0 C-N-CA 121.511 1.474 . . . . 0.0 111.733 -179.794 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 73' ' ' ARG . . . . . 0.432 ' O ' ' HB2' ' A' ' 74' ' ' ASN . 61.8 mtt-85 -107.89 -4.22 18.18 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.267 -0.896 . . . . 0.0 109.622 -179.919 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 74' ' ' ASN . . . . . 0.432 ' HB2' ' O ' ' A' ' 73' ' ' ARG . 84.5 m-20 61.7 36.41 16.46 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.231 -0.918 . . . . 0.0 109.493 -179.967 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 75' ' ' CYS . . . . . 0.465 ' SG ' ' HB2' ' A' ' 70' ' ' ASP . 21.9 p -130.85 137.09 49.22 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.266 -0.896 . . . . 0.0 109.477 -180.0 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -110.28 148.3 32.17 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.264 -0.897 . . . . 0.0 109.421 179.998 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 77' ' ' PHE . . . . . 0.465 ' HA ' ' O ' ' A' ' 42' ' ' LEU . 96.9 m-85 -114.2 132.08 56.24 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.214 -0.929 . . . . 0.0 109.528 179.989 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . 0.964 HG22 HD11 ' A' ' 67' ' ' LEU . 39.5 t -123.13 128.9 75.2 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 O-C-N 121.239 -0.913 . . . . 0.0 109.474 179.966 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 79' ' ' THR . . . . . 0.634 HG22 ' HA2' ' A' ' 39' ' ' GLY . 17.5 m -101.18 132.2 46.78 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.245 -0.91 . . . . 0.0 109.437 -179.994 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 80' ' ' TYR . . . . . 0.695 ' CD2' HD11 ' A' ' 42' ' ' LEU . 1.5 m-85 -112.11 145.93 38.91 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.241 -0.912 . . . . 0.0 109.491 -179.942 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 81' ' ' GLU . . . . . 0.488 ' O ' ' CD ' ' A' ' 38' ' ' LYS . 83.4 tt0 -70.9 -28.97 64.93 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.21 -0.931 . . . . 0.0 109.423 179.817 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 44.2 mttm -124.58 145.99 49.29 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.301 -0.875 . . . . 0.0 109.391 179.956 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 83' ' ' MET . . . . . 0.674 ' HG3' ' HB3' ' A' ' 117' ' ' ALA . 44.1 mtt -64.62 -22.6 67.02 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.241 -0.912 . . . . 0.0 109.468 179.992 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 97.6 mt-10 -69.92 -37.68 76.01 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.204 -0.935 . . . . 0.0 109.525 -179.953 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 85' ' ' SER . . . . . 0.426 ' HB2' ' CG ' ' A' ' 80' ' ' TYR . 17.3 m -59.92 -34.11 72.77 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.271 -0.893 . . . . 0.0 109.489 179.995 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 86' ' ' ALA . . . . . 0.56 ' CB ' HD21 ' A' ' 42' ' ' LEU . . . -79.63 -28.64 40.89 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.266 -0.897 . . . . 0.0 109.518 -179.959 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 87' ' ' ASP . . . . . 0.425 ' O ' ' CB ' ' A' ' 91' ' ' ALA . 94.4 m-20 -67.11 -44.6 79.51 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.257 -0.902 . . . . 0.0 109.517 -179.923 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 88' ' ' GLN . . . . . 0.52 ' HG2' ' CE2' ' A' ' 61' ' ' PHE . 62.5 tt0 -72.16 -39.38 68.76 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.218 -0.926 . . . . 0.0 109.448 -179.942 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 89' ' ' ALA . . . . . 0.569 ' HA ' ' CD2' ' A' ' 61' ' ' PHE . . . -73.96 -45.71 48.53 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.243 -0.911 . . . . 0.0 109.552 -179.98 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 90' ' ' VAL . . . . . 0.698 HG22 HG11 ' A' ' 105' ' ' VAL . 65.7 t -69.75 -36.12 68.53 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.574 0 O-C-N 121.237 -0.915 . . . . 0.0 109.551 -179.935 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 91' ' ' ALA . . . . . 0.425 ' CB ' ' O ' ' A' ' 87' ' ' ASP . . . -79.02 -40.48 31.32 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.295 -0.878 . . . . 0.0 109.647 -179.866 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 92' ' ' GLU . . . . . 0.537 ' OE1' ' CE2' ' A' ' 61' ' ' PHE . 40.1 tt0 -77.29 -42.67 36.04 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.221 -0.924 . . . . 0.0 109.527 -179.866 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 93' ' ' LEU . . . . . 0.694 HD13 ' CZ ' ' A' ' 58' ' ' PHE . 51.2 mt -69.97 -40.87 75.11 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.226 -0.921 . . . . 0.0 109.502 -179.942 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 94' ' ' ASN . . . . . 0.486 ' HB2' ' O ' ' A' ' 90' ' ' VAL . 63.4 t-20 -64.49 130.03 42.13 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.218 -0.926 . . . . 0.0 109.506 179.975 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 88.82 26.99 25.33 Favored Glycine 0 N--CA 1.49 2.257 0 N-CA-C 109.507 -1.437 . . . . 0.0 109.507 179.978 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 96' ' ' THR . . . . . 0.433 HG23 ' O ' ' A' ' 93' ' ' LEU . 27.2 p -124.29 144.62 49.88 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.212 -1.169 . . . . 0.0 109.557 179.932 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 97' ' ' GLN . . . . . 0.464 ' HG3' ' O ' ' A' ' 101' ' ' VAL . 56.0 tt0 -119.5 142.01 48.68 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.345 -0.847 . . . . 0.0 109.412 179.972 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 98' ' ' VAL . . . . . 0.53 HG12 ' H ' ' A' ' 99' ' ' GLU . 1.0 OUTLIER -85.23 -154.31 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 O-C-N 121.188 -0.945 . . . . 0.0 109.374 -179.91 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 99' ' ' GLU . . . . . 0.53 ' H ' HG12 ' A' ' 98' ' ' VAL . 96.4 mt-10 -58.8 -40.97 85.63 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.242 -0.911 . . . . 0.0 109.477 179.997 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 100' ' ' SER . . . . . 0.463 ' O ' ' OG ' ' A' ' 100' ' ' SER . 4.4 t -153.72 24.75 0.51 Allowed 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.295 -0.878 . . . . 0.0 109.394 -179.996 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 101' ' ' VAL . . . . . 0.604 HG12 ' N ' ' A' ' 102' ' ' GLN . 53.4 t -137.01 167.85 22.78 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.521 0 O-C-N 121.285 -0.885 . . . . 0.0 109.442 -179.957 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 102' ' ' GLN . . . . . 0.604 ' N ' HG12 ' A' ' 101' ' ' VAL . 93.7 mt-30 -123.83 149.8 45.31 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.233 -0.917 . . . . 0.0 109.264 179.909 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 103' ' ' LEU . . . . . 0.623 HD23 HG13 ' A' ' 44' ' ' VAL . 0.0 OUTLIER -120.08 121.23 38.41 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.135 -0.978 . . . . 0.0 109.777 -179.859 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 29.9 mttt -106.49 131.67 53.4 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.314 -0.866 . . . . 0.0 109.24 179.81 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 105' ' ' VAL . . . . . 0.698 HG11 HG22 ' A' ' 90' ' ' VAL . 15.6 t -111.43 139.19 36.71 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.572 0 O-C-N 121.195 -0.941 . . . . 0.0 109.665 -179.842 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 106' ' ' ASN . . . . . 0.421 ' HB2' ' HB3' ' A' ' 43' ' ' TYR . 87.4 m-20 -136.18 -172.03 3.03 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.311 -0.868 . . . . 0.0 109.297 179.86 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 23.5 mm -107.1 130.84 58.52 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.528 0 O-C-N 121.175 -0.953 . . . . 0.0 109.497 179.981 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -99.79 151.82 20.82 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.285 -0.884 . . . . 0.0 109.391 -179.943 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 90.1 mtt180 -99.15 9.27 43.79 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.211 -0.931 . . . . 0.0 109.519 179.965 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 110' ' ' LYS . . . . . 0.511 ' O ' ' CB ' ' A' ' 111' ' ' GLN . 90.8 mttt -84.68 172.12 11.8 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.201 -0.937 . . . . 0.0 109.343 179.932 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 111' ' ' GLN . . . . . 0.733 ' HG3' ' HE2' ' A' ' 113' ' ' MET . 4.5 tp-100 75.69 46.51 0.16 Allowed Pre-proline 0 N--CA 1.49 1.55 0 O-C-N 121.318 -0.864 . . . . 0.0 109.549 179.927 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 112' ' ' PRO . . . . . 0.571 ' CD ' ' N ' ' A' ' 111' ' ' GLN . 52.8 Cg_endo -72.93 -18.74 24.11 Favored 'Trans proline' 0 C--O 1.215 -0.638 0 C-N-CA 122.72 2.28 . . . . 0.0 111.646 179.981 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 113' ' ' MET . . . . . 0.733 ' HE2' ' HG3' ' A' ' 111' ' ' GLN . 0.0 OUTLIER -43.55 -26.79 0.24 Allowed 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.285 -0.885 . . . . 0.0 109.6 -179.827 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 114' ' ' LEU . . . . . 0.546 HD13 ' O ' ' A' ' 114' ' ' LEU . 0.2 OUTLIER -155.53 20.02 0.4 Allowed 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.159 -0.963 . . . . 0.0 109.685 179.973 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 115' ' ' ASP . . . . . 0.712 ' O ' ' HB3' ' A' ' 116' ' ' ALA . 77.5 m-20 40.04 47.21 1.93 Allowed 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.612 -0.68 . . . . 0.0 109.492 179.967 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 116' ' ' ALA . . . . . 0.712 ' HB3' ' O ' ' A' ' 115' ' ' ASP . . . 78.02 -76.31 0.05 OUTLIER 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.374 -0.829 . . . . 0.0 109.347 -179.52 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 117' ' ' ALA . . . . . 0.674 ' HB3' ' HG3' ' A' ' 83' ' ' MET . . . -165.62 -148.35 0.1 Allowed 'General case' 0 C--N 1.303 -1.432 0 O-C-N 121.329 -0.857 . . . . 0.0 109.575 -179.858 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 14.2 t -127.76 155.5 43.93 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.199 -0.938 . . . . 0.0 109.424 179.992 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 170.64 -175.57 44.42 Favored Glycine 0 N--CA 1.49 2.25 0 N-CA-C 109.484 -1.446 . . . . 0.0 109.484 179.977 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 12.4 mtmt -57.34 -35.49 69.97 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.295 -1.121 . . . . 0.0 109.535 179.967 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 121' ' ' SER . . . . . 0.422 ' OXT' ' OG ' ' A' ' 121' ' ' SER . 0.7 OUTLIER . . . . . 0 N--CA 1.49 1.555 0 CA-C-O 117.987 -1.006 . . . . 0.0 109.474 -179.958 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . 0.816 ' HB3' ' HD3' ' A' ' 36' ' ' PRO . . . . . . . . 0 N--CA 1.49 1.545 0 N-CA-C 109.461 -0.57 . . . . 0.0 109.461 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 36' ' ' PRO . . . . . 0.816 ' HD3' ' HB3' ' A' ' 35' ' ' ALA . 50.2 Cg_endo -70.03 146.05 57.35 Favored 'Trans proline' 0 C--O 1.216 -0.619 0 C-N-CA 122.766 2.31 . . . . 0.0 111.79 -179.988 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 37' ' ' ARG . . . . . 0.85 ' O ' HD13 ' A' ' 114' ' ' LEU . 90.6 mtt-85 -129.78 134.67 47.72 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.233 -0.917 . . . . 0.0 109.536 -179.992 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 38' ' ' LYS . . . . . 1.034 ' HA ' HD22 ' A' ' 114' ' ' LEU . 93.9 mttt -72.87 -170.16 0.68 Allowed 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.244 -0.91 . . . . 0.0 109.446 179.971 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . 0.818 ' HA3' HD11 ' A' ' 65' ' ' ILE . . . 151.84 78.56 0.02 OUTLIER Glycine 0 N--CA 1.489 2.191 0 N-CA-C 109.837 -1.305 . . . . 0.0 109.837 179.873 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 40' ' ' ASN . . . . . 0.476 ' O ' ' HA ' ' A' ' 79' ' ' THR . 47.1 t-20 -73.16 121.2 19.88 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.177 -1.19 . . . . 0.0 109.191 179.664 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 41' ' ' THR . . . . . 0.809 HG21 ' HB3' ' A' ' 110' ' ' LYS . 86.8 m -84.81 141.56 30.39 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.219 -0.925 . . . . 0.0 109.645 -179.714 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . 0.844 HD12 ' O ' ' A' ' 78' ' ' VAL . 5.1 mp -119.03 148.72 42.7 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.274 -0.891 . . . . 0.0 109.375 179.91 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 43' ' ' TYR . . . . . 0.48 ' HB3' ' HB2' ' A' ' 106' ' ' ASN . 62.5 t80 -102.18 113.57 26.96 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.248 -0.908 . . . . 0.0 109.61 -179.927 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . 0.525 HG13 HD23 ' A' ' 103' ' ' LEU . 17.7 t -109.47 138.79 35.24 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.573 0 O-C-N 121.272 -0.892 . . . . 0.0 109.483 179.978 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 73.9 t80 -134.12 132.6 40.08 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.247 -0.908 . . . . 0.0 109.571 -179.922 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -175.74 -167.18 34.35 Favored Glycine 0 N--CA 1.49 2.269 0 N-CA-C 109.488 -1.445 . . . . 0.0 109.488 179.99 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . 0.49 ' H ' HG11 ' A' ' 101' ' ' VAL . 89.9 mt-10 -116.92 157.85 25.02 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.2 -1.177 . . . . 0.0 109.392 -179.948 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . 0.404 ' C ' ' O ' ' A' ' 47' ' ' GLU . 23.0 t70 44.01 42.35 4.68 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.301 -0.874 . . . . 0.0 109.382 -179.992 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 49' ' ' MET . . . . . 0.409 ' HE1' HG12 ' A' ' 44' ' ' VAL . 54.4 mtp -73.9 139.44 44.97 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.234 -0.916 . . . . 0.0 109.549 179.943 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 50' ' ' THR . . . . . 0.668 ' O ' HD12 ' A' ' 54' ' ' LEU . 5.1 p -126.14 162.66 44.62 Favored Pre-proline 0 N--CA 1.49 1.566 0 O-C-N 121.336 -0.853 . . . . 0.0 109.425 179.996 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 51' ' ' PRO . . . . . 0.455 ' CA ' ' SD ' ' A' ' 69' ' ' MET . 49.4 Cg_endo -70.22 -50.73 0.39 Allowed 'Trans proline' 0 C--O 1.215 -0.65 0 C-N-CA 122.625 2.217 . . . . 0.0 111.73 -179.983 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 41.2 m -60.77 -40.74 93.65 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.225 -0.922 . . . . 0.0 109.422 179.951 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 15.7 tp -66.53 -46.88 74.7 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.298 -0.876 . . . . 0.0 109.36 179.985 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 54' ' ' LEU . . . . . 0.668 HD12 ' O ' ' A' ' 50' ' ' THR . 10.8 mt -58.24 -46.33 86.14 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.313 -0.867 . . . . 0.0 109.318 179.944 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 55' ' ' ARG . . . . . 0.509 ' O ' ' N ' ' A' ' 59' ' ' SER . 74.0 mtt180 -56.64 -36.7 69.79 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.282 -0.886 . . . . 0.0 109.543 179.995 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -67.64 -32.89 79.4 Favored Glycine 0 N--CA 1.49 2.294 0 N-CA-C 109.554 -1.418 . . . . 0.0 109.554 179.948 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . 0.455 ' O ' ' CD1' ' A' ' 61' ' ' PHE . . . -73.31 -23.83 60.31 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.266 -1.138 . . . . 0.0 109.411 -179.917 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 58' ' ' PHE . . . . . 0.807 ' HB2' HD11 ' A' ' 64' ' ' ILE . 98.6 m-85 -118.95 8.51 11.67 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.33 -0.856 . . . . 0.0 109.46 -179.98 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 59' ' ' SER . . . . . 0.53 ' N ' ' HD2' ' A' ' 60' ' ' PRO . 1.1 t -74.5 -57.51 2.06 Favored Pre-proline 0 N--CA 1.491 1.598 0 O-C-N 121.238 -0.914 . . . . 0.0 109.852 -179.715 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 60' ' ' PRO . . . . . 0.53 ' HD2' ' N ' ' A' ' 59' ' ' SER . 50.3 Cg_endo -69.84 -32.27 18.54 Favored 'Trans proline' 0 C--O 1.215 -0.627 0 C-N-CA 122.601 2.2 . . . . 0.0 111.945 -179.783 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 61' ' ' PHE . . . . . 0.577 ' CE2' ' HA ' ' A' ' 89' ' ' ALA . 67.6 m-85 -63.61 -31.82 73.11 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.163 -0.961 . . . . 0.0 109.406 -179.946 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 171.22 -176.7 44.46 Favored Glycine 0 N--CA 1.49 2.278 0 N-CA-C 109.634 -1.387 . . . . 0.0 109.634 -179.993 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 82.9 m-20 -90.04 145.15 25.29 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.302 -1.117 . . . . 0.0 109.461 179.991 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 64' ' ' ILE . . . . . 0.807 HD11 ' HB2' ' A' ' 58' ' ' PHE . 77.6 mt -106.85 131.3 57.11 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.525 0 O-C-N 121.3 -0.875 . . . . 0.0 109.619 -179.973 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 65' ' ' ILE . . . . . 0.818 HD11 ' HA3' ' A' ' 39' ' ' GLY . 28.2 pt -91.76 -22.85 5.94 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.599 0 O-C-N 121.3 -0.875 . . . . 0.0 109.393 179.948 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 66' ' ' ASP . . . . . 0.456 ' HB3' ' OG1' ' A' ' 79' ' ' THR . 53.6 t0 -149.5 115.3 5.64 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.239 -0.913 . . . . 0.0 109.467 -179.927 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . 0.701 HD23 HD13 ' A' ' 64' ' ' ILE . 0.5 OUTLIER -103.87 114.86 29.42 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.263 -0.898 . . . . 0.0 109.505 179.999 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 68' ' ' SER . . . . . 0.643 ' N ' HD13 ' A' ' 67' ' ' LEU . 39.2 t -119.5 149.72 41.43 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.176 -0.952 . . . . 0.0 109.53 179.978 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 69' ' ' MET . . . . . 0.455 ' SD ' ' CA ' ' A' ' 51' ' ' PRO . 77.2 mtp -128.46 148.91 50.76 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.309 -0.869 . . . . 0.0 109.472 -179.983 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 70' ' ' ASP . . . . . 0.516 ' CB ' ' O ' ' A' ' 75' ' ' CYS . 0.4 OUTLIER -127.84 94.66 36.59 Favored Pre-proline 0 N--CA 1.49 1.572 0 O-C-N 121.272 -0.892 . . . . 0.0 109.421 179.967 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 71' ' ' PRO . . . . . 0.593 ' N ' ' CD ' ' A' ' 72' ' ' PRO . 47.4 Cg_endo -74.66 -27.93 10.26 Favored 'Trans proline' 0 CA--C 1.542 0.922 0 C-N-CA 122.564 2.176 . . . . 0.0 113.584 179.98 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 72' ' ' PRO . . . . . 0.593 ' CD ' ' N ' ' A' ' 71' ' ' PRO . 55.4 Cg_endo -75.49 -21.44 14.97 Favored 'Trans proline' 0 C--N 1.352 0.761 0 C-N-CA 121.46 1.44 . . . . 0.0 111.797 -179.86 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 67.8 mtt85 -115.23 3.66 14.33 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.252 -0.905 . . . . 0.0 109.7 -179.878 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 78.6 m-20 60.12 44.64 12.72 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.234 -0.916 . . . . 0.0 109.474 179.958 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 75' ' ' CYS . . . . . 0.516 ' O ' ' CB ' ' A' ' 70' ' ' ASP . 28.0 p -149.86 153.2 36.34 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.26 -0.9 . . . . 0.0 109.566 -179.942 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -127.8 159.36 35.07 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.291 -0.88 . . . . 0.0 109.35 179.899 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 77' ' ' PHE . . . . . 0.476 ' HA ' ' O ' ' A' ' 42' ' ' LEU . 96.3 m-85 -120.94 136.79 54.87 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.179 -0.951 . . . . 0.0 109.533 179.997 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . 0.844 ' O ' HD12 ' A' ' 42' ' ' LEU . 39.7 t -125.45 135.14 64.93 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 O-C-N 121.247 -0.908 . . . . 0.0 109.546 -179.974 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 79' ' ' THR . . . . . 0.64 HG21 HD11 ' A' ' 65' ' ' ILE . 17.3 m -104.03 127.43 51.59 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.287 -0.883 . . . . 0.0 109.451 179.964 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 80' ' ' TYR . . . . . 0.504 ' CG ' ' HB2' ' A' ' 85' ' ' SER . 1.2 m-85 -108.44 139.82 42.63 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.273 -0.892 . . . . 0.0 109.507 179.958 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 81' ' ' GLU . . . . . 0.466 ' O ' ' HB2' ' A' ' 38' ' ' LYS . 76.8 tt0 -61.35 -24.43 66.46 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.232 -0.917 . . . . 0.0 109.326 179.867 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 42.8 mttm -134.18 144.61 48.59 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.28 -0.887 . . . . 0.0 109.32 179.948 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 83' ' ' MET . . . . . 0.674 ' HG3' ' HB3' ' A' ' 117' ' ' ALA . 53.8 mtt -65.55 -17.56 64.67 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.17 -0.956 . . . . 0.0 109.548 -179.912 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 97.4 mt-10 -69.98 -35.13 74.19 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.232 -0.918 . . . . 0.0 109.468 -179.924 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 85' ' ' SER . . . . . 0.504 ' HB2' ' CG ' ' A' ' 80' ' ' TYR . 18.0 m -66.84 -30.42 70.59 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.252 -0.905 . . . . 0.0 109.468 -179.943 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 86' ' ' ALA . . . . . 0.76 ' HA ' HD21 ' A' ' 42' ' ' LEU . . . -79.17 -37.43 38.39 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.223 -0.923 . . . . 0.0 109.504 -179.96 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 55.4 t0 -61.78 -47.19 86.27 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.166 -0.959 . . . . 0.0 109.407 179.97 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 88' ' ' GLN . . . . . 0.469 ' O ' ' HB2' ' A' ' 92' ' ' GLU . 64.2 tt0 -67.88 -39.96 83.63 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.289 -0.882 . . . . 0.0 109.316 179.957 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 89' ' ' ALA . . . . . 0.577 ' HA ' ' CE2' ' A' ' 61' ' ' PHE . . . -71.72 -38.91 70.42 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.283 -0.886 . . . . 0.0 109.531 -179.967 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 90' ' ' VAL . . . . . 0.778 HG22 HG12 ' A' ' 105' ' ' VAL . 74.1 t -66.0 -45.33 91.12 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.616 0 O-C-N 121.309 -0.869 . . . . 0.0 109.627 -179.858 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -70.98 -34.51 71.46 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.196 -0.94 . . . . 0.0 109.667 -179.854 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 92' ' ' GLU . . . . . 0.536 ' HB3' ' CZ ' ' A' ' 61' ' ' PHE . 2.4 tm-20 -82.85 -49.3 9.83 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.28 -0.888 . . . . 0.0 109.617 -179.948 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 93' ' ' LEU . . . . . 1.058 ' HB2' HG21 ' A' ' 105' ' ' VAL . 85.3 mt -65.8 -35.0 79.46 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.222 -0.924 . . . . 0.0 109.598 -179.892 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 94' ' ' ASN . . . . . 0.524 ' CB ' ' O ' ' A' ' 90' ' ' VAL . 56.5 t-20 -71.71 130.51 41.33 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.277 -0.889 . . . . 0.0 109.463 -179.985 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 87.24 30.66 19.02 Favored Glycine 0 N--CA 1.489 2.204 0 N-CA-C 109.51 -1.436 . . . . 0.0 109.51 179.97 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 96' ' ' THR . . . . . 0.474 ' CG2' ' O ' ' A' ' 92' ' ' GLU . 28.8 p -122.56 148.08 45.63 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.228 -1.16 . . . . 0.0 109.523 -179.956 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 97' ' ' GLN . . . . . 0.442 ' HG3' ' O ' ' A' ' 101' ' ' VAL . 57.2 tt0 -118.6 143.22 46.94 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.309 -0.869 . . . . 0.0 109.444 -179.953 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 98' ' ' VAL . . . . . 0.49 HG12 ' H ' ' A' ' 99' ' ' GLU . 1.3 t -92.4 -148.84 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 O-C-N 121.256 -0.902 . . . . 0.0 109.368 179.975 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 99' ' ' GLU . . . . . 0.49 ' H ' HG12 ' A' ' 98' ' ' VAL . 96.7 mt-10 -57.61 -37.2 72.85 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.272 -0.893 . . . . 0.0 109.432 179.918 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 22.6 m -165.82 30.64 0.05 Allowed 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.27 -0.894 . . . . 0.0 109.319 179.965 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 101' ' ' VAL . . . . . 0.604 HG12 ' N ' ' A' ' 102' ' ' GLN . 44.4 t -137.73 168.88 19.89 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.5 0 O-C-N 121.34 -0.85 . . . . 0.0 109.465 -179.892 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 102' ' ' GLN . . . . . 0.604 ' N ' HG12 ' A' ' 101' ' ' VAL . 91.5 mt-30 -116.39 145.54 43.16 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.191 -0.943 . . . . 0.0 109.076 179.815 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 103' ' ' LEU . . . . . 0.525 HD23 HG13 ' A' ' 44' ' ' VAL . 0.0 OUTLIER -121.81 134.91 54.9 Favored 'General case' 0 N--CA 1.488 1.444 0 O-C-N 121.18 -0.95 . . . . 0.0 109.851 -179.628 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 60.5 mttt -118.07 126.65 52.68 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.343 -0.848 . . . . 0.0 109.234 179.769 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 105' ' ' VAL . . . . . 1.058 HG21 ' HB2' ' A' ' 93' ' ' LEU . 26.4 t -110.48 142.3 23.32 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 O-C-N 121.174 -0.953 . . . . 0.0 109.667 -179.82 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 106' ' ' ASN . . . . . 0.499 ' ND2' ' O ' ' A' ' 105' ' ' VAL . 24.4 m120 -153.53 -168.18 2.92 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.417 -0.802 . . . . 0.0 109.266 179.85 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 22.9 mm -105.64 133.58 49.58 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 O-C-N 121.086 -1.009 . . . . 0.0 109.406 179.967 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 108' ' ' ALA . . . . . 0.472 ' O ' ' HB ' ' A' ' 41' ' ' THR . . . -124.2 153.21 41.93 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.353 -0.842 . . . . 0.0 109.505 179.912 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 89.4 mtt180 -99.77 33.64 2.49 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.265 -0.897 . . . . 0.0 109.54 -179.901 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 110' ' ' LYS . . . . . 0.809 ' HB3' HG21 ' A' ' 41' ' ' THR . 16.2 tttp -72.29 -8.36 54.47 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.2 -0.937 . . . . 0.0 109.436 179.889 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 111' ' ' GLN . . . . . 0.677 ' HG3' ' HE2' ' A' ' 113' ' ' MET . 5.0 tp60 -122.79 71.79 41.25 Favored Pre-proline 0 N--CA 1.49 1.561 0 O-C-N 121.205 -0.935 . . . . 0.0 109.53 -179.904 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 112' ' ' PRO . . . . . 0.438 ' O ' ' C ' ' A' ' 113' ' ' MET . 55.7 Cg_endo -82.77 -18.32 6.66 Favored 'Trans proline' 0 C--O 1.215 -0.66 0 C-N-CA 122.774 2.316 . . . . 0.0 111.929 179.992 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 113' ' ' MET . . . . . 0.677 ' HE2' ' HG3' ' A' ' 111' ' ' GLN . 0.0 OUTLIER -42.49 -37.48 1.64 Allowed 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.305 -0.872 . . . . 0.0 109.595 -179.793 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 114' ' ' LEU . . . . . 1.034 HD22 ' HA ' ' A' ' 38' ' ' LYS . 4.2 tt -134.42 26.49 3.78 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.15 -0.969 . . . . 0.0 109.39 179.84 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 115' ' ' ASP . . . . . 0.615 ' O ' ' HB3' ' A' ' 116' ' ' ALA . 89.1 m-20 47.07 45.69 15.89 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.213 -0.929 . . . . 0.0 109.28 -179.824 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 116' ' ' ALA . . . . . 0.615 ' HB3' ' O ' ' A' ' 115' ' ' ASP . . . 70.29 -84.03 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.2 -0.938 . . . . 0.0 109.5 -179.897 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 117' ' ' ALA . . . . . 0.674 ' HB3' ' HG3' ' A' ' 83' ' ' MET . . . -162.69 24.18 0.1 Allowed 'General case' 0 C--N 1.303 -1.454 0 O-C-N 121.382 -0.824 . . . . 0.0 109.59 -179.767 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 118' ' ' THR . . . . . 0.477 ' N ' ' HE3' ' A' ' 83' ' ' MET . 59.1 m -71.68 -34.14 69.43 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.183 -0.948 . . . . 0.0 109.419 -179.76 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 119' ' ' GLY . . . . . 0.417 ' O ' ' HB2' ' A' ' 120' ' ' LYS . . . 78.83 -169.8 54.4 Favored Glycine 0 N--CA 1.49 2.278 0 N-CA-C 109.415 -1.474 . . . . 0.0 109.415 179.984 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 120' ' ' LYS . . . . . 0.417 ' HB2' ' O ' ' A' ' 119' ' ' GLY . 26.5 mttm 60.74 46.01 9.45 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.243 -1.151 . . . . 0.0 109.468 179.965 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 38.2 t . . . . . 0 N--CA 1.49 1.533 0 CA-C-O 117.988 -1.006 . . . . 0.0 109.46 -179.951 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . 0.847 ' HB3' ' HD3' ' A' ' 36' ' ' PRO . . . . . . . . 0 N--CA 1.49 1.555 0 N-CA-C 109.461 -0.57 . . . . 0.0 109.461 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 36' ' ' PRO . . . . . 0.847 ' HD3' ' HB3' ' A' ' 35' ' ' ALA . 49.1 Cg_endo -69.93 149.04 65.26 Favored 'Trans proline' 0 C--O 1.215 -0.649 0 C-N-CA 122.749 2.299 . . . . 0.0 111.829 -179.979 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 37' ' ' ARG . . . . . 0.507 ' O ' HD13 ' A' ' 114' ' ' LEU . 34.3 ptt85 -143.05 157.33 44.63 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.314 -0.866 . . . . 0.0 109.331 179.938 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 38' ' ' LYS . . . . . 0.704 ' HG2' HD22 ' A' ' 114' ' ' LEU . 30.1 mttt -122.94 -157.26 0.74 Allowed 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.222 -0.924 . . . . 0.0 109.519 179.985 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . 0.664 ' HA3' HD11 ' A' ' 65' ' ' ILE . . . 175.04 75.23 0.05 OUTLIER Glycine 0 N--CA 1.489 2.231 0 N-CA-C 109.537 -1.425 . . . . 0.0 109.537 -179.959 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 40' ' ' ASN . . . . . 0.782 ' HA ' ' HB1' ' A' ' 116' ' ' ALA . 45.3 t-20 -68.45 117.13 9.81 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.195 -1.179 . . . . 0.0 109.512 -179.976 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 41' ' ' THR . . . . . 0.734 HG22 ' HB3' ' A' ' 108' ' ' ALA . 60.2 m -81.0 143.67 32.35 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.274 -0.891 . . . . 0.0 109.54 179.973 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . 0.895 HD12 ' O ' ' A' ' 78' ' ' VAL . 5.0 mp -116.08 146.7 42.0 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.176 -0.952 . . . . 0.0 109.521 -179.931 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 43' ' ' TYR . . . . . 0.471 ' HB3' ' HB2' ' A' ' 106' ' ' ASN . 35.4 t80 -106.08 112.58 25.67 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.177 -0.952 . . . . 0.0 109.513 -179.976 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . 0.473 ' HA ' ' O ' ' A' ' 104' ' ' LYS . 38.2 t -110.53 150.42 13.05 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.53 0 O-C-N 121.266 -0.896 . . . . 0.0 109.535 -179.919 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 70.0 t80 -141.68 138.92 32.79 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.2 -0.937 . . . . 0.0 109.606 179.9 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 177.29 -167.86 39.25 Favored Glycine 0 N--CA 1.49 2.289 0 N-CA-C 109.472 -1.451 . . . . 0.0 109.472 179.909 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . 0.423 ' O ' ' C ' ' A' ' 48' ' ' ASP . 89.0 mt-10 -115.66 161.98 17.9 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.275 -1.133 . . . . 0.0 109.42 179.945 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . 0.423 ' C ' ' O ' ' A' ' 47' ' ' GLU . 43.9 m-20 43.73 40.74 3.21 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.281 -0.887 . . . . 0.0 109.606 179.975 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 41.3 mtp -78.6 138.79 38.52 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.282 -0.886 . . . . 0.0 109.354 179.979 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 50' ' ' THR . . . . . 0.446 ' O ' ' HG ' ' A' ' 54' ' ' LEU . 0.4 OUTLIER -127.04 161.28 54.8 Favored Pre-proline 0 N--CA 1.49 1.56 0 O-C-N 121.252 -0.905 . . . . 0.0 109.533 179.94 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 50.2 Cg_endo -70.07 -51.94 0.33 Allowed 'Trans proline' 0 C--O 1.214 -0.688 0 C-N-CA 122.641 2.228 . . . . 0.0 111.815 -179.985 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 31.1 m -59.16 -41.2 87.83 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.214 -0.929 . . . . 0.0 109.41 179.904 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . 0.558 ' C ' HD23 ' A' ' 53' ' ' LEU . 9.0 tt -64.89 -44.44 89.63 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.305 -0.872 . . . . 0.0 109.467 179.987 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 54' ' ' LEU . . . . . 0.451 HD13 ' CB ' ' A' ' 76' ' ' ALA . 21.9 mt -63.93 -45.86 87.35 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.211 -0.931 . . . . 0.0 109.374 179.946 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 55' ' ' ARG . . . . . 0.454 ' O ' ' N ' ' A' ' 59' ' ' SER . 76.8 mtp180 -51.3 -41.33 60.42 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.235 -0.916 . . . . 0.0 109.358 179.965 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -69.44 -32.28 71.59 Favored Glycine 0 N--CA 1.49 2.253 0 N-CA-C 109.463 -1.455 . . . . 0.0 109.463 179.871 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -71.5 -23.72 61.85 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.339 -1.095 . . . . 0.0 109.398 179.934 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 58' ' ' PHE . . . . . 0.584 ' CE2' ' CD1' ' A' ' 93' ' ' LEU . 90.1 m-85 -120.62 10.11 10.98 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.365 -0.834 . . . . 0.0 109.453 -179.997 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 59' ' ' SER . . . . . 0.547 ' N ' ' HD2' ' A' ' 60' ' ' PRO . 3.4 t -76.78 -54.34 1.7 Allowed Pre-proline 0 N--CA 1.49 1.575 0 O-C-N 121.316 -0.865 . . . . 0.0 110.413 -179.505 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 60' ' ' PRO . . . . . 0.547 ' HD2' ' N ' ' A' ' 59' ' ' SER . 48.5 Cg_endo -69.97 -35.58 11.77 Favored 'Trans proline' 0 C--O 1.215 -0.644 0 C-N-CA 122.516 2.144 . . . . 0.0 112.251 -179.276 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 61' ' ' PHE . . . . . 0.663 ' CE2' HD21 ' A' ' 93' ' ' LEU . 70.0 m-85 -58.51 -39.29 79.67 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.183 -0.948 . . . . 0.0 109.631 -179.833 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 179.43 174.66 45.67 Favored Glycine 0 N--CA 1.49 2.239 0 N-CA-C 109.516 -1.434 . . . . 0.0 109.516 179.95 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 45.9 t-20 -80.18 140.9 36.13 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.263 -1.14 . . . . 0.0 109.414 179.93 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 64' ' ' ILE . . . . . 0.731 HD13 HD23 ' A' ' 67' ' ' LEU . 81.7 mt -100.78 131.04 49.16 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.52 0 O-C-N 121.223 -0.923 . . . . 0.0 109.542 -179.973 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 65' ' ' ILE . . . . . 0.664 HD11 ' HA3' ' A' ' 39' ' ' GLY . 20.4 pt -92.82 -24.02 5.38 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 O-C-N 121.264 -0.898 . . . . 0.0 109.575 -179.841 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 18.7 t70 -149.44 113.79 5.24 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.239 -0.913 . . . . 0.0 109.621 -179.888 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . 0.731 HD23 HD13 ' A' ' 64' ' ' ILE . 0.4 OUTLIER -104.74 117.06 33.14 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.282 -0.886 . . . . 0.0 109.342 179.803 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 68' ' ' SER . . . . . 0.665 ' N ' HD13 ' A' ' 67' ' ' LEU . 25.9 t -128.36 148.87 50.7 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.291 -0.881 . . . . 0.0 109.566 -179.906 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 69' ' ' MET . . . . . . . . . . . . . 86.6 mtp -124.9 148.54 48.27 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.233 -0.917 . . . . 0.0 109.408 179.93 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 70' ' ' ASP . . . . . 0.498 ' CB ' ' O ' ' A' ' 75' ' ' CYS . 0.8 OUTLIER -120.77 100.03 46.78 Favored Pre-proline 0 N--CA 1.491 1.624 0 O-C-N 121.253 -0.904 . . . . 0.0 109.614 -179.931 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 71' ' ' PRO . . . . . 0.596 ' N ' ' CD ' ' A' ' 72' ' ' PRO . 47.9 Cg_endo -74.72 -27.85 10.22 Favored 'Trans proline' 0 CA--C 1.543 0.938 0 C-N-CA 122.543 2.162 . . . . 0.0 113.733 179.944 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 72' ' ' PRO . . . . . 0.596 ' CD ' ' N ' ' A' ' 71' ' ' PRO . 55.5 Cg_endo -75.36 -28.62 8.44 Favored 'Trans proline' 0 C--N 1.352 0.762 0 C-N-CA 121.462 1.441 . . . . 0.0 111.846 -179.91 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 73' ' ' ARG . . . . . 0.439 ' O ' ' HB2' ' A' ' 74' ' ' ASN . 55.3 mtt-85 -109.41 0.06 19.2 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.295 -0.878 . . . . 0.0 109.666 -179.826 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 74' ' ' ASN . . . . . 0.439 ' HB2' ' O ' ' A' ' 73' ' ' ARG . 83.5 m-20 61.14 41.25 13.84 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.126 -0.984 . . . . 0.0 109.544 179.984 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 75' ' ' CYS . . . . . 0.498 ' O ' ' CB ' ' A' ' 70' ' ' ASP . 30.0 p -140.93 137.01 32.8 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.183 -0.948 . . . . 0.0 109.627 179.99 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . 0.451 ' CB ' HD13 ' A' ' 54' ' ' LEU . . . -105.02 160.6 14.91 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.286 -0.884 . . . . 0.0 109.454 179.996 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 77' ' ' PHE . . . . . 0.475 ' HA ' ' O ' ' A' ' 42' ' ' LEU . 97.1 m-85 -124.33 130.07 51.84 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.207 -0.933 . . . . 0.0 109.487 -179.987 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . 0.895 ' O ' HD12 ' A' ' 42' ' ' LEU . 21.2 t -122.09 132.97 69.84 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.549 0 O-C-N 121.273 -0.892 . . . . 0.0 109.341 179.927 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 79' ' ' THR . . . . . 0.543 HG22 ' CA ' ' A' ' 39' ' ' GLY . 6.8 m -106.01 135.86 46.71 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.238 -0.914 . . . . 0.0 109.36 -179.966 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 80' ' ' TYR . . . . . 0.52 ' OH ' ' CA ' ' A' ' 58' ' ' PHE . 1.6 m-85 -115.56 133.08 56.38 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.162 -0.961 . . . . 0.0 109.619 -179.932 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 76.8 tt0 -52.26 -25.81 10.32 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.339 -0.851 . . . . 0.0 109.537 179.959 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 67.6 mttm -134.23 132.97 40.33 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.176 -0.953 . . . . 0.0 109.617 -179.952 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 83' ' ' MET . . . . . 0.686 ' HB3' ' HB3' ' A' ' 117' ' ' ALA . 0.8 OUTLIER -57.38 -18.23 16.59 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.277 -0.889 . . . . 0.0 109.649 -179.964 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 99.5 mt-10 -65.76 -39.43 91.04 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.223 -0.923 . . . . 0.0 109.506 -179.922 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 13.9 t -63.58 -40.45 96.99 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.168 -0.957 . . . . 0.0 109.546 -179.897 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 86' ' ' ALA . . . . . 0.684 ' HA ' HD21 ' A' ' 42' ' ' LEU . . . -61.11 -41.45 96.71 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.204 -0.935 . . . . 0.0 109.538 -179.917 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 54.4 t0 -62.19 -45.1 94.89 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.218 -0.926 . . . . 0.0 109.601 -179.926 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 63.6 tt0 -65.16 -37.3 86.96 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.224 -0.922 . . . . 0.0 109.583 -179.817 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 89' ' ' ALA . . . . . 0.596 ' HB1' ' CD1' ' A' ' 93' ' ' LEU . . . -75.95 -45.95 32.36 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.225 -0.922 . . . . 0.0 109.609 -179.879 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 90' ' ' VAL . . . . . 0.772 HG21 HD11 ' A' ' 107' ' ' ILE . 78.0 t -56.9 -31.92 37.57 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.52 0 O-C-N 121.207 -0.933 . . . . 0.0 109.626 -179.889 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -80.06 -53.0 7.12 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.245 -0.91 . . . . 0.0 109.733 -179.82 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 92' ' ' GLU . . . . . 0.607 ' HB2' ' CZ ' ' A' ' 61' ' ' PHE . 75.4 mm-40 -71.72 -43.88 65.11 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.214 -0.929 . . . . 0.0 109.73 -179.637 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 93' ' ' LEU . . . . . 1.003 ' CB ' HG21 ' A' ' 105' ' ' VAL . 36.7 mt -64.67 -40.36 95.28 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.149 -0.969 . . . . 0.0 109.474 -179.916 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 94' ' ' ASN . . . . . 0.489 ' CB ' ' O ' ' A' ' 90' ' ' VAL . 64.0 t-20 -68.4 125.74 27.42 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.244 -0.91 . . . . 0.0 109.499 179.987 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 93.85 22.81 24.79 Favored Glycine 0 N--CA 1.49 2.294 0 N-CA-C 109.536 -1.426 . . . . 0.0 109.536 179.969 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 96' ' ' THR . . . . . 0.594 HG23 ' O ' ' A' ' 93' ' ' LEU . 29.5 p -111.49 159.7 17.83 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.268 -1.136 . . . . 0.0 109.465 -179.948 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 60.0 tt0 -136.13 149.02 48.49 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.281 -0.887 . . . . 0.0 109.491 179.968 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 98' ' ' VAL . . . . . 0.607 ' HB ' HG12 ' A' ' 101' ' ' VAL . 1.3 t -101.59 -151.92 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.543 0 O-C-N 121.195 -0.941 . . . . 0.0 109.204 179.947 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 99' ' ' GLU . . . . . 0.534 ' H ' HG12 ' A' ' 98' ' ' VAL . 95.7 mt-10 -48.29 -41.34 27.77 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.115 -0.991 . . . . 0.0 109.42 179.992 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 2.4 m -165.98 25.84 0.05 OUTLIER 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.236 -0.915 . . . . 0.0 109.505 -179.97 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 101' ' ' VAL . . . . . 0.607 HG12 ' HB ' ' A' ' 98' ' ' VAL . 9.8 p -130.17 140.2 49.51 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.547 0 O-C-N 121.233 -0.917 . . . . 0.0 109.644 -179.861 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 91.7 mt-30 -86.71 141.62 28.78 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.265 -0.897 . . . . 0.0 109.328 179.887 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 103' ' ' LEU . . . . . 0.438 HD23 ' HA ' ' A' ' 103' ' ' LEU . 73.5 mt -106.76 137.62 44.45 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.241 -0.912 . . . . 0.0 109.763 -179.819 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 104' ' ' LYS . . . . . 0.473 ' O ' ' HA ' ' A' ' 44' ' ' VAL . 41.9 mttm -119.38 135.53 54.69 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.284 -0.885 . . . . 0.0 109.245 179.831 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 105' ' ' VAL . . . . . 1.003 HG21 ' CB ' ' A' ' 93' ' ' LEU . 46.0 t -123.43 145.49 30.32 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.55 0 O-C-N 121.186 -0.946 . . . . 0.0 109.614 -179.788 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 106' ' ' ASN . . . . . 0.471 ' HB2' ' HB3' ' A' ' 43' ' ' TYR . 83.2 m-20 -148.54 -170.92 3.73 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.362 -0.836 . . . . 0.0 109.337 179.904 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 107' ' ' ILE . . . . . 0.772 HD11 HG21 ' A' ' 90' ' ' VAL . 28.5 mm -111.38 126.3 68.76 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.531 0 O-C-N 121.156 -0.965 . . . . 0.0 109.509 -179.991 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 108' ' ' ALA . . . . . 0.734 ' HB3' HG22 ' A' ' 41' ' ' THR . . . -107.68 138.93 43.03 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.232 -0.917 . . . . 0.0 109.469 179.993 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 79.8 mtt85 -108.75 18.12 21.14 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.213 -0.929 . . . . 0.0 109.474 -179.936 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 110' ' ' LYS . . . . . 0.465 ' O ' ' CD ' ' A' ' 112' ' ' PRO . 84.9 tttt -59.97 -50.88 72.0 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.223 -0.923 . . . . 0.0 109.488 -179.897 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 111' ' ' GLN . . . . . 0.53 ' HG3' ' CE ' ' A' ' 113' ' ' MET . 5.2 tp-100 -42.4 98.56 0.18 Allowed Pre-proline 0 N--CA 1.492 1.668 0 O-C-N 121.282 -0.886 . . . . 0.0 109.574 -179.896 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 112' ' ' PRO . . . . . 0.465 ' CD ' ' O ' ' A' ' 110' ' ' LYS . 53.4 Cg_endo -90.65 -22.52 0.67 Allowed 'Trans proline' 0 N--CA 1.456 -0.726 0 C-N-CA 123.103 2.535 . . . . 0.0 111.895 179.98 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 113' ' ' MET . . . . . 0.53 ' CE ' ' HG3' ' A' ' 111' ' ' GLN . 0.0 OUTLIER -49.01 -34.92 14.16 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.206 -0.934 . . . . 0.0 109.548 -179.914 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 114' ' ' LEU . . . . . 0.704 HD22 ' HG2' ' A' ' 38' ' ' LYS . 0.4 OUTLIER -150.68 26.93 0.74 Allowed 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.27 -0.894 . . . . 0.0 109.516 -179.956 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 115' ' ' ASP . . . . . 0.622 ' O ' ' HB3' ' A' ' 116' ' ' ALA . 83.3 m-20 54.27 44.14 29.49 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.243 -0.911 . . . . 0.0 109.15 -179.844 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 116' ' ' ALA . . . . . 0.782 ' HB1' ' HA ' ' A' ' 40' ' ' ASN . . . 72.3 -83.12 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.368 -0.832 . . . . 0.0 109.52 -179.921 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 117' ' ' ALA . . . . . 0.686 ' HB3' ' HB3' ' A' ' 83' ' ' MET . . . -169.8 132.61 1.16 Allowed 'General case' 0 N--CA 1.487 1.415 0 O-C-N 121.23 -0.919 . . . . 0.0 109.604 -179.985 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 118' ' ' THR . . . . . 0.572 ' N ' ' HE1' ' A' ' 83' ' ' MET . 21.6 p -130.04 168.31 16.93 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.286 -0.884 . . . . 0.0 109.517 179.956 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -61.39 -35.93 91.75 Favored Glycine 0 N--CA 1.49 2.279 0 N-CA-C 109.488 -1.445 . . . . 0.0 109.488 179.988 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 120' ' ' LYS . . . . . 0.423 ' O ' ' OG1' ' A' ' 118' ' ' THR . 48.0 tttp -109.05 134.19 52.0 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.236 -1.155 . . . . 0.0 109.437 179.962 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 2.9 m . . . . . 0 N--CA 1.491 1.584 0 CA-C-O 118.052 -0.975 . . . . 0.0 109.47 -179.982 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.566 0 N-CA-C 109.464 -0.569 . . . . 0.0 109.464 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 48.9 Cg_endo -69.36 145.54 59.77 Favored 'Trans proline' 0 C--O 1.215 -0.631 0 C-N-CA 122.642 2.228 . . . . 0.0 111.798 -179.998 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 72.9 mtm180 -131.56 145.14 51.57 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.214 -0.929 . . . . 0.0 109.582 -179.928 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 38' ' ' LYS . . . . . 0.525 ' O ' ' CD1' ' A' ' 65' ' ' ILE . 67.6 mttm -69.19 -167.73 0.12 Allowed 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.179 -0.95 . . . . 0.0 109.377 179.937 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . 0.737 ' HA3' HD11 ' A' ' 65' ' ' ILE . . . 150.65 99.9 0.2 Allowed Glycine 0 N--CA 1.491 2.332 0 N-CA-C 109.761 -1.336 . . . . 0.0 109.761 179.965 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 40' ' ' ASN . . . . . 0.475 ' N ' ' O ' ' A' ' 80' ' ' TYR . 47.3 t-20 -98.86 108.13 20.74 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.196 -1.179 . . . . 0.0 109.311 179.759 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 41' ' ' THR . . . . . 0.464 ' O ' HD23 ' A' ' 42' ' ' LEU . 43.7 m -71.11 133.79 46.51 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.257 -0.902 . . . . 0.0 109.74 -179.747 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . 0.795 HD11 ' CD2' ' A' ' 80' ' ' TYR . 16.6 mt -114.38 145.68 41.52 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.295 -0.878 . . . . 0.0 109.32 179.824 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 43' ' ' TYR . . . . . 0.473 ' HB3' ' HB2' ' A' ' 106' ' ' ASN . 74.1 t80 -100.38 122.61 43.41 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.258 -0.901 . . . . 0.0 109.488 -179.825 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . 0.468 ' HA ' ' O ' ' A' ' 104' ' ' LYS . 59.3 t -123.34 136.92 58.39 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.538 0 O-C-N 121.283 -0.885 . . . . 0.0 109.424 179.977 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 45' ' ' TYR . . . . . 0.476 ' HB3' ' HB2' ' A' ' 104' ' ' LYS . 70.1 t80 -120.56 142.09 49.68 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.223 -0.923 . . . . 0.0 109.46 -179.89 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . 0.429 ' HA3' ' SD ' ' A' ' 49' ' ' MET . . . 174.86 -175.87 47.02 Favored Glycine 0 N--CA 1.491 2.341 0 N-CA-C 109.54 -1.424 . . . . 0.0 109.54 -179.963 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . 0.428 ' O ' ' C ' ' A' ' 48' ' ' ASP . 94.6 mt-10 -120.85 157.03 30.68 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.265 -1.138 . . . . 0.0 109.392 179.962 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . 0.428 ' C ' ' O ' ' A' ' 47' ' ' GLU . 48.8 m-20 43.93 52.16 6.73 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.294 -0.879 . . . . 0.0 109.546 -179.979 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 49' ' ' MET . . . . . 0.429 ' SD ' ' HA3' ' A' ' 46' ' ' GLY . 64.8 mtm -103.4 142.41 34.28 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.314 -0.866 . . . . 0.0 109.504 179.975 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -122.15 163.62 30.73 Favored Pre-proline 0 N--CA 1.491 1.582 0 O-C-N 121.258 -0.901 . . . . 0.0 109.371 179.919 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 51' ' ' PRO . . . . . 0.44 ' HD3' ' SD ' ' A' ' 69' ' ' MET . 48.8 Cg_endo -69.56 -52.99 0.31 Allowed 'Trans proline' 0 C--O 1.215 -0.64 0 C-N-CA 122.617 2.211 . . . . 0.0 111.803 179.988 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 28.6 m -50.6 -48.87 57.7 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.249 -0.907 . . . . 0.0 109.302 179.931 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 22.3 tp -60.33 -47.23 86.92 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.249 -0.907 . . . . 0.0 109.343 179.836 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 21.9 mt -56.28 -47.09 79.29 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.284 -0.885 . . . . 0.0 109.357 179.824 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 55' ' ' ARG . . . . . 0.499 ' O ' ' N ' ' A' ' 59' ' ' SER . 36.4 mtp85 -51.43 -40.91 60.33 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.306 -0.871 . . . . 0.0 109.296 179.84 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -66.48 -34.35 87.46 Favored Glycine 0 N--CA 1.489 2.203 0 N-CA-C 109.34 -1.504 . . . . 0.0 109.34 179.864 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -71.23 -26.41 62.91 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.313 -1.11 . . . . 0.0 109.472 179.957 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 58' ' ' PHE . . . . . 0.856 ' HB2' HD11 ' A' ' 64' ' ' ILE . 96.9 m-85 -115.01 8.33 15.75 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.244 -0.91 . . . . 0.0 109.468 179.966 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 59' ' ' SER . . . . . 0.533 ' N ' ' HD2' ' A' ' 60' ' ' PRO . 0.8 OUTLIER -72.91 -58.14 2.76 Favored Pre-proline 0 N--CA 1.49 1.574 0 O-C-N 121.195 -0.941 . . . . 0.0 109.811 -179.784 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 60' ' ' PRO . . . . . 0.533 ' HD2' ' N ' ' A' ' 59' ' ' SER . 48.0 Cg_endo -68.9 -28.69 29.24 Favored 'Trans proline' 0 C--O 1.215 -0.65 0 C-N-CA 122.602 2.202 . . . . 0.0 111.973 -179.702 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 61' ' ' PHE . . . . . 0.572 ' CD1' ' HA ' ' A' ' 89' ' ' ALA . 61.2 m-85 -70.11 -31.74 69.44 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.181 -0.949 . . . . 0.0 109.548 -179.988 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . 0.413 ' HA3' ' HB3' ' A' ' 85' ' ' SER . . . 176.39 -171.41 44.4 Favored Glycine 0 N--CA 1.49 2.262 0 N-CA-C 109.504 -1.438 . . . . 0.0 109.504 179.881 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 85.6 m-20 -99.67 137.33 38.3 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.244 -1.15 . . . . 0.0 109.311 -179.963 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 64' ' ' ILE . . . . . 0.856 HD11 ' HB2' ' A' ' 58' ' ' PHE . 64.0 mt -99.53 131.72 46.35 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.517 0 O-C-N 121.238 -0.914 . . . . 0.0 109.581 -179.988 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 65' ' ' ILE . . . . . 0.737 HD11 ' HA3' ' A' ' 39' ' ' GLY . 18.3 pt -96.67 -22.47 5.06 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.549 0 O-C-N 121.346 -0.846 . . . . 0.0 109.427 179.982 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 66' ' ' ASP . . . . . 0.452 ' HB3' ' OG1' ' A' ' 79' ' ' THR . 54.9 t0 -143.76 135.96 26.74 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.219 -0.925 . . . . 0.0 109.563 -179.963 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . 0.747 ' C ' HD13 ' A' ' 67' ' ' LEU . 3.4 tm? -122.47 114.71 21.07 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.233 -0.917 . . . . 0.0 109.314 179.918 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 68' ' ' SER . . . . . 0.501 ' N ' HD13 ' A' ' 67' ' ' LEU . 37.7 t -129.25 145.43 51.35 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.247 -0.908 . . . . 0.0 109.518 -179.917 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 69' ' ' MET . . . . . 0.481 ' HA ' ' HA ' ' A' ' 76' ' ' ALA . 79.3 mtp -130.4 143.92 51.07 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.218 -0.926 . . . . 0.0 109.445 179.963 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 70' ' ' ASP . . . . . 0.478 ' C ' ' HD2' ' A' ' 72' ' ' PRO . 2.4 t70 -117.06 107.06 46.34 Favored Pre-proline 0 N--CA 1.489 1.514 0 O-C-N 121.229 -0.92 . . . . 0.0 109.575 -179.928 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 71' ' ' PRO . . . . . 0.604 ' N ' ' CD ' ' A' ' 72' ' ' PRO . 46.3 Cg_endo -74.85 -27.69 10.09 Favored 'Trans proline' 0 CA--C 1.543 0.962 0 C-N-CA 122.458 2.106 . . . . 0.0 113.571 179.923 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 72' ' ' PRO . . . . . 0.604 ' CD ' ' N ' ' A' ' 71' ' ' PRO . 55.2 Cg_endo -75.38 -29.56 7.53 Favored 'Trans proline' 0 C--N 1.353 0.787 0 C-N-CA 121.427 1.418 . . . . 0.0 111.81 -179.872 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 5.8 mtp85 -106.97 1.3 24.35 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.161 -0.962 . . . . 0.0 109.63 179.995 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 80.2 m-20 57.61 39.1 27.87 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.145 -0.972 . . . . 0.0 109.46 179.991 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 75' ' ' CYS . . . . . 0.44 ' HA ' ' O ' ' A' ' 44' ' ' VAL . 27.9 p -134.96 140.52 45.77 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.186 -0.946 . . . . 0.0 109.5 -179.963 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . 0.481 ' HA ' ' HA ' ' A' ' 69' ' ' MET . . . -108.22 152.23 24.86 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.34 -0.85 . . . . 0.0 109.395 179.964 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 77' ' ' PHE . . . . . 0.46 ' HB2' ' HB3' ' A' ' 68' ' ' SER . 96.8 m-85 -117.59 129.95 56.09 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.24 -0.913 . . . . 0.0 109.527 -179.955 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . 0.482 ' O ' ' N ' ' A' ' 42' ' ' LEU . 48.2 t -124.79 132.09 71.78 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.575 0 O-C-N 121.261 -0.9 . . . . 0.0 109.413 179.968 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 79' ' ' THR . . . . . 0.576 HG22 ' CA ' ' A' ' 39' ' ' GLY . 22.8 m -101.22 134.1 44.78 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.286 -0.884 . . . . 0.0 109.5 179.965 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 80' ' ' TYR . . . . . 0.795 ' CD2' HD11 ' A' ' 42' ' ' LEU . 0.4 OUTLIER -109.95 144.57 38.28 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.275 -0.891 . . . . 0.0 109.548 -179.977 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 81' ' ' GLU . . . . . 0.425 ' O ' ' CB ' ' A' ' 38' ' ' LYS . 84.9 tt0 -66.81 -31.16 71.6 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.177 -0.952 . . . . 0.0 109.514 179.836 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 46.1 mttm -128.11 152.32 48.14 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.327 -0.858 . . . . 0.0 109.445 -179.998 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 83' ' ' MET . . . . . 0.715 ' HE2' ' N ' ' A' ' 117' ' ' ALA . 40.7 mtt -69.79 -21.98 63.37 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.226 -0.921 . . . . 0.0 109.491 179.987 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 98.7 mt-10 -71.15 -33.42 70.04 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.27 -0.894 . . . . 0.0 109.605 -179.955 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 85' ' ' SER . . . . . 0.413 ' HB3' ' HA3' ' A' ' 62' ' ' GLY . 19.4 m -66.92 -31.07 71.41 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.167 -0.958 . . . . 0.0 109.479 -179.901 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 86' ' ' ALA . . . . . 0.496 ' O ' HG23 ' A' ' 90' ' ' VAL . . . -80.08 -33.74 38.61 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.253 -0.904 . . . . 0.0 109.476 -179.955 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 58.7 t0 -65.48 -40.57 93.28 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.262 -0.898 . . . . 0.0 109.589 -179.946 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 88' ' ' GLN . . . . . 0.437 ' O ' ' HB2' ' A' ' 92' ' ' GLU . 62.0 tt0 -73.92 -38.72 64.21 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.285 -0.884 . . . . 0.0 109.591 -179.917 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 89' ' ' ALA . . . . . 0.572 ' HA ' ' CD1' ' A' ' 61' ' ' PHE . . . -76.46 -41.22 48.07 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.249 -0.907 . . . . 0.0 109.507 179.975 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 90' ' ' VAL . . . . . 0.772 ' HA ' HG11 ' A' ' 105' ' ' VAL . 55.6 t -65.91 -40.97 88.97 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.591 0 O-C-N 121.286 -0.883 . . . . 0.0 109.623 -179.812 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -74.95 -38.26 61.76 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.145 -0.972 . . . . 0.0 109.741 -179.774 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 92' ' ' GLU . . . . . 0.557 ' HB3' ' CZ ' ' A' ' 61' ' ' PHE . 5.9 tm-20 -78.85 -50.8 10.65 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.187 -0.946 . . . . 0.0 109.722 -179.744 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 93' ' ' LEU . . . . . 0.724 HD13 ' CZ ' ' A' ' 58' ' ' PHE . 48.9 mt -62.64 -35.5 79.79 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.262 -0.899 . . . . 0.0 109.56 -179.829 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 94' ' ' ASN . . . . . 0.485 ' HB2' ' O ' ' A' ' 90' ' ' VAL . 56.8 t-20 -74.71 129.11 37.12 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.246 -0.909 . . . . 0.0 109.549 -179.909 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 91.55 24.44 26.02 Favored Glycine 0 N--CA 1.49 2.253 0 N-CA-C 109.551 -1.42 . . . . 0.0 109.551 179.926 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 96' ' ' THR . . . . . 0.48 ' CG2' ' O ' ' A' ' 92' ' ' GLU . 36.9 p -126.23 154.05 43.86 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.201 -1.176 . . . . 0.0 109.572 179.985 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 63.8 tt0 -117.83 138.9 51.78 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.225 -0.922 . . . . 0.0 109.491 -179.96 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 98' ' ' VAL . . . . . 0.552 HG23 ' O ' ' A' ' 101' ' ' VAL . 1.2 t -81.13 -151.99 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 121.204 -0.935 . . . . 0.0 109.315 -179.99 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 99' ' ' GLU . . . . . 0.533 ' H ' HG12 ' A' ' 98' ' ' VAL . 96.3 mt-10 -60.78 -37.89 83.41 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.204 -0.935 . . . . 0.0 109.477 179.983 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -158.1 22.81 0.25 Allowed 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.264 -0.897 . . . . 0.0 109.476 179.99 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 101' ' ' VAL . . . . . 0.552 ' O ' HG23 ' A' ' 98' ' ' VAL . 47.9 t -139.43 154.41 24.83 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.531 0 O-C-N 121.224 -0.923 . . . . 0.0 109.496 179.993 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 92.2 mt-30 -102.45 144.18 31.23 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.242 -0.911 . . . . 0.0 109.431 179.96 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 92.0 mt -110.37 138.89 46.16 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.311 -0.868 . . . . 0.0 109.564 179.997 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 104' ' ' LYS . . . . . 0.476 ' HB2' ' HB3' ' A' ' 45' ' ' TYR . 76.6 mttt -120.23 138.53 53.6 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.268 -0.895 . . . . 0.0 109.259 179.853 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 105' ' ' VAL . . . . . 0.772 HG11 ' HA ' ' A' ' 90' ' ' VAL . 18.4 t -122.48 137.17 56.92 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.549 0 O-C-N 121.142 -0.974 . . . . 0.0 109.657 -179.819 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 106' ' ' ASN . . . . . 0.473 ' HB2' ' HB3' ' A' ' 43' ' ' TYR . 92.2 m-20 -136.54 -174.33 3.67 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.255 -0.903 . . . . 0.0 109.168 179.818 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 22.7 mm -107.19 134.68 48.18 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.619 0 O-C-N 121.227 -0.921 . . . . 0.0 109.563 -179.949 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -110.17 151.94 26.66 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.312 -0.867 . . . . 0.0 109.437 179.969 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 25.8 mtm180 -101.15 10.78 40.5 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.289 -0.882 . . . . 0.0 109.626 -179.951 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 110' ' ' LYS . . . . . 0.524 ' O ' ' CB ' ' A' ' 111' ' ' GLN . 74.0 mttt -81.93 176.04 9.89 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.157 -0.964 . . . . 0.0 109.434 -179.963 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 111' ' ' GLN . . . . . 0.561 ' N ' ' CD ' ' A' ' 112' ' ' PRO . 6.6 tp-100 75.61 47.9 0.17 Allowed Pre-proline 0 N--CA 1.49 1.555 0 O-C-N 121.249 -0.907 . . . . 0.0 109.343 179.919 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 112' ' ' PRO . . . . . 0.561 ' CD ' ' N ' ' A' ' 111' ' ' GLN . 53.4 Cg_endo -72.34 -20.62 24.04 Favored 'Trans proline' 0 C--O 1.216 -0.613 0 C-N-CA 122.777 2.318 . . . . 0.0 111.99 -179.93 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 113' ' ' MET . . . . . 0.537 ' HE2' ' HG3' ' A' ' 111' ' ' GLN . 0.0 OUTLIER -43.62 -33.02 1.08 Allowed 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.277 -0.889 . . . . 0.0 109.512 -179.797 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 114' ' ' LEU . . . . . 0.7 ' CD1' HG23 ' A' ' 118' ' ' THR . 0.3 OUTLIER -148.49 17.47 1.04 Allowed 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.258 -0.901 . . . . 0.0 109.247 179.867 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 115' ' ' ASP . . . . . 0.718 ' O ' ' HB3' ' A' ' 116' ' ' ALA . 78.0 m-20 39.92 45.24 1.53 Allowed 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.6 -0.688 . . . . 0.0 109.519 179.975 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 116' ' ' ALA . . . . . 0.718 ' HB3' ' O ' ' A' ' 115' ' ' ASP . . . 76.66 -66.6 0.25 Allowed 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.39 -0.819 . . . . 0.0 109.395 -179.58 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 117' ' ' ALA . . . . . 0.715 ' N ' ' HE2' ' A' ' 83' ' ' MET . . . -166.19 157.08 13.01 Favored 'General case' 0 C--N 1.301 -1.505 0 C-N-CA 119.585 -0.846 . . . . 0.0 109.763 -179.66 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 118' ' ' THR . . . . . 0.7 HG23 ' CD1' ' A' ' 114' ' ' LEU . 15.7 p -124.95 168.37 13.39 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.265 -0.897 . . . . 0.0 109.555 -179.931 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 89.52 9.75 66.33 Favored Glycine 0 N--CA 1.491 2.312 0 N-CA-C 109.448 -1.461 . . . . 0.0 109.448 179.986 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 25.4 pttm -80.32 143.78 33.33 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.207 -1.172 . . . . 0.0 109.446 179.962 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 7.8 t . . . . . 0 N--CA 1.491 1.591 0 CA-C-O 118.023 -0.989 . . . . 0.0 109.457 179.98 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.539 0 N-CA-C 109.474 -0.565 . . . . 0.0 109.474 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 48.9 Cg_endo -69.93 141.92 45.8 Favored 'Trans proline' 0 C--O 1.215 -0.65 0 C-N-CA 122.65 2.233 . . . . 0.0 111.869 -179.987 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 37' ' ' ARG . . . . . 0.415 ' O ' ' C ' ' A' ' 38' ' ' LYS . 14.6 ptm180 -145.76 158.45 43.85 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.331 -0.856 . . . . 0.0 109.305 -179.978 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 38' ' ' LYS . . . . . 0.921 ' HA ' HD22 ' A' ' 114' ' ' LEU . 20.1 mttm 44.49 -162.5 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.22 -0.925 . . . . 0.0 109.279 -179.97 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . 0.777 ' HA3' HD11 ' A' ' 65' ' ' ILE . . . 129.57 71.36 0.13 Allowed Glycine 0 N--CA 1.49 2.291 0 N-CA-C 109.672 -1.371 . . . . 0.0 109.672 179.93 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 40' ' ' ASN . . . . . 0.493 ' HA ' ' HB1' ' A' ' 116' ' ' ALA . 47.1 t-20 -69.9 121.67 17.78 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.193 -1.181 . . . . 0.0 109.477 179.813 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 41' ' ' THR . . . . . 0.552 HG21 ' HB3' ' A' ' 110' ' ' LYS . 66.1 m -84.32 140.42 31.63 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.225 -0.922 . . . . 0.0 109.522 -179.954 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . 0.823 HD12 ' O ' ' A' ' 78' ' ' VAL . 5.2 mp -116.18 143.04 46.03 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.322 -0.861 . . . . 0.0 109.338 179.987 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 43' ' ' TYR . . . . . 0.505 ' HB2' ' HB2' ' A' ' 108' ' ' ALA . 70.1 t80 -98.0 108.23 20.89 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.366 -0.834 . . . . 0.0 109.584 -179.951 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . 0.474 ' HA ' ' O ' ' A' ' 104' ' ' LYS . 95.6 t -105.37 136.43 39.37 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 O-C-N 121.268 -0.895 . . . . 0.0 109.363 -180.0 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 45' ' ' TYR . . . . . 0.442 ' HB3' ' HB2' ' A' ' 104' ' ' LYS . 70.5 t80 -123.42 131.33 53.61 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.141 -0.974 . . . . 0.0 109.524 -179.949 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -179.69 -174.55 45.74 Favored Glycine 0 N--CA 1.491 2.333 0 N-CA-C 109.401 -1.48 . . . . 0.0 109.401 179.963 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 95.6 mt-10 -121.12 156.49 32.19 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.216 -1.167 . . . . 0.0 109.476 -179.958 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 59.4 t0 46.23 52.52 10.33 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.237 -0.915 . . . . 0.0 109.487 -179.985 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 49' ' ' MET . . . . . 0.408 ' O ' ' HE1' ' A' ' 69' ' ' MET . 61.6 mtm -104.17 139.8 38.71 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.247 -0.908 . . . . 0.0 109.547 -179.928 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 50' ' ' THR . . . . . 0.506 ' O ' HD12 ' A' ' 54' ' ' LEU . 0.1 OUTLIER -121.5 166.57 15.9 Favored Pre-proline 0 N--CA 1.49 1.547 0 O-C-N 121.208 -0.932 . . . . 0.0 109.414 -179.98 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 51' ' ' PRO . . . . . 0.485 ' N ' ' SD ' ' A' ' 69' ' ' MET . 48.2 Cg_endo -70.17 -55.73 0.16 Allowed 'Trans proline' 0 C--O 1.215 -0.651 0 C-N-CA 122.599 2.199 . . . . 0.0 111.918 179.937 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 26.2 m -48.88 -49.91 37.44 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.181 -0.95 . . . . 0.0 109.287 179.877 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 24.2 tp -58.08 -50.5 73.24 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.181 -0.949 . . . . 0.0 109.161 179.782 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 54' ' ' LEU . . . . . 0.506 HD12 ' O ' ' A' ' 50' ' ' THR . 11.6 mt -56.26 -44.42 79.68 Favored 'General case' 0 N--CA 1.488 1.475 0 O-C-N 121.272 -0.893 . . . . 0.0 109.238 179.742 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 55' ' ' ARG . . . . . 0.517 ' O ' ' N ' ' A' ' 59' ' ' SER . 93.6 mtt180 -51.38 -38.63 54.36 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.242 -0.911 . . . . 0.0 109.319 179.82 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -69.56 -33.3 71.81 Favored Glycine 0 N--CA 1.49 2.295 0 N-CA-C 109.508 -1.437 . . . . 0.0 109.508 179.926 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -75.92 -23.39 55.49 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.287 -1.125 . . . . 0.0 109.461 179.969 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 58' ' ' PHE . . . . . 0.672 ' HB2' HD11 ' A' ' 64' ' ' ILE . 97.0 m-85 -117.56 8.37 12.88 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.305 -0.872 . . . . 0.0 109.403 179.988 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 59' ' ' SER . . . . . 0.534 ' N ' ' HD2' ' A' ' 60' ' ' PRO . 0.6 OUTLIER -75.16 -57.12 1.8 Allowed Pre-proline 0 N--CA 1.491 1.606 0 O-C-N 121.231 -0.918 . . . . 0.0 110.066 -179.637 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 60' ' ' PRO . . . . . 0.534 ' HD2' ' N ' ' A' ' 59' ' ' SER . 49.8 Cg_endo -69.5 -25.12 30.1 Favored 'Trans proline' 0 C--O 1.214 -0.68 0 C-N-CA 122.62 2.213 . . . . 0.0 112.213 -179.56 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 61' ' ' PHE . . . . . 0.583 ' CZ ' ' HB2' ' A' ' 92' ' ' GLU . 64.4 m-85 -72.67 -27.17 61.93 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.149 -0.97 . . . . 0.0 109.491 179.985 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 169.31 -176.0 43.45 Favored Glycine 0 N--CA 1.49 2.275 0 N-CA-C 109.464 -1.454 . . . . 0.0 109.464 179.939 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 83.2 m-20 -93.93 139.82 30.45 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.269 -1.136 . . . . 0.0 109.416 -179.995 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 64' ' ' ILE . . . . . 0.672 HD11 ' HB2' ' A' ' 58' ' ' PHE . 61.1 mt -100.61 132.84 45.5 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.588 0 O-C-N 121.236 -0.915 . . . . 0.0 109.539 179.995 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 65' ' ' ILE . . . . . 0.777 HD11 ' HA3' ' A' ' 39' ' ' GLY . 26.7 pt -94.27 -24.04 5.07 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.604 0 O-C-N 121.341 -0.849 . . . . 0.0 109.442 179.98 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 66' ' ' ASP . . . . . 0.467 ' HB3' ' OG1' ' A' ' 79' ' ' THR . 55.3 t0 -147.78 136.6 21.95 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.22 -0.925 . . . . 0.0 109.561 -179.974 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . 0.748 ' C ' HD13 ' A' ' 67' ' ' LEU . 3.5 tm? -119.92 114.18 21.68 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.348 -0.845 . . . . 0.0 109.276 179.994 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 68' ' ' SER . . . . . 0.495 ' HB2' ' HB2' ' A' ' 77' ' ' PHE . 49.1 m -123.89 141.5 51.98 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.281 -0.887 . . . . 0.0 109.625 -179.993 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 69' ' ' MET . . . . . 0.485 ' SD ' ' N ' ' A' ' 51' ' ' PRO . 84.2 mtp -129.71 148.15 51.57 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.234 -0.916 . . . . 0.0 109.434 179.888 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 70' ' ' ASP . . . . . 0.485 ' C ' ' HD2' ' A' ' 72' ' ' PRO . 0.4 OUTLIER -124.21 102.0 34.29 Favored Pre-proline 0 N--CA 1.49 1.551 0 O-C-N 121.225 -0.922 . . . . 0.0 109.525 -179.959 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 71' ' ' PRO . . . . . 0.595 ' N ' ' CD ' ' A' ' 72' ' ' PRO . 46.5 Cg_endo -74.67 -27.6 10.54 Favored 'Trans proline' 0 CA--C 1.543 0.952 0 C-N-CA 122.519 2.146 . . . . 0.0 113.57 179.957 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 72' ' ' PRO . . . . . 0.595 ' CD ' ' N ' ' A' ' 71' ' ' PRO . 55.2 Cg_endo -75.57 -31.61 5.39 Favored 'Trans proline' 0 C--N 1.354 0.832 0 C-N-CA 121.452 1.435 . . . . 0.0 111.682 -179.911 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 73' ' ' ARG . . . . . 0.469 ' HG2' ' O ' ' A' ' 73' ' ' ARG . 19.5 ttt180 -103.85 -2.63 25.99 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.188 -0.945 . . . . 0.0 109.641 179.953 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 74' ' ' ASN . . . . . 0.432 ' HB2' ' O ' ' A' ' 73' ' ' ARG . 82.3 m-20 62.11 44.41 7.95 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.228 -0.92 . . . . 0.0 109.402 -179.901 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 75' ' ' CYS . . . . . 0.404 ' HA ' ' O ' ' A' ' 44' ' ' VAL . 23.9 p -143.13 134.73 26.42 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.237 -0.915 . . . . 0.0 109.439 -179.96 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . 0.452 ' HA ' ' HA ' ' A' ' 69' ' ' MET . . . -107.63 160.45 15.69 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.316 -0.865 . . . . 0.0 109.436 179.985 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 77' ' ' PHE . . . . . 0.495 ' HB2' ' HB2' ' A' ' 68' ' ' SER . 96.5 m-85 -128.0 130.74 48.82 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.264 -0.898 . . . . 0.0 109.546 -179.948 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . 0.823 ' O ' HD12 ' A' ' 42' ' ' LEU . 33.7 t -121.43 134.22 65.47 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.556 0 O-C-N 121.146 -0.971 . . . . 0.0 109.485 -179.946 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 79' ' ' THR . . . . . 0.621 HG22 ' CA ' ' A' ' 39' ' ' GLY . 5.2 m -102.67 130.11 49.49 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.241 -0.912 . . . . 0.0 109.452 -179.977 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 80' ' ' TYR . . . . . 0.492 ' OH ' ' HB2' ' A' ' 61' ' ' PHE . 0.6 OUTLIER -110.73 136.68 49.43 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.149 -0.969 . . . . 0.0 109.515 -179.945 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 81' ' ' GLU . . . . . 0.507 ' O ' ' CB ' ' A' ' 38' ' ' LYS . 81.8 tt0 -54.56 -28.6 47.06 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.218 -0.926 . . . . 0.0 109.446 179.986 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 57.4 mttm -135.9 148.78 48.72 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.204 -0.935 . . . . 0.0 109.589 -179.965 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 83' ' ' MET . . . . . 0.995 ' HE3' ' O ' ' A' ' 117' ' ' ALA . 61.2 mtt -67.84 -21.06 65.21 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.175 -0.953 . . . . 0.0 109.471 -179.96 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 97.2 mt-10 -66.96 -41.48 86.81 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.239 -0.913 . . . . 0.0 109.457 -179.949 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 19.8 m -64.05 -30.94 71.97 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.336 -0.853 . . . . 0.0 109.451 179.96 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 86' ' ' ALA . . . . . 0.833 ' O ' HG23 ' A' ' 90' ' ' VAL . . . -73.67 -31.08 63.28 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.297 -0.877 . . . . 0.0 109.455 179.903 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 58.6 t0 -67.99 -44.69 76.04 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.2 -0.937 . . . . 0.0 109.517 179.973 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 62.1 tt0 -64.28 -39.95 94.97 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.184 -0.948 . . . . 0.0 109.483 179.906 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 89' ' ' ALA . . . . . 0.893 ' HB1' ' CD1' ' A' ' 93' ' ' LEU . . . -74.51 -43.11 57.44 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.238 -0.914 . . . . 0.0 109.496 -179.901 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 90' ' ' VAL . . . . . 0.833 HG23 ' O ' ' A' ' 86' ' ' ALA . 88.9 t -61.49 -32.02 52.22 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.56 0 O-C-N 121.176 -0.953 . . . . 0.0 109.685 -179.867 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -80.14 -51.92 8.4 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.23 -0.919 . . . . 0.0 109.728 -179.841 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 92' ' ' GLU . . . . . 0.583 ' HB2' ' CZ ' ' A' ' 61' ' ' PHE . 74.1 mt-10 -71.63 -47.28 55.58 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.278 -0.889 . . . . 0.0 109.927 -179.699 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 93' ' ' LEU . . . . . 0.893 ' CD1' ' HB1' ' A' ' 89' ' ' ALA . 62.4 mt -63.78 -36.76 84.96 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.188 -0.945 . . . . 0.0 109.857 -179.643 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 94' ' ' ASN . . . . . 0.524 ' CB ' ' O ' ' A' ' 90' ' ' VAL . 61.0 t-20 -74.3 125.99 29.67 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.131 -0.98 . . . . 0.0 109.475 -179.865 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 96.1 22.1 21.01 Favored Glycine 0 N--CA 1.489 2.225 0 N-CA-C 109.461 -1.456 . . . . 0.0 109.461 179.916 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 96' ' ' THR . . . . . 0.521 ' CG2' ' O ' ' A' ' 92' ' ' GLU . 21.9 p -116.03 160.26 20.53 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.217 -1.166 . . . . 0.0 109.461 -179.975 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 97' ' ' GLN . . . . . 0.451 ' HG2' ' N ' ' A' ' 98' ' ' VAL . 64.2 tt0 -132.72 158.56 42.05 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.265 -0.897 . . . . 0.0 109.484 -179.911 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 98' ' ' VAL . . . . . 0.605 HG23 ' O ' ' A' ' 101' ' ' VAL . 1.2 t -108.56 -153.31 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.572 0 O-C-N 121.234 -0.916 . . . . 0.0 109.398 179.961 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 99' ' ' GLU . . . . . 0.537 ' H ' HG12 ' A' ' 98' ' ' VAL . 96.9 mt-10 -57.66 -36.76 72.33 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.217 -0.927 . . . . 0.0 109.61 -179.919 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -162.86 25.48 0.09 Allowed 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.25 -0.906 . . . . 0.0 109.494 179.944 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 101' ' ' VAL . . . . . 0.605 ' O ' HG23 ' A' ' 98' ' ' VAL . 84.8 t -139.37 146.61 25.35 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 O-C-N 121.239 -0.913 . . . . 0.0 109.496 179.938 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 90.3 mt-30 -100.83 147.42 26.11 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.263 -0.898 . . . . 0.0 109.495 -179.968 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 95.9 mt -113.7 133.84 55.1 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.241 -0.912 . . . . 0.0 109.493 -179.985 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 104' ' ' LYS . . . . . 0.474 ' O ' ' HA ' ' A' ' 44' ' ' VAL . 70.5 mttt -115.75 145.31 42.9 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.264 -0.897 . . . . 0.0 109.308 179.964 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 105' ' ' VAL . . . . . 0.773 HG11 ' HA ' ' A' ' 90' ' ' VAL . 29.2 t -127.52 146.73 32.78 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.524 0 O-C-N 121.12 -0.988 . . . . 0.0 109.718 -179.789 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 106' ' ' ASN . . . . . 0.463 ' HB2' ' HB3' ' A' ' 43' ' ' TYR . 74.9 m-20 -158.08 -167.9 2.35 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.315 -0.866 . . . . 0.0 109.272 179.975 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 25.4 mm -109.55 137.28 42.44 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.553 0 O-C-N 121.189 -0.944 . . . . 0.0 109.419 -179.978 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 108' ' ' ALA . . . . . 0.505 ' HB2' ' HB2' ' A' ' 43' ' ' TYR . . . -132.16 148.8 52.49 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.192 -0.943 . . . . 0.0 109.519 179.992 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 75.3 mtp85 -102.02 32.56 3.41 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.207 -0.933 . . . . 0.0 109.555 179.973 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 110' ' ' LYS . . . . . 0.552 ' HB3' HG21 ' A' ' 41' ' ' THR . 39.2 tttt -71.86 -4.49 28.37 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.272 -0.892 . . . . 0.0 109.573 -179.953 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 111' ' ' GLN . . . . . 0.528 ' HG3' ' HE2' ' A' ' 113' ' ' MET . 0.5 OUTLIER -119.08 73.33 12.89 Favored Pre-proline 0 N--CA 1.489 1.507 0 O-C-N 121.185 -0.947 . . . . 0.0 109.53 -179.983 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 112' ' ' PRO . . . . . 0.439 ' O ' ' C ' ' A' ' 113' ' ' MET . 55.7 Cg_endo -80.28 -20.93 8.09 Favored 'Trans proline' 0 C--O 1.216 -0.621 0 C-N-CA 122.759 2.306 . . . . 0.0 112.089 -179.757 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 113' ' ' MET . . . . . 0.528 ' HE2' ' HG3' ' A' ' 111' ' ' GLN . 0.0 OUTLIER -42.09 -34.43 0.73 Allowed 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.194 -0.941 . . . . 0.0 109.617 -179.707 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 114' ' ' LEU . . . . . 0.921 HD22 ' HA ' ' A' ' 38' ' ' LYS . 4.6 tt -142.66 25.96 1.78 Allowed 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.355 -0.841 . . . . 0.0 109.124 179.727 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 115' ' ' ASP . . . . . 0.494 ' O ' ' N ' ' A' ' 117' ' ' ALA . 75.9 m-20 44.58 55.78 5.57 Favored 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.227 -0.92 . . . . 0.0 109.076 -179.74 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 116' ' ' ALA . . . . . 0.519 ' O ' ' N ' ' A' ' 39' ' ' GLY . . . 62.8 -77.98 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.323 -0.86 . . . . 0.0 109.383 -179.667 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 117' ' ' ALA . . . . . 0.995 ' O ' ' HE3' ' A' ' 83' ' ' MET . . . -161.81 154.51 20.17 Favored 'General case' 0 C--N 1.302 -1.496 0 O-C-N 121.368 -0.832 . . . . 0.0 109.524 -179.811 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 18.3 p -130.39 167.13 19.06 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.208 -0.933 . . . . 0.0 109.629 -179.789 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 119' ' ' GLY . . . . . 0.416 ' O ' ' HB2' ' A' ' 120' ' ' LYS . . . -145.51 176.21 24.63 Favored Glycine 0 N--CA 1.49 2.269 0 N-CA-C 109.344 -1.502 . . . . 0.0 109.344 179.915 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 120' ' ' LYS . . . . . 0.416 ' HB2' ' O ' ' A' ' 119' ' ' GLY . 35.8 mttm 60.84 43.4 12.0 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.289 -1.124 . . . . 0.0 109.429 -179.995 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 2.2 p . . . . . 0 N--CA 1.49 1.544 0 CA-C-O 118.074 -0.965 . . . . 0.0 109.439 -179.998 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . 0.784 ' HB1' HD12 ' A' ' 114' ' ' LEU . . . . . . . . 0 N--CA 1.489 1.52 0 N-CA-C 109.498 -0.556 . . . . 0.0 109.498 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 49.4 Cg_endo -69.57 -9.13 25.38 Favored 'Trans proline' 0 C--O 1.215 -0.638 0 C-N-CA 122.739 2.293 . . . . 0.0 111.728 -179.985 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 72.7 mtt180 -122.25 139.9 53.23 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.274 -0.892 . . . . 0.0 109.526 -179.903 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 38' ' ' LYS . . . . . 0.467 ' HB3' ' O ' ' A' ' 116' ' ' ALA . 12.2 mttp -111.57 -163.21 0.83 Allowed 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.259 -0.9 . . . . 0.0 109.422 179.944 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . 0.526 ' HA2' ' CA ' ' A' ' 81' ' ' GLU . . . -177.09 177.07 48.29 Favored Glycine 0 N--CA 1.492 2.372 0 N-CA-C 109.548 -1.421 . . . . 0.0 109.548 179.882 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 40' ' ' ASN . . . . . 0.529 ' N ' ' O ' ' A' ' 80' ' ' TYR . 54.3 t30 -155.36 110.33 2.99 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.055 -1.262 . . . . 0.0 109.352 179.8 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 41' ' ' THR . . . . . 0.492 ' O ' HD23 ' A' ' 42' ' ' LEU . 45.1 m -74.49 136.55 42.24 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.273 -0.892 . . . . 0.0 109.839 -179.695 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . 0.867 HD11 ' CD2' ' A' ' 80' ' ' TYR . 13.7 mt -119.47 157.21 28.74 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.363 -0.836 . . . . 0.0 109.322 179.84 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 43' ' ' TYR . . . . . 0.471 ' HB3' ' HB2' ' A' ' 106' ' ' ASN . 69.9 t80 -114.14 121.38 43.59 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.261 -0.899 . . . . 0.0 109.448 -179.976 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 47.4 t -115.88 136.3 53.21 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.579 0 O-C-N 121.331 -0.855 . . . . 0.0 109.367 179.948 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 71.8 t80 -126.35 130.61 51.13 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.264 -0.897 . . . . 0.0 109.488 -179.923 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -175.83 -173.94 41.96 Favored Glycine 0 N--CA 1.49 2.272 0 N-CA-C 109.472 -1.451 . . . . 0.0 109.472 179.999 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . 0.422 ' O ' ' C ' ' A' ' 48' ' ' ASP . 94.8 mt-10 -115.88 156.39 26.22 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.231 -1.158 . . . . 0.0 109.487 -179.916 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . 0.422 ' C ' ' O ' ' A' ' 47' ' ' GLU . 38.1 m-20 44.21 51.19 7.49 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.229 -0.919 . . . . 0.0 109.551 179.936 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 55.3 mtm -100.57 137.09 39.45 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.272 -0.893 . . . . 0.0 109.433 179.981 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 50' ' ' THR . . . . . 0.476 ' O ' HD12 ' A' ' 54' ' ' LEU . 0.3 OUTLIER -119.76 163.21 28.86 Favored Pre-proline 0 N--CA 1.491 1.583 0 O-C-N 121.308 -0.87 . . . . 0.0 109.441 179.963 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 48.7 Cg_endo -70.13 -54.26 0.21 Allowed 'Trans proline' 0 C--O 1.214 -0.677 0 C-N-CA 122.629 2.22 . . . . 0.0 111.815 -179.992 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 37.3 m -53.27 -48.49 68.25 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.185 -0.947 . . . . 0.0 109.317 179.921 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 17.6 tp -58.63 -48.49 80.83 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.247 -0.908 . . . . 0.0 109.28 179.824 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 54' ' ' LEU . . . . . 0.66 HD11 ' HE1' ' A' ' 69' ' ' MET . 16.6 mt -57.87 -44.99 87.0 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.232 -0.917 . . . . 0.0 109.259 179.793 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 55' ' ' ARG . . . . . 0.514 ' O ' ' N ' ' A' ' 59' ' ' SER . 57.5 mtt-85 -50.94 -39.75 55.66 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.244 -0.91 . . . . 0.0 109.2 179.853 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -69.5 -30.87 70.92 Favored Glycine 0 N--CA 1.49 2.243 0 N-CA-C 109.313 -1.515 . . . . 0.0 109.313 179.767 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -79.51 -21.53 45.15 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.243 -1.151 . . . . 0.0 109.467 179.998 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 58' ' ' PHE . . . . . 0.66 ' CZ ' HD13 ' A' ' 93' ' ' LEU . 94.5 m-85 -119.09 7.97 11.47 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.26 -0.9 . . . . 0.0 109.384 179.929 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 59' ' ' SER . . . . . 0.539 ' N ' ' HD2' ' A' ' 60' ' ' PRO . 0.6 OUTLIER -75.24 -55.54 2.18 Favored Pre-proline 0 N--CA 1.49 1.562 0 O-C-N 121.286 -0.884 . . . . 0.0 110.196 -179.591 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 60' ' ' PRO . . . . . 0.539 ' HD2' ' N ' ' A' ' 59' ' ' SER . 48.4 Cg_endo -69.42 -29.6 25.24 Favored 'Trans proline' 0 C--O 1.214 -0.677 0 C-N-CA 122.542 2.161 . . . . 0.0 112.208 -179.408 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 61' ' ' PHE . . . . . 0.588 ' CB ' ' HB2' ' A' ' 89' ' ' ALA . 55.2 m-85 -67.48 -28.88 68.22 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.21 -0.931 . . . . 0.0 109.534 179.984 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 172.81 -178.43 44.85 Favored Glycine 0 N--CA 1.49 2.293 0 N-CA-C 109.579 -1.408 . . . . 0.0 109.579 179.951 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 47.9 t-20 -94.26 138.25 32.49 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.292 -1.122 . . . . 0.0 109.447 179.99 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 64' ' ' ILE . . . . . 0.514 HD11 ' HB2' ' A' ' 58' ' ' PHE . 57.7 mt -100.02 135.49 35.48 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.502 0 O-C-N 121.258 -0.901 . . . . 0.0 109.392 -179.972 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 65' ' ' ILE . . . . . 0.428 HG12 ' HB ' ' A' ' 79' ' ' THR . 27.2 pt -102.6 -21.76 5.05 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.636 0 O-C-N 121.326 -0.859 . . . . 0.0 109.659 -179.833 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 66' ' ' ASP . . . . . 0.458 ' HB3' ' OG1' ' A' ' 79' ' ' THR . 56.7 t0 -145.39 111.8 5.76 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.122 -0.986 . . . . 0.0 109.675 -179.966 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . 0.446 HD22 ' NE ' ' A' ' 55' ' ' ARG . 32.3 tp -108.11 123.6 48.95 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.328 -0.857 . . . . 0.0 109.358 179.919 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 68' ' ' SER . . . . . 0.481 ' HB3' ' HB2' ' A' ' 77' ' ' PHE . 23.2 t -134.25 140.71 46.64 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.271 -0.893 . . . . 0.0 109.505 -179.941 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 69' ' ' MET . . . . . 0.66 ' HE1' HD11 ' A' ' 54' ' ' LEU . 87.6 mmm -113.71 151.65 31.58 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.301 -0.874 . . . . 0.0 109.502 179.923 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 70' ' ' ASP . . . . . 0.472 ' C ' ' HD2' ' A' ' 72' ' ' PRO . 0.3 OUTLIER -131.84 100.29 16.14 Favored Pre-proline 0 N--CA 1.49 1.554 0 O-C-N 121.277 -0.89 . . . . 0.0 109.522 179.95 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 71' ' ' PRO . . . . . 0.595 ' CD ' ' CD ' ' A' ' 72' ' ' PRO . 46.7 Cg_endo -74.53 -27.9 10.56 Favored 'Trans proline' 0 CA--C 1.543 0.943 0 C-N-CA 122.497 2.131 . . . . 0.0 113.629 -179.897 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 72' ' ' PRO . . . . . 0.595 ' CD ' ' CD ' ' A' ' 71' ' ' PRO . 54.5 Cg_endo -75.46 -32.79 4.61 Favored 'Trans proline' 0 C--N 1.353 0.763 0 C-N-CA 121.431 1.42 . . . . 0.0 111.643 -179.89 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 73' ' ' ARG . . . . . 0.45 ' O ' ' HG3' ' A' ' 73' ' ' ARG . 13.6 tpt180 -101.45 -4.85 26.11 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.249 -0.907 . . . . 0.0 109.523 -179.978 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 74' ' ' ASN . . . . . 0.437 ' HB2' ' O ' ' A' ' 73' ' ' ARG . 77.5 m-20 61.95 43.78 8.84 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.194 -0.941 . . . . 0.0 109.507 -179.854 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 75' ' ' CYS . . . . . 0.432 ' CB ' ' CZ ' ' A' ' 43' ' ' TYR . 31.4 p -147.48 142.73 27.27 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.298 -0.876 . . . . 0.0 109.48 -179.954 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . 0.446 ' HB1' ' SD ' ' A' ' 69' ' ' MET . . . -107.29 163.17 13.25 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.296 -0.877 . . . . 0.0 109.469 179.984 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 77' ' ' PHE . . . . . 0.481 ' HB2' ' HB3' ' A' ' 68' ' ' SER . 96.7 m-85 -122.84 130.89 53.43 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.317 -0.864 . . . . 0.0 109.544 -179.969 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . 0.495 ' O ' ' N ' ' A' ' 42' ' ' LEU . 46.7 t -126.52 140.11 49.79 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.604 0 O-C-N 121.278 -0.889 . . . . 0.0 109.33 179.861 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 79' ' ' THR . . . . . 0.521 ' CG2' ' OE1' ' A' ' 111' ' ' GLN . 2.5 m -115.55 112.73 22.63 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.224 -0.922 . . . . 0.0 109.584 -179.849 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 80' ' ' TYR . . . . . 0.867 ' CD2' HD11 ' A' ' 42' ' ' LEU . 1.4 m-85 -93.12 123.15 36.17 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.25 -0.906 . . . . 0.0 109.402 179.932 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 81' ' ' GLU . . . . . 0.526 ' CA ' ' HA2' ' A' ' 39' ' ' GLY . 86.1 tt0 -38.88 -34.54 0.16 Allowed 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.537 -0.727 . . . . 0.0 110.302 -179.667 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 57.2 mttp -128.52 158.38 38.57 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.068 -1.02 . . . . 0.0 109.594 -179.911 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 83' ' ' MET . . . . . 0.631 ' HE3' ' C ' ' A' ' 117' ' ' ALA . 58.9 mtt -74.65 -21.71 59.29 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.274 -0.891 . . . . 0.0 109.452 179.936 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 75.6 mm-40 -68.51 -46.99 68.16 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.339 -0.851 . . . . 0.0 109.473 -179.958 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 14.0 m -55.5 -35.03 65.14 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.283 -0.885 . . . . 0.0 109.369 -179.945 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 86' ' ' ALA . . . . . 0.548 ' O ' HG23 ' A' ' 90' ' ' VAL . . . -75.44 -28.75 59.46 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.318 -0.863 . . . . 0.0 109.559 -179.968 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 57.1 t0 -66.18 -40.07 90.17 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.246 -0.908 . . . . 0.0 109.551 -179.925 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 88' ' ' GLN . . . . . 0.478 ' O ' ' CB ' ' A' ' 92' ' ' GLU . 47.7 tt0 -74.99 -35.64 62.01 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.244 -0.91 . . . . 0.0 109.431 -179.895 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 89' ' ' ALA . . . . . 0.624 ' HB1' ' CD1' ' A' ' 93' ' ' LEU . . . -77.47 -41.64 38.85 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.23 -0.919 . . . . 0.0 109.614 -179.912 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 90' ' ' VAL . . . . . 0.587 HG22 HG11 ' A' ' 105' ' ' VAL . 68.8 t -65.1 -47.35 88.11 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.603 0 O-C-N 121.247 -0.908 . . . . 0.0 109.638 -179.892 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -73.04 -39.65 65.77 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.218 -0.926 . . . . 0.0 109.582 -179.917 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 92' ' ' GLU . . . . . 0.583 ' HB3' ' CE1' ' A' ' 61' ' ' PHE . 44.4 tp10 -74.25 -50.22 19.93 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.266 -0.896 . . . . 0.0 109.682 -179.954 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 93' ' ' LEU . . . . . 0.66 HD13 ' CZ ' ' A' ' 58' ' ' PHE . 42.2 mt -65.24 -38.98 92.05 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.21 -0.931 . . . . 0.0 109.534 -179.841 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 94' ' ' ASN . . . . . 0.49 ' CB ' ' O ' ' A' ' 90' ' ' VAL . 59.3 t-20 -67.74 129.37 39.69 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.241 -0.912 . . . . 0.0 109.535 179.999 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 98.94 17.31 28.13 Favored Glycine 0 N--CA 1.49 2.285 0 N-CA-C 109.543 -1.423 . . . . 0.0 109.543 -179.997 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 96' ' ' THR . . . . . 0.516 HG23 ' O ' ' A' ' 93' ' ' LEU . 16.1 p -116.16 158.79 22.71 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.251 -1.146 . . . . 0.0 109.473 179.936 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 61.3 tt0 -122.8 139.83 53.58 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.255 -0.903 . . . . 0.0 109.497 179.998 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 98' ' ' VAL . . . . . 0.587 HG12 ' H ' ' A' ' 99' ' ' GLU . 1.1 t -81.79 -157.48 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.608 0 O-C-N 121.247 -0.908 . . . . 0.0 109.302 -179.982 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 99' ' ' GLU . . . . . 0.587 ' H ' HG12 ' A' ' 98' ' ' VAL . 76.4 mm-40 -60.64 -38.28 84.28 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.23 -0.919 . . . . 0.0 109.584 -179.958 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 100' ' ' SER . . . . . 0.426 ' O ' ' OG ' ' A' ' 100' ' ' SER . 4.9 t -155.04 24.04 0.43 Allowed 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.248 -0.907 . . . . 0.0 109.613 179.943 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 101' ' ' VAL . . . . . 0.548 ' O ' HG23 ' A' ' 98' ' ' VAL . 57.5 t -141.0 155.91 21.93 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.553 0 O-C-N 121.226 -0.921 . . . . 0.0 109.515 179.891 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 102' ' ' GLN . . . . . 0.415 ' N ' HG12 ' A' ' 101' ' ' VAL . 92.8 mt-30 -98.3 143.19 29.04 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.242 -0.911 . . . . 0.0 109.447 -179.971 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 103' ' ' LEU . . . . . 0.408 HD23 ' HA ' ' A' ' 103' ' ' LEU . 92.7 mt -101.85 141.86 34.05 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.25 -0.906 . . . . 0.0 109.44 179.975 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 1.3 mtpm? -131.45 134.21 45.97 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.281 -0.887 . . . . 0.0 109.4 179.921 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 105' ' ' VAL . . . . . 0.587 HG11 HG22 ' A' ' 90' ' ' VAL . 17.8 t -118.31 135.78 57.61 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.534 0 O-C-N 121.17 -0.956 . . . . 0.0 109.65 -179.931 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 106' ' ' ASN . . . . . 0.471 ' HB2' ' HB3' ' A' ' 43' ' ' TYR . 14.4 m120 -134.56 -178.43 5.06 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.358 -0.839 . . . . 0.0 109.401 179.812 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 44.1 mt -108.8 133.99 52.15 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.568 0 O-C-N 121.232 -0.918 . . . . 0.0 109.509 -179.948 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -112.96 161.51 16.93 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.284 -0.885 . . . . 0.0 109.451 -179.994 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 31.9 ttt85 -45.75 144.8 1.57 Allowed 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.177 -0.952 . . . . 0.0 109.432 -179.977 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 110' ' ' LYS . . . . . 0.471 ' HD3' ' O ' ' A' ' 115' ' ' ASP . 79.9 mttt -65.13 150.39 48.23 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.183 -0.948 . . . . 0.0 109.521 -179.923 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 111' ' ' GLN . . . . . 0.709 ' HB2' ' HE2' ' A' ' 113' ' ' MET . 0.7 OUTLIER -70.71 150.04 95.32 Favored Pre-proline 0 N--CA 1.491 1.618 0 O-C-N 121.411 -0.805 . . . . 0.0 109.648 -179.779 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 55.4 Cg_endo -74.18 -23.95 15.18 Favored 'Trans proline' 0 C--O 1.216 -0.62 0 C-N-CA 122.737 2.291 . . . . 0.0 112.756 -179.497 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 113' ' ' MET . . . . . 0.709 ' HE2' ' HB2' ' A' ' 111' ' ' GLN . 8.1 mtm -54.62 -24.14 20.15 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 120.908 -1.12 . . . . 0.0 109.516 -179.573 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 114' ' ' LEU . . . . . 0.784 HD12 ' HB1' ' A' ' 35' ' ' ALA . 2.7 tt -176.01 29.78 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.264 -0.898 . . . . 0.0 109.599 -179.814 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 115' ' ' ASP . . . . . 0.661 ' O ' ' HB3' ' A' ' 116' ' ' ALA . 79.6 m-20 48.23 36.56 6.95 Favored 'General case' 0 C--N 1.302 -1.462 0 O-C-N 121.213 -0.929 . . . . 0.0 108.868 -179.63 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 116' ' ' ALA . . . . . 0.661 ' HB3' ' O ' ' A' ' 115' ' ' ASP . . . 75.62 -82.32 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.477 -0.764 . . . . 0.0 109.648 -179.804 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 117' ' ' ALA . . . . . 0.631 ' C ' ' HE3' ' A' ' 83' ' ' MET . . . -167.03 -166.05 0.77 Allowed 'General case' 0 N--CA 1.487 1.416 0 O-C-N 121.11 -0.994 . . . . 0.0 109.611 -179.88 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 21.0 p -123.71 156.85 35.18 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.299 -0.875 . . . . 0.0 109.462 -179.987 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -178.34 -172.84 43.17 Favored Glycine 0 N--CA 1.491 2.303 0 N-CA-C 109.504 -1.439 . . . . 0.0 109.504 -179.985 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 9.2 tptt -58.22 -36.34 73.0 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.265 -1.138 . . . . 0.0 109.462 179.972 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 91.5 p . . . . . 0 N--CA 1.49 1.536 0 CA-C-O 118.013 -0.994 . . . . 0.0 109.477 179.971 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 1.505 0 N-CA-C 109.423 -0.584 . . . . 0.0 109.423 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 49.1 Cg_endo -70.02 -27.24 25.48 Favored 'Trans proline' 0 C--O 1.214 -0.702 0 C-N-CA 122.669 2.246 . . . . 0.0 111.767 -179.986 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 94.1 mtt180 -61.62 148.98 40.64 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.31 -0.869 . . . . 0.0 109.442 -179.986 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 38' ' ' LYS . . . . . 0.637 ' HA ' HD22 ' A' ' 114' ' ' LEU . 55.7 mttp -78.87 -166.01 0.83 Allowed 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.245 -0.909 . . . . 0.0 109.528 -179.81 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . 0.538 ' HA3' ' NE2' ' A' ' 111' ' ' GLN . . . 172.62 -178.7 44.57 Favored Glycine 0 N--CA 1.49 2.254 0 N-CA-C 109.41 -1.476 . . . . 0.0 109.41 -179.94 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 40' ' ' ASN . . . . . 0.698 ' HA ' ' HB1' ' A' ' 116' ' ' ALA . 61.7 t30 -171.23 113.22 0.38 Allowed 'General case' 0 N--CA 1.493 1.686 0 O-C-N 120.992 -1.299 . . . . 0.0 109.799 179.64 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 41' ' ' THR . . . . . 0.767 HG21 ' HB2' ' A' ' 110' ' ' LYS . 91.2 m -80.5 153.73 27.98 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.18 -0.95 . . . . 0.0 109.841 -179.913 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . 0.924 HD12 ' O ' ' A' ' 78' ' ' VAL . 4.7 mp -131.05 155.4 46.95 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.376 -0.827 . . . . 0.0 109.305 179.763 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 43' ' ' TYR . . . . . 0.455 ' HB3' ' HB2' ' A' ' 106' ' ' ASN . 39.2 t80 -113.67 108.9 17.76 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.206 -0.934 . . . . 0.0 109.594 -179.923 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . 0.459 ' HA ' ' O ' ' A' ' 104' ' ' LYS . 39.3 t -105.28 146.04 12.8 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 O-C-N 121.289 -0.882 . . . . 0.0 109.488 179.999 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 67.0 t80 -135.59 140.47 44.66 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.21 -0.931 . . . . 0.0 109.468 179.989 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 174.82 -165.17 36.26 Favored Glycine 0 N--CA 1.491 2.321 0 N-CA-C 109.464 -1.454 . . . . 0.0 109.464 -179.995 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 90.3 mt-10 -115.07 157.48 23.46 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.238 -1.154 . . . . 0.0 109.584 -179.908 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 56.0 t0 44.76 45.16 8.13 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.273 -0.892 . . . . 0.0 109.576 179.992 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 34.2 mtp -81.79 133.43 35.34 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.195 -0.941 . . . . 0.0 109.423 179.934 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 50' ' ' THR . . . . . 0.512 ' O ' HD12 ' A' ' 54' ' ' LEU . 0.1 OUTLIER -125.77 162.08 47.26 Favored Pre-proline 0 N--CA 1.49 1.527 0 O-C-N 121.208 -0.932 . . . . 0.0 109.461 -179.897 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 51' ' ' PRO . . . . . 0.467 ' N ' ' SD ' ' A' ' 69' ' ' MET . 50.2 Cg_endo -70.6 -53.28 0.23 Allowed 'Trans proline' 0 C--O 1.215 -0.648 0 C-N-CA 122.696 2.264 . . . . 0.0 111.644 179.957 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 30.2 m -55.87 -47.93 76.45 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.223 -0.923 . . . . 0.0 109.317 179.867 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 15.5 tp -56.94 -54.23 48.96 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.311 -0.868 . . . . 0.0 109.231 179.871 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 54' ' ' LEU . . . . . 0.512 HD12 ' O ' ' A' ' 50' ' ' THR . 12.4 mt -51.63 -52.83 44.65 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.221 -0.925 . . . . 0.0 109.225 179.766 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 55' ' ' ARG . . . . . 0.563 ' HE ' HD22 ' A' ' 67' ' ' LEU . 49.2 mtt180 -44.09 -40.28 4.8 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.354 -0.841 . . . . 0.0 109.212 179.872 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -70.43 -33.33 68.0 Favored Glycine 0 N--CA 1.49 2.273 0 N-CA-C 109.314 -1.514 . . . . 0.0 109.314 179.771 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . 0.456 ' N ' ' O ' ' A' ' 54' ' ' LEU . . . -79.81 -16.29 55.78 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.288 -1.125 . . . . 0.0 109.444 179.88 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 58' ' ' PHE . . . . . 0.631 ' CE2' ' CD1' ' A' ' 93' ' ' LEU . 96.3 m-85 -124.36 10.57 8.61 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.257 -0.902 . . . . 0.0 109.5 179.998 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 59' ' ' SER . . . . . 0.538 ' N ' ' HD2' ' A' ' 60' ' ' PRO . 0.6 OUTLIER -77.08 -54.47 1.54 Allowed Pre-proline 0 N--CA 1.491 1.622 0 O-C-N 121.258 -0.901 . . . . 0.0 110.268 -179.624 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 60' ' ' PRO . . . . . 0.538 ' HD2' ' N ' ' A' ' 59' ' ' SER . 50.4 Cg_endo -70.63 -35.07 10.66 Favored 'Trans proline' 0 C--O 1.214 -0.681 0 C-N-CA 122.5 2.133 . . . . 0.0 112.284 -179.213 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 61' ' ' PHE . . . . . 0.575 ' CE1' ' HA ' ' A' ' 89' ' ' ALA . 74.2 m-85 -59.53 -33.99 72.08 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.168 -0.958 . . . . 0.0 109.495 -179.907 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 175.46 178.11 45.04 Favored Glycine 0 N--CA 1.49 2.236 0 N-CA-C 109.489 -1.445 . . . . 0.0 109.489 179.921 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 54.5 t30 -86.99 144.18 27.02 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.246 -1.149 . . . . 0.0 109.433 179.938 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 64' ' ' ILE . . . . . 0.513 HD11 ' HB2' ' A' ' 58' ' ' PHE . 67.1 mt -106.28 134.32 48.21 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.534 0 O-C-N 121.23 -0.919 . . . . 0.0 109.388 -179.965 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 65' ' ' ILE . . . . . 0.605 HD11 ' NE2' ' A' ' 111' ' ' GLN . 37.8 pt -101.67 -25.78 3.7 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.524 0 O-C-N 121.233 -0.917 . . . . 0.0 109.661 -179.774 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 66' ' ' ASP . . . . . 0.426 ' HB3' ' OG1' ' A' ' 79' ' ' THR . 55.4 t0 -142.34 115.83 9.06 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.227 -0.92 . . . . 0.0 109.606 -179.853 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . 0.563 HD22 ' HE ' ' A' ' 55' ' ' ARG . 15.8 tp -105.41 115.95 31.12 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.288 -0.883 . . . . 0.0 109.467 179.908 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 68' ' ' SER . . . . . 0.469 ' HB2' ' HB2' ' A' ' 77' ' ' PHE . 67.7 m -123.94 146.66 48.32 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.271 -0.893 . . . . 0.0 109.414 179.972 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 69' ' ' MET . . . . . 0.478 ' HA ' ' HA ' ' A' ' 76' ' ' ALA . 72.0 mtp -131.51 150.89 51.98 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.219 -0.926 . . . . 0.0 109.609 -179.903 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 70' ' ' ASP . . . . . 0.474 ' C ' ' HD2' ' A' ' 72' ' ' PRO . 0.5 OUTLIER -126.24 103.84 25.9 Favored Pre-proline 0 N--CA 1.49 1.571 0 O-C-N 121.228 -0.92 . . . . 0.0 109.392 179.903 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 71' ' ' PRO . . . . . 0.605 ' N ' ' CD ' ' A' ' 72' ' ' PRO . 48.2 Cg_endo -74.91 -27.66 10.0 Favored 'Trans proline' 0 CA--C 1.542 0.903 0 C-N-CA 122.553 2.169 . . . . 0.0 113.793 -179.936 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 72' ' ' PRO . . . . . 0.605 ' CD ' ' N ' ' A' ' 71' ' ' PRO . 55.2 Cg_endo -74.89 -24.85 12.66 Favored 'Trans proline' 0 C--N 1.352 0.752 0 C-N-CA 121.525 1.483 . . . . 0.0 111.934 -179.783 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 61.1 mtt-85 -113.83 2.66 15.19 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.237 -0.914 . . . . 0.0 109.671 -179.812 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 82.8 m-20 58.09 38.9 26.59 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.128 -0.983 . . . . 0.0 109.533 179.924 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 75' ' ' CYS . . . . . . . . . . . . . 29.7 p -135.49 134.04 39.12 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.189 -0.944 . . . . 0.0 109.573 -179.941 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . 0.478 ' HA ' ' HA ' ' A' ' 69' ' ' MET . . . -106.48 161.73 14.34 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.257 -0.902 . . . . 0.0 109.339 179.882 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 77' ' ' PHE . . . . . 0.558 ' CD2' ' HE3' ' A' ' 110' ' ' LYS . 97.4 m-85 -125.43 128.33 47.91 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.241 -0.912 . . . . 0.0 109.599 -179.853 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . 0.924 ' O ' HD12 ' A' ' 42' ' ' LEU . 13.7 t -117.88 141.01 38.82 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.526 0 O-C-N 121.24 -0.913 . . . . 0.0 109.182 179.793 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 79' ' ' THR . . . . . 0.57 ' CG2' ' NE2' ' A' ' 111' ' ' GLN . 0.4 OUTLIER -112.18 127.73 56.03 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.279 -0.888 . . . . 0.0 109.612 -179.653 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 80' ' ' TYR . . . . . 0.524 ' OH ' ' CA ' ' A' ' 58' ' ' PHE . 1.8 m-85 -111.37 126.96 55.48 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.352 -0.842 . . . . 0.0 109.382 -179.948 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 81' ' ' GLU . . . . . 0.507 ' O ' ' N ' ' A' ' 39' ' ' GLY . 88.1 tt0 -40.74 -39.07 1.02 Allowed 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.456 -0.778 . . . . 0.0 110.192 -179.789 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 46.8 mttp -126.78 156.35 41.37 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.042 -1.036 . . . . 0.0 109.589 -179.766 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 83' ' ' MET . . . . . 1.04 ' HE3' ' O ' ' A' ' 117' ' ' ALA . 40.9 mtt -73.72 -20.74 60.44 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.272 -0.892 . . . . 0.0 109.404 179.895 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 97.5 mt-10 -65.57 -50.64 64.4 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.257 -0.902 . . . . 0.0 109.392 179.875 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 27.5 m -59.25 -35.16 73.18 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.152 -0.968 . . . . 0.0 109.252 179.847 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 86' ' ' ALA . . . . . 0.821 ' HB1' HD21 ' A' ' 42' ' ' LEU . . . -74.94 -31.04 61.41 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.344 -0.847 . . . . 0.0 109.157 179.76 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 90.5 m-20 -67.65 -37.46 82.44 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.26 -0.9 . . . . 0.0 109.276 179.855 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 64.4 tt0 -70.96 -42.14 70.15 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.255 -0.903 . . . . 0.0 109.374 179.841 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 89' ' ' ALA . . . . . 0.628 ' HB1' ' CD1' ' A' ' 93' ' ' LEU . . . -68.83 -42.73 76.81 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.249 -0.907 . . . . 0.0 109.296 -179.971 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 90' ' ' VAL . . . . . 0.782 ' HA ' HG11 ' A' ' 105' ' ' VAL . 79.3 t -58.1 -37.27 60.94 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.52 0 O-C-N 121.201 -0.937 . . . . 0.0 109.498 -179.944 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -76.1 -53.26 8.59 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.26 -0.9 . . . . 0.0 109.587 -179.832 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 92' ' ' GLU . . . . . 0.521 ' O ' ' CG2' ' A' ' 96' ' ' THR . 74.9 mm-40 -67.2 -42.99 83.22 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.361 -0.837 . . . . 0.0 109.648 -179.762 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 93' ' ' LEU . . . . . 0.94 ' HB2' HG21 ' A' ' 105' ' ' VAL . 87.4 mt -68.87 -39.0 80.08 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.206 -0.934 . . . . 0.0 109.617 -179.835 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 94' ' ' ASN . . . . . 0.517 ' CB ' ' O ' ' A' ' 90' ' ' VAL . 21.2 t-20 -67.84 129.99 41.6 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.243 -0.911 . . . . 0.0 109.51 -179.96 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 85.85 32.11 19.03 Favored Glycine 0 N--CA 1.489 2.221 0 N-CA-C 109.514 -1.435 . . . . 0.0 109.514 -179.986 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 96' ' ' THR . . . . . 0.612 HG23 ' O ' ' A' ' 93' ' ' LEU . 27.6 p -119.45 160.28 22.66 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.15 -1.206 . . . . 0.0 109.45 -179.994 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 97' ' ' GLN . . . . . 0.516 ' HG2' ' N ' ' A' ' 98' ' ' VAL . 62.1 tt0 -135.89 159.88 40.3 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.259 -0.9 . . . . 0.0 109.483 -179.951 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 98' ' ' VAL . . . . . 0.609 HG12 ' H ' ' A' ' 99' ' ' GLU . 1.1 t -113.26 -160.25 0.17 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.591 0 O-C-N 121.252 -0.905 . . . . 0.0 109.351 -179.993 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 99' ' ' GLU . . . . . 0.609 ' H ' HG12 ' A' ' 98' ' ' VAL . 95.9 mt-10 -51.73 -35.42 43.21 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.167 -0.958 . . . . 0.0 109.549 -179.943 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 100' ' ' SER . . . . . 0.431 ' O ' ' OG ' ' A' ' 100' ' ' SER . 6.1 t -164.9 28.59 0.06 Allowed 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.197 -0.939 . . . . 0.0 109.498 -179.943 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 101' ' ' VAL . . . . . 0.554 ' O ' HG23 ' A' ' 98' ' ' VAL . 59.7 t -140.42 147.99 22.7 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.564 0 O-C-N 121.244 -0.91 . . . . 0.0 109.464 179.968 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 91.5 mt-30 -97.34 146.65 24.96 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.239 -0.913 . . . . 0.0 109.508 -179.975 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 77.8 mt -111.54 135.21 52.43 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.26 -0.9 . . . . 0.0 109.489 -179.969 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 104' ' ' LYS . . . . . 0.459 ' O ' ' HA ' ' A' ' 44' ' ' VAL . 54.8 mttt -121.8 140.57 52.2 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.226 -0.921 . . . . 0.0 109.482 179.997 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 105' ' ' VAL . . . . . 0.94 HG21 ' HB2' ' A' ' 93' ' ' LEU . 34.3 t -126.2 146.17 32.46 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 121.274 -0.891 . . . . 0.0 109.421 -179.986 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 106' ' ' ASN . . . . . 0.455 ' HB2' ' HB3' ' A' ' 43' ' ' TYR . 84.2 m-20 -155.72 -167.06 2.38 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.342 -0.849 . . . . 0.0 109.505 179.995 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 65.9 mt -112.4 137.18 46.2 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.537 0 O-C-N 121.199 -0.938 . . . . 0.0 109.531 -179.905 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 108' ' ' ALA . . . . . 0.439 ' HB3' HG22 ' A' ' 41' ' ' THR . . . -110.62 155.9 21.73 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.289 -0.882 . . . . 0.0 109.422 179.928 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 20.4 mtm180 -91.15 15.12 12.4 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.331 -0.855 . . . . 0.0 109.54 -179.975 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 110' ' ' LYS . . . . . 0.767 ' HB2' HG21 ' A' ' 41' ' ' THR . 23.6 mttm -72.8 -171.35 0.83 Allowed 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.329 -0.857 . . . . 0.0 109.379 179.919 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 111' ' ' GLN . . . . . 0.605 ' NE2' HD11 ' A' ' 65' ' ' ILE . 5.0 tt0 69.26 52.13 0.45 Allowed Pre-proline 0 N--CA 1.491 1.581 0 O-C-N 121.265 -0.897 . . . . 0.0 109.521 179.922 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 112' ' ' PRO . . . . . 0.475 ' CD ' ' N ' ' A' ' 111' ' ' GLN . 51.3 Cg_endo -71.79 -26.01 19.63 Favored 'Trans proline' 0 C--O 1.214 -0.681 0 C-N-CA 122.652 2.235 . . . . 0.0 111.961 -179.905 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 113' ' ' MET . . . . . 0.589 ' CE ' ' HG3' ' A' ' 111' ' ' GLN . 1.7 ptp -53.94 -29.3 41.91 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.307 -0.871 . . . . 0.0 109.688 -179.809 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 114' ' ' LEU . . . . . 0.637 HD22 ' HA ' ' A' ' 38' ' ' LYS . 0.9 OUTLIER -147.69 26.87 1.01 Allowed 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.165 -0.96 . . . . 0.0 109.374 -179.849 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 115' ' ' ASP . . . . . 0.628 ' O ' ' HB3' ' A' ' 116' ' ' ALA . 77.1 m-20 46.39 36.55 3.5 Favored 'General case' 0 C--N 1.302 -1.468 0 O-C-N 121.137 -0.977 . . . . 0.0 108.643 -179.536 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 116' ' ' ALA . . . . . 0.698 ' HB1' ' HA ' ' A' ' 40' ' ' ASN . . . 72.08 -80.57 0.04 OUTLIER 'General case' 0 N--CA 1.488 1.442 0 O-C-N 121.57 -0.706 . . . . 0.0 109.75 -179.762 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 117' ' ' ALA . . . . . 1.04 ' O ' ' HE3' ' A' ' 83' ' ' MET . . . -162.42 154.97 19.4 Favored 'General case' 0 C--N 1.302 -1.485 0 O-C-N 121.149 -0.969 . . . . 0.0 109.716 -179.617 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 12.1 p -123.68 164.08 19.81 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.261 -0.899 . . . . 0.0 109.538 -179.903 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -142.1 172.08 24.3 Favored Glycine 0 N--CA 1.491 2.312 0 N-CA-C 109.434 -1.467 . . . . 0.0 109.434 -179.931 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 30.0 tttt -74.27 132.1 41.8 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.23 -1.159 . . . . 0.0 109.485 179.942 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 N--CA 1.49 1.531 0 CA-C-O 118.024 -0.989 . . . . 0.0 109.542 179.973 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 1.522 0 N-CA-C 109.493 -0.558 . . . . 0.0 109.493 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 36' ' ' PRO . . . . . 0.424 ' HB2' HD12 ' A' ' 114' ' ' LEU . 49.1 Cg_endo -69.91 143.4 50.0 Favored 'Trans proline' 0 C--O 1.215 -0.631 0 C-N-CA 122.71 2.273 . . . . 0.0 111.751 -179.971 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 37' ' ' ARG . . . . . 0.797 ' C ' HD13 ' A' ' 114' ' ' LEU . 67.3 mtt180 -124.85 158.67 32.88 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.215 -0.928 . . . . 0.0 109.441 179.946 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 38' ' ' LYS . . . . . 1.013 ' HA ' HD22 ' A' ' 114' ' ' LEU . 83.0 mttt -55.36 -170.02 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.233 -0.917 . . . . 0.0 109.246 179.87 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . 0.576 ' HA3' HD11 ' A' ' 65' ' ' ILE . . . 151.99 83.45 0.04 OUTLIER Glycine 0 N--CA 1.49 2.245 0 N-CA-C 109.995 -1.242 . . . . 0.0 109.995 179.921 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 40' ' ' ASN . . . . . 0.477 ' O ' ' HA ' ' A' ' 79' ' ' THR . 49.6 t30 -81.49 117.34 21.82 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.169 -1.194 . . . . 0.0 108.947 179.4 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 41' ' ' THR . . . . . 0.481 ' HA ' ' O ' ' A' ' 78' ' ' VAL . 34.2 m -78.01 149.17 34.09 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.259 -0.9 . . . . 0.0 110.105 -179.464 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . 0.781 HD12 ' O ' ' A' ' 78' ' ' VAL . 5.2 mp -126.31 154.4 43.51 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.278 -0.889 . . . . 0.0 109.28 179.723 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 43' ' ' TYR . . . . . 0.468 ' HB3' ' HB2' ' A' ' 106' ' ' ASN . 76.1 t80 -107.87 114.82 29.02 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.292 -0.88 . . . . 0.0 109.52 179.875 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . 0.625 HG13 HD23 ' A' ' 103' ' ' LEU . 40.6 t -108.52 137.4 40.45 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 121.299 -0.876 . . . . 0.0 109.451 -179.959 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 45' ' ' TYR . . . . . 0.422 ' HB3' ' HB2' ' A' ' 104' ' ' LYS . 65.7 t80 -127.66 135.38 50.14 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.217 -0.927 . . . . 0.0 109.581 -179.844 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 171.24 -177.79 43.97 Favored Glycine 0 N--CA 1.49 2.259 0 N-CA-C 109.553 -1.419 . . . . 0.0 109.553 179.93 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 95.4 mt-10 -116.29 161.83 18.42 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.282 -1.128 . . . . 0.0 109.441 179.997 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 49.9 m-20 44.0 49.51 7.32 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.256 -0.902 . . . . 0.0 109.518 179.947 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 51.1 mtm -101.88 138.82 38.35 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.307 -0.871 . . . . 0.0 109.537 -179.947 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 50' ' ' THR . . . . . 0.405 ' O ' ' HG ' ' A' ' 54' ' ' LEU . 0.9 OUTLIER -122.55 162.94 35.56 Favored Pre-proline 0 N--CA 1.489 1.505 0 O-C-N 121.343 -0.848 . . . . 0.0 109.363 179.914 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 51' ' ' PRO . . . . . 0.628 ' HA ' HD12 ' A' ' 54' ' ' LEU . 47.8 Cg_endo -69.6 -53.61 0.27 Allowed 'Trans proline' 0 C--O 1.215 -0.674 0 C-N-CA 122.592 2.194 . . . . 0.0 111.768 -179.991 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 31.1 m -49.3 -49.23 44.73 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.232 -0.918 . . . . 0.0 109.194 179.867 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 26.8 tp -59.7 -46.54 88.77 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.309 -0.869 . . . . 0.0 109.203 179.714 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 54' ' ' LEU . . . . . 0.657 HD11 ' HE1' ' A' ' 69' ' ' MET . 12.4 mt -57.39 -46.25 83.63 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.322 -0.861 . . . . 0.0 109.193 179.726 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 55' ' ' ARG . . . . . 0.513 ' O ' ' N ' ' A' ' 59' ' ' SER . 83.9 mtt-85 -51.34 -39.84 57.86 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.295 -0.878 . . . . 0.0 109.175 179.79 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -68.77 -35.2 79.46 Favored Glycine 0 N--CA 1.489 2.226 0 N-CA-C 109.35 -1.5 . . . . 0.0 109.35 179.909 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . 0.456 ' O ' ' CD1' ' A' ' 61' ' ' PHE . . . -73.4 -27.64 61.57 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.216 -1.167 . . . . 0.0 109.379 179.92 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 58' ' ' PHE . . . . . 0.794 ' HB2' HD11 ' A' ' 64' ' ' ILE . 96.3 m-85 -112.18 8.44 19.89 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.304 -0.873 . . . . 0.0 109.34 179.969 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 59' ' ' SER . . . . . 0.534 ' N ' ' HD2' ' A' ' 60' ' ' PRO . 1.0 OUTLIER -74.09 -57.25 2.37 Favored Pre-proline 0 N--CA 1.491 1.6 0 O-C-N 121.372 -0.83 . . . . 0.0 110.106 -179.693 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 60' ' ' PRO . . . . . 0.534 ' HD2' ' N ' ' A' ' 59' ' ' SER . 47.3 Cg_endo -68.7 -27.66 31.72 Favored 'Trans proline' 0 C--O 1.215 -0.666 0 C-N-CA 122.676 2.25 . . . . 0.0 112.037 -179.511 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 61' ' ' PHE . . . . . 0.583 ' CE2' ' HB3' ' A' ' 92' ' ' GLU . 72.0 m-85 -69.56 -33.41 72.71 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.201 -0.937 . . . . 0.0 109.514 179.981 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 175.18 -169.71 42.64 Favored Glycine 0 N--CA 1.49 2.278 0 N-CA-C 109.487 -1.445 . . . . 0.0 109.487 179.996 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 83.9 m-20 -99.93 138.86 36.42 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.201 -1.176 . . . . 0.0 109.439 179.916 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 64' ' ' ILE . . . . . 0.794 HD11 ' HB2' ' A' ' 58' ' ' PHE . 49.1 mt -101.31 128.51 53.54 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.521 0 O-C-N 121.266 -0.896 . . . . 0.0 109.585 -179.938 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 65' ' ' ILE . . . . . 0.576 HD11 ' HA3' ' A' ' 39' ' ' GLY . 23.0 pt -94.79 -25.19 4.66 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 O-C-N 121.238 -0.914 . . . . 0.0 109.409 -179.896 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 66' ' ' ASP . . . . . 0.466 ' HB3' ' OG1' ' A' ' 79' ' ' THR . 58.4 t0 -141.02 129.84 23.0 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.198 -0.939 . . . . 0.0 109.601 -179.955 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . 0.741 ' C ' HD13 ' A' ' 67' ' ' LEU . 3.4 tm? -119.29 116.35 26.05 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.303 -0.873 . . . . 0.0 109.364 179.934 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 68' ' ' SER . . . . . 0.492 ' HB2' ' HB2' ' A' ' 77' ' ' PHE . 58.0 m -121.13 145.35 47.9 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.14 -0.975 . . . . 0.0 109.532 -179.94 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 69' ' ' MET . . . . . 0.657 ' HE1' HD11 ' A' ' 54' ' ' LEU . 89.8 mmm -122.61 144.18 49.28 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.24 -0.912 . . . . 0.0 109.531 -179.952 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 70' ' ' ASP . . . . . 0.479 ' HB2' ' O ' ' A' ' 75' ' ' CYS . 0.2 OUTLIER -124.57 94.31 44.86 Favored Pre-proline 0 N--CA 1.49 1.566 0 O-C-N 121.2 -0.937 . . . . 0.0 109.461 179.917 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 71' ' ' PRO . . . . . 0.598 ' N ' ' CD ' ' A' ' 72' ' ' PRO . 46.5 Cg_endo -74.6 -28.0 10.31 Favored 'Trans proline' 0 CA--C 1.542 0.922 0 C-N-CA 122.506 2.137 . . . . 0.0 113.696 -179.989 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 72' ' ' PRO . . . . . 0.598 ' CD ' ' N ' ' A' ' 71' ' ' PRO . 55.2 Cg_endo -75.45 -22.38 14.11 Favored 'Trans proline' 0 C--N 1.352 0.722 0 C-N-CA 121.523 1.482 . . . . 0.0 111.75 -179.788 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 27.4 mtt85 -113.26 3.8 16.15 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.22 -0.925 . . . . 0.0 109.654 -179.9 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 73.4 m-20 58.23 47.86 13.59 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.244 -0.91 . . . . 0.0 109.45 179.972 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 75' ' ' CYS . . . . . 0.479 ' O ' ' HB2' ' A' ' 70' ' ' ASP . 31.1 p -152.63 148.26 27.11 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.284 -0.885 . . . . 0.0 109.456 -179.968 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . 0.468 ' HB1' ' SD ' ' A' ' 69' ' ' MET . . . -120.34 157.54 29.02 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.273 -0.892 . . . . 0.0 109.401 179.919 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 77' ' ' PHE . . . . . 0.492 ' HB2' ' HB2' ' A' ' 68' ' ' SER . 97.7 m-85 -119.59 139.75 51.66 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.202 -0.936 . . . . 0.0 109.569 -179.849 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . 0.781 ' O ' HD12 ' A' ' 42' ' ' LEU . 20.5 t -129.23 137.97 55.65 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.546 0 O-C-N 121.191 -0.943 . . . . 0.0 109.55 179.988 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 79' ' ' THR . . . . . 0.57 HG22 ' CA ' ' A' ' 39' ' ' GLY . 23.3 m -106.19 134.83 48.7 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.194 -0.941 . . . . 0.0 109.264 179.89 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 80' ' ' TYR . . . . . 0.612 ' HH ' ' HD2' ' A' ' 58' ' ' PHE . 0.7 OUTLIER -113.21 141.63 46.74 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.214 -0.929 . . . . 0.0 109.62 -179.917 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 81' ' ' GLU . . . . . 0.483 ' O ' ' HB2' ' A' ' 38' ' ' LYS . 80.8 tt0 -64.03 -22.6 67.0 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.209 -0.932 . . . . 0.0 109.359 179.795 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 38.2 mttp -136.05 135.93 39.8 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.243 -0.91 . . . . 0.0 109.461 179.982 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 83' ' ' MET . . . . . 0.687 ' HE2' ' N ' ' A' ' 117' ' ' ALA . 47.0 mtt -57.33 -24.64 56.37 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.244 -0.91 . . . . 0.0 109.401 179.928 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 98.4 mt-10 -66.2 -37.49 85.71 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.305 -0.872 . . . . 0.0 109.557 179.981 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 19.3 m -62.37 -31.48 72.15 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.236 -0.915 . . . . 0.0 109.571 -179.97 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 86' ' ' ALA . . . . . 0.645 ' O ' HG23 ' A' ' 90' ' ' VAL . . . -75.61 -34.54 60.6 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.255 -0.903 . . . . 0.0 109.449 -179.945 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 64.5 t0 -62.14 -45.42 93.53 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.286 -0.884 . . . . 0.0 109.647 -179.953 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 44.6 tt0 -69.08 -43.58 74.25 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.172 -0.955 . . . . 0.0 109.595 -179.882 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 89' ' ' ALA . . . . . 0.624 ' HB1' ' CD1' ' A' ' 93' ' ' LEU . . . -72.37 -37.13 68.84 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.195 -0.941 . . . . 0.0 109.552 -179.869 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 90' ' ' VAL . . . . . 0.747 ' CG2' HD23 ' A' ' 42' ' ' LEU . 61.2 t -69.38 -47.31 73.69 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.604 0 O-C-N 121.254 -0.904 . . . . 0.0 109.652 -179.89 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -73.56 -28.51 61.9 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.236 -0.915 . . . . 0.0 109.757 -179.721 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 92' ' ' GLU . . . . . 0.583 ' HB3' ' CE2' ' A' ' 61' ' ' PHE . 39.2 tp10 -87.21 -49.77 7.05 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.245 -0.909 . . . . 0.0 109.786 -179.731 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 93' ' ' LEU . . . . . 0.929 ' HB2' HG21 ' A' ' 105' ' ' VAL . 39.9 mt -68.02 -39.81 83.09 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.244 -0.91 . . . . 0.0 109.612 -179.907 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 94' ' ' ASN . . . . . 0.523 ' CB ' ' O ' ' A' ' 90' ' ' VAL . 57.2 t30 -68.35 128.05 35.19 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.24 -0.912 . . . . 0.0 109.481 -179.969 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 94.87 19.38 31.59 Favored Glycine 0 N--CA 1.491 2.308 0 N-CA-C 109.591 -1.404 . . . . 0.0 109.591 -179.947 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 96' ' ' THR . . . . . 0.428 ' CG2' ' O ' ' A' ' 92' ' ' GLU . 21.8 p -120.46 148.6 43.6 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.209 -1.171 . . . . 0.0 109.493 179.978 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 97' ' ' GLN . . . . . 0.474 ' HG3' ' O ' ' A' ' 101' ' ' VAL . 59.8 tt0 -119.73 140.76 50.2 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.232 -0.917 . . . . 0.0 109.478 179.996 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 98' ' ' VAL . . . . . 0.642 HG12 ' H ' ' A' ' 99' ' ' GLU . 1.3 t -81.74 -162.99 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.532 0 O-C-N 121.285 -0.885 . . . . 0.0 109.347 179.997 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 99' ' ' GLU . . . . . 0.642 ' H ' HG12 ' A' ' 98' ' ' VAL . 96.0 mt-10 -54.18 -37.36 64.41 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.232 -0.917 . . . . 0.0 109.558 -179.975 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -155.59 25.18 0.4 Allowed 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.322 -0.861 . . . . 0.0 109.521 179.957 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 101' ' ' VAL . . . . . 0.564 HG12 ' N ' ' A' ' 102' ' ' GLN . 60.0 t -137.77 164.62 28.02 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.552 0 O-C-N 121.236 -0.915 . . . . 0.0 109.5 -179.953 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 102' ' ' GLN . . . . . 0.564 ' N ' HG12 ' A' ' 101' ' ' VAL . 91.7 mt-30 -119.06 145.36 45.96 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.309 -0.869 . . . . 0.0 109.371 179.854 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 103' ' ' LEU . . . . . 0.625 HD23 HG13 ' A' ' 44' ' ' VAL . 0.0 OUTLIER -124.45 130.95 53.41 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.25 -0.907 . . . . 0.0 109.591 -179.785 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 104' ' ' LYS . . . . . 0.422 ' HB2' ' HB3' ' A' ' 45' ' ' TYR . 24.1 mttm -117.89 127.24 53.66 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.346 -0.846 . . . . 0.0 109.24 179.761 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 105' ' ' VAL . . . . . 0.929 HG21 ' HB2' ' A' ' 93' ' ' LEU . 12.1 t -106.24 146.18 13.19 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.551 0 O-C-N 121.231 -0.918 . . . . 0.0 109.736 -179.764 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 106' ' ' ASN . . . . . 0.468 ' HB2' ' HB3' ' A' ' 43' ' ' TYR . 82.0 m-20 -157.87 -165.89 1.85 Allowed 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.331 -0.856 . . . . 0.0 109.296 179.871 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 23.7 mm -102.15 135.18 40.32 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.567 0 O-C-N 121.295 -0.878 . . . . 0.0 109.471 179.937 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 108' ' ' ALA . . . . . 0.412 ' O ' ' C ' ' A' ' 109' ' ' ARG . . . -114.62 -150.99 0.47 Allowed 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.2 -0.937 . . . . 0.0 109.371 179.958 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 109' ' ' ARG . . . . . 0.412 ' C ' ' O ' ' A' ' 108' ' ' ALA . 17.3 mmt-85 -45.36 149.56 0.53 Allowed 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.156 -0.965 . . . . 0.0 109.301 179.881 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 110' ' ' LYS . . . . . 0.412 ' O ' ' HB3' ' A' ' 111' ' ' GLN . 91.0 mttt -73.94 -1.78 21.2 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.182 -0.949 . . . . 0.0 109.659 -179.952 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 111' ' ' GLN . . . . . 0.412 ' HB3' ' O ' ' A' ' 110' ' ' LYS . 9.2 tp-100 61.42 98.03 0.04 OUTLIER Pre-proline 0 N--CA 1.49 1.546 0 O-C-N 121.173 -0.955 . . . . 0.0 109.549 179.953 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 112' ' ' PRO . . . . . 0.426 ' O ' ' C ' ' A' ' 113' ' ' MET . 50.4 Cg_endo -69.96 -26.18 26.88 Favored 'Trans proline' 0 C--O 1.216 -0.622 0 C-N-CA 122.639 2.226 . . . . 0.0 111.811 179.947 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 113' ' ' MET . . . . . 0.537 ' HE3' ' HB3' ' A' ' 114' ' ' LEU . 0.0 OUTLIER -43.82 -27.29 0.32 Allowed 'General case' 0 N--CA 1.488 1.462 0 N-CA-C 108.829 -0.804 . . . . 0.0 108.829 179.593 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 114' ' ' LEU . . . . . 1.013 HD22 ' HA ' ' A' ' 38' ' ' LYS . 4.1 tt -173.07 29.21 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.233 -0.917 . . . . 0.0 109.263 179.616 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 115' ' ' ASP . . . . . 0.711 ' O ' ' HB3' ' A' ' 116' ' ' ALA . 75.3 m-20 46.04 35.49 2.52 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.279 -0.888 . . . . 0.0 108.885 -179.635 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 116' ' ' ALA . . . . . 0.711 ' HB3' ' O ' ' A' ' 115' ' ' ASP . . . 76.72 -78.18 0.04 OUTLIER 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.401 -0.812 . . . . 0.0 109.532 -179.775 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 117' ' ' ALA . . . . . 0.687 ' N ' ' HE2' ' A' ' 83' ' ' MET . . . -176.51 30.29 0.0 OUTLIER 'General case' 0 C--N 1.303 -1.417 0 O-C-N 121.37 -0.831 . . . . 0.0 109.664 -179.854 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 3.4 t -64.49 -34.38 78.09 Favored 'General case' 0 C--N 1.302 -1.492 0 O-C-N 121.189 -0.944 . . . . 0.0 109.564 -179.669 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -82.25 175.5 53.72 Favored Glycine 0 N--CA 1.49 2.26 0 N-CA-C 109.453 -1.459 . . . . 0.0 109.453 179.904 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 19.8 tttt -55.5 -36.03 66.23 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.23 -1.159 . . . . 0.0 109.48 179.975 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 121' ' ' SER . . . . . 0.583 ' O ' HD11 ' A' ' 114' ' ' LEU . 15.9 t . . . . . 0 N--CA 1.49 1.525 0 CA-C-O 117.974 -1.012 . . . . 0.0 109.518 179.941 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 1.511 0 N-CA-C 109.481 -0.563 . . . . 0.0 109.481 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 51.0 Cg_endo -70.25 -16.17 35.42 Favored 'Trans proline' 0 C--O 1.215 -0.668 0 C-N-CA 122.74 2.293 . . . . 0.0 111.738 179.964 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 86.0 mtt-85 -58.45 141.76 50.65 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.322 -0.862 . . . . 0.0 109.488 -179.989 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 38' ' ' LYS . . . . . 0.635 ' C ' HD21 ' A' ' 114' ' ' LEU . 44.5 mttp -100.32 -169.06 1.67 Allowed 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.237 -0.915 . . . . 0.0 109.343 179.954 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . 0.548 ' HA3' HD22 ' A' ' 114' ' ' LEU . . . -176.53 169.79 42.38 Favored Glycine 0 N--CA 1.491 2.315 0 N-CA-C 109.698 -1.361 . . . . 0.0 109.698 -179.879 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 40' ' ' ASN . . . . . 0.546 HD22 ' HB3' ' A' ' 86' ' ' ALA . 42.1 t30 -162.37 111.65 1.44 Allowed 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.166 -1.196 . . . . 0.0 109.1 179.801 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 41' ' ' THR . . . . . 0.487 ' HA ' ' O ' ' A' ' 78' ' ' VAL . 27.0 m -78.54 150.94 32.74 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.24 -0.913 . . . . 0.0 110.063 -179.479 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . 0.906 HD12 ' O ' ' A' ' 78' ' ' VAL . 5.1 mp -126.57 152.86 46.02 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.413 -0.805 . . . . 0.0 109.132 179.616 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 43' ' ' TYR . . . . . 0.446 ' HB3' ' HB2' ' A' ' 106' ' ' ASN . 39.8 t80 -107.92 111.37 23.44 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.224 -0.923 . . . . 0.0 109.42 179.865 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . 0.473 ' HA ' ' O ' ' A' ' 104' ' ' LYS . 96.5 t -109.16 142.26 22.18 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.551 0 O-C-N 121.202 -0.936 . . . . 0.0 109.384 179.969 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 68.1 t80 -128.35 130.97 48.54 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.251 -0.906 . . . . 0.0 109.561 -179.882 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -176.54 -166.44 33.7 Favored Glycine 0 N--CA 1.488 2.123 0 N-CA-C 109.483 -1.447 . . . . 0.0 109.483 179.928 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . 0.415 ' O ' ' C ' ' A' ' 48' ' ' ASP . 94.8 mt-10 -132.52 161.08 34.68 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.328 -1.101 . . . . 0.0 109.485 179.987 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . 0.415 ' C ' ' O ' ' A' ' 47' ' ' GLU . 42.8 m-20 43.66 51.55 6.45 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.271 -0.893 . . . . 0.0 109.601 179.934 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 72.6 mtm -103.78 145.0 30.73 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.249 -0.907 . . . . 0.0 109.475 -179.944 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 50' ' ' THR . . . . . 0.407 ' O ' HD12 ' A' ' 54' ' ' LEU . 0.0 OUTLIER -117.6 161.75 32.2 Favored Pre-proline 0 N--CA 1.49 1.561 0 O-C-N 121.296 -0.878 . . . . 0.0 109.53 -179.978 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 51' ' ' PRO . . . . . 0.48 ' CA ' ' SD ' ' A' ' 69' ' ' MET . 49.2 Cg_endo -69.93 -53.93 0.24 Allowed 'Trans proline' 0 C--O 1.214 -0.694 0 C-N-CA 122.731 2.288 . . . . 0.0 111.739 179.89 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 27.1 m -56.91 -44.71 82.64 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.286 -0.884 . . . . 0.0 109.33 179.887 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . 0.771 ' O ' HD13 ' A' ' 53' ' ' LEU . 2.3 tm? -59.94 -47.77 84.44 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.311 -0.868 . . . . 0.0 109.384 179.97 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 54' ' ' LEU . . . . . 0.498 HD11 ' CE ' ' A' ' 69' ' ' MET . 17.3 mt -59.36 -52.31 66.16 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.255 -0.903 . . . . 0.0 109.332 179.979 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 55' ' ' ARG . . . . . 0.513 ' O ' ' N ' ' A' ' 59' ' ' SER . 52.3 mtp180 -45.0 -41.04 7.01 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.242 -0.911 . . . . 0.0 109.292 179.83 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . 0.487 ' O ' ' HD2' ' A' ' 60' ' ' PRO . . . -64.07 -40.65 98.34 Favored Glycine 0 N--CA 1.49 2.252 0 N-CA-C 109.416 -1.474 . . . . 0.0 109.416 179.904 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . 0.429 ' O ' ' CD2' ' A' ' 61' ' ' PHE . . . -65.9 -23.3 66.61 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.286 -1.126 . . . . 0.0 109.323 179.956 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 58' ' ' PHE . . . . . 0.808 ' HB2' HD11 ' A' ' 64' ' ' ILE . 93.6 m-85 -116.81 9.36 13.89 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.287 -0.883 . . . . 0.0 109.395 179.975 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 59' ' ' SER . . . . . 0.548 ' N ' ' HD2' ' A' ' 60' ' ' PRO . 0.9 OUTLIER -76.89 -55.45 1.47 Allowed Pre-proline 0 N--CA 1.491 1.592 0 O-C-N 121.225 -0.922 . . . . 0.0 110.37 -179.569 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 60' ' ' PRO . . . . . 0.548 ' HD2' ' N ' ' A' ' 59' ' ' SER . 47.4 Cg_endo -69.26 -30.76 24.05 Favored 'Trans proline' 0 C--O 1.215 -0.65 0 C-N-CA 122.502 2.135 . . . . 0.0 112.158 -179.25 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 61' ' ' PHE . . . . . 0.557 ' CE1' ' HA ' ' A' ' 89' ' ' ALA . 82.3 m-85 -66.06 -38.32 88.03 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.165 -0.959 . . . . 0.0 109.442 179.933 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . 0.462 ' HA3' ' OG ' ' A' ' 85' ' ' SER . . . -179.51 -177.09 47.6 Favored Glycine 0 N--CA 1.49 2.277 0 N-CA-C 109.47 -1.452 . . . . 0.0 109.47 179.973 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 85.8 m-20 -91.46 140.35 29.83 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.171 -1.194 . . . . 0.0 109.489 179.965 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 64' ' ' ILE . . . . . 0.808 HD11 ' HB2' ' A' ' 58' ' ' PHE . 64.3 mt -101.63 133.32 45.41 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.531 0 O-C-N 121.235 -0.916 . . . . 0.0 109.506 -179.929 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 25.9 pt -96.68 -19.57 6.06 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 O-C-N 121.284 -0.885 . . . . 0.0 109.609 -179.955 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 66' ' ' ASP . . . . . 0.459 ' HB3' ' OG1' ' A' ' 79' ' ' THR . 58.5 t0 -153.4 110.8 3.5 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.185 -0.947 . . . . 0.0 109.571 -179.917 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . 0.747 HD23 HD13 ' A' ' 64' ' ' ILE . 0.2 OUTLIER -102.18 118.1 36.17 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.24 -0.913 . . . . 0.0 109.388 179.824 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 68' ' ' SER . . . . . 0.652 ' N ' HD13 ' A' ' 67' ' ' LEU . 25.6 t -126.49 145.34 50.54 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.245 -0.91 . . . . 0.0 109.556 -179.836 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 69' ' ' MET . . . . . 0.498 ' CE ' HD11 ' A' ' 54' ' ' LEU . 90.5 mtp -126.89 150.96 49.03 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.371 -0.831 . . . . 0.0 109.407 179.923 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 70' ' ' ASP . . . . . 0.48 ' C ' ' HD2' ' A' ' 72' ' ' PRO . 0.2 OUTLIER -125.41 98.31 35.31 Favored Pre-proline 0 N--CA 1.49 1.57 0 O-C-N 121.29 -0.882 . . . . 0.0 109.526 179.961 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 71' ' ' PRO . . . . . 0.603 ' N ' ' CD ' ' A' ' 72' ' ' PRO . 46.2 Cg_endo -74.61 -27.85 10.44 Favored 'Trans proline' 0 CA--C 1.542 0.925 0 C-N-CA 122.529 2.153 . . . . 0.0 113.647 179.945 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 72' ' ' PRO . . . . . 0.603 ' CD ' ' N ' ' A' ' 71' ' ' PRO . 55.3 Cg_endo -75.69 -26.19 10.1 Favored 'Trans proline' 0 C--N 1.353 0.782 0 C-N-CA 121.536 1.49 . . . . 0.0 111.771 -179.958 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 73' ' ' ARG . . . . . 0.406 ' O ' ' HB2' ' A' ' 74' ' ' ASN . 96.5 mtt180 -110.85 -0.01 17.06 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.294 -0.878 . . . . 0.0 109.652 -179.822 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 74' ' ' ASN . . . . . 0.406 ' HB2' ' O ' ' A' ' 73' ' ' ARG . 8.3 m120 61.2 44.73 9.64 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.166 -0.959 . . . . 0.0 109.343 -179.91 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 75' ' ' CYS . . . . . 0.458 ' O ' ' HB2' ' A' ' 70' ' ' ASP . 22.0 p -143.5 137.37 28.46 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.286 -0.884 . . . . 0.0 109.475 179.959 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -111.45 154.16 25.08 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.205 -0.935 . . . . 0.0 109.492 -179.96 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 77' ' ' PHE . . . . . 0.476 ' HA ' ' O ' ' A' ' 42' ' ' LEU . 97.0 m-85 -121.93 129.04 52.2 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.237 -0.915 . . . . 0.0 109.577 -179.925 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . 0.906 ' O ' HD12 ' A' ' 42' ' ' LEU . 26.5 t -120.21 138.53 50.47 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.569 0 O-C-N 121.206 -0.934 . . . . 0.0 109.289 179.858 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 79' ' ' THR . . . . . 0.534 ' O ' HG23 ' A' ' 64' ' ' ILE . 1.2 m -107.2 136.36 47.16 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.286 -0.884 . . . . 0.0 109.634 -179.826 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 80' ' ' TYR . . . . . 0.565 ' CE1' ' OG ' ' A' ' 85' ' ' SER . 0.9 OUTLIER -119.81 121.27 38.74 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.295 -0.878 . . . . 0.0 109.419 179.81 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 81' ' ' GLU . . . . . 0.487 ' HA ' ' HA2' ' A' ' 39' ' ' GLY . 83.5 tt0 -40.37 -39.74 1.04 Allowed 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.516 -0.74 . . . . 0.0 109.85 179.964 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 9.5 mtmm -122.87 162.97 21.17 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.193 -0.942 . . . . 0.0 109.514 179.931 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 83' ' ' MET . . . . . 0.68 ' HE1' ' HB1' ' A' ' 116' ' ' ALA . 4.4 mmt -80.17 -13.94 58.85 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.188 -0.945 . . . . 0.0 109.345 -179.999 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 96.1 mt-10 -69.82 -35.77 75.08 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.241 -0.912 . . . . 0.0 109.49 179.891 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 85' ' ' SER . . . . . 0.565 ' OG ' ' CE1' ' A' ' 80' ' ' TYR . 43.4 t -71.57 -32.08 67.67 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.2 -0.937 . . . . 0.0 109.476 -179.967 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 86' ' ' ALA . . . . . 0.81 ' O ' HG23 ' A' ' 90' ' ' VAL . . . -78.78 -31.38 46.04 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.244 -0.91 . . . . 0.0 109.532 -179.938 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 58.3 t0 -70.62 -46.73 62.81 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.243 -0.911 . . . . 0.0 109.646 -179.938 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 65.0 tt0 -68.64 -41.31 79.6 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.269 -0.895 . . . . 0.0 109.644 -179.873 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 89' ' ' ALA . . . . . 0.613 ' HB1' ' CD1' ' A' ' 93' ' ' LEU . . . -67.92 -41.1 83.14 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.208 -0.933 . . . . 0.0 109.653 -179.935 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 90' ' ' VAL . . . . . 0.953 HG21 HD11 ' A' ' 107' ' ' ILE . 55.6 t -60.4 -35.94 66.02 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.587 0 O-C-N 121.22 -0.925 . . . . 0.0 109.669 -179.902 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -75.42 -53.91 7.91 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.173 -0.954 . . . . 0.0 109.844 -179.723 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 92' ' ' GLU . . . . . 0.519 ' O ' ' CG2' ' A' ' 96' ' ' THR . 76.1 mm-40 -67.92 -44.37 77.04 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.223 -0.923 . . . . 0.0 109.768 -179.537 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 93' ' ' LEU . . . . . 0.756 ' HB2' HG21 ' A' ' 105' ' ' VAL . 92.1 mt -66.57 -38.95 88.14 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.079 -1.013 . . . . 0.0 109.541 -179.804 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 94' ' ' ASN . . . . . 0.532 ' CB ' ' O ' ' A' ' 90' ' ' VAL . 62.1 t-20 -72.74 120.23 18.07 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.237 -0.914 . . . . 0.0 109.553 -179.964 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 105.27 10.71 31.12 Favored Glycine 0 N--CA 1.491 2.315 0 N-CA-C 109.426 -1.47 . . . . 0.0 109.426 179.905 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 96' ' ' THR . . . . . 0.519 ' CG2' ' O ' ' A' ' 92' ' ' GLU . 27.7 p -107.77 157.62 17.98 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.201 -1.176 . . . . 0.0 109.494 -179.97 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 58.7 tt0 -129.25 145.95 51.25 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.182 -0.949 . . . . 0.0 109.479 -179.935 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 98' ' ' VAL . . . . . 0.478 HG23 ' O ' ' A' ' 101' ' ' VAL . 1.4 t -87.39 -147.8 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 O-C-N 121.275 -0.891 . . . . 0.0 109.385 179.996 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 99' ' ' GLU . . . . . 0.473 ' H ' HG12 ' A' ' 98' ' ' VAL . 96.7 mt-10 -63.44 -41.87 98.67 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.21 -0.931 . . . . 0.0 109.536 179.979 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -153.77 23.83 0.51 Allowed 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.257 -0.902 . . . . 0.0 109.478 -179.915 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 101' ' ' VAL . . . . . 0.478 ' O ' HG23 ' A' ' 98' ' ' VAL . 52.9 t -139.46 148.63 23.24 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 O-C-N 121.252 -0.905 . . . . 0.0 109.433 -179.979 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 47.2 tt0 -97.47 140.67 31.56 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.172 -0.955 . . . . 0.0 109.523 -179.867 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 90.7 mt -104.42 137.7 41.9 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.253 -0.904 . . . . 0.0 109.465 179.977 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 104' ' ' LYS . . . . . 0.473 ' O ' ' HA ' ' A' ' 44' ' ' VAL . 89.0 mttt -117.95 138.39 52.2 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.293 -0.88 . . . . 0.0 109.298 179.887 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 105' ' ' VAL . . . . . 0.756 HG21 ' HB2' ' A' ' 93' ' ' LEU . 59.9 t -122.91 143.31 36.3 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.54 0 O-C-N 121.225 -0.922 . . . . 0.0 109.458 -179.885 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 106' ' ' ASN . . . . . 0.508 ' ND2' ' O ' ' A' ' 105' ' ' VAL . 21.3 m120 -149.27 178.48 8.72 Favored 'General case' 0 N--CA 1.489 1.475 0 O-C-N 121.236 -0.915 . . . . 0.0 109.495 -179.989 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 107' ' ' ILE . . . . . 0.953 HD11 HG21 ' A' ' 90' ' ' VAL . 22.3 mm -112.48 120.17 62.02 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.514 0 O-C-N 121.246 -0.908 . . . . 0.0 109.463 179.997 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -61.31 153.12 27.42 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.214 -0.929 . . . . 0.0 109.505 -179.967 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 41.2 ttt180 -47.56 -47.7 28.12 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.218 -0.926 . . . . 0.0 109.491 179.93 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 110' ' ' LYS . . . . . 0.438 ' HG2' ' N ' ' A' ' 111' ' ' GLN . 19.8 tttt -178.87 150.2 0.48 Allowed 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.24 -0.913 . . . . 0.0 109.543 179.979 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 111' ' ' GLN . . . . . 0.46 ' CG ' ' OG1' ' A' ' 41' ' ' THR . 29.0 tp60 -114.9 97.71 48.27 Favored Pre-proline 0 N--CA 1.489 1.524 0 O-C-N 121.21 -0.932 . . . . 0.0 109.413 179.921 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 112' ' ' PRO . . . . . 0.408 ' O ' ' C ' ' A' ' 113' ' ' MET . 50.2 Cg_endo -70.14 -29.39 22.11 Favored 'Trans proline' 0 C--O 1.215 -0.654 0 C-N-CA 122.668 2.246 . . . . 0.0 111.823 -179.847 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 113' ' ' MET . . . . . 0.564 ' HE3' ' CB ' ' A' ' 114' ' ' LEU . 0.0 OUTLIER -44.75 -26.18 0.36 Allowed 'General case' 0 C--N 1.304 -1.406 0 O-C-N 121.292 -0.88 . . . . 0.0 108.754 179.513 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 114' ' ' LEU . . . . . 0.676 HD23 ' O ' ' A' ' 114' ' ' LEU . 2.2 tt -148.25 25.89 0.98 Allowed 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.176 -0.952 . . . . 0.0 109.279 179.719 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 115' ' ' ASP . . . . . 0.488 ' O ' ' N ' ' A' ' 117' ' ' ALA . 88.7 m-20 48.74 31.83 3.29 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.254 -0.904 . . . . 0.0 109.403 -179.914 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 116' ' ' ALA . . . . . 0.68 ' HB1' ' HE1' ' A' ' 83' ' ' MET . . . 44.84 -95.52 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.323 -0.86 . . . . 0.0 109.642 -179.949 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 117' ' ' ALA . . . . . 0.572 ' HB3' ' CE ' ' A' ' 83' ' ' MET . . . -173.11 -75.7 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.11 -0.994 . . . . 0.0 109.577 -179.767 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 118' ' ' THR . . . . . 0.581 HG23 ' HG3' ' A' ' 83' ' ' MET . 43.8 p -72.08 -27.34 62.6 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.303 -0.873 . . . . 0.0 109.449 -179.943 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 78.92 -152.38 36.69 Favored Glycine 0 N--CA 1.489 2.2 0 N-CA-C 109.493 -1.443 . . . . 0.0 109.493 179.98 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 34.6 mttp -86.58 143.71 27.54 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.21 -1.171 . . . . 0.0 109.465 179.981 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 N--CA 1.491 1.589 0 CA-C-O 118.021 -0.99 . . . . 0.0 109.393 179.985 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.525 0 N-CA-C 109.496 -0.557 . . . . 0.0 109.496 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 50.0 Cg_endo -69.46 138.98 40.09 Favored 'Trans proline' 0 C--O 1.215 -0.641 0 C-N-CA 122.692 2.262 . . . . 0.0 111.837 179.997 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 58.2 mtt180 -126.06 154.92 42.35 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.302 -0.873 . . . . 0.0 109.447 -179.984 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 38' ' ' LYS . . . . . 0.941 ' HA ' HD22 ' A' ' 114' ' ' LEU . 26.0 mttp -86.79 -162.96 0.83 Allowed 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.329 -0.857 . . . . 0.0 109.525 -179.97 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . 0.5 ' O ' ' CA ' ' A' ' 116' ' ' ALA . . . 142.21 168.98 11.93 Favored Glycine 0 N--CA 1.49 2.298 0 N-CA-C 109.299 -1.52 . . . . 0.0 109.299 -179.889 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 40' ' ' ASN . . . . . 0.596 ' H ' HG22 ' A' ' 79' ' ' THR . 47.4 t30 -155.25 100.02 2.12 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.127 -1.22 . . . . 0.0 109.493 179.988 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 41' ' ' THR . . . . . 0.823 ' O ' HD23 ' A' ' 42' ' ' LEU . 45.1 m -61.11 140.44 57.88 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.236 -0.915 . . . . 0.0 109.815 -179.771 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . 0.823 HD23 ' O ' ' A' ' 41' ' ' THR . 17.9 mt -125.33 143.44 50.97 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.253 -0.904 . . . . 0.0 109.483 179.722 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 71.1 t80 -96.27 120.46 36.6 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.277 -0.889 . . . . 0.0 109.52 -179.998 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . 0.643 ' CG1' HD21 ' A' ' 103' ' ' LEU . 58.7 t -118.49 139.06 47.16 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 O-C-N 121.171 -0.956 . . . . 0.0 109.421 179.96 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 65.6 t80 -129.39 141.6 51.01 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.261 -0.9 . . . . 0.0 109.562 -179.939 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 175.2 -174.82 47.0 Favored Glycine 0 N--CA 1.49 2.292 0 N-CA-C 109.424 -1.47 . . . . 0.0 109.424 179.935 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . 0.418 ' O ' ' C ' ' A' ' 48' ' ' ASP . 94.6 mt-10 -112.86 159.32 19.15 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.195 -1.18 . . . . 0.0 109.343 179.974 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . 0.418 ' C ' ' O ' ' A' ' 47' ' ' GLU . 51.4 m-20 44.34 40.2 3.59 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.211 -0.93 . . . . 0.0 109.262 -179.951 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 46.9 mtp -75.46 141.09 43.18 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.282 -0.886 . . . . 0.0 109.527 -179.951 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 50' ' ' THR . . . . . 0.457 ' O ' ' HG ' ' A' ' 54' ' ' LEU . 0.7 OUTLIER -130.98 161.94 58.54 Favored Pre-proline 0 N--CA 1.49 1.553 0 O-C-N 121.19 -0.944 . . . . 0.0 109.344 -179.974 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 51' ' ' PRO . . . . . 0.505 ' N ' ' SD ' ' A' ' 69' ' ' MET . 49.7 Cg_endo -70.6 -53.47 0.22 Allowed 'Trans proline' 0 C--O 1.214 -0.683 0 C-N-CA 122.657 2.238 . . . . 0.0 111.669 179.964 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 32.9 m -58.34 -41.69 85.19 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.268 -0.895 . . . . 0.0 109.348 179.886 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . 0.496 ' C ' HD23 ' A' ' 53' ' ' LEU . 9.2 tt -62.44 -46.08 90.18 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.277 -0.889 . . . . 0.0 109.385 179.92 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 54' ' ' LEU . . . . . 0.457 ' HG ' ' O ' ' A' ' 50' ' ' THR . 40.8 mt -64.76 -46.16 83.36 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.238 -0.914 . . . . 0.0 109.207 179.79 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 55' ' ' ARG . . . . . 0.478 ' O ' ' CB ' ' A' ' 59' ' ' SER . 74.4 ttt180 -48.0 -40.79 23.64 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.244 -0.91 . . . . 0.0 109.394 179.97 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -73.71 -31.55 60.32 Favored Glycine 0 N--CA 1.49 2.243 0 N-CA-C 109.476 -1.45 . . . . 0.0 109.476 179.892 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -73.55 -24.46 60.11 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.225 -1.162 . . . . 0.0 109.435 179.982 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 58' ' ' PHE . . . . . 0.713 ' CZ ' HD13 ' A' ' 93' ' ' LEU . 94.8 m-85 -119.09 8.86 11.65 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.371 -0.83 . . . . 0.0 109.421 179.977 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 59' ' ' SER . . . . . 0.526 ' N ' ' HD2' ' A' ' 60' ' ' PRO . 0.4 OUTLIER -74.9 -57.59 1.81 Allowed Pre-proline 0 N--CA 1.491 1.609 0 O-C-N 121.279 -0.888 . . . . 0.0 110.162 -179.582 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 60' ' ' PRO . . . . . 0.526 ' HD2' ' N ' ' A' ' 59' ' ' SER . 48.1 Cg_endo -68.74 -35.96 15.13 Favored 'Trans proline' 0 C--O 1.215 -0.63 0 C-N-CA 122.584 2.189 . . . . 0.0 112.259 -179.437 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 61' ' ' PHE . . . . . 0.579 ' CD1' ' HA ' ' A' ' 89' ' ' ALA . 64.7 m-85 -58.72 -33.89 70.73 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.16 -0.963 . . . . 0.0 109.703 -179.828 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 176.74 -174.32 46.95 Favored Glycine 0 N--CA 1.49 2.282 0 N-CA-C 109.617 -1.393 . . . . 0.0 109.617 179.974 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 82.0 m-20 -95.03 146.23 24.41 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.235 -1.156 . . . . 0.0 109.46 179.991 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 64' ' ' ILE . . . . . 0.797 HD13 HD12 ' A' ' 67' ' ' LEU . 51.5 mt -110.77 126.54 68.12 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 O-C-N 121.3 -0.875 . . . . 0.0 109.416 179.974 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 65' ' ' ILE . . . . . 0.459 HD13 ' O ' ' A' ' 38' ' ' LYS . 22.2 pt -91.15 -22.56 6.16 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 O-C-N 121.273 -0.892 . . . . 0.0 109.543 -179.896 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 45.2 t0 -155.49 95.0 1.64 Allowed 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.196 -0.94 . . . . 0.0 109.586 179.994 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . 0.797 HD12 HD13 ' A' ' 64' ' ' ILE . 0.5 OUTLIER -93.29 126.67 38.53 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.206 -0.934 . . . . 0.0 109.196 179.769 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 68' ' ' SER . . . . . 0.44 ' HB2' ' HB2' ' A' ' 77' ' ' PHE . 67.5 m -126.08 153.86 43.89 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.226 -0.921 . . . . 0.0 109.718 -179.802 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 69' ' ' MET . . . . . 0.505 ' SD ' ' N ' ' A' ' 51' ' ' PRO . 84.1 mtp -126.46 150.54 48.63 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.414 -0.804 . . . . 0.0 109.296 179.851 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 70' ' ' ASP . . . . . 0.484 ' C ' ' HD2' ' A' ' 72' ' ' PRO . 1.2 t0 -129.09 99.24 22.09 Favored Pre-proline 0 N--CA 1.49 1.565 0 O-C-N 121.195 -0.941 . . . . 0.0 109.55 -179.948 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 71' ' ' PRO . . . . . 0.6 ' N ' ' CD ' ' A' ' 72' ' ' PRO . 46.4 Cg_endo -74.54 -27.96 10.48 Favored 'Trans proline' 0 CA--C 1.542 0.897 0 C-N-CA 122.503 2.136 . . . . 0.0 113.523 179.845 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 72' ' ' PRO . . . . . 0.6 ' CD ' ' N ' ' A' ' 71' ' ' PRO . 55.6 Cg_endo -75.38 -26.62 10.15 Favored 'Trans proline' 0 C--N 1.353 0.772 0 C-N-CA 121.483 1.456 . . . . 0.0 111.82 -179.932 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 73' ' ' ARG . . . . . 0.429 ' O ' ' HB2' ' A' ' 74' ' ' ASN . 89.0 mtt-85 -109.23 -1.02 18.94 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.293 -0.88 . . . . 0.0 109.645 -179.959 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 74' ' ' ASN . . . . . 0.429 ' HB2' ' O ' ' A' ' 73' ' ' ARG . 79.8 m-20 61.6 43.99 9.49 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.21 -0.931 . . . . 0.0 109.568 179.955 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 75' ' ' CYS . . . . . 0.466 ' HA ' ' O ' ' A' ' 44' ' ' VAL . 27.5 p -146.94 150.5 35.3 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.271 -0.893 . . . . 0.0 109.395 179.978 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -116.35 154.25 30.55 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.171 -0.956 . . . . 0.0 109.522 -179.946 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 77' ' ' PHE . . . . . 0.47 ' HA ' ' O ' ' A' ' 42' ' ' LEU . 98.0 m-85 -124.16 106.31 10.23 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.299 -0.876 . . . . 0.0 109.476 -179.941 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . 0.735 HG23 HD12 ' A' ' 67' ' ' LEU . 5.9 p -109.8 136.19 46.48 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.503 0 O-C-N 121.131 -0.981 . . . . 0.0 109.638 179.907 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 79' ' ' THR . . . . . 0.7 HG23 ' OE1' ' A' ' 111' ' ' GLN . 3.7 m -102.5 127.05 49.72 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.308 -0.87 . . . . 0.0 109.699 -179.736 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 80' ' ' TYR . . . . . 0.823 ' HD2' HD11 ' A' ' 42' ' ' LEU . 0.5 OUTLIER -102.16 126.12 49.04 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.308 -0.87 . . . . 0.0 109.465 179.948 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 81' ' ' GLU . . . . . 0.477 ' HA ' ' HA2' ' A' ' 39' ' ' GLY . 88.5 tt0 -42.06 -47.4 4.49 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.476 -0.765 . . . . 0.0 109.766 179.949 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 36.4 mttm -113.7 155.86 24.8 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.26 -0.9 . . . . 0.0 109.635 -179.904 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 83' ' ' MET . . . . . 0.658 ' HE3' ' C ' ' A' ' 117' ' ' ALA . 57.7 mtt -77.46 -19.87 55.29 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.26 -0.9 . . . . 0.0 109.34 179.943 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 98.3 mt-10 -69.66 -44.6 70.19 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.181 -0.949 . . . . 0.0 109.303 179.918 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 16.0 m -61.56 -27.39 68.59 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.355 -0.841 . . . . 0.0 109.225 179.739 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 86' ' ' ALA . . . . . 0.611 ' O ' HG23 ' A' ' 90' ' ' VAL . . . -78.11 -34.42 50.06 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.383 -0.823 . . . . 0.0 109.416 -179.993 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 59.2 t0 -66.9 -33.63 76.02 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.294 -0.879 . . . . 0.0 109.388 179.897 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 88' ' ' GLN . . . . . 0.479 ' O ' ' HB2' ' A' ' 92' ' ' GLU . 63.5 tt0 -77.01 -37.6 54.69 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.287 -0.883 . . . . 0.0 109.384 179.933 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 89' ' ' ALA . . . . . 0.579 ' HA ' ' CD1' ' A' ' 61' ' ' PHE . . . -76.49 -35.09 58.57 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.285 -0.884 . . . . 0.0 109.385 179.939 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 90' ' ' VAL . . . . . 0.728 HG22 ' CG1' ' A' ' 105' ' ' VAL . 75.8 t -71.2 -39.77 73.7 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.513 0 O-C-N 121.325 -0.859 . . . . 0.0 109.464 -179.948 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -77.11 -34.31 56.76 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.209 -0.932 . . . . 0.0 109.496 -179.985 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 92' ' ' GLU . . . . . 0.579 ' HB3' ' CZ ' ' A' ' 61' ' ' PHE . 6.0 tm-20 -80.07 -46.28 16.8 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.215 -0.928 . . . . 0.0 109.644 -179.867 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 93' ' ' LEU . . . . . 0.713 HD13 ' CZ ' ' A' ' 58' ' ' PHE . 72.6 mt -70.42 -37.69 74.45 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.22 -0.925 . . . . 0.0 109.534 -179.918 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 94' ' ' ASN . . . . . 0.519 ' CB ' ' O ' ' A' ' 90' ' ' VAL . 49.6 t30 -70.12 136.68 50.42 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.231 -0.918 . . . . 0.0 109.462 -179.933 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 83.16 26.32 44.77 Favored Glycine 0 N--CA 1.49 2.279 0 N-CA-C 109.528 -1.429 . . . . 0.0 109.528 179.988 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 96' ' ' THR . . . . . 0.556 HG21 ' O ' ' A' ' 92' ' ' GLU . 27.9 p -125.89 146.63 49.75 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.29 -1.123 . . . . 0.0 109.575 -179.982 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 97' ' ' GLN . . . . . 0.502 ' CG ' ' O ' ' A' ' 101' ' ' VAL . 52.7 tt0 -117.92 137.81 52.57 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.293 -0.879 . . . . 0.0 109.424 -179.938 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 98' ' ' VAL . . . . . 0.547 HG12 ' H ' ' A' ' 99' ' ' GLU . 1.1 t -80.12 -153.55 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 O-C-N 121.283 -0.886 . . . . 0.0 109.337 -179.983 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 99' ' ' GLU . . . . . 0.547 ' H ' HG12 ' A' ' 98' ' ' VAL . 96.5 mt-10 -58.4 -38.31 77.12 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.165 -0.959 . . . . 0.0 109.5 -179.965 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -156.96 25.78 0.32 Allowed 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.183 -0.948 . . . . 0.0 109.483 -179.983 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 101' ' ' VAL . . . . . 0.586 HG12 ' N ' ' A' ' 102' ' ' GLN . 49.0 t -137.27 167.41 23.26 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.55 0 O-C-N 121.221 -0.925 . . . . 0.0 109.541 -179.878 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 102' ' ' GLN . . . . . 0.586 ' N ' HG12 ' A' ' 101' ' ' VAL . 92.1 mt-30 -122.61 147.37 46.49 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.248 -0.907 . . . . 0.0 109.126 179.885 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 103' ' ' LEU . . . . . 0.643 HD21 ' CG1' ' A' ' 44' ' ' VAL . 0.0 OUTLIER -121.69 135.68 54.96 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.11 -0.994 . . . . 0.0 109.93 -179.802 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 23.9 mttt -118.19 130.88 56.35 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.334 -0.854 . . . . 0.0 109.051 179.694 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 105' ' ' VAL . . . . . 0.728 ' CG1' HG22 ' A' ' 90' ' ' VAL . 21.5 t -109.6 132.56 57.45 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.611 0 O-C-N 121.167 -0.958 . . . . 0.0 109.776 -179.788 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 86.2 m-20 -133.12 -178.49 4.99 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.314 -0.866 . . . . 0.0 109.215 179.778 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 56.2 mt -107.71 135.48 46.18 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.573 0 O-C-N 121.174 -0.954 . . . . 0.0 109.442 179.898 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -108.38 164.29 12.46 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.253 -0.905 . . . . 0.0 109.512 -179.985 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 56.9 ttt180 -47.09 142.68 3.51 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.239 -0.913 . . . . 0.0 109.358 179.957 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 68.1 mttm -59.0 141.13 54.74 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.288 -0.882 . . . . 0.0 109.386 -179.93 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 111' ' ' GLN . . . . . 0.789 ' HB2' ' HE2' ' A' ' 113' ' ' MET . 8.2 pt20 -69.58 144.86 94.58 Favored Pre-proline 0 N--CA 1.49 1.574 0 O-C-N 121.236 -0.915 . . . . 0.0 109.537 -179.851 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 112' ' ' PRO . . . . . 0.432 ' O ' ' N ' ' A' ' 114' ' ' LEU . 52.6 Cg_endo -72.43 -35.54 6.26 Favored 'Trans proline' 0 C--O 1.214 -0.719 0 C-N-CA 122.823 2.348 . . . . 0.0 112.736 -179.491 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 113' ' ' MET . . . . . 0.789 ' HE2' ' HB2' ' A' ' 111' ' ' GLN . 13.2 mtm -42.91 -27.04 0.16 Allowed 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.242 -0.911 . . . . 0.0 109.626 -179.484 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 114' ' ' LEU . . . . . 0.941 HD22 ' HA ' ' A' ' 38' ' ' LYS . 2.2 tt -174.41 29.25 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.3 -0.875 . . . . 0.0 109.49 -179.895 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 115' ' ' ASP . . . . . 0.693 ' O ' ' HB3' ' A' ' 116' ' ' ALA . 75.1 m-20 50.81 33.53 8.69 Favored 'General case' 0 C--N 1.302 -1.478 0 O-C-N 121.248 -0.908 . . . . 0.0 108.685 -179.476 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 116' ' ' ALA . . . . . 0.693 ' HB3' ' O ' ' A' ' 115' ' ' ASP . . . 76.03 -79.8 0.04 OUTLIER 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.411 -0.805 . . . . 0.0 109.54 -179.784 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 117' ' ' ALA . . . . . 0.658 ' C ' ' HE3' ' A' ' 83' ' ' MET . . . -165.37 24.98 0.05 Allowed 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.273 -0.892 . . . . 0.0 109.775 -179.666 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 67.3 p -64.65 -11.7 38.16 Favored 'General case' 0 C--N 1.303 -1.449 0 O-C-N 121.174 -0.954 . . . . 0.0 109.572 -179.688 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -56.79 -31.04 60.49 Favored Glycine 0 N--CA 1.491 2.304 0 N-CA-C 109.556 -1.417 . . . . 0.0 109.556 -179.973 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 15.1 tptp -52.48 -34.2 48.23 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.181 -1.188 . . . . 0.0 109.582 -179.933 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 58.0 m . . . . . 0 N--CA 1.489 1.51 0 CA-C-O 118.007 -0.997 . . . . 0.0 109.541 -179.95 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.577 0 N-CA-C 109.467 -0.568 . . . . 0.0 109.467 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 49.3 Cg_endo -69.65 -23.2 31.58 Favored 'Trans proline' 0 C--O 1.214 -0.692 0 C-N-CA 122.72 2.28 . . . . 0.0 111.833 179.971 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 65.3 mtt85 -55.88 -41.2 74.08 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.266 -0.896 . . . . 0.0 109.362 179.865 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 38' ' ' LYS . . . . . 0.742 ' HG2' HD13 ' A' ' 114' ' ' LEU . 14.2 mttt -63.51 -168.86 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.25 -0.906 . . . . 0.0 109.374 179.924 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . 0.496 ' HA2' ' O ' ' A' ' 80' ' ' TYR . . . 160.58 -155.1 26.21 Favored Glycine 0 N--CA 1.488 2.12 0 N-CA-C 109.484 -1.446 . . . . 0.0 109.484 179.791 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 40' ' ' ASN . . . . . 0.749 ' HA ' ' HB1' ' A' ' 116' ' ' ALA . 62.0 t30 -165.8 115.31 1.0 Allowed 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.135 -1.214 . . . . 0.0 109.417 179.858 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 41' ' ' THR . . . . . 0.64 HG21 ' HB2' ' A' ' 110' ' ' LYS . 54.4 m -77.52 148.22 35.4 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.282 -0.886 . . . . 0.0 109.826 -179.712 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . 0.914 HD12 ' O ' ' A' ' 78' ' ' VAL . 4.9 mp -123.79 152.29 42.39 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.352 -0.842 . . . . 0.0 109.386 179.832 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 43' ' ' TYR . . . . . 0.415 ' HB3' ' HB2' ' A' ' 106' ' ' ASN . 46.8 t80 -110.22 112.07 23.8 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.246 -0.909 . . . . 0.0 109.358 179.782 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . 0.461 ' HA ' ' O ' ' A' ' 104' ' ' LYS . 48.8 t -108.29 143.88 17.88 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.535 0 O-C-N 121.301 -0.874 . . . . 0.0 109.351 -179.941 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 45' ' ' TYR . . . . . 0.468 ' HB3' ' HB2' ' A' ' 104' ' ' LYS . 71.1 t80 -131.53 135.87 47.39 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.282 -0.886 . . . . 0.0 109.506 -179.931 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . 0.474 ' O ' ' HB3' ' A' ' 74' ' ' ASN . . . 177.57 -170.53 43.0 Favored Glycine 0 N--CA 1.49 2.282 0 N-CA-C 109.476 -1.45 . . . . 0.0 109.476 179.989 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . 0.42 ' O ' ' C ' ' A' ' 48' ' ' ASP . 94.9 mt-10 -124.31 157.36 35.14 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.246 -1.15 . . . . 0.0 109.426 -179.922 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . 0.42 ' C ' ' O ' ' A' ' 47' ' ' GLU . 38.0 m-20 44.48 51.26 7.94 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.274 -0.891 . . . . 0.0 109.552 -179.977 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 60.9 mtm -102.84 137.93 40.4 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.158 -0.964 . . . . 0.0 109.432 179.992 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 50' ' ' THR . . . . . 0.745 ' O ' HD12 ' A' ' 54' ' ' LEU . 0.7 OUTLIER -116.29 164.15 19.15 Favored Pre-proline 0 N--CA 1.49 1.551 0 O-C-N 121.197 -0.939 . . . . 0.0 109.599 179.894 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 50.4 Cg_endo -70.25 -52.03 0.31 Allowed 'Trans proline' 0 C--O 1.216 -0.594 0 C-N-CA 122.69 2.26 . . . . 0.0 111.715 179.979 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 36.5 m -53.63 -43.17 68.52 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.316 -0.865 . . . . 0.0 109.369 179.993 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . 0.737 ' O ' HD13 ' A' ' 53' ' ' LEU . 3.3 tm? -62.02 -46.18 90.31 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.239 -0.913 . . . . 0.0 109.319 179.967 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 54' ' ' LEU . . . . . 0.745 HD12 ' O ' ' A' ' 50' ' ' THR . 3.9 mt -62.49 -44.81 95.48 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.285 -0.884 . . . . 0.0 109.441 179.923 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 55' ' ' ARG . . . . . 0.761 ' HE ' HD22 ' A' ' 67' ' ' LEU . 83.5 mtt180 -52.29 -39.06 60.02 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.318 -0.864 . . . . 0.0 109.379 179.919 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -70.69 -34.89 66.76 Favored Glycine 0 N--CA 1.49 2.238 0 N-CA-C 109.378 -1.489 . . . . 0.0 109.378 179.968 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . 0.47 ' HB1' HD22 ' A' ' 93' ' ' LEU . . . -76.05 -23.7 55.11 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.282 -1.128 . . . . 0.0 109.439 179.979 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 58' ' ' PHE . . . . . 0.633 ' CE1' ' CD1' ' A' ' 93' ' ' LEU . 96.8 m-85 -116.17 7.75 14.21 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.146 -0.971 . . . . 0.0 109.46 179.995 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 59' ' ' SER . . . . . 0.532 ' N ' ' HD2' ' A' ' 60' ' ' PRO . 0.5 OUTLIER -73.51 -57.46 2.65 Favored Pre-proline 0 N--CA 1.491 1.608 0 O-C-N 121.291 -0.881 . . . . 0.0 109.96 -179.643 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 60' ' ' PRO . . . . . 0.532 ' HD2' ' N ' ' A' ' 59' ' ' SER . 49.0 Cg_endo -69.25 -33.04 19.43 Favored 'Trans proline' 0 C--O 1.214 -0.711 0 C-N-CA 122.643 2.229 . . . . 0.0 112.28 -179.597 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 61' ' ' PHE . . . . . 0.584 ' CD2' ' HA ' ' A' ' 89' ' ' ALA . 51.0 m-85 -61.64 -33.18 73.49 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.202 -0.936 . . . . 0.0 109.612 -179.874 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 176.65 -173.49 46.33 Favored Glycine 0 N--CA 1.489 2.213 0 N-CA-C 109.533 -1.427 . . . . 0.0 109.533 179.967 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 85.6 m-20 -95.7 147.42 23.62 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.248 -1.149 . . . . 0.0 109.383 -179.957 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 64' ' ' ILE . . . . . 0.436 ' HA ' ' O ' ' A' ' 79' ' ' THR . 53.6 mt -111.14 124.95 68.4 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.522 0 O-C-N 121.205 -0.934 . . . . 0.0 109.525 -179.963 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 65' ' ' ILE . . . . . 0.719 HD11 ' NE2' ' A' ' 111' ' ' GLN . 31.1 pt -93.8 -26.79 4.53 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.573 0 O-C-N 121.342 -0.849 . . . . 0.0 109.382 179.926 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 66' ' ' ASP . . . . . 0.425 ' HB3' ' OG1' ' A' ' 79' ' ' THR . 58.2 t0 -140.43 130.36 24.65 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.214 -0.929 . . . . 0.0 109.511 179.937 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . 0.761 HD22 ' HE ' ' A' ' 55' ' ' ARG . 7.1 tp -121.46 120.4 34.82 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.239 -0.913 . . . . 0.0 109.438 179.923 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 68' ' ' SER . . . . . 0.458 ' HB3' ' HB2' ' A' ' 77' ' ' PHE . 43.3 t -128.87 140.66 51.59 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.242 -0.911 . . . . 0.0 109.479 -179.985 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 69' ' ' MET . . . . . . . . . . . . . 86.7 mtp -123.93 149.61 45.71 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.313 -0.867 . . . . 0.0 109.44 -179.993 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 70' ' ' ASP . . . . . 0.48 ' C ' ' HD2' ' A' ' 72' ' ' PRO . 0.7 OUTLIER -127.81 101.56 23.29 Favored Pre-proline 0 N--CA 1.49 1.555 0 O-C-N 121.251 -0.905 . . . . 0.0 109.433 179.964 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 71' ' ' PRO . . . . . 0.599 ' N ' ' CD ' ' A' ' 72' ' ' PRO . 47.3 Cg_endo -74.75 -27.81 10.2 Favored 'Trans proline' 0 CA--C 1.543 0.932 0 C-N-CA 122.527 2.151 . . . . 0.0 113.69 179.998 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 72' ' ' PRO . . . . . 0.599 ' CD ' ' N ' ' A' ' 71' ' ' PRO . 55.2 Cg_endo -75.41 -23.81 12.8 Favored 'Trans proline' 0 C--N 1.353 0.793 0 C-N-CA 121.496 1.464 . . . . 0.0 111.869 -179.83 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 73' ' ' ARG . . . . . 0.436 ' HB2' ' SG ' ' A' ' 75' ' ' CYS . 75.0 mtt85 -111.91 -1.11 15.59 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.197 -0.939 . . . . 0.0 109.666 -179.879 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 74' ' ' ASN . . . . . 0.474 ' HB3' ' O ' ' A' ' 46' ' ' GLY . 8.0 m120 60.78 44.21 11.29 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.133 -0.98 . . . . 0.0 109.519 179.985 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 75' ' ' CYS . . . . . 0.475 ' O ' ' HB2' ' A' ' 70' ' ' ASP . 24.4 p -144.79 140.74 28.67 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.211 -0.931 . . . . 0.0 109.541 -179.921 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -113.67 161.38 17.54 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.222 -0.924 . . . . 0.0 109.36 -180.0 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 77' ' ' PHE . . . . . 0.567 ' CE2' ' NZ ' ' A' ' 110' ' ' LYS . 96.9 m-85 -125.37 137.35 54.03 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.215 -0.928 . . . . 0.0 109.497 -179.9 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . 0.914 ' O ' HD12 ' A' ' 42' ' ' LEU . 25.3 t -130.55 139.78 50.44 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.611 0 O-C-N 121.391 -0.818 . . . . 0.0 109.362 179.849 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 79' ' ' THR . . . . . 0.51 ' CG2' ' NE2' ' A' ' 111' ' ' GLN . 2.0 m -110.61 121.28 44.93 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.213 -0.929 . . . . 0.0 109.431 179.936 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 80' ' ' TYR . . . . . 0.571 ' HH ' ' HD1' ' A' ' 58' ' ' PHE . 1.5 m-85 -99.41 138.41 36.54 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.251 -0.906 . . . . 0.0 109.613 -179.925 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 81' ' ' GLU . . . . . 0.454 ' C ' ' HA2' ' A' ' 39' ' ' GLY . 81.6 tt0 -48.69 -25.79 1.97 Allowed 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.327 -0.858 . . . . 0.0 109.787 179.997 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 48.1 mttp -143.48 159.46 42.36 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.142 -0.974 . . . . 0.0 109.591 -179.938 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 83' ' ' MET . . . . . 0.891 ' HE3' ' O ' ' A' ' 117' ' ' ALA . 61.8 mtt -72.83 -19.37 61.33 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.292 -0.88 . . . . 0.0 109.357 179.971 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 96.5 mt-10 -68.06 -51.4 47.11 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.277 -0.889 . . . . 0.0 109.513 179.904 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 7.4 m -56.35 -32.46 64.73 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.277 -0.89 . . . . 0.0 109.37 179.863 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 86' ' ' ALA . . . . . 0.596 ' HB1' HD21 ' A' ' 42' ' ' LEU . . . -74.12 -27.54 60.91 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.236 -0.915 . . . . 0.0 109.364 -179.999 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 22.1 t70 -69.31 -43.29 74.07 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.224 -0.922 . . . . 0.0 109.457 -179.933 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 88' ' ' GLN . . . . . 0.453 ' O ' ' HB2' ' A' ' 92' ' ' GLU . 61.4 tt0 -69.48 -36.75 76.84 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.289 -0.882 . . . . 0.0 109.416 -179.95 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 89' ' ' ALA . . . . . 0.781 ' HB1' ' CD1' ' A' ' 93' ' ' LEU . . . -74.02 -44.38 54.67 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.221 -0.924 . . . . 0.0 109.446 179.958 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 90' ' ' VAL . . . . . 0.787 HG22 HG12 ' A' ' 105' ' ' VAL . 84.1 t -67.22 -38.19 80.56 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.549 0 O-C-N 121.337 -0.852 . . . . 0.0 109.603 179.984 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -80.06 -29.12 39.15 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.269 -0.894 . . . . 0.0 109.906 -179.681 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 92' ' ' GLU . . . . . 0.566 ' HB3' ' CE2' ' A' ' 61' ' ' PHE . 23.0 tt0 -91.9 -45.59 8.28 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.158 -0.963 . . . . 0.0 109.677 -179.749 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 93' ' ' LEU . . . . . 0.781 ' CD1' ' HB1' ' A' ' 89' ' ' ALA . 21.3 mt -69.35 -43.14 74.21 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.207 -0.933 . . . . 0.0 109.587 -179.925 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 94' ' ' ASN . . . . . 0.515 ' CB ' ' O ' ' A' ' 90' ' ' VAL . 43.8 t30 -63.74 127.11 29.9 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.205 -0.934 . . . . 0.0 109.54 179.988 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 98.79 16.3 31.47 Favored Glycine 0 N--CA 1.49 2.268 0 N-CA-C 109.455 -1.458 . . . . 0.0 109.455 179.985 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 96' ' ' THR . . . . . 0.552 HG23 ' O ' ' A' ' 93' ' ' LEU . 18.1 p -116.54 157.42 25.28 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.183 -1.187 . . . . 0.0 109.383 -179.966 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 59.6 tt0 -117.99 139.55 51.01 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.194 -0.941 . . . . 0.0 109.478 -179.944 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 98' ' ' VAL . . . . . 0.784 HG22 HD11 ' A' ' 103' ' ' LEU . 1.2 t -83.83 -149.49 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 121.202 -0.936 . . . . 0.0 109.374 -179.966 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 99' ' ' GLU . . . . . 0.504 ' H ' HG12 ' A' ' 98' ' ' VAL . 76.5 mm-40 -60.38 -41.62 94.16 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.226 -0.921 . . . . 0.0 109.501 179.97 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 21.1 t -158.51 31.55 0.23 Allowed 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.293 -0.88 . . . . 0.0 109.426 179.952 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 101' ' ' VAL . . . . . 0.542 ' O ' HG23 ' A' ' 98' ' ' VAL . 58.9 t -147.03 147.86 17.23 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 O-C-N 121.227 -0.921 . . . . 0.0 109.464 179.995 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 91.7 mt-30 -86.43 145.73 26.72 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.253 -0.904 . . . . 0.0 109.574 -179.941 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 103' ' ' LEU . . . . . 0.784 HD11 HG22 ' A' ' 98' ' ' VAL . 96.0 mt -109.56 136.13 49.44 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.313 -0.867 . . . . 0.0 109.467 179.948 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 104' ' ' LYS . . . . . 0.468 ' HB2' ' HB3' ' A' ' 45' ' ' TYR . 57.3 mttm -122.09 133.55 54.77 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.242 -0.912 . . . . 0.0 109.48 -179.938 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 105' ' ' VAL . . . . . 0.787 HG12 HG22 ' A' ' 90' ' ' VAL . 7.0 t -122.01 154.5 26.52 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.527 0 O-C-N 121.241 -0.912 . . . . 0.0 109.602 -179.994 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 106' ' ' ASN . . . . . 0.415 ' HB2' ' HB3' ' A' ' 43' ' ' TYR . 73.5 m-20 -158.57 -172.51 3.87 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.287 -0.883 . . . . 0.0 109.425 179.94 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 26.2 mm -110.44 125.61 67.7 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.499 0 O-C-N 121.163 -0.961 . . . . 0.0 109.429 179.946 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -102.92 145.69 29.44 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.209 -0.932 . . . . 0.0 109.534 -179.928 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 38.0 ptt180 -88.26 17.17 5.38 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.269 -0.894 . . . . 0.0 109.447 179.968 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 110' ' ' LYS . . . . . 0.64 ' HB2' HG21 ' A' ' 41' ' ' THR . 38.3 mttp -68.68 -162.98 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.229 -0.919 . . . . 0.0 109.458 -179.891 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 111' ' ' GLN . . . . . 0.719 ' NE2' HD11 ' A' ' 65' ' ' ILE . 3.9 tt0 70.52 61.1 0.48 Allowed Pre-proline 0 N--CA 1.49 1.566 0 O-C-N 121.332 -0.855 . . . . 0.0 109.608 -179.942 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 52.4 Cg_endo -70.99 -10.12 26.97 Favored 'Trans proline' 0 C--O 1.214 -0.681 0 C-N-CA 122.764 2.309 . . . . 0.0 111.771 179.87 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 113' ' ' MET . . . . . 0.591 ' CE ' ' HG3' ' A' ' 111' ' ' GLN . 12.5 mtm -67.82 -8.71 38.31 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.314 -0.866 . . . . 0.0 109.488 -179.926 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 114' ' ' LEU . . . . . 0.8 HD23 ' O ' ' A' ' 114' ' ' LEU . 2.6 tt 178.07 31.78 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.332 -0.855 . . . . 0.0 109.36 -179.71 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 115' ' ' ASP . . . . . 0.538 ' O ' ' HB3' ' A' ' 116' ' ' ALA . 77.5 m-20 47.78 42.89 16.43 Favored 'General case' 0 C--N 1.3 -1.546 0 N-CA-C 107.994 -1.113 . . . . 0.0 107.994 -179.091 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 116' ' ' ALA . . . . . 0.749 ' HB1' ' HA ' ' A' ' 40' ' ' ASN . . . 68.46 -84.49 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.646 -0.659 . . . . 0.0 109.588 -179.435 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 117' ' ' ALA . . . . . 0.891 ' O ' ' HE3' ' A' ' 83' ' ' MET . . . -154.74 168.92 25.24 Favored 'General case' 0 C--N 1.3 -1.544 0 O-C-N 121.14 -0.975 . . . . 0.0 109.74 -179.596 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 12.3 p -122.04 163.57 19.17 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.232 -0.918 . . . . 0.0 109.472 -179.837 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -179.81 -163.38 30.38 Favored Glycine 0 N--CA 1.49 2.298 0 N-CA-C 109.388 -1.485 . . . . 0.0 109.388 -179.978 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 32.4 mttt -58.4 -31.59 67.83 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.286 -1.126 . . . . 0.0 109.449 180.0 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 1.5 p . . . . . 0 N--CA 1.49 1.561 0 CA-C-O 118.004 -0.998 . . . . 0.0 109.48 179.972 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . 0.802 ' HB3' ' HD3' ' A' ' 36' ' ' PRO . . . . . . . . 0 N--CA 1.49 1.565 0 N-CA-C 109.473 -0.565 . . . . 0.0 109.473 . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 36' ' ' PRO . . . . . 0.802 ' HD3' ' HB3' ' A' ' 35' ' ' ALA . 49.4 Cg_endo -69.93 -14.13 35.16 Favored 'Trans proline' 0 C--O 1.215 -0.665 0 C-N-CA 122.741 2.294 . . . . 0.0 111.715 -179.991 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 37' ' ' ARG . . . . . 0.457 ' O ' ' HG ' ' A' ' 114' ' ' LEU . 69.0 mtt85 -129.91 129.76 44.29 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.269 -0.894 . . . . 0.0 109.466 -179.964 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 38' ' ' LYS . . . . . 0.701 ' HA ' HD12 ' A' ' 114' ' ' LEU . 18.0 mttt -104.14 -167.04 1.31 Allowed 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.306 -0.871 . . . . 0.0 109.404 179.953 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . 0.604 ' CA ' HG22 ' A' ' 79' ' ' THR . . . 148.68 89.92 0.08 OUTLIER Glycine 0 N--CA 1.489 2.193 0 N-CA-C 109.778 -1.329 . . . . 0.0 109.778 179.951 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 40' ' ' ASN . . . . . 0.477 ' O ' ' HA ' ' A' ' 79' ' ' THR . 60.1 t-20 -84.08 121.51 27.52 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.197 -1.178 . . . . 0.0 109.134 179.634 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 41' ' ' THR . . . . . 0.916 HG21 ' HB3' ' A' ' 110' ' ' LYS . 92.6 m -81.96 140.57 33.93 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.241 -0.912 . . . . 0.0 109.956 -179.568 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . 0.889 HD23 ' CG2' ' A' ' 90' ' ' VAL . 5.4 mp -118.05 142.62 47.2 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.375 -0.828 . . . . 0.0 109.077 179.391 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 43' ' ' TYR . . . . . 0.575 ' HB2' ' HB2' ' A' ' 108' ' ' ALA . 59.7 t80 -99.76 109.91 22.32 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.322 -0.861 . . . . 0.0 109.611 -179.851 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . 0.475 ' HA ' ' O ' ' A' ' 104' ' ' LYS . 96.4 t -107.4 143.27 18.27 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.555 0 O-C-N 121.249 -0.907 . . . . 0.0 109.345 179.913 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 74.2 t80 -132.51 135.47 46.01 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.174 -0.954 . . . . 0.0 109.497 -179.891 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 177.9 -175.13 47.35 Favored Glycine 0 N--CA 1.489 2.222 0 N-CA-C 109.554 -1.418 . . . . 0.0 109.554 179.931 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . 0.429 ' O ' ' C ' ' A' ' 48' ' ' ASP . 94.0 mt-10 -114.9 158.51 21.88 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.254 -1.144 . . . . 0.0 109.432 -179.967 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . 0.429 ' C ' ' O ' ' A' ' 47' ' ' GLU . 48.8 m-20 44.07 50.44 7.35 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.302 -0.874 . . . . 0.0 109.444 -179.954 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 54.0 mtm -100.38 135.58 41.59 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.192 -0.943 . . . . 0.0 109.523 179.981 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -122.65 166.04 19.14 Favored Pre-proline 0 N--CA 1.49 1.558 0 O-C-N 121.266 -0.896 . . . . 0.0 109.41 179.946 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 51' ' ' PRO . . . . . 0.664 ' HA ' HD12 ' A' ' 54' ' ' LEU . 49.7 Cg_endo -70.24 -51.67 0.33 Allowed 'Trans proline' 0 C--O 1.214 -0.685 0 C-N-CA 122.671 2.247 . . . . 0.0 111.755 179.969 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 62.8 m -49.36 -48.65 46.54 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.217 -0.927 . . . . 0.0 109.288 179.96 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 18.0 tp -59.6 -47.82 84.06 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.175 -0.953 . . . . 0.0 109.228 179.901 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 54' ' ' LEU . . . . . 0.664 HD12 ' HA ' ' A' ' 51' ' ' PRO . 12.8 mt -56.08 -45.61 79.29 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.26 -0.9 . . . . 0.0 109.337 179.835 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 55' ' ' ARG . . . . . 0.509 ' O ' ' N ' ' A' ' 59' ' ' SER . 15.3 mtp-105 -51.73 -42.21 62.12 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.355 -0.841 . . . . 0.0 109.286 179.863 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -70.78 -29.11 69.77 Favored Glycine 0 N--CA 1.489 2.232 0 N-CA-C 109.308 -1.517 . . . . 0.0 109.308 179.891 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . 0.461 ' O ' ' CD1' ' A' ' 61' ' ' PHE . . . -79.57 -22.8 43.32 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.267 -1.137 . . . . 0.0 109.432 179.966 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 58' ' ' PHE . . . . . 0.698 ' HB2' HD11 ' A' ' 64' ' ' ILE . 96.3 m-85 -119.51 7.59 11.17 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.245 -0.909 . . . . 0.0 109.473 179.926 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 59' ' ' SER . . . . . 0.541 ' N ' ' HD2' ' A' ' 60' ' ' PRO . 0.6 OUTLIER -72.7 -57.07 3.41 Favored Pre-proline 0 N--CA 1.49 1.537 0 O-C-N 121.261 -0.899 . . . . 0.0 109.837 -179.888 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 60' ' ' PRO . . . . . 0.541 ' HD2' ' N ' ' A' ' 59' ' ' SER . 49.7 Cg_endo -69.57 -30.46 23.12 Favored 'Trans proline' 0 C--O 1.215 -0.664 0 C-N-CA 122.648 2.232 . . . . 0.0 111.954 -179.822 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 61' ' ' PHE . . . . . 0.679 ' CE1' HD21 ' A' ' 93' ' ' LEU . 58.6 m-85 -64.22 -34.38 77.97 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.231 -0.918 . . . . 0.0 109.27 179.965 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 173.62 -173.41 45.79 Favored Glycine 0 N--CA 1.49 2.235 0 N-CA-C 109.4 -1.48 . . . . 0.0 109.4 179.98 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 56.1 t30 -95.57 139.34 31.97 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.235 -1.156 . . . . 0.0 109.566 179.947 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 64' ' ' ILE . . . . . 0.698 HD11 ' HB2' ' A' ' 58' ' ' PHE . 58.2 mt -101.87 135.03 40.58 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 O-C-N 121.228 -0.92 . . . . 0.0 109.351 179.966 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 65' ' ' ILE . . . . . 0.594 HD11 ' HA3' ' A' ' 39' ' ' GLY . 24.6 pt -97.72 -23.1 4.72 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.527 0 O-C-N 121.313 -0.867 . . . . 0.0 109.645 -179.963 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 53.2 t0 -149.05 126.87 11.81 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.227 -0.92 . . . . 0.0 109.552 179.981 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 16.2 tp -112.26 117.05 31.45 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.241 -0.912 . . . . 0.0 109.466 179.949 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 68' ' ' SER . . . . . 0.488 ' HB2' ' HB2' ' A' ' 77' ' ' PHE . 68.0 m -123.35 145.61 48.6 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.191 -0.943 . . . . 0.0 109.476 -179.916 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 69' ' ' MET . . . . . 0.477 ' HA ' ' HA ' ' A' ' 76' ' ' ALA . 75.1 mtp -131.53 149.61 52.45 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.209 -0.932 . . . . 0.0 109.556 -179.966 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 70' ' ' ASP . . . . . 0.483 ' C ' ' HD2' ' A' ' 72' ' ' PRO . 2.6 t0 -123.36 104.76 34.28 Favored Pre-proline 0 N--CA 1.49 1.547 0 O-C-N 121.181 -0.949 . . . . 0.0 109.484 179.924 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 71' ' ' PRO . . . . . 0.6 ' N ' ' CD ' ' A' ' 72' ' ' PRO . 46.6 Cg_endo -74.87 -27.73 10.03 Favored 'Trans proline' 0 CA--C 1.543 0.952 0 C-N-CA 122.585 2.19 . . . . 0.0 113.608 -179.944 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 72' ' ' PRO . . . . . 0.6 ' CD ' ' N ' ' A' ' 71' ' ' PRO . 54.6 Cg_endo -75.14 -33.27 4.57 Favored 'Trans proline' 0 C--N 1.354 0.839 0 C-N-CA 121.437 1.425 . . . . 0.0 111.862 -179.82 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 73' ' ' ARG . . . . . 0.443 ' HG2' ' O ' ' A' ' 73' ' ' ARG . 67.5 ttt180 -103.62 -2.17 27.05 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.222 -0.924 . . . . 0.0 109.663 -179.927 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 74' ' ' ASN . . . . . 0.426 ' HB2' ' O ' ' A' ' 73' ' ' ARG . 79.9 m-20 61.88 40.38 12.66 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.177 -0.952 . . . . 0.0 109.505 -179.996 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 75' ' ' CYS . . . . . . . . . . . . . 24.7 p -136.03 137.43 41.16 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.286 -0.884 . . . . 0.0 109.434 -179.943 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . 0.477 ' HA ' ' HA ' ' A' ' 69' ' ' MET . . . -107.61 157.21 18.25 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.317 -0.864 . . . . 0.0 109.49 179.965 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 77' ' ' PHE . . . . . 0.488 ' HA ' ' O ' ' A' ' 42' ' ' LEU . 97.5 m-85 -123.45 131.19 53.57 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.282 -0.886 . . . . 0.0 109.583 -179.959 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . 0.794 ' O ' HD12 ' A' ' 42' ' ' LEU . 45.5 t -120.4 134.5 63.67 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 O-C-N 121.261 -0.899 . . . . 0.0 109.7 -179.954 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 79' ' ' THR . . . . . 0.604 HG22 ' CA ' ' A' ' 39' ' ' GLY . 9.1 m -103.48 129.3 50.61 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.256 -0.902 . . . . 0.0 109.471 179.927 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 80' ' ' TYR . . . . . 0.588 ' CG ' ' HB2' ' A' ' 85' ' ' SER . 0.7 OUTLIER -112.07 137.12 50.55 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.192 -0.942 . . . . 0.0 109.542 -179.898 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 81' ' ' GLU . . . . . 0.487 ' O ' ' HB2' ' A' ' 38' ' ' LYS . 84.4 tt0 -57.67 -27.56 62.99 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.26 -0.9 . . . . 0.0 109.48 179.98 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 24.8 mttp -132.59 146.62 52.04 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.174 -0.954 . . . . 0.0 109.426 -179.955 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 83' ' ' MET . . . . . 0.584 ' HE2' ' N ' ' A' ' 117' ' ' ALA . 35.6 mtt -64.73 -20.32 66.28 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.254 -0.904 . . . . 0.0 109.378 179.986 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 98.6 mt-10 -68.26 -37.06 80.35 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.317 -0.865 . . . . 0.0 109.439 179.993 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 85' ' ' SER . . . . . 0.588 ' HB2' ' CG ' ' A' ' 80' ' ' TYR . 18.7 m -61.45 -34.34 75.26 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.276 -0.89 . . . . 0.0 109.455 179.952 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 86' ' ' ALA . . . . . 0.646 ' CB ' HD21 ' A' ' 42' ' ' LEU . . . -76.26 -30.5 57.87 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.326 -0.859 . . . . 0.0 109.437 -179.995 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 54.2 t0 -63.71 -49.52 72.77 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.218 -0.926 . . . . 0.0 109.496 179.93 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 88' ' ' GLN . . . . . 0.467 ' O ' ' HB2' ' A' ' 92' ' ' GLU . 59.0 tt0 -66.72 -38.74 87.31 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.267 -0.896 . . . . 0.0 109.462 -179.988 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 89' ' ' ALA . . . . . 0.547 ' HA ' ' CE2' ' A' ' 61' ' ' PHE . . . -74.1 -49.67 22.89 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.319 -0.863 . . . . 0.0 109.624 -179.979 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 90' ' ' VAL . . . . . 0.889 ' CG2' HD23 ' A' ' 42' ' ' LEU . 69.8 t -63.22 -37.0 78.28 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.551 0 O-C-N 121.203 -0.935 . . . . 0.0 109.61 -179.846 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -80.16 -37.83 32.6 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.212 -0.93 . . . . 0.0 109.722 -179.775 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 92' ' ' GLU . . . . . 0.547 ' HB3' ' CE2' ' A' ' 61' ' ' PHE . 24.6 tt0 -83.53 -48.78 9.91 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.171 -0.956 . . . . 0.0 109.803 -179.654 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 93' ' ' LEU . . . . . 0.838 ' HB2' HG21 ' A' ' 105' ' ' VAL . 35.0 mt -64.15 -40.47 96.21 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.187 -0.946 . . . . 0.0 109.683 -179.753 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 94' ' ' ASN . . . . . 0.52 ' CB ' ' O ' ' A' ' 90' ' ' VAL . 56.4 t-20 -63.54 124.31 21.03 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.179 -0.951 . . . . 0.0 109.621 -179.998 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 92.05 29.84 11.02 Favored Glycine 0 N--CA 1.49 2.26 0 N-CA-C 109.502 -1.439 . . . . 0.0 109.502 179.973 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 96' ' ' THR . . . . . 0.637 HG23 ' O ' ' A' ' 93' ' ' LEU . 26.1 p -121.41 158.39 28.43 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.287 -1.125 . . . . 0.0 109.5 179.945 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 63.7 tt0 -122.67 148.93 44.71 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.236 -0.915 . . . . 0.0 109.509 -179.99 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 98' ' ' VAL . . . . . 0.495 HG12 ' H ' ' A' ' 99' ' ' GLU . 1.3 t -100.29 -148.72 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.574 0 O-C-N 121.229 -0.919 . . . . 0.0 109.373 179.971 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 99' ' ' GLU . . . . . 0.495 ' H ' HG12 ' A' ' 98' ' ' VAL . 96.4 mt-10 -61.24 -40.6 94.65 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.25 -0.906 . . . . 0.0 109.459 179.99 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 32.0 t -159.36 31.56 0.2 Allowed 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.354 -0.841 . . . . 0.0 109.487 -179.942 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 101' ' ' VAL . . . . . 0.481 ' O ' HG23 ' A' ' 98' ' ' VAL . 48.6 t -148.75 154.73 9.57 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.603 0 O-C-N 121.301 -0.874 . . . . 0.0 109.365 -179.987 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 88.8 mt-30 -100.99 138.7 37.69 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.294 -0.879 . . . . 0.0 109.455 179.855 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 94.6 mt -106.56 136.95 45.44 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.159 -0.963 . . . . 0.0 109.57 -179.956 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 104' ' ' LYS . . . . . 0.475 ' O ' ' HA ' ' A' ' 44' ' ' VAL . 30.1 mttp -118.87 144.5 46.35 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.346 -0.846 . . . . 0.0 109.296 179.747 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 105' ' ' VAL . . . . . 0.838 HG21 ' HB2' ' A' ' 93' ' ' LEU . 17.4 t -129.23 150.39 34.58 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.585 0 O-C-N 121.231 -0.918 . . . . 0.0 109.661 -179.837 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 106' ' ' ASN . . . . . 0.48 ' HB2' ' HB3' ' A' ' 43' ' ' TYR . 80.5 m-20 -156.88 -167.48 2.38 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.308 -0.87 . . . . 0.0 109.182 179.915 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 68.0 mt -111.76 137.66 43.55 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.552 0 O-C-N 121.103 -0.998 . . . . 0.0 109.475 -179.992 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 108' ' ' ALA . . . . . 0.575 ' HB2' ' HB2' ' A' ' 43' ' ' TYR . . . -133.43 153.27 51.75 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.277 -0.889 . . . . 0.0 109.461 -179.973 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 20.1 mtp180 -99.81 33.01 2.67 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.207 -0.933 . . . . 0.0 109.516 -179.995 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 110' ' ' LYS . . . . . 0.916 ' HB3' HG21 ' A' ' 41' ' ' THR . 30.5 tttp -69.26 -9.27 52.36 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.26 -0.9 . . . . 0.0 109.523 -179.94 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 111' ' ' GLN . . . . . 0.769 ' HG3' ' HE2' ' A' ' 113' ' ' MET . 5.1 tp60 -123.43 72.4 48.97 Favored Pre-proline 0 N--CA 1.491 1.593 0 O-C-N 121.262 -0.899 . . . . 0.0 109.475 -179.972 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 112' ' ' PRO . . . . . 0.424 ' O ' ' C ' ' A' ' 113' ' ' MET . 55.6 Cg_endo -82.67 -17.93 7.0 Favored 'Trans proline' 0 C--O 1.215 -0.659 0 C-N-CA 122.826 2.351 . . . . 0.0 112.026 -179.919 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 113' ' ' MET . . . . . 0.769 ' HE2' ' HG3' ' A' ' 111' ' ' GLN . 0.0 OUTLIER -43.26 -29.4 0.4 Allowed 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.234 -0.916 . . . . 0.0 109.758 -179.75 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 114' ' ' LEU . . . . . 0.955 HD13 ' O ' ' A' ' 114' ' ' LEU . 1.2 tm? -148.27 22.99 1.05 Allowed 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.207 -0.933 . . . . 0.0 109.091 179.957 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 115' ' ' ASP . . . . . 0.696 ' O ' ' HB3' ' A' ' 116' ' ' ALA . 74.4 m-20 42.75 37.33 1.02 Allowed 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.311 -0.868 . . . . 0.0 109.481 179.943 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 116' ' ' ALA . . . . . 0.696 ' HB3' ' O ' ' A' ' 115' ' ' ASP . . . 76.55 -72.05 0.11 Allowed 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.279 -0.888 . . . . 0.0 109.517 179.995 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 117' ' ' ALA . . . . . 0.584 ' N ' ' HE2' ' A' ' 83' ' ' MET . . . -169.88 68.23 0.05 Allowed 'General case' 0 C--N 1.303 -1.437 0 O-C-N 121.341 -0.849 . . . . 0.0 109.658 -179.74 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 56.5 m -124.81 136.45 53.84 Favored 'General case' 0 C--N 1.302 -1.464 0 O-C-N 121.165 -0.96 . . . . 0.0 109.497 -179.985 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -81.91 179.43 53.33 Favored Glycine 0 N--CA 1.49 2.286 0 N-CA-C 109.472 -1.451 . . . . 0.0 109.472 179.964 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 44.6 tttt -56.44 -36.58 69.18 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.217 -1.167 . . . . 0.0 109.469 179.957 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.489 1.511 0 CA-C-O 117.955 -1.021 . . . . 0.0 109.491 -179.985 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . 0.561 ' N ' ' CD ' ' A' ' 36' ' ' PRO . . . . . . . . 0 N--CA 1.49 1.53 0 N-CA-C 109.468 -0.567 . . . . 0.0 109.468 . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 36' ' ' PRO . . . . . 0.561 ' CD ' ' N ' ' A' ' 35' ' ' ALA . 50.0 Cg_endo -69.66 -22.57 32.34 Favored 'Trans proline' 0 C--O 1.215 -0.641 0 C-N-CA 122.742 2.294 . . . . 0.0 111.771 179.999 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 37' ' ' ARG . . . . . 0.542 ' O ' HD13 ' A' ' 114' ' ' LEU . 27.5 ptt180 -152.05 159.65 43.64 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.288 -0.882 . . . . 0.0 109.466 -179.951 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 38' ' ' LYS . . . . . 0.454 ' HB2' ' O ' ' A' ' 81' ' ' GLU . 27.7 mttm -91.31 -164.71 1.22 Allowed 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.126 -0.984 . . . . 0.0 109.459 179.988 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . 0.553 ' HA3' ' CD1' ' A' ' 65' ' ' ILE . . . 144.14 95.68 0.21 Allowed Glycine 0 N--CA 1.49 2.284 0 N-CA-C 109.559 -1.416 . . . . 0.0 109.559 -179.976 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 40' ' ' ASN . . . . . 0.484 ' O ' ' HA ' ' A' ' 79' ' ' THR . 45.8 t30 -91.69 120.3 32.33 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.159 -1.201 . . . . 0.0 109.718 -179.873 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 41' ' ' THR . . . . . 0.522 ' CG2' ' HB3' ' A' ' 77' ' ' PHE . 24.8 m -77.95 135.33 37.81 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.28 -0.887 . . . . 0.0 109.557 179.899 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . 0.902 HD11 ' CD2' ' A' ' 80' ' ' TYR . 12.7 mt -112.2 144.9 40.84 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.147 -0.971 . . . . 0.0 109.67 179.993 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 43' ' ' TYR . . . . . 0.652 ' HB2' ' HB2' ' A' ' 108' ' ' ALA . 60.2 t80 -94.9 116.9 29.29 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.428 -0.795 . . . . 0.0 109.359 179.676 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . 0.487 ' O ' ' HA ' ' A' ' 75' ' ' CYS . 44.5 t -116.52 135.33 57.14 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.494 0 O-C-N 121.216 -0.927 . . . . 0.0 109.239 179.847 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 45' ' ' TYR . . . . . 0.488 ' HB3' ' HB2' ' A' ' 104' ' ' LYS . 69.1 t80 -123.53 143.53 50.13 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.257 -0.902 . . . . 0.0 109.639 -179.804 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 164.64 174.12 34.03 Favored Glycine 0 N--CA 1.491 2.327 0 N-CA-C 109.444 -1.462 . . . . 0.0 109.444 -179.994 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 95.6 mt-10 -107.98 161.89 14.53 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.293 -1.122 . . . . 0.0 109.419 -179.997 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 21.5 m-20 44.41 58.17 3.96 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.249 -0.907 . . . . 0.0 109.4 179.96 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 43.2 mtm -111.29 136.76 49.92 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.317 -0.865 . . . . 0.0 109.432 179.954 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 50' ' ' THR . . . . . 0.584 ' O ' HD12 ' A' ' 54' ' ' LEU . 0.2 OUTLIER -123.72 166.5 18.54 Favored Pre-proline 0 N--CA 1.492 1.631 0 O-C-N 121.359 -0.838 . . . . 0.0 109.26 179.901 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 51' ' ' PRO . . . . . 0.443 ' HD3' ' SD ' ' A' ' 69' ' ' MET . 50.0 Cg_endo -71.4 -55.39 0.13 Allowed 'Trans proline' 0 C--O 1.214 -0.69 0 C-N-CA 122.495 2.13 . . . . 0.0 111.845 -179.962 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 21.3 m -48.84 -50.38 34.86 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.252 -0.905 . . . . 0.0 109.263 179.783 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 17.6 tp -58.89 -51.04 71.71 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.221 -0.924 . . . . 0.0 109.141 179.777 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 54' ' ' LEU . . . . . 0.584 HD12 ' O ' ' A' ' 50' ' ' THR . 14.1 mt -55.59 -49.92 71.48 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.343 -0.848 . . . . 0.0 109.16 179.744 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 55' ' ' ARG . . . . . 0.518 ' O ' ' N ' ' A' ' 59' ' ' SER . 73.0 mtp180 -47.16 -38.13 11.26 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.321 -0.862 . . . . 0.0 109.282 179.741 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -71.29 -31.65 65.94 Favored Glycine 0 N--CA 1.489 2.206 0 N-CA-C 109.369 -1.492 . . . . 0.0 109.369 179.844 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -76.56 -24.52 53.57 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.188 -1.184 . . . . 0.0 109.372 179.808 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 58' ' ' PHE . . . . . 0.762 ' HB2' HD11 ' A' ' 64' ' ' ILE . 91.7 m-85 -116.82 7.57 13.39 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.356 -0.84 . . . . 0.0 109.408 179.92 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 59' ' ' SER . . . . . 0.553 ' N ' ' HD2' ' A' ' 60' ' ' PRO . 0.6 OUTLIER -74.04 -55.68 3.0 Favored Pre-proline 0 N--CA 1.491 1.584 0 O-C-N 121.291 -0.881 . . . . 0.0 110.317 -179.622 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 60' ' ' PRO . . . . . 0.553 ' HD2' ' N ' ' A' ' 59' ' ' SER . 46.6 Cg_endo -68.19 -31.02 30.29 Favored 'Trans proline' 0 C--O 1.215 -0.656 0 C-N-CA 122.521 2.148 . . . . 0.0 112.215 -179.367 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 61' ' ' PHE . . . . . 0.571 ' CD1' ' HA ' ' A' ' 89' ' ' ALA . 70.1 m-85 -65.69 -30.4 71.08 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.116 -0.99 . . . . 0.0 109.491 -179.969 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . 0.464 ' HA3' ' OG ' ' A' ' 85' ' ' SER . . . 175.61 -165.76 36.74 Favored Glycine 0 N--CA 1.49 2.297 0 N-CA-C 109.421 -1.472 . . . . 0.0 109.421 179.956 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 85.4 m-20 -103.87 134.47 47.11 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.29 -1.124 . . . . 0.0 109.499 179.961 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 64' ' ' ILE . . . . . 0.762 HD11 ' HB2' ' A' ' 58' ' ' PHE . 76.1 mt -95.78 140.35 17.24 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.575 0 O-C-N 121.297 -0.877 . . . . 0.0 109.565 -179.951 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 65' ' ' ILE . . . . . 0.734 HD11 HG21 ' A' ' 79' ' ' THR . 26.2 pt -100.84 -24.49 4.07 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 O-C-N 121.302 -0.873 . . . . 0.0 109.452 179.922 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 40.2 t0 -149.35 140.79 23.31 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.251 -0.906 . . . . 0.0 109.573 -179.863 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . 0.7 ' C ' HD13 ' A' ' 67' ' ' LEU . 2.2 tm? -118.76 104.93 11.05 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.283 -0.886 . . . . 0.0 109.136 179.785 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 68' ' ' SER . . . . . 0.487 ' HB3' ' HB2' ' A' ' 77' ' ' PHE . 46.5 t -108.65 141.07 41.15 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.226 -0.921 . . . . 0.0 109.55 -179.891 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 69' ' ' MET . . . . . 0.495 ' HA ' ' HA ' ' A' ' 76' ' ' ALA . 63.2 mtp -133.63 141.62 47.72 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.3 -0.875 . . . . 0.0 109.504 -179.986 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 70' ' ' ASP . . . . . 0.474 ' C ' ' HD2' ' A' ' 72' ' ' PRO . 0.9 OUTLIER -124.51 107.16 29.61 Favored Pre-proline 0 N--CA 1.49 1.562 0 O-C-N 121.332 -0.855 . . . . 0.0 109.378 -179.971 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 71' ' ' PRO . . . . . 0.601 ' N ' ' CD ' ' A' ' 72' ' ' PRO . 47.1 Cg_endo -74.91 -27.85 9.85 Favored 'Trans proline' 0 CA--C 1.542 0.883 0 C-N-CA 122.495 2.13 . . . . 0.0 113.747 -179.908 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 72' ' ' PRO . . . . . 0.601 ' CD ' ' N ' ' A' ' 71' ' ' PRO . 54.4 Cg_endo -74.84 -25.66 12.0 Favored 'Trans proline' 0 C--N 1.353 0.772 0 C-N-CA 121.446 1.431 . . . . 0.0 111.745 -179.771 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 75.3 mtp180 -110.46 0.9 17.98 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.273 -0.892 . . . . 0.0 109.62 -179.833 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 66.2 m-20 56.39 48.56 16.72 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.153 -0.967 . . . . 0.0 109.512 179.943 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 75' ' ' CYS . . . . . 0.487 ' HA ' ' O ' ' A' ' 44' ' ' VAL . 26.6 p -148.18 135.73 20.67 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.186 -0.946 . . . . 0.0 109.46 -179.973 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . 0.495 ' HA ' ' HA ' ' A' ' 69' ' ' MET . . . -110.37 133.67 53.04 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.159 -0.963 . . . . 0.0 109.74 -179.994 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 77' ' ' PHE . . . . . 0.522 ' HB3' ' CG2' ' A' ' 41' ' ' THR . 12.0 m-30 -103.79 108.39 19.68 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.335 -0.853 . . . . 0.0 109.33 179.935 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . 0.494 ' O ' ' N ' ' A' ' 42' ' ' LEU . 1.8 p -105.76 141.28 21.44 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.405 0 O-C-N 121.144 -0.973 . . . . 0.0 109.401 179.979 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 79' ' ' THR . . . . . 0.734 HG21 HD11 ' A' ' 65' ' ' ILE . 11.5 m -97.47 155.42 16.94 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.138 -0.976 . . . . 0.0 109.874 -179.692 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 80' ' ' TYR . . . . . 0.902 ' CD2' HD11 ' A' ' 42' ' ' LEU . 0.1 OUTLIER -130.51 129.26 42.65 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.329 -0.857 . . . . 0.0 109.546 179.955 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 81' ' ' GLU . . . . . 0.454 ' O ' ' HB2' ' A' ' 38' ' ' LYS . 69.3 tt0 -44.25 -34.5 1.92 Allowed 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.205 -0.934 . . . . 0.0 109.489 179.88 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 33.5 mttm -141.43 152.18 44.05 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.119 -0.988 . . . . 0.0 109.596 -179.774 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 83' ' ' MET . . . . . 0.613 ' CE ' ' HB3' ' A' ' 117' ' ' ALA . 45.8 mtt -63.89 -26.72 68.73 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.352 -0.843 . . . . 0.0 109.415 179.973 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 96.4 mt-10 -56.27 -49.09 75.21 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.292 -0.88 . . . . 0.0 109.475 -179.976 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 85' ' ' SER . . . . . 0.555 ' OG ' ' CE1' ' A' ' 80' ' ' TYR . 41.5 t -61.04 -32.05 71.68 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.213 -0.929 . . . . 0.0 109.381 179.864 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 86' ' ' ALA . . . . . 0.684 ' O ' HG23 ' A' ' 90' ' ' VAL . . . -76.04 -33.42 59.62 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.308 -0.87 . . . . 0.0 109.774 -179.757 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 22.3 t70 -70.13 -43.77 70.28 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.145 -0.972 . . . . 0.0 109.725 -179.732 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 62.6 tt0 -71.14 -39.08 72.19 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.265 -0.897 . . . . 0.0 109.877 -179.717 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 89' ' ' ALA . . . . . 0.704 ' HB1' ' CD1' ' A' ' 93' ' ' LEU . . . -73.72 -43.38 59.35 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.154 -0.966 . . . . 0.0 109.741 -179.745 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 90' ' ' VAL . . . . . 0.753 HG22 HG11 ' A' ' 105' ' ' VAL . 74.3 t -61.26 -31.88 51.49 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.598 0 O-C-N 121.195 -0.941 . . . . 0.0 109.667 -179.778 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -78.96 -53.32 7.17 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.272 -0.892 . . . . 0.0 109.732 -179.857 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 92' ' ' GLU . . . . . 0.527 ' HB2' ' CE1' ' A' ' 61' ' ' PHE . 75.2 mm-40 -69.53 -41.45 75.97 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.224 -0.922 . . . . 0.0 109.928 -179.632 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 93' ' ' LEU . . . . . 0.704 ' CD1' ' HB1' ' A' ' 89' ' ' ALA . 81.2 mt -69.55 -40.55 76.76 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.074 -1.016 . . . . 0.0 109.642 -179.806 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 94' ' ' ASN . . . . . 0.527 ' CB ' ' O ' ' A' ' 90' ' ' VAL . 59.1 t30 -71.47 126.41 29.59 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.201 -0.937 . . . . 0.0 109.497 -179.945 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 99.09 20.0 19.7 Favored Glycine 0 N--CA 1.489 2.182 0 N-CA-C 109.515 -1.434 . . . . 0.0 109.515 179.94 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 96' ' ' THR . . . . . 0.409 ' CG2' ' O ' ' A' ' 92' ' ' GLU . 20.5 p -121.92 159.94 25.84 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.301 -1.117 . . . . 0.0 109.504 179.964 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 63.9 tt0 -125.35 149.08 48.45 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.334 -0.854 . . . . 0.0 109.453 -179.969 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 98' ' ' VAL . . . . . 0.627 ' HB ' HG12 ' A' ' 101' ' ' VAL . 1.4 t -93.78 -148.68 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 O-C-N 121.206 -0.934 . . . . 0.0 109.35 -179.982 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 99' ' ' GLU . . . . . 0.497 ' H ' HG12 ' A' ' 98' ' ' VAL . 95.9 mt-10 -56.69 -44.64 81.7 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.164 -0.96 . . . . 0.0 109.449 -179.977 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 3.5 p -157.2 21.21 0.3 Allowed 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.282 -0.886 . . . . 0.0 109.449 179.974 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 101' ' ' VAL . . . . . 0.627 HG12 ' HB ' ' A' ' 98' ' ' VAL . 8.7 p -129.03 139.5 51.73 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.524 0 O-C-N 121.231 -0.918 . . . . 0.0 109.519 -179.943 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 95.3 mt-30 -87.1 136.51 32.9 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.2 -0.937 . . . . 0.0 109.387 179.959 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 103' ' ' LEU . . . . . 0.57 HD11 HG22 ' A' ' 98' ' ' VAL . 97.8 mt -100.87 144.26 30.04 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.23 -0.919 . . . . 0.0 109.667 -179.934 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 104' ' ' LYS . . . . . 0.488 ' HB2' ' HB3' ' A' ' 45' ' ' TYR . 45.1 mttt -134.66 142.09 46.76 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.263 -0.898 . . . . 0.0 109.252 179.869 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 105' ' ' VAL . . . . . 0.753 HG11 HG22 ' A' ' 90' ' ' VAL . 25.5 t -126.28 138.21 55.34 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 O-C-N 121.225 -0.922 . . . . 0.0 109.686 -179.932 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 106' ' ' ASN . . . . . 0.559 ' HB2' ' CD1' ' A' ' 43' ' ' TYR . 80.1 m-20 -138.83 -161.19 1.15 Allowed 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.303 -0.873 . . . . 0.0 109.259 179.871 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 24.2 mm -107.65 134.14 50.32 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.526 0 O-C-N 121.144 -0.973 . . . . 0.0 109.462 -179.971 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 108' ' ' ALA . . . . . 0.652 ' HB2' ' HB2' ' A' ' 43' ' ' TYR . . . -131.82 157.19 44.56 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.313 -0.867 . . . . 0.0 109.521 179.948 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 37.9 mtm180 -131.47 121.44 24.53 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.245 -0.909 . . . . 0.0 109.561 179.951 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 110' ' ' LYS . . . . . 0.447 ' HG2' ' O ' ' A' ' 110' ' ' LYS . 55.9 tttm -173.09 34.03 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.276 -0.89 . . . . 0.0 109.372 179.96 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 111' ' ' GLN . . . . . 0.62 ' HG3' ' HE3' ' A' ' 113' ' ' MET . 7.4 tp-100 -130.5 83.47 62.19 Favored Pre-proline 0 N--CA 1.489 1.506 0 O-C-N 121.406 -0.808 . . . . 0.0 109.334 -179.948 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 112' ' ' PRO . . . . . 0.438 ' O ' ' C ' ' A' ' 113' ' ' MET . 51.2 Cg_endo -71.71 -29.49 15.75 Favored 'Trans proline' 0 C--O 1.214 -0.69 0 C-N-CA 122.696 2.264 . . . . 0.0 112.369 -179.6 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 113' ' ' MET . . . . . 0.62 ' HE3' ' HG3' ' A' ' 111' ' ' GLN . 0.0 OUTLIER -43.11 -27.19 0.19 Allowed 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.256 -0.903 . . . . 0.0 109.398 179.949 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 114' ' ' LEU . . . . . 0.85 HD23 ' O ' ' A' ' 114' ' ' LEU . 2.7 tt -161.59 27.77 0.13 Allowed 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.409 -0.807 . . . . 0.0 109.298 179.88 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 115' ' ' ASP . . . . . 0.708 ' O ' ' HB3' ' A' ' 116' ' ' ALA . 80.4 m-20 52.73 47.53 24.48 Favored 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.139 -0.976 . . . . 0.0 108.812 -179.561 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 116' ' ' ALA . . . . . 0.708 ' HB3' ' O ' ' A' ' 115' ' ' ASP . . . 76.16 -74.85 0.07 Allowed 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.367 -0.833 . . . . 0.0 109.239 -179.55 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 117' ' ' ALA . . . . . 0.613 ' HB3' ' CE ' ' A' ' 83' ' ' MET . . . -169.78 168.29 8.98 Favored 'General case' 0 C--N 1.304 -1.399 0 O-C-N 121.351 -0.843 . . . . 0.0 109.465 -179.897 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 13.5 t -115.87 162.73 16.9 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.275 -0.891 . . . . 0.0 109.414 179.979 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -177.34 179.51 48.07 Favored Glycine 0 N--CA 1.489 2.217 0 N-CA-C 109.379 -1.488 . . . . 0.0 109.379 -179.923 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 93.7 mttt -116.28 143.12 45.94 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.23 -1.159 . . . . 0.0 109.57 -179.982 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.49 1.53 0 CA-C-O 118.04 -0.981 . . . . 0.0 109.457 179.995 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.578 0 N-CA-C 109.435 -0.58 . . . . 0.0 109.435 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 48.5 Cg_endo -69.91 138.67 37.88 Favored 'Trans proline' 0 C--O 1.214 -0.701 0 C-N-CA 122.696 2.264 . . . . 0.0 111.789 179.946 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 37' ' ' ARG . . . . . 0.498 ' HG3' ' N ' ' A' ' 38' ' ' LYS . 24.1 tpt180 -117.28 149.69 40.03 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.251 -0.906 . . . . 0.0 109.355 -179.915 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 38' ' ' LYS . . . . . 0.498 ' N ' ' HG3' ' A' ' 37' ' ' ARG . 25.3 mttt -77.36 -165.04 0.53 Allowed 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.236 -0.915 . . . . 0.0 109.716 -179.828 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . 0.525 ' CA ' ' O ' ' A' ' 80' ' ' TYR . . . 155.85 -167.38 33.19 Favored Glycine 0 N--CA 1.49 2.277 0 N-CA-C 109.505 -1.438 . . . . 0.0 109.505 -179.932 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 40' ' ' ASN . . . . . 0.468 ' O ' ' HA ' ' A' ' 79' ' ' THR . 49.6 t-20 -159.71 122.71 3.54 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.131 -1.217 . . . . 0.0 109.535 179.974 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 41' ' ' THR . . . . . 0.613 ' O ' HD23 ' A' ' 42' ' ' LEU . 35.8 m -80.75 138.86 36.32 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.25 -0.906 . . . . 0.0 109.499 -179.997 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . 0.94 HD11 ' CD2' ' A' ' 80' ' ' TYR . 9.9 mt -120.13 151.05 39.64 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.211 -0.931 . . . . 0.0 109.626 179.941 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 43' ' ' TYR . . . . . 0.598 ' HB2' ' HB2' ' A' ' 108' ' ' ALA . 69.0 t80 -106.29 124.92 50.33 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.236 -0.915 . . . . 0.0 109.341 179.867 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . 0.459 ' O ' ' HA ' ' A' ' 75' ' ' CYS . 80.2 t -122.14 137.73 54.73 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.534 0 O-C-N 121.22 -0.925 . . . . 0.0 109.467 -179.941 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 45' ' ' TYR . . . . . 0.472 ' HB3' ' HB2' ' A' ' 104' ' ' LYS . 71.0 t80 -121.07 133.58 55.24 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.276 -0.89 . . . . 0.0 109.423 179.909 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -175.73 -175.37 43.08 Favored Glycine 0 N--CA 1.49 2.277 0 N-CA-C 109.482 -1.447 . . . . 0.0 109.482 -179.974 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 94.0 mt-10 -121.41 146.53 46.79 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.212 -1.17 . . . . 0.0 109.45 179.983 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 58.4 t0 47.79 52.97 12.03 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.277 -0.889 . . . . 0.0 109.481 -179.952 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 67.5 mtm -95.7 138.09 33.85 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.27 -0.894 . . . . 0.0 109.454 -179.929 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 50' ' ' THR . . . . . 0.814 HG22 ' HD2' ' A' ' 51' ' ' PRO . 0.0 OUTLIER -110.8 161.5 24.57 Favored Pre-proline 0 N--CA 1.49 1.543 0 O-C-N 121.23 -0.919 . . . . 0.0 109.48 179.979 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 51' ' ' PRO . . . . . 0.814 ' HD2' HG22 ' A' ' 50' ' ' THR . 49.4 Cg_endo -70.12 -52.5 0.3 Allowed 'Trans proline' 0 C--O 1.215 -0.648 0 C-N-CA 122.743 2.295 . . . . 0.0 111.674 -179.959 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 37.1 m -56.27 -44.49 79.81 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.322 -0.861 . . . . 0.0 109.383 179.995 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . 0.765 ' O ' HD13 ' A' ' 53' ' ' LEU . 3.1 tm? -60.45 -46.56 89.61 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.241 -0.912 . . . . 0.0 109.405 179.931 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 54' ' ' LEU . . . . . 0.693 HD12 ' SD ' ' A' ' 69' ' ' MET . 42.7 mt -62.81 -48.03 80.85 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.242 -0.911 . . . . 0.0 109.356 -179.916 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 55' ' ' ARG . . . . . 0.467 ' O ' ' N ' ' A' ' 59' ' ' SER . 48.0 mtt180 -48.53 -39.82 24.79 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.248 -0.907 . . . . 0.0 109.392 179.936 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -69.09 -34.78 76.73 Favored Glycine 0 N--CA 1.49 2.289 0 N-CA-C 109.312 -1.515 . . . . 0.0 109.312 179.881 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . 0.417 ' O ' HD21 ' A' ' 93' ' ' LEU . . . -71.26 -25.03 62.29 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.288 -1.125 . . . . 0.0 109.414 179.921 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 58' ' ' PHE . . . . . 0.736 ' HB2' HD11 ' A' ' 64' ' ' ILE . 76.2 m-85 -116.81 10.3 14.16 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.323 -0.86 . . . . 0.0 109.463 -179.979 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 59' ' ' SER . . . . . 0.559 ' N ' ' HD2' ' A' ' 60' ' ' PRO . 1.4 t -76.46 -53.74 1.99 Allowed Pre-proline 0 N--CA 1.492 1.63 0 O-C-N 121.3 -0.875 . . . . 0.0 110.473 -179.558 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 60' ' ' PRO . . . . . 0.559 ' HD2' ' N ' ' A' ' 59' ' ' SER . 47.8 Cg_endo -68.88 -34.03 18.8 Favored 'Trans proline' 0 C--O 1.215 -0.659 0 C-N-CA 122.405 2.07 . . . . 0.0 112.388 -179.152 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 61' ' ' PHE . . . . . 0.611 ' CE2' HD21 ' A' ' 93' ' ' LEU . 87.8 m-85 -63.52 -37.04 85.8 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.057 -1.027 . . . . 0.0 109.502 -179.971 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . 0.463 ' HA3' ' OG ' ' A' ' 85' ' ' SER . . . -178.74 -172.63 43.29 Favored Glycine 0 N--CA 1.49 2.27 0 N-CA-C 109.599 -1.4 . . . . 0.0 109.599 179.94 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 51.5 t-20 -96.99 136.81 37.03 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.266 -1.138 . . . . 0.0 109.577 -179.914 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 64' ' ' ILE . . . . . 0.776 HD13 HD23 ' A' ' 67' ' ' LEU . 54.6 mt -98.51 131.29 45.93 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 O-C-N 121.209 -0.932 . . . . 0.0 109.532 -179.946 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 18.6 pt -95.58 -19.31 6.35 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 O-C-N 121.32 -0.862 . . . . 0.0 109.579 -179.902 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 59.6 t0 -152.38 106.25 3.11 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.205 -0.934 . . . . 0.0 109.591 -179.99 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . 0.776 HD23 HD13 ' A' ' 64' ' ' ILE . 0.5 OUTLIER -99.22 120.22 39.16 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.27 -0.894 . . . . 0.0 109.375 179.755 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 68' ' ' SER . . . . . 0.748 ' N ' HD13 ' A' ' 67' ' ' LEU . 67.9 m -131.62 151.15 51.83 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.174 -0.954 . . . . 0.0 109.691 -179.793 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 69' ' ' MET . . . . . 0.693 ' SD ' HD12 ' A' ' 54' ' ' LEU . 18.2 mtm -130.94 144.62 51.6 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.309 -0.869 . . . . 0.0 109.346 179.886 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 70' ' ' ASP . . . . . 0.519 ' CB ' ' O ' ' A' ' 75' ' ' CYS . 0.9 OUTLIER -118.89 102.78 48.99 Favored Pre-proline 0 N--CA 1.491 1.604 0 O-C-N 121.22 -0.925 . . . . 0.0 109.533 -179.885 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 71' ' ' PRO . . . . . 0.601 ' N ' ' CD ' ' A' ' 72' ' ' PRO . 47.7 Cg_endo -74.9 -27.75 9.96 Favored 'Trans proline' 0 CA--C 1.542 0.888 0 C-N-CA 122.608 2.205 . . . . 0.0 113.697 179.886 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 72' ' ' PRO . . . . . 0.601 ' CD ' ' N ' ' A' ' 71' ' ' PRO . 55.4 Cg_endo -75.09 -25.16 11.98 Favored 'Trans proline' 0 C--N 1.353 0.814 0 C-N-CA 121.446 1.431 . . . . 0.0 111.809 -179.795 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 48.3 mtt85 -111.9 10.03 20.64 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.282 -0.886 . . . . 0.0 109.587 -179.946 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 83.1 m-20 53.3 36.61 23.24 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.249 -0.907 . . . . 0.0 109.506 -179.987 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 75' ' ' CYS . . . . . 0.519 ' O ' ' CB ' ' A' ' 70' ' ' ASP . 28.1 p -142.81 146.67 34.42 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.214 -0.929 . . . . 0.0 109.527 -179.868 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . 0.47 ' HA ' ' HA ' ' A' ' 69' ' ' MET . . . -114.17 162.48 16.47 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.188 -0.945 . . . . 0.0 109.553 -179.977 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 77' ' ' PHE . . . . . 0.406 ' CE1' ' HD1' ' A' ' 43' ' ' TYR . 96.7 m-85 -127.62 108.99 11.25 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.362 -0.836 . . . . 0.0 109.359 179.933 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . 0.533 HG23 ' CD2' ' A' ' 67' ' ' LEU . 6.1 p -109.67 135.58 48.22 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.449 0 O-C-N 121.247 -0.908 . . . . 0.0 109.624 -179.854 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 79' ' ' THR . . . . . 0.769 HG23 HE22 ' A' ' 111' ' ' GLN . 91.7 m -106.63 128.8 54.45 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.249 -0.907 . . . . 0.0 109.273 179.797 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 80' ' ' TYR . . . . . 0.94 ' CD2' HD11 ' A' ' 42' ' ' LEU . 0.9 OUTLIER -94.93 174.22 7.2 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.336 -0.852 . . . . 0.0 109.527 179.978 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 81' ' ' GLU . . . . . 0.479 ' O ' ' CG ' ' A' ' 82' ' ' LYS . 81.7 tt0 -86.37 -11.77 51.12 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.44 -0.787 . . . . 0.0 109.177 179.66 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 82' ' ' LYS . . . . . 0.479 ' CG ' ' O ' ' A' ' 81' ' ' GLU . 43.0 mttp -157.91 158.83 35.78 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.324 -0.86 . . . . 0.0 109.267 179.934 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 83' ' ' MET . . . . . 0.912 ' HE1' ' O ' ' A' ' 117' ' ' ALA . 31.4 mtt -71.83 -12.13 61.14 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.238 -0.914 . . . . 0.0 109.384 -179.947 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . 0.434 ' HA ' ' OE1' ' A' ' 84' ' ' GLU . 70.7 mm-40 -76.4 -40.11 51.77 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.317 -0.865 . . . . 0.0 109.609 179.93 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 85' ' ' SER . . . . . 0.463 ' OG ' ' HA3' ' A' ' 62' ' ' GLY . 29.1 t -65.45 -35.44 80.93 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.255 -0.903 . . . . 0.0 109.481 179.96 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 86' ' ' ALA . . . . . 0.547 ' O ' HG23 ' A' ' 90' ' ' VAL . . . -71.83 -35.78 70.0 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.425 -0.797 . . . . 0.0 109.764 -179.918 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 64.5 t0 -65.32 -43.64 90.38 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.158 -0.964 . . . . 0.0 109.786 -179.814 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 64.8 tt0 -72.57 -38.85 67.8 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.197 -0.939 . . . . 0.0 109.82 -179.745 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 89' ' ' ALA . . . . . 0.773 ' HB1' ' CD1' ' A' ' 93' ' ' LEU . . . -73.89 -42.12 61.16 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.206 -0.934 . . . . 0.0 109.745 -179.708 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 90' ' ' VAL . . . . . 0.836 ' HA ' HG11 ' A' ' 105' ' ' VAL . 51.1 t -62.07 -34.37 63.02 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.564 0 O-C-N 121.243 -0.91 . . . . 0.0 109.74 -179.79 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -76.03 -53.74 7.91 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.185 -0.947 . . . . 0.0 109.867 -179.678 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 92' ' ' GLU . . . . . 0.581 ' HB2' ' CE1' ' A' ' 61' ' ' PHE . 75.1 mm-40 -69.24 -44.37 72.13 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.196 -0.94 . . . . 0.0 109.9 -179.634 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 93' ' ' LEU . . . . . 0.773 ' CD1' ' HB1' ' A' ' 89' ' ' ALA . 69.8 mt -65.45 -36.84 85.12 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.109 -0.994 . . . . 0.0 109.709 -179.753 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 94' ' ' ASN . . . . . 0.485 ' HB2' ' O ' ' A' ' 90' ' ' VAL . 63.1 t-20 -72.99 125.38 27.47 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.169 -0.957 . . . . 0.0 109.452 -179.888 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 95.29 26.52 12.11 Favored Glycine 0 N--CA 1.49 2.263 0 N-CA-C 109.515 -1.434 . . . . 0.0 109.515 179.908 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 96' ' ' THR . . . . . 0.489 ' CG2' ' O ' ' A' ' 92' ' ' GLU . 17.7 p -121.47 155.3 35.2 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.23 -1.159 . . . . 0.0 109.469 -179.969 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 64.2 tt0 -128.74 153.08 47.71 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.257 -0.902 . . . . 0.0 109.481 -179.97 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 98' ' ' VAL . . . . . 0.538 HG12 ' H ' ' A' ' 99' ' ' GLU . 1.2 t -98.33 -152.58 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.627 0 O-C-N 121.235 -0.916 . . . . 0.0 109.254 -179.897 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 99' ' ' GLU . . . . . 0.538 ' H ' HG12 ' A' ' 98' ' ' VAL . 75.7 mm-40 -59.79 -39.13 83.89 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.168 -0.957 . . . . 0.0 109.475 179.943 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -157.6 24.85 0.28 Allowed 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.327 -0.858 . . . . 0.0 109.485 -179.958 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 101' ' ' VAL . . . . . 0.42 ' O ' HG23 ' A' ' 98' ' ' VAL . 47.4 t -137.57 152.5 27.19 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.552 0 O-C-N 121.165 -0.96 . . . . 0.0 109.498 179.998 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 91.8 mt-30 -108.42 145.08 35.14 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.268 -0.895 . . . . 0.0 109.483 179.937 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 93.3 mt -111.95 145.35 39.75 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.225 -0.922 . . . . 0.0 109.525 -179.961 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 104' ' ' LYS . . . . . 0.472 ' HB2' ' HB3' ' A' ' 45' ' ' TYR . 43.8 mttt -127.33 133.1 50.13 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.264 -0.897 . . . . 0.0 109.406 179.912 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 105' ' ' VAL . . . . . 0.836 HG11 ' HA ' ' A' ' 90' ' ' VAL . 21.9 t -116.9 133.41 63.7 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.514 0 O-C-N 121.217 -0.927 . . . . 0.0 109.576 -179.866 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 106' ' ' ASN . . . . . 0.513 ' ND2' ' O ' ' A' ' 105' ' ' VAL . 14.8 m120 -137.76 -172.77 3.32 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.31 -0.869 . . . . 0.0 109.368 179.908 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 24.4 mm -104.88 126.55 59.77 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.518 0 O-C-N 121.18 -0.95 . . . . 0.0 109.426 179.965 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 108' ' ' ALA . . . . . 0.598 ' HB2' ' HB2' ' A' ' 43' ' ' TYR . . . -106.39 166.75 10.31 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.218 -0.926 . . . . 0.0 109.474 -179.917 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 85.3 mtm-85 -51.2 148.35 4.71 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.262 -0.898 . . . . 0.0 109.409 179.883 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 110' ' ' LYS . . . . . 0.485 ' HD3' ' O ' ' A' ' 115' ' ' ASP . 73.5 mttt -71.59 142.99 49.99 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.273 -0.892 . . . . 0.0 109.392 179.981 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 111' ' ' GLN . . . . . 0.769 HE22 HG23 ' A' ' 79' ' ' THR . 0.9 OUTLIER -63.04 145.61 96.52 Favored Pre-proline 0 N--CA 1.49 1.538 0 O-C-N 121.259 -0.9 . . . . 0.0 109.715 -179.78 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 55.3 Cg_endo -74.65 -15.34 21.72 Favored 'Trans proline' 0 C--O 1.214 -0.703 0 C-N-CA 122.835 2.357 . . . . 0.0 112.987 -179.313 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 113' ' ' MET . . . . . 0.674 ' HE2' ' HB2' ' A' ' 111' ' ' GLN . 6.5 mtm -62.38 -16.28 53.7 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 120.8 -1.187 . . . . 0.0 109.26 -179.764 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 114' ' ' LEU . . . . . 0.608 HD23 ' O ' ' A' ' 114' ' ' LEU . 1.1 tt 178.27 31.69 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.394 -0.817 . . . . 0.0 109.42 -179.679 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 115' ' ' ASP . . . . . 0.691 ' O ' ' HB3' ' A' ' 116' ' ' ALA . 76.6 m-20 50.42 40.23 22.51 Favored 'General case' 0 C--N 1.302 -1.498 0 O-C-N 121.218 -0.927 . . . . 0.0 108.63 -179.417 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 116' ' ' ALA . . . . . 0.691 ' HB3' ' O ' ' A' ' 115' ' ' ASP . . . 77.55 -78.54 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.498 -0.751 . . . . 0.0 109.428 -179.618 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 117' ' ' ALA . . . . . 0.912 ' O ' ' HE1' ' A' ' 83' ' ' MET . . . -164.84 152.91 11.89 Favored 'General case' 0 N--CA 1.487 1.405 0 O-C-N 121.284 -0.885 . . . . 0.0 109.758 -179.785 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 16.6 p -134.25 169.46 17.17 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.288 -0.882 . . . . 0.0 109.426 179.842 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 92.32 8.81 62.45 Favored Glycine 0 N--CA 1.491 2.341 0 N-CA-C 109.48 -1.448 . . . . 0.0 109.48 179.976 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 29.2 tttm -73.13 133.26 44.05 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.252 -1.146 . . . . 0.0 109.47 -179.994 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 N--CA 1.49 1.562 0 CA-C-O 118.017 -0.992 . . . . 0.0 109.447 179.999 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . 0.411 ' HA ' ' HD2' ' A' ' 36' ' ' PRO . . . . . . . . 0 N--CA 1.49 1.571 0 N-CA-C 109.485 -0.561 . . . . 0.0 109.485 . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 36' ' ' PRO . . . . . 0.411 ' HD2' ' HA ' ' A' ' 35' ' ' ALA . 48.9 Cg_endo -69.69 149.99 68.04 Favored 'Trans proline' 0 C--O 1.214 -0.718 0 C-N-CA 122.796 2.331 . . . . 0.0 111.72 -179.936 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 37' ' ' ARG . . . . . 0.553 ' C ' HD13 ' A' ' 114' ' ' LEU . 79.1 mtm180 -102.1 -7.94 21.84 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.266 -0.896 . . . . 0.0 109.525 179.985 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 38' ' ' LYS . . . . . 0.508 ' O ' ' CD1' ' A' ' 65' ' ' ILE . 43.7 mttp -69.89 -173.81 0.68 Allowed 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.191 -0.943 . . . . 0.0 109.443 179.939 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . 0.864 ' HA3' HD11 ' A' ' 65' ' ' ILE . . . 148.16 99.78 0.23 Allowed Glycine 0 N--CA 1.49 2.29 0 N-CA-C 109.569 -1.412 . . . . 0.0 109.569 179.93 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 40' ' ' ASN . . . . . 0.456 ' N ' ' O ' ' A' ' 80' ' ' TYR . 45.9 t30 -95.66 102.29 14.07 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.109 -1.23 . . . . 0.0 109.605 179.873 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 41' ' ' THR . . . . . 0.456 ' OG1' ' HB2' ' A' ' 111' ' ' GLN . 36.2 m -72.46 127.76 33.55 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.18 -0.95 . . . . 0.0 109.48 -179.977 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . 0.77 HD13 HG23 ' A' ' 90' ' ' VAL . 13.3 mt -106.44 145.92 31.17 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.195 -0.941 . . . . 0.0 109.478 -179.989 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 85.3 t80 -96.76 117.6 31.41 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.216 -0.927 . . . . 0.0 109.42 179.98 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . 0.464 ' HA ' ' O ' ' A' ' 104' ' ' LYS . 63.8 t -113.79 138.99 41.68 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.547 0 O-C-N 121.214 -0.929 . . . . 0.0 109.504 179.981 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 45' ' ' TYR . . . . . 0.435 ' HB3' ' HB2' ' A' ' 104' ' ' LYS . 70.4 t80 -124.5 135.32 53.11 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.273 -0.892 . . . . 0.0 109.49 179.99 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -177.6 -174.87 44.34 Favored Glycine 0 N--CA 1.491 2.353 0 N-CA-C 109.484 -1.447 . . . . 0.0 109.484 -179.951 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 95.5 mt-10 -123.57 157.51 33.5 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.237 -1.155 . . . . 0.0 109.483 -179.98 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 58.3 t0 45.96 46.59 12.44 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.287 -0.883 . . . . 0.0 109.516 179.933 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 70.7 mtm -94.48 143.85 26.07 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.291 -0.881 . . . . 0.0 109.495 179.966 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 50' ' ' THR . . . . . 0.709 ' O ' HD12 ' A' ' 54' ' ' LEU . 2.5 p -120.9 163.99 26.2 Favored Pre-proline 0 N--CA 1.489 1.51 0 O-C-N 121.223 -0.923 . . . . 0.0 109.43 -179.958 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 51' ' ' PRO . . . . . 0.471 ' HD2' ' HB ' ' A' ' 50' ' ' THR . 49.1 Cg_endo -69.41 -52.76 0.33 Allowed 'Trans proline' 0 C--O 1.216 -0.607 0 C-N-CA 122.672 2.248 . . . . 0.0 111.761 179.992 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 56.3 m -57.54 -46.67 83.6 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.22 -0.925 . . . . 0.0 109.319 179.965 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 17.0 tp -58.57 -55.55 33.61 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.285 -0.884 . . . . 0.0 109.299 179.872 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 54' ' ' LEU . . . . . 0.709 HD12 ' O ' ' A' ' 50' ' ' THR . 9.0 mt -54.07 -42.99 69.9 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.267 -0.896 . . . . 0.0 109.285 179.806 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 55' ' ' ARG . . . . . 0.476 ' O ' ' N ' ' A' ' 59' ' ' SER . 32.4 ttt85 -51.66 -39.34 57.98 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.22 -0.925 . . . . 0.0 109.29 179.85 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . 0.435 ' HA2' ' HB2' ' A' ' 59' ' ' SER . . . -70.34 -31.43 68.68 Favored Glycine 0 N--CA 1.488 2.16 0 N-CA-C 109.436 -1.466 . . . . 0.0 109.436 179.898 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . 0.505 ' O ' ' CD2' ' A' ' 61' ' ' PHE . . . -72.85 -17.03 61.58 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.239 -1.153 . . . . 0.0 109.453 -179.958 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 58' ' ' PHE . . . . . 0.688 ' HB2' HD11 ' A' ' 64' ' ' ILE . 97.9 m-85 -126.54 5.34 6.84 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.238 -0.914 . . . . 0.0 109.349 179.855 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 59' ' ' SER . . . . . 0.544 ' N ' ' HD2' ' A' ' 60' ' ' PRO . 0.4 OUTLIER -74.04 -55.89 2.91 Favored Pre-proline 0 N--CA 1.49 1.565 0 O-C-N 121.249 -0.907 . . . . 0.0 109.989 -179.761 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 60' ' ' PRO . . . . . 0.544 ' HD2' ' N ' ' A' ' 59' ' ' SER . 49.5 Cg_endo -70.08 -34.15 14.05 Favored 'Trans proline' 0 C--O 1.215 -0.644 0 C-N-CA 122.51 2.14 . . . . 0.0 112.04 -179.553 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 61' ' ' PHE . . . . . 0.579 ' CE1' ' HB3' ' A' ' 92' ' ' GLU . 73.4 m-85 -58.91 -42.71 90.26 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.175 -0.953 . . . . 0.0 109.52 -179.947 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . 0.459 ' HA3' ' OG ' ' A' ' 85' ' ' SER . . . -178.79 179.88 48.71 Favored Glycine 0 N--CA 1.49 2.289 0 N-CA-C 109.469 -1.452 . . . . 0.0 109.469 179.996 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 39.8 t30 -85.29 140.9 30.47 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.276 -1.132 . . . . 0.0 109.462 179.987 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 64' ' ' ILE . . . . . 0.688 HD11 ' HB2' ' A' ' 58' ' ' PHE . 68.2 mt -103.92 134.22 45.77 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 O-C-N 121.223 -0.923 . . . . 0.0 109.427 -179.982 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 65' ' ' ILE . . . . . 0.864 HD11 ' HA3' ' A' ' 39' ' ' GLY . 23.7 pt -97.56 -20.67 5.55 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.538 0 O-C-N 121.277 -0.89 . . . . 0.0 109.548 -179.928 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 54.4 t0 -160.64 106.13 1.45 Allowed 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.215 -0.928 . . . . 0.0 109.514 -179.947 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . 1.028 HD11 HG22 ' A' ' 78' ' ' VAL . 0.6 OUTLIER -111.7 120.23 41.34 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.293 -0.879 . . . . 0.0 109.355 179.881 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 19.9 m -118.57 152.39 36.09 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.306 -0.871 . . . . 0.0 109.641 -179.945 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 69' ' ' MET . . . . . 0.471 ' SD ' ' CA ' ' A' ' 51' ' ' PRO . 91.9 mtp -121.02 140.95 51.22 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.297 -0.877 . . . . 0.0 109.46 -179.987 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 70' ' ' ASP . . . . . 0.473 ' C ' ' HD2' ' A' ' 72' ' ' PRO . 0.4 OUTLIER -119.38 105.7 43.73 Favored Pre-proline 0 N--CA 1.491 1.6 0 O-C-N 121.2 -0.937 . . . . 0.0 109.458 179.971 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 71' ' ' PRO . . . . . 0.601 ' N ' ' CD ' ' A' ' 72' ' ' PRO . 48.0 Cg_endo -74.6 -27.78 10.51 Favored 'Trans proline' 0 CA--C 1.542 0.893 0 C-N-CA 122.569 2.18 . . . . 0.0 113.653 179.939 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 72' ' ' PRO . . . . . 0.601 ' CD ' ' N ' ' A' ' 71' ' ' PRO . 55.2 Cg_endo -75.58 -39.59 0.99 Allowed 'Trans proline' 0 C--N 1.352 0.718 0 C-N-CA 121.479 1.453 . . . . 0.0 111.718 -179.879 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 73' ' ' ARG . . . . . 0.454 ' HG2' ' O ' ' A' ' 73' ' ' ARG . 57.4 ttt85 -93.84 -3.89 51.11 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.29 -0.881 . . . . 0.0 109.559 -179.885 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 71.7 m-20 60.15 46.41 10.57 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.183 -0.948 . . . . 0.0 109.388 179.96 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 75' ' ' CYS . . . . . 0.457 ' HA ' ' O ' ' A' ' 44' ' ' VAL . 24.1 p -146.12 143.45 29.34 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.231 -0.918 . . . . 0.0 109.468 179.938 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -111.22 156.32 21.62 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.257 -0.902 . . . . 0.0 109.585 -179.939 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 77' ' ' PHE . . . . . 0.442 ' HA ' ' O ' ' A' ' 42' ' ' LEU . 97.3 m-85 -119.32 131.9 55.8 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.266 -0.896 . . . . 0.0 109.436 179.99 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . 1.028 HG22 HD11 ' A' ' 67' ' ' LEU . 47.2 t -125.42 120.78 58.78 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.619 0 O-C-N 121.193 -0.942 . . . . 0.0 109.533 -179.958 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 79' ' ' THR . . . . . 0.562 HG22 ' CA ' ' A' ' 39' ' ' GLY . 17.3 m -95.12 132.59 39.86 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.244 -0.91 . . . . 0.0 109.436 179.94 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 80' ' ' TYR . . . . . 0.513 ' CE1' ' OG ' ' A' ' 85' ' ' SER . 2.0 m-85 -114.06 140.55 48.37 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.253 -0.904 . . . . 0.0 109.648 -179.862 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 81.2 tt0 -60.21 -30.07 69.13 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.326 -0.859 . . . . 0.0 109.665 -179.973 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 40.7 mttm -131.88 150.53 52.12 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.1 -1.0 . . . . 0.0 109.611 -179.922 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 83' ' ' MET . . . . . 0.859 ' HE2' ' HB3' ' A' ' 116' ' ' ALA . 54.0 mtt -66.67 -18.92 65.62 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.364 -0.835 . . . . 0.0 109.582 -179.997 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 98.7 mt-10 -64.39 -44.54 90.98 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.296 -0.877 . . . . 0.0 109.557 -179.86 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 85' ' ' SER . . . . . 0.513 ' OG ' ' CE1' ' A' ' 80' ' ' TYR . 43.6 t -61.51 -31.15 71.14 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.19 -0.944 . . . . 0.0 109.549 -179.89 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 86' ' ' ALA . . . . . 0.497 ' HA ' HD11 ' A' ' 42' ' ' LEU . . . -74.53 -31.03 62.0 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.237 -0.914 . . . . 0.0 109.647 -179.85 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 87' ' ' ASP . . . . . 0.423 ' O ' ' CB ' ' A' ' 91' ' ' ALA . 59.4 t0 -67.96 -49.39 62.02 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.21 -0.931 . . . . 0.0 109.559 -179.982 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 88' ' ' GLN . . . . . 0.438 ' HG2' ' CE1' ' A' ' 61' ' ' PHE . 62.9 tt0 -67.77 -36.78 81.11 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.251 -0.906 . . . . 0.0 109.524 -179.939 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 89' ' ' ALA . . . . . 0.57 ' HA ' ' CE1' ' A' ' 61' ' ' PHE . . . -75.7 -51.18 13.31 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.229 -0.919 . . . . 0.0 109.556 -179.928 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 90' ' ' VAL . . . . . 0.789 ' HA ' HG11 ' A' ' 105' ' ' VAL . 92.9 t -65.08 -33.67 65.32 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.545 0 O-C-N 121.321 -0.862 . . . . 0.0 109.552 -179.932 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 91' ' ' ALA . . . . . 0.423 ' CB ' ' O ' ' A' ' 87' ' ' ASP . . . -79.98 -45.25 18.77 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.31 -0.869 . . . . 0.0 109.663 -179.937 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 92' ' ' GLU . . . . . 0.579 ' HB3' ' CE1' ' A' ' 61' ' ' PHE . 34.0 tt0 -75.26 -46.87 30.89 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.255 -0.903 . . . . 0.0 109.658 -179.831 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 93' ' ' LEU . . . . . 0.773 ' HB2' HG21 ' A' ' 105' ' ' VAL . 42.5 mt -64.42 -41.84 96.38 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.206 -0.934 . . . . 0.0 109.606 -179.779 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 94' ' ' ASN . . . . . 0.492 ' CB ' ' O ' ' A' ' 90' ' ' VAL . 46.8 t30 -64.26 126.69 28.57 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.197 -0.939 . . . . 0.0 109.542 -179.93 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 91.78 25.87 21.43 Favored Glycine 0 N--CA 1.49 2.3 0 N-CA-C 109.556 -1.417 . . . . 0.0 109.556 179.966 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 96' ' ' THR . . . . . 0.637 HG23 ' O ' ' A' ' 93' ' ' LEU . 17.1 p -121.04 160.63 23.2 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.149 -1.206 . . . . 0.0 109.471 179.94 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 64.0 tt0 -130.38 149.92 51.84 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.257 -0.902 . . . . 0.0 109.477 -179.938 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 98' ' ' VAL . . . . . 0.547 HG23 ' O ' ' A' ' 101' ' ' VAL . 1.1 t -97.73 -151.3 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.609 0 O-C-N 121.315 -0.866 . . . . 0.0 109.357 -179.932 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 99' ' ' GLU . . . . . 0.513 ' H ' HG12 ' A' ' 98' ' ' VAL . 96.0 mt-10 -53.84 -38.43 64.65 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.202 -0.936 . . . . 0.0 109.529 -179.947 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 19.2 m -164.0 30.35 0.08 Allowed 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.268 -0.895 . . . . 0.0 109.521 179.965 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 101' ' ' VAL . . . . . 0.547 ' O ' HG23 ' A' ' 98' ' ' VAL . 59.7 t -144.78 144.17 22.15 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.516 0 O-C-N 121.21 -0.931 . . . . 0.0 109.487 -179.987 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 87.1 mt-30 -94.09 150.53 20.25 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.241 -0.912 . . . . 0.0 109.373 179.97 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 88.3 mt -117.29 134.99 54.16 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.205 -0.935 . . . . 0.0 109.499 -179.954 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 104' ' ' LYS . . . . . 0.464 ' O ' ' HA ' ' A' ' 44' ' ' VAL . 23.1 mttm -113.66 135.13 54.26 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.279 -0.888 . . . . 0.0 109.351 179.936 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 105' ' ' VAL . . . . . 0.789 HG11 ' HA ' ' A' ' 90' ' ' VAL . 21.2 t -118.83 139.28 46.72 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.551 0 O-C-N 121.172 -0.955 . . . . 0.0 109.541 -179.982 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 106' ' ' ASN . . . . . 0.444 ' OD1' ' O ' ' A' ' 105' ' ' VAL . 97.2 m-20 -143.57 -175.86 4.73 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.194 -0.941 . . . . 0.0 109.376 179.956 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 51.0 mt -100.01 135.61 34.96 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.511 0 O-C-N 121.234 -0.916 . . . . 0.0 109.596 -179.965 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -116.17 144.87 43.6 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.331 -0.856 . . . . 0.0 109.474 179.982 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 94.4 mtt180 -110.16 26.29 10.83 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.2 -0.937 . . . . 0.0 109.507 179.993 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 24.7 mttt -87.25 13.94 8.73 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.227 -0.921 . . . . 0.0 109.426 179.924 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 111' ' ' GLN . . . . . 0.491 ' HG2' ' O ' ' A' ' 39' ' ' GLY . 4.5 tp-100 -120.46 71.02 17.55 Favored Pre-proline 0 N--CA 1.49 1.541 0 O-C-N 121.219 -0.926 . . . . 0.0 109.701 -179.901 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 112' ' ' PRO . . . . . 0.427 ' O ' ' C ' ' A' ' 113' ' ' MET . 51.9 Cg_endo -72.63 -17.73 26.03 Favored 'Trans proline' 0 C--O 1.215 -0.634 0 C-N-CA 122.625 2.217 . . . . 0.0 110.826 179.485 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 113' ' ' MET . . . . . 0.523 ' HB3' ' HE2' ' A' ' 113' ' ' MET . 0.0 OUTLIER -42.58 -27.98 0.2 Allowed 'General case' 0 C--N 1.303 -1.424 0 N-CA-C 109.122 -0.695 . . . . 0.0 109.122 179.715 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 114' ' ' LEU . . . . . 0.941 HD23 ' O ' ' A' ' 114' ' ' LEU . 2.5 tt -170.18 25.38 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.024 -1.047 . . . . 0.0 110.305 179.885 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 115' ' ' ASP . . . . . 0.701 ' O ' ' HB3' ' A' ' 116' ' ' ALA . 88.0 m-20 41.94 42.06 2.15 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.291 -0.881 . . . . 0.0 109.348 179.927 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 116' ' ' ALA . . . . . 0.859 ' HB3' ' HE2' ' A' ' 83' ' ' MET . . . 78.72 -71.57 0.09 Allowed 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.459 -0.776 . . . . 0.0 110.021 -179.862 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 117' ' ' ALA . . . . . 0.556 ' HA ' ' CD2' ' A' ' 114' ' ' LEU . . . -167.45 -80.03 0.02 OUTLIER 'General case' 0 C--N 1.303 -1.447 0 O-C-N 121.142 -0.974 . . . . 0.0 110.465 -179.29 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 118' ' ' THR . . . . . 0.447 ' OG1' ' HE1' ' A' ' 83' ' ' MET . 55.2 p -54.37 -17.98 3.61 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.124 -0.985 . . . . 0.0 109.802 -179.509 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 119' ' ' GLY . . . . . 0.529 ' HA3' ' CB ' ' A' ' 115' ' ' ASP . . . -51.77 140.55 25.71 Favored Glycine 0 N--CA 1.489 2.232 0 N-CA-C 109.36 -1.496 . . . . 0.0 109.36 179.797 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 120' ' ' LYS . . . . . 0.455 ' HB2' ' O ' ' A' ' 119' ' ' GLY . 60.6 mttp 61.54 45.29 8.37 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.228 -1.16 . . . . 0.0 109.408 -179.964 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 121' ' ' SER . . . . . 0.434 ' OG ' ' O ' ' A' ' 118' ' ' THR . 92.5 p . . . . . 0 N--CA 1.489 1.508 0 CA-C-O 118.032 -0.985 . . . . 0.0 109.487 -179.979 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . 0.513 ' N ' ' CD ' ' A' ' 36' ' ' PRO . . . . . . . . 0 N--CA 1.489 1.508 0 N-CA-C 109.473 -0.565 . . . . 0.0 109.473 . . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 36' ' ' PRO . . . . . 0.513 ' CD ' ' N ' ' A' ' 35' ' ' ALA . 49.5 Cg_endo -69.61 -15.4 37.64 Favored 'Trans proline' 0 C--O 1.216 -0.603 0 C-N-CA 122.72 2.28 . . . . 0.0 111.843 -179.956 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 37' ' ' ARG . . . . . 0.478 ' O ' HD11 ' A' ' 114' ' ' LEU . 75.7 mtm-85 -124.25 138.65 54.37 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.2 -0.937 . . . . 0.0 109.523 179.987 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 38' ' ' LYS . . . . . 0.596 ' C ' HD21 ' A' ' 114' ' ' LEU . 39.0 mttt -108.17 -166.72 1.16 Allowed 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.188 -0.945 . . . . 0.0 109.423 179.951 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . 0.523 ' HA3' HD22 ' A' ' 114' ' ' LEU . . . -174.17 -178.7 44.29 Favored Glycine 0 N--CA 1.491 2.309 0 N-CA-C 109.789 -1.324 . . . . 0.0 109.789 179.942 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 40' ' ' ASN . . . . . 0.76 HD22 ' HB3' ' A' ' 86' ' ' ALA . 38.6 t30 -162.55 -178.35 6.18 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.163 -1.198 . . . . 0.0 109.311 179.576 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 41' ' ' THR . . . . . 0.604 HG22 ' HB3' ' A' ' 108' ' ' ALA . 8.1 m -139.81 159.18 42.77 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.251 -0.905 . . . . 0.0 109.687 -179.732 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . 0.783 HD12 ' O ' ' A' ' 78' ' ' VAL . 4.3 mp -144.78 143.91 30.9 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.279 -0.888 . . . . 0.0 109.469 -179.951 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 43' ' ' TYR . . . . . 0.458 ' HB3' ' HB2' ' A' ' 106' ' ' ASN . 51.7 t80 -105.04 109.79 21.93 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.174 -0.954 . . . . 0.0 109.519 179.925 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . 0.425 ' HA ' ' O ' ' A' ' 104' ' ' LYS . 99.8 t -101.16 144.23 13.22 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.518 0 O-C-N 121.346 -0.846 . . . . 0.0 109.481 179.862 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 64.6 t80 -135.86 134.81 39.21 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.303 -0.873 . . . . 0.0 109.425 -179.852 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 176.09 -166.0 36.88 Favored Glycine 0 N--CA 1.49 2.257 0 N-CA-C 109.453 -1.459 . . . . 0.0 109.453 179.918 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . 0.422 ' O ' ' C ' ' A' ' 48' ' ' ASP . 94.0 mt-10 -126.04 158.04 36.37 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.288 -1.125 . . . . 0.0 109.396 180.0 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . 0.422 ' C ' ' O ' ' A' ' 47' ' ' GLU . 51.7 m-20 44.38 48.85 8.15 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.174 -0.954 . . . . 0.0 109.486 -179.993 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 63.5 mtm -101.41 141.12 34.75 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.228 -0.92 . . . . 0.0 109.462 -179.976 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 50' ' ' THR . . . . . 0.602 ' O ' HD12 ' A' ' 54' ' ' LEU . 0.6 OUTLIER -122.12 167.28 14.29 Favored Pre-proline 0 N--CA 1.49 1.531 0 O-C-N 121.211 -0.931 . . . . 0.0 109.422 179.965 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 51' ' ' PRO . . . . . 0.471 ' CB ' HD21 ' A' ' 67' ' ' LEU . 49.5 Cg_endo -70.43 -55.0 0.17 Allowed 'Trans proline' 0 C--O 1.215 -0.664 0 C-N-CA 122.643 2.228 . . . . 0.0 111.864 180.0 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 35.3 m -51.88 -47.0 64.73 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.175 -0.953 . . . . 0.0 109.147 179.906 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 23.5 tp -59.46 -50.27 74.56 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.258 -0.901 . . . . 0.0 109.143 179.788 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 54' ' ' LEU . . . . . 0.602 HD12 ' O ' ' A' ' 50' ' ' THR . 8.1 mt -55.57 -48.7 74.36 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.309 -0.87 . . . . 0.0 109.175 179.705 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 55' ' ' ARG . . . . . 0.518 ' O ' ' N ' ' A' ' 59' ' ' SER . 93.5 mtt-85 -49.18 -37.04 21.24 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.275 -0.89 . . . . 0.0 109.229 179.824 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -69.38 -35.01 75.28 Favored Glycine 0 N--CA 1.489 2.223 0 N-CA-C 109.454 -1.458 . . . . 0.0 109.454 179.945 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . 0.511 ' O ' HD11 ' A' ' 93' ' ' LEU . . . -75.87 -22.83 55.77 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.217 -1.166 . . . . 0.0 109.362 179.925 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 58' ' ' PHE . . . . . 0.882 ' CE1' HD12 ' A' ' 93' ' ' LEU . 95.7 m-85 -116.63 9.54 14.15 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.287 -0.883 . . . . 0.0 109.328 179.825 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 59' ' ' SER . . . . . 0.562 ' N ' ' HD2' ' A' ' 60' ' ' PRO . 0.8 OUTLIER -76.92 -52.72 1.91 Allowed Pre-proline 0 N--CA 1.49 1.556 0 O-C-N 121.293 -0.879 . . . . 0.0 110.619 -179.506 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 60' ' ' PRO . . . . . 0.562 ' HD2' ' N ' ' A' ' 59' ' ' SER . 48.8 Cg_endo -70.45 -33.35 14.13 Favored 'Trans proline' 0 C--O 1.215 -0.658 0 C-N-CA 122.336 2.024 . . . . 0.0 112.526 -179.023 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 61' ' ' PHE . . . . . 0.73 ' CE2' HD21 ' A' ' 93' ' ' LEU . 78.1 m-85 -63.41 -36.64 84.39 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 120.983 -1.073 . . . . 0.0 109.648 -179.838 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . 0.452 ' HA3' ' OG ' ' A' ' 85' ' ' SER . . . 179.22 -176.98 48.21 Favored Glycine 0 N--CA 1.49 2.247 0 N-CA-C 109.447 -1.461 . . . . 0.0 109.447 179.952 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 78.9 m-20 -93.22 138.53 31.53 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.266 -1.138 . . . . 0.0 109.577 179.99 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 64' ' ' ILE . . . . . 0.901 HG23 ' O ' ' A' ' 79' ' ' THR . 41.1 mt -99.19 140.01 19.64 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.555 0 O-C-N 121.273 -0.892 . . . . 0.0 109.397 -179.989 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 22.3 pt -103.63 -19.3 6.29 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 O-C-N 121.204 -0.935 . . . . 0.0 109.705 -179.763 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 66' ' ' ASP . . . . . 0.462 ' HB3' ' OG1' ' A' ' 79' ' ' THR . 21.7 t70 -152.18 126.42 9.25 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.228 -0.92 . . . . 0.0 109.405 179.946 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . 0.471 HD21 ' CB ' ' A' ' 51' ' ' PRO . 8.3 tp -111.46 122.51 48.03 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.298 -0.876 . . . . 0.0 109.345 -179.965 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 68' ' ' SER . . . . . 0.459 ' HB3' ' HB2' ' A' ' 77' ' ' PHE . 26.5 t -126.21 139.19 53.54 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.328 -0.857 . . . . 0.0 109.412 -179.926 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 69' ' ' MET . . . . . 0.415 ' HA ' ' HA ' ' A' ' 76' ' ' ALA . 86.7 mtp -127.7 150.99 49.53 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.306 -0.872 . . . . 0.0 109.467 179.946 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 70' ' ' ASP . . . . . 0.469 ' C ' ' HD2' ' A' ' 72' ' ' PRO . 10.6 t70 -129.15 101.67 19.33 Favored Pre-proline 0 N--CA 1.491 1.577 0 O-C-N 121.276 -0.89 . . . . 0.0 109.447 179.986 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 71' ' ' PRO . . . . . 0.592 ' N ' ' CD ' ' A' ' 72' ' ' PRO . 47.5 Cg_endo -74.93 -27.89 9.77 Favored 'Trans proline' 0 CA--C 1.544 0.985 0 C-N-CA 122.561 2.174 . . . . 0.0 113.733 -179.863 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 72' ' ' PRO . . . . . 0.592 ' CD ' ' N ' ' A' ' 71' ' ' PRO . 55.4 Cg_endo -75.15 -20.63 16.38 Favored 'Trans proline' 0 C--N 1.352 0.728 0 C-N-CA 121.471 1.447 . . . . 0.0 111.803 -179.699 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 73' ' ' ARG . . . . . 0.454 ' N ' ' OD1' ' A' ' 70' ' ' ASP . 93.6 mtt180 -113.59 0.44 14.64 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.258 -0.901 . . . . 0.0 109.698 -179.899 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 74' ' ' ASN . . . . . 0.437 ' HB2' ' O ' ' A' ' 73' ' ' ARG . 81.7 m-20 61.19 41.83 12.96 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.247 -0.908 . . . . 0.0 109.493 179.938 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 75' ' ' CYS . . . . . 0.465 ' SG ' ' HB3' ' A' ' 70' ' ' ASP . 21.7 p -144.19 147.97 34.36 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.186 -0.946 . . . . 0.0 109.452 179.941 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . 0.415 ' HA ' ' HA ' ' A' ' 69' ' ' MET . . . -121.89 149.15 43.81 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.247 -0.908 . . . . 0.0 109.408 -179.954 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 77' ' ' PHE . . . . . 0.459 ' HB2' ' HB3' ' A' ' 68' ' ' SER . 90.9 m-85 -114.02 137.99 50.97 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.234 -0.916 . . . . 0.0 109.379 -179.973 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . 0.783 ' O ' HD12 ' A' ' 42' ' ' LEU . 61.7 t -123.76 145.3 31.02 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.491 0 O-C-N 121.145 -0.972 . . . . 0.0 109.615 -179.884 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 79' ' ' THR . . . . . 0.901 ' O ' HG23 ' A' ' 64' ' ' ILE . 1.3 m -113.99 130.77 56.51 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.316 -0.865 . . . . 0.0 108.995 179.886 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 80' ' ' TYR . . . . . 0.514 ' O ' ' HA2' ' A' ' 39' ' ' GLY . 0.9 OUTLIER -112.22 132.37 54.96 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.168 -0.958 . . . . 0.0 109.805 -179.665 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 81' ' ' GLU . . . . . 0.433 ' C ' ' HA2' ' A' ' 39' ' ' GLY . 86.7 tt0 -43.04 -25.81 0.12 Allowed 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.448 -0.782 . . . . 0.0 109.766 179.81 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 82' ' ' LYS . . . . . 0.425 ' N ' ' O ' ' A' ' 80' ' ' TYR . 34.6 mtmm -142.95 164.2 30.72 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.1 -1.0 . . . . 0.0 109.403 179.95 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 83' ' ' MET . . . . . 0.593 ' CE ' ' N ' ' A' ' 117' ' ' ALA . 15.8 mtt -80.41 -12.95 59.51 Favored 'General case' 0 N--CA 1.487 1.42 0 O-C-N 121.267 -0.895 . . . . 0.0 109.49 179.874 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 95.1 mt-10 -73.99 -40.75 62.74 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.243 -0.91 . . . . 0.0 109.183 179.722 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 85' ' ' SER . . . . . 0.452 ' OG ' ' HA3' ' A' ' 62' ' ' GLY . 10.9 t -66.78 -39.33 87.77 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.34 -0.85 . . . . 0.0 109.258 179.744 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 86' ' ' ALA . . . . . 0.795 ' O ' HG23 ' A' ' 90' ' ' VAL . . . -72.08 -23.97 61.43 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.433 -0.792 . . . . 0.0 109.24 -179.943 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 65.1 m-20 -72.97 -48.3 37.8 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.352 -0.843 . . . . 0.0 109.504 179.911 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 57.6 tt0 -68.41 -37.9 80.75 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.297 -0.877 . . . . 0.0 109.633 -179.96 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 89' ' ' ALA . . . . . 0.452 ' HA ' ' CD1' ' A' ' 61' ' ' PHE . . . -69.07 -41.35 77.66 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.213 -0.93 . . . . 0.0 109.513 -179.883 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 90' ' ' VAL . . . . . 0.795 HG23 ' O ' ' A' ' 86' ' ' ALA . 53.1 t -62.09 -33.21 57.33 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.535 0 O-C-N 121.205 -0.935 . . . . 0.0 109.627 -179.933 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -79.41 -48.16 14.46 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.231 -0.918 . . . . 0.0 109.856 -179.684 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 92' ' ' GLU . . . . . 0.58 ' HB2' ' CE1' ' A' ' 61' ' ' PHE . 75.6 mm-40 -73.72 -43.11 60.09 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.175 -0.953 . . . . 0.0 109.994 -179.405 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 93' ' ' LEU . . . . . 0.946 ' HB2' HG21 ' A' ' 105' ' ' VAL . 21.9 mt -69.6 -39.32 77.34 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.16 -0.962 . . . . 0.0 109.753 -179.655 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 94' ' ' ASN . . . . . 0.521 ' CB ' ' O ' ' A' ' 90' ' ' VAL . 51.4 t-20 -72.54 120.05 17.61 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.15 -0.968 . . . . 0.0 109.569 -179.995 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 102.03 26.61 7.37 Favored Glycine 0 N--CA 1.49 2.249 0 N-CA-C 109.493 -1.443 . . . . 0.0 109.493 179.971 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 96' ' ' THR . . . . . 0.493 ' CG2' ' O ' ' A' ' 92' ' ' GLU . 11.1 p -125.65 154.52 42.21 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.28 -1.13 . . . . 0.0 109.429 -179.957 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 63.2 tt0 -128.47 138.38 52.26 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.277 -0.89 . . . . 0.0 109.516 179.977 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 98' ' ' VAL . . . . . 0.479 HG23 ' O ' ' A' ' 101' ' ' VAL . 1.3 t -80.13 -148.48 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 O-C-N 121.286 -0.884 . . . . 0.0 109.396 -179.97 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 99' ' ' GLU . . . . . 0.473 ' H ' HG12 ' A' ' 98' ' ' VAL . 96.5 mt-10 -63.2 -39.2 93.96 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.271 -0.893 . . . . 0.0 109.435 179.986 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 1.2 m -155.99 25.52 0.37 Allowed 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.276 -0.89 . . . . 0.0 109.451 179.956 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 101' ' ' VAL . . . . . 0.479 ' O ' HG23 ' A' ' 98' ' ' VAL . 57.4 t -139.59 145.07 27.45 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.552 0 O-C-N 121.308 -0.87 . . . . 0.0 109.373 179.922 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 47.0 tt0 -103.11 138.72 39.57 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.221 -0.924 . . . . 0.0 109.666 -179.837 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 67.7 mt -110.23 142.97 41.07 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.217 -0.927 . . . . 0.0 109.375 179.883 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 104' ' ' LYS . . . . . 0.425 ' O ' ' HA ' ' A' ' 44' ' ' VAL . 44.7 mttp -125.76 124.23 40.56 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.267 -0.896 . . . . 0.0 109.437 179.917 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 105' ' ' VAL . . . . . 0.946 HG21 ' HB2' ' A' ' 93' ' ' LEU . 14.3 t -107.95 149.75 11.07 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.568 0 O-C-N 121.205 -0.934 . . . . 0.0 109.561 -179.886 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 106' ' ' ASN . . . . . 0.458 ' HB2' ' HB3' ' A' ' 43' ' ' TYR . 82.1 m-20 -157.03 -166.05 1.99 Allowed 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.294 -0.879 . . . . 0.0 109.389 179.88 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 27.4 mm -108.0 126.03 64.55 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.523 0 O-C-N 121.185 -0.947 . . . . 0.0 109.519 -179.975 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 108' ' ' ALA . . . . . 0.604 ' HB3' HG22 ' A' ' 41' ' ' THR . . . -101.07 169.3 9.03 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.309 -0.869 . . . . 0.0 109.409 179.926 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 109' ' ' ARG . . . . . 0.404 ' NH1' ' HG2' ' A' ' 109' ' ' ARG . 34.8 mtp85 -46.32 151.29 0.54 Allowed 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.216 -0.927 . . . . 0.0 109.432 179.942 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 110' ' ' LYS . . . . . 0.405 ' HB3' ' HB2' ' A' ' 116' ' ' ALA . 31.3 mttp -76.21 113.15 13.45 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.215 -0.928 . . . . 0.0 109.505 -179.957 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 111' ' ' GLN . . . . . 0.551 ' HG3' ' HE1' ' A' ' 113' ' ' MET . 0.0 OUTLIER -55.04 125.89 58.33 Favored Pre-proline 0 N--CA 1.489 1.478 0 O-C-N 121.262 -0.899 . . . . 0.0 109.478 -179.904 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 52.2 Cg_endo -72.26 -30.41 12.99 Favored 'Trans proline' 0 C--O 1.216 -0.622 0 C-N-CA 122.603 2.202 . . . . 0.0 111.679 -179.906 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 113' ' ' MET . . . . . 0.559 ' CE ' ' HB3' ' A' ' 114' ' ' LEU . 0.0 OUTLIER -45.79 -24.53 0.39 Allowed 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.307 -0.871 . . . . 0.0 109.57 179.901 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 114' ' ' LEU . . . . . 0.648 HD23 ' O ' ' A' ' 114' ' ' LEU . 2.1 tt -146.29 24.02 1.29 Allowed 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.082 -1.011 . . . . 0.0 109.824 -179.937 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 115' ' ' ASP . . . . . 0.433 ' C ' ' O ' ' A' ' 114' ' ' LEU . 71.5 m-20 42.7 31.45 0.3 Allowed 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.239 -0.913 . . . . 0.0 109.886 179.814 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 116' ' ' ALA . . . . . 0.58 ' O ' HD23 ' A' ' 114' ' ' LEU . . . 57.83 -89.1 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.168 -0.958 . . . . 0.0 109.988 179.786 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 117' ' ' ALA . . . . . 0.593 ' N ' ' CE ' ' A' ' 83' ' ' MET . . . -177.69 30.61 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.49 0 O-C-N 120.94 -1.1 . . . . 0.0 109.789 -179.701 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 118' ' ' THR . . . . . 0.574 HG23 ' HE3' ' A' ' 83' ' ' MET . 22.3 p -112.57 161.52 16.69 Favored 'General case' 0 C--N 1.302 -1.468 0 O-C-N 121.088 -1.007 . . . . 0.0 109.732 -179.752 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 97.45 167.58 32.58 Favored Glycine 0 N--CA 1.49 2.248 0 N-CA-C 109.55 -1.42 . . . . 0.0 109.55 179.916 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 120' ' ' LYS . . . . . 0.433 ' O ' ' HB3' ' A' ' 121' ' ' SER . 62.0 tttm -58.62 -38.43 78.02 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.219 -1.165 . . . . 0.0 109.461 179.923 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 121' ' ' SER . . . . . 0.433 ' HB3' ' O ' ' A' ' 120' ' ' LYS . 1.3 p . . . . . 0 N--CA 1.49 1.536 0 CA-C-O 117.948 -1.025 . . . . 0.0 109.494 179.954 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . 0.62 ' HB3' ' HG2' ' A' ' 113' ' ' MET . . . . . . . . 0 N--CA 1.491 1.577 0 N-CA-C 109.511 -0.552 . . . . 0.0 109.511 . . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 48.7 Cg_endo -69.65 -4.2 13.47 Favored 'Trans proline' 0 C--O 1.215 -0.669 0 C-N-CA 122.68 2.254 . . . . 0.0 111.939 -179.957 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 37' ' ' ARG . . . . . 0.546 ' O ' HD13 ' A' ' 114' ' ' LEU . 82.0 mtm180 -125.89 145.78 50.11 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.19 -0.944 . . . . 0.0 109.558 -179.977 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 38' ' ' LYS . . . . . 0.887 ' HA ' HD22 ' A' ' 114' ' ' LEU . 18.9 mttm -79.45 -163.09 0.47 Allowed 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.351 -0.843 . . . . 0.0 109.612 -179.876 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . 0.639 ' O ' ' HB2' ' A' ' 117' ' ' ALA . . . 178.72 -160.54 26.39 Favored Glycine 0 N--CA 1.49 2.292 0 N-CA-C 109.598 -1.401 . . . . 0.0 109.598 -179.925 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 40' ' ' ASN . . . . . 0.776 HD22 ' HB3' ' A' ' 86' ' ' ALA . 33.9 t-20 178.25 113.83 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.291 -1.123 . . . . 0.0 109.571 179.74 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 41' ' ' THR . . . . . 0.595 ' O ' HD23 ' A' ' 42' ' ' LEU . 40.1 m -80.72 136.71 36.21 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.24 -0.913 . . . . 0.0 109.34 179.859 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . 0.852 HD11 ' CD2' ' A' ' 80' ' ' TYR . 8.5 mt -120.18 157.58 28.76 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.205 -0.935 . . . . 0.0 109.614 -179.945 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 43' ' ' TYR . . . . . 0.489 ' CZ ' ' HB2' ' A' ' 75' ' ' CYS . 74.6 t80 -116.92 121.76 42.37 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.317 -0.865 . . . . 0.0 109.269 179.83 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . 0.773 HG13 HD23 ' A' ' 103' ' ' LEU . 61.8 t -116.21 134.17 60.41 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.479 0 O-C-N 121.167 -0.958 . . . . 0.0 109.572 -179.902 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 60.7 t80 -121.49 142.4 50.09 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.287 -0.883 . . . . 0.0 109.488 -179.976 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 173.97 -178.97 45.63 Favored Glycine 0 N--CA 1.491 2.338 0 N-CA-C 109.485 -1.446 . . . . 0.0 109.485 179.958 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . 0.411 ' O ' ' C ' ' A' ' 48' ' ' ASP . 92.7 mt-10 -111.66 154.93 24.2 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.253 -1.145 . . . . 0.0 109.434 -179.952 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . 0.411 ' C ' ' O ' ' A' ' 47' ' ' GLU . 43.4 m-20 43.99 51.6 6.99 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.212 -0.93 . . . . 0.0 109.488 -179.993 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 49.1 mtm -98.93 142.31 30.6 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.234 -0.916 . . . . 0.0 109.494 179.971 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 50' ' ' THR . . . . . 0.832 ' O ' HD12 ' A' ' 54' ' ' LEU . 0.6 OUTLIER -125.16 166.62 19.57 Favored Pre-proline 0 N--CA 1.49 1.571 0 O-C-N 121.225 -0.922 . . . . 0.0 109.503 179.949 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 51' ' ' PRO . . . . . 0.405 ' HD2' ' HB ' ' A' ' 50' ' ' THR . 49.2 Cg_endo -69.95 -48.21 0.72 Allowed 'Trans proline' 0 C--O 1.216 -0.623 0 C-N-CA 122.718 2.279 . . . . 0.0 111.769 -179.96 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 36.3 m -57.54 -45.74 84.73 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.253 -0.905 . . . . 0.0 109.457 179.985 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 15.6 tp -59.71 -50.28 74.45 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.325 -0.859 . . . . 0.0 109.445 179.84 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 54' ' ' LEU . . . . . 0.832 HD12 ' O ' ' A' ' 50' ' ' THR . 3.5 mt -56.81 -50.16 73.2 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.285 -0.885 . . . . 0.0 109.284 179.897 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 55' ' ' ARG . . . . . 0.506 ' O ' ' N ' ' A' ' 59' ' ' SER . 33.2 mtp180 -46.03 -41.03 11.48 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.172 -0.955 . . . . 0.0 109.262 179.895 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -69.18 -37.78 81.9 Favored Glycine 0 N--CA 1.489 2.229 0 N-CA-C 109.36 -1.496 . . . . 0.0 109.36 179.852 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -72.59 -21.05 61.2 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.245 -1.15 . . . . 0.0 109.394 179.953 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 58' ' ' PHE . . . . . 0.675 ' CZ ' HD13 ' A' ' 93' ' ' LEU . 92.5 m-85 -117.74 8.0 12.63 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.308 -0.87 . . . . 0.0 109.431 179.881 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 59' ' ' SER . . . . . 0.559 ' N ' ' HD2' ' A' ' 60' ' ' PRO . 1.2 t -75.16 -54.45 2.52 Favored Pre-proline 0 N--CA 1.492 1.632 0 O-C-N 121.313 -0.867 . . . . 0.0 110.391 -179.699 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 60' ' ' PRO . . . . . 0.559 ' HD2' ' N ' ' A' ' 59' ' ' SER . 47.4 Cg_endo -68.95 -30.5 26.03 Favored 'Trans proline' 0 C--O 1.215 -0.653 0 C-N-CA 122.456 2.104 . . . . 0.0 112.3 -179.252 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 61' ' ' PHE . . . . . 0.619 ' CB ' ' HB2' ' A' ' 89' ' ' ALA . 60.3 m-85 -66.68 -31.13 71.59 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.119 -0.988 . . . . 0.0 109.471 -179.979 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 168.56 179.15 40.66 Favored Glycine 0 N--CA 1.491 2.308 0 N-CA-C 109.579 -1.408 . . . . 0.0 109.579 179.928 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 37.0 t30 -87.89 134.86 33.62 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.365 -1.079 . . . . 0.0 109.492 -179.979 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 64' ' ' ILE . . . . . 0.656 HD11 ' HB2' ' A' ' 58' ' ' PHE . 33.4 mt -94.05 133.95 33.32 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.508 0 O-C-N 121.23 -0.919 . . . . 0.0 109.476 179.963 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 65' ' ' ILE . . . . . 1.028 HD11 ' OE1' ' A' ' 111' ' ' GLN . 26.1 pt -97.19 -20.71 5.57 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.486 0 O-C-N 121.17 -0.956 . . . . 0.0 109.376 179.911 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 66' ' ' ASP . . . . . 0.479 ' HB3' ' HB ' ' A' ' 79' ' ' THR . 60.9 t0 -138.82 125.96 21.37 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.225 -0.922 . . . . 0.0 109.433 179.854 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . 0.758 ' C ' HD13 ' A' ' 67' ' ' LEU . 3.5 tm? -121.26 108.24 13.5 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.209 -0.932 . . . . 0.0 109.355 179.897 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 68' ' ' SER . . . . . 0.476 ' HB2' ' HB2' ' A' ' 77' ' ' PHE . 58.3 m -122.66 149.27 44.25 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.238 -0.914 . . . . 0.0 109.463 -179.964 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 69' ' ' MET . . . . . 0.48 ' SD ' ' CD1' ' A' ' 54' ' ' LEU . 83.8 mmm -123.39 147.68 46.85 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.234 -0.916 . . . . 0.0 109.381 -179.979 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 70' ' ' ASP . . . . . 0.478 ' C ' ' HD2' ' A' ' 72' ' ' PRO . 0.6 OUTLIER -131.64 94.2 26.34 Favored Pre-proline 0 N--CA 1.49 1.541 0 O-C-N 121.252 -0.905 . . . . 0.0 109.483 179.959 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 71' ' ' PRO . . . . . 0.598 ' CD ' ' CD ' ' A' ' 72' ' ' PRO . 47.0 Cg_endo -74.84 -27.77 10.06 Favored 'Trans proline' 0 CA--C 1.543 0.967 0 C-N-CA 122.506 2.137 . . . . 0.0 113.664 -179.974 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 72' ' ' PRO . . . . . 0.598 ' CD ' ' CD ' ' A' ' 71' ' ' PRO . 55.2 Cg_endo -75.3 -22.19 14.55 Favored 'Trans proline' 0 C--N 1.353 0.803 0 C-N-CA 121.49 1.46 . . . . 0.0 111.868 -179.844 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 73' ' ' ARG . . . . . 0.401 ' O ' ' HB2' ' A' ' 74' ' ' ASN . 62.7 mtt180 -112.24 -0.39 15.51 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.167 -0.958 . . . . 0.0 109.65 -179.992 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 74' ' ' ASN . . . . . 0.401 ' HB2' ' O ' ' A' ' 73' ' ' ARG . 8.0 m120 60.82 45.47 9.8 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.082 -1.011 . . . . 0.0 109.402 -179.981 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 75' ' ' CYS . . . . . 0.489 ' HB2' ' CZ ' ' A' ' 43' ' ' TYR . 23.2 p -152.69 143.07 22.58 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.299 -0.875 . . . . 0.0 109.458 -179.979 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -112.08 156.99 21.33 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.307 -0.871 . . . . 0.0 109.485 179.952 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 77' ' ' PHE . . . . . 0.476 ' HB2' ' HB2' ' A' ' 68' ' ' SER . 97.0 m-85 -118.37 125.58 50.31 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.245 -0.909 . . . . 0.0 109.427 179.858 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . 0.485 HG13 HG21 ' A' ' 64' ' ' ILE . 59.6 t -127.11 126.78 68.7 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.546 0 O-C-N 121.234 -0.916 . . . . 0.0 109.489 -179.858 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 79' ' ' THR . . . . . 0.932 HG21 ' OE1' ' A' ' 111' ' ' GLN . 92.3 m -105.59 126.64 52.37 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.334 -0.854 . . . . 0.0 109.446 179.812 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 80' ' ' TYR . . . . . 0.852 ' CD2' HD11 ' A' ' 42' ' ' LEU . 2.3 m-85 -92.41 174.05 7.49 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.227 -0.921 . . . . 0.0 109.169 179.898 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 81' ' ' GLU . . . . . 0.475 ' HG2' ' O ' ' A' ' 81' ' ' GLU . 71.0 tt0 -90.23 -13.56 35.19 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.352 -0.842 . . . . 0.0 109.665 -179.678 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 23.2 mttt -150.08 127.93 11.77 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.051 -1.031 . . . . 0.0 110.018 179.921 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 83' ' ' MET . . . . . 0.885 ' HB3' ' HB3' ' A' ' 117' ' ' ALA . 0.4 OUTLIER -45.83 -24.89 0.44 Allowed 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.458 -0.777 . . . . 0.0 109.88 179.938 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . 0.422 ' HG3' ' SD ' ' A' ' 83' ' ' MET . 97.1 mt-10 -67.56 -62.35 1.46 Allowed 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.196 -0.94 . . . . 0.0 109.571 -179.868 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 13.7 m -46.82 -38.26 9.96 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.267 -0.896 . . . . 0.0 109.818 -179.804 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 86' ' ' ALA . . . . . 0.776 ' HB3' HD22 ' A' ' 40' ' ' ASN . . . -69.27 -39.45 78.38 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.161 -0.962 . . . . 0.0 109.751 -179.691 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 52.4 t0 -56.76 -38.31 72.27 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.212 -0.93 . . . . 0.0 109.591 -179.739 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 88' ' ' GLN . . . . . 0.483 ' O ' ' CB ' ' A' ' 92' ' ' GLU . 59.7 tt0 -74.39 -38.49 63.12 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.15 -0.969 . . . . 0.0 109.603 -179.839 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 89' ' ' ALA . . . . . 0.619 ' HB2' ' CB ' ' A' ' 61' ' ' PHE . . . -75.36 -41.95 55.28 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.168 -0.958 . . . . 0.0 109.651 -179.871 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 90' ' ' VAL . . . . . 0.852 ' HA ' HG11 ' A' ' 105' ' ' VAL . 53.9 t -64.68 -48.72 83.51 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 O-C-N 121.257 -0.902 . . . . 0.0 109.634 -179.834 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -72.22 -38.77 68.91 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.272 -0.892 . . . . 0.0 109.702 -179.882 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 92' ' ' GLU . . . . . 0.59 ' HB3' ' CE1' ' A' ' 61' ' ' PHE . 44.5 tp10 -74.4 -45.81 44.29 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.247 -0.908 . . . . 0.0 109.583 -179.876 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 93' ' ' LEU . . . . . 0.675 HD13 ' CZ ' ' A' ' 58' ' ' PHE . 68.0 mt -69.95 -37.76 75.93 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.165 -0.959 . . . . 0.0 109.545 -179.921 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 94' ' ' ASN . . . . . 0.475 ' HB2' ' O ' ' A' ' 90' ' ' VAL . 61.4 t-20 -64.64 129.85 41.39 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.226 -0.921 . . . . 0.0 109.547 -179.967 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 84.77 30.14 27.33 Favored Glycine 0 N--CA 1.489 2.219 0 N-CA-C 109.497 -1.441 . . . . 0.0 109.497 179.973 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 96' ' ' THR . . . . . 0.666 HG23 ' O ' ' A' ' 93' ' ' LEU . 19.7 p -121.27 151.54 39.92 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.261 -1.141 . . . . 0.0 109.468 -179.995 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 61.7 tt0 -116.94 143.73 45.37 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.314 -0.866 . . . . 0.0 109.498 -179.946 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 98' ' ' VAL . . . . . 0.602 HG12 ' H ' ' A' ' 99' ' ' GLU . 1.2 t -90.79 -159.41 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 O-C-N 121.233 -0.917 . . . . 0.0 109.282 179.935 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 99' ' ' GLU . . . . . 0.602 ' H ' HG12 ' A' ' 98' ' ' VAL . 95.9 mt-10 -54.68 -37.71 66.1 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.183 -0.948 . . . . 0.0 109.481 179.968 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 100' ' ' SER . . . . . 0.422 ' O ' ' OG ' ' A' ' 100' ' ' SER . 6.9 t -159.86 25.96 0.18 Allowed 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.198 -0.938 . . . . 0.0 109.554 -179.953 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 101' ' ' VAL . . . . . 0.606 HG12 ' N ' ' A' ' 102' ' ' GLN . 48.7 t -138.03 168.42 20.32 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.546 0 O-C-N 121.219 -0.926 . . . . 0.0 109.434 -179.955 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 102' ' ' GLN . . . . . 0.606 ' N ' HG12 ' A' ' 101' ' ' VAL . 92.5 mt-30 -116.12 147.12 41.67 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.22 -0.925 . . . . 0.0 109.169 179.874 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 103' ' ' LEU . . . . . 0.773 HD23 HG13 ' A' ' 44' ' ' VAL . 0.0 OUTLIER -122.15 130.94 53.68 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.198 -0.939 . . . . 0.0 109.715 -179.918 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 16.7 mttp -115.82 128.22 55.66 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.294 -0.879 . . . . 0.0 109.333 179.864 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 105' ' ' VAL . . . . . 0.852 HG11 ' HA ' ' A' ' 90' ' ' VAL . 22.7 t -104.18 136.15 38.73 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.519 0 O-C-N 121.179 -0.951 . . . . 0.0 109.583 -179.834 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 106' ' ' ASN . . . . . 0.451 ' HB2' ' HB3' ' A' ' 43' ' ' TYR . 90.2 m-20 -136.03 -168.04 2.15 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.195 -0.941 . . . . 0.0 109.296 179.897 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 22.9 mm -108.2 123.68 63.94 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.543 0 O-C-N 121.257 -0.902 . . . . 0.0 109.528 179.918 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 108' ' ' ALA . . . . . 0.594 ' HB3' HG22 ' A' ' 41' ' ' THR . . . -102.22 167.77 9.78 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.239 -0.913 . . . . 0.0 109.434 -179.998 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 28.0 mtp-105 -51.82 139.57 21.44 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.279 -0.888 . . . . 0.0 109.52 179.958 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 110' ' ' LYS . . . . . 0.424 ' HB3' ' C ' ' A' ' 115' ' ' ASP . 50.7 mttp -71.97 146.87 47.45 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.221 -0.924 . . . . 0.0 109.388 179.967 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 111' ' ' GLN . . . . . 1.028 ' OE1' HD11 ' A' ' 65' ' ' ILE . 5.5 pt20 -83.68 156.09 65.06 Favored Pre-proline 0 N--CA 1.489 1.516 0 O-C-N 121.243 -0.911 . . . . 0.0 109.562 179.991 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 112' ' ' PRO . . . . . 0.414 ' O ' ' C ' ' A' ' 113' ' ' MET . 49.7 Cg_endo -69.88 -26.26 27.19 Favored 'Trans proline' 0 C--O 1.214 -0.683 0 C-N-CA 122.79 2.327 . . . . 0.0 112.043 -179.474 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 113' ' ' MET . . . . . 0.657 ' HE3' ' HB3' ' A' ' 114' ' ' LEU . 0.0 OUTLIER -43.79 -27.2 0.31 Allowed 'General case' 0 N--CA 1.489 1.504 0 N-CA-C 108.777 -0.823 . . . . 0.0 108.777 179.55 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 114' ' ' LEU . . . . . 0.887 HD22 ' HA ' ' A' ' 38' ' ' LYS . 0.7 OUTLIER -179.03 31.4 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.218 -0.926 . . . . 0.0 109.367 179.878 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 115' ' ' ASP . . . . . 0.579 ' O ' ' HB3' ' A' ' 116' ' ' ALA . 86.1 m-20 46.91 49.46 14.56 Favored 'General case' 0 C--N 1.303 -1.454 0 N-CA-C 108.251 -1.018 . . . . 0.0 108.251 -179.327 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 116' ' ' ALA . . . . . 0.579 ' HB3' ' O ' ' A' ' 115' ' ' ASP . . . 68.93 -86.71 0.03 OUTLIER 'General case' 0 N--CA 1.488 1.441 0 N-CA-C 108.842 -0.799 . . . . 0.0 108.842 -179.162 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 117' ' ' ALA . . . . . 0.885 ' HB3' ' HB3' ' A' ' 83' ' ' MET . . . -172.9 -34.78 0.01 OUTLIER 'General case' 0 C--N 1.304 -1.411 0 O-C-N 121.301 -0.875 . . . . 0.0 109.658 179.749 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 34.0 m -112.81 139.49 48.4 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.238 -0.914 . . . . 0.0 109.528 179.988 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 149.81 77.12 0.02 OUTLIER Glycine 0 N--CA 1.49 2.276 0 N-CA-C 109.454 -1.458 . . . . 0.0 109.454 179.928 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 120' ' ' LYS . . . . . 0.427 ' O ' ' CB ' ' A' ' 121' ' ' SER . 7.4 ttmm -57.04 -39.0 74.01 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.232 -1.157 . . . . 0.0 109.524 179.995 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 121' ' ' SER . . . . . 0.427 ' CB ' ' O ' ' A' ' 120' ' ' LYS . 1.3 t . . . . . 0 N--CA 1.49 1.544 0 CA-C-O 118.017 -0.992 . . . . 0.0 109.455 179.979 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . 0.883 ' HB3' ' HD3' ' A' ' 36' ' ' PRO . . . . . . . . 0 N--CA 1.491 1.593 0 N-CA-C 109.459 -0.571 . . . . 0.0 109.459 . . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 36' ' ' PRO . . . . . 0.883 ' HD3' ' HB3' ' A' ' 35' ' ' ALA . 49.3 Cg_endo -69.79 150.49 68.11 Favored 'Trans proline' 0 C--O 1.216 -0.607 0 C-N-CA 122.81 2.34 . . . . 0.0 111.829 -179.94 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 37' ' ' ARG . . . . . 0.546 ' C ' HD13 ' A' ' 114' ' ' LEU . 82.5 mtt85 -61.37 -36.64 80.81 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.229 -0.919 . . . . 0.0 109.614 179.98 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 38' ' ' LYS . . . . . 0.519 ' O ' ' CD1' ' A' ' 65' ' ' ILE . 56.9 mttm -64.25 -173.33 0.09 Allowed 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.168 -0.958 . . . . 0.0 109.275 179.966 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . 0.813 ' HA3' HD11 ' A' ' 65' ' ' ILE . . . 144.03 98.22 0.26 Allowed Glycine 0 N--CA 1.491 2.317 0 N-CA-C 109.63 -1.388 . . . . 0.0 109.63 179.948 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 43.7 t30 -87.21 101.55 13.62 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.273 -1.134 . . . . 0.0 109.322 179.878 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 41' ' ' THR . . . . . 0.447 ' OG1' ' HB3' ' A' ' 111' ' ' GLN . 78.9 m -65.53 130.88 44.88 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.229 -0.92 . . . . 0.0 109.588 -179.935 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . 0.56 HD11 ' HD2' ' A' ' 80' ' ' TYR . 16.8 mt -111.51 146.05 37.97 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.262 -0.899 . . . . 0.0 109.464 179.957 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 43' ' ' TYR . . . . . 0.469 ' HB2' ' HB2' ' A' ' 108' ' ' ALA . 70.6 t80 -104.78 122.72 46.32 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.164 -0.96 . . . . 0.0 109.46 179.999 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . 0.462 ' HA ' ' O ' ' A' ' 104' ' ' LYS . 47.9 t -121.57 138.15 52.84 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.523 0 O-C-N 121.214 -0.929 . . . . 0.0 109.489 179.978 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 45' ' ' TYR . . . . . 0.476 ' HB3' ' HB2' ' A' ' 104' ' ' LYS . 72.3 t80 -118.68 138.9 52.3 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.226 -0.921 . . . . 0.0 109.441 -179.951 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 176.17 -178.54 47.57 Favored Glycine 0 N--CA 1.489 2.216 0 N-CA-C 109.448 -1.461 . . . . 0.0 109.448 179.929 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 94.2 mt-10 -124.91 156.04 38.58 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.344 -1.092 . . . . 0.0 109.488 179.995 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 22.2 t70 47.46 50.22 15.03 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.227 -0.92 . . . . 0.0 109.476 -179.99 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 66.7 mtm -105.54 145.21 31.24 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.247 -0.908 . . . . 0.0 109.513 -179.969 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 50' ' ' THR . . . . . 0.728 ' O ' HD12 ' A' ' 54' ' ' LEU . 3.5 p -119.42 161.73 35.83 Favored Pre-proline 0 N--CA 1.49 1.57 0 O-C-N 121.27 -0.894 . . . . 0.0 109.395 179.978 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 51' ' ' PRO . . . . . 0.464 ' N ' ' SD ' ' A' ' 69' ' ' MET . 48.2 Cg_endo -70.1 -55.35 0.17 Allowed 'Trans proline' 0 C--O 1.216 -0.593 0 C-N-CA 122.727 2.285 . . . . 0.0 111.87 -179.949 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 27.9 m -50.83 -47.17 60.16 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.152 -0.967 . . . . 0.0 109.216 179.894 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 18.7 tp -58.06 -56.12 26.08 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.256 -0.903 . . . . 0.0 109.241 179.766 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 54' ' ' LEU . . . . . 0.728 HD12 ' O ' ' A' ' 50' ' ' THR . 5.1 mt -53.9 -43.17 69.46 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.285 -0.884 . . . . 0.0 109.092 179.615 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 55' ' ' ARG . . . . . 0.499 ' O ' ' N ' ' A' ' 59' ' ' SER . 73.5 ttt180 -48.83 -41.82 34.15 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.266 -0.896 . . . . 0.0 109.208 179.712 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . 0.474 ' O ' ' HD2' ' A' ' 60' ' ' PRO . . . -67.66 -35.39 85.81 Favored Glycine 0 N--CA 1.489 2.213 0 N-CA-C 109.263 -1.535 . . . . 0.0 109.263 179.857 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . 0.469 ' O ' ' CD1' ' A' ' 61' ' ' PHE . . . -70.87 -22.15 62.33 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.324 -1.103 . . . . 0.0 109.425 179.961 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 58' ' ' PHE . . . . . 0.675 ' CE2' HD12 ' A' ' 93' ' ' LEU . 96.6 m-85 -118.07 4.72 12.03 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.272 -0.892 . . . . 0.0 109.544 -179.953 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 59' ' ' SER . . . . . 0.538 ' N ' ' HD2' ' A' ' 60' ' ' PRO . 2.6 t -73.63 -56.89 2.78 Favored Pre-proline 0 N--CA 1.49 1.569 0 O-C-N 121.208 -0.932 . . . . 0.0 110.075 -179.67 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 60' ' ' PRO . . . . . 0.538 ' HD2' ' N ' ' A' ' 59' ' ' SER . 48.0 Cg_endo -68.81 -24.84 33.86 Favored 'Trans proline' 0 C--O 1.215 -0.652 0 C-N-CA 122.59 2.193 . . . . 0.0 111.989 -179.496 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 61' ' ' PHE . . . . . 0.587 ' CE2' ' HA ' ' A' ' 89' ' ' ALA . 68.0 m-85 -72.73 -25.08 61.08 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.179 -0.95 . . . . 0.0 109.508 179.968 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 166.18 -178.04 40.94 Favored Glycine 0 N--CA 1.49 2.256 0 N-CA-C 109.548 -1.421 . . . . 0.0 109.548 179.951 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 85.8 m-20 -92.43 139.51 30.52 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.305 -1.115 . . . . 0.0 109.504 179.986 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 64' ' ' ILE . . . . . 0.588 HG23 ' O ' ' A' ' 79' ' ' THR . 51.4 mt -99.87 134.12 40.41 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.522 0 O-C-N 121.243 -0.911 . . . . 0.0 109.461 -179.969 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 65' ' ' ILE . . . . . 0.813 HD11 ' HA3' ' A' ' 39' ' ' GLY . 20.0 pt -96.36 -24.29 4.6 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.537 0 O-C-N 121.314 -0.866 . . . . 0.0 109.521 -179.92 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 50.8 t0 -146.28 121.14 9.94 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.229 -0.919 . . . . 0.0 109.597 -179.946 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 8.1 tp -110.14 121.39 45.14 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.236 -0.915 . . . . 0.0 109.389 179.902 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 68' ' ' SER . . . . . 0.468 ' HB3' ' HB2' ' A' ' 77' ' ' PHE . 34.6 t -134.69 144.51 47.83 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.224 -0.922 . . . . 0.0 109.419 179.941 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 69' ' ' MET . . . . . 0.464 ' SD ' ' N ' ' A' ' 51' ' ' PRO . 83.3 mtp -129.59 151.4 50.24 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.271 -0.893 . . . . 0.0 109.563 -179.96 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 70' ' ' ASP . . . . . 0.478 ' C ' ' HD2' ' A' ' 72' ' ' PRO . 0.2 OUTLIER -127.06 99.36 28.69 Favored Pre-proline 0 N--CA 1.491 1.6 0 O-C-N 121.3 -0.875 . . . . 0.0 109.419 179.982 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 71' ' ' PRO . . . . . 0.594 ' N ' ' CD ' ' A' ' 72' ' ' PRO . 47.4 Cg_endo -74.63 -27.85 10.39 Favored 'Trans proline' 0 CA--C 1.542 0.924 0 C-N-CA 122.476 2.118 . . . . 0.0 113.759 -179.972 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 72' ' ' PRO . . . . . 0.594 ' CD ' ' N ' ' A' ' 71' ' ' PRO . 53.9 Cg_endo -75.09 -25.8 11.38 Favored 'Trans proline' 0 C--N 1.352 0.759 0 C-N-CA 121.404 1.403 . . . . 0.0 111.823 -179.851 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 73' ' ' ARG . . . . . 0.431 ' O ' ' HB2' ' A' ' 74' ' ' ASN . 97.8 mtt180 -110.1 0.12 18.21 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.222 -0.924 . . . . 0.0 109.63 -179.918 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 74' ' ' ASN . . . . . 0.431 ' HB2' ' O ' ' A' ' 73' ' ' ARG . 79.1 m-20 61.03 46.28 8.45 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.19 -0.944 . . . . 0.0 109.589 179.9 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 75' ' ' CYS . . . . . 0.442 ' HA ' ' O ' ' A' ' 44' ' ' VAL . 23.9 p -146.68 133.72 20.34 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.212 -0.93 . . . . 0.0 109.51 179.987 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . 0.439 ' HA ' ' HA ' ' A' ' 69' ' ' MET . . . -106.35 161.28 14.7 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.282 -0.886 . . . . 0.0 109.488 179.932 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 77' ' ' PHE . . . . . 0.484 ' CZ ' ' HE3' ' A' ' 110' ' ' LYS . 98.5 m-85 -126.89 132.66 50.86 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.305 -0.872 . . . . 0.0 109.461 -179.979 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . 0.484 ' O ' ' N ' ' A' ' 42' ' ' LEU . 40.8 t -128.65 131.89 68.24 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 O-C-N 121.215 -0.928 . . . . 0.0 109.477 179.935 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 79' ' ' THR . . . . . 0.588 ' O ' HG23 ' A' ' 64' ' ' ILE . 7.0 m -104.38 139.39 39.4 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.228 -0.92 . . . . 0.0 109.429 -179.919 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 80' ' ' TYR . . . . . 0.56 ' HD2' HD11 ' A' ' 42' ' ' LEU . 0.8 OUTLIER -118.25 134.57 54.9 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.302 -0.874 . . . . 0.0 109.48 179.942 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 80.2 tt0 -52.35 -34.46 47.6 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.257 -0.902 . . . . 0.0 109.408 179.896 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 42.5 mtmt -128.55 142.17 51.14 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.277 -0.889 . . . . 0.0 109.524 179.9 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 83' ' ' MET . . . . . 0.821 ' HE2' ' HB3' ' A' ' 117' ' ' ALA . 31.3 mtm -62.56 -25.45 68.07 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.258 -0.901 . . . . 0.0 109.555 -179.946 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 96.9 mt-10 -62.59 -39.89 95.17 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.27 -0.894 . . . . 0.0 109.55 -179.949 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 16.0 m -63.89 -34.21 77.43 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.225 -0.922 . . . . 0.0 109.636 179.978 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 86' ' ' ALA . . . . . 0.469 ' CB ' HD21 ' A' ' 42' ' ' LEU . . . -72.39 -33.09 66.93 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.285 -0.884 . . . . 0.0 109.546 -179.966 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 22.2 t70 -65.11 -42.69 93.75 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.212 -0.93 . . . . 0.0 109.557 -179.947 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 64.6 tt0 -67.88 -36.77 80.84 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.223 -0.923 . . . . 0.0 109.579 -179.959 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 89' ' ' ALA . . . . . 0.587 ' HA ' ' CE2' ' A' ' 61' ' ' PHE . . . -76.69 -48.81 17.73 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.211 -0.931 . . . . 0.0 109.547 -179.944 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 90' ' ' VAL . . . . . 0.854 HG22 ' CG1' ' A' ' 105' ' ' VAL . 71.3 t -58.76 -29.21 39.52 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.524 0 O-C-N 121.22 -0.925 . . . . 0.0 109.455 -179.933 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -80.03 -54.18 6.03 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.248 -0.907 . . . . 0.0 109.758 -179.92 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 92' ' ' GLU . . . . . 0.506 ' HB2' ' CE2' ' A' ' 61' ' ' PHE . 91.0 mt-10 -71.21 -40.75 70.96 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.288 -0.882 . . . . 0.0 109.879 -179.597 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 93' ' ' LEU . . . . . 0.775 ' O ' HG23 ' A' ' 96' ' ' THR . 28.2 mt -68.56 -42.18 78.71 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.141 -0.974 . . . . 0.0 109.558 -179.828 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 94' ' ' ASN . . . . . 0.515 ' CB ' ' O ' ' A' ' 90' ' ' VAL . 60.6 t-20 -63.79 131.24 47.21 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.255 -0.903 . . . . 0.0 109.565 -179.965 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 86.66 35.21 10.49 Favored Glycine 0 N--CA 1.49 2.291 0 N-CA-C 109.513 -1.435 . . . . 0.0 109.513 -179.968 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 96' ' ' THR . . . . . 0.775 HG23 ' O ' ' A' ' 93' ' ' LEU . 22.0 p -124.21 160.36 28.08 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.221 -1.164 . . . . 0.0 109.367 179.952 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 97' ' ' GLN . . . . . 0.421 ' HG2' ' N ' ' A' ' 98' ' ' VAL . 62.3 tt0 -128.25 154.81 45.46 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.238 -0.914 . . . . 0.0 109.471 -179.942 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 98' ' ' VAL . . . . . 0.57 HG12 ' H ' ' A' ' 99' ' ' GLU . 1.2 t -106.19 -155.13 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.566 0 O-C-N 121.212 -0.93 . . . . 0.0 109.336 -179.978 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 99' ' ' GLU . . . . . 0.57 ' H ' HG12 ' A' ' 98' ' ' VAL . 96.2 mt-10 -56.76 -36.98 70.44 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.119 -0.988 . . . . 0.0 109.481 -179.943 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 20.9 t -160.95 23.28 0.14 Allowed 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.224 -0.923 . . . . 0.0 109.596 -179.953 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 101' ' ' VAL . . . . . 0.534 ' O ' HG23 ' A' ' 98' ' ' VAL . 48.7 t -138.57 154.29 26.86 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.547 0 O-C-N 121.214 -0.929 . . . . 0.0 109.558 -180.0 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 92.2 mt-30 -99.63 148.35 24.42 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.278 -0.889 . . . . 0.0 109.306 179.935 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 103' ' ' LEU . . . . . 0.421 HD23 ' HA ' ' A' ' 103' ' ' LEU . 91.9 mt -109.04 137.05 47.55 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.184 -0.947 . . . . 0.0 109.625 -179.905 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 104' ' ' LYS . . . . . 0.476 ' HB2' ' HB3' ' A' ' 45' ' ' TYR . 3.1 mtpm? -122.98 139.24 54.28 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.312 -0.868 . . . . 0.0 109.327 179.927 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 105' ' ' VAL . . . . . 0.854 ' CG1' HG22 ' A' ' 90' ' ' VAL . 25.8 t -121.96 136.65 58.16 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.519 0 O-C-N 121.207 -0.933 . . . . 0.0 109.559 -179.968 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 106' ' ' ASN . . . . . 0.458 ' OD1' ' O ' ' A' ' 105' ' ' VAL . 99.1 m-20 -142.17 -178.41 5.71 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.298 -0.876 . . . . 0.0 109.392 179.957 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 107' ' ' ILE . . . . . 0.417 HD13 HG21 ' A' ' 107' ' ' ILE . 41.0 mt -102.15 137.54 29.68 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.567 0 O-C-N 121.212 -0.93 . . . . 0.0 109.574 -179.891 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 108' ' ' ALA . . . . . 0.469 ' HB2' ' HB2' ' A' ' 43' ' ' TYR . . . -124.98 141.75 51.93 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.26 -0.9 . . . . 0.0 109.446 179.945 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 49.6 mtt180 -111.48 40.1 2.18 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.244 -0.91 . . . . 0.0 109.408 179.885 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 110' ' ' LYS . . . . . 0.496 ' O ' ' HD2' ' A' ' 112' ' ' PRO . 67.3 mttm -81.59 -11.87 58.97 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.193 -0.942 . . . . 0.0 109.526 -179.881 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 111' ' ' GLN . . . . . 0.586 ' CG ' ' O ' ' A' ' 111' ' ' GLN . 0.0 OUTLIER -113.94 57.16 0.77 Allowed Pre-proline 0 N--CA 1.491 1.589 0 O-C-N 121.205 -0.935 . . . . 0.0 109.356 179.746 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 112' ' ' PRO . . . . . 0.496 ' HD2' ' O ' ' A' ' 110' ' ' LYS . 44.0 Cg_endo -66.69 -2.6 7.81 Favored 'Trans proline' 0 C--O 1.214 -0.708 0 C-N-CA 122.785 2.324 . . . . 0.0 112.032 -179.848 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 113' ' ' MET . . . . . 0.554 ' HG2' ' N ' ' A' ' 114' ' ' LEU . 0.0 OUTLIER -56.86 -23.23 42.84 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.178 -0.951 . . . . 0.0 109.089 179.586 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 114' ' ' LEU . . . . . 0.554 ' N ' ' HG2' ' A' ' 113' ' ' MET . 0.3 OUTLIER -153.59 17.7 0.53 Allowed 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.322 -0.861 . . . . 0.0 109.894 -179.721 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 115' ' ' ASP . . . . . 0.728 ' O ' ' HB3' ' A' ' 116' ' ' ALA . 77.1 m-20 40.62 43.03 1.51 Allowed 'General case' 0 N--CA 1.492 1.639 0 N-CA-C 109.151 -0.685 . . . . 0.0 109.151 -179.768 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 116' ' ' ALA . . . . . 0.728 ' HB3' ' O ' ' A' ' 115' ' ' ASP . . . 79.62 -74.82 0.05 OUTLIER 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.567 -0.708 . . . . 0.0 109.312 -179.294 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 117' ' ' ALA . . . . . 0.821 ' HB3' ' HE2' ' A' ' 83' ' ' MET . . . -168.48 59.11 0.06 Allowed 'General case' 0 C--N 1.304 -1.399 0 O-C-N 121.385 -0.822 . . . . 0.0 109.726 -179.929 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 44.3 m -118.17 148.61 42.18 Favored 'General case' 0 C--N 1.303 -1.434 0 O-C-N 121.158 -0.964 . . . . 0.0 109.553 -179.965 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -147.24 179.39 24.2 Favored Glycine 0 N--CA 1.489 2.232 0 N-CA-C 109.541 -1.424 . . . . 0.0 109.541 179.937 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 33.5 mmtp -82.29 144.93 30.27 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.238 -1.154 . . . . 0.0 109.5 179.969 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 7.3 m . . . . . 0 N--CA 1.49 1.543 0 CA-C-O 117.99 -1.005 . . . . 0.0 109.448 -179.988 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . 0.416 ' HA ' ' HD2' ' A' ' 36' ' ' PRO . . . . . . . . 0 N--CA 1.49 1.552 0 N-CA-C 109.465 -0.569 . . . . 0.0 109.465 . . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 36' ' ' PRO . . . . . 0.416 ' HD2' ' HA ' ' A' ' 35' ' ' ALA . 49.5 Cg_endo -69.41 -4.73 14.38 Favored 'Trans proline' 0 C--O 1.215 -0.657 0 C-N-CA 122.727 2.285 . . . . 0.0 111.889 179.935 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 37' ' ' ARG . . . . . 0.653 ' O ' HD13 ' A' ' 114' ' ' LEU . 74.3 mtt-85 -128.52 135.27 49.17 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.161 -0.962 . . . . 0.0 109.588 -179.939 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 38' ' ' LYS . . . . . 0.489 ' HB2' ' O ' ' A' ' 81' ' ' GLU . 44.5 mttp -133.85 -160.21 1.03 Allowed 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.287 -0.883 . . . . 0.0 109.284 179.942 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . 0.474 ' O ' ' HA ' ' A' ' 116' ' ' ALA . . . -172.34 168.51 41.6 Favored Glycine 0 N--CA 1.492 2.37 0 N-CA-C 109.793 -1.323 . . . . 0.0 109.793 -179.97 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 40' ' ' ASN . . . . . 0.52 ' N ' ' O ' ' A' ' 80' ' ' TYR . 42.3 t30 -151.41 98.26 2.5 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.345 -1.091 . . . . 0.0 109.139 179.853 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 41' ' ' THR . . . . . 0.51 ' O ' HD23 ' A' ' 42' ' ' LEU . 8.2 m -63.88 134.01 54.36 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.315 -0.866 . . . . 0.0 109.986 -179.518 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . 0.87 HD11 ' HD2' ' A' ' 80' ' ' TYR . 20.4 mt -120.21 155.6 32.83 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.424 -0.797 . . . . 0.0 109.314 179.702 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 43' ' ' TYR . . . . . 0.577 ' HB2' ' HB2' ' A' ' 108' ' ' ALA . 69.9 t80 -109.59 127.24 54.37 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.179 -0.951 . . . . 0.0 109.468 179.965 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 46.7 t -126.66 136.22 61.43 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.544 0 O-C-N 121.153 -0.967 . . . . 0.0 109.4 179.935 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 45' ' ' TYR . . . . . 0.486 ' HB3' ' HB2' ' A' ' 104' ' ' LYS . 65.6 t80 -127.53 136.43 51.71 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.292 -0.88 . . . . 0.0 109.596 -179.84 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -173.54 -163.88 27.85 Favored Glycine 0 N--CA 1.49 2.27 0 N-CA-C 109.374 -1.49 . . . . 0.0 109.374 179.988 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . 0.426 ' O ' ' C ' ' A' ' 48' ' ' ASP . 89.5 mt-10 -120.96 147.25 45.72 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.163 -1.199 . . . . 0.0 109.512 179.947 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . 0.426 ' C ' ' O ' ' A' ' 47' ' ' GLU . 47.0 m-20 43.49 54.18 5.42 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.227 -0.921 . . . . 0.0 109.477 179.966 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 54.4 mtm -97.34 136.1 38.3 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.318 -0.864 . . . . 0.0 109.607 -179.889 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 50' ' ' THR . . . . . 0.863 ' O ' HD12 ' A' ' 54' ' ' LEU . 0.0 OUTLIER -118.61 161.95 33.1 Favored Pre-proline 0 N--CA 1.49 1.548 0 O-C-N 121.258 -0.902 . . . . 0.0 109.49 179.927 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 51' ' ' PRO . . . . . 0.671 ' HD2' HG22 ' A' ' 50' ' ' THR . 48.1 Cg_endo -69.85 -50.19 0.48 Allowed 'Trans proline' 0 C--O 1.214 -0.683 0 C-N-CA 122.724 2.282 . . . . 0.0 111.731 -179.914 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 50.7 m -52.91 -47.43 67.99 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.228 -0.92 . . . . 0.0 109.311 179.904 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 10.8 tp -61.85 -57.2 12.74 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.402 -0.811 . . . . 0.0 109.25 179.788 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 54' ' ' LEU . . . . . 0.863 HD12 ' O ' ' A' ' 50' ' ' THR . 4.4 mt -53.63 -49.66 67.4 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.284 -0.885 . . . . 0.0 109.219 179.758 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 55' ' ' ARG . . . . . 0.435 ' C ' ' O ' ' A' ' 54' ' ' LEU . 77.7 ttt180 -43.66 -44.72 6.58 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.294 -0.879 . . . . 0.0 109.201 179.87 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -68.79 -33.3 75.28 Favored Glycine 0 N--CA 1.489 2.219 0 N-CA-C 109.159 -1.577 . . . . 0.0 109.159 179.737 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . 0.443 ' N ' ' O ' ' A' ' 54' ' ' LEU . . . -72.55 -20.11 61.39 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.353 -1.087 . . . . 0.0 109.297 179.935 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 58' ' ' PHE . . . . . 0.712 ' CZ ' HD13 ' A' ' 93' ' ' LEU . 95.2 m-85 -117.98 7.94 12.41 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.301 -0.875 . . . . 0.0 109.324 179.856 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 59' ' ' SER . . . . . 0.586 ' N ' ' HD2' ' A' ' 60' ' ' PRO . 0.5 OUTLIER -76.68 -50.1 2.6 Favored Pre-proline 0 N--CA 1.49 1.562 0 O-C-N 121.243 -0.91 . . . . 0.0 110.577 -179.644 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 60' ' ' PRO . . . . . 0.586 ' HD2' ' N ' ' A' ' 59' ' ' SER . 49.9 Cg_endo -70.72 -33.79 12.4 Favored 'Trans proline' 0 C--O 1.215 -0.654 0 C-N-CA 122.215 1.943 . . . . 0.0 112.454 -179.15 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 61' ' ' PHE . . . . . 0.584 ' CE1' ' HA ' ' A' ' 89' ' ' ALA . 77.4 m-85 -61.74 -43.96 97.83 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.042 -1.036 . . . . 0.0 109.516 -179.983 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . 0.42 ' HA3' ' OG ' ' A' ' 85' ' ' SER . . . -174.44 -168.29 35.03 Favored Glycine 0 N--CA 1.491 2.315 0 N-CA-C 109.464 -1.455 . . . . 0.0 109.464 -179.965 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 86.6 m-20 -98.1 143.5 28.58 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.235 -1.156 . . . . 0.0 109.409 -179.981 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 64' ' ' ILE . . . . . 0.482 HD11 ' HB2' ' A' ' 58' ' ' PHE . 37.8 mt -105.02 129.65 57.35 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.511 0 O-C-N 121.239 -0.913 . . . . 0.0 109.544 -179.904 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 65' ' ' ILE . . . . . 0.405 HD13 ' O ' ' A' ' 38' ' ' LYS . 21.3 pt -96.68 -21.58 5.35 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.602 0 O-C-N 121.324 -0.86 . . . . 0.0 109.614 -179.903 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 66' ' ' ASP . . . . . 0.451 ' HB3' ' OG1' ' A' ' 79' ' ' THR . 57.7 t0 -144.87 109.79 5.07 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.187 -0.946 . . . . 0.0 109.56 179.99 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 15.1 tp -108.07 121.48 44.91 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.301 -0.874 . . . . 0.0 109.437 179.979 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 68' ' ' SER . . . . . 0.473 ' HB3' ' HB2' ' A' ' 77' ' ' PHE . 22.7 t -131.09 139.04 49.81 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.281 -0.887 . . . . 0.0 109.421 -179.942 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 69' ' ' MET . . . . . 0.7 ' HE1' ' CD1' ' A' ' 54' ' ' LEU . 94.9 mmm -114.82 150.87 34.8 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.187 -0.946 . . . . 0.0 109.522 179.998 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 70' ' ' ASP . . . . . 0.477 ' C ' ' HD2' ' A' ' 72' ' ' PRO . 6.1 t0 -132.24 95.97 20.39 Favored Pre-proline 0 N--CA 1.49 1.542 0 O-C-N 121.222 -0.924 . . . . 0.0 109.516 -179.967 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 71' ' ' PRO . . . . . 0.592 ' N ' ' CD ' ' A' ' 72' ' ' PRO . 47.9 Cg_endo -74.81 -27.83 10.05 Favored 'Trans proline' 0 CA--C 1.543 0.956 0 C-N-CA 122.451 2.101 . . . . 0.0 113.623 -179.881 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 72' ' ' PRO . . . . . 0.592 ' CD ' ' N ' ' A' ' 71' ' ' PRO . 55.2 Cg_endo -75.13 -26.5 10.65 Favored 'Trans proline' 0 C--N 1.353 0.769 0 C-N-CA 121.51 1.473 . . . . 0.0 111.825 -179.848 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 73' ' ' ARG . . . . . 0.448 ' O ' ' HB2' ' A' ' 74' ' ' ASN . 77.7 mtt85 -109.24 -1.9 18.31 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.208 -0.932 . . . . 0.0 109.67 -179.841 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 74' ' ' ASN . . . . . 0.448 ' HB2' ' O ' ' A' ' 73' ' ' ARG . 78.4 m-20 61.89 43.12 9.59 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.159 -0.963 . . . . 0.0 109.599 179.97 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 75' ' ' CYS . . . . . 0.459 ' O ' ' CB ' ' A' ' 70' ' ' ASP . 28.4 p -146.52 141.9 27.5 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.277 -0.89 . . . . 0.0 109.47 179.941 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . 0.458 ' HB1' ' SD ' ' A' ' 69' ' ' MET . . . -114.11 161.88 17.2 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.214 -0.929 . . . . 0.0 109.56 -179.906 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 77' ' ' PHE . . . . . 0.473 ' HB2' ' HB3' ' A' ' 68' ' ' SER . 97.4 m-85 -123.77 130.94 53.41 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.24 -0.912 . . . . 0.0 109.385 -179.931 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . 0.505 ' O ' ' N ' ' A' ' 42' ' ' LEU . 39.2 t -128.62 132.12 68.08 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.597 0 O-C-N 121.185 -0.947 . . . . 0.0 109.592 -179.938 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 79' ' ' THR . . . . . 0.473 ' O ' ' HA ' ' A' ' 64' ' ' ILE . 7.1 m -106.74 123.15 47.72 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.203 -0.935 . . . . 0.0 109.612 179.928 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 80' ' ' TYR . . . . . 0.87 ' HD2' HD11 ' A' ' 42' ' ' LEU . 1.7 m-85 -101.94 126.45 48.85 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.261 -0.9 . . . . 0.0 109.299 179.879 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 81' ' ' GLU . . . . . 0.489 ' O ' ' HB2' ' A' ' 38' ' ' LYS . 86.9 tt0 -42.89 -48.27 5.78 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.244 -0.91 . . . . 0.0 109.658 -179.758 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 29.8 mttt -110.96 153.84 24.97 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.184 -0.947 . . . . 0.0 109.526 179.972 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 83' ' ' MET . . . . . 0.587 ' HE3' ' C ' ' A' ' 117' ' ' ALA . 58.8 mtt -73.05 -16.66 61.48 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.315 -0.865 . . . . 0.0 109.424 -179.939 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 75.6 mm-40 -71.92 -41.04 68.36 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.269 -0.894 . . . . 0.0 109.443 179.965 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 85' ' ' SER . . . . . 0.449 ' OG ' ' CD1' ' A' ' 80' ' ' TYR . 14.3 t -58.9 -39.67 82.18 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.219 -0.925 . . . . 0.0 109.34 179.907 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 86' ' ' ALA . . . . . 0.519 ' CB ' HD21 ' A' ' 42' ' ' LEU . . . -67.9 -37.76 82.13 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.374 -0.829 . . . . 0.0 109.446 179.956 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 56.6 t0 -60.13 -41.25 92.26 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.267 -0.896 . . . . 0.0 109.594 -179.971 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 88' ' ' GLN . . . . . 0.442 ' O ' ' CB ' ' A' ' 92' ' ' GLU . 60.5 tt0 -74.63 -41.98 59.38 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.189 -0.945 . . . . 0.0 109.441 179.975 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 89' ' ' ALA . . . . . 0.584 ' HA ' ' CE1' ' A' ' 61' ' ' PHE . . . -69.76 -46.98 64.63 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.222 -0.924 . . . . 0.0 109.446 -179.983 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 90' ' ' VAL . . . . . 0.719 HG22 HG21 ' A' ' 105' ' ' VAL . 48.4 t -64.93 -54.47 29.27 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.535 0 O-C-N 121.205 -0.935 . . . . 0.0 109.615 -179.926 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -61.53 -40.3 94.15 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.176 -0.952 . . . . 0.0 109.855 -179.671 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 92' ' ' GLU . . . . . 0.546 ' HB3' ' CE1' ' A' ' 61' ' ' PHE . 47.5 tp10 -77.73 -46.2 22.48 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.223 -0.923 . . . . 0.0 109.887 -179.672 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 93' ' ' LEU . . . . . 0.712 HD13 ' CZ ' ' A' ' 58' ' ' PHE . 49.8 mt -67.69 -37.84 82.85 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.157 -0.964 . . . . 0.0 109.643 -179.809 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 94' ' ' ASN . . . . . 0.572 ' HB2' ' CG1' ' A' ' 105' ' ' VAL . 50.5 t-20 -61.64 139.35 58.3 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.298 -0.876 . . . . 0.0 109.562 -179.856 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 73.95 30.4 61.41 Favored Glycine 0 N--CA 1.49 2.269 0 N-CA-C 109.482 -1.447 . . . . 0.0 109.482 179.972 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 96' ' ' THR . . . . . 0.699 HG23 ' O ' ' A' ' 93' ' ' LEU . 24.5 p -121.18 146.41 46.8 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.275 -1.132 . . . . 0.0 109.42 -179.97 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 97' ' ' GLN . . . . . 0.446 ' HG3' ' O ' ' A' ' 101' ' ' VAL . 63.5 tt0 -116.58 137.08 52.45 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.261 -0.9 . . . . 0.0 109.522 179.982 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 98' ' ' VAL . . . . . 0.489 HG12 ' H ' ' A' ' 99' ' ' GLU . 1.3 t -83.01 -148.53 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.569 0 O-C-N 121.252 -0.905 . . . . 0.0 109.319 -179.976 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 99' ' ' GLU . . . . . 0.489 ' H ' HG12 ' A' ' 98' ' ' VAL . 95.8 mt-10 -59.33 -36.16 75.16 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.172 -0.955 . . . . 0.0 109.444 -179.995 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -161.13 23.53 0.13 Allowed 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.275 -0.891 . . . . 0.0 109.564 179.89 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 101' ' ' VAL . . . . . 0.465 HG12 ' N ' ' A' ' 102' ' ' GLN . 95.1 t -134.75 158.05 41.37 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.569 0 O-C-N 121.197 -0.939 . . . . 0.0 109.454 179.895 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 102' ' ' GLN . . . . . 0.465 ' N ' HG12 ' A' ' 101' ' ' VAL . 88.2 mt-30 -102.13 161.24 13.84 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.227 -0.921 . . . . 0.0 109.48 -179.988 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 103' ' ' LEU . . . . . 0.689 HD12 ' OG1' ' A' ' 96' ' ' THR . 49.3 mt -114.73 134.27 55.23 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.263 -0.898 . . . . 0.0 109.634 -179.865 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 104' ' ' LYS . . . . . 0.486 ' HB2' ' HB3' ' A' ' 45' ' ' TYR . 63.4 mttm -126.75 94.4 4.03 Favored 'General case' 0 N--CA 1.489 1.504 0 N-CA-C 108.737 -0.838 . . . . 0.0 108.737 179.746 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 105' ' ' VAL . . . . . 0.719 HG21 HG22 ' A' ' 90' ' ' VAL . 9.7 p -96.24 140.56 16.99 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.51 0 O-C-N 121.444 -0.785 . . . . 0.0 109.963 -179.421 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 106' ' ' ASN . . . . . 0.441 ' OD1' ' O ' ' A' ' 105' ' ' VAL . 97.7 m-20 -141.41 -165.68 2.03 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.379 -0.825 . . . . 0.0 109.101 179.777 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 28.2 mm -97.23 132.06 42.66 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.564 0 O-C-N 121.062 -1.024 . . . . 0.0 109.428 179.807 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 108' ' ' ALA . . . . . 0.577 ' HB2' ' HB2' ' A' ' 43' ' ' TYR . . . -111.18 170.74 7.91 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.289 -0.882 . . . . 0.0 109.539 -179.883 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 29.5 ttm105 -44.6 148.13 0.53 Allowed 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.248 -0.908 . . . . 0.0 109.52 179.925 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 110' ' ' LYS . . . . . 0.429 ' O ' ' C ' ' A' ' 111' ' ' GLN . 18.8 mttt -87.4 108.92 19.21 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.226 -0.921 . . . . 0.0 109.517 179.849 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 111' ' ' GLN . . . . . 0.57 ' NE2' ' N ' ' A' ' 111' ' ' GLN . 0.7 OUTLIER -42.49 133.73 2.73 Favored Pre-proline 0 N--CA 1.491 1.601 0 O-C-N 121.389 -0.819 . . . . 0.0 109.733 -179.889 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 112' ' ' PRO . . . . . 0.427 ' O ' ' C ' ' A' ' 113' ' ' MET . 55.6 Cg_endo -78.13 -24.46 8.13 Favored 'Trans proline' 0 C--O 1.215 -0.635 0 C-N-CA 122.718 2.278 . . . . 0.0 111.769 -179.814 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 113' ' ' MET . . . . . 0.543 ' CE ' ' HG3' ' A' ' 111' ' ' GLN . 0.0 OUTLIER -43.28 -26.55 0.19 Allowed 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.334 -0.854 . . . . 0.0 109.768 -179.978 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 114' ' ' LEU . . . . . 0.846 HD23 ' O ' ' A' ' 114' ' ' LEU . 3.4 tt -164.64 26.8 0.06 Allowed 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.195 -0.941 . . . . 0.0 109.618 -179.951 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 115' ' ' ASP . . . . . 0.632 ' O ' ' HB3' ' A' ' 116' ' ' ALA . 74.9 m-20 45.15 42.55 6.9 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.182 -0.949 . . . . 0.0 109.09 -179.897 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 116' ' ' ALA . . . . . 0.632 ' HB3' ' O ' ' A' ' 115' ' ' ASP . . . 73.3 -83.61 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.334 -0.854 . . . . 0.0 109.606 -179.898 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 117' ' ' ALA . . . . . 0.587 ' C ' ' HE3' ' A' ' 83' ' ' MET . . . -171.58 27.9 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.299 -0.875 . . . . 0.0 109.716 179.986 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 9.7 t -120.0 4.5 10.92 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.15 -0.969 . . . . 0.0 109.715 -179.844 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -49.56 -36.91 25.48 Favored Glycine 0 N--CA 1.49 2.269 0 N-CA-C 109.549 -1.42 . . . . 0.0 109.549 -179.861 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 67.3 mttm -55.2 -32.85 62.55 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.243 -1.151 . . . . 0.0 109.562 -179.9 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 4.1 m . . . . . 0 N--CA 1.49 1.573 0 CA-C-O 117.994 -1.003 . . . . 0.0 109.423 -179.904 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 1.52 0 N-CA-C 109.476 -0.565 . . . . 0.0 109.476 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 50.2 Cg_endo -69.95 142.33 46.81 Favored 'Trans proline' 0 C--O 1.215 -0.672 0 C-N-CA 122.768 2.312 . . . . 0.0 111.911 -179.956 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 37' ' ' ARG . . . . . 0.455 ' O ' ' O ' ' A' ' 38' ' ' LYS . 62.1 mtt180 -122.64 153.07 39.84 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.301 -0.874 . . . . 0.0 109.307 179.885 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 38' ' ' LYS . . . . . 1.055 ' HA ' HD12 ' A' ' 114' ' ' LEU . 96.5 mttt 44.6 -168.21 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.254 -0.904 . . . . 0.0 109.42 -179.893 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . 0.756 ' HA3' HD11 ' A' ' 65' ' ' ILE . . . 144.47 76.05 0.03 OUTLIER Glycine 0 N--CA 1.489 2.216 0 N-CA-C 109.829 -1.308 . . . . 0.0 109.829 179.921 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 40' ' ' ASN . . . . . 0.478 ' O ' ' HA ' ' A' ' 79' ' ' THR . 42.7 t30 -80.51 117.08 20.92 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.161 -1.199 . . . . 0.0 109.063 179.63 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 41' ' ' THR . . . . . 0.65 HG22 ' HB3' ' A' ' 108' ' ' ALA . 54.0 m -75.58 150.51 38.05 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.176 -0.953 . . . . 0.0 109.879 -179.656 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . 0.856 HD12 ' O ' ' A' ' 78' ' ' VAL . 4.7 mp -126.56 147.25 49.89 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.331 -0.855 . . . . 0.0 109.386 179.806 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 76.4 t80 -102.5 115.43 30.57 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.246 -0.909 . . . . 0.0 109.42 179.961 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . 0.454 ' HA ' ' O ' ' A' ' 104' ' ' LYS . 41.1 t -113.5 143.92 22.21 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.558 0 O-C-N 121.296 -0.878 . . . . 0.0 109.396 179.832 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 45' ' ' TYR . . . . . 0.424 ' HB3' ' HB2' ' A' ' 104' ' ' LYS . 71.5 t80 -136.2 143.33 44.32 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.224 -0.923 . . . . 0.0 109.544 -179.959 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . 0.449 ' N ' ' SD ' ' A' ' 49' ' ' MET . . . 167.24 -175.06 42.45 Favored Glycine 0 N--CA 1.491 2.3 0 N-CA-C 109.506 -1.438 . . . . 0.0 109.506 179.98 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . 0.407 ' O ' ' C ' ' A' ' 48' ' ' ASP . 91.7 mt-10 -107.89 158.54 17.25 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.286 -1.126 . . . . 0.0 109.522 179.998 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . 0.407 ' C ' ' O ' ' A' ' 47' ' ' GLU . 44.9 m-20 43.93 45.97 6.63 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.266 -0.897 . . . . 0.0 109.457 -179.991 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 49' ' ' MET . . . . . 0.449 ' SD ' ' N ' ' A' ' 46' ' ' GLY . 23.4 mtp -85.42 132.32 34.24 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.237 -0.914 . . . . 0.0 109.449 179.942 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 50' ' ' THR . . . . . 0.769 ' O ' HD12 ' A' ' 54' ' ' LEU . 0.6 OUTLIER -121.4 159.77 48.74 Favored Pre-proline 0 N--CA 1.49 1.528 0 O-C-N 121.278 -0.889 . . . . 0.0 109.362 179.83 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 50.2 Cg_endo -70.3 -42.73 2.63 Favored 'Trans proline' 0 C--O 1.214 -0.692 0 C-N-CA 122.574 2.183 . . . . 0.0 111.6 -179.972 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 58.4 m -64.83 -47.4 78.12 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.308 -0.87 . . . . 0.0 109.255 179.721 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 14.3 tp -57.15 -52.06 66.83 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.322 -0.861 . . . . 0.0 109.276 179.818 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 54' ' ' LEU . . . . . 0.769 HD12 ' O ' ' A' ' 50' ' ' THR . 5.8 mt -57.85 -45.88 85.61 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.344 -0.847 . . . . 0.0 109.225 179.713 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 55' ' ' ARG . . . . . 0.495 ' O ' ' CB ' ' A' ' 59' ' ' SER . 24.1 ttt-85 -48.86 -36.18 16.37 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.275 -0.89 . . . . 0.0 109.299 179.757 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -72.95 -36.16 57.51 Favored Glycine 0 N--CA 1.489 2.211 0 N-CA-C 109.422 -1.471 . . . . 0.0 109.422 179.847 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -71.65 -27.16 62.88 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.238 -1.154 . . . . 0.0 109.302 179.923 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 58' ' ' PHE . . . . . 0.679 ' CE2' HD12 ' A' ' 93' ' ' LEU . 58.2 m-85 -113.58 8.9 17.83 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.356 -0.84 . . . . 0.0 109.399 179.96 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 59' ' ' SER . . . . . 0.514 ' N ' ' HD2' ' A' ' 60' ' ' PRO . 0.6 OUTLIER -74.59 -58.84 1.67 Allowed Pre-proline 0 N--CA 1.491 1.588 0 O-C-N 121.288 -0.883 . . . . 0.0 109.958 -179.627 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 60' ' ' PRO . . . . . 0.514 ' HD2' ' N ' ' A' ' 59' ' ' SER . 48.6 Cg_endo -68.94 -27.59 30.26 Favored 'Trans proline' 0 C--O 1.215 -0.639 0 C-N-CA 122.681 2.254 . . . . 0.0 112.068 -179.6 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 61' ' ' PHE . . . . . 0.583 ' CE2' ' HB2' ' A' ' 92' ' ' GLU . 46.2 m-85 -67.17 -33.63 75.82 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.113 -0.992 . . . . 0.0 109.516 -179.966 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . 0.442 ' HA3' ' OG ' ' A' ' 85' ' ' SER . . . 178.92 -175.08 47.09 Favored Glycine 0 N--CA 1.491 2.317 0 N-CA-C 109.491 -1.444 . . . . 0.0 109.491 -179.974 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 81.7 m-20 -94.44 139.39 31.19 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.313 -1.11 . . . . 0.0 109.468 179.941 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 64' ' ' ILE . . . . . 0.457 ' HA ' ' O ' ' A' ' 79' ' ' THR . 63.7 mt -102.3 130.43 52.18 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.522 0 O-C-N 121.244 -0.91 . . . . 0.0 109.551 -179.92 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 65' ' ' ILE . . . . . 0.756 HD11 ' HA3' ' A' ' 39' ' ' GLY . 19.0 pt -95.94 -18.86 6.44 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.617 0 O-C-N 121.247 -0.908 . . . . 0.0 109.521 -179.989 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 66' ' ' ASP . . . . . 0.474 ' HB3' ' OG1' ' A' ' 79' ' ' THR . 52.1 t0 -145.57 144.46 30.51 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.227 -0.921 . . . . 0.0 109.585 179.904 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . 0.703 ' C ' HD13 ' A' ' 67' ' ' LEU . 2.5 tm? -126.09 110.45 13.54 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.303 -0.873 . . . . 0.0 109.218 179.94 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 68' ' ' SER . . . . . 0.519 ' N ' HD13 ' A' ' 67' ' ' LEU . 3.1 m -118.25 134.92 54.6 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.288 -0.883 . . . . 0.0 109.604 -179.73 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 69' ' ' MET . . . . . 0.499 ' SD ' ' HB1' ' A' ' 76' ' ' ALA . 77.7 mmm -120.57 146.47 46.3 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.33 -0.856 . . . . 0.0 109.327 179.86 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 70' ' ' ASP . . . . . 0.479 ' C ' ' HD2' ' A' ' 72' ' ' PRO . 0.1 OUTLIER -129.38 93.93 34.36 Favored Pre-proline 0 N--CA 1.491 1.582 0 O-C-N 121.147 -0.971 . . . . 0.0 109.491 -179.988 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 71' ' ' PRO . . . . . 0.593 ' N ' ' CD ' ' A' ' 72' ' ' PRO . 47.6 Cg_endo -74.93 -27.78 9.87 Favored 'Trans proline' 0 CA--C 1.543 0.936 0 C-N-CA 122.596 2.198 . . . . 0.0 113.738 179.968 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 72' ' ' PRO . . . . . 0.593 ' CD ' ' N ' ' A' ' 71' ' ' PRO . 55.2 Cg_endo -74.9 -21.5 16.03 Favored 'Trans proline' 0 C--N 1.353 0.804 0 C-N-CA 121.511 1.474 . . . . 0.0 111.86 -179.774 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 93.7 mtt-85 -115.31 4.29 14.4 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.243 -0.911 . . . . 0.0 109.591 -179.954 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 78.4 m-20 59.28 48.18 10.54 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.184 -0.948 . . . . 0.0 109.521 179.961 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 75' ' ' CYS . . . . . 0.472 ' O ' ' HB2' ' A' ' 70' ' ' ASP . 27.7 p -151.81 153.97 35.28 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.212 -0.93 . . . . 0.0 109.565 179.976 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . 0.499 ' HB1' ' SD ' ' A' ' 69' ' ' MET . . . -127.21 159.62 33.75 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.27 -0.894 . . . . 0.0 109.32 179.86 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 77' ' ' PHE . . . . . 0.48 ' HA ' ' O ' ' A' ' 42' ' ' LEU . 96.4 m-85 -125.19 126.21 44.86 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.255 -0.903 . . . . 0.0 109.571 -179.976 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . 0.856 ' O ' HD12 ' A' ' 42' ' ' LEU . 60.7 t -118.28 141.68 36.48 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.51 0 O-C-N 121.221 -0.924 . . . . 0.0 109.48 -179.984 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 79' ' ' THR . . . . . 0.575 HG22 ' CA ' ' A' ' 39' ' ' GLY . 26.1 m -109.1 127.85 54.5 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.275 -0.891 . . . . 0.0 109.495 179.836 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 80' ' ' TYR . . . . . 0.474 ' OH ' ' HB2' ' A' ' 61' ' ' PHE . 0.6 OUTLIER -103.76 148.93 25.5 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.337 -0.852 . . . . 0.0 109.511 -179.879 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 81' ' ' GLU . . . . . 0.452 ' O ' ' CD ' ' A' ' 38' ' ' LYS . 81.7 tt0 -75.11 -22.66 58.07 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.271 -0.893 . . . . 0.0 109.27 179.842 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 31.1 mttp -131.6 136.26 47.64 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.308 -0.87 . . . . 0.0 109.378 179.9 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 83' ' ' MET . . . . . 0.625 ' HE2' ' N ' ' A' ' 117' ' ' ALA . 49.5 mtt -60.89 -17.29 49.78 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.211 -0.931 . . . . 0.0 109.464 -179.926 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 97.7 mt-10 -71.13 -42.18 69.53 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.244 -0.91 . . . . 0.0 109.512 179.992 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 85' ' ' SER . . . . . 0.442 ' OG ' ' HA3' ' A' ' 62' ' ' GLY . 44.0 t -60.27 -39.49 87.02 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.212 -0.93 . . . . 0.0 109.465 179.975 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 86' ' ' ALA . . . . . 0.636 ' HA ' HD21 ' A' ' 42' ' ' LEU . . . -64.19 -42.12 96.79 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.266 -0.896 . . . . 0.0 109.505 -179.99 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 57.0 t0 -65.7 -39.81 91.63 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.28 -0.888 . . . . 0.0 109.577 -179.942 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 88' ' ' GLN . . . . . 0.437 ' HG2' ' CD2' ' A' ' 61' ' ' PHE . 52.2 tt0 -69.28 -41.48 76.78 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.187 -0.946 . . . . 0.0 109.613 -179.928 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 89' ' ' ALA . . . . . 0.482 ' HA ' ' CD2' ' A' ' 61' ' ' PHE . . . -74.35 -43.14 57.85 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.247 -0.908 . . . . 0.0 109.618 -179.9 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 90' ' ' VAL . . . . . 0.783 HG22 HG12 ' A' ' 105' ' ' VAL . 54.2 t -60.21 -33.04 52.13 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 O-C-N 121.229 -0.919 . . . . 0.0 109.756 -179.785 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -80.37 -51.05 9.32 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.144 -0.973 . . . . 0.0 110.122 -179.61 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 92' ' ' GLU . . . . . 0.583 ' HB2' ' CE2' ' A' ' 61' ' ' PHE . 76.1 mm-40 -72.69 -43.72 62.7 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.184 -0.948 . . . . 0.0 110.116 -179.368 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 93' ' ' LEU . . . . . 0.91 ' HB2' HG21 ' A' ' 105' ' ' VAL . 24.3 mt -68.69 -36.07 78.02 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.168 -0.957 . . . . 0.0 109.898 -179.508 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 94' ' ' ASN . . . . . 0.53 ' CB ' ' O ' ' A' ' 90' ' ' VAL . 53.1 t-20 -76.73 130.8 38.22 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.142 -0.974 . . . . 0.0 109.417 -179.891 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 94.66 20.55 28.79 Favored Glycine 0 N--CA 1.491 2.314 0 N-CA-C 109.64 -1.384 . . . . 0.0 109.64 179.89 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 96' ' ' THR . . . . . 0.438 ' CG2' ' O ' ' A' ' 92' ' ' GLU . 19.4 p -118.52 156.4 29.18 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.148 -1.207 . . . . 0.0 109.483 179.928 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 64.4 tt0 -126.18 152.27 46.23 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.241 -0.912 . . . . 0.0 109.434 -179.965 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 98' ' ' VAL . . . . . 0.595 HG12 ' H ' ' A' ' 99' ' ' GLU . 1.0 OUTLIER -100.22 -158.18 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 O-C-N 121.292 -0.88 . . . . 0.0 109.359 -179.943 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 99' ' ' GLU . . . . . 0.595 ' H ' HG12 ' A' ' 98' ' ' VAL . 76.1 mm-40 -55.51 -39.5 70.57 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.245 -0.91 . . . . 0.0 109.535 179.984 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 31.0 t -159.66 28.29 0.19 Allowed 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.267 -0.896 . . . . 0.0 109.44 -179.947 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 101' ' ' VAL . . . . . 0.558 ' O ' HG23 ' A' ' 98' ' ' VAL . 60.7 t -140.17 148.19 22.8 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.543 0 O-C-N 121.258 -0.901 . . . . 0.0 109.471 179.971 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 90.9 mt-30 -95.51 143.36 26.89 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.239 -0.913 . . . . 0.0 109.529 -179.911 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 103' ' ' LEU . . . . . 0.426 ' HA ' HD23 ' A' ' 103' ' ' LEU . 82.3 mt -109.7 136.48 48.97 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.284 -0.885 . . . . 0.0 109.404 179.926 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 104' ' ' LYS . . . . . 0.454 ' O ' ' HA ' ' A' ' 44' ' ' VAL . 42.9 mttt -126.05 128.82 48.0 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.182 -0.949 . . . . 0.0 109.509 -179.952 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 105' ' ' VAL . . . . . 0.91 HG21 ' HB2' ' A' ' 93' ' ' LEU . 21.4 t -121.18 145.16 28.14 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.52 0 O-C-N 121.233 -0.917 . . . . 0.0 109.34 179.9 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 106' ' ' ASN . . . . . 0.464 ' OD1' ' O ' ' A' ' 105' ' ' VAL . 81.8 m-20 -158.55 -165.7 1.73 Allowed 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.216 -0.928 . . . . 0.0 109.497 -179.901 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 27.2 mm -106.04 123.62 60.78 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.564 0 O-C-N 121.297 -0.877 . . . . 0.0 109.474 179.892 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 108' ' ' ALA . . . . . 0.65 ' HB3' HG22 ' A' ' 41' ' ' THR . . . -92.42 -156.71 0.48 Allowed 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.26 -0.9 . . . . 0.0 109.549 -179.936 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 46.0 mtm105 -47.07 164.85 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.248 -0.907 . . . . 0.0 109.468 179.95 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 30.0 mttt -81.77 7.31 12.96 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.127 -0.983 . . . . 0.0 109.59 -179.91 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 111' ' ' GLN . . . . . 0.417 ' HG2' ' O ' ' A' ' 39' ' ' GLY . 10.1 tp-100 55.76 100.29 0.04 OUTLIER Pre-proline 0 N--CA 1.491 1.59 0 O-C-N 121.245 -0.909 . . . . 0.0 109.467 179.903 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 112' ' ' PRO . . . . . 0.44 ' O ' ' C ' ' A' ' 113' ' ' MET . 51.2 Cg_endo -71.17 -27.2 20.31 Favored 'Trans proline' 0 C--O 1.214 -0.683 0 C-N-CA 122.608 2.205 . . . . 0.0 111.755 179.875 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 113' ' ' MET . . . . . 0.559 ' HE3' ' HB3' ' A' ' 114' ' ' LEU . 0.0 OUTLIER -43.81 -27.61 0.35 Allowed 'General case' 0 N--CA 1.489 1.491 0 N-CA-C 108.677 -0.86 . . . . 0.0 108.677 179.628 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 114' ' ' LEU . . . . . 1.055 HD12 ' HA ' ' A' ' 38' ' ' LYS . 0.9 OUTLIER -169.03 27.21 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.229 -0.919 . . . . 0.0 109.158 179.667 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 115' ' ' ASP . . . . . 0.708 ' O ' ' HB3' ' A' ' 116' ' ' ALA . 88.3 m-20 52.21 37.34 21.68 Favored 'General case' 0 N--CA 1.488 1.437 0 O-C-N 121.017 -1.052 . . . . 0.0 108.966 -179.711 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 116' ' ' ALA . . . . . 0.708 ' HB3' ' O ' ' A' ' 115' ' ' ASP . . . 77.03 -77.61 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.393 -0.817 . . . . 0.0 109.416 -179.811 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 117' ' ' ALA . . . . . 0.625 ' N ' ' HE2' ' A' ' 83' ' ' MET . . . -167.77 65.95 0.08 Allowed 'General case' 0 C--N 1.302 -1.491 0 O-C-N 121.201 -0.937 . . . . 0.0 109.719 -179.882 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 17.7 p -121.96 162.0 21.87 Favored 'General case' 0 C--N 1.303 -1.422 0 O-C-N 121.091 -1.006 . . . . 0.0 109.399 179.915 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 80.69 18.5 70.38 Favored Glycine 0 N--CA 1.49 2.251 0 N-CA-C 109.397 -1.481 . . . . 0.0 109.397 -179.874 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 22.4 mtmt -53.18 -33.31 52.09 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.288 -1.125 . . . . 0.0 109.503 -179.967 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.49 1.538 0 CA-C-O 118.019 -0.991 . . . . 0.0 109.433 -179.925 . . . . . . . . 1 1 . 1 stop_ save_